PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Krch, D; Frank, LE; Chiaravalloti, ND; Vakil, E; DeLuca, J				Krch, Denise; Frank, Lea E.; Chiaravalloti, Nancy D.; Vakil, Eli; DeLuca, John			Cognitive Reserve Protects Against Memory Decrements Associated With Neuropathology in Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive reserve; intelligence; neuropathology; neuropsychological tests; rehabilitation; traumatic brain injury	PERFORMANCE; EDUCATION; ATROPHY; EFFICIENCY; VARIANCE; RECOVERY; MODERATE; OUTCOMES; DECLINE	Objective: To evaluate whether cognitive reserve (CR) moderates the relationship between neuropathology and cognitive outcomes after traumatic brain injury (TBI). Setting: Outpatient research organization. Participants: Patients with complicated mild (n = 8), moderate (n = 9), and severe (n = 44) TBI. Design: Prospective, cross-sectional study. Main Measures: Cognitive reserve was estimated using a test of word reading (Wechsler Test of Adult Reading). Diffusion tensor imaging (functional anisotropy) was used to quantify neuropathology. Neuropsychological test scores were submitted to principal components analyses to create cognitive composites for memory, attention, executive function, and processing speed domains. Results: At lower levels of neuropathology, people with higher CR exhibited better memory than those with lower CR. This benefit diminished as neuropathology increased and disappeared at the highest levels of neuropathology. Cognitive reserve ceased exerting a protective effect at premorbid intelligence levels below average. Conclusion: Cognitive reserve may differentially protect some cognitive domains against neuropathology relative to others. A clinical cutoff below which CR is no longer protective, together with a possible neuropathology ceiling effect, may be instructive for prognostication and clinical decision-making in cognitive rehabilitation.	[Krch, Denise; Frank, Lea E.; Chiaravalloti, Nancy D.; DeLuca, John] Kessler Fdn, Traumat Brain Injury Res, E Hanover, NJ USA; [Krch, Denise; Chiaravalloti, Nancy D.; DeLuca, John] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Frank, Lea E.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Vakil, Eli] Bar Ilan Univ, Psychol Dept, Ramat Gan, Israel; [Vakil, Eli] Bar Ilan Univ, Gonda Multidisciplinary Brain Res Ctr, Ramat Gan, Israel		Krch, D (corresponding author), Kessler Fdn, Traumat Brain Injury Dept, 120 Eagle Rock Ave,Ste 100, E Hanover, NJ 07936 USA.	dkrch@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	New Jersey Commission on Brain Injury Research [CBIR11PJT020]	This work was funded by a grant from the New Jersey Commission on Brain Injury Research (CBIR11PJT020) to conduct the work in this article.	Arciniegas David B, 2011, Dialogues Clin Neurosci, V13, P325; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bright P, 2020, NEUROPSYCHOL REHABIL, V30, P1, DOI 10.1080/09602011.2018.1445650; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DElia LF, 1996, COLOR TRAILS TEST; Delis D.C., 2000, CALIFORNIA VERBAL LE; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Elkins JS, 2006, NEUROLOGY, V67, P435, DOI 10.1212/01.wnl.0000228246.89109.98; Golden CJ, 1978, STROOP COLOR WORD TE; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hayes, 2018, INTRO MEDIATION MODE; Hindle JV, 2014, PARKINSONISM RELAT D, V20, P1, DOI 10.1016/j.parkreldis.2013.08.010; Hoofien D, 2000, J CLIN EXP NEUROPSYC, V22, P305, DOI 10.1076/1380-3395(200006)22:3;1-V;FT305; IBM Corp, 2016, IBM SPSS STAT MAC VE; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; KOHR RL, 1974, J EXP EDUC, V43, P61, DOI 10.1080/00220973.1974.10806305; Lavrencic LM, 2018, APPL NEUROPSYCH-ADUL, V25, P473, DOI 10.1080/23279095.2017.1329146; Leary JB, 2018, J HEAD TRAUMA REHAB, V33, pE28, DOI 10.1097/HTR.0000000000000329; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Manivannan S, 2018, CLIN NEUROL NEUROSUR, V171, P6, DOI 10.1016/j.clineuro.2018.05.017; Manly JJ, 2005, J GERIATR PSYCH NEUR, V18, P213, DOI 10.1177/0891988705281868; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; SALTHOUSE TA, 1991, PSYCHOL AGING, V6, P118, DOI 10.1037/0882-7974.6.1.118; Schretlen D., 1997, BRIEF TEST ATTENTION; Schwarz L, 2009, CLIN NEUROPSYCHOL, V23, P255, DOI 10.1080/13854040802220034; Smith A., 1982, SYMBOL DIGIT MODALIT; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Steward KA, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000325; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Sumowski JF, 2010, NEUROLOGY, V74, P1942, DOI 10.1212/WNL.0b013e3181e396be; Sumowski JF, 2009, J CLIN EXP NEUROPSYC, V31, P913, DOI 10.1080/13803390902740643; Sumowski JF, 2009, J INT NEUROPSYCH SOC, V15, P606, DOI 10.1017/S1355617709090912; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TOMARKEN AJ, 1986, PSYCHOL BULL, V99, P90, DOI 10.1037/0033-2909.99.1.90; Vanderploeg R. D., 2014, CLIN GUIDE NEUROPSYC; Wechsler D., 2008, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT	50	7	7	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2019	34	5			SI		E57	E65		10.1097/HTR.0000000000000472			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ7NI	WOS:000487281100007	30829821				2022-02-06	
J	Stanley, IH; Buchman-Schmitt, JM; Chu, C; Rogers, ML; Gai, AR; Wagner, RK; Gutierrez, PM; Joiner, TE				Stanley, Ian H.; Buchman-Schmitt, Jennifer M.; Chu, Carol; Rogers, Megan L.; Gai, Anna R.; Wagner, Richard K.; Gutierrez, Peter M.; Joiner, Thomas E.			The Military Suicide Research Consortium Common Data Elements: An Examination of Measurement Invariance Across Current Service Members and Veterans	ASSESSMENT			English	Article						Military Suicide Research Consortium; MSRC; Common Data Elements; CDEs; suicide risk	INTERPERSONAL NEEDS QUESTIONNAIRE; INSOMNIA SEVERITY INDEX; TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; FIT INDEXES; THWARTED BELONGINGNESS; ANXIETY SENSITIVITY; US MILITARY; ASSESS RISK; VALIDATION	Suicide rates within the U.S. military are elevated, necessitating greater efforts to identify those at increased risk. This study utilized a multigroup confirmatory factor analysis to examine measurement invariance of the Military Suicide Research Consortium Common Data Elements (CDEs) across current service members (n = 2,015), younger veterans (<35 years; n = 377), and older veterans (>= 35 years; n = 1,001). Strong factorial invariance was supported with adequate model fit observed for current service members, younger veterans, and older veterans. The structures of all models were generally comparable with few exceptions. The Military Suicide Research Consortium CDEs demonstrate at least adequate model fit for current military service members and veterans, regardless of age. Thus, the CDEs can be validly used across military and veteran populations. Given similar latent structures, research findings in one group may inform clinical and policy decision making for the other.	[Stanley, Ian H.; Buchman-Schmitt, Jennifer M.; Chu, Carol; Rogers, Megan L.; Gai, Anna R.; Wagner, Richard K.; Joiner, Thomas E.] Florida State Univ, Tallahassee, FL 32306 USA; [Gutierrez, Peter M.] Univ Colorado, Sch Med, Denver, CO USA; [Gutierrez, Peter M.] Denver Vet Affairs Med Ctr, Denver, CO USA		Stanley, IH (corresponding author), Florida State Univ, Dept Psychol, 1107 West Call St, Tallahassee, FL 32306 USA.	stanley@psy.fsu.edu	Rogers, Megan/AAC-1894-2021	Rogers, Megan/0000-0002-4969-7035	MSRC; Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-10-2-0181, W81XWH-10-2-0178]; U.S. Department of Veterans AffairsUS Department of Veterans Affairs; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32 MH093311-04]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH093311] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by the MSRC, an effort supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award Nos. (W81XWH-10-2-0181 and W81XWH-10-2-0178) and by the U.S. Department of Veterans Affairs. This work was also supported in part by a grant from the National Institute of Mental Health (T32 MH093311-04).	Allan NP, 2016, PSYCHIATRY, V79, P249, DOI 10.1080/00332747.2016.1185893; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Batterham PJ, 2015, PSYCHOL ASSESSMENT, V27, P501, DOI 10.1037/pas0000053; Beck A.T., 1988, MANUAL BECK HOPELESS; Beck A.T., 1974, PREDICTION SUICIDE, P45; BECK AT, 1990, AM J PSYCHIAT, V147, P190; BECK RW, 1974, PSYCHOL REP, V34, P445, DOI 10.2466/pr0.1974.34.2.445; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brown TA., 2015, CONFIRMATORY FACTOR, V2; Bryan CJ, 2015, SUICIDE LIFE-THREAT, V45, P633, DOI 10.1111/sltb.12163; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Centers for Disease Control and Prevention, 2018, WISQARS WEB BAS INJ; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Chiurliza B, 2018, ASSESSMENT, V25, P667, DOI 10.1177/1073191116676363; Coll JE, 2011, SOC WORK HEALTH CARE, V50, P487, DOI 10.1080/00981389.2010.528727; Franklin K., 2016, DEP DEFENSE Q SUICID; Gutierrez PM, 2016, PSYCHOL ASSESSMENT, V28, P1684, DOI 10.1037/pas0000310; Hoge CW, 2012, JAMA-J AM MED ASSOC, V308, P671, DOI 10.1001/jama.2012.9955; Hom MA, 2017, J AFFECT DISORDERS, V209, P114, DOI 10.1016/j.jad.2016.11.032; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joiner T. E., 2018, MILITARY SUICIDE RES; Joiner TE, 2002, BEHAV RES THER, V40, P471, DOI 10.1016/S0005-7967(01)00017-1; Kang HK, 2015, ANN EPIDEMIOL, V25, P96, DOI 10.1016/j.annepidem.2014.11.020; Kaplan MS, 2012, AM J PUBLIC HEALTH, V102, pS131, DOI 10.2105/AJPH.2011.300445; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1111, DOI 10.1001/jama.2009.342; LeardMann CA, 2013, JAMA-J AM MED ASSOC, V310, P496, DOI 10.1001/jama.2013.65164; Meade AW, 2008, J APPL PSYCHOL, V93, P568, DOI 10.1037/0021-9010.93.3.568; Meade AW, 2004, ORGAN RES METHODS, V7, P361, DOI 10.1177/1094428104268027; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12; Meredith W, 2006, MED CARE, V44, pS69, DOI 10.1097/01.mlr.0000245438.73837.89; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Muthen L.K., 2015, MPLUS USERS GUIDE, V5th; Nock MK, 2014, JAMA PSYCHIAT, V71, P514, DOI 10.1001/jamapsychiatry.2014.30; Nock MK, 2013, PSYCHIATRY, V76, P97, DOI 10.1521/psyc.2013.76.2.97; Nock MK, 2010, PSYCHOL SCI, V21, P511, DOI 10.1177/0956797610364762; Oglesby ME, 2015, PSYCHIAT RES, V226, P252, DOI 10.1016/j.psychres.2014.12.057; Olson-Madden JH, 2014, ARCH PHYS MED REHAB, V95, P925, DOI 10.1016/j.apmr.2014.01.008; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Pernin C.G., 2011, WAR PREVENTING SUICI; Pruitt L. D., 2015, DODSER DEP DEFENSE S; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; Ringer FB, 2018, PSYCHOL ASSESSMENT, V30, P767, DOI 10.1037/pas0000519; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417; Silva C, 2017, J CLIN PSYCHOL, V73, P669, DOI 10.1002/jclp.22347; Stanley IH, 2017, J PSYCHIATR RES, V84, P161, DOI 10.1016/j.jpsychires.2016.10.004; STROSAHL K, 1992, COMPR PSYCHIAT, V33, P366, DOI 10.1016/0010-440X(92)90057-W; Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176; U.S. Department of Veterans Affairs Office of Suicide Prevention, 2016, SUIC VET OTHER AM 20; U.S. Surgeon General and of the National Action Alliance for Suicide Prevention, 2012, 2012 NAT STRAT SUIC; Ursano RJ, 2015, JAMA PSYCHIAT, V72, P917, DOI 10.1001/jamapsychiatry.2015.0987; van de Schoot R, 2012, EUR J DEV PSYCHOL, V9, P486, DOI 10.1080/17405629.2012.686740; Van Orden KA, 2012, PSYCHOL ASSESSMENT, V24, P197, DOI 10.1037/a0025358; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Villatte Jennifer L, 2015, Mil Behav Health, V3, P316; Warner CH, 2011, AM J PSYCHIAT, V168, P378, DOI 10.1176/appi.ajp.2010.10091303; Weathers F.W., 1991, PTSD CHECKLIST MILIT; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	57	7	7	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	SEP	2019	26	6					963	975		10.1177/1073191118777635			13	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	IR5RH	WOS:000481492400001	29847993	Bronze			2022-02-06	
J	Tulsky, DS; Kisala, PA				Tulsky, David S.; Kisala, Pamela A.			An Overview of the Traumatic Brain Injury-Quality of Life (TBI-QOL) Measurement System	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							PATIENT-REPORTED OUTCOMES; SPINAL-CORD-INJURY; ITEM RESPONSE THEORY; OF-LIFE; CLINICAL-PRACTICE; ISSUES RELEVANT; INDIVIDUALS; BANKS; LINKING; ANXIETY		[Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE 19716 USA; [Tulsky, David S.; Kisala, Pamela A.] Univ Delaware, Dept Phys Therapy, 100 Discovery Blvd, Newark, DE 19713 USA; [Tulsky, David S.; Kisala, Pamela A.] Univ Delaware, Dept Psychol & Brain Sci, 100 Discovery Blvd, Newark, DE 19713 USA		Tulsky, DS (corresponding author), Univ Delaware, Dept Phys Therapy, 100 Discovery Blvd, Newark, DE 19713 USA.	dtulsky@udel.edu		Tulsky, David/0000-0002-4335-4509	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, H133A70038]; NIDILRRUnited States Department of Health & Human Services [H133A120100]	This study was supported by grant nos. H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, and H133A70038 from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). Additional support for the preparation of the manuscript was provided by NIDILRR grant no. H133A120100.	Basch E, 2017, ANN ONCOL, V28, P2332, DOI 10.1093/annonc/mdx506; Basch E, 2017, NEW ENGL J MED, V376, P105, DOI 10.1056/NEJMp1611252; Baumhauer JF, 2017, NEW ENGL J MED, V377, P6, DOI 10.1056/NEJMp1702978; Boulton AJ, 2019, J HEAD TRAUMA REHAB, V34, P353, DOI 10.1097/HTR.0000000000000529; Broderick Joan E, 2013, EGEMS (Wash DC), V1, P1015, DOI 10.13063/2327-9214.1015; Capo-Lugo CE, 2019, J HEAD TRAUMA REHAB, V34, P340, DOI 10.1097/HTR.0000000000000511; Carlozzi NE, ARCHIVES OF PHYSICAL; Carlozzi NE, 2019, J HEAD TRAUMA REHAB, V34, P308, DOI 10.1097/HTR.0000000000000520; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Carlozzi NE, 2013, J HEALTH PSYCHOL, V18, P212, DOI 10.1177/1359105312438109; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2000, MED CARE, V38, P66; Cella D, 2010, NEUROQOL INVESTIGATO; Cella D, 2007, QUAL LIFE RES, V16, P133, DOI 10.1007/s11136-007-9204-6; Cella D, 2014, QUAL LIFE RES, V23, P2651, DOI 10.1007/s11136-014-0732-6; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Centers for Disease Control and Prevention, 2016, INJ PREV CONTR TRAUM; Choi SW, 2014, PSYCHOL ASSESSMENT, V26, P513, DOI 10.1037/a0035768; Cohen ML, 2019, J HEAD TRAUMA REHAB, V34, P326, DOI 10.1097/HTR.0000000000000528; Dawson J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c186; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrell BR, 1998, CANCER NURS, V21, P1, DOI 10.1097/00002820-199802000-00001; Fries JF, 2014, J RHEUMATOL, V41, P153, DOI 10.3899/jrheum.130813; Gershon Richard C, 2005, J Appl Meas, V6, P109; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Glaser B. G., 1967, THE DISCOVERY OF GRO; Hambleton RK, 2000, MED CARE, V38, P60; Heinmann AW, ARCH PHYS MED REHABI; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Jensen RE, 2016, J CLIN ONCOL, V34, P527, DOI 10.1200/JCO.2015.64.9491; Jette AM, 2012, ARCH PHYS MED REHAB, V93, P1733, DOI 10.1016/j.apmr.2012.05.008; Kisala PA, ARCH PHYS MED REHABI; Kisala PA, 2019, J HEAD TRAUMA REHAB, V34, P289, DOI 10.1097/HTR.0000000000000530; Kisala Pamela A, 2010, J Appl Meas, V11, P315; Kolen M., 2014, TEST EQUATING SCALIN, V3rd Edn; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; MESSICK S, 1980, AM PSYCHOL, V35, P1012, DOI 10.1037/0003-066X.35.11.1012; Miaskowski C, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw253; Michener LA, 2011, J SPORT REHABIL, V20, P37, DOI 10.1123/jsr.20.1.37; National Institute of Neurological Disorders and Stroke, 2016, COMMON DATA ELEMENTS; PROMIS, 2012, PROMIS INSTRUMENT DE; Quatrano LA, 2011, ARCH PHYS MED REHAB, V92, pS7, DOI 10.1016/j.apmr.2010.08.032; Reeve BB, 2007, QUAL LIFE RES, V16, P175, DOI 10.1007/s11136-007-9190-8; Reeve BB, 2016, QUAL LIFE RES, V25, P823, DOI 10.1007/s11136-015-1143-z; Reeve B, 2013, QUAL LIFE RES, V22, P1889, DOI 10.1007/s11136-012-0344-y; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Schalet BD, 2014, J ANXIETY DISORD, V28, P88, DOI 10.1016/j.janxdis.2013.11.006; Sherer M, 2020, ARCH PHYS MED REHAB, V101, P62, DOI 10.1016/j.apmr.2017.04.016; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, P125, DOI 10.1097/HTR.0000000000000207; Slavin MD, 2010, SPINAL CORD, V48, P262, DOI 10.1038/sc.2009.131; Snyder CF, 2012, QUAL LIFE RES, V21, P1305, DOI 10.1007/s11136-011-0054-x; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steinberg L, 1996, PSYCHOL METHODS, V1, P81, DOI 10.1037/1082-989X.1.1.81; Strauss E, 1998, CLIN ORTHOP RELAT R, P2; TEASDALE G, 1974, LANCET, V2, P81; Tulsky DS, 2019, J HEAD TRAUMA REHAB, V34, P298, DOI 10.1097/HTR.0000000000000532; Tulsky DS, 2019, QUAL LIFE RES, V28, P1217, DOI 10.1007/s11136-018-2073-3; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P413, DOI 10.1037/rep0000174; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Tulsky DS, 2015, J SPINAL CORD MED, V38, P257, DOI [10.1179/2045772315Y.0000000023, 10.1179/2045772315Y.0000000035]; Tulsky DS, 2012, ARCH PHYS MED REHAB, V93, P1722, DOI 10.1016/j.apmr.2012.05.007; Tulsky DS, 2011, ARCH PHYS MED REHAB, V92, pS44, DOI 10.1016/j.apmr.2011.04.024; Tyner CE, ARCH PHYS MED REHABI; WHO, 1946, PREAMBL CONST WHO AD; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; World Health Organization, 2008, INT CLASS FUNCT DIS; Wu AW, 2013, J CLIN EPIDEMIOL, V66, pS12, DOI 10.1016/j.jclinepi.2013.04.005	69	7	7	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2019	34	5			SI		281	288		10.1097/HTR.0000000000000531			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ7NI	WOS:000487281100009	31498227				2022-02-06	
J	Wilhelmsson, U; Stillemark-Billton, P; Boren, J; Pekny, M				Wilhelmsson, Ulrika; Stillemark-Billton, Pia; Boren, Jan; Pekny, Milos			Vimentin is required for normal accumulation of body fat	BIOLOGICAL CHEMISTRY			English	Article						body mass index; body weight; cellular stress; intermediate filaments; nanofilaments; stress proteins	FIBRILLARY ACIDIC PROTEIN; HORMONE-SENSITIVE LIPASE; MICE LACKING VIMENTIN; INTERMEDIATE-FILAMENTS; ASTROCYTE ACTIVATION; MULLER CELLS; DEFICIENT; GFAP; NEUROGENESIS; STRESS	Intermediate filaments (nanofilaments) have many functions, especially in response to cellular stress. Mice lacking vimentin (Vim(-/-)) display phenotypes reflecting reduced levels of cell activation and ability to counteract stress, for example, decreased reactivity of astrocytes after neurotrauma, decreased migration of astrocytes and fibroblasts, attenuated inflammation and fibrosis in lung injury, delayed wound healing, impaired vascular adaptation to nephrectomy, impaired transendothelial migration of lymphocytes and attenuated atherosclerosis. To address the role of vimentin in fat accumulation, we assessed the body weight and fat by dual-energy X-ray absorptiometry (DEXA) in Vim(-/-) and matched wildtype (WT) mice. While the weight of 1.5-month-old Vim(-/-) and WT mice was comparable, Vim(-/-) mice showed decreased body weight at 3.5, 5.5 and 8.5 months (males by 19-22%, females by 18-29%). At 8.5 months, Vim(-/-) males and females had less body fat compared to WT mice (a decrease by 24%, p < 0.05, and 33%, p < 0.0001, respectively). The body mass index in 8.5 months old Vim(-/-) mice was lower in males (6.8 vs. 7.8, p < 0.005) and females (6.0 vs. 7.7, p < 0.0001) despite the slightly lower body length of Vim(-/-) mice. Increased mortality was observed in adult Vim(-/-) males. We conclude that vimentin is required for the normal accumulation of body fat.	[Wilhelmsson, Ulrika; Pekny, Milos] Univ Gothenburg, Lab Astrocyte Biol & CNS Regenerat, Sahtgrenska Acad, Ctr Brain Repair,Dept Clin Neurosci,Inst Neurosci, Box 440, S-40530 Gothenburg, Sweden; [Pekny, Milos] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Pekny, Milos] Univ Newcastle, Newcastle, NSW, Australia; [Stillemark-Billton, Pia; Boren, Jan] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Wallenberg Lab, S-40530 Gothenburg, Sweden		Pekny, M (corresponding author), Univ Gothenburg, Lab Astrocyte Biol & CNS Regenerat, Sahtgrenska Acad, Ctr Brain Repair,Dept Clin Neurosci,Inst Neurosci, Box 440, S-40530 Gothenburg, Sweden.; Pekny, M (corresponding author), Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.; Pekny, M (corresponding author), Univ Newcastle, Newcastle, NSW, Australia.	Milos.Pekny@neuro.gu.se		Wilhelmsson, Ulrika/0000-0003-3227-2687	Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [2017-02255]; ALF Gothenburg [146051]; AFA Research Foundation; Soderbergs Foundations; Sten A. Olsson Foundation for Research and Culture; Amlov's Foundation; E. Jacobson's Donation Fund; VINNOVAVinnova; Swedish Stroke Foundation; NanoNet COST ActionEuropean Cooperation in Science and Technology (COST) [BM1002]; EU FP 7 Program EduGlia [237956]; EU FP 7 Program TargetBraIn [279017]; Hjarnfonden; EuroCellNet COST ActionEuropean Cooperation in Science and Technology (COST); Hagstromer's Foundation Millennium	The authors wish to thank Dr. Marcela Pekna for her comments on the manuscript. This work was supported by Swedish Medical Research Council (2017-02255), ALF Gothenburg (146051), AFA Research Foundation, Soderbergs Foundations, Sten A. Olsson Foundation for Research and Culture, Hjarnfonden, Hagstromer's Foundation Millennium, Amlov's Foundation, E. Jacobson's Donation Fund, VINNOVA, the Swedish Stroke Foundation, NanoNet COST Action (BM1002), EuroCellNet COST Action, EU FP 7 Program EduGlia (237956), and EU FP 7 Program TargetBraIn (279017).	Antfolk D, 2017, P NATL ACAD SCI USA, V114, pE4574, DOI 10.1073/pnas.1703057114; Bjorklund MM, 2014, CIRC RES, V114, P1684, DOI 10.1161/CIRCRESAHA.114.302937; Cheng F, 2016, P NATL ACAD SCI USA, V113, pE4320, DOI 10.1073/pnas.1519197113; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; de Pablo Y, 2013, HISTOCHEM CELL BIOL, V140, P81, DOI 10.1007/s00418-013-1110-0; Ding M, 1998, MOL BRAIN RES, V62, P77, DOI 10.1016/S0169-328X(98)00240-X; dos Santos G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7574; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; FRANKE WW, 1987, CELL, V49, P131, DOI 10.1016/0092-8674(87)90763-X; Haversen L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34659-2; Heid H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090386; Jarlestedt K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010397; Kamphuis W, 2015, GLIA, V63, P1036, DOI 10.1002/glia.22800; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Kumar N, 2007, J BIOL CHEM, V282, P9244, DOI 10.1074/jbc.M605571200; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Mor-Vaknin N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01045; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Pekny M, 2019, NEUROSCI LETT, V689, P45, DOI 10.1016/j.neulet.2018.07.021; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Shen WJ, 2012, ENDOCRINOLOGY, V153, P3249, DOI 10.1210/en.2012-1048; Shen WJ, 2010, J PROTEOME RES, V9, P1786, DOI 10.1021/pr900909t; Shen WJ, 2003, J BIOL CHEM, V278, P43870, DOI 10.1074/jbc.M303934200; Terzi F, 1997, J CLIN INVEST, V100, P1520, DOI 10.1172/JCI119675; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilhelmsson U, 2012, STEM CELLS, V30, P2320, DOI 10.1002/stem.1196; Wunderlich KA, 2015, FASEB J, V29, P4815, DOI 10.1096/fj.15-272963	42	7	7	0	5	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1431-6730	1437-4315		BIOL CHEM	Biol. Chem.	SEP	2019	400	9					1157	1162		10.1515/hsz-2019-0170			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5AB	WOS:000478687200008	30995202	Bronze			2022-02-06	
J	Stalnacke, BM; Saveman, BI; Stenberg, M				Stalnacke, Britt-Marie; Saveman, Britt-Inger; Stenberg, Maud			Long-Term Follow-Up of Disability, Cognitive, and Emotional Impairments after Severe Traumatic Brain Injury	BEHAVIOURAL NEUROLOGY			English	Article							GLASGOW OUTCOME SCALE; NEUROLOGICAL-INSTITUTE SCREEN; HOSPITAL ANXIETY; POPULATION; VALIDATION; VALIDITY; MODERATE; ALCOHOL	Aim. To assess the clinical course of disability, cognitive, and emotional impairments in patients with severe TBI (s-TBI) from 3 months to up to 7 years post trauma. Methods. A prospective cohort study of s-TBI in northern Sweden was conducted. Patients aged 18-65 years with acute Glasgow Coma Scale 3-8 were assessed with the Glasgow Outcome Scale Extended (GOSE), the Hospital Anxiety and Depression Scale (HADS), and the Barrow Neurological Institute Screen for Higher Cerebral Functions (BNIS) at 3 months, 1 year, and 7 years after the injury. Results. The scores on both GOSE and BNIS improved significantly from 3 months (GOSE mean: 4.4 +/- 2.3, BNIS mean: 31.5 +/- 7.0) to 1 year (GOSE mean: 5.5 +/- 2.7, p=0.003, BNIS mean: 33.2 +/- 6.3, p=0.04), but no significant improvement was found from 1 year to 7 years (GOSE mean: 4.7 +/- 2.8, p=0.13, BNIS mean: 33.5 +/- 3.9, p=0.424) after the injury. The BNIS subscale "speech/language" at 1 year was significantly associated with favourable outcomes on the GOSE at 7 years (OR=2.115, CI: 1.004-4.456, p=0.049). Conclusions. These findings indicate that disability and cognition seem to improve over time after s-TBI and appear to be relatively stable from 1 year to 7 years. Since cognitive function on some of the BNIS subscales was associated with outcome on the GOSE, these results indicate that both screening and follow-up of cognitive function could be of importance for the rehabilitation of persons with s-TBI.	[Stalnacke, Britt-Marie; Stenberg, Maud] Umea Univ, Dept Community Med & Rehabil Rehabil Med, Umea, Sweden; [Saveman, Britt-Inger] Umea Univ, Dept Nursing, Umea, Sweden		Stalnacke, BM (corresponding author), Umea Univ, Dept Community Med & Rehabil Rehabil Med, Umea, Sweden.	britt-marie.stalnacke@umu.se	Stenberg, Maud/AAX-4366-2021	Saveman, Britt-Inger/0000-0003-3716-6445	Swedish Association for Survivors of Polio, Accident and Injury	This study was supported by grants from the Swedish Association for Survivors of Polio, Accident and Injury.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Borgaro SR, 2004, BRAIN INJURY, V18, P33, DOI 10.1080/0269905031000110562; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Denvall V, 2002, J REHABIL MED, V34, P153, DOI 10.1080/16501970213231; Forslund MV, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00219; Hale AC, 2019, J NERV MENT DIS, V207, P38, DOI 10.1097/NMD.0000000000000915; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Hofgren C, 2007, J REHABIL MED, V39, P547, DOI 10.2340/16501977-0085; JENNETT B, 1975, LANCET, V1, P480; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Maegele M, 2019, DTSCH ARZTEBL INT, V116, P167, DOI 10.3238/arztebl.2019.0167; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Ryu WHA, 2010, INT J REHABIL RES, V33, P84, DOI 10.1097/MRR.0b013e32832e6b4b; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stenberg M, 2017, BRAIN INJURY, V31, P351, DOI 10.1080/02699052.2016.1261303; Stenberg M, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/680308; Stenberg M, 2013, J REHABIL MED, V45, P792, DOI 10.2340/16501977-1200; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	31	7	7	0	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.	AUG 27	2019	2019								9216931	10.1155/2019/9216931			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IX9EC	WOS:000485989300001	31534558	Green Published, gold			2022-02-06	
J	Karr, JE; Rau, HK; Shofer, JB; Hendrickson, RC; Peskind, ER; Pagulayan, KF				Karr, Justin E.; Rau, Holly K.; Shofer, Jane B.; Hendrickson, Rebecca C.; Peskind, Elaine R.; Pagulayan, Kathleen F.			Variables associated with subjective cognitive change among Iraq and Afghanistan war Veterans with blast-related mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Brain concussion; mild traumatic brain injury; blast injury; veteran; executive function	POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL PERFORMANCE; EXECUTIVE FUNCTION; OEF/OIF VETERANS; POSTCONCUSSION SYMPTOMS; METAANALYTIC METHODS; SLEEP DISTURBANCE; WORKING-MEMORY; US VETERANS; MILITARY	Introduction: This study investigated variables associated with subjective decline in executive function among Veterans of Operations Enduring Freedom, Iraqi Freedom, and New Dawn (OEF/OIF/OND) following a history of blast-related mild traumatic brain injury (mTBI).Method: Fifty-six male U.S. Veterans (M-Age=35.38.8years) with a history of blast-related mTBI (6.63.2years post injury) completed a battery of self-report questionnaires and neuropsychological measures. Participants rated current and retrospectively estimated pre-mTBI executive function difficulties on the Frontal Systems Behavior Scale (FrSBe). A difference score (post- minus pre-mTBI ratings) was the dependent variable (FrSBe). Linear regression models examined variables predicting FrSBe, including: pre-injury characteristics (education, premorbid intelligence), injury-related characteristics (number of blast exposures, losses of consciousness), post-injury clinical symptoms (PTSD Checklist-Military version; Pittsburgh Sleep Quality Index), and post-injury neuropsychological performances on executive function measures (Trail Making Test Part B; Controlled Oral Word Association Test; Auditory Consonant Trigrams; Wisconsin Card Sorting Test).Results: While 11% of participants had a clinically elevated pre-injury FrSBe total score, 82% had a clinically elevated post-injury FrSBe total score. Only self-reported PTSD symptom severity independently predicted perceived change in executive function.Conclusions: Many OEF/OIF/OND Veterans with a history of blast-related mTBI experience subjective decline in executive function following injury. Perceived executive function decline was associated with higher PTSD symptom severity, aligning with previous research associating PTSD with cognitive complaints. Results did not support a correspondence between perceived cognitive change and neuropsychological performances.	[Karr, Justin E.] Univ Victoria, Dept Psychol, Victoria, BC, Canada; [Karr, Justin E.; Rau, Holly K.; Shofer, Jane B.; Hendrickson, Rebecca C.; Peskind, Elaine R.; Pagulayan, Kathleen F.] Vet Affairs Puget Sound Healthcare Syst, Vet Affairs Northwest Network Mental Illness, Res Educ & Clin Ctr, Seattle, WA USA; [Shofer, Jane B.; Hendrickson, Rebecca C.; Peskind, Elaine R.; Pagulayan, Kathleen F.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Karr, Justin E.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Psychiat, Boston, MA 02115 USA; [Karr, Justin E.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Karr, Justin E.] Red Sox Fdn, Home Base, Boston, MA 02215 USA; [Karr, Justin E.] Massachusetts Gen Hosp Program, Boston, MA 02215 USA		Karr, JE (corresponding author), Univ Victoria, Dept Psychol, Victoria, BC, Canada.; Karr, JE (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Dept Psychiat, Boston, MA 02115 USA.; Karr, JE (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Karr, JE (corresponding author), Red Sox Fdn, Home Base, Boston, MA 02215 USA.; Karr, JE (corresponding author), Massachusetts Gen Hosp Program, Boston, MA 02215 USA.; Karr, JE; Pagulayan, KF (corresponding author), Vet Affairs Puget Sound Healthcare Syst, Vet Affairs Northwest Network, MIRECC, 1660 S Columbian Way S-116-MIRECC, Seattle, WA 98108 USA.	jkarr@uvic.ca	Pagulayan, Kati/AAR-9225-2020; Hendrickson, Rebecca/I-4923-2017	Hendrickson, Rebecca/0000-0003-2377-823X	United States (U.S.) Department of Veterans Affairs Clinical Science Research and Development Service [IK2CX000516]; U.S. Department of Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [I01 RX000521]; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and TreatmentUS Department of Veterans Affairs; Veterans Affairs Northwest Network Mental Illness, Research, Education, and Clinical Center; Veterans AffairsUS Department of Veterans Affairs [I01RX001612, IK2CX000516] Funding Source: NIH RePORTER	This work was supported by Career Development Award #IK2CX000516 from the United States (U.S.) Department of Veterans Affairs Clinical Science Research and Development Service, Merit Review #I01 RX000521 from the U.S. Department of Veterans Affairs Rehabilitation Research and Development Service, the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, and the Veterans Affairs Northwest Network Mental Illness, Research, Education, and Clinical Center.	Amick MM, 2013, J INT NEUROPSYCH SOC, V19, P792, DOI 10.1017/S1355617713000544; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Benitez A, 2012, CLIN NEUROPSYCHOL, V26, P214, DOI 10.1080/13854046.2012.658439; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eisenberg N, 2004, CHILD DEV, V75, P334, DOI 10.1111/j.1467-8624.2004.00674.x; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hendrickson RC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0908-5; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holdnack H.A., 2001, WECHSLER TEST ADULT; HOLM S, 1979, SCAND J STAT, V6, P65; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keane T.M., 1991, PCL M DSM 4; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Lenehan ME, 2012, INT PSYCHOGERIATR, V24, P1505, DOI 10.1017/S1041610212000695; Lewis MD, 2007, COGNITIVE DEV, V22, P406, DOI 10.1016/j.cogdev.2007.08.004; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Millard S. P, 2013, ENVSTATS R PACKAGE E, DOI [10.1007/978-1-4614-8456-1, DOI 10.1007/978-1-4614-8456-1]; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; O'Neil M. E., 2012, 05225 VAESP DEP VET; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; R Core Team, 2017, R LANG ENV STAT COMP; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rubin D.B., 1987, MULTIPLE IMPUTATION; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Shura RD, 2016, ARCH CLIN NEUROPSYCH, V31, P47, DOI 10.1093/arclin/acv083; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [DOI 10.1080/13854048708520046, 10.1080/13854048708520046]; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; US Department of Defense, 2018, DOD TBI WORLDW NUMB; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Waldron-Perrine B, 2012, MIL MED, V177, P1293, DOI 10.7205/MILMED-D-12-00169; Walter KH, 2010, J TRAUMA STRESS, V23, P292, DOI 10.1002/jts.20506; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wolf GK, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000344; Yang CC, 2014, J CLIN EXP NEUROPSYC, V36, P399, DOI 10.1080/13803395.2014.903899	92	7	7	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG 9	2019	41	7					680	693		10.1080/13803395.2019.1611740			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	IH7LB	WOS:000474684000002	31106695				2022-02-06	
J	Liu, R; Liao, XY; Tang, JC; Pan, MX; Chen, SF; Lu, PX; Lu, LJ; Zhang, ZF; Zou, YY; Bu, LH; Qin, XP; Wan, Q				Liu, Rui; Liao, Xin-Yu; Tang, Jun-Chun; Pan, Meng-Xian; Chen, Song-Feng; Lu, Pei-Xin; Lu, Long J.; Zhang, Zhi-Feng; Zou, Ying-Ying; Bu, Li-Hong; Qin, Xing-Ping; Wan, Qi			BpV(pic) confers neuroprotection by inhibiting M1 microglial polarization and MCP-1 expression in rat traumatic brain injury	MOLECULAR IMMUNOLOGY			English	Article						Traumatic brain injury; BpV(pic); Microglia; Neuroinflammation; NF-kappa B p65; MCP-1	PTEN; NEUROINFLAMMATION; PHOSPHATASE; PEPTIDE; BARRIER; CELLS; CORD	Traumatic brain injury (TBI) is a major cause of motor and cognitive impairment in young adults. It is associated with high mortality rates and very few effective treatment options. Bisperoxovanadium (pyridine-2-carboxyl) (bpV(pic)] is an commercially available inhibitor of Phosphatase and tensin homolog (PTEN). Previous studies have shown that bpV(pic) has protective effects in central nervous system. However, the role of bpV(pic) in TBI is unclear. In this study we aimed to investigate the neuroprotective role of bpV(pic) in rat TBI model. We found that injection of bpV(pic) significantly reduces brain edema and neurological dysfunction after TBI and this is mediated by AKT pathway. TBI is known to promote the Ml pro-inflammatory phenotype of microglial polarization and this effect is inhibited by bpV(pic) treatment which, instead promotes M2 microglial polarization in vivo and in vitro. We also found evidence of bpV(pic)-regulated neuroinflammation mediated by AKT activation and NF-kappa B p65 inhibition. BpV(pic) treatment also suppressed microglia in the peri-TBI region. MCP-1 is known to recruit monocytes and macrophages to promote inflammation, we show that bpV(pic) can inhibit TBI-induced up-regulation of MCP-1 via the AKT/NF-kappa B p65 signaling pathway. Taken together, our findings demonstrate that bpV(pic) plays a neuroprotective role in rat TBI, which may be achieved by inhibiting Ml microglia polarization and MCP-1 expression by modulating AKT/NF-kappa B p65 signaling pathway.	[Liu, Rui; Qin, Xing-Ping] Wuhan Univ, Dept Neurosurg, Renmin Hosp, 238 Jiefang Rd, Wuhan 430060, Hubei, Peoples R China; [Liu, Rui; Tang, Jun-Chun; Pan, Meng-Xian; Chen, Song-Feng] Wuhan Univ, Collaborat Innovat Ctr Brain Sci, Sch Med, Sch Basic Med Sci,Dept Physiol, 185 Donghu St, Wuhan 430071, Hubei, Peoples R China; [Liao, Xin-Yu; Zou, Ying-Ying] Kunming Med Univ, Dept Pathol & Pathophysiol, Fac Basic Med Sci, 1168 West Chunrong Rd, Kunming 650500, Yunnan, Peoples R China; [Lu, Pei-Xin; Lu, Long J.] Wuhan Univ, Sch Informat Management, Wuhan 430072, Hubei, Peoples R China; [Zhang, Zhi-Feng] Hubei Univ Med, Sch Basic Med Sci, Dept Physiol, Shiyan 442000, Hubei, Peoples R China; [Bu, Li-Hong] Wuhan Univ, Renmin Hosp, PET CT MRI Ctr, 99 Zhangzhidong Rd, Wuhan 430060, Hubei, Peoples R China; [Bu, Li-Hong] Wuhan Univ, Renmin Hosp, Mol Imaging Ctr, 99 Zhangzhidong Rd, Wuhan 430060, Hubei, Peoples R China; [Wan, Qi] Qingdao Univ, Affiliated Hosp, Dept Neurosurg, Inst Neuroregenerat & Neurorehabil, 308 Ningxia St, Qingdao 266071, Shandong, Peoples R China		Qin, XP (corresponding author), Wuhan Univ, Dept Neurosurg, Renmin Hosp, 238 Jiefang Rd, Wuhan 430060, Hubei, Peoples R China.; Bu, LH (corresponding author), Wuhan Univ, Renmin Hosp, PET CT MRI Ctr, 99 Zhangzhidong Rd, Wuhan 430060, Hubei, Peoples R China.; Bu, LH (corresponding author), Wuhan Univ, Renmin Hosp, Mol Imaging Ctr, 99 Zhangzhidong Rd, Wuhan 430060, Hubei, Peoples R China.; Wan, Q (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Neurosurg, Inst Neuroregenerat & Neurorehabil, 308 Ningxia St, Qingdao 266071, Shandong, Peoples R China.	bulihongs@whu.edu.cn; qxp718@whu.edu.cn; qiwanwh@foxmail.com			China Key Project of Basic Research ("973" Project)National Basic Research Program of China [2014CB541606]; Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81470599]; Fund of Collaborative Innovation Center for Brain Science	This work was supported by China Key Project of Basic Research ("973" Project; 2014CB541606), Natural Science Foundation of China (NSFC; 81470599) and The Fund of Collaborative Innovation Center for Brain Science to Q.W.	Benson MJ, 2015, EPILEPSIA, V56, P895, DOI 10.1111/epi.12960; Bromley-Brits K, 2011, J VIS EXP, V53; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen J, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0241-3; Chen JY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42001; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Chen YJ, 2015, NEUROSCI LETT, V588, P131, DOI 10.1016/j.neulet.2015.01.005; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Czeh M, 2011, DEV NEUROSCI-BASEL, V33, P199, DOI 10.1159/000328989; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Guadagno J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.151; Guo YQ, 2014, EXP THER MED, V8, P657, DOI 10.3892/etm.2014.1757; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Li L, 2015, EXP NEUROL, V272, P135, DOI 10.1016/j.expneurol.2014.12.020; Liu BS, 2010, STROKE, V41, P1018, DOI 10.1161/STROKEAHA.110.579011; Liu R, 2018, NEUROCHEM RES; Liu XY, 2017, NEUROL RES, V39, P758, DOI 10.1080/01616412.2017.1317916; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Majkutewicz I, 2016, BEHAV BRAIN RES, V308, P24, DOI 10.1016/j.bbr.2016.04.012; Makker A, 2014, J MOL ENDOCRINOL, V53, pR103, DOI 10.1530/JME-14-0220; Mason DY, 2000, J PATHOL, V191, P452; Milella M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00024; Muniyan S, 2014, BBA-REV CANCER, V1846, P88, DOI 10.1016/j.bbcan.2014.04.006; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Pan J, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0270-3; Poon JS, 2010, CELL CYCLE, V9, P4450, DOI 10.4161/cc.9.22.13936; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Sawyer AJ, 2014, BIOMATERIALS, V35, P6698, DOI 10.1016/j.biomaterials.2014.05.008; Schneider D, 2013, AM J PHYSIOL-LUNG C, V304, pL162, DOI 10.1152/ajplung.00182.2012; Shi GD, 2011, BIOCHEM BIOPH RES CO, V404, P941, DOI 10.1016/j.bbrc.2010.12.085; Skaper SD, 2014, CNS NEUROL DISORD-DR, V13, P1654; Szulzewsky F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116644; Tam WY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07279; Tian YQ, 2012, MOL MED REP, V5, P852, DOI 10.3892/mmr.2011.737; Tsuda M, 2016, J DIABETES INVEST, V7, P17, DOI 10.1111/jdi.12379; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang XX, 2015, AGING-US, V7, P1032, DOI 10.18632/aging.100855; Xiong Y, 2010, DISCOV MED, V10, P434; Xu Y, 2015, BRAIN BEHAV IMMUN, V50, P298, DOI 10.1016/j.bbi.2015.07.015; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Zhang C, 2016, BRAIN RES, V1650, P283, DOI 10.1016/j.brainres.2016.08.036; Zhang RP, 2012, ANTI-CANCER DRUG, V23, P827, DOI 10.1097/CAD.0b013e32835455f1; Zhang ZF, 2017, BRIT J PHARMACOL, V174, P641, DOI 10.1111/bph.13727	44	7	9	2	19	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0161-5890			MOL IMMUNOL	Mol. Immunol.	AUG	2019	112						30	39		10.1016/j.molimm.2019.04.010			10	Biochemistry & Molecular Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Immunology	IR6RE	WOS:000481565600004	31075560				2022-02-06	
J	Mallah, K; Quanico, J; Raffo-Romero, A; Cardon, T; Aboulouard, S; Devos, D; Kobeissy, F; Zibara, K; Salzet, M; Fournier, I				Mallah, Khalil; Quanico, Jusal; Raffo-Romero, Antonella; Cardon, Tristan; Aboulouard, Soulaimane; Devos, David; Kobeissy, Firas; Zibara, Kazem; Salzet, Michel; Fournier, Isabelle			Mapping Spatiotemporal Microproteomics Landscape in Experimental Model of Traumatic Brain Injury Unveils a link to Parkinson's Disease	MOLECULAR & CELLULAR PROTEOMICS			English	Article						Mass Spectrometry; Parkinson's disease; Lipidomics; Systems biology*; Imaging; Label-free quantification; Long chain Acylcarnitines; MALDI Mass spectrometry imaging; Spatially resolved Microproteomics; Spatiotemporal; Traumatic Brain Injury	PROTEIN; IDENTIFICATION; RISK	A spatiotemporal microproteomics analysis was applied to an experimental model of TBI within the first 10-day window post injury. Proteomics profiles linked to systems biology analysis revealed that the brain protein profile is restored to noninjured conditions at 10 days after injury. Analyzing the substantia nigra after 3 days of injury, the ipsilateral hemisphere substantia nigra revealed an upregulation of several proteins previously reported in Parkinson's disease, thus further suggesting a link between TBI and Parkinson's disease at 3 days. Traumatic brain injury (TBI) represents a major health concerns with no clinically-approved FDA drug available for therapeutic intervention. Several genomics and neuroproteomics studies have been employed to decipher the underlying pathological mechanisms involved that can serve as potential neurotherapeutic targets and unveil a possible underlying relation of TBI to other secondary neurological disorders. In this work, we present a novel high throughput systems biology approach using a spatially resolved microproteomics platform conducted on different brain regions in an experimental rat model of moderate of controlled cortical injury (CCI) at a temporal pattern postinjury (1 day, 3 days, 7 days, and 10 days). Mapping the spatiotemporal landscape of signature markers in TBI revealed an overexpression of major protein families known to be implicated in Parkinson's disease (PD) such as GPR158, HGMB1, synaptotagmin and glutamate decarboxylase in the ipsilateral substantia nigra. In silico bioinformatics docking experiments indicated the potential correlation between TBI and PD through alpha-synuclein. In an in vitro model, stimulation with palmitoylcarnitine triggered an inflammatory response in macrophages and a regeneration processes in astrocytes which also further confirmed the in vivo TBI proteomics data. Taken together, this is the first study to assess the microproteomics landscape in TBI, mainly in the substantia nigra, thus revealing a potential predisposition for PD or Parkinsonism post-TBI.	[Mallah, Khalil; Quanico, Jusal; Raffo-Romero, Antonella; Cardon, Tristan; Aboulouard, Soulaimane; Salzet, Michel; Fournier, Isabelle] Univ Lille, INSERM, U1192, Lab Proteom Reponse Inflammatoire & Spectrometrie, F-59000 Lille, France; [Zibara, Kazem] Lebanese Univ, Fac Sci 1, Dept Biol, PRASE,Lab Stem Cells,ER045, Beirut, Lebanon; [Devos, David] Univ Lille, CHU Lille, Expert Ctr Parkinsons Dis, Dept Neurol,Dept Pharmacol,INSERM,UMR S 1171,LICE, Lille, France; [Kobeissy, Firas] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon		Salzet, M; Fournier, I (corresponding author), Univ Lille, Lab Reponse Inflammatoire & Spectrometrie Masse P, Fac Sci, INSERM,U1192, Campus Cite Sci,Bat SN3,1 Er Etage, F-59655 Villeneuve Dascq, France.	michel.salzet@univ-lille.fr; isabelle.fournier@univ-lille.fr	Cardon, Tristan/AAD-2991-2022; FOURNIER, Isabelle/H-9195-2015; Quanico, Jusal/AAE-3366-2020; Kobeissy, Firas/E-7042-2017; Salzet, Michel/A-7675-2011; Devos, David/E-4059-2013	Cardon, Tristan/0000-0003-1751-0528; FOURNIER, Isabelle/0000-0003-1096-5044; Kobeissy, Firas/0000-0002-5008-6944; Salzet, Michel/0000-0003-4318-0817; Zibara, Kazem/0000-0002-9887-072X; Raffo Romero, Antonella Milagros/0000-0002-3905-9101; Mallah, Khalil/0000-0001-7622-8106; Devos, David/0000-0002-2417-799X; Aboulouard, Soulaimane/0000-0002-2045-4785	Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation (MESRI); Institut National de la Sante et de la Recherche Medicale (Inserm)Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille; Association of Scientific Orientation and Specialization (ASOS Scholarship)	This research was supported by funding from Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation (MESRI), Institut National de la Sante et de la Recherche Medicale (Inserm) and Universite de Lille. K.M. acknowledges funding from the Association of Scientific Orientation and Specialization (ASOS Scholarship).	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonnet Agnes, 2009, BMC Proc, V3 Suppl 4, pS11, DOI 10.1186/1753-6561-3-S4-S11; Cizkova D, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00105; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Comte I, 2011, J CELL SCI, V124, P2438, DOI 10.1242/jcs.079954; Console L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22170-7; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Devaux S, 2016, MOL CELL PROTEOMICS, V15, P2641, DOI 10.1074/mcp.M115.057794; Ding J, 2015, ARQ NEURO-PSIQUIAT, V73, P342, DOI 10.1590/0004-282X20150006; Duce JA, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0186-8; Faul M, 2010, TRAUMATIC BRAIN INJU; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Glavan G, 2009, ANAT REC, V292, P1849, DOI 10.1002/ar.21026; Guan Y, 2018, LIFE SCI, V202, P1, DOI 10.1016/j.lfs.2018.03.031; Gurung P, 2017, IMMUNITY, V46, P635, DOI 10.1016/j.immuni.2017.03.014; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Khrimian L, 2017, J EXP MED, V214, P2859, DOI 10.1084/jem.20171320; Ko EA, 2012, J IMMUNOL, V188; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; LLOYD KG, 1973, NATURE, V243, P521, DOI 10.1038/243521a0; Lolekha P, 2010, MOVEMENT DISORD, V25, P1895, DOI 10.1002/mds.23210; Mallah K, 2018, ANAL CHEM, V90, P10568, DOI 10.1021/acs.analchem.8b02682; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Nishikawa H, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8020030; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peng HJ, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201700260; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pyatnitskiy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084955; Quanico J, 2013, J PROTEOMICS, V79, P200, DOI 10.1016/j.jprot.2012.11.025; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Rosenberger K, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0003-1; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; Russo Isabella, 2012, Am J Neurodegener Dis, V1, P217; Rutkowsky JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1378, DOI 10.1152/ajpendo.00656.2013; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Sutton LP, 2018, ELIFE, V7, DOI 10.7554/eLife.33273; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Wang B, 2018, BRAIN BEHAV IMMUN, V72, P51, DOI 10.1016/j.bbi.2017.11.017; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu L, 2016, TUMOR BIOL, V2016, P1, DOI DOI 10.1152/AJPCELL.00309.2015; Xu YQ, 2002, BIOCHEMISTRY-US, V41, P5415, DOI 10.1021/bi015977a; Yamawaki Y, 2010, AM J PHYSIOL-REG I, V298, pR403, DOI 10.1152/ajpregu.00395.2009; Yip PK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41689; Yuryev A, 2009, EXPERT OPIN DRUG DIS, V4, P1307, DOI 10.1517/17460440903413488; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou W, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4461-z	55	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	1535-9476	1535-9484		MOL CELL PROTEOMICS	Mol. Cell. Proteomics	AUG	2019	18	8					1669	1682		10.1074/mcp.RA119.001604			14	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IS6LO	WOS:000482263500013		Green Published, hybrid			2022-02-06	
J	Marin, C; Langdon, C; Alobid, I; Fuentes, M; Bonastre, M; Mullol, J				Marin, Concepcio; Langdon, Cristobal; Alobid, Isam; Fuentes, Mireya; Bonastre, Merce; Mullol, Joaquim			Recovery of Olfactory Function After Excitotoxic Lesion of the Olfactory Bulbs Is Associated with Increases in Bulbar SIRT1 and SIRT4 Expressions	MOLECULAR NEUROBIOLOGY			English	Article						Excitotoxicity; Olfaction; Dopamine; Sirtuins; Parkinson's disease; Traumatic brain injury; Neurogenesis	METABOTROPIC GLUTAMATE RECEPTORS; ERK5 MAP KINASE; PARKINSONS-DISEASE; NORADRENERGIC MODULATION; NEUROPROTECTIVE ROLE; CALORIE RESTRICTION; SUBVENTRICULAR ZONE; HUNTINGTONS-DISEASE; OXIDATIVE STRESS; ISCHEMIC DAMAGE	Excitotoxicity consists in a cascade of intracellular events initiated by an excessive release of glutamate and hyperactivation of glutamatergic receptors that is involved in several pathologies, including traumatic brain injury and neurodegenerative diseases such as Parkinson's disease. Both disorders are a common cause of olfactory dysfunction. We previously reported a role for glutamate excitotoxicity in olfactory dysfunction showing an olfactory deficit 1week after lesion and a spontaneous recovery 2weeks after excitotoxicity lesion of the olfactory bulbs (OBs). The olfactory dysfunction recovery was associated with an increase in subventricular zone neurogenesis and an increase in the OB glomerular dopaminergic interneurons. However, the underlying molecular mechanisms involved in the OB dopaminergic differentiation and olfactory recovery are still unknown. To investigate the role of silent information regulator family proteins sirtuins (SIRTs), a family of NAD+-dependent histone deacetylases, on the olfactory function recovery, we examined the OB SIRT (SIRT1, SIRT2, and SIRT4) expressions after OB excitotoxic lesions in rodents. N-methyl-d-aspartate (NMDA) OB administration induced a decrease in the number of correct choices in the discrimination tests 1week after lesions (p<0.01) and a spontaneous recovery of the olfactory deficit 2weeks after lesions (p<0.01) associated with an increase in OB SIRT1 and SIRT4 expression. Our results point out for the first time the association between recovery of olfactory function and the increase in bulbar SIRT1 and SIRT4 expression suggesting a role for these SIRTs in the pathophysiology of recovery of loss of smell.	[Marin, Concepcio; Fuentes, Mireya; Bonastre, Merce; Mullol, Joaquim] IDIBAPS CELLEX, Inst Invest Biomed August Pi & Sunyer IDIBAPS, IRCE, INGENIO, Rossello 149-153, Barcelona 08036, Catalonia, Spain; [Marin, Concepcio; Langdon, Cristobal; Alobid, Isam; Fuentes, Mireya; Mullol, Joaquim] Ctr Biomed Invest Resp Dis CIBERES, Barcelona, Spain; [Langdon, Cristobal; Alobid, Isam; Mullol, Joaquim] Hosp Clin Barcelona, ENT Dept, Rhinol Unit, Barcelona, Catalonia, Spain; [Langdon, Cristobal; Alobid, Isam; Mullol, Joaquim] Hosp Clin Barcelona, ENT Dept, Smell Clin, Barcelona, Catalonia, Spain		Marin, C; Mullol, J (corresponding author), IDIBAPS CELLEX, Inst Invest Biomed August Pi & Sunyer IDIBAPS, IRCE, INGENIO, Rossello 149-153, Barcelona 08036, Catalonia, Spain.; Marin, C; Mullol, J (corresponding author), Ctr Biomed Invest Resp Dis CIBERES, Barcelona, Spain.; Mullol, J (corresponding author), Hosp Clin Barcelona, ENT Dept, Rhinol Unit, Barcelona, Catalonia, Spain.; Mullol, J (corresponding author), Hosp Clin Barcelona, ENT Dept, Smell Clin, Barcelona, Catalonia, Spain.	cmarin@clinic.cat; jmullol@clinic.cat		Langdon, Cristobal/0000-0003-1540-8095	Fundacio La Marato TV3 [110610]	This work was supported by a research grant (110610) from Fundacio La Marato TV3.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Albani D, 2009, J NEUROCHEM, V110, P1445, DOI 10.1111/j.1471-4159.2009.06228.x; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Ardiles Y, 2007, EXP NEUROL, V207, P275, DOI 10.1016/j.expneurol.2007.06.022; Berdichevsky A, 2006, CELL CYCLE, V5, P2588, DOI 10.4161/cc.5.22.3513; Bobrowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034805; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Brushfield AM, 2008, BEHAV NEUROSCI, V122, P54, DOI 10.1037/0735-7044.122.1.54; Burton SD, 2017, J NEUROSCI, V37, P1117, DOI 10.1523/JNEUROSCI.2880-16.2016; Butti E, 2012, BRAIN, V135, P3320, DOI 10.1093/brain/aws194; Chen D, 2008, EXP GERONTOL, V43, P1086, DOI 10.1016/j.exger.2008.08.050; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Corpas R, 2017, MOL NEUROBIOL, V54, P5604, DOI 10.1007/s12035-016-0087-9; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; DeLong MR, 2015, JAMA NEUROL, V72, P1354, DOI 10.1001/jamaneurol.2015.2397; Diaz-Ruiz C, 2015, ONCOTARGET, V6, P26675, DOI 10.18632/oncotarget.5596; Dong WP, 2008, J VASC SURG, V48, P709, DOI 10.1016/j.jvs.2008.04.007; Donmez G, 2013, EMBO MOL MED, V5, P344, DOI 10.1002/emmm.201302451; Donmez G, 2012, TRENDS PHARMACOL SCI, V33, P494, DOI 10.1016/j.tips.2012.05.007; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Dorsett CR, 2017, J NEUROTRAUM, V34, P220, DOI 10.1089/neu.2015.4372; Escanilla O, 2010, EUR J NEUROSCI, V32, P458, DOI 10.1111/j.1460-9568.2010.07297.x; Escanilla O, 2009, BEHAV NEUROSCI, V123, P828, DOI 10.1037/a0015855; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gengatharan A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00149; Ghatpande AS, 2009, J NEUROPHYSIOL, V101, P2052, DOI 10.1152/jn.90734.2008; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hattori Y, 2015, NEUROREPORT, V26, P113, DOI 10.1097/WNR.0000000000000308; Hernandez-Jimenez M, 2013, STROKE, V44, P2333, DOI 10.1161/STROKEAHA.113.001715; Herskovits AZ, 2014, NEURON, V81, P471, DOI 10.1016/j.neuron.2014.01.028; Hinzman JM, 2016, J NEUROTRAUM, V33, P1775, DOI 10.1089/neu.2015.4226; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jesko H, 2017, NEUROCHEM RES, V42, P876, DOI 10.1007/s11064-016-2110-y; Jesko H, 2016, FOLIA NEUROPATHOL, V54, P212, DOI 10.5114/fn.2016.62531; Jia N, 2016, BIOCHEM BIOPH RES CO, V478, P1376, DOI 10.1016/j.bbrc.2016.08.132; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kakefuda K, 2009, BIOCHEM BIOPH RES CO, V387, P784, DOI 10.1016/j.bbrc.2009.07.119; Kaneko N, 2017, J NEUROCHEM, V141, P835, DOI 10.1111/jnc.14002; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; Kim MJ, 2009, FEBS LETT, V583, P1183, DOI 10.1016/j.febslet.2009.03.007; Komlos D, 2013, GLIA, V61, P394, DOI 10.1002/glia.22442; Koo JH, 2017, EXP NEUROL, V288, P142, DOI 10.1016/j.expneurol.2016.11.014; Koronowski Kevin B, 2015, Brain Circ, V1, P69; Kupis W, 2016, J PHYSIOL BIOCHEM, V72, P371, DOI 10.1007/s13105-016-0492-6; Langdon C, 2018, J NEUROTRAUM, V35, P2641, DOI 10.1089/neu.2017.5230; Lee JY, 2009, NEUROSCI LETT, V461, P163, DOI 10.1016/j.neulet.2009.06.005; Lee JH, 2016, BRAIN STRUCT FUNCT, V221, P3259, DOI 10.1007/s00429-015-1099-3; Lethbridge R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035024; Libert S, 2008, NAT CELL BIOL, V10, P373, DOI 10.1038/ncb0408-373; Litim N, 2017, NEUROPHARMACOLOGY, V115, P166, DOI 10.1016/j.neuropharm.2016.03.036; Liu HA, 2011, EXP NEUROL, V228, P270, DOI 10.1016/j.expneurol.2011.01.021; Liu L, 2015, BEHAV BRAIN RES, V281, P215, DOI 10.1016/j.bbr.2014.12.035; Logan RW, 2019, MOL PSYCHIATR, V24, P1668, DOI 10.1038/s41380-018-0061-1; Mandairon N, 2008, EUR J NEUROSCI, V27, P1210, DOI 10.1111/j.1460-9568.2008.06101.x; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Marin C, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0796-4; Marin C, 2017, NEUROSCIENCE, V364, P28, DOI 10.1016/j.neuroscience.2017.09.008; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Min SW, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00053; Mullol J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001256; Neo SH, 2018, PROG MOL BIOL TRANSL, V154, P105, DOI 10.1016/bs.pmbts.2017.11.013; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Okawara M, 2007, BIOCHEM PHARMACOL, V73, P550, DOI 10.1016/j.bcp.2006.11.003; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049622; Pantazi E, 2013, WORLD J GASTROENTERO, V19, P7594, DOI 10.3748/wjg.v19.i43.7594; Pavlis M, 2006, PHYSIOL BEHAV, V87, P109, DOI 10.1016/j.physbeh.2005.09.011; Porquet D, 2014, J ALZHEIMERS DIS, V42, P1209, DOI 10.3233/JAD-140444; Proskynitopoulos Phileas J, 2016, Surg Neurol Int, V7, pS263, DOI 10.4103/2152-7806.181981; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Rajendran E, 2011, J BIOMED BIOTECHNOL, V2011, P1; Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008; Saharan S, 2013, J NEUROSCI RES, V91, P642, DOI 10.1002/jnr.23199; Satoh A, 2017, NAT REV NEUROSCI, V18, P362, DOI 10.1038/nrn.2017.42; Sebastianutto I, 2018, CURR OPIN PHARMACOL, V38, P81, DOI 10.1016/j.coph.2018.03.003; Seo JS, 2012, NEUROBIOL AGING, V33, P1110, DOI 10.1016/j.neurobiolaging.2010.09.019; She DT, 2017, TRANSL STROKE RES, V8, P405, DOI 10.1007/s12975-017-0544-4; Shih J, 2014, J NEUROCHEM, V131, P573, DOI 10.1111/jnc.12942; Singh P, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0364-1; Sohrabji F, 2000, J NEUROBIOL, V45, P61, DOI 10.1002/1097-4695(20001105)45:2<61::AID-NEU1>3.0.CO;2-L; Stefani MA, 2017, ANN CLIN TRANSL NEUR, V4, P392, DOI 10.1002/acn3.416; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Szego EM, 2017, NEUROBIOL AGING, V56, P7, DOI 10.1016/j.neurobiolaging.2017.04.001; Tang BL, 2017, J NEUROSCI RES, V95, P930, DOI 10.1002/jnr.23806; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tatti R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4791; Vergun O, 1999, J PHYSIOL-LONDON, V519, P451, DOI 10.1111/j.1469-7793.1999.0451m.x; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang WB, 2015, J NEUROSCI, V35, P7833, DOI 10.1523/JNEUROSCI.3745-14.2015; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Watanabe S, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0062-1; Watroba M, 2016, ADV MED SCI-POLAND, V61, P52, DOI 10.1016/j.advms.2015.09.003; Wong SY, 2016, REV NEUROSCIENCE, V27, P813, DOI 10.1515/revneuro-2016-0023; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238; Yang Xiaorong, 2017, Oxid Med Cell Longev, V2017, P2823454, DOI 10.1155/2017/2823454; Zak JD, 2015, J NEUROPHYSIOL, V113, P1907, DOI 10.1152/jn.00222.2014; Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001; Zhang XS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.292; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zou JH, 2012, J NEUROSCI, V32, P4118, DOI 10.1523/JNEUROSCI.6260-11.2012	111	7	7	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2019	56	8					5643	5653		10.1007/s12035-019-1472-y			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IJ1QK	WOS:000475673100027	30661205				2022-02-06	
J	Pargaonkar, R; Kumar, V; Menon, G; Hegde, A				Pargaonkar, Raghav; Kumar, Vinod; Menon, Girish; Hegde, Ajay			Comparative study of computed tomographic scoring systems and predictors of early mortality in severe traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Helsinki score; Marshall score; Rotterdam score; CT scoring; TBI	GLASGOW COMA SCALE; SEVERE HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; CT FINDINGS; CLASSIFICATION; VALIDATION; PROGNOSIS; MARSHALL; MODERATE; IMPACT	Traumatic Brain Injury (TBI) is a significant cause of disability, mortality and socio-economic loss in developing countries. Prognostication and early prediction of outcome will help in judicious allocation of resources. The three CT scoring systems, commonly employed in predicting outcome are the Marshall, Rotterdam and the Helsinki CT Scoring system. This is a prospective observational study to compare the above scoring systems and their role in predicting the outcome after TBI. A total of 157 patients were included in this study. Primary objective was early outcome assessed by Glasgow Outcome Scale at discharge and 3 months. On comparing the three CT scoring systems, the Helsinki CT score provided a better positive predictive value of 87.5% for mortality in comparison with Marshall (79.3%) and Rotterdam Score (82.5%). Summarising the results for ROC analysis of the three CT scoring systems, the area under curve was 0.742 for Marshall score, 0.751 for the Rotterdam score and 0.815 for the Helsinki score, which upholds the superiority of the Helsinki CT score in predicting the mortality compared to other two. The linear relationship of higher the score with added risk of mortality was seen with Rotterdam score and Helsinki score. Individual CT findings of positive midline shift, obliteration of suprasellar cisterns, presence of subarachnoid haemorrhage, intraventricular haemorrhage and large mass lesions were found to be independent predictors of mortality. The Helsinki Scoring system is a better prognostic model with significantly improved outcome prediction accuracy, although the Marshall and Rotterdam scoring systems have good predictability for assessing mortality. (C) 2019 Elsevier Ltd. All rights reserved.	[Pargaonkar, Raghav] Cooper Univ Hosp, Dept Neurosurg, Mumbai, Maharashtra, India; [Kumar, Vinod; Menon, Girish] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Neurosurg, Manipal 576104, Karnataka, India; [Hegde, Ajay] NHS Greater Glasgow & Clyde, Inst Neurol Sci, Glasgow, Lanark, Scotland		Kumar, V (corresponding author), Manipal Acad Higher Educ, Kasturba Med Coll, Dept Neurosurg, Manipal 576104, Karnataka, India.	vinodneuro@gmail.com	Hegde, Ajay/N-3334-2017	Hegde, Ajay/0000-0001-6970-2260			Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bobinski L, 2012, ACTA NEUROCHIR, V154, P1069, DOI 10.1007/s00701-012-1345-x; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Charry JD, 2017, J NEUROSCI RURAL PRA, V8, P23, DOI 10.4103/jnrp.jnrp_434_16; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Chieregato A, 2010, ACTA ANAESTH SCAND, V54, P696, DOI 10.1111/j.1399-6576.2010.02234.x; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; JENNETT B, 1975, LANCET, V1, P480; Katsnelson M, 2012, NEUROSURGERY, V70, P1095, DOI 10.1227/NEU.0b013e318240c1ed; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Talari HR, 2016, WORLD NEUROSURG, V87, P195, DOI 10.1016/j.wneu.2015.11.055; TEASDALE G, 1974, LANCET, V2, P81; Yao S, 2017, WORLD NEUROSURG, V101, P528, DOI 10.1016/j.wneu.2017.02.072	38	7	7	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	AUG	2019	66						100	106		10.1016/j.jocn.2019.05.011			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IM0PA	WOS:000477689500019	31103253				2022-02-06	
J	Parola, A; Bosco, FM; Gabbatore, I; Galetto, V; Zettin, M; Marini, A				Parola, Alberto; Bosco, Francesca M.; Gabbatore, Ilaria; Galetto, Valentina; Zettin, Marina; Marini, Andrea			The impact of the Cognitive Pragmatic Treatment on the pragmatic and informative skills of individuals with traumatic brain injury (TBI)	JOURNAL OF NEUROLINGUISTICS			English	Article						Narrative; Cognitive pragmatic; Rehabilitation; Traumatic brain injury; Inferential ability; Executive function; Theory of mind	NARRATIVE LANGUAGE; RIGHT-HEMISPHERE; COMMUNICATIVE IMPAIRMENT; DISCOURSE PRODUCTION; SOCIAL COGNITION; ABILITIES; MIND; ADULTS; DEFICITS; SPEECH	Objective: Pragmatic impairment and narrative difficulties commonly affect individuals after traumatic brain injury (TBI). Rehabilitative programs may improve such impaired capacities and promote social recovery. Cognitive Pragmatic treatment (CPT) is a rehabilitative group program that encompasses different communicative skills, including sessions dedicated to the ability to structure a discourse with an adequate amount of information and relevant contents. This study aims to determine the efficacy of the CPT program in improving informative skills during narrative production. We also investigated the impact of CPT on some of the patients' cognitive abilities that might affect their communicative skills (e.g., inhibitory control and cognitive flexibility). Methods: Ten individuals with chronic TBI took part in and completed the CPT program. The participants' narrative abilities were assessed before and after the CPT program, using a picture description task. Moreover, equivalent forms of the Assessment Battery for Communication (ABaCo), and a series of neuropsychological tasks, were administered to the participants to evaluate their pragmatic skills and cognitive profile. Results: The CPT program induced a significant improvement in pragmatic and informative skills, while no significant improvement was observed in neuropsychological tasks. Importantly, the improvement in pragmatic abilities persisted three months post-training. Conclusions: The study highlighted the efficacy of the CPT program in improving patients' informativeness, confirming previous reports of its effectiveness in the rehabilitation of communicative-pragmatic skills.	[Parola, Alberto; Bosco, Francesca M.; Gabbatore, Ilaria] Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, Italy; [Bosco, Francesca M.] Inst Neurosci Turin, Turin, Italy; [Gabbatore, Ilaria] Univ Oulu, Child Language Res Ctr, Oulu, Finland; [Galetto, Valentina; Zettin, Marina] Ctr Puzzle, Turin, Italy; [Marini, Andrea] Univ Udine, Dept Languages & Literatures Commun Educ & Soc, Udine, Italy; [Marini, Andrea] Claudiana Landesfachhsch Gesundheitsberufe, Bolzano, Italy		Gabbatore, I (corresponding author), Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, Italy.	ilaria.gabbatore@unito.it	Parola, alberto/AAK-3748-2020; Gabbatore, Ilaria/AAC-1925-2019; Marini, Andrea/A-1206-2012; bosco, francesca marina/B-6746-2013	Gabbatore, Ilaria/0000-0002-9724-8066; Marini, Andrea/0000-0002-6058-3864; bosco, francesca marina/0000-0001-6101-8587; PAROLA, ALBERTO/0000-0002-6039-0907	Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR): Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN); Project "The Interpretative Brain: Understanding and Promoting Pragmatic Abilities across Lifespan [201577HA9M]	The research was funded by Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR): Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN) 2017. Project "The Interpretative Brain: Understanding and Promoting Pragmatic Abilities across Lifespan and in Mental Illness" project code 201577HA9M.	Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Angeleri R., 2015, BATTERIA ASSESSMENT; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; [Anonymous], 2014, MINERVA PSICHIATRICA; Bambini V, 2016, COMPR PSYCHIAT, V71, P106, DOI 10.1016/j.comppsych.2016.08.012; Beeman MJ, 2000, BRAIN LANG, V71, P310, DOI 10.1006/brln.1999.2268; Bosco FM, 2018, J COMMUN DISORD, V75, P102, DOI 10.1016/j.jcomdis.2018.05.002; Bosco F. M, 2018, ARCH CLIN NEUROPSYCH, V41; Bosco F. M, 2017, RES CLIN PRAGMATICS, V11; Bosco FM, 2016, PSYCHOL CLIN SETTING, V7, P1, DOI DOI 10.3389/FPSYG.2016.00566; Bosco FM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01453; Bosco FM, 2017, BRAIN LANG, V168, P73, DOI 10.1016/j.bandl.2017.01.007; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Bosco FM, 2012, J COMMUN DISORD, V45, P290, DOI 10.1016/j.jcomdis.2012.03.002; Cannizzaro MS, 2002, BRAIN INJURY, V16, P1065, DOI 10.1080/02699050210155230; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; Carotenuto A, 2018, BRAIN LANG, V185, P47, DOI 10.1016/j.bandl.2018.08.003; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cruice M, 2003, APHASIOLOGY, V17, P333, DOI 10.1080/02687030244000707; Cummings L., 2017, RES CLIN PRAGMATICS; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Ferretti E, 2017, LANG SCI, V63, P105, DOI 10.1016/j.langsci.2017.01.002; Finch E, 2016, ARCH PHYS MED REHAB, V97, P1352, DOI [10.1016/j.apmr.2015.11.005, 10.1016/j.apmr.20.15.11.005]; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gabbatore I, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1612078; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; Gernsbacher M.A, 1990, LANGUAGE COMPREHENSI; Gindri Gigiane, 2014, Dement. neuropsychol., V8, P58, DOI 10.1590/S1980-57642014DN81000009; Goodglass H., 1972, BOSTON DIAGNOSTIC AP; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hillis A, 2007, APHASIA REHABILITATI, P261; Honan CA, 2015, BRAIN LANG, V150, P69, DOI 10.1016/j.bandl.2015.08.007; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hopper T, 2002, APHASIOLOGY, V16, P745, DOI 10.1080/02687030244000059; Huber W, 1984, Adv Neurol, V42, P291; Kertesz A., 1982, W APHASIA BATTERY; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Leonard CL, 2001, CORTEX, V37, P327, DOI 10.1016/S0010-9452(08)70577-X; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levinson Stephen., 1983, PRAGMATICS; Marangolo P, 2013, NEUROPSYCHOL REHABIL, V23, P715, DOI 10.1080/09602011.2013.804847; Marini A, 2005, J PSYCHOLINGUIST RES, V34, P439, DOI 10.1007/s10936-005-6203-z; Marini A, 2005, BRAIN LANG, V93, P46, DOI 10.1016/j.bandl.2004.08.002; Marini A, 2008, SCHIZOPHR RES, V105, P144, DOI 10.1016/j.schres.2008.07.011; Marini A, 2011, APHASIOLOGY, V25, P1372, DOI 10.1080/02687038.2011.584690; Marini A, 2017, J NEUROLINGUIST, V44, P91, DOI 10.1016/j.jneuroling.2017.03.005; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Marini A, 2012, J COGNITIVE NEUROSCI, V24, P2211, DOI 10.1162/jocn_a_00283; Marini A, 2012, SEMIN SPEECH LANG, V33, P68, DOI 10.1055/s-0031-1301164; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Matthews D, 2018, LANG LEARN DEV, V14, P186, DOI 10.1080/15475441.2018.1455584; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Parola A, 2018, PSYCHIAT RES, V260, P144, DOI 10.1016/j.psychres.2017.11.051; Parola A, 2016, J NEUROLINGUIST, V39, P10, DOI 10.1016/j.jneuroling.2015.12.003; Raven J., 2003, HDB NONVERBAL ASSESS; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rowley DA, 2017, BRAIN INJURY, V31, P1564, DOI 10.1080/02699052.2017.1341645; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00048; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Spinnler H., 1987, ITAL J NEUROL SCI, V6, P5; Steel J, 2019, BRAIN INJURY, V33, P48, DOI 10.1080/02699052.2018.1531304; Togher L, 2016, NEUROREHABILITATION, V38, P243, DOI 10.3233/NRE-151316; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [DOI 10.1375/brim.4.1.1.27031, https://doi.org/10.1375/brim.4.1.1.27031, DOI 10.1375/BRIM.4.1.1.27031]; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	84	7	7	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0911-6044			J NEUROLINGUIST	J. Neurolinguist.	AUG	2019	51						53	62		10.1016/j.jneuroling.2018.12.003			10	Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Linguistics; Neurosciences & Neurology; Psychology	IC8FC	WOS:000471210700004					2022-02-06	
J	Pour, MD; Ren, L; Jennische, E; Lange, S; Ewing, AG; Malmberg, P				Pour, Masoumeh Dowlatshani; Ren, Lin; Jennische, Eva; Lange, Stefan; Ewing, Andrew G.; Malmberg, Per			Mass spectrometry imaging as a novel approach to measure hippocampal zinc	JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY			English	Article							BRAIN; ION; COPPER; LOCALIZATION; SECTIONS; TISSUE; MICROSCOPY; ELEMENTS; INJURY; LIPIDS	Zinc (Zn2+) is an essential trace element that plays crucial roles in the functioning of hundreds of enzymes and DNA binding transcription factors. Zinc is also an essential neuromodulator and can act as a potent neurotoxin in excitotoxic brain injury after seizures, strokes, and brain trauma where high levels of Zn2+ can cause irreparable brain damage in certain brain regions. However, the mechanism of neurotoxicity has not been fully understood yet and is still under debate. In the present study, we have developed a time of flight secondary ion mass spectrometry (ToF-SIMS) imaging method to investigate the distribution of zinc in the rat brain. The zinc distribution in hippocampus sections from healthy rats and rats exposed to traumatic brain injury was imaged and the results were compared to those from conventional zinc-probe based fluorescence microscopy. Two related zinc species, ZnOH3 + and ZnO2H+, can successfully be visualized by ToF-SIMS in the rat hippocampus. Statistical data analysis of the image data demonstrated a substantial increase of both ZnOH3 + and ZnO2H+ in the zinc related species in the acute brain injury tissue. Our findings positively support the fact that toxic vesicular zinc accumulation might not be the sole source for neuronal degeneration following traumatic brain injuries. Also, we could successfully apply ToF-SIMS imaging for the first time to visualize the zinc content and distribution across hippocampus sections. Consequently, ToF-SIMS is a powerful method to further investigate biological phenomena such as seizures, ischemia, and strokes and also other forms of cellular damage in the central nervous system.	[Pour, Masoumeh Dowlatshani; Ren, Lin; Malmberg, Per] Chalmers Univ Technol, Dept Chem & Chem Engn, SE-41296 Gothenburg, Sweden; [Jennische, Eva; Lange, Stefan] Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, SE-40530 Gothenburg, Sweden; [Ewing, Andrew G.] Univ Gothenburg, Dept Chem & Mol Biol, SE-41296 Gothenburg, Sweden		Malmberg, P (corresponding author), Chalmers Univ Technol, Dept Chem & Chem Engn, SE-41296 Gothenburg, Sweden.	malmper@chalmers.se	Malmberg, Per/C-6352-2013; Ren, Lin/AAX-5885-2021	Malmberg, Per/0000-0002-6487-7851; 	Swedish Research CouncilSwedish Research CouncilEuropean Commission [2015-05274]; Wallenberg foundationEuropean Commission	The authors acknowledge support from the Swedish Research Council (2015-05274) and the Wallenberg foundation.	Ajiboye B, 2015, PLANT SOIL, V392, P357, DOI 10.1007/s11104-015-2467-8; Becker JS, 2007, ANAL CHEM, V79, P6074, DOI 10.1021/ac0700528; Becker JS, 2005, ANAL CHEM, V77, P3208, DOI 10.1021/ac040184q; Chandra S, 2003, APPL SURF SCI, V203, P679, DOI 10.1016/S0169-4332(02)00790-0; CHANDRA S, 1995, INT J MASS SPECTROM, V143, P161, DOI 10.1016/0168-1176(94)04134-S; Chuang JY, 2017, REDOX BIOL, V11, P135, DOI 10.1016/j.redox.2016.11.012; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Cole TB, 2000, EPILEPSY RES, V39, P153, DOI 10.1016/S0920-1211(99)00121-7; Frederickson CJ, 2004, NEUROSCIENTIST, V10, P18, DOI 10.1177/1073858403255840; Grabrucker Andreas M, 2011, Drug Deliv Lett, V1, P13; Grubman A, 2014, CHEM SCI, V5, P2503, DOI 10.1039/c4sc00316k; Hambidge M, 2000, J NUTR, V130, p1344S, DOI 10.1093/jn/130.5.1344S; Hanrieder J, 2013, ANAL CHEM, V85, P8741, DOI 10.1021/ac401830m; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Kay AR, 2003, J NEUROSCI, V23, P6847; Kindness A, 2003, CLIN CHEM, V49, P1916, DOI 10.1373/clinchem.2003.022046; Lee JY, 2003, EXP NEUROL, V184, P337, DOI 10.1016/S0014-4886(03)00382-0; Lee JY, 2000, J NEUROSCI, V20; Mai FD, 2006, APPL SURF SCI, V252, P6809, DOI 10.1016/j.apsusc.2006.02.227; Malmberg P, 2007, BBA-MOL CELL BIOL L, V1771, P185, DOI 10.1016/j.bbalip.2006.12.003; Morris DR, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/785647; Penen F, 2016, J TRACE ELEM MED BIO, V37, P62, DOI 10.1016/j.jtemb.2016.04.014; Pfaender S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45190; Shariatgorji M, 2016, METHODS, V104, P86, DOI 10.1016/j.ymeth.2016.05.021; Sjovall P, 2004, ANAL CHEM, V76, P4271, DOI 10.1021/ac049389p; Sodhi RNS, 2004, ANALYST, V129, P483, DOI 10.1039/b402607c; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Szewczyk B, 2011, PROG NEURO-PSYCHOPH, V35, P693, DOI 10.1016/j.pnpbp.2010.02.010; Touboul D, 2004, ANAL CHEM, V76, P1550, DOI 10.1021/ac035243z; Vela G, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/972791; Weng NY, 2017, ENVIRON SCI TECHNOL, V51, P14426, DOI 10.1021/acs.est.7b05090; Wood RJ, 2000, J NUTR, V130, p1350S, DOI 10.1093/jn/130.5.1350S; Yang YL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055384, 10.1371/journal.pone.0054736, 10.1371/journal.pone.0067755]; Yeiser EC, 1999, NEUROSCI LETT, V277, P75, DOI 10.1016/S0304-3940(99)00825-3	34	7	7	2	4	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	0267-9477	1364-5544		J ANAL ATOM SPECTROM	J. Anal. At. Spectrom.	AUG 1	2019	34	8					1581	1587		10.1039/c9ja00199a			7	Chemistry, Analytical; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Spectroscopy	IN7WX	WOS:000478893600021		hybrid			2022-02-06	
J	Sullivan, DR; Logue, MW; Wolf, EJ; Hayes, JP; Salat, DH; Fortier, CB; Fonda, JR; McGlinchey, RE; Milberg, WP; Miller, MW				Sullivan, Danielle R.; Logue, Mark W.; Wolf, Erika J.; Hayes, Jasmeet P.; Salat, David H.; Fortier, Catherine B.; Fonda, Jennifer R.; McGlinchey, Regina E.; Milberg, William P.; Miller, Mark W.			Close-Range Blast Exposure Is Associated with Altered White Matter Integrity in Apolipoprotein e4 Carriers	JOURNAL OF NEUROTRAUMA			English	Article						AD; APOE; blast; diffusion tensor imaging; white matter	TRAUMATIC BRAIN-INJURY; MILD COGNITIVE IMPAIRMENT; POSTTRAUMATIC-STRESS-DISORDER; ALZHEIMERS-DISEASE; AXONAL INJURY; E EPSILON-4; BETA-APP; ENCEPHALOPATHY; ABNORMALITIES; CONNECTIVITY	Evidence suggests that blast exposure has profound negative consequences for the health of the human brain, and that it may confer risk for the development of neurodegenerative diseases such as chronic traumatic encephalopathy and Alzheimer's disease (AD). Although the molecular mechanisms linking blast exposure to subsequent neurodegeneration is an active focus of research, recent studies suggest that genetic risk for AD may elevate the risk of neurodegeneration following traumatic brain injury (TBI). However, it is currently unknown if blast exposure also interacts with AD risk to promote neurodegeneration. In this study we examined whether apolipoprotein (APOE) e4, a well-known genetic risk factor for AD, influenced the relationship between blast exposure and white matter integrity in a cohort of 200 Iraq and Afghanistan war veterans. Analyses revealed a significant interaction between close-range blast exposure (CBE) (close range being within 10 m) and APOE e4 carrier status in predicting white matter abnormalities, measured by a voxelwise cluster-based method that captures spatial heterogeneity in white matter disruptions. This interaction remained significant after controlling for TBI, pointing to the specificity of CBE and APOE in white matter disruptions. Further, among veteran e4 carriers exposed to close-range blast, we observed a positive association between the number of CBEs and the number of white matter abnormalities. These results raise the possibility that CBE interacts with AD genetic influences on neuropathological processes such as the degradation of white matter integrity.	[Sullivan, Danielle R.; Logue, Mark W.; Wolf, Erika J.; Hayes, Jasmeet P.; Miller, Mark W.] VA Boston Healthcare Syst, Natl Ctr PTSD, 150 S Huntington Ave 116B-2, Boston, MA 02130 USA; [Hayes, Jasmeet P.; Salat, David H.] VA Boston Healthcare Syst, Neuroimaging Res Vet Ctr, Boston, MA USA; [Salat, David H.; Fortier, Catherine B.; Fonda, Jennifer R.; McGlinchey, Regina E.; Milberg, William P.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Salat, David H.; Fortier, Catherine B.; Fonda, Jennifer R.; McGlinchey, Regina E.; Milberg, William P.] VA Boston Healthcare Syst, GRECC, Boston, MA USA; [Sullivan, Danielle R.; Wolf, Erika J.; Hayes, Jasmeet P.; Fonda, Jennifer R.; Miller, Mark W.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Logue, Mark W.] Boston Univ, Sch Med, Biomed Genet, Boston, MA 02118 USA; [Logue, Mark W.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Hayes, Jasmeet P.] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Salat, David H.] Anthinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Fortier, Catherine B.; Fonda, Jennifer R.; McGlinchey, Regina E.; Milberg, William P.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA		Sullivan, DR (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD, 150 S Huntington Ave 116B-2, Boston, MA 02130 USA.	drsulliv@bu.edu	Miller, Mark Webber/G-7322-2011; Fortier, Catherine/AAS-2163-2021; Hayes, Jasmeet/AAN-4150-2020; Fonda, Jennifer R./ABG-2890-2021	Miller, Mark Webber/0000-0001-6393-8563; Fortier, Catherine/0000-0002-8953-9904; Hayes, Jasmeet/0000-0002-5157-0666; Fonda, Jennifer R./0000-0001-9482-2918; Wolf, Erika/0000-0003-2666-2435	Career Development Award from the United States Department of Veterans Affairs, Clinical Science Research and Development Service [1 IK2 CX001772-01]; Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development National Network Research Center [B9254-C]; National Center for PTSD; Neuroimaging Research for Veterans Center; VA Boston Healthcare SystemUS Department of Veterans Affairs; Pharmacogenomics Analysis Laboratory Research and Development Service, Central Arkansas VA Healthcare System, Little Rock, Arkansas; Veterans AffairsUS Department of Veterans Affairs [IK2CX001772] Funding Source: NIH RePORTER	This work was supported by Career Development Award (grant number: 1 IK2 CX001772-01) from the United States Department of Veterans Affairs, Clinical Science Research and Development Service awarded to D.R.S., and the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development National Network Research Center (B9254-C). This work was further supported with resources and the use of facilities at the National Center for PTSD, the Neuroimaging Research for Veterans Center, VA Boston Healthcare System, and the Pharmacogenomics Analysis Laboratory Research and Development Service, Central Arkansas VA Healthcare System, Little Rock, Arkansas. The authors thank the team of investigators at TRACTS for their assistance with data collection and management, and the team at the Pharmacogenomics Analysis Laboratory Research and Development Service. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Costafreda SG, 2013, J AFFECT DISORDERS, V150, P96, DOI 10.1016/j.jad.2013.02.028; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Esopenko C, 2015, J NEUROTRAUM, V32, P209, DOI 10.1089/neu.2014.3506; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Franzblau M, 2013, MED HYPOTHESES, V81, P842, DOI 10.1016/j.mehy.2013.09.012; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Hartman RE, 2002, J NEUROSCI, V22, P10083; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Huang J, 2007, AM J NEURORADIOL, V28, P1943, DOI 10.3174/ajnr.A0700; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Katzman R, 1996, NEUROLOGY, V46, P889; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Merritt V.C., 2018, J CLIN EXP NEUROPSYC, V40, P1; Merritt VC, 2019, ARCH CLIN NEUROPSYCH, V34, P706, DOI 10.1093/arclin/acy082; Miller DR, 2017, BRAIN IMAGING BEHAV, V11, P1129, DOI 10.1007/s11682-016-9593-7; Miller DR, 2017, DEPRESS ANXIETY, V34, P632, DOI 10.1002/da.22633; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Miller MW, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00299; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sullivan DR, 2019, J HEAD TRAUMA REHAB, V34, pE18, DOI 10.1097/HTR.0000000000000449; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068	55	7	7	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2019	36	23					3264	3273		10.1089/neu.2019.6489		AUG 2019	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	JO9FY	WOS:000479854900001	31232163				2022-02-06	
J	Hwang, SY; Ong, JW; Ng, ZM; Foo, CY; Chua, SZ; Sri, D; Lee, JH; Chong, SL				Hwang, Shih Yao; Ong, Jia Wei; Ng, Zhi Min; Foo, Ce Yu; Chua, Shu Zhen; Sri, Dianna; Lee, Jan Hau; Chong, Shu-Ling			Long-term outcomes in children with moderate to severe traumatic brain injury: a single-centre retrospective study	BRAIN INJURY			English	Article						Paediatric; traumatic brain injury; outcome	FUNCTIONAL INDEPENDENCE; NONACCIDENTAL TRAUMA; EPIDEMIOLOGY; INSTRUMENT; SAMPLE; WEEFIM	Traumatic brain injury (TBI) is a significant cause of mortality and disability in the pediatric population. Non-accidental trauma (NAT) has specifically been reported to result in more severe injury as compared to accidental mechanisms of injury. We aim to investigate the long-term neurological outcomes in children with moderate to severe traumatic brain injury. Our secondary aim is to evaluate the difference in outcomes between children presenting with NAT and non-NAT, in our study population. We performed a retrospective study in a tertiary pediatric hospital between January 2008 to October 2017 of all patients with TBI <16 years old with a Glasgow Coma Scale (GCS) <= 13. The dual primary outcomes were mortality and Paediatric Functional Independence Measure (WeeFIM) scores, recorded at the start of rehabilitation, discharge, 3 months and 6 months post-injury. The secondary outcome was the development of post-traumatic epilepsy. There were 68 patients with a median age of 4.5 [interquartile range (IQR) 1.0-9.0] years old. The most common presenting symptom was vomiting for children <2 years (11/20, 55.0%) while confusion and disorientation were common for those >= 2 years (27/48, 56.3%). WeeFIM scores at the start of rehabilitation [median 122.0, IQR 33.8-126.0] improved at 6 months post-injury (median 126.0, IQR 98.5-126.0). There was a greater incidence of post-traumatic epilepsy in age <2 years (6/20, 30.0%) compared to age >= 2 years (1/48, 2.1%) (p = .002). When comparing NAT versus non-NAT survivors, cognition WeeFIM scores were significantly different at the start of rehabilitation (p = .017) and at 3 months post-injury (p = .025). NAT predicts for poorer long-term outcomes, specifically in cognition, as measured by WeeFIM scores. Younger children <2 years had a higher incidence of post-traumatic epilepsy compared to older children.	[Hwang, Shih Yao; Ong, Jia Wei] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Ng, Zhi Min] KK Womens & Childrens Hosp, Dept Paediat Med, Singapore, Singapore; [Foo, Ce Yu; Chua, Shu Zhen] KK Womens & Childrens Hosp, Dept Rehabil, Singapore, Singapore; [Sri, Dianna] KK Womens & Childrens Hosp, KK Res Ctr, Singapore, Singapore; [Lee, Jan Hau] KK Womens & Childrens Hosp, Childrens Intens Care Unit, Singapore, Singapore; [Chong, Shu-Ling] KK Womens & Childrens Hosp, Dept Emergency Med, Singapore, Singapore		Chong, SL (corresponding author), KK Womens & Childrens Hosp, Dept Emergency Med, Singapore, Singapore.	chong.shu-ling@kkh.com.sg					Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Arndt DH, 2016, J CHILD NEUROL, V31, P46, DOI 10.1177/0883073814562249; Bray Liz, 2015, Nurs Child Young People, V27, P22, DOI 10.7748/ncyp.27.7.22.e618; Chevignard MP, 2014, PEDIATR RADIOL, V44, P548, DOI 10.1007/s00247-014-3169-8; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Chong SL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015759; Chong SL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010618; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P157, DOI 10.1097/TA.0b013e3182984acb; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Estroff JM, 2015, J EMERG MED, V48, P274, DOI 10.1016/j.jemermed.2014.07.030; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394, DOI 10.1001/archneur.1974.00490350052008; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; Ottenbacher KJ, 1997, ARCH PHYS MED REHAB, V78, P1309, DOI 10.1016/S0003-9993(97)90302-6; Ottenbacher KJ, 2000, ARCH PHYS MED REHAB, V81, P1317, DOI 10.1053/apmr.2000.9387; Paul AR, 2014, TRANSL PEDIATR, V3, P195, DOI 10.3978/j.issn.2224-4336.2014.06.01; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Ziviani Jenny, 2001, Physical and Occupational Therapy in Pediatrics, V21, P91	26	7	7	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2019	33	11					1420	1424		10.1080/02699052.2019.1641625		JUL 2019	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IP7SR	WOS:000476295600001	31314599				2022-02-06	
J	Yu, MM; Yang, DX; Wang, ML; Wei, XE; Li, WB				Yu, Mengmeng; Yang, Dianxu; Wang, Mingliang; Wei, Xiaoer; Li, Wenbin			Early stage of diffusional kurtosis imaging and dynamic contrast-enhanced magnetic resonance imaging correlated with long-term neurocognitive function after experimental traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Blood-brain barrier; Dynamic contrast-enhanced MRI; Diffusional kurtosis imaging; Traumatic brain injury; Rat; Cognitive dysfunction	WHITE-MATTER DAMAGE; COGNITIVE IMPAIRMENT; BARRIER BREAKDOWN; MRI; ACTIVATION; MARKER	Development of a reliable biomarker for prognostic monitoring of cognitive impairment after traumatic brain injury (TBI) is of great importance. The aim of the study was to explore the value of early diffusional kurtosis imaging (DKI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in evaluation of chronic cognitive function after TBI. MRI was performed on TBI and control rats at 7 days post-injury. MRI parameters were measured in bilateral cortex, hippocampus, thalamus and corpus callosum (CC). All the rats underwent Morris water maze (MWM) at 6 months after injury. Immunohistochemistry (IHC) analysis of neuron [NeuN], astroglia [GFAP], microglia [Iba-1], and myelin [MBPI was performed after the MWM test. Our study revealed that, TBI group showed higher volume transfer coefficient (K-trans) value in ipsilateral cortex (P < 0.0001) and no detectable changes in other regions-of-interest (ROIs), compared with control group. DKI showed higher MK in all ipsilateral ROIs (P < 0.05), higher MD in ipsilateral cortex, hippocampus and CC (P < 0.05 for all) in TBI group. TBI group had worse performance in MWM test at 6 months post-injury(P < 0.05). IHC analysis showed lower NeuN, and higher GFAP and Iba-1 in all ipsilateral ROIs (P < 0.05) in TBI rats. NeuN, and GFAP and Iba-1 correlated significantly with MK value in ipsilateral regions of cortex. The MK value of ipsilateral cortex and CC and K-trans value of ipsilateral cortex also correlated significantly with time in the target quadrant. Therefore, our study indicated that early DKI and DCE-MRI could be used to assess the microstructural changes associated with long-term cognitive outcome following TBI.	[Yu, Mengmeng; Wang, Mingliang; Wei, Xiaoer; Li, Wenbin] Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Yang, Dianxu] Shanghai Jiao Tong Univ, Dept Neurosurg, Affiliated Peoples Hosp 6, Shanghai 200233, Peoples R China; [Li, Wenbin] Kashgar Prefecture Second Peoples Hosp, Imaging Ctr, Kashgar 844000, Xinjiang, Peoples R China		Li, WB (corresponding author), Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China.	liwenbin@stju.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271540]; Natural Science Foundation of Xinjiang Province [2016D01C083]; Shanghai Key Discipline of Medical Imaging [2017ZZ02005]	This study was funded by the National Natural Science Foundation of China (grant number: 81271540), Natural Science Foundation of Xinjiang Province (grant number: 2016D01C083) and Shanghai Key Discipline of Medical Imaging (grant number: 2017ZZ02005).	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Arab A, 2018, BRAIN RES BULL, V139, P91, DOI 10.1016/j.brainresbull.2018.01.015; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Haris M, 2008, J MAGN RESON IMAGING, V28, P588, DOI 10.1002/jmri.21491; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; James ML, 2012, ANESTHESIOLOGY, V116, P1299, DOI 10.1097/ALN.0b013e318253a02a; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Li YH, 2012, NEUROL SCI, V33, P731, DOI 10.1007/s10072-011-0768-0; Lian H, 2015, NEURON, V85, P101, DOI 10.1016/j.neuron.2014.11.018; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Rudrapatna SU, 2014, NEUROIMAGE, V97, P363, DOI 10.1016/j.neuroimage.2014.04.013; Saggu R, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0350-3; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Stranahan AM, 2016, J CEREBR BLOOD F MET, V36, P2108, DOI 10.1177/0271678X16642233; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Villringer K, 2017, NEUROLOGY, V88, P433, DOI 10.1212/WNL.0000000000003566; Wang ML, 2018, AM J NEURORADIOL, V39, P1650, DOI 10.3174/ajnr.A5737; Wang ML, 2018, NEUROSCIENCE, V392, P180, DOI 10.1016/j.neuroscience.2018.09.030; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Wei XE, 2011, J TRAUMA, V71, P1645, DOI 10.1097/TA.0b013e31823498eb; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Xu WW, 2012, J TRAUMA ACUTE CARE, V72, P1024, DOI 10.1097/TA.0b013e31824475cc; Yates D, 2011, NAT REV NEUROL, V7, P63, DOI 10.1038/nrneurol.2010.190; Yoo R. E., 2018, EUR RADIOL; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	40	7	8	1	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUL 13	2019	705						206	211		10.1016/j.neulet.2019.04.034			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IF3NH	WOS:000472987000033	31005651				2022-02-06	
J	Pattinson, CL; Gill, JM; Lippa, SM; Brickell, TA; French, LM; Lange, RT				Pattinson, Cassandra L.; Gill, Jessica M.; Lippa, Sara M.; Brickell, Tracey A.; French, Louis M.; Lange, Rael T.			Concurrent Mild Traumatic Brain Injury and Posttraumatic Stress Disorder Is Associated With Elevated Tau Concentrations in Peripheral Blood Plasma	JOURNAL OF TRAUMATIC STRESS			English	Article							AMYLOID-BETA; MILITARY PERSONNEL; DEMENTIA; VETERANS; MEMORY; HIPPOCAMPUS; IMPAIRMENT; INCREASES; SYMPTOMS; VALIDITY	Concurrent mild traumatic brain injury (mTBI) and posttraumatic stress disorder (PTSD) are common in U.S. military service members and veterans. Tau and amyloid-beta-42 (A beta 42) are proteins that have been linked to cognitive impairment, neurological hallmarks of Alzheimer's disease, and may also relate to recovery from mTBI. However, the role of these proteins in the maintenance or resolution of chronic symptoms has not yet been determined. Participants in the current study were 102 service members and veterans who had sustained an mTBI (n = 84) or injured controls (IC) without TBI (n = 18). They were categorized into three groups based on the presence or absence of mTBI and PTSD: IC/PTSD-Absent (n = 18), mTBI/PTSD-Absent (n = 63), and mTBI/PTSD-Present (n = 21). Concentrations of tau and A beta 42 in peripheral blood plasma were measured using Simoa(TM), an ultrasensitive technology, and compared across groups. Tau concentrations were highest in the mTBI/PTSD-Present group, F(2, 99) = 4.33, p = .016, compared to the other two groups. Linear multiple regression was conducted to determine the independent effects of PTSD and mTBI on tau concentrations, controlling for gender and sleep medication. PTSD was a significant and independent predictor of tau concentrations, beta = .25, p = .009, eta(2)(p) = .26. A beta 42 concentrations did not differ between the groups. The results indicated that PTSD was associated with an elevation of tau in peripheral blood and suggest that there may be increased biological effects of PTSD in this young cohort of service members and veterans following mTBI.	[Pattinson, Cassandra L.; Gill, Jessica M.] NINR, NIH, 1 Cloister Court,Room 259b, Bethesda, MD 20814 USA; [Lippa, Sara M.; Brickell, Tracey A.; French, Louis M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lippa, Sara M.; Brickell, Tracey A.; French, Louis M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada		Pattinson, CL (corresponding author), NINR, NIH, 1 Cloister Court,Room 259b, Bethesda, MD 20814 USA.	cassie.pattinson@nih.gov	french, louis/AAB-2083-2020; Pattinson, Cassandra/AAY-5974-2020; Gill, Gill M/Q-2020-2017; Pattinson, Cassandra/A-5543-2019	french, louis/0000-0002-9451-0604; Pattinson, Cassandra/0000-0002-5975-7935	Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [Z99 NR999999] Funding Source: Medline		Averill C. L., 2017, POSTTRAUMATIC STRESS, DOI [10.1177/2470547017744538, DOI 10.1177/2470547017744538]; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Catania C, 2009, MOL PSYCHIATR, V14, P95, DOI 10.1038/sj.mp.4002101; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Defense and Veterans Brain Injury Center, 2017, DOD NUMB TRAUM BRAIN; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; Dong H, 2004, NEUROSCIENCE, V127, P601, DOI 10.1016/j.neuroscience.2004.05.040; Fitzgerald JM, 2018, HARVARD REV PSYCHIAT, V26, P116, DOI 10.1097/HRP.0000000000000185; Flatt JD, 2018, ALZHEIMERS DEMENT, V14, P28, DOI 10.1016/j.jalz.2017.04.014; Gates MA, 2012, PSYCHOL SERV, V9, P361, DOI 10.1037/a0027649; Gehrman P, 2013, SLEEP, V36, P1009, DOI 10.5665/sleep.2798; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Ham BJ, 2007, EUR J NEUROSCI, V25, P324, DOI 10.1111/j.1460-9568.2006.05253.x; Harper DG, 2014, AM J GERIAT PSYCHIAT, V22, P499, DOI 10.1016/j.jagp.2012.08.005; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Ju YE, 2017, BRAIN, V140, P2104, DOI 10.1093/brain/awx148; Karabatsiakis Alexander, 2015, J Mol Psychiatry, V3, P2, DOI 10.1186/s40303-015-0007-3; Lemaire CM, 2011, J AFFECT DISORDERS, V130, P231, DOI 10.1016/j.jad.2010.10.021; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; McCrae M., 2008, MILD TRAUMATIC BRAIN; Mellman TA, 2014, SLEEP, V37, P1321, DOI 10.5665/sleep.3922; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Motamedi V, 2018, SLEEP MED, V43, P71, DOI 10.1016/j.sleep.2017.11.1121; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Rissin DM, 2011, ANAL CHEM, V83, P2279, DOI 10.1021/ac103161b; Rogers Amy E, 2016, MSMR, V23, P2; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stricker NH, 2017, J CLIN EXP NEUROPSYC, V39, P768, DOI 10.1080/13803395.2016.1264575; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Weathers FW, 1993, ANN M INT SOC TRAUM, DOI [10.1101/gr.095406.109., DOI 10.1101/GR.095406.109]; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Widiger T, 1994, DSM 4 DIAGN STAT MAN; Wood PL, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt103; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Yang C, 2014, BRAZ J MED BIOL RES, V47, P237, DOI 10.1590/1414-431X20133275	52	7	9	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	AUG	2019	32	4					546	554		10.1002/jts.22418		JUL 2019	9	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	IQ2ZP	WOS:000477471300001	31291489	Green Accepted			2022-02-06	
J	Hofman, M; Rabenschlag, F; Andruszkow, H; Andruszkow, J; Mockel, D; Lammers, T; Kolejewska, A; Kobbe, P; Greven, J; Teuben, M; Poeze, M; Hildebrand, F				Hofman, Martijn; Rabenschlag, Frederik; Andruszkow, Hagen; Andruszkow, Julia; Moeckel, Diana; Lammers, Twan; Kolejewska, Aneta; Kobbe, Philipp; Greven, Johannes; Teuben, Michel (Paul Johan); Poeze, Martijn; Hildebrand, Frank			Effect of neurokinin-1-receptor blockage on fracture healing in rats	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; GENE-RELATED PEPTIDE; SUBSTANCE-P; NEURONAL REGULATION; OSTEOGENIC ACTIVITY; NERVE RESECTION; BONE-FORMATION; IN-VITRO; EXPRESSION; SYSTEM	Neurologic injury and selective blockage of sensory nerve endings is associated with impaired fracture healing, however, the role of specific neurotransmitters has not been sufficiently investigated. Our aim was to investigate the impact of specific Substance P-receptor blockage on fracture healing, since the neuropeptide Substance P has both neurogenic and osteogenic activity. After intramedullary stabilization, an isolated femur fracture was induced in 72 Sprague-Dawley rats. In the NK1-R group, the neurokinin-1-tachykinin receptor for substance P was blocked by a specific antagonist (SR140333) for the first two weeks after fracture induction. The control group only received vehicle. Gene-expression, histology, micro-computed tomography, and biomechanical tests were performed. NK1-receptor blocking suppressed osteocalcin expression at one week, collagen 1A2 expression at one and two weeks and collagen 2A1 expression at 2 weeks after fracture induction. Biomechanical testing revealed a significant reduction in maximal load to failure in the NK1-R group at 6 weeks (69.78 vs. 155.45 N, p = 0.029) and at 3 months (72.50 vs.176.33 N, p = 0.01) of fracture healing. Blocking the NK1-receptor suppresses gene expression in and reduces biomechanical strength of healing bone. Therefore, we assume a potential therapeutic relevance of Substance Pin cases of disturbed fracture healing.	[Hofman, Martijn; Rabenschlag, Frederik; Andruszkow, Hagen; Kolejewska, Aneta; Kobbe, Philipp; Greven, Johannes; Hildebrand, Frank] Univ Aachen, Dept Orthoped Trauma & Reconstruct Surg, Med Ctr, Aachen, Germany; [Andruszkow, Julia] Univ Aachen, Inst Pathol, Med Ctr, Aachen, Germany; [Moeckel, Diana; Lammers, Twan] Univ Aachen, Ctr Biohybrid Med Syst, Med Ctr, Inst Expt Mol Imaging, Aachen, Germany; [Teuben, Michel (Paul Johan)] Univ Hosp Zurich, Dept Trauma, Zurich, Switzerland; [Teuben, Michel (Paul Johan)] Univ Hosp Zurich, Harald Tscherne Lab, Zurich, Switzerland; [Poeze, Martijn] Maastricht Univ, Dept Surg, Div Traumasurg, Med Ctr, Maastricht, Netherlands		Hofman, M (corresponding author), Univ Aachen, Dept Orthoped Trauma & Reconstruct Surg, Med Ctr, Aachen, Germany.	mhofman@ukaachen.de	Lammers, Twan/U-2794-2018	Lammers, Twan/0000-0002-1090-6805	START-Program of the Faculty of Medicine, RWTH Aachen, Germany	This research project was supported by the START-Program of the Faculty of Medicine, RWTH Aachen, Germany.	Apel PJ, 2009, J BONE JOINT SURG AM, V91A, P2886, DOI 10.2106/JBJS.H.01878; ARO H, 1985, ACTA ORTHOP SCAND, V56, P233, DOI 10.3109/17453678508993002; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Cadosch D, 2010, J BONE JOINT SURG AM, V92A, P645, DOI 10.2106/JBJS.I.00097; Cherruau M, 1999, BONE, V25, P545, DOI 10.1016/S8756-3282(99)00211-2; Davis EL, 2018, BONE, V109, P22, DOI 10.1016/j.bone.2017.07.016; EMONDSALT X, 1993, EUR J PHARMACOL, V250, P403, DOI 10.1016/0014-2999(93)90027-F; Goto T, 2007, NEUROPEPTIDES, V41, P25, DOI 10.1016/j.npep.2006.11.002; Gremse F, 2016, THERANOSTICS, V6, P328, DOI 10.7150/thno.13624; Hegde A, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/601098; Heiner DE, 2006, J ORTHOP TRAUMA, V20, P27, DOI 10.1097/01.bot.0000184143.90448.aa; Hickman DL, 2010, J AM ASSOC LAB ANIM, V49, P155; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Hollensteiner M, 2016, IEEE ENG MED BIO, P2202, DOI 10.1109/EMBC.2016.7591166; HUKKANEN M, 1995, CLIN ORTHOP RELAT R, P247; Imai S, 2002, MICROSC RES TECHNIQ, V58, P61, DOI 10.1002/jemt.10119; Irie K, 2002, MICROSC RES TECHNIQ, V58, P85, DOI 10.1002/jemt.10122; Kan LX, 2011, J CELL BIOCHEM, V112, P2759, DOI 10.1002/jcb.23259; Kingery WS, 2003, BONE, V33, P927, DOI 10.1016/j.bone.2003.07.003; Lerner U. H., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P440; Lerner U. H., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P154; Li JA, 2010, J ORTHOP RES, V28, P1643, DOI 10.1002/jor.21169; Liu D, 2007, NEUROPEPTIDES, V41, P271, DOI 10.1016/j.npep.2007.05.003; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Lorente L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0911-z; Ma WH, 2015, BRAZ J MED BIOL RES, V48, P299, DOI 10.1590/1414-431X20144226; Madsen JE, 1998, CLIN ORTHOP RELAT R, P230; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Meyer RA, 2006, J ORTHOP RES, V24, P1933, DOI 10.1002/jor.20124; Milad MR, 2009, NEUROSCIENCE, V164, P887, DOI 10.1016/j.neuroscience.2009.09.011; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Niedermair T, 2014, MATRIX BIOL, V38, P22, DOI 10.1016/j.matbio.2014.06.007; NORDSLETTEN L, 1994, ACTA ORTHOP SCAND, V65, P299, DOI 10.3109/17453679408995457; Oberkircher L, 2016, J NEUROSURG-SPINE, V24, P580, DOI 10.3171/2015.6.SPINE15176; Offley SC, 2005, J BONE MINER RES, V20, P257, DOI 10.1359/JBMR.041108; Pagan B, 2010, ANTICANCER RES, V30, P3345; SANTAVIRTA S, 1992, ACTA ORTHOP SCAND, V63, P579; Shih C, 1997, PEPTIDES, V18, P323, DOI 10.1016/S0196-9781(96)00280-X; Takee Atsushi, 2002, J Orthop Sci, V7, P544, DOI 10.1007/s007760200097; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Wang LP, 2009, BONE, V45, P309, DOI 10.1016/j.bone.2009.04.203	42	7	9	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 5	2019	9								9744	10.1038/s41598-019-46278-6			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IH1DG	WOS:000474230900024	31278316	Green Published, Green Accepted, gold			2022-02-06	
J	Haran, FJ; Handy, JD; Servatius, RJ; Rhea, CK; Tsao, JW				Haran, F. J.; Handy, Justin D.; Servatius, Richard J.; Rhea, Christopher K.; Tsao, Jack W.			Acute neurocognitive deficits in active duty service members following subconcussive blast exposure	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Blast injury; mild traumatic brain injury; military; neurocognitive	TRAUMATIC BRAIN-INJURY; LOW-LEVEL BLAST; COGNITIVE-BEHAVIORAL THERAPY; POST-CONCUSSIVE SYMPTOMS; SPORT-RELATED CONCUSSION; BASE-LINE; NEUROPSYCHOLOGICAL OUTCOMES; NORMATIVE COMPARISONS; CLINICAL-SIGNIFICANCE; OEF/OIF VETERANS	Military service members are frequently subjected to subconcussive blast events during training and deployment. Emerging evidence suggests blast exposures of these magnitudes may have long-term consequences for dimensions of cognitive function. Less is known about cognitive sequelae acutely following deployment-related subconcussive blast events. The current study addressed this knowledge gap by assessing the extent to which subconcussive blast exposure affected performance on the Automated Neuropsychological Assessment Metrics 4 TBI-MIL (ANAM). Baseline-referenced and normative comparisons of archival ANAM data were analyzed for a cohort of personnel who were exposed to blast (blast group; n = 27) and personnel who were not exposed to blast (no-blast group; n = 36) that were otherwise asymptomatic for a concussion. The blast group exhibited statistically significant lower scores compared to the no-blast group (between-subjects), baseline assessments (within-subjects), and an age-matched normative population. Normative comparisons revealed that the scores for the reaction time subtests (i.e., procedural and both simple reaction time tasks) were outside the range of normal functioning (1 SD) and reliable change indices revealed clinically meaningful change only for simple reaction time. The results highlight covert effects of subconcussive blast exposure that may warrant further monitoring in the immediate aftermath of a blast event.	[Haran, F. J.] Naval Med Res Ctr, Neurotrauma Dept, Silver Spring, MD USA; [Haran, F. J.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Haran, F. J.; Rhea, Christopher K.] Univ N Carolina, Dept Kinesiol, Greensboro, NC USA; [Handy, Justin D.; Servatius, Richard J.] Stress & Motivated Behav Inst, Syracuse, NY USA; [Servatius, Richard J.] Syracuse VA Med Ctr, Res & Dev, Syracuse, NY USA; [Servatius, Richard J.] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA; [Tsao, Jack W.] Univ Tennessee, Ctr Hlth Sci, Dept Neurol, Memphis, TN 38163 USA; [Tsao, Jack W.] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA; [Tsao, Jack W.] Memphis Vet Affairs Med Ctr, Dept Neurol, Memphis, TN USA		Haran, FJ (corresponding author), Naval Med Res Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	francis.j.haran.mil@mail.mil			Navy Bureau of Medicine and Surgery Wounded, Ill, and Injury Program [255]	This report was supported by Navy Bureau of Medicine and Surgery Wounded, Ill, and Injury Program under Project #255. The authors report no conflicts of interest. The views expressed in this article are those of the author and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government. LCDR Haran is a military service member. This work was prepared as part of his official duties. Title 17 U.S.C. 105 provides that "Copyright protection under this title is not available for any work of the United States Government." Title 17 U.S.C. 101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person's official duties.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abramowitz JS, 1998, BEHAV THER, V29, P339, DOI 10.1016/S0005-7894(98)80012-9; Barwick F, 2012, CLIN NEUROPHYSIOL, V123, P278, DOI 10.1016/j.clinph.2011.06.027; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00128; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Cohen J., 1992, CURR DIR PSYCHOL SCI, V1, P98, DOI [DOI 10.2307/20182143, DOI 10.1111/1467-8721.EP10768783]; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Cribbie RA, 2004, J CLIN PSYCHOL, V60, P1, DOI 10.1002/jclp.10217; Cribbie RA, 2009, PSYCHOTHER RES, V19, P677, DOI 10.1080/10503300902926554; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Dretsch M, 2015, APPL NEUROPSYCH-ADUL, V22, P304, DOI 10.1080/23279095.2014.926454; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Faber LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048073; Fish L., 2018, PROTECTING WARFIGHTE; Grande LJ, 2018, J INT NEUROPSYCH SOC, V24, P466, DOI 10.1017/S1355617717001242; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Haran FJ, 2016, J HEAD TRAUMA REHAB, V31, P329, DOI 10.1097/HTR.0000000000000172; Haran FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079595; Haran FJ, 2016, BRAIN INJURY, V30, P280, DOI 10.3109/02699052.2015.1118766; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kelly JC, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/371970; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kendall PC, 1999, J CONSULT CLIN PSYCH, V67, P285, DOI 10.1037/0022-006X.67.3.285; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kucherov Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4765727; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Lundgren JD, 2004, INT J EAT DISORDER, V35, P262, DOI 10.1002/eat.10254; MacDonald J, 2018, J PEDIATR-US, V194, P177, DOI 10.1016/j.jpeds.2017.10.032; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; ROGERS JL, 1993, PSYCHOL BULL, V113, P553, DOI 10.1037/0033-2909.113.3.553; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schatz P, 2014, J ATHL TRAINING, V49, P659, DOI 10.4085/1062-6050-49.3.37; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Servatius RJ, 2018, J NEUROTRAUM, V35, P1008, DOI 10.1089/neu.2017.5314; Servatius RJ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01513; Sheldrick RC, 2001, CLIN PSYCHOL-SCI PR, V8, P418, DOI 10.1093/clipsy/8.4.418; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stone JR, 2013, J NEUROTRAUM, V30, pA120; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	76	7	7	1	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAY 4	2021	28	3					297	309		10.1080/23279095.2019.1630627		JUL 2019	13	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	RG2HQ	WOS:000475095300001	31269805				2022-02-06	
J	Kaminski, TW; Thompson, A; Wahlquist, VE; Glutting, J				Kaminski, Thomas W.; Thompson, Adam; Wahlquist, Victoria E.; Glutting, Joseph			Self-reported head injury symptoms exacerbated in those with previous concussions following an acute bout of purposeful soccer heading	RESEARCH IN SPORTS MEDICINE			English	Article						Self-reported; soccer; concussion; heading	POSTURAL CONTROL; SEX	Rates of concussion in soccer are high, especially in female players. The primary aim of this study was to examine differences in self-reported concussion-related symptoms (CRS), balance (BESS), and neurocognitive performance (ImPACT) following an acute bout of soccer heading in a group of female collegiate players with and without a history of concussion. Eighty-seven players with 0 to 3+ previous concussions participated. The measurement variables were assessed before and after heading sessions; including one linear and one rotational bout. Players with concussion histories reported more CRS than their non-concussed teammates both before and after the heading sessions. Balance and neurocognitive scores were generally unaffected. This finding should heighten our awareness to carefully monitor soccer players who have experienced concussions and be aware that they may develop concussion-like symptoms, especially after acute bouts of heading either during practice or in matches. The long-term implications of this finding remain unknown.	[Kaminski, Thomas W.; Wahlquist, Victoria E.] Univ Delaware, Athlet Training Res Lab, Dept Kinesiol & Appl Physiol, Room 159 Fred Rust Ice Arena,541 South Coll Ave, Newark, DE 19716 USA; [Thompson, Adam] Crozer Chester Med Ctr, Family Med, Springfield, PA USA; [Glutting, Joseph] Univ Delaware, Sch Educ, Newark, DE USA		Kaminski, TW (corresponding author), Univ Delaware, Athlet Training Res Lab, Dept Kinesiol & Appl Physiol, Room 159 Fred Rust Ice Arena,541 South Coll Ave, Newark, DE 19716 USA.	Kaminski@udel.edu					Barker DH, 2014, J PEDIATR PSYCHOL, V39, P233, DOI 10.1093/jpepsy/jst082; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; Caccese JB, 2021, CLIN J SPORT MED, V31, P266, DOI 10.1097/JSM.0000000000000709; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Harriss A, 2018, RES SPORTS MED, V26, P191, DOI 10.1080/15438627.2018.1431534; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Hunter LE, 2018, RES SPORTS MED, V26, P390, DOI 10.1080/15438627.2018.1492396; Hunter LE, 2019, NEUROBIOL DIS, V123, P122, DOI 10.1016/j.nbd.2018.06.016; Jamieson, 2004, METHODS PSYCHOL RES, V9, P37; Keith T.Z., 2006, MULTIPLE REGRESSION; Kenny D. A., 2013, CHANGE SCORE ANAL IN; Kontos AP, 2017, BRIT J SPORT MED, V51, P1118, DOI 10.1136/bjsports-2016-096276; Lincoln A. E., AM J SPORTS MED, V39, P958; Long A.S., 2019, ATHL TRAIN SPORTS HL, V11, P28; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Manalac FJ, 2019, CLIN J SPORT MED, V29, P1, DOI 10.1097/JSM.0000000000000518; Mangus Brent C, 2004, Sports Biomech, V3, P209, DOI 10.1080/14763140408522841; Oldham JR, 2017, SPORTS HEALTH, V9, P305, DOI 10.1177/1941738116680999; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Rieder C, 2011, ARCH CLIN NEUROPSYCH, V26, P583, DOI 10.1093/arclin/acr055; Riemann B. L., 1997, J SPORT REHABIL, V8, P71; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Tysvaer A, 1981, Br J Sports Med, V15, P163	33	7	7	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.	APR 2	2020	28	2					217	230		10.1080/15438627.2019.1635130		JUL 2019	14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	LK7PT	WOS:000475245900001	31257930				2022-02-06	
J	Stienen, MN; Geisseler, O; Velz, J; Maldaner, N; Sebok, M; Dannecker, N; Rothacher, Y; Schlosser, L; Smoll, NR; Keller, E; Brugger, P; Regli, L				Stienen, Martin Nikolaus; Geisseler, Olivia; Velz, Julia; Maldaner, Nicolai; Sebok, Martina; Dannecker, Noemi; Rothacher, Yannick; Schlosser, Ladina; Smoll, Nicolas Roydon; Keller, Emanuela; Brugger, Peter; Regli, Luca			Influence of the Intensive Care Unit Environment on the Reliability of the Montreal Cognitive Assessment	FRONTIERS IN NEUROLOGY			English	Article						Montreal Cognitive Assessment; intensive care unit; reliability; neuropsychology; cognitive evaluation; neuropsychological assessment; test quality; stroke	IMPAIRMENT	Background: Neuropsychological screening becomes increasingly important for the evaluation of subarachnoid hemorrhage (SAH) and stroke patients. It is often performed during the surveillance period on the intensive (ICU), while it remains unknown, whether the distraction in this environment influences the results. We aimed to study the reliability of the Montreal Cognitive Assessment (MoCA) in the ICU environment. Methods: Consecutive stable patients with recent brain injury (tumor, trauma, stroke, etc.) were evaluated twice within 36 h using official parallel versions of the MoCA (Delta MoCA). The sequence of assessment was randomized into (a) busy ICU first or (b) quiet office first with subsequent crossover. For repeated MoCA, we determined sequence, period, location effects, and the intraclass correlation coefficient (ICC). Results: N = 50 patients were studied [n = 30 (60%) male], with a mean age of 57 years. The assessment's sequence [ICU first" mean Delta MoCA -1.14 (SD 2.34) vs. "Office first" -0.73 (SD 1.52)] did not influence the MoCA (p = 0.47). On the 2nd period, participants scored 0.96 points worse (SD 2.01; p = 0.001), indicating no MoCA learning effect but a possible difference in parallel versions. There was no location effect (p = 0.31) with Delta MoCA between locations (Office minus ICU) of -0.32 (SD 2.21). The ICC for repeated MoCA was 0.87 (95% CI 0.79-0.92). Conclusions: The reliability of the MoCA was excellent, independent from the testing environment being ICU or office. This finding is helpful for patient care and studies investigating the effect of a therapeutic intervention on the neuropsychological outcome after SAH, stroke or traumatic brain injury.	[Stienen, Martin Nikolaus; Velz, Julia; Maldaner, Nicolai; Sebok, Martina; Keller, Emanuela; Regli, Luca] Univ Zurich, Univ Hosp Zurich, Dept Neurosurg, Zurich, Switzerland; [Stienen, Martin Nikolaus; Geisseler, Olivia; Velz, Julia; Maldaner, Nicolai; Sebok, Martina; Dannecker, Noemi; Rothacher, Yannick; Schlosser, Ladina; Keller, Emanuela; Brugger, Peter; Regli, Luca] Univ Zurich, Univ Hosp Zurich, Clin Neurosci Ctr, Zurich, Switzerland; [Geisseler, Olivia; Dannecker, Noemi; Rothacher, Yannick; Schlosser, Ladina; Brugger, Peter] Univ Zurich, Univ Hosp Zurich, Dept Neurol, Neuropsychol Unit, Zurich, Switzerland; [Smoll, Nicolas Roydon] Univ Melbourne, Sch Populat & Global Hlth, Carlton, Vic, Australia		Stienen, MN (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Neurosurg, Zurich, Switzerland.; Stienen, MN (corresponding author), Univ Zurich, Univ Hosp Zurich, Clin Neurosci Ctr, Zurich, Switzerland.	mnstienen@gmail.com	; Smoll, Nicolas/D-3322-2013	Dannecker, Noemi/0000-0001-6761-9674; Keller, Emanuela, Elisabeth, Sophia/0000-0002-7560-7574; Smoll, Nicolas/0000-0002-6923-9701; Velz, Julia/0000-0001-8027-9918; Sebok, Martina/0000-0002-7246-3421	Department of Neurosurgery, University Hospital Zurich; Idorsia Pharmaceuticals Ltd.	This research was financed by the Department of Neurosurgery, University Hospital Zurich. It was financially supported by Idorsia Pharmaceuticals Ltd. The external funding source was not involved and did not influence the data collection, measurements, interpretation, or drafting of the manuscript.	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Gill DJ, 2008, MOVEMENT DISORD, V23, P1043, DOI 10.1002/mds.22017; Peters C, 2012, NEUROL INT, V4, P9, DOI 10.4081/ni.2012.e3; Schweizer TA, 2012, J NEUROL SCI, V316, P137, DOI 10.1016/j.jns.2012.01.003; Stienen MN, 2019, NEUROCRIT CARE, V30, P102, DOI 10.1007/s12028-019-00737-0; Stienen MN, 2019, NEUROSURGERY, V84, P1124, DOI 10.1093/neuros/nyy155; Suarez JI, 2019, NEUROCRIT CARE, V30, P4, DOI 10.1007/s12028-019-00723-6; Wong GKC, 2017, J CLIN NEUROSCI, V46, P41, DOI 10.1016/j.jocn.2017.08.039; Wong GKC, 2012, J NEUROL NEUROSUR PS, V83, P1112, DOI 10.1136/jnnp-2012-302217; Zweifel-Zehnder AE, 2015, ACTA NEUROCHIR, V157, P1449, DOI 10.1007/s00701-015-2480-y	11	7	7	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 3	2019	10								734	10.3389/fneur.2019.00734			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IG3DU	WOS:000473682400001	31333576	gold, Green Published, Green Accepted			2022-02-06	
J	Tsushima, WT; Ahn, HJ; Siu, AM; Yoshinaga, K; Choi, SY; Murata, NM				Tsushima, William T.; Ahn, Hyeong Jun; Siu, Andrea M.; Yoshinaga, Kara; Choi, So Yung; Murata, Nathan M.			Effects of repetitive subconcussive head trauma on the neuropsychological test performance of high school athletes: A comparison of high, moderate, and low contact sports	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Contact; high school; neuropsychological; Subconcussive		The aim of this study was to examine the neuropsychological test results of non-concussed high school athletes playing at three different levels of contact sports. Based on the concussion risk data of 12 different sports, a High Contact group (n=2819; wrestling/martial arts, cheerleading, track and field, football), a Moderate Contact group (n=2323; softball, basketball, soccer), and a Low Contact group (n=1580; baseball, volleyball, water polo, tennis, cross-country) were formed and compared in terms of their scores on the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT). The results revealed that the High Contact group obtained small but statistically poorer performances in ImPACT Visual Memory, Visual Motor Speed, Impulse Control, and Total Symptom scores compared to the Moderate and Low Contact groups. The High Contact group also had poorer Reaction Time scores compared to the Low Contact group. No differences between the Moderate and Low Contact groups were noted. The findings, along with prior similar results, tentatively raise concerns that participant in high contact sports, exposed to repetitive subconcussive head trauma, may be at greater risk for lowered neuropsychological functioning and increased symptoms, compared to other high school athletes. In view of the preliminary nature of this investigation, more research into the effects of frequent head impacts in high school sports is strongly recommended.	[Tsushima, William T.] Straub Med Ctr, Psychiat & Psychol Dept, 888 South King St, Honolulu, HI 96813 USA; [Ahn, Hyeong Jun] Univ Hawaii, John A Burns Sch Med, Off Biostat & Quantitat Hlth Sci, Honolulu, HI 96822 USA; [Siu, Andrea M.] Hawaii Pacific Hlth, Res Inst, Honolulu, HI USA; [Yoshinaga, Kara] Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA; [Choi, So Yung] Univ Hawaii, John A Burns Sch Med, Dept Complementary & Integrat Med, Honolulu, HI 96822 USA; [Murata, Nathan M.] Univ Hawaii Manoa, Dept Kinesiol & Rehabil Sci, Honolulu, HI 96822 USA		Tsushima, WT (corresponding author), Straub Med Ctr, Psychiat & Psychol Dept, 888 South King St, Honolulu, HI 96813 USA.	wtsushima@straub.net		Choi, So Yung/0000-0002-1081-4951	National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD007584]	Hyeong Jun Ahn and So Yung Choi were partially supported by grant U54MD007584 from the National Institute on Minority Health and Health Disparities.	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Comstock R. D., 2016, NATL HIGH SCH SPORTS; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Datalys Center for Sports Injury Research and Prevention, 2013, NATA NATION PRELIMIN; Davenport Elizabeth M, 2016, Concussion, V1, pCNC19, DOI 10.2217/cnc-2016-0003; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Knowles SB, 2006, J ATHL TRAINING, V41, P347; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell M. R., 2006, SPORTS NEUROPSYCHOLO, P193; Lovell M.R., 2012, IMPACT WEBSITE; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Randolph C, 2005, J ATHL TRAINING, V40, P139; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; SAS Institute Inc, 2011, BASE SAS 9 3 PROCEDU; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tsushima WT, 2018, APPL NEUROPSYCH-CHIL, V7, P14, DOI 10.1080/21622965.2016.1220860; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; Tsushima William T, 2014, Hawaii J Med Public Health, V73, P208; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	46	7	7	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JUL 3	2019	8	3					223	230		10.1080/21622965.2018.1427095			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	VJ5KA	WOS:000607416600004	29393677				2022-02-06	
J	Arlehamn, CSL; Pham, J; Alcalay, RN; Frazier, A; Shorr, E; Carpenter, C; Sidney, J; Dhanwani, R; Agin-Liebes, J; Garretti, F; Amara, AW; Standaert, DG; Phillips, EJ; Mallal, SA; Peters, B; Sulzer, D; Sette, A				Arlehamn, Cecilia S. Lindestam; Pham, John; Alcalay, Roy N.; Frazier, April; Shorr, Evan; Carpenter, Chelsea; Sidney, John; Dhanwani, Rekha; Agin-Liebes, Julian; Garretti, Francesca; Amara, Amy W.; Standaert, David G.; Phillips, Elizabeth J.; Mallal, Simon A.; Peters, Bjoern; Sulzer, David; Sette, Alessandro			Widespread Tau-Specific CD4 T Cell Reactivity in the General Population	JOURNAL OF IMMUNOLOGY			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; HLA-DR; ALZHEIMERS-DISEASE; NEURODEGENERATION; MICROGLIA; DEMENTIA; ANTIGENS; PROTEIN; MAPT	Tau protein is found to be aggregated and hyperphosphorylated (p-tau) in many neurologic disorders, including Parkinson disease (PD) and related parkinsonisms, Alzheimer disease, traumatic brain injury, and even in normal aging. Although not known to produce autoimmune responses, we hypothesized that the appearance of aggregated tau and p-tau with disease could activate the immune system. We thus compared T cell responses to tau and p-tau-derived peptides between PD patients, age-matched healthy controls, and young healthy controls (<35 y old; who are less likely to have high levels of tau aggregates). All groups exhibited CD4+ T cell responses to tau-derived peptides, which were associated with secretion of IFN-gamma, IL-5, and/or IL-4. The PD and control participants exhibited a similar magnitude and breadth of responses. Some tau-derived epitopes, consisting of both unmodified and p-tau residues, were more highly represented in PD participants. These results were verified in an independent set of PD and control donors (either age-matched or young controls). Thus, T cells recognizing tau epitopes escape central and peripheral tolerance in relatively high numbers, and the magnitude and nature of these responses are not modulated by age or PD disease.	[Arlehamn, Cecilia S. Lindestam; Pham, John; Frazier, April; Carpenter, Chelsea; Sidney, John; Dhanwani, Rekha; Peters, Bjoern; Sette, Alessandro] La Jolla Inst Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Alcalay, Roy N.; Sulzer, David] Columbia Univ, New York State Psychiat Inst, Irving Med Ctr, Dept Neurol, New York, NY 10032 USA; [Shorr, Evan; Agin-Liebes, Julian; Garretti, Francesca; Sulzer, David] Columbia Univ, New York State Psychiat Inst, Irving Med Ctr, Dept Psychiat, New York, NY 10032 USA; [Shorr, Evan; Agin-Liebes, Julian; Garretti, Francesca; Sulzer, David] Columbia Univ, New York State Psychiat Inst, Irving Med Ctr, Dept Pharmacol, New York, NY 10032 USA; [Amara, Amy W.; Standaert, David G.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35233 USA; [Phillips, Elizabeth J.; Mallal, Simon A.] Vanderbilt Univ, Sch Med, 221 Kirkland Hall, Nashville, TN 37235 USA; [Phillips, Elizabeth J.; Mallal, Simon A.] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA 6150, Australia; [Peters, Bjoern; Sette, Alessandro] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA		Sette, A (corresponding author), La Jolla Inst Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.	alex@lji.org		Garretti, Francesca/0000-0002-6609-8034; Amara, Amy/0000-0003-0762-9656; Lindestam Arlehamn, Cecilia/0000-0001-7302-8002; Standaert, David/0000-0003-2921-8348; Shorr, Evan/0000-0003-4521-3993	National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS095435]; Parkinson's Foundation; Michael J. Fox Foundation; Jeffry M. Picower Foundation; William F. Richter Foundation; University of California, San Diego, La Jolla Institute Program in Immunology funding; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS095435] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke R01NS095435 (to A.S. and D.G.S.), the Parkinson's Foundation (to A.S. and D.G.S.), the Michael J. Fox Foundation (to A.S. and D.G.S.), the Jeffry M. Picower Foundation (to D.G.S.), the William F. Richter Foundation (to D.G.S.), and University of California, San Diego, La Jolla Institute Program in Immunology funding (to A.S.).	Alcalay RN, 2016, JAMA NEUROL, V73, P1282, DOI 10.1001/jamaneurol.2016.3335; Andreatta M, 2015, IMMUNOGENETICS, V67, P641, DOI 10.1007/s00251-015-0873-y; Arlehamn CSL, 2012, J IMMUNOL, V188, P5020, DOI 10.4049/jimmunol.1103556; Arnold SE, 2013, J COMP NEUROL, V521, P4339, DOI 10.1002/cne.23430; Bartos A, 2012, J NEUROIMMUNOL, V252, P100, DOI 10.1016/j.jneuroim.2012.08.001; Bernard-Valnet R, 2016, P NATL ACAD SCI USA, V113, P10956, DOI 10.1073/pnas.1603325113; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Cebrian C, 2015, CURR TOP BEHAV NEURO, V22, P237, DOI 10.1007/7854_2014_356; Cebrian C, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00114; Cook DA, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-017-0010-8; Davis AA, 2016, NEUROBIOL AGING, V37, DOI 10.1016/j.neurobiolaging.2015.09.014; Desikan RS, 2015, MOL PSYCHIATR, V20, P1588, DOI 10.1038/mp.2015.6; Duka V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075025; Foulds PG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02540; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Ghidoni R, 2006, NEUROBIOL DIS, V22, P357, DOI 10.1016/j.nbd.2005.11.013; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Harms AS, 2018, EXP NEUROL, V300, P179, DOI 10.1016/j.expneurol.2017.11.010; Harms AS, 2013, J NEUROSCI, V33, P9592, DOI 10.1523/JNEUROSCI.5610-12.2013; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Irwin D, 2017, LANCET NEUROL, V16, P55, DOI 10.1016/S1474-4422(16)30291-5; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Koehler NKU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064649; Kornum BR, 2017, J NEUROIMMUNOL, V309, P7, DOI 10.1016/j.jneuroim.2017.05.001; Latorre D, 2018, NATURE, V562, P63, DOI 10.1038/s41586-018-0540-1; Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Moehle MS, 2015, NEUROSCIENCE, V302, P59, DOI 10.1016/j.neuroscience.2014.11.018; Mogi M, 2007, NEUROSCI LETT, V414, P94, DOI 10.1016/j.neulet.2006.12.003; Mohan JF, 2012, NAT REV IMMUNOL, V12, P721, DOI 10.1038/nri3294; Moussaud S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-43; Oseroff C, 2012, J IMMUNOL, V189, P1800, DOI 10.4049/jimmunol.1200850; Oseroff C, 2010, J IMMUNOL, V185, P943, DOI 10.4049/jimmunol.1000405; Pascual G, 2017, ACTA NEUROPATHOL, V133, P767, DOI 10.1007/s00401-017-1705-y; Sadegh-Nasseri S, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00372; Schulten V, 2013, P NATL ACAD SCI USA, V110, P8750, DOI 10.1073/pnas.1307233110; Schulten V, 2013, P NATL ACAD SCI USA, V110, P5269, DOI 10.1073/pnas.1303818110; Schulten V, 2013, P NATL ACAD SCI USA, V110, P3459, DOI 10.1073/pnas.1300512110; Sengupta U, 2015, BIOL PSYCHIAT, V78, P672, DOI 10.1016/j.biopsych.2014.12.019; Sharma M, 2012, NEUROLOGY, V79, P659, DOI 10.1212/WNL.0b013e318264e353; Sidney J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177140; Sidney J, 2010, J IMMUNOL, V185, P4189, DOI 10.4049/jimmunol.1001006; Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655; Southwood S, 1998, J IMMUNOL, V160, P3363; Spillantini MG, 1998, BRAIN PATHOL, V8, P387; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sulzer D, 2017, NATURE, V546, P656, DOI 10.1038/nature22815; TOOYAMA I, 1990, BRAIN RES, V523, P273, DOI 10.1016/0006-8993(90)91496-4; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Wissemann WT, 2013, AM J HUM GENET, V93, P984, DOI 10.1016/j.ajhg.2013.10.009; Xing Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006957; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163; Zhang CC, 2016, MOL NEUROBIOL, V53, P4893, DOI 10.1007/s12035-015-9415-8	60	7	7	0	3	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	JUL 1	2019	203	1					84	92		10.4049/jimmunol.1801506			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7AZ	WOS:000471835400010	31085590	Bronze, Green Accepted			2022-02-06	
J	Boshra, R; Dhindsa, K; Boursalie, O; Ruiter, KI; Sonnadara, R; Samavi, R; Doyle, TE; Reilly, JP; Connolly, JF				Boshra, Rober; Dhindsa, Kiret; Boursalie, Omar; Ruiter, Kyle, I; Sonnadara, Ranil; Samavi, Reza; Doyle, Thomas E.; Reilly, James P.; Connolly, John F.			From Group-Level Statistics to Single-Subject Prediction: Machine Learning Detection of Concussion in Retired Athletes	IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING			English	Article						Event-related potentials; brain injury; electroencephalography; EEG; concussions; machine learning; explainable models	EVENT-RELATED POTENTIALS; LONG-TERM; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SPORT HELD; EEG; CLASSIFICATION; REDUCTION; DEFICITS; HISTORY	There has been increased effort to understand the neurophysiological effects of concussion aimed to move diagnosis and identification beyond current subjective behavioral assessments that suffer from poor sensitivity. Recent evidence suggests that event-related potentials (ERPs) measured with electroencephalography (EEG) are persistent neurophysiological markers of past concussions. However, as such evidence is limited to group-level analyzes, the extent to which they enable concussion detection at the individual-level is unclear. One promising avenue of research is the use of machine learning to create quantitative predictive models that can detect prior concussions in individuals. In this paper, we translate the recent group-level findings from ERP studies of concussed individuals into a machine learning framework for performing single-subject prediction of past concussion. We found that a combination of statistics of single-subject ERPs and wavelet features yielded a classification accuracy of 81% with a sensitivity of 82% and a specificity of 80%, improving on current practice. Notably, the model was able to detect concussion effects in individuals who sustained their last injury as much as 30 years earlier. However, failure to detect past concussions in a subset of individuals suggests that the clear effects found in group-level analyses may not provide us with a full picture of the neurophysiological effects of concussion.	[Boshra, Rober; Boursalie, Omar; Sonnadara, Ranil; Doyle, Thomas E.; Reilly, James P.; Connolly, John F.] McMaster Univ, Sch Biomed Engn, Hamilton, ON L8S 4L8, Canada; [Boshra, Rober; Dhindsa, Kiret; Ruiter, Kyle, I; Sonnadara, Ranil; Reilly, James P.; Connolly, John F.] McMaster Univ, ARiEAL Res Ctr, Hamilton, ON L8S 4L8, Canada; [Boshra, Rober; Dhindsa, Kiret; Boursalie, Omar; Sonnadara, Ranil; Samavi, Reza; Doyle, Thomas E.; Reilly, James P.; Connolly, John F.] Vector Inst, Toronto, ON M5G 1M1, Canada; [Sonnadara, Ranil] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; [Samavi, Reza] McMaster Univ, Dept Comp & Software, Hamilton, ON L8S 4L8, Canada; [Samavi, Reza; Doyle, Thomas E.] McMaster Univ, eHlth Grad Program, Hamilton, ON L8S 4L8, Canada; [Doyle, Thomas E.; Reilly, James P.] McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON L8S 4L8, Canada		Boshra, R; Connolly, JF (corresponding author), McMaster Univ, Sch Biomed Engn, Hamilton, ON L8S 4L8, Canada.	boshrar@mcmaster.ca; jconnol@mcmaster.ca	Boshra, Rober/AAE-6466-2019; Reilly, James/AAT-9223-2021; Sonnadara, Ranil/AAT-4794-2021	Boshra, Rober/0000-0003-2925-199X; Sonnadara, Ranil/0000-0001-8318-5714; Reilly, Jim/0000-0002-4109-1186; Connolly, John/0000-0001-8869-5369; Samavi, Reza/0000-0001-6768-0168; Doyle, Thomas/0000-0003-1059-110X; Dhindsa, Kiret/0000-0003-4849-732X	Hamilton Spectator; Senator William McMaster Chair in Cognitive Neuroscience of Language; Natural Sciences & Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Southern Ontario Smart Computing Innovation Platform (SOSCIP); Ontario Ministry of Research and InnovationMinistry of Research and Innovation, Ontario; Canada Foundation for InnovationCanada Foundation for InnovationCGIAR	This work was supported in part by The Hamilton Spectator, Canada Foundation for Innovation (JFC), in part by the Senator William McMaster Chair in Cognitive Neuroscience of Language (JFC), in part by the Natural Sciences & Engineering Research Council of Canada (NSERC; OB, JPR, RS, and TD), in part by the Southern Ontario Smart Computing Innovation Platform (SOSCIP; OB, RS, and TD), and in part by the Ontario Ministry of Research and Innovation (RB).	Armanfard N, 2019, IEEE J BIOMED HEALTH, V23, P1794, DOI 10.1109/JBHI.2018.2877738; Blankertz B, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00530; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Brush CJ, 2018, INT J PSYCHOPHYSIOL, V132, P124, DOI 10.1016/j.ijpsycho.2017.10.006; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Cao C, 2008, IEEE T NEUR SYS REH, V16, P327, DOI 10.1109/TNSRE.2008.918422; Cao C, 2011, CLIN NEUROPHYSIOL, V122, P1314, DOI 10.1016/j.clinph.2010.12.042; Chan AM, 2011, NEUROIMAGE, V54, P3028, DOI 10.1016/j.neuroimage.2010.10.073; Combrisson E, 2015, J NEUROSCI METH, V250, P126, DOI 10.1016/j.jneumeth.2015.01.010; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; Demiralp T, 2001, BRAIN TOPOGR, V13, P251, DOI 10.1023/A:1011102628306; Dhindsa K., 2017, P INT WORKSH PATT RE, P1, DOI [DOI 10.1109/PRNI.2017.7981501, 10.1109/PRNI.2017.7981501]; Dhindsa K, 2017, NEURAL COMPUT, V29, P2742, DOI [10.1162/neco_a_01001, 10.1162/NECO_a_01001]; Fickling SD, 2019, BRAIN, V142, P255, DOI 10.1093/brain/awy317; Frishkoff G, 2011, STAND GENOMIC SCI, V5, P211, DOI 10.4056/sigs.2025347; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry LC, 2017, NEUROSCIENTIST, V23, P567, DOI 10.1177/1073858416651034; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Lin YP, 2010, IEEE T BIO-MED ENG, V57, P1798, DOI 10.1109/TBME.2010.2048568; Lotte F, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aab2f2; Lundberg S.M., 2017, P 31 INT C NEUR INF, P4768; Lundberg SM, 2018, NAT BIOMED ENG, V2, P749, DOI 10.1038/s41551-018-0304-0; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Miotto R, 2018, BRIEF BIOINFORM, V19, P1236, DOI 10.1093/bib/bbx044; Munia TTK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17414-x; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Parvar Hossein, 2015, Brain Inform, V2, P1; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Quiroga RQ, 2001, BIOL CYBERN, V84, P291, DOI 10.1007/s004220000212; Ravan M, 2015, CLIN NEUROPHYSIOL, V126, P721, DOI 10.1016/j.clinph.2014.07.017; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Ruiter KI, 2019, CLIN NEUROPHYSIOL, V130, P111, DOI 10.1016/j.clinph.2018.10.013; Sculthorpe-Petley L, 2015, J NEUROSCI METH, V245, P64, DOI 10.1016/j.jneumeth.2015.02.008; Todd J, 2008, BIOL PSYCHIAT, V63, P58, DOI 10.1016/j.biopsych.2007.02.016; Tzovara A, 2013, BRAIN, V136, P81, DOI 10.1093/brain/aws264	49	7	7	1	9	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1534-4320	1558-0210		IEEE T NEUR SYS REH	IEEE Trans. Neural Syst. Rehabil. Eng.	JUL	2019	27	7					1492	1501		10.1109/TNSRE.2019.2922553			10	Engineering, Biomedical; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Rehabilitation	IH6KG	WOS:000474603800016	31199262				2022-02-06	
J	Brown, J; Knollman-Porter, K				Brown, Jessica; Knollman-Porter, Kelly			Evaluating Cognitive-Linguistic Deficits Postconcussion in Adults Contributions of Self-Report and Standardized Measures	TOPICS IN LANGUAGE DISORDERS			English	Article						assessment; chronic deficits; cognition; communication; self-report; standardized tests	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; NEUROCOGNITIVE PERFORMANCE; ECOLOGICAL VALIDITY; CONCUSSION SYMPTOMS; EXECUTIVE FUNCTION; NIH TOOLBOX; FOOTBALL; AWARENESS; LANGUAGE	Purpose: We sought to document the cognitive-linguistic challenges experienced by 3 adults with concussion at varying lengths postinjury. Method: A multiple case study design utilized motivational interviewing techniques, 4 self-report measurement tools, and 5 standardized neurocognitive tests. The 1 female and 2 male participants were 1, 21, and 37 months postconcussion. Results: All participants self-reported cognitive and linguistic challenges significantly impacting daily functioning and quality of life. Cognitively, participants demonstrated deficits in independence, metacognition, and cognitive flexibility. Linguistically, participants demonstrated deficits in verbal memory, verbal fluency, and reading. The participant 1-month postconcussion demonstrated deficits on multiple standardized measures; however, participants in the chronic phase of recovery demonstrated substantially more self-reported deficits than were noted on standardized testing. Discussion: Evaluation of cognitive-linguistic deficits postconcussion requires both self-report and standardized measurement; however, limitations of both tools exist. We discuss clinical implications for professionals selecting testing measures for use in this population.	[Brown, Jessica] Univ Arizona, Dept Speech Language & Hearing Sci, 1131 E 2nd St, Tucson, AZ 85721 USA; Miami Univ, Dept Speech Pathol & Audiol, Oxford, OH 45056 USA		Brown, J (corresponding author), Univ Arizona, Dept Speech Language & Hearing Sci, 1131 E 2nd St, Tucson, AZ 85721 USA.	jessicabrown@email.arizona.edu					Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Benedict, 2001, HOPKINS VERBAL LEARN; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Brookshire R. H., 2007, INTRO NEUROGENIC COM, P93; Brown J., 2018, AM SPEECH LANG HEAR; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Cella D., 2017, ASSESSMENT CTR SCORI; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chmiliar L., 2012, ENCY CASE STUDY RES, P583; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Constantinidou F, 2012, BRAIN INJURY, V26, P1549, DOI 10.3109/02699052.2012.698786; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; D'Cruz K, 2016, SCAND J OCCUP THER, V23, P30, DOI 10.3109/11038128.2015.1057521; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; de Villiers J. G., 2000, CHILDRENS REASONING, P191; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dirette DK, 2007, BRAIN INJURY, V21, P1131, DOI 10.1080/02699050701687326; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Eslinger P., 2011, BRAIN INJURY MED, P990; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gresham FM, 2001, SCHOOL PSYCHOL REV, V30, P156; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Health Measures, 2018, PAT REP OUTC MEAS IN; Heaton R. K., 2004, REVISED COMPREHENSIV; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; Howell David R, 2018, Concussion, V3, pCNC54, DOI 10.2217/cnc-2017-0014; ImPACT Applications Inc, 2016, IMPACT ADM INT MAN; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Krug H., 2015, SIG 2 PERSPECTIVES N, V25, P17, DOI [10.1044/nnsld25.1.17., DOI 10.1044/NNSLD25.1.17, 10.1044/nnsld25.1.17]; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Minen M, 2017, AM J EMERG MED, V35, P365, DOI 10.1016/j.ajem.2016.10.076; Mueller JA, 2013, J SPEECH LANG HEAR R, V56, P1051, DOI 10.1044/1092-4388(2012/12-0147); Musille A. M., 2016, THESIS MIAMI U; National Institute of Neurological Disorders and Stroke, 2015, US MAN QUAL LIF NEUR; O'Neil-Pirozzi TM, 2012, BRAIN INJURY, V26, P1425, DOI 10.3109/02699052.2012.694561; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Randolph C, 2005, J ATHL TRAINING, V40, P139; Rosenbaum AM, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P137, DOI 10.1007/0-387-32565-4_7; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sohlberg M. M., 2001, COGNITIVE REHABILITA, P89; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Steel J, 2015, NEUROREHABILITATION, V37, P221, DOI 10.3233/NRE-151255; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; Togher L., 2013, SOCIAL COMMUNICATION, P89; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wechsler D., 2008, WECHSLER ADULT INTEL; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; Zelazo PD, 2013, MONOGR SOC RES CHILD, V78, P16, DOI 10.1111/mono.12032	77	7	7	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	JUL-SEP	2019	39	3			SI		239	256		10.1097/TLD.0000000000000186			18	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	IM3IN	WOS:000477887000003					2022-02-06	
J	Cournoyer, J; Hoshizaki, TB				Cournoyer, Janie; Hoshizaki, T. Blaine			Abnormal Motor Response Associated With Concussive Injuries: Biomechanical Comparison Between Impact Seizures and Loss of Consciousness	JOURNAL OF ATHLETIC TRAINING			English	Article						loss of consciousness; impact seizure; strain rate; American football	PROFESSIONAL FOOTBALL; DECEREBRATE RIGIDITY; CORTICAL IMPACT; VIDEO ANALYSIS; STRAIN-RATE; CONVULSIONS; FEATURES; SPORT	Context: Loss of consciousness (LOC) and impact seizures associated with concussion represent different clinical presentations of concussion; however, they are often investigated and treated similarly. The biomechanical parameters differentiating these 2 distinct signs of injury are poorly described. Objective: To differentiate between cases of concussions with LOC and those with impact seizures by comparing the impact velocity, peak linear and peak rotational acceleration, as well as brain tissue deformation in the cerebral cortex, white matter, brainstem, cerebellum, thalamus, and corpus callosum. Design: Descriptive laboratory study. Patients or Other Participants: Elite American football players who sustained an LOC (n = 20) or impact seizures (n = 21). Main Outcome Measure(s): Impact velocity, peak linear and peak rotational acceleration, maximum principal strain, cumulative strain damage measure at 10%, and strain rate (SR). Results: The SR in the cerebral white matter was greater in the LOC group than in the impact-seizure group. Similar trends were observed for SRs in the cerebral cortex, brainstem, and corpus callosum. No differences were present between groups for the other variables in this study. Conclusions: A lower SR in certain brain regions helps to explain why motor function is preserved and can be observed in patients with impact seizures versus LOC from concussive injuries.	[Cournoyer, Janie; Hoshizaki, T. Blaine] Univ Ottawa, Sch Human Kinet, Neurotrauma Impact Sci Lab, A106-200 Lees Ave, Ottawa, ON K1S 5S9, Canada		Cournoyer, J (corresponding author), Univ Ottawa, Sch Human Kinet, Neurotrauma Impact Sci Lab, A106-200 Lees Ave, Ottawa, ON K1S 5S9, Canada.	jcour016@uottawa.ca					ADAMS RD, 1985, PRINCIPLES NEUROLOGY; BRICOLO A, 1977, J NEUROSURG, V47, P680, DOI 10.3171/jns.1977.47.5.0680; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; DAVIS RA, 1982, NEUROSURGERY, V10, P635, DOI 10.1227/00006123-198205000-00017; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Thiele FH, 1905, J PHYSIOL-LONDON, V32, P358; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	30	7	7	0	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2019	54	7					765	771		10.4085/1062-6050-253-18			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	IT4PV	WOS:000482843900004	31343274	Green Published, gold			2022-02-06	
J	Laeke, T; Tirsit, A; Debebe, F; Girma, B; Gere, D; Park, KB; Azazh, A				Laeke, Tsegazeab; Tirsit, Abenezer; Debebe, Finot; Girma, Biruk; Gere, Desalegn; Park, Kee B.; Azazh, Aklilu			Profile of Head Injuries: Prehospital Care, Diagnosis, and Severity in an Ethiopian Tertiary Hospital	WORLD NEUROSURGERY			English	Article						Head injury; Interhospital transfer; Mortality; Prehospital care; Resource limited setup; Vital signs	TRAUMATIC BRAIN-INJURY; MORTALITY; EPIDEMIOLOGY	BACKGROUND: Consistent data on head injury is lacking especially in the low-and middle-income countries. Our study tries to characterize patients with head injury at the emergency department of one of the few tertiary public hospitals giving neurosurgical care in the country. METHODS: A retrospective cross-sectional study was performed from May 2015 to October 2015 in one of the neurosurgical teaching hospitals, Black Lion Specialized Hospital. All adult patients with head injury who visited the emergency department during the study period were included. Data on patients' sociodemographic, mechanism of trauma, clinical presentation, imaging findings, and presence of polytrauma were collected by a pretested questionnaire. The source of data was emergency department logbooks and patient charts. RESULTS: A total of 390 patients with head injury who visited the emergency department were included during the study period. There were 335 males (85.9%) and 55 females (14.1%) with the mean age (standard deviation) of 35.4 (15.6) years. Majority of patients came by taxi constituting 149 (38.2%) of all patients, whereas 147 patients (37.7%) used ambulance. Of 147 patients brought by ambulances, 133 (90.4%) were referred from other hospitals. The majority, 26 (45.6%), of patientswho came directly to the emergency department used taxis. It is shown that the mode of arrival and origin of arrival are significantly related, P = 0.000. Mortality of severe head injury at the emergency department was 50.8%. CONCLUSIONS: Prehospital care coverage was low and ambulances were used mainly for interhospital transfers. Mortality of severe head injury at the emergency department is high and significantly associated with preventable causes like vital sign derangement.	[Laeke, Tsegazeab; Tirsit, Abenezer] Addis Ababa Univ, Coll Hlth Sci, Neurosurg Unit, Addis Ababa, Ethiopia; [Laeke, Tsegazeab; Tirsit, Abenezer] Univ Bergen, Dept Clin Med, Fac Med, Bergen, Norway; [Laeke, Tsegazeab; Tirsit, Abenezer] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Debebe, Finot; Girma, Biruk; Gere, Desalegn; Azazh, Aklilu] Addis Ababa Univ, Dept Emergency Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Park, Kee B.] Harvard Med Sch, Boston, MA 02115 USA		Laeke, T (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Neurosurg Unit, Addis Ababa, Ethiopia.; Laeke, T (corresponding author), Univ Bergen, Dept Clin Med, Fac Med, Bergen, Norway.; Laeke, T (corresponding author), Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England.	tselaeke@gmail.com					Adeleye A O, 2017, Ann Ib Postgrad Med, V15, P34; Azaj A., 2013, East and Central African Journal of Surgery, V18, P108; Bank W, 2018, WORLD BANK LIST EC; Boniface R, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.46.7487; Boschini LP, 2016, INJURY, V47, P1118, DOI 10.1016/j.injury.2016.01.015; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Djientcheu V, 2016, J NEUROL SCI, V371, P100, DOI 10.1016/j.jns.2016.10.016; Hunchak Cheryl, 2015, BMC Res Notes, V8, P605, DOI 10.1186/s13104-015-1592-z; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kesinger MR, 2014, INJURY, V45, P1350, DOI 10.1016/j.injury.2014.04.037; Kraus J, 2000, EPIDEMIOLOGY BRAIN I; Kuenzler M., 2015, EMERG MED OPEN ACCES, V05, P1; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Meskere Yehune, 2015, Ethiop Med J, V53, P141; Murad MK, 2012, PREHOSP DISASTER MED, V27, P36, DOI 10.1017/S1049023X11006819; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Peeters S, 2017, WORLD NEUROSURG, V97, P580, DOI 10.1016/j.wneu.2016.09.127; Qureshi JS, 2013, INT J SURG, V11, P265, DOI 10.1016/j.ijsu.2013.01.011; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; Sultan M, 2018, BMC HEALTH SERV RES, V18, P1; Thanni L O A, 2006, Afr Health Sci, V6, P104; Tiska MA, 2004, EMERG MED J, V21, P237, DOI 10.1136/emj.2002.002097; Wolde A., 2008, East and Central African Journal of Surgery, V13, P14; World Health Organization, 2008, The global burden of disease: 2004 update	27	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2019	127						E186	E192		10.1016/j.wneu.2019.03.044			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IF5NH	WOS:000473128300026	30878740				2022-02-06	
J	Patel, MV; Sewell, E; Dickson, S; Kim, H; Meaney, DF; Firestein, BL				Patel, Mihir V.; Sewell, Emily; Dickson, Samantha; Kim, Hyuck; Meaney, David F.; Firestein, Bonnie L.			A Role for Postsynaptic Density 95 and Its Binding Partners in Models of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						APC; CCI; dendrite morphology; EB3; mechanical injury; PSD-95; stretch-induced injury; TBI	NITRIC-OXIDE SYNTHASE; CONTROLLED CORTICAL IMPACT; D-ASPARTATE RECEPTOR; 1 ADAPTER PROTEIN; MOLECULAR MECHANISMS; SYNAPTIC PROTEINS; OXIDATIVE STRESS; IN-VITRO; PSD-95; APC	Postsynaptic density 95 (PSD-95), the major scaffold protein at excitatory synapses, plays a major role in mediating intracellular signaling by synaptic N-methyl-d-aspartate (NMDA) type glutamate receptors. Despite the fact that much is known about the role of PSD-95 in NMDA-mediated toxicity, less is known about its role in mechanical injury, and more specifically, in traumatic brain injury (TBI). Given that neural circuitry is disrupted after TBI and that PSD-95 and its interactors end-binding protein 3 (EB3) and adenomatous polyposis coli (APC) shape dendrites, we examined whether changes to these proteins and their interactions occur after brain trauma. Here, we report that total levels of PSD-95 and the interaction of PSD-95 with EB3 increase at 1 and 7 days after moderate controlled cortical impact (CCI), but these changes do not occur after mild injury. Because changes occur to PSD-95 following brain trauma in vivo, we next considered the functional consequences of PSD-95 alterations in vitro. Rapid deformation of cortical neurons leads to neuronal death 72 h after injury, but this outcome is not dependent on PSD-95 expression. However, disruptions in dendritic arborization following stretch injury in vitro require PSD-95 expression, and these changes in arborization can be mimicked with expression of PSD-95 mutants lacking the second PDZ domain. Thus, PSD-95 and its interactors may serve as therapeutic targets for repairing dendrites after TBI.	[Patel, Mihir V.; Kim, Hyuck; Firestein, Bonnie L.] Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA; [Patel, Mihir V.] Rutgers State Univ, Grad Program Neurosci, Piscataway, NJ USA; [Sewell, Emily; Dickson, Samantha; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Firestein, BL (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.	firestein@biology.rutgers.edu		Patel, Mihir/0000-0002-9839-8357; Firestein, Bonnie/0000-0002-1679-3565	New Jersey Commission on Brain Injury Research grant [CBIR14IRG019]; New Jersey Commission on Brain Injury Research [CBIR15-FEL009]	This work was funded by the New Jersey Commission on Brain Injury Research grant #CBIR14IRG019 (to B.L.F. and D.F.M.). M.V.P. was supported in part by a pre-doctoral fellowship from the New Jersey Commission on Brain Injury Research #CBIR15-FEL009.	Akum BF, 2004, NAT NEUROSCI, V7, P145, DOI 10.1038/nn1179; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Choo AM, 2013, BRAIN, V136, P65, DOI 10.1093/brain/aws286; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Gartner A, 2006, J CELL SCI, V119, P3927, DOI 10.1242/jcs.03159; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Hernandez K, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00006; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Koester MP, 2007, J NEUROSCI, V27, P12590, DOI 10.1523/JNEUROSCI.2250-07.2007; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kutzing MK, 2012, ANN BIOMED ENG, V40, P1170, DOI 10.1007/s10439-011-0494-z; Kutzing MK, 2011, ANN BIOMED ENG, V39, P2252, DOI 10.1007/s10439-011-0319-0; Kutzing MK, 2010, JOVE-J VIS EXP, DOI [10.3791/2354, DOI 10.3791/2354]; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Mendenhall A, 2012, JOVE-J VIS EXP, DOI 10.3791/3171; Mesfin MN, 2012, J NEUROTRAUM, V29, P1982, DOI 10.1089/neu.2011.2253; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Nakagawa H, 2000, ONCOGENE, V19, P210, DOI 10.1038/sj.onc.1203308; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; O'Neill KM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00285; Patel MV, 2018, MOL NEUROBIOL, V55, P6269, DOI 10.1007/s12035-017-0849-z; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rameau GA, 2000, NEUROPHARMACOLOGY, V39, P2255, DOI 10.1016/S0028-3908(00)00066-6; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Singh P, 2012, J BIOL CHEM, V287, P4348, DOI 10.1074/jbc.M111.253740; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Svane KC, 2018, MOL CELL NEUROSCI, V89, P20, DOI 10.1016/j.mcn.2018.03.011; Sweet Eric S, 2011, Bioarchitecture, V1, P69; Sweet ES, 2011, J NEUROSCI, V31, P1038, DOI 10.1523/JNEUROSCI.1205-10.2011; Swiatkowski P, 2018, NEUROBIOL DIS, V119, P13, DOI 10.1016/j.nbd.2018.07.019; Takamori N, 2006, NEUROSCI LETT, V403, P68, DOI 10.1016/j.neulet.2006.04.045; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tseng CY, 2011, J NEUROSCI, V31, P15468, DOI 10.1523/JNEUROSCI.2442-11.2011; Votin V, 2005, J CELL SCI, V118, P5699, DOI 10.1242/jcs.02679; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37063; Weiner AT, 2016, CYTOSKELETON, V73, P35, DOI 10.1002/cm.21270; Yamada Y, 1999, J BIOL CHEM, V274, P6647, DOI 10.1074/jbc.274.10.6647; Yanai H, 2000, GENES CELLS, V5, P815, DOI 10.1046/j.1365-2443.2000.00368.x; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	60	7	7	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2019	36	13					2129	2138		10.1089/neu.2018.6291			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IF4KG	WOS:000473049600434	30747034				2022-02-06	
J	Su, YS; Schuster, JM; Smith, DH; Stein, SC				Su, YouRong Sophie; Schuster, James M.; Smith, Douglas H.; Stein, Sherman C.			Cost-Effectiveness of Biomarker Screening for Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; cost-effectiveness; traumatic brain injury	CT HEAD RULE; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; SCANDINAVIAN GUIDELINES; EXTERNAL VALIDATION; INTRACRANIAL INJURY; INITIAL MANAGEMENT; MODERATE; MILD; MULTICENTER	Intracranial hemorrhage after traumatic brain injury (TBI) can be life threatening and requires prompt diagnosis. Computed tomography (CT) scans are a rapid and accurate way to evaluate for hemorrhage. In patients with mild and moderate TBI, however, in whom the incidence of intracranial pathology is low, scanning every patient with CT can be costly. The Food and Drug Administration recently approved a novel biomarker screen, the Banyan Trauma Indicator (BTI), to help streamline the decision for CT scanning in mild to moderate TBI. The BTI screen diagnoses intracranial lesions with a sensitivity and specificity of 97.5% and 99.6%, respectively. We performed cost analyses of the BTI screen to determine the threshold of cost-effectiveness, compared with application of clinical decision rules or routine CT scans, for cases of mild or moderate TBI. With a 0.104 probability of an intracranial lesion in mild TBI, the biomarker screen is cost-effective if the cost is $308.96 or below per test. In moderate TBI, because of the greater prevalence of intracranial lesions at 0.663, there is a lower need for screening, and BTI becomes cost-effective up to $73.41 per test.	[Su, YouRong Sophie; Schuster, James M.; Smith, Douglas H.; Stein, Sherman C.] Hosp Univ Penn, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA		Schuster, JM (corresponding author), Penn Presbyterian Med Ctr, Dept Neurosurg, 205 MOB Suite 205,51 N 39th St, Philadelphia, PA 19104 USA.	James.Schuster@uphs.upenn.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS092398] Funding Source: Medline		Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Arab AF, 2015, NEURORADIOL J, V28, P591, DOI 10.1177/1971400915610699; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Center for Medicare & Medicaid Services, 2017, FY 2017 IPPS FIN RUL; Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation National Research Council, 2005, HLTH RISKS EXP LOW L; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Concato J, 1997, J INVEST MED, V45, P394; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Einarson TR, 1997, CLIN THER, V19, P559, DOI 10.1016/S0149-2918(97)80140-3; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fearnside M, 1998, AUST NZ J SURG, V68, P58, DOI 10.1111/j.1445-2197.1998.tb04638.x; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gold M., 1996, COST EFFECTIVENESS H; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Haydel Micelle, 2012, Emerg Med Pract, V14, P1; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Kosty J, 2012, J NEUROTRAUM, V29, P1322, DOI 10.1089/neu.2011.2222; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Lund SB, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0269-5; Marshall SA, 2012, MIL MED, V177, P76, DOI 10.7205/MILMED-D-12-00142; Mower WR, 2002, ANN EMERG MED, V40, P505, DOI 10.1067/mem.2002.129245; National Institute for Clinical Excellence, 2007, HEAD INJ TRIAG ASS I; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Papa L, 2017, J NEUROTRAUM, V34, P2132, DOI 10.1089/neu.2016.4806; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Sharp AL, 2017, ACAD EMERG MED, V24, P22, DOI 10.1111/acem.13061; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Social Security Administration, 2017, RET SURV BEN LIF EXP; Sox H. C., 2007, MED DECISION MAKING, V2; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; Stein SC, 2001, J TRAUMA, V50, P759, DOI 10.1097/00005373-200104000-00032; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, ANN EMERG MED, V38, P317, DOI 10.1067/mem.2001.116795; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Strauss DJ, 1999, PEDIATR NEUROL, V21, P626, DOI 10.1016/S0887-8994(99)00051-X; Tan DW, 2018, SINGAP MED J, V59, P199, DOI 10.11622/smedj.2017046; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; U.S. Food and Drug Administration, 2018, FDA AUTH MARK 1 BLOO; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; US Department of Labor Bureau of Labor Statistics, 2018, CPI INFL CALC; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962	59	7	8	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2019	36	13					2083	2091		10.1089/neu.2018.6020			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	IF4KG	WOS:000473049600429	30547708	Green Published			2022-02-06	
J	Tarvonen-Schroder, S; Kaljonen, A; Laimi, K				Tarvonen-Schroder, Sinikka; Kaljonen, Anne; Laimi, Katri			Comparing functioning in spinal cord injury and in chronic spinal pain with two ICF-based instruments: WHODAS 2.0 and the WHO minimal generic data set covering functioning and health	CLINICAL REHABILITATION			English	Article						Chronic spinal pain; disability; spinal cord injury; WHODAS; the WHO minimal generic data set	LOW-BACK-PAIN; REPORTED OUTCOME INSTRUMENTS; 5 PARTICIPATION INSTRUMENTS; TRAUMATIC BRAIN-INJURY; INTERNATIONAL CLASSIFICATION; DISABILITY; EPIDEMIOLOGY; RELIABILITY; VALIDITY; DISEASE	Objective: To investigate whether the two briefest validated ICF-based (International Classification of Functioning, Disability and Health) tools can detect differences between different spinal conditions. Design: Cross-sectional study. Setting: University hospital rehabilitation clinic. Subjects: A total of 84 patients with spinal cord injury and 81 with chronic spinal pain. Main measures: Disability evaluated using self-reported and proxy 12-item WHODAS 2.0 ((World Health Organization Disability Assessment Schedule), and physician-rated WHO minimal generic data set covering functioning and health. Findings: The two measures used showed severe disability in both patient populations, those with spinal cord injury (mean age 47.5 years, SD 13.2) and those with chronic spinal pain (mean age 47.2 years, SD 9.5), WHODAS patient sum being 18.4 (SD 9.6) versus 22.0 (SD 9.0), P < 0.05, and the WHO generic data set 15.6 (SD 4.4) versus 14.2 (SD 3.7), P < 0.01, respectively. Correlations between patient and proxy ratings and between the two disability scales were mostly strong. Severe restrictions were found in the working ability of both the populations, in mobility of patients with spinal cord injury and in pain function of patients with chronic spinal pain. In this tertiary clinic patient population, patients with spinal pain perceived more problems in emotional and cognitive functions, and in participation than patients with spinal cord injury. Conclusions: Both scales were able to find differences between two patient populations with severe disability.	[Tarvonen-Schroder, Sinikka] Turku Univ Hosp, Div Clin Neurosci, Dept Rehabil & Brain Trauma, POB 52, FI-20521 Turku, Finland; [Tarvonen-Schroder, Sinikka; Laimi, Katri] Univ Turku, POB 52, FI-20521 Turku, Finland; [Kaljonen, Anne] Univ Turku, Dept Biostat, Turku, Finland; [Laimi, Katri] Turku Univ Hosp, Dept Phys & Rehabil Med, Turku, Finland		Tarvonen-Schroder, S (corresponding author), Turku Univ Hosp, Div Clin Neurosci, Dept Rehabil & Brain Trauma, POB 52, FI-20521 Turku, Finland.; Tarvonen-Schroder, S (corresponding author), Univ Turku, POB 52, FI-20521 Turku, Finland.	sinikka.tarvonen-schroder@tyks.fi					Alexander MS, 2009, SPINAL CORD, V47, P582, DOI 10.1038/sc.2009.18; Algattas H, 2017, J CRANIOVERTEBRAL JU, V8, P103, DOI 10.4103/jcvjs.JCVJS_29_17; Babington JR, 2018, PM&R, V10, P724, DOI 10.1016/j.pmrj.2017.12.004; Barclay L, 2015, INT J REHABIL RES, V38, P1, DOI 10.1097/MRR.0000000000000085; Bletzer J, 2017, SCHMERZ, V31, P93, DOI 10.1007/s00482-016-0143-4; Cieza A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-218; de Pedro-Cuesta J, 2011, GAC SANIT, V25, P21, DOI 10.1016/j.gaceta.2011.08.005; De Wolf AC, 2012, J REHABIL MED, V44, P747, DOI 10.2340/16501977-1016; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Duenas M, 2016, J PAIN RES, V9, P457, DOI 10.2147/JPR.S105892; Barcelos ACES, 2009, ACTA NEUROCHIR, V151, P369, DOI 10.1007/s00701-009-0238-0; Federici S, 2017, DISABIL REHABIL, V39, P2347, DOI 10.1080/09638288.2016.1223177; Fine PG, 2011, PAIN MED, V12, P996, DOI 10.1111/j.1526-4637.2011.01187.x; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Guzman JZ, 2016, SPINE, V41, P429, DOI 10.1097/BRS.0000000000001211; Kirshblum S, 2014, PHYS MED REH CLIN N, V25, P505, DOI 10.1016/j.pmr.2014.04.001; Kristman VL, 2012, SPINE, V37, P1003, DOI 10.1097/BRS.0b013e31823a426f; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; Magasi SR, 2008, J SPINAL CORD MED, V31, P145, DOI 10.1080/10790268.2008.11760705; Manchikanti L, 2014, NEUROMODULATION, V17, P3, DOI 10.1111/ner.12018; Meyers AR, 2000, ARCH PHYS MED REHAB, V81, pS81, DOI 10.1053/apmr.2000.20629; Moore JE, 2010, PHYS MED REH CLIN N, V21, P801, DOI 10.1016/j.pmr.2010.06.005; Noonan VK, 2010, J REHABIL MED, V42, P735, DOI 10.2340/16501977-0583; Noonan VK, 2010, J REHABIL MED, V42, P724, DOI 10.2340/16501977-0584; Noonan VK, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-93; Noonan VK, 2009, DISABIL REHABIL, V31, P1883, DOI 10.1080/09638280902846947; Noonan VK, 2010, TOP SPINAL CORD INJU, V15, P49, DOI DOI 10.1310/SCI1504-49; Patel MS, 2015, BONE JOINT J, V97B, P366, DOI 10.1302/0301-620X.97B3.34178; Post MWM, 2012, SPINAL CORD, V50, P382, DOI 10.1038/sc.2011.182; Post MWM, 2008, J REHABIL MED, V40, P620, DOI 10.2340/16501977-0223; Ramasamy A, 2017, PAIN MED, V18, P1098, DOI 10.1093/pm/pnw357; Shaw WS, 2016, ARCH PHYS MED REHAB, V97, P1573, DOI 10.1016/j.apmr.2016.02.004; Silva AG, 2015, PHYS THER, V95, P1628, DOI 10.2522/ptj.20140323; Silva AG, 2013, DISABIL HEALTH J, V6, P369, DOI 10.1016/j.dhjo.2013.04.007; Sure ATJ, 2016, ANN CLIN LAB RES, V4, P1; Tarvonen-Schroder S, 2018, INT J REHABIL RES, V41, P224, DOI 10.1097/MRR.0000000000000292; Tarvonen-Schroder S, 2018, CLIN REHABIL, V32, P1676, DOI 10.1177/0269215518785945; Ueda H, 2016, GLOB SPINE J, V6, P242, DOI 10.1055/s-0035-1559584; Walsh TL, 2003, SPINE, V28, P607, DOI 10.1097/00007632-200303150-00017	39	7	7	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	JUL	2019	33	7					1241	1251		10.1177/0269215519839104			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	ID9WW	WOS:000472038900015	30935211				2022-02-06	
J	Tribett, T; Erskine, B; Bailey, K; Brown, T; Castellani, RJ				Tribett, Taylor; Erskine, Brittany; Bailey, Kristi; Brown, Theodore; Castellani, Rudy J.			Chronic Traumatic Encephalopathy Pathology After Shotgun Injury to the Brain	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; autopsy; penetrating traumatic brain injury; shotgun injury; phosphorylated tau; TDP-43; chronic traumatic encephalopathy	DISEASE; NEUROPATHOLOGY; TAU	Chronic traumatic encephalopathy (CTE) was initially conceptualized in boxers, but has extended to other athletes in recent years, albeit with limited clinical correlations. It is often asserted that CTE pathology represents the substrate for progressive neurodegenerative disease. We report the case of a shotgun injury to the brain with 42-year survival and no neurological disease progression until shortly before death. The decedent had no other traumatic brain injury (TBI) exposure and did not play football or other high energy collision sport. Neuropathological examination confirmed tissue damage, but additionally demonstrated localized patterns of phosphorylated tau (p-tau) meeting criteria for CTE pathology. P-tau and TDP-43 deposits within marginal tissue of damaged brain were also present focally. No amyloid-beta (A beta) deposits were present. These findings indicate that CTE pathology may occur following a single, severe TBI.	[Tribett, Taylor; Erskine, Brittany; Bailey, Kristi; Brown, Theodore; Castellani, Rudy J.] Western Michigan Univ, Dept Pathol, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA		Castellani, RJ (corresponding author), Western Michigan Univ, Dept Pathol, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA.	rjcastellani@gmail.com					Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Castellani RJ, 2017, J ALZHEIMERS DIS, V60, P1209, DOI 10.3233/JAD-170669; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Fournier CN, 2015, NEUROLOGY, V84, P1788, DOI 10.1212/WNL.0000000000001522; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stern RA, 2011, PM R S2, V3, pS460	24	7	7	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	JUL	2019	64	4					1248	1252		10.1111/1556-4029.14001			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	IH1WR	WOS:000474285000040	30644555				2022-02-06	
J	Vaidya, M; Flint, RD; Wang, PT; Barry, A; Li, YC; Ghassemi, M; Tomic, G; Yao, J; Carmona, C; Mugler, EM; Gallick, S; Driver, S; Brkic, N; Ripley, D; Liu, C; Kamper, D; Do, AH; Slutzky, MW				Vaidya, Mukta; Flint, Robert D.; Wang, Po T.; Barry, Alex; Li, Yongcheng; Ghassemi, Mohammad; Tomic, Goran; Yao, Jun; Carmona, Carolina; Mugler, Emily M.; Gallick, Sarah; Driver, Sangeeta; Brkic, Nenad; Ripley, David; Liu, Charles; Kamper, Derek; Do, An H.; Slutzky, Marc W.			Hemicraniectomy in Traumatic Brain Injury: A Noninvasive Platform to Investigate High Gamma Activity for Brain Machine Interfaces	IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING			English	Article						Brain-machine interface; brain-computer interface; EEG; traumatic brain injury; high gamma	COMPUTER INTERFACE; MOVEMENTS; EEG; IDENTIFICATION; REPRESENTATION; INFORMATION; PREDICTION; SYSTEMS; IMPACT; MONKEY	Brain-machine interfaces (BMIs) translate brain signals into control signals for an external device, such as a computer cursor or robotic limb. These signals can be obtained either noninvasively or invasively. Invasive recordings, using electrocorticography (ECoG) or intracortical microelectrodes, provide higher bandwidth and more informative signals. Rehabilitative BMIs, which aim to drive plasticity in the brain to enhance recovery after brain injury, have almost exclusively used non-invasive recordings, such electroencephalography (EEG) or magnetoencephalography (MEG), which have limited bandwidth and information content. Invasive recordings provide more information and spatiotemporal resolution, but do incur risk, and thus are not usually investigated in people with stroke or traumatic brain injury (TBI). Here, in this paper, we describe a new BMI paradigm to investigate the use of higher frequency signals in brain-injured subjects without incurring significant risk. We recorded EEG in TBI subjects who required hemicraniectomies (removal of a part of the skull). EEG over the hemicraniectomy (hEEG) contained substantial information in the high gamma frequency range (65-115 Hz). Using this information, we decoded continuous fingerflexion force with moderate to high accuracy(variance accounted for 0.06 to 0.52), which at best approaches that using epidural signals. These results indicate that people with hemicraniectomies can provide a useful resource for developing BMI therapies for the treatment of brain injury.	[Vaidya, Mukta; Flint, Robert D.; Tomic, Goran; Mugler, Emily M.; Slutzky, Marc W.] Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA; [Wang, Po T.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Barry, Alex; Gallick, Sarah; Driver, Sangeeta; Brkic, Nenad; Ripley, David; Slutzky, Marc W.] Shirley Ryan Abil Lab, Chicago, IL 60611 USA; [Li, Yongcheng; Do, An H.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA; [Ghassemi, Mohammad; Kamper, Derek] North Carolina State Univ, Dept Biomed Engn, Raleigh, NC 27695 USA; [Yao, Jun; Carmona, Carolina] Northwestern Univ, Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Driver, Sangeeta; Brkic, Nenad; Ripley, David; Slutzky, Marc W.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Liu, Charles; Do, An H.] Rancho Los Amigos Natl Ctr Rehabil, Downey, CA 90242 USA; [Liu, Charles] Univ Southern Calif, Dept Neurosurg, Los Angeles, CA 90007 USA; [Slutzky, Marc W.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA		Vaidya, M (corresponding author), Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA.	mukta.vaidya@northwestern.edu; r.flint@northwestern.edu; ptwang@uci.edu; alex.barry92@gmail.com; yongchel@uci.edu; ghasemi.mohamad@gmail.com; goran.tomic@northwestern.edu; j-yao4@northwestern.edu; ccarmona@northwestern.edu; emilymugler@gmail.com; sgallick@sralab.edu; spatel@ric.org; nbrkic@sralab.org; dripley@sralab.org; chasliu@cheme.caltech.edu; dgkamper@ncsu.edu; and@uci.edu; mslutzky@northwestern.edu	Barry, Alexander/AAO-8188-2021; Slutzky, Marc/AAG-8197-2019; Yao, Jun/AAK-2006-2020; Wang, Po T./H-4878-2014	Slutzky, Marc/0000-0003-2269-7729; Ripley, David/0000-0002-5349-1830; Barry, Alexander/0000-0002-0904-155X; Wang, Po T./0000-0002-6611-3863	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [r01ns094748]; Doris Duke Charitable Foundation Clinical Scientist Development AwardAmerican Heart AssociationDoris Duke Charitable Foundation (DDCF) [2011039]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094748] Funding Source: NIH RePORTER	This work was supported in part by the NIH Grant r01ns094748, and in part by the Doris Duke Charitable Foundation Clinical Scientist Development Award under Grant 2011039.	Ajiboye AB, 2012, IEEE T BIO-MED ENG, V59, P2755, DOI 10.1109/TBME.2012.2209882; Ang KK, 2009, IEEE ENG MED BIO, P5981, DOI 10.1109/IEMBS.2009.5335381; Archavlis E, 2012, ACTA NEUROCHIR, V154, P1055, DOI 10.1007/s00701-012-1333-1; Bacher D, 2015, NEUROREHAB NEURAL RE, V29, P462, DOI 10.1177/1545968314554624; Ball T, 2008, NEUROIMAGE, V41, P302, DOI 10.1016/j.neuroimage.2008.02.032; Ball T, 2009, NEUROIMAGE, V46, P708, DOI 10.1016/j.neuroimage.2009.02.028; Castermans T, 2014, NEUROSCI LETT, V561, P166, DOI 10.1016/j.neulet.2013.12.059; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Darvas F, 2010, NEUROIMAGE, V49, P930, DOI 10.1016/j.neuroimage.2009.08.041; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fagg AH, 2009, IEEE T NEUR SYS REH, V17, P487, DOI 10.1109/TNSRE.2009.2029313; Flesher SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8083; Flint RD, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2560/14/1/016005; Flint RD, 2014, NEUROIMAGE, V101, P695, DOI 10.1016/j.neuroimage.2014.07.049; Flint RD, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046006; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; Gharabaghi A, 2014, RESTOR NEUROL NEUROS, V32, P517, DOI 10.3233/RNN-140387; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Holland M, 2004, OPER TECH NEUROSURG, V7, P10, DOI DOI 10.1053/J.OTNS.2004.04.006; HUNTER IW, 1986, BIOL CYBERN, V55, P135; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kubanek J, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066001; Mehring C, 2004, J PHYSIOL-PARIS, V98, P498, DOI 10.1016/j.jphysparis.2005.09.016; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; NIEDERMEYER E, 1991, CLIN ELECTROENCEPHAL, V22, P83, DOI 10.1177/155005949102200208; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Slutzky MW, 2019, NEUROSCIENTIST, V25, P139, DOI 10.1177/1073858418775355; Slutzky MW, 2017, J NEUROPHYSIOL, V118, P1329, DOI 10.1152/jn.00070.2017; Slutzky MW, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026004; Soekadar SR, 2015, NEUROBIOL DIS, V83, P172, DOI 10.1016/j.nbd.2014.11.025; Vansteensel MJ, 2016, NEW ENGL J MED, V375, P2060, DOI 10.1056/NEJMoa1608085; Voytek B, 2010, J COGNITIVE NEUROSCI, V22, P2491, DOI 10.1162/jocn.2009.21384; Wang PT, 2017, BRAIN STRUCT FUNCT, V222, P3705, DOI 10.1007/s00429-017-1429-8; Westwick DT, 2006, NEURAL COMPUT, V18, P329, DOI 10.1162/089976606775093855	36	7	7	1	15	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1534-4320	1558-0210		IEEE T NEUR SYS REH	IEEE Trans. Neural Syst. Rehabil. Eng.	JUL	2019	27	7					1467	1472		10.1109/TNSRE.2019.2912298			6	Engineering, Biomedical; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Rehabilitation	IH6KG	WOS:000474603800013	31021800	Green Accepted			2022-02-06	
J	Howell, DR; Lugade, V; Taksir, M; Meehan, WP				Howell, David R.; Lugade, Vipul; Taksir, Mikhail; Meehan, William P., III			Determining the utility of a smartphone-based gait evaluation for possible use in concussion management	PHYSICIAN AND SPORTSMEDICINE			English	Article						Locomotion; brain concussion; clinical research; mild traumatic brain injury; management	DUAL-TASK GAIT; BALANCE CONTROL; SINGLE-TASK; ADOLESCENTS; PERFORMANCE; PARAMETERS; RELIABILITY; STABILITY; CHILDREN; VALIDITY	Objectives: Our was objectives were to (1) assess the validity of a smartphone-based application to obtain spatiotemporal gait variables relative to an established movement monitoring system used previously to evaluate post-concussion gait, and (2) determine the test-retest reliability of gait variables obtained with a smartphone. Methods: Twenty healthy participants (n = 14 females, mean age = 22.2, SD = 2.1 years) were assessed at two time points, approximately two weeks apart. Two measurement systems (inertial sensor system, smartphone application) acquired and analyzed single-task and dual-task spatio-temporal gait variables simultaneously. Our primary outcome measures were average walking speed (m/s), cadence (steps/min), and stride length (m) measured by the inertial sensor system and smartphone application. Results: Correlations between the systems were high to very high (Pearson r = 0.77-0.98) at both time points, with the exception of dual-task stride length at time 2 (Pearson r = 0.55). Bland-Altman analysis for average gait speed and cadence indicated the average disagreement between systems was close to zero, suggesting little evidence for systematic bias between acquisition systems. Test-retest consistency measures using the smartphone revealed high to very high reliability for all measurements (ICC = 0.81-0.95). Conclusions: Our results indicate that sensors within a smartphone are capable of measuring spatio-temporal gait variables similar to a validated three-sensor inertial sensor system in single-task and dual-task conditions, and that data are reliable across a two-week time interval. A smartphone-based application might allow clinicians to objectively evaluate gait in the management of concussion with high ease-of-use and a relatively low financial burden.	[Howell, David R.] Childrens Hosp, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Howell, David R.; Taksir, Mikhail; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Lugade, Vipul] Control One LLC, Albuquerque, NM USA; [Lugade, Vipul] Chiang Mai Univ, Dept Phys Therapy, Chiang Mai, Thailand; [Meehan, William P., III] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA 02115 USA		Howell, DR (corresponding author), Univ Colorado, Sch Med, Childrens Hosp Colorado, Ctr Sports Med, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu		Howell, David/0000-0002-2955-0191; Lugade, Vipul/0000-0001-7226-6260	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD094560] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS100952, R41 NS103698] Funding Source: Medline		Baque E, 2016, BRAIN INJURY, V30, P948, DOI 10.3109/02699052.2016.1147079; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brandes M, 2006, GAIT POSTURE, V24, P482, DOI 10.1016/j.gaitpost.2005.12.006; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Capela NA, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0013-9; Dewey DC, 2014, J NEUROL SCI, V345, P131, DOI 10.1016/j.jns.2014.07.026; Ellis RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141694; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Horak F, 2015, PHYS THER, V95, P461, DOI 10.2522/ptj.20140253; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2019, ARCH PHYS MED REHAB, V100, P613, DOI 10.1016/j.apmr.2018.07.441; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Howell DR, 2016, J HEAD TRAUMA REHAB, V31, P262, DOI 10.1097/HTR.0000000000000176; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Katz-Leurer M, 2009, CLIN REHABIL, V23, P714, DOI 10.1177/0269215509335293; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; McDowell Margaret A, 2009, Vital Health Stat 11, P1; Mellone S, 2012, Z GERONTOL GERIATR, V45, P722, DOI 10.1007/s00391-012-0404-5; Mukaka MM, 2012, MALAWI MED J, V24, P69; Nishiguchi S, 2012, TELEMED E-HEALTH, V18, P292, DOI 10.1089/tmj.2011.0132; Silsupadol P, 2017, GAIT POSTURE, V58, P516, DOI 10.1016/j.gaitpost.2017.09.030; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Yamada M, 2012, RHEUMATOL INT, V32, P3869, DOI 10.1007/s00296-011-2283-2; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zijlstra W, 2003, GAIT POSTURE, V18, P1, DOI 10.1016/S0966-6362(02)00190-X	35	7	7	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	JAN 2	2020	48	1					75	80		10.1080/00913847.2019.1632155		JUN 2019	6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	KO4TF	WOS:000475256700001	31198074				2022-02-06	
J	Teel, EF; Zemek, RL; Tang, K; Gioia, G; Vaughan, C; Sady, M; Gagnon, IJ; Osmond, MH; Barrowman, N; Freedman, SB; Gravel, J; Sangha, G; Boutis, K; Beer, D; Craig, W; Burns, E; Farion, KJ				Teel, Elizabeth F.; Zemek, Roger L.; Tang, Kenneth; Gioia, Gerard; Vaughan, Christopher; Sady, Maegan; Gagnon, Isabelle J.; Osmond, Martin H.; Barrowman, Nick; Freedman, Stephen B.; Gravel, Jocelyn; Sangha, Gurinder; Boutis, Kathy; Beer, Darcy; Craig, William; Burns, Emma; Farion, Ken J.		Pediat Emergency Res Canada PERC	The Stability of Retrospective Pre-injury Symptom Ratings Following Pediatric Concussion	FRONTIERS IN NEUROLOGY			English	Article						mTBI; baseline; children; psychometric; diagnosis	BIAS; ASSESSMENTS; STATEMENT; CHILDREN; SPORT	Objective: To determine the stability of children's retrospective ratings of pre-injury levels of symptoms over time following concussion. Methods: Children and adolescents (n = 3,063) between the ages of 5-17 diagnosed with a concussion by their treating pediatric emergency department (PED) physician within 48 h of injury completed the Post-Concussion Symptom Inventory (PCSI) at the PED and at 1, 2, 4, 8, and 12-weeks post-injury. At each time point, participants retrospectively recalled their pre-injury levels of post-injury symptoms. The PCSI has three age-appropriate versions for children aged 5-7 (PCSI-SR5), 8-12 (PCSI-SR8), and 13-18 (PCSI-SR13). Total scale, subscales (physical, cognitive, emotional, and sleep), and individual items from the PCSI were analyzed for stability using Gini's mean difference (GMD). Results: The mean GMD for total score was 0.31 (95% CI = 0.28, 0.34) for the PCSI-SR5, 0.19 (95% CI = 0.18, 0.20) for the PCSI-SR8, and 0.17 (95% CI = 0.16, 0.18) for the PCSI-SR13. Subscales ranged from mean GMD 0.18 (physical) to 0.31 (emotional) for the PCSI-SR8 and 0.16 (physical) to 0.31 (fatigue) for the PCSI-SR13. At the item-level, mean GMD ranged from 0.13 to 0.60 on the PCSI-SR5, 0.08 to 0.59 on the PCSI-SR8, and 0.11 to 0.41 on the PCSI-SR13. Conclusions: Children and adolescents recall their retrospective pre-injury symptom ratings with good-to-perfect stability over the first 3-months following their concussion. Although some individual items underperformed, variability was reduced as items were combined at the subscale and full-scale level. There is limited benefit gained from collecting multiple pre-injury symptom queries.	[Teel, Elizabeth F.; Gagnon, Isabelle J.] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Zemek, Roger L.] Univ Ottawa, Dept Pediat & Emergency Med, Ottawa, ON, Canada; [Zemek, Roger L.; Tang, Kenneth; Barrowman, Nick] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Gioia, Gerard; Vaughan, Christopher; Sady, Maegan] Childrens Natl Med Ctr, Dept Pediat Neuropsychol, Washington, DC 20010 USA; [Gagnon, Isabelle J.] McGill Univ, Hlth Ctr, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ, Canada; [Osmond, Martin H.; Farion, Ken J.] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada; [Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Pediat, Calgary, AB, Canada; [Gravel, Jocelyn] Univ Montreal, Hosp Ste Justine, Dept Pediat, Montreal, PQ, Canada; [Sangha, Gurinder] Western Univ, Childrens Hosp Western Ontario, Dept Pediat, London, ON, Canada; [Boutis, Kathy] Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [Beer, Darcy] Manitoba Childrens Hosp, Dept Pediat, Winnipeg, MB, Canada; [Craig, William] Stollery Childrens Hosp, Dept Pediat, Edmonton, AB, Canada; [Burns, Emma] IWK Hlth Ctr, Dept Pediat, Halifax, NS, Canada		Teel, EF (corresponding author), McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada.	elizabeth.teel@mail.mcgill.ca	Barrowman, Nick/AAL-3166-2020; Freedman, Stephen/H-9102-2012	Barrowman, Nick/0000-0002-4704-9595; Gagnon, Isabelle/0000-0003-2043-1644; Freedman, Stephen/0000-0003-2319-6192; Osmond, Martin/0000-0001-8275-8381; Teel, Elizabeth/0000-0002-2846-5884	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP 126197]; CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury team grant [TM1 127047]; CIHR planning grantCanadian Institutes of Health Research (CIHR) [MRP 119829]	This study was supported by a Canadian Institutes of Health Research (CIHR) operating grant (MOP 126197); a CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury team grant (TM1 127047); and CIHR planning grant (MRP 119829).	Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Control NCfIPa, 2010, TRAUMATIC BRAIN INJU; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; R Core Team, 2016, R LANG ENV STAT COMP; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schmier Jordana K, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P159, DOI 10.1586/14737167.4.2.159; Schneider J, 2007, DEV NEUROREHABIL, V10, P282; van den Brink M, 2001, HEADACHE, V41, P11, DOI 10.1046/j.1526-4610.2001.111006011.x; Vaughan C, 2008, J INT NEUROPSYCH S1, V14, P207; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550	23	7	7	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 27	2019	10								672	10.3389/fneur.2019.00672			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IF7CW	WOS:000473240100001	31316452	gold, Green Published			2022-02-06	
J	Jiang, XB; Jiang, P; Mao, YS				Jiang, Xiaobin; Jiang, Ping; Mao, Yuanshen			Performance of Modified Early Warning Score (MEWS) and Circulation, Respiration, Abdomen, Motor, and Speech (CRAMS) score in trauma severity and in-hospital mortality prediction in multiple trauma patients: a comparison study	PEERJ			English	Article						Scoring system; MEWS; CRAMS; Multiple trauma	EMERGENCY-MEDICINE SCORE; BRAIN-INJURY; SCALE; CONSCIOUSNESS; VALIDATION; ADMISSION; SEPSIS; TRIAGE; LEVEL; CARE	Background: With an increasing number of motor vehicle crashes, there is an urgent need in emergency departments (EDs) to assess patients with multiple trauma quickly, easily, and reliably. Trauma severity can range from a minor to major threats to life or bodily function. In-hospital mortality and trauma severity prediction in such cases is crucial in the ED for the management of multiple trauma and improvement of the outcome of these patients. Previous studies have examined the performance of Modified Early Warning Score (MEWS) or Circulation, Respiration, Abdomen, Motor, and Speech (CRAMS) score based solely on mortality prediction or injury severity prediction. However, to the best of our knowledge, the performances of both scoring systems on in-hospital mortality and trauma severity prediction have not been compared previously. This retrospective study evaluated the value of MEWS and CRAMS score to predict in-hospital mortality and trauma severity in patients presenting to the ED with multiple traumatic injuries. Methods: All study subjects were multiple trauma patients. Medical data of 1,127 patients were analyzed between January 2014 and April 2018. The MEWS and CRAMS score were calculated, and logistic regression and receiver operating characteristic curve analysis were conducted to investigate their performances regarding in-hospital mortality and trauma severity prediction. Results: For in-hospital mortality prediction, the areas under the receiver operating characteristic curve (AUROCs) for MEWS and CRAMS score were 0.90 and 0.91, respectively, indicating that both of them were good in-hospital mortality predictors. Further, our study indicated that the CRAMS score performed better in trauma severity prediction, with an AUROC value of 0.84, which was higher than that of MEWS (AUROC = 0.77). For trauma severity prediction, the optimal cut-off value for MEWS was 2, while that of the CRAMS score was 8. Conclusions: We found that both MEWS and CRAMS score can be used as predictors for trauma severity and in-hospital mortality for multiple trauma patients, but that CRAMS score was superior to MEWS for trauma severity prediction. CRAMS score should be prioritized in the prediction of trauma severity due to its excellence as a multiple trauma triage tool and potential contribution to rapid emergency rescue decisions.	[Jiang, Xiaobin] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Emergency Dept 1, Sch Med, Shanghai, Peoples R China; [Jiang, Ping] Univ Tokyo, Ctr Engn RACE, Res Artifacts, Kashiwa, Chiba, Japan; [Mao, Yuanshen] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Urol, Sch Med, Shanghai, Peoples R China		Jiang, P (corresponding author), Univ Tokyo, Ctr Engn RACE, Res Artifacts, Kashiwa, Chiba, Japan.	jiang@race.u-tokyo.ac.jp		Mao, Yuanshen/0000-0003-4120-415X			[Anonymous], 2015, DISASTER MED RESCUE, V4, P66; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Burch VC, 2008, EMERG MED J, V25, P674, DOI 10.1136/emj.2007.057661; CLEMMER TP, 1985, J TRAUMA, V25, P188, DOI 10.1097/00005373-198503000-00003; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Fullerton JN, 2012, RESUSCITATION, V83, P557, DOI 10.1016/j.resuscitation.2012.01.004; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Goldhill DR, 2005, ANAESTHESIA, V60, P547, DOI 10.1111/j.1365-2044.2005.04186.x; Goodacre S, 2006, EMERG MED J, V23, P372, DOI 10.1136/emj.2005.028522; GORMICAN SP, 1982, ANN EMERG MED, V11, P132, DOI 10.1016/S0196-0644(82)80237-0; Ho LO, 2013, WORLD J EMERG MED, V4, P273, DOI [10.5847/wjem.j.issn.1920-8642.2013.04.005, 10.5847/wjem.j.1920-8642.2013.04.005]; Hung SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187495; Jones AE, 2009, CRIT CARE MED, V37, P1649, DOI 10.1097/CCM.0b013e31819def97; Kelly CA, 2004, ANN EMERG MED, V44, P108, DOI 10.1016/j.annemergmed.2004.03.028; LONG WB, 1986, AM J SURG, V151, P581, DOI 10.1016/0002-9610(86)90553-2; McNarry AF, 2004, ANAESTHESIA, V59, P34, DOI 10.1111/j.1365-2044.2004.03526.x; Ollivere B, 2012, ANN ROY COLL SURG, V94, P267, DOI 10.1308/003588412X13171221501744; Olsson T, 2004, J INTERN MED, V255, P579, DOI 10.1111/j.1365-2796.2004.01321.x; Olsson T, 2003, ACAD EMERG MED, V10, P1040, DOI 10.1197/S1069-6563(03)00342-7; Oprita B, 2014, J Med Life, V7 Spec No. 3, P4; Peng LY, 2017, AM J EMERG MED, V35, P1372, DOI 10.1016/j.ajem.2017.03.028; Raman S, 2011, INDIAN PEDIATR, V48, P331; Sartorius D, 2010, CRIT CARE MED, V38, P831, DOI 10.1097/CCM.0b013e3181cc4a67; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Tavares Rita Chelly Felix, 2008, Rev. bras. ter. intensiva, V20, P124, DOI 10.1590/S0103-507X2008000200002; Wang G, 2017, TIANJIN MED J, V45, P885; Wangara AA, 2019, INT J EMERG MED, V12, DOI 10.1186/s12245-019-0221-3; Wasserman EB, 2015, PREHOSP EMERG CARE, V19, P202, DOI 10.3109/10903127.2014.959225; Yin Q, 2015, J CLIN EMERGENCY, V16, P591; Yingcheng X, 2014, MODERN J INTEGRATED, V23, P2094; Zadravecz FJ, 2015, J HOSP MED, V10, P658, DOI 10.1002/jhm.2415; Zhang Z, 2018, J EMERG CRIT CARE ME, V2, P19, DOI DOI 10.21037/JECCM.2017.10.05	36	7	8	0	8	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	JUN 25	2019	7								e7227	10.7717/peerj.7227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IE9PW	WOS:000472708400009	31275766	Green Published, gold, Green Submitted			2022-02-06	
J	Booker, J; Sinha, S; Choudhari, K; Dawson, J; Singh, R				Booker, James; Sinha, Saurabh; Choudhari, Kishor; Dawson, Jeremy; Singh, Rajiv			Predicting functional recovery after mild traumatic brain injury: the SHEFBIT cohort	BRAIN INJURY			English	Article						Mild traumatic brain injury; post-concussion symptoms; prognosis; recovery	GLASGOW OUTCOME SCALE; HEAD-INJURY; ALCOHOL; IMPACT; TBI; DEPRESSION; SYMPTOMS	Background: Current prognostic models for mild Traumatic Brain Injury (mTBI) are unsatisfactory in identifying patients at risk of an unfavorable outcome following injury. Objective: To identify prognostic indicators of recovery one-year following mTBI. Methods: A large population (n = 596) of patients with mTBI were prospectively recruited following admission to the Emergency Department. Data were collected at brain injury clinics at 8-10 weeks and one-year after injury. Functional recovery at one year was assessed using the Glasgow Outcome Scale-Extended (GOSE). Results: A follow-up rate of 92% was achieved. The most common aetiologies of mTBI were falls (n = 222) and road traffic collisions (n = 154). Distribution of GCS was 15 (n = 363), 14 (n = 156) and 13 (n = 77). Ordinal regression analysis found that psychiatric history (p < .001), alcohol intoxication (p = .011), assault (p = .022) and GCS < 15 (p =< 0.001), were associated with worse outcome. An abnormal CT scan was not a predictor of disability. Conclusion: Patients with a previous psychiatric history, GCS < 15, etiology of assault, and alcohol intoxication result in worse long-term outcomes after mTBI. The predictors identified should be implemented when developing a future-validated a prognostic model for mTBI recovery.	[Booker, James; Singh, Rajiv] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [Sinha, Saurabh; Choudhari, Kishor] Sheffield Teaching Hosp, Dept Neurosurg, Sheffield, S Yorkshire, England; [Dawson, Jeremy] Univ Sheffield, Inst Work Psychol, Management Sch, Sheffield, S Yorkshire, England; [Singh, Rajiv] Sheffield Teaching Hosp, Dept Rehabil Med, Osborn Neurorehabil Unit, Sheffield, S Yorkshire, England		Booker, J (corresponding author), Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England.	jb38914@soton.ac.uk		Booker, James/0000-0001-7588-2827; Sinha, Saurabh/0000-0001-7453-9576			Bayen E, 2018, DISABIL REHABIL, V40, P2040, DOI 10.1080/09638288.2017.1325522; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Caplain S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00666; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Patel MB, 2015, J NEUROTRAUM, V32, P984, DOI 10.1089/neu.2014.3652; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Rose D., 2003, RES GUIDE NATL STAT; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stulemeijer M, 2007, BRAIN INJURY, V21, P309, DOI 10.1080/02699050701209980; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Uccella L, 2016, WORLD NEUROSURG, V93, P100, DOI 10.1016/j.wneu.2016.05.061; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue JK, 2017, J CLIN NEUROSCI, V45, P293, DOI 10.1016/j.jocn.2017.07.022; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	44	7	7	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2019	33	9					1158	1164		10.1080/02699052.2019.1629626		JUN 2019	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IO0TH	WOS:000472334600001	31215812				2022-02-06	
J	Draganich, C; Gerber, D; Monden, KR; Newman, J; Weintraub, A; Biggs, J; Philippus, A; Makley, M				Draganich, Christina; Gerber, Don; Monden, Kimberley R.; Newman, Jody; Weintraub, Alan; Biggs, Jennifer; Philippus, Angela; Makley, Michael			Disrupted sleep predicts next day agitation following moderate to severe brain injury	BRAIN INJURY			English	Article						Brain injury; sleep; agitation; actigraphy	CLOSED-HEAD-INJURY; REHABILITATION; ACTIGRAPHY; ORIENTATION; PREVALENCE	Objective: Disrupted sleep is common during acute recovery from traumatic brain injury (TBI) and has been linked to daytime agitation. This study investigated the relationship among nighttime sleep efficiency (SE), total sleep time (TST), wakefulness after sleep onset (WASO), and number of wake bouts (NWB) as measured by actigraphy to observer ratings of agitation for patients with TBI who were undergoing inpatient rehabilitation. Methods: This is a retrospective, observational study of a convenience sample of 65 individuals admitted to TBI inpatient rehabilitation who were monitored with actigraphy and the Agitated Behaviour Scale (ABS) for the first 72 h. Each patient's average SE, TST, WASO, and NWB for the 72-h period was calculated using actigraphy for the rest interval from 2100 to 0700. Daily ABS scores were obtained for each day following the nighttime sleep period. Results: Patients were not significantly different on age, gender, etiology of injury, days post-injury, rehabilitation length of stay, or severity of injury as measured by length of posttraumatic amnesia (PTA). SE and TST were significantly lower for patients with agitation than for patients without agitation. Conclusions: This study suggests a relationship between disrupted sleep and agitation for patients with TBI who are undergoing inpatient rehabilitation.	[Draganich, Christina; Gerber, Don; Monden, Kimberley R.; Newman, Jody; Weintraub, Alan; Biggs, Jennifer; Philippus, Angela; Makley, Michael] Craig Hosp, Englewood, CO 80113 USA; [Draganich, Christina; Gerber, Don; Monden, Kimberley R.; Weintraub, Alan; Makley, Michael] Univ Colorado, Dept PM&R, Aurora, CO USA		Draganich, C (corresponding author), Craig Hosp, Care CNS Med Grp, 3425 S Clarkson St, Englewood, CO 80113 USA.	cdraganich@gmail.com	Monden, Kimberley/AAE-9831-2020	Monden, Kimberley/0000-0002-5207-0452; Philippus, Angela/0000-0001-7427-8660			[Anonymous], 2009, TRAUM BRAIN INJ MOD; Beaulieu C, 2008, J HEAD TRAUMA REHAB, V23, P304, DOI 10.1097/01.HTR.0000336843.60961.b7; Bogner J, 2008, AGITATED BEHAV SCALE; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Cellini N, 2013, CHRONOBIOL INT, V30, P691, DOI 10.3109/07420528.2013.782312; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Evans D, 2002, INT J NURS STUD, V39, P735, DOI 10.1016/S0020-7489(02)00015-9; Fernandez-Mendoza J, 2011, PSYCHOSOM MED, V73, P88, DOI 10.1097/PSY.0b013e3181fe365a; Gorny S, 1997, SLEEP RES, V26, P662; Harmsen M, 2004, BRAIN INJURY, V18, P787, DOI 10.1080/02699050410001671757; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; Lai C, 2015, J NURSING CARE, V4, P1; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Makley MJ, 2016, INT BRAIN INJ C NETH; Mani Arash, 2015, Bull Emerg Trauma, V3, P93; MARKS W, 1992, ARCH INTERN MED, V152, P2203, DOI 10.1001/archinte.152.11.2203; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Sosso FAE, 2016, MENT HLTH FAM MED, V12, P215, DOI DOI 10.25149/1756-8358.1202010; Sosso FAE, 2017, NEURODEGENER DIS MAN, V7, P183, DOI 10.2217/nmt-2017-0012; Towns SJ, 2016, PM&R, V8, P1046, DOI 10.1016/j.pmrj.2016.04.005; Zinkhan M, 2014, SLEEP MED, V15, P1107, DOI 10.1016/j.sleep.2014.04.015	26	7	7	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2019	33	9					1194	1199		10.1080/02699052.2019.1631484		JUN 2019	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IO0TH	WOS:000475133400001	31215813				2022-02-06	
J	Opie, GM; Foo, N; Killington, M; Ridding, MC; Semmler, JG				Opie, George M.; Foo, Ngee; Killington, Maggie; Ridding, Michael C.; Semmler, John G.			Transcranial Magnetic Stimulation-Electroencephalography Measures of Cortical Neuroplasticity Are Altered after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						GABA(A); GABA(B); mild traumatic brain injury; neuroplasticity; TMS-EEG	THETA-BURST-STIMULATION; MOTOR CORTEX EXCITABILITY; DORSOLATERAL PREFRONTAL CORTEX; INDEPENDENT COMPONENT ANALYSIS; SPORTS CONCUSSION; TMS-EEG; LONG-TERM; INTRACORTICAL INHIBITION; COGNITIVE IMPAIRMENT; PLASTICITY	While the potential long-term side effects of mild traumatic brain injury (mTBI) are becoming increasingly recognized, the associated neurophysiological mechanisms remain poorly understood. However, changes in cortical inhibitory function and neuroplasticity have been suggested as possible contributing factors. The current study applied transcranial magnetic stimulation (TMS) in conjunction with electroencephalography (combined TMS-EEG) to investigate further the effects of mTBI on these processes. In 17 patients with a history of mTBI and 15 healthy control subjects with no mTBI history, paired-pulse TMS-EEG measures of short- (SICI) and long-interval intracortical inhibition (LICI) were used to assess intracortical inhibitory function. Single-pulse TMS-EEG was used to assess neuroplastic changes in cortical excitability after application of continuous theta burst stimulation (cTBS, a plasticity inducing TMS paradigm). Inhibition of the TMS-evoked EEG potential after application of SICI and LICI was not different between groups. In contrast, the inhibitory effects of cTBS on both P30 (p < 0.05) and N45 (p = 0.04) TEP components was significantly increased in patients, with the modulation of N45 in patients significantly related to the time since injury (p = 0.04). While these results provide further evidence that inhibitory circuits involving gamma-aminobutyric acid (GABA) are modified after mTBI, they place greater emphasis on the plasticity of inhibitory networks involving the GABA(A) receptor subtype.	[Opie, George M.; Semmler, John G.] Univ Adelaide, Adelaide Med Sch, Discipline Physiol, Adelaide, SA, Australia; [Foo, Ngee] Royal Adelaide Hosp, Trauma Serv, Adelaide, SA, Australia; [Killington, Maggie] Cent Adelaide Local Hlth Network, South Australia Brain Injury Rehabil Serv, Adelaide, SA, Australia; [Killington, Maggie] Flinders Univ S Australia, Coll Nursing & Hlth Sci, Adelaide, SA, Australia; [Opie, George M.; Ridding, Michael C.] Univ Adelaide, Adelaide Med Sch, Robinson Res Inst, Adelaide, SA, Australia		Opie, GM (corresponding author), Univ Adelaide, Adelaide Med Sch, Adelaide, SA 5005, Australia.	george.opie@adelaide.edu.au		Opie, George/0000-0001-7771-7569	Neurosurgical Research Foundation of South Australia; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1139723]	We would like to thank Emma Vo and Anne Gatley (Senior Speech Pathologists, Royal Adelaide Hospital) for their assistance in patient recruitment. Funding for this study was provided by the Neurosurgical Research Foundation of South Australia. GMO is supported by a National Health and Medical Research Council Early Career Fellowship (APP1139723).	Cash RFH, 2017, NEUROPSYCHOPHARMACOL, V42, P502, DOI 10.1038/npp.2016.133; Chung SW, 2017, CLIN NEUROPHYSIOL, V128, P1117, DOI 10.1016/j.clinph.2017.04.005; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Darmani G, 2016, J NEUROSCI, V36, P12312, DOI 10.1523/JNEUROSCI.1689-16.2016; Daskalakis ZJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2860, DOI 10.1038/npp.2008.22; Davidson TW, 2016, CLIN NEUROPHYSIOL, V127, P3364, DOI 10.1016/j.clinph.2016.07.012; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Dewan M.C., 2018, J NEUROSURG; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Edwards EK, 2017, BRAIN INJURY, V31, P1348, DOI 10.1080/02699052.2017.1327671; Ferreri F, 2011, NEUROIMAGE, V54, P90, DOI 10.1016/j.neuroimage.2010.07.056; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Goldsworthy MR, 2016, CLIN NEUROPHYSIOL, V127, P740, DOI 10.1016/j.clinph.2015.06.014; Goldsworthy MR, 2013, BRAIN STIMUL, V6, P340, DOI 10.1016/j.brs.2012.06.005; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kouchtir-Devanne N, 2012, J NEUROPHYSIOL, V107, P1522, DOI 10.1152/jn.00786.2011; Major BP, 2015, CLIN EXP PHARMACOL P, V42, P394, DOI 10.1111/1440-1681.12363; Maki H, 2010, NEUROSCI LETT, V478, P24, DOI 10.1016/j.neulet.2010.04.059; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDonnell MN, 2006, EXP BRAIN RES, V173, P86, DOI 10.1007/s00221-006-0365-2; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Muller-Dahlhaus JFM, 2008, J PHYSIOL-LONDON, V586, P495, DOI 10.1113/jphysiol.2007.142059; Murakami T, 2008, CLIN NEUROPHYSIOL, V119, P301, DOI 10.1016/j.clinph.2007.10.012; Oostenveld R., 2010, COMPUT INTEL NEUROSC, V2011; Opie GM, 2018, BRAIN STIMUL, V11, P545, DOI 10.1016/j.brs.2017.12.013; Opie GM, 2016, BRAIN SCI, V10, P65; Paus T, 2001, J NEUROPHYSIOL, V86, P1983, DOI 10.1152/jn.2001.86.4.1983; Pearce AJ, 2018, BRAIN INJURY, V32, P498, DOI 10.1080/02699052.2018.1430376; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Premoli I, 2018, BRAIN STIMUL, V11, P818, DOI 10.1016/j.brs.2018.03.008; Premoli I, 2014, NEUROIMAGE, V103, P152, DOI 10.1016/j.neuroimage.2014.09.028; Premoli I, 2014, J NEUROSCI, V34, P5603, DOI 10.1523/JNEUROSCI.5089-13.2014; Rogasch NC, 2017, NEUROIMAGE, V147, P934, DOI 10.1016/j.neuroimage.2016.10.031; Rogasch NC, 2015, CORTEX, V64, P68, DOI 10.1016/j.cortex.2014.10.003; Rogasch NC, 2014, NEUROIMAGE, V101, P425, DOI 10.1016/j.neuroimage.2014.07.037; Rogasch NC, 2013, HUM BRAIN MAPP, V34, P1652, DOI 10.1002/hbm.22016; Rogasch NC, 2013, J NEUROPHYSIOL, V109, P89, DOI 10.1152/jn.00762.2012; Sale MV, 2008, J NEUROSCI, V28, P8285, DOI 10.1523/JNEUROSCI.1963-08.2008; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Suppa A, 2008, J PHYSIOL-LONDON, V586, P4489, DOI 10.1113/jphysiol.2008.156596; Tallus J, 2013, J NEUROTRAUM, V30, P1270, DOI 10.1089/neu.2012.2760; Tremblay S, 2019, CLIN NEUROPHYSIOL; Tremblay S, 2015, RESTOR NEUROL NEUROS, V33, P611, DOI 10.3233/RNN-140459; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Vallence AM, 2014, NEUROSCI LETT, V570, P114, DOI 10.1016/j.neulet.2014.03.060; Wassermann EM, 1996, EXP BRAIN RES, V109, P158; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Wilke S, 2017, J NEUROTRAUM, V34, P281, DOI 10.1089/neu.2016.4399; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306	68	7	7	2	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2019	36	19					2774	2784		10.1089/neu.2018.6353		JUN 2019	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JB8IG	WOS:000475150800001	30848163				2022-02-06	
J	Ma, Q; Zhang, ZQ; Shim, JK; Venkatraman, TN; Lascola, CD; Quinones, QTJ; Mathew, JP; Terrando, N; Podgoreanu, MV				Ma, Qing; Zhang, Zhiquan; Shim, Jae-Kwang; Venkatraman, Talaignair N.; Lascola, Christopher D.; Quinones, Quin Tin J.; Mathew, Joseph P.; Terrando, Niccolo; Podgoreanu, Mihai, V			Annexin A1 Bioactive Peptide Promotes Resolution of Neuroinflammation in a Rat Model of Exsanguinating Cardiac Arrest Treated by Emergency Preservation and Resuscitation	FRONTIERS IN NEUROSCIENCE			English	Article						sirtuins; autophagy; apoptosis; neuroprotection; HMGB1	TRAUMATIC BRAIN-INJURY; HYPOTHERMIC CARDIOPULMONARY BYPASS; NLRP3 INFLAMMASOME ACTIVATION; MOBILITY GROUP BOX-1; SWINE MODEL; PROFOUND HYPOTHERMIA; DELAYED RESUSCITATION; COGNITIVE DYSFUNCTION; ISCHEMIA-REPERFUSION; CIRCULATORY ARREST	Neuroinflammation initiated by damage-associated molecular patterns, including high mobility group box 1 protein (HMGB1), has been implicated in adverse neurological outcomes following lethal hemorrhagic shock and polytrauma. Emergency preservation and resuscitation (EPR) is a novel method of resuscitation for victims of exsanguinating cardiac arrest, shown in preclinical studies to improve survival with acceptable neurological recovery. Sirtuin 3 (SIRT3), the primary mitochondrial deacetylase, has emerged as a key regulator of metabolic and energy stress response pathways in the brain and a pharmacological target to induce a neuronal pro-survival phenotype. This study aims to examine whether systemic administration of an Annexin-A1 bioactive peptide (ANXA1 sp) could resolve neuroinflammation and induce sirtuin-3 regulated cytoprotective pathways in a novel rat model of exsanguinating cardiac arrest and EPR. Adult male rats underwent hemorrhagic shock and ventricular fibrillation, induction of profound hypothermia, followed by resuscitation and rewarming using cardiopulmonary bypass (ERR). Animals randomly received ANXA1 sp (3 mg/kg, in divided doses) or vehicle. Neuroinflammation (HMGB1, TNF alpha, IL-6, and IL-10 levels), cerebral cell death (TUNEL, caspase-3, pro and antiapoptotic protein levels), and neurologic scores were assessed to evaluate the inflammation resolving effects of ANXA1sp following EPR. Furthermore, western blot analysis and immunohistochemistry were used to interrogate the mechanisms involved. Compared to vehicle controls, ANXA1 sp effectively reduced expression of cerebral HMGB1, IL-6, and TNF alpha and increased IL-10 expression, which were associated with improved neurological scores. ANXA1 sp reversed EPR-induced increases in expression of proapoptotic protein Bax and reduction in antiapoptotic protein Bcl-2, with a corresponding decrease in cerebral levels of cleaved caspase-3. Furthermore, ANXA1 sp induced autophagic flux (increased LC3II and reduced p62 expression) in the brain. Mechanistically, these findings were accompanied by upregulation of the mitochondrial protein deacetylase Sirtuin-3, and its downstream targets FOXO3a and MnSOD in ANXA1 sp-treated animals. Our data provide new evidence that engaging pro-resolving pharmacological strategies such as Annexin-A1 biomimetic peptides can effectively attenuate neuroinflammation and enhance the neuroprotective effects of EPR after exsanguinating cardiac arrest.	[Ma, Qing; Quinones, Quin Tin J.; Podgoreanu, Mihai, V] Duke Univ, Syst Modeling Perioperat Organ Injury Lab, Dept Anesthesiol, Durham, NC 27708 USA; [Zhang, Zhiquan; Terrando, Niccolo] Duke Univ, Dept Anesthesiol, Neuroinflammat & Cognit Outcomes Lab, Durham, NC 27708 USA; [Zhang, Zhiquan; Terrando, Niccolo] Duke Univ, Ctr Translat Pain Med, Durham, NC 27708 USA; [Shim, Jae-Kwang] Yonsei Univ, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea; [Venkatraman, Talaignair N.; Lascola, Christopher D.] Duke Univ, Dept Radiol, Durham, NC 27710 USA; [Venkatraman, Talaignair N.; Lascola, Christopher D.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Lascola, Christopher D.] Duke Univ, Duke UNC Brain Imaging & Anal Ctr, Durham, NC USA; [Mathew, Joseph P.] Duke Univ, Dept Anesthesiol, Durham, NC USA		Ma, Q (corresponding author), Duke Univ, Syst Modeling Perioperat Organ Injury Lab, Dept Anesthesiol, Durham, NC 27708 USA.; Zhang, ZQ (corresponding author), Duke Univ, Dept Anesthesiol, Neuroinflammat & Cognit Outcomes Lab, Durham, NC 27708 USA.; Zhang, ZQ (corresponding author), Duke Univ, Ctr Translat Pain Med, Durham, NC 27708 USA.	qing.ma@duke.edu; zhiquan.zhang@duke.edu		Shim, Jae-Kwang/0000-0001-9093-9692	American Heart Association (AHA)American Heart Association [11BGIA]; Department of Anesthesiology, Duke University Medical Center; 2009 SCA-IARS Mid-Career Grant; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HL092071]	This work was supported by grants from the American Heart Association (AHA)-11BGIA (ZZ), 2009 SCA-IARS Mid-Career Grant (QM), NIH R01 HL092071 (MP), and the Department of Anesthesiology, Duke University Medical Center.	Alam HB, 2008, J TRAUMA, V64, P912, DOI 10.1097/TA.0b013e3181659e7f; Alam HB, 2006, SURGERY, V140, P307, DOI 10.1016/j.surg.2006.03.015; Alam HB, 2010, J TRAUMA, V68, P1084, DOI 10.1097/TA.0b013e3181d76bd1; Alam HB, 2006, J TRAUMA, V60, P134, DOI 10.1097/01.ta.0000198469.95292.ec; Alam HB, 2005, J SURG RES, V126, P172, DOI 10.1016/j.jss.2005.01.019; Alam HB, 2004, J TRAUMA, V57, P961, DOI 10.1097/01.TA.0000149549.72389.3F; Alam HB, 2002, SURGERY, V132, P278, DOI 10.1067/msy.2002.125787; Ansari J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041211; Bambakidis T, 2016, J NEUROTRAUM, V33, P1514, DOI 10.1089/neu.2015.4163; Bartels K, 2014, HEART LUNG CIRC, V23, P981, DOI 10.1016/j.hlc.2014.04.131; Cao XZ, 2010, PROG NEURO-PSYCHOPH, V34, P1426, DOI 10.1016/j.pnpbp.2010.07.027; Chang PP, 2019, J AM COLL SURGEONS, V228, P265, DOI 10.1016/j.jamcollsurg.2018.12.026; Chen Z, 2005, RESUSCITATION, V66, P209, DOI 10.1016/j.resuscitation.2005.01.021; Cheng AW, 2016, CELL METAB, V23, P128, DOI 10.1016/j.cmet.2015.10.013; Dai SH, 2017, FREE RADICAL BIO MED, V108, P345, DOI 10.1016/j.freeradbiomed.2017.04.005; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Drabek T, 2007, RESUSCITATION, V75, P114, DOI 10.1016/j.resuscitation.2007.03.012; Drabek T, 2007, CRIT CARE MED, V35, P532, DOI 10.1097/01.CCM.0000253398.61666.0D; Drabek T, 2015, THER HYPOTHERMIA TEM, V5, P26, DOI 10.1089/ther.2014.0013; Festoff BW, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0670-z; Frank MG, 2016, BRAIN BEHAV IMMUN, V55, P215, DOI 10.1016/j.bbi.2015.10.009; Frank MG, 2015, BRAIN BEHAV IMMUN, V48, P1, DOI 10.1016/j.bbi.2015.03.010; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Gavins FNE, 2007, FASEB J, V21, P1751, DOI 10.1096/fj.06-7842com; Gloor SM, 2001, BRAIN RES REV, V36, P258, DOI 10.1016/S0165-0173(01)00102-3; Han F, 2008, RESUSCITATION, V79, P301, DOI 10.1016/j.resuscitation.2008.06.004; Hattori Y, 2015, NEUROREPORT, V26, P113, DOI 10.1097/WNR.0000000000000308; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; He Q, 2017, INT IMMUNOPHARMACOL, V50, P208, DOI 10.1016/j.intimp.2017.06.029; Homi HM, 2010, J CARDIOTHOR VASC AN, V24, P293, DOI 10.1053/j.jvca.2009.07.020; Hwabejire JO, 2013, SURGERY, V154, P234, DOI 10.1016/j.surg.2013.04.008; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; La M, 2001, FASEB J, V15, P2247, DOI 10.1096/fj.01-0196com; Lee OH, 2013, BIOCHEM BIOPH RES CO, V438, P388, DOI 10.1016/j.bbrc.2013.07.085; Li YQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/523481; Lin T, 2006, SURGERY, V139, P365, DOI 10.1016/j.surg.2005.08.022; Liu FD, 2013, ACTA PHARMACOL SIN, V34, P1121, DOI 10.1038/aps.2013.89; Liu L, 2015, NEUROCHEM RES, V40, P600, DOI 10.1007/s11064-014-1507-8; Liu PH, 2018, BBA-MOL BASIS DIS, V1864, P764, DOI 10.1016/j.bbadis.2017.12.027; Liu TF, 2015, J BIOL CHEM, V290, P396, DOI 10.1074/jbc.M114.566349; Netto MB, 2018, BRAIN BEHAV IMMUN, V73, P661, DOI 10.1016/j.bbi.2018.07.016; Nikolian VC, 2018, J TRAUMA ACUTE CARE, V84, P459, DOI 10.1097/TA.0000000000001765; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Novgorodov SA, 2016, J BIOL CHEM, V291, P1957, DOI 10.1074/jbc.M115.668228; Parker TM, 2017, BRAIN INJURY, V31, P2, DOI 10.1080/02699052.2016.1217045; Paudel YN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00628; Perretti M, 2015, TRENDS PHARMACOL SCI, V36, P737, DOI 10.1016/j.tips.2015.07.007; Preyat N, 2013, J LEUKOCYTE BIOL, V93, P669, DOI 10.1189/jlb.1112557; Qin CX, 2015, PHARMACOL THERAPEUT, V148, P47, DOI 10.1016/j.pharmthera.2014.11.012; Rangarajan P, 2015, NEUROSCIENCE, V311, P398, DOI 10.1016/j.neuroscience.2015.10.048; RELTON JK, 1991, J EXP MED, V174, P305, DOI 10.1084/jem.174.2.305; Rhee P, 2000, J TRAUMA, V48, P439, DOI 10.1097/00005373-200003000-00011; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Sailhamer EA, 2007, J AM COLL SURGEONS, V204, P642, DOI 10.1016/j.jamcollsurg.2007.01.017; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Shim JK, 2014, J THORAC CARDIOV SUR, V148, P298, DOI 10.1016/j.jtcvs.2014.02.076; Sidorova-Darmos E, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00333; Skvarc DR, 2018, NEUROSCI BIOBEHAV R, V84, P116, DOI 10.1016/j.neubiorev.2017.11.011; Smith HK, 2015, FASEB J, V29, P2161, DOI 10.1096/fj.14-263160; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Song WJ, 2013, NEUROBIOL DIS, V51, P72, DOI 10.1016/j.nbd.2012.07.004; Su X, 2012, MOL MED, V18, P1481, DOI 10.2119/molmed.2012.00351; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Tahsili-Fahadan P, 2018, BRAIN CIRC, V4, P1, DOI [10.4103/bc.bc_4_18, 10.4103/bc.BC_4_18]; Terrando N, 2013, FASEB J, V27, P3564, DOI 10.1096/fj.13-230276; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Tisherman SA, 2017, J TRAUMA ACUTE CARE, V83, P803, DOI 10.1097/TA.0000000000001585; Traba J, 2015, J CLIN INVEST, V125, P4592, DOI 10.1172/JCI83260; Utech M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/484987; Vacas S, 2013, BRIT MED BULL, V106, P161, DOI 10.1093/bmb/ldt006; Vachharajani V, 2014, EXPERT REV CLIN IMMU, V10, P1141, DOI 10.1586/1744666X.2014.943192; Vital SA, 2016, CIRCULATION, V133, P2169, DOI 10.1161/CIRCULATIONAHA.115.020633; Weir HJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048225; Wohleb ES, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00447; Wu XR, 2006, CIRCULATION, V113, P1974, DOI 10.1161/CIRCULATIONAHA.105.587204; Xiang YX, 2016, BIOMED REP, V5, P11, DOI 10.3892/br.2016.677; Yan WJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00116; Yang LJ, 2018, CELL PHYSIOL BIOCHEM, V46, P2532, DOI 10.1159/000489659; Yang QW, 2011, J CEREBR BLOOD F MET, V31, P593, DOI 10.1038/jcbfm.2010.129; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; ZHANG RL, 1994, J NEUROL SCI, V125, P3, DOI 10.1016/0022-510X(94)90234-8; Zhang ZQ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01050; Zhao H, 2018, CELL STRESS CHAPERON, V23, P1079, DOI 10.1007/s12192-018-0917-y; Zhao HS, 2017, NEUROSCIENCE, V348, P241, DOI 10.1016/j.neuroscience.2017.02.027	90	7	8	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	JUN 14	2019	13								608	10.3389/fnins.2019.00608			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ID9WJ	WOS:000472037600001	31258464	Green Published, gold			2022-02-06	
J	Hazy, A; Bochicchio, L; Oliver, A; Xie, E; Geng, S; Brickler, T; Xie, HH; Li, LW; Allen, IC; Theus, MH				Hazy, Amanda; Bochicchio, Lauren; Oliver, Andrea; Xie, Eric; Geng, Shuo; Brickler, Thomas; Xie, Hehuang; Li, Liwu; Allen, Irving C.; Theus, Michelle H.			Divergent age-dependent peripheral immune transcriptomic profile following traumatic brain injury	SCIENTIFIC REPORTS			English	Article							SUBVENTRICULAR ZONE; ENRICHMENT ANALYSIS; HEAD-INJURY; INFLAMMATION; RECEPTORS; CNS; DECTIN-1; NEUROPROTECTION; INCREASES; GENECODIS	The peripheral immune system is a major regulator of the pathophysiology associated with traumatic brain injury (TBI). While age-at-injury influences recovery from TBI, the differential effects on the peripheral immune response remain unknown. Here, we investigated the effects of TBI on gene expression changes in murine whole blood using RNAseq analysis, gene ontology and network topology-based key driver analysis. Genome-wide comparison of CCI-injured peripheral whole blood showed a significant increase in genes involved in proteolysis and oxidative-reduction processes in juvenile compared to adult. Conversely, a greater number of genes, involved in migration, cytokine-mediated signaling and adhesion, were found reduced in CCI-injured juvenile compared to CCI-injured adult immune cells. Key driver analysis also identified G-protein coupled and novel pattern recognition receptor (PRR), P2RY10, as a central regulator of these genes. Lastly, we found Dectin-1, a c-type lectin PRR to be reduced at the protein level in both naive neutrophils and on infiltrating immune cells in the CCI-injured juvenile cortex. These findings demonstrate a distinct peripheral inflammatory profile in juvenile mice, which may impact the injury and repair response to brain trauma.	[Hazy, Amanda; Bochicchio, Lauren; Oliver, Andrea; Brickler, Thomas; Xie, Hehuang; Allen, Irving C.; Theus, Michelle H.] Virginia Tech, Dept Biomed Sci & Pathobiol, 970 Washington St, Blacksburg, VA 24061 USA; [Xie, Eric] Virginia Tech, Dept Stat, 250 Drillfield Dr, Blacksburg, VA 24061 USA; [Xie, Hehuang] Virginia Tech, Biocomplex Inst, 1015 Life Sci Circle, Blacksburg, VA 24061 USA; [Theus, Michelle H.] Virginia Tech, Sch Neurosci, Blacksburg, VA 24061 USA; [Theus, Michelle H.] Coll Vet Med, Ctr Regenerat Med, Blacksburg, VA 24061 USA; [Geng, Shuo; Li, Liwu] Virginia Tech, Dept Biol Sci, Coll Sci, 970 Washington St, Blacksburg, VA 24061 USA		Theus, MH (corresponding author), Virginia Tech, Dept Biomed Sci & Pathobiol, 970 Washington St, Blacksburg, VA 24061 USA.; Theus, MH (corresponding author), Virginia Tech, Sch Neurosci, Blacksburg, VA 24061 USA.; Theus, MH (corresponding author), Coll Vet Med, Ctr Regenerat Med, Blacksburg, VA 24061 USA.	mtheus@vt.edu		Xie, Hehuang/0000-0001-5739-1653; Li, Liwu/0000-0001-8870-5299; Fritsch, Lauren E./0000-0003-2904-8510	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096281]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL115835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096281] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, R01NS096281 (MHT). We recognize the Regenerative Medicine-Interdisciplinary Graduate Education Program at Virginia Tech and The Institute of Critical Technology and Applied Sciences Programs for student support (TB, AH), The Center for Engineered Health and the Virginia-Maryland College of Veterinary Medicine.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Anthony D, 1998, CURR BIOL, V8, P923, DOI 10.1016/S0960-9822(07)00373-9; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Arneson D, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3057-8; Baldwin KT, 2015, P NATL ACAD SCI USA, V112, P2581, DOI 10.1073/pnas.1423221112; Baumann G, 2013, EXP BIOL MED, V238, P830, DOI 10.1177/1535370213494558; Brickler T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6373506; Brickler TR, 2018, J NEUROSCI, V38, P9618, DOI 10.1523/JNEUROSCI.0914-18.2018; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Gensel JC, 2015, J NEUROSCI, V35, P9966, DOI 10.1523/JNEUROSCI.0337-15.2015; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Kaminska B, 2009, ANAT REC, V292, P1902, DOI 10.1002/ar.21047; Kaur H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15700; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kumar DKV, 2015, J NEUROSCI, V35, P16015, DOI 10.1523/JNEUROSCI.3453-15.2015; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mencl S, 2014, J NEUROIMMUNOL, V274, P125, DOI 10.1016/j.jneuroim.2014.07.010; Meng Y, 2016, ONCOGENE, V35, P6359, DOI 10.1038/onc.2016.189; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Shao Y, 2018, ANTIOXID REDOX SIGN, V28, P973, DOI 10.1089/ars.2017.7069; Stark R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau1022; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; Wang X, 2016, J CARDIOVASC TRANSL, V9, P343, DOI 10.1007/s12265-016-9700-6; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zhang Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02274	42	7	7	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 12	2019	9								8564	10.1038/s41598-019-45089-z			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IC8GR	WOS:000471216000008	31189983	Green Published, gold			2022-02-06	
J	Mckinlay, A; Buck, K				Mckinlay, Audrey; Buck, Kimberly			Misconceptions about traumatic brain injury among educators: has anything changed over the last 20 years?	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; education; educator knowledge; children; misconceptions; concussion	CHILDHOOD; PROFESSIONALS; CONCUSSION; RECOVERY; OUTCOMES; CHILDREN	Purpose: To examine educational professionals' knowledge and understanding of childhood brain injury. Materials and methods: Educational professionals from all schools in the state of Victoria, Australia, were invited to participate in an online cross-sectional survey consisting of 20 questions assessing knowledge of concussion and 30 questions examining knowledge of traumatic brain injury (n = 364). Results: On average, participants correctly answered 16/20 (80%) questions about concussion and 24.3/30 (81%) about traumatic brain injuries. Participants who had previously taught a child with a brain injury demonstrated greater knowledge of traumatic brain injury, but not concussion, than those who had not. There were no differences in knowledge of concussion or brain injury between participants who had and had not attended a briefing session about concussion. Misconceptions displayed by educators predominantly related to the ongoing effects and impact of both concussion and traumatic brain injury, including effects on emotion, cognition, and social behaviour, as well as the increased risk of multiple injuries following an initial brain injury. When participants' responses to the brain injury questionnaire were compared with results reported by Farmer and Johnson-Gerard in 1997 using the same questionnaire, many of the same misconceptions were evident in the two samples of educational professionals. Conclusions: Although educators demonstrated reasonable understanding of concussion and brain injury, some gaps in knowledge were apparent. Providing educational professionals with further training and professional development regarding childhood brain injuries would enhance their preparedness to manage students with these injuries in the school environment.	[Mckinlay, Audrey; Buck, Kimberly] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia		Mckinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		McKinlay, Audrey/0000-0001-9846-8514; Buck, Kimberly/0000-0002-4484-0197			Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V A, 1999, Pediatr Rehabil, V3, P159; Australian Government, 2015, SCH LOC VICT; Canto AI, 2014, EDUC PSYCHOL PRACT, V30, P88, DOI 10.1080/02667363.2014.883498; Case RJL, 2017, NEW ZEAL J EDUC STUD, V52, P159, DOI 10.1007/s40841-017-0080-5; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chapman J. K, 2002, PHYS DISABILITIES ED, V21, P17; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Ettel D, 2016, EXCEPTIONALITY ED IN, V26, P1, DOI DOI 10.5206/EEI.V26I1.7732; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; IBM Corporation, 2014, IBM SPSS STAT WIND V; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keyser-Marcus L., 2002, TEACHING EXCEPTIONAL, V34, P62; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Mohr JD, 2005, PREV SCH FAIL, V49, P53, DOI 10.3200/PSFL.49.4.53-57; Molnar S. B., 2010, THESIS; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Van Droogenbroeck F, 2014, TEACH TEACH EDUC, V43, P99, DOI 10.1016/j.tate.2014.07.005; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613	40	7	7	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUN 5	2019	41	12					1419	1426		10.1080/09638288.2018.1429500			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HU3WG	WOS:000465205000006	29374978				2022-02-06	
J	Arulsamy, A; Corrigan, F; Collins-Praino, LE				Arulsamy, Alina; Corrigan, Frances; Collins-Praino, Lyndsey E.			Cognitive and neuropsychiatric impairments vary as a function of injury severity at 12 months post-experimental diffuse traumatic brain injury: Implications for dementia development	BEHAVIOURAL BRAIN RESEARCH			English	Article						Cognition; Anxiety; Diffuse injury; Injury severity; Chronic outcomes	CONTROLLED CORTICAL IMPACT; ALZHEIMERS-DISEASE; HEAD-INJURY; FLUID PERCUSSION; SPATIAL MEMORY; RECURRENT CONCUSSION; BEHAVIORAL DEFICITS; RECOGNITION MEMORY; PREFRONTAL CORTEX; INCREASED RISK	Traumatic brain injury (TBI) is a common risk factor for later neurodegeneration, which can manifest as dementia. Despite this, little is known about the time-course of development of functional deficits, particularly cognitive and neuropsychiatric impairments, and whether these differ depending on the nature of the initiating insult. Therefore, this study investigated long term functional impairment at 12 months post-injury following diffuse TBI of different severities. Male Sprague-Dawley rats (420-480 g; 10-12 weeks) were either given a sham surgery (n = 14) or subjected to Marmarou's impact acceleration model of diffuse TBI for a single mild TBI (n = 12), repetitive mild TBI (3 mild diffuse injuries at 5 day intervals) (n = 14) or moderate to severe TBI (n = 14). At 12 months after injury, they were tested on a functional battery encompassing motor, neuropsychiatric (anxiety and depressive-like) and cognitive function. Our results showed that moderate to severe TBI animals exhibited significant impairments in cognitive flexibility (p = 0.009) on the Barnes maze when compared to age-matched sham animals. Neither repetitive mild TBI nor single mild TBI animals showed significant functional impairments when compared to shams. Thus, this study provides the first insight into chronic functional impairments associated with different severities of diffuse TBI, with moderate to severe TBI being a higher risk factor for impaired cognitive function at 12 months post-injury. Taken together, this may have implications for risk of dementia development following different severities of injury.	[Arulsamy, Alina; Collins-Praino, Lyndsey E.] Univ Adelaide, Adelaide Med Sch, Cognit Ageing & Neurodegenerat Dis Lab, Adelaide, SA 5005, Australia; [Corrigan, Frances] Univ South Australia, Adelaide, SA 5005, Australia		Collins-Praino, LE (corresponding author), Univ Adelaide, Adelaide Med Sch, Discipline Anat & Pathol, Adelaide, SA 5005, Australia.	lyndsey.collins-praino@adelaide.edu.au	Arulsamy, Alina/AAU-9166-2021; Collins-Praino, Lyndsey/AAB-3318-2019	Arulsamy, Alina/0000-0003-0993-5622; Collins-Praino, Lyndsey/0000-0002-4380-7600; Corrigan, Frances/0000-0001-6150-8893	Neurosurgical Research Foundation	This work was supported by funding from the Neurosurgical Research Foundation. The authors have no conflict of interest to declare.	Arulsamy A, 2018, BEHAV BRAIN RES, V348, P127, DOI 10.1016/j.bbr.2018.04.009; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bizon JL, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00019; Bogdanova OV, 2013, PHYSIOL BEHAV, V118, P227, DOI 10.1016/j.physbeh.2013.05.012; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Chou A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151418; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Corrigan F, 2017, J NEUROTRAUM, V34, P971, DOI 10.1089/neu.2016.4589; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Darcet F, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00136; Deutsch MB, 2015, DEMENT GERIATR COGN, V39, P143, DOI 10.1159/000369787; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eakin K, 2015, BRAIN NEUROTRAUMA MO; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hausser N, 2018, JOVE-J VIS EXP, DOI 10.3791/56044; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178186; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kim C, 2011, J NEUROSCI, V31, P4771, DOI 10.1523/JNEUROSCI.5923-10.2011; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Lindemann Sven, 2007, Physiol Behav, V91, P551, DOI 10.1016/j.physbeh.2007.04.008; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Maughan PH, 2000, J NEUROTRAUM, V17, P1141, DOI 10.1089/neu.2000.17.1141; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McColl TJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00372; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nolan A, 2018, J NEUROTRAUM, V35, P2425, DOI 10.1089/neu.2018.5731; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Owens JA, 2018, BRAIN INJURY, V32, P776, DOI 10.1080/02699052.2018.1451656; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Robinson S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00451; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Sell SL, 2017, J NEUROTRAUM, V34, P1086, DOI 10.1089/neu.2016.4616; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Sundman MH, 2014, J ALZHEIMERS PARKINS, V4, P137; Sunyer B, 2007, BARNES MAZE USEFUL T; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Turner RC, 2016, BRAIN INJURY, V30, P1279, DOI 10.1080/02699052.2016.1193631; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Vasquez BP, 2018, NEUROREHAB NEURAL RE, V32, P191, DOI 10.1177/1545968318760727; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Ware A. L., 2018, J NEUROTRAUMA; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wolf  A., 2016, PLOS ONE, V11; Wright RL, 2005, STRESS, V8, P151, DOI 10.1080/10253890500156663; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	89	7	7	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUN 3	2019	365						66	76		10.1016/j.bbr.2019.02.045			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	HR9EY	WOS:000463463200008	30826298				2022-02-06	
J	Marschner, L; Schreurs, A; Lechat, B; Mogensen, J; Roebroek, A; Ahmed, T; Balschun, D				Marschner, Linda; Schreurs, An; Lechat, Benoit; Mogensen, Jesper; Roebroek, Anton; Ahmed, Tariq; Balschun, Detlef			Single mild traumatic brain injury results in transiently impaired spatial long-term memory and altered search strategies	BEHAVIOURAL BRAIN RESEARCH			English	Article						Concussion; Spatial learning; Morris water maze; Contextual fear conditioning; Immunoblotting	FIBRILLARY ACIDIC PROTEIN; POSTSYNAPTIC DENSITY; SYNAPTIC PLASTICITY; MOUSE; HIPPOCAMPUS; EXPRESSION; MODEL; NEUROINFLAMMATION; NEUROPATHOLOGY; DEFINITION	Mild traumatic brain injury (mTBI) can lead to diffuse neurophysical damage as well as cognitive and affective alterations. The nature and extent of behavioral changes after mTBI are still poorly understood and how strong an impact force has to be to cause long-term behavioral changes is not yet known. Here, we examined spatial learning acquisition, retention and reversal in a Morris water maze, and assessed search strategies during task performance after a single, mild, closed-skull traumatic impact referred to as "minimal" TBI. Additionally, we investigated changes in conditioned learning in a contextual fear-conditioning paradigm. Results show transient deficits in spatial memory retention, which, although limited, are indicative of deficits in long-term memory reconsolidation. Interestingly, minimal TBI causes animals to relapse to less effective search strategies, affecting performance after a retention pause. Apart from cognitive deficits, results yielded a sub-acute, transient increase in freezing response after fear conditioning, with no increase in baseline behavior, an indication of a stronger affective reaction to aversive stimuli after minimal TBI or greater susceptibility to stress. Furthermore, western blot analysis showed a short-term increase in hippocampal GFAP expression, most likely indicating astrogliosis, which is typically related to injuries of the central nervous system. Our findings provide evidence that even a very mild impact to the skull can have detectable consequences on the molecular, cognitive and affective-like level. However, these effects seemed to be very transient and reversible.	[Marschner, Linda; Mogensen, Jesper] Univ Copenhagen, Unit Cognit Neurosci, Dept Psychol, Oster Farimagsgade 2A, DK-1353 Copenhagen, Denmark; [Marschner, Linda; Schreurs, An; Ahmed, Tariq; Balschun, Detlef] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Lab Biol Psychol, Tiensestr 102,Box 3714, B-3000 Leuven, Belgium; [Lechat, Benoit; Roebroek, Anton] Katholieke Univ Leuven, Dept Human Genet, Lab Expt Mouse Genet, Herestr 49,Box 602, B-3000 Leuven, Belgium; [Ahmed, Tariq] Hamad bin Khalifa Univ, Qatar Biomed Res Inst, Neurol Disorders Res Ctr, POB 34110, Doha, Qatar		Marschner, L (corresponding author), Ctr Brain Injury Rehabil, Amagerfaelledvej 56A, DK-2300 Copenhagen K, Denmark.	linda.marschner@cfh.ku.dk		Schreurs, An/0000-0001-5407-7933; Ahmed, Tariq/0000-0002-0998-1103; Mogensen, Jesper/0000-0003-1959-581X	Research Foundation Flanders (FWO)FWO [G.0D76.14]; University of Copenhagen; Agency for Innovation by Science and Technology in Flanders (IWT)Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT) [141698]; KU Leuven (GOA)KU Leuven [12/008]	This work was funded by the Research Foundation Flanders (FWO) (G.0D76.14), the University of Copenhagen (scholarship to LM), the Agency for Innovation by Science and Technology in Flanders (IWT) (scholarship 141698 to AS) and an interdisciplinary research grant from KU Leuven (GOA) (12/008). The authors wish to thank R. D'Hooge for supporting the behavioural testing, F. Van Leuven for critical discussion and the donation of antibodies, the research group of L. Arckens (N. Lombaert, M. Hennes) for their assistance with microscopy, and K. Vinken for his help with the search strategy analysis.	Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chistiakov DA, 2017, LAB INVEST, V97, P4, DOI 10.1038/labinvest.2016.116; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Hendrickx DAE, 2017, J NEUROIMMUNOL, V309, P12, DOI 10.1016/j.jneuroim.2017.04.007; HERNDLERBRANDSTETT, 2013, FRONT IMMUNOL, V4, DOI DOI 10.3389/FIMMU.2013.00136; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Laeremans A, 2015, BRAIN STRUCT FUNCT, V220, P1273, DOI 10.1007/s00429-014-0722-z; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Marschner L, 2016, ARCH NEUROSCI, V3, DOI 10.5812/archneurosci.38039; McCrory P, 2012, BRIT J SPORT MED, V47, P9; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Paradee W, 1999, NEUROSCIENCE, V94, P185, DOI 10.1016/S0306-4522(99)00285-7; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Rosenzweig MR, 1996, ANNU REV PSYCHOL, V47, P1, DOI 10.1146/annurev.psych.47.1.1; Rossato JI, 2006, LEARN MEMORY, V13, P431, DOI 10.1101/lm.315206; Rossato JI, 2015, NEUROBIOL LEARN MEM, V125, P146, DOI 10.1016/j.nlm.2015.09.001; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shim SS, 2016, J NEUROTRAUM, V33, P2065, DOI 10.1089/neu.2015.4177; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Stankov Aleksandar, 2015, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V36, P141, DOI 10.1515/prilozi-2015-0062; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	52	7	7	1	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUN 3	2019	365						222	230		10.1016/j.bbr.2018.02.040			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	HR9EY	WOS:000463463200027	29499284	Green Accepted			2022-02-06	
J	Feldmann, LK; Le Prieult, F; Felzen, V; Thal, SC; Engelhard, K; Behl, C; Mittmann, T				Feldmann, Lucia K.; Le Prieult, Florie; Felzen, Vanessa; Thal, Serge C.; Engelhard, Kristin; Behl, Christian; Mittmann, Thomas			Proteasome and Autophagy-Mediated Impairment of Late Long-Term Potentiation (l-LTP) after Traumatic Brain Injury in the Somatosensory Cortex of Mice	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; long-term potentiation; plasticity related proteins; proteasome; autophagy; somatosensory cortex	SYNAPTIC PLASTICITY; PROTEIN HOMEOSTASIS; SELECTIVE AUTOPHAGY; CO-CHAPERONES; HEAD-INJURY; CELL-DEATH; DEGRADATION; UBIQUITIN; MAINTENANCE; EXPRESSION	Traumatic brain injury (TBI) can lead to impaired cognition and memory consolidation. The acute phase (24-48 h) after TBI is often characterized by neural dysfunction in the vicinity of the lesion, but also in remote areas like the contralateral hemisphere. Protein homeostasis is crucial for synaptic long-term plasticity including the protein degradation systems, proteasome and autophagy. Still, little is known about the acute effects of TBI on synaptic long-term plasticity and protein degradation. Thus, we investigated TBI in a controlled cortical impact (CCI) model in the motor and somatosensory cortex of mice ex vivo-in vitro. Late long-term potentiation (l-LTP) was induced by theta-burst stimulation in acute brain slices after survival times of 1-2 days. Protein levels for the plasticity related protein calcium/calmodulin-dependent protein kinase II (CaMKII) was quantified by Western blots, and the protein degradation activity by enzymatical assays. We observed missing maintenance of l-LTP in the ipsilateral hemisphere, however not in the contralateral hemisphere after TBI. Protein levels of CaMKII were not changed but, interestingly, the protein degradation revealed bidirectional changes with a reduced proteasome activity and an increased autophagic flux in the ipsilateral hemisphere. Finally, LTP recordings in the presence of pharmacologically modified protein degradation systems also led to an impaired synaptic plasticity: bath-applied MG132, a proteasome inhibitor, or rapamycin, an activator of autophagy, both administered during theta burst stimulation, blocked the induction of LTP. These data indicate that alterations in protein degradation pathways likely contribute to cognitive deficits in the acute phase after TBI, which could be interesting for future approaches towards neuroprotective treatments early after traumatic brain injury.	[Feldmann, Lucia K.; Le Prieult, Florie; Mittmann, Thomas] Johannes Gutenberg Univ Mainz, UMC, Inst Physiol, Duesbergweg 6, D-55128 Mainz, Germany; [Felzen, Vanessa; Behl, Christian] Johannes Gutenberg Univ Mainz, UMC, Inst Pathobiochem, Duesbergweg 6, D-55128 Mainz, Germany; [Thal, Serge C.; Engelhard, Kristin] Johannes Gutenberg Univ Mainz, UMC, Clin Anaesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany		Mittmann, T (corresponding author), Johannes Gutenberg Univ Mainz, UMC, Inst Physiol, Duesbergweg 6, D-55128 Mainz, Germany.	lucia.feldmann@charite.de; florie.leprieult@gmail.com; Vanessa.Felzen@gmail.com; thal@uni-mainz.de; engelhk@uni-mainz.de; cbehl@uni-mainz.de; mittmann@uni-mainz.de	Thal, Serge/D-6593-2011; Mittmann, Thomas/AAM-9047-2020	Thal, Serge/0000-0002-1222-8729; Felzen, VAnessa/0000-0001-6028-0743; Feldmann, Lucia Katharina/0000-0003-1290-208X; Behl, Christian/0000-0001-8453-2378; LE PRIEULT, Florie/0000-0002-9117-7375	IMB, Mainz; German Research Foundation (DFG)German Research Foundation (DFG) [CRC 1080, TP C02, TP B09, TP A07, CRC1177]; FTN-Mainz	We would like to thank Simone Dahms-Pratorius for technical assistance, and support by the IMB, Mainz is gratefully acknowledged. This work is supported by the German Research Foundation (DFG, CRC 1080 to T.M. (TP C02), C.B. (TP B09) and K.E. (TP A07), and CRC1177 to C.B.) and by a grant of the FTN-Mainz to LKF.	Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; Behl C, 2016, TRENDS PHARMACOL SCI, V37, P672, DOI 10.1016/j.tips.2016.04.007; Behl C, 2011, AUTOPHAGY, V7, P795, DOI 10.4161/auto.7.7.15844; Bliss TVP, 2011, CLINICS, V66, P3, DOI 10.1590/S1807-59322011001300002; Bockaert J, 2015, PHYSIOL REV, V95, P1157, DOI 10.1152/physrev.00038.2014; Butefisch CM, 2006, J PHYSIOL-PARIS, V99, P437, DOI 10.1016/j.jphysparis.2006.03.001; Byth LA, 2014, ANN NEUROSCI, V21, P151, DOI 10.5214/ans.0972.7531.210408; Cai F, 2010, NEUROSCIENCE, V169, P1520, DOI 10.1016/j.neuroscience.2010.06.032; Cajigas IJ, 2010, EMBO J, V29, P2746, DOI 10.1038/emboj.2010.173; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Castillo PE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005728; Chen L, 2013, BIOMATERIALS, V34, P10172, DOI 10.1016/j.biomaterials.2013.09.048; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Dohle CI, 2009, EXP BRAIN RES, V199, P423, DOI 10.1007/s00221-009-1964-5; Dong CG, 2008, LEARN MEMORY, V15, P335, DOI 10.1101/lm.984508; Dong CH, 2014, J NEUROSCI, V34, P3171, DOI 10.1523/JNEUROSCI.3291-13.2014; Edelmann E, 2014, NEUROPHARMACOLOGY, V76, P610, DOI 10.1016/j.neuropharm.2013.05.043; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Gamerdinger M, 2011, J MOL MED, V89, P1175, DOI 10.1007/s00109-011-0795-6; Ghiglieri V, 2010, EXP NEUROL, V226, P328, DOI 10.1016/j.expneurol.2010.09.012; Glatigny M, 2019, CURR BIOL, V29, P435, DOI 10.1016/j.cub.2018.12.021; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hao YH, 2018, PHYSIOL BEHAV, V188, P119, DOI 10.1016/j.physbeh.2018.02.005; Hernandez D, 2012, NEURON, V74, P277, DOI 10.1016/j.neuron.2012.02.020; Hu JY, 2011, J NEUROSCI, V31, P8841, DOI 10.1523/JNEUROSCI.1358-11.2011; Hu JY, 2017, J NEUROSCI, V37, P2746, DOI 10.1523/JNEUROSCI.2805-16.2017; Huemmeke M, 2002, EUR J NEUROSCI, V15, P1641, DOI 10.1046/j.1460-9568.2002.02002.x; Imbrosci B, 2015, BRAIN STRUCT FUNCT, V220, P1649, DOI 10.1007/s00429-014-0750-8; Imbrosci B, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/614329; Jarome TJ, 2013, NEUROBIOL LEARN MEM, V105, P107, DOI 10.1016/j.nlm.2013.03.009; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; Le Prieult F, 2017, J NEUROTRAUM, V34, P1097, DOI 10.1089/neu.2016.4575; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mittmann T, 2001, NEUROREPORT, V12, P3341, DOI 10.1097/00001756-200110290-00039; Morawe T, 2012, MOL NEUROBIOL, V46, P41, DOI 10.1007/s12035-012-8246-0; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Renziehausen J, 2015, J ALZHEIMERS DIS, V44, P879, DOI 10.3233/JAD-140600; Robbins and Cotran, 2010, PATHOLOGIC BASIS DIS, P1287; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sakai K, 2014, AM J FOREN MED PATH, V35, P38, DOI 10.1097/PAF.0000000000000067; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Santos XR, 2015, J NEUROSCI, V35, P3319, DOI 10.1523/JNEUROSCI.4521-14.2015; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Schwartz J.H., 2000, PRINCIPLES NEURAL SC, V4th, P280; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shao CY, 2012, HIPPOCAMPUS, V22, P1501, DOI 10.1002/hipo.20996; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Sunkaria A, 2017, NEUROSCIENCE, V367, P47, DOI 10.1016/j.neuroscience.2017.10.021; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Tsai NP, 2014, BBA-MOL CELL RES, V1843, P2838, DOI 10.1016/j.bbamcr.2014.08.006; Volk LJ, 2013, NATURE, V493, P420, DOI 10.1038/nature11802; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Yi Y, 2018, MOL NEUROBIOL, V55, P2454, DOI 10.1007/s12035-017-0504-8; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	76	7	7	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	JUN 2	2019	20	12							3048	10.3390/ijms20123048			17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	IG4ED	WOS:000473756000198	31234472	Green Published, Green Submitted, gold			2022-02-06	
J	Aertker, BM; Kumar, A; Prabhakara, KS; Smith, P; Furman, NET; Hasen, X; Cox, CS; Bedi, SS				Aertker, Benjamin M.; Kumar, Akshita; Prabhakara, Karthik S.; Smith, Philippa; Furman, Naama E. Toledano; Hasen, Xue; Cox, Charles S.; Bedi, Supinder S.			Pre-injury monocyte/macrophage depletion results in increased blood-brain barrier permeability after traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						clodronate liposomes; granulocytes; macrophage; microglia; monocyte; traumatic brain injury	REGULATES MICROGLIAL ACTIVATION; CEREBRAL EDEMA; SPINAL-CORD; MACROPHAGES; CELLS; RATS; PLAY	Traumatic brain injury (TBI) effects both the brain and the immune system. Circulating monocytes/macrophages (M-o/M-a) after a TBI may play an important role in preserving the blood-brain barrier (BBB), reducing brain edema, and interacting with resident microglia. To elucidate the role of circulating M-o/M-a, we utilized a monocyte/macrophage depletion model in response to TBI in male rats. Clodronate liposomes (CL) were used to deplete circulating M-o/M-a. A controlled cortical impact (CCI) injury model was used to create a TBI. All animals received either CL or PBS liposomes (PL), 48 and 24 hr prior to the procedure, and were sacrificed 72 hr post-injury for analysis of BBB permeability, brain edema, whole blood (M-o/M-a and granulocytes), and/or microglial analysis. Animals undergoing M-o/M-a depletion with CL prior to CCI (CCI-CL) were found to have increased BBB permeability when compared to non-depleted CCI (CCI-PL) animals. At 72 hr following injury, Sham-CL maintained on average an 82% reduction in the whole blood monocytes when compared to Sham-PL (p < 0.001). Monocytes in the whole blood remained significantly lower in CCI-CL animals when compared to CCI-PL (p < 0.001). The number of granulocytes in the whole blood of CCI-CL animals was higher at 3 days when compared to CCI-PL (p < 0.022). Surprisingly, the depletion of M-o/M-a did not affect brain edema. However, the depletion of M-o/M-a did result in a significant decrease in microglia (CCI-CL vs. CCI-PL, p < 0.012). In conclusion, an intact M-o/M-a population is required to repair BBB integrity and microglial response following injury.	[Aertker, Benjamin M.; Kumar, Akshita; Prabhakara, Karthik S.; Smith, Philippa; Furman, Naama E. Toledano; Hasen, Xue; Cox, Charles S.; Bedi, Supinder S.] Univ Texas Houston, Med Sch Houston, Dept Pediat Surg, 6431 Fannin St,MSB 5-230, Houston, TX 77030 USA		Bedi, SS (corresponding author), Univ Texas Houston, Med Sch Houston, Dept Pediat Surg, 6431 Fannin St,MSB 5-230, Houston, TX 77030 USA.	Supinder.Bedi@uth.tmc.edu		Kumar, Akshita/0000-0002-4021-4092			Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bedi SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1122-8; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Enzmann G, 2013, ACTA NEUROPATHOL, V125, P395, DOI 10.1007/s00401-012-1076-3; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Koneru R, 2011, NEUROSCI LETT, V501, P148, DOI 10.1016/j.neulet.2011.06.062; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Liao GP, 2014, J SURG RES, V190, P628, DOI 10.1016/j.jss.2014.05.011; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lobato-Pascual A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057406; Lou NH, 2016, P NATL ACAD SCI USA, V113, P1074, DOI 10.1073/pnas.1520398113; Ma YY, 2017, PROG NEUROBIOL, V157, P247, DOI 10.1016/j.pneurobio.2016.01.005; MICKLUS MJ, 1992, BIOCHIM BIOPHYS ACTA, V1124, P7, DOI 10.1016/0005-2760(92)90118-F; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; VANGOOR H, 1991, LAB INVEST, V64, P754; VANROOIJEN N, 1994, ADV EXP MED BIOL, V355, P69; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Wang MH, 2014, J NEUROSCI, V34, P3793, DOI 10.1523/JNEUROSCI.3153-13.2014; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008	28	7	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2019	97	6					698	707		10.1002/jnr.24395			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HW0OZ	WOS:000466382100006	30746753				2022-02-06	
J	Gamberini, L; Giugni, A; Ranieri, S; Meconi, T; Coniglio, C; Gordini, G; Bardi, T				Gamberini, Lorenzo; Giugni, Aimone; Ranieri, Serena; Meconi, Tommaso; Coniglio, Carlo; Gordini, Giovanni; Bardi, Tommaso			EARLY-ONSET VENTILATOR-ASSOCIATED PNEUMONIA IN SEVERE TRAUMATIC BRAIN INJURY: IS THERE A RELATIONSHIP WITH PREHOSPITAL AIRWAY MANAGEMENT?	JOURNAL OF EMERGENCY MEDICINE			English	Article						traumatic brain injury; ventilator-associated pneumonia; risk factors; prehospital emergency care; emergency medical services	RISK-FACTORS; INTUBATION; PROTECTION; ASPIRATION; IMPACT	Background: Prehospital airway management in severe traumatic brain injury (TBI) is widely recommended by international guidelines for the management of trauma. Early-onset ventilator-associated pneumonia (EOVAP) is a common occurrence in this population and can worsen mortality and functional outcome. Objectives: In this retrospective observational study, we aimed to evaluate the association between different prehospital airway management variables and the occurrence of EOVAP. Secondarily we evaluated the correlation between EOVAP and mortality and neurological outcome. Methods: The study retrospectively evaluated 223 patients admitted from 2010 to 2017 in our trauma intensive care unit for severe TBI. The population was divided into three groups on the basis of the airway management technique adopted (bag mask ventilation, laryngeal tube, orotracheal intubation). Uni-and multivariate logistic regression analyses were performed using the occurrence of EOVAP as the dependent variable, to investigate potential associations with prehospital airway management. Results: A total of 131 episodes (58.7%) of EOVAP were registered in the study population (223 patients). Laryngeal tube and orotracheal intubation were used in patients with significantly lower Glasgow Coma Scale score on scene and a higher Face Abbreviated Injury Scale; advanced airway management significantly increased the total rescue time. The prehospital airway management technique adopted, prehospital type of sedation or use of muscle relaxants, type of transport, and rescue times were not associated with the occurrence of EOVAP. Conclusions: Prehospital airway management does not have a significant impact on the occurrence of EOVAP in severe TBI patients. Similarly, it does not have a significant impact on mortality or long-term neurological outcome despite increasing duration of mechanical ventilation, intensive care unit, and hospital stay. (C) 2019 Elsevier Inc. All rights reserved.	[Gamberini, Lorenzo; Giugni, Aimone; Coniglio, Carlo; Gordini, Giovanni; Bardi, Tommaso] Maggiore Hosp Carlo Alberto Pizzardi, Div Anesthesia Intens Care & Prehosp Emergency, Largo Nigrisoli 2, I-40133 Bologna, Italy; [Ranieri, Serena; Meconi, Tommaso] Univ Bologna, Alma Mater Studiorum, Dept Med & Surg Sci DIMEC, Bologna, Italy; [Ranieri, Serena; Meconi, Tommaso] St Orsola Marcello Malpighi Hosp, Bologna, Italy		Gamberini, L (corresponding author), Maggiore Hosp Carlo Alberto Pizzardi, Div Anesthesia Intens Care & Prehosp Emergency, Largo Nigrisoli 2, I-40133 Bologna, Italy.		Coniglio, Carlo/AAB-7128-2022; Gamberini, Lorenzo/S-5476-2017; Gordini, Giovanni/AAB-8170-2022	Coniglio, Carlo/0000-0002-8207-0525; Gamberini, Lorenzo/0000-0002-4364-9163; Gordini, Giovanni/0000-0003-4518-0204; BARDI, TOMMASO/0000-0002-0263-706X	Department of Emergency of the Maggiore Hospital Carlo Alberto Pizzardi of Bologna	This study was fully supported by the Department of Emergency of the Maggiore Hospital Carlo Alberto Pizzardi of Bologna.	Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Di Bartolomeo S, 2006, EUR J EMERG MED, V13, P197, DOI 10.1097/01.mej.0000217974.54212.a1; Esnault P, 2017, NEUROCRIT CARE, V27, P187, DOI 10.1007/s12028-017-0397-4; Fevang E, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1787-x; Hoffmann M, 2017, J NEUROSURG ANESTH, V29, P161, DOI 10.1097/ANA.0000000000000275; JOHN RE, 1991, ANAESTHESIA, V46, P366, DOI 10.1111/j.1365-2044.1991.tb09545.x; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Mercer MH, 2001, RESUSCITATION, V51, P135, DOI 10.1016/S0300-9572(01)00390-2; Mohr NM, 2015, J CRIT CARE, V30, P787, DOI 10.1016/j.jcrc.2015.03.017; Moscote-Salazar Luis Rafael, 2016, Bull Emerg Trauma, V4, P8; Pakkanen T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0256-x; Piegeler T, 2016, RESUSCITATION, V102, P70, DOI 10.1016/j.resuscitation.2016.02.017; Rognas L, 2014, EUR J EMERG MED, V21, P418, DOI 10.1097/MEJ.0000000000000103; Sollid SJM, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-58; Tuma M, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/135986	17	7	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	JUN	2019	56	6					657	665		10.1016/j.jemermed.2019.02.005			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	ID9SH	WOS:000472026900017	31000428				2022-02-06	
J	Graff, HJ; Siersma, V; Moller, A; Kragstrup, J; Andersen, LL; Egerod, I; Rytter, HM				Graff, Heidi Jeannet; Siersma, Volkert; Moller, Anne; Kragstrup, Jakob; Andersen, Lars L.; Egerod, Ingrid; Rytter, Hana Mala			Labour market attachment after mild traumatic brain injury: nationwide cohort study with 5-year register follow-up in Denmark	BMJ OPEN			English	Article							HEAD-INJURY; ADMINISTRATIVE DATA; WORK; RETURN; SYMPTOMS; RISK; CONCUSSION; PREDICTORS; DISABILITY; MANAGEMENT	Objectives Sickness absence after mild traumatic brain injury (mTBI) is frequent due to postconcussive symptoms. We examined labour market attachment following mTBI up to 5 years postinjury. Design and setting Nationwide cohort study with register follow-up. Participants Patients between 18 and 60 years with mTBI (International Classification of Diseases, version 10 diagnosis S06.0) were extracted from the Danish National Patient Register (n= 19 732). Controls were matched on sex, age and municipality (n= 18 640). Patients with spinal cord and column injuries, traumatic brain injury and concussions 5 years preinjury or as secondary diagnosis to the concussion in the inclusion period were excluded. Primary and secondary outcome measures Data were extracted from the Danish Register for Evaluation of Marginalization. Primary outcome was 'not attending ordinary work' defined as receiving any social transfer payment. Secondary outcomes were health-related benefits, limited attachment to the labour market, permanent lack of attachment to the labour market and death. Results 5 years after diagnosis, 43% of patients were not attending ordinary work. The odds increased from 6 months (OR 1.30, 95% CI 1.24 to 1.36) to 5 years (OR 1.54, 95% CI 1.45 to 1.63). The odds of health-related benefits were 32% (OR 1.32, 95% CI 1.22 to 1.42) at 6 months and 22% (OR 1.22, 95% CI 1.12 to 1.33) at 5 years. Limited attachment to the labour market showed increased odds at 5 years (OR 1.38, 95% CI 1.27 to 1.51) and the odds of permanent lack of attachment to the labour market were higher for patients compared with controls (OR 2.59, 95% CI 2.30 to 2.92). Death was more than two times higher at 5 years postinjury (OR 2.62, 95% CI 2.10 to 3.26). Conclusions 43% of concussed patients were not attending ordinary work 5 years postinjury and received health and social transfer benefits. We conclude that mTBI has a long-term impact on labour market attachment. Prevention and treatment of persisting postconcussive symptoms should be considered. Trial registration number NCT03214432; Results	[Graff, Heidi Jeannet] Rigshosp, Univ Hosp, Ctr Head & Orthopaed, Dept Anaesthesia, Copenhagen, Denmark; [Siersma, Volkert; Moller, Anne; Kragstrup, Jakob] Univ Copenhagen, Res Unit Gen Practice, Dept Publ Hlth, Copenhagen, Denmark; [Siersma, Volkert; Moller, Anne; Kragstrup, Jakob] Univ Copenhagen, Sect Gen Practice, Copenhagen, Denmark; [Moller, Anne] Copenhagen Univ Hosp Holbaek, Dept Occupat & Social Med, Copenhagen, Denmark; [Andersen, Lars L.] Natl Res Ctr Working Environm, Musculoskeletal Disorders & Phys Workload, Copenhagen, Denmark; [Egerod, Ingrid] Rigshosp, Univ Hosp, Ctr Canc & Organ Dis, Dept Intens Care, Copenhagen, Denmark; [Rytter, Hana Mala] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Rytter, Hana Mala] Univ Hosp Bispebjerg Frederiksberg, Dept Neurol, Copenhagen, Denmark		Graff, HJ (corresponding author), Rigshosp, Univ Hosp, Ctr Head & Orthopaed, Dept Anaesthesia, Copenhagen, Denmark.	heidi.graff@supermail.dk	Andersen, Lars Louis/AAQ-4802-2020; Siersma, Volkert/G-6867-2016	Siersma, Volkert/0000-0003-1941-2681; Moller, Anne/0000-0003-0179-4108; Graff, Heidi/0000-0001-5726-6991; Rytter, Hana Mala/0000-0002-2910-372X	Research Foundation, Rigshospitalet [E-22260-03, E-23473-01]; Danish Health Foundation (Helsefonden) [16-B-0050]; Aase and Ejnar Danielsen's Foundation [20-000054]	This work was supported by the Research Foundation, Rigshospitalet (E-22260-03) (E-23473-01), the Danish Health Foundation (Helsefonden) (16-B-0050) and the Aase and Ejnar Danielsen's Foundation (20-000054).	[Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; de Koning ME, 2017, NEUROLOGY, V89, P1908, DOI 10.1212/WNL.0000000000004604; Dumke HA, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000244; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; Engberg Aase Worsaae, 2007, Ugeskr Laeger, V169, P199; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Galili SF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017735; Graff HJ, 2019, BMJ OPEN; Hannerz H, 2012, INT J OCCUP MED ENV, V25, P200, DOI 10.2478/S13382-012-0017-7; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Katz DI, 2015, HDB CLIN NEUROLOGY 1, V127, P129; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kristman VL, 2010, OPEN OCCUP HLTH SAF, V2, P1, DOI [10.2174/1876216601002010001, DOI 10.2174/1876216601002010001]; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lund T, 2008, OCCUP ENVIRON MED, V65, P28, DOI 10.1136/oem.2006.031393; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Ministry for Economic Affairs and the Interior, 2007, STRUCT REF; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Noonan VK, 2013, J NEUROTRAUM, V30, P173, DOI 10.1089/neu.2012.2441; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pedersen P, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3017-x; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Pransky G, 2005, J OCCUP REHABIL, V15, P453, DOI 10.1007/s10926-005-8027-y; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Stapelfeldt CM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-661; Statistics Denmark, 2017, HOUS FAM CHILDR SEC; Steenstra IA, 2012, J OCCUP REHABIL, V22, P394, DOI 10.1007/s10926-011-9349-6; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Styrelsen for Arbejdsmarked og Rekruttering [ Danish Agency for Labour Market and Recruitment], 2018, DREAM VERS 41; Sveen U, 2016, DISABIL REHABIL, V38, P2296, DOI 10.3109/09638288.2015.1129445; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Young AE, 2005, J OCCUP REHABIL, V15, P543, DOI 10.1007/s10926-005-8033-0	55	7	7	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JUN	2019	9	4							e026104	10.1136/bmjopen-2018-026104			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IC7MA	WOS:000471157200165	30975680	Green Published, gold			2022-02-06	
J	Jackson, EK; Mi, ZC; Janesko-Feldman, K; Jackson, TC; Kochanek, PM				Jackson, Edwin K.; Mi, Zaichuan; Janesko-Feldman, Keri; Jackson, Travis C.; Kochanek, Patrick M.			2 ',3 '-cGMP exists in vivo and comprises a 2 ',3 '-cGMP-guanosine pathway	AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY			English	Article						2',3'-cAMP-adenosinepathway; 2',3'-cGMP; 2'-GMP; 3'-GMP; 2',3'-cGMP-guanosine pathway	2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; ADENOSINE-MONOPHOSPHATE CGMP; TRAUMATIC BRAIN-INJURY; SMOOTH-MUSCLE-CELL; GUANOSINE PROTECTS; HIPPOCAMPAL SLICES; OXIDATIVE STRESS; 2',3'-CAMP-ADENOSINE PATHWAY; RAT; 2'-AMP	The discovery in 2009 that 2',3'-cAMP exists in biological systems was rapidly followed by identification of 2',3'-cGMP in cell and tissue extracts. To determine whether 2',3'-cGMP exists in mammals under physiological conditions, we used ultraperformance LC-MS/MS to measure 2',3'-cAMP and 2',3'-cGMP in timed urine collections (via direct bladder cannulation) from 25 anesthetized mice. Urinary excretion rates (means +/- SE) of 2',3'-cAMP (15.5 +/- 1.8 ng/30 min) and 2',3'-cGMP (17.9 +/- 1.9 ng/30 min) were similar. Mice also excreted 2'-AMP (3.6 +/- 1.1 ng/20 min) and 3'-AMP (9.5 +/- 1.2 ng/min), hydrolysis products of 2',3'-cAMP, and 2'-GMP (4.7 +/- 1.7 ng/30 min) and 3'-GMP (12.5 +/- 1.8 ng/30 min), hydrolysis products of 2',3'-cGMP. To validate that the chromatographic signals were from these endogenous noncanonical nucleotides, we repeated these experiments in mice (n = 18) lacking 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase), an enzyme known to convert 2',3'-cyclic nucleotides to their corresponding 2'-nucleotides. In CNPase-knockout mice, urinary excretions of 2',3'-cAMP, 3'-AMP, 2',3'-cGMP, and 3'-GMP were increased, while urinary excretions of 2'-AMP and 2'-GMP were decreased. Infusions of exogenous 2',3'-cAMP increased urinary excretion of 2',3'-cAMP, 2'-AMP, 3'-AMP, and adenosine, whereas infusions of exogenous 2',3'-cGMP increased excretion of 2',3'-cGMP, 2'-GMP, 3'-GMP, and guanosine. Together, these data suggest the endogenous existence of not only a 2',3'-cAMP-adenosine pathway (2',3'-cAMP -> 2'-AMP/3'-AMP -> adenosine), which was previously identified, but also a 2',3'-cGMP-guanosine pathway (2',3'-cGMP -> 2'-GMP/3'-GMP -> guanosine), observed here for the first time. Because it is well known that adenosine and guanosine protect tissues from injury, our data support the concept that both pathways may work together to protect tissues from injury.	[Jackson, Edwin K.; Mi, Zaichuan] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, 100 Technol Dr,Rm 514, Pittsburgh, PA 15219 USA; [Janesko-Feldman, Keri; Jackson, Travis C.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15219 USA; [Janesko-Feldman, Keri; Jackson, Travis C.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15219 USA		Jackson, EK (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, 100 Technol Dr,Rm 514, Pittsburgh, PA 15219 USA.	edj@pitt.edu		Jackson, Edwin/0000-0002-8101-6009	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-087978, DK-091190, HL-109002, HL-069846, DK-068575, DK-079307]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL069846, R01HL109002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK091190] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grants NS-087978, DK-091190, HL-109002, HL-069846, DK-068575, and DK-079307.	Azarashvili T, 2010, BIOL CHEM, V391, P619, DOI 10.1515/BC.2010.070; Azarashvili T, 2009, AM J PHYSIOL-CELL PH, V296, pC1428, DOI 10.1152/ajpcell.00006.2009; Bahre H, 2014, J CHROMATOGR B, V964, P208, DOI 10.1016/j.jchromb.2014.02.046; Belghit I, 2017, ALGAL RES, V26, P240, DOI 10.1016/j.algal.2017.08.001; Bellaver B, 2015, PURINERG SIGNAL, V11, P571, DOI 10.1007/s11302-015-9475-2; Burhenne H, 2013, BMC PHARMACOL TOXICO, V14, pP12, DOI [10.1186/2050-6511-14-S1-P12, DOI 10.1186/2050-6511-14-S1-P12]; Cohen MV, 2008, BASIC RES CARDIOL, V103, P203, DOI 10.1007/s00395-007-0687-7; Dal-Cim T, 2013, J NEUROCHEM, V126, P437, DOI 10.1111/jnc.12324; Corte CLD, 2012, BRAIN RES, V1430, P101, DOI 10.1016/j.brainres.2011.10.049; Dobrachinski F, 2019, MOL NEUROBIOL, V56, P3145, DOI 10.1007/s12035-018-1296-1; Fontaine BM, 2018, BIOCHEM J, V475, P1491, DOI 10.1042/BCJ20170906; Frizzo MED, 2002, CELL MOL NEUROBIOL, V22, P353; Hansel G, 2015, MOL NEUROBIOL, V52, P1791, DOI 10.1007/s12035-014-8978-0; Hansel G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090693; JACKSON D, 2017, HDB EXPT PHARM, P229; Jackson EK, 2016, J AM SOC NEPHROL, V27, P2069, DOI 10.1681/ASN.2015040397; Jackson EK, 2016, J NEUROCHEM, V137, P142, DOI 10.1111/jnc.13551; Jackson EK, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.24; Jackson EK, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12028; Jackson EK, 2014, J PHARMACOL EXP THER, V350, P719, DOI 10.1124/jpet.114.216978; Jackson EK, 2014, AM J PHYSIOL-RENAL, V307, pF14, DOI 10.1152/ajprenal.00134.2014; Jackson EK, 2013, J PHARMACOL EXP THER, V346, P190, DOI 10.1124/jpet.113.205757; Jackson EK, 2013, AM J PHYSIOL-CELL PH, V304, pC406, DOI 10.1152/ajpcell.00212.2012; Jackson EK, 2013, AM J PHYSIOL-RENAL, V304, pF49, DOI 10.1152/ajprenal.00571.2012; Jackson EK, 2011, AM J PHYSIOL-RENAL, V301, pF1160, DOI 10.1152/ajprenal.00450.2011; Jackson EK, 2011, AM J PHYSIOL-RENAL, V301, pF565, DOI 10.1152/ajprenal.00094.2011; Jackson EK, 2011, AM J PHYSIOL-HEART C, V301, pH391, DOI 10.1152/ajpheart.00336.2011; Jackson EK, 2011, J PHARMACOL EXP THER, V337, P444, DOI 10.1124/jpet.110.178137; Jackson EK, 2010, HYPERTENSION, V56, P151, DOI 10.1161/HYPERTENSIONAHA.110.152454; Jackson EK, 2009, J BIOL CHEM, V284, P33097, DOI 10.1074/jbc.M109.053876; Jackson TC, 2019, BRAIN RES, V1706, P101, DOI 10.1016/j.brainres.2018.11.002; Jia X, 2014, BIOMOLECULES, V4, P1070, DOI 10.3390/biom4041070; Kelly KJ, 2001, J CLIN INVEST, V108, P1291, DOI 10.1172/JCI13018; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Kochanek PM, 2005, J CEREBR BLOOD F MET, V25, P1596, DOI 10.1038/sj.jcbfm.9600154; Kochanek PM, 1997, ACT NEUR S, V70, P109; Kochanek PM, 2001, MAGNET RESON MED, V45, P924, DOI 10.1002/mrm.1123; Kosmacz M, 2018, PLANT PHYSIOL, V177, P411, DOI 10.1104/pp.18.00285; Lanznaster D, 2017, MOL NEUROBIOL, V54, P5482, DOI 10.1007/s12035-016-0082-1; Lara DR, 2001, BRAIN RES, V912, P176, DOI 10.1016/S0006-8993(01)02734-2; Li DW, 2014, INT J MOL MED, V34, P1358, DOI 10.3892/ijmm.2014.1904; Liu A, 2016, ACS CHEM BIOL, V11, P2414, DOI 10.1021/acschembio.6b00426; Molz S, 2011, J NEUROSCI RES, V89, P1400, DOI 10.1002/jnr.22681; Newell EA, 2015, BRAIN RES, V1594, P27, DOI 10.1016/j.brainres.2014.10.059; Paniz LG, 2014, METAB BRAIN DIS, V29, P645, DOI 10.1007/s11011-014-9548-x; Quincozes-Santos A, 2014, J NEUROCHEM, V130, P61, DOI 10.1111/jnc.12694; Quincozes-Santos A, 2013, PURINERG SIGNAL, V9, P643, DOI 10.1007/s11302-013-9377-0; Ren J, 2009, J PHARMACOL EXP THER, V328, P855, DOI 10.1124/jpet.108.146712; Schmidt AP, 2007, PHARMACOL THERAPEUT, V116, P401, DOI 10.1016/j.pharmthera.2007.07.004; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; Tarozzi A, 2010, J BIOL REG HOMEOS AG, V24, P297; Thomaz DT, 2016, PURINERG SIGNAL, V12, P707, DOI 10.1007/s11302-016-9534-3; Tomaselli B, 2005, NEUROCHEM INT, V46, P513, DOI 10.1016/j.neuint.2005.02.003; Van Damme T, 2014, PHYTOCHEMISTRY, V103, P59, DOI 10.1016/j.phytochem.2014.03.013; Van Damme T, 2012, J CHROMATOGR B, V909, P14, DOI 10.1016/j.jchromb.2012.10.002; Verrier JD, 2012, J NEUROCHEM, V122, P115, DOI 10.1111/j.1471-4159.2012.07705.x; Verrier JD, 2011, J NEUROCHEM, V118, P979, DOI 10.1111/j.1471-4159.2011.07392.x; Yap SC, 2012, CURR OPIN NEPHROL HY, V21, P24, DOI 10.1097/MNH.0b013e32834d2ec9	59	7	7	0	5	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6119	1522-1490		AM J PHYSIOL-REG I	Am. J. Physiol.-Regul. Integr. Comp. Physiol.	JUN	2019	316	6					R783	R790		10.1152/ajpregu.00401.2018			8	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	IJ1ZR	WOS:000475698500002	30789788	Bronze, Green Published			2022-02-06	
J	Kumar, SA; Devi, BI; Reddy, M; Shukla, D				Kumar, S. Arun; Devi, Bhagavatula Indira; Reddy, Madhusudan; Shukla, Dhaval			Comparison of equiosmolar dose of hyperosmolar agents in reducing intracranial pressure-a randomized control study in pediatric traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Mannitol; Hypertonic saline	HYPERTONIC SALINE; HEAD-INJURY; CHILDREN; THERAPY; HYPERTENSION	IntroductionThere are no comparative studies available for hyperosmolar therapy in children. The present study is a prospective open label randomized control trial to compare the effect of equiosmolar doses of mannitol and hypertonic saline in reducing intracranial pressure in children who sustained severe traumatic brain injury.MethodsThis is a prospective open-label randomized controlled trial. Thirty children aged less than or equal to 16years with severe traumatic brain injury and raised intracranial pressure as measured by ventricular catheter insertion were enrolled. Sixteen children received 20% mannitol, and 14 children received 3% saline as 2.5ml/kg bolus for episodes of intracranial pressure above cutoff value for age. The mean reduction in intracranial pressure and Glasgow outcome scale at 6months after injury was measured.ResultsThe mean reduction in intracranial pressure in mannitol group was 7.13mmHg and in hypertonic saline group was 5.67mmHg, and the difference was not statistically significant, p=0.33. The incidence of death or survival in vegetative state was 23.07% in mannitol group and 16.66% in hypertonic saline group, and the difference was not statistically significant, p=0.69.ConclusionBoth mannitol and hypertonic saline were equally effective for treatment of raised intracranial pressure in children with severe traumatic brain injury.	[Kumar, S. Arun; Devi, Bhagavatula Indira] NIMHANS, Dept Neurosurg, Bangalore, Karnataka, India; [Reddy, Madhusudan] NIMHANS, Dept Neuroanesthesia, Bangalore, Karnataka, India; [Shukla, Dhaval] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India		Shukla, D (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India.	neurodhaval@rediffmail.com		Shukla, Dhaval/0000-0001-7613-1929			Avellino A, 2005, CURRENT MANAGEMENT C, P563; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Gu JJ, 2019, NEUROSURG REV, V42, P499, DOI 10.1007/s10143-018-0991-8; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kirkham FJ, 2008, DEV MED CHILD NEUROL, V50, P267, DOI 10.1111/j.1469-8749.2008.02042.x; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Roumeliotis N, 2016, CHILD NERV SYST, V32, P2363, DOI 10.1007/s00381-016-3231-y; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; Yildizdas D, 2006, INDIAN PEDIATR, V43, P771; Ziai WC, 2007, J NEUROL SCI, V261, P157, DOI 10.1016/j.jns.2007.04.048	18	7	7	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUN	2019	35	6					999	1005		10.1007/s00381-019-04121-3			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	HY1UP	WOS:000467902900014	30879126				2022-02-06	
J	Lunter, CM; Carroll, EL; Housden, C; Outtrim, J; Forsyth, F; Rivera, A; Maimaris, C; Boyle, A; Sahakian, BJ; Menon, DK; Newcombe, VFJ				Lunter, Catherine M.; Carroll, Ellen L.; Housden, Charlotte; Outtrim, Joanne; Forsyth, Faye; Rivera, Annie; Maimaris, Chris; Boyle, Adrian; Sahakian, Barbara J.; Menon, David K.; Newcombe, Virginia F. J.			Neurocognitive testing in the emergency department: A potential assessment tool for mild traumatic brain injury	EMERGENCY MEDICINE AUSTRALASIA			English	Article						concussion; mild traumatic brain injury; neurocognitive testing	HEAD-INJURY; CONCUSSION; SYMPTOMS; SEQUELAE; OUTCOMES	ObjectiveDespite mild traumatic brain injury (mTBI) accounting for 80% of head injury diagnoses, recognition of individuals at risk of cognitive dysfunction remains a challenge in the acute setting. The objective of this study was to evaluate the feasibility and potential role for computerised cognitive testing as part of a complete ED head injury assessment. MethodsmTBI patients (n =36) who incurred a head injury within 24h of presentation to the ED were compared to trauma controls (n = 20) and healthy controls (n =20) on tests assessing reaction time, speed and attention, episodic memory, working memory and executive functioning. Testing occurred during their visit to the ED at a mean of 12h post-injury for mTBI and 9.4h for trauma controls. These tasks were part of the Cambridge Neuropsychological Test Automated Battery iPad application. Healthy controls were tested in both a quiet environment and the ED to investigate the potential effects of noise and distraction on neurocognitive function. ResultsReaction time was significantly slower in the mTBI group compared to trauma patients (P =0.015) and healthy controls (P =0.011), and deficits were also seen in working memory compared to healthy controls (P <= 0.001) and in executive functioning (P =0.021 and P <0.001) compared to trauma and healthy controls. Performances in the control group did not differ between testing environments. ConclusionComputerised neurocognitive testing in the ED is feasible and can be utilised to detect deficits in cognitive performance in the mTBI population as part of a routine head injury assessment.	[Lunter, Catherine M.; Carroll, Ellen L.; Outtrim, Joanne; Forsyth, Faye; Menon, David K.; Newcombe, Virginia F. J.] Univ Cambridge, Univ Div Anaesthesia, Cambridge, England; [Housden, Charlotte] Cambridge Cognit Ltd, Cambridge, England; [Rivera, Annie] Wellcome Trust Clin Res Facil, Natl Inst Hlth Res, Cambridge, England; [Maimaris, Chris; Boyle, Adrian] Addenbrookes Hosp, Dept Emergency Med, Cambridge, England; [Sahakian, Barbara J.] Univ Cambridge, Dept Psychiat, Cambridge, England		Newcombe, VFJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Univ Div Anaesthesia, Box 93,Hills Rd, Cambridge CB2 0QQ, England.	vfjn2@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745; LUNTER, Catherine/0000-0001-6921-0039; Newcombe, Virginia/0000-0001-6044-9035; Boyle, Adrian/0000-0002-9009-5423; Forsyth, Faye/0000-0003-2107-3690	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [FP7-270259-TBICare]; Neurosciences Theme of the Cambridge NIHR Biomedical Research Centre; UK Department of Health; Neurodegeneration Theme of the Cambridge NIHR Biomedical Research Centre; Mental Health Theme of the Cambridge NIHR Biomedical Research Centre; NIHR Brain Injury MedTech Co-operative; National Institute for Health Research (NIHR, UK) through the NIHR Cambridge Biomedical Centre grantNational Institute for Health Research (NIHR); Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship; National Institute for Health Research (NIHR, UK) through Senior Investigator AwardNational Institute for Health Research (NIHR)	This work was supported by the European Commission under the 7th Framework Programme (FP7-270259-TBICare, ), the Neurosciences Theme of the Cambridge NIHR Biomedical Research Centre, and the Technology Platform funding provided by the UK Department of Health. The NIHR/Wellcome Trust Cambridge Clinical Research Facility provided nursing support to aid in the data collection within the Emergency Department. Cambridge Cognition supplied the iPad research application. BJS receives funding from the Neurodegeneration Theme and Mental Health Theme of the Cambridge NIHR Biomedical Research Centre, and the NIHR Brain Injury MedTech Co-operative. DKM was supported by the National Institute for Health Research (NIHR, UK) through the NIHR Cambridge Biomedical Centre grant and a Senior Investigator Award. VFJN was supported by The Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship.	BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; National Institute for Health and Clinical Excellence, 2014, HEAD INJ TRIAG ASS I; Nelson LD, 2017, J INT NEUROPSYCH SOC, V23, P293, DOI 10.1017/S1355617717000157; Nithianantharajah J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14613; Peterson SE, 2009, ANN EMERG MED, V53, P796, DOI 10.1016/j.annemergmed.2008.10.015; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Salmond CH, 2006, NEUROPSYCHOLOGIA, V44, P1995, DOI 10.1016/j.neuropsychologia.2006.03.013; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Weathers FW, 1991, PCL C FOR DSM 4	20	7	7	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-6731	1742-6723		EMERG MED AUSTRALAS	Emerg. Med. Australas.	JUN	2019	31	3					355	361		10.1111/1742-6723.13163			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	IH9YI	WOS:000474862200009	30175893	Green Submitted			2022-02-06	
J	Shelmerdine, SC; Davendralingam, N; Palm, L; Minden, T; Cary, N; Sebire, NJ; Arthurs, OJ				Shelmerdine, Susan C.; Davendralingam, Natasha; Palm, Liina; Minden, Tom; Cary, Nat; Sebire, Neil J.; Arthurs, Owen J.			Diagnostic Accuracy of Postmortem CT of Children: A Retrospective Single-Center Study	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						autopsy; childhood; CT; pediatric; postmortem	COMPUTED-TOMOGRAPHY; IMAGING CT; AUTOPSY; FEASIBILITY; ANGIOGRAPHY; PERFORMANCE; DEATH	OBJECTIVE. The objective of our study was to determine the diagnostic accuracy of postmortem CT in children compared with standard autopsy. MATERIALS AND METHODS. This single-center retrospective study reviewed un-enhanced whole-body postmortem CT examinations of children less than 16 years old with corresponding autopsy reports irrespective of the clinical indication for referral for postmortem CT. Perinatal deaths were excluded. Postmortem CT was reported by experienced postmortem radiologists who were blinded to autopsy findings, with the primary outcome being concordance for the main pathologic diagnosis or findings leading to a cause of death. Autopsy performed by pediatric pathologists was the reference standard. RESULTS. One hundred thirty-six patients (74 [54.4%] male and 62 [456%] female patients) were included. The mean age of the 136 patients was 2 years 1 month (range, 2 days-14.7 years). A cause of death at autopsy was found for 77 of the 136 (56.6%) patients. Postmortem CT depicted a correct cause of death in 55 of 77 (71.4%) patients; (55/136 overall [40.4%]), with the majority attributable to traumatic brain or body injuries. For major pathologic findings, diagnostic accuracy rates were a sensitivity of 71.4% (95% CI, 60.5-80.3%), specificity of 81.4% (95% CI, 69.6-893%), positive predictive value of 83.3% (95% CI, 72.6-90.4%), negative predictive value of 68.6% (95% CI, 570-78.2%), and concordance rate of 75.7% (95% CI, 679-82.2%). The sensitivity of postmortem CT versus autopsy was highest for intracranial (75.6%; 95% CI, 60.7-86.2%) and musculoskeletal (98.4%; 95% CI, 91.4-99.7%) abnormalities and lowest for cardiac (31.3%; 95% CI, 14.2-55.6%) and abdominal (53.8%; 95% CI, 29.1-78.6%) findings. CONCLUSION. Postmortem CT gives an acceptable diagnostic concordance rate with autopsy of 71.4%, although identification of the cause of death overall was low at 40.4%. The highest accuracy rates were for intracranial and musculoskeletal abnormalities.	[Shelmerdine, Susan C.; Davendralingam, Natasha; Palm, Liina; Minden, Tom; Sebire, Neil J.; Arthurs, Owen J.] NHS Fdn Trust, Great Ormond St Hosp Children, Dept Clin Radiol, London WC1N 3JH, England; [Shelmerdine, Susan C.; Sebire, Neil J.; Arthurs, Owen J.] UCL Great Ormond St Inst Child Hlth, London, England; [Cary, Nat] Forens Pathol Serv, Wantage, Oxon, England		Shelmerdine, SC (corresponding author), NHS Fdn Trust, Great Ormond St Hosp Children, Dept Clin Radiol, London WC1N 3JH, England.; Shelmerdine, SC (corresponding author), UCL Great Ormond St Inst Child Hlth, London, England.	Susan.Shelmerdine@gosh.nhs.uk		Shelmerdine, Susan/0000-0001-6642-9967; Arthurs, Owen/0000-0003-1213-3516; Sebire, Neil/0000-0001-5348-9063	Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Royal College of Radiologists (RCR); National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); Great Ormond Street Children's Charity; Great Ormond Street Hospital NIHR Biomedical Research Center; RCUK/UKRI Innovation Fellowship; MRC Clinical Research Training FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/R00218/1]; NIHR Career Development Fellowship [NIHR-CDF-2017-10-037]; NIHR Senior Investigator award; RCR; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/R002118/1] Funding Source: UKRI	This article presents independent research funded by the Medical Research Council (MRC), the Royal College of Radiologists (RCR), and the National Institute for Health Research (NIHR), and the views expressed are those of the authors and not necessarily those of the NHS, MRC, RCR, and NIHR or the Department of Health.; Supported by funding from the Great Ormond Street Children's Charity and the Great Ormond Street Hospital NIHR Biomedical Research Center. S. C. Shelmerdine is supported by a RCUK/UKRI Innovation Fellowship and MRC Clinical Research Training Fellowship (grant MR/R00218/1). This award is jointly funded by the RCR. N. J. Sebire is funded by an NIHR Senior Investigator award. O. J. Arthurs is funded by an NIHR Career Development Fellowship (grant NIHR-CDF-2017-10-037).	Arthurs OJ, 2016, EUR RADIOL, V26, P2327, DOI 10.1007/s00330-015-4057-9; Arthurs OJ, 2015, INT J LEGAL MED, V129, P1113, DOI 10.1007/s00414-015-1189-z; Arthurs OJ, 2015, PEDIATR RADIOL, V45, P527, DOI 10.1007/s00247-014-3166-y; Ashwin C, 2017, PRENATAL DIAG, V37, P566, DOI 10.1002/pd.5043; Blokker BM, 2016, EUR RADIOL, V26, P1159, DOI 10.1007/s00330-015-3908-8; Bolliger SA, 2010, AM J ROENTGENOL, V195, P1051, DOI 10.2214/AJR.10.4600; Breeze ACG, 2011, ULTRASOUND OBST GYN, V37, P317, DOI 10.1002/uog.8844; Brinkmann B, 2000, FORENSIC SCI INT, V111, P5; Bruguier C, 2013, INT J LEGAL MED, V127, P639, DOI 10.1007/s00414-013-0840-9; Christine C, 2013, INT J LEGAL MED, V127, P981, DOI 10.1007/s00414-012-0814-3; Grabherr S, 2018, RADIOLOGY, V288, P270, DOI 10.1148/radiol.2018170559; Grabherr S, 2015, RADIOL MED, V120, P824, DOI 10.1007/s11547-015-0532-2; Judge-Kronis L, 2016, J FORENSIC RADIOL IM, V4, P7, DOI 10.1016/j.jofri.2015.12.001; Krentz BV, 2016, INT J LEGAL MED, V130, P1089, DOI 10.1007/s00414-016-1370-z; Maskell GW, RCR RCPATH STATEMENT; Noda Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/327903; Oyake Yuji, 2006, Radiat Med, V24, P493, DOI 10.1007/s11604-006-0061-y; Proisy M, 2013, EUR RADIOL, V23, P1711, DOI 10.1007/s00330-012-2738-1; Ross SG, 2012, RADIOLOGY, V264, P250, DOI 10.1148/radiol.12092415; Rutty GN, 2017, LANCET, V390, P145, DOI 10.1016/S0140-6736(17)30333-1; Rutty GN, 2016, J FORENSIC RADIOL IM, V4, P35, DOI 10.1016/j.jofri.2016.01.002; Sebire NJ, 2012, J MATERN-FETAL NEO M, V25, P513, DOI 10.3109/14767058.2011.601368; Sieswerda-Hoogendoorn T, 2014, INT J LEGAL MED, V128, P957, DOI 10.1007/s00414-014-0964-6; Sonnemans LJP, 2018, EUR J PEDIATR, V177, P791, DOI 10.1007/s00431-018-3135-9; Takahashi N, 2012, EUR RADIOL, V22, P152, DOI 10.1007/s00330-011-2248-6; Thayyil S, 2013, LANCET, V382, P223, DOI 10.1016/S0140-6736(13)60134-8; The Royal College of Pathologists website, NEW GUID INV SUDD UN; van Rijn RR, 2017, PEDIATR RADIOL, V47, P1514, DOI 10.1007/s00247-017-3911-0; Westphal SE, 2012, VIRCHOWS ARCH, V461, P211, DOI 10.1007/s00428-012-1257-4	29	7	7	0	3	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	JUN	2019	212	6					1335	1347		10.2214/AJR.18.20534			13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	HZ1HT	WOS:000468598300026	30917029				2022-02-06	
J	Tian, RF; Liu, WM; Dong, JQ; Zhang, J; Xu, L; Zhang, B; Tao, XG; Li, JS; Liu, BY				Tian, Runfa; Liu, Weiming; Dong, Jinqian; Zhang, Ji; Xu, Long; Zhang, Bin; Tao, Xiaogang; Li, Jingsheng; Liu, Baiyun			Prognostic Predictors of Early Outcomes and Discharge Status of Patients Undergoing Decompressive Craniectomy After Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Decompressive craniectomy; Discharge status; Prognostic predictors; Severe traumatic brain injury	SEVERE HEAD-INJURIES; SUBDURAL-HEMATOMA; SURGERY; AGE; COAGULOPATHY; MULTICENTER	OBJECTIVE: Although several prognostic factors for traumatic brain injury (TBI) have been evaluated, a useful predictive scoring model for the outcomes has not been developed for patients with severe TBI who undergo decompressive craniectomy (DC). The aim of the present study was to determine independent predictors and develop a multivariate logistic regression equation to predict the early outcome and discharge status for patients with severe TBI who have undergone DC. METHODS: A total of 13 different variables were evaluated. The data from all 278 patients with severe TBI who had undergone DC in the present study were retrospectively evaluated from July 2011 to June 2017. Using univariate, multiple logistic regression and prognostic regression scoring equations it was possible to draw receiver operating characteristic curves to predict the early outcomes and discharge status after TBI. RESULTS: We found that younger age (P = 0.012), no significant medical history (P = 0.044), diameter of both pupils < 4 mm (P = 0.032), higher admission Glasgow coma scale score (P = 0.004), no tracheotomy (P < 0.001), and DC for severe TBI were associated with a favorable early outcome and discharge status. Using receiver operating characteristic curves to predict the probability of a favorable outcome, the sensitivity was 80.0% and the specificity was 79.5%. CONCLUSIONS: Our preliminary findings have shown that 5 variables can be used as independent predictors in assessing the early outcome and discharge status for patients with severe TBI after DC.	[Tian, Runfa; Liu, Weiming; Dong, Jinqian; Xu, Long; Zhang, Bin; Tao, Xiaogang; Li, Jingsheng; Liu, Baiyun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Tian, Runfa; Liu, Weiming; Dong, Jinqian; Xu, Long; Zhang, Bin; Tao, Xiaogang; Li, Jingsheng; Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Tian, Runfa; Liu, Weiming; Dong, Jinqian; Xu, Long; Zhang, Bin; Tao, Xiaogang; Li, Jingsheng; Liu, Baiyun] Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China; [Tian, Runfa; Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Neurotrauma Lab, Beijing, Peoples R China; [Zhang, Ji] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China.; Liu, BY (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Liu, BY (corresponding author), Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Neurotrauma Lab, Beijing, Peoples R China.; Liu, BY (corresponding author), Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China.	liubaiyun1212@163.com	Liu, Weiming/O-7968-2019; Liu, Weiming/E-7512-2015; Dong, Jinqian/AAP-2298-2021	Liu, Weiming/0000-0002-6245-6287; Liu, Weiming/0000-0002-6245-6287; 	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801225, 81171144, 81471238]; Natural Science Foundation of Capital Medical University [PYZ2017075]; Youth Foundation of Beijing Tian Tan Hospital [2017-YQN-03]	The present study was supported by the National Natural Science Foundation of China (grants 81801225, 81171144, and 81471238), Natural Science Foundation of Capital Medical University (grant PYZ2017075), and Youth Foundation of Beijing Tian Tan Hospital (grant 2017-YQN-03).	Alarcon JD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009986.pub2; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; Carter BG, 2007, ANAESTH INTENS CARE, V35, P984, DOI 10.1177/0310057X0703500623; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; Fotakopoulos George, 2016, Surg Neurol Int, V7, P19, DOI 10.4103/2152-7806.176671; Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Hoffmann M, 2011, BR J SURG S1, V99, P122; Honeybul S, 2016, INJURY, V47, P1886, DOI 10.1016/j.injury.2016.04.017; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kuo JR, 2006, J CLIN NEUROSCI, V13, P218, DOI 10.1016/j.jocn.2005.01.012; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; Leitgeb J, 2013, EUR J TRAUMA EMERG S, V39, P285, DOI 10.1007/s00068-013-0269-3; Lemcke J, 2014, BLOOD COAGUL FIBRIN, V25, P353, DOI 10.1097/MBC.0000000000000042; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu B, 2008, J NEUROSURG, V24, P153; Mao X, 2015, THER CLIN RISK MANAG, V11, P1627, DOI 10.2147/TCRM.S89820; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Shutter LA, 2016, NEW ENGL J MED, V375, P1183, DOI 10.1056/NEJMe1609722; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762; ZWEIG MH, 1993, CLIN CHEM, V39, P561	30	7	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2019	126						E101	E108		10.1016/j.wneu.2019.01.246			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IA0BU	WOS:000469222400014	30790726				2022-02-06	
J	Blair, NP; Tan, MR; Felder, AE; Shahidi, M				Blair, Norman P.; Tan, Michael R.; Felder, Anthony E.; Shahidi, Mahnaz			Retinal Oxygen Delivery, Metabolism and Extraction Fraction and Retinal Thickness Immediately Following an Interval of Ophthalmic Vessel Occlusion in Rats	SCIENTIFIC REPORTS			English	Article							OXIDE SYNTHASE INHIBITION; OPTIC-NERVE HEAD; BLOOD-FLOW; ARTERY-OCCLUSION; POSTISCHEMIC HYPEREMIA; CEREBRAL-ISCHEMIA; GLAUCOMA PATIENTS; CELL-DEATH; NO-REFLOW; INNER	Limited knowledge is currently available about alterations of retinal blood flow (F), oxygen delivery (DO2), oxygen metabolism (MO2), oxygen extraction fraction (OEF), or thickness after the ophthalmic blood vessels have been closed for a substantial interval and then reopened. We ligated the ophthalmic vessels for 120 minutes in one eye of 17 rats, and measured these variables within 20 minutes after release of the ligature in the 10 rats which had immediate reflow. F, DO2 and MO2 were 5.2 +/- 3.1 mu L/min, 428 +/- 271 nL O-2/min, and 234 +/- 133nL O-2/min, respectively, that is, to 58%, 46% and 60% of values obtained from normal fellow eyes (P < 0.004). OEF was 0.65 +/- 0.23, 148% of normal (P = 0.03). Inner and total retinal thicknesses were 195 +/- 24 and 293 +/- 20 mu m, respectively, 117% and 114% of normal, and inversely related to MO2 (P <= 0.02). These results reflect how much energy is available to the retina immediately after an interval of nonperfusion for 120 minutes. Thus, they elucidate aspects of the pathophysiology of nonperfusion retinal injury and may improve therapy in patients with retinal artery or ophthalmic artery obstructions.	[Blair, Norman P.; Tan, Michael R.] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL USA; [Felder, Anthony E.] Univ Illinois, Richard & Loan Hill Dept Bioengn, Chicago, IL USA; [Shahidi, Mahnaz] Univ Southern Calif, Dept Ophthalmol, Los Angeles, CA 90089 USA		Shahidi, M (corresponding author), Univ Southern Calif, Dept Ophthalmol, Los Angeles, CA 90089 USA.	mshahidi@usc.edu		Tan, Michael/0000-0002-2449-563X	National Eye Institute, Bethesda, MDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY017918, EY001792]; Research to Prevent Blindness, New York, NYResearch to Prevent Blindness (RPB); NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY017918, P30EY001792] Funding Source: NIH RePORTER	This study was supported by research grants from the National Eye Institute, Bethesda, MD, EY017918 and EY001792, and Research to Prevent Blindness, New York, NY, Senior Scientific Investigator award (MS) and an unrestricted departmental award. We thank Tara Nguyen for animal care and surgical assistance.	AMES A, 1995, J CEREBR BLOOD F MET, V15, P433, DOI 10.1038/jcbfm.1995.54; AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; AMES A, 1968, AM J PATHOL, V52, P437; Ames A., 1965, BIOCHEMISTRY RETINA, P22; An HY, 2015, STROKE, V46, P982, DOI 10.1161/STROKEAHA.114.008154; BENNUN J, 1988, INVEST OPHTH VIS SCI, V29, P298; Blair NP, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.3.10; Blair NP, 2016, INVEST OPHTH VIS SCI, V57, P5903, DOI 10.1167/iovs.16-20082; Blair NP, 2016, EXP EYE RES, V143, P141, DOI 10.1016/j.exer.2015.09.018; BLAIR NP, 1991, ARCH OPHTHALMOL-CHIC, V109, P113, DOI 10.1001/archopht.1991.01080010115042; BLAIR NP, 1989, ARCH OPHTHALMOL-CHIC, V107, P417, DOI 10.1001/archopht.1989.01070010427039; Block F, 1997, NEUROSCI LETT, V232, P45, DOI 10.1016/S0304-3940(97)00575-2; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; BRESNICK GH, 1975, ARCH OPHTHALMOL-CHIC, V93, P1300; Bringmann A, 2005, ACTA OPHTHALMOL SCAN, V83, P528, DOI 10.1111/j.1600-0420.2005.00565.x; BUCHI ER, 1991, OPHTHALMOLOGICA, V203, P138; CARTHEUSER CF, 1993, COMP BIOCHEM PHYS A, V106, P775, DOI 10.1016/0300-9629(93)90396-L; Do BK, 2017, CURR OPIN OPHTHALMOL, V28, P623, DOI 10.1097/ICU.0000000000000423; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Felder AE, 2015, INVEST OPHTH VIS SCI, V56, P6633, DOI 10.1167/iovs.15-17321; Grubb RL, 1998, JAMA-J AM MED ASSOC, V280, P1055, DOI 10.1001/jama.280.12.1055; Hafez AS, 2003, AM J OPHTHALMOL, V136, P1022, DOI 10.1016/S0002-9394(03)00632-9; Hafez AS, 2003, OPHTHALMOLOGY, V110, P201, DOI 10.1016/S0161-6420(02)01716-5; HAMASAKI DI, 1968, ARCH OPHTHALMOL-CHIC, V80, P243, DOI 10.1001/archopht.1968.00980050245019; HATCHELL DL, 1994, MICROVASC RES, V47, P344, DOI 10.1006/mvre.1994.1027; HAYREH SS, 1980, OPHTHALMOLOGY, V87, P75, DOI 10.1016/s0161-6420(80)35283-4; HAYREH SS, 1980, BRIT J OPHTHALMOL, V64, P896, DOI 10.1136/bjo.64.12.896; Hayreh SS, 2004, EXP EYE RES, V78, P723, DOI 10.1016/S0014-4835(03)00214-8; HEYE N, 1991, NEUROSURG REV, V14, P7; Hu HJ, 2017, J STROKE CEREBROVASC, V26, P2706, DOI 10.1016/j.jstrokecerebrovasdis.2017.09.011; HUGHES WF, 1991, EXP EYE RES, V53, P573, DOI 10.1016/0014-4835(91)90215-Z; KROLL AJ, 1968, ARCH OPHTHALMOL-CHIC, V79, P453; Lafuente MP, 2002, NEUROSCIENCE, V109, P157, DOI 10.1016/S0306-4522(01)00458-4; Lam TT, 1999, INVEST OPHTH VIS SCI, V40, P967; Lelong DC, 2007, STROKE, V38, P3237, DOI 10.1161/STROKEAHA.107.499319; Li G, 2013, INVEST OPHTH VIS SCI, V54, P5123, DOI 10.1167/iovs.13-12404; Lin WL, 2018, J CEREBR BLOOD F MET, V38, P1481, DOI 10.1177/0271678X17722095; Liu SM, 2002, J CEREBR BLOOD F MET, V22, P1222, DOI 10.1097/01.wcb.0000037998.34930.83; MacDougall G, 2019, NEUROBIOL DIS, V121, P17, DOI 10.1016/j.nbd.2018.09.010; Marangoni D, 2012, ACTA OPHTHALMOL, V90, pE288, DOI 10.1111/j.1755-3768.2011.02340.x; Michelson G, 1998, GRAEF ARCH CLIN EXP, V236, P80, DOI 10.1007/s004170050046; MORI E, 1992, STROKE, V23, P712, DOI 10.1161/01.STR.23.5.712; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Nicolela MT, 1996, AM J OPHTHALMOL, V122, P775, DOI 10.1016/S0002-9394(14)70373-3; Nour M, 2012, INTERV NEUROL, V1, P185, DOI 10.1159/000353125; OSTWALD P, 1995, INVEST OPHTH VIS SCI, V36, P2396; Ostwald P, 1997, VISION RES, V37, P3453, DOI 10.1016/S0042-6989(96)00222-2; Palkovits S, 2014, AM J PHYSIOL-HEART C, V307, pH1412, DOI 10.1152/ajpheart.00479.2014; POWERS WJ, 1985, J CEREBR BLOOD F MET, V5, P600, DOI 10.1038/jcbfm.1985.89; Ritter M, 2012, BRIT J OPHTHALMOL, V96, P201, DOI 10.1136/bjo.2010.198937; ROTH S, 1995, CURR EYE RES, V14, P323, DOI 10.3109/02713689509033533; Shahidi M, 2009, INVEST OPHTH VIS SCI, V50, P820, DOI 10.1167/iovs.08-2343; Shahidi M, 2018, INVEST OPHTH VIS SCI, V59, P1905, DOI 10.1167/iovs.17-23647; SHIMIZU K, 1981, OPHTHALMOLOGY, V88, P601; Silva PS, 2015, OPHTHALMOLOGY, V122, P2465, DOI 10.1016/j.ophtha.2015.07.034; Song MK, 2014, TRANSL STROKE RES, V5, P17, DOI 10.1007/s12975-013-0314-x; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; STEFANSSON E, 1987, INVEST OPHTH VIS SCI, V28, P1281; STEFANSSON E, 1990, GRAEF ARCH CLIN EXP, V228, P120, DOI 10.1007/BF00935719; Sugiyama K, 1999, INVEST OPHTH VIS SCI, V40, P3084; SZABO ME, 1991, INVEST OPHTH VIS SCI, V32, P1471; TAKAHASHI K, 1992, ARCH OPHTHALMOL-CHIC, V110, P862, DOI 10.1001/archopht.1992.01080180134041; Tayyari F, 2015, INVEST OPHTH VIS SCI, V56, P6796, DOI 10.1167/iovs.15-17481; Teng PY, 2013, INVEST OPHTH VIS SCI, V54, P647, DOI 10.1167/iovs.12-11305; Touzani O, 1997, BRAIN RES, V767, P17, DOI 10.1016/S0006-8993(97)00515-5; Tsujikawa A, 2012, OPHTHALMOLOGICA, V227, P68, DOI 10.1159/000332080; Wanek J, 2011, BIOMED OPT EXPRESS, V2, P2562, DOI 10.1364/BOE.2.; Yamauchi H, 1996, J NEUROL NEUROSUR PS, V61, P18, DOI 10.1136/jnnp.61.1.18; Yamauchi H, 1999, J NUCL MED, V40, P1992; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022	70	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 30	2019	9								8092	10.1038/s41598-019-44250-y			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2UT	WOS:000469418100038	31147557	Green Published, gold			2022-02-06	
J	Ji, YS; Hu, Y; Ren, JH; Khanna, R; Yao, Y; Chen, Y; Li, Q; Sun, L				Ji, Yingshi; Hu, Yang; Ren, Jinghong; Khanna, Rajesh; Yao, Yuan; Chen, Yang; Li, Qi; Sun, Li			CRMP2-derived peptide ST2-104 (R9-CBD3) protects SH-SY5Y neuroblastoma cells against A beta(25)(-35)-induced neurotoxicity by inhibiting the pCRMP2/NMDAR2B signaling pathway	CHEMICO-BIOLOGICAL INTERACTIONS			English	Article						Alzheimer's disease; pCRMP2; NMDAR2B; ST2-104; Ca-2(+); Neuroprotection	MEDIATOR PROTEIN-2 CRMP2; ASPARTATE NMDA RECEPTOR; ALZHEIMERS-DISEASE; CALCIUM; DYSREGULATION; GLUTAMATE; INSIGHTS; MODELS; DAMAGE; PAIN	Collapsin response mediator protein 2 (CRMP2),by regulating voltage-gated calcium channel activity, is a crucial regulator of neuronal excitability. Hyperphosphorylation of CRMP2 has been reported in brains of Alzheimer's disease (AD) patients and other neurodegenerative diseases. CRMP2 acting on N-methyl-d-aspartate receptors (NMDARs) may contribute to AD pathology. A short peptide from CRMP2, designated the Ca2+ channel-binding domain 3 (CBD3) peptide, has recently emerged as a Ca2+ channel blocker that exerts neuroprotective effects in traumatic brain injury and cerebral ischemia by disrupting pCRMP2/NMDAR interaction to inhibit calcium influx. ST2-104, a nona-arginine (R9)-conjugated CBD3 peptide derived from CRMP2, exerts a beneficial effect on neuropathic pain; however, the effect of ST2-104 on AD and its mechanism of action have not been studied. In this study we investigated the effects of ST2-104 on SH-SY5Y neuroblastoma cells stimulated by A beta(25-)(35). To induce neurotoxicity, SH-SY5Y cells were incubated with A beta(25-)(35), the shortest toxic fragment of A beta. CRMP2 expression was manipulated by knockdown or overexpression of CRMP2 before ST2-104 treatment to further explore if the pCRMP2/NMDAR2B signaling pathway is involved in the action of the ST2-104 peptide. The results show that ST2-104 significantly enhanced cell viability, inhibited cell apoptosis, decreased LDH release, suppressed the expression of the pCRMP2 protein, disrupted pCRMP2/NMDAR2B interaction, inhibited A beta(25-)(35) induced NMDAR currents, and decreased intracellular Ca2+ levels. The effects of ST2-104 was abolished by overexpression of CRMP2 and intensified by knockdown of CRMP2 in SH-SY5Y cells. Taken together, our results support ST2-104 as a possible biologic therapeutic in the face of A beta(25-)(35)-induced injury via the inhibition of the pCRMP2/NMDAR2B signaling pathway.	[Ji, Yingshi; Hu, Yang; Ren, Jinghong; Yao, Yuan; Chen, Yang; Li, Qi] Jilin Univ, Coll Basic Med Sci, Dept Pharmacol, Changchun 130021, Jilin, Peoples R China; [Khanna, Rajesh] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA; [Sun, Li] Jilin Univ, Hosp 1, Dept Neurol, Changchun 130021, Jilin, Peoples R China; [Sun, Li] Jilin Univ, Hosp 1, Neurosci Ctr, Changchun 130021, Jilin, Peoples R China		Sun, L (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Changchun 130021, Jilin, Peoples R China.; Sun, L (corresponding author), Jilin Univ, Hosp 1, Neurosci Ctr, Changchun 130021, Jilin, Peoples R China.	2357515102@qq.com		Hu, Yang/0000-0002-1624-6895; Sun, Li/0000-0003-1169-4653; Khanna, Rajesh/0000-0002-9066-2969	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571231]; Health and Family Planning Commission of Jilin Province [2015Z043]; Talent Development Fund of Jilin Province; Department of Education Foundation of Jilin Province [JJKH20190102KJ]; Department Science and Technology Foundation of Jilin Province [20190701058GH]	This work was supported by the National Natural Science Foundation of China (grant no. 81571231), the Health and Family Planning Commission of Jilin Province (2015Z043), and the Talent Development Fund of Jilin Province (2014), Department of Education Foundation of Jilin Province (JJKH20190102KJ), Department Science and Technology Foundation of Jilin Province (20190701058GH).	Anekonda TS, 2011, NEUROBIOL DIS, V41, P62, DOI 10.1016/j.nbd.2010.08.020; Bading H, 2017, J EXP MED, V214, P569, DOI 10.1084/jem.20161673; Berridge MJ, 2014, J PHYSIOL-LONDON, V592, P281, DOI 10.1113/jphysiol.2013.257527; Berridge MJ, 2013, PRION, V7, P2, DOI 10.4161/pri.21767; Birnbaum JH, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.160; Brittain JM, 2012, CHANNELS, V6, P52, DOI 10.4161/chan.18919; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brustovetsky T, 2014, J BIOL CHEM, V289, P7470, DOI 10.1074/jbc.M113.518472; Carvajal FJ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2701526; Chung C, 2013, MOL CELLS, V36, P99, DOI 10.1007/s10059-013-0113-y; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Gao YL, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.04.23; Hane FT, 2017, J ALZHEIMERS DIS, V57, P645, DOI 10.3233/JAD-160907; Hensley K, 2016, J ALZHEIMERS DIS, V53, P1, DOI 10.3233/JAD-160076; Ip J. P., 2014, NEUROSCIENTIST, V20; IVERSEN LL, 1995, BIOCHEM J, V311, P1; Jang H, 2013, PHYS CHEM CHEM PHYS, V15, P8868, DOI 10.1039/c3cp00017f; Ju WN, 2013, J NEUROCHEM, V124, P869, DOI 10.1111/jnc.12070; Karthick C, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00028; Kazim SF, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0119-y; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Khanna R, 2012, FUTUR NEUROL, V7, P749, DOI 10.2217/FNL.12.68; Kumar A, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00473; Liang JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182743; Malinow R, 2012, CURR OPIN NEUROBIOL, V22, P559, DOI 10.1016/j.conb.2011.09.001; Moutal A, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00471; Olajide OJ, 2017, ANN NEUROSCI, V24, P32, DOI 10.1159/000464421; Olivares D, 2012, CURR ALZHEIMER RES, V9, P746; RUSH DK, 1992, NEUROBIOL AGING, V13, P591, DOI 10.1016/0197-4580(92)90061-2; Shaw AE, 2017, PHARMACOL THERAPEUT, V175, P17, DOI 10.1016/j.pharmthera.2017.02.031; Stroebel D, 2018, CURR OPIN PHYSIOL, V2, P1, DOI 10.1016/j.cophys.2017.12.004; Sun XY, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.329; Wang J, 2017, NAT REV NEUROL, V13, P612, DOI 10.1038/nrneurol.2017.111; Wang JM, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00194; Wang Z, 2017, J ALZHEIMERS DIS, V56, P415, DOI 10.3233/JAD-160724; Wang ZC, 2013, NEUROSCI BULL, V29, P752, DOI 10.1007/s12264-013-1383-2; Wilson SM, 2011, CHANNELS, V5, P447, DOI 10.4161/chan.5.5.17363; Xie JY, 2016, PAIN, V157, P2124, DOI 10.1097/j.pain.0000000000000628; Zhang Y, 2016, NEUROL SCI, V37, P1039, DOI 10.1007/s10072-016-2546-5; 2017, J INT NEUROPSYCH SOC, V23, P818, DOI DOI 10.1017/S135561771700100X	40	7	7	3	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0009-2797	1872-7786		CHEM-BIOL INTERACT	Chem.-Biol. Interact.	MAY 25	2019	305						28	39		10.1016/j.cbi.2019.03.005			12	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology	HW5EK	WOS:000466711900006	30871964				2022-02-06	
J	Gardner, RC; Cheng, J; Ferguson, AR; Boylan, R; Boscardin, J; Zafonte, RD; Manley, GT; Bagiella, E; Ansel, BM; Novack, TA; Friedewald, WT; Hesdorffer, DC; Timmons, SD; Jallo, J; Eisenberg, H; Hart, T; Ricker, JH; Diaz-Arrastia, R; Merchant, RE; Temkin, NR; Melton, S; Dikmen, SS; Okonkwo, DO				Gardner, Raquel C.; Cheng, Jing; Ferguson, Adam R.; Boylan, Ross; Boscardin, John; Zafonte, Ross D.; Manley, Geoffrey T.; Bagiella, Emilia; Ansel, Beth M.; Novack, Thomas A.; Friedewald, William T.; Hesdorffer, Dale C.; Timmons, Shelly D.; Jallo, Jack; Eisenberg, Howard; Hart, Tessa; Ricker, Joseph H.; Diaz-Arrastia, Ramon; Merchant, Randall E.; Temkin, Nancy R.; Melton, Sherry; Dikmen, Sureyya S.; Okonkwo, David O.		Citicoline Brain Injury Treatment	Divergent Six Month Functional Recovery Trajectories and Predictors after Traumatic Brain Injury: Novel Insights from the Citicoline Brain Injury Treatment Trial Study	JOURNAL OF NEUROTRAUMA			English	Article						functional outcome; predictors; TBI; trajectory	GLASGOW OUTCOME SCALE; CLINICAL-TRIALS; 1ST YEAR; LONGITUDINAL DESCRIPTION; EXTERNAL VALIDATION; NATIONAL INSTITUTE; OLDER-ADULTS; MILD; REHABILITATION; DISPARITIES	Cross-sectional approaches to outcome assessment may not adequately capture heterogeneity in recovery after traumatic brain injury (TBI). Using latent class mixed models (LCMM), a data-driven analytic that identifies groups of patients with similar trajectories, we identified distinct 6 month functional recovery trajectories in a large cohort (n = 1046) of adults 18-70 years of age with complicated mild to severe TBI who participated in the Citicoline Brain Injury Treatment Trial (COBRIT). We used multinomial logistic fixed effect models and backward elimination, forward selection, and forward stepwise selection with several stopping rules to explore baseline predictors of functional recovery trajectory. Based on statistical and clinical considerations, the seven-class model was deemed superior. Visualization of these seven functional recovery trajectories revealed that each trajectory class started at one of three recovery levels at 1 month, which, for ease of reference we labeled groups A-C: Group A, good recovery (two classes; A1 and A2); Group B, moderate disability (two classes; B1 and B2); and Group C, severe disability (three classes; C1, C2, and C3). By 6 months, these three groups experienced dramatically divergent trajectories. Group A experienced stable good recovery (A1, n = 115) or dramatic decline (A2, n = 4); Group B experienced rapid complete recovery (B1, n = 71) or gradual recovery (B2, n = 742); Group C experienced dramatic rapid recovery (C1, n = 12), no recovery (C2, n = 91), or death (C3, n = 11). Trajectory class membership was not predicted by citicoline treatment (p = 0.57). The models identified demographic, pre-injury, and injury-related predictors of functional recovery trajectory, including: age, race, education, pre-injury employment, pre-injury diabetes, pre-injury psychiatric disorder, site, Glasgow Coma Scale (GCS) score, post-traumatic amnesia, TBI mechanism, major extracranial injury, hemoglobin, and acute computed tomographic (CT) findings. GCS was the most consistently selected predictor across all models. All models also selected at least one demographic or pre-injury medical predictor. LCMM successfully identified dramatically divergent, clinically meaningful 6 month recovery trajectories with utility to inform clinical trial design.	[Gardner, Raquel C.] Univ Calif San Franscisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA USA; [Gardner, Raquel C.] Univ Calif San Franscisco, Weill Inst Neurosci, San Francisco, CA USA; [Gardner, Raquel C.] San Francisco Vet Affairs Mec Ctr, Dept Neurol, San Francisco, CA USA; [Gardner, Raquel C.] San Francisco Vet Affairs Mec Ctr, Ctr Populat Brain Hlth, San Francisco, CA USA; [Cheng, Jing; Boylan, Ross; Boscardin, John] Univ Calif San Francisco, Deparment Epidemiol & Biostat, San Francisco, CA 94121 USA; [Ferguson, Adam R.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94121 USA; [Ferguson, Adam R.; Manley, Geoffrey T.] Univ Calif San Francisco, Weil Inst Neurosci, San Francisco, CA 94121 USA; [Ferguson, Adam R.; Manley, Geoffrey T.] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA USA; [Ferguson, Adam R.; Boscardin, John] San Francisco VA Med Ctr, Dept Res & Dev, San Francisco, CA USA; [Boscardin, John] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Zafonte, Ross D.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Zafonte, Ross D.] Spaulding Rehabil Hosp, Boston, MA USA; [Zafonte, Ross D.] Harvard Med Sch, Dept Phys Med & Rehabil, Charlestown, MA USA; [Bagiella, Emilia] Mt Sinai Sch Med, Dept Populat Hlth Sci & Policy, New York, NY USA; [Ansel, Beth M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Traumat Brain Injury & Stroke Rehabil Program, NIH, Bethesda, MD USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Friedewald, William T.] Columbia Univ, Med Ctr, Dept Biostat & Epidemiol, New York, NY USA; [Friedewald, William T.] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Hesdorffer, Dale C.] Columbia Univ, Dept Epidemiol, Med Ctr, New York, NY USA; [Timmons, Shelly D.] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Jallo, Jack] Thomas Jefferson Univ, Dept Neurosurg, Div Neurotrauma & Crit Care, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Eisenberg, Howard] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Hart, Tessa] Thomas Jefferson Univ, Moss Rehabil Res Inst, Dept Rehabil Med, Sidney Kimmel Med Coll, Elkins Pk, PA USA; [Ricker, Joseph H.] NYU, Dept Rehabil Med, Div Psychol, Rusk Inst Rehabil, New York, NY USA; [Ricker, Joseph H.] NYU, Dept Psychiat, Div Psychol, Rusk Inst Rehabil, 550 1St Ave, New York, NY 10016 USA; [Ricker, Joseph H.] NYU, Dept Radiol, Div Psychol, Rusk Inst Rehabil, 550 1St Ave, New York, NY 10016 USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA; [Merchant, Randall E.] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Ctr Rehabil Sci & Engn, Richmond, VA USA; [Temkin, Nancy R.] Univ Washington, Dept Neurol Surg, Sch Publ Hlth, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Sch Publ Hlth, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Rehabil Med, Sch Publ Hlth, Seattle, WA 98195 USA; [Melton, Sherry] Lincoln Hosp, Dept Surg, Bronx, NY USA; [Dikmen, Sureyya S.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA		Gardner, RC (corresponding author), Univ Calif San Francisco, San Francisco VA Med Ctr, Ctr Populat Brain Hlth, Memory & Aging Ctr,Dept Neurol,Weill Inst Neurosc, 4150 Clement St,Neurol 127, San Francisco, CA 94121 USA.	Raquel.Gardner@ucsf.edu		Ricker, Joseph/0000-0003-3415-991X; Ferguson, Adam/0000-0001-7102-1608	National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [Beeson K23NS095755, U01NS086090]; American Federation for Aging Research; Weill Institute for Neurosciences; Department of DefenseUnited States Department of Defense [W81XWH-14-2-0176]; National Institute of Child Health and Human Development grant at the Temple University [U01HD042738]; National Institute of Child Health and Human Development grant at the University of Alabama at Birmingham [U01HD042687]; National Institute of Child Health and Human Development grant at the University of Maryland [U01HD042736]; National Institute of Child Health and Human Development grant at the University of Pittsburgh [U01HD042678]; National Institute of Child Health and Human Development grant at the University of Tennessee Health Sciences Center [U01HD042686]; National Institute of Child Health and Human Development grant at the University of Texas Southwestern [U01HD042652]; National Institute of Child Health and Human Development grant at the University of Washington [U01HD 042653]; National Institute of Child Health and Human Development grant at the Virginia Commonwealth University [U01HD042689]; National Institute of Child Health and Human Development grant at the Columbia University [U01HD042823]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS095755] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Neurological Disorders and Stroke (Beeson K23NS095755 to R.C.G. and U01NS086090 to G.T.M.), the American Federation for Aging Research (to R.C.G.), the Weill Institute for Neurosciences (Scholar Award to R.C.G.), and the Department of Defense (W81XWH-14-2-0176 to G.T.M.). The COBRIT study was supported by the National Institute of Child Health and Human Development grants at the following institutions: Temple University (U01HD042738), University of Alabama at Birmingham (U01HD042687), University of Maryland (U01HD042736), University of Pittsburgh (U01HD042678), University of Tennessee Health Sciences Center (U01HD042686), University of Texas Southwestern (U01HD042652), University of Washington (U01HD 042653), Virginia Commonwealth University (U01HD042689), and Columbia University (U01HD042823).	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Cheng J, 2010, STAT MED, V29, P504, DOI 10.1002/sim.3775; Chiang CC, 2016, QUAL LIFE RES, V25, P2009, DOI 10.1007/s11136-015-1215-0; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Duncan T. E., 2006, AN INTRODUCTION TO L; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Finkelstein E, 2006, THE INCIDENCE AND EC; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gomez R, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01320; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hanten G, 2013, J NEUROTRAUM, V30, P618, DOI 10.1089/neu.2012.2392; Howrey BT, 2017, ARCH PHYS MED REHAB, V98, P1606, DOI 10.1016/j.apmr.2017.03.009; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; LITTLE RJA, 1995, J AM STAT ASSOC, V90, P1112, DOI 10.2307/2291350; Lu J, 2018, J NEUROTRAUM, V35, P1596, DOI 10.1089/neu.2017.5299; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Manley G.T., 2017, J NEUROTRAUMA; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; McArdle JJ, 2009, ANNU REV PSYCHOL, V60, P577, DOI 10.1146/annurev.psych.60.110707.163612; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Narad ME, 2017, J HEAD TRAUMA REHAB, V32, P98, DOI 10.1097/HTR.0000000000000247; Nelson L.D., 2017, J NEUROTRAUMA; Noe E, 2010, BRAIN INJURY, V24, P886, DOI 10.3109/02699051003724952; Nuamah IF, 1996, COMPUT METH PROG BIO, V49, P199, DOI 10.1016/0169-2607(96)01718-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perrin PB, 2014, ARCH PHYS MED REHAB, V95, P2288, DOI 10.1016/j.apmr.2014.07.409; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2478, DOI 10.1016/j.apmr.2013.06.019; Proust-Lima C, 2017, J STAT SOFTW, V78, P1, DOI 10.18637/jss.v078.i02; R Development Care Team, 2010, R LANG ENV STAT COMP; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; SAS Institute Inc, 2017, SAS SOFTW; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; StataCorp, 2017, STATA STATISTICAL SO; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Strauss VY, 2014, J CLIN EPIDEMIOL, V67, P1163, DOI 10.1016/j.jclinepi.2014.06.003; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yue JK, 2018, NEUROREHABILITATION, V43, P169, DOI 10.3233/NRE-172375; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	56	7	7	2	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2019	36	17					2521	2532		10.1089/neu.2018.6167		MAY 2019	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	IW9BT	WOS:000469287800001	30909795	Green Published			2022-02-06	
J	Svobodova, B; Kloudova, A; Ruzicka, J; Kajtmanova, L; Navratil, L; Sedlacek, R; Suchy, T; Jhanwar-Uniyal, M; Jendelova, P; Urdzikova, LM				Svobodova, Barbora; Kloudova, Anna; Ruzicka, Jiri; Kajtmanova, Ludmila; Navratil, Leos; Sedlacek, Radek; Suchy, Tomas; Jhanwar-Uniyal, Meena; Jendelova, Pavla; Urdzikova, Lucia Machova			The effect of 808 nm and 905 nm wavelength light on recovery after spinal cord injury	SCIENTIFIC REPORTS			English	Article							LEVEL LASER THERAPY; TRAUMATIC BRAIN-INJURY; ENDOTHELIAL GROWTH-FACTOR; PHOTOBIOMODULATION; IRRADIATION; BONE; REGENERATION; TISSUE; MODEL; NERVE	We investigated the effect of a Multiwave Locked System laser (with a simultaneous 808 nm continuous emission and 905 nm pulse emission) on the spinal cord after spinal cord injury (SCI) in rats. The functional recovery was measured by locomotor tests (BBB, Beam walking, MotoRater) and a sensitivity test (Plantar test). The locomotor tests showed a significant improvement of the locomotor functions of the rats after laser treatment from the first week following lesioning, compared to the controls. The laser treatment significantly diminished thermal hyperalgesia after SCI as measured by the Plantar test. The atrophy of the soleus muscle was reduced in the laser treated rats. The histopathological investigation showed a positive effect of the laser therapy on white and gray matter sparing. Our data suggests an upregulation of M2 macrophages in laser treated animals by the increasing number of double labeled CD68+/CD206+ cells in the cranial and central parts of the lesion, compared to the control animals. A shift in microglial/macrophage polarization was confirmed by gene expression analysis by significant mRNA downregulation of Cd86 (marker of inflammatory M1), and non-significant upregulation of Arg1 (marker of M2). These results demonstrated that the combination of 808 nm and 905 nm wavelength light is a promising non-invasive therapy for improving functional recovery and tissue sparing after SCI.	[Svobodova, Barbora; Kloudova, Anna; Ruzicka, Jiri; Jendelova, Pavla; Urdzikova, Lucia Machova] Acad Sci, Inst Expt Med, Prague, Czech Republic; [Svobodova, Barbora; Jendelova, Pavla; Urdzikova, Lucia Machova] Charles Univ Prague, Fac Med 2, Prague, Czech Republic; [Kajtmanova, Ludmila] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Navratil, Leos] Czech Tech Univ, Fac Biomed Engn, Dept Hlth Care Disciplines & Populat Protect, Kladno, Czech Republic; [Sedlacek, Radek; Suchy, Tomas] Czech Tech Univ, Dept Mech Biomech & Mechatron, Lab Biomech, Fac Mech Engn, Prague, Czech Republic; [Jhanwar-Uniyal, Meena] New York Med Coll, New York, NY USA		Jendelova, P; Urdzikova, LM (corresponding author), Acad Sci, Inst Expt Med, Prague, Czech Republic.; Jendelova, P; Urdzikova, LM (corresponding author), Charles Univ Prague, Fac Med 2, Prague, Czech Republic.	pavla.jendelova@iem.cas.cz; lucia.machova@iem.cas.cz	Sedlacek, Radek/J-3496-2012	Sedlacek, Radek/0000-0001-8468-5921; Suchy, Tomas/0000-0002-2656-4280; Machova Urdzikova, Lucia/0000-0001-7622-5837; Svobodova, Barbora/0000-0002-5791-6349	Czech Science FoundationGrant Agency of the Czech Republic [GAUK 414216, GACR P304/12/G069]; project InterAction [LTAUSA 17120]; Operational Programme Research, Development and Education in the framework of the project "Center of Reconstructive Neuroscience" [CZ.02.1.01/0.0./0.0/15_003/0000419]; EATRIS-CZ [LM2015064]; Ministry of Education, Youth and Sports of CRMinistry of Education, Youth & Sports - Czech Republic [LQ1604]; BIOCEV [CZ.1.05/1.1.00/02.0109]; European Regional Development FundEuropean Commission [CZ.2.16/3.1.00/21527]; Czech Republic through the Operational Programme Prague - Competitiveness	This study was supported by the GAUK 414216, Czech Science Foundation GACR P304/12/G069; project InterAction LTAUSA 17120, Operational Programme Research, Development and Education in the framework of the project "Center of Reconstructive Neuroscience", registration number CZ.02.1.01/0.0./0.0/15_003/0000419 and from EATRIS-CZ (LM2015064). B.S., L.M.U. and P.J. were members of the BIOCEV (CZ.1.05/1.1.00/02.0109) and their work was supported by the Ministry of Education, Youth and Sports of CR within the LQ1604 National Sustainability Program II (Project BIOCEV-FAR). Histology images were obtained from the "Advanced Bioimaging of Living Tissues" project, reg. n. CZ.2.16/3.1.00/21527, which was financed from the budget of the European Regional Development Fund and public budgets of the Czech Republic through the Operational Programme Prague - Competitiveness. We would like to thank Lukas Jendele for writing the script for TUNEL analysis.	Aras R, 2012, BRAIN RES, V1450, P102, DOI 10.1016/j.brainres.2012.02.056; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Battaglino RA, 2012, CURR OSTEOPOROS REP, V10, P278, DOI 10.1007/s11914-012-0117-0; Benton RL, 2009, CURR NEUROVASC RES, V6, P124, DOI 10.2174/156720209788185678; Broulik PD, 2010, PHYSIOL RES, V59, P599, DOI 10.33549/physiolres.931799; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Burke D. A., 2012, SPRINGER PROTOCOLS H, P591; Burns AS, 2007, J COMP NEUROL, V500, P116, DOI 10.1002/cne.21143; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Piva JADC, 2011, AN BRAS DERMATOL, V86, P947, DOI 10.1590/S0365-05962011000500013; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; Demidova-Rice TN, 2007, LASER SURG MED, V39, P706, DOI 10.1002/lsm.20549; dos Reis FA, 2009, LASER MED SCI, V24, P741, DOI 10.1007/s10103-008-0634-3; Finnerup NB, 2003, BRAIN, V126, P57, DOI 10.1093/brain/awg007; Geneva II, 2016, INT J OPHTHALMOL-CHI, V9, P145, DOI 10.18240/ijo.2016.01.24; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Goldstein LB, 1997, RESTOR NEUROL NEUROS, V11, P55, DOI 10.3233/RNN-1997-111206; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Graumann U, 2011, CURR NEUROVASC RES, V8, P334, DOI 10.2174/156720211798121007; Hamblin MR, 2018, J NEUROSCI RES, V96, P731, DOI 10.1002/jnr.24190; Herrera JJ, 2009, J NEUROTRAUM, V26, P995, DOI [10.1089/neu.2008.0779, 10.1089/neu.2008-0779]; Hu D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0679-3; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Karu TI, 2004, PHOTOCHEM PHOTOBIOL, V80, P366, DOI 10.1562/2004-03-25-RA-123.1; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim J, 2017, TISSUE ENG REGEN MED, V14, P57, DOI 10.1007/s13770-016-0003-4; Kundi S, 2013, NEUROSCI RES, V76, P1, DOI 10.1016/j.neures.2013.03.013; Lane N, 2006, NATURE, V443, P901, DOI 10.1038/443901a; Li G, 2015, NEUROCHEM RES, V40, P1379, DOI 10.1007/s11064-015-1604-3; Silveira PCL, 2016, FREE RADICAL RES, V50, P503, DOI 10.3109/10715762.2016.1147649; Mandelbaum-Livnat MM, 2016, PHOTOMED LASER SURG, V34, P638, DOI 10.1089/pho.2016.4095; Mason MG, 2014, BBA-BIOENERGETICS, V1837, P1882, DOI 10.1016/j.bbabio.2014.08.005; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; MCKENZIE AL, 1995, J NEUROTRAUM, V12, P257, DOI 10.1089/neu.1995.12.257; Medalha CC, 2016, J PHOTOCH PHOTOBIO B, V159, P179, DOI 10.1016/j.jphotobiol.2016.03.041; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Nesic O, 2010, J NEUROTRAUM, V27, P1793, DOI 10.1089/neu.2010.1351; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Patrocinio-Silva TL, 2014, LASER MED SCI, V29, P1357, DOI 10.1007/s10103-013-1418-y; Paula AA, 2014, LASER MED SCI, V29, P1849, DOI 10.1007/s10103-014-1586-4; ROCHKIND S, 1989, LASER SURG MED, V9, P174, DOI 10.1002/lsm.1900090214; Rochkind S, 2013, PHOTOMED LASER SURG, V31, P499, DOI 10.1089/pho.2013.3537; Shu XQ, 1999, P NATL ACAD SCI USA, V96, P7693, DOI 10.1073/pnas.96.14.7693; Song JW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00553-6; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Veronez S, 2017, LASER MED SCI, V32, P343, DOI 10.1007/s10103-016-2120-7; von Leden RE, 2013, LASER SURG MED, V45, P253, DOI 10.1002/lsm.22133; Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Wu XJ, 2009, LASER SURG MED, V41, P36, DOI 10.1002/lsm.20729; Wu XJ, 2012, LASER MED SCI, V27, P525, DOI 10.1007/s10103-011-0983-1; Yang LD, 2018, EXP NEUROL, V299, P86, DOI 10.1016/j.expneurol.2017.10.013; YOSHIDA K, 1992, J NEUROCHEM, V59, P919, DOI 10.1111/j.1471-4159.1992.tb08331.x; Yu WR, 2009, EUR J NEUROSCI, V29, P114, DOI 10.1111/j.1460-9568.2008.06555.x; Zorner B, 2010, NAT METHODS, V7, P701, DOI 10.1038/nmeth.1484	63	7	8	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 21	2019	9								7660	10.1038/s41598-019-44141-2			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY8XL	WOS:000468423600032	31113985	gold, Green Published			2022-02-06	
J	Formisano, R; Contrada, M; Aloisi, M; Ferri, G; Schiattone, S; Iosa, M; Buzzi, MG				Formisano, R.; Contrada, M.; Aloisi, M.; Ferri, G.; Schiattone, S.; Iosa, M.; Buzzi, M. G.			Nociception Coma Scale with personalized painful stimulation versus standard stimulus in non-communicative patients with disorders of consciousness	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Disorder of consciousness; Pain; Responsiveness; Nociception Coma Scale-revised; Coma Recovery Scale-Revised; Non-communicative patients	TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; RECOVERY SCALE; ACTIVATION; MANAGEMENT	Introduction: Persons with disorders of consciousness (DoC) may perceive pain without being able to communicate their discomfort. Nociception Coma Scale (NCS) and its revised form (NCS-R) have been proposed to assess nociception in coma survivors with DoC. Objective: Aim of the present study was to compare, in non-communicative patients with DoC, NCS-R scores obtained with the standard pressure on fingernail bed (standard stimulus, SS) versus other personalized painful stimuli (PS), to verify possible correlations between NCS-R and Coma Recovery Scale-Revised (CRS-R). Materials and Methods: Twenty-one patients with DoC were included in the study. Responsiveness and pain perception were assessed by CRS-R and NCS-R with standard stimulus (NCS-R-SS) and personalized stimulation (NCS-R-PS). Statistical analysis was performed with the nonparametric Wilcoxon test for comparison of both total NCS-R-SS and NCS-R-PS scores. Results: NCS-R at admission showed that 9 of 21 patients (42.8%) had higher scores in response to personalized stimulus compared to standard stimulus. Significant correlation with CRS-R were found for both NCS-R-SS (R = 0.701, p = .008) and NCS-R-PS (R = 0.564, p = .045). Discussion: The preliminary results obtained in the present study suggest that NCS-R-PS may disclose pain perception in a larger number of non-communicative patients with DoC, compared to NCS-R-SS.	[Formisano, R.; Contrada, M.; Aloisi, M.; Ferri, G.; Schiattone, S.; Iosa, M.; Buzzi, M. G.] IRCCS Fdn Santa Lucia, Via Ardeatina 306, I-00179 Rome, Italy		Formisano, R (corresponding author), IRCCS Fdn Santa Lucia, Via Ardeatina 306, I-00179 Rome, Italy.	r.formisano@hsantalucia.it	Iosa, Marco/AAC-1693-2022; Contrada, MArianna/AAB-6049-2022; Iosa, Marco/B-9531-2012	Aloisi, Marta/0000-0002-8907-5847; CONTRADA, MARIANNA/0000-0002-9825-1347	European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant [778234]	This work has received funding from the European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement No 778234.	Bagnato S., 2018, NEUROL SCI, V8, P1; Boly M, 2005, NEUROPSYCHOL REHABIL, V15, P283, DOI 10.1080/09602010443000371; Boly M, 2008, LANCET NEUROL, V7, P1013, DOI 10.1016/S1474-4422(08)70219-9; Chatelle C, 2018, ARCH PHYS MED REHAB, V99, P1755, DOI 10.1016/j.apmr.2018.03.009; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Coleman MR, 2009, PROG BRAIN RES, V177, P231, DOI 10.1016/S0079-6123(09)17716-6; Damasio AR, 1998, PHILOS T ROY SOC B, V353, P1879, DOI 10.1098/rstb.1998.0339; De Salvo S, 2015, BRAIN INJURY, V29, P1467, DOI 10.3109/02699052.2015.1071430; de Tommaso M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00017; Estraneo A, 2015, EUR J PHYS REHAB MED, V51, P627; Feldt K S, 2000, Pain Manag Nurs, V1, P13, DOI 10.1053/jpmn.2000.5831; Flynn D, 2004, EUR J PSYCHOL ASSESS, V20, P49, DOI 10.1027/1015-5759.20.1.49; FOLTZ EL, 1962, J NEUROSURG, V19, P89, DOI 10.3171/jns.1962.19.2.0089; Formisano R, 2005, ACT NEUR S, V93, P201; Formisano R, 2011, FUNCT NEUROL, V26, P15; Garcia-Larrea L, 2018, PROG NEURO-PSYCHOPH, V87, P193, DOI 10.1016/j.pnpbp.2017.10.007; Garcia-Larrea L, 2013, PAIN, V154, pS29, DOI 10.1016/j.pain.2013.09.001; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Herr K, 2006, PAIN MANAG NURS, V7, P44, DOI 10.1016/j.pmn.2006.02.003; Hummel P, 2006, SEMIN FETAL NEONAT M, V11, P237, DOI 10.1016/j.siny.2006.02.004; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kassubek J, 2003, J NEUROL SCI, V212, P85, DOI 10.1016/S0022-510X(03)00106-0; Kinney H. C., 1994, NEW ENGL J MED, V26, P469; Klein M, 1997, Eur J Pain, V1, P165, DOI 10.1016/S1090-3801(97)90075-6; Kucyi A, 2017, NEUROSCIENTIST, V23, P397, DOI 10.1177/1073858416667716; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; MarinPadilla M, 1997, J NEUROPATH EXP NEUR, V56, P219, DOI 10.1097/00005072-199703000-00001; Merkel PA, 1997, ANN INTERN MED, V126, P866, DOI 10.7326/0003-4819-126-11-199706010-00003; Merker B, 2007, BEHAV BRAIN SCI, V30, P63, DOI 10.1017/S0140525X07000891; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Ronga I, 2013, J NEUROPHYSIOL, V109, P692, DOI 10.1152/jn.00464.2012; Sattin D., 2018, NEUROPSYCHOL REHABIL, V8, P1; Sattin D, 2013, INT J REHABIL RES, V36, P182, DOI 10.1097/MRR.0b013e3283618d68; Schnakers C, 2012, AAPS J, V14, P437, DOI 10.1208/s12248-012-9346-5; Schnakers C, 2007, CURR OPIN NEUROL, V20, P620, DOI 10.1097/WCO.0b013e3282f169d9; Schnakers C, 2015, PM&R, V7, pS270, DOI 10.1016/j.pmrj.2015.09.016; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schoenle PW, 2004, NEUROREHABILITATION, V19, P329; TEASDALE G, 1974, LANCET, V2, P81; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Tsetsou S, 2015, RESUSCITATION, V97, P34, DOI 10.1016/j.resuscitation.2015.09.380; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1016/S1525-8610(04)70258-3; Widerstrom-Noga E, 2016, J NEUROTRAUM, V33, P1380, DOI 10.1089/neu.2015.4098; Wiech K, 2016, SCIENCE, V354, P584, DOI 10.1126/science.aaf8934; Wijdicks EFM, 2006, MAYO CLIN PROC, V81, P1155, DOI 10.4065/81.9.1155	49	7	7	1	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	NOV 25	2020	30	10					1893	1904		10.1080/09602011.2019.1614464		MAY 2019	12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	OK4VL	WOS:000470455200001	31088203				2022-02-06	
J	Abraham, KJ; Casey, J; Subotic, A; Tarzi, C; Zhu, A; Cusimano, MD				Abraham, Karan Joshua; Casey, Julia; Subotic, Arsenije; Tarzi, Christopher; Zhu, Alice; Cusimano, Michael D.			Medical assessment of potential concussion in elite football: video analysis of the 2016 UEFA European championship	BMJ OPEN			English	Article							INJURY SURVEILLANCE SYSTEM; INTERNATIONAL-CONFERENCE; SPORT; EPIDEMIOLOGY	Objective The objective is to determine if suspected concussions in elite football are medically assessed according to the International Conferences on Concussion in Sport consensus statement recommendations. Setting Men's Union of European Football Association (UEFA) Football Championship. Participants All professional football players in the UEFA 2016 Championship Tournament. Design Observational study. Outcome measures Potential concussive events (PCEs) were defined as direct head collision incidents resulting in the athlete being unable to immediately resume play following impact. PCEs identified and description of PCE assessment and outcome were accomplished through direct standardised observation of video footage by trained observers in 51 games played in the Men's UEFA European Championship (10 June-10 July 2016). Results Sixty-nine total PCEs (1.35 per match) were identified in 51 games played during the 2016 Men's UEFA European Championship. Forty-eight PCEs (69.6%) resulted in two observable signs of concussion, 13 (18.8%) resulted in three signs and 1 (1.4%) resulted in four signs in the injured athletes. Nineteen (27.5%) PCEs were medically assessed by sideline healthcare personnel while 50 (72.5%) were not. Of the 50 PCEs that were not medically assessed, 44 (88%) PCEs resulted in two or more signs of concussion among injured athletes. Of the 19 medically assessed PCEs, 8 resulted in 3 signs of concussion, and 1 resulted in 4 signs; all assessments concluded in the same-game return for the injured athletes. Conclusions PCEs were frequent events in the 2016 UEFA Euro championship, but were rarely assessed concordant with the International Conferences on Concussion in Sport consensus statement recommendations. There is an imperative need to improve the assessment and management of players suspected of concussion in elite football.	[Abraham, Karan Joshua; Casey, Julia; Subotic, Arsenije; Tarzi, Christopher; Zhu, Alice; Cusimano, Michael D.] St Michaels Hosp, Neurosurg, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Publ Hlth, Toronto, ON, Canada		Cusimano, MD (corresponding author), St Michaels Hosp, Neurosurg, Toronto, ON, Canada.; Cusimano, MD (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Publ Hlth, Toronto, ON, Canada.	injuryprevention@smh.ca			Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation	This work is supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946 and the Ontario Neurotrauma Foundation.	Agel J, 2007, J ATHL TRAINING, V42, P270; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Covassin T, 2003, J ATHL TRAINING, V38, P238; Cusimano MD, 2017, JAMA-J AM MED ASSOC, V317, P2548, DOI 10.1001/jama.2017.6204; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Davis GA, 2018, BR J SPORTS MED; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; FIFA, 2014, 2014 FIFA WORLD CUP; Group IS, 2016, UEFA INJ STUD REP, V15; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kunz M., 2007, FIFA MAGAZINE, V7, P11, DOI DOI 10.1080/13673882.2007.9680857; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawrence DW, 2014, CLIN J SPORT MED, V24, P397, DOI 10.1097/JSM.0000000000000047; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P837, DOI 10.1136/bjsports-2017-097878; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P2624, DOI 10.1001/jama.2016.7407	24	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAY	2019	9	5							e024607	10.1136/bmjopen-2018-024607			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IC7YG	WOS:000471192800080	31147360	Green Published, gold			2022-02-06	
J	Alhaddad, AY; Cabibihan, JJ; Hayek, A; Bonarini, A				Alhaddad, Ahmad Yaser; Cabibihan, John-John; Hayek, Ahmad; Bonarini, Andrea			Safety experiments for small robots investigating the potential of soft materials in mitigating the harm to the head due to impacts	SN APPLIED SCIENCES			English	Article						Taguchi; ANOVA; Children with autism; Safety; Robots	AUTISM; COMMUNICATION; PERFORMANCE; CONCUSSION; BEHAVIORS; CHILDREN; MASS	There is a growing interest in social robots to be considered in the therapy of children with autism due to their effectiveness in improving the outcomes. However, children on the spectrum exhibit challenging behaviors that need to be considered when designing robots for them. A child could involuntarily throw a small social robot during meltdown and that could hit another person's head and cause harm (e.g. concussion). In this paper, the application of soft materials is investigated for its potential in attenuating head's linear acceleration upon impact. The thickness and storage modulus of three different soft materials were considered as the control factors while the noise factor was the impact velocity. The design of experiments was based on Taguchi method. A total of 27 experiments were conducted on a developed dummy head setup that reports the linear acceleration of the head. ANOVA tests were performed to analyze the data. The findings showed that the control factors are not statistically significant in attenuating the response. The optimal values of the control factors were identified using the signal-to-noise (S/N) ratio optimization technique. Confirmation tests at the optimal parameters (e.g. thickness of 3 mm or 5 mm) showed better responses as compared to other conditions. Designers of social robots should consider the application of soft materials to their designs as it helps in reducing the potential harm to the head.	[Alhaddad, Ahmad Yaser; Cabibihan, John-John; Hayek, Ahmad] Qatar Univ, Dept Mech & Ind Engn, Doha 2713, Qatar; [Alhaddad, Ahmad Yaser; Bonarini, Andrea] Politecn Milan, Dept Elect Informat & Bioengn, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy		Cabibihan, JJ (corresponding author), Qatar Univ, Dept Mech & Ind Engn, Doha 2713, Qatar.	Cabibihan.john.cabibihan@qu.edu.qa		Alhaddad, Ahmad Yaser/0000-0002-6062-5833	Qatar National Library; Qatar University [QUST-1-CENG-2019-10]	Open Access funding provided by the Qatar National Library. The work is supported by a research grant from Qatar University under the Grant No. QUST-1-CENG-2019-10. The statements made herein are solely the responsibility of the authors.	Alhaddad A. Y., 2018, ROBOTICS ED, P249; Alhaddad AY, 2019, DATA BRIEF, V24, DOI 10.1016/j.dib.2019.103885; Alhaddad AY, 2019, INT J SOC ROBOT, V11, P255, DOI 10.1007/s12369-018-0494-3; Alhaddad AY, 2019, DATA BRIEF, V22, P344, DOI 10.1016/j.dib.2018.11.143; Alhaddad AY, 2017, LECT NOTES ARTIF INT, V10652, P304, DOI 10.1007/978-3-319-70022-9_30; Alhaddad AY, 2018, HARV DATAVERSE, DOI [10.7910/DVN/AVC8GG, DOI 10.7910/DVN/AVC8GG]; Alhaddad AY, 2019, HARV DATAVERSE, DOI [10.7910/DVN/TXOPUH, DOI 10.7910/DVN/TXOPUH]; Baghdadli A, 2003, J INTELL DISABIL RES, V47, P622, DOI 10.1046/j.1365-2788.2003.00507.x; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; BOCCANFUSO L, 2016, ACMIEEE INT CONF HUM, P19; Bodfish JW, 2000, J AUTISM DEV DISORD, V30, P237, DOI 10.1023/A:1005596502855; Cabibihan John-John, 2018, Social Robotics. 10th International Conference, ICSR 2018. Proceedings: Lecture Notes in Artificial Intelligence (LNAI 11357), P103, DOI 10.1007/978-3-030-05204-1_11; Cabibihan J. J., 2018, WIPO Patent, Patent No. [WO2018033857, 2018033857]; Cabibihan J.-J., 2019, US Patent App., Patent No. [16/058,453, 16058453]; Cabibihan JJ, 2013, INT J SOC ROBOT, V5, P593, DOI 10.1007/s12369-013-0202-2; Cabibihan JJ, 2009, LECT NOTES ARTIF INT, V5928, P67, DOI 10.1007/978-3-642-10817-4_7; Cavazzuti M., 2012, OPTIMIZATION METHODS; Diep L, 2014, LECT NOTES ARTIF INT, V8755, P115, DOI 10.1007/978-3-319-11973-1_12; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Haddadin S, 2008, IEEE INT CONF ROBOT, P1331, DOI 10.1109/ROBOT.2008.4543388; Hebbale AM, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-0214-0; Herrmann G, 2010, INT J SOC ROBOT, V2, P217, DOI 10.1007/s12369-010-0061-z; Husain AR, 2016, JALA-J LAB AUTOM, V21, P660, DOI 10.1177/2211068215594770; Hutchins TL, 2014, CHILD ADOL PSYCH CL, V23, P41, DOI 10.1016/j.chc.2013.07.003; Hutchinson TP, 2014, EUR J SPORT SCI, V14, pS377, DOI 10.1080/17461391.2012.705334; International Organization for Standardization: ISO 8124-1, 2014, 81241 ISO; Kanne SM, 2011, J AUTISM DEV DISORD, V41, P926, DOI 10.1007/s10803-010-1118-4; Liu DV, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.14; McIntosh AS, 2003, BRIT J SPORT MED, V37, P325, DOI 10.1136/bjsm.37.4.325; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Moayyedian M, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-018-0075-y; Montgomery D.C., 2017, DESIGN ANAL EXPT; Mori T., 2011, TAGUCHI METHODS BENE; Moss WC, 2014, COMPUT METHOD BIOMEC, V17, P1173, DOI 10.1080/10255842.2012.739162; O'Sullivan DM, 2013, BRIT J SPORT MED, V47, P447, DOI 10.1136/bjsports-2012-091416; Plotz T, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P391; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Sadasivuni KK, 2017, BIOPOLYMER COMPOSITES IN ELECTRONICS, P437, DOI 10.1016/B978-0-12-809261-3.00016-4; So WC, 2016, J COMPUT ASSIST LEAR, V32, P632, DOI 10.1111/jcal.12159; Taguchi G., 1979, INTRO OFF LINE QUALI; Tamizharasan T, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-0170-8; Wykowska A, 2015, INT J SOC ROBOT, V7, P767, DOI 10.1007/s12369-015-0299-6; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	44	7	7	1	5	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2523-3963	2523-3971		SN APPL SCI	SN Appl. Sci.	MAY	2019	1	5							476	10.1007/s42452-019-0467-7			10	Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Science & Technology - Other Topics	IG1UO	WOS:000473581300094		Green Submitted, hybrid			2022-02-06	
J	Batulu, H; Du, GJ; Li, DZ; Sailike, D; Fan, YH; Geng, D				Batulu, Hu; Du, Guo-Jia; Li, Da-Zhi; Sailike, Duishanbai; Fan, Yu-Hua; Geng, Dangmurenjiafu			Effect of poly-arginine R18 on neurocyte cell growth via autophagy in traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						poly-arginine R18; traumatic brain injury; autophagy	PHASE-II; HYPOTHERMIA; DEATH	The present study assessed the effects of poly-arginine R18 and its promotion of neurocyte cell growth via autophagy in traumatic brain injury (TBI), and aimed to determine the possible mechanism by which this occurs. Brain water content was measured to analyze the effects of poly-arginine R18 in TBI. MTT and lactate dehydrogenase activity assays were performed to measure N2A cell growth. Western blotting and immunofluorescence staining were also performed to determine the protein expression of Bcl-2 associated X, LC3, Beclin-1 and p62. The results demonstrated that poly-arginine R18 treatment reduced neurocyte apoptosis and promoted neurocyte cell growth via the activation of autophagy in a rat model of TBI. Furthermore, poly-arginine R18 treatment promoted neurocyte cell growth, reduced apoptosis, induced the protein expression of LC3 and Beclin-1, and suppressed p62 expression by promoting autophagy in vitro. In addition, the inhibition of autophagy attenuated the effects of poly-arginine R18 on cell growth in vitro. Collectively, the results demonstrate the effects of poly-arginine R18 on neurocyte cell growth via autophagy activation in a model of TBI, and poly-arginine R18 is therefore a potential therapeutic target in TBI.	[Batulu, Hu; Du, Guo-Jia; Sailike, Duishanbai; Geng, Dangmurenjiafu] Xinjiang Med Univ, Affiliated Hosp 1, Dept Neurosurg, 137 Liyushan Rd, Urumqi 830054, Xinjiang, Peoples R China; [Li, Da-Zhi] Xinjiang Med Univ, Tradit Chinese Med Hosp, Dept Neurosurg, Urumqi 830000, Xinjiang, Peoples R China; [Fan, Yu-Hua] Peoples Hosp Xinjiang Bortala Autonomous Prefectu, Dept Nutr Sect, Bortala 833400, Xinjiang, Peoples R China		Geng, D (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Neurosurg, 137 Liyushan Rd, Urumqi 830054, Xinjiang, Peoples R China.	g989045181c@163.com					Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Blaha RZ, 2015, J HEAD TRAUMA REHAB, V30, pE33, DOI 10.1097/HTR.0000000000000059; Chen XQ, 2018, J MOL NEUROSCI, V64, P117, DOI 10.1007/s12031-017-0998-6; Chiu LS, 2017, TRANSL NEUROSCI, V8, P147, DOI 10.1515/tnsci-2017-0021; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; Cui CM, 2017, CELL PHYSIOL BIOCHEM, V42, P1888, DOI 10.1159/000479571; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Hammond FM, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0679-z; Jin YC, 2015, WORLD NEUROSURG, V84, P420, DOI 10.1016/j.wneu.2015.03.039; Milani D, 2016, STROKE RES TREAT, V2016, DOI 10.1155/2016/2372710; Milani D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193884; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Renaud MI, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1357-6; Sun LQ, 2015, MOL MED REP, V11, P4419, DOI 10.3892/mmr.2015.3264; Sun LQ, 2017, BIOCHEM BIOPH RES CO, V482, P1141, DOI 10.1016/j.bbrc.2016.12.001; Wolf MS, 2019, NEUROBIOL DIS, V122, P9, DOI 10.1016/j.nbd.2018.04.018; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4	18	7	7	1	5	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAY	2019	17	5					4109	4115		10.3892/etm.2019.7423			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	HW8JL	WOS:000466935600104	30988787	gold, Green Published, Green Submitted			2022-02-06	
J	Behn, N; Marshall, J; Togher, L; Cruice, M				Behn, Nicholas; Marshall, Jane; Togher, Leanne; Cruice, Madeline			Feasibility and initial efficacy of project-based treatment for people with ABI	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						treatment; rehabilitation; communication; cognitive communication; quality of life; project; controlled trial; brain injury	TRAUMATIC BRAIN-INJURY; SOCIAL COMMUNICATION-SKILLS; QUALITY-OF-LIFE; REHABILITATION; SATISFACTION; INDIVIDUALS; PARTNERS; ABILITY; CONVERSATION; MANAGEMENT	Background Communication impairments are common and pervasive for people a long time following acquired brain injury (ABI). These impairments have a significant impact on a person's quality of life (QOL) post-injury. Project-based treatment is a treatment approach that could have an impact on communication skills and QOL for people with ABI a long-term post-injury. This treatment is embedded in a context of meaningful activities chosen by people with ABI, whereby, as a group, they work collaboratively to achieve a tangible end product. Aims To evaluate the feasibility and initial efficacy of project-based treatment on improving the communication skills and QOL for people with ABI. Methods & Procedures An exploratory controlled trial with alternate allocation of groups, and follow-up at 6-8 weeks, was completed. Twenty-one people with chronic ABI were recruited in groups of two to three from community settings, allocated to either a TREATMENT (n = 11) or WAITLIST group (n = 10). Participants attended a 20-h group-based treatment over 6 weeks where they worked towards achieving a project that helped others. To determine feasibility, four criteria were used: demand, implementation, practicality and acceptability. A range of communication and QOL outcomes was used to determine a fifth feasibility criterion, initial efficacy. Some of these criteria were additionally used to evaluate the feasibility of the outcomes. Outcomes & Results All participants received the treatment as allocated with high attendance and no dropouts. The treatment was feasible to deliver as intended and was highly acceptable to participants. Medium and large effect sizes were found from pre- to post-treatment, and from pre-treatment to follow-up for measures of conversation, perceived communicative ability and QOL. Conclusions & Implications Project-based treatment is feasible with indications of initial efficacy for both communication skills and QOL. The treatment provides a promising new approach for improving communication skills and QOL in people with chronic acquired brain injuries in the community setting.	[Behn, Nicholas; Marshall, Jane; Cruice, Madeline] City Univ London, Sch Hlth Sci, Div Language & Commun Sci, Northampton Sq, London EC1V 0HB, England; [Togher, Leanne] Univ Sydney, Fac Hlth Sci, Speech Pathol, Lidcombe, NSW, Australia		Behn, N (corresponding author), City Univ London, Sch Hlth Sci, Div Language & Commun Sci, Northampton Sq, London EC1V 0HB, England.	Nicholas.Behn.1@city.ac.uk	Behn, Nicholas/AAR-1325-2020; Togher, Leanne/AAC-7083-2019	Behn, Nicholas/0000-0001-9356-9957; Cruice, Madeline/0000-0001-7344-2262; Togher, Leanne/0000-0002-4518-6748			Aboulafia-Brakha T, 2013, NEUROPSYCHOL REHABIL, V23, P216, DOI 10.1080/09602011.2012.747443; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; BLUMENFELD PC, 1991, EDUC PSYCHOL, V26, P369, DOI 10.1207/s15326985ep2603&4_8; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Culley C, 2010, NEUROPSYCHOL REHABIL, V20, P103, DOI 10.1080/09602010902906926; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Feeney T. J., 2010, J BEHAV NEUROSCIENCE, V8, P70; Finch E, 2016, ARCH PHYS MED REHAB, V97, P1352, DOI [10.1016/j.apmr.2015.11.005, 10.1016/j.apmr.20.15.11.005]; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Frydenberg E., 1996, COPING SCALE ADULTS; Grant M, 2012, NEUROPSYCHOL REHABIL, V22, P852, DOI 10.1080/09602011.2012.693455; Haahr M, 1998, LIST RANDOMISER; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hoofien D, 2001, BRAIN INJURY, V15, P189; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Knight C, 2010, AGEING SOC, V30, P1393, DOI 10.1017/S0144686X10000656; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; McDonald S, 2014, SOCIAL COMMUNICATION; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Ownsworth T., 2014, SELF IDENTITY BRAIN; Perdices M, 2018, BRAIN IMPAIR, V19, P70, DOI 10.1017/BrImp.2017.28; Randolph C., 1998, REPEATABLE BATTERY A; Rosenberg M., 1965, SOC ADOLESCENT SELF; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Snow P, 1997, BRAIN INJURY, V11, P409; Southcott JE, 2009, INT J COMMUNITY MUSI, V2, P143, DOI 10.1386/ijcm.2.2-3.143_1; Spencer L, 2004, QUALITATIVE RES PRAC, P199; Thomas M, 2004, BRAIN INJURY, V18, P1271, DOI 10.1080/02699050410001698776; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Vandiver VL, 2000, J COGNIT REHABIL, V18, P22; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P540, DOI 10.1016/j.apmr.2010.12.002; World Health Organization, 2007, INT CLASS FUNCT DIS; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [DOI 10.1375/brim.4.1.1.27031, https://doi.org/10.1375/brim.4.1.1.27031, DOI 10.1375/BRIM.4.1.1.27031]; YLVISAKER M, 2007, BRAIN IMPAIR, V8, P276, DOI DOI 10.1375/brim.8.3.276; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P303; Zencius AH, 1999, BRAIN INJURY, V13, P723; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	58	7	7	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	MAY-JUN	2019	54	3					465	478		10.1111/1460-6984.12452			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	HV4LC	WOS:000465956800012	30693611	Green Accepted			2022-02-06	
J	Chang, HK; Hsu, JW; Wu, JC; Huang, KL; Chang, HC; Bai, YM; Chen, TJ; Chen, MH				Chang, Hsuan-Kan; Hsu, Ju-Wei; Wu, Jau-Ching; Huang, Kai-Lin; Chang, Huang-Chou; Bai, Ya-Mei; Chen, Tzeng-Ji; Chen, Mu-Hong			Risk of attempted suicide among adolescents and young adults with traumatic brain injury: A nationwide longitudinal study	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Suicide; Adolescent; Traumatic brain injury (TBI); National Health Insurance Research Database (NHIRD); Psychiatric comorbidities	DISORDER; ASSOCIATIONS; IMPULSIVITY; VETERANS	Background: Traumatic brain injury (TBI) and suicidal behavior lead to serious morbidity and premature mortality. TBI in adulthood is associated with a higher incidence of suicide, but the risk in adolescents and young adults is not clear. Methods: Longitudinal follow-up data were extracted from a National Health Insurance Research Database. Adolescents and young adults (12-29 years old) with and without TBI (1: 4) were included, and the incidences of following attempted suicide were analyzed. The association of TBI severity, repeated TBI, and comorbid psychiatric disorders with attempted suicide were also investigated. Results: Overall, 31,599 and 126,396 subjects were enrolled in the TBI and control cohorts, respectively. The overall incidence of attempted suicide was significantly higher in the TBI cohort than in the control cohort (4.6% versus 1.0%, P < 0.001). The age at first suicide attempt was also lower in the TBI cohort (25.71 +/- 5.25 versus 28.99 +/- 5.26 years, P< 0.001). After adjusting for confounding factors, severe TBI, repeated TBI, female, younger age at TBI, and comorbid psychiatric conditions (unipolar depression, bipolar disorder, alcohol and substance use disorders) were associated with higher risks of attempted suicide. Long-term cumulative risks of attempted suicide were significantly elevated in the TBI cohort (P< 0.001). Limitation: Access to individual's detailed medical record was not available. Conclusion: TBI is associated with an elevated risk of attempted suicide in adolescents and young adults. TBI severity, repetitive injury, female, younger age at injury, and certain psychiatric comorbidities are independent risk factors.	[Chang, Hsuan-Kan; Wu, Jau-Ching] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei, Taiwan; [Chang, Hsuan-Kan; Wu, Jau-Ching] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chang, Hsuan-Kan] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Hsu, Ju-Wei; Huang, Kai-Lin; Bai, Ya-Mei; Chen, Mu-Hong] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Hsu, Ju-Wei; Huang, Kai-Lin; Bai, Ya-Mei; Chen, Mu-Hong] Natl Yang Ming Univ, Coll Med, Dept Psychiat, Taipei, Taiwan; [Wu, Jau-Ching] Natl Yang Ming Univ, Inst Pharmacol, Taipei, Taiwan; [Chang, Huang-Chou] Fu Jen Catholic Univ, Dept Surg, Taipei, Taiwan; [Chang, Huang-Chou] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan		Chen, MH (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, 201,Shih Pai Rd,Sec 2, Taipei 11217, Taiwan.	kremer7119@gmail.com	Chen, TJ/AAH-8430-2021; Wu, Jau-Ching/AAU-4009-2021	Wu, Jau-Ching/0000-0002-6996-3409	Taipei Veterans General HospitalTaipei Veterans General Hospital [V103E10-001, V104E10-002, V105E10-001-MY2-1, V105A-049, V106B-020, V107B-010, V107C-181]	The study was supported by grant from Taipei Veterans General Hospital (V103E10-001, V104E10-002, V105E10-001-MY2-1, V105A-049, V106B-020, V107B-010, V107C-181). The funding source had no role in any process of our study.	Ahern S, 2018, EUR CHILD ADOLES PSY, V27, P1295, DOI 10.1007/s00787-018-1120-5; Annor FB, 2018, MMWR-MORBID MORTAL W, V67, P329, DOI 10.15585/mmwr.mm6711a4; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Chen MH, 2016, DIABETES CARE, V39, P788, DOI 10.2337/dc15-1807; Chen MH, 2015, BRIT J PSYCHIAT, V206, P302, DOI 10.1192/bjp.bp.113.143610; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Fonda JR, 2017, AM J EPIDEMIOL, V186, P220, DOI 10.1093/aje/kwx044; Gardner P, 1996, Vital Health Stat 20, P1; Gorlyn Marianne, 2005, Int J Adolesc Med Health, V17, P205; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Kesinger MR, 2016, ARCH PHYS MED REHAB, V97, P1301, DOI 10.1016/j.apmr.2016.02.017; King CA, 2018, CURR OPIN PSYCHOL, V22, P89, DOI 10.1016/j.copsyc.2017.08.037; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Li CT, 2012, BRIT J PSYCHIAT, V200, P45, DOI 10.1192/bjp.bp.110.086983; Liu CY, 2006, J HEALTHC MANAG, V4, P1, DOI DOI 10.29805/JHM.200606.0001; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Richard YF, 2015, AM J EPIDEMIOL, V182, P177, DOI 10.1093/aje/kwv014; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Slawik H, 2009, J NEUROTRAUM, V26, P1891, DOI 10.1089/neu.2009.0942; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Wang YP, 2014, AM J PSYCHIAT, V171, P54, DOI 10.1176/appi.ajp.2013.12111467; Webner D, 2016, BRAIN INJURY, V30, P1718, DOI 10.1080/02699052.2016.1202451; Wortzel HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/424280; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	31	7	7	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	MAY 1	2019	250						21	25		10.1016/j.jad.2019.02.059			5	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	HS4UX	WOS:000463865400004	30826490				2022-02-06	
J	Choi, BY; Lee, SH; Choi, HC; Lee, SK; Yoon, HS; Park, JB; Chung, WS; Suh, SW				Choi, Bo Young; Lee, Song Hee; Choi, Hui Chul; Lee, Sang-Kyu; Yoon, Hyo Seop; Park, Jae Bong; Chung, Won Suk; Suh, Sang Won			Alcohol dependence treating agent, acamprosate, prevents traumatic brain injury-induced neuron death through vesicular zinc depletion	TRANSLATIONAL RESEARCH			English	Article							PROTEIN-KINASE-C; NADPH OXIDASE; GLUTAMATE RELEASE; CORTICAL-NEURONS; MICROGLIA; MECHANISM; TRIGGERS; RECEPTOR; ETHANOL; NEURODEGENERATION	Acamprosate, also known as N-acetyl homotaurine, is an N-methyl-D-aspartate receptor antagonist that is used for treating alcohol dependence. Although the exact mechanism of acamprosate has not been clearly established, it appears to work by promoting a balance between the excitatory and inhibitory neurotransmitters, glutamate, and gamma-aminobutyric acid, respectively. Several studies have demonstrated that acamprosate provides neuroprotection against ischemia-induced brain injury. However, no studies have been performed evaluating the effect of acamprosate on traumatic brain injury (TBI). In the present study, we sought to evaluate the therapeutic potential of acamprosate to protect against neuronal death following TBI. Rats were given oral acamprosate (200 mg/kg/d for 2 weeks) and then subjected to a controlled cortical impact injury localized over the parietal cortex. Histologic analysis was performed at 3 hours, 24 hours, and 7 days after TBI. We found that acamprosate treatment reduced the concentration of vesicular glutamate and zinc in the hippocampus. Consequently, this reduced vesicular glutamate and zinc level resulted in a reduction of reactive oxygen species production after TBI. When evaluated 24 hours after TBI, acamprosate administration reduced the number of degenerating neurons, zinc accumulation, blood-brain barrier disruption, neutrophil infiltration, and dendritic loss. Acamprosate also reduced glial activation and neuronal loss at 7 days after TBI. In addition, acamprosate rescued TBI-induced neurologic and cognitive dysfunction. The present study demonstrates that acamprosate attenuates TBI-induced brain damage by depletion of vesicular glutamate and zinc levels. Therefore, this study suggests that acamprosate may have high therapeutic potential for prevention of TBI-induced neuronal death.	[Choi, Bo Young; Lee, Song Hee; Suh, Sang Won] Hallym Univ, Coll Med, Dept Physiol, 1 Hallymdaehak Gil, Chunchon 24252, South Korea; [Choi, Hui Chul] Hallym Univ, Coll Med, Dept Neurol, Chunchon, South Korea; [Lee, Sang-Kyu] Hallym Univ, Coll Med, Dept Psychiat, Chunchon, South Korea; [Park, Jae Bong] Hallym Univ, Coll Med, Dept Biochem, Chunchon, South Korea; [Yoon, Hyo Seop] Hallym Clin, Inje Gun, Gangwon Do, South Korea; [Chung, Won Suk] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea		Suh, SW (corresponding author), Hallym Univ, Coll Med, Dept Physiol, 1 Hallymdaehak Gil, Chunchon 24252, South Korea.	swsuh@hallym.ac.kr		Suh, Sang Won/0000-0002-7492-579X; Chung, Won-Suk/0000-0003-1060-9007; Choi, Bo Young/0000-0002-9579-3503	National Research Foundation of Korea (NRF)National Research Foundation of Korea [NRF-2017R1C1B1004226]; Brain Research Program through the NRF - Ministry of Science, Information and Communication Technology and Future Planning [NRF-2017M3C7A1028937, 2017R1D1A1A09081190, 2018R1A4A1020922]	This study was supported by funding from the National Research Foundation of Korea (NRF) (NRF-2017R1C1B1004226) to Bo Young Choi. This work was also supported by the Brain Research Program through the NRF, funded by the Ministry of Science, Information and Communication Technology and Future Planning (NRF-2017M3C7A1028937, 2017R1D1A1A09081190, and 2018R1A4A1020922) to Sang Won Suh.	al Qatari M, 1998, ALCOHOL CLIN EXP RES, V22, P810, DOI 10.1097/00000374-199806000-00006; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Bashkatova V, 2005, J NEURAL TRANSM, V112, P779, DOI 10.1007/s00702-004-0224-x; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Brayer SW, 2015, NEUROREHAB NEURAL RE, V29, P483, DOI 10.1177/1545968314550367; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; CHAO CC, 1992, J IMMUNOL, V149, P2736; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Dahchour A, 2000, PROG NEUROBIOL, V60, P343, DOI 10.1016/S0301-0082(99)00031-3; DAOUST M, 1992, PHARMACOL BIOCHEM BE, V41, P669, DOI 10.1016/0091-3057(92)90210-7; Doeppner TR, 2015, J CEREBR BLOOD F MET, V35, P2089, DOI 10.1038/jcbfm.2015.179; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GIULIAN D, 1993, J NEUROSCI, V13, P29; GIULIAN D, 1993, GLIA, V7, P102, DOI 10.1002/glia.440070116; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Harris BR, 2003, ALCOHOL CLIN EXP RES, V27, P1724, DOI 10.1097/01.ALC.0000093601.33119.E3; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; Kay AR, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.119re3; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; LITTLETON J, 1995, ADDICTION, V90, P1179, DOI 10.1111/j.1360-0443.1995.tb01088.x; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Mann K, 2008, ALCOHOL CLIN EXP RES, V32, P1105, DOI 10.1111/j.1530-0277.2008.00690.x; Marmarou A, 2003, ACT NEUR S, V86, P7; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; Mennenga SE, 2015, PHYSIOL BEHAV, V138, P260, DOI 10.1016/j.physbeh.2014.09.001; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; MURAKAMI K, 1987, J BIOL CHEM, V262, P13902; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Naassila M, 1998, ALCOHOL CLIN EXP RES, V22, P802; Noh KM, 1999, J NEUROCHEM, V72, P1609, DOI 10.1046/j.1471-4159.1999.721609.x; Noh KM, 2000, J NEUROSCI, V20; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Sensi SL, 2006, BIOGERONTOLOGY, V7, P367, DOI 10.1007/s10522-006-9051-9; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; SLOMIANKA L, 1992, NEUROSCIENCE, V48, P325, DOI 10.1016/0306-4522(92)90494-M; Slotnick B.M., 1975, STEREOTAXIC ATLAS AL, P174; Suh SW, 2008, ANN NEUROL, V64, P654, DOI 10.1002/ana.21511; Suh SW, 2000, BRAIN RES, V879, P7, DOI 10.1016/S0006-8993(00)02675-5; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Takeda A, 2001, BIOMETALS, V14, P343, DOI 10.1023/A:1012982123386; Tang XAN, 2010, J NEUROSCI METH, V190, P240, DOI 10.1016/j.jneumeth.2010.05.004; Tani M, 1996, AM J PATHOL, V148, P889; Urenjak J, 1996, PHARMACOL REV, V48, P21; Williams SH, 2005, AM FAM PHYSICIAN, V72, P1775; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; ZEISE ML, 1993, EUR J PHARMACOL, V231, P47, DOI 10.1016/0014-2999(93)90682-8; ZORNOW MH, 1995, J NEUROSURG ANESTH, V7, P148, DOI 10.1097/00008506-199504000-00022; 2012, INFLAMMOPHARMACOLOGY, V20, P39, DOI DOI 10.1007/S10787-011-0097-1	62	7	7	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1931-5244	1878-1810		TRANSL RES	Transl. Res.	MAY	2019	207						1	18		10.1016/j.trsl.2019.01.002			18	Medical Laboratory Technology; Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology; General & Internal Medicine; Research & Experimental Medicine	HX4FK	WOS:000467350200001	30731068				2022-02-06	
J	Frick, KD; Singman, EL				Frick, Kevin D.; Singman, Eric L.			Cost of Military Eye Injury and Vision Impairment Related to Traumatic Brain Injury: 2001-2017	MILITARY MEDICINE			English	Article							VISUAL IMPAIRMENT; REHABILITATION; EPIDEMIOLOGY; VETERANS; CARE	Introduction: Annual incidence of eye injury among members of the US armed services is high and can cause vision impairment and blindness. Traumatic brain injury is also associated with visual function. An estimate of the cost of treatment, benefits for those who are disabled, productivity loss for those with reduced vision function, and the cost of replacing and retraining others to take the responsibility of those who are discharged from the military will provide a benchmark to which to compare the cost of new methods to prevent, diagnose, mitigate, treat, and rehabilitate vision loss after injury. Materials and Methods: The modeling exercise used a combination of data from military websites, results previously published in the literature, and from other government websites. Data were combined to estimate the number of superficial injuries, the number of injuries with a high risk of blindness, the cost of medical care, the cost of disability benefits, and the cost of potential lost productivity. Results: Over the time period in question, the average annual incidence of eye injury was 15,681 with 304 hospitalized and 298 at high risk of blindness. There were 4,394 annual TBI cases without injury to the eye but with visual impairment. The total cost of treatment, benefits, and potential lost productivity is $2.4 billion annually; $1.9 billion is associated with TBI. $11.7 million is associated with replacing and retraining members of the military. Conclusions: The cost of eye injury and vision dysfunction in the military is substantial. The cost of potential productivity loss associated with TBI makes up the largest proportion of total costs. Developing new standards to enhance eye safety and limit TBI could be cost-effective. Cost analyses such as this study should prove helpful in determining the economic return on investments to prevent, mitigate, treat, and rehabilitate visual system injury.	[Frick, Kevin D.] Johns Hopkins Carey Business Sch, 100 Int Dr, Baltimore, MD 21202 USA; [Singman, Eric L.] Johns Hopkins Univ Hosp, Wilmer Gen Eye Serv, Wilmer B-29,600 N Wolfe St, Baltimore, MD 21287 USA		Frick, KD (corresponding author), Johns Hopkins Carey Business Sch, 100 Int Dr, Baltimore, MD 21202 USA.			Frick, Kevin/0000-0002-0178-5319			[Anonymous], 2007, FINAL REPORT VETERAN; Armed Forces Health Surveillance Center, 2008, MSMR, V18, P2; Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Buckingham RS, 2005, MIL MED, V170, P196, DOI 10.7205/MILMED.170.3.196; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Frick KD, 2007, ARCH OPHTHALMOL-CHIC, V125, P544, DOI 10.1001/archopht.125.4.544; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Hilber David J, 2011, MSMR, V18, P2; Houtenville AJ, 2003, J VISUAL IMPAIR BLIN, V97, P133, DOI 10.1177/0145482X0309700302; Islam SS, 2000, J OCCUP ENVIRON MED, V42, P575, DOI 10.1097/00043764-200006000-00004; Keeffe JE, 2009, ARCH OPHTHALMOL-CHIC, V127, P1377, DOI 10.1001/archophthalmol.2009.242; Kuhn F, 2006, OPHTHAL EPIDEMIOL, V13, P209, DOI 10.1080/09286580600665886; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Ramirez DA, 2018, AM J OPHTHALMOL, V191, P149, DOI 10.1016/j.ajo.2018.04.020; Rein DB, 2006, ARCH OPHTHALMOL-CHIC, V124, P1754, DOI 10.1001/archopht.124.12.1754; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Stroupe KT, 2008, OPHTHAL EPIDEMIOL, V15, P84, DOI 10.1080/09286580802027836; Thach AB, 2008, OPHTHALMOLOGY, V115, P377, DOI 10.1016/j.ophtha.2007.04.032	22	7	7	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY-JUN	2019	184	5-6					E338	E343		10.1093/milmed/usy420			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HY5SU	WOS:000468188900032	30690455	Bronze			2022-02-06	
J	Huang, MX; Nichols, S; Robb-Swan, A; Angeles-Quinto, A; Harrington, DL; Drake, A; Huang, CW; Song, T; Diwakar, M; Risbrough, VB; Matthews, S; Clifford, R; Cheng, CK; Huang, JW; Sinha, A; Yurgil, KA; Ji, ZW; Lerman, I; Lee, RR; Baker, DG				Huang, Ming-Xiong; Nichols, Sharon; Robb-Swan, Ashley; Angeles-Quinto, Annemarie; Harrington, Deborah L.; Drake, Angela; Huang, Charles W.; Song, Tao; Diwakar, Mithun; Risbrough, Victoria B.; Matthews, Scott; Clifford, Royce; Cheng, Chung-Kuan; Huang, Jeffrey W.; Sinha, Anusha; Yurgil, Kate A.; Ji, Zhengwei; Lerman, Imanuel; Lee, Roland R.; Baker, Dewleen G.			MEG Working Memory N-Back Task Reveals Functional Deficits in Combat-Related Mild Traumatic Brain Injury	CEREBRAL CORTEX			English	Article						blast brain injury; frontal pole; magnetoencephalography; traumatic brain injury; working memory	PERSISTENT POSTCONCUSSIVE SYMPTOMS; ANTERIOR CINGULATE CORTEX; SIGNAL SPACE SEPARATION; SOURCE IMAGING APPROACH; MODERATE TBI; ACTIVATION; MECHANISMS; BLAST; FMRI; MAGNETOENCEPHALOGRAPHY	Combat-related mild traumatic brain injury (mTBI) is a leading cause of sustained cognitive impairment in military service members and Veterans. However, the mechanism of persistent cognitive deficits including working memory (WM) dysfunction is not fully understood in mTBI. Few studies of WM deficits in mTBI have taken advantage of the temporal and frequency resolution afforded by electromagnetic measurements. Using magnetoencephalography (MEG) and an N-back WM task, we investigated functional abnormalities in combat-related mTBI. Study participants included 25 symptomatic active-duty service members or Veterans with combat-related mTBI and 20 healthy controls with similar combat experiences. MEG source-magnitude images were obtained for alpha (8-12 Hz), beta (15-30 Hz), gamma (30-90 Hz), and low-frequency (1-7 Hz) bands. Compared with healthy combat controls, mTBI participants showed increased MEG signals across frequency bands in frontal pole (FP), ventromedial prefrontal cortex, orbitofrontal cortex (OFC), and anterior dorsolateral prefrontal cortex (dlPFC), but decreased MEG signals in anterior cingulate cortex. Hyperactivations in FP, OFC, and anterior dlPFC were associated with slower reaction times. MEG activations in lateral FP also negatively correlated with performance on tests of letter sequencing, verbal fluency, and digit symbol coding. The profound hyperactivations from FP suggest that FP is particularly vulnerable to combat-related mTBI.	[Huang, Ming-Xiong; Harrington, Deborah L.; Risbrough, Victoria B.; Clifford, Royce; Yurgil, Kate A.; Lerman, Imanuel; Lee, Roland R.; Baker, Dewleen G.] VA San Diego Healthcare Syst, Serv Radiol, San Diego, CA 92161 USA; [Huang, Ming-Xiong; Harrington, Deborah L.; Risbrough, Victoria B.; Clifford, Royce; Yurgil, Kate A.; Lerman, Imanuel; Lee, Roland R.; Baker, Dewleen G.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [Huang, Ming-Xiong; Harrington, Deborah L.; Risbrough, Victoria B.; Clifford, Royce; Yurgil, Kate A.; Lerman, Imanuel; Lee, Roland R.; Baker, Dewleen G.] VA San Diego Healthcare Syst, Psychiat Serv, San Diego, CA 92161 USA; [Huang, Ming-Xiong; Robb-Swan, Ashley; Angeles-Quinto, Annemarie; Harrington, Deborah L.; Song, Tao; Ji, Zhengwei; Lee, Roland R.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92093 USA; [Nichols, Sharon] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA; [Drake, Angela] Cedar Sinai Med Grp, Chron Pain Program, Beverly Hills, CA 90211 USA; [Huang, Charles W.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92093 USA; [Diwakar, Mithun] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94131 USA; [Risbrough, Victoria B.; Clifford, Royce; Baker, Dewleen G.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92093 USA; [Risbrough, Victoria B.; Clifford, Royce; Yurgil, Kate A.; Baker, Dewleen G.] VA Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA; [Matthews, Scott] ASPIRE Ctr, VASDHS Residential Rehabil Treatment Program, San Diego, CA 92110 USA; [Cheng, Chung-Kuan] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92093 USA; [Huang, Jeffrey W.] Columbia Univ, New York, NY 10027 USA; [Sinha, Anusha; Lee, Roland R.] CALTECH, Pasadena, CA 91125 USA; [Yurgil, Kate A.] Loyola Univ, New Orleans, LA 70118 USA		Huang, MX (corresponding author), Univ Calif San Diego, Radiol Imaging Lab, 3510 Dunhill St, San Diego, CA 92121 USA.	mxhuang@ucsd.edu	Clifford, Royce/X-8799-2019; Baker, Dewleen/O-4957-2019	Clifford, Royce/0000-0002-5515-4336; Baker, Dewleen/0000-0002-1736-9838; Cheng, Chung-Kuan/0000-0002-9865-8390	U.S. Department of Veterans AffairsUS Department of Veterans Affairs [I01-CX000499, I01-RX001988, MHBA-010-14F, NURC-022-10F, NEUC-044-06S, I01-CX000146]; U.S. Naval Medical Research Center's Advanced Medical Development program (Naval Medical Logistics Command Contract) [N62645-11-C-4037]; Veterans AffairsUS Department of Veterans Affairs [I01CX000146, I01CX000499, I01RX001988] Funding Source: NIH RePORTER	Supported in part by Merit Review Grants from the U.S. Department of Veterans Affairs to M.X. Huang (I01-CX000499, I01-RX001988, MHBA-010-14F, NURC-022-10F, NEUC-044-06S), R.R. Lee, D.L. Harrington (I01-CX000146), and The U.S. Naval Medical Research Center's Advanced Medical Development program (Naval Medical Logistics Command Contract #N62645-11-C-4037, for MRS-II (D.G. Baker, M.A. Geyer, M.X. Huang, V.B. Risbrough).	Baddeley A.D., 1986, WORKING MEMORY; Bailey NW, 2017, BRAIN INJURY, V31, P379, DOI 10.1080/02699052.2016.1239273; Bailey NW, 2014, BIOL PSYCHOL, V99, P115, DOI 10.1016/j.biopsycho.2014.03.008; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bludau S, 2014, NEUROIMAGE, V93, P260, DOI 10.1016/j.neuroimage.2013.05.052; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Cazalis F, 2006, BRAIN INJURY, V20, P1019, DOI 10.1080/02699050600664384; Cazalis Fabienne, 2011, Front Neurol, V1, P158, DOI 10.3389/fneur.2010.00158; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen D, 2002, P 13 INT C BIOM, P919; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Cusack R, 2003, NEUROIMAGE, V18, P127, DOI 10.1006/nimg.2002.1281; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Gillis MM, 2015, BRAIN IMAGING BEHAV, V9, P801, DOI 10.1007/s11682-014-9337-5; Glahn DC, 2005, HUM BRAIN MAPP, V25, P60, DOI 10.1002/hbm.20138; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00024; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Huang CW, 2016, CLIN NEUROPHYSIOL, V127, P2308, DOI 10.1016/j.clinph.2016.02.007; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2014, NEUROIMAGE, V84, P585, DOI 10.1016/j.neuroimage.2013.09.022; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Hyafil A, 2009, J NEUROSCI, V29, P5135, DOI 10.1523/JNEUROSCI.2828-08.2009; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Manktelow AE, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00058; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Medaglia JD, 2015, BRAIN IMAGING BEHAV, V9, P285, DOI 10.1007/s11682-014-9306-z; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; Niedermeyer E., 2005, ELECTROENCEPHALOGRAP; Nyberg L, 2003, NEUROPSYCHOLOGIA, V41, P371, DOI 10.1016/S0028-3932(02)00168-9; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Phillips NL, 2017, CHILD NEUROPSYCHOL, V23, P26, DOI 10.1080/09297049.2015.1085500; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song T, 2008, MED BIOL ENG COMPUT, V46, P923, DOI 10.1007/s11517-007-0290-y; Swan AR, 2015, J NEUROTRAUM, V32, P1510, DOI 10.1089/neu.2014.3654; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Taulu S, 2004, Neurol Clin Neurophysiol, V2004, P35; TEASDALE G, 1974, LANCET, V2, P81; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Ullsperger M, 2004, CORTEX, V40, P593, DOI 10.1016/S0010-9452(08)70155-2; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Young LA, 2015, SEMIN NEUROL, V35, P5, DOI 10.1055/s-0035-1544242	94	7	7	1	10	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	MAY	2019	29	5					1953	1968		10.1093/cercor/bhy075			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IS5FL	WOS:000482177800009	29668852				2022-02-06	
J	Kroshus, E; Gonzalez, LA; Chrisman, SPD; Jimenez, N				Kroshus, Emily; Gonzalez, Laura A.; Chrisman, Sara P. D.; Jimenez, Nathalia			Availability of Concussion Information in Spanish for Parents of Youth Athletes	HEALTH PROMOTION PRACTICE			English	Article						Spanish; brain concussion; sports; child; adolescent; consumer health information; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HEALTH LITERACY; UNITED-STATES; READABILITY; PREVALENCE; EDUCATION; WEBSITES	All but one U.S. state has passed legislation requiring that concussion information be provided to parents of youth participants in school-sponsored sport. Such information should be accessible and easily understood if it is to be used by parents to make informed decisions regarding their children's health and safety. Accessing and understanding information about concussion may be challenging for parents who lack fluency in English. The current study sought to describe the extent and nature of Spanish-language concussion information available on the websites of U.S. public high school athletic associations. We also examined information provided by leading youth sports and health organizations as well as the top U.S. children's hospitals. We sought to quantify the proportion of these websites with Spanish-language translation of concussion education materials and describe the readability, accessibility, and completeness of these translations. Only one quarter of the websites examined contained any concussion information in Spanish, and none of these websites offered a mirrored Spanish-language translation. Spanish information was also difficult to access, with the search process requiring English-language ability. Finally, the readability of the concussion information in both English and Spanish was higher than recommended guidelines. Our findings suggest that non-English-speaking parents may be inadequately informed about concussion because translation of concussion educational materials is absent, incomplete, or hard to access. This raises questions about whether they are able to provide informed consent for their children's participation in contact sport and suggests the need for improved translation of such informational materials.	[Kroshus, Emily; Gonzalez, Laura A.; Chrisman, Sara P. D.; Jimenez, Nathalia] Seattle Childrens Res Inst, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA; [Kroshus, Emily; Chrisman, Sara P. D.; Jimenez, Nathalia] Univ Washington, Seattle, WA 98195 USA		Kroshus, E (corresponding author), Seattle Childrens Res Inst, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA.	ekroshus@u.washington.edu		Chrisman, Sara/0000-0001-5373-7223; Jimenez, Nathalia/0000-0002-6785-8330	Seattle Children's Center for Diversity and Health Equity	We thank Monica Sanchez Avila for her assistance with qualitative coding. We acknowledge the financial support provided by Seattle Children's Center for Diversity and Health Equity. Address correspondence to Emily Kroshus, Seattle Children's Research Institute, 2001 8th Avenue, Suite 400, Seattle, WA 98121, USA; e-mail: ekroshus@u.washington.edu.	Arcia A, 2016, J AM MED INFORM ASSN, V23, P174, DOI 10.1093/jamia/ocv079; Barrio-Cantalejo IM, 2008, AN SIST SANIT NAVAR, V31, P135, DOI 10.4321/s1137-66272008000300004; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bjarnadottir RI, 2016, INFORM HEALTH SOC CA, V41, P341, DOI 10.3109/17538157.2015.1064429; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Bodey K., 2009, ICHPER SD J RES HLTH, V4, P58; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Camarota S. A., 2017, MAPPING IMPACT IMMIG; Centers for Disease Control and Prevention, HEADS; Cristancho S, 2014, GLOB HEALTH PROMOT, V21, P40, DOI 10.1177/1757975913510727; Diaz-Rios LK, 2016, J NUTR EDUC BEHAV, V48, P425, DOI 10.1016/j.jneb.2016.03.008; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Flores A., 2017, US HISPANIC POPULATI; Ford EW, 2012, J HEALTHC MANAG, V57, P47, DOI 10.1097/00115514-201201000-00009; Gallant LM, 2010, J COMPUT-MEDIAT COMM, V15, P552, DOI 10.1111/j.1083-6101.2009.01511.x; Grone O., 2009, INVENTARIO INSTRUMEN; Hamilton SN, 2015, J CANCER EDUC, V30, P580, DOI 10.1007/s13187-014-0711-1; Heilman CB, 2013, WORLD NEUROSURG, V80, pE109, DOI 10.1016/j.wneu.2011.11.013; Kirchhoff K, 2011, J AM MED INFORM ASSN, V18, P473, DOI 10.1136/amiajnl-2011-000176; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAvoy K., 2011, REAP BENEFITS GOOD C; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; National Federation of High School Associations, 2014 15 HIGH SCH ATH; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Randeree Ebrahim, 2004, Int J Electron Healthc, V1, P33, DOI 10.1504/IJEH.2004.004653; Smith J., 2008, RURAL ED, V29, P8; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stepler R, 2014, 2014 HISPANICS US ST; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; US Census Bureau, 2016, ANN EST RES POP SEX; Youdelman MK, 2008, HEALTH AFFAIR, V27, P424, DOI 10.1377/hlthaff.27.2.424; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	37	7	7	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1524-8399	1552-6372		HEALTH PROMOT PRACT	Health Promot. Pract.	MAY	2019	20	3					372	380		10.1177/1524839918790231			9	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	HT4BZ	WOS:000464509200009	30153750				2022-02-06	
J	McDonald, AA; Wilkerson, GB; McDermott, BP; Bonacci, JA				McDonald, Alexandra A.; Wilkerson, Gary B.; McDermott, Brendon P.; Bonacci, Jeffrey A.			Risk Factors for Initial and Subsequent Core or Lower Extremity Sprain or Strain Among Collegiate Football Players	JOURNAL OF ATHLETIC TRAINING			English	Article						musculoskeletal injury prevention; neurocognition; clinical decision making	CRUCIATE LIGAMENT INJURY; HIGH-SCHOOL; MUSCULOSKELETAL INJURY; CONCUSSION INCREASES; REACTION-TIME; SPORTS; NEUROCOGNITION; PREDICTION; RATES	Context: Exposure to game conditions and previous injury are known to increase the risk of injury, but little available evidence pertains to modifiable factors that may mediate dynamic control of body segments, such as core muscle endurance and neurocognitive capabilities. Objective: To identify potentially modifiable factors associated with the occurrence of a core or lower extremity sprain or strain during participation in football. Design: Prospective cohort study. Setting: National Collegiate Athletic Association Division I Football Bowl Subdivision football program. Patients or Other Participants: All team members who participated for the duration of 1 season or both of 2 consecutive seasons (n = 142). Main Outcome Measure(s): Predictors of injury occurrence were derived from analysis of preparticipation data that included the results of front plank hold (FPH) and neurocognitive tests. Receiver operating characteristic analysis was used to establish binary classifications of injury risk. Logistic regression analyses were conducted to build multivariable injury-prediction models for optimal discriminatory power. Results: Exceptionally good discrimination between injured and noninjured participants was provided by models that included the results of the FPH and ImPACT neurocognitive tests. A high level of exposure to game conditions and injury during the preceding year magnified the effects of other risk factors. A model for identifying players with an elevated risk for injury occurrence during both of 2 consecutive seasons included FPH <= 120 seconds, verbal memory score <= 87, composite reaction time >= 560 milliseconds, and starter status. Having >= 2 of the 4 risk factors demonstrated 44% sensitivity and 91% specificity, with an odds ratio = 8.40. Conclusions: Core muscle endurance and neurocognitive processes may both play important roles in generating anticipatory muscle stiffness during participation in collegiate football. These factors may be particularly important for players who sustained an injury during the previous year and those who have a high level of game exposure.	[McDonald, Alexandra A.] DC United Soccer Club, 2400 East Capitol St SE, Washington, DC 20003 USA; [Wilkerson, Gary B.] Univ Tennessee, Chattanooga, TN USA; [McDermott, Brendon P.; Bonacci, Jeffrey A.] Univ Arkansas, Fayetteville, AR 72701 USA		McDonald, AA (corresponding author), DC United Soccer Club, 2400 East Capitol St SE, Washington, DC 20003 USA.	amcdonald159@gmail.com	Wilkerson, Gary B./AAG-4103-2021	Wilkerson, Gary B./0000-0001-8433-7329			Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Clark JF, 2017, CLIN J SPORT MED, V27, P457, DOI 10.1097/JSM.0000000000000381; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Grooms D, 2015, J ORTHOP SPORT PHYS, V45, P381, DOI 10.2519/jospt.2015.5549; Grooms DR, 2017, J ORTHOP SPORT PHYS, V47, P180, DOI 10.2519/jospt.2017.7003; Hagel BE, 2003, AM J EPIDEMIOL, V157, P825, DOI 10.1093/aje/kwg050; Hamilton GM, 2011, AM J EPIDEMIOL, V173, P941, DOI 10.1093/aje/kwq461; Herman DC, 2016, AM J SPORT MED, V44, P2347, DOI 10.1177/0363546516657338; Herman DC, 2015, CURR SPORT MED REP, V14, P194, DOI 10.1249/JSR.0000000000000157; Hosmer DW., 2000, APPL LOGISTIC REGRES; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Needle AR, 2014, SCAND J MED SCI SPOR, V24, P737, DOI 10.1111/sms.12181; Needle AR, 2017, SPORTS MED, V47, P1271, DOI 10.1007/s40279-016-0666-y; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801; Westermann RW, 2016, AM J SPORT MED, V44, P3230, DOI 10.1177/0363546516659290; Wilkerson GB, 2017, J SPORT REHABIL, V26, P26, DOI 10.1123/jsr.2015-0068; Wilkerson GB, 2015, J ATHL TRAINING, V50, P643, DOI 10.4085/1062-6050-50.2.04; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4; Wilkerson GB, 2012, J ATHL TRAINING, V47, P264, DOI 10.4085/1062-6050-47.3.17; Williams JZ, 2017, AM J SPORT MED, V45, P1171, DOI 10.1177/0363546516685317; Zazulak B, 2008, J AM ACAD ORTHOP SUR, V16, P497, DOI 10.5435/00124635-200809000-00002	30	7	7	1	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY	2019	54	5					489	496		10.4085/1062-6050-152-17			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ID7OX	WOS:000471873300004	31084505	Green Published, gold			2022-02-06	
J	Moffitt, JK; Wainwright, DJ; Bartz-Kurycki, M; Wainwright, DJ; Demian, N; Teichgraeber, JF; Greives, MR				Moffitt, Joseph K.; Wainwright, D'Arcy J.; Bartz-Kurycki, Marisa; Wainwright, David J.; Demian, Nagi; Teichgraeber, John F.; Greives, Matthew R.			Factors Associated With Surgical Management for Pediatric Facial Fractures at a Level One Trauma Center	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Craniofacial trauma; maxillofacial trauma; operative management; pediatric facial fractures	INJURIES; PATTERNS; CHILDREN	Pediatric facial fractures present and are managed differently than the adult population. This study describes the pattern and mechanism of facial fractures in children and identifies factors associated with need for surgical management. An IRB-approved retrospective chart analysis of all pediatric patients age <= 18 years diagnosed with facial fractures at our level 1 trauma center over a 10-year period (January 2006-December 2015) was performed. Demographics, fracture location, mechanism of injury, concomitant head and neck injuries, and surgical management were reviewed. Statistical analysis was then performed comparing surgical and nonsurgical cohorts using univariate and multivariate analyses. One thousand two hundred seventy-four patients were diagnosed with facial fractures. Five hundred seventeen (40.6%) underwent surgical management. Two thousand one hundred seventy-two total facial fractures were recorded. Orbit fractures (29%) were the most commonly recorded, observed in 49% of patients presenting. Increased age was associated with increased odds of surgical management (OR 1.13; 95% CI 1.09-1.16). Mandible (OR 9.28; 95% CI 6.88-12.51) and Le Fort fractures (OR 19.73; 95% CI 9.78-39.77) had increased odds of surgical management. Patients with traumatic brain injury had reduced odds (OR 0.54; 95% CI 0.35-0.83) of surgical management for their facial fractures. Older pediatric patients may be more likely to require surgical management of their facial fractures, especially those with mandible or Le Fort fractures. Patients with traumatic brain injury are likely to sustain life threatening injuries, deferring repair of their facial fractures. Patient education and counseling, as well as predictive models, can be improved to reflect these data.	[Moffitt, Joseph K.; Wainwright, D'Arcy J.; Teichgraeber, John F.; Greives, Matthew R.] Univ Texas Hlth Sci Ctr Houston, Div Pediat Plast Surg, McGovern Sch Med, Dept Surg, Houston, TX 77030 USA; [Bartz-Kurycki, Marisa] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, McGovern Sch Med, Dept Surg, Houston, TX 77030 USA; [Wainwright, David J.] Univ Texas Hlth Sci Ctr Houston, Div Plast Surg, McGovern Sch Med, Dept Surg, Houston, TX 77030 USA; [Demian, Nagi] Univ Texas Hlth Sci Ctr Houston, Div Oral Maxillofacial Surg, McGovern Sch Med, Dept Surg, Houston, TX 77030 USA		Greives, MR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Pediat Plast Surg, Dept Pediat Surg, McGovern Sch Med, 6431 Fannin St MSB 5-281, Houston, TX 77030 USA.	Matthew.R.Greives@uth.tmc.edu					[Anonymous], ZIP COD CHAR MEAN ME; Boyette JR, 2014, OTOLARYNG CLIN N AM, V47, P747, DOI 10.1016/j.otc.2014.06.008; Chapman VM, 2009, J COMPUT ASSIST TOMO, V33, P70, DOI 10.1097/RCT.0b013e318169bfdc; CURREY JD, 1975, J BONE JOINT SURG BR, V57, P810; Ferreira PC, 2005, PLAST RECONSTR SURG, V115, P1500, DOI 10.1097/01.PRS.0000160268.20294.FD; Ferreira PC, 2015, J CRANIO MAXILL SURG, V43, P437, DOI 10.1016/j.jcms.2015.01.008; Gassner R, 2004, J ORAL MAXIL SURG, V62, P399, DOI 10.1016/j.joms.2003.05.013; Grunwaldt L, 2011, PLAST RECONSTR SURG, V128, P1263, DOI 10.1097/PRS.0b013e318230c8cf; Hoppe IC, 2014, J CRANIO MAXILL SURG, V42, P1408, DOI 10.1016/j.jcms.2014.04.002; Imahara SD, 2008, J AM COLL SURGEONS, V207, P710, DOI 10.1016/j.jamcollsurg.2008.06.333; Kim DB, 1997, PLAST SURG, V167, P1997; Kim SH, 2012, ARCH PLAST SURG-APS, V39, P606, DOI 10.5999/aps.2012.39.6.606; Marano AA, 2015, CRANIOMAXILLOFAC TRA, V9, P35; Rodriguez-Merchan EC, 2005, CLIN ORTHOP RELAT R, P8, DOI 10.1097/01.blo.0000155377.95940.81; Siy RW, 2011, J CRANIOFAC SURG, V22, P1190, DOI [10.1097/SCS.0b013e31821c0cf9, 10.1097/SCS.0b013e31822eaabc]; Stotland MA, 2011, J CRANIOFAC SURG, V22, P1230, DOI 10.1097/SCS.0b013e31821c0f52; Totonchi A, 2012, J CRANIOFAC SURG, V23, P793, DOI 10.1097/SCS.0b013e31821c0cc7; Vyas RM, 2008, J CRANIOFAC SURG, V19, P339, DOI 10.1097/SCS.0b013e31814fb5e3; Zimmermann CE, 2006, INT J ORAL MAX SURG, V35, P1, DOI 10.1016/j.ijom.2005.06.015	19	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2019	30	3					854	859		10.1097/SCS.0000000000005245			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	HX9JR	WOS:000467724100096	31048613				2022-02-06	
J	Neitzke, G; Rogge, A; Luecking, KM; Boell, B; Burchardi, H; Dannenberg, K; Duttge, G; Dutzmann, J; Erchinger, R; Gretenkort, P; Hartog, C; Jobges, S; Knochel, K; Liebig, M; Meier, S; Michalsen, A; Michels, G; Mohr, M; Nauck, F; Salomon, F; Seidlein, AH; Soffker, G; Stopfkuchen, H; Janssens, U				Neitzke, G.; Rogge, A.; Luecking, K. M.; Boell, B.; Burchardi, H.; Dannenberg, K.; Duttge, G.; Dutzmann, J.; Erchinger, R.; Gretenkort, P.; Hartog, C.; Joebges, S.; Knochel, K.; Liebig, M.; Meier, S.; Michalsen, A.; Michels, G.; Mohr, M.; Nauck, F.; Salomon, F.; Seidlein, A. -H.; Soeffker, G.; Stopfkuchen, H.; Janssens, U.			Decision-making support in Intensive Care to facilitate organ donation. Position paper of the Ethics Section and the Organ Donation and Transplantation Section of the German Interdisciplinary Association of Critical Care and Emergency Medicine (DIVI) in collaboration with the Ethics Section of the German Society of Medical Intensive Care Medicine and Emergency Medicine (DGIIN)	MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN			German	Article						Extent of intensive care treatment; End-of-life care; Organ donation; Organ transplantation; Intensive care medicine		Background and challengeInjuries, especially traumatic brain injury, or specific illnesses and their respective sequelae can result in the demise of the patients afflicted despite all efforts of modern intensive care medicine. If in principle organ donation is an option after apatient's death, intensive therapeutic measures are regularly required in order to maintain the homeostasis of the organs. These measures, however, cannot benefit the patient afflicted anymorewhich in turn might lead to an ethical conflict between dignified palliative care for him/her and expanded intensive treatment to facilitate organ donation for others, especially if the patient has opted for the limitation of life-sustaining therapies in an advance directive.MethodThe Ethics Section and the Organ Donation and Transplantation Section of the German Interdisciplinary Association of Critical Care and Emergency Medicine (DIVI) have convened several meetings and atelephone conference and have arrived at adecision-making aid as to the extent of treatment for potential organ donors. This instrument focusses first on the assessment of five individual dimensions regarding organ donation, namely the certitude of acomplete and irreversible loss of all brain function, the patient's wishes as to organ donation, his or her wishes as to limiting life-sustaining therapies, the intensity of expanded intensive treatment for organ protection and the odds of its successful attainment. Then, the combination of the individual assessments, as graphically shown in a{Netzdiagramm}, will allow for ajudgement as to whether acontinuation or possibly an expansion of intensive care measures is ethically justified, questionable or even inappropriate.ResultThe aid described can help mitigate ethical conflicts as to the extent of intensive care treatment for moribund patients, when organ donation is amedically sound option.NoteGerald Neitzke und Annette Rogge contributed equally to this paper and should be considered co-first authors.	[Neitzke, G.] Hannover Med Sch, Inst Geschichte Eth & Philosophie Med, Hannover, Germany; [Rogge, A.] Univ Klinikum Schleswig Holstein Campus Kiel, Klin Ethikberatung, Kiel, Germany; [Luecking, K. M.] Univ Klinikum Freiburg, Freiburg, Germany; [Boell, B.] Uniklin Koln, Klin Innere Med 1, Cologne, Germany; [Dannenberg, K.] BG Klinikum Bergmannstrost, Med Klin, Halle, Germany; [Duttge, G.] Georg August Univ Gottingen, Abt Strafrechtl Med & Biorecht, Gottingen, Germany; [Dutzmann, J.] Univ Klinikum Halle Saale, Angiol & Internist Intensivmed, Univ Klin & Poliklin Innere Med Kardiol 3, Halle, Germany; [Gretenkort, P.] Helios Klinikum Krefeld, Simulat & Notfallakad, Krefeld, Germany; [Hartog, C.] Klin Bavaria Kreischa, Patienten & Angehorigenzentrierte Versorgung, Kreischa, Germany; [Hartog, C.; Joebges, S.] Charite Univ Med Berlin, Campus Charite Mitte, Klin Anasthesiol Schwerpunkt Operat Intens Med, Berlin, Germany; [Hartog, C.; Joebges, S.] Charite Univ Med Berlin, Campus Virchow Klinikum, Berlin, Germany; [Knochel, K.] Klinikum Univ Munchen, Dr von Haunerschen Kinderspital, Kinderpalliativzentrum Munchen, Kinderklin & Kinderpoliklin, Munich, Germany; [Liebig, M.] Klinikum Gorlitz, Med Klin, Gorlitz, Germany; [Meier, S.] Univ Klinikum Dusseldorf, Klin Anasthesiol, Dusseldorf, Germany; [Michalsen, A.] Klin Tettnang, Klin Anasthesiol Intens Med Notfallmed & Schmerzt, Tettnang, Germany; [Michels, G.] Uniklin Koln, Klin Innere Med 3, Cologne, Germany; [Mohr, M.] Ev Diakonie Krankenhaus, Klin Anasthesiol & Intens Med, Bremen, Germany; [Nauck, F.] Univ Med Gottingen, Klin Palliat Med, Gottingen, Germany; [Seidlein, A. -H.] Univ Med Greifswald, Inst Eth & Geschichte Med, Greifswald, Germany; [Soeffker, G.] Univ Klinikum Hamburg Eppendorf, Zentrum Intens Med, Hamburg, Germany; [Janssens, U.] St Antonius Hosp, Klin Innere Med & Internist Intens Med, Dechant Deckers Str 8, D-52249 Eschweiler, Germany		Janssens, U (corresponding author), St Antonius Hosp, Klin Innere Med & Internist Intens Med, Dechant Deckers Str 8, D-52249 Eschweiler, Germany.	uwe.janssens@sah-eschweiler.de		Hartog, Christiane/0000-0003-1098-9775; Jobges, Susanne/0000-0002-9509-8631			[Anonymous], 2013, DTSCH ARZTEBL, V113, pS29; Ave ALD, 2016, TRANSPL INT, V29, P12, DOI 10.1111/tri.12623; Bundesarztekammer, 2011, DTSCH ARZTEBL, V108, pA346; Castleberry AW, 2013, AM J RESP CRIT CARE, V188, P466, DOI 10.1164/rccm.201303-0588OC; Duttge G, 2015, DIVI, V6, P144; Essien EOI, 2017, WORLD J SURG, V41, P2933, DOI 10.1007/s00268-017-4089-1; Hahnenkamp K, 2016, DIVI, V7, P10; Hahnenkamp K, 2016, DTSCH ARZTEBL INT, V113, P552, DOI 10.3238/arztebl.2016.0552; Janssens U, 2012, DIVI, V3, P103; Maria O, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13230; Salim A, 2005, J TRAUMA, V58, P991, DOI 10.1097/01.TA.0000168708.78049.32	11	7	7	1	10	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2193-6218	2193-6226		MED KLIN-INTENSIVMED	Med. Klin.-Intensivmed Notfallmed.	MAY	2019	114	4					319	326		10.1007/s00063-019-0578-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HX5XD	WOS:000467477000008	30976838				2022-02-06	
J	Orlando, A; Levy, AS; Rubin, BA; Tanner, A; Carrick, MM; Lieser, M; Hamilton, D; Mains, CW; Bar-Or, D				Orlando, Alessandro; Levy, A. Stewart; Rubin, Benjamin A.; Tanner, Allen; Carrick, Matthew M.; Lieser, Mark; Hamilton, David; Mains, Charles W.; Bar-Or, David			Isolated subdural hematomas in mild traumatic brain injury. Part 1: the association between radiographic characteristics and neurosurgical intervention	JOURNAL OF NEUROSURGERY			English	Article						neurosurgical intervention; neurosurgery; mild; traumatic brain injury; subdural hematoma; epidemiology	CT HEAD RULE; INTRACRANIAL LESIONS; COMPUTED-TOMOGRAPHY; CARE; PREDICTORS; ADMISSION; MODELS	OBJECTIVE Isolated subdural hematomas (iSDHs) are one of the most common intracranial hemorrhage (ICH) types in the population with mild traumatic brain injury (mTBI; Glasgow Coma Scale score 13-15), account for 66%-75% of all neurosurgical procedures, and have one of the highest neurosurgical intervention rates. The objective of this study was to examine how quantitative hemorrhage characteristics of iSDHs in patients with mTBI at admission are associated with subsequent neurosurgical intervention. METHODS This was a 3.5-year, retrospective observational cohort study at a Level I trauma center. All adult trauma patients with mTBI and iSDHs were included in the study. Maximum length and thickness (in mm) of acute SDHs, the presence of acute-on-chronic SDH, mass effect, and other hemorrhage-related variables were double-data entered; discrepant results were adjudicated after a maximum of 4 reviews. Patients with coagulopathy, skull fractures, no acute hemorrhage, a non-SDH ICH, or who did not undergo imaging on admission were excluded. The primary outcome was neurosurgical intervention (craniotomy, burr hole, catheter drainage of SDH, placement of intracranial pressure monitor, shunt, or ventriculostomy). Multivariate stepwise logistic regression was used to identify significant covariates and to assess interactions. RESULTS A total of 176 patients were included in our study: 28 patients did and 148 patients did not receive a neurosurgical intervention. Increasing head Abbreviated Injury Scale score was significantly associated with neurosurgical interventions. There was a strong correlation between the first 3 reviews on maximum hemorrhage length (R-2 = 0.82) and maximum hemorrhage thickness (R-2 = 0.80). The neurosurgical intervention group had a mean maximum SDH length and thickness that were 61 mm longer and 13 mm thicker than those of the nonneurosurgical intervention group (p < 0.001 for both). After adjusting for the presence of an acute-on-chronic hemorrhage, for every 1-mm increase in the thickness of an iSDH, the odds of a neurosurgical intervention increase by 32% (95% CI 1.16-1.50). There were no interventions for any SDH with a maximum thickness <= 5 mm on initial presenting scan. CONCLUSIONS This is the first study to quantify the odds of a neurosurgical intervention based on hemorrhage characteristics in patients with an iSDH and mTBI. Once validated in a second population, these data can be used to better inform patients and families of the risk of future neurosurgical intervention, and to evaluate the necessity of interhospital transfers.	[Orlando, Alessandro; Bar-Or, David] Swedish Med Ctr, Trauma Res Dept, Englewood, CO 80110 USA; [Rubin, Benjamin A.] Swedish Med Ctr, Dept Neurosurg, Englewood, CO 80110 USA; [Levy, A. Stewart] St Anthony Hosp, Dept Neurosurg, Lakewood, CO USA; [Orlando, Alessandro; Mains, Charles W.; Bar-Or, David] St Anthony Hosp, Trauma Res Dept, Lakewood, CO USA; [Orlando, Alessandro; Carrick, Matthew M.; Bar-Or, David] Med City Plano, Trauma Res Dept, Plano, TX USA; [Orlando, Alessandro; Tanner, Allen; Hamilton, David; Bar-Or, David] Penrose Community Hosp, Trauma Res Dept, Colorado Springs, CO USA; [Lieser, Mark] Res Med Ctr, Trauma Serv Dept, Kansas City, MO USA; [Bar-Or, David] Rocky Vista Univ, Coll Osteopath Med, Parker, CO USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Englewood, CO 80110 USA.	dbaror@ampiopharma.com	Bar-Or, David/AAE-9328-2020				Barker DE, 2006, AM SURGEON, V72, P1166; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Ditty BJ, 2015, J NEUROSURG, V123, P649, DOI 10.3171/2014.10.JNS132713; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Faul M, 2010, TRAUMATIC BRAIN INJU; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Orlando A, 2017, WORLD NEUROSURG, V107, P94, DOI [10.1016/j.wneu.2017.07.130, 10.1016/J.WNEU.2017.07.130]; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Shih FY, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0069-2; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Svennerholm L, 1997, ACTA NEUROPATHOL, V94, P345, DOI 10.1007/s004010050717; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Weinberg AM, 2010, EUR J TRAUMA EMERG S, V36, P318, DOI 10.1007/s00068-010-1120-8; Wu C, 2012, J TRAUMA ACUTE CARE, V73, P1247, DOI 10.1097/TA.0b013e318265d24e; 2006, J CLIN EPIDEMIOL, V59, P132, DOI DOI 10.1016/J.JCLINEPI.2005.06.009; 2006, J TRAUMA, V61, P862, DOI DOI 10.1097/01.TA.0000224225.54982.90; 2015, BRAIN INJURY, V29, P11, DOI DOI 10.3109/02699052.2014.945959	36	7	7	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2019	130	5					1616	1625		10.3171/2018.1.JNS171884			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HW0VW	WOS:000466401100025	29905513	Bronze			2022-02-06	
J	Russell, ER; Stewart, K; Mackay, DF; MacLean, J; Pell, JP; Stewart, W				Russell, Emma R.; Stewart, Katy; Mackay, Daniel F.; MacLean, John; Pell, Jill P.; Stewart, William			Football's InfluencE on Lifelong health and Dementia risk (FIELD): protocol for a retrospective cohort study of former professional footballers	BMJ OPEN			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; SCOTTISH MILITARY VETERANS; PHYSICAL-ACTIVITY; CONSEQUENCE; ASSOCIATION; CONCUSSION	Introduction In the past decade, evidence has emerged suggesting a potential link between contact sport participation and increased risk of late neurodegenerative disease, in particular chronic traumatic encephalopathy. While there remains a lack of clear evidence to test the hypothesis that contact sport participation is linked to an increased incidence of dementia, there is growing public concern regarding the risk. There is, therefore, a pressing need for research to gain greater understanding of the potential risks involved in contact sports participation, and to contextualise these within holistic health benefits of sport. Methods and analysis Football's InfluencE on Lifelong health and Dementia risk is designed as a retrospective cohort study, with the aim to analyse data from former professional footballers (FPF) in order to assess the incidence of neurodegenerative disease in this population. Comprehensive electronic medical and death records will be analysed and compared with those of a demographically matched population control cohort. As well as neurodegenerative disease incidence, all-cause, and disease-specific mortality, will be analysed in order to assess lifelong health. Cox proportional hazards models will be run to compare the data collected from FPFs to matched population controls. Ethics and dissemination Approvals for study have been obtained from the University of Glasgow College of Medical, Veterinary and Life Sciences Research Ethics Committee (Project Number 200160147) and from National Health Service Scotland's Public Benefits and Privacy Panel (Application 1718-0120).	[Russell, Emma R.; Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Glasgow Brain Injury Res Grp, Glasgow, Lanark, Scotland; [Stewart, Katy; MacLean, John] Univ Glasgow, Inst Cardiovasc & Med Sci, Sport & Exercise Med, Glasgow, Lanark, Scotland; [Stewart, Katy; MacLean, John] Hampden Sports Clin, Hampden Stadium, Glasgow, Lanark, Scotland; [Mackay, Daniel F.; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Publ Hlth, Glasgow, Lanark, Scotland; [Stewart, William] Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow, Lanark, Scotland		Stewart, W (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow Brain Injury Res Grp, Glasgow, Lanark, Scotland.; Stewart, W (corresponding author), Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow, Lanark, Scotland.	william.stewart@glasgow.ac.uk		Stewart, William/0000-0003-2199-2582	Football Association; Professional Footballers' Association; NHS Research Scotland Career Researcher Fellowship	This study is supported by funding from The Football Association and Professional Footballers' Association and an NHS Research Scotland Career Researcher Fellowship (W Stewart).	Bergman BP, 2017, CANCER EPIDEMIOL, V47, P100, DOI 10.1016/j.canep.2017.02.001; Bergman BP, 2015, OCCUP ENVIRON MED, V72, P877, DOI 10.1136/oemed-2015-103066; Bergman BP, 2014, AM J EPIDEMIOL, V179, P1434, DOI 10.1093/aje/kwu082; Centers for Disease Control and Prevention, PHYS ACTIVITY; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harvey RJ, 2003, J NEUROL NEUROSUR PS, V74, P1206, DOI 10.1136/jnnp.74.9.1206; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Jones SAV, 2014, BRIT J SPORT MED, V48, P159, DOI 10.1136/bjsports-2013-092758; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; McMillan TM, 2017, J NEUROL NEUROSUR PS, P88; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Rutherford A, 2019, BRIT J SPORT MED, P53; Smith DH, 2016, LANCET NEUROL, V15, P662, DOI 10.1016/S1474-4422(16)30037-0; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wittenberg R, 2014, IGARSS 2014	22	7	7	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAY	2019	9	5							e028654	10.1136/bmjopen-2018-028654			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IC7YG	WOS:000471192800369	31123003	gold, Green Published, Green Accepted			2022-02-06	
J	Shura, RD; Nazem, S; Miskey, HM; Hostetter, TA; Rowland, JA; Brenner, LA; Taber, KH; Brancu, M; Beckham, JC; Calhoun, PS; Dedert, E; Elbogen, EB; Fairbank, JA; Green, KT; Hurley, RA; Kilts, JD; Kimbrel, NA; Kirby, A; Marx, CE; McCarthy, G; McDonald, SD; Moore, SD; Morey, RA; Naylor, JC; Pickett, TC; Runnals, JJ; Swinkels, C; Szabo, ST; Tupler, LA; Van Voorhees, EE; Wagner, HR; Weiner, RD; Yoash-Gantz, RE				Shura, Robert D.; Nazem, Sarra; Miskey, Holly M.; Hostetter, Trisha A.; Rowland, Jared A.; Brenner, Lisa A.; Taber, Katherine H.; Brancu, Mira; Beckham, Jean C.; Calhoun, Patrick S.; Dedert, Eric; Elbogen, Eric B.; Fairbank, John A.; Green, Kimberly T.; Hurley, Robin A.; Kilts, Jason D.; Kimbrel, Nathan A.; Kirby, Angela; Marx, Christine E.; McCarthy, Gregory; McDonald, Scott D.; Moore, Scott D.; Morey, Rajendra A.; Naylor, Jennifer C.; Pickett, Treven C.; Runnals, Jennifer J.; Swinkels, Cindy; Szabo, Steven T.; Tupler, Larry A.; Van Voorhees, Elizabeth E.; Wagner, H. Ryan; Weiner, Richard D.; Yoash-Gantz, Ruth E.		VA Mid-Atlantic MIRECC Workgrp	Relationship Between Traumatic Brain Injury History and Recent Suicidal Ideation in Iraq/Afghanistan-Era Veterans	PSYCHOLOGICAL SERVICES			English	Article						veteran; suicidal ideation; traumatic brain injury; depression; sleep	POSTTRAUMATIC-STRESS-DISORDER; OPERATION ENDURING FREEDOM; AFGHANISTAN VETERANS; RISK-FACTORS; US MILITARY; ACTIVE-DUTY; IRAQ; HEALTH; DEPLOYMENT; RUMINATION	This study evaluated whether a history of traumatic brain injury (TBI) was associated with increased risk for recent suicidal ideation (SI) after accounting for demographics, depression, posttraumatic stress disorder (PTSD), and sleep quality. In terms of increased risk, we hypothesized that a history of lifetime TBI would be associated with increased recent SI when compared with no history of TBI; multiple injuries were also evaluated. The sample included Iraq and Afghanistan war-era veterans (n = 838) who served in the United States military since 9/2001 and completed a structured TBI interview. Approximately 50% reported a lifetime history of at least 1 TBI, and 17.9% met criteria for current major depressive disorder (MDD). SI over the past week per the Beck Scale for Suicide Ideation was the primary outcome. Demographics, current MDD and posttraumatic stress disorder (PTSD) per Structured Clinical Interview of DSM-IV Axis I Disorders, sleep quality per Pittsburgh Sleep Quality Index, and TBI history per structured interview were included in all statistical models. Current depression and poor sleep quality were consistently associated with recent SI. A history of any TBI history across the life span was not associated with increased recent SI (OR = 1.35, 95% CI [0.83, 2.19]). However, a history of multiple TBIs compared with no history of TBI was associated with increased recent SI (OR = 1.76, 95% CI [1.01, 3.06]). Results support the assertion than an accumulation of injuries amplifies risk. Severity of injury and deployment injuries were not significant factors. Among those with a history of 1 TBI, sleep, and depression, which may also be injury sequelae, may be salient treatment targets.	[Shura, Robert D.; Miskey, Holly M.; Rowland, Jared A.; Taber, Katherine H.] VA Midatlant Mental Illness Res Educ & Clin Ctr, Salisbury, NC USA; [Shura, Robert D.; Miskey, Holly M.; Rowland, Jared A.; Taber, Katherine H.] WG Bill Hefner Vet Affairs Med Ctr, Salisbury, NC USA; [Shura, Robert D.; Miskey, Holly M.] Wake Forest Sch Med, Dept Psychiat & Behav Med, Winston Salem, NC USA; [Nazem, Sarra; Hostetter, Trisha A.; Brenner, Lisa A.] VA Rocky Mt Mental Illness Res Educ & Clin Ctr, Denver, CO USA; [Nazem, Sarra] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Boulder, CO 80309 USA; [Nazem, Sarra] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Boulder, CO 80309 USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Psychiat, Winston Salem, NC USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Behav Med, Winston Salem, NC USA; [Brenner, Lisa A.] Univ Colorado, Dept Phys Med & Rehabil, Boulder, CO 80309 USA; [Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Boulder, CO 80309 USA; [Brenner, Lisa A.] Univ Colorado, Dept Neurol, Boulder, CO 80309 USA; [Taber, Katherine H.] Via Coll Osteopath Med, Div Biol Sci, Auburn, AL USA		Shura, RD (corresponding author), Hefner VAMC, 11M-2 MH-BS,1601 Brenner Ave, Salisbury, NC 28144 USA.	Robert.Shura2@va.gov	Fairbank, John/F-8972-2013; Brenner, Lisa A./AAG-2442-2019; Rowland, Jared A./AAN-3030-2021	Fairbank, John/0000-0003-2604-7256; Rowland, Jared A./0000-0002-3655-3411; Miskey, Holly/0000-0002-5139-4586; Shura, Robert/0000-0002-9505-0080	W.G. Bill" Hefner Veterans Affairs Medical Center; Mid-Atlantic Mental Illness Research Education and Clinical Center; Rocky Mountain Mental Illness Research, Education and Clinical Center; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment - Department of Veterans Affairs Clinical Science Research and Development Career Development Award [IK2CX000718]; Department of Veterans Affairs Clinical Science Research and Development Career Development Award [IK2CX000525]; Department of Veterans Affairs Rehabilitation Research and Development Career Development AwardUS Department of Veterans Affairs [1K2RX001298]	This research was supported by resources of the W.G. "Bill" Hefner Veterans Affairs Medical Center, the Mid-Atlantic Mental Illness Research Education and Clinical Center, the Rocky Mountain Mental Illness Research, Education and Clinical Center, and the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment. The prospective studies from which these data were drawn were reviewed and approved by Institutional Review Boards at all Mid-Atlantic MIRECC sites. Additionally, the Colorado Multiple IRB reviewed and approved the project analytics. The welfare and privacy of human subjects was protected and maintained. We wish to acknowledge Jeri Forster, Beeta Homaifar, and Ruth Yoash-Gantz for their contributions to this project.; The Mid-Atlantic MIRECC Workgroup contributors for this article include: Mira Brancu, Jean C. Beckham, Patrick S. Calhoun, Eric Dedert, Eric B. Elbogen, John A. Fairbank, Kimberly T. Green, Robin A. Hurley, Jason D. Kilts, Nathan A. Kimbrel, Angela Kirby, Christine E. Marx, Gregory McCarthy, Scott D. McDonald, Scott D. Moore, Rajendra A. Morey, Jennifer C. Naylor, Treven C. Pickett, Jared A. Rowland, Jennifer J. Runnals, Cindy Swinkels, Steven T. Szabo, Katherine H. Taber, Larry A. Tupler, Elizabeth E. Van Voorhees, H. Ryan Wagner, Richard D. Weiner, and Ruth E. Yoash-Gantz. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, the Department of Defense, or the U.S. government. Eric Dedert is funded by a Department of Veterans Affairs Clinical Science Research and Development Career Development Award (IK2CX000718). Nathan A. Kimbrel is funded by a Department of Veterans Affairs Clinical Science Research and Development Career Development Award (IK2CX000525). Scott D. McDonald is funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (1IK2RX000703-01). Jennifer C. Naylor is funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (1lK2RX000908). Elizabeth E. Van Voorhees is funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (1K2RX001298).	Armistead-Jehle P, 2017, PHYS MED REH CLIN N, V28, P323, DOI 10.1016/j.pmr.2016.12.008; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Beck AT., 1991, BECK SCALE SUICIDE I; Borders A, 2015, PSYCHOL TRAUMA-US, V7, P76, DOI 10.1037/a0036937; Brancu M, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1570; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Committee on the Assessment of the Readjustment Needs of Military Personnel Veterans and Their Families; Board on the Health of Select Populations; Institute of Medicine, 2013, RET HOM IR AFGH ASS; DeBeer BB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167464; Defense and Veterans Brain Injury Center, 2016, DOD WORLDW TBI NUMB; Eaton KM, 2006, SUICIDE LIFE-THREAT, V36, P182, DOI 10.1521/suli.2006.36.2.182; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; First M., 1997, STRUCTURED CLIN INTE; Gibbons RD, 2012, AM J PUBLIC HEALTH, V102, pS17, DOI 10.2105/AJPH.2011.300491; Gradus JL, 2015, J TRAUMA STRESS, V28, P361, DOI 10.1002/jts.22021; Huang XYN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180793; Kang HK, 2015, ANN EPIDEMIOL, V25, P96, DOI 10.1016/j.annepidem.2014.11.020; Lewis VM, 2017, J AFFECT DISORDERS, V208, P662, DOI 10.1016/j.jad.2016.08.038; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; LONDON AS, 2014, J SOCIOL SOC WELFARE, V41, P49; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miranda R, 2007, BEHAV RES THER, V45, P3088, DOI 10.1016/j.brat.2007.07.015; Miranda R, 2013, COGNITIVE THER RES, V37, P786, DOI 10.1007/s10608-013-9524-5; Orman JA, 2011, TXB TRAUMATIC BRAIN, V2nd, P3; Pigeon Wilfred R, 2012, J Clin Psychiatry, V73, pe1160, DOI 10.4088/JCP.11r07586; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; Richard YF, 2015, AM J EPIDEMIOL, V182, P177, DOI 10.1093/aje/kwv014; Sampson RobertJ., 1997, DEV THEORIES CRIME D, P133; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; The Management of Concussion/ mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Ursano RJ, 2016, JAMA PSYCHIAT, V73, P741, DOI 10.1001/jamapsychiatry.2016.0600; Vanderploeg RD, 2015, ARCH SUICIDE RES, V19, P453, DOI 10.1080/13811118.2014.957454; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wisco BE, 2014, J CLIN PSYCHIAT, V75, P1338, DOI 10.4088/JCP.14m09328; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900	39	7	7	2	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	MAY	2019	16	2			SI		312	320		10.1037/ser0000208			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	HW6BL	WOS:000466773000020	30382745				2022-02-06	
J	Hanas, JS; Hocker, JRS; Lerner, MR; Couch, JR				Hanas, Jay S.; Hocker, James R. S.; Lerner, Megan R.; Couch, James R.			Distinguishing and phenotype monitoring of traumatic brain injury and post-concussion syndrome including chronic migraine in serum of Iraq and Afghanistan war veterans	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; NATURAL-HISTORY; HEADACHE; BLOOD; AUTOPHAGY; DEPRESSION; BARRIER; CANCER	Traumatic Brain Injury (TBI) and persistent post-concussion syndrome (PCS) including chronic migraine (CM) are major health issues for civilians and the military. It is important to understand underlying biochemical mechanisms of these conditions, and be able to monitor them in an accurate and minimally invasive manner. This study describes the initial use of a novel serum analytical platform to help distinguish TBI patients, including those with post-traumatic headache (PTH), and to help identify phenotypes at play in these disorders. The hypothesis is that physiological responses to disease states like TBI and PTH and related bodily stresses are reflected in biomolecules in the blood in disease-specific manner. Leave one out (serum sample) cross validations (LOOCV) and sample randomizations were utilized to distinguished serum samples from the following TBI patient groups: TBI + PTSD + CM + severe depression (TBI "most affected" group) vs healthy controls, TBI "most affected" vs TBI, TBI vs controls, TBI + CM vs controls, and TBI + CM vs TBI. Inter-group discriminatory p values were <= 10(-10), and sample group randomizations resulted in p non-significant values. Peptide/protein identifications of discriminatory mass peaks from the TBI "most affected" vs controls and from the TBI plus vs TBI minus CM groups yielded information of the cellular/molecular effects of these disorders (immune responses, amyloidosis/Alzheimer's disease/dementia, neuronal development). More specific biochemical disease effects appear to involve blood brain barrier, depression, migraine headache, autoimmunity, and autophagy pathways. This study demonstrated the ability for the first time of a novel, accurate, biomarker platform to monitor these conditions in serum, and help identify biochemical relationships leading to better understanding of these disorders and to potential therapeutic approaches.	[Hanas, Jay S.; Hocker, James R. S.] Univ Oklahoma, Coll Med, Dept Biochem, Oklahoma City, OK 73190 USA; [Hanas, Jay S.; Lerner, Megan R.] Univ Oklahoma, Coll Med, Dept Surg, Oklahoma City, OK 73190 USA; [Hanas, Jay S.] Vet Adm Hosp, Oklahoma City, OK 73104 USA; [Couch, James R.] Univ Oklahoma, Coll Med, Dept Neurol, Oklahoma City, OK 73190 USA; [Couch, James R.] Vet Adm Hosp, Dept Neurol, Oklahoma City, OK USA		Hanas, JS (corresponding author), Univ Oklahoma, Coll Med, Dept Biochem, Oklahoma City, OK 73190 USA.; Hanas, JS (corresponding author), Univ Oklahoma, Coll Med, Dept Surg, Oklahoma City, OK 73190 USA.; Hanas, JS (corresponding author), Vet Adm Hosp, Oklahoma City, OK 73104 USA.	jay-hanas@ouhsc.edu	Hocker, James Randolph Sanders/AAV-4893-2020; Hocker, James R.S./G-7217-2018	Hocker, James Randolph Sanders/0000-0002-7111-9119; Hocker, James R.S./0000-0002-7111-9119	Department of DefenseUnited States Department of Defense [W81XWH-16-1-0295]; Veterans Administration Research and Education Fund [829-VREF]	This study was supported by a grant from the Department of Defense (W81XWH-16-1-0295, to JRC and JSH), and the Veterans Administration Research and Education Fund (829-VREF, to JSH and JRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2015, CEPHALALGIA, V35, P563, DOI 10.1177/0333102414552532; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; Araki Y, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/2608605; Ayoglu B, 2016, P NATL ACAD SCI USA, V113, P2188, DOI 10.1073/pnas.1518553113; Baker Stuart G, 2002, BMC Med Res Methodol, V2, P4, DOI 10.1186/1471-2288-2-4; Barton A, 2009, HUM MOL GENET, V18, P2518, DOI 10.1093/hmg/ddp177; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Ceylan M, 2016, CEPHALALGIA, V36, P518, DOI 10.1177/0333102415598757; Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856; Chuang TY, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0343-2; Cohen J., 1988, PERCEPT MOT SKILLS, V67, P1007; Couch JR, 2016, HEADACHE, V56, P1004, DOI 10.1111/head.12837; Dickinson JD, 2018, REDOX BIOL, V14, P272, DOI 10.1016/j.redox.2017.09.013; Guan W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-259; Hek K, 2010, HUM MOL GENET, V19, P731, DOI 10.1093/hmg/ddp529; Hocker JR, 2017, CANCER INVEST, V35, P573, DOI 10.1080/07357907.2017.1373120; Hocker JR, 2015, CANCER LETT, V359, P314, DOI 10.1016/j.canlet.2015.01.035; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P2179; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kim TS, 2010, DIS MODEL MECH, V3, P752, DOI 10.1242/dmm.004689; Kobrosly R, 2010, NEUROTOXICOLOGY, V31, P126, DOI 10.1016/j.neuro.2009.10.005; Kozler P, 2015, PHYSIOL RES, V64, pS603, DOI 10.33549/physiolres.933220; Kulikova E, 2017, CURR PROTEIN PEPT SC, V18, P1152, DOI 10.2174/1389203718666170710121532; Kuramoto T, 2001, P NATL ACAD SCI USA, V98, P559, DOI 10.1073/pnas.98.2.559; Lahiri A, 2015, P NATL ACAD SCI USA, V112, P10461, DOI 10.1073/pnas.1501752112; Lee JH, 2016, PSYCHOPHARMACOLOGY, V233, P591, DOI 10.1007/s00213-015-4131-7; Li J, 2015, NEUROSCI LETT, V606, P167, DOI 10.1016/j.neulet.2015.08.038; Li Q, 2018, J POLLUTION, V1, P2, DOI DOI 10.1088/2053-1591/aae227; Liu CC, 2017, J NEUROSCI, V37, P4023, DOI 10.1523/JNEUROSCI.3442-16.2017; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Maher BH, 2013, GENE, V528, P343, DOI 10.1016/j.gene.2013.07.030; Mbarek H, 2017, TWIN RES HUM GENET, V20, P267, DOI 10.1017/thg.2017.30; Megiorni F, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-88; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; Natoli JL, 2010, CEPHALALGIA, V30, P599, DOI 10.1111/j.1468-2982.2009.01941.x; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Ogawa M, 2011, CELL HOST MICROBE, V9, P376, DOI 10.1016/j.chom.2011.04.010; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; Ramon C, 2017, CURR OPIN NEUROL, V30, P281, DOI 10.1097/WCO.0000000000000440; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Rao AS, 2015, HEADACHE, V55, P1323, DOI 10.1111/head.12698; Rist PM, 2013, CEPHALALGIA, V33, P1017, DOI 10.1177/0333102413483930; Rubino E, 2013, J HEADACHE PAIN, V14; Sahyouni Ronald, 2017, J Concussion, V1, DOI 10.1177/2059700216684518; Schurks M, 2012, J HEADACHE PAIN, V13, P1, DOI 10.1007/s10194-011-0399-0; Seripa D, 2008, J ALZHEIMERS DIS, V14, P335; Shibata N, 2007, J GERONTOL A-BIOL, V62, P350, DOI 10.1093/gerona/62.4.350; Sokolov AY, 2011, NEUROCHEM J+, V5, P92, DOI 10.1134/S1819712411020085; Song H, 2018, JAMA, V319; Soper D., 2018, POSTHOC STAT POWER C; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Starokadomskyy P, 2016, NAT IMMUNOL, V17, P495, DOI 10.1038/ni.3409; Suidan GL, 2013, ARTERIOSCL THROM VAS, V33, P2112, DOI 10.1161/ATVBAHA.113.301362; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Tian Y, 2013, P NATL ACAD SCI USA, V110, P17071, DOI 10.1073/pnas.1315110110; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Vachani A, 2015, J THORAC ONCOL, V10, P629, DOI 10.1097/JTO.0000000000000447; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Weiss LA, 2004, EUR J HUM GENET, V12, P949, DOI 10.1038/sj.ejhg.5201239; Wu DJ, 2017, CLIN IMMUNOL, V176, P55, DOI 10.1016/j.clim.2017.01.007; Zhao YH, 2016, REV NEUROSCIENCE, V27, P623, DOI 10.1515/revneuro-2015-0069; Zhou J, 2014, GENET MOL RES, V13, P4320, DOI 10.4238/2014.June.9.18; 2002, SCIENCE, V295, P2442, DOI DOI 10.1126/SCIENCE.1069989	71	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2019	14	4							e0215762	10.1371/journal.pone.0215762			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HV2UQ	WOS:000465846200018	31026304	Green Submitted, gold, Green Published			2022-02-06	
J	Russell, K; Selci, E; Black, B; Cochrane, K; Ellis, M				Russell, Kelly; Selci, Erin; Black, Brian; Cochrane, Karis; Ellis, Michael			Academic outcomes following adolescent sport-related concussion or fracture injury: A prospective cohort study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; CHILDREN; SCHOOL; SYMPTOMS; RETURN	Objectives The objectives were 1) to compare the effects of adolescent sport-related concussion (SRC) and sport-related extremity fracture (SRF) on academic outcomes including change in school grades and school attendance; and 2) to determine which specific academic accommodations were most helpful during recovery from these injuries. Methods A prospective cohort study was conducted to compare changes in school grades, school attendance and academic accommodations among students (grades 8-12) with an SRC or SRF. School grades were extracted from student immediate pre- and post-injury report cards. Students completed attendance log books and an exit interview to determine which accommodations were helpful and how accommodating they perceived their school to be during their recovery. Results Overall, 124 students (92 with SRC and 32 with SRF) submitted both pre- and post-injury report cards. Students who sustained an SRC or SRF experienced similar decreases in grades post-injury (SRC: -1.0%; 95% CI: -2.1, 0.1 and SRF: -0.9%: 95% CI: -2.1, 0.3). Students with an SRC missed significantly more days of school compared to those with an SRF (median of 4 days [IQR: 1, 7] versus 1 day [IQR: 0, 4], p<0.0001). In total, 60/113 (53.1%) SRC students reported their school to be very accommodating while only 31/77 (40.3%) SRF students reported their school to be very accommodating (p = 0.082). Conclusions Students who sustain an SRC miss significantly more days of school but demonstrate similar changes in school grades post-injury compared to those with an SRF. Future studies are needed to identify the pre- and post-injury factors associated with poor academic functioning following concussion and identify measures that can be taken to help optimize academic outcomes in these patients.	[Russell, Kelly; Selci, Erin; Cochrane, Karis; Ellis, Michael] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Russell, Kelly; Selci, Erin; Cochrane, Karis; Ellis, Michael] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Russell, Kelly; Ellis, Michael] Canada North Concuss Network, Winnipeg, MB, Canada; [Black, Brian; Ellis, Michael] Univ Manitoba, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Black, Brian; Ellis, Michael] Pan Am Concuss Program, Winnipeg, MB, Canada		Russell, K (corresponding author), Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada.; Russell, K (corresponding author), Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada.; Russell, K (corresponding author), Canada North Concuss Network, Winnipeg, MB, Canada.	krussell@chrim.ca		Russell, Kelly/0000-0002-9159-9201	Research Manitoba	Dr Russell received an Establishment Grant from The Manitoba Health Research Council (now Research Manitoba) and this funding was used to support this study; however, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; Grady MF, 2017, PEDIATR ANN, V46, pE93, DOI 10.3928/19382359-20170220-04; Grubenhoff JA, 2015, BRAIN INJURY, P1; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hendrickson P, 2014, BRAIN INJURY, V28, P721; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makki Ali Y, 2016, Glob Pediatr Health, V3, p2333794X16630493, DOI 10.1177/2333794X16630493; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Purcell LK, 2014, PAED CHILD HEALT-CAN, V19, P153, DOI 10.1093/pch/19.3.153; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rozbacher A, 2017, J NEUROTRAUM, V34, P2195, DOI 10.1089/neu.2016.4765; Russell K, 2017, CONCUSSION, V2; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	27	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2019	14	4							e0215900	10.1371/journal.pone.0215900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU8EY	WOS:000465519100064	31022262	gold, Green Submitted, Green Published			2022-02-06	
J	Kaye, S; Sundman, MH; Hall, EE; Williams, E; Patel, K; Ketcham, CJ				Kaye, Sarah; Sundman, Mark H.; Hall, Eric E.; Williams, Ethan; Patel, Kirtida; Ketcham, Caroline J.			Baseline Neurocognitive Performance and Symptoms in Those With Attention Deficit Hyperactivity Disorders and History of Concussion With Previous Loss of Consciousness	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; concussion management; pre-existing conditions; ADHD; LOC	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; ADHD; IMPACT; STATEMENT; SCORES; SPORT	Previous consensus statements on sports concussion have highlighted the importance of Attention Deficit Hyperactivity Disorder (ADHD) and loss of consciousness (LOC) as risk factors related to concussion management. The present study investigated how self-reported history of either ADHD diagnosis or history of previous concussion resulting in LOC influence baseline neurocognitive performance and self-reported symptoms. This analysis was performed retrospectively on data collected primarily from student-athletes, both Division 1 and club sports athletes. The dataset (n = 1460) is comprised of college students (age = 19.1 +/- 1.4 years). Significant differences were found for composite scores on the ImPACT for both history of concussion (p = 0.016) and ADHD (p = 0.014). For concussion history, those with a previous concussion, non-LOC, performed better on the visual motor speed (p = 0.004). Those with diagnosis of ADHD performed worse on verbal memory (p = 0.001) and visual motor speed (p = 0.033). For total symptoms, concussion history (p < 0.001) and ADHD (p = 0.001) had an influence on total symptoms. Those with ADHD reported more symptoms for concussion history; those with previous LOC concussion reported more symptoms than those with non-LOC concussion (p = 0.003) and no history (p < 0.001). These results highlight the importance of baseline measures of neurocognitive function and symptoms in concussion management in order to account for pre-existing conditions such as ADHD and LOC from previous concussion that could influence these measures.	[Kaye, Sarah] McLean Hosp, Mailman Res Ctr, Belmont, MA 02178 USA; [Sundman, Mark H.] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; [Hall, Eric E.; Ketcham, Caroline J.] Elon Univ, Dept Exercise Sci, Elon, NC 27244 USA; [Williams, Ethan] Elon Univ, Off Dean Students, Eon, NC USA; [Patel, Kirtida] Elon Univ, Dept Sports Med, Eon, NC USA		Hall, EE (corresponding author), Elon Univ, Dept Exercise Sci, Elon, NC 27244 USA.	ehall@elon.edu		Ketcham, Caroline/0000-0002-6713-130X			Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Chuang TC, 2013, PSYCHIAT RES-NEUROIM, V211, P186, DOI 10.1016/j.pscychresns.2012.11.008; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Danielson ML, 2018, J PEDIATR-US, V192, P240, DOI 10.1016/j.jpeds.2017.08.040; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Gardner RM, 2017, PHYSICIAN SPORTSMED, V45, P1, DOI 10.1080/00913847.2017.1248221; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; Nagel BJ, 2011, J AM ACAD CHILD PSY, V50, P283, DOI 10.1016/j.jaac.2010.12.003; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Poysophon P, 2018, SPORTS HEALTH, V10, P317, DOI 10.1177/1941738117751387; Quinlan Donald M, 2003, J Atten Disord, V6, P143, DOI 10.1177/108705470300600401; Salinas CM, 2016, APPL NEUROPSYCH-CHIL, V5, P264, DOI 10.1080/21622965.2015.1052814; Xu GF, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1471; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	31	7	7	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 24	2019	10								396	10.3389/fneur.2019.00396			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HU7XD	WOS:000465496000001	31068890	Green Published, gold			2022-02-06	
J	Ashendorf, L				Ashendorf, Lee			Neurobehavioral symptom validity in US Department of Veterans Affairs (VA) mild traumatic brain injury evaluations	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Military; mild traumatic brain injury; psychological assessment; symptom validity; veterans	RECOGNITION TRIAL; CLINICAL UTILITY; SCALE; EXAGGERATION; VALIDATION; MMPI-2-RF; SENSITIVITY; PERFORMANCE	Introduction: The use of the Neurobehavioral Symptom Inventory (NSI) by U.S. Department of Defense and Veterans Affairs (VA) providers for all mild traumatic brain injury (mTBI) evaluations led to the development of methods to screen for symptom exaggeration. The present study was designed to explore the clinical utility of three metrics-the Validity-10 scale, the NSI total score, and the mild Brain Injury Atypical Symptoms Scale (mBIAS)-relative to the results of several different criterion measures of symptom validity. Method: Participants in this study were 82 U.S. military veterans referred for evaluations by a VA polytrauma clinic in the context of a history of mTBI. All participants were administered the Minnesota Multiphasic Personality Inventory-Second Edition-Restructured Form (MMPI-2-RF), NSI, and mBIAS. Results: None of the three scales displayed adequate accuracy at predicting failure on cognitive performance validity tests or on the MMPI-2-RF Fp-r scale. For the remaining MMPI-2-RF overreporting indices (F-r, Fs, FBS-r, RBS) and for an index based on elevation of any single MMPI-2-RF overreporting index, both the NSI total score and Validity-10 displayed high positive predictive power with adequate to good sensitivity values (39% to 76%). Conclusion: These findings support the use of Validity-10 and NSI total score as symptom validity tests (SVTs) that can be used to assess for neurobehavioral symptom exaggeration.	[Ashendorf, Lee] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Ashendorf, Lee] VA Cent Western Massachusetts, Mental Hlth Serv Line, Worcester, MA USA		Ashendorf, L (corresponding author), VA Cent Western Massachusetts, Worcester Lake Ave Clin, 55 North Lake Ave,ACC 7th Floor, Worcester, MA 01605 USA.	Lee.Ashendorf@va.gov	Ashendorf, Lee/R-7206-2019		Department of Veterans Affairs, Veterans Health AdministrationUS Department of Veterans Affairs	This study was supported by salary and research support from the Department of Veterans Affairs, Veterans Health Administration.	Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Ashendorf L, 2016, CLIN NEUROPSYCHOL, V30, P599, DOI 10.1080/13854046.2016.1172668; Assistant Secretary of Defense, 2015, TRAUM BRAIN INJ UPD; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Bodapati A. S., CLIN NEUROPSYCHOLOGI; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; McCaffrey R.J., 2003, J FORENSIC NEUROPSYC, V3, P45, DOI [https://doi.org/10.1300/J151v03n03_03, DOI 10.1300/J151V03N03_03]; Morey, 1991, PERSONALITY ASSESSME; Rogers R., 2008, CLIN ASSESSMENT MALI; Sellbom M, 2012, PSYCHIAT RES, V197, P295, DOI 10.1016/j.psychres.2011.12.043; Sellbom M, 2010, PSYCHOL ASSESSMENT, V22, P757, DOI 10.1037/a0020825; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P353, DOI 10.1080/23279095.2015.1079714; Tellegen, 2008, MINNESOTA MULTIPHASI; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; WechslerD, 2001, WECHSLER TEST ADULT; Wygant DB, 2011, PSYCHOL INJ LAW, V4, P13, DOI 10.1007/s12207-011-9098-z; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; Wygant DB, 2009, ARCH CLIN NEUROPSYCH, V24, P671, DOI 10.1093/arclin/acp073	34	7	7	1	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR 21	2019	41	4					432	441		10.1080/13803395.2019.1567693			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	HP7LG	WOS:000461869000009	30712457				2022-02-06	
J	Li, DW; Yang, MF; Li, HX; Mao, LL; Wang, Y; Sun, BL				Li, Dawei; Yang, Mingfeng; Li, Hanxia; Mao, Leilei; Wang, Ying; Sun, Baoliang			SERS based protocol using flow glass-hemostix for detection of neuron-specific enolase in blood plasma	NEW JOURNAL OF CHEMISTRY			English	Article							ENHANCED RAMAN-SCATTERING; TRAUMATIC BRAIN-INJURY; DRUG-RELEASE; CELLS; NANOPARTICLES; ADSORPTION; BIOMARKER; DYNAMICS; TRACKING; TAGS	An inexpensive and disposable lateral flow glass-hemostix (FGH) has been developed as an immunoassay, in which surface-enhanced Raman scattering (SERS) is utilized for sensing signal transduction. Gold nanocage@Raman reporter nanoparticles are developed as SERS tags, which is the key to the high sensitivity of the device. Compared with ELISA, the SERS-FGH exhibits superior performance in terms of sensitivity and limit of detection (LOD) in a blood plasma-containing sample matrix. In addition, the SERS-FGH has been successfully used for the detection of neuron-specific enolase (NSE), a traumatic brain injury (TBI) protein biomarker, in diluted blood plasma samples, achieving a LOD of 0.74 ng mL(-1). Moreover, the SERS-FGH was successfully employed to measure the NSE level in clinical blood plasma samples taken from identified TBI patients. This work demonstrates that the SERS-FGH has great potential in assisting screening of TBI patients in the point-of-care setting.	[Li, Dawei; Yang, Mingfeng; Li, Hanxia; Mao, Leilei; Wang, Ying; Sun, Baoliang] Taishan Med Univ, Life Sci Res Ctr, Inst Neurol Dis, Key Lab Cerebral Microcirculat Univ Shandong, Tai An 271000, Shandong, Peoples R China; [Sun, Baoliang] Taishan Med Univ, Affiliated Hosp, Tai An 271000, Shandong, Peoples R China		Wang, Y; Sun, BL (corresponding author), Taishan Med Univ, Life Sci Res Ctr, Inst Neurol Dis, Key Lab Cerebral Microcirculat Univ Shandong, Tai An 271000, Shandong, Peoples R China.; Sun, BL (corresponding author), Taishan Med Univ, Affiliated Hosp, Tai An 271000, Shandong, Peoples R China.	yingw9@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471212, 81701179, 81271275]; Taishan Scholars Project of Shandong Province; Development Plan of Science and Technology of Traditional Chinese Medicine in Shandong [2017-245]; Natural Science Foundation of ShandongNatural Science Foundation of Shandong Province [ZR2012HZ006]	This work was supported in part by funds from the National Natural Science Foundation of China (Grant No. 81471212, 81701179 and 81271275), the Taishan Scholars Project of Shandong Province, the Development Plan of Science and Technology of Traditional Chinese Medicine in Shandong (Grant No. 2017-245), and the Natural Science Foundation of Shandong (Grant No. ZR2012HZ006).	Adsul M, 2014, RSC ADV, V4, P44726, DOI 10.1039/c4ra08129c; Al-Ogaidi I, 2014, CHEM COMMUN, V50, P1344, DOI 10.1039/c3cc47701k; Bao Y, 2013, RSC ADV, V3, P8998, DOI 10.1039/c3ra41322e; Barbosa O, 2014, RSC ADV, V4, P1583, DOI 10.1039/c3ra45991h; Cela S.-A., 2010, J R SOC INTERFACE, V7, P435; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, 2017, SEV TBI; Cheng SS, 2015, SENSOR ACTUAT B-CHEM, V212, P329, DOI 10.1016/j.snb.2015.02.038; Deka J, 2012, RSC ADV, V2, P4736, DOI 10.1039/c2ra20056b; Enders D, 2006, SURF SCI, V600, pL71, DOI 10.1016/j.susc.2006.01.019; Esenturk EN, 2009, J RAMAN SPECTROSC, V40, P86, DOI 10.1002/jrs.2084; Fan MK, 2011, ANAL CHIM ACTA, V693, P7, DOI 10.1016/j.aca.2011.03.002; Fu X, 2016, BIOSENS BIOELECTRON, V78, P530, DOI 10.1016/j.bios.2015.11.099; Gao XF, 2014, BIOSENS BIOELECTRON, V54, P578, DOI 10.1016/j.bios.2013.10.055; Han GM, 2014, ANAL CHEM, V86, P11503, DOI 10.1021/ac503539w; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Jiang XH, 2012, ANALYST, V137, P3995, DOI 10.1039/c2an35713e; Kang B, 2013, ACS NANO, V7, P7420, DOI 10.1021/nn403351z; Kang B, 2012, SMALL, V8, P777, DOI 10.1002/smll.201101714; Kuchler A, 2015, RSC ADV, V5, P44530, DOI 10.1039/c5ra06268c; Li M, 2015, ANALYST, V140, P386, DOI 10.1039/c4an01079e; Lin DH, 2014, ACS APPL MATER INTER, V6, P1320, DOI 10.1021/am405396k; Lu G, 2012, SMALL, V8, P1336, DOI 10.1002/smll.201102258; MacLaughlin CM, 2013, NANOMED-NANOTECHNOL, V9, P55, DOI 10.1016/j.nano.2012.04.003; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Nazzoly R., 2015, RSC ADV, V5, P11212; North S., 2013, NRL REV, V13, P164; Ock K, 2012, ANAL CHEM, V84, P2172, DOI 10.1021/ac2024188; Parisi J, 2015, RSC ADV, V5, P14081, DOI 10.1039/c4ra15174g; Song CY, 2014, ACS APPL MATER INTER, V6, P21842, DOI 10.1021/am502636h; Tian LM, 2013, ACS NANO, V7, P4252, DOI 10.1021/nn400728t; Vendrell M, 2013, TRENDS BIOTECHNOL, V31, P249, DOI 10.1016/j.tibtech.2013.01.013; Wang XY, 2013, J AM CHEM SOC, V135, P9805, DOI 10.1021/ja402903h; Wang Y., 2016, RSC ADV, V6; Wen HY, 2011, CHEM COMMUN, V47, P3550, DOI 10.1039/c0cc04983b; Yang J, 2012, MOL PHARMACEUT, V9, P842, DOI 10.1021/mp200667d; Yu XY, 2015, ANAL CHEM, V87, P4237, DOI 10.1021/ac504456w; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhou LM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22234	38	7	7	6	52	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1144-0546	1369-9261		NEW J CHEM	New J. Chem.	APR 21	2019	43	15					5925	5931		10.1039/c8nj02561d			7	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	HU4JM	WOS:000465240500030					2022-02-06	
J	Buchmann, I; Dangel, M; Finkel, L; Jung, R; Makhkamova, I; Binder, A; Dettmers, C; Herrmann, L; Liepert, J; Moller, JC; Richter, G; Vogler, T; Wolf, C; Randerath, J				Buchmann, Ilka; Dangel, Mareike; Finkel, Lisa; Jung, Rebecca; Makhkamova, Inara; Binder, Andreas; Dettmers, Christian; Herrmann, Laura; Liepert, Joachim; Moeller, Jens Carsten; Richter, Gabriel; Vogler, Tobias; Wolf, Caroline; Randerath, Jennifer			Limb apraxia profiles in different clinical samples	CLINICAL NEUROPSYCHOLOGIST			English	Article						Limb apraxia; DILA-S; stroke; dementia; multiple sclerosis; traumatic brain injury	TOOL USE; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; HEMISPHERE STROKE; PARIETAL CORTEX; OBJECT USE; PANTOMIME; DEMENTIA; GESTURES; FEATURES	Objective: Limb apraxia is a motor cognitive disorder that has been mainly studied in patients with dementia or left hemisphere stroke (LHS). However, limb apraxia has also been reported in patients with right hemisphere stroke (RHS), multiple sclerosis (MS) or traumatic brain injury (TBI). This study's aim was to report detailed praxis performance profiles in samples suffering from these different neurological disorders by use of the Diagnostic Instrument for Limb Apraxia (DILA-S). Method: 44 LHS patients, 36 RHS patients, 27 patients with dementia, 26 MS and 44 TBI patients participated. The diagnostics included the imitation of meaningless and meaningful hand gestures, pantomime of tool-use, single real tool-use as well as a multistep naturalistic action task (preparing breakfast). Results: Apraxia occurred in all tested samples but to a varying degree and with dissimilar profiles. LHS patients demonstrated most severe deficits in pantomime, but they were also vulnerable to deficits in real tool-use. Dementia patients showed high incidence rates of apraxia in almost all subscales of the DILA-S. RHS patients demonstrated difficulties in imitation and pantomime of tool-use, but they did not show severe difficulties with real tool-use. TBI patients appeared challenged by multistep naturalistic actions. The tested MS sample did not show clinically relevant symptoms in the DILA-S. Conclusion: Different types of patients display varying limb apraxic symptoms detectable by the DILA-S. In these limb apraxia susceptible populations, testing should be warranted as standard. Prospectively, individual error profiles may be helpful for shaping motor cognitive training.	[Buchmann, Ilka; Dangel, Mareike; Finkel, Lisa; Jung, Rebecca; Makhkamova, Inara; Randerath, Jennifer] Univ Konstanz, Constance, Germany; [Buchmann, Ilka; Finkel, Lisa; Dettmers, Christian; Liepert, Joachim; Randerath, Jennifer] Univ Konstanz, Lurija Inst Rehabil Sci & Hlth Res, Constance, Germany; [Makhkamova, Inara] Ludwig Maximilians Univ Munchen, Grad Sch Syst Neurosci, Munich, Germany; [Binder, Andreas; Moeller, Jens Carsten] Rehaklin Zihlschlacht, Ctr Neurol Rehabil, Zihlschlacht, Switzerland; [Dettmers, Christian] Kliniken Schmieder, Constance, Germany; [Liepert, Joachim] Kliniken Schmieder, Allensbach, Germany; [Moeller, Jens Carsten] Philipps Univ, Dept Neurol, Marburg, Germany; [Herrmann, Laura; Richter, Gabriel; Vogler, Tobias; Wolf, Caroline] Zentrum Psychiat Reichenau, Klin Alterspsychiat, Reichenau, Germany		Randerath, J (corresponding author), Univ Konstanz, Dept Psychol, Pb 216,Univ Str 10, D-78457 Constance, Germany.; Randerath, J (corresponding author), Univ Konstanz, Lurija Inst, Kliniken Schmieder Allensbach, Pb 216,Univ Str 10, D-78457 Constance, Germany.	J_Randerath@hotmail.com	Randerath, Jennifer/AAC-1530-2019	Randerath, Jennifer/0000-0002-0794-5571	DFGGerman Research Foundation (DFG)European Commission [RA2492/3-1]; EU FP7 Marie Curie Zukunftskolleg Incoming Fellowship Programme at the University of Konstanz [291784]; Landesgraduiertenforderungsgesetz (LGFG) in Baden-Wurttemberg	This work was supported by grants of the DFG (grant no. RA2492/3-1) and the EU FP7 Marie Curie Zukunftskolleg Incoming Fellowship Programme at the University of Konstanz (grant no. 291784) awarded to Dr. Jennifer Randerath and the Landesgraduiertenforderungsgesetz (LGFG) in Baden-Wurttemberg awarded to M. Sc. Ilka Buchmann.	Acosta LM, 2014, NEUROCASE, V20, P599, DOI 10.1080/13554794.2013.826683; Ahmed S, 2016, J NEUROL NEUROSUR PS, V87, P1158, DOI 10.1136/jnnp-2015-312945; Bader P, 2014, PRAKTISCHE NEUROREHA, V1, P35; Bartels C., 2009, LEHRBUCH KLIN NEUROP, V2. Aufl., P719; Baumard J, 2016, CORTEX, V82, P119, DOI 10.1016/j.cortex.2016.06.007; Binkofski F, 2013, BRAIN LANG, V127, P222, DOI 10.1016/j.bandl.2012.07.007; Borroni B, 2008, ARCH NEUROL-CHICAGO, V65, P796, DOI 10.1001/archneur.65.6.796; Buchmann I, 2017, CORTEX, V94, P49, DOI 10.1016/j.cortex.2017.06.001; Buxbaum LJ, 2007, CORTEX, V43, P411, DOI 10.1016/S0010-9452(08)70466-0; Buxbaum LJ, 2003, NEUROPSYCHOLOGIA, V41, P1091, DOI 10.1016/S0028-3932(02)00314-7; Chandra SR, 2015, INDIAN J PSYCHOL MED, V37, P42, DOI 10.4103/0253-7176.150817; Cotelli M, 2014, J CLIN EXP NEUROPSYC, V36, P843, DOI 10.1080/13803395.2014.948389; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Del Ser T, 2001, ALZ DIS ASSOC DIS, V15, P31; DERENZI E, 1982, BRAIN, V105, P301, DOI 10.1093/brain/105.2.301; Deutsch-Lezak M., 2012, NEUROPSYCHOLOGICAL A, P607; Donkervoort M, 2000, CLIN REHABIL, V14, P130, DOI 10.1191/026921500668935800; Dovern A, 2012, J NEUROL, V259, P1269, DOI 10.1007/s00415-011-6336-y; Dutschke LL, 2018, SCHIZOPHR RES, V200, P42, DOI 10.1016/j.schres.2017.07.012; Edwards D. F., 1991, DEMENT GERIATR COGN, V2, P142; Falchook AD, 2015, J CLIN EXP NEUROPSYC, V37, P1062, DOI 10.1080/13803395.2015.1077930; Finkel L, 2018, NEUROIMAGE-CLIN, V19, P1008, DOI 10.1016/j.nicl.2018.06.019; Foki T, 2016, EUR J NEUROL, V23, P1301, DOI 10.1111/ene.13021; Frey SH, 2007, CORTEX, V43, P368, DOI 10.1016/S0010-9452(08)70462-3; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Moreno MJG, 2013, PSICOTHEMA, V25, P452, DOI 10.7334/psicothema2012.308; Goldenberg G, 1996, J NEUROL NEUROSUR PS, V61, P176, DOI 10.1136/jnnp.61.2.176; Goldenberg G, 1998, NEUROPSYCHOLOGIA, V36, P581, DOI 10.1016/S0028-3932(97)00165-6; Goldenberg G, 2003, NEUROPSYCHOLOGIA, V41, P1565, DOI 10.1016/S0028-3932(03)00120-9; Goldenberg G., 2011, APRAXIEN; Goldenberg G, 2013, APRAXIA COGNITIVE SI, P184; Goldenberg G, 2015, NEUROPSYCHOLOGIA, V75, P40, DOI 10.1016/j.neuropsychologia.2015.05.017; Goldenberg G, 2009, NEUROPSYCHOLOGIA, V47, P1449, DOI 10.1016/j.neuropsychologia.2008.07.014; Hamilton JM, 2003, NEUROPSYCHOLOGIA, V41, P614, DOI 10.1016/S0028-3932(02)00218-X; HARDYCK C, 1977, PSYCHOL BULL, V84, P385, DOI 10.1037/0033-2909.84.3.385; Harscher K. M., 2017, Z NEUROPSYCHOL, V38, P1; Heilman K.M., 1993, CLIN NEUROPSYCHOLOGY, P141; Hodges JR, 2000, BRAIN, V123, P1913, DOI 10.1093/brain/123.9.1913; Huber W., 1983, AACHENER APHASIE TES; Johnen A, 2016, CORTEX, V84, P1, DOI 10.1016/j.cortex.2016.08.009; Johnen A, 2016, J ALZHEIMERS DIS, V49, P593, DOI 10.3233/JAD-150447; Johnen A, 2015, J NEUROL NEUROSUR PS, V86, P809, DOI 10.1136/jnnp-2014-308773; Kamm CP, 2012, ARCH PHYS MED REHAB, V93, P1081, DOI 10.1016/j.apmr.2012.01.008; Kaya K, 2006, J REHABIL MED, V38, P108, DOI 10.1080/16501970500312255; Kroliczak G, 2009, CEREB CORTEX, V19, P2396, DOI 10.1093/cercor/bhn261; Kubel S, 2018, HUM BRAIN MAPP, V39, P3691, DOI 10.1002/hbm.24204; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Larner A J, 2007, Int MS J, V14, P76; LeClerc CM., 2004, ALZHEIMERS CARE TODA, V5, P123; Lesourd M, 2013, NEUROPSYCHOL REV, V23, P234, DOI 10.1007/s11065-013-9235-4; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lewis JW, 2006, NEUROSCIENTIST, V12, P211, DOI 10.1177/1073858406288327; McKenna Cristin, 2013, Front Biosci (Schol Ed), V5, P732; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Niessen E, 2014, NEUROIMAGE-CLIN, V5, P42, DOI 10.1016/j.nicl.2014.05.017; Ozkan S, 2013, NEUROPSYCH DIS TREAT, V9, P947, DOI 10.2147/NDT.S47879; Parakh R, 2004, BRAIN COGNITION, V55, P272, DOI 10.1016/j.bandc.2004.02.049; Peigneux P, 2001, NEUROLOGY, V57, P1259, DOI 10.1212/WNL.57.7.1259; Plummer P, 2003, PHYS THER, V83, P732, DOI 10.1093/ptj/83.8.732; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Przybylski L, 2017, J INT NEUROPSYCH SOC, V23, P108, DOI 10.1017/S1355617716001120; Randerath J., 2017, DIAGNOSTIC INSTRUMEN; Randerath J, 2017, NEUROPSYCHOLOGIA, V105, P135, DOI 10.1016/j.neuropsychologia.2017.04.024; Randerath J, 2011, NEUROPSYCHOLOGIA, V49, P2410, DOI 10.1016/j.neuropsychologia.2011.04.017; Rapaic D, 2014, VOJNOSANIT PREGL, V71, P821, DOI 10.2298/VSP121105024R; Rohrer S, 2013, THESIS; Rumiati RI, 2004, NEUROIMAGE, V21, P1224, DOI 10.1016/j.neuroimage.2003.11.017; SALMASO D, 1983, PERCEPT MOTOR SKILL, V57, P1039, DOI 10.2466/pms.1983.57.3f.1039; Schwartz MF, 2002, NEUROPSYCHOL REHABIL, V12, P311, DOI 10.1080/09602010244000084; Seebauer B, 2015, THESIS; Sehle A., 2014, NEUROREHA, V6, P22, DOI DOI 10.1055/s-0034-1372453; Spatt J, 2002, J NEUROL, V249, P601, DOI 10.1007/s004150200070; Staff NP, 2009, ARCH NEUROL-CHICAGO, V66, P1139, DOI 10.1001/archneurol.2009.190; Stamenova V, 2010, THESIS; Stamenova V, 2015, NEUROCASE, V21, P642, DOI 10.1080/13554794.2014.964730; Stamenova V, 2014, J NEUROPSYCHOL, V8, P246, DOI 10.1111/jnp.12023; Stegmayer K, 2016, CORTEX, V78, P125, DOI 10.1016/j.cortex.2016.02.014; Tessari A, 2015, NEUROL SCI, V36, P977, DOI 10.1007/s10072-015-2203-4; Valyear KF, 2015, NEUROIMAGE, V114, P226, DOI 10.1016/j.neuroimage.2015.03.058; Vanbellingen T, 2011, J NEUROL NEUROSUR PS, V82, P389, DOI 10.1136/jnnp.2010.213371; Vanbellingen T, 2010, EUR J NEUROL, V17, P59, DOI 10.1111/j.1468-1331.2009.02741.x; Weiss PH, 2016, BRAIN STRUCT FUNCT, V221, P563, DOI 10.1007/s00429-014-0925-3; Weiss PH, 2013, KOLNER APRAXIE SCREE; Wirth K, 2016, FORTSCHR NEUROL PSYC, V84, P634, DOI 10.1055/s-0042-115843; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Wu HS, 2015, BIOL RES NURS, V17, P199, DOI 10.1177/1099800414536773	87	7	7	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 2	2020	34	1					217	242		10.1080/13854046.2019.1585575		APR 2019	26	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	OM4WU	WOS:000465934600001	31002018	Green Published, hybrid			2022-02-06	
J	Bodanapally, UK; Archer-Arroyo, KL; Dreizin, D; Shanmuganathan, K; Schwartzbauer, G; Li, G; Fleiter, TR				Bodanapally, Uttam K.; Archer-Arroyo, Krystal L.; Dreizin, David; Shanmuganathan, Kathirkamanathan; Schwartzbauer, Gary; Li, Guang; Fleiter, Thorsten R.			Dual-Energy Computed Tomography Imaging of Head: Virtual High-Energy Monochromatic (190 keV) Images Are More Reliable Than Standard 120 kV Images for Detecting Traumatic Intracranial Hemorrhages	JOURNAL OF NEUROTRAUMA			English	Article						dual-energy X-ray absorptiometry scan; intracranial hemorrhages; multi-detector computed tomography; traumatic brain hemorrhage	MANAGEMENT; INJURY; CT; GUIDELINES	High-energy monochromatic (190 keV) images may be more reliable than standard 120 kV Images for detecting intracranial hemorrhages. We aimed to retrospectively compare virtual high monochromatic (190 keV) and standard 120 kV images from dual-energy computed tomography (CT; DECT) for the diagnosis of intracranial hemorrhages in traumatic brain injury (TBI). We analyzed admission CT studies in 100 trauma patients. Three radiologists independently reviewed four image sets: 120 kV and 190 keV (thin [1 mm] and thick [5 mm] section) images for the presence of various types of intracranial hemorrhages. The proportions of positive variables were compared and differences calculated by McNemar test and sensitivities determined by contingency tables. Randomly selected hemorrhagic lesions were analyzed for contrast index (CI). Thin-section 190 keV images were superior in the detection of subdural hematomas (SDH) (p < 0.0001), supratentorial contusions (p < 0.0001), and epidural hematomas (EDH) (p = 0.014), when compared with standard 120 kV images. However, 190 keV images were inferior to standard 120 kV images in diagnosis of subarachnoid hemorrhage (SAH) (thin-sections, p = 0.059; thick-sections, 0.0075). The 190 keV images yielded moderate increase in CI of contusions (Cohen's d > 0.53) and a large increase in CI of extra-axial hematomas (Cohen's d > 0.86). Our results indicate that virtual high monochromatic (190 keV, thin-section) images combined with standard 120 kV images may provide optimal diagnostic performance for evaluation of patients suspected of TBI.	[Bodanapally, Uttam K.; Dreizin, David; Shanmuganathan, Kathirkamanathan; Li, Guang; Fleiter, Thorsten R.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Schwartzbauer, Gary] Univ Maryland, Sch Med, Dept Neurosurg, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Archer-Arroyo, Krystal L.] Emory Univ, Sch Med, Dept Diagnost Radiol & Imaging Sci, Atlanta, GA USA		Bodanapally, UK (corresponding author), Univ Maryland, Med Ctr, Dept Radiol, 22S Greene St, Baltimore, MD 21201 USA.	ubodanapally@umm.edu					Bodanapally UK, 2015, RADIOL CLIN N AM, V53, P695, DOI 10.1016/j.rcl.2015.02.011; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Grant KL, 2014, INVEST RADIOL, V49, P586, DOI 10.1097/RLI.0000000000000060; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Postma A.A., 2015, CURR RADIOL REP, V3, P1; Potter CA, 2016, RADIOGRAPHICS, V36, P2186, DOI 10.1148/rg.2016160069; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Wu X., 2009, MEDICAL IMAGING, V156, pK65, DOI DOI 10.1117/12.811698; Yu LF, 2012, AM J ROENTGENOL, V199, pS9, DOI 10.2214/AJR.12.9121	20	7	7	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2019	36	8					1375	1381		10.1089/neu.2018.5985			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HS4DK	WOS:000463812000015	30328766				2022-02-06	
J	Soni, N; Mohamed, AZ; Kurniawan, ND; Borges, K; Nasrallah, F				Soni, Neha; Mohamed, Abdalla Z.; Kurniawan, Nyoman D.; Borges, Karin; Nasrallah, Fatima			Diffusion Magnetic Resonance Imaging Unveils the Spatiotemporal Microstructural Gray Matter Changes following Injury in the Rodent Brain	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; cytotoxic edema; diffusion tensor imaging; gliosis; vasogenic edema	CONTROLLED CORTICAL IMPACT; TRAUMATIC AXONAL INJURY; REACTIVE ASTROGLIOSIS; COGNITIVE IMPAIRMENT; MOUSE MODEL; TIME-COURSE; WHITE; KURTOSIS; MILD; EDEMA	Traumatic brain injury (TBI) is associated with gray and white matter alterations in brain tissue. Gray matter alterations are not yet as well studied as those of the white matter counterpart. This work utilized T2-weighted structural imaging, diffusion tensor imaging (DTI), and diffusion kurtosis imaging to unveil the gray matter changes induced in a controlled cortical impact (CCI) mouse model of TBI at 5 h, 1 day, 3 days, 7 days, 14 days, and 30 days post-CCI. A cross-sectional histopathology approach was used to confer validity of the magnetic resonance imaging (MRI) data by performing cresyl violet staining and glial fibrillary acidic protein (GFAP) immunohistochemistry. The results demonstrated a significant increase in lesion volume up to 3 days post-injury followed by a significant decrease in the cavity volume for the period of 1 month. GFAP signals peaked on Day 7 and persisted until Day 30 in both ipsilateral and contralateral hippocampus, ipsilateral cortex, and thalamic areas. An increase in fractional anisotropy (FA) was seen at Day 7 in the pericontusional area but decreased FA in the contralateral cortex, hippocampus, and thalamus. Mean diffusivity (MD) was significantly lower in the pericontusional cortex. Increased MD and decreased mean kurtosis were limited to the injury site on Days 7 to 30 and to the contralateral hippocampus and thalamus on Days 3 and 7. This work is one of the few cross-sectional studies to demonstrate a link between MRI measures and histopathological readings to track gray matter changes in the progression of TBI.	[Soni, Neha; Mohamed, Abdalla Z.; Nasrallah, Fatima] Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia; [Borges, Karin] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Kurniawan, Nyoman D.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia		Nasrallah, F (corresponding author), Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia.	f.nasrallah@uq.edu.au	Kurniawan, Nyoman/D-9764-2011; Mohamed, Abdalla/ABG-8718-2021; Mohaned, Abdalla/AAL-8721-2020; Mohaned, Abdalla/ABF-9320-2021; Borges, Karin/B-4276-2011; Nasrallah, Fatima/N-3398-2016	Kurniawan, Nyoman/0000-0001-6340-182X; Mohaned, Abdalla/0000-0003-4499-672X; Mohaned, Abdalla/0000-0003-4499-672X; Borges, Karin/0000-0001-7448-0770; Nasrallah, Fatima/0000-0002-7385-9559			Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Cercignani M, 2001, J NEUROL NEUROSUR PS, V70, P311, DOI 10.1136/jnnp.70.3.311; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chou MC, 2017, J COMPUT ASSIST TOMO, V41, P868, DOI 10.1097/RCT.0000000000000621; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Garcia-Finana M, 2003, NEUROIMAGE, V18, P505, DOI 10.1016/S1053-8119(02)00021-6; Genrikhs EE, 2017, B EXP BIOL MED+, V164, P211, DOI 10.1007/s10517-017-3960-2; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guglielmetti C, 2016, NEUROIMAGE, V125, P363, DOI 10.1016/j.neuroimage.2015.10.052; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Lanzafame S, 2016, MED PHYS, V43, DOI 10.1118/1.4946819; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Lu H, 2014, NEURAL REGEN RES, V9, P973, DOI 10.4103/1673-5374.133150; Maas A, 2016, CHIN J TRAUMATOL, V19, P3, DOI 10.1016/j.cjtee.2016.01.001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Schober ME, 2016, J NEUROTRAUM, V33, P390, DOI 10.1089/neu.2015.3945; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Shen QH, 2016, WORLDV EVID-BASED NU, V13, P380, DOI 10.1111/wvn.12167; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Stroop R, 1998, ACT NEUR S, V71, P303; Szczepankiewicz F, 2013, NEUROIMAGE, V76, P145, DOI 10.1016/j.neuroimage.2013.02.078; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Veraart J, 2011, MAGN RESON MED, V65, P138, DOI 10.1002/mrm.22603; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zhuo JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136151; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	68	7	7	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2019	36	8					1306	1317		10.1089/neu.2018.5972			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HS4DK	WOS:000463812000009	30381993				2022-02-06	
J	Vissoci, JRN; de Oliveira, LP; Gafaar, T; Haglund, MM; Mvungi, M; Mmbaga, BT; Staton, CA				Vissoci, Joao Ricardo Nickenig; de Oliveira, Leonardo Pestillo; Gafaar, Temitope; Haglund, Michael M.; Mvungi, Mark; Mmbaga, Blandina Theophil; Staton, Catherine A.			Cross-cultural adaptation and psychometric properties of the MMSE and MoCA questionnaires in Tanzanian Swahili for a traumatic brain injury population	BMC NEUROLOGY			English	Article						Tanzania; Traumatic brain injury; Cognitive impairment; MoCA; MMSE; Validity; Reliability	MONTREAL COGNITIVE ASSESSMENT; MINI-MENTAL-STATE; BRIEF SCREENING TOOL; CHINESE VERSION; AXIS-I; VALIDATION; IMPAIRMENT; VALIDITY; DIMENSIONS; DEMENTIA	BackgroundTraumatic Brain Injury (TBI) is the most common cause of injury-related death and disability globally, and a common sequelae is cognitive impairment. Addressing post-TBI cognitive deficits is crucial because they affect rehabilitation outcomes, but doing this requires valid and reliable cognitive assessment measures. However, no such instrument has been validated in Tanzania's TBI population. Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) are two commonly used instruments to measure cognitive impairment, and there have been a few studies reporting their use in post-TBI cognitive assessment. Our aim was to report the psychometric properties of the Swahili version of both scales amongst the TBI population in Tanzania.MethodsA cross-cultural adaptation committee participated in the translation and content validation process for both questionnaires. Our patient sample consisted of 192 adults with TBI who were admitted to Kilimanjaro Christian Medical Center (KCMC) in Tanzania. Confirmatory factor analysis, reliability and external validity were evaluated.ResultsMoCA showed adequate factor loadings (values >0.50 for all items except items 7 & 10) and adequate reliability (values >0.70). Factor loadings for most of the MMSE items were below 0.5 and internal consistency was medium (<0.7). Polychoric correlation between MMSE and MoCA was strong, positive and statistically significant (r=0.68, p=0.001); correlation with the cognitive subscale of FIM indicated moderately positive relationships - MMSE (r=0.35, p=0.001) and MoCA (r=0.43, p=0.001).ConclusionsWith the exception of the language and memory items, MoCA is a valid and reliable instrument for cognitive impairment screening in Tanzania's adult TBI population. On the other hand, MMSE does not appear to be an appropriate tool in this patient group, but its positive correlations with MoCA and cFIM indicate similar theoretical concepts. Both instruments require further validation studies to prove their predictive ability for screening cognitive impairment before they are considered suitable for clinical use.	[Vissoci, Joao Ricardo Nickenig; Haglund, Michael M.; Staton, Catherine A.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA; [Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.] Duke Univ, Sch Med, Duke Emergency Med, Durham, NC 27710 USA; [Vissoci, Joao Ricardo Nickenig; Haglund, Michael M.; Staton, Catherine A.] Duke Univ, Div Global Neurosurg & Neurosci, Durham, NC USA; [de Oliveira, Leonardo Pestillo] UniCesumar, Maringa, Parana, Brazil; [Gafaar, Temitope] Duke Univ, Sch Med, Durham, NC USA; [Mvungi, Mark; Mmbaga, Blandina Theophil] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Mmbaga, Blandina Theophil] Kilimanjaro Clin Res Inst, Moshi, Tanzania		Vissoci, JRN (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA.; Vissoci, JRN (corresponding author), Duke Univ, Sch Med, Duke Emergency Med, Durham, NC 27710 USA.	jnv4@duke.edu	OLIVEIRA, LEONARDO P/L-7300-2018; Mmbaga, Blandina Theophil/AAR-8707-2021; Oliveira, Leonardo/O-5281-2019	OLIVEIRA, LEONARDO P/0000-0001-5278-0676; Mmbaga, Blandina Theophil/0000-0002-5550-1916; Oliveira, Leonardo/0000-0001-5278-0676; Staton, Catherine/0000-0002-6468-2894	HRSAUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [T84HA21123-02]; U.S. National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Duke Division of Emergency Medicine; Fogarty International Center of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K01TW010000]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K01TW010000] Funding Source: NIH RePORTER	This project was made possible by the Mentored Research Training Program in collaboration with the HRSA-funded KCMC MEPI grant #T84HA21123-02; U.S. National Institutes of Health and the Duke Division of Emergency Medicine. Dr. Staton would like to acknowledge salary support provided by the Fogarty International Center of the National Institutes of Health under Award Number K01TW010000 (PI, Staton). Funding bodies were not involved in the design of the study, data collection, analysis, interpretation or writing the manuscript.	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Blunch N., 2008, INTRO STRUCTURAL EQU; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Brugnolo A, 2009, ARCH GERONTOL GERIAT, V49, P180, DOI 10.1016/j.archger.2008.07.005; Burton L, 2015, J REHABIL MED, V47, P193, DOI 10.2340/16501977-1930; Castro-Costa E, 2009, AM J GERIAT PSYCHIAT, V17, P863, DOI 10.1097/JGP.0b013e3181ab8b4d; Chen KL, 2016, J AM GERIATR SOC, V64, pE285, DOI 10.1111/jgs.14530; de Guise E, 2013, BRAIN INJURY, V27, P1428, DOI 10.3109/02699052.2013.835867; de Vellis RF, 2003, SCALE DEV THEORY APP, V2nd; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Delgado C, 2017, NEUROLOGIA; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Duro D, 2010, J NEUROL, V257, P728, DOI 10.1007/s00415-009-5399-5; Erkut S, 2010, CHILD DEV PERSPECT, V4, P19, DOI 10.1111/j.1750-8606.2009.00111.x; FILLENBAUM GG, 1987, ARCH NEUROL-CHICAGO, V44, P924, DOI 10.1001/archneur.1987.00520210026014; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freitas S, 2012, J INT NEUROPSYCH SOC, V18, P242, DOI 10.1017/S1355617711001573; Fujiwara Y, 2010, GERIATR GERONTOL INT, V10, P225, DOI 10.1111/j.1447-0594.2010.00585.x; Ganti L, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0091-4; Gil L, 2015, INT J GERIATR PSYCH, V30, P655, DOI 10.1002/gps.4199; Hair JF., 2006, MULTIVARIATE DATA AN, V6; Hammond FM, 2018, PM&R, V10, P993, DOI 10.1016/j.pmrj.2018.02.010; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; Heyman N, 2017, GERIATR GERONTOL INT, V17, P2507, DOI 10.1111/ggi.13117; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hollis AM, 2015, J AM GERIATR SOC, V63, P988, DOI 10.1111/jgs.13384; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Janelidze M, 2017, AM J ALZHEIMERS DIS, V32, P36, DOI 10.1177/1533317516679304; Jones RN, 2000, PSYCHOL MED, V30, P605, DOI 10.1017/S0033291799001853; Karunaratne S., 2011, Ceylon Medical Journal, V56, P147, DOI 10.4038/cmj.v56i4.3892; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Kaya D, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2015.12.093; Kline R, 2010, PRINCIPLES PRACTICE, V3rd Edn; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kosaka B., 2006, BRIT COLOMBIA MEDICA, V48, P447; Kumar S, 2015, NEUROLOGY, V84, P1500, DOI 10.1212/WNL.0000000000001449; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee Chung Nam, 2015, Korean J Neurotrauma, V11, P6, DOI 10.13004/kjnt.2015.11.1.6; Lee JY, 2008, J GERIATR PSYCH NEUR, V21, P104, DOI 10.1177/0891988708316855; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; Lovell Mark R., 1994, P133; Maroco J., 2010, ANALISE EQUACOES EST; Mathias JL, 2007, CHANGES ATTENTION IN; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Memoria CM, 2013, INT J GERIATR PSYCH, V28, P34, DOI 10.1002/gps.3787; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; O'Shanick GJOSA, 1994, ARLINGTON NEUROPSYCH, V163, P188; Ozer S, 2016, INT J GERIATR PSYCH, V31, P1139, DOI 10.1002/gps.4444; Padilla MA, 2016, EDUC PSYCHOL MEAS, V76, P436, DOI 10.1177/0013164415593776; Rasquin S, 2011, BRAIN INJURY, V25, P777, DOI 10.3109/02699052.2011.580311; Ruff RM, 1989, RECOVERY MEMORY MILD; Saleh AA, 2019, AGING MENT HEALTH, V23, P551, DOI 10.1080/13607863.2018.1428936; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Su JH, 2017, KAOHSIUNG J MED SCI, V33, P344, DOI 10.1016/j.kjms.2017.05.002; Sweet L, 2011, INT PSYCHOGERIATR, V23, P1582, DOI 10.1017/S1041610211001451; Tanzania National Bureau of Statistics, TANZ 2012 CENS DESHB; Team RC, 2014, R LANG ENVR STAT COM; Tinklenberg J, 1990, Int Psychogeriatr, V2, P123, DOI 10.1017/S1041610290000382; Toglia J, 2011, ARCH PHYS MED REHAB, V92, P792, DOI 10.1016/j.apmr.2010.12.034; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Wong GKC, 2013, BRAIN INJURY, V27, P394, DOI 10.3109/02699052.2012.750746; Xu GL, 2003, INT J GERIATR PSYCH, V18, P609, DOI 10.1002/gps.890; Zhang H, 2016, CHIN J TRAUMATOL, V19, P271, DOI 10.1016/j.cjtee.2015.03.007; Zhang WT, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006960	71	7	8	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	APR 8	2019	19								57	10.1186/s12883-019-1283-9			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HS8QI	WOS:000464133800001	30961532	Green Published, gold			2022-02-06	
J	Withiel, TD; Stolwyk, RJ; Ponsford, JL; Cadilhac, DA; Wong, D				Withiel, Toni D.; Stolwyk, Renerus J.; Ponsford, Jennie L.; Cadilhac, Dominique A.; Wong, Dana			Effectiveness of a manualised group training intervention for memory dysfunction following stroke: a series of single case studies	DISABILITY AND REHABILITATION			English	Article						Memory; compensatory strategies; stroke; memory group; cognitive rehabilitation	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; RELIABILITY; IMPAIRMENT; SURVIVORS; PEOPLE; ADULTS; NEEDS	Purpose: Deficits in memory are common following stroke and have been independently linked with poorer outcomes. Outcomes and best-practice processes of post-stroke memory rehabilitation remain equivocal. Materials and method: In this study an AB with follow up single-case design was repeated across four participants to explore the effectiveness of a compensatory memory skills group in patients with stroke. Target behaviour was subjective everyday and prospective memory failures, assessed weekly. Secondary outcomes included goal attainment and performance on neuropsychological tests of memory. Following three-week baseline, participants completed six weekly two-hour sessions of a manualised memory group. Data was analysed visually and statistically. Results and conclusion: Frequency of everyday memory complaints reduced for all participants during the six-week post-intervention period. This change was significant for three participants. One of the four participants reported a significant reduction in the frequency of prospective memory failures during the maintenance period. All participants described attaining at least one memory specific goal following intervention. Group participation did not result in meaningful change on neuropsychological measures of memory. Taken together, results provided preliminary support for the effectiveness of group-based compensatory memory rehabilitation for reducing subjective everyday memory failures and functional goal attainment. `IMPLICATIONS FOR REHABILITATION Memory skills group training can improve subjective everyday memory and functional goal attainment in community dwelling survivors of stroke. Participants who are closer to date of injury may show greater changes in self- awareness as a consequence of group participation than those who are further from injury. Exploration of change following memory rehabilitation on standard neuropsychological tests may not be the best way to capture improvement following memory skills group training. A focus on functional memory outcomes is recommended to facilitate translation to person- centred clinical practice.	[Withiel, Toni D.; Stolwyk, Renerus J.; Ponsford, Jennie L.; Wong, Dana] Monash Univ, Sch Psychol Sci, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia; [Withiel, Toni D.] Royal Melbourne Hosp, Allied Hlth, Melbourne, Vic, Australia; [Stolwyk, Renerus J.; Ponsford, Jennie L.; Wong, Dana] Monash Epworth Rehabil Res Ctr, Epworth Healthcare, Melbourne, Vic, Australia; [Cadilhac, Dominique A.] Monash Univ, Sch Clin Sci, Stroke & Ageing Res, Clayton, Vic, Australia; [Cadilhac, Dominique A.] Florey Inst Neurosci & Mental Hlth, Stroke Div, Heidelberg, Vic, Australia; [Wong, Dana] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic 3086, Australia		Wong, D (corresponding author), La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic 3086, Australia.	d.wong@latrobe.edu.au	Wong, Dana/AAD-3410-2020; Ponsford, Jennie/H-8341-2014; Cadilhac, Dominique/I-1912-2014	Stolwyk, Renerus/0000-0002-4975-3332; Withiel, Toni/0000-0001-8075-2760; Ponsford, Jennie/0000-0003-0430-125X; Wong, Dana/0000-0001-9619-1929; Cadilhac, Dominique/0000-0001-8162-682X			Andrew NE, 2014, INT J STROKE, V9, P106, DOI 10.1111/ijs.12325; Auerbach C, 2013, SSD R COMPREHENSIVE, V3; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741; Brossart DF, 2014, NEUROPSYCHOL REHABIL, V24, P464, DOI 10.1080/09602011.2013.868361; Bulte I, 2012, METHODOLOGY-EUR, V8, P104, DOI 10.1027/1614-2241/a000042; Chau LT, 2007, NEUROPSYCHOL REHABIL, V17, P707, DOI 10.1080/09602010600923926; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002293.pub3; das Nair R, 2012, CLIN REHABIL, V26, P894, DOI 10.1177/0269215511435424; Devilly GJ, 2005, CLINTOOLS SOFTWARE F; Fish JE, 2015, NEUROPSYCHOL REHABIL, V25, P159, DOI 10.1080/09602011.2014.921204; Fleming J., 2012, MANUAL COMPREHENSIVE; Geusgens CAV, 2007, J REHABIL MED, V39, P425, DOI 10.2340/16501977-0092; Glisky EL, 2004, SCI PRACT NEUROPSYCH, P100; Graham JE, 2012, ARCH PHYS MED REHAB, V93, pS111, DOI 10.1016/j.apmr.2011.12.017; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jamieson M, 2017, NEUROPSYCHOL REHABIL, V27, P919, DOI 10.1080/09602011.2015.1103760; Jokinen H, 2015, EUR J NEUROL, V22, P1288, DOI 10.1111/ene.12743; Kalaria R N, 2001, Curr Atheroscler Rep, V3, P334, DOI 10.1007/s11883-001-0028-5; Keefe Richard S E, 2013, Innov Clin Neurosci, V10, p4S; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Krasny-Pacini A, 2018, ANN PHYS REHABIL MED, V61, P164, DOI 10.1016/j.rehab.2017.12.002; Kratochwill TR, 2010, PSYCHOL METHODS, V15, P124, DOI 10.1037/a0017736; Lane JD, 2014, NEUROPSYCHOL REHABIL, V24, P445, DOI 10.1080/09602011.2013.815636; Manasse NJ, 2005, BRAIN INJURY, V19, P633, DOI 10.1080/02699050400013667; Manolov R., 2014, R SYNTAX PROJECTION; Manolov R, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00032; Martin KJ, 2016, CLIN REHABIL, V30, P705, DOI 10.1177/0269215515595273; McKevitt C, 2011, STROKE, V42, P1398, DOI 10.1161/STROKEAHA.110.598839; Miller LA, 2014, NEUROPSYCHOL REHABIL, V24, P721, DOI 10.1080/09602011.2014.894479; National Stroke Foundation, 2007, WALK OUR SHOES STROK; Nys GMS, 2006, J NEUROL SCI, V247, P149, DOI 10.1016/j.jns.2006.04.005; O'Neil-Pirozzi TM, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000181; Page P, 2014, INT J SPORTS PHYS TH, V9, P726; Parker RI, 2011, BEHAV THER, V42, P284, DOI 10.1016/j.beth.2010.08.006; Perdices M, 2012, BRAIN IMPAIR, V6, P219; Radford K., 2010, MAKING MOST YOUR MEM; Radford K, 2012, J INT NEUROPSYCH SOC, V18, P738, DOI 10.1017/S1355617712000379; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Royle J, 2008, DISABIL REHABIL, V30, P114, DOI 10.1080/09638280701223876; Schmidt M., 1996, REY AUDITORY VERBAL; Sheldon S., 2014, BEHAV CONSEQUENCES S; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Tate RL, 2015, THE RISK OF BIAS IN; Tate RL, 2016, J SCHOOL PSYCHOL, V56, P133, DOI 10.1016/j.jsp.2016.04.001; Tate RL, 2014, NEUROPSYCHOL REHABIL, V24, P315, DOI 10.1080/09602011.2013.875043; Thickpenny-Davis KL, 2007, J HEAD TRAUMA REHAB, V22, P303, DOI 10.1097/01.HTR.0000290975.09496.93; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; Vannest J, 2016, SINGLE CASE RES WEB; Vannest KJ, 2015, J COUNS DEV, V93, P403, DOI 10.1002/jcad.12038; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Viscogliosi C, 2011, APPL NEUROPSYCHOL, V18, P117, DOI 10.1080/09084282.2010.547779; Wechsler D, 2009, WAIS 4 TECHNICAL INT; Wechsler D, 2008, WMS 4 TECHNICAL INTE; Wilson B, 2009, MEMORY REHABILITATIO; Withiel TD, 2020, NEUROPSYCHOL REHABIL, V30, P503, DOI 10.1080/09602011.2018.1479275; World Health Organisation, 2001, INTERNATIONAL CLASSI	61	7	8	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	OCT 8	2020	42	21					3033	3042		10.1080/09638288.2019.1579260		APR 2019	10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	NZ6JD	WOS:000466638300001	30978122				2022-02-06	
J	Bai, GH; Bai, LJ; Cao, JL; Sun, CZ; Wang, S; Yin, B; Zhuang, JF; Wang, ZN; Gan, SQ; Niu, X; Huang, WM; Xu, H; Shao, MH; Yan, ZH; Zhang, M				Bai, Guanghui; Bai, Lijun; Cao, Jieli; Sun, Chuanzhu; Wang, Shan; Yin, Bo; Zhuang, Jinfei; Wang, Zhuonan; Gan, Shuoqiu; Niu, Xuan; Huang, Wenmin; Xu, Hui; Shao, Meihua; Yan, Zhihan; Zhang, Ming			Sex differences in cerebral perfusion changes after mild traumatic brain injury: Longitudinal investigation and correlation with outcome	BRAIN RESEARCH			English	Article						Mild traumatic brain injury; Sex modulatory effect; Cerebral blood flow; Longitudinal changes; Clinical outcome	POST-CONCUSSION SYMPTOMS; BLOOD-FLOW; GENDER-DIFFERENCES; UNITED-STATES; HEAD-INJURY; SEVERITY; SPORTS; HYPOPERFUSION; PERFORMANCE; METABOLISM	Cerebral blood flow (CBF) is known to have marked developmental sex differences. We investigated whether gender differences exert modulatory effect on mild traumatic brain injury (mTBI) from both neuropsychological testing and brain CBF changes using a longitudinal design from acute stage to subacute 1 month post-injury. Our results supported that cognitive information processing speed (IPS), as one of core cognitive impairments following mTBI, were at least partially independent from other self-reported syndromes, such as post concussive symptom and posttraumatic stress disorder, and that it can be selectively impaired in specific male mTBI individuals. The gender difference of this cognitive domain in healthy control attenuated following mTBI and only male patients showed impaired language fluency accompanying with increased CBF changes compared with male controls. The increased CBF in the posterior parietal cortex (PPC) can predict much worse cognitive IPS performance in male patients. In contrast, female patients with mTBI displayed no impairments on any neuropsychological performance, and female sex may be a protective factor against neuropsychological impairments. Moreover, the significant interaction effect of time and gender exhibited in the left inferior frontal cortex (Broca's area). Simple effect test suggested gender differences in this area was mainly derived from the patients group at later subacute but not acute phase, for the reduced CBF at subacute mainly in the male patients. Thus, the current findings suggest that regional CBF may provide an objective biomarker for tracking gender modulatory effect on mTBI and its potentially pathological recovery process.	[Bai, Guanghui; Wang, Zhuonan; Gan, Shuoqiu; Niu, Xuan; Xu, Hui; Zhang, Ming] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian, Shaanxi, Peoples R China; [Bai, Lijun; Cao, Jieli; Sun, Chuanzhu; Wang, Shan; Gan, Shuoqiu; Huang, Wenmin; Xu, Hui] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Key Lab Biomed Informat Engn,Minist Educ, Xian, Shaanxi, Peoples R China; [Bai, Guanghui; Shao, Meihua; Yan, Zhihan] Wenzhou Med Univ, Affiliated Hosp 2, Dept Radiol, Wenzhou, Peoples R China; [Bai, Guanghui; Yin, Bo; Zhuang, Jinfei; Shao, Meihua; Yan, Zhihan] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Yin, Bo] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, Wenzhou, Peoples R China; [Zhuang, Jinfei] Wenzhou Med Univ, Affiliated Hosp 2, Dept Rehabil Med, Wenzhou, Peoples R China		Zhang, M (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian, Shaanxi, Peoples R China.; Bai, LJ (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Key Lab Biomed Informat Engn,Minist Educ, Xian, Shaanxi, Peoples R China.	bailijun@mail.xjtu.edu.cn; zhangming01@mail.xjtu.edu.cn	Xu, Hui/AAB-9421-2020; Wang, Zhuonan/E-3691-2017; Niu, Xuan/AAD-7351-2022; Bai, Lijun/C-5119-2015	Xu, Hui/0000-0003-4514-0413; Wang, Zhuonan/0000-0002-5745-4340; Bai, Lijun/0000-0001-8790-5424; Shao, Meihua/0000-0003-1203-9730	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571752, 81771914, 81571640]; Shanxi Nova Program [2014KJXX-34]; National key research and development plan of China [2016YFC0100300]; Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LY15H090016, LY19H180003, LY16H180009]; Wenzhou Municipal Sci-Tech Bureau [Y20140577]	This research was supported by the National Natural Science Foundation of China [Grant Numbers 81571752, 81771914, 81571640]; Shanxi Nova Program [Grant Number 2014KJXX-34]; National key research and development plan of China [Grant Number 2016YFC0100300]; Natural Science Foundation of Zhejiang Province [Grant Number LY15H090016, LY19H180003, LY16H180009] and Wenzhou Municipal Sci-Tech Bureau [Grant Number Y20140577].	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Alsop DC, 2000, ANN NEUROL, V47, P93, DOI 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.3.CO;2-#; Filippetti VA, 2011, CLIN NEUROPSYCHOL, V25, P413, DOI 10.1080/13854046.2011.559481; Arnold C, 2014, LANCET NEUROL, V13, P136, DOI 10.1016/S1474-4422(13)70287-4; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Capitani E, 2005, BRAIN LANG, V95, P56, DOI 10.1016/j.bandl.2005.07.022; Caro D.H.J., 2011, GLOBAL J HLTH SCI, V3; Chalela J.A., 2006, NEUROLOGY; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2012, J NEUROSCI NURS, V44, P124, DOI 10.1097/JNN.0b013e318252737d; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Du AT, 2006, NEUROLOGY, V67, P1215, DOI 10.1212/01.wnl.0000238163.71349.78; Farace E, 2000, Neurosurg Focus, V8, pe6; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Harman-Smith YE, 2013, J CLIN EXP NEUROPSYC, V35, P785, DOI 10.1080/13803395.2013.824554; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Ilie G., 2015, J HEAD TRAUMA REHABI; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; James A.A., 1995, AM PSYCHOL ASS, V7; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Kempler D, 1998, J INT NEUROPSYCH SOC, V4, P531, DOI 10.1017/S1355617798466013; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Krainin Benjamin M, 2011, J Spec Oper Med, V11, P38; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; McGoron Anthony J, 2008, BMC Med Imaging, V8, P4, DOI 10.1186/1471-2342-8-4; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Munro CA, 2012, AGING NEUROPSYCHOL C, V19, P759, DOI 10.1080/13825585.2012.690366; Neff K. D., 2017, ENCY PERSONALITY IND, P1, DOI [10.1007/978-3-319-8099-8_1159-1., DOI 10.1007/978-3-319-28099-8]; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Sadeghniiat-Haghighi K, 2014, QUAL LIFE RES, V23, P533, DOI 10.1007/s11136-013-0489-3; Shin YB, 2006, BRAIN INJURY, V20, P661, DOI 10.1080/02699050600677071; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Venkat P, 2016, CROAT MED J, V57, P223, DOI 10.3325/cmj.2016.57.223; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Weathers FW, 1991, PTSD CHECKLIST CIVIL	54	7	7	2	25	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 1	2019	1708						93	99		10.1016/j.brainres.2018.12.018			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HO1ZX	WOS:000460712300011	30553777				2022-02-06	
J	Carlozzi, NE; Lange, RT; French, LM; Sander, AM; Ianni, PA; Tulsky, DS; Miner, JA; Kallen, MA; Brickell, TA				Carlozzi, Noelle E.; Lange, Rael T.; French, Louis M.; Sander, Angelle M.; Ianni, Phillip A.; Tulsky, David S.; Miner, Jennifer A.; Kallen, Michael A.; Brickell, Tracey A.			Understanding Health-Related Quality of Life in Caregivers of Civilians and Service Members/Veterans With Traumatic Brain Injury: Reliability and Validity Data for the TBI-CareQOL Measurement System	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injury; Health-related quality of life; Military family; Patient reported outcome; Rehabilitation; Traumatic brain injury; Veterans	HEAD-INJURY; FAMILY; OUTCOMES; REHABILITATION; INDIVIDUALS; VALIDATION; PREVALENCE; DISABILITY; DEPRESSION; INVENTORY	Objectives: To establish the reliability and validity of the newly developed TBI-CareQOL patient-reported outcome (PRO) measures in caregivers of civilians and service members/veterans (SMVs) with traumatic brain injury (TBI) so that they can be used with confidence in clinical research and practice. Design: Computer-based surveys delivered through an on-line data capture platform. Setting: Three TBI Model Systems rehabilitation hospitals, an academic medical center, and a military medical treatment facility. Participants: Caregivers (N=560) of individuals with TBI; this included 2 different study samples: 344 caregivers of civilians with TBI and 216 caregivers of SMVs with TBI. Intervention: Not Applicable. Main outcome measures: Five Traumatic Brain Injury Caregiver Quality of Life (TBI-CareQOL) item banks. Results: Reliabilities for the TBI-CareQOL measures were excellent (all Cronbach's alpha >.88); 3-week test-retest reliability ranged from .75 to .90 across the 2 samples. Convergent validity was supported by moderate to high associations among the TBI-CareQOL measures and moderate correlations between the TBI-CareQOL measures and other measures of health-related quality of life (HRQOL) and caregiver burden. Discriminant validity was supported by low correlations between the TBI-CareQOL measures and less-related constructs (eg, caregiver satisfaction). Known-groups validity was supported: caregivers of individuals that were low functioning had worse HRQOL than caregivers of high-functioning individuals. Conclusions: Results provide psychometric support for the new TBI-CareQOL item banks. As such, these measures fill a significant gap in the caregiver literature where sensitive PRO measures that capture changes in HRQOL are needed to detect improvements for interventions designed to assist family caregivers. (C) 2018 by the American Congress of Rehabilitation Medicine	[Carlozzi, Noelle E.; Ianni, Phillip A.; Miner, Jennifer A.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Lange, Rael T.; French, Louis M.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.; French, Louis M.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [French, Louis M.; Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Tulsky, David S.] Univ Delaware, Ctr Assessment Res & Translat, Dept Psychol & Brain Sci, Newark, DE USA; [Kallen, Michael A.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604; Tulsky, David/0000-0002-4335-4509	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433, UL1TR002240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658] Funding Source: NIH RePORTER	Supported by the National Institutes of Health (NIH), National Institute of Nursing Research (R01NR013658), the National Center for Advancing Translational Sciences (UL1TR000433), and the Defense and Veterans Brain Injury Center (DVBIC). We thank the investigators, coordinators, and research associates/assistants who worked on this study, the study participants, and organizations who supported recruitment efforts. The University of Michigan Research Team would also like to thank the Hearts of Valor and the Brain Injury Association of Michigan for assistance with community outreach for recruitment efforts at this site.	Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Bulmer, 1979, PRINCIPLES STAT; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; CANTOR MH, 1983, GERONTOLOGIST, V23, P597, DOI 10.1093/geront/23.6.597; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS110, DOI 10.1016/j.apmr.2018.06.026; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS43, DOI 10.1016/j.apmr.2018.06.025; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS13, DOI 10.1016/j.apmr.2018.05.033; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS31, DOI 10.1016/j.apmr.2018.05.026; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS22, DOI 10.1016/j.apmr.2018.05.027; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS94, DOI 10.1016/j.apmr.2018.05.021; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS102, DOI 10.1016/j.apmr.2018.05.020; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; CELLA DF, 1995, SEMIN ONCOL, V22, P73; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cramer D., 2004, SAGE DICT STAT; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; DeVellis R.F., 2017, SCALE DEV THEORY APP; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hays RD, 1995, USERS MANUAL MED OUT; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Krauss Joachim K, 2015, Handb Clin Neurol, V128, P475, DOI 10.1016/B978-0-444-63521-1.00030-3; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Mahoney R, 2005, AM J GERIAT PSYCHIAT, V13, P795, DOI 10.1176/appi.ajgp.13.9.795; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, MAYO PORTLAND ADAPTA; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marwit SJ, 2002, GERONTOLOGIST, V42, P751, DOI 10.1093/geront/42.6.751; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Panting A, 1972, REHABILITATION, V38, P33; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Sander A. M., 2005, REHABILITATION TRAUM, P156; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Simpson GK, 2013, J HEAD TRAUMA REHAB, V28, P202, DOI 10.1097/HTR.0b013e31828dc5ae; Smith A M, 1998, Rehabil Nurs, V23, P252; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	60	7	7	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4		1			S85	S93		10.1016/j.apmr.2018.05.034			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FV	WOS:000462951900010	29966648	Green Accepted			2022-02-06	
J	Durish, CL; Yeates, KO; Brooks, BL				Durish, Christianne Laliberte; Yeates, Keith Owen; Brooks, Brian L.			Psychological Resilience as a Predictor of Symptom Severity in Adolescents With Poor Recovery Following Concussion	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Concussion; Pediatric; Mild traumatic brain injury; Hardiness; Post-concussive symptoms; Child	TRAUMATIC BRAIN-INJURY; CONNOR-DAVIDSON RESILIENCE; POSTCONCUSSIVE SYMPTOMS; DEPRESSIVE SYMPTOMS; HEAD-INJURY; CHILDREN; OUTCOMES; ANXIETY; HEALTH; STRATEGIES	Objectives: Examine the mediating effects of anxiety and depressive symptoms on the relationship between psychological resilience and post-concussive symptoms (PCS) in children with poor recovery following concussion. Participants and Methods: Adolescents (N=93), ages 13 to 18 years, were assessed at a neuropsychology screening clinic at a children's hospital. They sustained concussions more than 1 month before the clinic visit (median time since injury=5.1 months; range=42-473 days) and were seen on the basis of poor recovery (i.e., presence of persistent PCS and complaints of cognitive problems). Self-reported psychological resilience was measured using the 10-item version of the Connor-Davidson Resilience Scale; self- and parent-reported anxiety and depressive symptoms were measured using the Behaviour Assessment System for Children - Second Edition; and self- and parent-reported PCS were measured using the Post-Concussion Symptom Inventory. All variables were measured concurrently. Regression-based mediation analyses were conducted to examine anxiety and depressive symptoms as mediators of the relationship between psychological resilience and PCS. Results: Psychological resilience significantly predicted self-reported PCS. Self-reported anxiety and depressive symptoms significantly mediated the relationship between resilience and self-reported PCS, and parent-reported child depressive symptoms significantly mediated the relationship between resilience and self- and parent-reported PCS. Conclusions: Psychological resilience plays an important role in recovery from concussion, and this relationship may be mediated by anxiety and depressive symptoms. These results help shed light on the mechanisms of the role of psychological resilience in predicting PCS in children with prolonged symptom recovery. (JINS, 2019, 25, 346-354)	[Durish, Christianne Laliberte; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Psychol, 2500 Univ Dr NM, Calgary, AB T2N 1N4, Canada		Durish, CL (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NM, Calgary, AB T2N 1N4, Canada.	christianne.lalibert@ucalgary.ca	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	Alberta Innovates Health Solutions (AIHS); Alberta Children's Hospital Research Institute (ACHRI); Robert and Irene Ward Chair in Pediatric Brain Injury from the Alberta Children's Hospital Foundation; CIHR Embedded Clinical Research Award	Special thanks to the families who participated in this research. The authors thank Helen Carlson PhD and Shane Virani MSc for their time and expertise with data management, as well as (alphabetically) Kalina Askin, Christina Bigras, Dominique Bonneville, Shauna Bulman, Claire David, Hussain Daya, Lisa Goodman, Andrea Jubinville, Courtney Habina, Michelle Huie, Shelby MacPhail, Lonna Mitchell, Carlie Montpetit, Victoria Purcell, Alysha Rajaram, Jasmine Santos, Kalina Slepicka, Emily Tam, Julie Wershler, and Nikola Zivanovic for help with data entry into the BrainChild database program. Funding: Christianne Laliberte Durish received funding from Alberta Innovates Health Solutions (AIHS) and Alberta Children's Hospital Research Institute (ACHRI) in the form of graduate studentships. Brian Brooks acknowledges support from the Neurosciences Program at the Alberta Children's Hospital for database management and salary support from the CIHR Embedded Clinical Research Award. Keith Yeates is supported by the Robert and Irene Ward Chair in Pediatric Brain Injury from the Alberta Children's Hospital Foundation. Conflict of Interest: Brian Brooks receives royalties for the sales of the Pediatric Forensic Neuropsychology textbook (2012, Oxford University Press) and three pediatric neuropsychological tests [Child and Adolescent Memory Profile (ChAMP, Sherman and Brooks, 2015, PAR Inc.), Memory Validity Profile (MVP, Sherman and Brooks, 2015, PAR Inc.), and Multidimensional Everyday Memory Ratings for Youth (MEMRY, Sherman and Brooks, 2017, PAR Inc.)]. He previously received in-kind support (free test credits) from the publisher of a computerized cognitive test (CNS Vital Signs, Chapel Hill, North Carolina) for prior studies. Keith Yeates receives royalties for book sales from Guilford Press and Cambridge University Press, and occasionally serves as a paid expert in forensic cases. None of the authors have a financial interest in any measures used in the present study.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Durish CL, 2018, J INT NEUROPSYCH SOC, V24, P759, DOI 10.1017/S1355617718000437; Durish CL, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000343; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hayes A.F., 2013, METHODOLOGY SOCIAL S; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Horris H.B., 2017, ATHL TRAIN SPORTS HL, V9, P39, DOI DOI 10.3928/19425864-20160926-01; Hubble, 2010, HEART SOUL CHANGE DE; IBM Corp, 2016, IBM SPSS STAT WIND V; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnston MC, 2015, PSYCHOSOMATICS, V56, P168, DOI 10.1016/j.psym.2014.10.005; Laliberte Durish C, 2017, J INT NEUROPSYCHO S1, V23, P294; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P745, DOI 10.1002/da.20558; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Poole JC, 2017, J AFFECT DISORDERS, V217, P144, DOI 10.1016/j.jad.2017.03.047; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Rainey EE, 2014, AM J SURG, V208, P517, DOI 10.1016/j.amjsurg.2014.05.016; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schulz A, 2014, J PSYCHOSOM RES, V77, P97, DOI 10.1016/j.jpsychores.2014.06.008; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Stein E, 2017, BRAIN INJURY, V31, P1736, DOI 10.1080/02699052.2017.1380843; Steinhardt M, 2008, J AM COLL HEALTH, V56, P445, DOI 10.3200/JACH.56.44.445-454; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Vincent, 2008, J INT NEUROPSYCH SOC, V1, P204; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	51	7	7	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2019	25	4					346	354		10.1017/S1355617718001169			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	IC9LS	WOS:000471304800002	31050328				2022-02-06	
J	Gano, A; Vore, AS; Sammakia, MN; Deak, T				Gano, Anny; Vore, Andrew S.; Sammakia, Maryam N.; Deak, Terrence			Assessment of Extracellular Cytokines in the Hippocampus of the Awake Behaving Rat Using Large-Molecule Microdialysis Combined with Multiplex Arrays After Acute and Chronic Ethanol Exposure	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Adolescence; CIE; EtOH; Cytokine; Microdialysis	PITUITARY-ADRENAL AXIS; TRAUMATIC BRAIN-INJURY; ALCOHOL EXPOSURE; GENE-EXPRESSION; PROTEIN-SYNTHESIS; ADOLESCENT; WITHDRAWAL; INTOXICATION; IL-1-BETA; NEUROINFLAMMATION	Background Studies have demonstrated persistent changes in central nervous system (CNS) cytokine gene expression following ethanol (EtOH) exposure. However, the low endogenous expression and short half-lives of cytokines in the CNS have made cytokine protein detection challenging. The goal of these studies was to establish parameters for use of large-molecule microdialysis and sensitive multiplexing technology for the simultaneous detection of brain cytokines, corticosterone (CORT), and EtOH concentrations in the awake behaving rat. Methods Adult (P75+) male Sprague Dawley rats that were either naive to EtOH (Experiment 1) or had a history of adolescent chronic intermittent EtOH (CIE; Experiment 2) were given an acute EtOH challenge during microdialysis. Experiment 1 examined brain EtOH concentrations, CORT and a panel of neuroimmune analytes, including cytokines associated with innate and adaptive immunity. The natural time course of changes in these cytokines was compared to the effects of an acute 1.5 or 3.0 g/kg intraperitoneal (i.p.) EtOH challenge. In Experiment 2, rats with a history of adolescent CIE or controls exposed to vehicle were challenged with 3.0 g/kg i.p. EtOH during microdialysis in adulthood, and a panel of cytokines was examined in parallel with brain EtOH concentrations and CORT. Results The microdialysis procedure itself induced a cytokine-specific response that replicated across studies, specifically a sequential elevation of interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-alpha), and IL-10. Surprisingly, acute EtOH did not significantly alter this course of cytokine fluctuations in the hippocampus. However, a history of adolescent CIE showed drastic effects on multiple neuroimmune analytes when rechallenged with EtOH as adults. Rats with a history of adolescent EtOH displayed a severely blunted neuroimmune response in adulthood, evinced by suppressed IL-1 beta, IL-10, and TNF-alpha. Conclusions Together, these findings provide a methodological framework for assessment of cytokine release patterns, their modulation by EtOH, and the long-lasting changes to neuroimmune reactivity evoked by a history of adolescent CIE.	[Gano, Anny; Vore, Andrew S.; Sammakia, Maryam N.; Deak, Terrence] SUNY Binghamton, Dept Psychol, Behav Neurosci Program, Binghamton, NY 13902 USA		Deak, T (corresponding author), SUNY Binghamton, Dept Psychol, Behav Neurosci Program, Binghamton, NY 13902 USA.	tdeak@binghamton.edu	Gano, Anny/AAJ-7973-2021	Deak, Terrence/0000-0002-1514-4600; Gano, Anny/0000-0002-7403-9202	Center for Development and Behavioral Neuroscience at Binghamton University [P50AA017823]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P50AA017823, T32AA025606] Funding Source: NIH RePORTER	This work was supported by the Developmental Exposure Alcohol Research Center (DEARC; P50AA017823) and the Center for Development and Behavioral Neuroscience at Binghamton University. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the above-stated funding agencies.	Agnello D, 2000, BRAIN RES, V869, P241, DOI 10.1016/S0006-8993(00)02392-1; Alfonso-Loeches S, 2013, TOXICOLOGY, V311, P27, DOI 10.1016/j.tox.2013.03.001; Arakawa H, 2010, HORM BEHAV, V57, P330, DOI 10.1016/j.yhbeh.2010.01.002; Barney TM, 2019, ALCOHOL, V79, P37, DOI 10.1016/j.alcohol.2018.11.004; Barrientos RM, 2015, NEUROBIOL AGING, V36, P1483, DOI 10.1016/j.neurobiolaging.2014.12.003; Bhattacharya A, 2013, BRIT J PHARMACOL, V170, P624, DOI 10.1111/bph.12314; Blednov YA, 2005, BEHAV BRAIN RES, V165, P110, DOI 10.1016/j.bbr.2005.06.026; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; Bodnar TS, 2018, BRAIN BEHAV IMMUN, V73, P205, DOI 10.1016/j.bbi.2018.05.004; Brenhouse HC, 2016, NEUROSCI BIOBEHAV R, V70, P288, DOI 10.1016/j.neubiorev.2016.05.035; Buck HM, 2011, PSYCHOPHARMACOLOGY, V218, P203, DOI 10.1007/s00213-011-2388-z; Chourbaji S, 2006, NEUROBIOL DIS, V23, P587, DOI 10.1016/j.nbd.2006.05.001; Crews FT, 2006, ALCOHOL CLIN EXP RES, V30, P720, DOI 10.1111/j.1530-0277.2006.00084.x; DAVID ET, 1983, J BIOL CHEM, V258, P7702; Dinel AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024325; Donegan JJ, 2014, J NEUROSCI, V34, P953, DOI 10.1523/JNEUROSCI.3968-13.2014; Dood PR, 1998, ANN NY ACAD SCI, V844, P50, DOI 10.1111/j.1749-6632.1998.tb08221.x; Doremus-Fitzwater TL, 2018, BRAIN BEHAV IMMUN, V70, P141, DOI 10.1016/j.bbi.2018.02.009; Doremus-Fitzwater TL, 2015, PHYSIOL BEHAV, V148, P131, DOI 10.1016/j.physbeh.2015.02.032; Doremus-Fitzwater TL, 2014, ALCOHOL CLIN EXP RES, V38, P2186, DOI 10.1111/acer.12481; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; Ferguson LB, 2014, NEUROPHARMACOLOGY, V86, P397, DOI 10.1016/j.neuropharm.2014.06.024; FERRARO TN, 1990, ALCOHOL, V7, P129, DOI 10.1016/0741-8329(90)90073-L; Frank MG, 2018, BRAIN BEHAV IMMUN, V73, P352, DOI 10.1016/j.bbi.2018.05.020; Gano A, 2017, NEUROBIOL AGING, V54, P40, DOI 10.1016/j.neurobiolaging.2017.01.025; Gano A, 2016, BRAIN RES, V1646, P62, DOI 10.1016/j.brainres.2016.05.027; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Girard-Joyal O, 2015, NEUROSCIENCE, V305, P293, DOI 10.1016/j.neuroscience.2015.06.035; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Goujon E, 1996, MOL BRAIN RES, V36, P53, DOI 10.1016/0169-328X(95)00242-K; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Grossman I, 2010, EPMA J, V1, P317, DOI 10.1007/s13167-010-0020-7; Harden LM, 2008, BRAIN BEHAV IMMUN, V22, P838, DOI 10.1016/j.bbi.2007.12.006; Hashimoto JG, 2008, NEUROPSYCHOPHARMACOL, V33, P1084, DOI 10.1038/sj.npp.1301494; Hennessy MB, 2014, BRAIN BEHAV IMMUN, V37, P15, DOI 10.1016/j.bbi.2013.10.021; Hong-Brown LQ, 2001, ALCOHOL CLIN EXP RES, V25, P1373; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Kane CJM, 2014, ALCOHOL CLIN EXP RES, V38, P384, DOI 10.1111/acer.12244; Knapp DJ, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6030025; Lang CH, 2001, INT J BIOCHEM CELL B, V33, P457, DOI 10.1016/S1357-2725(00)00081-9; Lewohl JM, 2000, ALCOHOL CLIN EXP RES, V24, P1873, DOI 10.1097/00000374-200012000-00018; Lewohl JM, 2004, ANN NY ACAD SCI, V1025, P14, DOI 10.1196/annals.1316.002; Lippai D, 2013, J LEUKOCYTE BIOL, V94, P171, DOI 10.1189/jlb.1212659; Marshall SA, 2017, J NEUROIMMUNE PHARM, V12, P249, DOI 10.1007/s11481-016-9709-2; Miller AH, 2013, DEPRESS ANXIETY, V30, P297, DOI 10.1002/da.22084; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Mulligan MK, 2011, ALCOHOL CLIN EXP RES, V35, P659, DOI 10.1111/j.1530-0277.2010.01384.x; Murray CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078385; National Institute on Alcohol Abuse and Alcoholism [NIAAA], 2017, UND DRINK; Pascual M, 2015, NEUROPHARMACOLOGY, V89, P352, DOI 10.1016/j.neuropharm.2014.10.014; Powrozek TA, 2012, ALCOHOL, V46, P619, DOI 10.1016/j.alcohol.2012.07.003; Pry, 2008, CLIN BIOCHEM REV, V29, pS49; Qian XX, 2012, ENDOCRINOLOGY, V153, P4346, DOI 10.1210/en.2012-1484; Risher ML, 2015, ALCOHOL CLIN EXP RES, V39, P989, DOI 10.1111/acer.12725; Robinson DL, 2000, J NEUROCHEM, V75, P1685, DOI 10.1046/j.1471-4159.2000.0751685.x; Schier CJ, 2012, JOVE-J VIS EXP, V5, P67; Spear LP, 2014, NEUROSCI BIOBEHAV R, V45, P1, DOI 10.1016/j.neubiorev.2014.04.012; SPENCER RL, 1990, NEUROENDOCRINOLOGY, V52, P481, DOI 10.1159/000125632; Spencer RL, 2017, PHYSIOL BEHAV, V178, P43, DOI 10.1016/j.physbeh.2016.11.014; Suryanarayanan A, 2016, NEUROPHARMACOLOGY, V107, P181, DOI 10.1016/j.neuropharm.2016.03.027; Telles TMBB, 2017, ALCOHOL CLIN EXP RES, V41, P507, DOI 10.1111/acer.13333; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Tha KK, 2000, BRAIN RES, V885, P25, DOI 10.1016/S0006-8993(00)02883-3; Torcaso A, 2017, PSYCHONEUROENDOCRINO, V76, P154, DOI 10.1016/j.psyneuen.2016.11.032; Vasicek TW, 2013, ACS CHEM NEUROSCI, V4, P737, DOI 10.1021/cn400025m; Vetreno R, 2014, HDB CLIN NEUROL, V125, P466; Vore AS, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00078; Whitman BA, 2013, ALCOHOL CLIN EXP RES, V37, P2086, DOI 10.1111/acer.12189; Wilhelm CJ, 2016, BRAIN PATHOL, V26, P433, DOI 10.1111/bpa.12276	69	7	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-6008	1530-0277		ALCOHOL CLIN EXP RES	Alcoholism (NY)	APR	2019	43	4					640	654		10.1111/acer.13963			15	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse	HR2AV	WOS:000462938800009	30667526	Green Accepted			2022-02-06	
J	Gupta, R; Saha, P; Sen, T; Sen, N				Gupta, Rajaneesh; Saha, Pampa; Sen, Tanusree; Sen, Nilkantha			An augmentation in histone dimethylation at lysine nine residues elicits vision impairment following traumatic brain injury	FREE RADICAL BIOLOGY AND MEDICINE			English	Article							RETINAL GANGLION-CELLS; ANTIOXIDANT RESPONSE ELEMENT; OXIDATIVE STRESS; OPTIC-NERVE; METHYLTRANSFERASE ACTIVITY; AXONAL-TRANSPORT; NRF2; METHYLATION; SURVIVAL; MYELIN	Traumatic Brain Injury (TBI) affects more than 1.7 million Americans each year and about 30% of TBI-patients having visual impairments. The loss of retinal ganglion cells (RGC) in the retina and axonal degeneration in the optic nerve have been attributed to vision impairment following TBI; however, the molecular mechanism has not been elucidated. Here we have shown that an increase in histone di-methylation at lysine 9 residue (H3K9Me2), synthesized by the catalytic activity of a histone methyltransferase, G9a is responsible for RGC loss and axonal degeneration in the optic nerve following TBI. To elucidate the molecular mechanism, we found that an increase in H3K9Me2 results in the induction of oxidative stress both in the RGC and optic nerve by decreasing the mRNA level of antioxidants such as Superoxide dismutase (sod) and catalase through impairing the transcriptional activity of Nuclear factor E2-related factor 2 (Nrf2) via direct interaction. The induction of oxidative stress is associated with death in RGC and oligodendrocyte precursor cells (OPCs). The death in OPCs is correlated with a reduction in myelination, and the expression of myelin binding protein (MBP) in association with degeneration of neurofilaments in the optic nerve. This event allied to an impairment of the retrograde transport of axons and loss of nerve fiber layer in the optic nerve following TBI. An administration of G9a inhibitor, UNC0638 attenuates the induction of H3K9Me2 both in RGC and optic nerve and subsequently activates Nrf2 to reduce oxidative stress. This event was concomitant with the rescue in the loss of retinal thickness, attenuation in optic nerve degeneration and improvement in the retrograde transport of axons following TBI.	[Gupta, Rajaneesh; Saha, Pampa; Sen, Tanusree; Sen, Nilkantha] Univ Pittsburgh, Dept Neurol Surg, 200 Lothrop St,Scaife Hall, Pittsburgh, PA 15213 USA		Sen, N (corresponding author), Univ Pittsburgh, Dept Neurol Surg, 200 Lothrop St,Scaife Hall, Pittsburgh, PA 15213 USA.	senn@pitt.edu	Gupta, Rajaneesh/AAD-5893-2019; Sen, Nilkantha/AAW-9788-2020	Gupta, Rajaneesh/0000-0003-0212-6478; 	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1NS094516]; NIH/NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY025622]; NIH CORE GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 EY08098]; Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness, New York, NYResearch to Prevent Blindness (RPB); NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY008098, R01EY025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094516] Funding Source: NIH RePORTER	We would like to like to acknowledge funding from NIH/NINDS (RO1NS094516) and NIH/NEI (R01EY025622) to N.S. We want to thank Kira Lathrop from the Department of Opthalmology for her generous help to perform confocal analysis and SD-OCT analysis. This work was also supported by NIH CORE Grant P30 EY08098 to the Department of Ophthalmology, the Eye and Ear Foundation of Pittsburgh, and from an unrestricted grant from Research to Prevent Blindness, New York, NY	AITKEN RJ, 1993, MOL REPROD DEV, V35, P302, DOI 10.1002/mrd.1080350313; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Batliwala S, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1703810; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Callaway EM, 2005, J PHYSIOL-LONDON, V566, P13, DOI 10.1113/jphysiol.2005.088047; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chen H, 2001, INVEST OPHTH VIS SCI, V42, P966; Chidlow G, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00478; Chidlow G, 2011, ACTA NEUROPATHOL, V121, P737, DOI 10.1007/s00401-011-0807-1; Chintalapudi SR, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00093; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; David JA, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/4826724; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Erskine L, 2014, ASN NEURO, V6, DOI 10.1177/1759091414562107; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Gazaryan IG, 2016, NEURAL REGEN RES, V11, P1708, DOI 10.4103/1673-5374.194706; Giacci M, 2018, J EXP NEUROSCI, V12, DOI 10.1177/1179069518810004; Giacci MK, 2018, J NEUROSCI, V38, P6491, DOI 10.1523/JNEUROSCI.1898-17.2018; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Himori N, 2013, J NEUROCHEM, V127, P669, DOI 10.1111/jnc.12325; Hu R, 2006, LIFE SCI, V79, P1944, DOI 10.1016/j.lfs.2006.06.019; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jadeja RN, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3453926; Juarez AL, 2016, BRAIN RES, V1638, P209, DOI 10.1016/j.brainres.2015.10.051; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Katoh K, 2012, J NEUROSCI, V32, P17658, DOI 10.1523/JNEUROSCI.1869-12.2012; Kawai S, 2014, APL MATER, V2, DOI 10.1063/1.4869035; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kondadi AK, 2014, EMBO J, V33, P1011, DOI 10.1002/embj.201387009; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Louis ED, 2012, NEUROSCI LETT, V518, P49, DOI 10.1016/j.neulet.2012.04.054; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Marty MC, 2002, P NATL ACAD SCI USA, V99, P8856, DOI 10.1073/pnas.122079599; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; Mir S, 2014, MOL CELL, V56, P786, DOI 10.1016/j.molcel.2014.10.019; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Monsma PC, 2012, J NEUROSCI METH, V209, P344, DOI 10.1016/j.jneumeth.2012.06.015; Morgan JE, 2004, EYE, V18, P1089, DOI 10.1038/sj.eye.6701574; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Pelzel HR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-62; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Qin Q, 2008, PROSTAG LEUKOTR ESS, V79, P201, DOI 10.1016/j.plefa.2008.09.022; Ravera S, 2015, FREE RADICAL RES, V49, P1156, DOI 10.3109/10715762.2015.1050962; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Roberts PS, 2016, J REHABIL RES DEV, V53, P693, DOI 10.1682/JRRD.2015.06.0113; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Saha P, 2018, NEUROBIOL DIS, V118, P108, DOI 10.1016/j.nbd.2018.07.010; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; Sen N, 2017, NEUROCHEM INT, V111, P103, DOI 10.1016/j.neuint.2017.01.019; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Sen T, 2016, NEUROPHARMACOLOGY, V107, P79, DOI 10.1016/j.neuropharm.2016.03.009; Sharma M, 2017, CEREB CORTEX, V27, P3161, DOI 10.1093/cercor/bhw170; Shi JY, 1998, J NEUROSCI, V18, P4627; Stowell Cheri, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P148; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Takemura N, 2002, PHOTOCHEM PHOTOBIOL, V76, P657, DOI 10.1562/0031-8655(2002)076&lt;0657:DBNTAL&gt;2.0.CO;2; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P3859, DOI 10.1167/iovs.05-0672; Tao WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12225-6; Tsai RK, 2008, EXP EYE RES, V87, P242, DOI 10.1016/j.exer.2008.06.004; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Ueda H, 1999, J CELL BIOL, V146, P1365, DOI 10.1083/jcb.146.6.1365; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Wang SW, 2002, DEVELOPMENT, V129, P467; Watson AB, 2014, J VISION, V14, DOI 10.1167/14.7.15; Wegener A, 2015, BRAIN, V138, P120, DOI 10.1093/brain/awu375; Xu ZH, 2015, J NEUROCHEM, V133, P233, DOI 10.1111/jnc.13064; Xu ZH, 2014, DIABETOLOGIA, V57, P204, DOI 10.1007/s00125-013-3093-8; Yu DY, 2005, EXP EYE RES, V80, P745, DOI 10.1016/j.exer.2005.01.018; Yun HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107446; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	86	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	APR	2019	134						630	643		10.1016/j.freeradbiomed.2019.02.015			14	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	ID6WQ	WOS:000471822700055	30790655	Green Accepted			2022-02-06	
J	Howell, DR; Oldham, JR; Brilliant, AN; Meehan, WP				Howell, David R.; Oldham, Jessie R.; Brilliant, Anna N.; Meehan, William P.			Trouble Falling Asleep After Concussion Is Associated With Higher Symptom Burden Among Children and Adolescents	JOURNAL OF CHILD NEUROLOGY			English	Article						head injury; pediatric sports medicine; mild traumatic brain injury; sleep disturbance	DUAL-TASK GAIT; HIGH-SCHOOL; RECOVERY; DURATION; RETURN; RISK	Our objective was to identify factors associated with trouble falling asleep postconcussion. Patients seen for care after sport-related concussion were assessed <= 10 days postinjury and were between 6 and 19 years of age. Outcomes included symptoms (Post-Concussion Symptom Scale), postural steadiness, missed school, and medical history. There were 261 patients (49% female; mean age=14.8 +/- 2.5 years): 45% reported trouble falling asleep. A greater proportion of patients who reported trouble falling asleep missed >= 2 days of school (64% vs 49%; P = .02). Patients who reported trouble falling asleep endorsed more severe symptom severity than those who did not (median=38 vs 18; P < .001). After covariate adjustment, confusion (aOR = 1.95, 95% CI = 1.131-3.375), missing >= 2 days of school (aOR = 4.52, 95% CI = 1.553-13.16), and noise sensitivity (aOR = 1.48, 95% CI = 1.1.042-2.010) were independently associated with trouble falling asleep. Sleep disturbances are associated with poorer clinical outcomes after concussion. Inclusion of sleep assessments may help to provide early therapeutic pathways for pediatric concussion patients.	[Howell, David R.] Childrens Hosp Colorado, Ctr Sports Med, 13123 E 16th Ave,B060, Aurora, CO 80045 USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Howell, David R.; Oldham, Jessie R.; Brilliant, Anna N.; Meehan, William P.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Oldham, Jessie R.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Oldham, Jessie R.; Brilliant, Anna N.; Meehan, William P.] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA; [Meehan, William P.] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA 02115 USA; [Meehan, William P.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Ctr Sports Med, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu		Howell, David/0000-0002-2955-0191	National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; National Football League	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Unrelated to this study, DRH has received research support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development, the National Institute of Neurological Disorders and Stroke, and from a research contract between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and ElMindA Ltd. WPM receives royalties from (1) ABC-Clio publishing for the sale of his books, Kids, Sports, and Concussion: A Guide for Coaches and Parents and Concussions; (2) Springer International for the book Head and Neck Injuries in Young Athletes and (3) Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and the National Football League.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hoffman NL, 2020, CLIN J SPORT MED, V30, pS29, DOI 10.1097/JSM.0000000000000538; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Howell DR, 2017, CLIN J SPORT MED, V27, P444, DOI 10.1097/JSM.0000000000000374; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Howell DR, 2016, J HEAD TRAUMA REHAB, V31, P262, DOI 10.1097/HTR.0000000000000176; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Ming X, 2011, CLIN MED INSIGHTS-CI, V5, P71, DOI 10.4137/CCRPM.S7955; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Register-Mihalik JK, 2015, CLIN J SPORT MED, V25, P502, DOI 10.1097/JSM.0000000000000161; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; Worster A, 2004, ACAD EMERG MED, V11, P187, DOI 10.1197/j.aem.2003.03.002	30	7	7	1	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	APR	2019	34	5					256	261		10.1177/0883073818824000			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	HP4FI	WOS:000461631400003	30669925				2022-02-06	
J	Martin, GE; Pugh, AM; Moran, R; Veile, R; Friend, LA; Pritts, TA; Makley, AT; Caldwell, CC; Goodman, MD				Martin, Grace E.; Pugh, Amanda M.; Moran, Ryan; Veile, Rose; Friend, Lou Ann; Pritts, Timothy A.; Makley, Amy T.; Caldwell, Charles C.; Goodman, Michael D.			Microvesicles generated following traumatic brain injury induce platelet dysfunction via adenosine diphosphate receptor	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	77th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery / 4th World Trauma Congress	SEP 26-29, 2018	San Diego, CA	Amer Assoc Surg Trauma		Traumatic brain injury; microvesicles; platelet aggregability; P2Y(12) receptor; adenosine diphosphate	ACUTE COAGULOPATHY; MURINE MODEL; HEAD-INJURY; MICROPARTICLES; COAGULATION; TRANSFUSION; BLOOD; HEMOSTASIS; ESTROGEN; MARKER	BACKGROUND: Traumatic brain injury (TBI) can result in an acute coagulopathy including platelet dysfunction that can contribute to ongoing intracranial hemorrhage. Previous studies have shown adenosine diphosphate (ADP)-induced platelet aggregation to be reduced after TBI. In addition, circulating microvesicles (MVs) are increased following TBI and have been shown to play a role in post-TBI coagulopathy and platelet function. We hypothesized that post-TBIMVs would affect platelet aggregation in a murine head injury model. METHODS: Moderate TBI was performed using a weight-drop method in male C57BL6 mice. Whole blood, plasma, MVs, and MV-poor plasma were isolated from blood collected 10 minutes following TBI and were mixed separately with whole blood from uninjured mice. Platelet aggregation was measured with Multiplate impedance platelet aggregometry in response to ADP. The ADP P2Y(12) receptor inhibitor, R-138727, was incubated with plasma and MVs from TBI mice, and platelet inhibition was again measured. RESULTS: Whole blood taken from 10-minute post-TBI mice demonstrated diminished ADP-induced platelet aggregation compared with sham mice. When mixed with normal donor blood, post-TBI plasma and MVs induced diminished ADP-induced platelet aggregation compared with shamplasma and shamMVs. By contrast, the addition of post-TBIMV-poor plasma to normal blood did not change ADP-induced platelet aggregation. The observed dysfunction in post-TBI ADP platelet aggregation was prevented by the pretreatment of post-TBI plasma with R-138727. Treatment of post-TBI MVs with R-138727 resulted in similar findings of improved ADP-induced platelet aggregation compared with nontreated post-TBI MVs. CONCLUSION: Adenosine diphosphate-induced platelet aggregation is inhibited acutely following TBI in a murine model. This platelet inhibition is reproduced in normal blood by the introduction of post-TBI plasma and MVs. Furthermore, observed platelet dysfunction is prevented when post-TBI plasma and MVs are treated with an inhibitor of the P2Y12 ADP receptor. Clinically observed postTBI platelet dysfunction may therefore be partially explained by the presence of the ADP P2Y12 receptor within post-TBI MVs.	[Martin, Grace E.; Pugh, Amanda M.; Moran, Ryan; Veile, Rose; Friend, Lou Ann; Pritts, Timothy A.; Makley, Amy T.; Caldwell, Charles C.; Goodman, Michael D.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA		Goodman, MD (corresponding author), Univ Cincinnati, Sect Gen Surg, Dept Surg, 231 Albert SabinWay,ML 0558, Cincinnati, OH 45267 USA.	goodmamd@ucmail.uc.edu		Pritts, Timothy/0000-0003-2495-3255	NIH/NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM124156-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM124156] Funding Source: NIH RePORTER	NIH/NIGMS R01 GM124156-01A1 (M.D.G.).	Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Baharoglu MI, 2017, TRANSFUS MED REV, V31, P236, DOI 10.1016/j.tmrv.2017.07.002; Belizaire RM, 2012, J AM COLL SURGEONS, V214, P648, DOI 10.1016/j.jamcollsurg.2011.12.032; Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Burnier L, 2009, THROMB HAEMOSTASIS, V101, P439, DOI 10.1160/TH08-08-0521; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chang R, 2018, SURGERY, V163, P819, DOI 10.1016/j.surg.2017.10.050; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Donahue DL, 2014, J NEUROTRAUM, V31, P404, DOI 10.1089/neu.2013.3089; Gryglewski RJ, 2008, PHARMACOL REP, V60, P3; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Luddington RJ, 2005, CLIN LAB HAEMATOL, V27, P81, DOI 10.1111/j.1365-2257.2005.00681.x; Maani CV, 2009, CURR OPIN ANESTHESIO, V22, P255, DOI 10.1097/ACO.0b013e32832922be; Martin G, 2018, NEUROCRIT CARE, V28, P330, DOI 10.1007/s12028-017-0485-5; Martin GE, 2018, SHOCK, V50, P551, DOI 10.1097/SHK.0000000000001056; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Midura EF, 2015, J SURG RES, V197, P25, DOI 10.1016/j.jss.2015.02.064; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Nekludov M, 2014, J NEUROTRAUM, V31, P1927, DOI 10.1089/neu.2013.3168; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Stettler GR, 2017, SURGERY, V162, P1286, DOI 10.1016/j.surg.2017.07.022; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; TANS G, 1991, BLOOD, V77, P2641; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Wafaisade A, 2010, EMERG MED J, V27, P934, DOI 10.1136/emj.2009.088484; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Woulfe D, 2001, J CLIN INVEST, V107, P1503, DOI 10.1172/JCI13361; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075	33	7	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2019	86	4					592	600		10.1097/TA.0000000000002171			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	HR5QD	WOS:000463201000005	30614923	Green Accepted			2022-02-06	
J	Mesghali, E; Fitter, S; Bahjri, K; Moussavi, K				Mesghali, Elhaam; Fitter, Scott; Bahjri, Khaled; Moussavi, Kayvan			SAFETY OF PERIPHERAL LINE ADMINISTRATION OF 3% HYPERTONIC SALINE AND MANNITOL IN THE EMERGENCY DEPARTMENT	JOURNAL OF EMERGENCY MEDICINE			English	Article						hypertonic saline; mannitol; intravenous; emergency department; medication safety; extravasation	MANAGEMENT	Background: Hypertonic saline (HTS) and mannitol are frequently utilized in the emergency department (ED) to manage elevations in intracranial pressure (ICP). Objective: The objective of this study was to compare the incidence of extravasation injury when HTS or mannitol was administered via peripheral i.v. line (PIV). Methods: This retrospective cohort study evaluated adult and pediatric patients given either 3% HTS or mannitol via PIV while in the ED. The primary outcome was extravasation incidence. Results: One hundred and ninety-two patients were included, of which 85 (44%) received HTS and 107 (56%) received mannitol. Patients who received HTS were younger (27.5 +/- 24.3 years vs. 53.9 +/- 22.3 years; p < 0.001); 55.3% of patients given HTS received it for traumatic brain injury (TBI) versus 38.3% of patients given mannitol (p = 0.021); and 44.9% of patients given mannitol received it for intracerebral hemorrhage versus 21.2% of patients given HTS (p = 0.001). There was no incidence of extravasation in either group. Patients who received HTS had lower ICP measurement 24 h post admission (2.107 +/- 5.5 mm Hg vs. 4.236 +/- 8.1 mm Hg; p = 0.047) and higher Glasgow Coma Scale (GCS) score upon discharge (GCS 14; interquartile range [IQR] 3-15 vs. GCS 3; IQR 3-14.2; p = 0.004). In-hospital mortality was higher in the mannitol group (54.7% vs. 32.9%; p = 0.003). Duration of mechanical ventilation was shorter in those patients who received HTS (1 day; IQR 0-56 days vs. 2 days; IQR 0-56 days; p = 0.023). Conclusions: There were no incidences of extravasation among patients given 3% HTS or mannitol. Clinicians should reconsider recommendations to restrict HTS or mannitol to central lines. (C) 2018 Elsevier Inc. All rights reserved.	[Mesghali, Elhaam] Loma Linda Univ, Sch Pharm, Loma Linda, CA 92350 USA; [Fitter, Scott] Loma Linda Univ, Med Ctr, Loma Linda, CA USA; [Bahjri, Khaled] Loma Linda Univ, Sch Pharm, Dept Pharmaceut & Adm Sci, Loma Linda, CA 92350 USA; [Moussavi, Kayvan] Marshall B Ketchum Univ, Dept Pharm Practice, Coll Pharm, 2575 Yorba Linda Blvd, Fullerton, CA 92831 USA		Moussavi, K (corresponding author), Marshall B Ketchum Univ, Dept Pharm Practice, Coll Pharm, 2575 Yorba Linda Blvd, Fullerton, CA 92831 USA.			Bahjri, Khaled/0000-0002-4422-1687			Alnemari AM, 2017, WORLD NEUROSURG, V106, P509, DOI 10.1016/j.wneu.2017.07.009; [Anonymous], 2005, OSM INJ MANN INJ PAC; [Anonymous], 2016, J INFUS NURS, V39, P1; [Anonymous], 2017, MANN INJ 25 PACK INS; [Anonymous], 2005, 3 5 SOD CHLOR INJ PA; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Dillon RC, 2018, J INTENSIVE CARE MED, V33, P48, DOI 10.1177/0885066617702590; Jones GM, 2017, AM J CRIT CARE, V26, P37, DOI 10.4037/ajcc2017439; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Luu JL, 2011, PEDIATR EMERG CARE, V27, P1113, DOI 10.1097/PEC.0b013e31823aff59; Perez CA, 2017, J NEUROSCI NURS, V49, P191, DOI 10.1097/JNN.0000000000000286; Reynolds PM, 2014, PHARMACOTHERAPY, V34, P617, DOI 10.1002/phar.1396	12	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	APR	2019	56	4					431	436		10.1016/j.jemermed.2018.12.046			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HS6YO	WOS:000464017400019	30745195				2022-02-06	
J	Oleck, NC; Dobitsch, AA; Liu, FC; Halsey, JN; Le, TMT; Hoppe, IC; Lee, ES; Granick, MS				Oleck, Nicholas C.; Dobitsch, Andrew A.; Liu, Farrah C.; Halsey, Jordan N.; Le, Thuy-My T.; Hoppe, Ian C.; Lee, Edward S.; Granick, Mark S.			Traumatic Falls in the Pediatric Population Facial Fracture Patterns Observed in a Leading Cause of Childhood Injury	ANNALS OF PLASTIC SURGERY			English	Article						facial fracture; facial trauma; falls	ORBITAL FRACTURES; MANAGEMENT; CHILDREN; EPIDEMIOLOGY; VIOLENCE	Purpose: Falls are a leading cause of nonfatal injury in the pediatric population, resulting in numerous hospitalizations. Children may not have fully developed reflexive and balancing abilities, rendering them more susceptible to traumatic falls. Here the authors present their findings regarding patterns of facial fracture and concomitant injury seen in the pediatric population secondary to falls. Methods: A retrospective chart review was performed of all facial fractures as a result of falls in the pediatric population in a level 1 trauma center in an urban environment (University Hospital in Newark, NJ). Patient demographics were collected, as well as location of fractures, concomitant injuries, and surgical management strategies. Results: Fifty-five patients were identified as 18 years or younger and having sustained a facial fracture as the result of a fall. This cohort was compared with 418 pediatric patients with facial fractures due to nonfall etiologies. The mean age was 9.6 years (range, 0-18 years), with a male predominance of 67.3%. There were a total of 70 fractures identified on radiological imaging. The most frequently fractured bones were the orbit (n = 27), nasal bone (n = 15), and mandible (n = 11). Orbital and frontal sinus fractures each occurred more frequently due to falls compared with all other causes of injury. Patients with orbital fractures were significantly more likely to present with an additional facial fracture compared with those without (P < 0.01). The most common concomitant injuries were traumatic brain injury, skull fracture, and intracranial hemorrhage. Patients who suffered a facial fracture due to a fall were significantly more likely to sustain a concomitant skull fracture (P < 0.05) and intra-abdominal injury (P < 0.05) compared with all other etiologies. Fourteen patients required surgical intervention. One patient died. Conclusions: Pediatric facial fractures are a unique entity. The general plasticity of the pediatric anatomy can predispose patients to significant injury without obvious external signs. A high level of clinical suspicion is required to avoid misdiagnosis and delay of treatment. The authors hope this study can address a preventable issue in child safety, educate caregivers, and provide insight towards fracture management that fosters functional and aesthetic recovery.	[Oleck, Nicholas C.; Dobitsch, Andrew A.; Liu, Farrah C.; Halsey, Jordan N.; Le, Thuy-My T.; Lee, Edward S.; Granick, Mark S.] Rutgers New Jersey Med Sch, Dept Surg, Div Plast & Reconstruct Surg, Newark, NJ USA; [Hoppe, Ian C.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA		Oleck, NC (corresponding author), Rutgers New Jersey Med Sch, 185 S Orange Ave, Newark, NJ 07103 USA.	nco32@njms.rutgers.edu	Halsey, Jordan N/D-2545-2011	Halsey, Jordan N/0000-0001-5513-5162			Bisson JI, 1997, J TRAUMA, V43, P496, DOI 10.1097/00005373-199709000-00018; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Chandler DB, 2001, INT OPHTHALMOL CLIN, V41, P87, DOI 10.1097/00004397-200110000-00010; Cubbin C, 2000, AM J PUBLIC HEALTH, V90, P70, DOI 10.2105/AJPH.90.1.70; Ferreira PC, 2005, PLAST RECONSTR SURG, V115, P1500, DOI 10.1097/01.PRS.0000160268.20294.FD; Gassner R, 2004, J ORAL MAXIL SURG, V62, P399, DOI 10.1016/j.joms.2003.05.013; Grunwaldt L, 2011, PLAST RECONSTR SURG, V128, P1263, DOI 10.1097/PRS.0b013e318230c8cf; Hajiaghamemar M, 2019, INT J LEGAL MED, V133, P847, DOI 10.1007/s00414-018-1918-1; Haug RH, 2000, ORAL SURG ORAL MED O, V90, P126, DOI 10.1067/moe.2000.107974; Hoppe IC, 2014, J CRANIOFAC SURG, V25, P1825, DOI 10.1097/SCS.0000000000001055; Loberg JA, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012606; Losee JE, 2008, PLAST RECONSTR SURG, V122, P886, DOI 10.1097/PRS.0b013e3181811e48; Mericli AF, 2011, J CRANIOFAC SURG, V22, P1342, DOI 10.1097/SCS.0b013e31821c944c; Miller AF, 2018, PEDIATR EMERG CARE, V34, P21, DOI 10.1097/PEC.0000000000001306; Neligan P, 2018, PLASTIC SURG; Oji C, 1998, J CRANIO MAXILL SURG, V26, P322, DOI 10.1016/S1010-5182(98)80062-0; Oleck NC, 2018, AM SURGEON, V84, pE254; Peden M, 2008, WORLD REPORT CHILD I; Prowse SJB, 2010, J PLAST RECONSTR AES, V63, P1105, DOI 10.1016/j.bjps.2009.05.057; Ryan ML, 2011, J CRANIOFAC SURG, V22, P1183, DOI 10.1097/SCS.0b013e31821c0d52; Shaikh ZS, 2002, INJURY, V33, P669, DOI 10.1016/S0020-1383(01)00201-7; Wong FK, 2016, J CRANIOFAC SURG, V27, P128, DOI 10.1097/SCS.0000000000002185; Wright RJ, 2011, FACIAL PLAST SURG, V27, P483, DOI 10.1055/s-0031-1288931	23	7	7	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	APR	2019	82			3			S195	S198		10.1097/SAP.0000000000001861			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	IF7QP	WOS:000473279100007	30730318				2022-02-06	
J	Ribeiro, CJN; Lima, AGCF; de Araujo, RAS; Nunes, MD; Alves, JAB; Dantas, DV; Ribeiro, MDD				Ribeiro, Caique J. N.; Fontes Lima, Alanna G. C.; Santiago de Araujo, Raphael A.; Nunes, Mariangela da Silva; Barreto Alves, Jose A.; Dantas, Daniele Vieira; de Oliveira Ribeiro, Maria do C.			Psychometric Properties of the Behavioral Pain Scale in Traumatic Brain Injury	PAIN MANAGEMENT NURSING			English	Article							INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; PHYSIOLOGICAL INDICATORS; MANAGEMENT ALGORITHM; POSITION STATEMENT; BRAZILIAN VERSION; COMMON PROCEDURES; VITAL SIGNS; VALIDATION; SEDATION	Background: Pain assessment of patients with traumatic brain injury is a challenge because they are unable to self-report their pain experience. Aims: To investigate the psychometric properties of validity, reliability, and responsiveness of the Brazilian version of the Behavioral Pain Scale (BPS-Br) in patients with traumatic brain injury. Methods: This was an observational, cross-sectional, repeated-measure and analytical study. This study was developed at the medical and surgical ICUs in a high-complexity public hospital at Aracaju, Sergipe, Brazil. Thirty-seven adult patients with moderate or severe TBI were included. This study was completed with 444 independent observations, a pairwise comparison, and was performed simultaneously before, during, and after eye cleaning and endotracheal suctioning of 37 adult patients with moderate to severe traumatic brain injury. Results: The BPS-Br had good internal consistency (.7 <= alpha <= .9), good discriminant validity (p < .001), moderate to excellent reliability based on inter-rater agreement (intraclass correlation coefficient = 0.66-1.00; kappa = 0.5-1.0), and high responsiveness (0.7-1.7). The upper limbs subscale had the highest score during the nociceptive procedure (1.8 +/- 0.9). Deep sedation affected the increase of grading during painful procedures (p < .001). Conclusions: Our results suggest the BPS-Br is a useful tool for clinical practice to evaluate the pain experienced by patients with traumatic brain injury. Further studies of different samples are needed to evaluate the benefits of systematic pain assessment of critically ill patients. (C) 2019 American Society for Pain Management Nursing. Published by Elsevier Inc. All rights reserved.	[Ribeiro, Caique J. N.; Fontes Lima, Alanna G. C.] Univ Fed Sergipe, Postgrad Program Hlth Sci, Sergipe, Brazil; [Santiago de Araujo, Raphael A.; Barreto Alves, Jose A.; Dantas, Daniele Vieira] Univ Fed Sergipe, Dept Med, Sergipe, Brazil; [Nunes, Mariangela da Silva; de Oliveira Ribeiro, Maria do C.] Univ Fed Sergipe, Postgrad Program Nursing, Sergipe, Brazil		Ribeiro, CJN (corresponding author), Univ Fed Sergipe, Teaching Hosp, Postgrad Program Hlth Sci, Claudio Batista St, Aracaju, Sergipe, Brazil.	caiquejordan_enf@yahoo.com.br	Ribeiro, Caique JN/O-1899-2017; Dantas, Daniele Vieira/AAW-9644-2020	Ribeiro, Caique JN/0000-0001-9767-3938; Vieira Dantas, Daniele/0000-0003-0307-2424			Aissaoui Y, 2005, ANESTH ANALG, V101, P1470, DOI 10.1213/01.ANE.0000182331.68722.FF; Al Darwish ZQ, 2016, AACN ADV CRIT CARE, V27, P162, DOI 10.4037/aacnacc2016287; Arbour C, 2014, PAIN RES TREAT, V2014, P1; Arbour C, 2014, CLIN J PAIN, V30, P960, DOI 10.1097/AJP.0000000000000061; Arbour C, 2014, PAIN MANAG NURS, V15, P506, DOI 10.1016/j.pmn.2012.03.004; Arif-Rahu Mamoona, 2010, Intensive Crit Care Nurs, V26, P343, DOI 10.1016/j.iccn.2010.08.007; Azevedo-Santos IF, 2016, PAIN PRACT, V16, P451, DOI 10.1111/papr.12287; Azevedo-Santos IF, 2017, REV BRAS ANESTESIOL, V67, P271, DOI [10.1016/j.bjane.2015.11.003, 10.1016/j.bjan.2015.11.006]; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Boitor M, 2016, J CARDIOVASC NURS, V31, P425, DOI 10.1097/JCN.0000000000000250; Chen HJ, 2015, PAIN MANAG NURS, V16, P105, DOI 10.1016/j.pmn.2014.05.012; Chen YY, 2011, INT J NURS STUD, V48, P438, DOI 10.1016/j.ijnurstu.2010.07.016; Choi J, 2014, J PAIN SYMPTOM MANAG, V47, P257, DOI 10.1016/j.jpainsymman.2013.03.019; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Czarnecki ML, 2011, PAIN MANAG NURS, V12, P95, DOI 10.1016/j.pmn.2011.02.003; GELINAS C, 2009, J CRIT CARE, V24, P628; Gelinas C, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.01.013; Georgiou E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/503830; Herr K, 2006, PAIN MANAG NURS, V7, P44, DOI 10.1016/j.pmn.2006.02.003; Kapoustina O, 2014, J ADV NURS, V70, P2562, DOI 10.1111/jan.12409; Le Q, 2013, PAIN MANAG NURS, V14, pE251, DOI 10.1016/j.pmn.2012.02.005; Merskey H., 2012, CLASSIFICATION CHRON, P209; Navarro-Colom M, 2015, ENFERM INTENSIV, V26, P24, DOI 10.1016/j.enfi.2014.10.002; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Olsen BE, 2015, HEART LUNG, V44, P528, DOI 10.1016/j.hrtlng.2015.08.001; Olsen BF, 2015, HEART LUNG, V44, P521, DOI 10.1016/j.hrtlng.2015.09.001; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; Puntillo K A, 2001, Am J Crit Care, V10, P238; Puntillo KA, 2004, CRIT CARE MED, V32, P421, DOI 10.1097/01.CCM.0000108875.35298.D2; Rahu MA, 2013, AM J CRIT CARE, V22, P412, DOI 10.4037/ajcc2013705; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Rijkenberg S, 2015, J CRIT CARE, V30, P167, DOI 10.1016/j.jcrc.2014.09.007; Roulin MJ, 2015, PAIN MANAG NURS, V16, P221, DOI 10.1016/j.pmn.2014.06.003; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Sigakis MJG, 2015, CRIT CARE MED, V43, P2468, DOI 10.1097/CCM.0000000000001256; Stites M, 2013, CRIT CARE NURSE, V33, P68, DOI 10.4037/ccn2013804; Wiatrowski R, 2016, PAIN MANAG NURS, V17, P204, DOI 10.1016/j.pmn.2016.02.052; 2016, INTENSIVE CRITICAL C, V34, P1, DOI DOI 10.1016/J.ICCN.2016.03.001; 2008, PAIN MANAGEMENT NURS, V9, P120, DOI DOI 10.1016/J.PMN.2007.12.001; 2016, ACTA ANAESTHESIOLOGI, V60, P821, DOI DOI 10.1111/AAS.12688	40	7	7	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1524-9042	1532-8635		PAIN MANAG NURS	Pain Manag. Nurs.	APR	2019	20	2					152	157		10.1016/j.pmn.2018.09.004			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	HV6NS	WOS:000466100700065	30528364				2022-02-06	
J	Tiwari, D; Goldberg, A; Yorke, A; Marchetti, GF; Alsalaheen, B				Tiwari, Devashish; Goldberg, Allon; Yorke, Amy; Marchetti, Gregory F.; Alsalaheen, Bara			CHARACTERIZATION OF CERVICAL SPINE IMPAIRMENTS IN CHILDREN AND ADOLESCENTS POST-CONCUSSION	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Cervicogenic; movement system; traumatic brain injury; youth	HIGH-SCHOOL FOOTBALL; CERVICOCEPHALIC KINESTHETIC SENSIBILITY; NECK FLEXOR ENDURANCE; DIAGNOSTIC-ACCURACY; CLINICAL-ASSESSMENT; DISABILITY INDEX; BEIGHTON SCORE; NORMATIVE DATA; ACTIVE RANGE; RELIABILITY	Background: Patients with concussion may present with cervical spine impairments, therefore accurate characterization of cervical post-concussion impairments is needed to develop targeted physical therapy interventions. Purpose: To characterize the type, frequency and severity of cervical impairments in children and adolescents referred for physical therapy after concussion. Study design: Retrospective, descriptive study Methods: A retrospective analysis was conducted for 73 consecutive children and adolescents who received cervical physical therapy following a concussion. Data was classified into six broad categories. The frequency and intensity of cervical impairments within and across the categories was reported. Results: Ninety percent of patients demonstrated impairments in at least three out of five assessment categories whereas 55% demonstrated impairments in at least four out five assessment categories. Of the five assessment categories, posture (99%) and myofascial impairment (98%) demonstrated highest impairment frequency followed by joint mobility (86%) and muscle strength (62%). Cervical joint proprioception was the least commonly evaluated assessment category. Conclusion: High prevalence of cervical spine impairments was observed in the subjects included in this study with muscle tension, joint mobility, and muscle strength being most commonly affected. The categories of impairments examined in this cohort were consistent with the recommendations of the most recent clinical practice guidelines for neck pain. This study provides preliminary data to support the framework for a cervical spine evaluation tool in children and adolescents following concussion.	[Tiwari, Devashish] Massachusetts Coll Pharm & Hlth Sci, 10 Lincoln Sq, Worcester, MA 01608 USA; [Goldberg, Allon; Yorke, Amy; Alsalaheen, Bara] Univ Michigan, Flint, MI 48503 USA; [Marchetti, Gregory F.] Duquesne Univ, Pittsburgh, PA 15219 USA		Tiwari, D (corresponding author), Massachusetts Coll Pharm & Hlth Sci, 10 Lincoln Sq, Worcester, MA 01608 USA.	devashit@umflint.edu	Yorke, Amy/Q-4091-2019	Yorke, Amy/0000-0003-4998-0313			Aartun E, 2014, BMC MUSCULOSKEL DIS, V15, P15; Anttila P, 2002, CEPHALALGIA, V22, P340, DOI 10.1046/j.1468-2982.2002.00352.x; Armstrong B, 2008, SPORTS MED, V38, P101, DOI 10.2165/00007256-200838020-00002; ASPINALL W, 1990, Journal of Orthopaedic and Sports Physical Therapy, V12, P47; Bailes JE, 2007, J ATHL TRAINING, V42, P126; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlow KM, PEDIATRICS; Blanpied Peter R, 2017, J Orthop Sports Phys Ther, V47, pA1, DOI 10.2519/jospt.2017.0302; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; BURDI AR, 1969, J BIOMECH, V2, P267, DOI 10.1016/0021-9290(69)90083-9; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Coles W., 2018, PAEDIAT CHILD HLTH, V28, P50, DOI [DOI 10.1016/J.PAED.2017.12.001, 10.1016/j.paed.2017.12.001]; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Conable KM, 2011, J CHIROPR MED, V10, P157, DOI 10.1016/j.jcm.2011.04.001; Cook CE, 2012, MANUAL THER, V17, P325, DOI 10.1016/j.math.2012.02.020; Cox Jocelyn, 2016, J Can Chiropr Assoc, V60, P212; Daenen L, 2013, J REHABIL MED, V45, P113, DOI 10.2340/16501977-1091; Domenech MA, 2011, PM&R, V3, P105, DOI 10.1016/j.pmrj.2010.10.023; Dutton M., 2017, DUTTONS ORTHOPAEDIC; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Evans AM, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-1; Fares Jawad, 2017, Surg Neurol Int, V8, P72, DOI 10.4103/sni.sni_445_16; Faul M, 2010, INJ PREV S1, V16, pA1; Fischer AA, 1998, WORLD C PAIN NEW YOR; GONNELLA C, 1982, PHYS THER, V62, P436, DOI 10.1093/ptj/62.4.436; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hamilton DF, 2012, BONE JOINT RES, V1, P152, DOI 10.1302/2046-3758.17.2000079; Harris KD, 2005, PHYS THER, V85, P1349, DOI 10.1093/ptj/85.12.1349; Heikkila HV, 1998, ARCH PHYS MED REHAB, V79, P1089, DOI 10.1016/S0003-9993(98)90176-9; Helgadottir H, 2010, J ORTHOP SPORT PHYS, V40, P784, DOI 10.2519/jospt.2010.3405; Hrysomallis C, 2016, SPORTS MED, V46, P1111, DOI 10.1007/s40279-016-0490-4; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Humphreys BK, 2008, J MANIP PHYSIOL THER, V31, P540, DOI 10.1016/j.jmpt.2008.08.007; Hutting N, 2013, PHYS THER, V93, P1686, DOI 10.2522/ptj.20130186; Jarman NF, 2017, PM&R, V9, P969, DOI 10.1016/j.pmrj.2017.02.002; Johansson F, 2006, MANUAL THER, V11, P331, DOI 10.1016/j.math.2005.06.014; Jull GA, 2008, J MANIP PHYSIOL THER, V31, P525, DOI 10.1016/j.jmpt.2008.08.003; Kaale BR, 2008, MANUAL THER, V13, P397, DOI 10.1016/j.math.2007.03.007; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Kristjansson E, 2001, Physiother Res Int, V6, P224, DOI 10.1002/pri.230; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Kvale A., 2003, ADV PHYSIOTHER, V5, P122; Lavallee AV, 2013, J BIOMECH, V46, P527, DOI 10.1016/j.jbiomech.2012.09.029; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Lee HY, 2006, MANUAL THER, V11, P61, DOI 10.1016/j.math.2005.03.008; Leslie O, 2013, CLIN J SPORT MED, V23, P331, DOI 10.1097/JSM.0b013e318295bbb1; MacDermid JC, 2009, J ORTHOP SPORT PHYS, V39, P400, DOI 10.2519/jospt.2009.2930; Magee DJ., 2008, ORTHOPEDIC PHYS ASSE, V5; Magee DJ., 2008, ORTHOPEDIC PHYS ASSE, V5th ed.; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Morin M, 2016, J SPORTS MED, V2016, P1; Morris SL, 2017, J PEDIATR-US, V181, P213, DOI 10.1016/j.jpeds.2016.09.060; NETZER O, 1993, GERONTOLOGY, V39, P320; Nyland J, 2004, J ATHL TRAINING, V39, P146; O'Neill S, 2017, CHIROPR MAN THER, V25, DOI 10.1186/s12998-017-0159-6; Osiewicz MA, 2018, J ORAL REHABIL, V45, P185, DOI 10.1111/joor.12600; Painkra J, 2014, INT J THER REHABIL, V21, P227, DOI 10.12968/ijtr.2014.21.5.227; Pietrobon B, 2002, SPINE, V27, P515, DOI 10.1097/00007632-200203010-00012; Sara RPA, 2006, MANUAL THER, V11, P321, DOI 10.1016/j.math.2005.09.001; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rihn JA, SPORTS MED; Rubinstein SM, 2007, EUR SPINE J, V16, P307, DOI 10.1007/s00586-006-0225-6; Rudolfsson T, 2011, MAN THER, V17, P53; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Schneider GM, 2014, ARCH PHYS MED REHAB, V95, P1695, DOI 10.1016/j.apmr.2014.02.026; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Smith L, 2016, INT J SPORTS PHYS TH, V11, P156; Smits-Engelsman B, 2011, J PEDIATR-US, V158, P130, DOI 10.1016/j.jpeds.2010.07.021; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Strimpakos N, 2011, J BODYW MOV THER, V15, P114, DOI 10.1016/j.jbmt.2009.06.003; Struyf F, 2011, SCAND J MED SCI SPOR, V21, P352, DOI 10.1111/j.1600-0838.2010.01274.x; Tong HC, 2002, SPINE, V27, P156; TUNKS E, 1995, J RHEUMATOL, V22, P944; van der Giessen LJ, 2001, J RHEUMATOL, V28, P2726; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Wainner RS, 2003, SPINE, V28, P52, DOI 10.1097/00007632-200301010-00014; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537	83	7	7	0	3	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	APR	2019	14	2					282	295		10.26603/ijspt20190282			14	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	IB1KH	WOS:000470023600013	30997280				2022-02-06	
J	Venkateswaran, P; Sriganesh, K; Chakrabarti, D; Srinivas, DB; Rao, GSU				Venkateswaran, Pavithra; Sriganesh, Kamath; Chakrabarti, Dhritiman; Srinivas, Deepti B.; Rao, Ganne S. Umamaheswara			Regional Cerebral Oxygen Saturation Changes After Decompressive Craniectomy for Malignant Cerebral Venous Thrombosis: A Prospective Cohort Study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						cerebral oxygen saturation; near-infrared spectroscopy; decompressive craniectomy; intracranial pressure; cerebral venous thrombosis	NEAR-INFRARED SPECTROSCOPY; BRAIN-TISSUE OXYGEN; INTRACRANIAL-PRESSURE	Background: Decompressive craniectomy (DC) is a life-saving intervention for malignant cerebral venous thrombosis (CVT). Earlier studies have shown increase in cerebral oxygenation after DC in traumatic brain injury but similar studies are lacking in CVT. We hypothesized that regional cerebral (tissue) oxygen saturation (rSO(2)) on the side of CVT is lower than the contralateral side and improves after DC. Materials and Methods: In this prospective cohort study, rSO(2) was monitored using near-infrared spectroscopy technique, before and after DC on both cerebral hemispheres. Data regarding factors likely to affect rSO(2) such as systolic blood pressure, partial pressure of oxygen and carbon dioxide in blood (PaO2 and PaCO2), and hemoglobin were simultaneously collected. The primary outcome measure was pre-post change in rSO(2) on the ipsilateral cerebral hemisphere. The secondary outcomes were in-hospital mortality and duration of postoperative hospital stay. Results: Seventeen patients underwent DC during the 6-month study period. Their mean age was 39.2 +/- 12.4 years. The pre-post DC change in rSO(2) on the hemisphere with CVT was significant (mean difference=3.6%; 95% confidence interval, 1.5-5.7; P=0.002). One patient died in the hospital. There was no difference in the duration of postoperative hospital stay (10 d [range, 6 to 21 d] vs. 14 d [range, 1 to 30 d], P=0.92) between patients with preoperative ipsilateral rSO(2) 60%. There was no correlation between PaO2, PaCO2, systolic blood pressure, and hemoglobin with rSO(2). Conclusions: Patients with malignant CVT had a lower rSO(2) on ipsilateral side of the lesion, which improved significantly after DC. Preoperative rSO(2) was not correlated with the duration of hospital stay.	[Venkateswaran, Pavithra] MS Ramaiah Med Coll, Dept Anaesthesia, Bengaluru, India; [Sriganesh, Kamath; Chakrabarti, Dhritiman; Srinivas, Deepti B.; Rao, Ganne S. Umamaheswara] Natl Inst Mental Hlth & Neurosci, Dept Neuroanaesthesia & Neurocrit Care, Bengaluru, India		Sriganesh, K (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neuroanaesthesia & Neurocrit Care, 3rd Floor,Neurosci Fac Block,Hosur Rd, Bengaluru 560029, Karnataka, India.	drsri23@gmail.com					Aaron S, 2013, J NEUROL NEUROSUR PS, V84, P995, DOI 10.1136/jnnp-2012-303356; Damian MS, 2007, NEUROCRIT CARE, V6, P165, DOI 10.1007/s12028-007-0010-3; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; Figaji AA, 2008, ACTA NEUROCHIR SUPPL, V102, P77, DOI 10.1007/978-3-211-85578-2_15; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Jaeger M, 2005, ACT NEUR S, V95, P117; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Lubillo ST, 2018, J NEUROSURG, V128, P1538, DOI 10.3171/2017.1.JNS161840; Mahale R, 2017, J THROMB THROMBOLYS, V43, P530, DOI 10.1007/s11239-017-1489-x; Reithmeier T, 2005, ACTA NEUROCHIR, V147, P947, DOI 10.1007/s00701-005-0543-1; Slotty PJ, 2015, J NEUROSURG, V123, P59, DOI 10.3171/2014.12.JNS141250; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Theaudin M, 2010, STROKE, V41, P727, DOI 10.1161/STROKEAHA.109.572909; Vivakaran TTR, 2012, J NEUROSURG, V117, P738, DOI 10.3171/2012.6.JNS11102; Weigl W, 2016, J CEREBR BLOOD F MET, V36, P1825, DOI 10.1177/0271678X16667953	17	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	APR	2019	31	2					241	246		10.1097/ANA.0000000000000498			6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	HQ1NQ	WOS:000462165200011	29481444				2022-02-06	
J	Wade, SL; Cassedy, AE; Sklut, M; Taylor, HG; McNally, KA; Kirkwood, MW; Stancin, T; Kurowski, BG				Wade, Shari L.; Cassedy, Amy E.; Sklut, McKenna; Taylor, H. Gerry; McNally, Kelly A.; Kirkwood, Michael W.; Stancin, Terry; Kurowski, Brad G.			The Relationship of Adolescent and Parent Preferences for Treatment Modality With Satisfaction, Attrition, Adherence, and Efficacy: The Coping With Head Injury Through Problem-Solving (CHIPS) Study	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						behavior problems; family therapy; health behavior; randomized control trial; rehabilitation	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; FAMILY INTERVENTION; EXECUTIVE FUNCTION; RANDOMIZED-TRIAL; SELF-REGULATION; TEEN; OUTCOMES; CHILD; BEHAVIOR	Objective To characterize treatment preferences for delivery of family problem-solving treatment (F-PST) to adolescents with behavioral challenges following traumatic brain injury (TBI) and to examine associations with attrition, adherence, satisfaction, and efficacy. Method Adolescents who had been hospitalized for moderate to severe TBI were randomized to face-to-face F-PST (n=34), therapist-guided online F-PST (n=56), and self-guided online F-PST (n=60). Adolescents and parents rated treatment convenience and anticipated benefit before group assignment. Sessions completed served as an index of adherence. Satisfaction was rated posttreatment. The Behavior Rating Inventory of Executive Function and Strengths and Difficulties Questionnaire were used to assess parent-reported behavioral concerns. Results Both parents and adolescents were more likely to agree or strongly agree that they anticipated self-guided online F-PST to be the most convenient relative to either of the therapist-involved approaches. Parents were also less likely to anticipate face-to-face treatment as most beneficial, relative to the two online treatments. Adolescent preferences were significantly related to attrition with 27% versus 13% dropout rates for those assigned to nonpreferred and preferred treatments, respectively. Parent and adolescent preferences before treatment were unrelated to post-intervention satisfaction, adherence, or improvements in parent-reported child behavior problems. Conclusions Online treatments are perceived favorably among adolescents with TBI and their parents. For adolescents, these pretreatment preferences influenced treatment completion. Poor correspondence between initial preferences and posttreatment satisfaction and benefit suggests that therapeutic experience more strongly influences ultimate satisfaction.	[Wade, Shari L.; Cassedy, Amy E.; Sklut, McKenna; Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave MLC 4009, Cincinnati, OH 45229 USA; [Wade, Shari L.; Kurowski, Brad G.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Taylor, H. Gerry] Nationwide Childrens Hosp Res Inst, Columbus, OH USA; [Taylor, H. Gerry; McNally, Kelly A.] Ohio State Univ, Columbus, OH 43210 USA; [Taylor, H. Gerry; Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Univ Hosp Cleveland, Med Ctr, Cleveland, OH USA; [McNally, Kelly A.] Nationwide Childrens Hosp, Columbus, OH USA; [Kirkwood, Michael W.] Univ Colorado, Childrens Hosp Colorado, Sch Med, Boulder, CO 80309 USA; [Stancin, Terry] Metrohlth Med Ctr, Cleveland, OH USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave MLC 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org		McNally, Kelly/0000-0001-9278-9413	Patient-Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [CER-1306-02435];  [PCORI-CER-1306-02435]	This research was supported by CER-1306-02435 from the The Patient-Centered Outcomes Research Institute to the first author. Information reported in this work/publication was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (grant number PCORI-CER-1306-02435). The views, statements, and opinions in this work/publication are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee.	Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Carey JC, 2008, CYBERPSYCHOL BEHAV, V11, P188, DOI 10.1089/cpb.2007.0025; D'Zurilla T.J., 1996, MANUAL SOCIAL PROBLE; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Jenkins-Guarnieri MA, 2015, TELEMED E-HEALTH, V21, P652, DOI 10.1089/tmj.2014.0165; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Kurowski BG, 2018, CONT CLIN TRIAL COMM, V10, P111, DOI 10.1016/j.conctc.2018.04.001; Narad ME, 2015, J DEV BEHAV PEDIATR, V36, P700, DOI 10.1097/DBP.0000000000000208; Petranovich CL, 2015, J PEDIATR PSYCHOL, V40, P680, DOI 10.1093/jpepsy/jsv001; Schoenberg MR, 2008, PROF PSYCHOL-RES PR, V39, P169, DOI 10.1037/0735-7028.39.2.169; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2018, J NEUROSURG SCI, V62, P187, DOI 10.23736/S0390-5616.17.04277-1; Wade SL, 2017, REHABIL PSYCHOL, V62, P290, DOI 10.1037/rep0000160; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2014, REHABIL PSYCHOL, V59, P1, DOI 10.1037/a0034911; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wentzel J, 2016, JMIR MENT HEALTH, V3, DOI 10.2196/mental.4534; Woods D., 2014, SOCIAL CARE NEURODIS, V5, P51, DOI [10.1108/SCN-01-2013-0002, DOI 10.1108/SCN-01-2013-0002]; Zhao SY, 2009, SOC SCI MED, V69, P1501, DOI 10.1016/j.socscimed.2009.08.039	31	7	7	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	APR	2019	44	3					388	401		10.1093/jpepsy/jsy087			14	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	IO3NG	WOS:000479286700015	30452665				2022-02-06	
J	Wang, CF; Zhao, CC; He, Y; Li, ZY; Liu, WL; Huang, XJ; Deng, YF; Li, WP				Wang, Chuan-Fang; Zhao, Cheng-Cheng; He, Yi; Li, Zong-Yang; Liu, Wen-Lan; Huang, Xian-Jian; Deng, Yue-Fei; Li, Wei-Ping			Mild hypothermia reduces endoplasmic reticulum stress-induced apoptosis and improves neuronal functions after severe traumatic brain injury	BRAIN AND BEHAVIOR			English	Article						apoptosis; C; EBP-homologous protein; endoplasmic reticulum stress; hypothermia; traumatic brain injury	UNFOLDED PROTEIN RESPONSE; CELL-DEATH; MODERATE HYPOTHERMIA; ER-STRESS; MECHANISMS; PROTECTION; DEFICITS; IMPACT	Background Mild hypothermia is wildly used in clinical treatment of traumatic brain injury (TBI). However, the effect of mild hypothermia on endoplasmic reticulum (ER) stress-induced apoptosis after severe TBI is still unknown. Methods In the present study, we used BALB/c mice to investigate the efficacy of posttraumatic mild hypothermia in reducing ER stress. Severe TBI was induced by controlled cortical impact injury. Mild hypothermia treatment was performed immediately after surgery and maintained for 4 hr. The animals were euthanized at 1 and 7 days after severe TBI. The expression levels of ER stress marker proteins were evaluated using Western blot and immunofluorescence. Cell apoptosis rate was analyzed by TUNEL staining. Neuronal functions of the mice were assessed using rotarod test and Morris water maze. Results Our results revealed that mild hypothermia significantly attenuated ER stress marker proteins, including p-eIF2 alpha/eIF2 alpha, ATF4, CHOP and IRE-1 alpha, and reduced apoptosis rate in the pericontusion region at 1 and 7 days after severe TBI. Interestingly, mild hypothermia also prevented the translocation of CHOP into nucleus. In addition, posttraumatic mild hypothermia significantly improved neuronal functions after severe TBI. Conclusions Our findings illustrated that mild hypothermia could reduce ER stress-induced apoptosis and improve neuronal functions after severe traumatic brain injury.	[Wang, Chuan-Fang; Li, Wei-Ping] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China; [Wang, Chuan-Fang; He, Yi; Li, Zong-Yang; Liu, Wen-Lan; Huang, Xian-Jian; Li, Wei-Ping] Shenzhen Univ, Shenzhen Peoples Hosp 2, Affiliated Hosp 1, Brain Ctr,Shenzhen Key Lab Neurosurg, Shenzhen, Peoples R China; [Zhao, Cheng-Cheng; Deng, Yue-Fei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China		Deng, YF (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China.; Li, WP (corresponding author), Shenzhen Univ, Shenzhen Peoples Hosp 2, Shenzhen Key Lab Neurosurg, Brain Ctr, Shenzhen, Peoples R China.	yuefei_deng@hotmail.com; wpli@szu.edu.cn			China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2018M643330]; international cooperation research projects of Shenzhen Science and Technology Program [GJHZ20160301163419476]; Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2018A030310042]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772685]; Shenzhen Development and Reform Commissions Stroke Screening and Prevention Public Service Platform improving program; basic research projects (subject arrangement) of Shenzhen Science and Technology Program [JCYJ20170413173149177]	China Postdoctoral Science Foundation, Grant/Award Number: 2018M643330; the international cooperation research projects of Shenzhen Science and Technology Program, Grant/Award Number: GJHZ20160301163419476; Natural Science Foundation of Guangdong Province, Grant/Award Number: 2018A030310042; National Natural Science Foundation of China, Grant/Award Number: 81772685; Shenzhen Development and Reform Commissions Stroke Screening and Prevention Public Service Platform improving program; the basic research projects (subject arrangement) of Shenzhen Science and Technology Program, Grant/Award Number: JCYJ20170413173149177	Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Chen C, 2016, NEUROSCIENCE, V335, P114, DOI 10.1016/j.neuroscience.2016.08.038; Eroglua O, 2017, INJURY, V48, P2675, DOI 10.1016/j.injury.2017.09.032; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Gong P, 2015, RESUSCITATION, V97, P109, DOI 10.1016/j.resuscitation.2015.10.003; Halliday M, 2014, NEUROPHARMACOLOGY, V76, P169, DOI 10.1016/j.neuropharm.2013.08.034; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Holzer M, 2008, EUR J ANAESTH, V25, P31, DOI 10.1017/S0265021507003274; Iurlaro R, 2016, FEBS J, V283, P2640, DOI 10.1111/febs.13598; Jiang JY, 2007, CURR OPIN CRIT CARE, V13, P153, DOI 10.1097/MCC.0b013e32807f2a80; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Popescu C, 2015, J Med Life, V8, P272; Rao JH, 2015, BIOCHEM J, V466, P369, DOI 10.1042/BJ20140412; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37063; Xin Q, 2014, NEUROCHEM INT, V68, P18, DOI 10.1016/j.neuint.2014.02.001; Zhang HB, 2017, BRAIN INJURY, V31, P406, DOI 10.1080/02699052.2016.1225984	36	7	8	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	APR	2019	9	4							e01248	10.1002/brb3.1248			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	HW0YZ	WOS:000466410200023	30834702	Green Published, gold			2022-02-06	
J	Zhang, LN; Gong, WD; Luo, J; Yu, YJ; Qi, SH; Yue, ZY				Zhang, Li-Na; Gong, Wei-Dong; Luo, Juan; Yu, Yong-Jing; Qi, Si-Hua; Yue, Zi-Yong			Exogenous ghrelin ameliorates acute lung injury by modulating the nuclear factor kappa B inhibitor kinase/nuclear factor kappa B inhibitor/nuclear factor kappa B pathway after hemorrhagic shock	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Acute lung injury; Ghrelin; Hemorrhagic shock; Nuclear factor kappa B pathway	TRAUMATIC BRAIN-INJURY; MESSENGER-RNA; ACTIVATION; INFLAMMATION; EXPRESSION; PROTECTS; RECEPTOR; RATS	Previous studies have shown that ghrelin, a peptide produced in the stomach, attenuates acute lung injury (ALI) in various animal models, and that some of these effects are associated with inhibition of the nuclear factor kappa B signaling pathway. This study investigated whether ghrelin exerts beneficial effects on hemorrhagic shock (HS)-induced ALI by modulating nuclear factor kappa B inhibitor kinase/nuclear factor kappa B inhibitor/nuclear factor kappa B (IKK/I kappa B alpha/NF-kappa B) pathway activity. HS was induced in male SD rats by withdrawing blood to a mean arterial pressure (MAP) of 40 mm Hg for 1 h; rats then received ghrelin (10 nmol/kg) or vehicle intravenously and were resuscitated with the shed blood and an equal volume of Ringer lactate solution followed by observation for 2 h. After resuscitation, samples were collected and analyzed for lung histopathology, wet to dry weight ratio (W/D), bronchoalveolar lavage fluid (BALF) protein, neutrophil infiltration, plasma inflammatory cytokines (TNF-alpha and IL-6), and cytoplasmic phosphorylated IKK beta, I kappa B alpha, phosphorylated I kappa B alpha and nuclear NF-kappa B expression. Compared to those in the two sham groups, lung injury, W/D, BALF protein, neutrophil infiltration, plasma TNF-alpha and IL-6 levels, and IKK/I kappa B alpha/NF-kappa B pathway activation were significantly increased in HS rats. After ghrelin administration, all parameters analyzed were decreased compared to those without ghrelin in HS rats. Moreover, ghrelin alleviated the decreased MAP after resuscitation compared to that in HS rats. Exogenous ghrelin attenuates the inflammatory response and acute lung injury after HS. These beneficial effects appear to be mediated through inhibition of IKK/I kappa B alpha/NF-kappa B signaling.	[Zhang, Li-Na; Qi, Si-Hua] Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 4, 37 Yiyuan St, Harbin 150001, Heilongjiang, Peoples R China; [Gong, Wei-Dong; Luo, Juan; Yu, Yong-Jing; Yue, Zi-Yong] Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 2, 246 Xuefu Rd, Harbin 150001, Heilongjiang, Peoples R China		Yue, ZY (corresponding author), Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 2, 246 Xuefu Rd, Harbin 150001, Heilongjiang, Peoples R China.	yueziyong00@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30772085]	This work was supported by the National Natural Science Foundation of China [grant number 30772085]. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Angele MK, 2002, CRIT CARE, V6, P298, DOI 10.1186/cc1514; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Cannon JW, 2018, NEW ENGL J MED, V378, P370, DOI 10.1056/NEJMra1705649; Cheyuo C, 2012, AM J PHYSIOL-ENDOC M, V302, pE265, DOI 10.1152/ajpendo.00508.2011; Chima RS, 2008, CRIT CARE MED, V36, P2849, DOI 10.1097/CCM.0b013e318187810e; Ciesla DJ, 2005, SURGERY, V138, P749, DOI 10.1016/j.surg.2005.07.020; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Douzinas EE, 2012, CRIT CARE MED, V40, P1348, DOI 10.1097/CCM.0b013e31823e9501; Fan A, 2001, AM J PHYSIOL-LUNG C, V281, P1037; Garcia EA, 2006, CURR OPIN PHARMACOL, V6, P142, DOI 10.1016/j.coph.2005.10.006; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Li G, 2017, INT IMMUNOPHARMACOL, V52, P85, DOI 10.1016/j.intimp.2017.08.026; Li WG, 2004, CIRCULATION, V109, P2221, DOI 10.1161/01.CIR.0000127956.43874.F2; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Luedde T, 2005, J CLIN INVEST, V115, P849, DOI 10.1172/JCI200523493; Mac Sweeney R, 2016, LANCET, V388, P2416, DOI 10.1016/S0140-6736(16)00578-X; Nagaya N, 2001, AM J PHYSIOL-REG I, V280, pR1483, DOI 10.1152/ajpregu.2001.280.5.R1483; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Park GY, 2006, CURR DRUG TARGETS, V7, P661, DOI 10.2174/138945006777435317; Peng ZY, 2012, INT IMMUNOPHARMACOL, V13, P440, DOI 10.1016/j.intimp.2012.04.006; Qi L, 2014, ANN SURG, V260, P169, DOI 10.1097/SLA.0000000000000328; Qi L, 2012, MOL MED, V18, P186, DOI 10.2119/molmed.2011.00390; Robb CT, 2016, SEMIN IMMUNOPATHOL, V38, P425, DOI 10.1007/s00281-016-0560-6; Shenker R., 2001, AM J PHYSIOL-LUNG C, V281, P418; Slomiany BL, 2013, INFLAMMOPHARMACOLOGY, V21, P241, DOI 10.1007/s10787-013-0169-5; Smith RG, 2001, ENDOCRINE, V14, P9, DOI 10.1385/ENDO:14:1:009; Volante M, 2002, J HISTOCHEM CYTOCHEM, V50, P1013, DOI 10.1177/002215540205000803; Waseern T, 2008, SURGERY, V143, P334, DOI 10.1016/j.surg.2007.09.039; Wu R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1697, DOI 10.1152/ajpendo.00098.2007; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Wu RQ, 2012, J SURG RES, V178, P370, DOI 10.1016/j.jss.2011.12.021	40	7	9	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	APR	2019	69						95	102		10.1016/j.intimp.2019.01.019			8	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	HR4OG	WOS:000463125200011	30690345				2022-02-06	
J	Kim, S; Mortera, M; Hu, XL; Krishnan, S; Hoffecker, L; Herrold, A; Terhorst, L; King, L; Machtinger, J; Zumsteg, JM; Negm, A; Heyn, P				Kim, Sonya; Mortera, Marianne; Hu, Xiaolei; Krishnan, Shilpa; Hoffecker, Lilian; Herrold, Amy; Terhorst, Lauren; King, Laurie; Machtinger, Joseph; Zumsteg, Jennifer M.; Negm, Ahmed; Heyn, Patricia			Overview of pharmacological interventions after traumatic brain injuries: impact on selected outcomes	BRAIN INJURY			English	Article						Systematic review; meta-analysis; traumatic brain injury; pharmacological interventions	RANDOMIZED CONTROLLED-TRIALS; CLOSED-HEAD INJURY; SYSTEMATIC REVIEWS; SUBARACHNOID HEMORRHAGE; AMANTADINE TREATMENT; ANIMAL-MODELS; VALPROIC ACID; RISK-FACTORS; EFFICACY; SAFETY	The purpose of this study was to conduct an overview of systematic reviews (SRs) to appraise the published evidence related to pharmacological interventions after traumatic brain injury (TBI). Searches were conducted with Medline, Embase, PsycINFO, Web of Science, PubMed. 780 retrieved SRs underwent a two-level screening to determine inclusion. Data extracted included participant characteristics, TBI severity, study design, pharmacological interventions, and outcomes. SRs were assessed for methodological quality by using the AMSTAR measurement tool. After removing duplicates, 166/780 SRs published between 1990-2017 were reviewed, 62 of which met inclusion criteria. More than 90 drugs and 22 substance-classes were extracted. Most medications were administered during the acute stage. Mild TBI was included in 3% of the SRs. Physiological outcomes comprised 45% of the SRs, primarily mortality. Activities of daily living (ADLs) outcomes constituted 22% of the SRs followed by cognition (13%) and psychological/behavioral outcomes (13%). Only 7% of the SRs assessed adverse events. Inconsistencies in definitions, methods, and heterogeneity of instruments used to measure treatment response were noted. Only a third of the SRs had high methodological quality. Most SRs had heterogeneous TBI samples, outcomes, or methodologies making it difficult to synthesize findings into recommended guidelines. This study demonstrated a need for adequately powered and rigorous randomized clinical trials (RCTs) to provide generalizable evidence on the effectiveness of pharmacologic interventions for TBI. PROSPERO Registration: CRD42015017355	[Kim, Sonya] NYU, Sch Med, Dept Neurol, New York, NY USA; [Kim, Sonya] NYU, Sch Med, Dept Rehabil Med, E 240 East 38 St,17th Floor, New York, NY USA; [Mortera, Marianne] NYU, Dept Occupat Therapy, NYU Steinhardt, New York, NY USA; [Hu, Xiaolei] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden; [Krishnan, Shilpa] Emory Univ, Div Phys Therapy, Dept Rehabil Med, Atlanta, GA 30322 USA; [Hoffecker, Lilian] Univ Colorado, Hlth Sci Lib, Anschutz Med Campus, Aurora, CO USA; [Herrold, Amy] Edward Hines Jr VA Hosp, Ctr Innovat Complex Chron Healthcare, Hines, IL USA; [Terhorst, Lauren] Univ Pittsburgh, Dept Occupat Therapy, Sch Hlth & Rehabil Serv, Pittsburgh, PA USA; [King, Laurie] Oregon Hlth & Sci Univ, Neurol, Portland, OR 97201 USA; [Machtinger, Joseph] Univ Colorado, Sch Med, Dept Neurol, Div Multiple Sclerosis, Aurora, CO USA; [Zumsteg, Jennifer M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Negm, Ahmed] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Heyn, Patricia] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA		Kim, S (corresponding author), NYU, Sch Med, Dept Rehabil Med, E 240 East 38 St,17th Floor, New York, NY USA.	sonya.kim@nyumc.org	Shilpa Krishnan, PT/H-9628-2019; NEGM, AHMED/Z-1108-2018	Shilpa Krishnan, PT/0000-0002-9419-0495; Hu, Xiaolei Hu/0000-0001-9864-7432; kim, sonya/0000-0001-7454-2476; NEGM, AHMED/0000-0001-5849-1402; Zumsteg, Jennifer/0000-0002-0678-0103	American Congress of Rehabilitation Medicine Measurement Networking Group; Veterans AffairsUS Department of Veterans Affairs [IK2RX000949] Funding Source: NIH RePORTER	The authors want to thank the contribution of taskforce members, Drs Zach Bayer and Pallavi Sood, who were critical in different components of the project but could not participate in its entire process. Thank you to Dr. Dawn Ehde for her careful review of this manuscript. This manuscript was developed with the generous support of the American Congress of Rehabilitation Medicine Measurement Networking Group. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.	Aaronson A, 2015, PSYCHIAT ANN, V45, P422, DOI 10.3928/00485713-20150803-08; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS60; Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Arango MF, 2008, COCHRANE DB SYST REV, V08; Aromataris E, 2015, INT J EVID-BASED HEA, V13, P132, DOI 10.1097/XEB.0000000000000055; Azouvi P, 1999, BRAIN INJURY, V13, P797, DOI 10.1080/026990599121188; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Barker-Collo S, 2013, BRAIN INJURY, V27, P1124, DOI 10.3109/02699052.2013.801513; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Bellamy CJ, 2009, J TRAUMA, V66, P954, DOI 10.1097/TA.0b013e31818e90ed; Bouzat P, 2011, CRIT CARE MED, V39, P2099, DOI 10.1097/CCM.0b013e31821cb7b2; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Centers for Disease Control and Prevention Rates of TBI related Deaths by Age Group United States, 2001, RAT TBI REL DEATHS A; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; ChathamShowalter PE, 1996, J NEUROPSYCH CLIN N, V8, P96; Chelladurai Yohalakshmi, 2013, F1000Res, V2, P132, DOI 10.12688/f1000research.2-132.v1; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Deb S, 2004, BRAIN INJURY, V18, P1, DOI 10.1080/0269905031000110463; DeMarchi R, 2005, CAN J NEUROL SCI, V32, P4, DOI 10.1017/S0317167100016826; Deselms H, 2016, J NEUROSCI METH, V272, P69, DOI 10.1016/j.jneumeth.2016.02.002; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng JF, 2011, BRAIN RES, V1395, P62, DOI 10.1016/j.brainres.2011.04.022; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; GERACIOTI TD, 1994, J CLIN PSYCHIAT, V55, P416; Godfrey J, 2009, J PSYCHOPHARMACOL, V23, P194, DOI 10.1177/0269881108089809; Gosseries O, 2014, CURR PHARM DESIGN, V20, P4167; Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; GREENDYKE RM, 1986, J CLIN PSYCHIAT, V47, P423; Gu JW, 2014, J CRIT CARE, V29, P287, DOI 10.1016/j.jcrc.2013.10.021; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Gultekin R, 2016, INJURY, V47, P516, DOI 10.1016/j.injury.2015.10.011; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Heinemann AW, 2013, ARCH PHYS MED REHAB, V94, P2157, DOI 10.1016/j.apmr.2013.05.017; Jamjoom AAB, 2013, J NEUROTRAUM, V30, P503, DOI 10.1089/neu.2012.2584; Kant R, 1998, BRAIN INJURY, V12, P661, DOI 10.1080/026990598122223; Ker K, 2015, COCHRANE DB SYST REV, V5; Ker K, 2008, COCHRANE DB SYST REV, V23; Khan F, 2016, J REHABIL MED, V48, P442, DOI 10.2340/16501977-2084; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; Kim E, 2002, J NEUROPSYCH CLIN N, V14, P202, DOI 10.1176/appi.neuropsych.14.2.202; Kim E, 2006, J NEUROPSYCH CLIN N, V18, P547, DOI 10.1176/appi.neuropsych.18.4.547; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Langham J, 2003, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD000565, DOI 10.1002/14651858.CD000565]; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Ma J, 2012, COCHRANE DB SYST REV, V17; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maryniak O, 2001, BRAIN INJURY, V15, P167, DOI 10.1080/026990501458399; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; Moher D, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0087-2; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Murray GD, 1996, ACTA NEUROCHIR, V138, P1163, DOI 10.1007/BF01809745; NEUGEBAUER E, 1990, THEOR SURG, V5, P44; Newburn G, 1999, BRAIN INJURY, V13, P637; Noe E, 2007, BEHAV NEUROL, V18, P7, DOI 10.1155/2007/529076; Park S, 2016, WESTERN J NURS RES, V38, P394, DOI 10.1177/0193945915593180; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Poole NA, 2008, BRAIN INJURY, V22, P519, DOI 10.1080/02699050802132495; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Radosevich JJ, 2013, BRAIN INJURY, V27, P1492, DOI 10.3109/02699052.2013.823658; Reeves F, 2013, J TRAUMA ACUTE CARE, V75, P642, DOI 10.1097/TA.0b013e3182a12a45; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Roberts I, 2000, COCHRANE DB SYST REV; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Rowland Todd R., 1992, Archives of Physical Medicine and Rehabilitation, V73, P963; Roy D, 2018, PSYCHOSOMATICS, V59, P47, DOI 10.1016/j.psym.2017.07.008; Salter KL, 2016, J HEAD TRAUMA REHAB, V31, pE21, DOI 10.1097/HTR.0000000000000193; Sandel ME, 1996, AGITATED BRAIN INJ 1; Sashika H, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005968; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; Schneider WN, 1999, BRAIN INJURY, V13, P863; Shanks Niall, 2009, Philos Ethics Humanit Med, V4, P2, DOI 10.1186/1747-5341-4-2; Sharif Mohammad O, 2013, Oral Health Dent Manag, V12, P9; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shen X, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000077; Showalter PEC, 2000, J NEUROPSYCH CLIN N, V12, P395; Singh S, 2013, AHRQ COMP EFFECTIVEN; Sivan M, 2010, CLIN REHABIL, V24, P110, DOI 10.1177/0269215509343234; Stanislav SW, 2000, BRAIN INJURY, V14, P261; Tan PG, 2011, EMERG MED AUSTRALAS, V23, P665, DOI 10.1111/j.1742-6723.2011.01455.x; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Vallat-Azouvi C, 2018, J NEUROSCI RES, V96, P601, DOI 10.1002/jnr.24180; Vergouwen MDI, 2006, LANCET NEUROL, V5, P1029, DOI 10.1016/S1474-4422(06)70582-8; Villareal Carolyn L., 2007, JOURNAL OF PHARMACY TECHNOLOGY, V23, P95; Wakai A, 2013, COCHRANE DB SYST REV, V05; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Williams SE, 2007, BRAIN INJURY, V21, P885, DOI 10.1080/02699050701553213; Willis C, 2004, COCHRANE DB SYST REV; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; World Health Organization (WHO), 2017, INT CLASS FUNCT DIS; Writer BW, 2009, J NEUROPSYCH CLIN N, V21, P362, DOI 10.1176/appi.neuropsych.21.4.362; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791; Wu TS, 2005, J EMERG MED, V28, P289, DOI 10.1016/j.jemermed.2004.11.016; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu DY, 2015, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00274; Xu GZ, 2013, BRAIN RES BULL, V99, P41, DOI 10.1016/j.brainresbull.2013.09.011; YUWAIMAN P, 2013, COCHRANE DB SYST REV, V17, DOI DOI 10.1002/14651858.CD006032.PUB4; Zafar SN, 2011, J NEUROTRAUM, V28, P1307, DOI 10.1089/neu.2010.1724; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023; Zeiler FA, 2014, NEUROCRIT CARE, V21, P163, DOI 10.1007/s12028-013-9950-y; Zhao ZL, 2013, CHINESE MED J-PEKING, V126, P3754, DOI 10.3760/cma.j.issn.0366-6999.20130116	125	7	7	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2019	33	4					442	455		10.1080/02699052.2019.1565896			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HL7QM	WOS:000458936100007	30694081				2022-02-06	
J	Straudi, S; Bonsangue, V; Mele, S; Craighero, L; Montis, A; Fregni, F; Lavezzi, S; Basaglia, N				Straudi, Sofia; Bonsangue, Valentina; Mele, Sonia; Craighero, Laila; Montis, Andrea; Fregni, Felipe; Lavezzi, Susanna; Basaglia, Nino			Bilateral M1 anodal transcranial direct current stimulation in post traumatic chronic minimally conscious state: a pilot EEG-tDCS study	BRAIN INJURY			English	Article						Minimally conscious state; tDCS; coma recovery scale-revised; traumatic brain injury; EEG	MOTOR CORTEX; DISORDERS; BRAIN; RECOVERY; COMA; CONNECTIVITY; IMPROVEMENTS; TRIAL; PAIN	Objective: We tested the preliminary effects of bilateral anodal transcranial direct current stimulation (tDCS) in patients with disorders of consciousness. Design: Open label pilot study. Subjects: Ten chronic (greater than 12 months) patients in a minimally conscious state (MCS) following severe traumatic brain injury. Methods: The patients received 10 sessions of bilateral M1 anodal tDCS. Behavioural changes were assessed with the Coma Recovery Scale-Revised (CRS-R) before stimulation (T-1, T0), after five sessions (T1), at the end of the stimulation (T2), after two weeks (T3) and after three months (T4). Moreover, an EEG assessment was conducted. Results: Eight out of 10 patients showed new clinical signs of consciousness; specifically, a 2-point CRS-R improvement was detected in the last follow-up (p = 0.004). EEG upper alpha bandwidth was greater in the parietal site at T1 (p < 0.034). In addition, we found a significant correlation between behavioral and EEG indices at T1 (r = 0.89; p = 0.001). Conclusion: This preliminary study presents several limitations (small sample size and no control group). However, it provides important initial data that can be used to design randomized clinical trials testing this novel approach in MCS and to further explore EEG as a neural marker for the effects of tDCS.	[Straudi, Sofia; Bonsangue, Valentina; Lavezzi, Susanna; Basaglia, Nino] Ferrara Univ Hosp, Neurosci & Rehabil Dept, Via Aldo Moro 8, I-44124 Ferrara, Italy; [Mele, Sonia; Craighero, Laila] Ferrara Univ, Biomed & Specialty Surg Sci Dept, Ferrara, Italy; [Montis, Andrea] San Martino Hosp, Neurorehabil Unit, Sardinian Hlth Trust, Oristano, Italy; [Fregni, Felipe] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Neuromodulat Ctr, Boston, MA 02115 USA		Straudi, S (corresponding author), Ferrara Univ Hosp, Neurosci & Rehabil Dept, Via Aldo Moro 8, I-44124 Ferrara, Italy.	s.straudi@ospfe.it	Straudi, Sofia/AAI-6971-2021; Craighero, Laila/F-3408-2015	Straudi, Sofia/0000-0002-2061-9922; mele, sonia/0000-0001-7110-7209; Fregni, Felipe/0000-0001-9359-8643; Craighero, Laila/0000-0002-5400-8732	Emilia Romagna RegionRegione Emilia Romagna [1786/2012]	This work was supported by the Emilia Romagna Region [Grant 1786/2012].	Angelakis E, 2014, ARCH PHYS MED REHAB, V95, P283, DOI 10.1016/j.apmr.2013.09.002; Bagnato S, 2017, ARCH PHYS MED REHAB, V98, P665, DOI 10.1016/j.apmr.2016.09.132; Bagnato S, 2015, CLIN NEUROPHYSIOL, V126, P959, DOI 10.1016/j.clinph.2014.08.005; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Boggio PS, 2008, INT J NEUROPSYCHOPH, V11, P249, DOI 10.1017/S1461145707007833; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; DaSilva AF, 2012, HEADACHE, V52, P1283, DOI 10.1111/j.1526-4610.2012.02141.x; Demertzi Athena, 2008, Expert Rev Neurother, V8, P1719, DOI 10.1586/14737175.8.11.1719; Estraneo A, 2017, J NEUROL SCI, V375, P464, DOI 10.1016/j.jns.2017.02.036; Fregni F, 2005, NEUROREPORT, V16, P1551, DOI 10.1097/01.wnr.0000177010.44602.5e; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Husain AM, 2006, J CLIN NEUROPHYSIOL, V23, P208, DOI 10.1097/01.wnp.0000220094.60482.b5; Jox RJ, 2012, LANCET NEUROL, V11, P732, DOI 10.1016/S1474-4422(12)70154-0; Kobylarz EJ, 2005, NEUROPSYCHOL REHABIL, V15, P323, DOI 10.1080/09602010443000605; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lefaucheur JP, 2008, CLIN NEUROPHYSIOL, V119, P2179, DOI 10.1016/j.clinph.2008.07.007; Lehembre R, 2012, FUNCT NEUROL, V27, P41; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Mancuso M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00524; Naro A, 2016, CLIN NEUROPHYSIOL, V127, P1845, DOI 10.1016/j.clinph.2015.12.010; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Piccione F, 2011, NEUROREHAB NEURAL RE, V25, P98, DOI 10.1177/1545968310369802; Polania R, 2011, NEUROIMAGE, V54, P2287, DOI 10.1016/j.neuroimage.2010.09.085; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Thibaut A, 2015, BRAIN STIMUL, V8, P1116, DOI 10.1016/j.brs.2015.07.024; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Xia XY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00182; Zhang Y, 2018, INT J NEUROSCI, V128, P255, DOI 10.1080/00207454.2017.1381094	37	7	7	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2019	33	4					490	495		10.1080/02699052.2019.1565894			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HL7QM	WOS:000458936100011	30632807				2022-02-06	
J	He, YX; Yan, HY; Ni, HB; Liang, WB; Jin, W				He, Yuxin; Yan, Huiying; Ni, Hongbin; Liang, Weibang; Jin, Wei			Expression of nuclear factor erythroid 2-related factor 2 following traumatic brain injury in the human brain	NEUROREPORT			English	Article						glutathione S-transferase; NAD(P)H quinine oxidoreductase 1; nuclear factor erythroid 2-related factor 2; traumatic brain injury	OXIDATIVE STRESS; INHIBITION; PATHWAY; NRF2; PROTECTS; ENZYMES; RATS	Secondary brain injury imposes great effects on the prognosis of patients following traumatic brain injury (TBI). Accumulating evidence suggests that nuclear factor erythroid 2-related factor 2 (Nrf2) could play a neuroprotective role in experimental TBI models by regulating the expression of numerous antioxidant, anti-inflammatory, and neuroprotective proteins. However, whether Nrf2 is activated in patients following TBI is still unknown. In this study, human brain tissues were obtained during surgery from patients suffering from TBI. The purpose of this study was to investigate the expression of Nrf2 and Nrf2-regulated gene products, NAD(P)H quinine oxidoreductase 1, and glutathione S-transferase in human injured brain tissue after TBI. Our results revealed that the nuclear level of Nrf2 was significantly increased in injured brain tissues, whereas the cytoplasmic level of Nrf2 was markedly decreased. In addition, the expression of NAD(P)H quinine oxidoreductase 1 and glutathione S-transferase was significantly upregulated. Nrf2 may be activated and confer neuroprotection against secondary brain injury following TBI. Therefore, Nrf2 could serve as a promising molecular target for the treatment of TBI.	[He, Yuxin; Ni, Hongbin; Jin, Wei] Nanjing Med Univ, Drum Tower Clin Med Coll, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Yan, Huiying; Liang, Weibang] Nanjing Univ, Med Sch, Affiliated Hosp, Nanjing Drum Tower Hosp,Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China		Ni, HB; Jin, W (corresponding author), Nanjing Univ, Med Sch, Affiliated Hosp, Nanjing Drum Tower Hosp,Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	glyy110@163.com; njneurosurgery@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571192, 81200938]; Natural Science Foundation of Jiangsu Province, ChinaNatural Science Foundation of Jiangsu Province [BK20151083]; Medical Science and technology development Foundation, Nanjing Department of Health [YKK16086]	This study was supported by National Natural Science Foundation of China (nos 81571192 and 81200938), Natural Science Foundation of Jiangsu Province, China (no. BK20151083), and Key Project supported by Medical Science and technology development Foundation, Nanjing Department of Health (no. YKK16086).	Armstrong R. N., 2010, ANN REV PHARM TOXICO, V8, P51; Bello M, 2017, INT J BIOL MACROMOL, V105, P981, DOI 10.1016/j.ijbiomac.2017.07.117; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Gallorini M, 2015, BIOMATERIALS, V56, P114, DOI 10.1016/j.biomaterials.2015.03.047; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Lu MC, 2016, MED RES REV, V36, P924, DOI 10.1002/med.21396; Lu XY, 2014, J SURG RES, V188, P206, DOI 10.1016/j.jss.2013.11.1106; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Piao MS, 2011, J DERMATOL SCI, V62, P147, DOI 10.1016/j.jdermsci.2011.02.003; Stefanson AL, 2014, NUTRIENTS, V6, P3777, DOI 10.3390/nu6093777; Wang B, 2012, FREE RADICAL BIO MED, V52, P928, DOI 10.1016/j.freeradbiomed.2011.12.006; Wei G, 2017, NEUROIMMUNOMODULAT, V24, P348, DOI 10.1159/000487998; Wu G, 2016, MED SCI MONITOR, V22, P2161, DOI 10.12659/MSM.896568; Wu Q, 2014, MAR DRUGS, V12, P6125, DOI 10.3390/md12126125; Yan HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16124-8; Zhang DD, 2015, J BIOL CHEM, V290, P19900, DOI 10.1074/jbc.M115.636795; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007	20	7	7	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	MAR 20	2019	30	5					344	349		10.1097/WNR.0000000000001205			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ1RS	WOS:000462176900005	30724850				2022-02-06	
J	Nijsse, B; Spikman, JM; Visser-Meily, JMA; de Kort, PLM; van Heugten, CM				Nijsse, Britta; Spikman, Jacoba M.; Visser-Meily, Johanna M. A.; de Kort, Paul L. M.; van Heugten, Caroline M.			Social cognition impairments are associated with behavioural changes in the long term after stroke	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; EMOTION RECOGNITION; MIND; GUIDELINE	Background and purpose Behavioural changes after stroke might be explained by social cognition impairments. The aim of the present study was to investigate whether performances on social cognition tests (including emotion recognition, Theory of Mind (ToM), empathy and behaviour regulation) were associated with behavioural deficits (as measured by proxy ratings) in a group of patients with relatively mild stroke. Methods Prospective cohort study in which 119 patients underwent neuropsychological assessment with tests for social cognition (emotion recognition, ToM, empathy, and behaviour regulation) 3-4 years post stroke. Test scores were compared with scores of 50 healthy controls. Behavioural problems were assessed with the Dysexecutive Questionnaire (DEX) self-rating and proxy rating scales. Pearson correlations were used to determine the relationship between the social cognition measures and DEX scores. Results Patients performed significantly worse on emotion recognition, ToM and behaviour regulation tests than controls. Mean DEX-self score did not differ significantly from the mean DEX-proxy score. DEX-proxy ratings correlated with tests for emotion recognition, empathy, and behavioural regulation (lower scores on these items were associated with more problems on the DEX-proxy scale). Conclusions Social cognition impairments are present in the long term after stroke, even in a group of mildly affected stroke patients. Most of these impairments also turned out to be associated with a broad range of behavioural problems as rated by proxies of the patients. This strengthens the proposal that social cognition impairments are part of the underlying mechanism of behavioural change. Since tests for social cognition can be administered in an early stage, this would allow for timely identification of patients at risk for behavioural problems in the long term.	[Nijsse, Britta; de Kort, Paul L. M.] Elisabeth Tweesteden Hosp, Dept Neurol, Tilburg, Netherlands; [Spikman, Jacoba M.] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Spikman, Jacoba M.] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Visser-Meily, Johanna M. A.] Hoogstr Rehabil, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Rehabil Phys Therapy Sci & Sports, Utrecht, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Med Ctr, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands		van Heugten, CM (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands.; van Heugten, CM (corresponding author), Maastricht Univ, Med Ctr, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	c.vanheugten@maastrichtuniversity.nl		Spikman, Jacoba/0000-0002-6477-0763	VSB foundation [89000004]	This research project is funded by the VSB foundation, grant number 89000004, www.vsbfonds.nl (JMAVM, CMvH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aben HP, 2018, JMIR RES PROTOC, V7, DOI 10.2196/resprot.9431; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; BANDURA A, 1991, ORGAN BEHAV HUM DEC, V50, P248, DOI 10.1016/0749-5978(91)90022-L; Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Burgess PW, 1997, HAYLING BRIXTON TEST, P858, DOI [10.1002/hbm.20547, DOI 10.1002/HBM.20547]; Collin C, 1988, Int Disabil Stud, V10, P61; Dal Monte O, 2013, SOC COGN AFFECT NEUR, V8, P632, DOI 10.1093/scan/nss041; Ferro JM, 2009, CEREBROVASC DIS, V27, P197, DOI 10.1159/000200460; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; Harciarek M, 2009, J CLIN EXP NEUROPSYC, V31, P322, DOI 10.1080/13803390802119930; Henry JD, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.229; Herbet G, 2014, BRAIN, V137, P944, DOI 10.1093/brain/awt370; Hillis A. E., 2014, ADV MED, V2014; Hillis AE, 2014, BRAIN, V137, P981, DOI 10.1093/brain/awt317; Hoche F, 2016, CEREBELLUM, V15, P732, DOI 10.1007/s12311-015-0746-9; Hochstenbach J, 2005, ARCH PHYS MED REHAB, V86, P1587, DOI 10.1016/j.apmr.2004.11.050; Kaplan E, 1983, ASSESSMENT APHASIA R; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Lim JS, 2015, J STROKE, V17, P256, DOI 10.5853/jos.2015.17.3.256; Limongi R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00380; Mehrabian A, 2000, GENET SOC GEN PSYCH, V126, P133; Meijer R, 2006, INT J REHABIL RES, V29, P1, DOI 10.1097/01.mrr.0000175269.59788.41; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Nakajima R, 2018, NEUROPSYCHOLOGIA, V115, P179, DOI 10.1016/j.neuropsychologia.2018.01.024; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Van Overwalle F, 2014, NEUROIMAGE, V86, P554, DOI 10.1016/j.neuroimage.2013.09.033; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; van Mierlo ML, 2014, INT J STROKE, V9, P148, DOI 10.1111/j.1747-4949.2012.00882.x; Verhage F, 1964, INTELLIGENTIE LEEFTI; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; Wilkos Ewelina, 2015, Neuropsychiatr Dis Treat, V11, P1031, DOI 10.2147/NDT.S78037; Wilson B.A., 1997, METHODOLOGY FRONTAL, P239; Yeh ZT, 2014, PSYCHIAT CLIN NEUROS, V68, P612, DOI 10.1111/pcn.12173; Young A., 2002, FACIAL EXPRESSIONS E; Yuvaraj R, 2013, DEMENT GERIATR COGN, V36, P179, DOI 10.1159/000353440; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zinchenko O, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00227	46	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213725	10.1371/journal.pone.0213725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO9WM	WOS:000461316400025	30875394	Green Published, Green Submitted, gold			2022-02-06	
J	Widehammar, C; Lidstrom, H; Hermansson, L				Widehammar, Cathrine; Lidstroem, Helene; Hermansson, Liselotte			Environmental barriers to participation and facilitators for use of three types of assistive technology devices	ASSISTIVE TECHNOLOGY			English	Article						Electronic aids to daily living; information technology and telecommunications; prosthetics; service delivery; wheelchair transportation; wheeled mobility aids	CRAIG-HOSPITAL INVENTORY; TRAUMATIC BRAIN-INJURY; PEOPLE; ADULTS; INDIVIDUALS; EXPERIENCES; USABILITY; COGNITION; CAPACITY; CHILDREN	The aim was to compare the presence of environmental barriers to participation and facilitators for assistive technology (AT) use and study the relation between barriers and AT use in three different AT devices. A cross-sectional survey was conducted. Inclusion criteria were >= one year of experience as a user of myoelectric prosthesis (MEP), powered mobility device (PMD), or assistive technology for cognition (ATC) and age 20-90 years. Overall, 156 participants answered the Swedish version of the Craig Hospital Inventory of Environmental Factors and a study-specific questionnaire on facilitating factors. Non-parametric tests were used for comparisons. Barriers to participation were lowest in MEP users (md=0.12; p>0.001), and highest in ATC users (md=1.56; p>0.001) with the least support for AT use (p>0.001 - p=0.048). A positive correlation between fewer barriers and higher use of MEP was seen (r=0.30, p=0.038). The greatest barriers to participation were Natural environment, Surroundings and Information, and the most support came from relatives and professionals. Support, training and education are vital in the use of AT. These factors may lead to a more sustained and prolonged use of AT and may enable increased participation. Future research should focus on interventions that meet the needs of people with cognitive disabilities.	[Widehammar, Cathrine] Orebro Univ, Dept Pediat, Orebro, Sweden; [Widehammar, Cathrine; Hermansson, Liselotte] Orebro Univ, Univ Hlth Care Res Ctr, Orebro, Sweden; [Lidstroem, Helene] Linkoping Univ, Dept Social & Welf Studies, Linkoping, Sweden; [Hermansson, Liselotte] Orebro Univ, Dept Prosthet & Orthot, Orebro, Sweden		Widehammar, C (corresponding author), Orebro Univ Hosp, Dept Pediat, SE-70185 Orebro, Sweden.	cathrine.widehammar@regionorebrolan.se	de Jager, Aimee/AAL-1264-2021; Hermansson, Liselotte/W-8579-2019	Hermansson, Liselotte/0000-0003-4247-2236	Research Committee of Orebro County Council, Sweden [OLL-590701, OLL-615061, OLL-642141, OLL-685701]	This research was funded by the Research Committee of Orebro County Council, Sweden (Grant IDs OLL-590701, OLL-615061, OLL-642141, and OLL-685701).	Arthanat S, 2009, AM J OCCUP THER, V63, P751, DOI 10.5014/ajot.63.6.751; Auger C, 2008, AM J PHYS MED REHAB, V87, P666, DOI 10.1097/PHM.0b013e31816de163; BATAVIA A I, 1990, Journal of Rehabilitation Research and Development, V27, P425, DOI 10.1682/JRRD.1990.10.0425; Biddiss E, 2007, AM J PHYS MED REHAB, V86, P977, DOI 10.1097/PHM.0b013e3181587f6c; Biddiss EA, 2007, PROSTHET ORTHOT INT, V31, P236, DOI 10.1080/03093640600994581; Borgestig M, 2017, DEV NEUROREHABIL, V20, P129, DOI 10.3109/17518423.2015.1132281; BOSCHEN K, 1997, CAN J REHABIL, V11, P13; Brunner M, 2017, BRAIN INJURY, V31, P1028, DOI 10.1080/02699052.2017.1292429; Cao Y, 2015, J SPINAL CORD MED, V38, P557, DOI 10.1179/2045772314Y.0000000275; De Jonge DM, 2006, DISABIL REHABIL-ASSI, V1, P79, DOI 10.1080/09638280500167324; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; Ephraim PL, 2006, ARCH PHYS MED REHAB, V87, P328, DOI 10.1016/j.apmr.2005.11.010; Fleming J, 2014, J HEAD TRAUMA REHAB, V29, P125, DOI 10.1097/HTR.0b013e318286545d; Gramstad A, 2013, DISABIL REHABIL-ASSI, V8, P287, DOI 10.3109/17483107.2012.699993; Gray DB, 2008, DISABIL REHABIL, V30, P434, DOI 10.1080/09638280701625377; Hemmingsson H, 2009, AM J OCCUP THER, V63, P463, DOI 10.5014/ajot.63.4.463; HERMANSSON LM, 1991, PROSTHET ORTHOT INT, V15, P88; International Standards Organization (ISO), 2011, 99992011EN ISO; Janeslatt G, 2015, DISABIL REHABIL-ASSI, V10, P371, DOI 10.3109/17483107.2014.917124; Judge S, 2009, DISABIL REHABIL-ASSI, V4, P151, DOI 10.1080/17483100802715100; Kielhofner G., 2007, MODEL HUMAN OCCUPATI; Lenker JA, 2003, ASSIST TECHNOL, V15, P1, DOI 10.1080/10400435.2003.10131885; Lenker JA, 2013, DISABIL REHABIL-ASSI, V8, P373, DOI 10.3109/17483107.2012.749429; Liao LR, 2012, J REHABIL MED, V44, P740, DOI 10.2340/16501977-1014; Lidstrom H, 2015, STUD HEALTH TECHNOL, V217, P189, DOI 10.3233/978-1-61499-566-1-189; Lidstrom H, 2014, SCAND J OCCUP THER, V21, P251, DOI 10.3109/11038128.2014.880940; Lien WC, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-59; Lindner H, 2018, PROSTHET ORTHOT INT, V42, P14, DOI 10.1177/0309364617704802; Lindner HYN, 2013, J REHABIL RES DEV, V50, P1391, DOI 10.1682/JRRD.2012.12.0231; Lund ML, 2009, SCAND J OCCUP THER, V16, P194, DOI 10.3109/11038120802676691; Pless M., 2011, HANDBOK ATT ANVANDA; Powell LE, 2015, NEUROREHABILITATION, V37, P437, DOI 10.3233/NRE-151272; Radomski MV, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020776; Richter A., 2014, TECHNOLOGY DISABILIT, V26, P191, DOI DOI 10.3233/TAD-140416; Sorbye R., 1980, CLIN ORTHOP RELAT R, V148, P131; Steel E. J., 2011, TECHNOL DISABIL, V23, P131; Sveriges riksdag, 2016, DISKR 2008 567; United Nations, 2008, CONV RIGHTS PERS DIS; Wang J, 2016, MIL MED, V181, P560, DOI 10.7205/MILMED-D-14-00704; Wessels R., 2003, TECHNOL DISABIL, V15, P231; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; Widehammar C, 2018, PROSTHET ORTHOT INT, V42, P28, DOI 10.1177/0309364617704801; World Health Organization, 2007, INT CLASS FUNCT DIS; Zhang LF, 2015, ARCH PHYS MED REHAB, V96, P1222, DOI 10.1016/j.apmr.2015.01.024	44	7	7	1	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1040-0435	1949-3614		ASSIST TECHNOL	Assist. Technol.	MAR 15	2019	31	2					68	76		10.1080/10400435.2017.1363828			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	HL2VI	WOS:000458565800002	28783455	Green Submitted, hybrid, Green Published			2022-02-06	
J	Gracies, JM; Pradines, M; Ghedira, M; Loche, CM; Mardale, V; Hennegrave, C; Gault-Colas, C; Audureau, E; Hutin, E; Baude, M; Bayle, N; Yelnik, A; Dehail, P; Marque, P; Boyer, F; Giraux, P; Tlili, L; Jousse, M; De Boissezon, X; Belassian, G; Gassie, P; Aguirre, A; Agueros, D; Rimaud, D; Tarri, M				Gracies, Jean-Michel; Pradines, Maud; Ghedira, Mouna; Loche, Catherine-Marie; Mardale, Valentina; Hennegrave, Catherine; Gault-Colas, Caroline; Audureau, Etienne; Hutin, Emilie; Baude, Marjolaine; Bayle, Nicolas; Yelnik, Alain; Dehail, Patrick; Marque, Philippe; Boyer, Francois; Giraux, Pascal; Tlili, Leila; Jousse, Marylene; De Boissezon, Xavier; Belassian, Gael; Gassie, Paul; Aguirre, Alice; Agueros, Diego; Rimaud, Diane; Tarri, Mohamed		Neurorestore Study Grp	Guided Self-rehabilitation Contract vs conventional therapy in chronic stroke-induced hemiparesis: NEURORESTORE, a multicenter randomized controlled trial	BMC NEUROLOGY			English	Article						Stroke; Chronic hemiparesis; Self-rehabilitation; Plasticity; Motor function	TRAUMATIC BRAIN-INJURY; WALKING SPEED; UPPER-LIMB; SPASTIC PARESIS; DOUBLE-BLIND; RECOVERY; PHYSIOTHERAPY; REINFORCEMENT; HOME; DISABILITY	After discharge from hospital following a stroke, prescriptions of community-based rehabilitation are often downgraded to "maintenance" rehabilitation or discontinued. This classic therapeutic behavior stems from persistent confusion between lesion-induced plasticity, which lasts for the first 6 months essentially, and behavior-induced plasticity, of indefinite duration, through which intense rehabilitation might remain effective. This prospective, randomized, multicenter, single-blind study in subjects with chronic stroke-induced hemiparesis evaluates changes in active function with a Guided Self-rehabilitation Contract vs conventional therapy alone, pursued for a year. One hundred and twenty four adult subjects with chronic hemiparesis (> 1 year since first stroke) will be included in six tertiary rehabilitation centers. For each patient, two treatments will be compared over a 1-year period, preceded and followed by an observational 6-month phase of conventional rehabilitation. In the experimental group, the therapist will implement the diary-based and antagonist-targeting Guided Self-rehabilitation Contract method using two monthly home visits. The method involves: i) prescribing a daily antagonist-targeting self-rehabilitation program, ii) teaching the techniques involved in the program, iii) motivating and guiding the patient over time, by requesting a diary of the work achieved to be brought back by the patient at each visit. In the control group, participants will benefit from conventional therapy only, as per their physician's prescription. The two co-primary outcome measures are the maximal ambulation speed barefoot over 10 m for the lower limb, and the Modified Frenchay Scale for the upper limb. Secondary outcome measures include total cost of care from the medical insurance point of view, physiological cost index in the 2-min walking test, quality of life (SF 36) and measures of the psychological impact of the two treatment modalities. Participants will be evaluated every 6 months (D1/M6/M12/M18/M24) by a blinded investigator, the experimental period being between M6 and M18. Each patient will be allowed to receive any medications deemed necessary to their attending physician, including botulinum toxin injections. This study will increase the level of knowledge on the effects of Guided Self-rehabilitation Contracts in patients with chronic stroke-induced hemiparesis.	[Gracies, Jean-Michel; Pradines, Maud; Ghedira, Mouna; Hutin, Emilie; Baude, Marjolaine; Bayle, Nicolas] UPEC, Lab Anal & Restaurat Mouvement, EA BIOTN 7377, F-94010 Creteil, France; [Gracies, Jean-Michel; Pradines, Maud; Ghedira, Mouna; Loche, Catherine-Marie; Mardale, Valentina; Hennegrave, Catherine; Gault-Colas, Caroline; Hutin, Emilie; Baude, Marjolaine; Bayle, Nicolas] Hop Univ Henri Mondor, AP HP, Serv Reeducat Neurolocomotrice, Unite Neuroreeduc, F-94010 Creteil, France; [Audureau, Etienne] Hop Univ Henri Mondor, AP HP, Serv Sante Publ, F-94010 Creteil, France; [Audureau, Etienne] Univ Paris Est Creteil, DHU A TVB, IRMB, EA CEpiA Clin Epidemiol & Ageing Unit 7376, F-94010 Creteil, France; Hop Henri Mondor, Creteil, France; [Yelnik, Alain; Tlili, Leila; Jousse, Marylene] Hop Fernand Widal, Paris, France; [Dehail, Patrick; Gassie, Paul; Aguirre, Alice] CHU Bordeaux, Bordeaux, France; [Marque, Philippe; De Boissezon, Xavier; Tarri, Mohamed] CHU Rangueil, Toulouse, France; [Boyer, Francois; Belassian, Gael; Agueros, Diego] CHU Reims, Reims, France; [Giraux, Pascal; Rimaud, Diane] CHU St Etienne, St Etienne, France		Pradines, M (corresponding author), UPEC, Lab Anal & Restaurat Mouvement, EA BIOTN 7377, F-94010 Creteil, France.; Pradines, M (corresponding author), Hop Univ Henri Mondor, AP HP, Serv Reeducat Neurolocomotrice, Unite Neuroreeduc, F-94010 Creteil, France.	jean-michel.gracies@aphp.fr; maudprad@gmail.com; mouna.ghedira@aphp.fr; catherine-marie.loche@aphp.fr; valentina.mardale@aphp.fr; catherine.hennegrave@aphp.fr; caroline.colas@aphp.fr; etienne.audureau@aphp.fr; emilie.hutin@aphp.fr; marjolaine.baude@aphp.fr; nicolas.bayle@aphp.fr; alain.yelnik@aphp.fr; patrick.dehail@chu-bordeaux.fr; marque.ph@chu-toulouse.fr; fboyer@chu-reims.fr; pascal.giraux@chu-st-etienne.fr; leila.tlili@aphp.fr; marylene.jousse@aphp.fr; deboissezon.xavier@chu-toulouse.fr; gbelassian@chu-reims.fr; paul.gassie@chu-bordeaux.fr; alice.aguirre@chu-bordeaux.fr; dagueros@chu-reims.fr; diana.rimaud@chu-st-etienne.fr; mohamed.tarri@inserm.fr	MARQUE, Philippe/AAC-4798-2019; Boyer, Francois Constant/P-4544-2016; Dehail, Patrick/T-5081-2019; Giraux, Pascal/D-8105-2018	Boyer, Francois Constant/0000-0003-1035-9108; Giraux, Pascal/0000-0002-8581-1472; nicolas, bayle/0000-0002-3726-2712; Audureau, Etienne/0000-0002-6166-149X	Government of France; Ministry of Health and Sports, through a Hospital Programme of Clinical Research (PHRC) grant	The study received funding from the Government of France, i.e. The Ministry of Health and Sports, through a Hospital Programme of Clinical Research (PHRC) grant, after peer-review process. This grant covered the staff fees, ie fees for evaluating investigators, referent coordinators, therapists who implemented the GSC method in each center, as well as research assistants and statistician. The funder had no influence on the study design, neither on writing the report nor on the decision to submit the report for publication.	Abrams P, 2016, NEUROUROL URODYNAM, V35, P743, DOI 10.1002/nau.22800; ACKERMAN AM, 1984, J APPL BEHAV ANAL, V17, P403, DOI 10.1901/jaba.1984.17-403; Alkandari S, 2011, ANN PHYS REHABIL MED, V54, pe243; Baer G, 2001, Physiother Res Int, V6, P135, DOI 10.1002/pri.222; Baskett JJ, 1999, CLIN REHABIL, V13, P23, DOI 10.1191/026921599701532090; Bayle N, 2016, ANN PHYS REHABIL MED, V59, pE59; Brashear A, 2002, ARCH PHYS MED REHAB, V83, P1349, DOI 10.1053/apmr.2002.35474; BROCKLEHURST JC, 1978, BRIT MED J, V1, P1307, DOI 10.1136/bmj.1.6123.1307; Butefisch CM, 2000, P NATL ACAD SCI USA, V97, P3661, DOI 10.1073/pnas.050350297; BUTLER P, 1984, DEV MED CHILD NEUROL, V26, P607; Calugi S, 2016, EUR J PHYS REHAB MED, V52, P72; Chaiyawat P, 2012, PSYCHOGERIATRICS, V12, P193, DOI 10.1111/j.1479-8301.2012.00412.x; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Collin C, 1988, Int Disabil Stud, V10, P61; de Gooijer-van de Groep KL, 2016, CLIN BIOMECH, V35, P93, DOI 10.1016/j.clinbiomech.2016.03.012; Dean CM, 2001, CLIN REHABIL, V15, P415, DOI 10.1191/026921501678310216; Dobkin BH, 2010, NEUROREHAB NEURAL RE, V24, P235, DOI 10.1177/1545968309357558; Floeter MK, 2013, RESTOR NEUROL NEUROS, V31, P53, DOI 10.3233/RNN-120247; French B, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006073.pub3; Gallien P., 2005, Annales de Readaptation et de Medecine Physique, V48, P225, DOI 10.1016/j.annrmp.2005.02.001; Gault-Colas C, 2012, ANN PHYS REHABIL MED, V55, pe301; Gracies JM, 2015, ANN PHYS REHABIL MED, V58, P173, DOI 10.1016/j.rehab.2015.04.004; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Gracies JM, 2014, ARCH PHYS MED REHAB, V95, P1303, DOI 10.1016/j.apmr.2014.03.016; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Gracies JM, 2002, HDB BOTULINUM TOXIN, P221; Gracies JM, 2016, GUIDED SELF REHABILI, DOI [10.1007/978-3-319-29108-6, DOI 10.1007/978-3-319-29108-6]; Gracies JM, 2003, ANN MED PHYS, V46, P429; Gracies JM, 2009, ARCH PHYS MED REHAB, V90, pE5; Green J, 2004, CLIN REHABIL, V18, P249, DOI 10.1191/0269215504cr747oa; Green J, 2002, LANCET, V359, P199, DOI 10.1016/S0140-6736(02)07443-3; HANEL F, 1980, INT J REHABIL RES, V3, P505, DOI 10.1097/00004356-198012000-00004; Harvey LA, 2017, J PHYSIOTHER, V63, P67, DOI 10.1016/j.jphys.2017.02.014; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hu XL, 2007, ARCH PHYS MED REHAB, V88, P1022, DOI 10.1016/j.apmr.2007.05.006; Hutin E, 2018, TOP STROKE REHABIL, P1; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; Jorgensen HS, 1997, STROKE, V28, P1138, DOI 10.1161/01.STR.28.6.1138; Jorger M, 2001, NEUROREHAB NEURAL RE, V15, P15, DOI 10.1177/154596830101500103; Kendall E, 2007, SOC SCI MED, V64, P735, DOI 10.1016/j.socscimed.2006.09.012; Khalil N, 2013, ANN PHYS REHABIL MED, V56, pe45, DOI 10.1016/j.rehab.2013.07.017; Knight C, 2002, BRAIN INJURY, V16, P75, DOI 10.1080/02699050110082188; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Lang CE, 2005, EXP BRAIN RES, V166, P126, DOI 10.1007/s00221-005-2350-6; Langhammer B, 2007, CLIN REHABIL, V21, P495, DOI 10.1177/0269215507075207; Langhammer B, 2014, BRAIN INJURY, V28, P1396, DOI 10.3109/02699052.2014.919534; Lenderking WR, 2008, CONTEMP CLIN TRIALS, V29, P867, DOI 10.1016/j.cct.2008.05.012; Leonard C T, 1998, J Stroke Cerebrovasc Dis, V7, P145, DOI 10.1016/S1052-3057(98)80142-0; Liu Y, 1999, EXP BRAIN RES, V128, P149, DOI 10.1007/s002210050830; Marsden DL, 2016, J STROKE CEREBROVASC, V25, P2386, DOI 10.1016/j.jstrokecerebrovasdis.2016.06.007; Meimoun M, 2015, REV NEUROL-FRANCE, V171, P130, DOI 10.1016/j.neurol.2014.09.011; Moore JL, 2010, STROKE, V41, P129, DOI 10.1161/STROKEAHA.109.563247; Moriyama H, 2013, CLIN ORTHOP RELAT R, V471, P3626, DOI 10.1007/s11999-013-3196-z; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Natta DDN, 2015, ANN PHYS REHABIL MED, V58, P322, DOI 10.1016/j.rehab.2015.08.003; Nippita S, 2015, CONTRACEPTION, V92, P578, DOI 10.1016/j.contraception.2015.09.004; NOLAND MP, 1989, RES Q EXERCISE SPORT, V60, P216, DOI 10.1080/02701367.1989.10607443; Park HY, 2012, NEUROREHABILITATION, V31, P185, DOI 10.3233/NRE-2012-0788; Parker V M, 1986, Int Rehabil Med, V8, P69; Pila O, 2018, INT J NEUROSCI, V128, P1030, DOI 10.1080/00207454.2018.1461626; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001920.pub3; Poltawski L, 2015, DISABIL REHABIL, V37, P795, DOI 10.3109/09638288.2014.946154; Pound P, 1994, Qual Health Care, V3, P69, DOI 10.1136/qshc.3.2.69; Pradines M, 2018, EFFECT PASSIVE RANGE; Rinne P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163413; Roth EJ, 1997, AM J PHYS MED REHAB, V76, P128, DOI 10.1097/00002060-199703000-00008; Saunders DH, 2016, COCHRANE DB SYST REV, V24; Saw AE, 2015, J SPORT SCI MED, V14, P137; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; Smith MC, 2017, STROKE, V48, P1400, DOI 10.1161/STROKEAHA.116.016478; Spieler JF, 2004, REV NEUROL-FRANCE, V160, P1023, DOI 10.1016/S0035-3787(04)71139-X; Spieler JF, 2003, EUR J NEUROL, V10, P621, DOI 10.1046/j.1468-1331.2003.00665.x; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Tanaka H, 2014, INT ARCH OCC ENV HEA, V87, P445, DOI 10.1007/s00420-013-0883-8; van Delden AEQ, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-57; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; VanWormer JJ, 2009, AM J PREV MED, V36, P70, DOI 10.1016/j.amepre.2008.09.022; Vecchio M, 2017, J STROKE CEREBROVASC; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Vinti M, 2015, J NEURAL TRANSM, V122, P1089, DOI 10.1007/s00702-015-1379-3; Viosca E, 2005, ARCH PHYS MED REHAB, V86, P1239, DOI 10.1016/j.apmr.2004.11.015; WADE DT, 1992, BRIT MED J, V304, P609, DOI 10.1136/bmj.304.6827.609; WADE DT, 1983, J NEUROL NEUROSUR PS, V46, P521, DOI 10.1136/jnnp.46.6.521; Wade JE, 1992, MED CARE, V30, P473, DOI [DOI 10.1097/00005650-199206000-00002, 10.1007/BF03260127]; Wilkins KB, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00284; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	87	7	8	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	MAR 12	2019	19								39	10.1186/s12883-019-1257-y			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HP4NF	WOS:000461652100001	30871480	gold, Green Published			2022-02-06	
J	McKerral, M; Moreno, A; Delhomme, P; Gelinas, I				McKerral, Michelle; Moreno, Alexander; Delhomme, Patricia; Gelinas, Isabelle			Driving Behaviors 2-3 Years After Traumatic Brain Injury Rehabilitation: A Multicenter Case-Control Study	FRONTIERS IN NEUROLOGY			English	Article						automobile driving; driving behaviors; interdisciplinary neurorehabilitation; road accidents; social participation; traffic offenses; traumatic brain injury	ANGER EXPRESSION INVENTORY; OF-THE-LITERATURE; EXECUTIVE FUNCTION; SELF-AWARENESS; ACCIDENT RATE; FOLLOW-UP; DRIVERS; FITNESS; RETURN; ABILITY	Introduction: Driving an automobile is an important activity for the social participation of individuals with traumatic brain injury (TBI). Return to safe driving is usually addressed during rehabilitation, but we know little about driving behaviors in the years following TBI rehabilitation. Objective: To explore self-reported and objective (official driving records) post-rehabilitation driving behaviors and offenses in individuals with TBI: (a) having passed a driving evaluation, (b) who did not undergo a driving evaluation, and (c) non-injured controls. Methods: Cross-sectional design with 162 adults: (a) 48 participants with mild, moderate, or severe TBI whose drivers' license was suspended and reinstated following a driving evaluation during rehabilitation (TBI-DE; M = 42.2 years of age, SD = 11.5); (b) 24 participants with TBI who maintained their driving privileges without undergoing a driving evaluation (TBI-NE; M = 36.5 years of age, SD = 9.9); (c) 90 non-injured controls (M = 43.8 years of age, SD = 11.4). Participants with TBI were recruited from seven rehabilitation centers, 2-3 years after the end of rehabilitation in the province of Quebec, Canada. During a telephone interview, data were obtained regarding self-reported driving: (a) habits; (b) self-efficacy; (c) anger expression; (d) sensation-seeking; (e) violations/errors; (f) accidents, driving offenses, and demerit points for the two-year interval predating the study. Objective data for driving offenses, accidents, and demerit points were obtained from the automobile regulatory body for the same period and for the two-year interval before the injury for the TBI groups. Results: Compared to non-injured controls, the TBI-DE group reported significantly lower scores for self-reported verbal aggressive expression of anger and driving violations/errors. Conversely, their official driving records showed significantly more demerit points for the last 2 years, and a significantly higher frequency of serious post-rehabilitation accidents (10), compared to the TBI-NE group (one) and the control group (none). Compared to pre-injury levels, individuals with TBI had significantly more demerit points post-rehabilitation. Conclusions: Individuals with TBI may underestimate risky driving behaviors even if they have been deemed fit to drive. Reduced self-awareness, memory, and dysexecutive problems following TBI could influence self-report of driving behaviors and explain discrepancies between self-reported and objective driving-related behaviors. Recommendations for research and practice are provided.	[McKerral, Michelle; Moreno, Alexander] CIUSSS Ctr Sud de Lile de Monbeal, Ctr Interdisciplinary Res Rehabil Greater Montrea, CRIR, Montreal, PQ, Canada; [McKerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Delhomme, Patricia] French Inst Sci & Technol Transport Dev & Network, IFSTTAR, Versailles, France; [Gelinas, Isabelle] McGill Univ, Ctr Interdisciplinary Res Rehabil Greater Montrea, CRIR, CISSS Laval, Montreal, PQ, Canada; [Gelinas, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada		McKerral, M (corresponding author), CIUSSS Ctr Sud de Lile de Monbeal, Ctr Interdisciplinary Res Rehabil Greater Montrea, CRIR, Montreal, PQ, Canada.; McKerral, M (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.	michelie.mckerral@umontreal.ca			Traumatology Research Consortium, Fonds de recherche du Quebec - Sante (FRQS)	Funding was provided by the Traumatology Research Consortium, Fonds de recherche du Quebec - Sante (FRQS).	Alexandersen A, 2009, BRAIN INJURY, V23, P313, DOI 10.1080/02699050902788428; Ameratunga SN, 2004, INJURY, V35, P1116, DOI 10.1016/j.injury.2003.12.016; Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; Anschutz JR, 2010, TOP STROKE REHABIL, V17, P337, DOI 10.1310/tsr1705-337; Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Baker A, 2015, ACCIDENT ANAL PREV, V79, P50, DOI 10.1016/j.aap.2015.03.014; Beaulieu-Bonneau S, 2017, NEUROPSYCHOL REHABIL, V27, P216, DOI 10.1080/09602011.2015.1077145; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Bliokas VV, 2011, BRAIN INJURY, V25, P471, DOI 10.3109/02699052.2011.559609; Boccara V, 2011, ACCIDENT ANAL PREV, V43, P241, DOI 10.1016/j.aap.2010.08.016; Bourrat V, 2010, ECHELLE AUTO EVALUAT; Brooks N, 2005, BRAIN INJURY, V19, P165, DOI 10.1080/02699050410001720004; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; Brouwer WH, 2002, J HEAD TRAUMA REHAB, V17, P1, DOI 10.1097/00001199-200202000-00003; Chee JN, 2019, J HEAD TRAUMA REHAB, V34, pE27, DOI 10.1097/HTR.0000000000000400; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Cizman US, 2017, INT J REHABIL RES, V40, P107, DOI 10.1097/MRR.0000000000000213; Classen S, 2017, OTJR-OCCUP PART HEAL, V37, P62, DOI 10.1177/1539449216675582; Classen S, 2014, OCCUP THER HEALTH CA, V28, P154, DOI 10.3109/07380577.2014.901590; Cohen J., 2013, STAT POWER ANAL BEHA; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; D'apolito A. -C., 2013, Annals of Physical and Rehabilitation Medicine, V56, P63, DOI 10.1016/j.rehab.2012.12.002; D'apolito AC, 2017, ANN PHYS REHABIL MED, V60, P263, DOI 10.1016/j.rehab.2017.04.001; Deffenbacher JL, 2001, PSYCHOL REP, V89, P535, DOI 10.2466/PR0.89.7.535-540; Deffenbacher JL, 2003, BEHAV RES THER, V41, P333, DOI 10.1016/S0005-7967(02)00014-1; Deffenbacher JL, 2002, BEHAV RES THER, V40, P717, DOI 10.1016/S0005-7967(01)00063-8; Delhomme P, 2009, J SAFETY RES, V40, P333, DOI 10.1016/j.jsr.2009.09.003; Devos H, 2013, EUR J NEUROL, V20, P1225, DOI 10.1111/ene.12168; Fisk GD, 1998, BRAIN INJURY, V12, P683; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Fueger C, 2018, J CLIN EXP NEUROPSYC, V40, P1074, DOI 10.1080/13803395.2018.1458823; Gamache PL, 2011, BRAIN INJURY, V25, P416, DOI 10.3109/02699052.2011.558039; Gershon P, 2018, J ADOLESCENT HEALTH, V63, P568, DOI 10.1016/j.jadohealth.2018.04.012; Gooden JR, 2019, NEUROPSYCHOL REHABIL, V29, P92, DOI 10.1080/09602011.2016.1261716; Gooden JR, 2017, J HEAD TRAUMA REHAB, V32, pE50, DOI 10.1097/HTR.0000000000000212; Government of Quebec/Ministere de la Sante et des Services Sociaux & Societe de l'assurance automobile du Quebec, 2005, OR MIN TCCL; Hargrave DD, 2012, NEUROPSYCHOL REHABIL, V22, P489, DOI 10.1080/09602011.2012.662333; Haselkorn JK, 1998, ARCH PHYS MED REHAB, V79, P738, DOI 10.1016/S0003-9993(98)90349-5; Huseth-Zosel AL, 2018, J COMMUN HEALTH, V43, P827, DOI 10.1007/s10900-018-0489-x; IBM, 2017, IMB SPSS STAT VERS 2; Kar IN, 2018, J ADOLESCENT HEALTH, V62, P626, DOI 10.1016/j.jadohealth.2018.01.006; Lawton R, 1997, J APPL SOC PSYCHOL, V27, P1258, DOI 10.1111/j.1559-1816.1997.tb01805.x; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Mani R, 2018, BRAIN INJURY, V32, P1315, DOI 10.1080/02699052.2018.1483030; Martin RJ, 2018, TRAFFIC INJ PREV, V19, P563, DOI 10.1080/15389588.2018.1476690; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Oviedo-Trespalacios O, 2018, TRAFFIC INJ PREV, V19, P9, DOI 10.1080/15389588.2017.1333606; PARKER D, 1995, ERGONOMICS, V38, P1036, DOI 10.1080/00140139508925170; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; PRIDDY D A, 1990, Brain Injury, V4, P267, DOI 10.3109/02699059009026176; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Rike PO, 2014, BRAIN INJURY, V28, P1687, DOI 10.3109/02699052.2014.947632; Ross P, 2016, DISABIL REHABIL, V38, P994, DOI 10.3109/09638288.2015.1074293; Ross PE, 2018, DISABIL REHABIL, V40, P757, DOI 10.1080/09638288.2016.1274341; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Schwab Karen A, 2015, Handb Clin Neurol, V128, P649, DOI 10.1016/B978-0-444-63521-1.00040-6; SHUTE RH, 1990, OPHTHAL PHYSL OPT, V10, P327, DOI 10.1111/j.1475-1313.1990.tb00878.x; Sommer M, 2010, ARCH CLIN NEUROPSYCH, V25, P99, DOI 10.1093/arclin/acp109; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Taubman O., 1996, COGNITIVE MOTIVATION; Victoir A, 2005, TRANSPORT RES F-TRAF, V8, P59, DOI 10.1016/j.trf.2005.01.002; Villieux A, 2008, TRAV HUMAIN, V71, P359, DOI 10.3917/th.714.0359; Villieux A, 2010, J SAFETY RES, V41, P417, DOI 10.1016/j.jsr.2010.08.003	72	7	7	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 7	2019	10								144	10.3389/fneur.2019.00144			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HO3ES	WOS:000460802700001	30899239	Green Published, gold			2022-02-06	
J	Kondziella, D; Cheung, MC; Dutta, A				Kondziella, Daniel; Cheung, Man Cheung; Dutta, Anirban			Public perception of the vegetative state/unresponsive wakefulness syndrome: a crowdsourced study	PEERJ			English	Article						Consciousness; Coma; Neurorehabilitation; Traumatic brain injury; Disorders of consciousness; Ethics; Cognitive motor dissociation; Brain injury; Locked-in syndrome; Intensive care	MINIMALLY CONSCIOUS STATE; LOCKED-IN SYNDROME; VISUAL PURSUIT; BRAIN-INJURY; DISORDERS; RECOVERY; AWARENESS; CONSENSUS	Background. The vegetative state (VS)/unresponsive wakefulness syndrome (UWS) denotes brain-injured, awake patients who are seemingly without awareness. Still, up to 15% of these patients show signs of covert consciousness when examined by functional magnetic resonance imaging (fMRI) or EEG, which is known as cognitive motor dissociation (CMD). Experts often prefer the term unresponsive wakefulness syndrome to avoid the negative connotations associated with vegetative state and to highlight the possibility for CMD. However, the perception of VS/UWS by the public has never been studied systematically. Methods. Using an online crowdsourcing platform, we recruited 1,297 lay people from 32 countries. We investigated if vegetative state and unresponsive wakefulness syndrome might have a different influence on attitudes towards VS/UWS and the concept of CMD. Results. Participants randomized to be inquired about the vegetative state believed that CMD was less plausible (mean estimated frequency in unresponsive patients 38.07% +/- SD 25.15) than participants randomized to unresponsive wakefulness syndrome (42.29% +/- SD 26.63; Cohen's d 0.164; p = 0.016). Attitudes towards treatment withdrawal were similar. Most participants preferred unresponsive wakefulness syndrome (60.05%), although a sizeable minority favored vegetative state (24.21%; difference 35.84%, 95% CI 29.36 to 41.87; p < 0.0001). Searches on PubMed and Google Trends revealed that unresponsive wakefulness syndrome is increasingly used by academics but not lay people. Discussion. Simply replacing vegetative state with unresponsive wakefulness syndrome may not be fully appropriate given that one of four prefer the first term. We suggest that physicians take advantage of the controversy around the terminology to explain relatives the concept of CMD and its ethical implications.	[Kondziella, Daniel] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Copenhagen, Denmark; [Kondziella, Daniel] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Kondziella, Daniel] Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway; [Cheung, Man Cheung; Dutta, Anirban] Univ Buffalo State Univ New York SUNY, Dept Biomed Engn, Buffalo, NY USA		Kondziella, D (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Copenhagen, Denmark.; Kondziella, D (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark.; Kondziella, D (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway.	daniel_kondziella@yahoo.com	Dutta, Anirban/AAG-6604-2021	Dutta, Anirban/0000-0002-7298-9773; Kondziella, Daniel/0000-0001-5562-9808			Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Bodien YG, 2017, SEMIN NEUROL, V37, P485, DOI 10.1055/s-0037-1607310; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Bruno MA, 2011, PROG BRAIN RES, V193, P323, DOI 10.1016/B978-0-444-53839-0.00021-1; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Chatelle C, 2016, ARCH PHYS MED REHAB, V97, P1295, DOI 10.1016/j.apmr.2016.02.009; Chennu S, 2017, BRAIN, V140, P2120, DOI 10.1093/brain/awx163; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Curley WH, 2018, BRAIN, V141, P1404, DOI 10.1093/brain/awy070; Demertzi A, 2014, BRAIN INJURY, V28, P1209, DOI 10.3109/02699052.2014.920526; Di HB, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-147; Di Perri C, 2016, LANCET NEUROL, V15, P830, DOI 10.1016/S1474-4422(16)00111-3; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Engemann DA, 2018, BRAIN, V141, P3179, DOI 10.1093/brain/awy251; Faugeras F, 2011, NEUROLOGY, V77, P264, DOI 10.1212/WNL.0b013e3182217ee8; Faugeras F, 2018, BRAIN INJURY, V32, P72, DOI 10.1080/02699052.2017.1364421; Formisano R, 2013, BRAIN INJURY, V27, P1332, DOI 10.3109/02699052.2013.809555; Fraser H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200303; Giacino JT, 2018, NEUROLOGY, V91, P461, DOI 10.1212/WNL.0000000000005928; Gipson J, 2014, NEUROETHICS-NETH, V7, P1, DOI 10.1007/s12152-012-9174-4; Gosseries O, 2011, NEUROREHABILITATION, V28, P3, DOI 10.3233/NRE-2011-0625; Gray K, 2011, COGNITION, V121, P275, DOI 10.1016/j.cognition.2011.06.014; Harvey D, 2018, BRIT J ANAESTH, V120, P138, DOI 10.1016/j.bja.2017.10.002; Hermann B, 2018, BIORXIV370775, DOI [10.1101/370775, DOI 10.1101/370775]; JENNETT B, 1972, LANCET, V1, P734; Kondziella D, 2018, NEUROSCIENCE, V382, P125, DOI 10.1016/j.neuroscience.2018.03.046; Kondziella D, 2017, J NEUROL SCI, V379, P276, DOI 10.1016/j.jns.2017.06.033; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Koon AD, 2016, HEALTH POLICY PLANN, V31, P801, DOI 10.1093/heapol/czv128; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Laureys S, 2005, PROG BRAIN RES, V150, P495, DOI 10.1016/S0079-6123(05)50034-7; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Machado C, 2012, NEUROREHABILITATION, V31, P345, DOI 10.3233/NRE-2012-00802; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Naccache L, 2018, BRAIN, V141, P949, DOI 10.1093/brain/awx324; Peer E, 2017, J EXP SOC PSYCHOL, V70, P153, DOI 10.1016/j.jesp.2017.01.006; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Thonnard M, 2014, BRAIN INJURY, V28, P1164, DOI 10.3109/02699052.2014.920521; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vanhaudenhuyse A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00671; von Wild K, 2012, J Med Life, V5, P3; Wannez S, 2017, BRAIN INJURY, V31, P1429, DOI 10.1080/02699052.2017.1376755; Wannez S, 2017, J NEUROL, V264, P928, DOI 10.1007/s00415-017-8469-0; Wannez S, 2018, NEUROPSYCHOL REHABIL, V28, P1350, DOI 10.1080/09602011.2017.1310656; Woods AT, 2015, PEERJ, V3, DOI 10.7717/peerj.1058	50	7	7	2	4	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	MAR 6	2019	7								e6575	10.7717/peerj.6575			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HN9HX	WOS:000460511600005	30863687	Green Submitted, Green Published, gold			2022-02-06	
J	Bajwa, NM; Lee, JB; Halavi, S; Hartman, RE; Obenaus, A				Bajwa, Nikita M.; Lee, Jeong B.; Halavi, Shina; Hartman, Richard E.; Obenaus, Andre			Repeated isoflurane in adult male mice leads to acute and persistent motor decrements with long-term modifications in corpus callosum microstructural integrity	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						anesthesia; behavior; diffusion Tensor Imaging; injury; white matter	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; IN-VIVO; AXONAL INJURY; PROTEIN EXPRESSION; MOUSE MODEL; RAT MODELS; ANESTHESIA; EXPOSURE; MILD	Isoflurane is a commonly used inhalational anesthetic, clinically and in animal experimental studies. Although it has been reported as safe, recent findings suggest that despite widespread use, isoflurane-induced inhalational anesthesia can lead to various pathophysiological and cognitive alterations. Therefore, we aimed to investigate the long-term behavioral and white matter consequences of repeated isoflurane exposure. Twenty 3-month-old C57BL/6J male mice received one exposure of isoflurane for 40 min or 2 exposures to isoflurane separated by 3 days. Behavioral paradigms (open field, balance beam, foot fault, rotarod, elevated zero maze, tail suspension, water maze, and social recognition tests) were administered at 1, 3, 5, 7, and 90 days post exposure. Animals exposed to repeated isoflurane showed significant motor deficits on the balance beam and increased anxiety-like behavior. Animals exposed to single isoflurane showed impaired performance on the foot fault test. Diffusion tensor imaging showed that repeated isoflurane exposure led to long-term disruption of water diffusivity in corpus callosum (CC) white matter. Furthermore, 2-D structure-tensor analysis from stained brain sections showed differences in the microstructural organization of CC white matter in mice with single versus repeated isoflurane exposures. These results suggest that behavioral deficits observed up to 90 days after repeated isoflurane exposure resulted from, at least in part, altered CC white matter microstructural integrity.	[Bajwa, Nikita M.] VA Loma Linda Healthcare Syst, Musculoskeletal Dis Ctr, Loma Linda, CA USA; [Lee, Jeong B.; Obenaus, Andre] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA USA; [Halavi, Shina; Hartman, Richard E.] Loma Linda Univ, Sch Behav Hlth, Dept Psychol, Loma Linda, CA 92350 USA; [Obenaus, Andre] Univ Calif Irvine, Sch Med, Dept Pediat, Irvine, CA 92717 USA		Obenaus, A (corresponding author), Univ Calif Irvine, Dept Pediat, Preclin & Translat Imaging Ctr, Irvine, CA 92697 USA.	obenausa@uci.edu		, Andre/0000-0003-0081-6950	School of Behavioral Health Loma Linda University	School of Behavioral Health Loma Linda University, Grant/Award Number: Seed Grant	Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Bar-Klein G, 2016, ANN NEUROL, V80, P896, DOI 10.1002/ana.24804; Bellone JA, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.19; Brambrink AM, 2012, ANN NEUROL, V72, P525, DOI 10.1002/ana.23652; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Burchell SR, 2013, J INVEST MED, V61, P1078, DOI 10.2310/JIM.0b013e3182a07921; Butterfield NN, 2004, ANESTH ANALG, V98, P1305, DOI 10.1213/01.ANE.0000108484.91089.13; Callaway JK, 2012, EUR J ANAESTH, V29, P239, DOI 10.1097/EJA.0b013e32835103c1; Cao YY, 2015, NEUROSCI LETT, V587, P51, DOI 10.1016/j.neulet.2014.12.018; Carr ZJ, 2011, J NEUROSURG ANESTH, V23, P138, DOI 10.1097/ANA.0b013e3182049f19; Chang EH, 2017, NEUROIMAGE, V147, P253, DOI 10.1016/j.neuroimage.2016.11.068; Coleman K, 2017, ANESTHESIOLOGY, V126, P74, DOI 10.1097/ALN.0000000000001383; Creeley CE, 2014, ANESTHESIOLOGY, V120, P626, DOI 10.1097/ALN.0000000000000037; DeYoung TP, 2017, J NEUROSURG ANESTH, V29, P439, DOI 10.1097/ANA.0000000000000365; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Dulcich MS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/940830; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Giattino CM, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00024; Gozzi A, 2016, NEUROIMAGE, V127, P496, DOI 10.1016/j.neuroimage.2015.12.017; Hall C, 1932, STUDY RATS BEHAV FIE; Hammelrath L, 2016, NEUROIMAGE, V125, P144, DOI 10.1016/j.neuroimage.2015.10.009; Harada H, 1999, ANESTH ANALG, V89, P1442, DOI 10.1097/00000539-199912000-00022; Hartman R, 2009, BRAIN RES, V1280, P148, DOI 10.1016/j.brainres.2009.05.038; Hartman RE, 2006, NEUROBIOL DIS, V24, P506, DOI 10.1016/j.nbd.2006.08.006; Hohlbaum K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179588; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Jevtovic-Todorovic Vesna, 2012, Front Neurol, V3, P141, DOI 10.3389/fneur.2012.00141; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; JONES BJ, 1968, N-S ARCH PHARMAKOL, V259, P211, DOI 10.1007/BF00537801; Judenhofer MS, 2008, NAT MED, V14, P459, DOI 10.1038/nm1700; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kang E, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001246; Kawaguchi M, 2004, ANESTH ANALG, V98, P798; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kumar M, 2012, BRAIN RES, V1455, P56, DOI 10.1016/j.brainres.2012.03.041; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lee BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105340; Lekic T, 2011, EXP NEUROL, V227, P96, DOI 10.1016/j.expneurol.2010.09.017; Li CX, 2014, MAGN RESON IMAGING, V32, P956, DOI 10.1016/j.mri.2014.04.019; Li GH, 2015, TOXICOL LETT, V233, P102, DOI 10.1016/j.toxlet.2014.11.026; Li ZQ, 2015, NEUROSCI BULL, V31, P505, DOI 10.1007/s12264-015-1549-1; Liu JH, 2017, NEUROCHEM RES, V42, P595, DOI 10.1007/s11064-016-2114-7; Liu XA, 2011, CEREB CORTEX, V21, P374, DOI 10.1093/cercor/bhq105; Loepke AW, 2009, ANESTH ANALG, V108, P90, DOI 10.1213/ane.0b013e31818cdb29; Loepke AW, 2006, ANESTH ANALG, V102, P75, DOI 10.1213/01.ANE.0000181102.92729.B8; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mawhinney LJ, 2012, BRAIN RES, V1431, P23, DOI 10.1016/j.brainres.2011.11.004; Meier A, 2018, ANESTH ANALG, V126, P1910, DOI 10.1213/ANE.0000000000002902; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murphy KL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00087; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Noguchi KK, 2017, BRIT J ANAESTH, V119, P524, DOI 10.1093/bja/aex123; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Ramage TM, 2013, BRIT J ANAESTH, V110, P39, DOI 10.1093/bja/aet103; REINSTRUP P, 1995, ANESTHESIOLOGY, V82, P359, DOI 10.1097/00000542-199502000-00006; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Rosenholm M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175258; Rothstein S, 2008, NEUROSCIENCE, V152, P959, DOI 10.1016/j.neuroscience.2008.01.027; Rudobeck E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186168; Sakai H, 2007, ANESTHESIOLOGY, V106, P92, DOI 10.1097/00000542-200701000-00017; Schlunzen L, 2006, ACTA ANAESTH SCAND, V50, P306, DOI 10.1111/j.1399-6576.2006.00954.x; Schmanke TD, 1996, J NEUROTRAUM, V13, P293, DOI 10.1089/neu.1996.13.293; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Sinner B, 2014, ANAESTHESIA, V69, P1009, DOI 10.1111/anae.12637; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Su D, 2011, ACTA ANAESTH SCAND, V55, P468, DOI 10.1111/j.1399-6576.2010.02385.x; Tao G, 2016, BIOMED RES INT BIOME, V2016, P2016, DOI DOI 10.1155/2016/7919640; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wang HL, 2016, MED GAS RES, V6, P194, DOI 10.4103/2045-9912.196901; Wang Hui-Lin, 2015, J Cell Death, V8, P9, DOI 10.4137/JCD.S30596; Wey HY, 2011, J CEREBR BLOOD F MET, V31, P715, DOI 10.1038/jcbfm.2010.154; Yi XW, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/315872; Zhou R, 2017, ANESTH ANALG, V124, P582, DOI 10.1213/ANE.0000000000001698; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	81	7	7	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAR	2019	97	3					332	345		10.1002/jnr.24343			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI3HA	WOS:000456338100011	30394562	Bronze			2022-02-06	
J	Bogdanov, S; Brookes, N; Epps, A; Naismith, SL; Teng, A; Lah, S				Bogdanov, Stefan; Brookes, Naomi; Epps, Adrienne; Naismith, Sharon L.; Teng, Arthur; Lah, Suncica			Sleep Disturbance in Children With Moderate or Severe Traumatic Brain Injury Compared With Children With Orthopedic Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescence; brain injuries; child; sleep	1ST 6 MONTHS; PSYCHOMETRIC PROPERTIES; ADOLESCENTS; HYGIENE; TERM; PREVALENCE; OUTCOMES; DIFFICULTIES; PREDICTORS; DEPRESSION	Objectives: To characterize the sleep disturbance in children with moderate or severe traumatic brain injury (TBI), and to identify associated factors. Setting: An urban tertiary pediatric healthcare facility. Participants: Children aged 5 to 15 years with a moderate TBI (n = 21), severe TBI (n = 23), or an orthopedic injury (OI; n =38) comparable in age, gender, and socioeconomic status. Design: Cohort study. Measures: Primary: Sleep Disturbance Scale for Children (SDSC). Secondary: Injury-specific factors (TBI severity, age at injury, and time since injury), and other factors of interest (sleep hygiene; pain intensity; difficulties with internalizing, externalizing, or attention/hyperactivity; parental distress; and parental knowledge of TBI). Results: On the SDSC, parents rated children with moderate TBI (but not severe TBI) as experiencing greater overall sleep disturbance, as well as excessive somnolence and sleep breathing disturbance, relative to OI controls. Children with severe TBI (but not moderate TBI) were rated as experiencing greater disturbance with initiating and maintaining sleep. The moderate and severe TBI groups did not differ on any of the sleep outcomes. Only 3 factors were associated with sleep disturbance in the combined TBI group: (1) lower TBI severity with greater excessive somnolence; (2) greater internalizing difficulties with greater overall sleep disturbance, and disturbance with initiating and maintaining sleep specifically; and (3) younger age at injury with greater overall sleep disturbance, and sleep breathing disturbance specifically. Conclusion: Children with moderate or severe TBI experience greater overall and/or specific forms of sleep disturbance. Different forms of sleep disturbance may be associated with different factors.	[Bogdanov, Stefan; Lah, Suncica] Univ Sydney, Sch Psychol, Camperdown, NSW 2006, Australia; [Naismith, Sharon L.] Univ Sydney, Brain & Mind Ctr, Camperdown, NSW, Australia; [Naismith, Sharon L.] Univ Sydney, Charles Perkins Ctr, Camperdown, NSW, Australia; [Brookes, Naomi; Epps, Adrienne] Sydney Childrens Hosp, Rehab2Kids Rehabil Unit, Randwick, NSW, Australia; [Teng, Arthur] Sydney Childrens Hosp, Dept Sleep Med, Randwick, NSW, Australia; [Teng, Arthur] Univ New South Wales, Sch Paediat & Womens Hlth, Kensington, NSW, Australia; [Lah, Suncica] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, N Ryde, NSW, Australia		Bogdanov, S (corresponding author), Univ Sydney, Sch Psychol, Camperdown, NSW 2006, Australia.	sbog4215@gmail.com		Naismith, Sharon/0000-0001-9076-2778			Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; [Anonymous], 2011, ABS CAT NO 2033 0 55; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Bogdanov S, 2017, BRAIN INJURY, V31, P422, DOI 10.1080/02699052.2017.1282042; Bruni O, 1996, J SLEEP RES, V5, P251, DOI 10.1111/j.1365-2869.1996.00251.x; Dahl RE, 2002, J ADOLESCENT HEALTH, V31, P175, DOI 10.1016/S1054-139X(02)00506-2; Dahl RE, 2007, SLEEP MED CLIN, V2, P501, DOI 10.1016/j.jsmc.2007.05.002; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Fischer JT, 2018, NEUROPSYCHOLOGY, V32, P161, DOI 10.1037/neu0000420; Harsh JR, 2002, SLEEP, V25, pA316; Henderson JA, 2010, J PSYCHOPATHOL BEHAV, V32, P271, DOI 10.1007/s10862-009-9143-3; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Jan JE, 2008, PEDIATRICS, V122, P1343, DOI 10.1542/peds.2007-3308; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; LeBourgeois MK, 2005, PEDIATRICS, V115, P257, DOI 10.1542/peds.2004-0815H; Lewandowski AS, 2011, J PEDIATR PSYCHOL, V36, P780, DOI 10.1093/jpepsy/jsq119; Lumeng Julie C, 2008, Proc Am Thorac Soc, V5, P242, DOI 10.1513/pats.200708-135MG; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Mindell JA, 2006, SLEEP, V29, P1263; Osorio MB, 2013, PM&R, V5, P554, DOI 10.1016/j.pmrj.2012.11.006; Palisano RJ, 2008, DEV MED CHILD NEUROL, V50, P744, DOI 10.1111/j.1469-8749.2008.03089.x; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Sambuco M, 2012, J HEAD TRAUMA REHAB, V27, P413, DOI 10.1097/HTR.0b013e3182274162; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Spruyt K, 2015, DEV MED CHILD NEUROL, V57, P120, DOI 10.1111/dmcn.12623; Spruyt K, 2011, SLEEP MED REV, V15, P19, DOI 10.1016/j.smrv.2010.07.005; Storfer-Isser A, 2013, J SLEEP RES, V22, P707, DOI 10.1111/jsr.12059; Sumpter RE, 2013, J INT NEUROPSYCH SOC, V19, P829, DOI 10.1017/S1355617713000465; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Theadom A, 2016, BRAIN INJURY, V30, P1243, DOI 10.1080/02699052.2016.1183171; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wiseman-Hakes C, 2016, J SLEEP DISORD THER, V5, P2167	42	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2019	34	2			SI		122	131		10.1097/HTR.0000000000000426			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HU9CK	WOS:000465590400015	30045218				2022-02-06	
J	Borczuk, P; Van Ornam, J; Yun, BJ; Penn, J; Pruitt, P				Borczuk, Pierre; Van Ornam, Jonathan; Yun, Brian J.; Penn, Joshua; Pruitt, Peter			Rapid Discharge After Interfacility Transfer for Mild Traumatic Intracranial Hemorrhage: Frequency and Associated Factors	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article							BRAIN-INJURY; LOW-RISK; SUBARACHNOID HEMORRHAGE; SECONDARY OVERTRIAGE; DECISION INSTRUMENT; ADULT PATIENTS; MANAGEMENT; TRANSPORT; SYSTEM; CARE	Introduction: Traumatic intracranial hemorrhage (TIH), brain injury with radiographic hemorrhage, is a common emergency department (ED) presentation, and encompasses a wide range of clinical syndromes. Patients with moderate and severe neurotrauma (Glasgow Coma Scale [GCS] < 13) with intracranial hemorrhage require care at a trauma center with neurosurgical capabilities. However, many patients with mild traumatic intracranial hemorrhage (mTIH), defined as radiographic bleeding and GCS >= 13, do not require operative intervention or intensive care unit monitoring, but are still routinely transferred to tertiary care centers. We hypothesized that a significant proportion of patients are managed non-operatively and are discharged within 24 hours of admission. Methods: This was a retrospective, observational study of consecutive patients age >= 16 years, GCS >= 13 who were transferred to an urban, medical school-affiliated, 100,000 annual visit ED over a seven-year period with blunt isolated mTIH. The primary outcome was discharge within 24 hours of admission. We measured rates of neurosurgical intervention, computed tomography hemorrhage progression, and neurologic deterioration as well as other demographic and clinical variables. Results: There were 1079 transferred patients with isolated mTIH. Of these, 92.4% were treated non-operatively and 35.8% were discharged within 24 hours of presentation to the tertiary ED. Patient characteristics associated with rapid discharge after transfer include a GCS of 15 (odds ratio [OR] 2.9, 95% confidence interval [CI], 1.9 - 4.4), subdural hematoma <= 6mm (OR 3.1, 95% CI, 2.2 - 4.5) or the presence of an isolated subarachnoid hemorrhage (OR 1.7, 95% CI, 1.3 - 2.4). Of patients with length of stay < 24 hours, 79.8% were discharged directly from the ED or ED observation unit. Conclusion: Patients transferred to tertiary care centers are frequently discharged after brief observation without intervention. Risk can be predicted by clinical and radiographic data. Further prospective research is required to determine a safe cohort of patients who could be managed at community sites.	[Borczuk, Pierre; Van Ornam, Jonathan; Yun, Brian J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Penn, Joshua] Winchester Hosp, Emergency Serv, Winchester, MA USA; [Pruitt, Peter] Northwestern Univ, Dept Emergency Med, Chicago, IL 60611 USA		Borczuk, P (corresponding author), Harvard Med Sch, Dept Emergency Med, Zero Emerson Pl,Suite 3B, Boston, MA 02114 USA.	Borczuk.Pierre@mgh.harvard.edu		Yun, Brian/0000-0002-3842-420X			Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Ciesla DJ, 2008, J AM COLL SURGEONS, V206, P131, DOI 10.1016/j.jamcollsurg.2007.06.285; Ciesla DJ, 2015, J TRAUMA ACUTE CARE, V79, P263, DOI 10.1097/TA.0000000000000660; Ditty BJ, 2015, J NEUROSURG, V123, P649, DOI 10.3171/2014.10.JNS132713; Garwe T, 2011, J TRAUMA, V70, P1118, DOI 10.1097/TA.0b013e3181e243b8; Haas B, 2012, J TRAUMA ACUTE CARE, V72, P1510, DOI 10.1097/TA.0b013e318252510a; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hill AD, 2011, J TRAUMA, V71, P1885, DOI 10.1097/TA.0b013e31823ac642; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Nassiri F, 2017, J TRAUMA ACUTE CARE, V83, P725, DOI 10.1097/TA.0000000000001617; Nishijima DK, 2014, ANN EMERG MED, V63, P448, DOI 10.1016/j.annemergmed.2013.11.003; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Osen HB, 2010, J TRAUMA, V69, P602, DOI 10.1097/TA.0b013e3181e7db37; Pruitt P, 2017, ACAD EMERG MED, V24, P1377, DOI 10.1111/acem.13306; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Sorensen MJ, 2013, JAMA SURG, V148, P763, DOI 10.1001/jamasurg.2013.2132; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tang A, 2014, J TRAUMA ACUTE CARE, V77, P969, DOI 10.1097/TA.0000000000000462; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI [10.2471/BLT.07.045120, 10.1371/journal.pmed.0040296]; Yun BJ, 2017, AM J EMERG MED, V35, P1281, DOI 10.1016/j.ajem.2017.03.071; Zhao T, 2016, J TRAUMA ACUTE CARE, V81, P743, DOI 10.1097/TA.0000000000001088	27	7	7	0	0	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	MAR	2019	20	2					307	315		10.5811/westjem.2018.12.39337			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HU1IO	WOS:000465026300018	30881551	gold, Green Published, Green Submitted			2022-02-06	
J	Burns, EC; Burns, B; Newgard, CD; Laurie, A; Fu, RW; Graif, T; Ward, CS; Bauer, A; Steinhardt, D; Ibsen, LM; Spiro, DM				Burns, Erin Corner; Burns, Beech; Newgard, Craig D.; Laurie, Amber; Fu, Rongwei; Graif, Theresa; Ward, Casey S.; Bauer, Abbie; Steinhardt, David; Ibsen, Laura M.; Spiro, David M.			Pediatric Minor Traumatic Brain Injury With Intracranial Hemorrhage: Identifying Low-Risk Patients Who May Not Benefit From ICU Admission	PEDIATRIC EMERGENCY CARE			English	Article						mild traumatic brain injury; traumatic intracranial hemorrhage; intensive care unit admission	COMPUTED-TOMOGRAPHY; ADULT PATIENTS; MANAGEMENT	Background Pediatric patients with any severity of traumatic intracranial hemorrhage (tICH) are often admitted to intensive care units (ICUs) for early detection of secondary injury. We hypothesize that there is a subset of these patients with mild injury and tICH for whom ICU care is unnecessary. Objectives To quantify tICH frequency and describe disposition and to identify patients at low risk of inpatient critical care intervention (CCI). Methods We retrospectively reviewed patients aged 0 to 17 years with tICH at a single level I trauma center from 2008 to 2013. The CCI included mechanical ventilation, invasive monitoring, blood product transfusion, hyperosmolar therapy, and neurosurgery. Binary recursive partitioning analysis led to a clinical decision instrument classifying patients as low risk for CCI. Results Of 296 tICH admissions without prior CCI in the field or emergency department, 29 had an inpatient CCI. The decision instrument classified patients as low risk for CCI when patients had absence of the following: midline shift, depressed skull fracture, unwitnessed/unknown mechanism, and other nonextremity injuries. This clinical decision instrument produced a high likelihood of excluding patients with CCI (sensitivity, 96.6%; 95% confidence interval, 82.2%-99.9%) from the low-risk group, with a negative likelihood ratio of 0.056 (95% confidence interval, -0.053-0.166). The decision instrument misclassified 1 patient with CCI into the low-risk group, but would have impacted disposition of 164 pediatric ICU admissions through 5 years (55% of the sample). Conclusions A subset of low-risk patients may not require ICU admission. The proposed decision rule identified low-risk children with tICH who may be observable outside an ICU, although this rule requires external validation before implementation.	[Burns, Erin Corner; Newgard, Craig D.; Graif, Theresa; Ward, Casey S.; Bauer, Abbie; Ibsen, Laura M.; Spiro, David M.] Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA; [Burns, Erin Corner; Ibsen, Laura M.] Oregon Hlth & Sci Univ, Div Pediat Crit Care Med, Portland, OR 97201 USA; [Burns, Beech; Newgard, Craig D.; Laurie, Amber; Fu, Rongwei; Steinhardt, David] Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, Dept Emergency Med, Portland, OR 97201 USA; [Laurie, Amber; Fu, Rongwei] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA		Burns, EC (corresponding author), CDRC P, 707 SW Gaines Ave, Portland, OR 97239 USA.	comer@ohsu.edu					Barrett M., 2011, HCUP STAT BRIEF, V185, P2014; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Egol A, 1999, CRIT CARE MED, V27, P633; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heffler S, 2003, HLTH AFF MILLWOOD S; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Huff JS, 2014, AM J EMERG MED, V32, P606, DOI 10.1016/j.ajem.2014.03.010; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Nishijima DK, 2014, ANN EMERG MED, V63, P448, DOI 10.1016/j.annemergmed.2013.11.003; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Odetola FO, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1920; Pastores SM, 2012, CRIT CARE CLIN, V28, P1, DOI 10.1016/j.ccc.2011.10.003; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Ryu JH, 2013, NEUROCRIT CARE, V19, P222, DOI 10.1007/s12028-013-9824-3; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shorr Andrew F, 2002, Curr Opin Crit Care, V8, P337, DOI 10.1097/00075198-200208000-00011; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	26	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAR	2019	35	3					161	169		10.1097/PEC.0000000000000950			9	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	HQ7XY	WOS:000462638500007	27798539				2022-02-06	
J	Cengiz, O; Atalar, AC; Tekin, B; Bebek, N; Baykan, B; Gurses, C				Cengiz, Ozan; Atalar, Arife Cimen; Tekin, Betul; Bebek, Nerses; Baykan, Betul; Gurses, Candan			Impact of seizure-related injuries on quality of life	NEUROLOGICAL SCIENCES			English	Article						Seizure-related injury; Quality of life; Multiple injury; Dental trauma; Burns; Fractures	ILAE COMMISSION; POSITION PAPER; EPILEPSY; RISK; PEOPLE; HEALTH; CLASSIFICATION; CONSEQUENCE; CHILDREN; BURDEN	Objective Our aim is to assess the types and frequency of seizure-related injuries and to determine their effects on Quality of Life (QoL). Methods Fifty-seven patients with epilepsy were included to our study. The demographic and clinical data of all the participants were recorded. All patients completed the Quality of Life in Epilepsy Inventory 89 (QOLIE-89). Injury types were classified as bums, head trauma, dental traumas, fractures, body injuries, penetrating traumas, road injuries, and drowning. Results Forty-two patients had seizure-related physical injury history whereas 15 of them declared no history of injury. Lower education levels and more frequent seizures were associated with higher seizure-related injury rates (p < 0.05). The most common types of seizure-related injuries were head trauma (22%) and fractures (17%). Fifty-seven (64%)of the injuries took place at home. There was no difference in QOLIE-89 scores between patients with or without seizure-related injury. Multiple injuries, admission to emergency, older than 20 years of the first seizure-related injury, and shorter than 10 years after last seizure-related injury are negatively effective on the QoL scores. Conclusion Patients with epilepsy are likely to have seizure-related injuries which may be severe but do not affect the patients' QoL. Seizure-related injuries most commonly occur at home and therefore simple precautions (supervised bathing, using microwave ovens instead of classical stoves, avoiding electric irons and electric heaters, and sleeping close to the floor to avoid falling) taken to reduce the incidence of seizure-related injuries will help reduce hospitalizations and will also be cost-effective.	[Cengiz, Ozan; Bebek, Nerses; Baykan, Betul; Gurses, Candan] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Epilepsy Div, Istanbul, Turkey; [Atalar, Arife Cimen] Istanbul Educ & Res Hosp, Neurol Dept, Fatih Istanbul, Turkey; [Tekin, Betul] Rumeli Hosp, Neurol Dept, Istanbul, Turkey		Atalar, AC (corresponding author), Istanbul Educ & Res Hosp, Neurol Dept, Fatih Istanbul, Turkey.	cimenatalar@yahoo.com.tr	bebek, nerses/W-7266-2019; baykan, betul b/J-5307-2014; atalar, Arife cimen/K-3743-2019	atalar, Arife cimen/0000-0003-0328-9607			Asadi-Pooya AA, 2012, SEIZURE-EUR J EPILEP, V21, P165, DOI 10.1016/j.seizure.2011.10.009; Auriel E, 2009, EPILEPSY BEHAV, V14, P130, DOI 10.1016/j.yebeh.2008.09.027; Barry JJ, 2003, EPILEPSIA, V44, P30, DOI 10.1046/j.1528-1157.44.s4.4.x; Buck D, 1997, EPILEPSIA, V38, P439, DOI 10.1111/j.1528-1157.1997.tb01733.x; Camfield C, 2015, SEIZURE-EUR J EPILEP, V27, P80, DOI 10.1016/j.seizure.2015.02.031; DEVINSKY O, 1995, EPILEPSIA, V36, P1089, DOI 10.1111/j.1528-1157.1995.tb00467.x; Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670; Friedman DE, 2010, EPILEPSY BEHAV, V19, P400, DOI 10.1016/j.yebeh.2010.07.029; Gawlak D, 2017, NEUROL NEUROCHIR POL, V51, P361, DOI 10.1016/j.pjnns.2017.06.004; Grant AC, 2013, EPILEPSY BEHAV, V27, P283, DOI 10.1016/j.yebeh.2013.01.031; Jacoby A, 2009, NEUROL CLIN, V27, P843, DOI 10.1016/j.ncl.2009.06.003; Kwon CS, 2010, EPILEPSIA, V51, P2247, DOI 10.1111/j.1528-1167.2010.02697.x; Lagunju IA, 2016, EPILEPSY BEHAV, V54, P131, DOI 10.1016/j.yebeh.2015.11.019; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Mollaoglu M, 2013, NOROPSIKIYATRI ARS, V50, P269, DOI 10.4274/npa.y6632; Neufeld MY, 1999, EPILEPSY RES, V34, P123, DOI 10.1016/S0920-1211(98)00105-3; Noble AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090789; Persson HBI, 2002, EPILEPSIA, V43, P768, DOI 10.1046/j.1528-1157.2002.15801.x; Prasad V, 2014, PEDIATRICS, V133, P827, DOI 10.1542/peds.2013-2554; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Senol V, 2007, EPILEPSY BEHAV, V10, P96, DOI 10.1016/j.yebeh.2006.08.006; Sherman EMS, 2011, EPILEPSIA, V52, P857, DOI 10.1111/j.1528-1167.2011.03022.x; Sheth SG, 2004, NEUROLOGY, V63, P1002, DOI 10.1212/01.WNL.0000138590.00074.9A; Spencer SS, 2007, ANN NEUROL, V62, P327, DOI 10.1002/ana.21131; Spitz MC, 1998, EPILEPSIA, V39, P904, DOI 10.1111/j.1528-1157.1998.tb01189.x; Unglaub F, 2005, J BURN CARE REHABIL, V26, P526, DOI 10.1097/01.bcr.0000185445.05608.a8; van den Broek M, 2004, EPILEPSIA, V45, P667, DOI 10.1111/j.0013-9580.2004.33903.x; Wiebe S, 1999, CAN J NEUROL SCI, V26, P263, DOI 10.1017/S0317167100000354; Willems LM, 2018, FRONT NEUROL, V414, P1	29	7	7	0	1	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	MAR	2019	40	3					577	583		10.1007/s10072-018-3697-3			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ6EO	WOS:000462505300018	30612277				2022-02-06	
J	Dalla Costa, FA; Gibson, TJ; Oliveira, SEO; Gregory, NG; Coldebella, A; Faucitano, L; Dalla Costa, OA				Dalla Costa, Filipe Antonio; Gibson, Troy John; Octavio Oliveira, Steffan Edward; Gregory, Neville George; Coldebella, Arlei; Faucitano, Luigi; Dalla Costa, Osmar Antonio			On-farm pig dispatch methods and stockpeople attitudes on their use	LIVESTOCK SCIENCE			English	Article						Animal welfare; Caretaker; Culling; Killing; Survey; Stockpeople attitudes		This study surveyed the on-farm dispatching methods used at pig farms, the characteristics of stockpeople operating them, in terms of training and management, and their opinions and attitudes about the efficiency and safety of the applied procedures. Independently of the pig type, the most used dispatching methods at the surveyed Brazilian farms were concussion (90%) and electrocution (5%). Both methods were reported as being efficient and safe for on-farm pig dispatching by most stockpeople (83%). However, 33% of all stockpeople reported they would prefer to use alternative methods, i.e., anesthetics (23%) or electrocution (32%). Only 7% of the stockpeople received training resulting in a more efficient application of the method (P < 0.05). Most stockpeople (96%) declared to feel uncomfortable with the dispatching procedure they use. This discomfort lasted for half a day or longer in 22% of them. The results of this survey suggest that the application of dispatching methods at pig farms may result in animal welfare issues related to the effectiveness of the methods and the attitudes of stockpeople.	[Dalla Costa, Filipe Antonio] UNESP Sao Paulo State Univ, Fac Ciencias Agr & Vet, Programa Posgrad Zootecnia, BR-14884900 Jaboticabal, SP, Brazil; [Gibson, Troy John; Gregory, Neville George] Univ London, Royal Vet Coll, London, England; [Octavio Oliveira, Steffan Edward] Univ Sao Paulo, Fac Med Vet & Zootecnia, BR-13635900 Pirassununga, SP, Brazil; [Coldebella, Arlei; Dalla Costa, Osmar Antonio] Embrapa Swine & Poultry, BR 153,Km 110, BR-89700991 Concordia, Brazil; [Faucitano, Luigi] Agr & Agri Food Canada, 2000 Coll St, Sherbrooke, PQ J1M 0C8, Canada		Dalla Costa, FA (corresponding author), UNESP Sao Paulo State Univ, Fac Ciencias Agr & Vet, Programa Posgrad Zootecnia, BR-14884900 Jaboticabal, SP, Brazil.	filipedallacosta@gmail.com	Gibson, Troy/AAA-8687-2019; Costa, Filipe Dalla/AAV-5252-2021	Gibson, Troy/0000-0002-1242-2695; Dalla Costa, Filipe Antonio/0000-0002-6038-841X	CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); EMBRAPA Swine and PoultryEmpresa Brasileira de Pesquisa Agropecuaria (EMBRAPA) [TED 21000.004262/2018-51]; Humane Slaughter Association	This study was conducted as part of the PhD program of F.A. Dalla Costa within the Animal Science Graduate Program at the Faculty of Agricultural and Veterinary Sciences of the Universidade Estadual Paulista (UNESP, Jaboticabal, SP, Brazil). The authors are grateful to the CNPq for granting the scholarship to F.A. Dalla Costa, to EMBRAPA Swine and Poultry for the financial support (grant number TED 21000.004262/2018-51) and to the Humane Slaughter Association for granting a Special Travel Award to T.J. Gibson. The authors appreciate the assistance of E. L. Klein, I. P. Piccinin, N. Armiliato, A. C. Holdelfer, B. Conte, A. M. Lorenzetti for the technical assistance in the data collection. Special thanks goes to M. J.R. Paranhos da Costa for the help during the project planning.	[Anonymous], 2009, OFF J EUR UNION, V303, P1; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; Campler MR, 2018, TRANSL ANIM SCI, V2, P254, DOI 10.1093/tas/txy015; Cardoso CS, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7120089; Denicourt M, 2010, ANN M IMPL KNOWL, P451; Fogle B., 1992, Anthrozoos, V3, P143, DOI 10.2752/089279390787057568; Gibson TJ, 2015, J APPL ANIM WELF SCI, V18, P222, DOI 10.1080/10888705.2014.980579; Lowery K, 2005, J TRAUMA STRESS, V18, P171, DOI 10.1002/jts.20016; Matthis IS., 2004, SELECTED EMPLOYEE AT; Maunder E. Z., 2017, INT PARAMED PRACT, V7, P3; Maunder EZ, 2008, INDIAN J PALLIAT CAR, V14, P45, DOI 10.4103/0973-1075.41935; Ministry of Petroleum and Natural Gas Government of India ( GOI), 2000, IMPL IMM PROGR AG BI, P1; Mullins CR, 2017, ANIM WELFARE, V26, P449, DOI 10.7120/09627286.26.4.449; Oliveira SEO, 2018, MEAT SCI, V140, P9, DOI 10.1016/j.meatsci.2018.02.010; Oliveira SEO, 2017, MEAT SCI, V130, P64, DOI 10.1016/j.meatsci.2017.04.007; Rault JL, 2017, J ANIM SCI, V95, P949, DOI 10.2527/jas.2016.0922; RAWNSLEY K, 1985, BRIT MED J, V291, P922, DOI 10.1136/bmj.291.6500.922; Spooner JM, 2014, J AGR ENVIRON ETHIC, V27, P569, DOI 10.1007/s10806-013-9477-4; TELNER JI, 1984, J PSYCHIAT RES, V18, P207, DOI 10.1016/0022-3956(84)90011-6; Verhoeven MTW, 2015, ANIMAL, V9, P320, DOI 10.1017/S1751731114002596; Woods J., 2010, IMPROVING ANIMAL WEL, P195; You XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109177; Yunes MC, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7100075	23	7	7	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1871-1413	1878-0490		LIVEST SCI	Livest. Sci.	MAR	2019	221						1	5		10.1016/j.livsci.2019.01.007			5	Agriculture, Dairy & Animal Science	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture	HO9ER	WOS:000461264700001		Green Accepted, Green Published			2022-02-06	
J	Devi, BI; Shukla, DP; Bhat, DI; Tripathi, M; Warren, A; Shanbhag, NC; Konar, SK; Stake, AL; Singhal, R				Devi, Bhagavatula Indira; Shukla, Dhaval P.; Bhat, Dhananjaya, I; Tripathi, Manjul; Warren, Amara; Shanbhag, Nagesh C.; Konar, Subhas K.; Stake, Anne L.; Singhal, Ruchika			Neurotrauma Care Delivery in a Limited Resource Setting-Lessons Learned From Referral and Patient Flow in a Tertiary Care Center	WORLD NEUROSURGERY			English	Article						Computed tomography; Lean Six Sigma approach; Referral; Tertiary care hospital; Traumatic brain injury; Triage	TRAUMA CARE; INDIA; SYSTEMS; NEUROSURGERY; DELAYS	BACKGROUND: With the increasing population, motorization, and road traffic accidents, neurotrauma has been increasing in India. Inadequate triage and underusage of locally available resources at all healthcare levels has led to nonuniform neurotrauma care delivery. We present our experience at a tertiary care hospital. We evaluated the referral pattern of mild traumatic brain injury (mTBI) cases to enable adequate care to patients with moderate and severely injured TBI. METHODS: All patients with head injury (n = 3891) referred to the emergency department of our institution during a 4-month period were evaluated. The demographic characteristics, ambulance usage, and time management during in-hospital patient flow were evaluated using the Lean Six Sigma approach. We have also provided solutions for optimal usage of available resources. RESULTS: Patients with mTBI comprised 77% of head injury referrals. Of all the patients referred from peripheral hospitals, 48% had normal head computed tomography (CT) scan findings. The CT waiting and lead (arrival-to-discharge) times were 35 +/- 44 minutes and 114 minutes, respectively. No clinical to radiological correlation was found between the head CT scan findings and a decision to refer a patient to our institute. Only 10% of the patients with abnormal head CT scans (41%) required neurosurgical intervention. The mean duration from CT imaging to the initiation of surgery was 192.7 +/- 172.1 minutes. CONCLUSIONS: Most of the patients with mTBI were referred to a tertiary care center, leading to secondary overtriage and overburdening of the existing resources at a specialized care hospital, possibly owing to ineffective triage at the primary and secondary healthcare centers. This would limit the adequate management of moderate to severe TBI cases in such a hospital.	[Devi, Bhagavatula Indira; Shukla, Dhaval P.; Bhat, Dhananjaya, I; Tripathi, Manjul; Shanbhag, Nagesh C.; Konar, Subhas K.] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India; [Warren, Amara; Singhal, Ruchika] Medtron Labs & Global Hlth, Fridley, MN USA; [Stake, Anne L.] Medtron Labs, Brooklyn, NY USA; [Tripathi, Manjul] Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh, Punjab, India		Devi, BI (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India.	bidevidr@gmail.com	Tripathi, Manjul/AAN-8701-2021; Tripathi, Manjul/AAE-7128-2019	Tripathi, Manjul/0000-0002-5679-3439; Shanbhag, Nagesh/0000-0002-5304-8783	Medtronic, Inc.Medtronic [MIST/003/306/2014/00762]; Medtronic, Inc.Medtronic	The present study received funding from Medtronic, Inc., "Traumatic Brain Injury: Phase 1" (code no. MIST/003/306/2014/00762). Amara Warren, Anne L. Stake, and Ruchika Singhal received financial remuneration for working as assistants in this project from Medtronic, Inc.	[Anonymous], 2006, INT J 6 SIGMA COMPET; Bishop CV, 2006, ANZ J SURG, V76, P53, DOI 10.1111/j.1445-2197.2006.03642.x; Chokshi M, 2016, J PERINATOL, V36, pS9, DOI 10.1038/jp.2016.184; Ganapathy K, 2015, NEUROL INDIA, V63, P142, DOI 10.4103/0028-3886.156274; Ganapathy K, 2013, WORLD NEUROSURG, V79, P621, DOI 10.1016/j.wneu.2013.02.071; Gururaj G, 2017, USITC PUBL, V138; Gururaj G., 2017, USITC PUBL, V137; Indian Public Health Standards (IPHS), GUID DISTR HOSP 101 GUID DISTR HOSP 101; Joshipura M, 2006, WORLD J SURG, V30, P930, DOI 10.1007/s00268-005-0765-7; Joshipura MK, 2003, INJURY, V34, P686, DOI 10.1016/S0020-1383(03)00163-3; Luck T, 2015, ANZ J SURG, V85, P610, DOI 10.1111/ans.13138; Marcoux J, 2016, J NEUROSURG, V125, P642, DOI 10.3171/2015.6.JNS15175; Niemeijer GC, 2010, J TRAUMA, V69, P614, DOI 10.1097/TA.0b013e3181e70f90; Oestern HJ, 2013, CLIN ORTHOP RELAT R, V471, P2869, DOI 10.1007/s11999-013-3035-2; Parks JK, 2008, J TRAUMA, V65, P1098, DOI 10.1097/TA.0b013e318188e8ad; Reddy KS, 2015, NEW ENGL J MED, V373, P1, DOI 10.1056/NEJMp1414214; Strengthening of District Hospitals and the Creation of District Hospital Knowledge Centers (DHKCs), STRENGTH DISTR HOSP	17	7	7	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2019	123						E588	E596		10.1016/j.wneu.2018.11.227			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HR2II	WOS:000462958400069	30529521				2022-02-06	
J	Downing, M; Bragge, P; Ponsford, J				Downing, Marina; Bragge, Peter; Ponsford, Jennie			Cognitive Rehabilitation Following Traumatic Brain Injury: A Survey of Current Practice in Australia	BRAIN IMPAIRMENT			English	Article						Brain injuries; traumatic; rehabilitation; cognition	RANDOMIZED CONTROLLED-TRIAL; OF-THE-LITERATURE; INCOG RECOMMENDATIONS; MANAGEMENT; GUIDELINES; EPIDEMIOLOGY; PERFORMANCE; ATTENTION; QUALITY; ADULTS	Background and Objective: As cognitive impairments represent the greatest impediment to participation following moderate-severe traumatic brain injury (TBI), cognitive rehabilitation is vital. Several sets of guidelines for cognitive rehabilitation have been published, including INCOG in 2014. However, little is known about current practice by therapists working with individuals with TBI. This study aimed to characterise current cognitive rehabilitation practices via an online survey of therapists engaged in rehabilitation in individuals with TBI. Method: The survey documented demographic information, current cognitive rehabilitation practice, resources used to inform cognitive rehabilitation, and reflections on cognitive rehabilitation provided. Results: The 221 Australian respondents were predominantly occupational therapists, neuropsychologists, and speech pathologists with an average 9 years of clinical experience in cognitive rehabilitation and TBI. Cognitive retraining and compensatory strategies were the most commonly identified approaches used in cognitive rehabilitation. Executive functioning was mostly targeted for retraining, whereas memory was targeted with compensatory strategies. Attentional problems were less frequently addressed. Client self-awareness, family involvement, team collaboration, and goal-setting were seen as important ingredients for success. Conclusion: Clinical practice of cognitive rehabilitation in Australia is broadly consistent with guidelines. However, addressing the impediments to its delivery is important to enhance the quality of life for individuals with TBI.	[Downing, Marina; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Melbourne, Vic 3800, Australia; [Bragge, Peter] Monash Univ, Monash Sustainable Dev Inst, Behav Works Australia, Melbourne, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Melbourne, Vic 3800, Australia.	jennie.ponsford@monash.edu	Downing, Marina/AAX-2380-2020	Downing, Marina/0000-0002-3126-6632; Bragge, Peter/0000-0003-0745-5131	National Trauma Research Institute, Centre of Excellence in Traumatic Brain Injury Research (CETBIR)	This study was supported by a grant received from the National Trauma Research Institute, Centre of Excellence in Traumatic Brain Injury Research (CETBIR).	Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Bragge P, 2014, J HEAD TRAUMA REHAB, V29, P277, DOI 10.1097/HTR.0000000000000066; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Finkelstein E., 2006, INCIDENCE EC BURDEN; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Institute of Medicine, 2011, COGN REH THER TRAUM; KEWMAN DG, 1985, REHABIL PSYCHOL, V30, P11; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Mazmanian Paul E., 1993, Brain Injury, V7, P319, DOI 10.3109/02699059309034958; McDonald S, 2013, NEUROPSYCHOL REHABIL, V23, P267, DOI 10.1080/09602011.2012.751340; National Institute of Neurological Disorders and Stroke, 2013, TRAUM BRAIN INJ INF; Pagan E, 2015, BRAIN IMPAIR, V16, P173, DOI 10.1017/BrImp.2015.34; Pattuwage L, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000234; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Shum D, 2011, J REHABIL MED, V43, P216, DOI 10.2340/16501977-0647; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; TWUM M, 1994, J CLIN EXP NEUROPSYC, V16, P630, DOI 10.1080/01688639408402674; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069	40	7	7	1	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAR	2019	20	1					24	36		10.1017/BrImp.2018.12			13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	HL2WZ	WOS:000458571400003					2022-02-06	
J	Jackson, WT; Starling, AJ				Jackson, William T.; Starling, Amaal J.			Concussion Evaluation and Management	MEDICAL CLINICS OF NORTH AMERICA			English	Article						Concussion; Postconcussion syndrome; Mild traumatic brain injury; Traumatic brain injury; Posttraumatic headache	QUALITY STANDARDS SUBCOMMITTEE; AMERICAN ACADEMY; HEADACHE; SPORTS; SYMPTOMS; EXERCISE; RETURN; EPIDEMIOLOGY; GUIDELINES; RECOVERY	Concussion is a public health crisis affecting vulnerable populations including youth athletes. As awareness increases, more patients with acute concussion are seeking medical evaluations. Internists are frontline medical providers and thus should be able to identify, diagnose, manage, and know when to refer patients with concussion. Management of concussion includes rapid removal from play, symptomatic treatment, and return to learn/play recommendations. Inappropriate management may lead to recurrent concussions, prolonged recovery, and potential long-term consequences. Understanding the key features of diagnosis, postinjury assessment tools, symptomatic treatment, and management of concussion, including return to learn/play recommendations, is essential for primary care providers.	[Jackson, William T.; Starling, Amaal J.] Mayo Clin, Dept Neurol, Coll Med, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA		Starling, AJ (corresponding author), Mayo Clin, Dept Neurol, Coll Med, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	Starling.amaal@mayo.edu					Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Conidi FX, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0570-z; Crane AT, 2012, RESTOR NEUROL NEUROS, V30, P325, DOI 10.3233/RNN-2012-120232; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goodman BP, 2013, NEUROLOGY S, V80; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Holland S, 2012, NEUROLOGY, V78, P1346, DOI 10.1212/WNL.0b013e3182535d0c; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Legarreta AD, 2018, J NEUROSURG-PEDIATR, V22, P238, DOI 10.3171/2018.3.PEDS1850; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; May KH, 2014, INT J SPORTS PHYS TH, V9, P242; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miranda NA, 2018, J NEUROL PHYS THER, V42, P163, DOI 10.1097/NPT.0000000000000231; Mokri Bahram, 2015, Continuum (Minneap Minn), V21, P1086, DOI 10.1212/CON.0000000000000193; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; O'Connor FG, 2018, CURR SPORT MED REP, V17, P244, DOI 10.1249/JSR.0000000000000502; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Seifert T, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0568-6; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Starling AJ, 2015, QUICK QUESTIONS SPOR, P113; Starling A, 2013, NEUROLOGY, V81, P1789, DOI 10.1212/01.wnl.0000435555.13695.22; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Zaleski A, 2015, OTOL NEUROTOL, V36, P295, DOI 10.1097/MAO.0000000000000665	47	7	7	1	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0025-7125	1557-9859		MED CLIN N AM	Med. Clin. N. Am.	MAR	2019	103	2					251	+		10.1016/j.mcna.2018.10.005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HM5QD	WOS:000459529300008	30704680				2022-02-06	
J	Mazzeo, AT; Fanelli, V; Boffini, M; Medugno, M; Filippini, C; Simonato, E; Costamagna, A; Delsedime, L; Brazzi, L; Rinaldi, M; Ranieri, VM; Mascia, L				Mazzeo, Anna Teresa; Fanelli, Vito; Boffini, Massimo; Medugno, Mariangela; Filippini, Claudia; Simonato, Erika; Costamagna, Andrea; Delsedime, Luisa; Brazzi, Luca; Rinaldi, Mauro; Ranieri, V. Marco; Mascia, Luciana			Feasibility of lung microdialysis to assess metabolism during clinical ex vivo lung perfusion	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Article						ex vivo lung perfusion; lung metabolism; microdialysis; glutamate; lactate; glucose; lactate/pyruvate ratio	TRAUMATIC BRAIN-INJURY; ANTIBIOTIC PENETRATION; TISSUE	BACKGROUND: Lung metabolism during ex vivo lung perfusion (EVLP) is increasingly studied. Microdialysis (MD) allows metabolic monitoring by sampling parenchymal interstitial fluid. This study investigated lung metabolism using MD during EVLP and evaluated whether microdialysate metabolites could improve selection and discriminate outcome of donor lungs. METHODS: MD monitoring was used during 14 clinical EVLP procedures. Paired microdialysate and perfusate samples were analyzed for glucose, lactate, pyruvate, glutamate, and the lactate/pyruvate (L/P) ratio, and values that best discriminated an unfavorable outcome were determined. Outcome was defined as unfavorable (lungs not transplanted or transplanted with primary graft dysfunction at 72 hours = 2) or favorable (lungs transplanted with primary graft dysfunction < 2). RESULTS: Microdialysate markers and the perfusate L/P ratio could discriminate unfavorable outcome with sensitivity and specificity of 0.85 and 0.81 for MD glutamate > 18.4 mmol/liter, 0.81 and 0.74 for MD lactate > 685 mmol/liter, 0.92 and 0.75 for MD glucose > 530 mu mol/liter, 0.85 and 0.65 for MD pyruvate > 25 mmol/liter, and 0.73 and 0.67 for perfusate L/P ratio > 24.17. All microdialysate markers, perfusate and microdialysate L/P ratio, and perfusate lactate discriminated outcome when we limited analysis only to transplanted lungs. CONCLUSIONS: We report the use of MD to evaluate lung metabolism during clinical EVLP, demonstrating that MD metabolites can contribute to selection of reconditioned lungs and discriminate early outcome after transplantation. Furthermore, glutamate as a marker of lung injury during EVLP is proposed and could hence be used as a potential target for future therapies. (C) 2018 International Society for Heart and Lung Transplantation. All rights reserved.	[Mazzeo, Anna Teresa; Fanelli, Vito; Medugno, Mariangela; Filippini, Claudia; Costamagna, Andrea; Brazzi, Luca] Univ Torino, Div Anesthesia & Intens Care, Dept Surg Sci, Turin, Italy; [Boffini, Massimo; Simonato, Erika; Rinaldi, Mauro] Univ Torino, Cardiothorac Surg, Dept Surg Sci, Turin, Italy; [Delsedime, Luisa] Univ Torino, Pathol Unit, Dept Med Sci, Turin, Italy; [Ranieri, V. Marco] Univ Bologna, Dept Anesthesia & Intens Care Med, Alma Mater Studiorum, Bologna, Italy; [Mascia, Luciana] Sapienza Univ Rome, Dept Med & Surg Sci & Biotechnol, Rome, Italy		Mazzeo, AT (corresponding author), Univ Torino, Dept Surg Sci, Div Anesthesia & Intens Care, Presidio Molinette, Corso Dogliotti 14, I-10126 Turin, Italy.	anna.mazzeo@unito.it	Costamagna, Andrea/M-5003-2019; Fanelli, Vito/K-4028-2018; Brazzi, Luca/AAS-4978-2020	Costamagna, Andrea/0000-0002-0231-1545; Brazzi, Luca/0000-0001-7059-0622; Mazzeo, Anna Teresa/0000-0002-8454-7243	Ministry of Health [RF-2010-2321713-Det, 918_12/12/12]; University of Torino [MAZA_RILO_16_01]	The study was supported by Ministry of Health Grant RF-2010-2321713-Det. Reg. No. 918_12/12/12 and University of Torino grant MAZA_RILO_16_01.	Bellani G, 2009, CRIT CARE MED, V37, P2216, DOI 10.1097/CCM.0b013e3181aab31f; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dhanani J, 2010, INT J ANTIMICROB AG, V36, P491, DOI 10.1016/j.ijantimicag.2010.08.013; Du J, 2016, EUR J PHARMACOL, V784, P42, DOI 10.1016/j.ejphar.2016.05.009; FISHER AB, 1984, ENVIRON HEALTH PERSP, V55, P149, DOI 10.2307/3429699; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Herkner H, 2002, AM J RESP CRIT CARE, V165, P273, DOI 10.1164/ajrccm.165.2.2106082; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hsin MK, 2018, ANN SURG, V267, P196, DOI 10.1097/SLA.0000000000002016; Hutschala D, 2008, INTENS CARE MED, V34, P1827, DOI 10.1007/s00134-008-1122-8; Iskender I, 2018, J HEART LUNG TRANSPL, V37, P283, DOI 10.1016/j.healun.2017.05.021; Jalloh I, 2018, J NEUROTRAUM, V35, P2025, DOI 10.1089/neu.2017.5459; Johnson ML, 2012, AM J PHYSIOL-REG I, V302, pR143, DOI 10.1152/ajpregu.00402.2011; Johnson ML, 2011, AM J PHYSIOL-REG I, V301, pR769, DOI 10.1152/ajpregu.00206.2011; Koike T, 2011, J HEART LUNG TRANSPL, V30, P1312, DOI 10.1016/j.healun.2011.07.014; Li Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125873; Lindenmann J, 2011, J ANTIMICROB CHEMOTH, V66, P160, DOI 10.1093/jac/dkq413; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; MEYERSON BA, 1990, LIFE SCI, V46, P301, DOI 10.1016/0024-3205(90)90037-R; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Said SI, 1996, P NATL ACAD SCI USA, V93, P4688, DOI 10.1073/pnas.93.10.4688; Snell GI, 2017, J HEART LUNG TRANSPL, V36, P1097, DOI 10.1016/j.healun.2017.07.021; Tang FG, 2005, PEDIATR PULM, V40, P437, DOI 10.1002/ppul.20299; Thelin EP, 2017, AAPS J, V19, P367, DOI 10.1208/s12248-016-0027-7; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tomaselli F, 2004, ANTIMICROB AGENTS CH, V48, P2228, DOI 10.1128/AAC.48.6.2228-2232.2004; Tomaselli F, 2003, BRIT J CLIN PHARMACO, V55, P620, DOI 10.1046/j.1365-2125.2003.01797.x; Valenza F, 2011, TRANSPL P, V43, P993, DOI 10.1016/j.transproceed.2011.01.122; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073	33	7	7	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	MAR	2019	38	3					267	276		10.1016/j.healun.2018.12.015			10	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	HL5VY	WOS:000458800500006	30642797				2022-02-06	
J	Ndode-Ekane, XE; Santana-Gomez, C; Casillas-Espinosa, PM; Ali, I; Brady, RD; Smith, G; Andrade, P; Immonen, R; Puhakka, N; Hudson, MR; Braine, EL; Shultz, SR; Staba, RJ; O'Brien, TJ; Pitkanen, A				Ndode-Ekane, Xavier Ekolle; Santana-Gomez, Cesar; Casillas-Espinosa, Pablo M.; Ali, Idrish; Brady, Rhys D.; Smith, Gregory; Andrade, Pedro; Immonen, Riikka; Puhakka, Noora; Hudson, Matthew R.; Braine, Emma L.; Shultz, Sandy R.; Staba, Richard J.; O'Brien, Terence J.; Pitkanen, Asla			Harmonization of lateral fluid-percussion injury model production and post-injury monitoring in a preclinical multicenter biomarker discovery study on post-traumatic epileptogenesis	EPILEPSY RESEARCH			English	Article						Biomarkers; Multicenter study; Post-traumatic epileptogenesis; Post-traumatic epilepsy; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; EPILEPSY; RAT; RESPONSES; SEVERITY; OPTIMIZE; SEIZURES; OUTCOMES; RISK	Multi-center preclinical studies can facilitate the discovery of biomarkers of antiepileptogenesis and thus facilitate the diagnosis and treatment development of patients at risk of developing post-traumatic epilepsy. However, these studies are often limited by the difficulty in harmonizing experimental protocols between laboratories. Here, we assess whether the production of traumatic brain injury (TBI) using the lateral fluid-percussion injury (FPI) in adult male Sprague-Dawley rats (12 weeks at the time of injury) was harmonized between three laboratories - located in the University of Eastern Finland (UEF), Monash University in Melbourne, Australia (Melbourne) and The University of California, Los Angeles, USA (UCLA). These laboratories are part of the international multicenter-based project, the Epilepsy Bioinformatics Study for Antiepileptogenesis Therapy (EpiBioS4Rx). Lateral FPI was induced in adult male Sprague-Dawley rats. The success of methodological harmonization was assessed by performing inter-site comparison of injury parameters including duration of anesthesia during surgery, impact pressure, post-impact transient apnea, post-impact seizure-like behavior, acute mortality ( < 72 h post-injury), time to self-right after the impact, and severity of the injury (assessed with the neuroscore). The data was collected using Common Data Elements and Case Report Forms. The acute mortality was 15% (UEF), 50% (Melbourne) and 57% (UCLA) (p < 0.001). The sites differed in the duration of anesthesia, the shortest being at UEF < Melbourne < UCLA (p < 0.001). The impact pressure used also differed between the sites, the highest being in UEF > Melbourne > UCLA (p < 0.001). The impact pressure associated with the severity of the functional deficits (low neuroscore) (P < 0.05) only at UEF, but not at any of the other sites. Additionally, the sites differed in the duration of post-impact transient apnea (p < 0.001) and time to self-right (P < 0.001), the highest values in both parameters was registered in Melbourne. Post-impact seizure-like behavior was observed in 51% (UEF), 25% (Melbourne) and 2% (UCLA) of rats (p < 0.001). Despite the differences in means when all sites were compared there was significant overlap in injury parameters between the sites. The data reflects the technical difficulties in the production of lateral FPI across multiple sites. On the other hand, the data can be used to model the heterogeneity in human cohorts with closed-head injury. Our animal cohort will provide a good starting point to investigate the factors associated with epileptogenesis after lateral FPI.	[Ndode-Ekane, Xavier Ekolle; Andrade, Pedro; Immonen, Riikka; Puhakka, Noora; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627,Neulaniementie 2, Kuopio 70211, Finland; [Casillas-Espinosa, Pablo M.; Ali, Idrish; Brady, Rhys D.; Hudson, Matthew R.; Braine, Emma L.; Shultz, Sandy R.; O'Brien, Terence J.] Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic, Australia; [Santana-Gomez, Cesar; Staba, Richard J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Casillas-Espinosa, Pablo M.; Ali, Idrish; Brady, Rhys D.; Hudson, Matthew R.; Braine, Emma L.; Shultz, Sandy R.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3052, Australia; [O'Brien, Terence J.] Alfred Hosp, Dept Neurol, Commercial Rd, Melbourne, Vic 3004, Australia; [O'Brien, Terence J.] Royal Melbourne Hosp, Dept Neurol, Grattan St, Parkville, Vic 3050, Australia; [Smith, Gregory] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA		Ndode-Ekane, XE (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627,Neulaniementie 2, Kuopio 70211, Finland.	xavier.ekollendode-ekane@uef.fi	Santana-Gomez, Cesar/AAY-1014-2021; Andrade, Pedro/N-8410-2018; Staba, Richard/AAN-3149-2021; O'Brien, Terence/AAU-5525-2021; Ali, Idrish/P-4989-2018; O'Brien, Terence/L-8102-2013; Hudson, Matthew/AAH-9168-2020	Santana-Gomez, Cesar/0000-0001-9163-5615; Andrade, Pedro/0000-0001-9118-8341; Ali, Idrish/0000-0002-0971-4654; O'Brien, Terence/0000-0002-7198-8621; Hudson, Matthew/0000-0001-5016-735X; Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632	National Institute of Neurological Disorders and Stroke (NINDS) Center without Walls of the National Institutes of Health (NIH) [U54N8100064]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS100064] Funding Source: NIH RePORTER	This research was supported by the National Institute of Neurological Disorders and Stroke (NINDS) Center without Walls of the National Institutes of Health (NIH) under Award Number U54N8100064 (EpiBioS4Rx).	Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Brady R. D, 2018, NEUROBIOL DIS; Casillas-Espinosa P. M., 2019, EPILEPSY RES; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; DeWitt D., 2018, J NEUROTRAUMA; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eakin K., 2015, MODELING FLUID PERCU; Engel J, 2013, EPILEPSIA, V54, P61, DOI 10.1111/epi.12299; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gaidhani N, 2017, BRAIN RES BULL, V134, P168, DOI 10.1016/j.brainresbull.2017.07.018; Galanopoulou AS, 2013, EPILEPSIA, V54, P1, DOI 10.1111/epi.12293; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hickman DL, 2010, J AM ASSOC LAB ANIM, V49, P155; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Johnstone MR, 2018, BRAIN INJURY, V32, P257, DOI 10.1080/02699052.2017.1394492; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; MILLEN JE, 1985, J NEUROSURG, V62, P587, DOI 10.3171/jns.1985.62.4.0587; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; O'Bryant AJ, 2011, BEHAV BRAIN RES, V224, P112, DOI 10.1016/j.bbr.2011.05.028; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A., 2018, NEUROBIOL DIS; Pitkanen A, 2017, MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION, P661, DOI 10.1016/B978-0-12-804066-9.00046-8; Pitkanen A, 2016, LANCET NEUROL, V15, P843, DOI 10.1016/S1474-4422(16)00112-5; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; Santana Gomez C., 2019, EPILEPSY RES; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Simonato M, 2014, LANCET NEUROL, V13, P949, DOI 10.1016/S1474-4422(14)70076-6; Simonato M, 2013, CURR OPIN NEUROL, V26, P195, DOI 10.1097/WCO.0b013e32835efe29; Tan AA, 2009, J NEUROTRAUM, V26, P539, DOI 10.1089/neu.2008.0611; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Wang CC, 2013, J SURG RES, V185, P753, DOI 10.1016/j.jss.2013.07.002; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	53	7	7	1	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	MAR	2019	151						7	16		10.1016/j.eplepsyres.2019.01.006			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ0QR	WOS:000462100600002	30711714	Green Accepted			2022-02-06	
J	Nnamani, NS; Pugh, MJ; Amuan, ME; Eapen, BC; Hudak, SJ; Liss, MA; Orman, JA				Nnamani, Nina S.; Pugh, Mary Jo; Amuan, Megan E.; Eapen, Blessen C.; Hudak, Steven J.; Liss, Michael A.; Orman, Jean A.			Outcomes of Genitourinary Injury in US Iraq and Afghanistan War Veterans Receiving Care from the Veterans Health Administration	MILITARY MEDICINE			English	Article							SEXUAL DYSFUNCTION; TRAUMA; IMPACT; ASSOCIATION; PREVALENCE; DISORDERS; FREEDOM	Introduction: In the recent conflicts, unprecedented numbers of US service personnel have survived with genitourinary (GU) injury, but few reports have focused on outcomes of these injuries. Outcomes of combat-related GU injury were investigated in wounded US male veterans of Operations Enduring/Iraqi Freedom and New Dawn receiving Veterans Health Administration (VHA) care. Materials and Methods: Department of Defense Trauma Registry (DoDTR) data for male service members injured in theater were linked with VHA electronic health records (EHRs) for veterans who received VHA care at least once from October 2001 through September 2011. Abbreviated Injury Scale scores and International Classification of Diseases-9th Revision-Clinical Modification codes were used to identify GU injuries, severity, and outcomes. Wounded veterans with vs. without GU injury were compared. Results: A total of 12,923 injured veterans were found in both databases; 591 (4.6%) had a GU injury diagnosis in the DoDTR; 18 (3.0% of 591) had a GU injury diagnosis in VHA EHRs. Of the 591 with GU injury, 179 (30.3%) had at least one severe GU injury. The prevalence of both urinary symptoms (6.3% vs. 3.1%; p < 0.0001) and sexual dysfunction (13.5% vs. 7.1%; p < 0.0001) was higher among those with vs. without GU injury, respectively. Traumatic brain injury prevalence was also higher (48.0 % vs. 40.0%; p < 0.0001); post-traumatic stress disorder prevalence was similar between the two groups (51.6% vs. 50.6%). Conclusion: We identified an opportunity to improve the diagnosis and coordination of care for veterans with GU injury. Routine screening and better documentation upon transfer from DoD to VHA care should be implemented to alert multi-specialty care teams to provide care for the urinary, sexual, fertility, and psychological health problems of these patients.	[Nnamani, Nina S.] US Army Inst Surg Res, 3698 Chambers Pass, Jbsa Ft Sam Houston, TX 78234 USA; [Pugh, Mary Jo] Univ Texas Hlth San Antonio, Dept Epidemiol & Biostat, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Pugh, Mary Jo; Liss, Michael A.] South Texas Vet Hlth Care Syst, 7400 Merton Minter St, San Antonio, TX 78229 USA; [Amuan, Megan E.] Edith Nourse Rogers Mem VA Hosp, Ctr Healthcare Org & Implementat Res, 200 Springs Rd, Bedford, MA 01730 USA; [Eapen, Blessen C.] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, 7400 Merton Minter St, San Antonio, TX 78229 USA; [Eapen, Blessen C.] Univ Texas Hlth San Antonio, Dept Rehabil Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Hudak, Steven J.] Brooke Army Med Ctr, Dept Surg, Urol Clin, 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 USA; [Hudak, Steven J.; Orman, Jean A.] Uniformed Serv Univ Hlth Sci, Dept Surg, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Liss, Michael A.] Univ Texas Hlth San Antonio, Dept Urol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Orman, Jean A.] Joint Trauma Syst, 3698 Chambers Pass, San Antonio, TX 78234 USA		Nnamani, NS (corresponding author), US Army Inst Surg Res, 3698 Chambers Pass, Jbsa Ft Sam Houston, TX 78234 USA.			Liss, Michael/0000-0001-6978-1026	Department of Veterans AffairsUS Department of Veterans Affairs [I01 HX000329-05]	This study was funded by the Department of Veterans Affairs (I01 HX000329-05). The funding organization had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or of the manuscript.	[Anonymous], 2012, VHA HDB; [Anonymous], 2017, EACE R AMP DAT; Breyer BN, 2014, J SEX MED, V11, P75, DOI 10.1111/jsm.12201; Breyer BN, 2014, UROLOGY, V83, P312, DOI 10.1016/j.urology.2013.08.047; Coyne KS, 2008, BJU INT, V101, P1388, DOI 10.1111/j.1464-410X.2008.07601.x; Dean WK, 2016, HASTINGS CENT REP, V46, P10, DOI 10.1002/hast.643; Department of Defense, 2017, US CAS STAT; Eapen BC, 2013, CURR PHYS MED REHABI, V1, P151, DOI DOI 10.1007/S40141-013-0023-0; Han JS, 2013, J MENS HEALTH, V10, P124, DOI 10.1089/jomh.2013.1504; Hosain GMM, 2013, J SEX MED, V10, P516, DOI 10.1111/j.1743-6109.2012.02978.x; Janak JC, 2017, J UROLOGY, V197, P414, DOI 10.1016/j.juro.2016.08.005; Lucas PA, 2014, INJURY, V45, P825, DOI 10.1016/j.injury.2013.12.009; Nnamani NS, 2016, J TRAUMA ACUTE CARE, V81, pS95, DOI 10.1097/TA.0000000000001122; Paquette EL, 2007, J UROLOGY, V177, P2196, DOI 10.1016/j.juro.2007.01.132; Reed AM, 2018, MIL MED, V183, pE304, DOI 10.1093/milmed/usx079; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Turchik JA, 2012, INT J SEX HEALTH, V24, P45, DOI 10.1080/19317611.2011.639592; U. S. Army, 2016, NON TRADITIONAL REF; United States Department of Veterans Affairs and Department of Defense Management of Concussion/mTBI Working Group, 2016, VA DOD CLIN PRACT GU; US Department of Defense/Department of Veterans Affairs, 2017, VA DOD CLIN PRACT GU; Wilcox SL, 2014, J SEX MED, V11, P2537, DOI 10.1111/jsm.12643; Wilkinson CW, 2012, FRONT NEUROL, V3, P1	22	7	7	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2019	184	3-4					E297	E301		10.1093/milmed/usy196			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN6MF	WOS:000460299500028	30124961	hybrid			2022-02-06	
J	Novgorodov, SA; Voltin, JR; Wang, WX; Tomlinson, S; Riley, CL; Gudz, TI				Novgorodov, Sergei A.; Voltin, Joshua R.; Wang, Wenxue; Tomlinson, Stephen; Riley, Christopher L.; Gudz, Tatyana I.			Acid sphingomyelinase deficiency protects mitochondria and improves function recovery after brain injury	JOURNAL OF LIPID RESEARCH			English	Article						sphingolipids; inflammasome; neuroinflammation; astrogliosis	CONTROLLED CORTICAL IMPACT; TRAUMATIC BRAIN; NERVOUS-SYSTEM; OXIDATIVE STRESS; NLRP3 INFLAMMASOME; SIGNALING PATHWAY; WATER-MAZE; CELL-DEATH; CERAMIDE; ACTIVATION	Traumatic brain injury (TBI) is one of the leading causes of disability worldwide and a prominent risk factor for neurodegenerative diseases. The expansion of nervous tissue damage after the initial trauma involves a multifactorial cascade of events, including excitotoxicity, oxidative stress, inflammation, and deregulation of sphingolipid metabolism that further mitochondrial dysfunction and secondary brain damage. Here, we show that a posttranscriptional activation of an acid sphingomyelinase (ASM), a key enzyme of the sphingolipid recycling pathway, resulted in a selective increase of sphingosine in mitochondria during the first week post-TBI that was accompanied by reduced activity of mitochondrial cytochrome oxidase and activation of the Nod-like receptor protein 3 inflammasome. TBI-induced mitochondrial abnormalities were rescued in the brains of ASM KO mice, which demonstrated improved behavioral deficit recovery compared with WT mice. Furthermore, an elevated autophagy in an ASM-deficient brain at the baseline and during the development of secondary brain injury seems to foster the preservation of mitochondria and brain function after TBI. Of note, ASM deficiency attenuated the early stages of reactive astrogliosis progression in an injured brain. These findings highlight the crucial role of ASM in governing mitochondrial dysfunction and brain-function impairment, emphasizing the importance of sphingolipids in the neuroinflammatory response to TBI.	[Novgorodov, Sergei A.; Voltin, Joshua R.; Gudz, Tatyana I.] Med Univ South Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Wang, Wenxue; Tomlinson, Stephen] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Riley, Christopher L.; Gudz, Tatyana I.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA		Gudz, TI (corresponding author), Med Univ South Carolina, Dept Neurosci, Charleston, SC 29425 USA.; Gudz, TI (corresponding author), Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA.	gudz@musc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS083544]; US Department of Veterans Affairs Merit AwardUS Department of Veterans Affairs [I01BX002991]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS083544] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002991] Funding Source: NIH RePORTER	This work was supported in part by National Institutes of Health Grants R01NS083544 (T.I.G.) and US Department of Veterans Affairs Merit Award I01BX002991 (T.I.G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arora AS, 1997, HEPATOLOGY, V25, P958, DOI 10.1002/hep.510250428; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Beckmann N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00331; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bortolotti P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01900; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chatelut M, 1998, FEBS LETT, V426, P102, DOI 10.1016/S0014-5793(98)00325-1; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Clarke CJ, 2011, ADV ENZYME REGUL, V51, P51, DOI 10.1016/j.advenzreg.2010.09.016; Erdreich-Epstein A, 2005, BLOOD, V105, P4353, DOI 10.1182/blood-2004-08-3098; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Gulbins A., 2018, MOL PSYCHIATR, V23, P2251, DOI DOI 10.1038/S41380-018-0319-7; Gulbins E, 2013, NAT MED, V19, P934, DOI 10.1038/nm.3214; Gupta S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-26; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Henry Brian, 2013, Handb Exp Pharmacol, P77, DOI 10.1007/978-3-7091-1368-4_4; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Horng T, 2014, TRENDS IMMUNOL, V35, P253, DOI 10.1016/j.it.2014.02.007; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; Justice MJ, 2018, J LIPID RES, V59, P596, DOI 10.1194/jlr.M080242; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kornhuber J, 2010, CELL PHYSIOL BIOCHEM, V26, P9, DOI 10.1159/000315101; Lee JK, 2014, J EXP MED, V211, P1551, DOI 10.1084/jem.20132451; Lee SW, 2018, J NEUROTRAUM, V35, P1681, DOI 10.1089/neu.2017.5530; Li X, 2012, CELL PHYSIOL BIOCHEM, V30, P815, DOI 10.1159/000341460; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Lozano J, 2001, CELL DEATH DIFFER, V8, P100, DOI 10.1038/sj.cdd.4400775; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Martinez TN, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-45; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Novgorodov AS, 2007, FASEB J, V21, P1503, DOI 10.1096/fj.06-7420com; Novgorodov SA, 2018, J LIPID RES, V59, P312, DOI 10.1194/jlr.M080374; Novgorodov SA, 2016, J BIOL CHEM, V291, P1957, DOI 10.1074/jbc.M115.668228; Novgorodov SA, 2014, J BIOL CHEM, V289, P13142, DOI 10.1074/jbc.M113.530311; Novgorodov SA, 2011, J BIOL CHEM, V286, P4644, DOI 10.1074/jbc.M110.164392; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Roth AG, 2009, ANGEW CHEM INT EDIT, V48, P7560, DOI 10.1002/anie.200903288; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schiweck J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00261; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Stiban J, 2008, J LIPID RES, V49, P625, DOI 10.1194/jlr.M700480-JLR200; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zigdon H, 2013, J BIOL CHEM, V288, P4947, DOI 10.1074/jbc.M112.402719; Zoccarato F, 2009, J BIOENERG BIOMEMBR, V41, P387, DOI 10.1007/s10863-009-9238-2	87	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	MAR	2019	60	3					609	623		10.1194/jlr.M091132			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HN1GL	WOS:000459935400017	30662008	Green Published, hybrid			2022-02-06	
J	Park, GJ; Shin, J; Kim, SC; Na, DS; Lee, HJ; Kim, H; Lee, SW; In, YN				Park, Gwan-Jin; Shin, Jaeho; Kim, Sang-Chul; Na, Dae-Seok; Lee, Hae-Ju; Kim, Hoon; Lee, Seok-Woo; In, Yong-Nam			Protective effect of helmet use on cervical injury in motorcycle crashes: A case-control study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Motorcycle helmet; Cervical spine injury; Preventive effect; Motor vehicle accidents; Injury severity	SPINE INJURY; NECK INJURIES; HEAD; TRAUMA; RISK; ACCIDENTS; OUTCOMES; IMPACT	Introduction: Helmet use during motorcycle crashes (MCCs) has been shown to reduce traumatic brain injury and mortality. However, preventive effects of its use on cervical spine injury remain controversial. In this study, we evaluated whether helmet use can reduce cervical spine injury during MCCs. Patients and Methods: A case-control study using data from the Emergency Department-based Injury In-depth Surveillance (EDIIS) registry was conducted. Cases were defined as patients with cervical spine injury [>= 2 points in the Abbreviated Injury Scale (AIS)] in MCCs from 2011 to 2016. Four controls were matched to one case with strata which included age and sex from the EDIIS registry. Primary outcome was cervical spine injury, secondary outcome was intensive care unit (ICU) admission, and tertiary outcomes was mortality. Multivariable logistic regression analysis was used to calculate odds ratios (OR) with 95% confidence intervals (CIs) to evaluate the associations between helmet use and related outcomes. Results: In total, 2600 patients were analysed; among these, 1145 (44.0%) used helmets at the time of crashes. The helmet group showed lower alcohol consumption and mortality rates than the no helmet group (alcohol: 3.2% vs. 9.2%, respectively, and mortality: 2.4% vs. 7.1%, respectively; p < 0.01). Compared with the no helmet group, the helmet group was less likely to have cervical spine injury [adjusted OR, 0.62 (0.51-0.77)]. In addition, helmet use has been shown to help prevent ICU admission and mortality [adjusted OR, 0.45 (0.36-0.56) and 0.32 (0.21-0.51), respectively]. Conclusion: Helmet use was found to have significant preventive effects on cervical spine injury during MCCs. (C) 2019 Elsevier Ltd. All rights reserved.	[Park, Gwan-Jin; Kim, Sang-Chul; Na, Dae-Seok; Lee, Hae-Ju; Kim, Hoon; Lee, Seok-Woo; In, Yong-Nam] Chungbuk Natl Univ Hosp, Dept Emergency Med, 776,1st Sunhwan Ro, Cheongju 28646, Chungcheongbuk, South Korea; [Shin, Jaeho] Kyungil Univ, Sch Mech & Automot Engn, Gyongsan, South Korea		Kim, SC (corresponding author), Chungbuk Natl Univ Hosp, Dept Emergency Med, 776,1st Sunhwan Ro, Cheongju 28646, Chungcheongbuk, South Korea.	pkj83531@naver.com; jhshin@kiu.kr; ooiarahan@nate.com; dsna0404@gmail.com; emt_hju@naver.com; nichekh2000@hanmail.net; drrhec@chungbuk.ac.kr; ynsoft@naver.com		Kim, Sang Chul/0000-0001-9377-4993	Korea Centers for Disease Control and Prevention (CDC); Korea CDC (2017-2018)	This study was supported by the Korea Centers for Disease Control and Prevention (CDC). The study was funded by the Korea CDC (2017-2018).	Ackaah W, 2010, TRAFFIC INJ PREV, V11, P522, DOI 10.1080/15389588.2010.489198; Arthur Goodwin, 2015, COUNTERMEASURES WORK; Cini MA, 2014, BRIT J ORAL MAX SURG, V52, P789, DOI 10.1016/j.bjoms.2014.05.006; Crompton JG, 2011, J AM COLL SURGEONS, V212, P295, DOI 10.1016/j.jamcollsurg.2010.09.032; Eltorai AEM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2914-3; GOLDSTEIN JP, 1986, EVALUATION REV, V10, P355, DOI 10.1177/0193841X8601000306; Hooten KG, 2014, J NEUROTRAUM, V31, P1329, DOI 10.1089/neu.2013.3253; Khor D, 2017, INJURY, V48, P1093, DOI 10.1016/j.injury.2017.02.006; Kim CY, 2015, TRAFFIC INJ PREV, V16, P732, DOI 10.1080/15389588.2015.1005207; Kim S, 2018, AM J EMERG MED, V36, P173, DOI 10.1016/j.ajem.2017.07.044; Kwak BH, 2015, J KOREAN MED SCI, V30, P1881, DOI 10.3346/jkms.2015.30.12.1881; Landwijt M, 2015, FIBRES TEXT EAST EUR, V23, P103, DOI 10.5604/12303666.1152740; Lastfogel J, 2016, JAMA SURG, V151, P88, DOI 10.1001/jamasurg.2015.3225; Li GL, 2008, TRAFFIC INJ PREV, V9, P125, DOI 10.1080/15389580801895152; Lin MR, 2009, ACCIDENT ANAL PREV, V41, P710, DOI 10.1016/j.aap.2009.03.010; Liu BC, 2008, COCHRANE DB SYST REV, V23, P1; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P835, DOI 10.1080/15389588.2013.774083; Moskal A, 2008, INJURY PREV, V14, P238, DOI 10.1136/ip.2007.018093; National Center for Statistics and Analysis, 2018, 812492 DOT HS NAT CT; Ooi SS, 2011, ASIA-PAC J PUBLIC HE, V23, P608, DOI 10.1177/1010539511413750; Organization WH, 2015, GLOB HLTH OBS DAT RE; Page PS, 2018, J NEUROSURG-SPINE, V28, P607, DOI 10.3171/2017.7.SPINE17540; Peng YA, 2017, AM J PREV MED, V52, P820, DOI 10.1016/j.amepre.2016.11.030; Ramli R, 2016, INJURY, V47, P2442, DOI 10.1016/j.injury.2016.09.022; Ramli R, 2014, BMC EMERG MED, V14, DOI 10.1186/1471-227X-14-17; Rice TM, 2016, ACCIDENT ANAL PREV, V91, P200, DOI 10.1016/j.aap.2016.03.002; Sung K-M, 2016, BIOMED RES INT, V2016, P1; Yu WY, 2011, INT J EPIDEMIOL, V40, P794, DOI 10.1093/ije/dyr040	28	7	7	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAR	2019	50	3					657	662		10.1016/j.injury.2019.01.030			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	HU0OG	WOS:000464969600006	30765183				2022-02-06	
J	Vince, GH; Kraschl, J; Rauter, H; Stein, M; Grossauer, S; Uhl, E				Vince, G. H.; Kraschl, J.; Rauter, H.; Stein, M.; Grossauer, S.; Uhl, E.			Comparison between autologous bone grafts and acrylic (PMMA) implants - A retrospective analysis of 286 cranioplasty procedures	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Decompressive craniectomy; Cranioplasty; Complications	ACUTE SUBDURAL HEMATOMAS; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; HEMICRANIECTOMY; EVACUATION; INFECTION; SURGERY	Decompressive craniectomy (DC) is an accepted surgical technique for reducing life-threatening levels of intracranial pressure. Remodelling the cranial vault following DC can constitute a reconstructive challenge and is known to carry significant morbidity. The aim of our study was to evaluate acrylic versus autologous cranioplasty with regard to specific complication rates. A retrospective analysis was conducted of 286 consecutive adult patients who underwent cranioplasty following supratentorial decompressive craniectomy at our institution between January 2003 and June 2013. The patients were followed based on medical records, operative reports, imaging and outpatient contacts in the postoperative course. A total of 221/286 patients in our series received an autologous bone flap. 65/286 cranioplasty procedures were carried out using acrylic (PMMA) implants to cover uni- or bilateral defects. Within the follow-up period a total of 100 operative revisions were performed. 33.3% patients in the autologous bone group and 40.6% of patients in the acrylic group developed complications requiring surgical attention. The main reason for revision was infection with a total of 37 revisions necessary to treat disturbed wound healing. Postoperative sub- and epidural hematomas requiring revision were more frequent in the acrylic group. Resorption of the autologous bone flap requiring operative revision was seen in 8/222 (3.6%) cases. Other complications included loosening of the implant or dislocation. From our data it can be concluded that cranioplasty procedures using autologous bone-flaps and acrylic implants carry signifikant morbidity, but that both are justifiable techniques for cranioplasty in adult patients. (C) 2018 Elsevier Ltd. All rights reserved.	[Vince, G. H.] Acad Hosp Aschaffenburg, Dept Neurosurg, D-63739 Aschaffenburg, Germany; [Kraschl, J.; Rauter, H.] Acad Hosp Klagenfurt, Dept Neurosurg, A-9020 Klagenfurt, Austria; [Stein, M.; Uhl, E.] Univ Giessen, Dept Neurosurg, D-35392 Giessen, Germany; [Grossauer, S.] Univ Bochum, Dept Neurosurg, D-44892 Bochum, Germany		Vince, GH (corresponding author), Univ Wurzburg, Klinikum Aschaffenburg Alzenau, Acad Hosp, Dept Neurosurg, D-63739 Aschaffenburg, Germany.	giles.vince@klinikum-ab-alz.de					Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Inamasu J, 2010, J TRAUMA, V68, P183, DOI 10.1097/TA.0b013e3181c45384; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Juttler E, 2011, INT J STROKE, V6, P79, DOI 10.1111/j.1747-4949.2010.00544.x; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Lee EI, 2014, PLAST RECONSTR SURG, V133, P675, DOI 10.1097/01.prs.0000438061.46290.33; Lethaus B, 2014, J CRANIOFAC SURG, V25, P206, DOI 10.1097/SCS.0000000000000396; Lethaus B, 2011, J CRANIO MAXILL SURG, V39, P435, DOI 10.1016/j.jcms.2010.10.003; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Morina Arsim, 2011, Surg Neurol Int, V2, P72, DOI 10.4103/2152-7806.81735; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Sultan SM, 2011, PLAST RECONSTR SURG, V127, P1855, DOI 10.1097/PRS.0b013e31820e89a5; Tagliaferri F, 2012, ACTA NEUROCHIR, V154, P919, DOI 10.1007/s00701-012-1318-0; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002	20	7	7	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAR	2019	61						205	209		10.1016/j.jocn.2018.10.017			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HO3SY	WOS:000460844400037	30396817				2022-02-06	
J	Friedman, R; Haimy, A; Epstein, Y; Gefen, A				Friedman, Rinat; Haimy, Ayelet; Epstein, Yoram; Gefen, Amit			Evaluation of helmet and goggle designs by modeling non-penetrating projectile impacts	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Finite element modelling; traumatic brain injury simulations; ocular trauma; combat helmet; goggles	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT MODELS; HUMAN HEAD; IRAQI FREEDOM; TISSUE; SIMULATION; RESPONSES	Despite the progress in developing personal combat-protective gear, eye and brain injuries are still widely common and carry fatal or long-term repercussions. The complex nature of the cranial tissues suggests that simple methods (e.g. crash-dummies) for testing the effectiveness of personal protective gear against non-penetrating impacts are both expensive and ineffective, and there are ethical issues in using animal or cadavers. The present work presents a versatile testing framework for quantitatively evaluating protective performances of head and eye combat-protective gear, against non-penetrating impacts. The biomimetic finite element (FE) head model that was developed provides realistic representation of cranial structure and tissue properties. Simulated crash impact results were validated against a former cadaveric study and by using a crash-phantom developed in our lab. The model was then fitted with various helmet and goggle designs onto which a non-penetrating ballistic impact was applied. Example data show that reduction of the elastic and shear moduli by 30% and 80% respectively of the helmet outer Kevlar-29 layer, lowered intracranial pressures by 20%. Our modeling suggests that the level of stresses that develop in brain tissues, which ultimately cause the brain damage, cannot be predicted solely by the properties of the helmet/goggle materials. We further found that a reduced contact area between goggles and face is a key factor in reducing the mechanical loads transmitted to the optic nerve and eye balls following an impact. Overall, this work demonstrates the simplicity, flexibility and usefulness for development, evaluation, and testing of combat-protective equipment using computational modeling.	[Friedman, Rinat; Haimy, Ayelet; Gefen, Amit] Tel Aviv Univ, Fac Engn, Dept Biomed Engn, Tel Aviv, Israel; [Epstein, Yoram] Sheba Med Ctr, Heller Inst Med Res, Ramat Gan, Israel; [Epstein, Yoram] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel		Gefen, A (corresponding author), Tel Aviv Univ, Fac Engn, Dept Biomed Engn, Tel Aviv, Israel.	gefen@eng.tau.ac.il			Research and Development Directorate (MAFAT) of the Israeli Ministry of Defense; Medical Corps of the IDF [4440789254, 4440592886, 4440698400]	This work was funded by the Research and Development Directorate (MAFAT) of the Israeli Ministry of Defense and the Medical Corps of the IDF (grants awarded to Profs. Gefen and Epstein). Grant numbers 4440789254, 4440592886 and 4440698400.	Aare M, 2007, INT J IMPACT ENG, V34, P596, DOI 10.1016/j.ijimpeng.2005.08.001; Ari Adrienne B, 2006, Optometry, V77, P329, DOI 10.1016/j.optm.2006.03.015; Bailoor S, 2015, BIOMECH MODEL MECHAN, V14, P1227, DOI 10.1007/s10237-015-0667-z; Botteri M, 2008, CRIT CARE MED, V36, P3089, DOI 10.1097/CCM.0b013e31818bd7df; Brands DWA, 2002, THESIS; Brooks AJ, 2011, RYAN'S BALLISTIC TRAUMA: A PRACTICAL GUIDE, THIRD EDITION, P251, DOI 10.1007/978-1-84882-124-8_19; Chen Y.H., 2011, THESIS; Cortes DH, 2014, J BIOMECH, V47, P2088, DOI 10.1016/j.jbiomech.2013.12.021; Cotton RT, 2016, COMPUT METHOD BIOMEC, V19, P101, DOI 10.1080/10255842.2014.994118; De Pellegrin DV, 2014, MATER SCI FORUM, V773-774, P488, DOI 10.4028/www.scientific.net/MSF.773-774.488; Farvid MS, 2005, DIABETES OBES METAB, V7, P406, DOI 10.1111/j.1463-1326.2004.00410.x; Freitas CJ, 2014, INT J MED SCI, V11, P409, DOI 10.7150/ijms.8079; Friedman R, 2016, STUD MECHANOBIOL TIS, V19, P209, DOI 10.1007/8415_2016_189; Frissen R.J.T., 1996, THESIS; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Ghajari M, 2008, MOTORCYCLE MOTORCYCL; Greaves CY, 2008, ANN BIOMED ENG, V36, P396, DOI 10.1007/s10439-008-9440-0; Gunther Peter J, 2008, Optometry, V79, P663, DOI 10.1016/j.optm.2008.01.023; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; LENHART MK, 2012, COMBAT CASUALTY CARE, P347; Little LP, 2004, THESIS; Lo M, 2013, 201312 USAARL USA ME; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahoney PF, 2017, INT J LEGAL MED, V131, P1043, DOI 10.1007/s00414-017-1557-y; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meng Q, 2010, INT J SPORTS SCI ENG, V4, P48; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Power E. D., 2001, THESIS; Qiu ZX, 2008, THESIS; Rodriguez-Millan M, 2017, MATER DESIGN, V117, P58, DOI 10.1016/j.matdes.2016.12.081; Salimi JM, 2014, COMPUT METHOD BIOMEC, V17, P1368, DOI [10.1080/10255842.2012.748755, DOI 10.1080/10255842.2012.748755]; Schmitt K, 2004, TRAUMA BIOMECHANICS, DOI [10.1007/978-3-662-05448-2, DOI 10.1007/978-3-662-05448-2]; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Sopher R, 2010, J BIOMECH, V43, P280, DOI 10.1016/j.jbiomech.2009.08.021; Soza G, 2005, INT J MED ROBOT COMP, V1, P87, DOI 10.1002/rcs.32; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P79; Tse KM, 2014, INT J NUMER METH BIO, V30, P397, DOI 10.1002/cnm.2609; van Hoof J, 2000, COMBINING HEAD MODEL; Vlasov A, 2017, MIL MED, V182, P114, DOI 10.7205/MILMED-D-16-00041; Wallace D, 2012, J MIL VETERANS HEALT, V20, P10; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weaver AA, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003328; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Yang J, 2010, COMPUT AIDED DES APP, V7, P59, DOI DOI 10.3722/cadaps.2010.59-73; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	54	7	7	2	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	FEB 17	2019	22	3					229	242		10.1080/10255842.2018.1549238			14	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	HU6QE	WOS:000465404800001	30596531				2022-02-06	
J	Bown, D; Belli, A; Qureshi, K; Davies, D; Toman, E; Upthegrove, R				Bown, Dominic; Belli, Antonio; Qureshi, Kasim; Davies, David; Toman, Emma; Upthegrove, Rachel			Post-traumatic stress disorder and self-reported outcomes after traumatic brain injury in victims of assault	PLOS ONE			English	Article							QUALITY-OF-LIFE; RISK-FACTORS; HEALTH; EPIDEMIOLOGY; ASSOCIATIONS; SYMPTOMS; VETERANS; ETIOLOGY; MODERATE; VIOLENCE	Introduction Assault is the third most common cause of traumatic brain injury (TBI), after falls and road traffic collisions. TBI can lead to multiple long-term physical, cognitive and emotional sequelae, including post-traumatic stress disorder (PTSD). Intentional violence may further compound the psychological trauma of the event, in a way that conventional outcome measures, like the Glasgow Outcome Scale (GOS), fail to capture. This study aims to examine the influence of assault on self-reported outcomes, including quality of life and symptoms of PTSD. Methods Questionnaire were completed by 256 patients attending a TBI clinic, including Quality of Life after Brain Injury (QOLIBRI) and PTSD checklist (PCL-C). Medical records provided demographics, clinical data and aetiology of injury. Subjective outcomes were compared between assault and other causes. Results Of 202 patients analysed, 21% sustained TBI from assault. There was no difference in severity of injuries between assault and non-assault groups. No relationship was found between self-reported outcomes and TBI severity or GOS. The assault group scored worse in all self-reported questionnaires, with statistically significant differences for measures of PTSD and post-concussion symptoms. However, using threshold scores, the prevalence of PTSD in assaulted patients was not higher than non-assault. After adjusting for age, ethnicity and the presence of extra-cranial trauma, assault did not have a significant effect on questionnaire scores. Exploratory analysis showed that assault and road traffic accidents were associated with significantly worse outcomes compared to falls. Conclusion Quality of life is significantly related to functional and psychological outcomes after TBI. Assaulted patients suffer from worse self-reported outcomes than other patients, but these differences were insignificant when adjusted for demographic factors. Intentionality behind the traumatic event is likely more important than cause alone. Differences in quality of life and other self-reported outcomes are not reflected by the Glasgow Outcome Scale. This information is useful in arranging earlier and targeted review and support.	[Bown, Dominic; Qureshi, Kasim; Upthegrove, Rachel] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Belli, Antonio] Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England; [Belli, Antonio; Davies, David] Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Toman, Emma] Univ Cent Lancashire, Preston, Lancs, England; [Upthegrove, Rachel] Univ Birmingham, Inst Mental Hlth, Birmingham, W Midlands, England		Upthegrove, R (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England.; Upthegrove, R (corresponding author), Univ Birmingham, Inst Mental Hlth, Birmingham, W Midlands, England.	r.upthegrove@bham.ac.uk	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933; Upthegrove, Rachel/0000-0001-8204-5103			Asmundson GJG, 2000, BEHAV RES THER, V38, P203, DOI 10.1016/S0005-7967(99)00061-3; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dagher JH, 2010, BRAIN INJURY, V24, P1389, DOI 10.3109/02699052.2010.523042; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Ghroubi S, 2016, ANN PHYS REHABIL M S, V59S, pe135; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu XB, 2012, BRAIN INJURY, V26, P183, DOI 10.3109/02699052.2011.648707; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kaminer D, 2008, SOC SCI MED, V67, P1589, DOI 10.1016/j.socscimed.2008.07.023; Kim H, 2013, DISABIL REHABIL, V35, P2213, DOI 10.3109/09638288.2013.774063; Machamer JE, 2003, J HEAD TRAUMA REHAB, V18, P387, DOI 10.1097/00001199-200309000-00001; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mathias JL, 2014, J NEUROTRAUM, V31, P658, DOI 10.1089/neu.2013.3160; Motzkin Julian C, 2015, Handb Clin Neurol, V128, P633, DOI 10.1016/B978-0-444-63521-1.00039-X; Nachit-Ouinekh F, 2005, EUR J NEUROL, V12, P189, DOI 10.1111/j.1468-1331.2004.00934.x; National Institute for Health and Care Excellence, 2014, HEAD INJ ASS EARL MA; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Patel MB, 2015, J NEUROTRAUM, V32, P984, DOI 10.1089/neu.2014.3652; Perkonigg A, 2000, ACTA PSYCHIAT SCAND, V101, P46, DOI 10.1034/j.1600-0447.2000.101001046.x; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schopp LH, 2006, J HEAD TRAUMA REHAB, V21, P213, DOI 10.1097/00001199-200605000-00002; Seidl JNT, 2015, REHABIL PSYCHOL, V60, P335, DOI 10.1037/rep0000064; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Trost Z, 2015, REHABIL PSYCHOL, V60, P213, DOI 10.1037/rep0000043; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	48	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211684	10.1371/journal.pone.0211684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK5RX	WOS:000458026000043	30730924	Green Published, Green Accepted, Green Submitted, gold			2022-02-06	
J	Abrahams, S; Mcfie, S; Lacerda, M; Patricios, J; Suter, J; September, AV; Posthumus, M				Abrahams, Shameemah; Mcfie, Sarah; Lacerda, Miguel; Patricios, Jon; Suter, Jason; September, Alison V.; Posthumus, Michael			Unravelling the interaction between the DRD2 and DRD4 genes, personality traits and concussion risk	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article							PROMOTER REGION; MESSENGER-RNA; DOPAMINE; ASSOCIATION; EXPRESSION; INJURY; SPORT; IDENTIFICATION; POLYMORPHISMS; TEMPERAMENT	Background Concussion occurs when biomechanical forces transmitted to the head result in neurological deficits. Personality may affect the balance between safe and dangerous play potentially influencing concussion risk. Dopamine receptor D2 (DRD2) and dopamine receptor D4 (DRD4) genetic polymorphisms were previously associated with personality traits. Objectives This case-control genetic association study investigated the associations of (1) DRD2 and DRD4 genotypes with concussion susceptibility and personality, (2) personality with concussion susceptibility and (3) the statistical model of genotype, personality and concussion susceptibility. Methods In total, 138 non-concussed controls and 163 previously concussed cases were recruited from high school (n=135, junior), club and professional rugby teams (n=166, senior). Participants were genotyped for DRD2 rs12364283 (A>G), DRD2 rs1076560 (C>A) and DRD4 rs1800955 (T>C) genetic variants. Statistical analyses including structural equation modelling were performed using the R environment and STATA. Results The rs1800955 CC genotype (p=0.014) and inferred DRD2 (rs12364283-rs1076560)-DRD4 (rs1800955) A-C-C allele combination (p=0.019) were associated with decreased concussion susceptibility in juniors. The rs1800955 TT and CT genotypes were associated with low reward dependence in juniors (p<0.001) and seniors (p=0.010), respectively. High harm avoidance was associated with decreased concussion susceptibility in juniors (p=0.009) and increased susceptibility in seniors (p=0.001). The model showed that a genetic variant was associated with personality while personality was associated with concussion susceptibility. Conclusion These findings highlight the linear relationship between genetics, personality and concussion susceptibility. Identifying a genetic profile of 'high risk' behaviour, together with the development of personalised behavioural training, can potentially reduce concussion risk.	[Abrahams, Shameemah; Mcfie, Sarah; September, Alison V.; Posthumus, Michael] Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, Cape Town, South Africa; [Abrahams, Shameemah] Stellenbosch Univ, Div Mol Biol & Human Genet, Fac Med & Hlth Sci, Cape Town, South Africa; [Lacerda, Miguel] Univ Cape Town, Dept Stat Sci, Fac Sci, Cape Town, South Africa; [Patricios, Jon] Sports Concuss South Africa, Johannesburg, South Africa; [Patricios, Jon] Univ Pretoria, Sect Sports Med, Pretoria, South Africa; [Patricios, Jon] Univ Witwatersrand, Dept Emergency Med, Johannesburg, South Africa; [Suter, Jason] Sports Sci Inst, Cape Sports Med, Cape Town, South Africa		Posthumus, M (corresponding author), Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, Cape Town, South Africa.	mposthumus@me.com		Abrahams, Shameemah/0000-0002-1120-678X; September, Alison V/0000-0003-0950-286X	South African National Research FoundationNational Research Foundation - South Africa [90942, 93416, 85534]; Deutscher Akademischer Austauschdienst (DAAD)Deutscher Akademischer Austausch Dienst (DAAD); University of Cape Town	This study and authors were funded by the South African National Research Foundation (grant numbers: 90942, 93416, 85534), the Deutscher Akademischer Austauschdienst (DAAD) and the University of Cape Town. Funders had no involvement in the paper.	Abrahams S, 2018, J SCI MED SPORT, V21, P117, DOI 10.1016/j.jsams.2017.06.004; Bandura A, 2012, J MANAGE, V38, P9, DOI 10.1177/0149206311410606; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Brandstrom S, 2001, PSYCHOL REP, V89, P747, DOI 10.2466/PR0.89.7.747-758; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/PR0.69.7.1047-1057; Dretsch MN, 2017, J NEUROTRAUM, V34, P869, DOI 10.1089/neu.2016.4480; Frank MJ, 2009, NEUROSCIENCE, V164, P131, DOI 10.1016/j.neuroscience.2009.04.048; Fresan A, 2011, COMPR PSYCHIAT, V52, P774, DOI 10.1016/j.comppsych.2010.11.003; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; HALL H, 1994, NEUROPSYCHOPHARMACOL, V11, P245, DOI 10.1038/sj.npp.1380111; Hamidovic A, 2009, EXP CLIN PSYCHOPHARM, V17, P374, DOI 10.1037/a0017840; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Karched M, 2012, J MICROBIOL METH, V89, P71, DOI 10.1016/j.mimet.2012.01.016; Kereszturi E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-18; Kontos AP, 2004, J PEDIATR PSYCHOL, V29, P447, DOI 10.1093/jpepsy/jsh048; Little J, 2009, GENET EPIDEMIOL, V33, P581, DOI 10.1002/gepi.20410; Lober S, 2011, TRENDS PHARMACOL SCI, V32, P148, DOI 10.1016/j.tips.2010.12.003; Mc Fie S, 2016, CLIN J SPORT MED, V26, P398, DOI 10.1097/JSM.0000000000000276; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mcintosh AS, 2010, MED SCI SPORT EXER, V42, P977, DOI 10.1249/MSS.0b013e3181c07b5b; McMichael Gai L, 2009, J Biomol Tech, V20, P232; Mokone GG, 2006, SCAND J MED SCI SPOR, V16, P19, DOI 10.1111/j.1600-0838.2005.00439.x; Okuyama Y, 1999, BIOCHEM BIOPH RES CO, V258, P292, DOI 10.1006/bbrc.1999.0630; Okuyama Y, 2000, MOL PSYCHIATR, V5, P64, DOI 10.1038/sj.mp.4000563; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; R Core Team, 2017, R LANG ENV STAT COMP; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Simpson J, 2010, AM J MED GENET B, V153B, P1228, DOI 10.1002/ajmg.b.31084; Toft M, 2007, J NEUROL NEUROSUR PS, V78, P82, DOI 10.1136/jnnp.2006.097840; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; Verweij KJH, 2010, BIOL PSYCHOL, V85, P306, DOI 10.1016/j.biopsycho.2010.07.018; Viljoen W., 2008, S AFR J SPORTS MED, V20, P64, DOI [10.17159/2078-516X/2008/v20i3a633, DOI 10.17159/2078-516X/2008/V20I3A633]; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Xiang LB, 2008, BRAIN RES, V1207, P214, DOI 10.1016/j.brainres.2008.02.009; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104	43	7	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	FEB	2019	5	1							e000465	10.1136/bmjsem-2018-000465			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PC2AQ	WOS:000596810500011	30815277	Green Published, gold			2022-02-06	
J	Bradt, J; Biondo, J; Vaudreuil, R				Bradt, Joke; Biondo, Jacelyn; Vaudreuil, Rebecca			Songs created by military service members in music therapy: A retrospective analysis	ARTS IN PSYCHOTHERAPY			English	Article						Music therapy; Songwriting; Military; Rehabilitation; Traumatic brain injury; Posttraumatic stress disorder	COMMUNITY REINTEGRATION; CARE; CULTURE; BARRIERS; STIGMA; DUTY	A successful transition to civilian life is challenging for many service members returning from deployment. Psychological and physical injuries may hamper successful reintegration into home life and communities and, as a result, many service members report feeling lonely, isolated and misunderstood. This study analyzed 14 songs written by 11 active-duty service members with post-traumatic stress disorder, mild traumatic brain injury, and psychological health conditions, who received music therapy services at the National Intrepid Center of Excellence, a Directorate of Walter Reed National Military Medical Center in the United States of America. Service members wrote songs over the course of two or more individual music therapy sessions. Latent thematic analysis of the song lyrics yielded four main themes: (a) personal struggles and barriers to recovery, (b) moving forward, (c) relational challenges, and (d) positive relationships and support. The songs offer a window into service members' lived experiences of military service, injury, recovery, homecoming, and transition from active-duty. Songwriting enabled service members to share their thoughts, emotions, fears and hopes with family, friends and other providers, often for the first time, and as such played an important role in their personal growth and recovery process. This is the first study to examine the therapeutic benefits of songwriting in a military population.	[Bradt, Joke; Biondo, Jacelyn] Drexel Univ, Dept Creat Arts Therapies, 1601 Cherry St, Philadelphia, PA 19102 USA; [Vaudreuil, Rebecca] Natl Endowment Arts, Creat Forces Natl Endowment Arts Mil Healing Arts, 400 7th St SW, Washington, DC 20506 USA		Bradt, J (corresponding author), Drexel Univ, Coll Nursing & Hlth Profess, Dept Creat Arts Therapies, Three Pkwy,1601 Cherry St, Philadelphia, PA 19102 USA.	jbradt@drexel.edu	bradt, joke/C-5930-2014	bradt, joke/0000-0001-7313-9829	Creative Forces(R): NEA Military Healing Arts Network	This work was supported by Creative Forces (R): NEA Military Healing Arts Network.	Adler JM, 2007, PSYCHOL INQ, V18, P97, DOI 10.1080/10478400701416145; Aigen K, 2004, COMMUNITY MUSIC THER; Baker F., SONGWRITING METHODS, P11; Baker F, 2008, NORD J MUSIC THER, V17, P105, DOI 10.1080/08098130809478203; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bronson H, 2018, MUSIC THER PERSPECT, V36, P195, DOI 10.1093/mtp/miy006; Bruscia KE., 1998, DYNAMIC MUSIC PSYCHO; Bryan CJ, 2011, PROF PSYCHOL-RES PR, V42, P16, DOI 10.1037/a0022290; Burnell KJ, 2009, NARRAT INQ, V19, P91, DOI 10.1075/ni.19.1.06bur; Coll JE, 2011, SOC WORK HEALTH CARE, V50, P487, DOI 10.1080/00981389.2010.528727; Demers A, 2011, J LOSS TRAUMA, V16, P160, DOI 10.1080/15325024.2010.519281; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lemaire CM, 2011, J AFFECT DISORDERS, V130, P231, DOI 10.1016/j.jad.2010.10.021; MacEachron A., 2012, ADV SOC WORK, V13, P586, DOI 10.18060/2391; Myers-Coffman K, 2018, THESIS; Pease JL, 2016, SOC WORK, V61, P83, DOI 10.1093/sw/swv050; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Ricoeur Paul., 1992, ONESELF ANOTHER; Sayer NA, 2011, J TRAUMA STRESS, V24, P660, DOI 10.1002/jts.20706; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tedeschi RG, 2011, J CLIN PSYCHOL MED S, V18, P137, DOI 10.1007/s10880-011-9255-2; Vaudreuil R, 2019, DISABIL REHABIL, V41, P2333, DOI 10.1080/09638288.2018.1462412; Whitty M., 2002, IDENTITY, V2, P211	26	7	7	2	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-4556	1873-5878		ART PSYCHOTHER	Arts Psychother.	FEB	2019	62				SI		19	27		10.1016/j.aip.2018.11.004			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	IG5IR	WOS:000473837200006		hybrid			2022-02-06	
J	Caprelli, MT; Mothe, AJ; Tator, CH				Caprelli, Mitchell T.; Mothe, Andrea J.; Tator, Charles H.			CNS Injury: Posttranslational Modification of the Tau Protein as a Biomarker	NEUROSCIENTIST			English	Article						tau; biomarker; trauma; spinal cord injury; traumatic brain injury; concussion	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; GLYCOGEN-SYNTHASE KINASE-3-BETA; CEREBROSPINAL-FLUID; CLEAVED-TAU; ALZHEIMERS-DISEASE; AMYLOID-BETA; HYPERPHOSPHORYLATED TAU; PHOSPHORYLATED TAU; NEURONAL DAMAGE	The ideal biomarker for central nervous system (CNS) trauma in patients would be a molecular marker specific for injured nervous tissue that would provide a consistent and reliable assessment of the presence and severity of injury and the prognosis for recovery. One candidate biomarker is the protein tau, a microtubule-associated protein abundant in the axonal compartment of CNS neurons. Following axonal injury, tau becomes modified primarily by hyperphosphorylation of its various amino acid residues and cleavage into smaller fragments. These posttrauma products can leak into the cerebrospinal fluid or bloodstream and become candidate biomarkers of CNS injury. This review examines the primary molecular changes that tau undergoes following traumatic brain injury and spinal cord injury, and reviews the current literature in traumatic CNS biomarker research with a focus on the potential for hyperphosphorylated and cleaved tau as sensitive biomarkers of injury.	[Caprelli, Mitchell T.; Tator, Charles H.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Caprelli, Mitchell T.; Mothe, Andrea J.; Tator, Charles H.] Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada		Tator, CH (corresponding author), Toronto Western Hosp, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.	Charles.tator@uhn.ca					Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Burns AS, 2003, J NEUROTRAUM, V20, P477, DOI 10.1089/089771503765355540; Canu N, 1998, J NEUROSCI, V18, P7061; Chatfield DA, 2002, BRIT J NEUROSURG, V16, P471, DOI 10.1080/0268869021000030285; Chen LJ, 2010, J NEUROTRAUM, V27, P1657, DOI 10.1089/neu.2010.1308; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Dugger BN, 2013, J ALZHEIMERS DIS, V34, P529, DOI 10.3233/JAD-121864; Fasulo L, 2000, J NEUROCHEM, V75, P624, DOI 10.1046/j.1471-4159.2000.0750624.x; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; Goedert M, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0495-z; Guo YJ, 2016, NEUROPSYCH DIS TREAT, V12, P445, DOI 10.2147/NDT.S90735; Hashiguchi M, 2002, J BIOL CHEM, V277, P44525, DOI 10.1074/jbc.M207426200; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Hung KS, 2005, J NEUROPATH EXP NEUR, V64, P15, DOI 10.1093/jnen/64.1.15; Hung KS, 2007, J NEUROSURG-SPINE, V6, P35, DOI 10.3171/spi.2007.6.1.7; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Irazuzta JE, 2001, BRAIN RES, V913, P95, DOI 10.1016/S0006-8993(01)02764-0; Garrido JJ, 2007, FEBS LETT, V581, P1579, DOI 10.1016/j.febslet.2007.03.018; Koh PO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054217; Kwon BK, 2017, J NEUROTRAUM, V34, P567, DOI 10.1089/neu.2016.4435; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Le Meghan N, 2012, Am J Neurodegener Dis, V1, P316; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Li B, 2007, ACTA NEUROPATHOL, V113, P501, DOI 10.1007/s00401-007-0207-8; Li M, 2000, NEUROSCIENCE, V99, P333, DOI 10.1016/S0306-4522(00)00173-1; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lv QS, 2014, J NEUROL SCI, V345, P48, DOI 10.1016/j.jns.2014.06.037; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Saito M, 2010, NEUROCHEM RES, V35, P651, DOI 10.1007/s11064-009-0116-4; SEGAL MB, 1993, J INHERIT METAB DIS, V16, P617, DOI 10.1007/BF00711896; Sendek A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104965; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Shields DC, 2000, J NEUROSCI RES, V61, P146; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Van den Haute C, 2001, NEUROBIOL DIS, V8, P32, DOI 10.1006/nbdi.2000.0333; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wallace TL, 2003, NEUROSCIENCE, V116, P1063, DOI 10.1016/S0306-4522(02)00795-9; Wang JZ, 2014, ESSAYS BIOCHEM, V56, P111, DOI [10.1042/BSE0560111, 10.1042/bse0560111]; Wang JZ, 2014, NEUROSCI BULL, V30, P359, DOI 10.1007/s12264-013-1415-y; Wang YX, 2015, NEUROBIOL AGING, V36, P188, DOI 10.1016/j.neurobiolaging.2014.07.035; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yang WJ, 2017, ACTA NEUROL SCAND, V135, P622, DOI 10.1111/ane.12644; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2003, NEUROSCIENCE, V121, P399, DOI 10.1016/S0306-4522(03)00459-7; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang SX, 2000, J NEUROPATH EXP NEUR, V59, P287, DOI 10.1093/jnen/59.4.287	88	7	7	2	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-8584	1089-4098		NEUROSCIENTIST	Neuroscientist	FEB	2019	25	1					8	21		10.1177/1073858417742125			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HL5PI	WOS:000458780400003	29283022				2022-02-06	
J	Colville, GA; Pierce, CM; Peters, MJ				Colville, Gillian A.; Pierce, Christine M.; Peters, Mark J.			Self-Reported Fatigue in Children Following Intensive Care Treatment	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						outcome measures; PedsQL Multidimensional Fatigue Scale; quality of life; recovery; traumatic brain injury	QUALITY-OF-LIFE; GENERIC CORE SCALES; MULTIDIMENSIONAL FATIGUE; RELIABILITY; PEDSQL(TM); FEASIBILITY; ADMISSION; VALIDITY	Objectives: Adults report high levels of fatigue after intensive care, but little is known about pediatric survivors. This study aimed to explore rates of self-reported fatigue in children after critical illness. Design: Prospective cohort study. Setting: Tertiary children's hospital. Patients: Ninety-seven children aged 7-17 years old. Interventions: None. Measurements and Main Results: Children completed the Pediatric Quality of Life Inventory Multidimensional Fatigue Scale 3 months after discharge from PICU. Comparisons with normative data (n = 209) showed that PICU survivors reported similar mean (sd) total fatigue scores to their healthy peers (79.6 [16.3] vs 81.8 [12.5]; p = 0.239), but greater cognitive fatigue (77.4 [21.9] vs 82.4 [16.4]; p = 0.048). Also children who had sustained a traumatic brain injury reported "less" sleep/rest fatigue (84.6 [15.0] vs 76.8 [16.3]; p = 0.006). Baseline indices of severity of illness were not associated with fatigue. Conclusions: The Pediatric Quality of Life Inventory Multidimensional Fatigue Scale appears to be a promising tool for use in outcomes research with PICU survivors. These results highlight the need to bear in mind the heterogeneity of PICU patients and the multidimensional nature of fatigue symptoms.	[Colville, Gillian A.; Pierce, Christine M.; Peters, Mark J.] Great Ormond St Hosp Children NHS Fdn Trust, Paediat Intens Care Unit, London, England; [Colville, Gillian A.] St Georges Univ Hosp NHS Fdn Trust, Paediat Psychol Serv, London, England; [Colville, Gillian A.] St Georges Univ London, Populat Hlth Res Inst, London, England		Colville, GA (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, Paediat Intens Care Unit, London, England.; Colville, GA (corresponding author), St Georges Univ Hosp NHS Fdn Trust, Paediat Psychol Serv, London, England.; Colville, GA (corresponding author), St Georges Univ London, Populat Hlth Res Inst, London, England.	gcolvill@sgul.ac.uk	Peters, Mark/AAD-7518-2019; Colville, Gillian/ABH-3180-2020	Peters, Mark/0000-0003-3653-4808; Colville, Gillian/0000-0001-8530-2822	Health Foundation Leading Practice Through Research Award [2224/2386]	Supported, in part, by Health Foundation Leading Practice Through Research Award to Ms. Colville (Project Ref: 2224/2386).	Als LC, 2015, PEDIATR CRIT CARE ME, V16, pE141, DOI 10.1097/PCC.0000000000000424; Als LC, 2013, CRIT CARE MED, V41, P1094, DOI 10.1097/CCM.0b013e318275d032; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Boyle K, 2018, PEDIATR CRIT CARE ME, V19, P760, DOI 10.1097/PCC.0000000000001612; Chaboyer Wendy, 2003, Nurs Crit Care, V8, P149, DOI 10.1046/j.1478-5153.2003.00020.x; Colville GA, 2013, PEDIATR CRIT CARE ME, V14, pE85, DOI 10.1097/PCC.0b013e3182712997; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; Griffiths RD, 2007, CURR OPIN CRIT CARE, V13, P508, DOI 10.1097/MCC.0b013e3282efae05; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Manning JC, 2018, PEDIATR CRIT CARE ME, V19, P298, DOI 10.1097/PCC.0000000000001476; Marcus SB, 2009, CLIN GASTROENTEROL H, V7, P554, DOI 10.1016/j.cgh.2009.01.022; Panepinto JA, 2014, PEDIATR BLOOD CANCER, V61, P171, DOI 10.1002/pbc.24776; Pearson GA, 2001, ARCH DIS CHILD, V84, P125, DOI 10.1136/adc.84.2.125; Steenbergen S, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0121-x; TEASDALE G, 1974, LANCET, V2, P81; Typpo K, 2016, PEDIATR CRIT CARE ME, V17, P473, DOI 10.1097/PCC.0000000000000712; Upton Penney, 2005, Health Qual Life Outcomes, V3, P22, DOI 10.1186/1477-7525-3-22; Varni JW, 2013, QUAL LIFE RES, V22, P2581, DOI 10.1007/s11136-013-0370-4; Varni JW, 2010, INT J PEDIATR OBES, V5, P34, DOI 10.3109/17477160903111706; Varni JW, 2009, PEDIATR DIABETES, V10, P321, DOI 10.1111/j.1399-5448.2008.00482.x; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2004, J RHEUMATOL, V31, P2494; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Watson RS, 2018, J PEDIATR-US, V198, P16, DOI 10.1016/j.jpeds.2017.12.084	24	7	7	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	FEB	2019	20	2					E98	E101		10.1097/PCC.0000000000001794			4	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	HK3HS	WOS:000457805300007	30461576	Green Submitted, Green Accepted			2022-02-06	
J	Greenberg, JK; Jeffe, DB; Carpenter, CR; Yan, Y; Pineda, JA; Lumba-Brown, A; Keller, MS; Berger, D; Bollo, RJ; Ravindra, VM; Naftel, RP; Dewan, MC; Shah, MN; Burns, EC; O'Neill, BR; Hankinson, TC; Whitehead, WE; Adelson, PD; Tamber, MS; McDonald, PJ; Ahn, ES; Titsworth, W; West, AN; Brownson, RC; Limbrick, DD				Greenberg, Jacob K.; Jeffe, Donna B.; Carpenter, Christopher R.; Yan, Yan; Pineda, Jose A.; Lumba-Brown, Angela; Keller, Martin S.; Berger, Daniel; Bollo, Robert J.; Ravindra, Vijay M.; Naftel, Robert P.; Dewan, Michael C.; Shah, Manish N.; Burns, Erin C.; O'Neill, Brent R.; Hankinson, Todd C.; Whitehead, William E.; Adelson, P. David; Tamber, Mandeep S.; McDonald, Patrick J.; Ahn, Edward S.; Titsworth, William; West, Alina N.; Brownson, Ross C.; Limbrick, David D., Jr.			North American survey on the post-neuroimaging management of children with mild head injuries	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; health services research; clinical decision making; survey research; intracranial injury; trauma	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY USE; EMERGENCY-DEPARTMENT; DECISION RULES; TRENDS; HOSPITALIZATION; IMPLEMENTATION; VISITS; RATES	OBJECTIVE There remains uncertainty regarding the appropriate level of care and need for repeating neuroimaging among children with mild traumatic brain injury (mTBI) complicated by intracranial injury (ICI). This study's objective was to investigate physician practice patterns and decision-making processes for these patients in order to identify knowledge gaps and highlight avenues for future investigation. METHODS The authors surveyed residents, fellows, and attending physicians from the following pediatric specialties: emergency medicine; general surgery; neurosurgery; and critical care. Participants came from 10 institutions in the United States and an email list maintained by the Canadian Neurosurgical Society. The survey asked respondents to indicate management preferences for and experiences with children with mTBI complicated by ICI, focusing on an exemplar clinical vignette of a 7-year-old girl with a Glasgow Coma Scale score of 15 and a 5-mm subdural hematoma without midline shift after a fall down stairs. RESULTS The response rate was 52% (n = 536). Overall, 326 (61%) respondents indicated they would recommend ICU admission for the child in the vignette. However, only 62 (12%) agreed/strongly agreed that this child was at high risk of neurological decline. Half of respondents (45%; n = 243) indicated they would order a planned follow-up CT (29%; n = 155) or MRI scan (19%; n = 102), though only 64 (12%) agreed/strongly agreed that repeat neuroimaging would influence their management. Common factors that increased the likelihood of ICU admission included presence of a focal neurological deficit (95%; n = 508 endorsed), midline shift (90%; n = 480) or an epidural hematoma (88%; n = 471). However, 42% (n = 225) indicated they would admit all children with mTBI and ICI to the ICU. Notably, 27% (n = 143) of respondents indicated they had seen one or more children with mTBI and intracranial hemorrhage demonstrate a rapid neurological decline when admitted to a general ward in the last year, and 13% (n = 71) had witnessed this outcome at least twice in the past year. CONCLUSIONS Many physicians endorse ICU admission and repeat neuroimaging for pediatric mTBI with ICI, despite uncertainty regarding the clinical utility of those decisions. These results, combined with evidence that existing practice may provide insufficient monitoring to some high-risk children, emphasize the need for validated decision tools to aid the management of these patients.	[Greenberg, Jacob K.; Berger, Daniel; Limbrick, David D., Jr.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA; [Jeffe, Donna B.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Yan, Yan; Keller, Martin S.; Brownson, Ross C.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Pineda, Jose A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Pineda, Jose A.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Carpenter, Christopher R.] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO USA; [Brownson, Ross C.] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA; [Brownson, Ross C.] Washington Univ, Sch Med, Prevent Res Ctr, St Louis, MO USA; [Lumba-Brown, Angela] Stanford Univ, Dept Emergency Med, Stanford, CA 94305 USA; [Bollo, Robert J.; Ravindra, Vijay M.] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT USA; [Naftel, Robert P.; Dewan, Michael C.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA; [Shah, Manish N.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurosurg, Houston, TX 77030 USA; [Burns, Erin C.] Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA; [O'Neill, Brent R.; Hankinson, Todd C.] Univ Colorado, Sch Med, Dept Neurosurg, Aurora, CO USA; [Whitehead, William E.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Tamber, Mandeep S.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [McDonald, Patrick J.] Univ British Columbia, Div Neurosurg, Vancouver, BC, Canada; [Ahn, Edward S.; Titsworth, William] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [West, Alina N.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA		Greenberg, JK (corresponding author), Washington Univ, St Louis Childrens Hosp, Sch Med, St Louis, MO 63110 USA.	jacobgreenberg@wustl.edu	Adelson, David/W-2083-2019; Jeffe, Donna B./AAI-3732-2020; Tamber, Mandeep/ABF-5085-2020; Pineda, Jose/W-2806-2019	Jeffe, Donna B./0000-0002-7642-3777; Tamber, Mandeep/0000-0003-3329-1011; Yan, Yan/0000-0002-5917-1475	Washington University School of Medicine Faculty Practice Plan [FPP-1501]; Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002345]; St. Louis Children's Hospital Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002345] Funding Source: NIH RePORTER	This work was supported by a grant from the Washington University School of Medicine Faculty Practice Plan (FPP-1501) to Drs. Limbrick, Greenberg, and Brownson. Research reported in this publication was also supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH), as well as funding from the St. Louis Children's Hospital Foundation to Dr. Pineda.	Ament JD, 2017, J NEUROSURG-PEDIATR, V19, P668, DOI 10.3171/2017.2.PEDS16419; American Association for Public Opinion Research, STAND DEF FIN DISP C; Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Berdahl C, 2015, ACAD EMERG MED, V22, P1393, DOI 10.1111/acem.12829; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Bulsara KR, 2015, J NEUROINTERV SURG, V7, P408, DOI 10.1136/neurintsurg-2014-011223; Burns EC, 2016, PEDIAT EMERG CARE; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Chen C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040414; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Dawson EC, 2012, PEDIATR NEUROSURG, V48, P221, DOI 10.1159/000346697; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Finkelhor D, 2015, JAMA PEDIATR, V169, P746, DOI 10.1001/jamapediatrics.2015.0676; Finnerty NM, 2015, ACAD EMERG MED, V22, P1406, DOI 10.1111/acem.12828; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Greenberg JK, 2017, JAMA PEDIATR, V171, P342, DOI 10.1001/jamapediatrics.2016.4520; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Hill EP, 2017, J TRAUMA ACUTE CARE, V82, P896, DOI 10.1097/TA.0000000000001406; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Howe J, 2014, J TRAUMA ACUTE CARE, V76, P292, DOI 10.1097/TA.0000000000000119; JOBE JB, 1990, PUBLIC HEALTH REP, V105, P518; JOBE JB, 1989, AM J PUBLIC HEALTH, V79, P1053, DOI 10.2105/AJPH.79.8.1053; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; Kanzaria HK, 2016, ACAD EMERG MED, V23, P1368, DOI 10.1111/acem.13075; Kanzaria HK, 2015, ACAD EMERG MED, V22, P399, DOI 10.1111/acem.12627; Kelley K, 2003, INT J QUAL HEALTH C, V15, P261, DOI 10.1093/intqhc/mzg031; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kraemer MR, 2017, J NEUROSURG-PEDIATR, V20, P216, DOI 10.3171/2017.2.PEDS16265; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McDonnell WM, 2015, PEDIATR EMERG CARE, V31, P101, DOI 10.1097/PEC.0000000000000349; Natale JE, 2012, ARCH PEDIAT ADOL MED, V166, P732, DOI 10.1001/archpediatrics.2012.307; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Patel SK, 2018, J PEDIAT SURG; Pew Research Center, 2012, ASSESSING REPRESENTA; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Vance CW, 2013, WEST J EMERG MED, V14, P29, DOI 10.5811/westjem.2012.3.6924	42	7	7	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	FEB	2019	23	2					227	235		10.3171/2018.7.PEDS18263			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	HO6BY	WOS:000461014800015	30485194	Bronze, Green Accepted			2022-02-06	
J	Leung, FT; Rahmann, A; Mendis, MD; Smith, MMF; Sonsearay, C; Choy, NL; Hides, JA				Leung, Felix T.; Rahmann, Ann; Mendis, M. Dilani; Smith, Melinda M. Franettovich; Sonsearay, Christine; Choy, Nancy Low; Hides, Julie A.			Vestibulo-ocular dysfunction in adolescent rugby union players with and without a history of concussion	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article						Oculomotor; Sensorimotor; Sports injury; Vestibular	HEAD IMPULSE TEST; NORMATIVE DATA; SPORTS; INJURIES; EPIDEMIOLOGY; VERTIGO	Objectives: Sport-related concussions are common in adolescent contact sports. Vestibulo-ocular dysfunction has been reported in athletes post-concussion. There is a lack of research on vestibulo-ocular function in sporting adolescents, and the influence of previous concussions on the vestibular system in this population. The aim of this study was to investigate vestibulo-ocular function in a cohort of adolescent rugby players with and without a history of concussion during pre-season assessment. Design: Cross-sectional cohort. Methods: 213 male adolescent (13-18 years old) rugby players were recruited from six schools in Queensland, Australia. Vestibulo-ocular assessments were conducted during the preseason and included clinical assessment of oculomotor function and the vestibulo-ocular reflex (VOR) using the clinical and video-Head Impulse Test (HIT). Players were allocated into two groups: no history of concussion in the last 12 months (n = 165); and concussion in the last 12 months (n = 48). Results: There were no between group differences in vestibulo-ocular function for players with and without a history of concussion (p = 0.65). However, vestibulo-ocular dysfunction was reported in 69 (32.7%) of the players tested, who had either abnormal oculomotor control or VOR function. Conclusions: The high prevalence of vestibulo-ocular dysfunction in adolescent rugby players suggests that positive clinical findings post-concussion need to be interpreted carefully in the absence of baseline or pre-concussion assessments.	[Leung, Felix T.; Mendis, M. Dilani; Hides, Julie A.] Griffith Univ, Sch Allied Hlth Sci, 170 Kessels Rd, Nathan, Qld 4111, Australia; [Rahmann, Ann; Sonsearay, Christine; Choy, Nancy Low] Australian Catholic Univ, Sch Physiotherapy, Banyo, Qld 4014, Australia; [Mendis, M. Dilani] Mater Hlth Serv, Physiotherapy Dept, South Brisbane, Qld 4101, Australia; [Smith, Melinda M. Franettovich] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Hides, Julie A.] Mater Hlth Serv, Mater Back Stabil Res Clin, South Brisbane, Qld 4101, Australia		Leung, FT (corresponding author), Griffith Univ, Sch Allied Hlth Sci, 170 Kessels Rd, Nathan, Qld 4111, Australia.	felix.leung@griffithuni.edu.au	Smith, Melinda Franettovich/AAK-1568-2021; Hides, Julie Anne/F-2141-2011	Smith, Melinda Franettovich/0000-0002-0098-7656; Hides, Julie Anne/0000-0002-1830-8121; Rahmann, Ann/0000-0002-5458-2849	Australian National Health and Medical Research Council scholarship [GNT1133186]; Australian Catholic University Research Fund [2013000523]	The authors would like to acknowledge the principals, directors of sport and players from the 6 schools involved for their support and participation in this study. The authors would like to thank the physiotherapists that were involved as part of a larger study during data collection, in particular, Nigel Smith, Margot Sexton, Laura Schwab, Rosemary Parker, Jaz Walsh, Juan da Cal, James Rees, Conor Honeywill, Jordan Craig, Michael Murphy and James Grafton. The authors would also like to thank Jenny Peat, Andrew Cooper and Chris Sexton for their assistance, and physiotherapy students, in particular Liam Codd, Peter Sloss, Joe Kerby, Zac Caughey, Brittany Grantham, Jacob Johannessen, Roneill Prasad and Ben Harris. Felix Leung was supported by an Australian National Health and Medical Research Council scholarship (GNT1133186). This project was funded by a Collaborative Research Network and Australian Catholic University Research Fund (Grant No. 2013000523).	Archbold HAP, 2017, BRIT J SPORT MED, V51, P600, DOI 10.1136/bjsports-2015-095491; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Blodow A, 2013, AURIS NASUS LARYNX, V40, P348, DOI 10.1016/j.anl.2012.11.002; Brodsky J. R., 2018, OTOLARYNGOL HEAD NEC; Charpiot A, 2010, AUDIOL NEURO-OTOL, V15, P203, DOI 10.1159/000255338; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Herdman SJ, 2007, VESTIBULAR REHABILIT; Hides JA, 2017, MUSCULOSKEL SCI PRAC, V29, P7, DOI 10.1016/j.msksp.2017.02.003; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; Honaker JA, 2015, CLIN J SPORT MED, V25, P361, DOI 10.1097/JSM.0000000000000138; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kearney PE, 2017, J SCI MED SPORT, V20, P981, DOI 10.1016/j.jsams.2017.04.019; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Leung FT, 2017, J SPORT SCI, V35, P2088, DOI 10.1080/02640414.2016.1255771; Leung FT, 2017, J SCI MED SPORT, V20, P740, DOI 10.1016/j.jsams.2017.03.006; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Matino-Soler E, 2015, OTOL NEUROTOL, V36, P466, DOI 10.1097/MAO.0000000000000661; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mossman B, 2015, J OTOLARYNGOL-HEAD N, V44, DOI 10.1186/s40463-015-0081-7; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Quatman-Yates CC, 2012, BRIT J SPORT MED, V46, P649, DOI 10.1136/bjsm.2010.079616; Rine RM, 2013, NEUROREHABILITATION, V32, P507, DOI 10.3233/NRE-130873; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Wiener-Vacher SR, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00434; Yard EE, 2006, J ATHL TRAINING, V41, P325; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	35	7	7	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	FEB	2019	39						144	149		10.1016/j.msksp.2018.12.007			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	HI6NV	WOS:000456572900023	30599447				2022-02-06	
J	McLeod, TCV; Cardenas, JF				McLeod, Tamara C. Valovich; Cardenas, Javier F.			Emergency Preparedness of Secondary School Athletic Programs in Arizona	JOURNAL OF ATHLETIC TRAINING			English	Article						emergency action plans; concussions; heat illness; automated external defibrillator; athletic trainer	ASSOCIATION POSITION STATEMENT; PREVENTING SUDDEN-DEATH; CONCUSSION; MANAGEMENT; EDUCATION; STUDENT; CARE	Context: Schools that sponsor athletic programs have an obligation to provide a safe environment with appropriate policies for addressing emergencies. Objective: To describe the emergency preparedness of secondary schools in Arizona specific to emergency action plans (EAPs), cardiac arrest, concussion, and heat illness. Design: Cross-sectional study. Setting: Online survey. Patients or Other Participants: Athletic directors from 143 Arizona secondary schools (response rate = 54%). Intervention(s): A 6-section survey that included questions related to athletic trainer (AT) access, EAPs, automated external defibrillators (AEDs), concussion, heat illness, and other policies. Main Outcome Measure(s): Descriptive statistics were reported. Comparisons of responses between schools with and without AT access were conducted with Mann-Whitney U tests. Results: Most respondents (81%, n = 116) indicated their school had access to an AT, and 95% (n =125) of respondents reported their school had a written EAP. The AEDs were available at most (93%, n =121) schools. All respondents were familiar with the interscholastic concussion policy, and 98% (n = 123) indicated they had a school-specific policy. Almost all respondents (99%, n = 121) reported being familiar with the state heat-illness policy. Environmental measures were taken before practices at 48% (n = 60) of schools. Schools with access to an AT were more likely to have an EAP, venue-specific EAPs, physician approval of EAPs, AEDs, heat-illness policies, and cold-water immersion tubs and to take environmental measures. Conclusions: Whereas the majority of schools reported AT access, not all schools had adequate EAPs in place. Schools would benefit from educational opportunities regarding best practices and policy development to improve emergency preparedness.	[McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Programs, 5850 East Still Circle, Mesa, AZ 85206 USA; [Cardenas, Javier F.] Barrow Neurol Inst, Phoenix, AZ 85013 USA		McLeod, TCV (corresponding author), AT Still Univ, Athlet Training Programs, 5850 East Still Circle, Mesa, AZ 85206 USA.	tmcleod@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			Almquist J, 2008, J ATHL TRAINING, V43, P416, DOI 10.4085/1062-6050-43.4.416; Andersen JC, 2002, J ATHL TRAINING, V37, P99; [Anonymous], PRACT AN; [Anonymous], 2000, CIRCULATION S, V102, P160; [Anonymous], POS STAT SPORTS CONC; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Casa DJ, 2013, J ATHL TRAINING, V48, P546, DOI 10.4085/1062-6050-48.4.12; Casa DJ, 2012, J ATHL TRAINING, V47, P96; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Commission on Accreditation of Athletic Training Education, 2020 STAND ACCR PROF 2020 STAND ACCR PROF; Courson R, 2014, J ATHL TRAINING, V49, P128, DOI 10.4085/1062-6050-49.1.06; Drezner JA, 2009, CIRCULATION, V120, P518, DOI 10.1161/CIRCULATIONAHA.109.855890; Grantham J, 2015, NATA NEWS        MAY, P26; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; Kerr ZY, 2014, MED SCI SPORT EXER, V46, P124, DOI 10.1249/MSS.0b013e3182a11f45; Kucera KL, 1982, CATASTROPHIC SPORTS; Lear A, 2015, J ATHL TRAINING, V50, P1054, DOI 10.4085/1062-6050-50.8.01; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Monroe Anna, 2009, N C Med J, V70, P198; Olympia RP, 2007, PEDIATR EMERG CARE, V23, P703, DOI 10.1097/PEC.0b013e318155adfc; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; The National Federation of State High School Associations, 2014 15 HIGH SCH ATH; Toresdahl B, 2012, BRIT J SPORT MED, V46, P85, DOI 10.1136/bjsports-2012-091447; Toresdahl BG, 2013, J ATHL TRAINING, V48, P242, DOI 10.4085/1062-6050-48.1.20; US Dept of Health and Human Services: Assistant Secretary for Planning and Evaluation, PHYS ACT FUND PREV D; Wasilko SM, 2013, SPORTS HEALTH, V5, P548, DOI 10.1177/1941738113484250; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482	32	7	7	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2019	54	2					133	141		10.4085/1062-6050-35-18			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HR9YS	WOS:000463518100004	30517023	Green Published, gold			2022-02-06	
J	Pandamooz, S; Salehi, MS; Zibaii, MI; Safari, A; Nabiuni, M; Ahmadiani, A; Dargahi, L				Pandamooz, Sareh; Salehi, Mohammad Saied; Zibaii, Mohammad Ismail; Safari, Anahid; Nabiuni, Mohammad; Ahmadiani, Abolhassan; Dargahi, Leila			Modeling traumatic injury in organotypic spinal cord slice culture obtained from adult rat	TISSUE & CELL			English	Article						Spinal cord; Organotypic culture; Traumatic injury; Ex vivo	NEURAL PROGENITOR CELLS; IN-VITRO MODEL; VALPROIC ACID; AXON GROWTH; NEURONS; DAMAGE; NEUROPROTECTION; DEGENERATION; NEUROTRAUMA; INHIBITORS	Nowadays there are various models of spinal cord injury (SCI) that recreate mechanisms of human SCI. The ex vivo modeling of injury is a robust approach, confronts with less experimental and ethical challenges. Currently almost all ex vivo models are obtained either from embryonic or postnatal animals, which can hardly mimic features of human SCI. This study was designed to develop SCI in slice culture of adult rats. Here, the lumbar enlargement of an adult rat was sliced and cultured. After seven days in vitro, a weight was dropped to simulate the injury. The result showed that although the rate of cell death in first days of in vitro was high, it reduced after 7 days and dropping a weight at the time caused significant rate of cell death in slices. It was shown that injury can disturb histological features and neuronal integrity in the slices. Treating the injured slices with valproic acid resulted in a significant decrease of TNF-a and increase of BDNF expression. Collected data revealed obtained slices from adult rat were able to adjust to the culture environment after 7 days and dropping a weight at the time point could simulate the injury. Besides mimicking the disturbing features of human SCI, this model can response to VPA pharmacological treatment.	[Pandamooz, Sareh; Salehi, Mohammad Saied; Ahmadiani, Abolhassan] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Salehi, Mohammad Saied] Shiraz Univ Med Sci, Clin Neurol Res Ctr, Shiraz, Iran; [Zibaii, Mohammad Ismail] Shahid Beheshti Univ, Laser & Plasma Res Inst, Tehran, Iran; [Safari, Anahid] Shiraz Univ Med Sci, Stem Cells Technol Res Ctr, Shiraz, Iran; [Nabiuni, Mohammad] Kharazmi Univ, Fac Biol Sci, Dept Anim Biol, Tehran, Iran; [Dargahi, Leila] Shahid Beheshti Univ Med Sci, NeuroBiol Res Ctr, Tehran 196151178, Iran		Dargahi, L (corresponding author), Shahid Beheshti Univ Med Sci, NeuroBiol Res Ctr, Tehran 196151178, Iran.	l.dargahi@sbmu.ac.ir	Salehi, Mohammad Saied/AAQ-5519-2021; Dargahi, Leila/K-4693-2017; Ahmadiani, Abolhassan/AAP-9004-2021; Safari, Anahid/Q-8432-2018; Pandamooz, Sareh/ABC-6229-2021	Dargahi, Leila/0000-0001-7777-5435; Safari, Anahid/0000-0001-8272-291X; pandamooz, sareh/0000-0002-6877-7102; Salehi, Mohammad Saied/0000-0002-3535-1578; Nabiuni, Mohammad/0000-0002-0349-6676	Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran [A-A-915-1393]	This work was supported by the Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, under Grant No. A-A-915-1393. The authors wish to thank Mr. H. Argasi at the Research Consultation Center (RCC) of Shiraz University of Medical Sciences for his invaluable assistance in editing this manuscript.	Abu-Rub M, 2010, DRUG DISCOV TODAY, V15, P436, DOI 10.1016/j.drudis.2010.03.008; BALENTINE JD, 1988, LAB INVEST, V58, P93; Boomkamp SD, 2012, GLIA, V60, P441, DOI 10.1002/glia.22278; Byrnes KR, 2010, J MAGN RESON IMAGING, V32, P836, DOI 10.1002/jmri.22323; Cavaliere F, 2010, J NEUROSCI METH, V188, P205, DOI 10.1016/j.jneumeth.2010.02.008; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; Chen S, 2014, NEUROCHEM RES, V39, P1621, DOI 10.1007/s11064-014-1241-2; Cheriyan T, 2014, SPINAL CORD, V52, P588, DOI 10.1038/sc.2014.91; Chu TC, 2015, REGEN MED, V10, P193, DOI [10.2217/RME.14.86, 10.2217/rme.14.86]; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Daviaud N, 2014, NEUROSCIENCE, V256, P10, DOI 10.1016/j.neuroscience.2013.10.021; Daviaud N, 2013, EXP NEUROL, V248, P429, DOI 10.1016/j.expneurol.2013.07.012; Davids E, 2002, EUR NEUROPSYCHOPHARM, V12, P201, DOI 10.1016/S0924-977X(02)00024-X; De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228; Esposito E, 2012, SPINE, V37, pE73, DOI 10.1097/BRS.0b013e3182276d88; Esposito E, 2011, TRENDS PHARMACOL SCI, V32, P107, DOI 10.1016/j.tips.2010.11.009; Fernandez-Zafra T., 2017, EXP CELL RES; Freund P, 2013, NEUROSCIENTIST, V19, P116, DOI 10.1177/1073858412449192; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Hamasaki T, 2007, SPINE, V32, P2300, DOI 10.1097/BRS.0b013e318154c651; Ichiyama T, 2000, BRAIN RES, V857, P246, DOI 10.1016/S0006-8993(99)02439-7; Inman DM, 2003, J COMP NEUROL, V462, P431, DOI 10.1002/cne.10768; Kamei N, 2007, SPINE, V32, P1272, DOI 10.1097/BRS.0b013e318059afab; Kim Hyuk Min, 2010, Exp Neurobiol, V19, P106, DOI 10.5607/en.2010.19.2.106; Kjell J, 2016, DIS MODEL MECH, V9, P1125, DOI 10.1242/dmm.025833; Krassioukov AV, 2002, BRAIN RES PROTOC, V10, P60, DOI 10.1016/S1385-299X(02)00180-0; Labombarda F, 2013, NEUROPHARMACOLOGY, V71, P46, DOI 10.1016/j.neuropharm.2013.03.010; Leng Y, 2008, J NEUROSCI, V28, P2576, DOI 10.1523/JNEUROSCI.5467-07.2008; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; Lukovic D., 2015, SCI REP, V5; Lv L, 2012, EXP NEUROL, V233, P783, DOI 10.1016/j.expneurol.2011.11.042; Ma MH, 2001, EXP NEUROL, V169, P239, DOI 10.1006/exnr.2001.7679; Mazzone GL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.431; Mazzone GL, 2010, NEUROSCIENCE, V168, P451, DOI 10.1016/j.neuroscience.2010.03.055; Mazzone GL, 2014, J NEUROCHEM, V130, P598, DOI 10.1111/jnc.12748; Mazzone GL, 2011, J NEUROSCI METH, V197, P128, DOI 10.1016/j.jneumeth.2011.01.033; Mladinic M., 2013, FRONTIERS NEUROENGIN, P6; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Pandamooz S, 2017, J SPINAL CORD MED, V40, P100, DOI 10.1080/10790268.2016.1213518; Pandamooz S, 2016, MOL NEUROBIOL, V53, P4659, DOI 10.1007/s12035-015-9403-z; Park HW, 2010, GLIA, V58, P1118, DOI 10.1002/glia.20992; Shoichet Molly S., 2008, P221; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Su Y., 2015, SPINAL CORD; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Sypecka J, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/471216; Taccola G, 2008, NEUROSCIENCE, V155, P538, DOI 10.1016/j.neuroscience.2008.06.008; Talac R, 2004, BIOMATERIALS, V25, P1505, DOI 10.1016/S0142-9612(03)00497-6; Weightman AP, 2014, BIOMATERIALS, V35, P3756, DOI 10.1016/j.biomaterials.2014.01.022; York EM, 2013, NEUROTHERAPEUTICS, V10, P757, DOI 10.1007/s13311-013-0228-z	52	7	7	2	6	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0040-8166			TISSUE CELL	Tissue Cell	FEB	2019	56						90	97		10.1016/j.tice.2019.01.002			8	Anatomy & Morphology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Cell Biology	HK8XM	WOS:000458273000012	30736910				2022-02-06	
J	Spano, M; Risucci, DA; Etienne, M; Petersen, KH				Spano, Matthew; Risucci, Donald A.; Etienne, Mill; Petersen, Kristina H.			Epidemiology of Sports Related Concussion in Brazilian Jiu-Jitsu: A Cross-Sectional Study	SPORTS			English	Article						Brazilian Jiu-Jitsu; BJJ; concussion; sport-related concussion; martial arts	HIGH-SCHOOL; COLLEGIATE; SYMPTOMS	Brazilian Jiu-Jitsu (BJJ) is a rapidly growing grappling sport with a wide spectrum of participants. This cross-sectional study examined the lifetime prevalence of concussion in adult BJJ practitioners in the United States using a 17-item survey. A total of 778 (11.4% female) BJJ practitioners with a median age of 31 years completed the survey. Overall, the lifetime prevalence of the self-reported BJJ-related concussion was 25.2%. However, the prevalence was higher among females than males (43.0% versus 22.9%; X-2(1,740) = 15.129; p < 0.001). Factors independently associated with significantly increased odds of having sustained a BJJ-related concussion included a prior history of concussion (OR 1.76, 95% CI 1.14-2.74; p = 0.011) and female gender (OR 1.95, 95% CI 1.04-3.65; p = 0.037). The median return to sports time was three days, with 30.3% of participants returning on the same day as being concussed. The present study represents the first epidemiological research examining the concussions in BJJ. The results underscore the need for increased education on concussions and return to sports guidelines among BJJ coaches and practitioners.	[Spano, Matthew] New York Med Coll, Dept Undergrad Med Educ, Valhalla, NY 10595 USA; [Risucci, Donald A.] New York Med Coll, Dept Undergrad Med Educ, New York, NY 10595 USA; [Risucci, Donald A.] New York Med Coll, Dept Surg, New York, NY 10595 USA; [Etienne, Mill] New York Med Coll, Dept Neurol, New York, NY 10595 USA; [Petersen, Kristina H.] New York Med Coll, Dept Biochem & Mol Biol, New York, NY 10595 USA		Spano, M (corresponding author), New York Med Coll, Dept Undergrad Med Educ, Valhalla, NY 10595 USA.	Matthew.a.spano@gmail.com; Donald_Risucci@nymc.edu; Mill_Etienne@nymc.edu; K_HarrisPetersen@nymc.edu					Barreto A.P., 2017, J EXERC PHYSL, V20, P10; Bell L., 2014, SELF REPORTED CONCUS; Blumenfeld RS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00098; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; das Gracas D, 2017, BMC SPORTS SCI MED R, V9, DOI 10.1186/s13102-017-0080-2; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Lopez V., 2017, J SCI MED SPORT, V20, P63, DOI [10.1016/j.jsams.2017.09.320, DOI 10.1016/J.JSAMS.2017.09.320]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDonald AR, 2017, SPORTS, V5, DOI 10.3390/sports5020039; Scoggin JF, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114522184; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	19	7	7	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2075-4663			SPORTS	Sports	FEB	2019	7	2							53	10.3390/sports7020053			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	HN6VK	WOS:000460324200010	30823550	gold, Green Published, Green Submitted			2022-02-06	
J	Unnerback, M; Bloomfield, EL; Soderstrom, S; Reinstrup, P				Unnerbaeck, Marten; Bloomfield, Eric L.; Soederstroem, Sven; Reinstrup, Peter			The intracranial pressure curve correlates to the pulsatile component of cerebral blood flow	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Cerebral blood flow; Phase contrast magnetic resonance imaging; Intracranial pressure; Mathematical analysis; Monitoring	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; MAGNETIC-RESONANCE; PULSE; MANAGEMENT; AMPLITUDE; DYNAMICS; MRI; ICP	Current methods to measure cerebral blood flow (CBF) in the neuro critical care setting cannot monitor the CBF continuously. In contrast, continuous measurement of intracranial pressure (ICP) is readily accomplished, and there is a component of ICP that correlates with arterial inflow of blood into the cranial cavity. This property may have utility in using continuous ICP curve analysis to continuously estimate CBF. We examined the data from 13 patients, monitored with an intraventricular ICP device determining the pulsatile amplitude ICPamp as well as the area under the ICP curve (AUC(ICP)). Using an elastance measurement, the ICP curve was converted to craniospinal volume (AUC(Delta V)). The patients were examined with Phase Contrast Magnetic Resonance Imaging (MRI), measuring flow in the carotid and vertebral arteries. This made it possible to calculate CBF for one cardiac cycle (ccCBF(MRtot)) and divide it into the pulsatile (ccCBF(MRpuls)) and non-pulsatile (ccCBF(MRconst)) flow. ICP derived data and MRI measurements were compared. Linear regression was used to establish wellness of fit and ANOVA was used to calculate the P value. No correlation was found between ICPamp and the ccICP(MRpuls) (P = 0.067). In contrast there was a correlation between the AUC(ICP) and ccCBF(MRpuls) (R-2 = 0.440 P = 0.013). The AUC(Delta V) correlated more appropriately with the ccCBF(MRpuls). (R-2 = 0.688 P < 0.001). Our findings suggests that the pulsatile part of the intracranial pressure curve, especially when transformed into a volume curve, correlates to the pulsatile part of the CBF.	[Unnerbaeck, Marten] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Intens Care & Perioperat Med, Malmo, Sweden; [Bloomfield, Eric L.] Mayo Clin, Dept Anesthesiol CCM, Rochester, MN USA; [Soederstroem, Sven; Reinstrup, Peter] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Neurosurg, Lund, Sweden; [Unnerbaeck, Marten] IPV SUS Malmo, Inga Marie Nilssons Gata 47, S-20502 Malmo, Sweden		Unnerback, M (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Intens Care & Perioperat Med, Malmo, Sweden.; Unnerback, M (corresponding author), IPV SUS Malmo, Inga Marie Nilssons Gata 47, S-20502 Malmo, Sweden.	Marten.Unnerback@skane.se	Unnerback, Marten/AAX-4210-2021		Department of Intensive and Perioperative Care, Skanes University Hospital; Swedish National Training and Research Fund, Region Skane [48451]	This study received financial support from the Department of Intensive and Perioperative Care, Skanes University Hospital and the Swedish National Training and Research Fund, Region Skane, Grant No. 48451.	AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; Alperin N, 2005, J MAGN RESON IMAGING, V22, P591, DOI 10.1002/jmri.20427; Alperin N, 2005, J NEUROSURG, V103, P46, DOI 10.3171/jns.2005.103.1.0046; Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; ANILE C, 1987, NEUROSURGERY, V20, P389, DOI 10.1227/00006123-198703000-00006; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Baledent O, 2001, INVEST RADIOL, V36, P368, DOI 10.1097/00004424-200107000-00003; Bhadelia RA, 1997, NEURORADIOLOGY, V39, P258, DOI 10.1007/s002340050404; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; BRYANT DJ, 1984, J COMPUT ASSIST TOMO, V8, P588, DOI 10.1097/00004728-198408000-00002; Carmelo A, 2002, Acta Neurochir Suppl, V81, P112; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; Hu X, 2010, PHYSIOL MEAS, V31, P679, DOI 10.1088/0967-3334/31/5/006; Inao S, 1997, NEUROL RES, V19, P35; Koerte I, 2013, J MAGN RESON IMAGING, V38, P655, DOI 10.1002/jmri.24013; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P557; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MARKS MP, 1992, RADIOLOGY, V182, P467, DOI 10.1148/radiology.182.2.1732966; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Muller LO, 2014, J BIOMECH, V47, P3361, DOI 10.1016/j.jbiomech.2014.08.005; Piper I, 1999, BRIT J NEUROSURG, V13, P581, DOI 10.1080/02688699943097; Poon WS, 2005, ACT NEUR S, V95, P9; RYDER HW, 1953, J LAB CLIN MED, V41, P428; Unnerback M, 2018, ACTA NEUROCHIR, V160, P219, DOI 10.1007/s00701-017-3435-2	28	7	7	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	FEB	2019	33	1					77	83		10.1007/s10877-018-0129-0			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	HG2UH	WOS:000454820400010	29549499	Green Published, hybrid			2022-02-06	
J	Pakkanen, T; Nurmi, J; Huhtala, H; Silfvast, T				Pakkanen, Toni; Nurmi, Jouni; Huhtala, Heini; Silfvast, Tom			Prehospital on-scene anaesthetist treating severe traumatic brain injury patients is associated with lower mortality and better neurological outcome	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Prehospital emergency care (MeSH); Emergency medical services (MeSH); Critical care (MeSH); Traumatic brain injury (MeSH); Airway management (MeSH); Endotracheal intubation (MeSH); Patient outcome assessment (MeSH); Glasgow outcome scale (MeSH)	EMERGENCY MEDICAL-SERVICES; SYSTOLIC BLOOD-PRESSURE; COMA SCALE SCORE; HYPOTENSION; INTUBATION; MANAGEMENT; ADMISSION; EPIDEMIOLOGY; GUIDELINES; SURVIVAL	Background: Patients with isolated traumatic brain injury (TBI) are likely to benefit from effective prehospital care to prevent secondary brain injury. Only a few studies have focused on the impact of advanced interventions in TBI patients by prehospital physicians. The primary end-point of this study was to assess the possible effect of an on-scene anaesthetist on mortality of TBI patients. A secondary end-point was the neurological outcome of these patients. Methods: Patients with severe TBI (defined as a head injury resulting in a Glasgow Coma Score of <= 8) from 2005 to 2010 and 2012-2015 in two study locations were determined. Isolated TBI patients transported directly from the accident scene to the university hospital were included. A modified six-month Glasgow Outcome Score (GOS) was defined as death, unfavourable outcome (GOS 2-3) and favourable outcome (GOS 4-5) and used to assess the neurological outcomes. Binary logistic regression analysis was used to predict mortality and good neurological outcome. The following prognostic variables for TBI were available in the prehospital setting: age, on-scene GCS, hypoxia and hypotension. As per the hypothesis that treatment provided by an on-scene anaesthetist would be beneficial to TBI outcomes, physician was added as a potential predictive factor with regard to the prognosis. Results: The mortality data for 651 patients and neurological outcome data for 634 patients were available for primary and secondary analysis. In the primary analysis higher age (OR 1.06 CI 1.05-1.07), lower on-scene GCS (OR 0.85 CI 0.79-0.92) and the unavailability of an on-scene anaesthetist (OR 1.89 CI 1.20-2.94) were associated with higher mortality together with hypotension (OR 3.92 CI 1.08-14.23). In the secondary analysis lower age (OR 0.95 CI 0.94-0.96), a higher on-scene GCS (OR 1.21 CI 1.20-1.30) and the presence of an on-scene anaesthetist (OR 1.75 CI 1.09-2.80) were demonstrated to be associated with good patient outcomes while hypotension (OR 0.19 CI 0.04-0.82) was associated with poor outcome. Conclusion: Prehospital on-scene anaesthetist treating severe TBI patients is associated with lower mortality and better neurological outcome.	[Pakkanen, Toni] FinnHEMS Ltd, Res & Dev Unit, Vantaa, Finland; [Pakkanen, Toni] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Nurmi, Jouni] Helsinki Univ Hosp, Emergency Med & Serv, Helsinki, Finland; [Nurmi, Jouni] Univ Helsinki, Dept Emergency Med, Helsinki, Finland; [Huhtala, Heini] Univ Tampere, Fac Social Sci, Tampere, Finland; [Silfvast, Tom] Univ Helsinki, Helsinki Univ Hosp, Dept Anaesthesia & Intens Care, Helsinki, Finland		Pakkanen, T (corresponding author), FinnHEMS Ltd, Res & Dev Unit, Vantaa, Finland.; Pakkanen, T (corresponding author), Univ Tampere, Fac Med & Life Sci, Tampere, Finland.	toni.pakkanen@fimnet.fi			FinnHEMS ltd, Research and Development Unit	This study was supported by a study grant from FinnHEMS ltd, Research and Development Unit.	Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Botker MT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-12; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; de Jongh MAC, 2012, INJURY, V43, P1362, DOI 10.1016/j.injury.2012.01.009; Frankema SPG, 2004, BRIT J SURG, V91, P1520, DOI 10.1002/bjs.4756; Franschman G, 2012, INJURY, V43, P1838, DOI 10.1016/j.injury.2012.05.020; Fuller G, 2014, INJURY, V45, P612, DOI 10.1016/j.injury.2013.09.008; Garner AA, 2015, EMERG MED J, V32, P869, DOI 10.1136/emermed-2014-204390; Gellerfors M, 2018, BRIT J ANAESTH, V120, P1103, DOI 10.1016/j.bja.2017.12.036; JENNETT B, 1975, LANCET, V1, P480; KOTWICA Z, 1995, ACTA NEUROCHIR, V133, P56, DOI 10.1007/BF01404948; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Pakkanen T, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0438-1; Pakkanen T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0256-x; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rakier A., 1995, Harefuah, V128, P474; Rakier A, 1995, HAREFUAH, V128, P528; Ringburg AN, 2007, J TRAUMA, V63, P258, DOI 10.1097/01.ta.0000240449.23201.57; Ringburg Akkie N, 2009, Air Med J, V28, P298, DOI 10.1016/j.amj.2009.03.007; Sadaka F, 2018, AM J EMERG MED, V36, P1624, DOI 10.1016/j.ajem.2018.01.051; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Traumatic Brain Injury, 2017, CURR CAR GUID; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008	43	7	7	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JAN 28	2019	27								9	10.1186/s13049-019-0590-x			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HK7UD	WOS:000458194300001	30691530	Green Published, gold			2022-02-06	
J	Aldossary, NM; Kotb, MA; Kamal, AM				Aldossary, Nasser M.; Kotb, Mamdouh Ali; Kamal, Ahmed M.			Predictive value of early MRI findings on neurocognitive and psychiatric outcomes in patients with severe traumatic brain injury	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Brain injury; Diffuse axonal injury; Neurocognitive; Psychiatric outcome	DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; MAGNETIC-RESONANCE; PROGNOSTIC VALUE; STEM INJURY; POSTTRAUMATIC AMNESIA; MODERATE; LESIONS; CLASSIFICATION; REHABILITATION	Background: Traumatic brain injury (TBI) is the major public health problem worldwide, particularly in the Middle East. Diffuse axonal injury (DAI) is commonly found in TBI. Although DAI can lead to physical and psychosocial disabilities, its prognostic value is still a matter of debate. Magnetic Resonance (MR) is more sensitive for detecting DAI lesions. Objective: To identify the radiological and clinical factors associated with the functional capacity one year after the traumatic brain injury. Methods: The study included 251 patients with severe head trauma for whom Brain MRI was done within one month after injury. Demographic, clinical, and radiological data were collected during hospitalization. Neurocognitive and psychiatric evaluation were done one year thereafter. Results: DAI was more frequent in our patients. Psychiatric disorders, cognitive impairment, and poor functional outcome were more common in patients with DAI especially those with cerebral hemisphere and brain stem lesion, and mixed lesions. Duration of post traumatic amnesia (DPTA), lost consciousness and hospital stay (DHS) as well as the volume of diffuse axonal injury (DAI) were associated with poor neurocognitive outcome. DPTA, and DAIV may be considered independent factors that could predict the neurocognitive outcome. Conclusion: MRI following traumatic brain injury yields important prognostic information, with several lesion patterns significantly associated with poor long-term neurocognitive and psychiatric outcomes.	[Aldossary, Nasser M.] Prince Sattam Bin AbdulAziz Univ, Coll Med, Radiol Dept, POB 173, Alkharj 11942, Saudi Arabia; [Kotb, Mamdouh Ali] Prince Sattam Bin AbdulAziz Univ, Coll Med, Neurol Dept, Alkharj, Saudi Arabia; [Kotb, Mamdouh Ali] Menia Univ, Fac Med, Neurol Dept, Al Minya, Egypt; [Kamal, Ahmed M.] Prince Sattam Bin AbdulAziz Univ, Coll Med, Psychiat Dept, Alkharj, Saudi Arabia; [Kamal, Ahmed M.] Menia Univ, Fac Med, Psychiat Dept, Al Minya, Egypt		Aldossary, NM (corresponding author), Prince Sattam Bin AbdulAziz Univ, Coll Med, Radiol Dept, POB 173, Alkharj 11942, Saudi Arabia.	nasseraldossary2018@gmail.com	Kotb, Mamdouh/AAA-5108-2021	Kotb, Mamdouh/0000-0001-7049-1237			Aguas J, 2005, NEUROCIRUGIA, V16, P14; Bhatoe HS, 1999, ACTA NEUROCHIR, V141, P515, DOI 10.1007/s007010050333; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; Chaudhury S, 2005, INDIAN J NEUROTRAUM, V2, P13, DOI 10.1016/S0973-0508(05)80005-X; Cicuendez M, 2017, ACTA NEUROCHIR, V159, P25, DOI 10.1007/s00701-016-3000-4; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Dilley M., 2011, PSYCHIAT DISORD WORL; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Fleminger S., 2010, PSYCHIAT TIMES; GENTRY LR, 1994, RADIOLOGY, V191, P1; Giugni E, 2005, AM J NEURORADIOL, V26, P1140; HASHIMOTO T, 1993, NEUROSURG REV, V16, P291, DOI 10.1007/BF00383839; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Hoelper BM, 2000, ACTA NEUROCHIR SUPPL, V76, P21; Humble S. S., 2018, J TRAUMA ACUTE CARE; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Lagares A, 2006, NEUROCIRUGIA, V17, P105; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; MRC CRASH Trial National Coordinators, 2003, Curr Opin Crit Care, V9, P92; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Pelegrin-Valero C, 2001, REV NEUROLOGIA, V32, P681, DOI 10.33588/rn.3207.2000180; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schwarzbold M., 2008, NEUROPSYCHIATR DIS T; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Tang YP, 1997, EUR J NEUROSCI, V9, P1720, DOI 10.1111/j.1460-9568.1997.tb01529.x; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; von Wild KRH, 2008, ACT NEUR S, V101, P55; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107	49	7	8	0	50	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	JAN 15	2019	243						1	7		10.1016/j.jad.2018.09.001			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	GW4DE	WOS:000446860300001	30218878				2022-02-06	
J	Nasi, D; di Somma, L; Gladi, M; Moriconi, E; Scerrati, M; Iacoangeli, M; Dobran, M				Nasi, Davide; di Somma, Lucia; Gladi, Maurizio; Moriconi, Elisa; Scerrati, Massimo; Iacoangeli, Maurizio; Dobran, Mauro			New or Blossoming Hemorrhagic Contusions After Decompressive Craniectomy in Traumatic Brain Injury: Analysis of Risk Factors	FRONTIERS IN NEUROLOGY			English	Article						decompressive craniectomy; traumatic brain injury; hemorrhagic contusion; expansion of hemorrhagic contusions; acute subdural hematoma	HEAD-INJURY	Background: The development or expansion of a cerebral hemorrhagic contusion after decompressive craniectomy (DC) for traumatic brain injury (TBI) occurs commonly and it can result in an unfavorable outcome. However, risk factors predicting contusion expansion after DC are still uncertain. The aim of this study was to identify the factors associated with the growth or expansion of hemorrhagic contusion after DC in TBI. Then we evaluated the impact of contusion progression on outcome. Methods: We collected the data of patients treated with DC for TBI in our Center. Then we analyzed the risk factors associated with the growth or expansion of a hemorrhagic contusion after DC. Results: 182 patients (149 males and 41 females) were included in this study. Hemorrhagic contusions were detected on the initial CT scan or in the last CT scan before surgery in 103 out of 182 patients. New or blossoming hemorrhagic contusions were registered after DC in 47 patients out of 182 (25.82%). At multivariate analysis, only the presence of an acute subdural hematoma (p = 0.0076) and a total volume of contusions >20 cc before DC (p = < 0.0001) were significantly associated with blossoming contusions. The total volume of contusions before DC resulted to have higher accuracy and ability to predict postoperative blossoming of contusion with strong statistical significance rather than the presence of acute subdural hematoma (these risk factors presented respectively an area under the curve [AUC] of 0.896 vs. 0.595; P < 0.001). Patients with blossoming contusions presented an unfavorable outcome compared to patients without contusion progression (p < 0.0185). Conclusions: The presence of an acute subdural hematoma was associated with an increasing rate of new or expanded hemorrhagic contusions after DC. The total volume of hemorrhagic contusions > 20 cc before surgery was an independent and extremely accurate predictive radiological sign of contusion blossoming in decompressed patients for severe TBI. After DC, the patients who develop new or expanding contusions presented an increased risk for unfavorable outcome.	[Nasi, Davide; di Somma, Lucia; Gladi, Maurizio; Moriconi, Elisa; Scerrati, Massimo; Iacoangeli, Maurizio; Dobran, Mauro] Univ Politecn Marche, Dept Neurosurg, Umberto I Gen Hosp, Ancona, Italy		Nasi, D (corresponding author), Univ Politecn Marche, Dept Neurosurg, Umberto I Gen Hosp, Ancona, Italy.	davidenasi83@gmail.com					Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; di Somma Lucia, 2016, Surg Neurol Int, V7, pS12, DOI 10.4103/2152-7806.173561; Dobran M, 2017, G CHIR, V38, P124, DOI 10.11138/gchir/2017.38.3.124; Dobran M, 2017, Surg Neurol Int, V8, P212, DOI 10.4103/sni.sni_222_17; Dobran Mauro, 2017, BMJ Case Rep, V2017, DOI 10.1136/bcr-2017-220792; Dobran M, 2016, WORLD NEUROSURG, V96, P152, DOI 10.1016/j.wneu.2016.08.100; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iaccarino C, 2013, CLIN NEUROL NEUROSUR, V115, P2207, DOI 10.1016/j.clineuro.2013.06.004; Iaccarino C, 2010, ACTA NEUROCHIR, V152, P1189, DOI 10.1007/s00701-010-0639-0; Iacoangeli M, 2016, NEUROL MED-CHIR, V56, P180, DOI 10.2176/nmc.oa.2015-0242; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Nasi D, 2018, ACTA NEUROCHIR, V160, P2127, DOI 10.1007/s00701-018-3688-4; Nasi D, 2018, ACTA NEUROCHIR, V160, P1691, DOI 10.1007/s00701-018-3639-0; Nasi D, 2018, WORLD NEUROSURG, V116, pE543, DOI 10.1016/j.wneu.2018.05.028; Nasi D, 2016, WORLD NEUROSURG, V91, DOI 10.1016/j.wneu.2016.04.041; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Szczygielski J, 2016, J NEUROTRAUM, V33, P122, DOI 10.1089/neu.2014.3835; Wang JL, 2021, J NEUROSURG SCI, V65, P69, DOI 10.23736/S0390-5616.17.04123-6	25	7	7	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 15	2019	9								01186	10.3389/fneur.2018.01186			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HH4TE	WOS:000455717700001	30697186	gold, Green Published			2022-02-06	
J	Konstantinou, N; Pettemeridou, E; Stamatakis, EA; Seimenis, I; Constantinidou, F				Konstantinou, Nikos; Pettemeridou, Eva; Stamatakis, Emmanuel A.; Seimenis, Ioannis; Constantinidou, Fofi			Altered Resting Functional Connectivity Is Related to Cognitive Outcome in Males With Moderate-Severe Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; resting state; functional connectivity; cognitive outcome; intrinsic connectivity contrast	WHITE-MATTER INJURY; CLOSED-HEAD-INJURY; WORKING-MEMORY; ADDITIONAL EVIDENCE; DEFAULT NETWORK; VERBAL FLUENCY; CELL-DEATH; DEFICITS; RECOVERY; ATTENTION	TBI results in significant cognitive impairments and in altered brain functional connectivity. However, no studies explored so far, the relationship between global functional connectivity and cognitive outcome in chronic moderate-severe TBI. This proof of principle study employed the intrinsic connectivity contrast, an objective voxel-based metric of global functional connectivity, in a small sample of chronic moderate-severe TBI participants and a group of healthy controls matched on gender (males), age, and education. Cognitive tests assessing executive functions, verbal memory, visual memory, attention/organization, and cognitive reserve were administered. Group differences in terms of global functional connectivity maps were assessed and the association between performance on the cognitive measures and global functional connectivity was examined. Next, we investigated the spatial extent of functional connectivity in the brain regions found to be associated with cognitive performance, using traditional seed-based analyses. Global functional connectivity of the TBI group was altered, compared to the controls. Moreover, the strength of global functional connectivity in affected brain areas was associated with cognitive outcome. These findings indicate that impaired global functional connectivity is a significant consequence of TBI suggesting that cognitive impairments following TBI may be partly attributed to altered functional connectivity between brain areas involved in the specific cognitive functions.	[Konstantinou, Nikos] Cyprus Univ Technol, Dept Rehabil Sci, Limassol, Cyprus; [Pettemeridou, Eva; Constantinidou, Fofi] Univ Cyprus, Ctr Appl Neurosci, Nicosia, Cyprus; [Pettemeridou, Eva; Constantinidou, Fofi] Univ Cyprus, Dept Psychol, Nicosia, Cyprus; [Stamatakis, Emmanuel A.] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Seimenis, Ioannis] Democritus Univ Thrace, Med Phys Lab, Med Sch, Alexandroupolis, Greece		Konstantinou, N (corresponding author), Cyprus Univ Technol, Dept Rehabil Sci, Limassol, Cyprus.	nikos.konstantinou@cut.ac.cy	Seimenis, Ioannis/AAF-4406-2021	Seimenis, Ioannis/0000-0003-3665-5271; Konstantinou, Nikos/0000-0003-4531-3636; PETTEMERIDOU, EVA/0000-0001-5081-0042	Cyprus Research Promotion Foundation - Cyprus Government; European Regional Development FundEuropean Commission [NEWINFRASTRUCTURE/STRATEGIC/0309/37]	This work was supported by the Cyprus Research Promotion Foundation through a grant co-funded by the Cyprus Government and the European Regional Development Fund (FC, PI; NEWINFRASTRUCTURE/STRATEGIC/0309/37).	Alho K, 2015, BRAIN RES, V1626, P136, DOI 10.1016/j.brainres.2014.12.050; [Anonymous], 2013, DIAGN STAT MAN MENT, DOI 10.1176/appi.books.9780890425596; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bennett ER, 2016, GENETIC INFLUENCES T; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2015, BRAIN CONNECT, V5, P423, DOI 10.1089/brain.2014.0293; Caravasso CF, 2016, J NEUROTRAUM, V33, P1247, DOI 10.1089/neu.2015.4003; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chase S, 2012, HEALTH CARE WOMEN IN, V33, P631, DOI 10.1080/07399332.2012.673652; Chen Q, 2009, CEREB CORTEX, V19, P805, DOI 10.1093/cercor/bhn128; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Clement F, 2013, CORTEX, V49, P1268, DOI 10.1016/j.cortex.2012.06.004; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; Constantinidou F, 2012, CHILD NEUROPSYCHOL, V18, P256, DOI 10.1080/09297049.2011.602013; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dunn D. M., 2007, PEABODY PICTURE VOCA; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Feredoes E, 2007, J NEUROSCI, V27, P11003, DOI 10.1523/JNEUROSCI.1573-07.2007; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gaillard WD, 2003, HUM BRAIN MAPP, V18, P176, DOI 10.1002/hbm.10091; Gerlach KD, 2011, NEUROIMAGE, V55, P1816, DOI 10.1016/j.neuroimage.2011.01.030; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Konstantinou N, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00029; Kosmidis MH, 2004, J INT NEUROPSYCH SOC, V10, P164, DOI 10.1017/S1355617704102014; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Martuzzi R, 2011, NEUROIMAGE, V58, P1044, DOI 10.1016/j.neuroimage.2011.06.075; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McGugin RW, 2015, CEREB CORTEX, V25, P2610, DOI 10.1093/cercor/bhu060; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Meyers JE., 1995, REY COMPLEX FIGURE T; Moreno-Lopez L, 2016, BRAIN INJURY, V30, P1319, DOI 10.1080/02699052.2016.1186839; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Pallesen KJ, 2009, J COGNITIVE NEUROSCI, V21, P1065, DOI 10.1162/jocn.2009.21086; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; Perry RJ, 2000, BRAIN, V123, P2273, DOI 10.1093/brain/123.11.2273; Persson J, 2013, J COGNITIVE NEUROSCI, V25, P338, DOI 10.1162/jocn_a_00321; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Postle BR, 2007, CEREB CORTEX, V17, P2151, DOI 10.1093/cercor/bhl123; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Rahm B, 2014, NEUROIMAGE, V90, P413, DOI 10.1016/j.neuroimage.2013.12.017; ROJAS DC, 1995, ARCH CLIN NEUROPSYCH, V10, P101, DOI 10.1016/0887-6177(94)E0038-Q; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Sakai K, 2004, CEREB CORTEX, V14, P914, DOI 10.1093/cercor/bhh050; Seurinck R, 2005, NEUROIMAGE, V25, P1187, DOI 10.1016/j.neuroimage.2005.01.010; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Simos PG, 2013, J INT NEUROPSYCH SOC, V19, P355, DOI 10.1017/S1355617712001518; Simos PG, 2011, APHASIOLOGY, V25, P475, DOI 10.1080/02687038.2010.512118; Smith A., 1982, SYMBOL DIGIT MODALIT, P22; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Strandberg M, 2011, BRAIN IMAGING BEHAV, V5, P1, DOI 10.1007/s11682-010-9106-z; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; van den Heuvel OA, 2013, HUM BRAIN MAPP, V34, P347, DOI 10.1002/hbm.21443; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Wylie GR, 2004, HUM BRAIN MAPP, V21, P279, DOI 10.1002/hbm.20003; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Xiao H, 2015, NEURAL REGEN RES, V10, P2062, DOI 10.4103/1673-5374.172328; Zalonis I, 2008, CLIN NEUROPSYCHOL, V22, P842, DOI 10.1080/13854040701629301; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	105	7	7	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 10	2019	9								1163	10.3389/fneur.2018.01163			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HH0JB	WOS:000455401100001	30687219	Green Published, gold			2022-02-06	
J	Westerhof-Evers, HJ; Fasotti, L; van der Naalt, J; Spikman, JM				Westerhof-Evers, Herma J.; Fasotti, Luciano; van der Naalt, Joukje; Spikman, Jacoba M.			Participation after traumatic brain injury: the surplus value of social cognition tests beyond measures for executive functioning and dysexecutive behavior in a statistical prediction model	BRAIN INJURY			English	Article						Traumatic brain injury (TBI); social cognition; dysexecutive behavior; participation; return to work; outcome	QUALITY-OF-LIFE; ECOLOGICALLY VALID TEST; COMMUNITY INTEGRATION; EMOTION RECOGNITION; SELF-AWARENESS; OUTCOMES; RETURN; IMPAIRMENTS; PERFORMANCE; DEFICITS	Objective: This study evaluates the contribution of measures for social cognition (SC), executive functioning (EF) and dysexecutive behavior to the statistical prediction of social and vocational participation in patients with traumatic brain injury (TBI), taking into account age and injury severity. Method: A total of 63 patients with moderate to severe TBI participated. They were administered a semi-structured Role Resumption List for social (RRL-SR) and vocational participation (RRL-RTW). EF was measured with planning- and switching tasks. Assessment of SC included tests for facial affect recognition and Theory of Mind (ToM). Dysexecutive behavior was proxy-rated with a questionnaire. Additionally, healthy controls were assessed with the same protocol. Results: Patients with TBI performed significantly worse on tests and had significantly more behavioral problems compared to healthy controls. Hierarchical multiple regression analyses for the TBI group revealed that SC accounted for 22% extra variance in RRL-RTW and 10% extra variance in RRL-SR, which was significant over and above the amounts of variance explained by EF, dysexecutive behavior, age and injury severity. Conclusions: Our findings underline the added value of measures of SC and dysexecutive behavior in the prediction of social and vocational participation post-TBI. In particular, impairments in ToM, and dysexecutive behavior were related to a lower participation making them important targets for rehabilitation.	[Westerhof-Evers, Herma J.; Spikman, Jacoba M.] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Westerhof-Evers, Herma J.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Fasotti, Luciano] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [van der Naalt, Joukje; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands		Westerhof-Evers, HJ (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Behav & Social Sci, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	h.j.evers@rug.nl		van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763	Hersenstichting [F2008-1-18]	This work was supported by the Hersenstichting [F2008-1-18].	Abwender DA, 2001, ASSESSMENT, V8, P323, DOI 10.1177/107319110100800308; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Allain P, 2005, BRAIN COGNITION, V57, P4, DOI 10.1016/j.bandc.2004.08.011; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; Hendry K, 2016, FRONT BEHAV NEUROSCI, V10, DOI [10.3389/fnbeh.2016.00020, DOI 10.3389/FNBEH.2016.00020]; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levasseur M, 2010, SOC SCI MED, V71, P2141, DOI 10.1016/j.socscimed.2010.09.041; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Luria A.R., 1966, HIGHER CORTICAL FUNC; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Pepin M, 2000, BRAIN INJURY, V14, P563; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Ryan NP, 2016, SOC COGN AFFECT NEUR, V11, P683, DOI 10.1093/scan/nsw007; Saxton ME, 2013, NEUROREHABILITATION, V33, P263, DOI 10.3233/NRE-130954; Schmand B, 2008, Tijdschr Gerontol Geriatr, V39, P64; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Spikman JM, 2016, J NEUROTRAUM, V33, P22, DOI 10.1089/neu.2014.3788; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Verhage F, 1964, INTELLIGENTIE LEEFTI; Vlagsma TT, 2017, ARCH PHYS MED REHAB, V98, P2181, DOI 10.1016/j.apmr.2017.03.016; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Westerhof-Evers HJ, 2014, J CLIN EXP NEUROPSYC, V36, P1031, DOI 10.1080/13803395.2014.966661; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Yeates G, 2016, NEUROREHABILITATION, V38, P299, DOI 10.3233/NRE-161321; Young A., 2002, FACIAL EXPRESSIONS E	64	7	7	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2019	33	1			SI		78	86		10.1080/02699052.2018.1531303			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG2RW	WOS:000454812400010	30325200	Green Published, hybrid			2022-02-06	
J	Ahl, R; Sarani, B; Sjolin, G; Mohseni, S				Ahl, Rebecka; Sarani, Babak; Sjolin, Gabriel; Mohseni, Shahin			The Association of Intracranial Pressure Monitoring and Mortality: A Propensity Score-Matched Cohort of Isolated Severe Blunt Traumatic Brain Injury	JOURNAL OF EMERGENCIES TRAUMA AND SHOCK			English	Article						Intracranial pressure monitoring; mortality; traumatic brain injury	EVIDENCE-BASED GUIDELINES; SEVERE HEAD-INJURY; INTENSIVE-CARE; MANAGEMENT; OUTCOMES	Background: Intracranial pressure (ICP) monitoring in traumatic brain injury (TBI) is common. Yet, its efficacy varies between studies, and the actual effect on the outcome is debated. This study investigates the association of ICP monitoring and clinical outcome in patients with an isolated severe blunt TBI. Patients and Methods: Patients were recruited from the American College of Surgeons-Trauma Quality Improvement Program database during 2014. Inclusion criteria were limited to adult patients (>= 18 years) who had a sustained isolated severe intracranial injury (Abbreviated Injury Scale [AIS] head of >= 3 and Glasgow Coma Scale [GCS] of <= 8) following blunt trauma to the head. Patients with AIS score >0 for any extracranial body area were excluded. Patients' demographics, injury characteristics, interventions, and outcomes were collected for analysis. Patients receiving ICP monitoring were matched in a 1:1 ratio with controls who were not ICP monitored using propensity score matching. Results: A total of 3289 patients met inclusion criteria. Of these, 601 (18.3%) were ICP monitored. After propensity score matching, 557 pairs were available for analysis with a mean age of 44 (standard deviation 18) years and 80.2% of them were male. Median GCS on admission was 4[3,7], and a third of patients required neurosurgical intervention. There were no statistical differences in any variables included in the analysis between the ICP-monitored group and their matched counterparts. ICP-monitored patients required significantly longer intensive care unit and hospital length of stay and had an increased mortality risk with odds ratio of 1.6 (95% confidence interval: 1.1-2.5, P = 0.038). Conclusion: ICP monitoring is associated with increased in-hospital mortality in patients with an isolated severe TBI. Further investigation into which patients may benefit from this intervention is required.	[Ahl, Rebecka] Karolinska Univ Hosp, Dept Surg, Stockholm, Sweden; [Ahl, Rebecka; Sjolin, Gabriel; Mohseni, Shahin] Orebro Univ, Sch Med Sci, Orebro, Sweden; [Sarani, Babak] George Washington Univ, Ctr Trauma & Crit Care, Dept Surg, Washington, DC USA; [Sjolin, Gabriel; Mohseni, Shahin] Orebro Univ Hosp, Dept Surg, Div Trauma & Emergency Surg, S-70185 Orebro, Sweden		Mohseni, S (corresponding author), Orebro Univ Hosp, Dept Surg, Div Trauma & Emergency Surg, S-70185 Orebro, Sweden.	mohsenishahin@yahoo.com	Ahl, Rebecka/AAG-4162-2020	Ahl, Rebecka/0000-0001-7930-3845			Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255	20	7	9	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0974-2700	0974-519X		J EMERG TRAUMA SHOCK	J. Emerg. Trauma Shock	JAN-MAR	2019	12	1					18	22		10.4103/JETS.JETS_59_18			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	HV4RP	WOS:000465973700004	31057279				2022-02-06	
J	Alexiou, GA; Sotiropoulos, A; Lianos, GD; Zigouris, A; Metaxas, D; Nasios, A; Michos, E; Mitsis, M; Pachatouridis, D; Voulgaris, S				Alexiou, George A.; Sotiropoulos, Athanasios; Lianos, Georgios D.; Zigouris, Andreas; Metaxas, Dimitrios; Nasios, Anastasios; Michos, Evaggelos; Mitsis, Michail; Pachatouridis, Dimitrios; Voulgaris, Spyridon			Blood Glucose Levels May Aid the Decision for CT Scan in Minor Head Trauma	DISEASE MARKERS			English	Article								Traumatic brain injury has been associated with increased blood glucose levels. In the present study, we set out to investigate if blood glucose level in mild head trauma could predict the need for CT. One hundred fifty-nine patients with minor TBI (GCS 13-15) and a mean age of 44.8 +/- 23.8 years were included in the study. The most common mechanism of trauma was falls. Patients with positive CT findings had significantly higher glucose levels than patients with negative CT findings. Using ROC curve analysis, serum glucose levels higher than 120mgdl(-1) were the optimal cutoff value for the detection of patients with positive CT findings with a sensitivity of 74.4% and a specificity of 90.7%. Serum glucose level evaluation at presentation in the emergency department may aid CT decision-making in mild TBI.	[Alexiou, George A.; Sotiropoulos, Athanasios; Zigouris, Andreas; Metaxas, Dimitrios; Nasios, Anastasios; Michos, Evaggelos; Pachatouridis, Dimitrios; Voulgaris, Spyridon] Univ Hosp Ioannina, Dept Neurosurg, Ioannina, Greece; [Lianos, Georgios D.; Mitsis, Michail] Univ Hosp Ioannina, Dept Surg, Ioannina, Greece		Lianos, GD (corresponding author), Univ Hosp Ioannina, Dept Surg, Ioannina, Greece.	georgiolianos@yahoo.gr	Alexiou, George A/B-3995-2012	Alexiou, George A/0000-0003-0257-4481			Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Chong SL, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/719476; HARNAN S, 2002, THE JOURNAL OF TRAUM, V71, P245, DOI DOI 10.1097/TA.0B013E31820D090F; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; INGEBRIGTSEN T, 2002, JOURNAL OF NEUROSURG, V85, P945, DOI DOI 10.3171/JNS.1996.85.5.0945; INGEBRIGTSEN T, 2002, JOURNAL OF NEUROLOGY, V59, P103, DOI DOI 10.1136/JNNP.59.1.103-A; Jacome T, 2018, NEUROCRIT CARE, V28, P110, DOI 10.1007/s12028-017-0410-y; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; MITCHELL J, 2002, ULTRASOUND, V26, P37, DOI DOI 10.1053/J.SULT.2004.10.004; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Sharp AL, 2017, ACAD EMERG MED, V24, P22, DOI 10.1111/acem.13061; Sheppard John P, 2018, Brain Tumor Res Treat, V6, P1, DOI 10.14791/btrt.2018.6.e4; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Unden J, 2009, SCAND J CLIN LAB INV, V69, P13, DOI 10.1080/00365510802651833; WEISSMAN C, 1990, ANESTHESIOLOGY, V73, P308, DOI 10.1097/00000542-199008000-00020	18	7	7	1	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0278-0240	1875-8630		DIS MARKERS	Dis. Markers		2019	2019								1065254	10.1155/2019/1065254			4	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine; Pathology	HU4PZ	WOS:000465259500001	31093304	gold, Green Published, Green Submitted			2022-02-06	
J	Brett, BL; Wilmoth, K; Cummings, P; Solomon, GS; McCrea, MA; Zuckerman, SL				Brett, Benjamin L.; Wilmoth, Kristin; Cummings, Peter; Solomon, Gary S.; McCrea, Michael A.; Zuckerman, Scott L.			The Neuropathological and Clinical Diagnostic Criteria of Chronic Traumatic Encephalopathy: A Critical Examination in Relation to Other Neurodegenerative Diseases	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Chronic traumatic encephalopathy; concussion; football; neurodegenerative diseases; sports; traumatic brain injury	LEWY BODIES; ALZHEIMERS-DISEASE; PROGRESSIVE DEMENTIA; NATIONAL INSTITUTE; BODY; GUIDELINES; ACCURACY; FOOTBALL; SPECT; SPECIFICITY	This work critically reviews chronic traumatic encephalopathy (CTE), with a specific focus on the single criterion necessary and sufficient for diagnosis. Herein, CTE is compared to other well-established neurodegenerative entities including Alzheimer's disease and dementia with Lewy bodies. Each neurodegenerative disorder is reviewed in five pertinent areas: 1) historical perspective, 2) guideline formation process, 3) clinical diagnostic criteria, 4) pathological diagnostic criteria, and 5) validation of previously described diagnostic criteria (e.g., sensitivity and specificity). These comparisons indicate that CTE is a disease in the earliest stages of formation and has yet to undergo rigorous development and refinement similar to other neurodegenerative diseases. Suggested future revisions to the diagnostic criterion of CTE include establishing a lower threshold for accumulation of pathology, as well as accounting for the presence of concomitant neuropathology and comorbid neurodegenerative disorders. Currently, while initial efforts have been attempted, agreed upon antemortem clinical criteria do not exist. As has been the scientific standard with similar neurodegenerative disorders, antemortem diagnostic guidelines should first be refined through subcommittees of neuroscientists from diverse institutional backgrounds with a subclassification of levels of diagnostic certainty (possible, probably, and definite). Validation studies should then assess the predictive value and accuracy of proposed antemortem diagnostic criteria in relation to potential pathological criteria.	[Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Vanderbilt Sports Concuss Ctr, Nashville, TN USA; [Brett, Benjamin L.; Wilmoth, Kristin; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Cummings, Peter] Boston Univ, Med Ctr, Dept Anat & Neurobiol, Boston, MA USA; [Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA		Brett, BL (corresponding author), Med Coll Wisconsin, Dept Neurol, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.; Brett, BL (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	bbrett@mcw.edu	Wilmoth, Kristin/ABB-4014-2020	Wilmoth, Kristin/0000-0003-4192-8756			Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Alzheimer A, 1995, Clin Anat, V8, P429; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; [Anonymous], 1997, Neurobiol Aging, V18, pS1; [Anonymous], 1991, DEMENTIA; Barr WB, 2013, NEUROPSYCHOL REV, V23, P271, DOI 10.1007/s11065-013-9244-3; Belson K., 2017, NY TIMES; Bowman K, 1490, INJURIES SKULL BRAIN, P309; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Castellani RJ, 2015, J NEUROPATH EXP NEUR, V74, P493, DOI 10.1097/NEN.0000000000000193; Cheng WC, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/428385; Collerton D, 2003, DEMENT GERIATR COGN, V16, P229, DOI 10.1159/000072807; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Davis DG, 1999, J NEUROPATH EXP NEUR, V58, P376, DOI 10.1097/00005072-199904000-00008; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Fandel TM, 2008, J PATHOL, V216, P193, DOI 10.1002/path.2395; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gaugler JE, 2013, AM J ALZHEIMERS DIS, V28, P337, DOI 10.1177/1533317513488910; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Harper L, 2016, BRAIN, V139, P1211, DOI 10.1093/brain/aww005; Hsu ET, 2018, ACTA NEUROPATHOL, V136, P955, DOI 10.1007/s00401-018-1902-3; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; KOSAKA K, 1976, ACTA NEUROPATHOL, V36, P221, DOI 10.1007/BF00685366; Kosaka K, 1996, NEUROPATHOLOGY, V16, P32, DOI 10.1111/j.1440-1789.1996.tb00152.x; KOSAKA K, 1978, ACTA NEUROPATHOL, V42, P127, DOI 10.1007/BF00690978; KOSAKA K, 1984, CLIN NEUROPATHOL, V3, P185; Kosaka K, 1980, PSYCHIAT NEUROL JPN, V82, P292; Lewy F, 1912, HDB NEUROLOGIE, P920; Lobotesis K, 2001, NEUROLOGY, V56, P643, DOI 10.1212/WNL.56.5.643; Lopez OL, 1999, NEUROLOGY, V53, P1292, DOI 10.1212/WNL.53.6.1292; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith I, 2007, LANCET NEUROL, V6, P305, DOI 10.1016/S1474-4422(07)70057-1; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; MCKEITH IG, 1992, PSYCHOL MED, V22, P911, DOI 10.1017/S0033291700038484; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Montine TJ, 2016, ALZHEIMERS DEMENT, V12, P164, DOI 10.1016/j.jalz.2015.07.492; Mu J, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00301; Nagy Z, 1997, DEMENT GERIATR COGN, V8, P248, DOI 10.1159/000106639; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; O'Brien JT, 2014, J NUCL MED, V55, P1959, DOI 10.2967/jnumed.114.143347; OKAZAKI H, 1961, J NEUROPATH EXP NEUR, V20, P237, DOI 10.1097/00005072-196104000-00007; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Rizzo G, 2018, J NEUROL NEUROSUR PS, V89, P358, DOI 10.1136/jnnp-2017-316844; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Schmidt RL, 2013, ARCH PATHOL LAB MED, V137, P558, DOI 10.5858/arpa.2012-0198-RA; Solomon GS, 2014, PHYSICIAN SPORTSMED, V42, P26, DOI 10.3810/psm.2014.09.2072; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tretiakoff C, 1919, CONTRIBUTION ETUDE A; Yoshita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120540	75	7	8	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2019	68	2					591	608		10.3233/JAD-181058			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HR1FP	WOS:000462875000017	30856113				2022-02-06	
J	Byom, L; Duff, M; Mutlu, B; Turkstra, L				Byom, Lindsey; Duff, Melissa; Mutlu, Bilge; Turkstra, Lyn			Facial emotion recognition of older adults with traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; social cognition; affect recognition; aging; speech-language pathology	FUNCTIONING 10 YEARS; FOLLOW-UP; COGNITIVE DECLINE; SOCIAL-ADJUSTMENT; AGE-DIFFERENCES; HEAD-INJURY; REHABILITATION; COMMUNICATION; PERCEPTION; EXPRESSION	Objectives: The objective of this study was to examine the effects of traumatic brain injury (TBI) and age on facial emotion recognition abilities in adults. Age and TBI were expected to have negative effects on emotion recognition and a TBI by age interaction was hypothesized such that older adults with TBI would have the lowest emotion recognition scores. Methods: A prospective cohort study was conducted. Participants were 26 adults with moderate-severe TBI (13 older and 13 younger) and 26 uninjured peers matched for age, sex, and education. Emotion recognition was measured using the Emotion Recognition Task, which is comprised of dynamically morphed facial expressions of the six basic emotions, presented at different intensity levels. Results : TBI and older age were associated with poorer recognition of both subtle and intense expressions, but only for expressions of anger and sadness. There was no interaction of age and TBI. Conclusions: Results add to the growing evidence of emotion recognition impairments after TBI, particularly for select negative emotions, and extend this finding to adults over the age of 60. Further research is needed to better understand social cognitive effects of TBI across the adult lifespan.	[Byom, Lindsey] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Div Speech & Hearing Sci, Chapel Hill, NC 27515 USA; [Byom, Lindsey; Turkstra, Lyn] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI USA; [Duff, Melissa] Vanderbilt Univ, Dept Hearing & Speech Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Mutlu, Bilge] Univ Wisconsin, Dept Comp Sci, 1210 W Dayton St, Madison, WI 53706 USA; [Turkstra, Lyn] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada		Byom, L (corresponding author), Univ N Carolina, Sch Med, Dept Allied Hlth, Div Speech & Hearing Sci, Bondurant Hall, Chapel Hill, NC 27514 USA.	lindsey_byom@med.unc.edu	Byom, Lindsey/AAC-5095-2019; Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921; Byom, Lindsey/0000-0002-2457-1735	NICHD/NCMRR grant [R01 HD071089]; GRECC [003-2019]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER	This manuscript was prepared in part at the William S. Middleton Memorial Veterans Hospital in Madison, WI; GRECC manuscript No. 003-2019. The views and content expressed in this article are solely the responsibility of the authors and do not necessarily reflect the position, policy, or official views of the Department of Veteran Affairs or the US government. This work was supported by NICHD/NCMRR grant [R01 HD071089]. The authors have no conflicts of interest to report.	Ao BT, 2015, NEUROEPIDEMIOLOGY, V44, P255, DOI 10.1159/000431043; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Biszak AM, 2014, BRAIN INJURY, V28, P97, DOI 10.3109/02699052.2013.856475; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; CORKIN S, 1989, J NEUROSCI, V9, P3876; Cornwell EY, 2009, J HEALTH SOC BEHAV, V50, P31, DOI 10.1177/002214650905000103; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Faul M, 2010, TRAUMATIC BRAIN INJU; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; GORDON NG, 1972, J CLIN PSYCHOL, V28, P167, DOI 10.1002/1097-4679(197204)28:2<167::AID-JCLP2270280212>3.0.CO;2-X; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoofien D, 2001, BRAIN INJURY, V15, P189; IBM, 2015, SPSS STAT MAC; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kessels RPC, 2014, J NEUROPSYCHOL, V8, P75, DOI 10.1111/jnp.12009; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Lambrecht L, 2012, EMOTION, V12, P529, DOI 10.1037/a0026827; Ma Z., 2013, PSYCHOL REC, V63, P629, DOI DOI 10.11133/J.TPR.2013.63.3.015; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Sarabia-Cobo CM, 2016, INT J NURS STUD, V54, P104, DOI 10.1016/j.ijnurstu.2015.08.005; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Merkley TL, 2013, J INT NEUROPSYCH SOC, V19, P899, DOI 10.1017/S135561771300074X; Miekisiak G, 2016, BRAIN INJURY, V30, P79, DOI 10.3109/02699052.2015.1104550; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Morrow DG, 2003, PSYCHOL AGING, V18, P268, DOI 10.1037/0882-7974.18.2.268; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Noh SR, 2013, EMOTION, V13, P238, DOI 10.1037/a0030234; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; Ortman JM, 2014, AGING NATION OLDER P, V1140, P1; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenberg H, 2018, J NEUROPSYCHOL, V12, P145, DOI 10.1111/jnp.12109; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; SHEWAN CM, 1980, J SPEECH HEAR DISORD, V45, P308, DOI 10.1044/jshd.4503.308; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Sullivan S, 2004, INT J NEUROSCI, V114, P403, DOI 10.1080/00207450490270901; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Sze JA, 2012, PSYCHOL AGING, V27, P940, DOI 10.1037/a0029367; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tomaka J, 2006, J AGING HEALTH, V18, P359, DOI 10.1177/0898264305280993; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wechsler D., 2008, WECHSLER ADULT INTEL; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; West JT, 2012, EXP AGING RES, V38, P146, DOI 10.1080/0361073X.2012.659997; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wood RL, 2017, BRAIN INJURY, V31, P1270, DOI 10.1080/02699052.2017.1332387; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6	69	7	8	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2019	33	3					322	332		10.1080/02699052.2018.1553066			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HM7DB	WOS:000459636400008	30526138	Green Accepted			2022-02-06	
J	Chen, Q; Zheng, WM; Chen, X; Li, XJ; Wang, L; Qin, W; Li, KC; Chen, N				Chen, Qian; Zheng, Weimin; Chen, Xin; Li, Xuejing; Wang, Ling; Qin, Wen; Li, Kuncheng; Chen, Nan			Reorganization of the somatosensory pathway after subacute incomplete cervical cord injury	NEUROIMAGE-CLINICAL			English	Article						Somatosensory pathway; Task-related; Reorganization; fMRI; Incomplete cervical cord injury	BRAIN-STEM CONTRIBUTIONS; SPINAL-CORD; NEUROPATHIC PAIN; CORTICAL REORGANIZATION; MOTOR CORTEX; FUNCTIONAL REORGANIZATION; SENSORIMOTOR CORTEX; HUMAN CEREBELLUM; DORSAL COLUMNS; SYSTEM ATROPHY	Objective: The main purpose of the present study was to investigate the possible somatosensory-related brain functional reorganization after traumatic spinal cord injury (SCI). Methods: Thirteen patients with subacute incomplete cervical cord injury (ICCI) and thirteen age- and sex-matched healthy controls (HCs) were recruited. Eleven patients and all the HCs underwent both sensory task-related brain functional scanning and whole brain structural scanning on a 3.0 Tesla MRI system, and two patients underwent only structural scanning; the process of structural scanning was completed on thirteen patients, while functional scanning was only applied to eleven patients. We performed sensory task-related functional MRI (fMRI) to investigate the functional changes in the brain. In addition, voxel-based morphometry (VBM) was applied to explore whether any sensory-related brain structural changes occur in the whole brain after SCI. Results: Compared with HCs, ICCI patients exhibited decreased activation in the left postcentral gyrus (postCG), the brainstem (midbrain and right pons) and the right cerebellar lobules IV-VI. Moreover, a significant positive association was found between the activation in the left PostCG and the activation in both the brainstem and the right cerebellar lobules IV-VI. Additionally, the decrease in gray matter volume (GMV) was detected in the left superior parietal lobule (SPL). The decrease of white matter volume (WMV) was observed in the right temporal lobe, the right occipital lobe, and the right calcarine gyrus. No structural change in the primary sensory cortex (S1), the secondary somatosensory cortex (S2) or the thalamus was detected. Conclusion: These functional and structural findings may demonstrate the existence of an alternative pathway in the impairment of somatosensory function after SCI, which consists of the ipsilateral cerebellum, the brainstem and the contralateral postCG. It provides a new theoretical basis for the mechanism of sensory-related brain alteration in SCI patients and the rehabilitation therapy based on this pathway in the future.	[Chen, Qian; Zheng, Weimin; Chen, Xin; Li, Xuejing; Wang, Ling; Li, Kuncheng; Chen, Nan] Capital Med Univ, Xuanwu Hosp, Dept Radiol, 45 Chang Chun St, Beijing, Peoples R China; [Chen, Qian; Zheng, Weimin; Chen, Xin; Li, Xuejing; Wang, Ling; Li, Kuncheng; Chen, Nan] Beijing Key Lab Magnet Resonance Imaging & Brain, 45 Chang Chun St, Beijing, Peoples R China; [Zheng, Weimin] Beijing Univ Chinese Med, Dept Radiol, Dongfang Hosp, 6 Star Pk 1 Dist, Beijing, Peoples R China; [Qin, Wen] Tianjin Med Univ, Dept Radiol, Gen Hosp, 154 Anshan Rd, Tianjin, Peoples R China		Chen, N (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Radiol, 45 Chang Chun St, Beijing, Peoples R China.; Chen, N (corresponding author), Beijing Key Lab Magnet Resonance Imaging & Brain, 45 Chang Chun St, Beijing, Peoples R China.	chenzen8057@sina.com	Chen, Qian/AAN-1922-2021; QIN, WEN/F-3783-2015; CHEN, NAN/L-1223-2019	Chen, Qian/0000-0001-5210-9647; QIN, WEN/0000-0002-9121-8296; 	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81871339, 81271556]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201609]; Beijing Municipal Natural Science FoundationBeijing Natural Science Foundation [7113155]; Science Foundation of Beijing Municipal Commission of Education [KM201210025013]	This study was supported by the National Natural Science Foundation of China (No. 81871339; No. 81271556), Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201609), Beijing Municipal Natural Science Foundation (No. 7113155), and Science Foundation of Beijing Municipal Commission of Education (No. KM201210025013).	Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Arrigo A, 2017, RADIOLOGY, V285, P885, DOI 10.1148/radiol.2017161732; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baradaran H, 2016, NEUROLOGY, V86, pe154, DOI 10.1212/WNL.0000000000002544; Benarroch EE, 2012, NEUROLOGY, V78, P210, DOI 10.1212/WNL.0b013e31823fcdee; Bose P, 2005, EXP NEUROL, V191, P13, DOI 10.1016/j.expneurol.2004.08.028; Brooks JCW, 2017, J NEUROSCI, V37, P2279, DOI 10.1523/JNEUROSCI.2193-16.2016; Chen LM, 2012, J NEUROSCI, V32, P14649, DOI 10.1523/JNEUROSCI.1841-12.2012; Chen Q, 2017, FRONT HUM NEUROSCI, V11; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Crawley AP, 2004, BRAIN RES, V1028, P19, DOI 10.1016/j.brainres.2004.08.060; Cuppini C, 2018, J NEUROSCI, V38, P3453, DOI 10.1523/JNEUROSCI.2631-17.2018; Curt A, 2002, J NEUROTRAUM, V19, P43, DOI 10.1089/089771502753460222; Ferilli MAN, 2018, J NEUROL NEUROSUR PS, V89, P311, DOI 10.1136/jnnp-2017-315930; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Freund P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051729; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Grabher P, 2017, NEUROIMAGE-CLIN, V15, P494, DOI 10.1016/j.nicl.2017.05.026; Grabher P, 2015, ANN NEUROL, V78, P751, DOI 10.1002/ana.24508; Graves, 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; Grodd W, 2001, HUM BRAIN MAPP, V13, P55, DOI 10.1002/hbm.1025; Gustin SM, 2014, PAIN, V155, P1027, DOI 10.1016/j.pain.2014.02.008; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Holler Y, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00662; Hou JM, 2014, NEUROSCIENCE, V266, P208, DOI 10.1016/j.neuroscience.2014.02.013; Hougaard A, 2017, HUM BRAIN MAPP, V38, P2635, DOI 10.1002/hbm.23548; Humanes-Valera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069655; Ilvesmaki T, 2017, HUM BRAIN MAPP, V38, P3637, DOI 10.1002/hbm.23619; Insola A, 2014, CLIN NEUROPHYSIOL, V125, P1859, DOI 10.1016/j.clinph.2013.12.112; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Jurkiewicz MT, 2006, NEUROLOGY, V66, P762, DOI 10.1212/01.wnl.0000201276.28141.40; Jutzeler C. R, 2016, SCI REP UK, V6; Jutzeler CR, 2015, J PAIN, V16, P1256, DOI 10.1016/j.jpain.2015.08.008; Kaas JH, 2008, EXP NEUROL, V209, P407, DOI 10.1016/j.expneurol.2007.06.014; Karakaya IC, 2014, J BACK MUSCULOSKELET, V27, P191, DOI 10.3233/BMR-130435; Liao CC, 2015, J COMP NEUROL, V523, P2138, DOI 10.1002/cne.23783; Lilja J, 2006, J NEUROSCI, V26, P6330, DOI 10.1523/JNEUROSCI.0626-06.2006; Manganotti P, 2012, CLIN NEUROPHYSIOL, V123, P142, DOI 10.1016/j.clinph.2011.05.028; Marino RJ, 2008, J SPINAL CORD MED, V31, P166, DOI 10.1080/10790268.2008.11760707; Moxon KA, 2014, NEUROSCIENCE, V283, P78, DOI 10.1016/j.neuroscience.2014.06.056; Mtui EG, 2016, FITZGERALDS CLIN NEU; Mylius J, 2015, BRAIN STRUCT FUNCT, V220, P3273, DOI 10.1007/s00429-014-0855-0; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Qi HX, 2011, J NEUROSCI, V31, P13662, DOI 10.1523/JNEUROSCI.2366-11.2011; Rao JS, 2014, MAGN RESON IMAGING, V32, P482, DOI 10.1016/j.mri.2014.02.001; Salmi J, 2010, J COGNITIVE NEUROSCI, V22, P2663, DOI 10.1162/jocn.2009.21382; Sang L, 2012, NEUROIMAGE, V61, P1213, DOI 10.1016/j.neuroimage.2012.04.011; Siddall PJ, 2001, SPINAL CORD, V39, P63, DOI 10.1038/sj.sc.3101116; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; Squatrito S, 2001, J NEUROSCI, V21, part. no.; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Stroman PW, 2016, J NEUROTRAUM, V33, P1450, DOI 10.1089/neu.2015.4257; Villiger M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00254; Warner FM, 2019, J NEUROTRAUM, V36, P1461, DOI 10.1089/neu.2018.5960; Wrigley PJ, 2009, PAIN, V141, P52, DOI 10.1016/j.pain.2008.10.007; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; Wrigley PJ, 2018, HUM BRAIN MAPP, V39, P588, DOI 10.1002/hbm.23868; Wydenkeller S, 2009, EUR J NEUROSCI, V30, P91, DOI 10.1111/j.1460-9568.2009.06801.x; Yoon EJ, 2013, BRAIN RES, V1540, P64, DOI 10.1016/j.brainres.2013.10.007	64	7	8	3	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	21								101674	10.1016/j.nicl.2019.101674			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN6ZP	WOS:000460337700087	30642754	Green Published, gold			2022-02-06	
J	Dalecki, M; Gorbet, DJ; Macpherson, A; Sergio, LE				Dalecki, Marc; Gorbet, Diana J.; Macpherson, Alison; Sergio, Lauren E.			Sport experience is correlated with complex motor skill recovery in youth following concussion	EUROPEAN JOURNAL OF SPORT SCIENCE			English	Article						Mild traumatic brain injury; children; adolescents; return to play; cognitive-motor integration	SUBCONCUSSIVE HEAD IMPACTS; SEX-DIFFERENCES; RECURRENT CONCUSSION; BRAIN-INJURY; FOOTBALL; ABNORMALITIES; PLASTICITY; LIFE; EYE	A previous study showed prolonged cognitive-motor integration (CMI) deficits in youth with a history of concussion who were classified as asymptomatic by current return-to-play protocols, highlighting potential differences between clinical symptom recovery and skill recovery. The present study examines factors that may influence skilled performance recovery (defined as matching the skill level of no-concussion history peers) post-concussion in a similar cohort. Sixty-four asymptomatic youth (M = 13 yrs.) soccer, hockey, and lacrosse players with a concussion history (M = 14 months post-concussion) who returned to play and sixty-two age-matched team members with no previous concussion participated in this study. They performed two touchscreen-based eye- hand coordination tasks, including a direct interaction and a CMI task. We analysed the relationship between CMI performance and concussion history, and whether age, sex, number of concussions, and years of sport experience in their sport affected skill recovery. Individuals with concussion history and higher amounts of sport experience (7-12 years) reached a performance level matching their no-history peers quicker (after 12 months) than those with concussion history and lower sport experience (1-6 years; recovery after 30 months). This effect was independent of the number of concussions, age, and sex. The present results point towards an important role of eye-limb coordination-related sport experience in functional CMI recovery post-concussion. Youth with a concussion history but greater sport experience may have more skill-related motor "reserve". This reserve may directly aid in behavioural recovery post-concussion, or the greater neurological efficiency associated with athletic experience provides a compensatory mechanism that provides faster functional recovery.	[Dalecki, Marc] Louisiana State Univ, Sch Kinesiol, 71 Huey P Long Field House, Baton Rouge, LA 70803 USA; [Gorbet, Diana J.; Macpherson, Alison; Sergio, Lauren E.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Gorbet, Diana J.; Sergio, Lauren E.] York Univ, Ctr Vis Res, Toronto, ON, Canada		Dalecki, M (corresponding author), Louisiana State Univ, Sch Kinesiol, 71 Huey P Long Field House, Baton Rouge, LA 70803 USA.	mdalecki@lsu.edu	Sergio, Lauren/AAK-3274-2020		Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [125915]; Donald Sanderson Memorial Trust	Funding for this research was provided by the Canadian Institutes of Health Research operating grant #125915(LS), and the Donald Sanderson Memorial Trust.	Albines D., 2016, J MOTOR LEARNING DEV, V4, P274; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Brown JA, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0019-4; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Dalecki Marc, 2016, Concussion, V1, pCNC14, DOI 10.2217/cnc-2016-0001; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Di X, 2012, BRAIN CONNECT, V2, P225, DOI 10.1089/brain.2011.0050; Gorbet DJ, 2016, BEHAV BRAIN RES, V298, P229, DOI 10.1016/j.bbr.2015.11.012; Gorbet DJ, 2007, EUR J NEUROSCI, V25, P1228, DOI 10.1111/j.1460-9568.2007.05358.x; Gorbet DJ, 2009, BRAIN RES, V1284, P77, DOI 10.1016/j.brainres.2009.05.057; Granek JA, 2015, J NEUROPHYSIOL, V114, P1298, DOI 10.1152/jn.00233.2014; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hawkins KM, 2013, J COGNITIVE NEUROSCI, V25, P436, DOI 10.1162/jocn_a_00318; Hurtubise Johanna, 2016, Concussion, V1, pCNC17, DOI 10.2217/cnc-2016-0006; KARLIN AM, 2011, PM&R, V3, P369; Kissick J, 2005, CLIN J SPORT MED, V15, P426, DOI 10.1097/01.jsm.0000186683.59158.8b; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Lubans DR, 2010, SPORTS MED, V40, P1019, DOI 10.2165/11536850-000000000-00000; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Park IS, 2009, CEREBELLUM, V8, P334, DOI 10.1007/s12311-009-0100-1; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Sayegh PF, 2014, J NEUROPHYSIOL, V111, P2210, DOI 10.1152/jn.00793.2013; Sergio L.E., 2017, BRIT J SPORT MED, V51, pA41; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P185, DOI 10.1016/S1388-2457(01)00737-4; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Wang JJ, 2016, BRAIN STRUCT FUNCT, V221, P3503, DOI 10.1007/s00429-015-1116-6; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	40	7	7	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1746-1391	1536-7290		EUR J SPORT SCI	Eur. J. Sport Sci.		2019	19	9					1257	1266		10.1080/17461391.2019.1584249			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JE2PO	WOS:000490537000012	30880595				2022-02-06	
J	Divolis, G; Stavropoulos, A; Manioudaki, M; Apostolidou, A; Doulou, A; Gavriil, A; Dafnis, I; Chroni, A; Mummery, C; Xilouri, M; Sideras, P				Divolis, Georgios; Stavropoulos, Athanasios; Manioudaki, Maria; Apostolidou, Anastasia; Doulou, Athanasia; Gavriil, Ariana; Dafnis, Ioannis; Chroni, Angeliki; Mummery, Christine; Xilouri, Maria; Sideras, Paschalis			Activation of both transforming growth factor-beta and bone morphogenetic protein signalling pathways upon traumatic brain injury restrains pro-inflammatory and boosts tissue reparatory responses of reactive astrocytes and microglia	BRAIN COMMUNICATIONS			English	Article						astrocytes; BMP; microglia; TGF beta; traumatic brain injury	TGF-BETA; MACROPHAGE PLASTICITY; SCAR FORMATION; RAT-BRAIN; EXPRESSION; TIME; NEURONS; SYSTEM; CELLS; ROLES	Various ligands and receptors of the transforming growth factor-beta superfamily have been found upregulated following traumatic brain injury; however, the role of this signalling system in brain injury pathophysiology is not fully characterized. To address this, we utilized an acute stab wound brain injury model to demonstrate that hallmarks of transforming growth factor-beta superfamily system activation, such as levels of phosphorylated Smads, ligands and target genes for both transforming growth factor-beta and bone morphogenetic protein pathways, were upregulated within injured tissues. Using a bone morphogenetic protein-responsive reporter mouse model, we showed that activation of the bone morphogenetic protein signalling pathway involves primarily astrocytes that demarcate the wound area. Insights regarding the potential role of transforming growth factor-beta superfamily activation in glia cells within the injured tissues were obtained indirectly by treating purified reactive astrocytes and microglia with bone morphogenetic protein-4 or transforming growth factor-beta 1 and characterizing changes in their transcriptional profiles. Astrocytes responded to both ligands with considerably overlapping profiles, whereas, microglia responded selectively to transforming growth factor-beta 1. Novel pathways, crucial for repair of tissue-injury and blood-brain barrier, such as activation of cholesterol biosynthesis and transport, production of axonal guidance and extracellular matrix components were upregulated by transforming growth factor-beta 1 and/or bone morphogenetic protein-4 in astrocytes. Moreover, both ligands in astrocytes and transforming growth factor-beta 1 in microglia shifted the phenotype of reactive glia cells towards the anti-inflammatory and tissue reparatory 'A2'-like and 'M0/M2'-like phenotypes, respectively. Increased expression of selected key components of the in vitro modulated pathways and markers of 'A2'-like astrocytes was confirmed within the wound area, suggesting that these processes could also be modulated in situ by the integrated action of transforming growth factor-beta and/or bone morphogenetic protein-mediated signalling. Collectively, our study provides a comprehensive comparative analysis of transforming growth factor-beta superfamily signalling in reactive astrocytes and microglia and points towards a crucial role of both transforming growth factor-beta and bone morphogenetic protein pathways in modulating the inflammatory and brain injury reparatory functions of activated glia cells.	[Divolis, Georgios; Stavropoulos, Athanasios; Manioudaki, Maria; Apostolidou, Anastasia; Doulou, Athanasia; Gavriil, Ariana; Xilouri, Maria; Sideras, Paschalis] Acad Athens, Ctr Clin Res Expt Surg & Translat Res, Biomed Res Fdn, 4 Soranou Ephessiou St, Athens 11527, Greece; [Dafnis, Ioannis; Chroni, Angeliki] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens 15341, Greece; [Mummery, Christine] Leiden Univ, Dept Anat & Embryol, Med Ctr, NL-2333 ZC Leiden, Netherlands		Sideras, P (corresponding author), Acad Athens, Ctr Clin Res Expt Surg & Translat Res, Biomed Res Fdn, 4 Soranou Ephessiou St, Athens 11527, Greece.	sideras@bioacademy.gr		Divolis, Georgios/0000-0002-8721-1307; Chroni, Angeliki/0000-0003-3107-1189	National Parkinson Foundation [NPF-UP202]; General Secretariat of Research and Development, Hellenic Ministry of Education, Research and Religious Affairs, programme ARISTEIA II [3451]	This work was supported by a grant from the National Parkinson Foundation (NPF-UP202), and the General Secretariat of Research and Development, Hellenic Ministry of Education, Research and Religious Affairs, programme ARISTEIA II (#3451).	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Asher RA, 2000, J NEUROSCI, V20, P2427; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Budi EH, 2017, TRENDS CELL BIOL, V27, P658, DOI 10.1016/j.tcb.2017.04.005; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Buss A, 2008, SPINAL CORD, V46, P364, DOI 10.1038/sj.sc.3102148; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Bylicky M. A., 2018, OXIDATIVE MED CELLUL, V2018, P1; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen J, 2018, J NEUROSCI, V38, P3840, DOI 10.1523/JNEUROSCI.2031-17.2018; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Dettman RW, 2018, DEV NEUROSCI-BASEL, V40, P23, DOI 10.1159/000485379; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Frik J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745294; Fuller ML, 2007, ANN NEUROL, V62, P288, DOI 10.1002/ana.21179; Fumagalli M, 2011, FRONT BIOSCI-LANDMRK, V16, P2326, DOI 10.2741/3856; Funa K, 2014, J NEUROIMMUNE PHARM, V9, P168, DOI 10.1007/s11481-013-9479-z; Gao ZW, 2013, MOL NEUROBIOL, V48, P690, DOI 10.1007/s12035-013-8460-4; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hampton DW, 2007, EUR J NEUROSCI, V26, P3024, DOI 10.1111/j.1460-9568.2007.05940.x; He L, 2006, J IMMUNOL, V177, P3644, DOI 10.4049/jimmunol.177.6.3644; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Huang RQ, 2010, NEUROSCI LETT, V473, P22, DOI 10.1016/j.neulet.2010.02.011; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Kang WF, 2014, P NATL ACAD SCI USA, V111, pE2987, DOI 10.1073/pnas.1320401111; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Komuta Y, 2010, CELL MOL NEUROBIOL, V30, P101, DOI 10.1007/s10571-009-9435-x; Lewen A, 1997, NEUROREPORT, V8, P475, DOI 10.1097/00001756-199701200-00020; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; MATHEWSON AJ, 1985, BRAIN RES, V327, P61, DOI 10.1016/0006-8993(85)91499-4; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Miyazawa K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022095; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Monteiro RM, 2008, GENESIS, V46, P335, DOI 10.1002/dvg.20402; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2001, J CELL SCI, V114, P4359; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nieweg K, 2009, J NEUROCHEM, V109, P125, DOI 10.1111/j.1471-4159.2009.05917.x; Pabon MM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-9; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Quaglio G, 2017, LANCET NEUROL, V16, P951, DOI 10.1016/S1474-4422(17)30370-8; Ramachandran A, 2018, ELIFE, V7, DOI 10.7554/eLife.31756; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Rosendahl A, 2002, AM J RESP CELL MOL, V27, P160, DOI 10.1165/ajrcmb.27.2.4779; Rosendahl A, 2001, AM J RESP CELL MOL, V25, P60, DOI 10.1165/ajrcmb.25.1.4396; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Samanta J, 2010, STROKE, V41, P357, DOI 10.1161/STROKEAHA.109.565523; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Setoguchi T, 2001, BRAIN RES, V921, P219, DOI 10.1016/S0006-8993(01)03123-7; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shin JA, 2012, CELL MOL NEUROBIOL, V32, P587, DOI 10.1007/s10571-012-9806-6; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sidoryk-Wegrzynowicz M, 2011, TOXICOL PATHOL, V39, P115, DOI 10.1177/0192623310385254; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sountoulidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041460; Spittau B, 2013, GLIA, V61, P287, DOI 10.1002/glia.22435; Szepesi Z, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00323; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Van Deijk ALF, 2017, GLIA, V65, P670, DOI 10.1002/glia.23120; Xilouri M, 2012, HUM MOL GENET, V21, P874, DOI 10.1093/hmg/ddr521; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang HL, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/949072; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zoller T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06224-y	82	7	7	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2019	1	1							28	10.1093/braincomms/fcz028			20	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	NW3RF	WOS:000574927100028	32954268	gold, Green Published			2022-02-06	
J	Ettenhofer, ML; Guise, B; Brandler, B; Bittner, K; Gimbel, SI; Cordero, E; Schmitt, SN; Williams, K; Cox, D; Roy, MJ; Chan, L				Ettenhofer, Mark L.; Guise, Brian; Brandler, Brian; Bittner, Katie; Gimbel, Sarah I.; Cordero, Evelyn; Schmitt, Shawn Nelson; Williams, Kathy; Cox, Daniel; Roy, Michael J.; Chan, Leighton			Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE): A pilot clinical trial for chronic traumatic brain injury	NEUROREHABILITATION			English	Article						Traumatic brain injury; rehabilitation; cognition; virtual reality; driving	POSTTRAUMATIC-STRESS-DISORDER; REALITY EXPOSURE THERAPY; COGNITIVE REHABILITATION; MILITARY PERSONNEL; EMPLOYMENT; PLASTICITY; DRIVERS; RETURN; RISK; INDIVIDUALS	BACKGROUND: Virtual reality (VR) technology may provide an effective means to integrate cognitive and functional approaches to TBI rehabilitation. However, little is known about the effectiveness of VR rehabilitation for TBI-related cognitive deficits. In response to these clinical and research gaps, we developed Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE), an intervention designed to improve cognitive performance, driving safety, and neurobehavioral symptoms. OBJECTIVE: This pilot clinical trial was conducted to examine feasibility and preliminary efficacy of NeuroDRIVE for rehabilitation of chronic TBI. METHODS: Eleven participants who received the intervention were compared to six wait-listed participants on driving abilities, cognitive performance, and neurobehavioral symptoms. RESULTS: The NeuroDRIVE intervention was associated with significant improvements in working memory and visual search/selective attention-two cognitive skills that represented a primary focus of the intervention. By comparison, no significant changes were observed in untrained cognitive areas, neurobehavioral symptoms, or driving skills. CONCLUSIONS: Results suggest that immersive virtual environments can provide a valuable and engaging means to achieve some cognitive rehabilitation goals, particularly when these goals are closely matched to the VR training exercises. However, additional research is needed to augment our understanding of rehabilitation for driving skills, cognitive performance, and neurobehavioral symptoms in chronic TBI.	[Ettenhofer, Mark L.; Guise, Brian; Schmitt, Shawn Nelson; Roy, Michael J.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Ettenhofer, Mark L.; Bittner, Katie; Roy, Michael J.; Chan, Leighton] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Ettenhofer, Mark L.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Ettenhofer, Mark L.; Gimbel, Sarah I.; Cordero, Evelyn] Naval Med Ctr San Diego, San Diego, CA USA; [Ettenhofer, Mark L.] Univ Calif San Diego, San Diego, CA 92103 USA; [Brandler, Brian; Bittner, Katie; Gimbel, Sarah I.; Cordero, Evelyn; Schmitt, Shawn Nelson; Williams, Kathy] Henry M Jackson Fdn, Bethesda, MD USA; [Cox, Daniel] Univ Virginia, Charlottesville, VA USA; [Chan, Leighton] NIH, Bldg 10, Bethesda, MD 20892 USA		Ettenhofer, ML (corresponding author), ATTN DVBIC, 34730 Bob Wilson Dr,Suite 201, San Diego, CA 92134 USA.	mark.ettenhofer@usuhs.edu			Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; CLINICAL CENTER [ZIACL060079] Funding Source: NIH RePORTER	This study was sponsored by the Center for Neuroscience and Regenerative Medicine, with additional institutional support provided by the Uniformed Services University of the Health Sciences and the Defense and Veterans Brain Injury Center.	Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Ball K, 2007, J GERONTOL B-PSYCHOL, V62, P19, DOI 10.1093/geronb/62.special_issue_1.19; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benton L. A., 1994, MULTILINGUAL APHASIA, V3; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Bottari C, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/837301; Brooks JO, 2010, ACCIDENT ANAL PREV, V42, P788, DOI 10.1016/j.aap.2009.04.013; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Classen S, 2011, AM J OCCUP THER, V65, P419, DOI 10.5014/ajot.2011.000893; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cox D. J., 2014, VIRTUAL REALITY DRIV; Cox DJ, 2010, MIL MED, V175, P411, DOI 10.7205/MILMED-D-09-00081; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Delis D.C., 2000, CALIFORNIA VERBAL LE; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Devos H, 2009, NEUROREHAB NEURAL RE, V23, P699, DOI 10.1177/1545968309334208; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Fisher M, 2009, AM J PSYCHIAT, V166, P805, DOI 10.1176/appi.ajp.2009.08050757; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Gerardi M, 2010, CURR PSYCHIAT REP, V12, P298, DOI 10.1007/s11920-010-0128-4; Giles GM, 2010, AM J OCCUP THER, V64, P182, DOI 10.5014/ajot.64.1.182; Imhoff S, 2016, NEUROREHABILITATION, V39, P239, DOI 10.3233/NRE-161354; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Langford J, 2006, TRANSPORT RES F-TRAF, V9, P309, DOI 10.1016/j.trf.2006.03.005; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; Lebowitz MS, 2012, J REHABIL RES DEV, V49, P1547, DOI 10.1682/JRRD.2011.07.0133; Lew HL, 2009, J HEAD TRAUMA REHAB, V24, P51, DOI 10.1097/HTR.0b013e3181956fe3; Lovell MR, 2011, APPL NEUROPSYCHOL, V18, P197, DOI 10.1080/09084282.2011.595446; Lundqvist A, 2001, BRAIN INJURY, V15, P981, DOI 10.1080/02699050110065637; Lundqvist A, 2001, NEUROPSYCHOL REHABIL, V11, P171, DOI 10.1080/09602010042000240; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Novack TA, 2000, BRAIN INJURY, V14, P987; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Parsons TD, 2008, J BEHAV THER EXP PSY, V39, P250, DOI 10.1016/j.jbtep.2007.07.007; Pearson N., 2009, ADV CLIN SOLUTIONS W, V503, DOI [10.1037/a0018903, DOI 10.1037/A0018903]; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Reitan RM, 1992, TRAIL MAKING TEST MA; Rizzo Albert, 2009, POSTTRAUMATIC STRESS, P375, DOI [DOI 10.1007/978-1-60327-329-9_18, DOI 10.1007/978-1]; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Schneider JJ, 2005, APPL NEUROPSYCHOL, V12, P138, DOI 10.1207/S15324826AN1203_3; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Spiers HJ, 2007, NEUROIMAGE, V36, P245, DOI 10.1016/j.neuroimage.2007.02.032; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Walshe DG, 2003, CYBERPSYCHOL BEHAV, V6, P329, DOI 10.1089/109493103322011641; Ware JE, 1993, SCORING SF 36 SF 36; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Wechsler D., 2008, WECHSLER ADULT INTEL; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	64	7	8	6	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2019	44	4					531	544		10.3233/NRE-192718			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IK4NR	WOS:000476564100007	31256093	hybrid, Green Published			2022-02-06	
J	Hanks, R; Millis, S; Scott, S; Gattu, R; O'Hara, NB; Haacke, M; Kou, ZF				Hanks, Robin; Millis, Scott; Scott, Selena; Gattu, Ramtilak; O'Hara, Nolan B.; Haacke, Mark; Kou, Zhifeng			The relation between cognitive dysfunction and diffusion tensor imaging parameters in traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury (TBI); diffusion tensor imaging (DTI); fractional anisotropy (FA); diffuse axonal injury (DAI); cognition	WHITE-MATTER INJURY; INFORMATION-PROCESSING SPEED; AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; HEAD-INJURY; MILD; ANISOTROPY; DAMAGE; VALIDATION; INTEGRITY	Purpose of the Study: To investigate the association among global and regional white matter fractional anisotropy (FA) values following traumatic brain injury (TBI) and cognitive functioning. Materials and Methods: This research was conducted in an urban rehabilitation hospital. Participants included adults who were healthy controls (n =18) or who had a TBI (n =27). Diffusion tensor imaging using a Siemens VERIO 3T scanner and calculation of global and regional FA values were undertaken. FA values were correlated with neuropsychological test scores and injury severity variables. Logistic regression and receiver operating characteristic (ROC) curve analysis were used to investigate discriminative ability of the FA values. Neuropsychological measures, including the Symbol Digit Modalities Test (SDMT), Trail Making Test, Wechsler Test of Adult Reading, California Verbal Learning Test 2nd Edition, Digit Vigilance Test, and Wisconsin Card Sorting Test, comprised the cognitive measures. Results: Within the TBI group, regional FA values were significantly lower across regions compared with controls; global FA and five brain regions were associated with SDMT scores. The FA value within the body of the corpus callosum (CC) yielded excellent discrimination between groups. Conclusions: Convergent findings support the discriminability and potential clinical utility of the CC body FA value in the context of TBI.	[Hanks, Robin; Millis, Scott] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI 48202 USA; [Scott, Selena] Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Detroit, MI USA; [Gattu, Ramtilak; Haacke, Mark; Kou, Zhifeng] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA; [O'Hara, Nolan B.] Wayne State Univ, Sch Med, Detroit, MI USA; [Haacke, Mark; Kou, Zhifeng] Wayne State Univ, Coll Engn, Dept Biomed Engn, Detroit, MI USA		Hanks, R (corresponding author), Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI 48202 USA.	rhanks@wayne.edu			National Institute on Disability and Rehabilitation Research [H133A080044, H133G080064]	The authors report no conflicts of interest. This work was supported by the National Institute on Disability and Rehabilitation Research under grant H133A080044 and grant H133G080064.	ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Benton AL, 1994, MULTILINGUAL APHASIA; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Burgmans S, 2010, NEUROIMAGE, V49, P2083, DOI 10.1016/j.neuroimage.2009.10.035; Conturo TE, 1996, MAGNET RESON MED, V35, P399, DOI 10.1002/mrm.1910350319; Delis D.C., 2000, CALIFORNIA VERBAL LE; Forn C, 2011, J CLIN EXP NEUROPSYC, V33, P42, DOI 10.1080/13803395.2010.481620; Heaton R., 2000, WISCONSIN CARD SORTI; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kourtidou P, 2013, J HEAD TRAUMA REHAB, V28, P433, DOI 10.1097/HTR.0b013e3182585d06; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Lewis R., 1995, DIGIT VIGILANCE TEST; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Mac Donald CL, 2006, 24 ANN NAT NEUR SOC; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McLellan D, 1990, COMA EMERGING PATIEN, P75; Meda SA, 2006, ANN M INT SOC MAGN R; Meyers JE, 2009, APPL NEUROPSYCHOL, V16, P237, DOI 10.1080/09084280903098752; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Newcombe V, 2006, 24 ANN NAT NEUR SOC; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe VFJ, 2008, ACTA NEUROCHIR SUPPL, V102, P247, DOI 10.1007/978-3-211-85578-2_47; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Owens JA, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.608; Owens JA, 2018, BRAIN INJURY, V32, P776, DOI 10.1080/02699052.2018.1451656; Palacios EM, 2013, J NEUROTRAUM, V30, P1991, DOI 10.1089/neu.2012.2836; Penna S, 2007, ARCH PHYS MED REHAB, V88, P1360, DOI 10.1016/j.apmr.2007.07.005; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shimony JS, 1999, RADIOLOGY, V212, P770, DOI 10.1148/radiology.212.3.r99au51770; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith A., 1982, SYMBOL DIGIT MODALIT; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wallace E. J, 2018, BRAIN IMAGING BEHAV, P1; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wolfson, 1993, HALSTEAD REITAN NEUR	53	7	9	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2019	33	3					355	363		10.1080/02699052.2018.1553073			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HM7DB	WOS:000459636400011	30563361				2022-02-06	
J	He, QG; Zhou, Y; Liu, C; Zhang, X; Huang, N; Wang, F; Liu, GD; Cheng, Y; Xie, ZY				He, Qiuguang; Zhou, You; Liu, Chang; Zhang, Xiang; Huang, Ning; Wang, Feng; Liu, Guodong; Cheng, Yuan; Xie, Zongyi			Thromboelastography with Platelet Mapping Detects Platelet Dysfunction in Patients with Aneurysmal Subarachnoid Hemorrhage with Rebleeding	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						aneurysmal subarachnoid hemorrhage; thromboelastography; platelet function; rebleeding	TRAUMATIC BRAIN-INJURY; ACTIVATION; INFLAMMATION	Background: Aneurysmal subarachnoid hemorrhage (aSAH) has high rates of disability and mortality, and aneurysm rebleeding is associated with poor functional outcomes. Thrombelastography with platelet mapping (TEG-PM) measures platelet function; however, it has not yet been researched in aSAH. We aimed to use TEG-PM to detect changes in platelet function in patients with aSAH and the difference in patients with and without rebleeding. Methods: We retrospectively included patients with aSAH who underwent a TEG-PM test on admission. Rebleeding was diagnosed according to clinical and imaging data. TEG-PM data of patients with unruptured intracranial aneurysms (UIA) were also obtained as controls. Univariate and multivariate logistic regression models were performed to investigate the relationship between the platelet function and rebleeding. Results: A total of 245 aSAH patients and 32 UIA patients were included in our study. Compared with controls, patients with aSAH demonstrated higher arachidonic acid (AA) and adenosine diphosphate (ADP) inhibition of platelet function (P<0.05). Among them, 27 patients with Hunt-Hess grade IV or V were classified as the severe SAH group. There was a significant correlation between the severe SAH group and the degree of pathway inhibition (P<0.05). Furthermore, AA (Spearman's r=0.264, P<0.001) and ADP (Spearman's r=0.183, P=0.004) inhibition were elevated in Hunt-Hess grade-dependent manners. The AA (Spearman's r=0.169, P=0.008) and ADP (Spearman's r=0.233, P<0.001) inhibition were also significantly correlated with Fisher grade. Thirty-five patients (14.3%) suffered rebleeding. Rebleeding was significantly correlated with systolic blood pressure (P=0.011), diastolic blood pressure (P=0.008), Hunt-Hess grade (P=0.034), Fisher grade (P=0.015), AA inhibition (P<0.001), and ADP inhibition (P<0.001). Multivariate logistic regression analysis model revealed that both AA (P=0.037) and ADP inhibition (P=0.008) were independent determinants for rebleeding. Conclusion: TEG-PM may assess platelet dysfunction in patients with aSAH, and the diminished platelet response to ADP and AA may be associated with rebleeding. These findings deserve further investigation.	[He, Qiuguang; Zhang, Xiang; Huang, Ning; Wang, Feng; Liu, Guodong; Cheng, Yuan; Xie, Zongyi] Chongqing Med Univ, Hosp 2, Dept Neurosurg, Chongqing, Peoples R China; [Zhou, You] Chongqing Med Univ, Affiliated Hosp 2, Dept Crit Care Med, Chongqing, Peoples R China; [Liu, Chang] Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, Chongqing, Peoples R China		Xie, ZY (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Neurosurg, Chongqing 400010, Peoples R China.	zyxieneuro2013@yahoo.com		He, Qiuguang/0000-0001-8680-7670			Baharoglu MI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001245.pub2; Bochsen Louise, 2007, Thromb J, V5, P3, DOI 10.1186/1477-9560-5-3; Boluijt J, 2015, J CEREBR BLOOD F MET, V35, P724, DOI 10.1038/jcbfm.2015.13; Boogaarts HD, 2015, J NEUROSURG, V122, P921, DOI 10.3171/2014.12.JNS14931; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Collyer TC, 2009, BRIT J ANAESTH, V102, P492, DOI 10.1093/bja/aep039; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Conzen C, 2019, TRANSL STROKE RES, V10, P566, DOI 10.1007/s12975-018-0674-3; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; DOCZI T, 1986, NEUROSURGERY, V18, P733, DOI 10.1227/00006123-198606000-00010; Friedrich V, 2010, NEUROSCIENCE, V165, P968, DOI 10.1016/j.neuroscience.2009.10.038; Frontera JA, 2012, J THROMB HAEMOST, V10, P711, DOI 10.1111/j.1538-7836.2012.04651.x; Frontera JA, 2017, NEUROCRIT CARE, V26, P48, DOI 10.1007/s12028-016-0292-4; Fujimoto M, 2016, J NEUROSURG, V124, P1693, DOI 10.3171/2015.4.JNS15484; HAINING JL, 1988, STROKE, V19, P898, DOI 10.1161/01.STR.19.7.898; Herbert JP, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070092; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; JUVELA S, 1991, J NEUROSURG, V74, P21, DOI 10.3171/jns.1991.74.1.0021; Kawano-Castillo J, 2014, STROKE, V45, P683, DOI 10.1161/STROKEAHA.113.003826; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Larsen CC, 2010, ACTA NEUROCHIR, V152, P1577, DOI 10.1007/s00701-010-0699-1; Larsen CC, 2013, WORLD NEUROSURG, V79, P307, DOI 10.1016/j.wneu.2012.06.023; Perez P, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1062-z; Ramchand P, 2016, WORLD NEUROSURG, V96, P215, DOI 10.1016/j.wneu.2016.04.002; Ray B, 2018, TRANSL STROKE RES, V9, P459, DOI 10.1007/s12975-017-0594-7; Siddiqui TI, 2013, CURR MED CHEM, V20, P2779, DOI 10.2174/0929867311320220004; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; van Donkelaar CE, 2015, STROKE, V46, P2100, DOI 10.1161/STROKEAHA.115.010037; Wikkelso A, 2017, ANAESTHESIA, V72, P519, DOI 10.1111/anae.13765; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Yin C, 2015, GENE, V563, P52, DOI 10.1016/j.gene.2015.03.009	31	7	8	0	3	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2019	15						3443	3451		10.2147/NDT.S229284			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	JX0LC	WOS:000503434400001	31908459	Green Published, gold			2022-02-06	
J	Hsu, SPC; Yeh, CC; Chou, YC; Shih, CC; Hu, CJ; Cherng, YG; Chen, TL; Liao, CC				Hsu, Sanford P. C.; Yeh, Chun-Chieh; Chou, Yi-Chun; Shih, Chun-Chuan; Hu, Chaur-Jong; Cherng, Yih-Giun; Chen, Ta-Liang; Liao, Chien-Chang			Stroke risk and outcomes in epilepsy patients: Two retrospective cohort studies based on National Health Insurance in Taiwan	ATHEROSCLEROSIS			English	Article						Epilepsy; Outcomes; Risk; Stroke	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; VALIDATION; COMORBIDITIES; HEMORRHAGE; PREDICTOR; COUNTRIES; SEIZURES	Background and aims: The risk of stroke in epileptic patients and the impact of epilepsy history on stroke patients' outcome have not been studied completely. Our purpose is to evaluate whether patients with epilepsy have increased risk of stroke or post-stroke mortality. Methods: In Study I, we conducted a retrospective cohort study of 6746 patients with newly diagnosed epilepsy and 26,984 persons without epilepsy between 2000 and 2008, in the database of National Health Insurance in Taiwan. The incidences and risks of stroke during the follow-up period were compared between cohorts until the end of 2013. In Study II, we conducted a nested cohort study of 484,990 hospitalized patients with newly diagnosed stroke between 2000 and 2009. We compared the short-term mortality and complications during stroke admission between stroke patients with previous epilepsy and those without epilepsy. Results: The epileptic cohort had an increased stroke risk (hazard ratio [HR] 2.24, 95% CI 2.02 to 2.49). The relationship between epilepsy and stroke risk remains significant in every age group and both sexes. Among hospitalized stroke patients, history of epilepsy was associated with complications, including pneumonia (odds ratio [OR] 1.08, 95% CI 1.00 to 1.18), urinary tract infection (OR 1.16, 95% CI 1.08 to 1.26), and longer stay (p < 0.0001) during the index stroke admission. Conclusions: Epileptic patients face increased stroke risk and adverse outcomes of stroke admission. It is necessary to develop a prevention strategy for stroke in epileptic patients.	[Hsu, Sanford P. C.] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei, Taiwan; [Hsu, Sanford P. C.] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Hsu, Sanford P. C.] Univ Virginia, Dept Neurosurg, Charlottesville, VA 22903 USA; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Chou, Yi-Chun] China Med Univ Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Shih, Chun-Chuan] Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Shuan Ho Hosp, Dept Neurol, Taipei, Taiwan; [Cherng, Yih-Giun; Liao, Chien-Chang] Taipei Med Univ, Shuan Ho Hosp, Dept Anesthesiol, New Taipei, Taiwan; [Cherng, Yih-Giun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Liao, Chien-Chang] Taipei Med Univ Hosp, Hlth Policy Res Ctr, Taipei, Taiwan; [Liao, Chien-Chang] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan		Chen, TL; Liao, CC (corresponding author), Taipei Med Univ, Dept Anesthesiol, 252 Wuxing St, Taipei 110, Taiwan.	ccliao@tmu.edu.tw			Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST106-2314-B-038-036-MY3, MOST106-2221-E-038-003]	Ministry of Science and Technology, Taiwan (MOST106-2314-B-038-036-MY3; MOST106-2221-E-038-003).	Bergey GK, 2004, NEUROLOGY, V63, pS40, DOI 10.1212/WNL.63.10_suppl_4.S40; Brodie MJ, 2000, LANCET, V356, P323, DOI 10.1016/S0140-6736(00)02515-0; Chang CS, 2014, SEIZURE-EUR J EPILEP, V23, P377, DOI 10.1016/j.seizure.2014.02.007; Chang CC, 2012, EPILEPSIA, V53, P987, DOI 10.1111/j.1528-1167.2012.03448.x; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chuang YC, 2012, EPILEPSIA, V53, P120, DOI 10.1111/j.1528-1167.2011.03316.x; Cleary P, 2004, LANCET, V363, P1184, DOI 10.1016/S0140-6736(04)15946-1; Cloyd J, 2006, EPILEPSY RES, V68, pS39, DOI 10.1016/j.eplepsyres.2005.07.016; COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; Feast A, 2012, EPILEPSIA, V53, P1349, DOI 10.1111/j.1528-1167.2012.03591.x; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Foreman, 2012, LANCET, V380; Gaitatzis A, 2004, EPILEPSIA, V45, P1613, DOI 10.1111/j.0013-9580.2004.17504.x; Graham NSN, 2013, STROKE, V44, P605, DOI 10.1161/STROKEAHA.111.000220; Gualtieri F, 2013, NEUROMOL MED, V15, P133, DOI 10.1007/s12017-012-8203-0; Hajat C, 2004, STROKE, V35, P1562, DOI 10.1161/01.STR.0000131903.04708.b8; HOLMES GL, 1980, CLIN ELECTROENCEPHAL, V11, P83, DOI 10.1177/155005948001100207; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Hung LC, 2017, J EPIDEMIOL, V27, P24, DOI 10.1016/j.je.2016.08.003; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Liao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031527; MATTSON RH, 1985, NEW ENGL J MED, V313, P145, DOI 10.1056/NEJM198507183130303; Murray C., 2012, LANCET, V380; Nikolaos T, 2004, MED SCI MONITOR, V10, pMT50; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Ottman R, 2011, EPILEPSIA, V52, P308, DOI 10.1111/j.1528-1167.2010.02927.x; Pinto Antonio, 2004, Semin Vasc Med, V4, P287, DOI 10.1055/s-2004-861497; Ramsay RE, 2004, NEUROLOGY, V62, pS24, DOI 10.1212/WNL.62.5_suppl_2.S24; Shih CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032540; SHINTON RA, 1987, LANCET, V1, P11; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Sung SF, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1769-8; Sung SF, 2016, INT J CARDIOL, V215, P277, DOI 10.1016/j.ijcard.2016.04.069; Talaat FM, 2015, INT J NEUROSCI, V125, P507, DOI 10.3109/00207454.2014.949704; Tan TY, 2009, EPILEPSIA, V50, P1579, DOI 10.1111/j.1528-1167.2009.02024.x; Tanaka A, 2013, SEIZURE-EUR J EPILEP, V22, P772, DOI 10.1016/j.seizure.2013.06.005; Tomoum HY, 2008, J CHILD NEUROL, V23, P1275, DOI 10.1177/0883073808318538; Wilner AN, 2014, EPILEPSY BEHAV, V32, P15, DOI 10.1016/j.yebeh.2013.12.032; Yeh CC, 2013, MAYO CLIN PROC, V88, P1091, DOI 10.1016/j.mayocp.2013.06.024; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547	41	7	7	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	JAN	2019	280						147	154		10.1016/j.atherosclerosis.2018.11.009			8	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	HI4LB	WOS:000456421100020	30521995				2022-02-06	
J	Hunnicutt, G; Murray, C; Lundgre, K; Crowe, A; Olson, L				Hunnicutt, Gwen; Murray, Christine; Lundgre, Kristine; Crowe, Allison; Olson, Loreen			Exploring Correlates of Probable Traumatic Brain Injury among Intimate Partner Violence Survivors	JOURNAL OF AGGRESSION MALTREATMENT & TRAUMA			English	Article						Traumatic brain injury; HELPS screening tool; intimate partner violence; abuse; domestic violence survivors; partner abuse; concussion	DOMESTIC VIOLENCE; BATTERED WOMEN; HEALTH CONSEQUENCES; HELP-SEEKING; HEAD; VICTIMS; TERRORISM; SYMPTOMS; STRESS; ABUSE	Although intimate partner violence (IPV) related (TBI) is increasingly recognized as an important area of concern, there is no existing research that seeks to identify correlates of IPV related TBI. Given the profound consequences of TBI, it is important to identify individual and social-ecological conditions that are associated with probable TBI among persons with a history of physical violence in their intimate partnerships. In this paper, we are concerned specifically with physical abuse that occurs in violent intimate relationships. The sample included 130 participants who were formerly abused by an intimate partner. This study was part of a larger research project that utilized a web-based survey to learn about the socio-ecological conditions surrounding IPV-related TBI. The HELPS screening tool was employed to calculate risk for TBI. Approximately half of the survey respondents (n= 64) were determined to have likely experienced IPV-related TBI. This finding is consistent with existing literature showing that TBIs are highly prevalent among individuals who have experienced IPV. Logistic regression analysis was used to explore the correlates of IPV-related TBI. The results show that punishment for the abuser, time since the relationship ended, and seeking help for the health consequences of IPV were significantly associated with probable TBI. Results, limitations, future directions and implications are discussed.	[Hunnicutt, Gwen] Univ North Carolina Greensboro, Dept Sociol, 316 Graham Bldg,POB 26170, Greensboro, NC 27402 USA; [Murray, Christine] Univ North Carolina Greensboro, Dept Counseling & Educ Dev, Greensboro, NC 27402 USA; [Lundgre, Kristine] Univ North Carolina Greensboro, Dept Commun Sci & Disorders, Greensboro, NC 27402 USA; [Crowe, Allison] East Carolina Univ, Dept Counselor Educ, Greenville, NC 27858 USA; [Olson, Loreen] Univ North Carolina Greensboro, Dept Commun Studies, Greensboro, NC 27402 USA		Hunnicutt, G (corresponding author), Univ North Carolina Greensboro, Dept Sociol, 316 Graham Bldg,POB 26170, Greensboro, NC 27402 USA.	gchunnic@uncg.edu	Hunnicutt, Gwen/AAS-1272-2020				Ackerman RJ, 2003, WOMEN THER, V26, P343, DOI 10.1300/J015v26n03_11; Arosarena OA, 2009, ARCH FACIAL PLAST S, V11, P48, DOI 10.1001/archfacial.2008.507; Banks ME, 2002, WOMEN THER, V25, P133, DOI 10.1300/J015v25n03_10; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Centers for Disease Control, 2010, OV INT PARTN VIOL US; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Corrigan J. D., 2001, AM J OBSTET GYNECOL, V188, P571; Covassin T, 2012, J NEUROSCI NURS, V44, P124, DOI 10.1097/JNN.0b013e318252737d; Crowe A, 2019, VIOLENCE GEND, V6, P64, DOI 10.1089/vio.2018.0003; Crowe A, 2015, PARTN ABUSE, V6, P157, DOI 10.1891/1946-6560.6.2.157; Diaz-Olavarrieta C, 1999, ARCH NEUROL-CHICAGO, V56, P681, DOI 10.1001/archneur.56.6.681; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; HOUSKAMP BM, 1991, J INTERPERS VIOLENCE, V6, P367, DOI 10.1177/088626091006003008; Hughes K, 2012, LANCET, V379, P1621, DOI 10.1016/S0140-6736(11)61851-5; Hunnicutt G, 2017, J FAM VIOLENCE, V32, P471, DOI 10.1007/s10896-016-9854-7; IVANY A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI DOI 10.1097/FCH.0000000000000094; Iverson KM, 2020, J INTERPERS VIOLENCE, V35, P2422, DOI 10.1177/0886260517702491; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Johnson MP, 2014, VIOLENCE AGAINST WOM, V20, P186, DOI 10.1177/1077801214521324; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kleinbaum DG., 2010, LOGISTIC REGRESSION, V3rd ed; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Leone JM, 2007, FAM RELAT, V56, P427, DOI 10.1111/j.1741-3729.2007.00471.x; Mechanic MB, 2008, VIOLENCE AGAINST WOM, V14, P1148, DOI 10.1177/1077801208323792; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Murray CE, 2013, RESPONDING TO FAMILY VIOLENCE: A COMPREHENSIVE, RESEARCH-BASED GUIDE FOR THERAPISTS, P1; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; Picard M., 1991, HELPS; Plichta SB, 2004, J INTERPERS VIOLENCE, V19, P1296, DOI 10.1177/0886260504269685; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Reichard AA, 2007, J HEAD TRAUMA REHAB, V22, P390, DOI 10.1097/01.HTR.0000300234.36361.b1; Roberts AR, 2005, J SOC SERV RES, V32, P33, DOI 10.1300/J079v32n01_03; St Ivany A, 2018, QUAL HEALTH RES, V28, P1708, DOI 10.1177/1049732318786705; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Tjaden P, 2000, NIJ PUBLICATION; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	40	7	7	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1092-6771	1545-083X		J AGGRESS MALTREAT T	J. Aggress. Maltreatment Trauma		2019	28	6			SI		677	694		10.1080/10926771.2019.1587656			18	Psychology, Clinical; Criminology & Penology; Family Studies; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology; Family Studies; Psychiatry	IM2YW	WOS:000477859700003					2022-02-06	
J	Ju, SM; Xu, C; Wang, G; Zhang, L				Ju, Shiming; Xu, Chen; Wang, Gan; Zhang, Lin			VEGF-C Induces Alternative Activation of Microglia to Promote Recovery from Traumatic Brain Injury	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Microglia; polarization; traumatic brain injury; VEGF-C; VEGFR3	MACROPHAGE; LYMPHANGIOGENESIS; INFLAMMATION; EXPRESSION; GENE	Traumatic brain injury (TBI), a brain disorder that causes death and long-term disability in humans, is increasing in prevalence, though there is a lack of protective or therapeutic strategies for mitigating the damage after TBI and for preserving neurological functionality. Microglia cells play a key role in neuroinflammation following TBI, but their regulation and polarization by a member of the vascular endothelial growth factor (VEGF) family, VEGF-C, is unknown. Here, we show that VEGF-C induced M2 polarization in a murine microglia cell line, BV-2, in vitro, by a mechanism that required signaling from its unique receptor, VEGF receptor 3 (VEGFR3). Moreover, in a TBI model in rats, VEGF-C administration induced M2 polarization of microglia cells, significantly improved motor deficits after experimental TBI, and significantly improved neurological function following TBI, likely through a reduction in cell apoptosis. Together, our data reveal a previously unknown role of VEGF-C/VEGFR3 signaling in the regulation of post-TBI microglia cell polarization, which appears to be crucial for recovery from TBI.	[Ju, Shiming; Xu, Chen; Wang, Gan; Zhang, Lin] Shanghai Jiao Tong Univ, Dept Neurosurg, Affiliated Peoples Hosp 6, Sch Med, 600 Yishan Rd, Shanghai 200233, Peoples R China		Zhang, L (corresponding author), Shanghai Jiao Tong Univ, Dept Neurosurg, Affiliated Peoples Hosp 6, Sch Med, 600 Yishan Rd, Shanghai 200233, Peoples R China.	18930170167@163.com					Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Cao RH, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.989777; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Fukuda S, 1996, HUM MUTAT, V7, P123, DOI 10.1002/(SICI)1098-1004(1996)7:2<123::AID-HUMU6>3.0.CO;2-D; Hu JM, 2017, EXP MOL PATHOL, V102, P15, DOI 10.1016/j.yexmp.2016.12.001; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kochanek PM, 2016, LANCET NEUROL, V15, P13, DOI 10.1016/S1474-4422(15)00339-7; Liu F, 2014, STROKE, V45, P3691, DOI 10.1161/STROKEAHA.114.006635; Maegele M, 2018, LANCET NEUROL, V17, P13, DOI 10.1016/S1474-4422(17)30419-2; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Marnat G, 2015, J NEURO-ONCOL, V125, P443, DOI 10.1007/s11060-015-1921-z; Mauceri D, 2011, NEURON, V71, P117, DOI 10.1016/j.neuron.2011.04.022; Moussai D, 2011, J INVEST DERMATOL, V131, P229, DOI 10.1038/jid.2010.266; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008; Savitz SI, 2016, STEM CELLS, V34, P537, DOI 10.1002/stem.2253; Shi VY, 2012, MICROCIRCULATION, V19, P567, DOI 10.1111/j.1549-8719.2012.00189.x; Shibata MA, 2012, MED MOL MORPHOL, V45, P179, DOI 10.1007/s00795-012-0576-5; Shin YJ, 2015, J HISTOCHEM CYTOCHEM, V63, P170, DOI 10.1369/0022155414564218; Wen YR, 2018, NEURAL REGEN RES, V13, P709, DOI 10.4103/1673-5374.230299; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zhang JN, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0797-5	28	7	8	1	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2019	68	4					1687	1697		10.3233/JAD-190063			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HU9KE	WOS:000465612500031	30958378				2022-02-06	
J	Jutzeler, CR; Streijger, F; Aguilar, J; Shortt, K; Manouchehri, N; Okon, E; Hupp, M; Curt, A; Kwon, BK; Kramer, JLK				Jutzeler, Catherine R.; Streijger, Femke; Aguilar, Juan; Shortt, Katelyn; Manouchehri, Neda; Okon, Elena; Hupp, Markus; Curt, Armin; Kwon, Brian K.; Kramer, John L. K.			Sensorimotor plasticity after spinal cord injury: a longitudinal and translational study	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							BRAIN WAVE ACTIVITY; ONE-YEAR EVOLUTION; EVOKED POTENTIALS; NEUROPATHIC PAIN; PORCINE MODEL; MOTOR CORTEX; REORGANIZATION; STIMULATION; ENHANCEMENT	Objective The objective was to track and compare the progression of neuroplastic changes in a large animal model and humans with spinal cord injury. Methods A total of 37 individuals with acute traumatic spinal cord injury were followed over time (1, 3, 6, and 12 months post-injury) with repeated neurophysiological assessments. Somatosensory and motor evoked potentials were recorded in the upper extremities above the level of injury. In a reverse-translational approach, similar neurophysiological techniques were examined in a porcine model of thoracic spinal cord injury. Twelve Yucatan mini-pigs underwent a contusive spinal cord injury at T10 and tracked with somatosensory and motor evoked potentials assessments in the fore- and hind limbs pre- (baseline, post-laminectomy) and post-injury (10 min, 3 h, 12 weeks). Results In both humans and pigs, the sensory responses in the cranial coordinates of upper extremities/forelimbs progressively increased from immediately post-injury to later time points. Motor responses in the forelimbs increased immediately after experimental injury in pigs, remaining elevated at 12 weeks. In humans, motor evoked potentials were significantly higher at 1-month (and remained so at 1 year) compared to normative values. Conclusions Despite notable differences between experimental models and the human condition, the brain's response to spinal cord injury is remarkably similar between humans and pigs. Our findings further underscore the utility of this large animal model in translational spinal cord injury research.	[Jutzeler, Catherine R.; Manouchehri, Neda; Okon, Elena; Hupp, Markus; Curt, Armin] Univ Zurich, Univ Hosp Balgrist, Spinal Cord Injury Ctr, Zurich, Switzerland; [Jutzeler, Catherine R.; Streijger, Femke; Shortt, Katelyn; Kwon, Brian K.; Kramer, John L. K.] Univ British Columbia, ICORD, Vancouver, BC, Canada; [Jutzeler, Catherine R.; Kramer, John L. K.] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada; [Aguilar, Juan] Hosp Nacl Paraplejicos, Expt Neurophysiol Grp, SESCAM, Toledo, Spain; [Curt, Armin] Univ Zurich, Univ Hosp Balgrist, European Multictr Study Spinal Cord Injury EMSCI, CH-8008 Zurich, Switzerland		Jutzeler, CR (corresponding author), 818 W 10th Ave, Vancouver, BC V5Z 1M9, Canada.	catherine.jutzeler@ubc.ca	Aguilar, Juan/Q-2206-2015; Aguilar, Juan/N-3850-2019	Aguilar, Juan/0000-0002-8070-3923; Aguilar, Juan/0000-0002-8070-3923; Hupp, Markus/0000-0003-0845-2514	Clinical Research Priority Program in Neurorehabilitation of the University of Zurich, Switzerland [320030_169250]; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC) [1502]; International Foundation for Research in Paraplegia (IRP) [F16-01769]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [P2EZP3_172162]; Craig H. Neilsen Foundation [460378]; Spanish Government, Ministerio de Ciencia Innovacion y Universidades [BFU-2016-80665-P]; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; Rick Hansen Institute Scholar Award	The study was supported by Clinical Research Priority Program in Neurorehabilitation of the University of Zurich, Switzerland (Armin Curt, 320030_169250) and NSERC Discovery Grant (John Kramer, 1502). CRJ is supported by postdoctoral research fellowships from International Foundation for Research in Paraplegia (IRP, F16-01769), the Swiss National Science Foundation (P2EZP3_172162), and the Craig H. Neilsen Foundation (460378). JA is supported by a grant from Spanish Government, Ministerio de Ciencia Innovacion y Universidades (BFU-2016-80665-P). JLKK is supported by the Michael Smith Foundation for Health Research and Rick Hansen Institute Scholar Award.	Agoston DV, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00092; Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Bazley FA, 2014, IEEE T NEUR SYS REH, V22, P953, DOI 10.1109/TNSRE.2014.2319313; Boord P, 2008, SPINAL CORD, V46, P118, DOI 10.1038/sj.sc.3102077; Brandt ME, 1984, INT J NEUROSCI, V1991, P261; Curt A, 2002, BRAIN, V125, P2567, DOI 10.1093/brain/awf250; Davey NJ, 1998, J NEUROL NEUROSUR PS, V65, P80, DOI 10.1136/jnnp.65.1.80; Ding YM, 2005, CURR PHARM DESIGN, V11, P1441, DOI 10.2174/1381612053507855; Finnerup NB, 2014, J PAIN, V15, P40, DOI 10.1016/j.jpain.2013.09.008; Ghosh A, 2010, NAT NEUROSCI, V13, P97, DOI 10.1038/nn.2448; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Herbert D, 2007, INT J NEUROSCI, V117, P1731, DOI 10.1080/00207450701242826; Hou SP, 2014, COMPR PHYSIOL, V4, P1419, DOI 10.1002/cphy.c130045; Humanes-Valera D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07278; Humanes-Valera D, 2016, CEREB CORTEX, DOI 10.1093/cercor/bhw142.; Humanes-Valera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069655; Jutzeler CR, 2015, NEUROIMAGE-CLIN, V9, P599, DOI 10.1016/j.nicl.2015.09.018; Jutzeler CR, 2016, SCI REP-UK, V6, DOI 10.1038/srep18534; Jutzeler CR, 2015, J PAIN, V16, P1256, DOI 10.1016/j.jpain.2015.08.008; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kramer JLK, 2008, J NEUROTRAUM, V25, P1019, DOI 10.1089/neu.2007.0503; Kuhn F, 2012, J NEUROTRAUM, V29, P1829, DOI 10.1089/neu.2011.2277; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lee JHT, 2013, J NEUROTRAUM, V30, P142, DOI 10.1089/neu.2012.2386; LEVY WJ, 1990, BRAIN RES, V510, P130, DOI 10.1016/0006-8993(90)90738-W; Petersen JA, 2012, NEUROREHAB NEURAL RE, V26, P939, DOI 10.1177/1545968312438437; RAHN E, 1993, INT J NEUROSCI, V72, P123, DOI 10.3109/00207459308991629; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Sauseng P, 2009, NEUROPSYCHOLOGIA, V47, P284, DOI 10.1016/j.neuropsychologia.2008.07.021; Spiess M, 2008, CLIN NEUROPHYSIOL, V119, P1051, DOI 10.1016/j.clinph.2008.01.021; Streijger F, 2015, J NEUROTRAUM, V32, P908, DOI 10.1089/neu.2014.3707; Streletz Leopold J., 1995, Brain Topography, V7, P245, DOI 10.1007/BF01202383; TOPKA H, 1991, NEUROLOGY, V41, P1276, DOI 10.1212/WNL.41.8.1276; Tran Y, 2004, SPINAL CORD, V42, P73, DOI 10.1038/sj.sc.3101543; Wrigley PJ, 2009, PAIN, V141, P52, DOI 10.1016/j.pain.2008.10.007	36	7	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	JAN	2019	6	1					68	82		10.1002/acn3.679			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HH7MM	WOS:000455915000007	30656185	Green Published, Green Accepted, gold			2022-02-06	
J	Kamnaksh, A; Puhakka, N; Ali, I; Smith, G; Aniceto, R; McCullough, J; Das Gupta, S; Ndode-Ekane, XE; Brady, R; Casillas-Espinosa, P; Hudson, M; Santana-Gomez, C; Immonen, R; de Abreu, PA; Jones, N; Shultz, S; Staba, RJ; O'Brien, TJ; Agoston, D; Pitkanen, A				Kamnaksh, Alaa; Puhakka, Noora; Ali, Idrish; Smith, Gregory; Aniceto, Roxanne; McCullough, Jesse; Das Gupta, Shalini; Ndode-Ekane, Xavier Ekolle; Brady, Rhys; Casillas-Espinosa, Pablo; Hudson, Matt; Santana-Gomez, Cesar; Immonen, Riikka; de Abreu, Pedro Andrade; Jones, Nigel; Shultz, Sandy; Staba, Richard J.; O'Brien, Terence J.; Agoston, Denes; Pitkanen, Asia			Harmonization of pipeline for preclinical multicenter plasma protein and miRNA biomarker discovery in a rat model of post-traumatic epileptogenesis	EPILEPSY RESEARCH			English	Article						Case report form; Common data elements; Post-traumatic epilepsy; Quality control; Standardization; Traumatic brain injury	COMMON DATA ELEMENTS; CIRCULATING MICRORNAS; EPILEPSY; SERUM; BRAIN; OSCILLATIONS; ANESTHESIA; ISOFLURANE; IMPACT	The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) is an international, multicenter, multidisciplinary study aimed at preventing epileptogenesis (EpiBioS4Rx: https://epibios.loni.usc.edu/). One of the study's major objectives is the discovery of diagnostic, prognostic, and predictive plasma protein and microRNA (miRNA) biomarkers that are sensitive, specific, and translatable to the human condition. Epilepsy due to structural brain abnormalities, secondary to neurological insults such as traumatic brain injury (TBI), currently represents similar to 50% of all epilepsy cases. In the preclinical EpiBioS4Rx study, TBI was induced in adult male Sprague Dawley rats using a standardized protocol for lateral fluid-percussion injury. Whole blood was collected from the tail vein at baseline and 2, 9 and 30 days post-injury and processed for plasma separation. Biomaterial properties, sample preparation and integrity, and choice of analysis platform can significantly impact measured marker levels and, in turn, interpretation with respect to injury and/or other variables. We present here the results of procedural harmonization for the first 320 rats included in the EpiBioS4Rx study study, from three international research centers, and preliminary proteomic and miRNA analyses. We also discuss experimental considerations for establishing rigorous quality controls with the goal of harmonizing operating procedures across study sites, and delivering high-quality specimens for preclinical biomarker discovery in a rat model of post-traumatic epilepsy (PTE).	[Kamnaksh, Alaa; Aniceto, Roxanne; McCullough, Jesse; Agoston, Denes] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Puhakka, Noora; Das Gupta, Shalini; Ndode-Ekane, Xavier Ekolle; Immonen, Riikka; de Abreu, Pedro Andrade; Pitkanen, Asia] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Ali, Idrish; Brady, Rhys; Casillas-Espinosa, Pablo; Hudson, Matt; Jones, Nigel; Shultz, Sandy; O'Brien, Terence J.] Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic, Australia; [Ali, Idrish; Brady, Rhys; Casillas-Espinosa, Pablo; Hudson, Matt; Jones, Nigel; Shultz, Sandy; O'Brien, Terence J.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne, Vic, Australia; [Smith, Gregory] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Santana-Gomez, Cesar; Staba, Richard J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA		Kamnaksh, A (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	alaa.kamnaksh.ctr@usuhs.edu	Andrade, Pedro/N-8410-2018; Santana-Gomez, Cesar/AAY-1014-2021; Hudson, Matthew/AAH-9168-2020; O'Brien, Terence/AAU-5525-2021; Staba, Richard/AAN-3149-2021; O'Brien, Terence/L-8102-2013; Ali, Idrish/P-4989-2018	Andrade, Pedro/0000-0001-9118-8341; Santana-Gomez, Cesar/0000-0001-9163-5615; Ali, Idrish/0000-0002-0971-4654; Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632; O'Brien, Terence/0000-0002-7198-8621; Hudson, Matthew/0000-0001-5016-735X	National Institute of Neurological Disorders and Stroke (NINDS) Centers without Walls [U54 NS100064]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS100064] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS) Centers without Walls [grant number U54 NS100064].	Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Avila J, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00262; Bar-Klein G, 2016, ANN NEUROL, V80, P896, DOI 10.1002/ana.24804; Benveniste H, 2017, ANESTHESIOLOGY, V127, P976, DOI 10.1097/ALN.0000000000001888; Bibow S, 2011, J AM CHEM SOC, V133, P15842, DOI 10.1021/ja205836j; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; COHEN M, 1978, THROMB RES, V12, P965, DOI 10.1016/0049-3848(78)90052-X; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; EpiBioS4Rx, 2018, EP BIOINF STUD ANT T; Fort A, 2010, BLOOD, V116, P2608, DOI 10.1182/blood-2010-02-268011; Fortunato O, 2014, MOLECULES, V19, P3038, DOI 10.3390/molecules19033038; Gakuba C, 2018, THERANOSTICS, V8, P710, DOI 10.7150/thno.19154; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; Grasedieck S, 2012, LEUKEMIA, V26, P2414, DOI 10.1038/leu.2012.106; Grote T, 2008, PROTEOMICS, V8, P3051, DOI 10.1002/pmic.200700951; Gyorgy AB, 2010, J NEUROSCI METH, V192, P96, DOI 10.1016/j.jneumeth.2010.07.029; Harte-Hargrove LC, 2017, EPILEPSIA, V58, P78, DOI 10.1111/epi.13906; Heegaard NHH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160577; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kinoshita C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4823; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lapinlampi N, 2017, EPILEPSY RES, V129, P87, DOI 10.1016/j.eplepsyres.2016.11.010; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Nishizuka SS, 2016, DRUG METAB PHARMACOK, V31, P35, DOI 10.1016/j.dmpk.2015.11.009; Pitkanen A, 2019, NEUROBIOL DIS, V123, P42, DOI 10.1016/j.nbd.2018.05.007; Prahl S., 1999, OPTICAL ABSORPTION H; Roncon P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14143; Schifilliti D, 2010, CNS DRUGS, V24, P893, DOI 10.2165/11584760-000000000-00000; Shah JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153200; Signore M, 2017, METHODS MOL BIOL, V1606, P51, DOI 10.1007/978-1-4939-6990-6_4; SOULBAN G, 1989, LIFE SCI, V45, P2485, DOI 10.1016/0024-3205(89)90015-5; Sowemimo-Coker SO, 2002, TRANSFUS MED REV, V16, P46, DOI 10.1053/tmrv.2002.29404; Teruel-Montoya R, 2015, J THROMB HAEMOST, V13, P170, DOI 10.1111/jth.12788; van Vliet EA, 2017, EPILEPSIA, V58, P2013, DOI 10.1111/epi.13915; Vespa PM, 2019, NEUROBIOL DIS, V123, P110, DOI 10.1016/j.nbd.2018.07.025; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Weller MG, 2018, ANAL CHEM INSIGHTS, V13, DOI 10.1177/1177390118757462; Zaias J, 2009, J AM ASSOC LAB ANIM, V48, P387	45	7	7	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	JAN	2019	149						92	101		10.1016/j.eplepsyres.2018.11.009			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI9BY	WOS:000456751500016	30553097	Green Accepted			2022-02-06	
J	Kaup, AR; Toomey, R; Bangen, KJ; Delano-Wood, L; Yaffe, K; Panizzon, MS; Lyons, MJ; Franz, CE; Kremen, WS				Kaup, Allison R.; Toomey, Rosemary; Bangen, Katherine J.; Delano-Wood, Lisa; Yaffe, Kristine; Panizzon, Matthew S.; Lyons, Michael J.; Franz, Carol E.; Kremen, William S.			Interactive Effect of Traumatic Brain Injury and Psychiatric Symptoms on Cognition among Late Middle-Aged Men: Findings from the Vietnam Era Twin Study of Aging	JOURNAL OF NEUROTRAUMA			English	Article						aging; cognition; psychiatric symptoms; TBI	POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL OUTCOMES; PSYCHOMETRIC PROPERTIES; INDIVIDUAL-DIFFERENCES; APOLIPOPROTEIN-E; PTSD CHECKLIST; INCREASED RISK; DEMENTIA RISK; DEPRESSION; IMPAIRMENT	Traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), and depressive symptoms each increase the risk for cognitive impairment in older adults. We investigated whether TBI has long-term associations with cognition in late middle-aged men, and examined the role of current PTSD/depressive symptoms. Participants were 953 men (ages 56-66) from the Vietnam Era Twin Study of Aging (VETSA), who were classified by presence or absence of (1) history of TBI and (2) current elevated psychiatric symptoms (defined as PTSD or depressive symptoms above cutoffs). TBIs had occurred an average of 35 years prior to assessment. Participants completed cognitive testing examining nine domains. In mixed-effects models, we tested the effect of TBI on cognition including for interactions between TBI and elevated psychiatric symptoms. Models adjusted for age, pre-morbid cognitive ability assessed at average age 20 years, apolipoprotein E genotype, and substance abuse; 33% (n=310) of participants had TBI, mostly mild and remote; and 23% (n=72) of those with TBI and 18% (n=117) without TBI had current elevated psychiatric symptoms. TBI and psychiatric symptoms had interactive effects on cognition, particularly executive functioning. Group comparison analyses showed that men with both TBI and psychiatric symptoms demonstrated deficits primarily in executive functioning. Cognition was largely unaffected in men with either risk factor in isolation. Among late middle-aged men, the combination of even mild and very remote TBI with current elevated psychiatric symptoms is associated with deficits in executive function and related abilities. Future longitudinal studies should investigate how TBI and psychiatric factors interact to impact brain aging.	[Kaup, Allison R.] San Francisco VA Hlth Care Syst, Res Serv, 4150 Clement St,116B, San Francisco, CA 94121 USA; [Kaup, Allison R.] Univ Calif San Francisco, Dept Psychiat, Weill Inst Neurosci, 4150 Clement St,116B, San Francisco, CA 94121 USA; [Toomey, Rosemary; Lyons, Michael J.] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [Bangen, Katherine J.; Delano-Wood, Lisa; Panizzon, Matthew S.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Bangen, Katherine J.; Delano-Wood, Lisa; Panizzon, Matthew S.; Franz, Carol E.; Kremen, William S.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Panizzon, Matthew S.; Franz, Carol E.; Kremen, William S.] Univ Calif San Diego, Ctr Behav Genet Aging, La Jolla, CA 92093 USA; [Delano-Wood, Lisa] Vet Affairs San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, La Jolla, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Yaffe, Kristine] San Francisco VA Hlth Care Syst, San Francisco, CA USA		Kaup, AR (corresponding author), San Francisco VA Hlth Care Syst, Res Serv, 4150 Clement St,116B, San Francisco, CA 94121 USA.; Kaup, AR (corresponding author), Univ Calif San Francisco, Dept Psychiat, Weill Inst Neurosci, 4150 Clement St,116B, San Francisco, CA 94121 USA.	allison.kaup@ucsf.edu			National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01s AG018384, AG018386, AG050595, R01 AG022381, R01 AG022982]; United States Department of Veterans Affairs, Rehabilitation Research and Development Service [1IK2RX001629]; United States Department of Veterans Affairs, Clinical Science Research and Development Service [1IK2CX000938]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG050595, R01AG022381] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2RX001629, IK2CX000938] Funding Source: NIH RePORTER	The content of this manuscript is the responsibility of the authors and does not represent official views of the National Institutes of Health (NIH), the VA, the United States Department of Veterans Affairs, or the United States government. The United States Department of Veterans Affairs, DOD; National Personnel Records Center, National Archives and Records Administration; Internal Revenue Service; National Opinion Research Center; National Research Council, National Academy of Sciences; and the Institute for Survey Research, Temple University provided invaluable assistance in the conducting of the VET Registry. The authors gratefully acknowledge the continued cooperation of the twins and the efforts of many staff members. VETSA has been supported by the National Institute of Aging: R01s AG018384, AG018386, and AG050595 (PIs: Drs. Kremen and Lyons), R01 AG022381 (PI: Dr. Kremen), and R01 AG022982 (PI: Dr. Kremen). Dr. Kaup is supported by Career Development Award (1IK2RX001629) from the United States Department of Veterans Affairs, Rehabilitation Research and Development Service. Dr. Bangen is supported by Career Development Award (1IK2CX000938) from the United States Department of Veterans Affairs, Clinical Science Research and Development Service.	Albrecht MA, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00105; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Ashman TA, 2006, MT SINAI J MED, V73, P999; Barnes D.E., 2018, JAMA NEUROL; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bookheimer S, 2009, ANNU REV CLIN PSYCHO, V5, P343, DOI 10.1146/annurev.clinpsy.032408.153625; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Centers for Disease Control and Prevention, 2016, TBI GET FACTS; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Department of Veterans Affairs Department of Defense, 2009, CLIN PRACT GUID MAN; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; EISEN S, 1987, ACTA GENET MED GEMEL, V36, P61, DOI 10.1017/S0001566000004591; Ekstrom RB., 1976, MANUAL KIT FACTOR RE; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; Franz CE, 2011, AM J GERIAT PSYCHIAT, V19, P559, DOI 10.1097/JGP.0b013e3181ef79f1; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Golden CJ, 1978, STROOP COLOR WORD TE; Gong QY, 2015, BIOL PSYCHIAT, V77, P223, DOI 10.1016/j.biopsych.2014.08.009; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HENDERSON WG, 1990, PUBLIC HEALTH REP, V105, P368; HIXSON JE, 1990, J LIPID RES, V31, P545; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Ikin JF, 2010, J AFFECT DISORDERS, V125, P279, DOI 10.1016/j.jad.2009.12.005; Institute of Medicine (IoM), 2008, GULF WAR HLTH; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kaup AR, 2017, J INT NEUROPSYCH SOC, V23, P56, DOI 10.1017/S1355617716000849; Kremen WS, 2006, TWIN RES HUM GENET, V9, P1009, DOI 10.1375/twin.9.6.1009; Kremen WS, 2013, TWIN RES HUM GENET, V16, P399, DOI 10.1017/thg.2012.86; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; Miller SC, 2015, OCCUP ENVIRON MED, V72, P560, DOI 10.1136/oemed-2014-102646; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Moore CS, 2014, PSYCHOL AGING, V29, P163, DOI 10.1037/a0035463; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Plassman Brenda L, 2015, Handb Clin Neurol, V128, P711, DOI 10.1016/B978-0-444-63521-1.00044-3; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Soble JR, 2013, J CLIN EXP NEUROPSYC, V35, P551, DOI 10.1080/13803395.2013.798398; Sundstrom A, 2007, INT PSYCHOGERIATR, V19, P159, DOI 10.1017/S1041610206003498; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Thurstone L. L, 1944, FACTORIAL STUDY PERC; Uhlaner J. E., 1952, DEV ARMED FORCES QUA; US Department of Veterans Affairs and National Center for PTSD, 2014, US PTSD CHECKL DSM 4; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, MANUAL WECHSLER MEMO; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Young JS, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0719-9	75	7	7	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					338	347		10.1089/neu.2018.5695			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800016	29978738	Green Published			2022-02-06	
J	Kuharic, J; Grabusic, K; Tokmadzic, VS; Stifter, S; Tulic, K; Shevchuk, O; Lucin, P; Sustic, A				Kuharic, Janja; Grabusic, Kristina; Tokmadzic, Vlatka Sotosek; Stifter, Sanja; Tulic, Ksenija; Shevchuk, Olga; Lucin, Pero; Sustic, Alan			Severe Traumatic Brain Injury Induces Early Changes in the Physical Properties and Protein Composition of Intracranial Extracellular Vesicles	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; cerebrospinal fluid; neuroplasticity; traumatic brain injury	CEREBROSPINAL-FLUID; MICROPARTICLES; EXOSOMES; REGENERATION; PATHOGENESIS; COAGULATION; SECRETION; ADHESION; DISEASE; IMPACT	Extracellular vesicles (EVs) are membranous nanostructures that can indicate undergoing processes in organs and thus help in diagnostics and prognostics. They are secreted by all cells, contained in body fluids, and able to transfer proteins, lipids and nucleic acids to distant cells. Intracranial EVs were shown to change their composition after severe traumatic brain injury (TBI) and therefore to have biomarker potential to evaluate brain events. Properties of intracranial EVs early after TBI, however, have not been characterized. Here, we assessed cerebrospinal fluid (CSF) up to seven days after isolated severe TBI for physical properties of EVs and their proteins associated with neuroregeneration. These findings were compared with healthy controls and correlated to patient outcome. The study included 17 patients with TBI and 18 healthy controls. EVs in TBI-CSF were visualized by electron microscopy and confirmed by immunoblotting for membrane associated Flotillin-1 and Flotillin-2. Using nanoparticle tracking analysis, we detected the highest range in EV concentration at day 1 after injury and significantly increased EV size at days 4-7. CSF concentrations of neuroregeneration associated proteins Flotillin-1, ADP-ribosylation Factor 6 (Arf6), and Ras-related protein Rab7a (Rab7a) were monitored by enzyme-linked immunosorbent assays. Flotillin-1 was detected solely in TBI-CSF in about one third of tested patients. Unfavorable outcomes included decreasing Arf6 concentrations and a delayed Rab7a concentration increase in CSF. CSF concentrations of Arf6 and Rab7a were negatively correlated. Our data suggest that the brain response within several days after severe TBI includes shedding of EVs associated with neuroplasticity. Extended studies with a larger number of participants and CSF collected at shorter intervals are necessary to further evaluate neuroregeneration biomarker potential of Rab7a, Arf6, and Flotillin-1.	[Kuharic, Janja; Tokmadzic, Vlatka Sotosek; Sustic, Alan] Univ Rijeka, Dept Anaesthesia Resuscitat & Intens Care Med, Fac Med, Rijeka, Croatia; [Kuharic, Janja; Tokmadzic, Vlatka Sotosek; Sustic, Alan] Clin Hosp Ctr Rijeka, Dept Anaesthesia & Intens Care Med, Rijeka, Croatia; [Grabusic, Kristina] Univ Rijeka, Dept Biotechnol, Radmile Matejcic 2, Rijeka 51000, Croatia; [Tokmadzic, Vlatka Sotosek; Sustic, Alan] Univ Rijeka, Fac Hlth Studies, Dept Clin Med Sci 2, Rijeka, Croatia; [Stifter, Sanja] Univ Rijeka, Fac Med, Dept Gen Pathol & Pathol Anat, Rijeka, Croatia; [Stifter, Sanja] Clin Hosp Ctr Rijeka, Dept Pathol, Rijeka, Croatia; [Tulic, Ksenija; Lucin, Pero] Univ Rijeka, Dept Physiol & Immunol, Fac Med, Rijeka, Croatia; [Shevchuk, Olga] Leibniz Inst Analyt Wissensch, ISAS Campus, Dortmund, Germany		Grabusic, K (corresponding author), Univ Rijeka, Dept Biotechnol, Radmile Matejcic 2, Rijeka 51000, Croatia.	kristina.grabusic@biotech.uniri.hr	Tarcukovic, Janja/P-9468-2018; Lucin, Pero/R-8341-2018; Grabusic, Kristina/ABE-3317-2021; Shevchuk, Olga/AAX-2808-2021; Grabusic, Kristina/Q-8708-2018	Tarcukovic, Janja/0000-0002-3591-0341; Lucin, Pero/0000-0001-8776-8634; Grabusic, Kristina/0000-0002-4165-0291; Grabusic, Kristina/0000-0002-4165-0291	Croatian Science Foundation [IP-2014-9-9564]; University of Rijeka, Rijeka, Croatia [13.06.1.1.12, 13.06.1.1.4]	This work was supported by Croatian Science Foundation (grant IP-2014-9-9564) and grant sponsor University of Rijeka, Rijeka, Croatia (contract grant numbers: 13.06.1.1.12. and 13.06.1.1.4).	Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Akiyama Masahiro, 2015, Small GTPases, V6, P160, DOI 10.1080/21541248.2015.1043041; Akiyama M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5744; Andrews AM, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00043; Basso M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00127; Bianco F, 2005, J IMMUNOL, V174, P7268, DOI 10.4049/jimmunol.174.11.7268; Bodin S, 2014, J CELL SCI, V127, P5139, DOI 10.1242/jcs.159764; Bohman LE, 2016, J NEUROTRAUM, V33, P168, DOI 10.1089/neu.2015.3885; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chiasserini D, 2014, J PROTEOMICS, V106, P191, DOI 10.1016/j.jprot.2014.04.028; Chivet M, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24722; Chivet M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00145; Ciregia F, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00276; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dickens AM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai7696; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Gangoda L, 2015, PROTEOMICS, V15, P260, DOI 10.1002/pmic.201400234; Glebov K, 2015, GLIA, V63, P626, DOI 10.1002/glia.22772; Gupta A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-68; Hannawi Y, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0642-9; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Hazelton I, 2018, J NEUROTRAUM, V35, P639, DOI 10.1089/neu.2017.5049; Kim Y, 2015, J BIOL CHEM, V290, P7323, DOI 10.1074/jbc.M114.634527; Koch JC, 2013, NEUROBIOL DIS, V51, P168, DOI 10.1016/j.nbd.2012.11.007; Kumar D, 2018, MOL NEUROBIOL, V55, P2112, DOI 10.1007/s12035-017-0474-x; Lachenal G, 2011, MOL CELL NEUROSCI, V46, P409, DOI 10.1016/j.mcn.2010.11.004; Lane RE, 2015, SCI REP-UK, V5, DOI 10.1038/srep07639; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mahmutefendic H, 2017, J CELL PHYSIOL, V232, P872, DOI 10.1002/jcp.25495; Midura EF, 2015, J SURG RES, V197, P25, DOI 10.1016/j.jss.2015.02.064; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Nekludov M, 2014, J NEUROTRAUM, V31, P1927, DOI 10.1089/neu.2013.3168; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Park K, 2013, FUTUR NEUROL, V8, P555, DOI 10.2217/FNL.13.35; Patz S, 2013, J NEUROTRAUM, V30, P1232, DOI 10.1089/neu.2012.2596; Pegtel D.M., 2014, PHILOS T R SOC LON B, P369; Raiborg C, 2015, NATURE, V520, P234, DOI 10.1038/nature14359; Saxena S, 2005, J NEUROSCI, V25, P10930, DOI 10.1523/JNEUROSCI.2029-05.2005; Schulte T, 1997, DEVELOPMENT, V124, P577; Silva-Vargas V, 2016, CELL STEM CELL, V19, P643, DOI 10.1016/j.stem.2016.06.013; Sommer JB, 2002, EUR NEUROL, V47, P224, DOI 10.1159/000057904; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Stuermer CAO, 2012, CELL TISSUE RES, V349, P71, DOI 10.1007/s00441-012-1343-6; Tang BL, 2016, J CELL PHYSIOL, V231, P1417, DOI 10.1002/jcp.25261; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thompson AG, 2016, NAT REV NEUROL, V12, P346, DOI 10.1038/nrneurol.2016.68; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Vaccari JPD, 2016, J NEUROCHEM, V136, P39, DOI 10.1111/jnc.13036; van der Pol E, 2016, J THROMB HAEMOST, V14, P48, DOI 10.1111/jth.13190; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Wang KZ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0853-2; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Werner JK, 2015, CURR OPIN NEUROL, V28, P565, DOI 10.1097/WCO.0000000000000265; Yang Y, 2015, J NEUROPATH EXP NEUR, V74, P672, DOI 10.1097/NEN.0000000000000207	64	7	7	3	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					190	200		10.1089/neu.2017.5515			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800002	29690821				2022-02-06	
J	Ma, H; Li, HT; Liu, XC; Li, WC; Xia, JY; Liu, BY; Shi, XT; Dong, XZ; Fu, F				Ma, Hang; Li, Haoting; Liu, Xuechao; Li, Weichen; Xia, Junying; Liu, Benyuan; Shi, Xuetao; Dong, Xiuzhen; Fu, Feng			Real-Time Monitoring of Contact Impedance From Multiple Electrode-Scalp Interfaces During Cerebral Electrical Impedance Tomography	IEEE ACCESS			English	Article						Contact impedance; electrical impedance tomography; electrode-scalp interface	IN-VIVO; HEMORRHAGE; BRAIN; MODEL; RECONSTRUCTION; HEAD; EEG; EIT	Electrical impedance tomography (EIT) is a promising medical technique for monitoring brain injury through the reflection of electrical impedance changes in internal brain tissues. However, the contact impedances at the electrode-scalp interfaces can still notably affect the EIT accuracy. Hence, we propose a method for real-time monitoring the multi-channel contact impedances of cerebral EIT using a reference electrode attached close to the head vertex. This method allows to approximate inter-channel differences and changes over time of multi-channel contact impedances. The experimental results on 36 volunteers show that the maximum relative inter-channel difference obtained from 16 disposable surface electrodes reaches 18.7%, and the maximum relative change over time reaches 19.2%. The proposed method can assist clinicians in real-time monitoring of contact conditions from the multiple electrode-scalp interfaces during the clinical application of the cerebral EIT.	[Ma, Hang; Li, Haoting; Liu, Xuechao; Li, Weichen; Xia, Junying; Liu, Benyuan; Shi, Xuetao; Dong, Xiuzhen; Fu, Feng] Air Force Med Univ, Sch Biomed Engn, Xian 710032, Shaanxi, Peoples R China		Dong, XZ; Fu, F (corresponding author), Air Force Med Univ, Sch Biomed Engn, Xian 710032, Shaanxi, Peoples R China.	dongxiuzhen@fmmu.edu.cn; fengfu@fmmu.edu.cn	; li, weichen/L-1905-2018	xia, juying/0000-0002-6755-3043; Ma, hang/0000-0002-8012-1317; Li, Haoting/0000-0002-0496-6705; Fu, Feng/0000-0002-4286-5227; li, weichen/0000-0002-6998-9246	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51837011, 61571445]	This work was supported in part by the Project of the National Natural Science Foundation of China under Grant 51837011, and in part by the National Natural Science Foundation of China under Grant 61571445.	Adler A, 2004, PHYSIOL MEAS, V25, P227, DOI 10.1088/0967-3334/25/1/028; [Anonymous], 2015, 60601122015 INT EL C; Avery J, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17020280; BARBER CC, 1983, ELECTRON LETT, V19, P933, DOI 10.1049/el:19830637; Bayford R, 2012, ANALYST, V137, P4635, DOI 10.1039/c2an35874c; Boone KG, 1996, MED BIOL ENG COMPUT, V34, P351, DOI 10.1007/BF02520003; Boverman G, 2016, PHYSIOL MEAS, V37, P727, DOI 10.1088/0967-3334/37/6/727; Boyle A, 2011, PHYSIOL MEAS, V32, DOI 10.1088/0967-3334/32/7/S02; Cardu R, 2012, PHYSIOL MEAS, V33, P817, DOI 10.1088/0967-3334/33/5/817; Casas O, 1999, ANN NY ACAD SCI, V873, P51, DOI 10.1111/j.1749-6632.1999.tb09448.x; Clay MT, 2002, IEEE T MED IMAGING, V21, P629, DOI 10.1109/TMI.2002.800572; Dai M, 2010, PHYSIOL MEAS, V31, P1229, DOI 10.1088/0967-3334/31/9/012; Djajaputra D., 2005, MED PHYS, V32, P2731, DOI 10.1118/1.1995712; Goren N, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.112; Guermandi M, 2015, IEEE T BIOMED CIRC S, V9, P21, DOI 10.1109/TBCAS.2014.2311836; Hartinger AE, 2007, PHYSIOL MEAS, V28, pS13, DOI 10.1088/0967-3334/28/7/S02; Hartinger AE, 2009, IEEE T BIO-MED ENG, V56, P369, DOI 10.1109/TBME.2008.2003103; Heikkinen LM, 2002, MEAS SCI TECHNOL, V13, P1855, DOI 10.1088/0957-0233/13/12/308; Holder D S, 1988, Clin Phys Physiol Meas, V9 Suppl A, P111, DOI 10.1088/0143-0815/9/4A/019; Li YD, 2018, J CARDIOTHOR VASC AN, V32, P2469, DOI 10.1053/j.jvca.2018.05.002; Liu XY, 2018, IEEE T BIOMED CIRC S, V12, P623, DOI 10.1109/TBCAS.2018.2816946; Manwaring PK, 2013, ANESTH ANALG, V117, P866, DOI 10.1213/ANE.0b013e318290c7b7; Morucci JP, 1996, CRIT REV BIOMED ENG, V24, P655, DOI 10.1615/CritRevBiomedEng.v24.i4-6.60; Nissinen A, 2016, PHYSIOL MEAS, V37, P1, DOI 10.1088/0967-3334/37/1/1; Nissinen A, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/105504; Romsauerova A, 2006, PHYSIOL MEAS, V27, pS147, DOI 10.1088/0967-3334/27/5/S13; Sadleir RJ, 2009, IEEE ENG MED BIO, P3169, DOI 10.1109/IEMBS.2009.5334510; Shi XT, 2018, IEEE SENS J, V18, P5974, DOI 10.1109/JSEN.2018.2836336; Shuai WJ, 2008, PHYSIOL MEAS, V29, P217, DOI 10.1088/0967-3334/29/2/005; Shuai WJ, 2009, ANN BIOMED ENG, V37, P2373, DOI 10.1007/s10439-009-9778-y; Soleimani M, 2006, PHYSIOL MEAS, V27, pS103, DOI 10.1088/0967-3334/27/5/S09; Tang T, 2010, ANN BIOMED ENG, V38, P2733, DOI 10.1007/s10439-010-0003-9; Tang T, 2016, PHYSIOL MEAS, V37, P751, DOI 10.1088/0967-3334/37/6/751; Xu CH, 2010, J INT MED RES, V38, P1596, DOI 10.1177/147323001003800504; Xu SW, 2011, ANN BIOMED ENG, V39, P2059, DOI 10.1007/s10439-011-0302-9; Yang L, 2017, INT J ELECTROCHEM SC, V12, P1, DOI 10.20964/2017.01.12; Yang L, 2018, BIOMED ENG ONLINE, V17, DOI 10.1186/s12938-018-0617-y	37	7	7	5	11	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2019	7						95186	95196		10.1109/ACCESS.2019.2928580			11	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	IN4WB	WOS:000478676600084		gold			2022-02-06	
J	McLeod, TV; Bay, RC; Lam, KC; Valier, ARS				McLeod, Tamara Valovich; Bay, R. Curtis; Lam, Kenneth C.; Valier, Alison R. Snyder			The Association Between Length of Recovery Following Sport-Related Concussion and Generic and Specific Health-Related Quality of Life in Adolescent Athletes: A Prospective, Longitudinal Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						fatigue; healthcare outcomes; HIT-6; mild traumatic brain injury; Pediatric Quality of Life Inventory; school	MULTIDIMENSIONAL FATIGUE SCALE; PROLONGED RECOVERY; CORE SCALES; HIGH-SCHOOL; RELIABILITY; VALIDITY; INJURY; IDENTIFICATION; MANAGEMENT; PEDSQL(TM)	Objective: Our purpose was to determine the association between concussion recovery and health-related quality of life (HRQOL). Setting: Secondary school athletic training facilities. Participants: Patients (N = 122) with a concussion. Study Design: Prospective, longitudinal cohort. Main Measures: The Pediatric Quality-of-Life Inventory (PedsQL), PedsQL Multidimensional Fatigue Scale (MFS), and Headache Impact Test-6 (HIT-6) were completed at preseason and days 3 (D3), 10 (D10), and 30 (D30) postconcussion. The independent variable was the recovery group. Results: Interactions between group and time (P < .001) were noted for all PedsQL subscales, except Social Functioning (P = .75). Significantly lower scores were found among Prolonged than in Short on D3 (P < .05). Significant interactions (P < .001) were also noted for all MFS subscales. Pairwise comparisons for General and Sleep subscales revealed Prolonged had lower scores than Short and Moderate on D3 and D10. A group by time interaction was found for the HIT-6 (P < .001), with scores being higher (P < .01) in Prolonged than in Short on D3 and D10. Conclusions: Adolescents with a prolonged recovery demonstrated lower HRQOL in the immediate days postinjury, particularly in physical and school functioning, fatigue, and headache. There was a strong association between recovery length and school functioning. Additional research is needed to understand how to minimize the impact of concussion on HRQOL.	[McLeod, Tamara Valovich; Valier, Alison R. Snyder] AT Still Univ, Dept Interdisciplinary Hlth Sci, Sch Osteopath Med, Mesa, AZ USA; [Bay, R. Curtis; Lam, Kenneth C.] AT Still Univ, Dept Interdisciplinary Hlth Sci, Mesa, AZ USA		McLeod, TV (corresponding author), AT Still Univ, 5850 E Still Cir, Mesa, AZ 85206 USA.	tmcleod@atsu.edu	Lam, Kenny/ABB-9733-2020; Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Lam, Kenneth/0000-0002-2185-0990			Bjorner JB, 2003, QUAL LIFE RES, V12, P981, DOI 10.1023/A:1026123400242; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Kasamatsu TK, 2016, J ATHL TRAIN S, V51, pS; Kawata AK, 2005, HEADACHE, V45, P638, DOI 10.1111/j.1526-4610.2005.05130.x; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2011, J SPORT REHABIL, V20, P46, DOI 10.1123/jsr.20.1.46; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Moonie S, 2008, J SCHOOL HEALTH, V78, P140, DOI 10.1111/j.1746-1561.2007.00276.x; Piebes SK, 2011, J SPORT REHABIL, V20, P129, DOI 10.1123/jsr.20.1.129; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Roiger T, 2015, J ATHL TRAINING, V50, P256, DOI 10.4085/1062-6050-49.3.83; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tkachenko N, 2016, PEDIATR NEUROL, V57; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Valovich McLeod TC, 2010, ATHL TRAIN SPORTS HL, V2, P218; Valovich TC, 2008, J ATHL TRAINING, V43, P437, DOI 10.4085/1062-6050-43.4.437; Varni JW, 2008, QUAL LIFE RES, V17, P105, DOI 10.1007/s11136-007-9282-5; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Vassilyadi M, 2014, PEDIATR NEUROSURG, V50, P196, DOI 10.1159/000431232; Wagner AJ, 2016, J ATHL TRAIN S, V51, pS; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81	50	7	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2019	34	1			SI		E1	E9		10.1097/HTR.0000000000000394			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HK0FH	WOS:000457573600001	29863613				2022-02-06	
J	O'Rourke, J; Critchfield, E; Soble, J; Bain, K; Fullen, C; Eapen, B				O'Rourke, Justin; Critchfield, Edan; Soble, Jason; Bain, Kathleen; Fullen, Chrystal; Eapen, Blessen			The Utility of the Mayo-Portland Adaptability Inventory Participation Index (M2PI) in US Military Veterans With a History of Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adult; brain injuries/complications; cross-sectional studies; health status; humans; male; mental disorders/complications; postconcussion syndrome; stress disorders; posttraumatic; United States veterans	OUTCOMES	Objective: To examine the utility of the Mayo-Portland Adaptability Inventory-4th Edition Participation Index (M2PI) as a self-report measure of functional outcome following mild traumatic brain injury (mTBI) in US Military veterans. Setting: Department of Veterans Affairs Polytrauma Rehabilitation Center specialty hospital. Participants: On hundred thirty-nine veterans with a history of self-reported mTBI. Design: Retrospective cross-sectional examination of data collected from regular clinical visits. Main Measures: M2PI, Neurobehavioral Symptoms Inventory with embedded validity measures, Posttraumatic Stress Disorder Checklist-Military Version. Results: Forty-one percent of the sample provided symptom reports that exceeded established cut scores on embedded symptom validity tests. Invalid responders had higher levels of unemployment and endorsed significantly greater functional impairment, posttraumatic stress symptoms, and postconcussive complaints. For valid responders, regression analyses revealed that self-reported functioning was primarily related to posttraumatic stress complaints, followed by postconcussive cognitive complaints. For invalid responders, posttraumatic stress complaints also predicted self-reported functioning. Conclusion: Caution is recommended when utilizing the M2PI to measure functional outcome following mTBI in military veterans, particularly in the absence of symptom validity tests.	[O'Rourke, Justin; Soble, Jason; Bain, Kathleen] US Dept Vet Affairs, South Texas Vet Healthcare Syst Neuropsychol Cons, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA; [Critchfield, Edan; Eapen, Blessen] US Dept Vet Affairs, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Fullen, Chrystal] Our Lady Lake Univ, Psychol Dept, San Antonio, TX USA		O'Rourke, J (corresponding author), US Dept Vet Affairs, South Texas Vet Healthcare Syst Neuropsychol Cons, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA.	justin.o'rourke@va.gov					Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Denning JH, 2019, APPL NEUROPSYCH-ADUL, V26, P1, DOI 10.1080/23279095.2017.1350684; Eapen BC, 2013, CURR PHYS MED REHABI, V1, P151, DOI DOI 10.1007/S40141-013-0023-0; Kean J, 2013, ARCH PHYS MED REHAB, V94, P2417, DOI 10.1016/j.apmr.2013.08.006; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; McCulloch K, 2015, J HEAD TRAUMA REHAB, V30, P38, DOI 10.1097/HTR.0000000000000041; McGarity S, 2017, J HEAD TRAUMA REHAB, V32, P34, DOI 10.1097/HTR.0000000000000242; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Weathers FW, 1991, PCL M FOR DSM IV	17	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2019	34	1			SI		30	35		10.1097/HTR.0000000000000405			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HK0FH	WOS:000457573600009	29863620				2022-02-06	
J	Patterson, F; Fleming, J; Doig, E				Patterson, Freyr; Fleming, Jennifer; Doig, Emmah			Patient perceptions of participation in group-based rehabilitation in an inpatient brain injury rehabilitation setting	PATIENT EDUCATION AND COUNSELING			English	Article						Groups; Traumatic brain injury; Patient perspectives	QUALITATIVE CONTENT-ANALYSIS; OCCUPATIONAL-THERAPY GROUPS; DEVELOPED SUPPORT GROUP; GROUP INTERVENTION; HELPING FACTORS; HEAD-INJURY; PEOPLE; ADULTS; COMMUNICATION; EXPERIENCES	Objectives: The use of groups is common in healthcare. There is a paucity of research which captures patient experiences of group participation. The aims of this study were to explore the perceptions and experiences of people with traumatic brain injury (TBI) about their participation in inpatient occupational therapy rehabilitation groups. Method: A phenomenological approach guided the study. Patients with a TBI who were participating in an inpatient occupational therapy group program were recruited. Data were collected through semi-structured interviews and analysed using content analysis. Results: Fifteen participants consented to the study. Three themes emerged from the data; 1) feeling normal, comfortable and connected; 2) learning by doing, seeing and sharing and; 3) practicalities of groups. Participants highlighted that groups facilitated opportunities to practice skills and prepared them for the real world. Opportunities for interaction and support were also emphasised as positive by participants. Conclusion: Perceptions of patients about participation in groups were generally positive, and as such a consumer-focused approach to healthcare would support the use of occupational therapy groups in TBI rehabilitation. Practice implications: Recommendations from the perspectives of patients include consideration of the selection of group participants, and meeting individual needs and goals within a group setting. (c) 2018 Elsevier B.V. All rights reserved.	[Patterson, Freyr; Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld, Australia; [Patterson, Freyr; Fleming, Jennifer; Doig, Emmah] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Fleming, Jennifer; Doig, Emmah] Queensland Hlth, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia		Patterson, F (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia.	freyr.patterson@uqconnect.edu.au	Doig, Emmah/AAG-6674-2021; Fleming, Jennifer/AAH-5108-2020	Doig, Emmah/0000-0002-7020-053X; Fleming, Jennifer/0000-0002-5603-2410	PAH Research Foundation-Small Grant 2013; Moving Ahead Centre for Research Excellence Small Seed Grant 2016; Moving Ahead Centre for Research Excellence Post-Doctoral Fellowship [1023043]	This project was support by a PAH Research Foundation-Small Grant 2013 and a Moving Ahead Centre for Research Excellence Small Seed Grant 2016.; Dr Emmah Doig was supported by a Moving Ahead Centre for Research Excellence Post-Doctoral Fellowship (Grant Number: 1023043).	Access Economics, 2009, EC COST SPINAL CORD; [Anonymous], 2013, 36 AG HEALTHC RES QU; Appleton S, 2011, BRAIN IMPAIR, V12, P210; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Bertisch H, 2011, J SPEC GROUP WORK, V36, P264, DOI 10.1080/01933922.2011.613901; Carlsson E, 2007, QUAL HEALTH RES, V17, P1361, DOI 10.1177/1049732307306926; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Charles N, 2007, NEUROREHABILITATION, V22, P61; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Drum D, 2011, J SPEC GROUP WORK, V36, P247, DOI 10.1080/01933922.2011.613902; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Falk-Kessler J, 1994, AM J OCCUP THER, V45, P59; Fleming J, 2009, DISABIL REHABIL, V31, P1666, DOI 10.1080/09638280902738425; Fraas M, 2007, BRAIN INJURY, V21, P1267, DOI 10.1080/02699050701721794; Fuller PR, 2013, J PSYCHOSOC NURS MEN, V51, P22, DOI 10.3928/02793692-20130314-01; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Greenwood A, 2015, BRAIN INJURY, V29, P592, DOI 10.3109/02699052.2014.1002422; Gregory J, 2008, ENGAGING CONSUMERS D; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS282, DOI 10.1016/j.apmr.2014.11.029; Hassett LM, 2012, J PHYSIOTHER, V58, P105, DOI 10.1016/S1836-9553(12)70090-5; Health Consumers Queensland, 2009, INF PAP CONS COMM EN; Higgins S., 2014, GROUP, V38, P317, DOI DOI 10.13186/GROUP.38.4.0317; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Knis-Matthews L., 2006, AM J RECREATION THER, V5, P18; Law M, 1995, Can J Occup Ther, V62, P250; Lexell EM, 2013, BRAIN INJURY, V27, P529, DOI 10.3109/02699052.2013.765598; Liamputtong P., 2005, QUALITATIVE RES METH; Lincoln YS., 1985, NATURALISTIC INQUIRY, DOI 10.1016/0147-1767(85)90062-8; Lundqvist A, 2010, BRAIN INJURY, V24, P823, DOI 10.3109/02699051003724986; Malec JF., 2014, HDB NEUROPSYCHOLOGY, P283; Nilsson C, 2011, DISABIL REHABIL, V33, P969, DOI 10.3109/09638288.2010.528141; Pagan E, 2015, BRAIN IMPAIR, V16, P173, DOI 10.1017/BrImp.2015.34; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Patterson F, 2017, AUST OCCUP THER J, V64, P408, DOI 10.1111/1440-1630.12392; Patterson F, 2017, BRAIN INJURY, V31, P1077, DOI 10.1080/02699052.2017.1296974; Patterson F, 2016, DISABIL REHABIL, V38, P1961, DOI 10.3109/09638288.2015.1111436; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Poland B. D., 1995, QUAL INQ, V1, P290, DOI [10.1177/107780049500100302, DOI 10.1177/107780049500100302]; Richard L., 2008, AM J RECREATION THER, V7, P9; Rodgers ML, 2007, AM J PHYS MED REHAB, V86, P482, DOI 10.1097/PHM.0b013e31805c00a1; Sarrami Foroushani P, 2012, CONSUMER COMMUNITY E; SCHULZ CH, 1994, AM J OCCUP THER, V48, P305, DOI 10.5014/ajot.48.4.305; SCHWARTZBERG SL, 1994, AM J OCCUP THER, V48, P297, DOI 10.5014/ajot.48.4.297; Schwartzberg SL, 2008, GROUPS APPLYING FUNC; Smalley V, 2007, CLIN PSYCHOL FORUM, V172, P23; Straits-Troster K, 2013, PSYCHIAT SERV, V64, P541, DOI 10.1176/appi.ps.001632012; Thomas M, 2004, BRAIN INJURY, V18, P1271, DOI 10.1080/02699050410001698776; von Mensenkampff B, 2015, BRAIN INJURY, V29, P1292, DOI 10.3109/02699052.2015.1042407; Wilkins S, 2001, Can J Occup Ther, V68, P70; World Health Organization, 1978, DECL ALM AT INT C PR; Yalom I. D., 2005, THEORY PRACTICE GROU, V5th	53	7	7	1	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0738-3991	1873-5134		PATIENT EDUC COUNS	Patient Educ. Couns.	JAN	2019	102	1					148	154		10.1016/j.pec.2018.08.001			7	Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Social Sciences - Other Topics	HD2ZN	WOS:000452381100020	30115414	Green Accepted			2022-02-06	
J	Pierpoint, LA; Caswell, SV; Walker, N; Lincoln, AE; Currie, DW; Knowles, SB; Wasserman, EB; Dompier, TP; Comstock, RD; Marshall, SW; Kerr, ZY				Pierpoint, Lauren A.; Caswell, Shane, V; Walker, Nina; Lincoln, Andrew E.; Currie, Dustin W.; Knowles, Sarah B.; Wasserman, Erin B.; Dompier, Thomas P.; Comstock, R. Dawn; Marshall, Stephen W.; Kerr, Zachary Y.			The First Decade of Web-Based Sports Injury Surveillance: Descriptive Epidemiology of Injuries in US High School Girls' Lacrosse (2008-2009 Through 2013-2014) and National Collegiate Athletic Association Women's Lacrosse (2004-2005 Through 2013-2014)	JOURNAL OF ATHLETIC TRAINING			English	Article						injury surveillance; females; concussion	STATES HIGH-SCHOOL; UNITED-STATES; RISK COMPENSATION; RECURRENT INJURIES; ANKLE INJURIES; HEAD-INJURIES; CONCUSSIONS; PREVENTION; MANAGEMENT; PLAYERS	Context: The advent of Web-based sports injury surveillance via programs such as the High School Reporting Information Online (HS RIO) system and the National Collegiate Athletic Association Injury Surveillance Program (NCAA-ISP) has aided the acquisition of girls' and women's lacrosse injury data. Objective: To describe the epidemiology of injuries sustained in high school girls' lacrosse in the 2008-2009 through 2013-2014 academic years and collegiate women's lacrosse in the 2004-2005 through 2013-2014-academic years using Web-based sports injury surveillance. Design: Descriptive epidemiology study. Setting: Online injury surveillance from high school girls' (annual average = 55) and collegiate women's (annual average = 19) lacrosse teams. Patients or Other Participants: Female lacrosse players who participated in practices or competitions during the 2008-2009 through 2013-2014 academic years for high school or the 2004-2005 through 2013-2014 academic years for college. Main Outcome Measure(s): Athletic trainers collected time-loss injury (>= 24 hours) and exposure data. We calculated injury rates per 1000 athlete-exposures (AEs), injury rate ratios (IRRs) with 95% confidence intervals (Cis), and injury proportions by body site and diagnosis. Results: High school RIO documented 700 time-loss injuries during 481 687 AEs; the NCAA-ISP documented 1027 time-loss injuries during 287 856 AEs. The total injury rate during 2008-2009 through 2013-2014 was higher in college than in high school (2.55 versus 1.45/1000 AEs; IRR = 1.75; 95% CI = 1.54, 1.99). Most injuries occurred during competitions in high school (51.1%) and practices in college (63.8%). Rates were higher during competitions compared with practices in high school (IRR = 2.32; 95% CI = 2.00, 2.69) and college (IRR = 2.38; 95% CI = 2.09, 2.70). Concussion was the most common diagnosis among all high school and most collegiate player positions, and the main mechanism of contact was with a playing apparatus (eg, stick, ball). Ligament sprains were also common (HS RIO practices = 22.2%, competitions = 30.3%; NCAA-ISP practices = 25.5%, competitions = 30.9%). Conclusions: Rates of injury were higher in college versus high school female lacrosse players and in competitions versus practices. Injury-prevention strategies are essential to decrease the incidence and severity of concussions and ligament sprains.	[Pierpoint, Lauren A.; Currie, Dustin W.] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Caswell, Shane, V] George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, Manassas, VA USA; [Walker, Nina] Univ N Carolina, Dept Sports Med, Chapel Hill, NC 27599 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Marshall, Stephen W.; Kerr, Zachary Y.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Lincoln, Andrew E.] MedStar Sports Med Res Ctr, Baltimore, MD USA; [Knowles, Sarah B.] Palo Alto Med Fdn Res Inst, Palo Alto, CA USA; [Wasserman, Erin B.] Injury Res & Prevent Inc, Datalys Ctr Sports, Indianapolis, IN USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Injury Prevent Res Ctr, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu		Wasserman, Erin/0000-0001-5957-5878	NCAA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; National Federation of State High School Associations (Indianapolis, IN); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DonJoy Orthotics (Vista, CA); EyeBlack (Potomac, MD)	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention, Inc. The NCAA-ISP was funded by the NCAA. Funding for HS RIO was provided in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and the National Center for Research Resources award KL2 RR025754. We also acknowledge the research funding contributions of the National Federation of State High School Associations (Indianapolis, IN), National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), DonJoy Orthotics (Vista, CA), and EyeBlack (Potomac, MD). The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. We thank the many ATs who have volunteered their time and efforts to submit data to HS RIO and the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school and collegiate student-athletes.	[Anonymous], WOM RUL; [Anonymous], 2014 15 NCAA SPORTS; [Anonymous], STAND SPEC HEADG US; [Anonymous], WOM LACR HEADG FAQ; [Anonymous], LAXPREP; [Anonymous], 2013 14 HIGH SCH ATH; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Chomiak J, 2000, AM J SPORT MED, V28, pS58; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Comstock RD, CONVENIENCE SAMPLE S; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick R, 2007, J ATHL TRAINING, V42, P262; Gerrard D F, 1993, Br J Sports Med, V27, P14; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza E, 2005, BRIT J SPORT MED, V39, P212, DOI 10.1136/bjsm.2004.011973; Green L., LEGAL PERSPECTIVES R; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Hedlund J, 2000, Inj Prev, V6, P82, DOI 10.1136/ip.6.2.82; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hopper Diana M., 1995, Journal of Sports Sciences, V13, P213, DOI 10.1080/02640419508732230; Hosea TM, 2000, CLIN ORTHOP RELAT R, P45; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2017, CLIN J SPORT MED, V27, P548, DOI 10.1097/JSM.0000000000000405; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2014, CLIN J SPORT MED, V24, P355, DOI 10.1097/JSM.0000000000000011; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCriskin BJ, 2015, WORLD J ORTHOP, V6, P161, DOI 10.5312/wjo.v6.i2.161; McGuine TA, 2011, AM J SPORT MED, V39, P1840, DOI 10.1177/0363546511406242; McLeod TCV, 2011, J ATHL TRAINING, V46, P206, DOI 10.4085/1062-6050-46.2.206; Mihata LCS, 2006, AM J SPORT MED, V34, P899, DOI 10.1177/0363546505285582; National Collegiate Athletic Association, 2014, 1981 1982 2013 14 NC; National Federation of State High School Associations, 1969 2014 HIGH SCH A; Putukian M, 2014, CURR SPORT MED REP, V13, P334, DOI 10.1249/JSR.0000000000000092; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Reeser JC, 2015, SPORTS HEALTH, V7, P504, DOI 10.1177/1941738115600143; Roos KG, 2015, AM J SPORT MED, V43, P1790, DOI 10.1177/0363546515580790; Ruedl G, 2012, EPIDEMIOLOGY, V23, P936, DOI 10.1097/EDE.0b013e31826d2403; Ruedl G, 2012, ACCIDENT ANAL PREV, V48, P292, DOI 10.1016/j.aap.2012.01.031; Ruzic L, 2011, WILD ENVIRON MED, V22, P291, DOI 10.1016/j.wem.2011.09.001; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Small EW, 2007, PEDIATRICS, V119, P1242, DOI 10.1542/peds.2007-0887; Swenson DM, 2013, CLIN J SPORT MED, V23, P190, DOI 10.1097/JSM.0b013e31827d21fe; Swenson DM, 2009, AM J SPORT MED, V37, P1586, DOI 10.1177/0363546509332500; Van Reijen M, 2017, J SCI MED SPORT, V20, P549, DOI 10.1016/j.jsams.2016.12.001; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	54	7	7	1	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2019	54	1					42	54		10.4085/1062-6050-201-17			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HO1BA	WOS:000460639000006	30848952	gold, Green Published			2022-02-06	
J	Provvidenza, CF; Hartman, LR; Carmichael, J; Reed, N				Provvidenza, Christine F.; Hartman, Laura R.; Carmichael, Jason; Reed, Nick			Does a picture speak louder than words? The role of infographics as a concussion education strategy	JOURNAL OF VISUAL COMMUNICATION IN MEDICINE			English	Article						Concussion; infographics; knowledge translation	SPORT-RELATED CONCUSSION; PEDIATRIC CONCUSSION; FAMILY PHYSICIANS; KNOWLEDGE-BASE; CARE; PROGRAM; NEED	Knowledge gaps exist regarding how to best educate audiences about concussion. Knowledge translation (KT) plays a critical role in how information is shared. In the field of concussion, infographics are becoming a popular KT strategy for synthesising and sharing information. Study objectives were to explore how infographics enhance concussion knowledge, infographic use and preferences across various stakeholders, and to determine their utility as a KT strategy. Six infographics were created to provide concussion information in a user-friendly and accessible format. A prospective design using a self-developed survey was conducted. Data were collected from youth (n = 78) and adults (n = 88) including students, teachers and healthcare professionals. Descriptive statistics exored perceived knowledge acquisition and infographic use. Thematic analysis of written feedback provided insight on participant responses. Participants identified that the infographics met their knowledge needs (91%) and provided them with new knowledge (87%). Participants also identified that they intend to use the infographics to build their knowledge (89%) and educate others (55%). Enhancement opportunities included incorporating graphics that appeal to different audiences and sharing the lived experiences of individuals who have a concussion. This study demonstrates the potential impact of infographics as a KT strategy that meets the knowledge needs of many audiences.	[Provvidenza, Christine F.; Hartman, Laura R.; Carmichael, Jason; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada; [Provvidenza, Christine F.; Hartman, Laura R.; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Reed, Nick] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada		Provvidenza, CF (corresponding author), Holland Bloorview Kids Rehabil Hosp, Concuss Ctr, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	cprovvidenza@hollandbloorview.ca		Hartman, Laura/0000-0001-7246-7863			Ahmed OH, 2016, PHYS THER SPORT, V21, P82, DOI 10.1016/j.ptsp.2016.03.001; Akkoyunlu B., 2017, J VISUAL LITERACY, V36, P20, DOI [10.1080/1051144X.2017.1331680, DOI 10.1080/1051144X.2017.1331680]; Arcia A, 2016, J AM MED INFORM ASSN, V23, P174, DOI 10.1093/jamia/ocv079; Babul S, 2015, CAN FAM PHYSICIAN, V61, P660; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Barton CJ, 2019, BRIT J SPORT MED, V53, DOI 10.1136/bjsports-2017-098367; Barwick M., 2013, KNOWLEDGE TRANSLATIO; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Crick K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140029; Dunlap J. C., 2016, J VISUAL LITERACY, V35, P42, DOI DOI 10.1080/1051144X.2016.1205832; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Featherstone RM, 2014, J CAN HEALTH LIBRARI, V35, P147, DOI 10.5596/c14-031; Gagliardi AR, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0399-1; Gent M., 2015, 7 GRAPHIC PRINCIPLES; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Hunt AW, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1664-3; Jensen S.D., 2011, HLTH COMMUNICATION M, P171; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Krum R., 2013, COOL INFOGRAPHICS EF; Kuhl HN, 2014, SPORTS HEALTH, V6, P136, DOI 10.1177/1941738113508073; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Martin LJ, 2019, HLTH PROF ED, V5, P48, DOI DOI 10.1016/J.HPE.2018.03.005; McAllister-Deitrick J, 2014, ATHL TRAIN SPORTS HL, V6, P280, DOI DOI 10.3928/01484834-20141112-03; McCrorie A D, 2016, Ulster Med J, V85, P71; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Murray AD, 2018, BRIT J SPORT MED, V52, P1421, DOI 10.1136/bjsports-2018-099771; Parker EM, 2015, J HEAD TRAUMA REHAB, V30, P198, DOI 10.1097/HTR.0000000000000097; Quesenberry AC, 2017, J CONS HLTH INTERNET, V21, P209, DOI 10.1080/15398285.2017.1311611; Saunders EA, 2013, ATHLETIC TRAINING SP, V5, P11, DOI DOI 10.3928/19425864-20121217-02; Scott H, 2016, BRIT J SPORT MED, V50, P1104, DOI 10.1136/bjsports-2016-096133; Stein CJ, 2016, CLIN J SPORT MED, V26, P386, DOI 10.1097/JSM.0000000000000268; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Turck CJ, 2014, J CONTIN EDUC HEALTH, V34, pS36, DOI 10.1002/chp.21232; Van de Ven AH, 2006, ACAD MANAGE REV, V31, P802, DOI 10.5465/AMR.2006.22527385; Williams D, 2014, BRIT J SPORT MED, V48, P107, DOI 10.1136/bjsports-2012-091853; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475	43	7	9	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1745-3054	1745-3062		J VIS COMMUN MED	J. Vis. Commun. Med.		2019	42	3					102	113		10.1080/17453054.2019.1599683			12	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	JP2AV	WOS:000498073600003	31056987				2022-02-06	
J	Raine, A				Raine, Adrian			A neurodevelopmental perspective on male violence	INFANT MENTAL HEALTH JOURNAL			English	Article						brain; brain imaging; health; lead; neurodevelopment; nutrition; violence	MINOR PHYSICAL ANOMALIES; ANTISOCIAL PERSONALITY-DISORDER; CALLOUS-UNEMOTIONAL TRAITS; MATERNAL CIGARETTE-SMOKING; TRAUMATIC BRAIN-INJURY; PRENATAL EXPOSURE; EXTERNALIZING BEHAVIOR; BIRTH COMPLICATIONS; CRIMINAL BEHAVIOR; SEPTUM PELLUCIDUM	Research is increasingly documenting a neurobiological basis to violence. This review takes a neurodevelopmental perspective on the very small group of males who grow up to become persistent violent offenders. After outlining six criteria for what constitutes a neurodevelopmental disorder, the extent to which chronic violence meets these definitional criteria is examined, covering the fields of genetics, structural and functional brain imaging, and neuropsychology. Early health risk factors for violence are then outlined, including birth complications, minor physical anomalies, prenatal smoking and alcohol exposure, poor nutrition, lead exposure, and traumatic brain injury. Persistent adult violence is argued to originate in aberrant temperamental behavior in early childhood, to have a stable developmental trajectory, and to be associated with impaired education, social, and occupational functioning. Taken together, it is argued that chronic adult violence meets criterion for being conceptualized as having neurodevelopmental origins and that an important, but not sole, source of neural maldevelopment lies in prenatal and early postnatal risk factors. This review concludes with a recognition of the sociopolitical context within which a neurodevelopmental perspective on chronic violence sits, together with directions for future research, including whether a neurodevelopmental hypothesis is best applied to reactive as opposed to proactive aggression.	[Raine, Adrian] Univ Penn, Dept Criminol, Philadelphia, PA 19104 USA; [Raine, Adrian] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Raine, Adrian] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA		Raine, A (corresponding author), Dept Criminol, McNeil Bldg,3718 Locust Walk, Philadelphia, PA 19104 USA.; Raine, A (corresponding author), Dept Psychiat, McNeil Bldg,3718 Locust Walk, Philadelphia, PA 19104 USA.; Raine, A (corresponding author), Dept Psychol, McNeil Bldg,3718 Locust Walk, Philadelphia, PA 19104 USA.	araine@sas.upenn.edu			Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD087485]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD087485] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, Grant/Award Number: R01HD087485	Abel EL, 2004, ADDICT BIOL, V9, P127, DOI 10.1080/13556210410001716980; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Arseneault L, 2000, AM J PSYCHIAT, V157, P917, DOI 10.1176/appi.ajp.157.6.917; Barker ED, 2007, ARCH GEN PSYCHIAT, V64, P592, DOI 10.1001/archpsyc.64.5.592; Barnes JC, 2013, J PSYCHIATR RES, V47, P371, DOI 10.1016/j.jpsychires.2012.10.016; Beckley AL, 2018, JAMA PEDIATR, V172, P166, DOI 10.1001/jamapediatrics.2017.4005; Bishop DVM, 2008, RUTTERS CHILD ADOLES, V208, P32, DOI DOI 10.1002/9781444300895.CH3.PP.32-41; Brennan PA, 1999, ARCH GEN PSYCHIAT, V56, P215, DOI 10.1001/archpsyc.56.3.215; Brennan PA, 1997, NATO ADV SCI I A-LIF, V292, P163; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Bublitz MH, 2012, NICOTINE TOB RES, V14, P388, DOI 10.1093/ntr/ntr191; Burt SA, 2009, CLIN PSYCHOL REV, V29, P163, DOI 10.1016/j.cpr.2008.12.004; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; Chan SC, 2010, PSYCHIAT RES, V176, P246, DOI 10.1016/j.psychres.2008.12.013; Chen CY, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0278-3; Choy O, 2017, CRIMINOLOGY, V55, P465, DOI 10.1111/1745-9125.12138; Coccaro EF, 2018, PSYCHIAT RES-NEUROIM, V271, P126, DOI 10.1016/j.pscychresns.2017.11.007; Corvo K, 2013, AGGRESS VIOLENT BEH, V18, P175, DOI 10.1016/j.avb.2012.11.017; da Cunha-Bang S, 2017, SOC COGN AFFECT NEUR, V12, P802, DOI 10.1093/scan/nsx006; Dawel A, 2012, NEUROSCI BIOBEHAV R, V36, P2288, DOI 10.1016/j.neubiorev.2012.08.006; Day J, 2016, AM J STEM CELLS, V5, P11; De Brito SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065566; Ducharme S, 2011, BIOL PSYCHIAT, V70, P283, DOI 10.1016/j.biopsych.2011.03.015; Dyshniku F, 2015, ARCH SEX BEHAV, V44, P2151, DOI 10.1007/s10508-015-0564-7; Farah MJ, 2017, NEURON, V96, P56, DOI 10.1016/j.neuron.2017.08.034; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Gan G, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00179; Gao Y, 2009, CAN J PSYCHIAT, V54, P813, DOI 10.1177/070674370905401204; Glenn AL, 2014, NAT REV NEUROSCI, V15, P54, DOI 10.1038/nrn3640; Glenn AL, 2010, BIOL PSYCHIAT, V67, P52, DOI 10.1016/j.biopsych.2009.06.018; Golding P, 2019, INFANT MENT HEALTH J, V40, P5, DOI 10.1002/imhj.21753; Haghighi A, 2013, JAMA PSYCHIAT, V70, P98, DOI 10.1001/archgenpsychiatry.2012.1101; Hanlon RE, 2013, CRIM JUSTICE BEHAV, V40, P933, DOI 10.1177/0093854813479779; Hoaken PNS, 2007, AGGRESSIVE BEHAV, V33, P412, DOI 10.1002/ab.20194; Jaffee SR, 2012, PSYCHOL BULL, V138, P272, DOI 10.1037/a0026020; Jennings WG, 2012, AGGRESS VIOLENT BEH, V17, P16, DOI 10.1016/j.avb.2011.09.003; Joseph J, 2014, HUM BRAIN MAPP, V35, P659, DOI 10.1002/hbm.22209; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Kuin N, 2015, AGGRESS VIOLENT BEH, V25, P159, DOI 10.1016/j.avb.2015.07.018; Larkby CA, 2011, J AM ACAD CHILD PSY, V50, P262, DOI 10.1016/j.jaac.2010.12.004; Lee TMC, 2008, MOL PSYCHIATR, V13, P655, DOI 10.1038/mp.2008.46; Levi MD, 2010, CRIM JUSTICE BEHAV, V37, P633, DOI 10.1177/0093854810362342; Liu JH, 2004, AM J PSYCHIAT, V161, P2005, DOI 10.1176/appi.ajp.161.11.2005; Liu JH, 2009, J RES ADOLESCENCE, V19, P93, DOI 10.1111/j.1532-7795.2009.00583.x; Lozier LM, 2014, JAMA PSYCHIAT, V71, P627, DOI 10.1001/jamapsychiatry.2013.4540; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Mednick S A, 1988, Bull Am Acad Psychiatry Law, V16, P101; Millan MJ, 2013, NEUROPHARMACOLOGY, V68, P2, DOI 10.1016/j.neuropharm.2012.11.015; Moffitt T., 2001, SEX DIFFERENCES ANTI; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Neugebauer R, 1999, JAMA-J AM MED ASSOC, V282, P455, DOI 10.1001/jama.282.5.455; Odgers CL, 2008, DEV PSYCHOPATHOL, V20, P673, DOI 10.1017/S0954579408000333; Pansky B., 1988, REV NEUROSCIENCE; Piquero AR, 2014, INT J OFFENDER THER, V58, P286, DOI 10.1177/0306624X12472655; RAINE A, 1994, ARCH GEN PSYCHIAT, V51, P984; RAINE A, 1994, BIOL PSYCHIAT, V36, P365, DOI 10.1016/0006-3223(94)91211-4; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; Raine A, 1993, PSYCHOPATHOLOGY CRIM; Raine A., 2013, ANATOMY VIOLENCE BIO; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; Raine A, 2018, ANNU REV CLIN PSYCHO, V14, P259, DOI [10.1146/annurev-clinpsy-050817084819, 10.1146/annurev-clinpsy-050817-084819]; Raine A, 2016, J CHILD PSYCHOL PSYC, V57, P1038, DOI 10.1111/jcpp.12565; Raine A, 2010, BRIT J PSYCHIAT, V197, P186, DOI 10.1192/bjp.bp.110.078485; Rasanen P, 1999, AM J PSYCHIAT, V156, P857; Rogers JC, 2016, JAMA PSYCHIAT, V73, P64, DOI 10.1001/jamapsychiatry.2015.2423; SARWAR M, 1989, AM J NEURORADIOL, V10, P989; Schore AN, 2017, INFANT MENT HEALTH J, V38, P15, DOI 10.1002/imhj.21616; Shaw DS, 2012, DEV PSYCHOPATHOL, V24, P871, DOI 10.1017/S0954579412000429; Swayze VW, 1997, PEDIATRICS, V99, P232, DOI 10.1542/peds.99.2.232; Tenyi T, 2015, PSYCHIAT RES, V225, P702, DOI 10.1016/j.psychres.2014.11.012; Tiihonen J, 2015, MOL PSYCHIATR, V20, P786, DOI 10.1038/mp.2014.130; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Toro R, 2008, NEUROPSYCHOPHARMACOL, V33, P1019, DOI 10.1038/sj.npp.1301484; Treit S, 2013, J NEUROSCI, V33, P10098, DOI 10.1523/JNEUROSCI.5004-12.2013; Tuvblad C, 2014, PSYCHOL ASSESSMENT, V26, P704, DOI 10.1037/a0036711; Vassos E, 2014, MOL PSYCHIATR, V19, P471, DOI 10.1038/mp.2013.31; Viding E, 2005, J CHILD PSYCHOL PSYC, V46, P592, DOI 10.1111/j.1469-7610.2004.00393.x; Wakschlag LS, 2018, AM J PSYCHIAT, V175, P114, DOI 10.1176/appi.ajp.2017.17010045; WALDROP MF, 1978, SCIENCE, V199, P563, DOI 10.1126/science.622559; White SF, 2013, J CHILD PSYCHOL PSYC, V54, P575, DOI 10.1111/j.1469-7610.2012.02603.x; Yang YL, 2008, BEHAV SCI LAW, V26, P65, DOI 10.1002/bsl.788; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Zou ZL, 2013, PSYCHIAT RES, V207, P218, DOI 10.1016/j.psychres.2012.09.013	85	7	7	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0163-9641	1097-0355		INFANT MENT HEALTH J	Infant Ment. Health J.	JAN-FEB	2019	40	1			SI		84	97		10.1002/imhj.21761			14	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	HH8FO	WOS:000455967500006	30586472				2022-02-06	
J	Whyte, J; Ketchum, JM; Bogner, J; Brunner, RC; Hammond, FM; Zafonte, R; Whiteneck, GG; Weintraub, A				Whyte, John; Ketchum, Jessica M.; Bogner, Jenny; Brunner, Robert C.; Hammond, Flora M.; Zafonte, Ross; Whiteneck, Gale G.; Weintraub, Alan			Effects of Statin Treatment on Outcomes after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injuries; hydroxymethylglutaryl-CoA reductase inhibitors; neuroprotection; propensity score; treatment outcome	ANEURYSMAL SUBARACHNOID HEMORRHAGE; DENSITY-LIPOPROTEIN CHOLESTEROL; NEUROPROTECTIVE PROPERTIES; MYOCARDIAL-INFARCTION; ENCEPHALOMYELITIS; LOVASTATIN; ROSUVASTATIN; SIMVASTATIN; VASOSPASM; STROKE	Neuroprotective treatments that have shown promise in reducing secondary injury and improving recovery in animal models of traumatic brain injury (TBI) have not been found effective to date in humans. One reason may be the delay after injury in initiating treatment. Statin medications are among the promising neuroprotective agents in animal models, and their presence in the bloodstream of many individuals at the time of injury might optimize their clinical impact. This observational study conducted by a subset of centers participating in the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)-funded TBI Model System program sought to examine the effects of taking statin medication at the time injury on functional outcomes. Participants >50 years of age were prospectively enrolled during patient rehabilitation. Demographic data, cardiovascular history, and brain injury history were obtained through chart abstraction and interview. Prescription medication use in the year prior to enrollment was determined from a national pharmacy search service. Propensity scoring was used to create 49 pairs of participants who were well matched on demographic and clinical attributes but discordant for statin use. The treated and untreated participants did not differ on initial Glasgow Coma Score, time until commands were followed, duration of post-traumatic amnesia, or Functional Independence Measure (FIM) scores at rehabilitation admission, discharge, or 1 year post-injury, or on acute or rehabilitation hospital lengths of stay. Evidence of greater and lesser statin compliance was not associated with outcome. This study did not provide support for a clinically important benefit of statin use at the time of moderate to severe TBI.	[Whyte, John] Einstein Healthcare Network, Moss Rehabil Res Inst, Elkins Pk, PA USA; [Ketchum, Jessica M.; Whiteneck, Gale G.] Craig Hosp, Res Dept, Englewood, CO USA; [Ketchum, Jessica M.] Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Bogner, Jenny] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [Brunner, Robert C.] Univ Alabama Birmingham, Spain Rehabil Ctr, Birmingham, AL USA; [Hammond, Flora M.] Indiana Univ Sch Med, Rehabil Hosp Indiana, Indianapolis, IN 46202 USA; [Zafonte, Ross] Harvard Med Sch, Spaulding Rehabil Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil,Brigham & Womens Hosp, Boston, MA USA; [Zafonte, Ross] Home Base, Boston, MA USA; [Weintraub, Alan] Rocky Mt Reg Brain Injury Syst, Craig Hosp, Englewood, CO USA		Whyte, J (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	jwhyte@einstein.edu	Ketchum, Jessica/AAE-8200-2020				Aktas O, 2003, J EXP MED, V197, P725, DOI 10.1084/jem.20021425; Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Chen JH, 2016, INT J MOL MED, V37, P1059, DOI 10.3892/ijmm.2016.2506; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Greenwood J, 2003, FASEB J, V17, P905, DOI 10.1096/fj.02-1014fje; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Hoglund K, 2007, CNS DRUGS, V21, P449; Huang XM, 2007, MOVEMENT DISORD, V22, P377, DOI 10.1002/mds.21290; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lynch JR, 2005, STROKE, V36, P2024, DOI 10.1161/01.STR.0000177879.11607.10; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Paintlia AS, 2004, J NEUROSCI RES, V77, P63, DOI 10.1002/jnr.20130; PEDERSEN TR, 1994, LANCET, V344, P1383; Robertson CS, 2017, J NEUROTRAUM, V34, P1394, DOI 10.1089/neu.2016.4717; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sanchez-Aguilar M, 2013, J NEUROSURG, V118, P669, DOI 10.3171/2012.12.JNS121084; Shen J, 2017, J NEUROSURG, V127, P291, DOI 10.3171/2016.5.JNS152900; SOMA MR, 1995, CANCER RES, V55, P597; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Stepien K, 2005, PHARMACOL REP, V57, P561; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; Vaughan CJ, 1999, STROKE, V30, P1969, DOI 10.1161/01.STR.30.9.1969; Wahner AD, 2008, NEUROLOGY, V70, P1418, DOI 10.1212/01.wnl.0000286942.14552.51; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wolazin B, 2006, ACTA NEUROL SCAND, V114, P63; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20	35	7	7	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					118	125		10.1089/neu.2017.5545			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000453863000011	29954258	Green Published			2022-02-06	
J	Zhang, YL; Chopp, M; Zhang, ZG; Zhang, Y; Zhang, L; Lu, M; Zhang, T; Winter, S; Doppler, E; Brandstaetter, H; Mahmood, A; Xiong, Y				Zhang, Yanlu; Chopp, Michael; Zhang, Zheng Gang; Zhang, Yi; Zhang, Li; Lu, Mei; Zhang, Talan; Winter, Stefan; Doppler, Edith; Brandstaeetter, Hemma; Mahmood, Asim; Xiong, Ye			Cerebrolysin Reduces Astrogliosis and Axonal Injury and Enhances Neurogenesis in Rats After Closed Head Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						cerebrolysin; cognitive recovery; dose response; mild traumatic brain injury; neuroinflammation; neurological outcome; neuroplasticity	TRAUMATIC BRAIN-INJURY; AMYLOID PRECURSOR PROTEIN; APP TRANSGENIC MODEL; NEUROTROPHIC FACTORS; COGNITIVE PERFORMANCE; FUNCTIONAL RECOVERY; ADULT RATS; MILD; IMPROVES; NEUROPROTECTION	Background. Cerebrolysin is a neuropeptide preparation with neuroprotective and neurotrophic properties. Our previous study demonstrates that cerebrolysin significantly improves functional recovery in rats after mild traumatic brain injury (mTBI). Objective. To determine histological outcomes associated with therapeutic effects of cerebrolysin on functional recovery after TBI. Methods. In this prospective, randomized, blinded, and placebo-controlled study, adult Wistar rats with mild TBI induced by a closed head impact were randomly assigned to one of the cerebrolysin dose groups (0.8, 2.5, 7.5 mL/kg) or placebo, which were administered 4 hours after TBI and then daily for 10 consecutive days. Functional tests assessed cognitive, behavioral, motor, and neurological performance. Study end point was day 90 after TBI. Brains were processed for histological tissue analyses of astrogliosis, axonal injury, and neurogenesis. Results. Compared with placebo, cerebrolysin significantly reduced amyloid precursor protein accumulation, astrogliosis, and axonal damage in various brain regions and increased the number of neuroblasts and neurogenesis in the dentate gyrus. There was a significant dose effect of cerebrolysin on functional outcomes at 3 months after injury compared with saline treatment. Cerebrolysin at a dose of > 0.8 mL/kg significantly improved cognitive function, whereas at a dose of > 2.5 mL/kg, cerebrolysin also significantly improved sensorimotor function at various time points. There were significant correlations between multiple histological and functional outcomes 90 days after mTBI. Conclusions. Our findings demonstrate that cerebrolysin reduces astrogliosis and axonal injury and promotes neurogenesis, which may contribute to improved functional recovery in rats with mTBI.	[Zhang, Yanlu; Chopp, Michael; Zhang, Zheng Gang; Zhang, Yi; Zhang, Li; Lu, Mei; Zhang, Talan; Mahmood, Asim; Xiong, Ye] Henry Ford Hosp, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Rochester, MI 48063 USA; [Winter, Stefan; Doppler, Edith; Brandstaeetter, Hemma] EVER Neuro Pharma GmbH, Unterach Am Attersee, Austria		Xiong, Y (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, E&R Bldg,Room 3096,2799 West Grand Blvd, Detroit, MI 48202 USA.	yxiong1@hfhs.org		Xiong, Ye/0000-0001-9770-6031	EVER Neuro Pharma GmbH	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded by EVER Neuro Pharma GmbH.	Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Castren E, 2017, MOL PSYCHIATR, V22, P1085, DOI 10.1038/mp.2017.61; Chen CC, 2013, BRIT J NEUROSURG, V27, P803, DOI 10.3109/02688697.2013.793287; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Gonzales ELT, 2015, BIOMOL THER, V23, P251, DOI 10.4062/biomolther.2014.120; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jarero-Basulto JJ, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010017; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kashon ML, 2004, J ALZHEIMERS DIS, V6, P595; Khalili H, 2017, CLIN NEUROL NEUROSUR, V152, P34, DOI 10.1016/j.clineuro.2016.11.011; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Mannix R, 2014, J NEUROSURG, V121, P1337, DOI 10.3171/2014.8.JNS14715; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masliah E, 2012, DRUG TODAY, V48, P3, DOI 10.1358/dot.2012.48(Suppl.A).1739716; Menon PK, 2012, CNS NEUROL DISORD-DR, V11, P40; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; Newcombe VFJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1522; Nudo RJ, 2011, J COMMUN DISORD, V44, P515, DOI 10.1016/j.jcomdis.2011.04.004; Onose G, 2009, J Med Life, V2, P350; Orman JA, 2012, J TRAUMA ACUTE CARE, V73, pS496, DOI 10.1097/TA.0b013e318275473c; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pardridge WM, 2002, ADV EXP MED BIOL, V513, P397; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Robinson C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1347987; Rockenstein E, 2007, ACTA NEUROPATHOL, V113, P265, DOI 10.1007/s00401-006-0166-5; Rockenstein E, 2006, J NEUROSCI RES, V83, P1252, DOI 10.1002/jnr.20818; Rockenstein E, 2015, STEM CELL RES, V15, P54, DOI 10.1016/j.scr.2015.04.008; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Satou T, 2000, J NEURAL TRANSM, V107, P1253, DOI 10.1007/s007020070015; Sharma HS, 2012, INT REV NEUROBIOL, V102, P249, DOI 10.1016/B978-0-12-386986-9.00010-7; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Stoica B, 2009, NEUROTHERAPEUTICS, V6, P14, DOI 10.1016/j.nurt.2008.10.029; Stuart SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075467; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2014, NEURAL REGEN RES, V9, P688, DOI 10.4103/1673-5374.131567; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Turner RC, 2013, J NEUROSURG, V118, P1072, DOI 10.3171/2012.11.JNS12408; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yang Y, 2016, NEUROCHEM RES, V41, P748, DOI 10.1007/s11064-015-1745-4; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Zhang L, 2016, INT J STROKE, V11, P347, DOI 10.1177/1747493015625645; Zhang L, 2013, STROKE, V44, P1965, DOI 10.1161/STROKEAHA.111.000831; Zhang YL, 2015, J NEUROSURG, V122, P843, DOI 10.3171/2014.11.JNS14271; Zhang YL, 2013, J NEUROSURG, V118, P1343, DOI 10.3171/2013.3.JNS122061; Zhang Y, 2018, J AM COLL NUTR, V37, P708, DOI 10.1080/07315724.2018.1463876	60	7	8	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JAN	2019	33	1					15	26		10.1177/1545968318809916			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	HI4LJ	WOS:000456421900002	30499355	Bronze			2022-02-06	
J	Zia, N; Mehmood, A; Namaganda, RH; Ssenyonjo, H; Kobusingye, O; Hyder, AA				Zia, Nukhba; Mehmood, Amber; Namaganda, Rukia H.; Ssenyonjo, Hussein; Kobusingye, Olive; Hyder, Adnan A.			Causes and outcomes of traumatic brain injuries in Uganda: analysis from a pilot hospital registry	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						traumatic brain injury; unintentional injury; intentional injury; trauma; Uganda; Africa		Background Traumatic brain injury (TBI) is an important cause of morbidity and mortality in low/middle-income countries. The objective was to assess causes and outcomes of unintentional and intentional TBI among patients presenting to a tertiary care hospital in Uganda. Methods This study was conducted at Mulago National Referral Hospital, Kampala, Uganda, for 15months in 2016-2017. Patients of all ages, males and females, presenting to the emergency department with suspected or documented TBI were enrolled. Patient demographics, TBI causes and outcomes were recorded. The outcome of interest was unintentional and intentional TBI. Results Intent was known for 3749 patients, of these 69.7% were unintentional TBI and 30.3% were intentional TBI. The average age of patients in both groups was similar (2814 years) with over 70% of patients between 19 and 45 years age group. About 80% were males in both groups. The main causes of unintentional TBI were road traffic injuries (RTI) (88.9%) and falls (11.1%). Pedestrians (42.1%) and motorcycle drivers (28.1%) were the most common road users. Among patients with unintentional TBI, about 43.6% were admitted, 34.0% were sent home. There were 73 deaths: 63 were patients with RTI and 10 had a fall. Although assault (97.1%) was the main cause of intentional TBI, those patients with self-harm were likely to be in severe Glasgow Coma Scale range (39.4%) compared with victims of assault (14.2%). Among patients with intentional TBI, 42.6% were admitted and 37.1% were sent home. There were 30 deaths: 29 were assault victims and 1 of self-harm. Discussion Unintentional TBI caused by RTI and intentional TBI caused by assault are common among young males attending Mulago Hospital in Kampala. Level of evidence Prospective observational study, level III.	[Zia, Nukhba; Mehmood, Amber] Johns Hopkins Univ, Sch Publ Hlth, Dept Int Hlth, Johns Hopkins Int Injury Res Unit,Hlth Syst Progr, Baltimore, MD USA; [Namaganda, Rukia H.; Kobusingye, Olive] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Ssenyonjo, Hussein] Mulago Hosp, Dept Neurosurg, Kampala, Uganda; [Hyder, Adnan A.] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC USA		Zia, N (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Johns Hopkins Int Injury Res Unit, Hlth Syst Program,Dept Int Hlth, Baltimore, MD 21205 USA.	nukhba.zia@jhu.edu	Hyder, Adnan/AAT-9503-2021	Mehmood, Amber/0000-0002-8417-1282; Kobusingye, Olive/0000-0003-2413-599X; Hyder, Adnan/0000-0002-7292-577X	Global Brain Disorders Research award of the Fogarty International Center at the US National Institutes of Health (NIH) [R21NS085094]	The study was supported by grant (R21NS085094) to Johns Hopkins University under the Global Brain Disorders Research award of the Fogarty International Center at the US National Institutes of Health (NIH).	Abdelgadir J, 2018, J CLIN NEUROSCI, V47, P79, DOI 10.1016/j.jocn.2017.10.004; Abdelgadir J, 2017, WORLD NEUROSURG, V102, P526, DOI 10.1016/j.wneu.2017.03.019; Angulo-Menendez P, 2017, AN SIST SANIT NAVAR, V40, P177, DOI [10.23938/ASSN.0033, 10.23938/assn.0033]; [Anonymous], 2017, WORLD BANK DAT TOT P WORLD BANK DAT TOT P; [Anonymous], 2013, PED SAF ROAD SAF MAN; [Anonymous], 2015, **NON-TRADITIONAL**; [Anonymous], 2015, COUNTR PROF UG GLOB COUNTR PROF UG GLOB; Bachani AM, 2017, ANN GLOB HEALTH, V83, P791, DOI 10.1016/j.aogh.2017.10.030; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Global Burden of Disease 2016 Seattle, 2016, I HLTH METRICS EVALU; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kim H, 2008, J TRAUMA, V65, P1287, DOI 10.1097/TA.0b013e31817196f5; Kim TK, 2015, KOREAN J ANESTHESIOL, V68, P540, DOI 10.4097/kjae.2015.68.6.540; King M, 2013, IMPROVING PEDESTRIAN; Kobusingye OC, 2000, J TRAUMA, V48, P498, DOI 10.1097/00005373-200003000-00022; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; MacLeod JBA., 2003, EUR J TRAUMA, V29, P392, DOI [10.1007/s00068-003-1277-5, DOI 10.1007/S00068-003-1277-5]; McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018; Mehmood Amber, 2018, BMC Res Notes, V11, P299, DOI 10.1186/s13104-018-3419-1; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; O'Reilly GM, 2013, INJURY, V44, P713, DOI 10.1016/j.injury.2013.02.003; Pickett William, 2004, Chronic Dis Can, V25, P32; Punchak M, 2018, WORLD NEUROSURG, V114, pE396, DOI 10.1016/j.wneu.2018.02.191; Reed JR., 2018, J Spec Oper Med, V18, P57; Saatian Mohamadreza, 2018, Bull Emerg Trauma, V6, P45, DOI 10.29252/beat-060107; Sperandei S, 2014, BIOCHEM MEDICA, V24, P12, DOI 10.11613/BM.2014.003; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Woo BH., 2000, REHABILITATION PEOPL; , 2017, SYST REV POS YOUTH D SYST REV POS YOUTH D	38	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open	JAN	2019	4	1							e000259	10.1136/tsaco-2018-000259			6	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	VK2XU	WOS:000672553800020	30899793	Green Published, gold			2022-02-06	
J	Betcher, J; Becker, TK; Stoyanoff, P; Cranford, J; Theyyunni, N				Betcher, Joseph; Becker, Torben K.; Stoyanoff, Peter; Cranford, Jim; Theyyunni, Nik			Military trainees can accurately measure optic nerve sheath diameter after a brief training session	MILITARY MEDICAL RESEARCH			English	Article						Ultrasound; Military; Optic nerve sheath diameter; Intracranial pressure; Education	INTRACRANIAL-PRESSURE; SONOGRAPHIC ASSESSMENT; ULTRASONOGRAPHIC MEASUREMENT; RELIABILITY	BackgroundIdentification of elevated intracranial pressure is important following traumatic brain injury. We assessed the feasibility of educating military trainees on accurately obtaining optic nerve sheath diameter measurements using a brief didactic and hands-on training session. Optic nerve sheath diameter is a noninvasive surrogate marker for elevated intracranial pressure, and may be of value in remote military operations, where rapid triage decisions must be made without access to advanced medical equipment.MethodsMilitary trainees with minimal ultrasound experience were given a 5-min didactic presentation on optic nerve sheath diameter ultrasound. Trainees practiced optic nerve sheath diameter measurements guided by emergency physician ultrasound experts. Trainees then measured the optic nerve sheath diameter on normal volunteers. Following this, a trained physician measured the optic nerve sheath diameter on the same volunteer as a criterion standard. An average of three measurements was taken.ResultsTwenty-three military trainees were enrolled. A mixed design ANOVA was used to compare measurements by trainees to those of physicians, with a mean difference of -0.6mm (P=0.76). A Bland-Altman analysis showed that the degree of bias in optic nerve sheath diameter measures provided by trainees was very small: d=-0.004 for the right eye and d=-0.007 for the left eye.ConclusionThis study demonstrates that optic nerve sheath diameter measurement can be accurately performed by novice ultrasonographers after a brief training session. If validated, point-of-care optic nerve sheath diameter measurement could impact the triage of injured patients in remote areas.	[Betcher, Joseph] Mercy Hlth Muskegon, Dept Emergency Med, 1500 E Sherman Blvd, Muskegon, MI 49444 USA; [Becker, Torben K.] Univ Pittsburgh, Dept Crit Care Med, Med Ctr, 200 Lothrop St, Pittsburgh, PA 15213 USA; [Stoyanoff, Peter] Hurley Hosp, Dept Emergency Med, 1 Hurley Plaza, Flint, MI 48503 USA; [Cranford, Jim] Univ Michigan, Med Ctr, Dept Psychiat, Ann Arbor, MI 48109 USA; [Theyyunni, Nik] Univ Michigan, Dept Emergency Med, Med Ctr, Ann Arbor, MI 48109 USA		Betcher, J (corresponding author), Mercy Hlth Muskegon, Dept Emergency Med, 1500 E Sherman Blvd, Muskegon, MI 49444 USA.	joebetcher@gmail.com	Becker, Torben K/I-2134-2019	Becker, Torben K/0000-0002-5287-8056; Betcher, Joseph/0000-0003-4443-3820			Amini R, 2015, J ULTRAS MED, V34, P1607, DOI 10.7863/ultra.15.14.09039; Backlund BH, 2010, PREHOSP EMERG CARE, V14, P118, DOI 10.3109/10903120903349770; Bauerle J, 2012, J NEUROIMAGING, V22, P42, DOI 10.1111/j.1552-6569.2010.00546.x; Bauerle J, 2011, J NEUROL, V258, P2014, DOI 10.1007/s00415-011-6059-0; Beck-Razi N, 2007, J ULTRAS MED, V26, P1149, DOI 10.7863/jum.2007.26.9.1149; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brooks AJ, 2005, EMERG MED J, V22, P263, DOI 10.1136/emj.2004.014308; Carkeet A, 2015, OPTOMETRY VISION SCI, V92, pE71, DOI 10.1097/OPX.0000000000000513; Dimitriou J, 2016, WORLD NEUROSURG, V89, P641, DOI 10.1016/j.wneu.2015.11.037; Dubourg J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-62; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Frumin E, 2014, WEST J EMERG MED, V15, P217, DOI 10.5811/westjem.2013.9.16191; Heiner Jason D, 2010, J Spec Oper Med, V10, P7; Hile DC, 2012, MIL MED, V177, P983, DOI 10.7205/MILMED-D-12-00020; Hill M, 2012, J NEUROSCI NURS, V44, P188, DOI 10.1097/JNN.0b013e3182527672; Le A, 2008, ANN EMERG MED, V53, P1; Liu DB, 2017, BMC SURG, V17, DOI 10.1186/s12893-016-0201-y; Lochner P, 2016, J ULTRASOUND, V19, P41, DOI 10.1007/s40477-014-0144-z; Miletic D, 1999, MIL MED, V164, P600; Miller C, 2017, J NEUROSURG, V126, P289, DOI 10.3171/2015.12.JNS152341; Monti Jonathan D, 2009, J Spec Oper Med, V9, P43; Oberfoell S, 2017, J ULTRAS MED, V36, P1579, DOI 10.7863/ultra.16.05055; Potgieter DW, 2011, ANAESTH INTENS CARE, V39, P95, DOI 10.1177/0310057X1103900116; Raffiz M, 2016, AM J EMERG MED, V35, P8; Roberts J, 2006, PREHOSP EMERG CARE, V10, P502, DOI 10.1080/10903120600887023; Tayal V, 2016, ACEP ULTRASOUND GUID; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Topcuoglu MA, 2015, J NEUROIMAGING, V25, P906, DOI 10.1111/jon.12233; Toscano M, 2017, BIOMED RES INT, V2017, P1; Zeiler FA, 2016, CRIT ULTRASOUND J, V8, DOI 10.1186/s13089-016-0044-x	30	7	8	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2095-7467	2054-9369		MILITARY MED RES	MILITARY MED. RES.	DEC 20	2018	5								42	10.1186/s40779-018-0189-y			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HF3TY	WOS:000454158600001	30572931	Green Published, gold			2022-02-06	
J	Nemani, SK; Notari, S; Cali, I; Alvarez, VE; Kofskey, D; Cohen, M; Stern, RA; Appleby, B; Abrams, J; Schonberger, L; McKee, A; Gambetti, P				Nemani, Satish Kumar; Notari, Silvio; Cali, Ignazio; Alvarez, Victor E.; Kofskey, Diane; Cohen, Mark; Stern, Robert A.; Appleby, Brian; Abrams, Joseph; Schonberger, Lawrence; McKee, Ann; Gambetti, Pierluigi			Co-occurrence of chronic traumatic encephalopathy and prion disease	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Chronic traumatic encephalopathy; Post-traumatic stress disorder; Traumatic brain injury; Prion diseases; Sporadic Creutzfeldt-Jakob disease; Comorbidity; Tau protein; Amyloid; Parkinson's disease	CREUTZFELDT-JAKOB-DISEASE; ALZHEIMERS-DISEASE; BRAIN-INJURY; CONFORMATIONAL STABILITY; PROTEIN; CLASSIFICATION; SCRAPIE; ASSOCIATION; SPECTRUM; CJD	Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with repetitive traumatic brain injury (TBI). CTE is generally found in athletes participating in contact sports and military personnel exposed to explosive blasts but can also affect civilians. Clinically and pathologically, CTE overlaps with post-traumatic stress disorder (PTSD), a term mostly used in a clinical context. The histopathology of CTE is defined by the deposition of hyperphosphorylated tau protein in neurons and astrocytes preferentially with perivascular distribution and at the depths of the cortical sulci. In addition to hyperphosphorylated tau, other pathologic proteins are deposited in CTE, including amyloid (A), transactive response(TAR) DNA-binding protein 43kDa (TDP-43) and -synuclein. However, the coexistence of prion disease in CTE has not been observed. We report three cases of histopathologically validated CTE with co-existing sporadic prion disease. Two were identified in a cohort of 55 pathologically verified cases of CTE submitted to the CTE Center of Boston University. One was identified among brain tissues submitted to the National Prion Disease Pathology Surveillance Center of Case Western Reserve University. The histopathological phenotype and properties of the abnormal, disease-related prion protein (PrPD) of the three CTE cases were examined using lesion profile, immunohistochemistry, electrophoresis and conformational tests. Subjects with sporadic Creutzfeldt-Jakob disease (sCJD) matched for age, PrP genotype and PrPD type were used as controls. The histopathology phenotype and PrPD properties of the three CTE subjects showed no significant differences from their respective sCJD controls suggesting that recurring neurotrauma or coexisting CTE pathology did not detectably impact the prion disease phenotype and PrPD conformational characteristics. Based on the reported incidence of sporadic prion disease, the detection of two cases with sCJD in the CTE Center series of 55 CTE cases by chance alone would be highly unlikely (p=8.93*10(-6)). Nevertheless, examination of a larger cohort of CTE is required to conclusively determine whether the risk of CJD is significantly increased in patients with CTE.	[Nemani, Satish Kumar; Notari, Silvio; Cali, Ignazio; Cohen, Mark; Gambetti, Pierluigi] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Alvarez, Victor E.; McKee, Ann] VA Boston Healthcare Syst, Boston, MA 02130 USA; [Alvarez, Victor E.; McKee, Ann] Boston Univ, Sch Med, Dept Neurol & Pathol, Boston, MA 02118 USA; [Alvarez, Victor E.; Stern, Robert A.; McKee, Ann] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Alvarez, Victor E.; Stern, Robert A.; McKee, Ann] Boston Univ, Sch Med, CTE Program, Boston, MA 02118 USA; [Kofskey, Diane; Cohen, Mark; Appleby, Brian] Case Western Reserve Univ, Natl Pr Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Appleby, Brian] Case Western Reserve Univ, Sch Med, Dept Neurol, Cleveland, OH 44106 USA; [Appleby, Brian] Case Western Reserve Univ, Sch Med, Dept Psychiat, Cleveland, OH 44106 USA; [Abrams, Joseph; Schonberger, Lawrence] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA		Notari, S; Gambetti, P (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA.	sxn194@case.edu; pxg13@case.edu	cali, ignazio/AAS-1127-2020; , Bob/ABA-8507-2020; Cali, Ignazio/AAH-6093-2020	cali, ignazio/0000-0001-5770-3848; Abrams, Joseph/0000-0002-2278-2467	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS083687, P01AI106705]; Charles S. Britton Fund; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS086659, R01 NS078337, R56 NS078337, U01 NS093334, F32 NS096803]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23 AG046377, P30AG13846, R01 AG1649, AG057902, 0572063345-5]; U.S. Department of DefenseUnited States Department of Defense [W81XWH-13-2-0064]; U.S. Department of Veterans AffairsUS Department of Veterans Affairs [I01 CX001038, CSP 501]; Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; Department of Defense Peer Reviewed Alzheimer's Research Program [13267017]; National Operating Committee on Standards for Athletic Equipment; Alzheimer's AssociationAlzheimer's Association [NIRG-15-362697, NIRG-305779]; Concussion Legacy Foundation; Lynn Buoniconti Foundation; Andlinger Family Foundation; National Football League; Chronic Effects of Neurotrauma Consortium (CENC) Award [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [P01AI106705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS093334, U01NS086659, F32NS096803, R01NS083687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG057902, K23AG046377, P30AG013846] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001135, I01CX001038] Funding Source: NIH RePORTER	The study was supported by NIH P01AI106705, NIH 5R01NS083687 and Charles S. Britton Fund to PG, and National Institute of Neurological Disorders and Stroke (grants U01 NS086659, R01 NS078337, R56 NS078337, U01 NS093334, F32 NS096803), the National Institute on Aging (grants K23 AG046377, P30AG13846; supplement 0572063345-5, R01 AG1649, AG057902), the U.S. Department of Defense (grant W81XWH-13-2-0064), Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095 and Department of Veterans Affairs CENC Award I01 CX001135, the U.S. Department of Veterans Affairs (I01 CX001038), the Veterans Affairs Biorepository (CSP 501), the Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (grant B6796-C), the Department of Defense Peer Reviewed Alzheimer's Research Program (DoD-PRARP grant 13267017), the National Operating Committee on Standards for Athletic Equipment, the Alzheimer's Association (grants NIRG-15-362697, NIRG-305779), the Concussion Legacy Foundation, Nick and Lynn Buoniconti Foundation, the Andlinger Family Foundation, WWE, and the National Football League to AMK.	Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; BOLLER F, 1980, ANN NEUROL, V7, P329, DOI 10.1002/ana.410070408; Cali I, 2006, BRAIN, V129, P2266, DOI 10.1093/brain/awl224; Cali I, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-017-0503-z; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Cannon A, 2014, ACTA NEUROPATHOL, V128, P313, DOI 10.1007/s00401-014-1309-8; Cescatti M, 2016, J VIROL, V90, P6244, DOI 10.1128/JVI.00144-16; Chen C, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0143-8; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Collins SJ, 2006, BRAIN, V129, P2278, DOI 10.1093/brain/awl159; Cracco L, 2017, SCI REP-UK, V7, DOI 10.1038/srep38280; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Gambetti P, 2011, ACTA NEUROPATHOL, V121, P79, DOI 10.1007/s00401-010-0761-3; Ghoshal N, 2009, ARCH NEUROL-CHICAGO, V66, P1240, DOI 10.1001/archneurol.2009.224; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Kobayashi A, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-74; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Lucke-Wold BP, 2016, J NEUROSURG, V124, P687, DOI 10.3171/2015.3.JNS141802; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Moreno JA, 2017, METHODS MOL BIOL, V1658, P219, DOI 10.1007/978-1-4939-7244-9_16; Moreno-Gonzalez I, 2017, MOL PSYCHIATR, V22, P1327, DOI 10.1038/mp.2016.230; Notari S, 2004, J BIOL CHEM, V279, P16797, DOI 10.1074/jbc.M313220200; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Parchi P, 2009, ACTA NEUROPATHOL, V118, P659, DOI 10.1007/s00401-009-0585-1; Pastore M, 2005, AM J PATHOL, V167, P1729, DOI 10.1016/S0002-9440(10)61254-0; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Pirisinu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012723; Poggiolini Ilaria, 2013, Int J Cell Biol, V2013, P910314, DOI 10.1155/2013/910314; Puoti G, 2012, LANCET NEUROL, V11, P618, DOI 10.1016/S1474-4422(12)70063-7; Ritchie DL, 2017, ACTA NEUROPATHOL, V133, P579, DOI 10.1007/s00401-016-1638-x; Rodriguez-Diehl R, 2012, NEUROPATHOLOGY, V32, P158, DOI 10.1111/j.1440-1789.2011.01232.x; Safar JG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004832; Safer J, 1998, PROG BRAIN RES, V117, P421; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Soto C, 2018, NAT NEUROSCI, V21, P1332, DOI 10.1038/s41593-018-0235-9; Spires-Jones TL, 2017, ACTA NEUROPATHOL, V134, P187, DOI 10.1007/s00401-017-1709-7; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Tousseyn T, 2015, J NEUROPATH EXP NEUR, V74, P873, DOI 10.1097/NEN.0000000000000228; Tsuchiya K, 2004, NEUROPATHOLOGY, V24, P46, DOI 10.1111/j.1440-1789.2003.00513.x; Vasconcelos B, 2016, ACTA NEUROPATHOL, V131, P549, DOI 10.1007/s00401-015-1525-x; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; Zerr I, 2000, J CLIN EPIDEMIOL, V53, P747, DOI 10.1016/S0895-4356(99)00207-3; Zou WQ, 2004, P NATL ACAD SCI USA, V101, P1380, DOI 10.1073/pnas.0307825100; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	64	7	7	2	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	DEC 18	2018	6								140	10.1186/s40478-018-0643-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE8CM	WOS:000453670900001	30563563	Green Published, gold			2022-02-06	
J	Vaughan, LE; Ranganathan, PR; Kumar, RG; Wagner, AK; Rubin, JE				Vaughan, Leah E.; Ranganathan, Prerna R.; Kumar, Raj G.; Wagner, Amy K.; Rubin, Jonathan E.			A mathematical model of neuroinflammation in severe clinical traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Biomarker; Cerebrospinal fluid; Cytokines; Glasgow outcome scale; Inflammation; Mathematical modeling; Microglia; Patient outcome; Traumatic brain injury	CEREBROSPINAL-FLUID; MICROGLIAL POLARIZATION; INFLAMMATORY RESPONSE; M2 MICROGLIA; ACTIVATION; SURVIVORS; PROFILES; DISEASE; IL-4	BackgroundUnderstanding the interdependencies among inflammatory mediators of tissue damage following traumatic brain injury (TBI) is essential in providing effective, patient-specific care. Activated microglia and elevated concentrations of inflammatory signaling molecules reflect the complex cascades associated with acute neuroinflammation and are predictive of recovery after TBI. However, clinical TBI studies to date have not focused on modeling the dynamic temporal patterns of simultaneously evolving inflammatory mediators, which has potential in guiding the design of future immunomodulation intervention studies.MethodsWe derived a mathematical model consisting of ordinary differential equations (ODE) to represent interactions between pro- and anti-inflammatory cytokines, M1- and M2-like microglia, and central nervous system (CNS) tissue damage. We incorporated variables for several cytokines, interleukin (IL)-1, IL-4, IL-10, and IL-12, known to have roles in microglial activation and phenotype differentiation. The model was fit to cerebrospinal fluid (CSF) cytokine data, collected during the first 5days post-injury in n=89 adults with severe TBI. Ensembles of model fits were produced for three patient subgroups: (1) a favorable outcome group (GOS=4,5) and (2) an unfavorable outcome group (GOS=1,2,3) both with lower pro-inflammatory load, and (3) an unfavorable outcome group (GOS=1,2,3) with higher pro-inflammatory load. Differences in parameter distributions between subgroups were ranked using Bhattacharyya metrics to identify mechanistic differences underlying the neuroinflammatory patterns of patient groups with different TBI outcomes.ResultsOptimal model fits to data showed different microglial and damage responses by patient subgroup. Upon comparison of model parameter distributions, unfavorable outcome groups were characterized by either a prolonged, pathophysiological or a transient, sub-physiological course of neuroinflammation.ConclusionBy developing a mathematical characterization of inflammatory processes informed by clinical data, we have created a system for exploring links between acute neuroinflammatory components and patient outcome in severe TBI.	[Vaughan, Leah E.; Ranganathan, Prerna R.; Kumar, Raj G.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA; [Vaughan, Leah E.; Rubin, Jonathan E.] Univ Pittsburgh, Dept Math, 301 Thackeray Hall, Pittsburgh, PA 15260 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.; Rubin, Jonathan E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA.; Rubin, JE (corresponding author), Univ Pittsburgh, Dept Math, 301 Thackeray Hall, Pittsburgh, PA 15260 USA.	wagnerak@upmc.edu; jonrubin@pitt.edu	RUBIN, JONATHAN/AAD-9071-2019		US National Science FoundationNational Science Foundation (NSF) [DMS 1612913]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [TL1-TR001858]; Department of DefenseUnited States Department of Defense [W81XWH-071-0701]; University of Pittsburgh Physicians Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA047904] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001858] Funding Source: NIH RePORTER	This work was supported by the US National Science Foundation [DMS 1612913], the National Institutes of Health [TL1-TR001858], the Department of Defense [W81XWH-071-0701], and the University of Pittsburgh Physicians Foundation.	Abboud A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00342; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Bhattacharyya A., 1943, Bulletin of the Calcutta Mathematical Society, V35, P99; Brown D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3636; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Cheng ZQ, 2016, JOURNAL PRACT, V10, P744, DOI [10.1111/jnc.13062, 10.1080/17512786.2015.1063079]; Cherry JD, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00594; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Choi P, 1998, CLIN EXP IMMUNOL, V113, P317; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Daun S, 2008, J CRIT CARE, V23, P585, DOI 10.1016/j.jcrc.2008.02.003; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Espinosa-Garcia C, 2017, BRAIN BEHAV IMMUN, V66, P177, DOI 10.1016/j.bbi.2017.06.012; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Gadani SP, 2012, J IMMUNOL, V189, P4213, DOI 10.4049/jimmunol.1202246; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kim JY, 2015, CNS NEUROSCI THER, V21, P309, DOI 10.1111/cns.12360; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar RG, 2016, BRAIN BEHAV IMMUN, V53, P183, DOI 10.1016/j.bbi.2015.12.008; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Luo XG, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-9; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Tronel C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040802; Vodovotz Y, 2009, MATH BIOSCI, V217, P1, DOI 10.1016/j.mbs.2008.07.013; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104; Yuan JC, 2017, ONCOTARGET, V8, P19855, DOI 10.18632/oncotarget.15774	52	7	7	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	DEC 18	2018	15								345	10.1186/s12974-018-1384-1			19	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	HE9RL	WOS:000453791100001	30563537	Green Published, gold			2022-02-06	
J	Hill, RL; Singh, IN; Wang, JA; Hall, ED				Hill, Rachel L.; Singh, Indrapal N.; Wang, Juan A.; Hall, Edward D.			Effects of Phenelzine Administration on Mitochondrial Function, Calcium Handling, and Cytoskeletal Degradation after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						4-hydroxynonenal (4-HNE); acrolein; mitochondria; phenelzine; spectrin; traumatic brain injury (TBI)	ALZHEIMERS-DISEASE BRAIN; CENTRAL-NERVOUS-SYSTEM; LIPID-PEROXIDATION PRODUCT; SPINAL-CORD MITOCHONDRIA; MAO INHIBITOR PHENELZINE; INDUCED OXIDATIVE DAMAGE; T-BUTYL HYDROXYLAMINE; ALDEHYDE DEHYDROGENASE; OXIDIZED PHOSPHOLIPIDS; PERMEABILITY TRANSITION	Traumatic brain injury (TBI) results in the production of peroxynitrite (PN), leading to oxidative damage of lipids and protein. PN-mediated lipid peroxidation (LP) results in production of reactive aldehydes 4-hydroxynonenal (4-HNE) and acrolein. The goal of these studies was to explore the hypothesis that interrupting secondary oxidative damage following a TBI via phenelzine (PZ), analdehyde scavenger, would protect against LP-mediated mitochondrial and neuronal damage. Male Sprague-Dawley rats received a severe (2.2 mm) controlled cortical impact (CCI)-TBI. PZ was administered subcutaneously (s.c.) at 15 min (10 mg/kg) and 12 h (5 mg/kg) post-injury and for the therapeutic window/delay study, PZ was administered at 1 h (10 mg/kg) and 24 h (5 mg/kg). Mitochondrial and cellular protein samples were obtained at 24 and 72 h post-injury (hpi). Administration of PZ significantly improved mitochondrial respiration at 24 and 72 h compared with vehicle-treated animals. These results demonstrate that PZ administration preserves mitochondrial bioenergetics at 24 h and that this protection is maintained out to 72 hpi. Additionally, delaying the administration still elicited significant protective effects. PZ administration also improved mitochondrial Ca2+ buffering (CB) capacity and mitochondrial membrane potential parameters compared with vehicle-treated animals at 24 h. Although PZ treatment attenuated aldehyde accumulation post-injury, the effects were insignificant. The amount of alpha-spectrin breakdown in cortical tissue was reduced by PZ administration at 24 h, but not at 72 hpi compared with vehicle-treated animals. In conclusion, these results indicate that acute PZ treatment successfully attenuates LP-mediated oxidative damage eliciting multiple neuroprotective effects following TBI.	[Hill, Rachel L.; Singh, Indrapal N.; Wang, Juan A.; Hall, Edward D.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA; [Singh, Indrapal N.; Hall, Edward D.] Univ Kentucky, Coll Med, Dept Neurosci, Lexington, KY USA		Hall, ED (corresponding author), Univ Kentucky, Med Ctr, Spinal Cord & Brain Injury Res Ctr SCoBIRC, 741 South Limestone St, Lexington, KY 40536 USA.	edhall@uky.edu			NIH from NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS083405, R01 NS084857]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 NS051220]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F30NS096876, R01NS083405, R01NS084857, T32NS077889] Funding Source: NIH RePORTER	This work was supported by NIH grants R01 NS083405 and R01 NS084857 from NINDS and by NIH grant P30 NS051220.	Agil A, 2006, J NEUROL SCI, V240, P31, DOI 10.1016/j.jns.2005.08.016; AMBROZIAK W, 1991, J BIOL CHEM, V266, P13011; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741; BAKER GB, 1991, J AFFECT DISORDERS, V21, P207, DOI 10.1016/0165-0327(91)90041-P; Barrera G, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5010007; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BECKMAN JS, 1994, ANN NY ACAD SCI, V738, P69; Benson CA, 2013, BEHAV BRAIN RES, V252, P302, DOI 10.1016/j.bbr.2013.06.019; Bhosale G, 2015, ANN NY ACAD SCI, V1350, P107, DOI 10.1111/nyas.12885; Binda C, 2008, BIOCHEMISTRY-US, V47, P5616, DOI 10.1021/bi8002814; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Brunk UT, 2001, REDOX REP, V6, P91, DOI 10.1179/135100001101536094; Burcham PC, 2002, TOXICOLOGY, V181, P229, DOI 10.1016/S0300-483X(02)00287-1; Butterfield DA, 2010, BBA-MOL CELL BIOL L, V1801, P924, DOI 10.1016/j.bbalip.2010.02.005; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; Carini R, 1996, BIOCHEM BIOPH RES CO, V218, P772, DOI 10.1006/bbrc.1996.0137; Carrico KM, 2009, J NEUROTRAUM, V26, P1369, DOI 10.1089/neu.2008-0870; Carroll RT, 2000, CHEM RES TOXICOL, V13, P294, DOI 10.1021/tx990159t; Castegna A, 2004, BRAIN RES, V1004, P193, DOI 10.1016/j.brainres.2004.01.036; Castro JP, 2017, FREE RADICAL BIO MED, V111, P309, DOI 10.1016/j.freeradbiomed.2016.10.497; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chavez JD, 2011, J PROTEOMICS, V74, P2417, DOI 10.1016/j.jprot.2011.03.031; Chen Z, 2016, J NEUROCHEM, V138, P328, DOI 10.1111/jnc.13639; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Clarkson AN, 2004, FASEB J, V18, P1114, DOI 10.1096/fj.03-1203fje; CLIFTON G L, 1989, Journal of Neurotrauma, V6, P71, DOI 10.1089/neu.1989.6.71; Conte V, 2004, J NEUROCHEM, V90, P758, DOI 10.1111/j.1471-4159.2004.02560.x; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Di Domenico F, 2017, FREE RADICAL BIO MED, V111, P253, DOI 10.1016/j.freeradbiomed.2016.10.490; Dianzani Mario Umberto, 2003, Molecular Aspects of Medicine, V24, P263; Dianzani MU, 1999, ACTA BIOCHIM POL, V46, P61, DOI 10.18388/abp.1999_4184; DOAMARAL L, 1966, J AM CHEM SOC, V88, P2225, DOI 10.1021/ja00962a027; Domingues RM, 2013, J PROTEOMICS, V92, P110, DOI 10.1016/j.jprot.2013.06.004; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Dubinina EE, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1069, DOI 10.1134/S0006297910090014; Duchen MR, 2012, PFLUG ARCH EUR J PHY, V464, P111, DOI 10.1007/s00424-012-1112-0; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Due MR, 2014, J NEUROCHEM, V128, P776, DOI 10.1111/jnc.12500; ESTERBAUER H, 1986, BIOCHIM BIOPHYS ACTA, V876, P154, DOI 10.1016/0005-2760(86)90329-2; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Ghilarducci DP, 1995, REV ENVIRON CONTAM T, V144, P95; Gubisne-Haberle D, 2004, J PHARMACOL EXP THER, V310, P1125, DOI 10.1124/jpet.104.068601; Guiotto A, 2005, J MED CHEM, V48, P6156, DOI 10.1021/jm050507q; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; HALL ED, 1991, J PHARMACOL EXP THER, V258, P688; Hall ED, 2016, J BIOENERG BIOMEMBR, V48, P169, DOI 10.1007/s10863-015-9600-5; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hamann K, 2008, J NEUROCHEM, V104, P708, DOI 10.1111/j.1471-4159.2007.05002.x; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; He NG, 1998, TOXICOL APPL PHARM, V152, P83, DOI 10.1006/taap.1998.8511; Hill RL, 2018, NEUROSCIENCE, V386, P265, DOI 10.1016/j.neuroscience.2018.06.028; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Hipkiss AR, 2001, MECH AGEING DEV, V122, P169, DOI 10.1016/S0047-6374(00)00231-1; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; KIEDROWSKI L, 1995, MOL PHARMACOL, V47, P140; Kikonyogo A, 1996, BIOCHEM J, V316, P317, DOI 10.1042/bj3160317; Kinnunen PKJ, 2012, BBA-BIOMEMBRANES, V1818, P2446, DOI 10.1016/j.bbamem.2012.04.008; Kruman I, 1997, J NEUROSCI, V17, P5089; Kulbe JR, 2018, J NEUROTRAUM, V35, P1280, DOI 10.1089/neu.2017.5353; Lai J C, 1979, Methods Enzymol, V55, P51; Lee JH, 2004, CARCINOGENESIS, V25, P1435, DOI 10.1093/carcin/bgh139; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Leung G, 2011, NEUROSCIENCE, V173, P150, DOI 10.1016/j.neuroscience.2010.11.018; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li W, 2003, BIOCHEM J, V371, P429, DOI 10.1042/BJ20021520; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lin MH, 2014, TOXICOLOGY, V315, P24, DOI 10.1016/j.tox.2013.11.007; Linhart I, 1996, TOXICOL APPL PHARM, V136, P155, DOI 10.1006/taap.1996.0019; Llorente-Folch I, 2015, J PHYSIOL-LONDON, V593, P3447, DOI 10.1113/JP270254; LOVAAS E, 1991, FREE RADICAL BIO MED, V11, P455, DOI 10.1016/0891-5849(91)90061-7; Lovell MA, 1998, NEUROLOGY, V51, P1562, DOI 10.1212/WNL.51.6.1562; Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001; Maciel EN, 2001, J NEUROCHEM, V79, P1237, DOI 10.1046/j.1471-4159.2001.00670.x; Markesbery WR, 1998, NEUROBIOL AGING, V19, P33, DOI 10.1016/S0197-4580(98)00009-8; Martinez-Lara E, 2003, NEUROBIOL AGING, V24, P501, DOI 10.1016/S0197-4580(02)00139-2; Matsunaga T, 2006, DRUG METAB PHARMACOK, V21, P1, DOI 10.2133/dmpk.21.1; McCracken E, 2000, J CEREBR BLOOD F MET, V20, P1529, DOI 10.1097/00004647-200011000-00002; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; Meyer MJ, 2004, CHEM RES TOXICOL, V17, P1272, DOI 10.1021/tx049843k; MINK JW, 1981, AM J PHYSIOL, V241, pR203, DOI 10.1152/ajpregu.1981.241.3.R203; Morrow CS, 1998, CARCINOGENESIS, V19, P109, DOI 10.1093/carcin/19.1.109; Murphy TC, 2003, J NEUROCHEM, V84, P1313, DOI 10.1046/j.1471-4159.2003.01628.x; Musgrave T, 2011, BRAIN BEHAV IMMUN, V25, P1677, DOI 10.1016/j.bbi.2011.06.011; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nagaraj RH, 2002, ARCH BIOCHEM BIOPHYS, V402, P110, DOI 10.1016/S0003-9861(02)00067-X; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; NICHOLLS D, 1982, BIOCHIM BIOPHYS ACTA, V683, P57, DOI 10.1016/0304-4173(82)90013-1; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; NICHOLLS DG, 1985, PROG BRAIN RES, V63, P97; Pandya JD, 2015, NEUROBIOL AGING, V36, P1903, DOI 10.1016/j.neurobiolaging.2015.01.018; Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006; Park J, 2014, NEURAL REGEN RES, V9, P677, DOI 10.4103/1673-5374.131564; Park J, 2014, J NEUROCHEM, V129, P339, DOI 10.1111/jnc.12628; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; Pfizer, 2009, NARD PHEN SULF TABL; Picklo MJ, 2001, BBA-MOL BASIS DIS, V1535, P145, DOI 10.1016/S0925-4439(00)00093-4; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Pocernich CB, 2003, NEUROTOX RES, V5, P515, DOI 10.1007/BF03033161; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Raza H, 2008, TOXICOL APPL PHARM, V226, P161, DOI 10.1016/j.taap.2007.09.002; Raza H, 2006, TOXICOL APPL PHARM, V216, P309, DOI 10.1016/j.taap.2006.06.001; Reed TT, 2009, BRAIN RES, V1274, P66, DOI 10.1016/j.brainres.2009.04.009; Rooke N, 2000, J MED CHEM, V43, P4169, DOI 10.1021/jm990614i; Rueda CB, 2014, BBA-BIOENERGETICS, V1837, P1617, DOI 10.1016/j.bbabio.2014.04.010; Sava IG, 2006, FREE RADICAL BIO MED, V41, P1272, DOI 10.1016/j.freeradbiomed.2006.07.008; Seiler N, 2000, NEUROCHEM RES, V25, P471, DOI 10.1023/A:1007508008731; Sengpiel B, 1998, EUR J NEUROSCI, V10, P1903, DOI 10.1046/j.1460-9568.1998.00202.x; Shoeb M, 2014, CURR MED CHEM, V21, P230; Sidell KR, 2003, J NEUROPATH EXP NEUR, V62, P146, DOI 10.1093/jnen/62.2.146; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Singh M, 2010, J ALZHEIMERS DIS, V21, P741, DOI 10.3233/JAD-2010-100405; Sousa BC, 2017, FREE RADICAL BIO MED, V111, P294, DOI 10.1016/j.freeradbiomed.2017.02.003; Sowa Bernard N., 2004, Current Neuropharmacology, V2, P153, DOI 10.2174/1570159043476800; Spickett CM, 2013, REDOX BIOL, V1, P145, DOI 10.1016/j.redox.2013.01.007; Srivastava S, 2001, ATHEROSCLEROSIS, V158, P339, DOI 10.1016/S0021-9150(01)00454-3; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Starkov AA, 2010, FEBS J, V277, P3652, DOI 10.1111/j.1742-4658.2010.07756.x; Stemmer U, 2012, BBA-BIOMEMBRANES, V1818, P2436, DOI 10.1016/j.bbamem.2012.03.006; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Subramaniam R, 1997, J NEUROCHEM, V69, P1161; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 2004, J COMP NEUROL, V474, P524, DOI 10.1002/cne.20130; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Sultana R, 2004, NEUROCHEM RES, V29, P2215, DOI 10.1007/s11064-004-7028-0; Sultana R, 2013, FREE RADICAL BIO MED, V62, P157, DOI 10.1016/j.freeradbiomed.2012.09.027; Tatton WG, 1996, J NEURAL TRANSM-SUPP, P45; Toninello A, 2004, AMINO ACIDS, V26, P339, DOI 10.1007/s00726-004-0080-x; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/nchem.1924, 10.1038/NCHEM.1924]; Tzeng SC, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00002; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Ullery JC, 2012, BBA-BIOMEMBRANES, V1818, P2424, DOI 10.1016/j.bbamem.2012.04.014; Usatyuk PV, 2012, MICROVASC RES, V83, P45, DOI 10.1016/j.mvr.2011.04.012; Vaishnav RA, 2010, J NEUROTRAUM, V27, P1311, DOI 10.1089/neu.2009.1172; Votyakova TV, 2005, J NEUROCHEM, V93, P526, DOI 10.1111/j.1471-4159.2005.03042.x; Wadia JS, 1998, J NEUROSCI, V18, P932; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Westfall T.C., 2011, PHARM BASIS THERAPEU, V12th, P171; WITZ G, 1989, FREE RADICAL BIO MED, V7, P333, DOI 10.1016/0891-5849(89)90137-8; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004; Wood PL, 2006, BRAIN RES, V1122, P184, DOI 10.1016/j.brainres.2006.09.003; Xiao MQ, 2017, FREE RADICAL BIO MED, V111, P316, DOI 10.1016/j.freeradbiomed.2017.04.363; Xie CS, 1998, FREE RADICAL BIO MED, V25, P979, DOI 10.1016/S0891-5849(98)00186-5; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xiong YQ, 2009, FREE RADICAL RES, V43, P604, DOI 10.1080/10715760902977432; Yu ZQ, 2003, APMIS, V111, P643, DOI 10.1034/j.1600-0463.2003.1110607.x; Yu ZQ, 2004, BRAIN RES, V1016, P163, DOI 10.1016/j.brainres.2004.04.075; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zarkovic Kamelija, 2003, Molecular Aspects of Medicine, V24, P293, DOI 10.1016/S0098-2997(03)00024-4	167	7	7	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2019	36	8					1231	1251		10.1089/neu.2018.5946		DEC 2018	21	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HS4DK	WOS:000452949000001	30358485	Green Published			2022-02-06	
J	Ojo, JO; Algamal, M; Leary, P; Abdullah, L; Mouzon, B; Evans, JE; Mullan, M; Crawford, F				Ojo, Joseph O.; Algamal, Moustafa; Leary, Paige; Abdullah, Laila; Mouzon, Benoit; Evans, James E.; Mullan, Michael; Crawford, Fiona			Disruption in Brain Phospholipid Content in a Humanized Tau Transgenic Model Following Repetitive Mild Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						repetitive mild traumatic brain injury; hTau; cortex; hippocampus; phospholipids; omega-3 and 6 fatty acids; arachidonic acid; docosahexaenoic acid	FREE FATTY-ACIDS; ALZHEIMERS-DISEASE; HEAD-INJURY; OLEIC-ACID; AXONAL INJURY; MOUSE MODEL; RISK-FACTOR; RAT-BRAIN; LIPIDS; MICE	Repetitive mild traumatic brain injury (mTBI) is a risk factor for the development of neurodegenerative diseases such as chronic traumatic encephalopathy typified by immunoreactive tau aggregates in the depths of the sulci. However, the underlying neurobiological mechanisms involved have not been largely explored. Phospholipids are important molecules which form membrane lipid bilayers; they are ubiquitous to every cell in the brain, and carry out a host of different functions. Imbalance in phospholipid metabolism, signaling and transport has been documented in some neurological conditions. However, not much is currently known about their roles in repetitive mTBI and how this may confer risk for the development of age-related neurodegenerative diseases. To address this question, we designed a longitudinal study (24 h, 3, 6, 9, and 12 months post-injury) to comprehensively investigate mTBI dependent brain phospholipid profiles compared to sham counterparts. We use our established mouse model of repetitive mTBI that has been extensively characterized up to 1-year post-injury in humanized tau (hTau) mice, which expresses all six human tau isoforms, on a null murine background. Our data indicates a significant increase in sphingomyelin, phosphatidylethanolamine (PE), phosphatidylcholine (PC), and derivative lysoPE and lysoPC at acute and/or sub-acute time points post-injury within the cortex and hippocampus. There was also a parallel increase at early time points in monounsaturated, polyunsaturated and saturated fatty acids. Omega-6 (arachidonic acid) to omega-3 (docosahexaenoic acid) fatty acid ratio for PE and PC species was increased also at 24 h and 3 months post-injury in both hippocampus and cortex. The long-term consequences of these early changes in phospholipids on neuronal and non-neuronal cell function is unclear, and warrants further study. Understanding phospholipid metabolism, signaling and transport following TBI could be valuable; they may offer novel targets for therapeutic intervention not only in TBI but other neurodegenerative diseases.	[Ojo, Joseph O.; Algamal, Moustafa; Leary, Paige; Abdullah, Laila; Mouzon, Benoit; Evans, James E.; Mullan, Michael; Crawford, Fiona] Roskamp Inst, Expt Neuropathol & Omics Lab, Sarasota, FL 34243 USA; [Ojo, Joseph O.; Abdullah, Laila; Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Ojo, Joseph O.; Algamal, Moustafa; Abdullah, Laila; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona] Open Univ, Sch Life Hlth & Chem Sci, Milton Keynes, Bucks, England		Ojo, JO (corresponding author), Roskamp Inst, Expt Neuropathol & Omics Lab, Sarasota, FL 34243 USA.; Ojo, JO (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.; Ojo, JO (corresponding author), Open Univ, Sch Life Hlth & Chem Sci, Milton Keynes, Bucks, England.	jojo@roskampinstitute.org		Algamal, Moustafa/0000-0002-6215-0122	CDMRP awardUnited States Department of Defense [DOD/W81XWH-13-1-0253]; Roskamp Foundation	This project was supported by the CDMRP award to Fiona Crawford DOD/W81XWH-13-1-0253 and by the Roskamp Foundation. The content presented do not express the views of the Department of Defense or Veteran Affairs or the United States Government.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Abdullah L, 2013, NEUROTOXICOL TERATOL, V40, P74, DOI 10.1016/j.ntt.2013.10.002; Abdullah L, 2012, NEUROMOL MED, V14, P349, DOI 10.1007/s12017-012-8192-z; Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; Amen DG, 2016, J ALZHEIMERS DIS, V53, P237, DOI 10.3233/JAD-160207; Amtul Z, 2011, BRAIN PATHOL, V21, P321, DOI 10.1111/j.1750-3639.2010.00449.x; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Bailes JE, 2014, MIL MED, V179, P112, DOI 10.7205/MILMED-D-14-00139; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; BAUDIER J, 1987, J BIOL CHEM, V262, P17577; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Carrillo C, 2012, NUTR HOSP, V27, P978, DOI 10.3305/nh.2012.27.4.5783; Emmerich T, 2017, NEUROMOL MED, V19, P122, DOI 10.1007/s12017-016-8436-4; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FOLCH J, 1957, J BIOL CHEM, V226, P497; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; Gellermann GP, 2006, BIOL CHEM, V387, P1267, DOI 10.1515/BC.2006.157; Girardot N, 2003, NEUROPATH APPL NEURO, V29, P451, DOI 10.1046/j.1365-2990.2003.00479.x; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Homayoun P, 1997, J NEUROCHEM, V69, P199; Katsinelos T, 2018, CELL REP, V23, P2039, DOI 10.1016/j.celrep.2018.04.056; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Kosicek M, 2013, INT J MOL SCI, V14, P1310, DOI 10.3390/ijms14011310; Lohner K, 1996, CHEM PHYS LIPIDS, V81, P167, DOI 10.1016/0009-3084(96)02580-7; Mankidy R, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-62; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Medina JM, 2002, J PHYSIOL-PARIS, V96, P265, DOI 10.1016/S0928-4257(02)00015-3; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Mouzon B, 2018, BRAIN INJURY, V32, P1285, DOI 10.1080/02699052.2018.1486457; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Oestvang J, 2011, J LIPIDS, V2011, DOI 10.1155/2011/532145; Ojo J. O, 2018, FRONT NEUROSCI; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Patil Sachin, 2008, BMC Res Notes, V1, P20, DOI 10.1186/1756-0500-1-20; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Shea TB, 1997, J NEUROSCI RES, V50, P114, DOI 10.1002/(SICI)1097-4547(19971001)50:1<114::AID-JNR12>3.0.CO;2-B; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sparvero LJ, 2010, J NEUROCHEM, V115, P1322, DOI 10.1111/j.1471-4159.2010.07055.x; SPECTOR R, 1988, NEUROCHEM RES, V13, P785, DOI 10.1007/BF00971603; SPECTOR R, 1988, J NEUROCHEM, V50, P639, DOI 10.1111/j.1471-4159.1988.tb02958.x; Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	54	7	7	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	DEC 4	2018	12								893	10.3389/fnins.2018.00893			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HC8XP	WOS:000452088900001	30564087	gold, Green Published, Green Accepted			2022-02-06	
J	Ikeshima-Kataoka, H; Matsui, Y; Uede, T				Ikeshima-Kataoka, Hiroko; Matsui, Yutaka; Uede, Toshimitsu			Osteopontin is indispensable for activation of astrocytes in injured mouse brain and primary culture	NEUROLOGICAL RESEARCH			English	Article						Blood-brain barrier; bromo-deoxy uridine; glial fibllirary acidic protein; IgG; lipopolysaccharide; primary culture of astrocytes; primary culture of microglial cells; tenascin-C	CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; FORMATION IN-VITRO; MATRICELLULAR PROTEINS; INFLAMMATORY DISEASES; REACTIVE ASTROCYTES; EPITHELIAL-CELLS; TENASCIN-C; MICE; CYTOKINE	Objectives: Osteopontin (OPN) is an inflammatory cytokine inducer involved in cell proliferation and migration in inflammatory diseases or tumors. To investigate the function of OPN in astrocyte activation during brain injury, we compared OPN-deficient (OPN/KO) with wild-type (WT) mouse brains after stab wound injury and primary culture of astrocytes. Methods: Primary cultures of astrocytes were prepared from either WT or OPN/KO postnatal mouse brains. Activation efficiency of astrocytes in primary culture was accessed using Western blotting by examining the protein levels of glial fibrillary acidic protein (GFAP) and tenascin-C (TN-C), which are markers for reactive astrocytes, following lipopolysaccharide (LPS) stimulation. Furthermore, the stab wound injury on the cerebral cortex as a brain traumatic injury model was used, and activation of astrocytes and microglial cells was investigated using immunofluorescent analysis on fixed brain sections. Results: Primary cultures of astrocytes prepared from WT or OPN/KO postnatal mouse brains showed that only 25% of normal shaped astrocytes in a flask were produced in OPN/KO mice. The expression levels of both GFAP and TN-C were downregulated in the primary culture of astrocytes from OPN/KO mice compared with that from WT mice. By the immunofluorescent analysis on the injured brain sections, glial activation was attenuated in OPN/KO mice compared with WT mice. Discussion: Our data suggest that OPN is essential for proper astrocytic generation in vitro culture prepared from mouse cerebral cortex. OPN is indispensable for astrocyte activation in the mouse brain injury model and in LPS stimulated primary culture.	[Ikeshima-Kataoka, Hiroko] Keio Univ, Sch Med, Dept Pharmacol & Neurosci, Tokyo, Japan; [Ikeshima-Kataoka, Hiroko] Waseda Univ, Fac Sci & Engn, Tokyo, Japan; [Matsui, Yutaka] Tonan Hosp, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Matsui, Yutaka; Uede, Toshimitsu] Hokkaido Univ, Dept Matrix Med, Inst Med Genet, Sapporo, Hokkaido, Japan		Ikeshima-Kataoka, H (corresponding author), Keio Univ, Sch Med, Dept Pharmacol & Neurosci, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ikeshima@1988.jukuin.keio.ac.jp			Global Center of Excellence (GCOE) Program for Humanoid Metabolomic Systems Biology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Society for the Promotion of Science (JSPS)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [15K15532]; Kurata Memorial Hitachi Science and Technology Foundation; Waseda University Grants [2012A-872, 2013A-6287, 2013B-127, 2014B-247, 2014K-6137, 2016B-158, 2016K-196]	This work was supported by Global Center of Excellence (GCOE) Program for Humanoid Metabolomic Systems Biology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan for HI-K, Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (JSPS; 15K15532) for HI-K, Waseda University Grants for Special Research Projects [2012A-872, 2013A-6287, 2013B-127, 2014B-247, 2014K-6137, 2016B-158, and 2016K-196] for HI-K, and The Kurata Memorial Hitachi Science and Technology Foundation for HI-K.	Brenner M, 2014, NEUROSCI LETT, V565, P7, DOI 10.1016/j.neulet.2014.01.055; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cantor H, 2009, NAT REV IMMUNOL, V9, P137, DOI 10.1038/nri2460; Ceyzeriat K, 2016, NEUROSCIENCE, V330, P205, DOI 10.1016/j.neuroscience.2016.05.043; Chaboub LS, 2016, J NEUROSCI, V36, P11904, DOI 10.1523/JNEUROSCI.1658-16.2016; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Gliem M, 2015, GLIA, V63, P2198, DOI 10.1002/glia.22885; Gravallese EM, 2003, J CLIN INVEST, V112, P147, DOI 10.1172/JCI200310109; Hostenbach S, 2014, NEUROSCI LETT, V565, P39, DOI 10.1016/j.neulet.2013.10.012; Ikeshima-Kataoka H, 2008, IN VIVO, V22, P409; Ikeshima-Kataoka H, 2007, IN VIVO, V21, P629; Ikeshima-Kataoka H, 2016, NEUROREPORT, V27, P894, DOI 10.1097/WNR.0000000000000619; Ikeshima-Kataoka H, 2015, J NEUROSCI RES, V93, P121, DOI 10.1002/jnr.23467; Ikeshima-Kataoka H, 2013, MOL CELL NEUROSCI, V56, P65, DOI 10.1016/j.mcn.2013.02.002; Imoto K, 2017, J VET MED SCI, V79, P1096, DOI 10.1292/jvms.17-0053; Jovicic N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134089; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; Kang WS, 2008, BRAIN RES, V1228, P208, DOI 10.1016/j.brainres.2008.06.106; Kawakami K, 2017, BIOCHEM BIOPH RES CO, V485, P468, DOI 10.1016/j.bbrc.2017.02.047; Kon S, 2018, J CELL COMMUN SIGNAL, V12, P333, DOI 10.1007/s12079-017-0413-7; Konno S, 2011, CLIN EXP ALLERGY, V41, P1360, DOI 10.1111/j.1365-2222.2011.03775.x; Liu W, 2011, LIFE SCI, V89, P141, DOI 10.1016/j.lfs.2011.05.011; Lukovic D, 2015, STEM CELLS, V33, P1036, DOI 10.1002/stem.1959; Maeno Y, 2006, INFECT IMMUN, V74, P2423, DOI 10.1128/IAI.74.4.2423-2427.2006; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morimoto J, 2010, CURR DRUG TARGETS, V11, P494, DOI 10.2174/138945010790980321; Plantman S, 2012, NEUROREPORT, V23, P647, DOI 10.1097/WNR.0b013e328355380e; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Schellings MWM, 2004, CARDIOVASC RES, V64, P24, DOI 10.1016/j.cardiores.2004.06.006; Selvaraju R, 2004, MOL CELL NEUROSCI, V25, P707, DOI 10.1016/j.mcn.2003.12.014; Shijubo N, 2000, CRIT REV ONCOGENESIS, V11, P135; Subraman V, 2015, J CLIN DIAGN RES, V9, pZE10, DOI 10.7860/JCDR/2015/12872.6111; Uede T, 1997, MICROBIOL IMMUNOL, V41, P641, DOI 10.1111/j.1348-0421.1997.tb01906.x; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; Xiao HB, 2015, PATHOL BIOL, V63, P11, DOI 10.1016/j.patbio.2014.10.005; Yan YP, 2009, J NEUROCHEM, V109, P1624, DOI 10.1111/j.1471-4159.2009.06059.x; Zhao W, 2011, J IMMUNOL, V186, P3173, DOI 10.4049/jimmunol.1003626	37	7	7	2	24	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	DEC 2	2018	40	12					1071	1079		10.1080/01616412.2018.1517995			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GX9OK	WOS:000448133500009	30246619				2022-02-06	
J	Bresee, N; Aglipay, M; Dubrovsky, AS; Ledoux, AA; Momoli, F; Gravel, J; Freedman, SB; Barlow, K; Richer, L; Barrowman, NJ; Zemek, R				Bresee, Natalie; Aglipay, Mary; Dubrovsky, Alexander Sasha; Ledoux, Andree-Anne; Momoli, Franco; Gravel, Jocelyn; Freedman, Stephen B.; Barlow, Karen; Richer, Lawrence; Barrowman, Nicholas J.; Zemek, Roger			No association between metoclopramide treatment in ED and reduced risk of post-concussion headache	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Post-concussion symptoms; Headache; Metoclopramide; Phannacotherapy; Pediatric; Concussion	TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENTS; ACUTE MIGRAINE; CHILDREN; SYMPTOMS; MANAGEMENT; SPORT; SENSITIZATION; EPIDEMIOLOGY; ADOLESCENTS	Objective: There is a lack of definitive pediatric literature on effective pharmacotherapy for persistent post-concussion headache symptoms. This study assessed whether acute metoclopramide treatment in the Emergency Department (ED) was associated with a reduction in persistent headache in children at 1- and 4-weeks post-concussion. Methods: Children aged 8-17 years with acute concussion presenting to 9-Canadian Pediatric EN were enrolled in a prospective cohort study, from August 2013-June 2015. Primary and secondary outcomes were persistent headache at 1- and 4-week post-injury respectively. Headache persistence was based on the one and four-week headache scores minus recalled pre-injury score using the Post-Concussion Symptom Inventory. The association between metoclopramide and headache persistence at 1- and 4-weeks were examined using unadjusted and adjusted regression and 1:4 propensity score matching model. Results: Baseline assessments were completed in 2095 participants; 65 (3.1%) received metoclopramide within 48-hours of injury. At 1- and 4-weeks, 54% (963/1808) and 26% (456/1780) of participants had persistent headache relative to baseline respectively. In unadjusted analysis, no association between metoclopramide and headache persistence at 1-week was found [treated vs. untreated: 1-week (53% vs. 53%; relative risk (RR) - 1.0 (95% CI: 0.8, 1.3); 4-weeks (27.3% vs. 25.6%; RR = 1.0 (95% CI: 0.9, 1.2)]. Metoclopramide was not associated with lower headache risk on propensity score matching [treated vs. untreated: 1-week, n = 220 (52% vs. 59.4%; RR = 0.8 (95%CI: 0.6, 12) and 4-weeks, n = 225 (27.1% vs. 32.8%; RR - 0.9 (95%CI: 0.8,1.1)]. Conclusion: Metoclopramide administration was not associated with a reduction in headache persistence in children seeking ED care due to a concussion. Further research is necessary to determine which pharmacother- apies may be effective for acute and persistent post-concussive headache. (C) 2018 Elsevier Inc. All rights reserved.	[Bresee, Natalie; Zemek, Roger] Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada; [Bresee, Natalie; Momoli, Franco; Barrowman, Nicholas J.; Zemek, Roger] Univ Ottawa, Ottawa, ON, Canada; [Aglipay, Mary; Ledoux, Andree-Anne; Momoli, Franco; Barrowman, Nicholas J.; Zemek, Roger] Childrens Hosp Eastern Ontario Res Inst, Ottawa, ON, Canada; [Dubrovsky, Alexander Sasha] McGill Univ, Hlth Ctr, Montreal Childrens Hosp, Montreal, PQ, Canada; [Momoli, Franco] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Gravel, Jocelyn] Univ Montreal, Hosp Ste Justine, Dept Pediat, Montreal, PQ, Canada; [Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp, Cumming Schoot Med, Sect Pediat Emergency Med,Dept Pediat,Res Inst, Calgary, AB, Canada; [Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp, Cumming Schoot Med, Sect Gastroenterol,Dept Pediat,Res Inst, Calgary, AB, Canada; [Barlow, Karen] Albertas Childrens Hosp, Dept Pediat & Clin Neurosci, Calgary, AB, Canada; [Richer, Lawrence] Univ Alberta, Women & Childrens Hlth Res Inst, Dept Pediat, Edmonton, AB, Canada; [Bresee, Natalie; Aglipay, Mary; Ledoux, Andree-Anne; Momoli, Franco; Barrowman, Nicholas J.] Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada; [Dubrovsky, Alexander Sasha] McGill Univ, Hlth Ctr, Montreal Childrens Hosp, 1001 Blvd Decarie, Montreal, PQ H4A 3J1, Canada; [Gravel, Jocelyn] Hosp Ste Justine, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C4, Canada; [Freedman, Stephen B.] Heritage Med Res Bldg 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada; [Barlow, Karen] Hlth Res Innovat Ctr, Room 1A10,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada; [Richer, Lawrence] Univ Alberta, Women & Childrens Hlth Res Inst, 4-081 Edmonton Clin Hlth Acad ECHA, Edmonton, AB T6G 1C9, Canada		Zemek, R (corresponding author), Childrens Hosp Eastern Ontario, Dept Pediat & Emergency Med, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	nbresee@cheo.on.ca; magliplay@cheo.on.ca; sasha.dubrovsky@mcgill.ca; aledoux@cheo.on.ca; finomoli@uottawa.ca; Stephen.Freedman@albertahealthservices.ca; kbarlow@ucalgary.ca; lricher@ualberta.ca; nbarrowman@cheo.on.ca; rzemek@cheo.on.ca	Barlow, Karen/C-1323-2014; Barrowman, Nick/AAL-3166-2020; Barlow, Karen/I-6492-2019; Richer, Lawrence/D-3622-2009; Freedman, Stephen/H-9102-2012	Barlow, Karen/0000-0003-2612-8507; Barrowman, Nick/0000-0002-4704-9595; Barlow, Karen/0000-0003-2612-8507; Richer, Lawrence/0000-0002-6897-8668; Freedman, Stephen/0000-0003-2319-6192; Gravel, Jocelyn/0000-0001-5901-4990	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP 126197]; CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury team grant [TM1 127047]; CIHR planning grantCanadian Institutes of Health Research (CIHR) [MRP 119829]	This study was supported by the Canadian Institutes of Health Research (CIHR) operating grant (MOP 126197); the CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury team grant (TM1 127047); and CIHR planning grant (MRP 119829).	[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Colman I, 2004, BMJ-BRIT MED J, V329, P1369, DOI 10.1136/bmj.38281.595718.7C; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Dubrovsky AS, 2014, HEADACHE, V54, P878, DOI 10.1111/head.12334; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Friedman BW, 2018, AM J EMERG MED, V36, P285, DOI 10.1016/j.ajem.2017.10.034; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2009, TOP LANG DISORD, V29, P266, DOI 10.1097/TLD.0b013e3181b5322b; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gordon KE, 2018, BRAIN INJURY, V32, P41, DOI 10.1080/02699052.2017.1403046; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kienbacher C, 2006, CEPHALALGIA, V26, P820, DOI 10.1111/j.1468-2982.2006.01108.x; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lumba-Brown A, 2014, PEDIATR EMERG CARE, V30, P139, DOI 10.1097/PEC.0000000000000084; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Orr SL, 2016, HEADACHE, V56, P911, DOI 10.1111/head.12835; Orr SL, 2015, CEPHALALGIA, V35, P271, DOI 10.1177/0333102414535997; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P270, DOI 10.1016/j.pediatrneurol.2014.10.015; POST RM, 1992, PHARMACOPSYCHIATRY, V25, P41, DOI 10.1055/s-2007-1014386; Richer LP, 2010, PEDIATRICS, V126, pE150, DOI 10.1542/peds.2009-2337; Rome HP, 2000, PAIN MED, V1, P7, DOI 10.1046/j.1526-4637.2000.99105.x; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Vincent, 2008, J INT NEUROPSYCH SOC, V1, P204; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R, 2013, BMJ OPEN, V3; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	43	7	7	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	DEC	2018	36	12					2225	2231		10.1016/j.ajem.2018.04.007			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HB4MM	WOS:000451027100016	29661668				2022-02-06	
J	Fidan, E; Cummings, DD; Manole, MD				Fidan, Emin; Cummings, Dana D.; Manole, Mioara D.			A Case of Lenticulostriate Stroke Due to Minor Closed Head Injury in a 2-Year-Old Child Role of Mineralizing Angiopathy	PEDIATRIC EMERGENCY CARE			English	Article						concussion; mineralizing angiopathy; stroke	BASAL GANGLIA; POSTTRAUMATIC INFARCTION; RISK-FACTORS; ISCHEMIA; TRAUMA; ARTERY	Objective Cerebral infarction due to minor head injury is rare. Mineralizing angiopathy is considered a predisposing factor for lenticulostriate stroke after minor closed head injury. This entity is characterized by infarction of the basal ganglia and most often occurs in young children, from infancy to 2 years of age. Symptoms usually occur immediately after the injury. Methods and Results We present the case of a previously healthy 2-year-old female child presenting with right facial hemiparesis and aphasia, along with right arm and leg weakness that occurred immediately after a fall from the couch onto a carpeted floor. A brain computed tomography scan revealed small and linear calcifications of the basal ganglia and subcortical frontoparietal area, in the absence of signs of intracranial hemorrhage. Brain magnetic resonance imaging with stroke protocol revealed restriction of water diffusion in the left basal ganglia on diffusion-weighted imaging sequences as well as apparent diffusion coefficient sequences, suggesting an acute infarct of the left basal ganglia within the distribution of the lenticulostriate vessels. The patient was treated with aspirin and conservative management and had gradual improvement over the next few days, with full recovery of the aphasia, facial nerve function, and arm and leg mobility, within 2 months. Conclusions Some infants can present with the onset of stroke-like symptoms after minor head injuries. Presence of linear calcifications of the basal ganglia noticed on brain computed tomography in many of these patients suggests that mineralizing angiopathy may be a predisposing factor for lenticulostriate stroke after minor closed head injury in infants. Brain magnetic resonance imaging to further delineate possible cerebral infarction is indicated.	[Fidan, Emin] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Pediat Crit Care Med, Pittsburgh, PA 15213 USA; [Cummings, Dana D.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Child Neurol, Pittsburgh, PA 15213 USA; [Manole, Mioara D.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Pediat Emergency Med, 4401 Penn Ave, Pittsburgh, PA 15224 USA		Manole, MD (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Pediat Emergency Med, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	manomd@upmc.edu					Ahn JY, 2006, CHILD NERV SYST, V22, P1493, DOI 10.1007/s00381-006-0157-9; Deveber G, 2014, DEV MED CHILD NEUROL, V56, P9, DOI 10.1111/dmcn.12296; DHARKER SR, 1993, NEUROSURGERY, V33, P863; Erbayraktar Serhat, 2001, Kobe Journal of Medical Sciences, V47, P113; Faul M, 2010, TRAUMATIC BRAIN INJU; Garg K, 2015, BD CHAURASIAS HUMAN, V3, P43; Hills NK, 2012, ANN NEUROL, V72, P850, DOI 10.1002/ana.23688; KAYA T, 1995, EUR J RADIOL, V20, P48, DOI 10.1016/0720-048X(95)00607-R; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Landi A, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-2; Lingappa L, 2014, DEV MED CHILD NEUROL, V56, P78, DOI 10.1111/dmcn.12275; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nabika S, 2007, PEDIATR NEUROSURG, V43, P312, DOI 10.1159/000103313; National Clinical Guideline Centre (UK), 2007, HEAD INJ TRIAG ASS I; Rana KS, 2006, INDIAN PEDIATR, V43, P994; Seckin H, 2008, TURK NEUROSURG, V18, P415; Shaffer L, 2003, ARCH DIS CHILD, V88, P267, DOI 10.1136/adc.88.3.267; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; UMANSKY F, 1985, J NEUROSURG, V62, P261, DOI 10.3171/jns.1985.62.2.0261; Yang FH, 2013, PEDIATR NEUROL, V48, P220, DOI 10.1016/j.pediatrneurol.2012.12.008	21	7	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	DEC	2018	34	12					E233	E235		10.1097/PEC.0000000000001229			3	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	HE1YW	WOS:000453071000004	28816772				2022-02-06	
J	Kirk, B; Pugh, JN; Cousins, R; Phillips, SM				Kirk, Ben; Pugh, Jamie N.; Cousins, Rosanna; Phillips, Shaun M.			Concussion in University Level Sport: Knowledge and Awareness of Athletes and Coaches	SPORTS			English	Article						sport-related concussion; signs; symptoms; return to play guidelines; traumatic brain injury	RUGBY UNION PLAYERS; YOUTH SPORTS; RETURN; BEHAVIORS; ATTITUDES; EDUCATION; HOCKEY	Using a cross-sectional survey concussion knowledge was evaluated among forty university-level athletes (n = 20, rugby union players; n = 20, Gaelic football players) and eight experienced team coaches (n = 2, rugby union; n = 2, Gaelic football; n = 1, soccer; n = 1, hockey; n = 1, netball; n = 1, basketball). Levels of knowledge of concussion were high across all participants. Coaches had higher knowledge scores for almost all areas; however, there was evidence of important gaps even in this group. Knowledge was not sufficient in identifying concussion, and when it is safe to return to play following a concussion. Impaired knowledge of how to recognise a concussion, and misunderstanding the need for rest and rehabilitation before return to play presents a hazard to health from second impact and more catastrophic brain injury We discuss reasons for these guideline misconceptions, and suggest that attitude issues on the significance of concussion may underlie a willingness to want to play with a concussion. This suggests the current education on sport-related concussion needs to be expanded for the appropriate management of university-level contact sports.	[Kirk, Ben; Cousins, Rosanna] Liverpool Hope Univ, Sch Hlth Sci, Hope Pk, Liverpool L16 9JD, Merseyside, England; [Pugh, Jamie N.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UA, Merseyside, England; [Phillips, Shaun M.] Univ Edinburgh, Inst Sport Phys Educ & Hlth Sci, Edinburgh EH8 8AQ, Midlothian, Scotland		Kirk, B (corresponding author), Liverpool Hope Univ, Sch Hlth Sci, Hope Pk, Liverpool L16 9JD, Merseyside, England.	kirkb@hope.ac.uk; j.pugh@2014.ljmu.ac.uk; cousinr@hope.ac.uk; shaun.phillips@ed.ac.uk	Kirk, Ben/AAD-8514-2019; Cousins, Rosanna/H-6358-2019	Kirk, Ben/0000-0002-0176-776X; Cousins, Rosanna/0000-0003-4829-5138; Pugh, Jamie/0000-0002-5930-4709; Phillips, Shaun/0000-0002-7947-3403			Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Boles M, 2014, PREV MED, V67, pS40, DOI 10.1016/j.ypmed.2014.07.023; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Brown JC, 2015, INJURY PREV, V21, P173, DOI 10.1136/injuryprev-2014-041326; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Festinger L., 1962, THEORY COGNITIVE DIS, V2; Fraas MR, 2016, EUR J SPORT SCI, V16, P1212, DOI 10.1080/17461391.2016.1170207; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Kissick J, 2005, CLIN J SPORT MED, V15, P426, DOI 10.1097/01.jsm.0000186683.59158.8b; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Perkins HW, 2010, ADDICT BEHAV, V35, P866, DOI 10.1016/j.addbeh.2010.05.004; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Raj R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002316; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	31	7	7	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2075-4663			SPORTS	Sports	DEC	2018	6	4							102	10.3390/sports6040102			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	HH3UC	WOS:000455644100001	30241295	Green Published, gold, Green Accepted, Green Submitted			2022-02-06	
J	Nobre, MC; Veloso, AT; Santiago, CFG; Barbosa, WD; Lages, GV; Nobre, IG; Silva, TVF; Monteiro, R; Paiva, WS				Nobre, Marcio Costa; Veloso, Adriano Teixeira; Gusmao Santiago, Cesar Felipe; Barbosa, Warley de Freitas; Lages, Gustavo Veloso; Nobre, Isabela Goncalves; Flores Silva, Thierry Vinicius; Monteiro, Ruy; Paiva, Wellingson Silva			Bone Flap Conservation in the Scalp After Decompressive Craniectomy	WORLD NEUROSURGERY			English	Article						Bone preservation; Cranioplasty; Decompressive craniectomy; Intracranial hypertension	CRANIOPLASTY; COMPLICATIONS; STORAGE; SERIES; CRANIOTOMY; INFARCTION; INFECTION; SECONDARY	BACKGROUND: Decompressive craniectomy may be used as a primary or secondary treatment for intracranial hypertension and is clearly associated with reduced mortality. The removed bone flap is usually preserved in the abdominal subcutaneous tissue or in the bone bank. The aim of this study was to describe an option for preserving the bone flap after decompressive craniectomy using bone flap preservation in the skull subcutaneous tissue in subgaleal space over the pericranium contralateral to the craniectomy site. METHODS: This was a multicenter retrospective study including patients with severe traumatic brain injury from 2014 to 2016. There were 23 patients who had their bone fragments preserved below the scalp in the subcutaneous tissue for analysis. The following results were analyzed: surgical site infection, bone flap resorption during the period of preservation, and patient discomfort. RESULTS: Five patients died of systemic infectious complications, and the remaining patients underwent cranioplasty a mean 118 days after craniectomy. There were no surgical wound infections, macroscopically evident bone absorption, or site discomfort in any of the patients during a period of 18 months. CONCLUSIONS: This variant of the bone flap preservation technique has been shown to be satisfactory as an option for routine use.	[Nobre, Marcio Costa; Veloso, Adriano Teixeira; Gusmao Santiago, Cesar Felipe; Barbosa, Warley de Freitas; Lages, Gustavo Veloso] Santa Casa Montes Claros, Montes Claros, Brazil; [Nobre, Isabela Goncalves; Flores Silva, Thierry Vinicius] Univ Estadual Montes Claros, Montes Claros, Brazil; [Monteiro, Ruy] Hosp Miguel Couto, Rio De Janeiro, Brazil; [Paiva, Wellingson Silva] Univ Sao Paulo, Sao Paulo, Brazil		Paiva, WS (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.	wellingsonpaiva@yahoo.com.br	Paiva, Wellingson S/G-5517-2013	Paiva, Wellingson S/0000-0002-5165-7040			Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Cheng Cheng-Hsin, 2014, Clin Neurol Neurosurg, V124, P85, DOI 10.1016/j.clineuro.2014.06.029; Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Corliss B, 2016, WORLD NEUROSURG, V96, P510, DOI 10.1016/j.wneu.2016.09.025; Faleiro RM, 2005, ARQ NEURO-PSIQUIAT, V63, P508, DOI 10.1590/S0004-282X2005000300026; Grindlinger GA, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3251-9; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Inamasu J, 2010, J TRAUMA, V68, P183, DOI 10.1097/TA.0b013e3181c45384; Kim Ji Sang, 2015, Korean J Neurotrauma, V11, P1, DOI 10.13004/kjnt.2015.11.1.1; Kim Jin Seong, 2015, Korean J Neurotrauma, V11, P100, DOI 10.13004/kjnt.2015.11.2.100; KORFALI E, 1988, SURG NEUROL, V30, P269, DOI 10.1016/0090-3019(88)90297-2; Krishnan P, 2016, BRIT J NEUROSURG, V30, P272, DOI 10.3109/02688697.2015.1123218; Lammy S, 2016, WORLD NEUROSURG, V96, P383, DOI 10.1016/j.wneu.2016.09.004; Miller K, 2016, WORLD NEUROSURG, V95, P441, DOI 10.1016/j.wneu.2016.08.061; Movassaghi K, 2006, PLAST RECONSTR SURG, V117, P202, DOI 10.1097/01.prs.0000187152.48402.17; Nobre MC, 2007, ARQ NEURO-PSIQUIAT, V65, P107, DOI 10.1590/S0004-282X2007000100022; Pasaoglu A, 1996, NEUROSURG REV, V19, P153, DOI 10.1007/BF00512044; Schoekler B, 2014, CLIN NEUROL NEUROSUR, V120, P64, DOI 10.1016/j.clineuro.2014.02.014; Silav G, 2014, PEDIATR NEUROSURG, V50, P161, DOI 10.1159/000381748; Stieglitz LH, 2015, ACTA NEUROCHIR, V157, P275, DOI 10.1007/s00701-014-2310-7; Sundseth J, 2014, ACTA NEUROCHIR, V156, P805, DOI 10.1007/s00701-013-1992-6; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	23	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2018	120						E269	E273		10.1016/j.wneu.2018.08.048			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HA9ZO	WOS:000450668300034	30138734				2022-02-06	
J	Olympia, RP; Wilkinson, R; Dunnick, J; Dougherty, BJ; Zauner, D				Olympia, Robert P.; Wilkinson, Robert; Dunnick, Jennifer; Dougherty, Brendan J.; Zauner, Debra			Pediatric Referrals to an Emergency Department From Urgent Care Centers	PEDIATRIC EMERGENCY CARE			English	Article						urgent care medicine; referrals; preparedness	NONURGENT EMERGENCY; PREPAREDNESS; CHILDREN; OFFICE; RECOMMENDATIONS; VISITS	Objective The aims of this study were to describe pediatric emergency department (ED) referrals from urgent care centers and to determine the percentage of referrals considered essential and serious. Methods A prospective study was conducted between April 2013 and April 2015 on patients younger than 21 years referred directly to an ED in central Pennsylvania from surrounding urgent care centers. Referrals were considered essential or serious based on investigations/procedures performed or medications/consultations received in the ED. Results Analysis was performed on 455 patient encounters (mean age, 8.7 y), with 347 (76%) considered essential and 40 (9%) considered serious. The most common chief complaints were abdominal pain (83 encounters), extremity injury (76), fever (39), cough/cold (29), and head/neck injury (29). Thirty-three percent of the patients received laboratory diagnostic investigations (74% serum, 56% urine), and 52% received radiologic investigations (67% x-ray, 17% computed tomography scan, 13% ultrasound, 11% magnetic resonance imaging). Forty-four percent of the patients received a procedure, with the most common being intravenous (IV) placement (66%); reduction, casting, or splinting of extremity fracture/dislocation (18%); and laceration repair (14%). The most common medications administered were IV fluids (33%), oral analgesics (30%), and IV analgesics (26%). Eighty-three percent of the patients were discharged home, 12% were hospitalized, and 4% had emergent surgical intervention. The most common primary diagnoses were closed extremity fracture (60 encounters), gastroenteritis (42), brain concussion (28), upper respiratory infection (24), and nonsurgical, unspecified abdominal pain (24). Conclusions Many ED referrals directed from urgent care centers in our sample were considered essential, and few were considered serious. Urgent care centers should develop educational and preparedness strategies based on the epidemiology of emergencies that may occur.	[Olympia, Robert P.; Dougherty, Brendan J.] Penn State Milton S Hershey Med Ctr, Dept Emergency Med, 500 Univ Dr,POB 850, Hershey, PA 17033 USA; [Wilkinson, Robert] Univ New Mexico, Dept Emergency Med, Albuquerque, NM 87131 USA; [Dunnick, Jennifer] Primary Childrens Med Ctr, Dept Pediat, Salt Lake City, UT USA; [Zauner, Debra] Penn State Childrens Hosp, Dept Pediat, Hershey, PA USA		Olympia, RP (corresponding author), Penn State Milton S Hershey Med Ctr, Dept Emergency Med, 500 Univ Dr,POB 850, Hershey, PA 17033 USA.	rolympia@hmc.psu.edu		Dunnick, Jennifer/0000-0003-1577-0318			Arora R, 2013, PEDIATR CLIN N AM, V60, P1049, DOI 10.1016/j.pcl.2013.06.009; Barber JW, 2000, PEDIATRICS, V105, P819, DOI 10.1542/peds.105.4.819; Brousseau DC, 2007, PEDIATRICS, V119, P1131, DOI 10.1542/peds.2006-3518; Catherine AT, 2016, PEDIATR EMERG CARE, V32, P357, DOI 10.1097/PEC.0000000000000702; Doctor K, 2014, PEDIATR EMERG CARE, V30, P798, DOI 10.1097/PEC.0000000000000262; Flores G, 1996, ARCH PEDIAT ADOL MED, V150, P249, DOI 10.1001/archpedi.1996.02170280019003; Freedman SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128754; Freedman SB, 2015, J PEDIATR-US, V166, P908, DOI 10.1016/j.jpeds.2014.12.029; FUCHS S, 1989, PEDIATRICS, V83, P931; Gordon JA, 2001, ACAD EMERG MED, V8, P1024, DOI 10.1111/j.1553-2712.2001.tb01110.x; Green NA, 2012, PEDIATR EMERG CARE, V28, P753, DOI 10.1097/PEC.0b013e3182621813; Guttman N, 2001, QUAL HEALTH RES, V11, P161, DOI 10.1177/104973201129119028; Heath BW, 2000, PEDIATRICS, V106, P1391, DOI 10.1542/peds.106.6.1391; Knapp JF, 2004, PEDIATRICS, V114, P878; Krug SE, 2005, PEDIATRICS, V116, P258; Kulik DM, 2013, J CLIN EPIDEMIOL, V66, P95, DOI 10.1016/j.jclinepi.2012.09.004; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Leonard JC, 2011, ANN EMERG MED, V58, P145, DOI 10.1016/j.annemergmed.2010.08.038; Mathison DJ, 2013, ACAD PEDIATR, V13, P278, DOI 10.1016/j.acap.2013.02.006; Rambaud-Althaus C, 2015, LANCET INFECT DIS, V15, P439, DOI 10.1016/S1473-3099(15)70017-4; Santillanes G, 2006, PEDIATR EMERG CARE, V22, P694, DOI 10.1097/01.pec.0000238744.73735.0e; Sarver JH, 2002, ACAD EMERG MED, V9, P916, DOI 10.1197/aemj.9.9.916; Shetty AK, 1998, SOUTHERN MED J, V91, P745, DOI 10.1097/00007611-199808000-00008; Simon HK, 1997, AM J EMERG MED, V15, P551, DOI 10.1016/S0735-6757(97)90154-6; Timm NL, 2010, AM J EMERG MED, V28, P56, DOI 10.1016/j.ajem.2008.09.035; Walsh-Kelly CM, 2004, PEDIATR EMERG CARE, V20, P289; Wilkinson R, 2016, PEDIATR EMERG CARE, V32, P77, DOI 10.1097/PEC.0000000000000698; Young GP, 1996, JAMA-J AM MED ASSOC, V276, P460, DOI 10.1001/jama.276.6.460	28	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	DEC	2018	34	12					872	877		10.1097/PEC.0000000000000955			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	HE1YW	WOS:000453071000018	27753717				2022-02-06	
J	Parrington, L; Jehu, DA; Fino, PC; Pearson, S; El-Gohary, M; King, LA				Parrington, Lucy; Jehu, Deborah A.; Fino, Peter C.; Pearson, Sean; El-Gohary, Mahmoud; King, Laurie A.			Validation of an Inertial Sensor Algorithm to Quantify Head and Trunk Movement in Healthy Young Adults and Individuals with Mild Traumatic Brain Injury	SENSORS			English	Article						concussion; inertial motion units (IMUs); vestibular exercises; validation; motion capture	VESTIBULAR REHABILITATION; SYSTEM	Wearable inertial measurement units (IMUs) may provide useful, objective information to clinicians interested in quantifying head movements as patients' progress through vestibular rehabilitation. The purpose of this study was to validate an IMU-based algorithm against criterion data (motion capture) to estimate average head and trunk range of motion (ROM) and average peak velocity. Ten participants completed two trials of standing and walking tasks while moving the head with and without moving the trunk. Validity was assessed using a combination of Intra-class Correlation Coefficients (ICC), root mean square error (RMSE), and percent error. Bland-Altman plots were used to assess bias. Excellent agreement was found between the IMU and criterion data for head ROM and peak rotational velocity (average ICC > 0.9). The trunk showed good agreement for most conditions (average ICC > 0.8). Average RMSE for both ROM (head = 2.64 degrees; trunk = 2.48 degrees) and peak rotational velocity (head = 11.76 degrees/s; trunk = 7.37 degrees/s) was low. The average percent error was below 5% for head and trunk ROM and peak rotational velocity. No clear pattern of bias was found for any measure across conditions. Findings suggest IMUs may provide a promising solution for estimating head and trunk movement, and a practical solution for tracking progression throughout rehabilitation or home exercise monitoring.	[Parrington, Lucy; Jehu, Deborah A.; Fino, Peter C.; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Parrington, Lucy; Jehu, Deborah A.; Fino, Peter C.; King, Laurie A.] VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Fino, Peter C.] Univ Utah, Dept Hlth Kinesiol & Recreat, 250 S 1850 E, Salt Lake City, UT 84112 USA; [Pearson, Sean; El-Gohary, Mahmoud] APDM Wearable Technol, Portland, OR 97201 USA; [King, Laurie A.] VA Portland Hlth Care Syst, NCRAR, 3710 SW US Vet Hosp Rd P5, Portland, OR 97239 USA		Parrington, L (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Parrington, L (corresponding author), VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	parringt@ohsu.edu; deb.jehu@ubc.ca; peter.fino@utah.edu; seanp@apdm.com; mahmoud@apdm.com; kingla@ohsu.edu		Fino, Peter/0000-0002-8621-3706; Jehu, Deborah/0000-0002-9084-7445; Parrington, Lucy/0000-0001-8507-9974; El-Gohary, Mahmoud/0000-0002-2678-8823	 [W81XWH-17-1-0424]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002369] Funding Source: NIH RePORTER	This work was supported by the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-17-1-0424. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Borel L, 2002, BRAIN, V125, P880, DOI 10.1093/brain/awf085; Chambers R, 2015, SPORTS MED, V45, P1065, DOI 10.1007/s40279-015-0332-9; Cuesta-Vargas AI, 2010, PHYS THER REV, V15, P462, DOI 10.1179/1743288X11Y.0000000006; Cutti AG, 2005, GAIT POSTURE, V21, P341, DOI 10.1016/j.gaitpost.2004.04.001; Damgrave R. G. J., 2009, P 19 CIRP DES C COMP; de Magalhaes FA, 2015, J SPORT SCI, V33, P732, DOI 10.1080/02640414.2014.962574; de Vries WHK, 2009, GAIT POSTURE, V29, P535, DOI 10.1016/j.gaitpost.2008.12.004; Duc C, 2014, MED ENG PHYS, V36, P49, DOI 10.1016/j.medengphy.2013.09.002; El-Gohary M, 2014, SENSORS-BASEL, V14, P356, DOI 10.3390/s140100356; Fino P. C., 2018, J HEAD TRAUMA REHABI; Kok M, 2017, FOUND TRENDS SIGNAL, V11, P1, DOI 10.1561/2000000094; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; O'Reilly M, 2018, SPORTS MED, V48, P1221, DOI 10.1007/s40279-018-0878-4; Pearson S., 2015, P 1 INT C SPORTS SCI, P19; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sprager S, 2015, SENSORS-BASEL, V15, P22089, DOI 10.3390/s150922089; The Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU, P1; Theobald PS, 2012, MANUAL THER, V17, P92, DOI 10.1016/j.math.2011.06.007; vanderKruk E., 2018, EUR J SPORT SCI	22	7	7	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	DEC	2018	18	12							4501	10.3390/s18124501			10	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	HG2TJ	WOS:000454817100420	30572640	Green Published, gold, Green Submitted			2022-02-06	
J	Powers, AY; Pinto, MB; Aldridge, AM; Tang, OY; Chen, JS; Berube, RL; Doberstein, C; Fox, JM; Carnevale, JA; Asaad, WF				Powers, Andrew Y.; Pinto, Mauricio B.; Aldridge, Ashley M.; Tang, Oliver Y.; Chen, Jia-Shu; Berube, Rebecca L.; Doberstein, Cody; Fox, Jordan M.; Carnevale, Joseph A.; Asaad, Wael F.			Factors associated with the progression of conservatively managed acute traumatic subdural hemorrhage	JOURNAL OF CRITICAL CARE			English	Article						Hemorrhage Subdural; Subdural Hematoma; Hemorrhage, Intracranial; Traumatic Brain Injury; Critical Care; Injuries, Head	COMA SCALE SCORE; BRAIN-INJURY; RISK-FACTORS; CEREBRAL CONTUSIONS; HEMATOMA; ETHANOL; INTOXICATION; PROSTACYCLIN; AGGREGATION; PREDICTORS	Purpose: Traumatic subdural hemorrhage (SDH) is associated with high mortality, yet many patients are not managed surgically. We sought to understand what factors might be associated with SDH enlargement to contribute to the triage of these conservatively managed patients. Materials and methods: A consecutive series of 117 patients admitted to our institution's level 1 trauma center for SDH between January 1, 2010 and December 31, 2010 were evaluated. Volumetric measurement of SDHs was performed on initial and follow-up head computed tomography (CT) scans with recording of initial midline shift and classification by location. Multimodel analysis quantified associations with change in SDH volume. Results: Systolic blood pressure, presence of subarachnoid hemorrhage, and initial SDH volume demonstrated positive associations with change in SDH volume, while initial midline shift and transfusion of platelets demonstrated negative associations. Initial convexity SDH volume demonstrated positive association with change in convexity SDH volume, while initial midline shift and transfusion of platelets demonstrated negative associations. Anticoagulant/antiplatelet use demonstrated positive association with change in tentorial SDH volume, while time between CT scans demonstrated negative association. Conclusions: Platelet transfusion, anticoagulation, and hypertension have significant associations with expansion in non-surgical cases of SDH. Monitoring these factors may assist triaging these patients. (C) 2018 Elsevier Inc. All rights reserved.	[Powers, Andrew Y.; Pinto, Mauricio B.; Aldridge, Ashley M.; Tang, Oliver Y.; Chen, Jia-Shu; Berube, Rebecca L.; Doberstein, Cody; Fox, Jordan M.; Asaad, Wael F.] Brown Univ, Dept Neurosurg, Warren Alpert Med Sch, Providence, RI 02903 USA; [Carnevale, Joseph A.] Weill Cornell Med Coll, Dept Neurosurg, New York, NY 10065 USA; [Asaad, Wael F.] Rhode Isl Hosp, Norman Prince Neurosci Inst, Providence, RI 02903 USA		Powers, AY (corresponding author), Brown Univ, Dept Neurosurg, Rhode Isl Hosp, 593 Eddy St,APC 633, Providence, RI 02903 USA.	andrew_powers@brown.edu	; Asaad, Wael/I-8485-2012	Powers, Andrew/0000-0002-3156-7777; Asaad, Wael/0000-0003-4406-9096; Carnevale, Joseph Anthony/0000-0002-9477-9996; Pinto, Mauricio/0000-0002-6170-8382			Allison RZ, 2017, NEUROCRIT CARE, V26, P80, DOI 10.1007/s12028-016-0303-5; Australian Institute of Health and Welfare, 2007, DIS AUSTR BRAIN INJ; Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Ehrlich D, 2014, PLATELETS, V25, P16, DOI 10.3109/09537104.2013.764979; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; Flynn-O'Brien KT, 2015, NEUROSURGERY, V76, P451, DOI 10.1227/NEU.0000000000000693; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Freeman WD, 2008, NEUROCRIT CARE, V9, P307, DOI 10.1007/s12028-008-9089-4; Fujimoto K, 2014, CLIN NEUROL NEUROSUR, V118, P94, DOI 10.1016/j.clineuro.2013.11.030; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Guilburd JN, 2001, J NEUROSURG, V95, P263, DOI 10.3171/jns.2001.95.2.0263; JAKUBOWSKI JA, 1988, ARTERIOSCLEROSIS, V8, P436, DOI 10.1161/01.ATV.8.4.436; Katada R, 2009, J NEUROTRAUM, V26, P2015, DOI 10.1089/neu.2008.0552; Lee JJ, 2018, J NEUROSURG, V128, P236, DOI 10.3171/2016.5.JNS16255; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Lucke-Wold BP., 2016, ARCH EMERG MED CRIT, P1; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Manickam A, 2017, J CLIN NEUROSCI, V40, P39, DOI 10.1016/j.jocn.2016.12.043; Marumo M, 2010, ALCOHOL, V44, P343, DOI 10.1016/j.alcohol.2010.02.002; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; MEHTA P, 1987, THROMB RES, V48, P653, DOI 10.1016/0049-3848(87)90431-2; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pascrell B Jr, 2001, N J Med, V98, P47; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Son S, 2013, J KOREAN NEUROSURG S, V54, P211, DOI 10.3340/jkns.2013.54.3.211; Spinella PC, 2011, J TRAUMA, V71, pS343, DOI 10.1097/TA.0b013e318227ef2d; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vega RA, 2017, NEUROSURG CLIN N AM, V28, P247, DOI 10.1016/j.nec.2016.11.007; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; WONG CW, 1995, ACTA NEUROCHIR, V135, P38, DOI 10.1007/BF02307412; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460	41	7	7	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2018	48						243	250		10.1016/j.jcrc.2018.09.014			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ4JL	WOS:000449360800040	30245365				2022-02-06	
J	Rogatzki, MJ; Keuler, SA; Harris, AE; Ringgenberg, SW; Breckenridge, RE; White, JL; Baker, JS				Rogatzki, Matthew J.; Keuler, Sydney A.; Harris, Abigail E.; Ringgenberg, Scott W.; Breckenridge, Ryanne E.; White, Jeffrey L.; Baker, Julien S.			Response of protein S100B to playing American football, lifting weights, and treadmill running	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						exercise; sport-related concussion; subconcussion	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; SERUM-LEVELS; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; S-100 ANTIGEN; BIOCHEMICAL MARKERS; TISSUE DAMAGE; ELITE PLAYERS	Objective To determine if serum S100B increases similarly as a result of playing American football compared to exercise alone. Methods Serum S100B was measured in division III collegiate football players before and after every home game during a single football season. Serum S100B was also measured before and after subjects walked on a treadmill for 30 minutes at a leisurely pace, ran on a treadmill while wearing and not wearing a football helmet at 6 mph for 8 minutes, and performed low-, moderate-, or high-intensity resistance exercise. Results Serum S100B increased significantly (P < 0.05) when subjects played in a football game, ran on a treadmill, or performed moderate-intensity resistance exercise. Pre-game serum S100B did not accumulate throughout the football season in any of the players (P > 0.05). The increase in serum S100B during football games was moderately and significantly correlated with both the number of hits (R-2 = 0.407) and the number of plays (R-2 = 0.484) that each player experienced (P < 0.001). Post-game serum S100B was greater in football players who played more than 50 plays compared to those players who played <50 plays, subjects who exercised on a treadmill, or subjects performing resistance exercise (P < 0.05). Conclusion It is unclear if the higher S100B concentration in football players playing at least 50 plays was caused by exercise or hits. Therefore, if serum S100B is to be used as a biomarker of impacts, and possible brain injury in sport, exercise time and intensity should be taken into account as confounding variables.	[Rogatzki, Matthew J.] Appalachian State Univ, Dept Hlth & Exercise Sci, Boone, NC 28608 USA; [Keuler, Sydney A.; Harris, Abigail E.; Ringgenberg, Scott W.] Univ Wisconsin, Dept Hlth & Human Performance, Platteville, WI USA; [Harris, Abigail E.] Palmer Coll Chiropract, Port Orange, FL USA; [Breckenridge, Ryanne E.] Univ Wisconsin, Dept Athlet, Platteville, WI USA; [White, Jeffrey L.] Med Associates Clin, Platteville, WI USA; [Baker, Julien S.] Univ West Scotland, Inst Clin Exercise & Hlth Sci, Sch Sci & Sport, Hamilton, Scotland		Rogatzki, MJ (corresponding author), Appalachian State Univ, Dept Hlth & Exercise Sci, Boone, NC 28608 USA.	rogatzkimj@appstate.edu			Medical Associates Clinic, P.C., Dubuque, IA, USA	Medical Associates Clinic, P.C., Dubuque, IA, USA	Stocchero CMA, 2014, APPL PHYSIOL NUTR ME, V39, P340, DOI 10.1139/apnm-2013-0308; Ballesteros MA, 2018, J NEUROL SCI, V385, P109, DOI 10.1016/j.jns.2017.12.017; Buttner T, 1997, STROKE, V28, P1961, DOI 10.1161/01.STR.28.10.1961; COCCHIA D, 1981, NATURE, V294, P85, DOI 10.1038/294085a0; Dietrich MO, 2003, CAN J APPL PHYSIOL, V28, P710, DOI 10.1139/h03-054; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Graham MR, 2015, INT J IMMUNOPATH PH, V28, P539, DOI 10.1177/0394632015577045; Graham MR, 2011, INT J IMMUNOPATH PH, V24, P119, DOI 10.1177/039463201102400114; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Ingebrigtsen T, 1997, J CLIN NEUROSCI, V4, P29, DOI 10.1016/S0967-5868(97)90007-2; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; MICHETTI F, 1980, J NEUROL SCI, V44, P259, DOI 10.1016/0022-510X(80)90133-1; MICHETTI F, 1979, NEUROSCI LETT, V11, P171, DOI 10.1016/0304-3940(79)90122-8; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Rogatzki MJ, 2016, INT J IMMUNOPATH PH, V29, P450, DOI 10.1177/0394632016657091; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; SINDIC CJM, 1982, J NEUROL NEUROSUR PS, V45, P1130, DOI 10.1136/jnnp.45.12.1130; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Stalnacke BM, 2008, BIOMARK INSIGHTS, V3, P87; Straume-Naesheim TM, 2008, NEUROSURGERY, V62, P1297, DOI 10.1227/01.neu.0000333301.34189.3d; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Westaby S, 1996, ANN THORAC SURG, V61, P88, DOI 10.1016/0003-4975(95)00904-3; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Zetterberg H, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037143; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	36	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	DEC	2018	28	12					2505	2514		10.1111/sms.13297			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GZ9ST	WOS:000449842400005	30203865	Green Accepted			2022-02-06	
J	Rumalla, K; Smith, KA; Letchuman, V; Gandham, M; Kombathula, R; Arnold, PM				Rumalla, Kavelin; Smith, Kyle A.; Letchuman, Vijay; Gandham, Mrudula; Kombathula, Rachana; Arnold, Paul M.			Nationwide incidence and risk factors for posttraumatic seizures in children with traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						posttraumatic seizure; traumatic brain injury; trauma	HYDROCEPHALUS; PREDICTORS; EPILEPSY	OBJECTIVE Posttraumatic seizures (PTSs) are the most common complication following a traumatic brain injury (TBI) and may lead to posttraumatic epilepsy. PTS is well described in the adult literature but has not been studied extensively in children. Here, the authors utilized the largest nationwide registry of pediatric hospitalizations to report the national incidence, risk factors, and outcomes associated with PTS in pediatric TBI. METHODS The authors queried the Kids' Inpatient Database (KID) using ICD-9-CM codes to identify all patients (age < 21 years) who had a primary diagnosis of TBI (850.xx-854.xx) and a secondary diagnosis of PTS (780.33, 780.39). Parameters of interest included patient demographics, preexisting comorbidities, hospital characteristics, nature of injury (open/closed), injury type (concussion, laceration/contusion, subarachnoid hemorrhage, subdural hematoma, or epidural hematoma), loss of consciousness (LOC), surgical management (Clinical Classification Software code 1 or 2), discharge disposition, in-hospital complications, and in-hospital mortality. The authors utilized the IBM SPSS statistical package (version 24) for univariate comparisons, as well as the identification of independent risk factors for PTS in multivariable analysis (alpha set at < 0.05). RESULTS The rate of PTS was 6.9% among 124,444 unique patients hospitalized for TBI. The utilization rate of continuous electroencephalography (cEEG) was 0.3% and increased between 2003 (0.1%) and 2012 (0.7%). The most common etiologies of TBI were motor vehicle accident (n = 50,615), accidental fall (n = 30,847), and blunt trauma (n = 13,831). However, the groups with the highest rate of PTS were shaken infant syndrome (41.4%), accidental falls (8.1%), and cycling accidents (7.4%). In multivariable analysis, risk factors for PTS included age 0-5 years (compared with 6-10, 11-15, and 16-20 years), African American race (OR 1.4), >= 3 preexisting comorbidities (OR 4.0), shaken infant syndrome (OR 4.4), subdural hematoma (OR 1.6), closed-type injury (OR 2.3), brief LOC (OR 1.4), moderate LOC (OR 1.5), and prolonged LOC with baseline return (OR 1.8). Surgically managed patients were more likely to experience PTS (OR 1.5) unless they were treated within 24 hours of admission (OR 0.8). PTS was associated with an increased likelihood of in-hospital complications (OR 1.7) and adverse (nonroutine) discharge disposition (OR 1.2), but not in-hospital mortality (OR 0.5). The overall utilization rate of cEEG was 1.3% in PTS patients compared with 0.2% in patients without PTS. Continuous EEG monitoring was associated with higher rates of diagnosed PTS (35.4% vs 6.8%; OR 4.9, p < 0.001). CONCLUSIONS PTS is common in children with TBI and is associated with adverse outcomes. Independent risk factors for PTS include younger age (< 5 years), African American race, increased preexisting comorbidity, prolonged LOC, and injury pattern involving cortical exposure to blood products. However, patients who undergo urgent surgical evacuation are less likely to develop PTS.	[Rumalla, Kavelin; Letchuman, Vijay; Gandham, Mrudula; Kombathula, Rachana] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Smith, Kyle A.; Arnold, Paul M.] Univ Kansas, Med Ctr, Dept Neurosurg, Kansas City, KS 66103 USA		Arnold, PM (corresponding author), Univ Kansas, Med Ctr, Kansas City, KS 66103 USA.	parnold@kumc.edu	Kavelin Rumalla, Neurosurgery PGY-1/AAS-6131-2021	Kavelin Rumalla, Neurosurgery PGY-1/0000-0002-2063-9587; Letchuman, Vijay/0000-0001-6594-596X			Agency for Healthcare Research and Quality, 2011, HCUP CLIN CLASS SOFT; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 2003, HCUP OV KIDS INP DAT; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Ates O, 2006, CHILD NERV SYST, V22, P279, DOI 10.1007/s00381-005-1177-6; Bakr A, 2018, BR J NEUROSURG; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chen H, 2017, METAB BRAIN DIS, V32, P1427, DOI 10.1007/s11011-017-0008-2; Dingman AL, 2018, PEDIATR NEUROL, V82, P29, DOI 10.1016/j.pediatrneurol.2017.12.003; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Hale AT, 2018, CHILD NERV SYST, V34, P1361, DOI 10.1007/s00381-018-3779-9; Huguenard AL, 2016, J NEUROSURG-PEDIATR, V17, P476, DOI 10.3171/2015.7.PEDS14723; Kilbride RD, 2009, ARCH NEUROL-CHICAGO, V66, P723, DOI 10.1001/archneurol.2009.100; Kuluz J, 2017, PEDIATR CRIT CARE ME, V18, P87, DOI 10.1097/PCC.0000000000000968; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Omar M, 2017, J CRIT CARE, V41, P1, DOI 10.1016/j.jcrc.2017.04.031; Petridis AK, 2012, CLINICS PRACT, V2, P164, DOI 10.4081/cp.2012.e66; Ratan SK, 1999, PEDIATR NEUROSURG, V30, P127, DOI 10.1159/000028779; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Rumalla K, 2018, PEDIATR NEUROL, V80, P70, DOI 10.1016/j.pediatrneurol.2017.11.015; Ruzas CM, 2017, NEUROCRIT CARE, V26, P256, DOI 10.1007/s12028-016-0329-8; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478; Won SY, 2017, SEIZURE-EUR J EPILEP, V45, P28, DOI 10.1016/j.seizure.2016.11.017	30	7	8	1	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2018	22	6					684	693		10.3171/2018.6.PEDS1813			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	HE7BK	WOS:000453578500014	30239282	Bronze			2022-02-06	
J	Silva, ABCG; Wrobel, LC; Ribeiro, FLB				Silva, Ana Beatriz C. G.; Wrobel, Luiz C.; Ribeiro, Fernando L. B.			A thermoregulation model for whole body cooling hypothermia	JOURNAL OF THERMAL BIOLOGY			English	Article						Thermoregulation; Hypothermia; Brain cooling; Intravascular catheter; Finite element method	TRAUMATIC BRAIN-INJURY; CEREBRAL HYPOTHERMIA; ARREST	This paper presents a thermoregulation model based on the finite element method to perform numerical analyses of brain cooling procedures as a contribution to the investigation on the use of therapeutic hypothermia after ischemia in adults. The use of computational methods can aid clinicians to observe body temperature using different cooling methods without the need of invasive techniques, and can thus be a valuable tool to assist clinical trials simulating different cooling options that can be used for treatment. In this work, we developed a finite element method (FEM) package using isoparametric linear three-dimensional elements which is applied to the solution of the continuum bioheat Pennes equation. Blood temperature changes were considered using a blood pool approach and a lumped analysis for intravascular catheter methods of blood cooling. Some analyses are performed using a three-dimensional mesh based on a complex geometry obtained from computed tomography medical images, considering a cooling blanket and an intravascular catheter. A comparison is made between the results obtained with the two techniques and the effects of each case in brain temperature reduction in a required period of time, maintenance of body temperature at moderate hypothermia levels and gradual rewarming.	[Silva, Ana Beatriz C. G.; Ribeiro, Fernando L. B.] COPPE Fed Univ Rio de Janeiro, Civil Engn Program, Technol Ctr, BR-21945970 Rio De Janeiro, Brazil; [Wrobel, Luiz C.] Brunel Univ London, Inst Mat & Mfg, Uxbridge UB8 3PH, Middx, England		Silva, ABCG (corresponding author), COPPE Fed Univ Rio de Janeiro, Civil Engn Program, Technol Ctr, BR-21945970 Rio De Janeiro, Brazil.	anabeatrizgonzaga@coc.ufrj.br; luiz.wrobel@brunel.ac.uk; fernando@coc.ufrj.br	Gonzaga e Silva, Ana Beatriz/AAF-6448-2019	Ribeiro, Fernando/0000-0002-9385-3015	Carlos Chagas Filho Research Foundation of the State of Rio de Janeiro (FAPERJ)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ); Coordination for the Improvement of Higher Education Personnel (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Carlos Chagas Filho Research Foundation of the State of Rio de Janeiro (FAPERJ) and the Coordination for the Improvement of Higher Education Personnel (CAPES).	Al-Othmani M, 2008, INT J HEAT MASS TRAN, V51, P5522, DOI 10.1016/j.ijheatmasstransfer.2008.04.017; Bhowmik A, 2013, J THERM BIOL, V38, P107, DOI 10.1016/j.jtherbio.2012.12.003; Callaway CW, 2002, RESUSCITATION, V52, P159, DOI 10.1016/S0300-9572(01)00462-2; Christiansen M., 2010, MODELING BRAIN COOLI; Dae MW, 2003, STROKE, V34, P734, DOI 10.1161/01.STR.0000057461.56040.FE; Denn BH, 2003, J BIOMECH ENG-T ASME, V125, P832, DOI [10.1115/1.16324991, 10.1115/1.1634991]; Diao CG, 2003, ANN BIOMED ENG, V31, P346, DOI 10.1114/1.1554924; Eicher D. J., 2005, MODERATE HYPOTHERMIA; Fiala D, 1999, J APPL PHYSIOL, V87, P1957, DOI 10.1152/jappl.1999.87.5.1957; Fiala D., 1998, THESIS; Fiala D, 2012, INT J BIOMETEOROL, V56, P429, DOI 10.1007/s00484-011-0424-7; Gordon CJ, 2001, EMERG MED J, V18, P81, DOI 10.1136/emj.18.2.81; Harris B, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16450; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Hickey RW, 2006, NEUROL CLIN, V24, P147, DOI 10.1016/j.ncl.2005.10.002; Hoque N, 2010, PEDIATRICS, V126, pE124, DOI 10.1542/peds.2009-2995; Hughes T.JR., 1987, FINITE ELEMENT METHO; Kingma BRM, 2014, INT J BIOMETEOROL, V58, P87, DOI 10.1007/s00484-012-0628-5; Laszczyk J. E, 2015, ANAL NEWBORNS BRAIN; Laszczyk JE, 2016, INT J NUMER METHOD H, V26, P571, DOI 10.1108/HFF-05-2015-0191; National Perinatal Epidemiology Unit, 2006, TOBY STUD PROT WHOL; Nozari A, 2006, CIRCULATION, V113, P2690, DOI 10.1161/CIRCULATIONAHA.106.613349; Silva AKL, 2016, THESIS; Silva ABCG, 2016, MED ENG PHYS, V38, P988, DOI 10.1016/j.medengphy.2016.06.018; Silva Junior A. F., 2012, THESIS; Tisherman SA, 2005, THERAPEUTIC HYPOTHER; Vallez LJ, 2016, NUMER HEAT TR A-APPL, V69, P227, DOI 10.1080/10407782.2015.1080573; Van Leeuwen GMJ, 2000, PEDIATR RES, V48, P351, DOI 10.1203/00006450-200009000-00015; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Xiang SH, 2008, INT J HEAT MASS TRAN, V51, P5486, DOI 10.1016/j.ijheatmasstransfer.2008.04.024; Yang Y., 2006, CHIN NURS RES, V20, P45; Zhu L, 2009, ADV NUMER HEAT TRANS, V3, P197; Zhu L, 2001, MED BIOL ENG COMPUT, V39, P681, DOI 10.1007/BF02345442	33	7	7	1	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4565			J THERM BIOL	J. Therm. Biol.	DEC	2018	78						122	130		10.1016/j.jtherbio.2018.08.019			9	Biology; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Zoology	HF8CE	WOS:000454467700016	30509628	Green Submitted			2022-02-06	
J	Tunthanathip, T; Khocharoen, K; Phuenpathom, N				Tunthanathip, Thara; Khocharoen, Kanutpon; Phuenpathom, Nakornchai			Blast-induced traumatic brain injury: the experience from a level I trauma center in southern Thailand	NEUROSURGICAL FOCUS			English	Article						traumatic brain injury; blast injury; blast-induced traumatic brain injury; prognostic factors	EXPLOSIVE BLAST; HEAD-INJURY; DAMAGE; COAGULOPATHY; OUTCOMES	OBJECTIVE In the ongoing conflict in southern Thailand, the improvised explosive device (IED) has been a common cause of blast-induced traumatic brain injury (bTBI). The authors investigated the particular characteristics of bTBI and the factors associated with its clinical outcome. METHODS A retrospective cohort study was conducted on all patients who had sustained bTBI between 2009 and 2017. Collected data included clinical characteristics, intracranial injuries, and outcomes. Factors analysis was conducted using a forest plot. RESULTS During the study period, 70 patents met the inclusion criteria. Fifty individuals (71.4%) were military personnel. One-third of the patients (32.9%) suffered moderate to severe bTBI, and the rate of intracerebral injuries on brain CT was 65.7%. Coup contusion was the most common finding, and primary blast injury was the most common mechanism of blast injury. Seventeen individuals had an unfavorable outcome (Glasgow Outcome Scale score 1-3), and the overall mortality rate for bTBI was 11.4%. In the univariate analysis, factors associated with an unfavorable outcome were preoperative coagulopathy, midline shift of the brain >= 5 mm, basal cistern effacement, moderate to severe TBI, hypotension, fixed and dilated pupils, surgical site infection, hematocrit < 30% on admission, coup contusion, and subdural hematoma. In the multivariable analysis, midline shift >= 5 mm (OR 29.1, 95% CI 2.5-328.1) and coagulopathy (OR 28.7, 95% CI 4.5-180.3) were the only factors predicting a poor outcome of bTBI. CONCLUSIONS bTBIs range from mild to severe. Midline shift and coagulopathy are treatable factors associated with an unfavorable outcome. Hence, in cases of bTBI, reversing an abnormal coagulogram is required as soon as possible to improve clinical outcomes. The management of brain shift needs further study.	[Tunthanathip, Thara; Khocharoen, Kanutpon; Phuenpathom, Nakornchai] Prince Songkla Univ, Fac Med, Dept Surg, Neurosurg Unit, Hat Yai, Songkhla, Thailand		Tunthanathip, T (corresponding author), Prince Songkla Univ, Hat Yai, Thailand.	tsus4@hotmail.com		Tunthanathip, Thara/0000-0002-6303-836X			Arul GS, 2012, ANN ROY COLL SURG, V94, P52, DOI 10.1308/003588412X13171221499027; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Cernak I, 2017, YOUMANS NEUROLOGICAL, V4, P2934; Chaiphrom N, 2009, J MED ASS THAI S1, V92, pS47; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Freeman JL, 2015, J TRAUMA ACUTE CARE, V79, P865, DOI 10.1097/TA.0000000000000836; Funston J, 2008, CONFLICT SO THAILAND; Gean A. D., 2014, BRAIN INJURY APPL WA; JENNETT B, 1975, LANCET, V1, P480; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Knuth T., 2005, GUIDELINES FIELD MAN; LIPPER MH, 1985, AM J ROENTGENOL, V144, P483, DOI 10.2214/ajr.144.3.483; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Nanuam W, 2015, ENGAGEMENT MALAYSIA; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rosenfeld JV, 2004, INJURY, V35, P655, DOI 10.1016/j.injury.2004.03.006; Rosenfeld JV, 2009, ESSENTIALS TERROR ME, P313; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Samuel J., 2008, COMMON SURG DIS ALGO, P391, DOI DOI 10.1007/978-0-387-75246-4_97; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Thompson DC, 2017, J R ARMY MED CORPS; Toklu HZ, 2018, BEHAV BRAIN RES, V340, P14, DOI 10.1016/j.bbr.2017.04.025; Tunthanathip T, 2017, J NEUROSCI RURAL PRA, V8, P601, DOI 10.4103/jnrp.jnrp_381_17; Wang JM, 2016, CHIN J TRAUMATOL, V19, P125, DOI 10.1016/j.cjtee.2016.03.001; Wu X, 2014, J TRAUMA ACUTE CARE, V76, P114, DOI 10.1097/TA.0b013e3182a8fe48; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	31	7	7	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	DEC	2018	45	6							E7	10.3171/2018.8.FOCUS18311			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HD6HR	WOS:000452637400007	30544306	gold			2022-02-06	
J	Zhang, FC; Wu, H; Jin, YC; Zhang, XH				Zhang, Fengchen; Wu, Hui; Jin, Yichao; Zhang, Xiaohua			Proton Magnetic Resonance Spectroscopy (H1-MRS) Study of the Ketogenic Diet on Repetitive Mild Traumatic Brain Injury in Adolescent Rats and Its Effect on Neurodegeneration	WORLD NEUROSURGERY			English	Article						Ketogenic diet; Magnetic resonance spectroscopy; Mild traumatic brain injury; Neurodegeneration	CORTICAL CONTUSION; MR SPECTROSCOPY; TEMPORAL WINDOW; JUVENILE; ADULT; CONCUSSION; EXPRESSION; RECOVERY; TERM; VULNERABILITY	OBJECTIVE: A ketogenic diet (KD) improves cellular metabolism and functional recovery after moderate-tosevere traumatic brain injury. Here, we evaluated the changes of neurochemical metabolites after KD therapy for repetitive mild traumatic brain injury (rmTBl) and its possible role in neurodegeneration. METHODS: Postnatal day 35 rats were randomly divided into 3 groups: sham, control, and KD groups. Rats in control and KD groups were given 3 rmTBl by a fluid percussion traumatic brain injury device 24 hours apart. All rats were killed at 7 days after the last injury. The ipsilateral cortex were analyzed with hematoxylin and eosin staining; betahydroxybutyrate was measured; conventional magnetic resonance imaging and the dry-wet weight method were used to assess the brain edema; changes of neurochemical metabolites were assessed using the ratio of N-acetylaspartate (NAA)/creatine (Cr), choline compound (Cho)/Cr, and NAA/Cho with magnetic resonance spectroscopy; the effect of KD therapy on neurodegeneration was evaluated with double immunofluorescence staining of lba-1/beclin-1; behavioral outcome was assessed with beam walk/ beam balance tests. RESULTS: KD significantly elevated beta-hydroxybutyrate levels, and there was no brain edema associated with rmTBl and KD therapy; behavioral assessment showed KD therapy significantly improved motor performance; magnetic resonance spectroscopy showed that rmTBl reduced the ratio of NAA/Cr and had no effect on the ratios of Cho/Cr and NAA/ Cho whereas KD increased the ratio of NAA/Cr; double immunofluorescence staining showed KD therapy could significantly decrease microglial beclin-1 expression in the ipsilateral cortex. CONCLUSIONS: These results suggest the effect of KD on metabolic status and its possible role in preventing neurodegeneration in adolescent rats after rmTBI.	[Zhang, Fengchen; Wu, Hui; Jin, Yichao; Zhang, Xiaohua] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai, Peoples R China		Jin, YC; Zhang, XH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai, Peoples R China.	honam612@163.com; zhangxh1969@hotmail.com		Zhang, Xiaohua/0000-0001-9679-2767	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601061, 81471333]	This work was supported by grants from National Natural Science Foundation of China (no. 81601061 and 81471333).	Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Ashbaugh A, 2016, CURR SPORT MED REP, V15, P16, DOI 10.1249/JSR.0000000000000219; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bajaj S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00616; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DUVDEVANI R, 1995, J NEUROTRAUM, V12, P65, DOI 10.1089/neu.1995.12.65; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fidan E, 2018, ASN NEURO, V10, DOI 10.1177/1759091418770543; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Gerhart DZ, 1997, AM J PHYSIOL-ENDOC M, V273, pE207, DOI 10.1152/ajpendo.1997.273.1.E207; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Grant DA, 2018, J NEUROTRAUM, V35, P94, DOI 10.1089/neu.2017.5042; Greco T, 2016, J CEREBR BLOOD F MET, V36, P1603, DOI 10.1177/0271678X15610584; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Hu ZG, 2009, BRAIN INJURY, V23, P459, DOI 10.1080/02699050902788469; Huang L, 2016, MED GAS RES, V6, P187, DOI 10.4103/2045-9912.196900; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Kitazawa M, 2011, J IMMUNOL, V187, P6539, DOI 10.4049/jimmunol.1100620; Kubas B, 2010, POL J RADIOL, V75, P7; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McDougall A, 2018, BRAIN INJURY, V32, P416, DOI 10.1080/02699052.2018.1429025; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKenna MC, 2015, NEUROCHEM RES, V40, P2527, DOI 10.1007/s11064-015-1600-7; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; O'Brien CE, 2014, J NEUROIMMUNE PHARM, V9, P285, DOI 10.1007/s11481-013-9519-8; Plaza-Zabala A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030598; Price WS, 1996, J MAGN RESON SER B, V112, P190, DOI 10.1006/jmrb.1996.0129; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; Su P, 2016, NEUROSCIENCE, V319, P155, DOI 10.1016/j.neuroscience.2016.01.035; Sundman MH, 2014, J ALZHEIMERS PARKINS, V4, P137; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Vile AR, 2017, J CLIN NEUROSCI, V41, P24, DOI 10.1016/j.jocn.2017.03.035; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	52	7	7	2	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2018	120						E1193	E1202		10.1016/j.wneu.2018.09.037			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HA9ZO	WOS:000450668300139	30236814				2022-02-06	
J	Baker, VB; Eliasen, KM; Hack, NK				Baker, Virginia B.; Eliasen, Kathryn M.; Hack, Nawaz K.			Lifestyle modifications as therapy for medication refractory post-traumatic headache (PTHA) in the military population of Okinawa	JOURNAL OF HEADACHE AND PAIN			English	Article						Post-traumatic headache (PTHA); Chronic post-traumatic headache (CPTHA); Lifestyle; Polypharmacy	TRAUMATIC BRAIN-INJURY; STRESS-DISORDER; CHRONIC PAIN; MIGRAINE; CONCUSSION; VETERANS; PREVALENCE; PREDICTORS; PHARMACOTHERAPY; SEVERITY	ObjectiveOur aim was 1) to reduce disability, as characterized by headache frequency, duration and severity in patients with post-traumatic headache (PTHA), 2) to reduce the number of medical boards and work limitations in patients with post traumatic headache, and 3) to reduce use of medical resources and clinic visits related to headache or migraine.BackgroundModifiable risk factors for PTHA include stressful life event, sleep disturbances, and medication overuse. Cognitive-behavioral strategies, biofeedback, and relaxation therapy may have an important role in treatment and preventing progression to chronic post-traumatic headache (CPTHA). There is limited literature and a known practice gap for implementation of these techniques.Design/methodsAn IRB approved project focused on patients who were seen for PTHA and CPTHA. 1) Intervention consisted of lifestyle teaching, cognitive-behavioral therapy and biofeedback, supplemented by decreasing polypharmacy. 2) Patients were followed for 2years and a retrospective review was conducted for 2years prior to presentation. 3) Outcome measures included reduction in migraine intensity or frequency, improved quality of life, duty status, and decreased utilization of clinic visits.ResultsOver the course of one year, 221 patients were treated for migraines in the Naval Okinawa Neurology Clinic. Of these, 22 active duty service members and 3 Dependents suffered a mild TBI prior to onset. After intervention, there was a 36% decrease in PTHA frequency, 56% decrease in headache severity and 60% of patients had improved quality of life as compared to the 2years prior to intervention. Twenty-four percent had reduction in polypharmacy. Appointment frequency for migraine decreased from an average of 6.8 to 2.6 per year.ConclusionsAn implemented program geared towards reducing polypharmacy was shown to improve safety, quality of life and reduce hospitalizations from the burden of migraines. Our systematic approach resulted in quality of life improvements and decreased use of medical resources.Trial registrationAuthors received the approval of NAVMED West, Okinawa Naval Hospital Institutional Review Board on January 13th, 2016. QI.2016.0021.	[Baker, Virginia B.; Hack, Nawaz K.] Walter Reed Natl Mil Med Ctr, Dept Neurol, 8901 Rockville Pike, Bethesda, MD 20889 USA; [Eliasen, Kathryn M.] Walter Reed Natl Mil Med Ctr, Dept Anesthesiol, 8901 Rockville Pike, Bethesda, MD 20889 USA		Baker, VB (corresponding author), Walter Reed Natl Mil Med Ctr, Dept Neurol, 8901 Rockville Pike, Bethesda, MD 20889 USA.	virginia.b.baker11.mil@mail.mil	Hack, Nawaz/AAH-4509-2020				Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bomyea J, 2016, HEADACHE, V56, P699, DOI 10.1111/head.12799; Bowe A, 2015, J DUAL DIAGN, V11, P22, DOI 10.1080/15504263.2014.989653; CAMPBELL DA, 1951, BMJ-BRIT MED J, V2, P1424, DOI 10.1136/bmj.2.4745.1424; Choe M, 2016, PATHOPHYSIOLOGY CONC, V20; Collett Garen A, 2016, Drugs Real World Outcomes, V3, P45; Conidi FX, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0570-z; Couch JR, 2016, HEADACHE, V56, P1004, DOI 10.1111/head.12837; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Diamond M, 2005, AM J MED, V118, p18S, DOI 10.1016/j.amjmed.2005.01.016; Dindo L, 2014, HEADACHE, V54, P528, DOI 10.1111/head.12258; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; Friedman LE, 2017, CLIN J PAIN, V33, P659, DOI 10.1097/AJP.0000000000000440; Gaul C, 2011, J HEADACHE PAIN, V12, P475, DOI 10.1007/s10194-011-0348-y; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Hickling EJ, 1992, HEADACHE Q-CURR TREA, V3, P285; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; John PJ, 2007, HEADACHE, V47, P654, DOI 10.1111/j.1526-4610.2007.00789.x; Juang KD, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0405-8; Kulas JF, 2018, MIL MED, V183, pE114, DOI 10.1093/milmed/usx050; Kumar RG, 2018, BRAIN INJURY, V32, P383, DOI 10.1080/02699052.2018.1427888; KWENTUS JA, 1985, PSYCHOSOMATICS, V26, P8, DOI 10.1016/S0033-3182(85)72900-3; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Marmura MJ, 2015, HEADACHE, V55, P3, DOI 10.1111/head.12499; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mohamed S, 2008, J CLIN PSYCHIAT, V69, P959, DOI 10.4088/JCP.v69n0611; Morgan M, 2012, PSYCHIAT SERV, V63, P182, DOI 10.1176/appi.ps.201000531; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Pistoia F, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0374-3; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Silberstein S, 2008, HEADACHE, V48, P1087, DOI 10.1111/j.1526-4610.2008.01185.x; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Winkler EA, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15613; Yerry JA, 2015, HEADACHE, V55, P395, DOI 10.1111/head.12495	50	7	7	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	NOV 22	2018	19								113	10.1186/s10194-018-0943-2			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB4QS	WOS:000451040500001	30466384	gold, Green Published			2022-02-06	
J	Oyama, N; Winek, K; Backer-Koduah, P; Zhang, T; Dames, C; Wench, M; Kershaw, O; Meisel, C; Meisel, A; Dirnagl, U				Oyama, Naoki; Winek, Katarzyna; Baecker-Koduah, Priscilla; Zhang, Tian; Dames, Claudia; Wench, Martina; Kershaw, Olivia; Meisel, Christian; Meisel, Andreas; Dirnagl, Ulrich			Exploratory Investigation of Intestinal Function and Bacterial Translocation After Focal Cerebral Ischemia in the Mouse	FRONTIERS IN NEUROLOGY			English	Article						bacterial translocation; gut-brain axis; gut permeability; gut associated lymphatic tissue; immune system; stroke; tight junctions	TRAUMATIC BRAIN-INJURY; EXPERIMENTAL STROKE; INFLAMMATORY RESPONSE; BARRIER FUNCTION; MUCOSA STRUCTURE; GUT MICROBIOTA; IGA SYNTHESIS; PERMEABILITY; IMMUNE; 16S	Background and Purpose: The gut communicates with the brain bidirectionally via neural, humoral and immune pathways. All these pathways are affected by acute brain lesions, such as stroke. Brain-gut communication may therefore impact on the overall outcome after CNS-injury. Until now, contradictory reports on intestinal function and translocation of gut bacteria after experimental stroke have been published. Accordingly, we aimed to specifically investigate the effects of transient focal cerebral ischemia on intestinal permeability, gut associated lymphoid tissue and bacterial translocation in an exploratory study using a well-characterized murine stroke model. Methods: After 60 min of middle cerebral artery occlusion (MCAO) we assessed intestinal morphology (time points after surgery day 0, 3, 5, 14, 21) and tight junction protein expression (occludin and claudin-1 at day 1 and 3) in 12-week-old male C57BI/6J mice. Lactulose/mannitol/sucralose test was performed to assess intestinal permeability 24-72 h after surgery. To investigate the influence of cerebral ischemia on the local immune system of the gut, main immune cell populations in Peyer's patches (PP) were quantified by flow cytometry. Finally, we evaluated bacterial translocation to extraintestinal organs 24 and 72 h after MCAO by microbiological culture and fluorescence in situ hybridization targeting bacterial 16S rRNA. Results: Transient MCAO decreased claudin-1 expression in the ileum but not in the colon. Intestinal morphology (assessed by light microscopy) and permeability did not change measurably after MCAO. After MCAO, animals had significantly fewer B cells in PP compared to naive mice. Conclusions: In a murine model of stroke, which leads to large brain infarctions in the middle cerebral artery territory, we did not find evidence for overt alterations neither in gut morphology, barrier proteins and permeability nor presence of intestinal bacterial translocation.	[Oyama, Naoki; Winek, Katarzyna; Baecker-Koduah, Priscilla; Zhang, Tian; Meisel, Andreas; Dirnagl, Ulrich] Charite, Dept Expt Neurol, Berlin, Germany; [Oyama, Naoki; Winek, Katarzyna; Baecker-Koduah, Priscilla; Zhang, Tian; Dames, Claudia; Wench, Martina; Meisel, Christian; Meisel, Andreas; Dirnagl, Ulrich] Humboldt Univ, Freie Univ Berlin, Berlin, Germany; [Oyama, Naoki; Winek, Katarzyna; Baecker-Koduah, Priscilla; Zhang, Tian; Dames, Claudia; Wench, Martina; Meisel, Christian; Meisel, Andreas; Dirnagl, Ulrich] Berlin Inst Hlth, Berlin, Germany; [Oyama, Naoki; Winek, Katarzyna; Zhang, Tian; Meisel, Andreas; Dirnagl, Ulrich] Charite, Ctr Stroke Res Berlin, Berlin, Germany; [Winek, Katarzyna; Baecker-Koduah, Priscilla; Meisel, Andreas; Dirnagl, Ulrich] Charite, Neurocure Cluster Excellence, Berlin, Germany; [Dames, Claudia; Meisel, Christian] Charite, Inst Med Immunol, Berlin, Germany; [Wench, Martina] Charite, Div Hepatol & Gastroenterol, Med Dept, Berlin, Germany; [Kershaw, Olivia] Free Univ Berlin, Fac Vet Med, Inst Vet Pathol, Berlin, Germany; [Meisel, Andreas; Dirnagl, Ulrich] Charite, Dept Neurol, Berlin, Germany; [Dirnagl, Ulrich] German Ctr Neurodegenerat Dis DZNE, Partner Site Berlin, Berlin, Germany; [Dirnagl, Ulrich] Berlin Inst Hlth, QUEST Ctr Transforming Biomed Res, Berlin, Germany		Winek, K (corresponding author), Charite, Dept Expt Neurol, Berlin, Germany.; Winek, K (corresponding author), Humboldt Univ, Freie Univ Berlin, Berlin, Germany.; Winek, K (corresponding author), Berlin Inst Hlth, Berlin, Germany.; Winek, K (corresponding author), Charite, Ctr Stroke Res Berlin, Berlin, Germany.; Winek, K (corresponding author), Charite, Neurocure Cluster Excellence, Berlin, Germany.	katarzyna.winek@charite.de		Dames, Claudia/0000-0002-9030-9532; Meisel, Andreas/0000-0001-7233-5342; Kershaw, Olivia/0000-0002-3686-9993; Zhang, Tian/0000-0001-8059-0677; Winek, Katarzyna/0000-0003-3085-9054; Meisel, Christian/0000-0003-0222-991X; Dirnagl, Ulrich/0000-0003-0755-6119	International Max Planck Research School for Infectious Diseases and Immunology (IMPRS-IDI); Sonnenfeld-Stiftung; Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [01 EO 08 01]; German Research Foundation (DFG)German Research Foundation (DFG) [Exc257, SFB TR84, TR167]; Open Access Publication Fund of Charite - Universitatsmedizin Berlin	KW received a Ph.D stipend from the International Max Planck Research School for Infectious Diseases and Immunology (IMPRS-IDI) and the Sonnenfeld-Stiftung. The study was financially supported from the German Research Foundation (Exc257; SFB TR84, TR167), the Federal Ministry of Education and Research (01 EO 08 01). We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charite - Universitatsmedizin Berlin.	Asrat S, 2015, CELL MICROBIOL, V17, P785, DOI 10.1111/cmi.12445; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Caso JR, 2009, AM J PHYSIOL-REG I, V296, pR979, DOI 10.1152/ajpregu.90825.2008; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Cohen DL, 2016, INT J STROKE, V11, P399, DOI 10.1177/1747493016639057; Crapser J, 2016, AGING-US, V8, P1049, DOI 10.18632/aging.100952; Feng D, 2007, J INT MED RES, V35, P644, DOI 10.1177/147323000703500509; Gosiewski T, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0313-4; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hetze S, 2013, J CEREBR BLOOD F MET, V33, P846, DOI 10.1038/jcbfm.2013.6; Hoffmann S, 2017, J CEREBR BLOOD F MET, V37, P3671, DOI 10.1177/0271678X16671964; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Jung C, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/823710; Kimmelman J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001863; Kumar S, 2010, LANCET NEUROL, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; Lelouard H, 2010, GASTROENTEROLOGY, V138, P173, DOI 10.1053/j.gastro.2009.09.051; Loken E, 2013, GARDEN FORKING PATHS; LUDWIG W, 1994, FEMS MICROBIOL REV, V15, P155, DOI 10.1111/j.1574-6976.1994.tb00132.x; McCulloch L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15051; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Philipp S, 2010, TRANSFUS MED HEMOTH, V37, P21, DOI 10.1159/000265571; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Prass K, 2006, STROKE, V37, P2607, DOI 10.1161/01.STR.0000240409.68739.2b; Rohde A, 2015, FOOD MICROBIOL, V46, P395, DOI 10.1016/j.fm.2014.09.002; Rohweder G, 2015, STROKE, V46, P65, DOI 10.1161/STROKEAHA.114.006667; Schaller BJ, 2006, AM J GASTROENTEROL, V101, P1655, DOI 10.1111/j.1572-0241.2006.00540.x; Schulte-Herbruggen O, 2009, NEUROIMMUNOMODULAT, V16, P213, DOI 10.1159/000205514; Singh V, 2018, J CEREBR BLOOD F MET, V38, P1293, DOI 10.1177/0271678X18780130; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Stanley D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18904-8; Stanley D, 2016, NAT MED, V22, P1277, DOI 10.1038/nm.4194; Suzuki K, 2008, TRENDS IMMUNOL, V29, P523, DOI 10.1016/j.it.2008.08.001; Suzuki K, 2014, INT IMMUNOL, V26, P489, DOI 10.1093/intimm/dxu059; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Tascilar N, 2010, BRATISL MED J, V111, P194; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x; Volynets V, 2016, DIGEST DIS SCI, V61, P737, DOI 10.1007/s10620-015-3935-y; Winek K, 2016, J CEREBR BLOOD F MET, V36, P891, DOI 10.1177/0271678X16636890; Winek K, 2016, STROKE, V47, P1354, DOI 10.1161/STROKEAHA.115.011800	44	7	8	7	18	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 19	2018	9								937	10.3389/fneur.2018.00937			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HA7UL	WOS:000450489900001	30510535	Green Published, gold			2022-02-06	
J	van Veen, E; van der Jagt, M; Cnossen, MC; Maas, AIR; de Beaufort, ID; Menon, DK; Citerio, G; Stocchetti, N; Rietdijk, WJR; van Dijck, JTJM; Kompanje, EJO				van Veen, Ernest; van der Jagt, Mathieu; Cnossen, Maryse C.; Maas, Andrew I. R.; de Beaufort, Inez D.; Menon, David K.; Citerio, Giuseppe; Stocchetti, Nino; Rietdijk, Wim J. R.; van Dijck, Jeroen T. J. M.; Kompanje, Erwin J. O.		CENTER-TBI Investigators	Brain death and postmortem organ donation: report of a questionnaire from the CENTER-TBI study	CRITICAL CARE			English	Article						Traumatic brain injury; Brain death; Ethics; Postmortem organ donation; Withdrawing life-sustaining measures; Ventricular drainage	VARIABILITY; GUIDELINES; POLICIES	BackgroundWe aimed to investigate the extent of the agreement on practices around brain death and postmortem organ donation.MethodsInvestigators from 67 Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study centers completed several questionnaires (response rate: 99%).ResultsRegarding practices around brain death, we found agreement on the clinical evaluation (prerequisites and neurological assessment) for brain death determination (BDD) in 100% of the centers. However, ancillary tests were required for BDD in 64% of the centers. BDD for nondonor patients was deemed mandatory in 18% of the centers before withdrawing life-sustaining measures (LSM). Also, practices around postmortem organ donation varied. Organ donation after circulatory arrest was forbidden in 45% of the centers. When withdrawal of LSM was contemplated, in 67% of centers the patients with a ventricular drain in situ had this removed, either sometimes or all of the time.ConclusionsThis study showed both agreement and some regional differences regarding practices around brain death and postmortem organ donation. We hope our results help quantify and understand potential differences, and provide impetus for current dialogs toward further harmonization of practices around brain death and postmortem organ donation.	[van Veen, Ernest; van der Jagt, Mathieu; Rietdijk, Wim J. R.; Kompanje, Erwin J. O.] Erasmus Univ, Med Ctr, Dept Intens Care, Rotterdam, Netherlands; [van Veen, Ernest; Cnossen, Maryse C.] Erasmus Univ, Med Ctr, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; [van Veen, Ernest; de Beaufort, Inez D.; Kompanje, Erwin J. O.] Erasmus Univ, Med Ctr, Dept Med Eth & Philosophy Med, Rotterdam, Netherlands; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Menon, David K.] Univ Cambridge, Dept Anaesthesia, Cambridge, England; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] ASST Monza, San Gerardo Hosp, Monza, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Stocchetti, Nino] Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Poli, Milan, Italy; [van Dijck, Jeroen T. J. M.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands		Kompanje, EJO (corresponding author), Erasmus Univ, Med Ctr, Dept Intens Care, Rotterdam, Netherlands.; Kompanje, EJO (corresponding author), Erasmus Univ, Med Ctr, Dept Med Eth & Philosophy Med, Rotterdam, Netherlands.	e.vanveen.1@erasmusmc.nl; e.j.o.kompanje@erasmusmc.nl	Raj, Rahul/K-7693-2012; Posti, Jussi P./Y-2908-2019; Radoi, Andreea/N-5613-2019; Poca, Maria A./B-8475-2008; Lanyon, Linda/L-9238-2019; van Dijck, Jeroen/AAM-4123-2021; Oresic, Matej/K-7673-2016; Badenes, Rafael/K-6628-2019; Cooper, D. James/G-7961-2013; Ercole, Ari/B-6288-2009; Santos, Edgar/AAV-2506-2021; Castano-Leon, Ana M/ABF-6322-2020; Boogert, Hugo F den/B-2782-2016; Vande Vyvere, Thijs/AAB-5180-2022; Maas, Andrew IR/C-5584-2013; Lagares, Alfonso/B-2969-2011; Sahuquillo, Juan/B-3577-2008; Citerio, Giuseppe/B-1839-2015; Gomez, Pedro/N-5051-2019; van der Jagt, Mathieu/G-1905-2017	Raj, Rahul/0000-0003-4243-9591; Posti, Jussi P./0000-0002-5925-5193; Radoi, Andreea/0000-0002-0677-3544; Poca, Maria A./0000-0002-3831-0536; Lanyon, Linda/0000-0002-0885-1825; van Dijck, Jeroen/0000-0002-9893-632X; Oresic, Matej/0000-0002-2856-9165; Badenes, Rafael/0000-0001-7017-0150; Cooper, D. James/0000-0002-5872-9051; Ercole, Ari/0000-0001-8350-8093; Santos, Edgar/0000-0002-8976-5549; Castano-Leon, Ana M/0000-0002-7918-5049; Vande Vyvere, Thijs/0000-0003-4032-5443; Maas, Andrew IR/0000-0003-1612-1264; Lagares, Alfonso/0000-0003-3996-0554; Sahuquillo, Juan/0000-0003-0713-5875; Citerio, Giuseppe/0000-0002-5374-3161; Gomez, Pedro/0000-0002-4185-5238; Sakowitz, Oliver/0000-0003-3248-6335; Della Corte, Francesco/0000-0003-1736-2318; Kolias, Angelos/0000-0003-3992-0587; Coles, Jonathan/0000-0003-4013-679X; Rossi, Sandra/0000-0002-9963-8121; Te Ao, Braden/0000-0002-1050-200X; Wessels, lars/0000-0001-8056-9659; Dawes, Helen/0000-0002-2933-5213; Blaabjerg, Morten/0000-0001-6007-1861; Sanchez-Porras, Renan/0000-0002-9084-8114; van der Jagt, Mathieu/0000-0003-2566-8325; Van Essen, Thomas/0000-0003-4657-5283; van Veen, Ernest/0000-0002-5495-3996; Dippel, Diederik/0000-0002-9234-3515; Parizel, Paul M./0000-0002-0221-2854; van der Naalt, Joukje/0000-0001-9873-2418; Stewart, William/0000-0003-2199-2582; Esser, Patrick/0000-0002-3227-0115; Kondziella, Daniel/0000-0001-5562-9808; Newcombe, Virginia/0000-0001-6044-9035	Framework 7 program of the European Union [602150]; National Institute for Health Research (UK)National Institute for Health Research (NIHR)	Data used in preparation of this manuscript were obtained in the context of the CENTER-TBI study, a large collaborative project, supported by the Framework 7 program of the European Union (602150). The funder had no role in the design of the study, the collection, analysis, and interpretation of data, or in writing the manuscript.; DKM was supported by a Senior Investigator Award from the National Institute for Health Research (UK). The funder had no role in the design of the study, the collection, analysis, and interpretation of data, or in writing the manuscript.	Academy of Medical Royal Colleges, 2008, COD PRACT DIAGN CONF; [Anonymous], 1968, J AMER MED ASSOC, V205, P337; Citerio G, 2014, NEUROCRIT CARE, V21, P376, DOI 10.1007/s12028-014-9983-x; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Dominguez-Gil B, 2011, TRANSPL INT, V24, P676, DOI 10.1111/j.1432-2277.2011.01257.x; EDQM Council of Europe, 2017, NEWSL TRANSPL INT FI, V22; Greer DM, 2008, NEUROLOGY, V70, P284, DOI 10.1212/01.wnl.0000296278.59487.c2; Greer DM, 2016, JAMA NEUROL, V73, P213, DOI 10.1001/jamaneurol.2015.3943; Haupt WF, 1999, J NEUROL, V246, P432, DOI 10.1007/s004150050378; Hornby K, 2006, CAN J ANAESTH, V53, P613, DOI 10.1007/BF03021854; LYNN J, 1981, JAMA-J AM MED ASSOC, V246, P2184; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MOLLARET P., 1959, REV NEUROL [PARIS], V101, P3; Payer L., 1988, MED CULTURE VARIETIE; Powner DJ, 2004, CRIT CARE MED, V32, P1284, DOI 10.1097/01.ccm.0000127265.62431.0d; Shappell CN, 2013, NEUROLOGY, V81, P2009, DOI 10.1212/01.wnl.0000436938.70528.4a; Shemie SD, 2014, INTENS CARE MED, V40, P788, DOI 10.1007/s00134-014-3242-7; Wahlster S, 2015, NEUROLOGY, V84, P1870, DOI 10.1212/WNL.0000000000001540; Wijdicks EFM, 2010, NEUROLOGY, V75, P77, DOI 10.1212/WNL.0b013e3181e62194; Wijdicks EFM, 2010, NEUROLOGY, V74, P1911, DOI 10.1212/WNL.0b013e3181e242a8; Wijdicks EFM, 2002, NEUROLOGY, V58, P20, DOI 10.1212/WNL.58.1.20; WIJDICKS EFM, 1995, NEUROLOGY, V45, P1003, DOI 10.1212/WNL.45.5.1003; Wind J, 2013, CRIT CARE, V17, DOI 10.1186/cc13034	24	7	7	1	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	NOV 16	2018	22								306	10.1186/s13054-018-2241-4			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HA7QR	WOS:000450478400002	30446017	Green Published, gold, Green Accepted			2022-02-06	
J	Clark, VD; Layson, A; Charkviani, M; Muradashvili, N; Lominadze, D				Clark, Vincent D.; Layson, Ailey; Charkviani, Mariam; Muradashvili, Nino; Lominadze, David			Hyperfibrinogenemia-mediated astrocyte activation	BRAIN RESEARCH			English	Article						Astrocyte; Fibrinogen; ICAM-1; TrkB	BLOOD-BRAIN-BARRIER; VASCULAR CONTRIBUTIONS; COGNITIVE IMPAIRMENT; ALZHEIMER-DISEASE; LONG-TERM; FIBRINOGEN; INJURY; ADHESION; BETA; PERMEABILITY	Fibrinogen (Fg)-containing plaques are associated with memory loss during various inflammatory neurodegenerative diseases such as Alzheimer's disease, multiple sclerosis, stroke, and traumatic brain injury. However, mechanisms of its action in neurovascular unit are not clear. As Fg is a high molecular weight blood protein and cannot translocate far from the vessel after extravasation, we hypothesized that it may interact with astrocytes first causing their activation. Cultured mouse cortical astrocytes were treated with Fg in the presence or absence of function-blocking anti-mouse intercellular adhesion molecule 1 (ICAM-1) antibody, or with medium alone (control). Expressions of ICAM-1 and tyrosine receptor kinase B (TrkB) as markers of astrocyte activation, and phosphorylation of TrkB (pTrkB) were assessed. Fg dose-dependently increased activation of astrocytes defined by their shape change, retraction of processes, and enhanced expressions of ICAM-1 and TrkB, and increased pTrkB. Blocking of ICAM-1 function ameliorated these Fg effects. Data suggest that Fg interacts with astrocytes causing overexpression of ICAM-1 and TrkB, and TrkB phosphorylation, and thus, astrocyte activation. Since TrkB is known to be involved in neurodegeneration, interaction of Fg with astrocytes and the resultant activation of TrkB can be a possible mechanism involved in memory reduction, which were observed in previous studies and were associated with formation of complexes of Fg deposited in extravascular space with proteins such as Amyloid beta or prion, the proteins involved in development of dementia.	[Clark, Vincent D.; Layson, Ailey; Charkviani, Mariam; Muradashvili, Nino; Lominadze, David] Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40202 USA; [Muradashvili, Nino] Caucasus Int Univ, Dept Basic Med, Tbilisi, Georgia; [Lominadze, David] Univ Louisville, Sch Med, Kentucky Spinal Cord Res Ctr, Louisville, KY 40202 USA		Lominadze, D (corresponding author), Univ Louisville, Hlth Sci Ctr, Sch Med, Dept Physiol, A-1113,500 South Preston St, Louisville, KY 40202 USA.	david.lominadze@louisville.edu		Charkviani, Mariam/0000-0002-8854-8796	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-084823]; AHAAmerican Heart Association [17SDG33670372]; University of Louisville (UofL) SOM [57139]; UoL Summer Cardiovascular Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084823] Funding Source: NIH RePORTER	Supported in part by grants from NIH (NS-084823), AHA (17SDG33670372), University of Louisville (UofL) SOM (Basic 57139) and UoL Summer Cardiovascular Research Program.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; AKIYAMA H, 1993, ACTA NEUROPATHOL, V85, P628, DOI 10.1007/BF00334673; ALTIERI DC, 1995, J BIOL CHEM, V270, P696, DOI 10.1074/jbc.270.2.696; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Boutcher PA, 1996, THROMB RES, V81, P231, DOI 10.1016/0049-3848(95)00240-5; BROSNAN CF, 1995, NEUROLOGY, V45, pS16, DOI 10.1212/WNL.45.6_Suppl_6.S16; Cernich AN, 2010, CURR TREAT OPTION NE, V12, P412, DOI 10.1007/s11940-010-0085-6; Chhabra G, 2010, NEUROL INDIA, V58, P756, DOI 10.4103/0028-3886.72175; CHIEN S, 1966, J APPL PHYSIOL, V21, P81, DOI 10.1152/jappl.1966.21.1.81; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Colombo E, 2012, J EXP MED, V209, P521, DOI 10.1084/jem.20110698; Corriveau RA, 2016, CELL MOL NEUROBIOL, V36, P281, DOI 10.1007/s10571-016-0334-7; Cortes-Canteli M, 2009, J THROMB HAEMOST, V7, P146, DOI 10.1111/j.1538-7836.2009.03376.x; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Davies PF, 2003, CIRC RES, V92, P359, DOI 10.1161/01.RES.0000060201.41923.88; Davis A E, 2000, Crit Care Nurs Q, V23, P1; del Zoppo GJ, 2009, STROKE, V40, P1687, DOI 10.1161/STROKEAHA.108.527804; DERASMO E, 1993, J MED, V24, P185; ERNST E, 1988, STROKE, V19, P634, DOI 10.1161/01.STR.19.5.634; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gaffney PJ, 2001, ANN NY ACAD SCI, V936, P594; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gordon GRJ, 2011, EXP PHYSIOL, V96, P393, DOI 10.1113/expphysiol.2010.053132; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hsiao TW, 2013, ACTA BIOMATER, V9, P7200, DOI 10.1016/j.actbio.2013.02.047; HUMPHRIES SE, 1995, EUR HEART J, V16, P16, DOI 10.1093/eurheartj/16.suppl_A.16; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kerlin B, 2004, BLOOD, V103, P1728, DOI 10.1182/blood-2003-08-2886; LANDIN K, 1990, J INTERN MED, V227, P273, DOI 10.1111/j.1365-2796.1990.tb00157.x; LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y; LEE AJ, 1993, BRIT HEART J, V69, P338; Lee SJ, 2000, J IMMUNOL, V165, P4658, DOI 10.4049/jimmunol.165.8.4658; LETCHER RL, 1981, AM J MED, V70, P1195, DOI 10.1016/0002-9343(81)90827-5; LIP GYH, 1994, J HUM HYPERTENS, V8, P693; Lominadze D, 2005, AM J PHYSIOL-HEART C, V288, pH1257, DOI 10.1152/ajpheart.00856.2004; Lominadze D, 1998, AM J HYPERTENS, V11, P784, DOI 10.1016/S0895-7061(98)00056-9; Lowe GDO, 1997, BRIT J HAEMATOL, V96, P168, DOI 10.1046/j.1365-2141.1997.8532481.x; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Muradashvili N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070077; Muradashvili N, 2016, J PHYSIOL-LONDON, V594, P5941, DOI 10.1113/JP272558; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Muradashvili N, 2014, J CEREBR BLOOD F MET, V34, P1472, DOI 10.1038/jcbfm.2014.102; Muradashvili N, 2014, CELL BIOCHEM BIOPHYS, V69, P283, DOI 10.1007/s12013-013-9797-z; Muradashvili N, 2013, BRAIN INJURY, V27, P1508, DOI 10.3109/02699052.2013.823562; Muradashvili N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00166; Muradashvili N, 2012, J CEREBR BLOOD F MET, V32, P150, DOI 10.1038/jcbfm.2011.144; Muradashvili N, 2011, BIOCHEM BIOPH RES CO, V413, P509, DOI 10.1016/j.bbrc.2011.07.133; Murphy MP, 2016, BBA-MOL BASIS DIS, V1862, P857, DOI 10.1016/j.bbadis.2016.02.010; Pahatouridis D, 2010, BRAIN INJURY, V24, P1189, DOI 10.3109/02699052.2010.490510; Pankow JS, 1998, ARTERIOSCL THROM VAS, V18, P1559, DOI 10.1161/01.ATV.18.10.1559; Patibandla PK, 2009, J CELL PHYSIOL, V221, P195, DOI 10.1002/jcp.21845; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Pluskota E, 2000, EUR J BIOCHEM, V267, P4693, DOI 10.1046/j.1432-1327.2000.01520.x; Rosenberg G A, 2014, J Prev Alzheimers Dis, V1, P138; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sahni A, 2009, INT J CANCER, V125, P577, DOI 10.1002/ijc.24340; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Sen U, 2009, AM J PHYSIOL-CELL PH, V296, pC840, DOI 10.1152/ajpcell.00515.2008; Shenhar-Tsarfaty S, 2008, THROMB HAEMOSTASIS, V99, P169, DOI 10.1160/TH07-08-0484; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Tyagi N, 2008, MOL CELL BIOCHEM, V307, P13, DOI 10.1007/s11010-007-9579-2; van de Haar HJ, 2015, NEUROSCI BIOBEHAV R, V49, P71, DOI 10.1016/j.neubiorev.2014.11.022; van Oijen M, 2005, STROKE, V36, P2637, DOI 10.1161/01.STR.0000189721.31432.26; Vasse M, 1996, HAEMOSTASIS, V26, P331; Vos CMP, 2005, NEUROBIOL DIS, V20, P953, DOI 10.1016/j.nbd.2005.06.012; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	80	7	7	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 15	2018	1699						158	165		10.1016/j.brainres.2018.08.023			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GZ1KE	WOS:000449126200017	30153459	Green Accepted			2022-02-06	
J	Wang, ML; Yu, MM; Yang, DX; Liu, YL; Wei, XE; Li, WB				Wang, Ming-Liang; Yu, Meng-Meng; Yang, Dian-Xu; Liu, Ying-Liang; Wei, Xiao-Er; Li, Wen-Bin			Diffusion Kurtosis Imaging Characterizes Brain Microstructural Changes Associated with Cognitive Impairment in a Rat Model of Chronic Traumatic Brain Injury	NEUROSCIENCE			English	Article						traumatic brain injury; cognitive impairment; diffusion kurtosis imaging; pathological changes	BEHAVIORAL DEFICITS; MATTER; WHITE; TENSOR; DYSFUNCTION; PATHOLOGY; GLIOSIS; MYELIN; DTI	This study aims to investigate the value of diffusion kurtosis imaging (DKI) in assessing microstructurel changes associated with cognitive impairment in chronic traumatic brain injury (TBI). At 7 months, six TBI rats and six control rats underwent Morris water maze (MWM) tests, followed by DKI examinations. DKI parameters were measured in bilateral cortex, hippocampus, and callosum. Brain immunohistochemistry (IHC) analysis of neuron [neuron-specific nuclear protein (NeuN)], astroglia [glial fibrillary acidic protein (GFAP)], microglia [ionized calcium binding adaptor molecule 1 (Iba-1)], and myelin [myelin basic protein (MBP)] was performed in the same area as DKI parameter. The DKI parameters, IHC results, and MWM results were compared between TBI and control groups. Correlation analysis was performed to analyze the relationship between DKI parameters and IHC and MWM results. TBI group had worse performance in MWM test. DKI showed higher mean diffusion (MD) in all ipsilateral regions of interest (ROls), and lower mean kurtosis (MK) in ipsilateral cortex and callosum in TBI group (P < 0.05). TBI group also showed lower IHC staining of NeuN, and higher staining of lba-1 and MBP in all ipsilateral ROls (P < 0.05). Further correlational study showed a positive relationship between MK and NeuN, MD and MBP in ipsilateral cortex, and a negative relationship between MK and Iba-1, MBP in ipsilateral cortex and hippocampus (P < 0.05). The MK in ipsilateral cortex and hippocampus were also correlated with MWM test results (P < 0.05). Our study suggests that DKI could be used to assess the microstructurel changes associated with cognitive impairment in chronic TBI. (C) 2018 IBRO. Published by Elsevier Ltd. All rights reserved.	[Wang, Ming-Liang; Yu, Meng-Meng; Wei, Xiao-Er; Li, Wen-Bin] Shanghai Jiao Tong Univ, Sch Med, Affiliated Peoples Hosp 6, Dept Radiol, 600 Yi Shan Rd, Shanghai 200233, Peoples R China; [Yang, Dian-Xu; Liu, Ying-Liang] Shanghai Jiao Tong Univ, Sch Med, Affiliated Peoples Hosp 6, Dept Neurosurg, 600 Yi Shan Rd, Shanghai 200233, Peoples R China; [Li, Wen-Bin] Kashgar Prefecture Second Peoples Hosp, Imaging Ctr, 1 Jiankang Rd, Kashgar 844000, Peoples R China		Li, WB (corresponding author), 600 Yi Shan Rd, Shanghai 200233, Peoples R China.	liwenbin@sjtu.edu.cn			Institutional Animal Care and Experiment Committee of Shanghai Jiao Tong University Affiliated Sixth Peoples' Hospital; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271540, 81301213]; Natural Science Foundation of Xinjiang Province [2016D01C083]; Medical-Engineering Cross Project of Shanghai Jiao Tong University [YG2015MS19]; Shanghai Health and Family Planning Commission research projects [20164Y0065]; Shanghai key discipline of medical imaging [2017ZZ02005]	This study was approved by the Institutional Animal Care and Experiment Committee of Shanghai Jiao Tong University Affiliated Sixth Peoples' Hospital. This study is supported by National Natural Science Foundation of China (No: 81271540, 81301213), Natural Science Foundation of Xinjiang Province (No: 2016D01C083), Medical-Engineering Cross Project of Shanghai Jiao Tong University (No: YG2015MS19), Shanghai Health and Family Planning Commission research projects (No. 20164Y0065) and Shanghai key discipline of medical imaging (No: 2017ZZ02005). WB.L. and ML.W. conceived and designed research. ML.W., MM.Y., DX. Y., YL. L and XE. W. contributed to data collection. ML. W. and MM.Y. contributed to data analysis. ML.W. and WB.L. wrote the manuscript and all other authors helped with revisions.	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Brooks DM, 2017, EXP NEUROL, V297, P62, DOI 10.1016/j.expneurol.2017.07.015; Chida Y, 2011, BRAIN RES, V1414, P22, DOI 10.1016/j.brainres.2011.07.026; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Guglielmetti C, 2016, NEUROIMAGE, V125, P363, DOI 10.1016/j.neuroimage.2015.10.052; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kelma ND, 2016, NEUROIMAGE, V124, P612, DOI 10.1016/j.neuroimage.2015.09.028; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Novikov DS, 2018, MAGN RESON MED, V79, P3172, DOI 10.1002/mrm.27101; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Pottker B, 2017, BRAIN STRUCT FUNCT, V222, P4005, DOI 10.1007/s00429-017-1452-9; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	39	7	7	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 10	2018	392						180	189		10.1016/j.neuroscience.2018.09.030			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY0GY	WOS:000448194900016	30278249				2022-02-06	
J	Dailey, NS; Smith, R; Vanuk, JR; Raikes, AC; Killgore, WDS				Dailey, Natalie S.; Smith, Ryan; Vanuk, John R.; Raikes, Adam C.; Killgore, William D. S.			Resting-state functional connectivity as a biomarker of aggression in mild traumatic brain injury	NEUROREPORT			English	Article						aggression; default mode network; functional connectivity; mild traumatic brain injury; postconcussive symptoms; resting state functional magnetic resonance imaging	DEFAULT-MODE NETWORK; SUPPRESSION; CONCUSSION	Mild traumatic brain injury (mTBI) can alter the structure of the brain and result in a range of symptoms, including elevated aggression. Neurological damage associated with mTBI is traditionally viewed as transient, yet a growing number of studies suggest long-lasting psychological and neurological changes following mTBI. However, research examining the neural basis of emotion processing in the chronic stage of mTBI recovery remains sparse. In the current study, we utilized resting state functional MRI to explore the association between default mode network connectivity and aggression in 17 healthy controls and 17 adults at least 6 months post-mTBI. The association between within-network connectivity and aggression was examined using general linear models, controlling for the effects of depression. Increased connectivity between the right hippocampus and midcingulate cortex was associated with elevated aggression in adults with mTBI, but not in healthy controls. The results provide evidence for a link between intrinsic functional network disruptions and the manifestation of postconcussive symptoms within chronic stages of recovery following mTBI. These findings expand upon the current research, providing evidence for the use of resting state functional connectivity as a potential biomarker of postconcussive aggression in chronic mTBI.	[Dailey, Natalie S.; Smith, Ryan; Vanuk, John R.; Raikes, Adam C.; Killgore, William D. S.] Univ Arizona, Coll Med, Dept Psychiat, 1501N Campbell Ave, Tucson, AZ 85701 USA		Dailey, NS (corresponding author), Univ Arizona, Coll Med, Dept Psychiat, 1501N Campbell Ave, Tucson, AZ 85701 USA.	ndailey@email.arizona.edu	Raikes, Adam/M-2600-2019	Raikes, Adam/0000-0002-1609-6727; Dailey, Natalie S./0000-0003-4800-4118; Smith, Ryan/0000-0002-4448-185X	Office of the Assistant Secretary of Defense for Health Affairs; Defense Health Agency J9, Research and Development Directorate, through the US Army Medical Research and Materiel Command (USAMRMC) [W81XWH-12-0386]	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs and the Defense Health Agency J9, Research and Development Directorate, through the US Army Medical Research and Materiel Command (USAMRMC) under Award No. W81XWH-12-0386, to W.D.S. Killgore. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense.	BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Cui JL, 2014, NEUROREPORT, V25, P771, DOI 10.1097/WNR.0000000000000175; Dailey NS, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00118; Dall'Acqua P, 2017, J NEUROTRAUM, V34, P3270, DOI 10.1089/neu.2017.5124; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; Epstein DJ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.581; Faul M, 2010, TRAUMATIC BRAIN INJU; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Killgore WDS, 2017, SOC COGN AFFECT NEUR, V12, P1624, DOI 10.1093/scan/nsx088; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Pan JH, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00070; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith R, 2017, NEUROIMAGE, V159, P99, DOI 10.1016/j.neuroimage.2017.07.044; van der Horn HJ, 2017, J NEUROTRAUM, V34, P3262, DOI 10.1089/neu.2017.5185; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	26	7	7	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	NOV 7	2018	29	16					1413	1417		10.1097/WNR.0000000000001127			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GW0BT	WOS:000446527800012	30204638				2022-02-06	
J	Amoo, M; O'Halloran, PJ; Leo, AM; O'Loughlin, A; Mahon, P; Lim, C				Amoo, Michael; O'Halloran, Philip J.; Leo, Anne-Marie; O'Loughlin, Aoife; Mahon, Padraig; Lim, Chris			Outcomes of emergency neurosurgical intervention in neuro-critical care patients with traumatic brain injury at Cork University Hospital	BRITISH JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; intensive care unit; Glasgow outcome scale extended; disability	SEVERE HEAD-INJURY; EPIDEMIOLOGY; MODERATE; COMA	Traumatic Brain Injury (TBI) is a major cause of death and disability; the leading cause of mortality and morbidity in previously healthy people aged under 40 in the United Kingdom (UK). There are currently little official Irish statistics regarding TBI or outcome measures following TBI, although it is estimated that over 2000 people per year sustain TBI in Ireland. We performed a retrospective cohort study of TBI patients who were managed in the intensive care unit (ICU) at CUH between July 2012 and December 2015. Demographic data were compiled by patients' charts reviews. Using the validated Glasgow outcome scale extended (GOS-E) outcome measure tool, we interviewed patients and/or their carers to measure functional outcomes. Descriptive statistical analyses were performed. Spearman's correlation analysis was used to assess association between different variables using IBM's Statistical Package for the Social Sciences (SPSS) 20. In the 42-month period, 102 patients were identified, mainly males (81%). 49% had severe TBI and 56% were referred from other hospitals. The mean age was 44.7 and a most of the patients were previously healthy, with 65% of patients having ASA I or II. Falls accounted for the majority of the TBI, especially amongst those aged over 50. The 30-day mortality was 25.5% and the mean length of hospital stay (LOS-H) was 33 days. 9.8% of the study population had a good recovery (GOS-E 8), while 7.8% had a GOS-E score of 3 (lower sever disability). Patients with Extra-Dural haemorrhage had better outcomes compared with those with SDH or multi-compartmental haemorrhages (p = 0.007). Older patients had a higher mortality, with the highest mortality (37.5%) among those over 50 years old (p = 0.009). TBI is associated with significant morbidity and mortality. Despite the young mean age and low ASA the mortality, morbidity and average LOS-H were significant, highlighting the health and socioeconomic burden of TBI.	[Amoo, Michael; O'Halloran, Philip J.; Lim, Chris] Cork Univ Hosp, Dept Neurol Surg, Cork T12 DC4A, Ireland; [Leo, Anne-Marie; O'Loughlin, Aoife; Mahon, Padraig] Cork Univ Hosp, Dept Anaesthesia, Cork, Ireland		Amoo, M (corresponding author), Cork Univ Hosp, Dept Neurol Surg, Cork T12 DC4A, Ireland.	m.amoo@umail.ucc.ie	Amoo, Michael/AAZ-8650-2021	Amoo, Michael/0000-0001-6886-6714			Ariza M, 2004, J NEUROTRAUM, V21, P864, DOI 10.1089/0897715041526203; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; BTF AANS CNS, 2007, J NEUROTRAUM, V24, P6; Excellence NIfHaC, 2014, HEAD INJ ASS EARL MA; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Klemenc-Ketis Z, 2011, ULUS TRAVMA ACIL CER, V17, P509, DOI 10.5505/tjtes.2011.35336; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Phillips J, 2008, PHILLIPS REPORT NATL; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; TEASDALE G, 1974, LANCET, V2, P81	21	7	7	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	NOV 2	2018	32	6					585	589		10.1080/02688697.2018.1522416			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HH8WM	WOS:000456014500002	30394116				2022-02-06	
J	Cusimano, MD; Zhang, S; Topolovec-Vranic, J; Grosso, A; Jing, R; Ilie, G				Cusimano, Michael D.; Zhang, Stanley; Topolovec-Vranic, Jane; Grosso, Ashley; Jing, Rowan; Ilie, Gabriela			Pros and Cons of 19 Sport-Related Concussion Educational Resources in Canada: Avenues for Better Care and Prevention	FRONTIERS IN NEUROLOGY			English	Article						concussion; mild traumatic brain injury (mTBI); concussion education and awareness programs; concussion prevention; sports injury prevention	HOCKEY PLAYERS; ICE HOCKEY; KNOWLEDGE; INJURY	Objective: The goal of this research was to assess the effectiveness of available concussion educational resources in Canada, the means used to disseminate this knowledge and the impact of these educational resources on players' concussion prevention knowledge. Methods: We assessed concussion knowledge before and after exposure to one or more of 19 resources introduced through a national program aimed to increase awareness and knowledge of concussion. The effectiveness of the mode of delivery was measured by changes in concussion knowledge scores (CKS) between pre and pro scores. Measures: Concussion knowledge scores (CKS) were calculated for pre- and post- exposure to concussion educational resources and used as a measure of both, the effectiveness of each resource as well as the effectiveness of the delivery method. The effectiveness of each educational resource was also measured by the respondents' rating of each concussion educational resource. Results: Respondents in post- survey had higher CKS than those in pre- survey. Two out of the 19 newly developed concussion educational resources were effective in improving the resource users' CKS. Linear regression showed that using more resources further increased CKS. Four out of six modes of delivery enhanced respondents' concussion knowledge. Conclusion: Our findings demonstrate that the newly developed Canadian concussion educational resources were effective at improving users' concussion knowledge. Our data demonstrates that using three or more resources further enhanced the users' concussion knowledge. Future research, however, is critical to assess whether concussion prevention knowledge is sufficient to reduce injuries and factors influencing it.	[Cusimano, Michael D.; Zhang, Stanley; Grosso, Ashley; Jing, Rowan] St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Daila Lana Sch Publ Hlth, Toronto, ON, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Ilie, Gabriela] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada		Ilie, G (corresponding author), Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada.	Gabriela.ilie@dal.ca	Ilie, Gabriela/AAM-9122-2021; Cusimano, Michael/X-4059-2019		Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation; Public Health Agency of Canada	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946 (MC), the Ontario Neurotrauma Foundation (MC), and Public Health Agency of Canada (MC).	Agarwal N, 2013, J CLIN NEUROSCI, V20, P1357, DOI 10.1016/j.jocn.2012.10.047; Armstrong S, 2004, THE NEW LITERACY; Bandura A., 1977, SOCIAL LEARNING THEO; Baur C, 2006, EXPANDING REACH IMPA; Boston University School of Public Health, 2013, BEHAV CHANGE MODELS; Canadian Institute of Health Research, 2012, NEW OPP TRAUM BRAIN; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Carroll-Alfano M, 2017, J ATHL TRAINING, V52, P689, DOI 10.4085/1062-6050-52.3.08; Centers for Disease Control and Prevention, 2014, SEV TRAUM BRAIN INJ; Coronado Victor G, 2010, TRAUMATIC BRAIN INJU; Cusimano MD, 2017, SAGE OPEN MED, V5, DOI [10.1177/2050312117694794, 10.1177/2050312117699799]; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Do MT, 2013, INT J CIRCUMPOL HEAL, V72, DOI 10.3402/ijch.v72i0.21090; Eagles ME, 2016, CAN J NEUROL SCI, V43, P659, DOI 10.1017/cjn.2016.263; Finkelstein E., 2006, INCIDENCE EC BURDEN; Hachem LD, 2016, CAN J NEUROL SCI, V43, P554, DOI 10.1017/cjn.2016.41; Harari P, 2000, HEINEMANN THEMES PSY; Hunt TN., 2015, ATHLETIC TRAIN ED J, V10, P65, DOI [10.4085/100165, DOI 10.4085/100165]; Jordan-Marsh M., 2011, HLTH TECHNOLOGY LITE; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kimbler DE, 2011, J NEUROSCI NURS, V43, P286, DOI 10.1097/JNN.0b013e31823858a6; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Macdonald I, 2016, J NEUROSCI NURS, V48, P297, DOI 10.1097/JNN.0000000000000212; MALONE TW, 1981, COGNITIVE SCI, V5, P333, DOI 10.1016/S0364-0213(81)80017-1; Mckinlay A, 2019, DISABIL REHABIL, V41, P1419, DOI 10.1080/09638288.2018.1429500; Mcleod S.A., 2011, BANDURA SOCIAL LEARN; Mrazik M, 2015, J HEAD TRAUMA REHAB, V30, P219, DOI 10.1097/HTR.0000000000000018; Paas F, 2008, CURR PERSP CONG LEAR, P11; Parker EM, 2015, J HEAD TRAUMA REHAB, V30, P198, DOI 10.1097/HTR.0000000000000097; Piaget  J., 1970, PIAGETS THEORY; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Robinson DH, 2008, CURR PERSP CONG LEAR, P1; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sahyouni R, 2017, NEUROSURGERY, V81, P787, DOI 10.1093/neuros/nyx095; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Selwyn N., 2011, SCH SCH DIGITAL AGE; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Taylor AM, 2018, CLIN PEDIATR, V57, P806, DOI 10.1177/0009922817734363; Topolovec-Vranic J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141699; U. S Department of Health and Human Services Office of Disease Prevention and Health Promotion, 2010, 6 STRAT WRIT DES EAS; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482	47	7	7	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 2	2018	9								872	10.3389/fneur.2018.00872			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GZ0YS	WOS:000449092300001	30450073	Green Published, gold			2022-02-06	
J	Bennett, CN; Gupta, RK; Prabhakar, P; Christopher, R; Sampath, S; Thennarasu, K; Rajeswaran, J				Bennett, Cathlyn N.; Gupta, Rajnish K.; Prabhakar, Puttachandra; Christopher, Rita; Sampath, Somanna; Thennarasu, K.; Rajeswaran, Jamuna			Clinical and Biochemical Outcomes Following EEG Neurofeedback Training in Traumatic Brain Injury in the Context of Spontaneous Recovery	CLINICAL EEG AND NEUROSCIENCE			English	Article						neurofeedback; traumatic brain injury (TBI); EEG; stress; cortisol	POSTTRAUMATIC-STRESS-DISORDER; CORTISOL	It has been found that reduction of posttraumatic stress symptoms is positively associated with the reduction of postconcussive symptoms. Cortisol is commonly used as a biomarker of stress. Understanding the role of posttraumatic stress and cortisol in symptom reduction has implication for neuropsychological rehabilitation particularly in the context of spontaneous recovery. Objective. The aim of the research was to study the effectiveness of EEG neurofeedback training on clinical symptoms, perceived stress, and cortisol in traumatic brain injury (TBI) patients in the context of spontaneous recovery. Methods. The design was an experimental longitudinal design with the pre-post comparison. The sample comprised 60 patients with the diagnosis of TBI30 patients in the neurofeedback training (NFT) group and 30 patients in the treatment as usual group (TAU) group. Half of the patients were recruited within 6 months of injury to study the role of spontaneous recovery and the other half were recruited in the 12 to 18 months postinjury phase. Alpha-theta training was given to the NFT group over 20 sessions. Pre and post comparisons were made on clinical symptom rating, perceived stress, and serum cortisol levels. Results. The results indicate significant differences in symptom reporting and perceived stress between the NFT and TAU groups. Significant differences were also seen in cortisol levels with implications for the acute recovery phase. Conclusion. Alpha-theta NFT has a beneficial effect on symptom reduction as well as perceived stress. It also has a beneficial effect on levels of serum cortisol, corroborating these findings.	[Bennett, Cathlyn N.; Gupta, Rajnish K.; Rajeswaran, Jamuna] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Hosur Rd, Bengaluru 560029, Karnataka, India; [Prabhakar, Puttachandra; Christopher, Rita] Natl Inst Mental Hlth & Neurosci, Dept Neurochem, Bengaluru, Karnataka, India; [Sampath, Somanna] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bengaluru, Karnataka, India; [Thennarasu, K.] Natl Inst Mental Hlth & Neurosci, Dept Biostat, Bengaluru, Karnataka, India		Rajeswaran, J (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Hosur Rd, Bengaluru 560029, Karnataka, India.	drjamunarajan@gmail.com	BENNETT, CATHLYN NIRANJANA/AAQ-5348-2020	Gupta, Rajnish K/0000-0001-9354-360X; BENNETT, CATHLYN NIRANJANA/0000-0002-1797-2653	Department of Biotechnology, Government of IndiaDepartment of Biotechnology (DBT) India	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the Department of Biotechnology, Government of India as a grant for the project titled, "A Study of Cognitive Functions and Biochemical Correlates in Traumatic Brain Injury."	Bay Esther, 2006, Care Manag J, V7, P3, DOI 10.1891/cmaj.7.1.3; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Beseoglu K, 2013, BRIT J NEUROSURG, V27, P202, DOI 10.3109/02688697.2012.717984; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Hammond D. C., 2005, J NEUROTHERAPY, V9, P27, DOI [10.1300/J184v09n01_03, DOI 10.1300/J184V09N01_03]; Hammond DC, 2005, CHILD ADOL PSYCH CL, V14, P105, DOI 10.1016/j.chc.2004.07.008; Het S, 2012, PSYCHOSOM MED, V74, P23, DOI 10.1097/PSY.0b013e31823a4a25; Keller I, 2001, J NEUROTHERAPY, V5, P19; Koberda JL., 2015, J NEUROL NEUROBIOL, V1, P1, DOI [10.16966/2379-7150.113., DOI 10.16966/2379-7150.113.]; NOWLIS DP, 1970, PSYCHOPHYSIOLOGY, V6, P476, DOI 10.1111/j.1469-8986.1970.tb01756.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARKER R, 1990, TRAUMATIC BRAIN INJU; Peniston E. G., 1991, MED PSYCHOTHERAPY, V4, P47, DOI DOI 10.1021/MA0483701; Peniston EG, PENISTON KULKOSKY BR; Reddy R. P., 2009, INT J PSYCHOSOCIAL R, V14, P21; Seldenrijk A, 2012, PSYCHONEUROENDOCRINO, V37, P48, DOI 10.1016/j.psyneuen.2011.05.001; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Sime W.E., 2007, PRINCIPLES PRACTICE, P249; Sojka P, 2006, BRAIN INJURY, V20, P613, DOI 10.1080/02699050600676982; Thatcher RW, 1999, CLIN ELECTROENCEPHAL, V30, P94, DOI 10.1177/155005949903000304; Thornton K, 2000, J HEAD TRAUMA REHAB, V15, P1285, DOI 10.1097/00001199-200012000-00008; Tinius TP, 2003, ARCH CLIN NEUROPSYCH, V18, P199, DOI 10.1016/S0887-6177(01)00196-2; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254	26	7	8	1	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1550-0594	2169-5202		CLIN EEG NEUROSCI	Clin. EEG Neurosci.	NOV	2018	49	6					433	440		10.1177/1550059417744899			8	Clinical Neurology; Neurosciences; Neuroimaging; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	GV4VC	WOS:000446098200010	29268620				2022-02-06	
J	Bolzenius, JD; Velez, CS; Lewis, JD; Bigler, ED; Wade, BSC; Cooper, DB; Kennedy, JE; Reid, MW; Ritter, JL; York, GE; Tate, DF				Bolzenius, Jacob D.; Velez, Carmen S.; Lewis, Jeffrey D.; Bigler, Erin D.; Wade, Benjamin S. C.; Cooper, Douglas B.; Kennedy, Jan E.; Reid, Matthew W.; Ritter, John L.; York, Gerald E.; Tate, David F.			Diffusion Imaging Findings in US Service Members With Mild Traumatic Brain Injury and Posttraumatic Stress Disorder	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						diffusion tensor imaging; military personnel; posttraumatic stress disorder; traumatic brain injury; white matter	WHITE-MATTER INTEGRITY; POSTCONCUSSIONAL DISORDER; VOXELWISE ANALYSIS; SYMPTOMS; MILITARY; VETERANS; PTSD; ABNORMALITIES; DEPLOYMENT; IRAQ	Objective: Use diffusion tensor imaging to investigate white matter microstructure attributable to mild TBI (mTBI) and/or posttraumatic stress disorder (PTSD). Participants: Twenty-seven individuals with mTBI only, 16 with PTSD only, 42 with mTBI + PTSD, and 43 service members who sustained orthopedic injury. Design: Descriptive cross-sectional study. Main Measures: Clinical diffusion tensor imaging sequence to assess fractional anisotropy, mean, axial, and radial diffusivity within selected regions of interest. Results: Corrected analyses revealed a pattern of lower white matter integrity in the PTSD group for several scalar metrics. Regions affected included primarily right hemisphere areas of the internal capsule. These differences associated with the PTSD only cohort were observed in relation to all 3 comparison groups, while the mTBI + PTSD group did not exhibit any notable pattern of white matter abnormalities. Conclusion: Results suggest that lower resolution scan sequences are sensitive to post-acute abnormalities associated with PTSD, particularly in the right hemisphere. In addition, these findings suggest that ongoing PTSD symptoms are associated with differences in white matter diffusion that are more readily detected in a clinical scan sequence than mTBI abnormalities. Future studies are needed to prospectively assess service members prior to onset of injury to verify this pattern of results.	[Bolzenius, Jacob D.; Velez, Carmen S.; Wade, Benjamin S. C.; Tate, David F.] Univ Missouri St Louis, Missouri Inst Mental Hlth, 4633 World Pkwy Circle, Berkeley, MO 63134 USA; [Lewis, Jeffrey D.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Sch Med, Bethesda, MD 20814 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Cooper, Douglas B.; Kennedy, Jan E.; Reid, Matthew W.] Def & Vet Brain Injury Ctr, San Antonio, TX USA; [Ritter, John L.] Brooke Army Med Ctr, Dept Radiol, San Antonio, TX USA; [York, Gerald E.] Alaska Radiol Associates, TBI Imaging & Res, Anchorage, AK USA		Tate, DF (corresponding author), Univ Missouri St Louis, Missouri Inst Mental Hlth, 4633 World Pkwy Circle, Berkeley, MO 63134 USA.	David.Tate@mimh.edu; David.Tate@mimh.edu	Tate, David F/I-3963-2013; Ritter, John/AAG-8899-2020	Tate, David F/0000-0003-0213-1920; Wade, Benjamin/0000-0003-2461-6101	Defense and Veterans Brain Injury Centers at the US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0025]; Chronic Effects of Neurotrauma Consortium (CENC) [PT108802-SC104835]	This work is supported in part by the Defense and Veterans Brain Injury Centers at the US Army Medical Research and Materiel Command (USAMRMC; W81XWH-13-2-0025) and the Chronic Effects of Neurotrauma Consortium (CENC; PT108802-SC104835).	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Bigler ED, 2015, BRAIN INJURY, V29, P1062, DOI 10.3109/02699052.2015.1011234; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Boasso AM, 2016, J PSYCHIATR RES, V83, P54, DOI 10.1016/j.jpsychires.2016.08.002; Boks MP, 2016, NEUROPSYCHOPHARMACOL, V41, P1350, DOI 10.1038/npp.2015.286; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Bremner JD, 1996, AM J PSYCHIAT, V153, P369; Brenner LA, 2015, REHABIL PSYCHOL, V60, P277, DOI 10.1037/rep0000048; Clark AL, 2016, BRAIN IMAGING BEHAV, V11, P1; Cohen GH, 2015, EPIDEMIOL REV, V37, P7, DOI 10.1093/epirev/mxu007; Costanzo ME, 2016, NEUROSCI LETT, V618, P66, DOI 10.1016/j.neulet.2016.02.041; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Davenport ND, 2016, BRAIN INJURY, V30, P1491, DOI 10.1080/02699052.2016.1219057; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Defense Medical Surveillance System (DMSS) and Theater Medical Data Store (TMDS) provided by the Armed Forces Health Surveillance Branch, 2016, DOD NUMB TRAUM BRAIN; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hines LA, 2014, CAN J PSYCHIAT, V59, P468, DOI 10.1177/070674371405900903; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu H, 2016, J AFFECT DISORDERS, V190, P714, DOI 10.1016/j.jad.2015.09.044; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061; Jenkins LM, 2016, NEUROIMAGE-CLIN, V12, P1022, DOI 10.1016/j.nicl.2016.09.001; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Jurick SM, 2016, BRAIN INJURY, V30, P1452, DOI 10.1080/02699052.2016.1219064; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Klein E, 2003, CAN J PSYCHIAT, V48, P28, DOI 10.1177/070674370304800106; Kochunov P, 2014, NEUROIMAGE, V95, P136, DOI 10.1016/j.neuroimage.2014.03.033; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Liu Y, 2016, PROC SPIE, V9788, DOI 10.1117/12.2216389; Long ZL, 2013, J AFFECT DISORDERS, V150, P798, DOI 10.1016/j.jad.2013.03.004; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Metzger LJ, 2004, J ABNORM PSYCHOL, V113, P324, DOI 10.1037/0021-843X.113.2.324; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Miller DR, 2016, BRAIN IMAGING BEHAV, V11, P1; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Sekiguchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083967; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sorensen HJ, 2016, J AFFECT DISORDERS, V196, P148, DOI 10.1016/j.jad.2016.02.037; Spoont MR, 2015, JAMA-J AM MED ASSOC, V314, P501, DOI 10.1001/jama.2015.7877; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F.W., 1993, 9 ANN C ISTSS; Wolfe J, 1999, J CONSULT CLIN PSYCH, V67, P520, DOI 10.1037/0022-006X.67.4.520; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358	61	7	7	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					393	402		10.1097/HTR.0000000000000378			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600015	29385017				2022-02-06	
J	Gandy, M; Karin, E; Fogliati, VJ; Meares, S; Nielssen, O; Titov, N; Dear, BF				Gandy, Milena; Karin, Eyal; Fogliati, Vincent J.; Meares, Susanne; Nielssen, Olav; Titov, Nickolai; Dear, Blake F.			Emotional and Cognitive Difficulties, Help-Seeking, and Barriers to Treatment in Neurological Disorders	REHABILITATION PSYCHOLOGY			English	Article						barriers; online; cognitive rehabilitation; psychological distress; quality of life	DISABILITY ASSESSMENT SCHEDULE; PAIN MANAGEMENT PROGRAM; TRAUMATIC BRAIN-INJURY; INCOG RECOMMENDATIONS; BEHAVIORAL THERAPY; MENTAL-DISORDERS; HEALTH; DEPRESSION; ANXIETY; PEOPLE	Purpose/Objective: To (a) explore the mental health and wellbeing of Australian adults with neurological disorders, (b) examine their history of help-seeking behavior and perceived barriers to treatment for emotional and cognitive difficulties, and (c) assess their interest in online self-management programs. Method/Design: A sample of 2,254 (mean age = 46.3 year; SD = 14.1; 80% were female), Australians with a neurological disorder completed an online survey of standardized measures of mental health and wellbeing, and questions about help-seeking and perceived barriers to treatment. Results: There was consistent evidence of poor mental health and wellbeing across measures of psychological distress (Kessler 10, K10; M [24.6]; SD [8.6]), depression (Neurological Depressive Disorders Inventory-Epilepsy, NDDI-E; M [15.6]; SD [4.3]), disability (World Health Organization Disability Assessment Schedule 2.0, WHODAS 2.0; M [16.3]; SD [10.2]), Satisfaction With Life Scale (SWLS; M [20.0]; SD [8.0]), and perceived cognitive deficits (Perceived Cognitive Questionnaires, PDQ) in attention/concentration (M [2.1]; SD [1.2]); retrospective memory (M [2.0]; SD [1.0]); prospective memory (M [1.7]; SD [.9]); and planning/organization (M [2.0]; SD [1.0]). Participants reported using both formal (e.g., advice from GP and neurologist) and informal help-seeking (e.g., searching the Internet) for both emotional symptoms and cognitive difficulties, but most (>70%) reported unmet needs and experiencing barriers to seeking care, including the lack of available services and beliefs that symptoms could not change. Conclusions/Implications: We found high levels of comorbid psychological distress among people with neurological disorders, widespread barriers to receiving care, and a high level of interest in an online self-management program that might help overcome barriers to accessing psychological treatment for mood symptoms and impaired cognitive function.	[Gandy, Milena; Karin, Eyal; Fogliati, Vincent J.; Titov, Nickolai; Dear, Blake F.] Macquarie Univ, Dept Psychol, eCentreClin, N Ryde, NSW, Australia; [Meares, Susanne] Macquarie Univ, Dept Psychol, N Ryde, NSW, Australia; [Nielssen, Olav] Macquarie Univ, Dept Med & Hlth Sci, N Ryde, NSW, Australia		Gandy, M (corresponding author), Macquarie Univ, Dept Psychol, N Ryde, NSW, Australia.	milena.gandy@mq.edu.au	Karin, Eyal/AAO-4822-2021; Gandy, Milena/AAV-3617-2020	Karin, Eyal/0000-0002-6152-9704; Gandy, Milena/0000-0003-2161-3298; Meares, Susanne/0000-0002-3859-9974; Nielssen, Olav/0000-0001-5172-2781; Titov, Nickolai/0000-0002-7268-729X; Dear, Blake/0000-0001-9324-3092	Macquarie University Research Fellowship	This research was supported by a Macquarie University Research Fellowship. The authors gratefully acknowledge all of the participants for their involvement. We also thank the neurological advocacy groups: Epilepsy Action Australia, MS Research Australia, Brain Injury Australia, the Stroke Foundation and Synapse, who helped promote the research.	A.B.o. Statistics, 2007, NAT SURV MENT HLTH W; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Andersson G, 2014, WORLD PSYCHIATRY, V13, P4, DOI 10.1002/wps.20083; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; [Anonymous], 2001, WORLD HLTH ORG DIS A; Australian Institute of Health and Welfare (AIHW), 2016, AUSTR BURD DIS STUD; Gamez LDA, 2014, SALUD MENT, V37, P399; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Beatty L, 2013, CLIN PSYCHOL REV, V33, P609, DOI 10.1016/j.cpr.2013.03.004; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cuijpers P, 2008, J BEHAV MED, V31, P169, DOI 10.1007/s10865-007-9144-1; Dear BF, 2017, PAIN, V158, P1289, DOI 10.1097/j.pain.0000000000000916; Dear BF, 2015, PAIN, V156, P1920, DOI 10.1097/j.pain.0000000000000251; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dobkin RD, 2013, J GERIATR PSYCH NEUR, V26, P105, DOI 10.1177/0891988713481269; Doering B, 2011, CURR OPIN PSYCHIATR, V24, P156, DOI 10.1097/YCO.0b013e328343804e; Ebert DD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119895; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Fernie BA, 2015, J PSYCHOSOM RES, V78, P411, DOI 10.1016/j.jpsychores.2015.02.012; Ferro MA, 2016, EPIDEMIOL PSYCH SCI, V25, P462, DOI 10.1017/S2045796015000700; Fischer A, 2015, LANCET PSYCHIAT, V2, P217, DOI 10.1016/S2215-0366(14)00049-2; Gandy M, 2016, EPILEPSIA, V57, P1887, DOI 10.1111/epi.13569; Gandy M, 2014, COGN BEHAV THERAPY, V43, P153, DOI 10.1080/16506073.2014.892530; Gandy M, 2012, NEUROLOGY, V79, P371, DOI 10.1212/WNL.0b013e318260cbfc; Garin O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-51; Gilliam FG, 2006, LANCET NEUROL, V5, P399, DOI 10.1016/S1474-4422(06)70415-X; Hall KE, 2009, CLIN PSYCHOL REV, V29, P354, DOI 10.1016/j.cpr.2009.03.001; Harris MG, 2016, EPIDEMIOL PSYCH SCI, V25, P548, DOI 10.1017/S2045796015000876; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kraepelien Martin, 2015, Internet Interventions, V2, P1, DOI 10.1016/j.invent.2014.11.006; LaMonica HM, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7981; Lucas-Carrasco R, 2014, DISABIL REHABIL, V36, P1001, DOI 10.3109/09638288.2013.825650; Marrie RA, 2003, MULT SCLER, V9, P621, DOI 10.1191/1352458503ms971oa; Mitchell AJ, 2010, ACTA NEUROPSYCHIATR, V22, P2, DOI 10.1111/j.1601-5215.2009.00439.x; Olesen SC, 2010, AUST NZ J PSYCHIAT, V44, P823, DOI 10.3109/00048674.2010.483680; Patel V, 2016, LANCET, V387, P1672, DOI 10.1016/S0140-6736(15)00390-6; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Radford K, 2012, J INT NEUROPSYCH SOC, V18, P738, DOI 10.1017/S1355617712000379; Ruwaard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040089; Schroder J, 2014, EPILEPSIA, V55, P2069, DOI 10.1111/epi.12833; Simons DJ, 2016, PSYCHOL SCI PUBL INT, V17, P103, DOI 10.1177/1529100616661983; Sin J, 2018, CLIN PSYCHOL REV, V60, P109, DOI 10.1016/j.cpr.2018.01.008; Slade T, 2011, AUST NZ J PSYCHIAT, V45, P308, DOI 10.3109/00048674.2010.543653; Spence J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021864; Sullivan M, 1990, CAN J REHABIL, V4, P99; Tapp B, 2018, AUST J PSYCHOL, V70, P113, DOI 10.1111/ajpy.12170; Thompson AE, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0440-0; Titov N, 2017, AUST NZ J PSYCHIAT, V51, P1227, DOI 10.1177/0004867416671598; Titov N, 2015, PSYCHIAT SERV, V66, P1043, DOI 10.1176/appi.ps.201400477; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Waldron B, 2013, NEUROPSYCHOL REHABIL, V23, P64, DOI 10.1080/09602011.2012.724196; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Yousaf O, 2015, HEALTH PSYCHOL REV, V9, P264, DOI 10.1080/17437199.2013.840954	55	7	7	2	7	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2018	63	4					563	574		10.1037/rep0000241			12	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	GZ4AT	WOS:000449333400009	30247055				2022-02-06	
J	Ibrahim, AS; Elmasry, K; Wan, M; Abdulmoneim, S; Still, A; Khan, F; Khalil, A; Saul, A; Hoda, MN; Al-Shabrawey, M				Ibrahim, Ahmed S.; Elmasry, Khaled; Wan, Ming; Abdulmoneim, Samer; Still, Amber; Khan, Farid; Khalil, Abraham; Saul, Alan; Hoda, Md Nasrul; Al-Shabrawey, Mohamed			A Controlled Impact of Optic Nerve as a New Model of Traumatic Optic Neuropathy in Mouse	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						traumatic optic neuropathy; TON; PSTR; scotopic threshold response; controlled impact; microglia; retinal ganglion cell (RGC)	RETINAL GANGLION-CELLS; INJURY; DYSFUNCTION; CRUSH; DEATH; INNER; MICE	PURPOSE. Traumatic optic neuropathy (TON) is the most feared visual consequence of head and ocular trauma in both military and civilian communities, for which standard treatment does not exist. Animal models are critical for the development of novel TON therapies as well as the understanding of TON pathophysiology. However, the models currently used for TON have some limitations regarding consistency and mirroring the exact pathological progression of TON in closed ocular trauma. In this study, we modified the model of controlled cortical impact and adapted it for studying TON. METHODS. We defined new standardized procedures to induce TON in mice, wherein the optic nerve is reproducibly exposed to a graded controlled impact of known velocity to produce a graded deficit in retinal ganglion cell (RGC) electrophysiological functions. RESULTS. The key results of validating this newly modified model, "controlled orbital impact (COI),''included (1) the injury parameters (velocity as well as contusion depth and time), which were quantifiable and manageable to generate a wide range of TON severities; (2) a reproducible endpoint of diminished positive scotopic threshold response (pSTR) has been achieved without the interference of surgical variability and destruction of surrounding tissues; (3) the contralateral eyes showed no significant difference to the eyes of naive mice, allowing them to be used as an internal control to minimize interindividual variability among mice; and (4) the occurrence of injury-associated mortality and/or ocular comorbidity was rare. CONCLUSIONS. Taken together, this model overcomes some limitations of prior TON mouse models and provides an innovative platform to identify therapeutic targets for neuroprotection and/or neurorestoration following traumatic ocular injury.	[Ibrahim, Ahmed S.; Elmasry, Khaled; Wan, Ming; Abdulmoneim, Samer; Khalil, Abraham; Al-Shabrawey, Mohamed] Augusta Univ, Dent Coll Georgia, Dept Oral Biol & Diagnost Sci, Augusta, GA 30912 USA; [Ibrahim, Ahmed S.; Still, Amber; Saul, Alan; Al-Shabrawey, Mohamed] Augusta Univ, MCG, Dept Ophthalmol, Augusta, GA 30912 USA; [Ibrahim, Ahmed S.; Still, Amber; Saul, Alan; Al-Shabrawey, Mohamed] Augusta Univ, MCG, Culver Vis Discovery Inst, Augusta, GA 30912 USA; [Ibrahim, Ahmed S.] Mansoura Univ, Dept Biochem, Fac Pharm, Mansoura, Egypt; [Elmasry, Khaled; Al-Shabrawey, Mohamed] Mansoura Univ, Dept Anat, Fac Med, Mansoura, Egypt; [Elmasry, Khaled; Abdulmoneim, Samer; Al-Shabrawey, Mohamed] Augusta Univ, Cellular Biol & Anat, MCG, Augusta, GA 30912 USA; [Elmasry, Khaled] Harvard Med Sch, Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA USA; [Elmasry, Khaled] Harvard Med Sch, Dept Ophthalmol, Boston, MA USA; [Wan, Ming] Jianghan Univ, Sch Med, Wuhan, Hubei, Peoples R China; [Khan, Farid] Tulane Univ Med Ctr Hosp & Clin, Dept Ophthalmol, New Orleans, LA USA; [Hoda, Md Nasrul] Augusta Univ, Dept Neurol, Med Coll Georgia, Dept Med Lab Imaging & Radiol Sci,Coll Allied Hlt, Augusta, GA 30912 USA		Al-Shabrawey, M (corresponding author), Augusta Univ, Dept Oral Biol & Diagnost Sci, Ophthalmol & Cellular Biol & Anat, Coll Dent Med, 1120 15th St, Augusta, GA 30912 USA.; Al-Shabrawey, M (corresponding author), Augusta Univ, Med Coll Georgia, 1120 15th St, Augusta, GA 30912 USA.	malshabrawey@augusta.edu			National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY023315]; American Heart AssociationAmerican Heart Association [18CDA34080403]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY023315] Funding Source: NIH RePORTER	Supported by the National Eye Institute grant R01EY023315 (MA; Bethesda, MD, USA) and the American Heart Association Grant 18CDA34080403 (ASI; Dallas, TX, USA).	Abd-El-Barr MM, 2009, J NEUROPHYSIOL, V102, P1945, DOI 10.1152/jn.00142.2009; Ahmad S, 2013, J NEUROIMMUNOL, V264, P54, DOI 10.1016/j.jneuroim.2013.09.015; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; ALQURAINY IA, 1991, BRIT J ORAL MAX SURG, V29, P291; Bahr M, 2000, TRENDS NEUROSCI, V23, P483, DOI 10.1016/S0166-2236(00)01637-4; Biousse V, 2016, LANCET NEUROL, V15, P1355, DOI 10.1016/S1474-4422(16)30237-X; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Carta A, 2003, J NEUROL NEUROSUR PS, V74, P246, DOI 10.1136/jnnp.74.2.246; CHAN JW, 2007, OPTIC NERVE DISORDER, P130; Chaon BC, 2015, CURR OPIN OPHTHALMOL, V26, P445, DOI 10.1097/ICU.0000000000000198; Cuenca N, 2014, PROG RETIN EYE RES, V43, P17, DOI 10.1016/j.preteyeres.2014.07.001; Cuenca N, 2010, EXP EYE RES, V91, P273, DOI 10.1016/j.exer.2010.05.020; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; He Z, 2006, INVEST OPHTH VIS SCI, V47, P4872, DOI 10.1167/iovs.06-0590; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Ibrahim AS, 2015, BBA-MOL CELL BIOL L, V1851, P290, DOI 10.1016/j.bbalip.2014.12.017; Levin Leonard A, 2004, Ophthalmol Clin North Am, V17, P455, DOI 10.1016/j.ohc.2004.05.008; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Magharious Mark M, 2011, J Vis Exp, DOI 10.3791/2241; Mahapatra A, 2012, TXB NEUROSURGERY, P513; MISANTONE LJ, 1984, J NEUROCYTOL, V13, P449, DOI 10.1007/BF01148334; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nuschke AC, 2015, EXP EYE RES, V141, P111, DOI 10.1016/j.exer.2015.06.006; de Lara MJP, 2014, EXP EYE RES, V122, P40, DOI 10.1016/j.exer.2014.02.022; Pirouzmand F, 2012, J CRANIOFAC SURG, V23, P516, DOI 10.1097/SCS.0b013e31824cd4a7; Romine J, 2014, JOVE-J VIS EXP, V90, P51781; Sahraravand A, 2017, ACTA OPHTHALMOL, V95, P288, DOI 10.1111/aos.13313; Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; Saul AB, 2017, DOC OPHTHALMOL, V134, P195, DOI 10.1007/s10633-017-9585-y; Shosha E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.295; Steinsapir KD, 2011, AM J OPHTHALMOL, V151, P928, DOI 10.1016/j.ajo.2011.02.007; Tang Zhongshu, 2011, J Vis Exp, DOI 10.3791/2685; Tao WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12225-6; Urolagin SB, 2012, J ORAL MAXIL SURG, V70, P1123, DOI 10.1016/j.joms.2011.09.045; Yu-Wai-Man Patrick, 1800, Taiwan J Ophthalmol, V5, P3; Yu-Wai-Man P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006032.pub3	39	7	9	0	1	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	NOV	2018	59	13					5548	5557		10.1167/iovs.18-24773			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	HD5ZB	WOS:000452609300006	30480743	Green Published, gold			2022-02-06	
J	Jang, Y; Woo, KA; Lee, ST; Park, SH; Chu, K; Lee, SK				Jang, Yoonhyuk; Woo, Kyung Ah; Lee, Soon-Tae; Park, Sung-Hye; Chu, Kon; Lee, Sang Kun			Cerebral autoinflammatory disease treated with anakinra	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; AUTOIMMUNE ENCEPHALITIS; INFLAMMATION	Interest in autoimmune encephalitis has been growing since the discovery of various autoimmune antibodies, such as N-methyl D-aspartate receptors antibody and leucine-rich glioma-inactivated 1 antibody. However, in contrast to autoimmune encephalitis associated with dysregulated adaptive immunity in the brain, the question of whether innate immunity-mediated autoinflammatory diseases exist in the brain has drawn much attention. Herein, we report a patient with microglia-dominant acute autoinflammatory encephalitis successfully treated with anakinra, an including interleukin-1 receptor blocker. In comparison to systemic autoinflammatory disease, we term this encephalitis cerebral autoinflammatory disease. Cerebral autoinflammatory disease could suggest new conceptual approaches to patients previously diagnosed with an unspecified encephalitis.	[Jang, Yoonhyuk; Woo, Kyung Ah; Lee, Soon-Tae; Chu, Kon; Lee, Sang Kun] Seoul Natl Univ Hosp, Dept Neurol, 101 Daehak Ro, Seoul 03080, South Korea; [Park, Sung-Hye] Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea		Lee, ST (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, 101 Daehak Ro, Seoul 03080, South Korea.	slee@snuh.org		Lee, Soon-Tae/0000-0003-4767-7564	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, and the Republic of Korea [2016R1C1B2011815, 2016 M3C7A1914002]; Lee Sueng Moon Research Fund of Seoul National University Hospital [3020170130]	This study was supported by National Research Foundation of Korea (NRF) grants funded by the Ministry of Science, ICT & Future Planning, and the Republic of Korea (2016R1C1B2011815 and 2016 M3C7A1914002). Y.J., K.A.W. and S-T.L. were supported by the Lee Sueng Moon Research Fund of Seoul National University Hospital (3020170130).	Brenton JN, 2016, NEUROTHERAPEUTICS, V13, P84, DOI 10.1007/s13311-015-0396-0; Dalmau J, 2018, NEW ENGL J MED, V378, P840, DOI 10.1056/NEJMra1708712; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Kenney-Jung DL, 2016, ANN NEUROL, V80, P939, DOI 10.1002/ana.24806; Laurent C, 2016, AUTOIMMUN REV, V15, P1129, DOI 10.1016/j.autrev.2016.09.008; Le Bihan D, 2015, PLOS BIOL, V13, DOI [10.1371/journal.pbio.1002203, 10.1371/journal.pbio.1002246]; Lee WJ, 2016, NEUROTHERAPEUTICS, V13, P824, DOI 10.1007/s13311-016-0442-6; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Li T, 2013, BRAIN, V136, P3578, DOI 10.1093/brain/awt287; Makuch M, 2018, ANN NEUROL, V83, P553, DOI 10.1002/ana.25173; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wilson R, 2018, BRAIN, V141, DOI 10.1093/brain/awy010	18	7	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	NOV	2018	5	11					1428	1433		10.1002/acn3.656			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HA9RZ	WOS:000450644900012	30480037	gold, Green Published			2022-02-06	
J	Kaltiainen, H; Helle, L; Liljestrom, M; Renvall, H; Forss, N				Kaltiainen, Hanna; Helle, Liisa; Liljestrom, Mia; Renvall, Hanna; Forss, Nina			Theta-Band Oscillations as an Indicator of Mild Traumatic Brain Injury	BRAIN TOPOGRAPHY			English	Article						Low frequency activity; Traumatic brain injury (TBI); Magnetoencephalography (MEG); Repeated measurements; Resting-state; Oscillations	CONCUSSION SYMPTOMS QUESTIONNAIRE; SPACE SEPARATION METHOD; HEAD TRAUMA; FUNCTIONAL CONNECTIVITY; IMAGING APPROACH; MEG; LESIONS; SIGNAL; EEG; MAGNETOENCEPHALOGRAPHY	Mild traumatic brain injury (mTBI) patients continue to pose a diagnostic challenge due to their diverse symptoms without trauma-specific changes in structural imaging. We addressed here the possible early changes in spontaneous oscillatory brain activity after mTBI, and their feasibility as an indicator of injury in clinical evaluation. We recorded resting-state magnetoencephalography (MEG) data in both eyes-open and eyes-closed conditions from 26 patients (11 females and 15 males, aged 20-59) with mTBI 6days-6months after the injury, and compared their spontaneous oscillatory activity to corresponding data from 139 healthy controls. Twelve of the patients underwent a follow-up measurement at 6months. Ten of all patients were without structural lesions in MRI. At single-subject level, aberrant 4-7Hz (theta) band activity exceeding the +2 SD limit of the healthy subjects was visible in 7 out of 26 patients; three out of the seven patients with abnormal theta activity were without any detectable lesions in MRI. Of the patients that participated in the follow-up measurements, five showed abnormal theta activity in the first recording, but only two in the second measurement. Our results suggest that aberrant theta-band oscillatory activity can provide an early objective sign of brain dysfunction after mTBI. In 3/7 patients, the slow-wave activity was transient and visible only in the first recording, urging prompt timing for the measurements in clinical settings.	[Kaltiainen, Hanna; Helle, Liisa; Liljestrom, Mia; Renvall, Hanna; Forss, Nina] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, POB 12200, Espoo 00076, Finland; [Kaltiainen, Hanna; Helle, Liisa; Liljestrom, Mia; Renvall, Hanna; Forss, Nina] Aalto Univ, MEG Core, Aalto Neuroimaging, Espoo, Finland; [Kaltiainen, Hanna] Lohja Dist Hosp, Dept Neurol, Sairaalatie 8, Lohja 08200, Finland; [Helle, Liisa] Elekta Oy, POB 34, Helsinki 00531, Finland; [Kaltiainen, Hanna; Renvall, Hanna; Forss, Nina] Univ Helsinki, Clin Neurosci, POB 340, Helsinki 00029, Finland; [Kaltiainen, Hanna; Renvall, Hanna; Forss, Nina] Univ Helsinki, Dept Neurol, POB 340, Helsinki 00029, Finland; [Kaltiainen, Hanna; Renvall, Hanna; Forss, Nina] Univ Helsinki, Cent Hosp, POB 340, Helsinki 00029, Finland		Kaltiainen, H (corresponding author), Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, POB 12200, Espoo 00076, Finland.; Kaltiainen, H (corresponding author), Aalto Univ, MEG Core, Aalto Neuroimaging, Espoo, Finland.; Kaltiainen, H (corresponding author), Lohja Dist Hosp, Dept Neurol, Sairaalatie 8, Lohja 08200, Finland.; Kaltiainen, H (corresponding author), Univ Helsinki, Clin Neurosci, POB 340, Helsinki 00029, Finland.; Kaltiainen, H (corresponding author), Univ Helsinki, Dept Neurol, POB 340, Helsinki 00029, Finland.; Kaltiainen, H (corresponding author), Univ Helsinki, Cent Hosp, POB 340, Helsinki 00029, Finland.	hanna-leena.kaltiainen@aalto.fi	Liljestrom, Mia/ABE-5251-2021	Liljestrom, Mia/0000-0002-9110-6788; Helle, Liisa/0000-0002-0001-9292; Forss, Nina/0000-0002-1620-8573	TEKES the Finnish Funding for Innovation [1988/31/2015]; Paulo Foundation; Academy of FinlandAcademy of FinlandEuropean Commission [277655]; Aalto Brain Centre; Maud Kuistila Memorial Foundation; Swedish cultural foundation	This research has been funded by TEKES the Finnish Funding for Innovation, Seamless patient care project funding Grant No. 1988/31/2015 (to HK, NF), State Research funding (to HK, NF), The Paulo Foundation (to HK), Academy of Finland Grant No. #277655 (to HR), Aalto Brain Centre (to ML), Maud Kuistila Memorial Foundation (ML) and The Swedish cultural foundation (to ML).	[Anonymous], 1993, ARCH PHYS MED REHAB, V74, pS8; Beauchemin P, 2012, CAN J NEUROL SCI, V39, P97, DOI 10.1017/S0317167100012798; Brandstack N, 2006, BRAIN INJURY, V20, P409, DOI 10.1080/02699050500487951; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Butz M, 2004, NEUROSCI LETT, V355, P93, DOI 10.1016/j.neulet.2003.10.065; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Ganti L, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0091-4; Geets W, 1985, Rev Electroencephalogr Neurophysiol Clin, V14, P333; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Goldenholz DM, 2009, HUM BRAIN MAPP, V30, P1077, DOI 10.1002/hbm.20571; Gomez C, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066006; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hunold A, 2016, PHYSIOL MEAS, V37, P1146, DOI 10.1088/0967-3334/37/7/1146; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Kaltiainen HL, 2016, J CLIN NEUROPHYSIOL, V33, P367, DOI 10.1097/WNP.0000000000000251; Kamada K, 2001, J NEUROL SCI, V186, P13, DOI 10.1016/S0022-510X(01)00483-X; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; STERIADE M, 1990, ELECTROEN CLIN NEURO, V76, P481, DOI 10.1016/0013-4694(90)90001-Z; Swan AR, 2015, J NEUROTRAUM, V32, P1510, DOI 10.1089/neu.2014.3654; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; TEASDALE G, 1974, LANCET, V2, P81; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vieth J B, 1990, Adv Neurol, V54, P261; VONBIERBRAUER A, 1992, EEG-EMG-Z ELEK ELEKT, V23, P151; Zouridakis G, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412400064	51	7	7	1	6	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0896-0267	1573-6792		BRAIN TOPOGR	Brain Topogr.	NOV	2018	31	6					1037	1046		10.1007/s10548-018-0667-2			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GV8WT	WOS:000446432000011	30097835	hybrid, Green Published			2022-02-06	
J	Lindfors, M; Vehvilainen, J; Siironen, J; Kivisaari, R; Skrifvars, MB; Raj, R				Lindfors, Matias; Vehvilainen, Juho; Siironen, Jari; Kivisaari, Riku; Skrifvars, Markus B.; Raj, Rahul			Temporal changes in outcome following intensive care unit treatment after traumatic brain injury: a 17-year experience in a large academic neurosurgical centre	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Outcome; Mortality; Epidemiology	HEAD-INJURY; TRENDS; CLASSIFICATION; MANAGEMENT; EPIDEMIOLOGY; IMPROVEMENT; GUIDELINES; MORTALITY; TRIALS	Traumatic brain injury (TBI) is a major cause of morbidity and mortality. However, it remains undetermined whether long-term outcomes after TBI have improved over the past two decades. We conducted a retrospective analysis of consecutive TBI patients admitted to an academic neurosurgical ICU during 1999-2015. Primary outcomes of interest were 6-month all-cause mortality (available for all patients) and 6-month Glasgow Outcome Scale (GOS, available from 2005 onwards). GOS was dichotomized to favourable and unfavourable functional outcome. Temporal changes in outcome were assessed using multivariate logistic regression analysis, adjusting for age, sex, GCS motor score, pupillary light responsiveness, Marshall CT classification and major extracranial injury. Altogether, 3193 patients were included. During the study period, patient age and admission Glasgow Coma Scale score increased, while the overall TBI severity did not change. Overall unadjusted 6-month mortality was 25% and overall unadjusted unfavourable outcome (2005-2015) was 44%. There was no reduction in the adjusted odds of 6-month mortality (OR 0.98; 95% CI 0.96-1.00), but the adjusted odds of favourable functional outcome significantly increased (OR 1.08; 95% CI 1.04-1.11). Subgroup analysis showed outcome improvements only in specific subgroups (conservatively treated patients, moderate-to-severe TBI patients, middle-aged patients). During the past two decades, mortality after significant TBI has remained largely unchanged, but the odds of favourable functional outcome have increased significantly in specific subgroups, implying an improvement in quality of care. These developments have been paralleled by notable changes in patient characteristics, emphasizing the importance of continuous epidemiological monitoring.	[Lindfors, Matias; Vehvilainen, Juho; Siironen, Jari; Kivisaari, Riku; Raj, Rahul] Helsinki Univ Hosp, Dept Neurosurg, Topeliuksenkatu 5,PB 266, Hus Helsinki 00029, Finland; [Lindfors, Matias; Vehvilainen, Juho; Siironen, Jari; Kivisaari, Riku; Raj, Rahul] Univ Helsinki, Topeliuksenkatu 5,PB 266, Hus Helsinki 00029, Finland; [Skrifvars, Markus B.] Helsinki Univ Hosp, Dept Emergency Med & Serv, Helsinki, Finland; [Skrifvars, Markus B.] Univ Helsinki, Helsinki, Finland		Raj, R (corresponding author), Helsinki Univ Hosp, Dept Neurosurg, Topeliuksenkatu 5,PB 266, Hus Helsinki 00029, Finland.; Raj, R (corresponding author), Univ Helsinki, Topeliuksenkatu 5,PB 266, Hus Helsinki 00029, Finland.	rahul.raj@hus.fi	Raj, Rahul/K-7693-2012	Raj, Rahul/0000-0003-4243-9591	Maire Taposen Saatio; Svenska Kulturfonden; Medicinska Understodsforeningen Liv and Halsa; Finska Lakaresallskapet; Eemil Aaltosen Saatio; Maud Kuistilan Saatio; Ella and Georg Ehrnroothin Saatio; Suomalais-Norjalainen Laaketieteen Saatio; Suomen Laaketieteen Saatio	The study did not receive any specific funding. ML and JV have received a personal research grant from Maire Taposen Saatio. RR has received personal research grants from Svenska Kulturfonden, Medicinska Understodsforeningen Liv and Halsa, Finska Lakaresallskapet, Maud Kuistilan Saatio, Eemil Aaltosen Saatio, Ella and Georg Ehrnroothin Saatio, Suomalais-Norjalainen Laaketieteen Saatio, Suomen Laaketieteen Saatio and Maire Taposen Saatio. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ad Hoc Committee on Health Research Relating to Future Intervention Options, 1996, INV HLTH RES DEV REP; Beck B, 2018, J NEUROTRAUM, V35, P1021, DOI 10.1089/neu.2017.5287; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Depreitere B, 2012, Acta Neurochir Suppl, V114, P289, DOI 10.1007/978-3-7091-0956-4_56; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Flynn-O'Brien KT, 2015, NEUROSURGERY, V76, P451, DOI 10.1227/NEU.0000000000000693; Fuller G, 2011, BRIT J NEUROSURG, V25, P414, DOI 10.3109/02688697.2011.570882; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Hamill V, 2015, J NEUROTRAUM, V32, P689, DOI 10.1089/neu.2014.3670; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raj R, 2018, CRIT CARE MED, V46, pE302, DOI 10.1097/CCM.0000000000002959; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206	30	7	7	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2018	160	11					2107	2115		10.1007/s00701-018-3670-1			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GZ7PP	WOS:000449674300005	30191364	Green Published			2022-02-06	
J	O'Connor, KL; Allred, CD; Cameron, KL; Campbell, DE; D'Lauro, CJ; Houston, MN; Johnson, BR; Kelly, TF; McGinty, G; O'Donnell, PG; Peck, KY; Svoboda, SJ; Pasquina, P; McAllister, T; McCrea, M; Broglio, SP				O'Connor, Kathryn L.; Allred, C. Dain; Cameron, Kenneth L.; Campbell, Darren E.; D'Lauro, Christopher J.; Houston, Megan N.; Johnson, Brian R.; Kelly, Tim F.; McGinty, Gerald; O'Donnell, Patrick G.; Peck, Karen Y.; Svoboda, Steven J.; Pasquina, Paul; McAllister, Thomas; McCrea, Michael; Broglio, Steven P.			Descriptive Analysis of a Baseline Concussion Battery Among US Service Academy Members: Results from the Concussion Assessment, Research, and Education (CARE) Consortium	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; 4TH INTERNATIONAL-CONFERENCE; HIGH-SCHOOL; NEUROPSYCHOLOGICAL FUNCTION; COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION; CONSENSUS STATEMENT; FOOTBALL PLAYERS; SEX-DIFFERENCES; SPORT HELD	Introduction: The prevalence and possible long-term consequences of concussion remain an increasing concern to the U.S. military, particularly as it pertains to maintaining a medically ready force. Baseline testing is being used both in the civilian and military domains to assess concussion injury and recovery. Accurate interpretation of these baseline assessments requires one to consider other influencing factors not related to concussion. To date, there is limited understanding, especially within the military, of what factors influence normative test performance. Given the significant physical and mental demands placed on service academy members (SAM), and their relatively high risk for concussion, it is important to describe demographics and normative profile of SAMs. Furthermore, the absence of available baseline normative data on female and non-varsity SAMs makes interpretation of post-injury assessments challenging. Understanding how individuals perform at baseline, given their unique individual characteristics (e.g., concussion history, sex, competition level), will inform post-concussion assessment and management. Thus, the primary aim of this manuscript is to characterize the SAM population and determine normative values on a concussion baseline testing battery. Materials and Methods: All data were collected as part of the Concussion Assessment, Research and Education (CARE) Consortium. The baseline test battery included a post-concussion symptom checklist (Sport Concussion Assessment Tool (SCAT), psychological health screening inventory (Brief Symptom Inventory (BSI-18) and neurocognitive evaluation (ImPACT), Balance Error Scoring System (BESS), and Standardized Assessment of Concussion (SAC). Linear regression models were used to examine differences across sexes, competition levels, and varsity contact levels while controlling for academy, freshman status, race, and previous concussion. Zero inflated negative binomial models estimated symptom scores due to the high frequency of zero scores. Results: Significant, but small, sex effects were observed on the ImPACT visual memory task. While, females performed worse than males (p < 0.0001, (P)eta(2) = 0.01), these differences were small and not larger than the effects of the covariates. A similar pattern was observed for competition level on the SAC. There was a small, but significant difference across competition level. SAMs participating in varsity athletics did significantly worse on the SAC compared to SAMs participating in club or intramural athletics (all p's < 0.001, eta(2) = 0.01). When examining symptom reporting, males were more than two times as likely to report zero symptoms on the SCAT or BSI-18. Intramural SAMs had the highest number of symptoms and severity compared to varsity SAMs (p < 0.0001, Cohen's d < 0.2). Contact level was not associated with SCAT or BSI-18 symptoms among varsity SAMs. Notably, the significant differences across competition level on SCAT and BSI-18 were sub-clinical and had small effect sizes. Conclusion: The current analyses provide the first baseline concussion battery normative data among SAMs. While statistically significant differences may be observed on baseline tests, the effect sizes for competition and contact levels are very small, indicating that differences are likely not clinically meaningful at baseline. Identifying baseline differences and significant covariates is important for future concussion-related analyses to inform concussion evaluations for all athlete levels.	[O'Connor, Kathryn L.; Broglio, Steven P.] Univ Michigan, NeuroTrauma Res Lab, 401 Washtenaw Ave, Ann Arbor, MI 48104 USA; [Allred, C. Dain; Campbell, Darren E.; D'Lauro, Christopher J.; Johnson, Brian R.; McGinty, Gerald] US Air Force Acad, 2355 Fac Dr,Suite 1N207, Colorado Springs, CO 80840 USA; [Cameron, Kenneth L.; Houston, Megan N.; Peck, Karen Y.; Svoboda, Steven J.] Keller Army Community Hosp, 900 Washington Rd, West Point, NY 10996 USA; [Kelly, Tim F.] US Mil Acad, Dept Intercoll Athlet, 639 Howard Rd, West Point, NY 10996 USA; [O'Donnell, Patrick G.] US Coast Guard Acad, 31 Mohegan Ave Pkwy, New London, CT 06320 USA; [Pasquina, Paul] Uniformed Serv Univ Hlth Sci, Walter Reed Natl Mil Med Ctr, Dept Rehabil Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [McAllister, Thomas] Indiana Univ Sch Med, Goodman Hall,355W 16th St,Suite 4800, Indianapolis, IN 46202 USA; [McCrea, Michael] Med Coll Wisconsin, Froedtert West Clin, 9200W Wisconsin Ave, Milwaukee, WI 53226 USA		O'Connor, KL (corresponding author), Univ Michigan, NeuroTrauma Res Lab, 401 Washtenaw Ave, Ann Arbor, MI 48104 USA.		D'Lauro, Christopher/V-2587-2019; D'Lauro, Christopher/X-1518-2019	D'Lauro, Christopher/0000-0003-0894-6602; Cameron, Kenneth/0000-0002-6276-4482	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DoD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DoD). This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151.	[Anonymous], 2015, 2015 DEM PROF MIL CO, P1; Benedict C, 2014, BASELINE CONCUSSION, P319; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; CARD JJ, 1977, J VOCAT BEHAV, V11, P196, DOI 10.1016/0001-8791(77)90007-0; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.3.CO;2-D; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Defense and Veterans Brain Injury Center Defense Center VBI, 2016, DOD WORLDW NUMB TBI; Defense Manpower Data Center, 2017, DOD PERS WORKF REP P; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Franke VC, 2001, J POLIT MIL SOCIOL, V29, P92; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glaser R, 1999, BRAIN BEHAV IMMUN, V13, P240, DOI 10.1006/brbi.1999.0566; Gold MA, 2000, MIL MED, V165, P147, DOI 10.1093/milmed/165.2.147; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harvey CM, 2012, THESIS, P1; HOAGLIN DC, 1986, J AM STAT ASSOC, V81, P991, DOI 10.2307/2289073; Iverson G.L., 2011, ENCY CLIN NEUROPSYCH, P2150; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Ivins BJ, 2010, NEUROREHABILITATION, V26, P199, DOI 10.3233/NRE-2010-0556; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Loeys T, 2012, BRIT J MATH STAT PSY, V65, P163, DOI 10.1111/j.2044-8317.2011.02031.x; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Mrazik M, 2013, J ATHL TRAINING, V48, P654, DOI 10.4085/1062-6050-48.3.19; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Parker Kim., 2017, 6 FACTS US MILITARY; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Peck KY, 2013, SPORTS HEALTH, V5, P327, DOI 10.1177/1941738113487165; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Shuttleworth-Edwards AB, 2008, J CLIN EXP NEUROPSYC, V30, P870, DOI 10.1080/13803390701846914; Thomas DQ, 2004, J STRENGTH COND RES, V18, P904; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	70	7	7	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV-DEC	2018	183	11-12					E580	E590		10.1093/milmed/usx130			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HC4ZP	WOS:000451813600033	29608767	Green Submitted, hybrid			2022-02-06	
J	Romm, KE; Ambegaonkar, JP; Caswell, AM; Parham, C; Cortes, NE; Kerr, Z; Broshek, DK; Caswell, SV				Romm, Kaitlin E.; Ambegaonkar, Jatin P.; Caswell, Amanda M.; Parham, Candace; Cortes, Nelson E.; Kerr, Zachary; Broshek, Donna K.; Caswell, Shane V.			Schoolteachers' and Administrators' Perceptions of Concussion Management and Implementation of Return-to-Learn Guideline	JOURNAL OF SCHOOL HEALTH			English	Article						return-to-learn; concussion; injury control; sports injury; teachers; school administrators	TRAUMATIC BRAIN-INJURY; COGNITIVE REST; SCHOOL; SUPPORT; SPORT; RECOMMENDATIONS; CHILDREN; STUDENT; HEADS; NEEDS	BACKGROUND: Concussions are a public health concern and concussion management in school requires a team approach. We examined schoolteachers' and administrators' perceptions of concussions, management, and implementation of return-to-learn (RTL) guidelines. METHODS: We audio-recorded and transcribed semistructured interviews with teachers (N = 16) and administrators (N = 6) from a public school system. We analyzed data using an analytic induction and constant comparison approach. RESULTS: Two themes emerged: different understanding, and school context. Participants with no sport coaching experience were less familiar with concussions than those who coached a sport. Participants with personal experience with concussions were more sympathetic toward concussed students' needs. Teachers expressed feeling ill-equipped to implement RTL guidelines without specific instructions in the complex school environment. However, school administrators had minimal understanding of teacher-described challenges. CONCLUSIONS: Teachers and administrators recognize that concussions are a health concern, but differ in their perceptions of concussions, management, and implementation of RTL guidelines. Personal experiences mediate individual perceptions about concussions. The daily realities of a school environment complicate teachers' capacity to implement RTL guidelines. Conversely, school administrators did not express awareness of any challenges with concussion management. To best facilitate students' recovery schools should include all stakeholders when devising concussion management policies.	[Romm, Kaitlin E.; Caswell, Shane V.] George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, 10900 Univ Blvd,Bull Run Hall 220,MSN 4E5, Manassas, VA 20110 USA; [Ambegaonkar, Jatin P.; Caswell, Amanda M.; Parham, Candace] George Mason Univ, Athlet Training Educ Program, 10900 Univ Blvd,Bull Run Hall 220,MSN 4E5, Manassas, VA 20110 USA; [Cortes, Nelson E.] George Mason Univ, Kinesi, 10900 Univ Blvd,Bull Run Hall 220,MSN 4E5, Manassas, VA 20110 USA; [Kerr, Zachary] Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8605, Chapel Hill, NC 27599 USA; [Broshek, Donna K.] Univ Virginia Hlth Syst, Neurocognit Assessment Lab, Psychiat & Neurobehav Sci, POB 800626, Charlottesville, VA 22908 USA		Caswell, SV (corresponding author), George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, 10900 Univ Blvd,Bull Run Hall 220,MSN 4E5, Manassas, VA 20110 USA.; Caswell, SV (corresponding author), George Mason Univ, Athlet Training Educ Program, 10900 Univ Blvd,Bull Run Hall 220,MSN 4E5, Manassas, VA 20110 USA.	kromm@gmu.edu; jambegao@gmu.edu; aalleni@gmu.edu; cparham@gmu.edu; ncortes@gmu.edu; zkerr@email.unc.edu; dkb6v@hscmail.mcc.virginia.edu; scaswell@gmu.edu	Broshek, Donna/ABA-4208-2021	Broshek, Donna/0000-0002-7175-7815; Cortes, Nelson/0000-0001-8762-3144; Caswell, Shane/0000-0002-8775-2971; Ambegaonkar, Jatin/0000-0002-3790-915X	Potomac Health Foundation	This project was supported in part by non-restrictive grant funding from the Potomac Health Foundation. We greatly appreciate the support of the public school administrators and teachers that assisted with this project.	Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Bradley-Klug K., 2015, SCH PSYCHOL FORUM, V9, P184; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Canto AI, 2014, EDUC PSYCHOL PRACT, V30, P88, DOI 10.1080/02667363.2014.883498; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Goetz J., APP MAKES ATHLETES T; Grady MF, 2012, PEDIATR ANN, V41, P377, DOI 10.3928/00904481-20120827-12; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Innocorp Ltd, FAT VIS CONC EV KIT; Kasamatsu TM, 2017, TEACH TEACH EDUC, V68, P181, DOI 10.1016/j.tate.2017.09.005; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lyons VH, 2017, J SCHOOL HEALTH, V87, P416, DOI 10.1111/josh.12510; McAvoy K, 2012, NATL ASS SCH PSYCHOL, V40, P1; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Roach AT, 2009, J EDUC PSYCHOL CONS, V19, P300, DOI 10.1080/10474410802463304; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schensul, 1999, DESIGNING CONDUCTING; US Centers for Disease Control and Prevention. National Center for Injury Prevention and Control, HEADS BRAIN INJ BAS; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879	26	7	7	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health	NOV	2018	88	11					813	820		10.1111/josh.12687			8	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	GW3VO	WOS:000446837000004	30300931				2022-02-06	
J	Smith, D; Rau, T; Poulsen, A; MacWilliams, Z; Patterson, D; Kelly, W; Poulsen, D				Smith, Debbie; Rau, Thomas; Poulsen, Austin; MacWilliams, Ziven; Patterson, David; Kelly, William; Poulsen, David			Convulsive seizures and EEG spikes after lateral fluid-percussion injury in the rat	EPILEPSY RESEARCH			English	Article						TBI; Fluid percussion injury; Convulsive seizures	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC EPILEPSY; EPILEPTOGENESIS; MODEL; MULTICENTER; PROGRESSION; EXPRESSION; COMMON; RISK	The rat lateral fluid-percussion injury (FPI) model has been used extensively to study post-traumatic epilepsy (PTE). Epidemiological studies have reported that the risk of PTE is higher after more severe injury. Adult, male Wistar rats subjected to different atmospheric pressures of injury during FPI showed great variability in injury severity when functional behavior was determined based on the Neurological Severity Score (NSS) assessment. When NSS was used to select rats with the most severe FPI-induced brain injury, 63% of rats experienced at least one convulsive seizure 2-5 weeks after FPI. This same cohort of rats (i.e., selected for severe TBI based on NSS) were significantly more susceptible to PTZ-induced seizures compared to sham controls. Video/EEG recordings from a second cohort of rats with severe FPI-induced injury (based on NSS) showed a similar incidence and frequency of spike wave discharges between rats with severe TBI and sham controls. However, the rate of isolated EEG spikes was greater in rats with severe FPI-induced injury compared to sham controls. These data suggest that convulsive seizures can be obtained in FPI-treated rats when NSS is used as an inclusion criterion to select rats with severe injury. Furthermore, although spike-wave discharges were equally prevalent in rats with severe FPI and sham controls, spontaneous spikes were more prevalent in the rats with severe FPI.	[Smith, Debbie; Rau, Thomas; Poulsen, Austin; MacWilliams, Ziven] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Patterson, David] Univ Montana, Dept Math, Missoula, MT 59812 USA; [Kelly, William; Poulsen, David] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurosurg, Buffalo, NY USA		Poulsen, D (corresponding author), SUNY Buffalo, Neurosurg Dept, CTRC Buffalo, 875 Ellicott St, Buffalo, NY 14203 USA.	davidpou@buffalo.edu					Annegers JF, 1998, EPILEPSIA, V39, P206, DOI 10.1111/j.1528-1157.1998.tb01360.x; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2013, EXPERT REV NEUROTHER, V13, P615, DOI [10.1586/ern.13.54, 10.1586/ERN.13.54]; D'Ambrosio R, 2010, EPILEPSY CURR, V10, P61, DOI 10.1111/j.1535-7511.2010.01358.x; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dudek FE, 2010, EPILEPSY CURR, V10, P91, DOI 10.1111/j.1535-7511.2010.01368.x; Eastman CL, 2015, EXP NEUROL, V264, P150, DOI 10.1016/j.expneurol.2014.12.010; Eastman CL, 2011, J PHARMACOL EXP THER, V336, P779, DOI 10.1124/jpet.110.175133; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey L, 2014, NEUROL RES, V36, P26, DOI 10.1179/1743132813Y.0000000269; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Kadam SD, 2017, EPILEPSIA, V58, P10, DOI 10.1111/epi.13903; Kelly KM, 2006, EXP NEUROL, V201, P495, DOI 10.1016/j.expneurol.2006.05.006; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Rau TF, 2014, EXP NEUROL, V253, P31, DOI 10.1016/j.expneurol.2013.12.001; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; Rau TF, 2011, NEUROPHARMACOLOGY, V61, P677, DOI 10.1016/j.neuropharm.2011.05.010; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Staley KJ, 2011, NEUROSCI LETT, V497, P247, DOI 10.1016/j.neulet.2011.03.070; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Webb TS, 2015, BRAIN INJURY, V29, P430, DOI 10.3109/02699052.2014.989904; White A, 2010, EPILEPSIA, V51, P371, DOI 10.1111/j.1528-1167.2009.02339.x; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	37	7	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	NOV	2018	147						87	94		10.1016/j.eplepsyres.2018.09.005			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GZ2TT	WOS:000449242000013	30286390				2022-02-06	
J	Stout, DM; Buchsbaum, MS; Spadoni, AD; Risbrough, VB; Strigo, IA; Matthews, SC; Simmons, AN				Stout, Daniel M.; Buchsbaum, Monte S.; Spadoni, Andrea D.; Risbrough, Victoria B.; Strigo, Irina A.; Matthews, Scott C.; Simmons, Alan N.			Multimodal canonical correlation reveals converging neural circuitry across trauma-related disorders of affect and cognition	NEUROBIOLOGY OF STRESS			English	Article						Trauma; TBI; PTSD; Multimodal imaging; Canonical correlation	POSTTRAUMATIC-STRESS-DISORDER; VERBAL MEMORY PERFORMANCE; AVERSIVE VISUAL-STIMULI; BRAIN IMAGING DATA; EMOTION REGULATION; COMBAT VETERANS; THREAT ANTICIPATION; ANXIETY DISORDER; FEAR EXTINCTION; INJURY	Trauma-related disorders of affect and cognition (TRACs) are associated with a high degree of diagnostic comorbidity, which may suggest that these disorders share a set of underlying neural mechanisms. TRACs are characterized by aberrations in functional and structural circuits subserving verbal memory and affective anticipation. Yet, it remains unknown how the neural circuitry underlying these multiple mechanisms contribute to TRACs. Here, in a sample of 47 combat Veterans, we measured affective anticipation using functional magnetic resonance imaging (fMRI), verbal memory with fluorodeoxyglucose positron emission tomography (FDG-PET), and grey matter volume with structural magnetic resonance imaging (sMRI). Using a voxel-based multimodal canonical correlation analysis (mCCA), the set of neural measures were statistically integrated, or fused, with a set of TRAC symptom measures including mild traumatic brain injury (mTBI), posttraumatic stress, and depression severity. The first canonical correlation pair revealed neural convergence in clusters encompassing the middle frontal gyrus and supplemental motor area, regions implicated in top-down cognitive control and affect regulation. These results highlight the potential of leveraging multivariate neuroimaging analysis for linking neurobiological mechanisms associated with TRACs, paving the way for transdiagnostic biomarkers and targets for treatment.	[Stout, Daniel M.; Spadoni, Andrea D.; Risbrough, Victoria B.; Matthews, Scott C.; Simmons, Alan N.] San Diego VA Hlth Care Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Stout, Daniel M.; Buchsbaum, Monte S.; Spadoni, Andrea D.; Risbrough, Victoria B.; Matthews, Scott C.; Simmons, Alan N.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Buchsbaum, Monte S.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Strigo, Irina A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Strigo, Irina A.] San Francisco VA Hlth Care Syst, San Francisco, CA USA		Stout, DM (corresponding author), VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA.	dastout@ucsd.edu	Simmons, Alan N/A-9815-2008; Risbrough, Victoria/X-3344-2019	Simmons, Alan N/0000-0003-3963-2112; Spadoni, Andrea/0000-0002-8367-6406	United States Department of Veterans AffairsUS Department of Veterans Affairs [I01-CX-000816, I01-CX000292, I01-CX000715, IK2-CX000864, IO1-BX002558]; VA Center of Excellence in Stress and Mental Health; Veterans AffairsUS Department of Veterans Affairs [I01CX000816, I01CX001762, I01BX002558, I01CX000715, IK2CX000864, I01CX000292] Funding Source: NIH RePORTER	We thank Alexander Decastro for his assistance with PET data analysis, as well as Elena Kosheleva, Laurel Glockler and Ryan O'Connell for their assistance with data collection. This work was supported in part by the United States Department of Veterans Affairs I01-CX-000816 (IAS), I01-CX000292 & I01-CX000715 (ANS), IK2-CX000864 (ADS), VBR (IO1-BX002558), and (SCM), and from the VA Center of Excellence in Stress and Mental Health (DMS, ANS, ADS). Writing of this manuscript was partially supported by the Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs.	Acheson DT, 2012, NEUROPHARMACOLOGY, V62, P674, DOI 10.1016/j.neuropharm.2011.04.029; Admon R, 2013, TRENDS COGN SCI, V17, P337, DOI 10.1016/j.tics.2013.05.005; Arend I, 2015, NEUROPSYCHOLOGY, V29, P191, DOI 10.1037/neu0000139; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Belzung C, 2015, CURR OPIN NEUROBIOL, V30, P24, DOI 10.1016/j.conb.2014.08.013; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bomyea J, 2017, J AFFECT DISORDERS, V223, P130, DOI 10.1016/j.jad.2017.07.003; Bremner J. D, 2009, NEUROIMAGING CLIN, V17, P809, DOI [10.1016/j.nic.2007.07.003.Neuroimaging, DOI 10.1016/J.NIC.2007.07.003.NEUROIMAGING]; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Brinkmann L, 2017, NEUROIMAGE-CLIN, V13, P320, DOI 10.1016/j.nicl.2016.12.015; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Buchsbaum MS, 2015, J NEUROTRAUM, V32, P1736, DOI 10.1089/neu.2014.3660; Calhoun Vince D, 1800, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P230; Clark LA, 2017, PSYCHOL SCI PUBL INT, V18, P72, DOI 10.1177/1529100617727266; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Deng Z, 2014, NEUROSCIENCE, V275, P500, DOI 10.1016/j.neuroscience.2014.06.040; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Glenn DE, 2017, DEPRESS ANXIETY, V34, P723, DOI 10.1002/da.22642; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Goldstein-Piekarski AN, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.108; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Grupe DW, 2016, PSYCHOL MED, V46, P1885, DOI 10.1017/S0033291716000374; Grupe DW, 2013, NAT REV NEUROSCI, V14, P488, DOI 10.1038/nrn3524; Gu XS, 2013, CEREB CORTEX, V23, P20, DOI 10.1093/cercor/bhr367; Hardle W. K., 2015, APPL MULTIVARIATE AN; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Hazlett EA, 2010, NEUROBIOL AGING, V31, P826, DOI 10.1016/j.neurobiolaging.2008.10.005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.1093/biomet/28.3-4.321; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Jovanovic T, 2010, DEPRESS ANXIETY, V27, P244, DOI 10.1002/da.20663; Kohn N, 2014, NEUROIMAGE, V87, P345, DOI 10.1016/j.neuroimage.2013.11.001; Lang P. J., 1999, INT AFFECTIVE PICTUR; Liberzon I, 2016, NEURON, V92, P14, DOI 10.1016/j.neuron.2016.09.039; Linden DEJ, 2012, NEURON, V73, P8, DOI 10.1016/j.neuron.2011.12.014; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacNamara A, 2016, NEUROPSYCHOPHARMACOL, V41, P611, DOI 10.1038/npp.2015.190; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Marx BP, 2009, J INT NEUROPSYCH SOC, V15, P840, DOI 10.1017/S1355617709990488; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milham MP, 2017, DEPRESS ANXIETY, V34, P578, DOI 10.1002/da.22627; Mohn C, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0815-8; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; Nijdam MJ, 2015, J CLIN PSYCHIAT, V76, pE1023, DOI 10.4088/JCP.14m09438; O'Muircheartaigh J, 2015, CEREB CORTEX, V25, P4477, DOI 10.1093/cercor/bhv063; Paulus MP, 2010, BRAIN STRUCT FUNCT, V214, P451, DOI 10.1007/s00429-010-0258-9; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rive MM, 2013, NEUROSCI BIOBEHAV R, V37, P2529, DOI 10.1016/j.neubiorev.2013.07.018; Samuelson Kristin W, 2011, Dialogues Clin Neurosci, V13, P346; Schmitt LI, 2017, NATURE, V545, P219, DOI 10.1038/nature22073; Scott JC, 2017, BEHAV RES THER, V91, P24, DOI 10.1016/j.brat.2017.01.004; Shackman AJ, 2016, J NEUROSCI, V36, P8050, DOI 10.1523/JNEUROSCI.0982-16.2016; Simmons A, 2004, NEUROREPORT, V15, P2261, DOI 10.1097/00001756-200410050-00024; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; Simmons AN, 2013, J AFFECT DISORDERS, V146, P426, DOI 10.1016/j.jad.2012.08.006; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Simmons AN, 2011, HUM BRAIN MAPP, V32, P1836, DOI 10.1002/hbm.21154; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stevens JS, 2017, BIOL PSYCHIAT, V81, P1023, DOI 10.1016/j.biopsych.2016.11.015; Strigo IA, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.15; Sui J, 2015, BIOL PSYCHIAT, V78, P794, DOI 10.1016/j.biopsych.2015.02.017; Sui J, 2013, NEUROIMAGE, V66, P119, DOI 10.1016/j.neuroimage.2012.10.051; Sui J, 2012, J NEUROSCI METH, V204, P68, DOI 10.1016/j.jneumeth.2011.10.031; Tabachnick B. G., 2006, USING MULTIVARIATE S, V5th; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; van Marle H, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.27633; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Walther S, 2012, NEUROBIOL DIS, V47, P13, DOI 10.1016/j.nbd.2012.03.019; Wesley MJ, 2014, BIOL PSYCHIAT, V75, P435, DOI 10.1016/j.biopsych.2013.08.008; Wise T, 2016, BIOL PSYCHIAT, V79, P293, DOI 10.1016/j.biopsych.2015.03.004; Woo CW, 2017, NAT NEUROSCI, V20, P365, DOI 10.1038/nn.4478; Yehuda R, 2016, JAMA PSYCHIAT, V73, P433, DOI 10.1001/jamapsychiatry.2015.2878; Zeidman P, 2016, NAT REV NEUROSCI, V17, P173, DOI 10.1038/nrn.2015.24; Zhang J, 2010, J NEUROTRAUM, V27, P35, DOI 10.1089/neu.2009.1049; Zhang Y., 2016, APPL INF, V3, P8, DOI [10.1186/s40535-016-0025-y, DOI 10.1186/S40535-016-0025-Y]; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zuj DV, 2016, NEUROSCI BIOBEHAV R, V69, P15, DOI 10.1016/j.neubiorev.2016.07.014	89	7	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	2352-2895			NEUROBIOL STRESS	Neurobiol. Stress	NOV	2018	9						241	250		10.1016/j.ynstr.2018.09.006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GZ9CN	WOS:000449794300023	30450388	Green Published, gold			2022-02-06	
J	Wu, M; Bao, WX; Zhang, J; Hu, YF; Gao, J; Luo, BY				Wu, Min; Bao, Wang-Xiao; Zhang, Jie; Hu, Yang-Fan; Gao, Jian; Luo, Ben-Yan			Effect of acoustic stimuli in patients with disorders of consciousness: a quantitative electroencephalography study	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; auditory stimulation; disorders of consciousness; frontal lobe; neuroplasticity; quantitative electroencephalography; Coma Recovery Scale-Revised; awakening; music; subjects' own name; white noise; neural regeneration	VEGETATIVE STATE; COMA; BRAIN; LEVEL; RECOVERY; THALAMUS; INJURY; EEG	Auditory stimuli are proposed as beneficial neurorehabilitation methods in patients with disorders of consciousness. However, precise and accurate quantitative indices to estimate their potential effect remain scarce. Fourteen patients were recruited from the Neuro-Rehabilitation Unit of Hangzhou Hospital of Zhejiang Armed Police Corps of China. Altogether, there were seven cases of unresponsive wakefulness syndrome (five males and two females, aged 45.7 +/- 16.8 years) and seven cases of minimally conscious state (six males and one female, aged 42.3 +/- 20.8 years). Simultaneously, fourteen healthy controls (10 males and 4 females, aged 51.7 +/- 9.7 years) also participated in this case-control experiment. Brain response to music, subjects' own name, and noise was monitored by quantitative electroencephalography (QEEG) in the resting state and with acoustic stimulation. Predictive QEEG values in various brain regions were investigated. Our results show that cerebral activation was high in subjects stimulated by their own name, especially in the temporal lobe in patients with disorders of consciousness, and the frontal lobe in the control group. Further, during resting and stimulation, QEEG index (delta + theta/alpha + beta ratio) negatively correlated with the Coma Recovery Scale-Revised score in traumatic disorders of consciousness patients. Hence, we speculate that a subject's own name might be an effective awakening therapy for patients with disorders of consciousness. Moreover, QEEG index in specific stimulation states may be used as a prognostic indicator for disorders of consciousness patients (sensitivity, 75%; specificity, 50%).	[Wu, Min; Bao, Wang-Xiao; Zhang, Jie; Luo, Ben-Yan] Zhejiang Univ, Affiliated Hosp 1, Dept Neurol, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Wu, Min; Bao, Wang-Xiao; Zhang, Jie; Luo, Ben-Yan] Zhejiang Univ, Affiliated Hosp 1, Brain Med Ctr, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Hu, Yang-Fan] Zhejiang Univ, Dept Comp Sci, Hangzhou, Zhejiang, Peoples R China; [Gao, Jian] Hangzhou Hosp Zhejiang Armed Police Corps, Dept Rehabil, Hangzhou, Zhejiang, Peoples R China		Luo, BY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Neurol, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Luo, BY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Brain Med Ctr, Sch Med, Hangzhou, Zhejiang, Peoples R China.	luobenyan@zju.edu.cn		Zhang, Jie/0000-0002-1397-5224	General Project Plan of Zhejiang Medical Technology of China [2014RCA007]; Medical Science and Technology Project by Zhejiang Province; Ministry of Health of China [2016152769]	This study was supported by grants from the General Project Plan of Zhejiang Medical Technology of China, No. 2014RCA007; the Medical Science and Technology Project Co-founded by Zhejiang Province and the Ministry of Health of China, No. 2016152769.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Babiloni C, 2009, CLIN NEUROPHYSIOL, V120, P719, DOI 10.1016/j.clinph.2009.02.157; Bekinschtein T, 2005, NEUROPSYCHOL REHABIL, V15, P307, DOI 10.1080/09602010443000443; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Castro M, 2015, NEUROREHAB NEURAL RE, V29, P734, DOI 10.1177/1545968314565464; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Crone JS, 2014, NEUROIMAGE-CLIN, V4, P240, DOI 10.1016/j.nicl.2013.12.005; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Demertzi A, 2013, CURR OPIN NEUROBIOL, V23, P239, DOI 10.1016/j.conb.2012.12.003; Fellinger R, 2011, CLIN NEUROPHYSIOL, V122, P2177, DOI 10.1016/j.clinph.2011.03.004; Fingelkurts AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025967; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gerrard P, 2014, ARCH PHYS MED REHAB, V95, P2335, DOI 10.1016/j.apmr.2014.06.018; Herdener M, 2010, J NEUROSCI, V30, P1377, DOI 10.1523/JNEUROSCI.4513-09.2010; Janata P, 2009, CEREB CORTEX, V19, P2579, DOI 10.1093/cercor/bhp008; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; Kliuchko M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39236; Laureys S, 2004, NEUROLOGY, V63, P916, DOI 10.1212/01.WNL.0000137421.30792.9B; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lechinger J, 2013, J NEUROL, V260, P2348, DOI 10.1007/s00415-013-6982-3; Leon-Carrion J, 2012, BRAIN RES, V1476, P22, DOI 10.1016/j.brainres.2012.03.055; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Luo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036568; Machado C, 2002, NEUROLOGY, V59, P1473; Mega MS, 1997, J NEUROPSYCH CLIN N, V9, P315; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Oliveira L, 2011, BRAIN INJURY, V25, P315, DOI 10.3109/02699052.2011.556103; Sara M, 2010, NONLIN DYNAM PSYCHOL, V14, P1; Schnakers C, 2008, BRAIN INJURY, V22, P926, DOI 10.1080/02699050802530565; Schnakers C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00297; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sikstrom S, 2007, PSYCHOL REV, V114, P1047, DOI 10.1037/0033-295X.114.4.1047; Soderlund GBW, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01331; Tacikowski P, 2016, CONSCIOUS COGN, V41, P139, DOI 10.1016/j.concog.2016.02.013; Wilkins RW, 2014, SCI REP-UK, V4, DOI 10.1038/srep06130; Zhu XQ, 2014, J NEUROSCI, V34, P5406, DOI 10.1523/JNEUROSCI.5310-13.2014	39	7	7	2	11	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	NOV	2018	13	11					1900	1906		10.4103/1673-5374.238622			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	HD4QE	WOS:000452511900010	30233062	gold, Green Published			2022-02-06	
J	Zhang, YL; Chopp, M; Zhang, ZG; Zhang, Y; Zhang, L; Lu, M; Zhang, TL; Winter, S; Brandstatter, H; Mahmood, A; Xiong, Y				Zhang, Yanlu; Chopp, Michael; Zhang, Zheng Gang; Zhang, Yi; Zhang, Li; Lu, Mei; Zhang, Talan; Winter, Stefan; Brandstaetter, Hemma; Mahmood, Asim; Xiong, Ye			Prospective, randomized, blinded, and placebo-controlled study of Cerebrolysin dose-response effects on long-term functional outcomes in a rat model of mild traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						Cerebrolysin; cognitive recovery; dose-response; mild traumatic brain injury; neurological outcome	ACUTE ISCHEMIC-STROKE; COGNITIVE PERFORMANCE; BEHAVIORAL DEFICITS; RECOVERY; EFFICACY; MEMORY; SAFETY; TRIAL; IMPAIRMENT; CHALLENGES	OBJECTIVE Cerebrolysin is a neuropeptide preparation that mimics the properties of neurotrophic factors and has had beneficial effects in the treatment of neurodegenerative diseases, stroke, and traumatic brain injury (TBI). To further evaluate treatment schemes, the authors assessed the dose-response of Cerebrolysin on functional improvement in a rat model of mild TBI (mTBI). METHODS This dose-response study was a prospective, randomized, blinded, and placebo-controlled preclinical experiment. Male Wistar adult rats, subjected to mTBI induced by a closed head impact, were treated randomly with 0 (saline as placebo), 0.8, 2.5, or 7.5 ml/kg of Cerebrolysin 4 hours after mTBI and daily for a total of 10 consecutive days. A battery of cognitive and sensorimotor functional tests was performed over 90 days. RESULTS The primary outcome was functional improvement over the 90 days; animal weight and death were the secondary and safety outcomes, respectively. A significant (p < 0.001) dose effect of Cerebrolysin on cognitive recovery 3 months after injury was found. Cerebrolysin at a dose of >=>= 0.8 ml/kg significantly (p < 0.001) improved cognitive outcome. The higher dose (7.5 ml/kg) resulted in significantly better cognitive recovery than the lowest doses (0.8 ml/kg) but not relative to the 2.5-ml/kg dose. Cerebrolysin at a dose of 2.5 or 7.5 ml/kg also caused different onset times of significant improvement in sensorimotor function. No differences in body weight or mortality rate among the groups were found. CONCLUSIONS This preclinical randomized, placebo-controlled, and blinded study with a clinically relevant treatment scheme revealed that Cerebrolysin at doses of 0.8-7.5 ml/kg, administered 4 hours after mTBI and then once daily for a total of 10 consecutive days, improved functional outcomes 3 months after injury. A dose of 2.5 ml/kg is likely an optimal dose for the treatment of experimental mTBI.	[Zhang, Yanlu; Mahmood, Asim; Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael; Zhang, Zheng Gang; Zhang, Yi; Zhang, Li] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Lu, Mei; Zhang, Talan] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Winter, Stefan; Brandstaetter, Hemma] EVER Pharma GmbH, Unterach, Austria		Xiong, Y (corresponding author), Henry Ford Hlth Syst, Detroit, MI 48202 USA.	yxiong1@hfhs.org		Xiong, Ye/0000-0001-9770-6031	EVER Pharma GmbH	Drs. Winter and Brandstatter are employees of Clinical Research and Pharmacology, EVER Neuro Pharma GmbH (Unterach, Austria), which did not participate in the animal studies, data collection, or data analyses. All the authors designed the study together, and EVER Neuro reviewed the report and manuscript without interfering with the conclusions that were drawn. This work was supported by EVER Pharma GmbH.	Alvarez XA, 2011, EUR J NEUROL, V18, P59, DOI 10.1111/j.1468-1331.2010.03092.x; Alvarez XA, 2003, INT CLIN PSYCHOPHARM, V18, P271, DOI 10.1097/07.yic.0000085765.24936.9a; Alvarez XA, REDUCTIONS QEEG SLOW; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Bengoetxea Xabier, 2015, Front Biosci (Schol Ed), V7, P10; Bornstein N, 2012, DRUG TODAY, V48, P43, DOI 10.1358/dot.2012.48(Suppl.A).1739723; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Chen CC, 2013, BRIT J NEUROSURG, V27, P803, DOI 10.3109/02688697.2013.793287; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; El Sayed I, 2016, NEUROSURG REV; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Gonzales ELT, 2015, BIOMOL THER, V23, P251, DOI 10.4062/biomolther.2014.120; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Heiss WD, 2012, STROKE, V43, P630, DOI 10.1161/STROKEAHA.111.628537; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hong Z, 2009, INT J STROKE, V4, P406, DOI 10.1111/j.1747-4949.2009.00340.x; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Kamins J, 2016, NEUROSURG CLIN N AM, V27, P441, DOI 10.1016/j.nec.2016.05.005; Khalili H, 2017, CLIN NEUROL NEUROSUR, V152, P34, DOI 10.1016/j.clineuro.2016.11.011; Kilkenny C, 2010, J GENE MED, V12, P561, DOI 10.1002/jgm.1473; Ladurner G, 2005, J NEURAL TRANSM, V112, P415, DOI 10.1007/s00702-004-0248-2; Lang W, 2013, INT J STROKE, V8, P95, DOI 10.1111/j.1747-4949.2012.00901.x; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Miyauchi T, 2014, J NEUROTRAUM, V31, P773, DOI 10.1089/neu.2013.3181; Muresanu DF, 2016, STROKE, V47, P151, DOI 10.1161/STROKEAHA.115.009416; Muresanu DF, 2015, CNS NEUROL DISORD-DR, V14, P587, DOI 10.2174/1871527314666150430162531; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Newcombe VFJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1522; Plosker GL, 2009, DRUG AGING, V26, P893, DOI 10.2165/11203320-000000000-00000; Poon W, 2015, J NEUROTRAUM, V32, P571, DOI 10.1089/neu.2014.3558; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Stuart SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075467; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Thomsen GM, 2016, J TRAUMA ACUTE CARE, V81, P1070, DOI 10.1097/TA.0000000000001248; Ubhi K, 2009, ACTA NEUROPATHOL, V117, P699, DOI 10.1007/s00401-009-0505-4; US Food and Drug Administration's Centre for Drug Evaluation and Research (CDER), 2005, GUID IND EST MAX SAF; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Zhang L, 2016, INT J STROKE, V11, P347, DOI 10.1177/1747493015625645; Zhang YL, 2017, J NEUROSURG, V126, P782, DOI 10.3171/2016.3.JNS152699; Zhang YL, 2015, J NEUROSURG, V122, P843, DOI 10.3171/2014.11.JNS14271	61	7	8	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2018	129	5					1295	1304		10.3171/2017.6.JNS171007			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HE4XT	WOS:000453373600025	29303438	Bronze			2022-02-06	
J	Yokobori, S; Wang, KKK; Yang, ZH; Zhu, T; Tyndall, JA; Mondello, S; Shibata, Y; Tominaga, N; Kanaya, T; Takiguchi, T; Igarashi, Y; Hagiwara, J; Nakae, R; Onda, H; Masuno, T; Fuse, A; Yokota, H				Yokobori, Shoji; Wang, Kevin K. K.; Yang, Zhihui; Zhu, Tian; Tyndall, Joseph A.; Mondello, Stefania; Shibata, Yasushi; Tominaga, Naoki; Kanaya, Takahiro; Takiguchi, Toru; Igarashi, Yutaka; Hagiwara, Jun; Nakae, Ryuta; Onda, Hidetaka; Masuno, Tomohiko; Fuse, Akira; Yokota, Hiroyuki			Quantitative pupillometry and neuron-specific enolase independently predict return of spontaneous circulation following cardiogenic out-of-hospital cardiac arrest: a prospective pilot study	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; AMERICAN-HEART-ASSOCIATION; CARDIOPULMONARY-RESUSCITATION; NEUROLOGICAL OUTCOMES; TERMINATION; GUIDELINES; MANAGEMENT; STATEMENT; S-100B; RULE	This study aimed to identify neurological and pathophysiologica I factors that predicted return of spontaneous circulation (ROSC) among patients with out-of-hospital cardiac arrest (OHCA). This prospective 1-year observational study evaluated patients with cardiogenic OHCA who were admitted to a tertiary medical center, Nippon Medical School Hospital. Physiological and neurological examinations were performed at admission for quantitative infrared pupillometry (measured with NPi-200, NeurOptics, CA, USA), arterial blood gas, and blood chemistry. Simultaneous blood samples were also collected to determine levels of neuron-specific enolase (NSE), 5-100b, phosphorylated neurofilament heavy subunit, and interleukin-6. In-hospital standard advanced cardiac life support was performed for 30 minutes.The ROSC (n = 26) and non-ROSC (n = 26) groups were compared, which a revealed significantly higher pupillary light reflex ratio, which was defined as the percent change between maximum pupil diameter before light stimuli and minimum pupil diameter after light stimuli, in the ROSC group (median: 1.3% [interquartile range (IQR): 0.0-2.0%] vs. non-ROSC: (median: 0%), (Cut-off: 0.63%). Furthermore, NSE provided the great sensitivity and specificity for predicting ROSC, with an area under the receiver operating characteristic curve of 0.86, which was created by plotting sensitivity and 1-specificity. Multivariable logistic regression analyses revealed that the independent predictors of ROSC were maximum pupillary diameter (odds ratio: 0.25, 95% confidence interval: 0.07-0.94, P = 0.04) and NSE at admission (odds ratio: 0.96, 95% confidence interval: 0.93-0.99, P = 0.04). Pupillary diameter was also significantly correlated with NSE concentrations (r = 0.31, P = 0.027). Conclusively, the strongest predictors of ROSC among patients with OHCA were accurate pupillary diameter and a neuronal biomarker, NSE. Quantitative pupillometry may help guide the decision to terminate resuscitation in emergency departments using a neuropathological rationale. Further large-scale studies are needed.	[Yokobori, Shoji; Shibata, Yasushi; Tominaga, Naoki; Kanaya, Takahiro; Takiguchi, Toru; Igarashi, Yutaka; Hagiwara, Jun; Nakae, Ryuta; Onda, Hidetaka; Masuno, Tomohiko; Fuse, Akira; Yokota, Hiroyuki] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo, Japan; [Wang, Kevin K. K.; Yang, Zhihui; Zhu, Tian] Univ Florida, Dept Psychiat, Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA; [Zhu, Tian] Third Mil Med Univ, Dept Pediat, Daping Hosp, 10 Changjigang Zhilu, Chongqing 400042, Peoples R China; [Tyndall, Joseph A.] Univ Florida, Dept Emergency Med, Gainesville, FL USA; [Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Mondello, Stefania] Oasi Res Inst IRCCS, Troina, Italy; [Shibata, Yasushi] Nippon Med Coll Hosp, Dept Clin Lab, Tokyo, Japan		Yokobori, S (corresponding author), Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo, Japan.	shoji@nms.ac.jp	Mondello, Stefania/A-1813-2012	Mondello, Stefania/0000-0002-8587-3614; Wang, Kevin/0000-0002-9343-6473			Bailey E D, 2000, Prehosp Emerg Care, V4, P190, DOI 10.1080/10903120090941498; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Behrends M, 2012, RESUSCITATION, V83, P1223, DOI 10.1016/j.resuscitation.2012.05.013; Brinkrolf P, 2018, RESUSCITATION, V122, P19, DOI 10.1016/j.resuscitation.2017.11.040; Choi S, 2016, EMERG MED J, V33, P690, DOI 10.1136/emermed-2015-205423; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Drennan IR, 2017, RESUSCITATION, V111, P96, DOI 10.1016/j.resuscitation.2016.11.021; Duez CHV, 2018, RESUSCITATION, V122, P79, DOI 10.1016/j.resuscitation.2017.11.052; Floerchinger B, 2017, RESUSCITATION, V121, P166, DOI 10.1016/j.resuscitation.2017.09.001; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Hasegawa K, 2013, JAMA-J AM MED ASSOC, V309, P257, DOI 10.1001/jama.2012.187612; Hayashi Y, 2012, CIRC J, V76, P1639, DOI 10.1253/circj.CJ-11-1433; Kajino K, 2013, RESUSCITATION, V84, P54, DOI 10.1016/j.resuscitation.2012.05.027; Koyama K, 2017, CYTOKINE, V95, P22, DOI 10.1016/j.cyto.2017.02.002; Mancini ME, 2015, CIRCULATION, V132, pS383, DOI 10.1161/CIR.0000000000000254; Mikkelsen S, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0381-1; Millin MG, 2011, PREHOSP EMERG CARE, V15, P547, DOI 10.3109/10903127.2011.608872; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Morrison LJ, 2006, NEW ENGL J MED, V355, P478, DOI 10.1056/NEJMoa052620; Olson DM, 2016, CRIT CARE NURS CLIN, V28, P101, DOI 10.1016/j.cnc.2015.09.003; Ono Y, 2017, RESUSCITATION, V111, P62, DOI 10.1016/j.resuscitation.2016.11.017; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Shoyombo I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25477-7; Sinha N, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0770-x; Tamura T, 2018, RESUSCITATION, V131, P108, DOI 10.1016/j.resuscitation.2018.06.027; Verhaert DVM, 2016, RESUSCITATION, V100, P60, DOI 10.1016/j.resuscitation.2015.12.014	27	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 29	2018	8								15964	10.1038/s41598-018-34367-x			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5CZ	WOS:000448589200040	30374189	Green Published, gold			2022-02-06	
J	Spees, WM; Lin, TH; Sun, P; Song, CY; George, A; Gary, SE; Yang, HC; Song, SK				Spees, William M.; Lin, Tsen-Hsuan; Sun, Peng; Song, Chunyu; George, Ajit; Gary, Sam E.; Yang, Hsin-Chieh; Song, Sheng-Kwei			MRI-based assessment of function and dysfunction in myelinated axons	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						diffusion MRI; fMRI; white matter; myelin; action potential	IN-DIFFUSION MRI; HUMAN CONNECTOME PROJECT; FROG SCIATIC-NERVE; MOUSE OPTIC-NERVE; WHITE-MATTER; EXTRACELLULAR-SPACE; WATER DIFFUSION; PERIPHERAL-NERVE; T-2 RELAXATION; VOLUME CHANGES	Repetitive electrical activity produces microstructural alteration in myelinated axons, which may afford the opportunity to non-invasively monitor function of myelinated fibers in peripheral nervous system (PNS)/CNS pathways. Microstructural changes were assessed via two different magnetic-resonance-based approaches: diffusion fMRI and dynamic T-2 spectroscopy in the ex vivo perfused bullfrog sciatic nerves. Using this robust, classical model as a platform for testing, we demonstrate that noninvasive diffusion fMRI, based on standard diffusion tensor imaging (DTI), can clearly localize the sites of axonal conduction blockage as might be encountered in neurotrauma or other lesion types. It is also shown that the diffusion fMRI response is graded in proportion to the total number of electrical impulses carried through a given locus. Dynamic T-2 spectroscopy of the perfused frog nerves point to an electrical-activity-induced redistribution of tissue water and myelin structural changes. Diffusion basis spectrum imaging (DBSI) reveals a reversible shift of tissue water into a restricted isotropic diffusion signal component. Submyelinic vacuoles are observed in electron-microscopy images of tissue fixed during electrical stimulation. A slowing of the compound action potential conduction velocity accompanies repetitive electrical activity. Correlations between electrophysiology and MRI parameters during and immediately after stimulation are presented. Potential mechanisms and interpretations of these results are discussed.	[Spees, William M.; Lin, Tsen-Hsuan; Sun, Peng; George, Ajit; Gary, Sam E.; Yang, Hsin-Chieh; Song, Sheng-Kwei] Washington Univ, Mallinckrodt Inst Radiol, Biomed MR Lab, Sch Med, St Louis, MO 63110 USA; [Spees, William M.; Song, Sheng-Kwei] Washington Univ, Hope Ctr Neurol Disorders, Sch Med, St Louis, MO 63110 USA; [Song, Chunyu; Song, Sheng-Kwei] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA		Spees, WM (corresponding author), Washington Univ, Mallinckrodt Inst Radiol, Biomed MR Lab, Sch Med, St Louis, MO 63110 USA.; Spees, WM (corresponding author), Washington Univ, Hope Ctr Neurol Disorders, Sch Med, St Louis, MO 63110 USA.	spees@wustl.edu		Gary, Sam/0000-0001-6526-4953	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS047592, P01-NS059560, U01-EY025500]; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG-1701-26617, FG-1507-05315]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [U01EY025500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047592, P01NS059560] Funding Source: NIH RePORTER	EM imaging, including sample preparation and sectioning, were performed in part through the use of Washington University Center for Cellular Imaging. This work was supported in part by National Institutes of Health Grants R01-NS047592, P01-NS059560, and U01-EY025500; and National Multiple Sclerosis Society Grants RG-1701-26617 (to S.-K.S.) and FG-1507-05315 (to T.-H.L.).	ANDREW RD, 1994, NEUROSCIENCE, V62, P371, DOI 10.1016/0306-4522(94)90372-7; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Batchelor PG, 2003, MAGN RESON MED, V49, P1143, DOI 10.1002/mrm.10491; Beaulieu C, 1998, MAGN RESON IMAGING, V16, P1201, DOI 10.1016/S0730-725X(98)00151-9; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; BERTHOLD CH, 1978, PHYSL PATHOBIOLOGY A, P3; BRINK F, 1952, COLD SPRING HARB SYM, V17, P53, DOI 10.1101/SQB.1952.017.01.008; BUTT AM, 1994, J NEUROCYTOL, V23, P469, DOI 10.1007/BF01184071; Chiang CW, 2014, NEUROIMAGE, V101, P310, DOI 10.1016/j.neuroimage.2014.06.064; CHIU SY, 1982, J PHYSIOL-LONDON, V322, P485, DOI 10.1113/jphysiol.1982.sp014051; Clever HL, 2014, J PHYS CHEM REF DATA, V43, DOI 10.1063/1.4883876; de Graaf RA, 2006, MAGN RESON MED, V56, P386, DOI 10.1002/mrm.20946; DIETZEL I, 1980, EXP BRAIN RES, V40, P432; DOES MD, 1995, MAGN RESON IMAGING, V13, P575, DOI 10.1016/0730-725X(94)00138-S; Easton Dexter M., 1993, American Journal of Physiology, V265, pS35; EASTON DM, 1960, SCIENCE, V132, P1312, DOI 10.1126/science.132.3436.1312; ERLANGER J, 1937, ELECT SIGNS NERVOUS; Gawryluk JR, 2009, NEUROIMAGE, V45, P83, DOI 10.1016/j.neuroimage.2008.11.005; Haldar JP, 2013, MAGN RESON MED, V69, P277, DOI 10.1002/mrm.24229; Hartline DK, 2007, CURR BIOL, V17, pR29, DOI 10.1016/j.cub.2006.11.042; Holthoff K, 1996, J NEUROSCI, V16, P2740, DOI 10.1523/jneurosci.16-08-02740.1996; Jin T, 2008, NEUROIMAGE, V41, P801, DOI 10.1016/j.neuroimage.2008.03.014; Kroenke CD, 2007, J NEUROSCI, V27, P12506, DOI 10.1523/JNEUROSCI.3063-07.2007; Land BR, 2001, J NEUROSCI METH, V106, P47, DOI 10.1016/S0165-0270(01)00328-4; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Le Bihan D, 2006, P NATL ACAD SCI USA, V103, P8263, DOI 10.1073/pnas.0600644103; Le Bihan D, 2006, J MAGN RESON IMAGING, V24, P478, DOI 10.1002/jmri.20683; Le Bihan D, 2012, NEUROIMAGE, V62, P1131, DOI 10.1016/j.neuroimage.2011.09.058; Lee HH, 2018, NEUROIMAGE, V182, P500, DOI 10.1016/j.neuroimage.2017.12.038; Lin TH, 2014, NEUROBIOL DIS, V67, P1, DOI 10.1016/j.nbd.2014.02.007; Mandl RCW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003631; Marussich L, 2017, NEUROIMAGE, V146, P1128, DOI 10.1016/j.neuroimage.2016.10.005; Miller KL, 2007, P NATL ACAD SCI USA, V104, P20967, DOI 10.1073/pnas.0707257105; MORAN O, 1983, NATURE, V304, P344, DOI 10.1038/304344a0; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Peled S, 1999, MAGNET RESON MED, V42, P911; RANSOM BR, 1985, J NEUROSCI, V5, P532; Rash JE, 2010, NEUROSCIENCE, V168, P982, DOI 10.1016/j.neuroscience.2009.10.028; Rokem A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123272; Rostrup E, 2000, NEUROIMAGE, V11, P87, DOI 10.1006/nimg.1999.0526; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Setsompop K, 2013, NEUROIMAGE, V80, P220, DOI 10.1016/j.neuroimage.2013.05.078; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Spaeth CS, 2010, J NEUROSCI, V30, P15790, DOI 10.1523/JNEUROSCI.4155-10.2010; Spees WM, 2013, NEUROIMAGE, V65, P209, DOI 10.1016/j.neuroimage.2012.10.021; Stinner JN, 2000, J EXP BIOL, V203, P2065; SVOBODA J, 1991, BRAIN RES, V560, P216, DOI 10.1016/0006-8993(91)91235-S; Takagi S, 2002, NEUROSCI RES, V44, P315, DOI 10.1016/S0168-0102(02)00153-0; Tasaki I., 1953, NERVOUS TRANSMISSION; Tu TW, 2014, MAGN RESON IMAGING, V32, P1335, DOI 10.1016/j.mri.2014.07.004; VASILESCU V, 1978, EXPERIENTIA, V34, P1443, DOI 10.1007/BF01932339; Veraart J, 2016, MAGN RESON MED, V76, P301, DOI 10.1002/mrm.25866; Vigneau-Roy N, 2014, HUM BRAIN MAPP, V35, P1906, DOI 10.1002/hbm.22301; Wachowicz K, 2002, MAGNET RESON MED, V47, P239, DOI 10.1002/mrm.10053; WANG GK, 1985, J PHYSIOL-LONDON, V368, P309, DOI 10.1113/jphysiol.1985.sp015859; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; WHITTALL KP, 1989, J MAGN RESON, V84, P134, DOI 10.1016/0022-2364(89)90011-5; WURTZ CC, 1986, J NEUROSCI, V6, P3133; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; ZHONG J, 1993, MAGN RESON MED, V30, P241, DOI 10.1002/mrm.1910300214; Zhong JH, 1997, MAGN RESON MED, V37, P1, DOI 10.1002/mrm.1910370102	63	7	7	2	17	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 23	2018	115	43					E10225	E10234		10.1073/pnas.1801788115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8MQ	WOS:000448040500025	30297414	Green Published, Bronze			2022-02-06	
J	Shao, MH; Cao, JL; Bai, LJ; Huang, WM; Wang, S; Sun, CZ; Gan, SQ; Ye, LM; Yin, B; Zhang, DB; Gu, CH; Hu, LX; Bai, GH; Yan, ZH				Shao, Meihua; Cao, Jieli; Bai, Lijun; Huang, Wenming; Wang, Shan; Sun, Chuanzhu; Gan, Shuoqiu; Ye, Limei; Yin, Bo; Zhang, Danbin; Gu, Chenghui; Hu, Liuxun; Bai, Guanghui; Yan, Zhihan			Preliminary Evidence of Sex Differences in Cortical Thickness Following Acute Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; cortical thickness; gender difference; interaction effect; clinical outcomes	HUMAN CEREBRAL-CORTEX; POSTTRAUMATIC-STRESS-DISORDER; SURFACE-BASED ANALYSIS; COGNITIVE IMPAIRMENT; COLLABORATING CENTER; CONCUSSION SYMPTOMS; TASK-FORCE; RELIABILITY; GENDER; VETERANS	The main objective of this study was to evaluate sex differences in cortical thickness after acute mild traumatic brain injury (mTBI) and its associations with clinical outcomes. Thirty-two patients with mTBI at acute phase (2.4 +/- 1.3 days post-injury) and 30 healthy controls were enrolled. All the participants underwent comprehensive neurocognitive assessments and MRI to assess cortical thickness. Significant sex differences were determined by using variance analysis of factorial design. Relations between the cortical thickness and clinical assessments were measured with the Spearman Correlation. Results revealed that patients with mTBI had significantly reduced cortical thickness in the left entorhinal cortex while increased cortical thickness in the left precuneus cortex and right lateral occipital cortex, compared with healthy controls. The interaction effect of the group x sex on cortical thickness was significant. Female patients had significant thicker cortical thickness in the left caudal anterior cingulate cortex (ACC) than male patients and had higher scores on Posttraumatic stress disorder Checklist-Civilian Version (PCL-C). Spearman correlational analysis showed a significantly positive correlations between the cortical thickness of the left caudal ACC and PCL-C ratings in female patients. Sex differences in cortical thickness support its potential as a neuroimaging phenotype for investigating the differences in clinical profiles of mild TBI between women and men.	[Shao, Meihua; Ye, Limei; Zhang, Danbin; Bai, Guanghui; Yan, Zhihan] Wenzhou Med Univ, Affiliated Hosp 2, Radiol Dept, Wenzhou, Peoples R China; [Shao, Meihua; Ye, Limei; Yin, Bo; Zhang, Danbin; Gu, Chenghui; Hu, Liuxun; Bai, Guanghui; Yan, Zhihan] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Cao, Jieli; Bai, Lijun; Huang, Wenming; Wang, Shan; Sun, Chuanzhu; Gan, Shuoqiu] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Key Lab Biomed Informat Engn,Minist Educ, Xian, Shaanxi, Peoples R China; [Yin, Bo; Gu, Chenghui; Hu, Liuxun] Wenzhou Med Univ, Affiliated Hosp 2, Neurosurg Dept, Wenzhou, Peoples R China		Bai, GH; Yan, ZH (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Radiol Dept, Wenzhou, Peoples R China.; Bai, GH; Yan, ZH (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China.	bghu79@126.com; zhihanyanwz@163.com	; Bai, Lijun/C-5119-2015	Shao, Meihua/0000-0003-1203-9730; Bai, Lijun/0000-0001-8790-5424	Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571752, 81771914]; National key research and development plan of China [2016YFC0100300]; Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LY16H180009, LY15H090016]	This research was supported by the Natural Science Foundation of China under Grant Nos. 81571752 and 81771914, the National key research and development plan of China, 2016YFC0100300, the Natural Science Foundation of Zhejiang Province (nos. LY16H180009 and LY15H090016).	ARNETT JA, 1995, PSYCHOL ASSESSMENT, V7, P220; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; Breslau Naomi, 2002, J Gend Specif Med, V5, P34; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Caplan B MJE, 2011, EDINBURGH HANDEDNESS; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2012, J NEUROSCI NURS, V44, P124, DOI 10.1097/JNN.0b013e318252737d; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; DUM RP, 1991, J NEUROSCI, V11, P667; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Farace E, 2000, Neurosurg Focus, V8, pe6; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Harman-Smith YE, 2013, J CLIN EXP NEUROPSYC, V35, P785, DOI 10.1080/13803395.2013.824554; Hermans EJ, 2011, SCIENCE, V334, P1151, DOI 10.1126/science.1209603; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hsu HL, 2015, RADIOLOGY, V276, P828, DOI 10.1148/radiol.2015142549; Im K, 2006, NEUROIMAGE, V31, P31, DOI 10.1016/j.neuroimage.2005.11.042; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Kennis M, 2015, HUM BRAIN MAPP, V36, P99, DOI 10.1002/hbm.22615; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; McGlade E, 2015, BRAIN IMAGING BEHAV, V9, P535, DOI 10.1007/s11682-015-9379-3; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wonderlick JS, 2009, NEUROIMAGE, V44, P1324, DOI 10.1016/j.neuroimage.2008.10.037	46	7	7	2	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 17	2018	9								878	10.3389/fneur.2018.00878			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GX1RC	WOS:000447494600001	30386291	gold, Green Published			2022-02-06	
J	Eliacin, J; Fortney, S; Rattray, NA; Kean, J				Eliacin, Johanne; Fortney, Sarah; Rattray, Nicholas A.; Kean, Jacob			Access to health services for moderate to severe TBI in Indiana: patient and caregiver perspectives	BRAIN INJURY			English	Article						Traumatic brain injury; qualitative research; access to care; health services delivery; caregivers	TRAUMATIC BRAIN-INJURY; NEEDS; CARE; REHABILITATION; SUPPORTS; PEOPLE; STATE	Objective: We examined patient and caregiver experiences of health services for moderate to severe traumatic brain injury (TBI) in Indiana. The objective was to provide an understanding of their lived experiences and to inform policies and practices for health services delivery for TBI. Methods: We conducted qualitative, semi-structured interviews with 62 participants (34 patients and 28 caregivers). Data analysis was guided by constructive grounded theory. Results: Three interrelated themes emerged from the data and characterised participants' experiences accessing health services for TBI: 1) inadequate access to health services; 2) unavailability of specialised, age-appropriate, and long-term health services; and 3) transportation barriers to health services that limit access to care and amplify rural health disparities for patients. Conclusion: Our findings identified significant barriers to health services for patients with TBI at different points in the care continuum. Gaps in health services and barriers to care transcend geographical boundaries within the state. We suggest ways to improve access to TBI care including: 1) decentralisation of trauma centers; 2) development of neurobehavioural and age-appropriate long-term care facilities; 3) increased workforce with expertise in TBI treatment; and 4) improved access to transportation services for patients with a TBI.	[Eliacin, Johanne; Fortney, Sarah; Rattray, Nicholas A.] Richard L Roudebush Dept Vet Affairs Med Ctr, Ctr Hlth Informat & Commun, Dept Hlth Serv Res & Dev, Indianapolis, IN USA; [Eliacin, Johanne; Fortney, Sarah] Indiana Univ Purdue Univ, Dept Psychol, Indianapolis, IN 46202 USA; [Eliacin, Johanne] Regenstrief Inst Inc, Ctr Hlth Serv Res, Indianapolis, IN USA; [Eliacin, Johanne] Act Ctr Indiana, Indianapolis, IN USA; [Rattray, Nicholas A.] Indiana Univ Purdue Univ, Dept Anthropol, Indianapolis, IN 46202 USA; [Kean, Jacob] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, Dept Hlth Serv Res & Dev, Salt Lake City, UT USA; [Kean, Jacob] Univ Utah, Sch Med, Dept Populat Hlth Sci, Salt Lake City, UT USA; [Kean, Jacob] Univ Utah, Sch Med, Dept Commun Sci & Disorders, Salt Lake City, UT USA		Eliacin, J (corresponding author), Richard L Roudebush VA Med Ctr, Ctr Hlth Informat & Commun, Hlth Serv Res & Dev, 1481 W 10th St,11H, Indianapolis, IN 46202 USA.	jeliacin@iupui.edu		Eliacin, Johanne/0000-0001-8027-2935; Rattray, Nicholas/0000-0002-9683-889X	Indiana Spinal Cord and Brain Injury Research (ISCBIR); Indiana State Department of Health; VA Rehabilitation Research and Development Career Development Award [IK2RX000879]	This work was supported by the Indiana Spinal Cord and Brain Injury Research (ISCBIR) and the Indiana State Department of Health. Dr. Kean also received support from the VA Rehabilitation Research and Development Career Development Award [IK2RX000879].	Andelic N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/2678081; [Anonymous], 2007, MMWR SURVEILL SUMM, V2017, P1; [Anonymous], 2016, HAMILTON COUNTY EXPR; Atlas. ti Scientific Software Development GmbH, 2010, ATL TI VERS 6 COMP S; Auerbach C.F., 2003, QUALITATIVE STUDIES; Bernard H.R., 2011, RES METHODS ANTHR QU, V5th; Briks M, 2001, MILLS GROUNDED THEOR; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Callender L, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0828-z; Charmaz Kathy, 2006, CONSTRUCTING GROUND; Clinin D.J., 2000, NARRATIVE INQUIRY EX; Coffey NT, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7027; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Guest G., 2012, APPL THEMATIC ANAL; Harrison AL, 2017, DISABIL REHABIL, V39, P2071, DOI 10.1080/09638288.2016.1217081; Honeybul S, 2013, J NEUROSCI RURAL PRA, V4, P33, DOI 10.4103/0976-3147.105607; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; KADUSHIN C, 1968, AM SOCIOL REV, V33, P685, DOI 10.2307/2092880; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McLean AM, 2010, JTCT, V14, P17; Mills Jane, 2006, Int J Nurs Pract, V12, P8, DOI 10.1111/j.1440-172X.2006.00543.x; Murphy J., 2004, TOPICS EMERG MED, V26, P231; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Saldana J, 2015, CODING MANUAL QUALIT; Schatz P, 2001, NEUROREHABILITATION, V16, P281; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Shigaki CL, 2009, DISABIL REHABIL, V31, P484, DOI 10.1080/09638280802240449; Solovieva TI, 2014, J REHABIL, V80, P10; Spearman RC, 2007, BRAIN INJURY, V21, P837, DOI 10.1080/02699050701426857; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Suter WN., 2012, INTRO ED RES CRITICA, VSecond; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Trexler L, 2011, BRAIN INJURY SERVICE	43	7	7	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2018	32	12					1510	1517		10.1080/02699052.2018.1499964			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GX0EO	WOS:000447382800009	30036117				2022-02-06	
J	Gangolli, M; Benetatos, J; Esparza, TJ; Fountain, EM; Seneviratne, S; Brody, DL				Gangolli, Mihika; Benetatos, Joseph; Esparza, Thomas J.; Fountain, Emeka M.; Seneviratne, Shamilka; Brody, David L.			Repetitive Concussive and Subconcussive Injury in a Human Tau Mouse Model Results in Chronic Cognitive Dysfunction and Disruption of White Matter Tracts, But Not Tau Pathology	JOURNAL OF NEUROTRAUMA			English	Article						chronic behavior; concussive; subconcussive; white matter injury	TRAUMATIC BRAIN-INJURY; HEAD IMPACT MODEL; AXONAL INJURY; AMYLOID-BETA; NEUROBEHAVIORAL CHANGES; TANGLE FORMATION; A-BETA; MICE; ENCEPHALOPATHY; ACCUMULATION	Due to the unmet need for a means to study chronic traumatic encephalopathy (CTE) in vivo, there have been numerous efforts to develop an animal model of this progressive tauopathy. However, there is currently no consensus in the field on an injury model that consistently reproduces the neuropathological and behavioral features of CTE. We have implemented a repetitive Closed-Head Impact Model of Engineered Rotational Acceleration (CHIMERA) injury paradigm in human transgenic (hTau) mice. Animals were subjected to daily subconcussive or concussive injuries for 20 days and tested acutely, 3 months, and 12 months post-injury for deficits in social behavior, anxiety, spatial learning and memory, and depressive behavior. Animals also were assessed for chronic tau pathology, astrogliosis, and white matter degeneration. Repetitive concussive injury caused acute deficits in Morris water maze performance, including reduced swimming speed and increased distance to the platform during visible and hidden platform phases that persisted during the subacute and chronic time-points following injury. We found evidence of white matter disruption in animals injured with subconcussive and concussive injuries, with the most severe disruption occurring in the repetitive concussive injury group. Severity of white matter disruption in the corpus callosum was moderately correlated with swimming speed, while white matter disruption in the fimbria showed weak but significant correlation with worse performance during probe trial. There was no evidence of tau pathology or astrogliosis in sham or injured animals. In summary, we show that repetitive brain injury produces persistent behavioral abnormalities as late as 1 year post-injury that may be related to chronic white matter disruption, although the relationship with CTE remains to be determined.	[Gangolli, Mihika] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Benetatos, Joseph] Washington Univ, Dept Neurol, St Louis, MO USA; [Esparza, Thomas J.; Fountain, Emeka M.; Seneviratne, Shamilka; Brody, David L.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia		Brody, DL (corresponding author), Uniformed Serv Univ Hlth Sci, Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 20814 USA.	brodyd@wustl.edu			Washington University School of Medicine; Children's Discovery Institute of Washington University; St. Louis Children's Hospital [CDI-CORE-2015-505]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS086741]; DMRDP [PT110816]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS065069]; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R24NS086741, R01NS065069] Funding Source: NIH RePORTER	The authors thank Theodore Floros for his contribution when measuring righting times following injuries, as well as the remaining members of the Brody laboratory for helpful discussion of the data presented here. We would also like to thank Terrance Kummer, MD, PhD, and Andrew Sauerbeck, PhD, for development of open field thigmotaxis that was used as one of our outcome measures, and Kathleen Schoch, PhD, for providing hTau tail DNA used as the positive control during PCR. Finally, we are grateful to Hao Jiang, PhD, for extensive effort and helpful discussion when performing Western blot experiments. Acquisition of histological images was performed in part through the use of Washington University Center for Cellular Imaging (WUCCI) supported by Washington University School of Medicine, The Children's Discovery Institute of Washington University and St. Louis Children's Hospital (CDI-CORE-2015-505) and the National Institute of Neurological Disorders and Stroke (NS086741). This work was supported by DMRDP PT110816 and NIH R01 NS065069 (PI: Brody) and the Center for Neuroscience and Regenerative Medicine. The views expressed here are those of the authors.	Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Barnette AR, 2009, PEDIATR RES, V66, P80, DOI 10.1203/PDR.0b013e3181a291d9; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Castagne Vincent, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as55; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; d'Orange M, 2018, BRAIN, V141, P535, DOI 10.1093/brain/awx342; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; DeWalt GJ, 2018, NEUROSCI LETT, V664, P160, DOI 10.1016/j.neulet.2017.11.016; Gangolli M, 2017, NEUROIMAGE, V153, P152, DOI 10.1016/j.neuroimage.2017.03.059; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Hutchinson EB, 2016, SHOCK, V46, P167, DOI 10.1097/SHK.0000000000000659; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kovacs GG, 2017, BRAIN PATHOL, V27, P675, DOI 10.1111/bpa.12536; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mahar I, 2017, NEUROSCI BIOBEHAV R, V83, P622, DOI 10.1016/j.neubiorev.2017.08.023; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146540; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Schwerin SC, 2017, J NEUROSCI METH, V285, P82, DOI 10.1016/j.jneumeth.2017.05.010; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Soltys Z, 2003, BRAIN RES, V987, P186, DOI 10.1016/S0006-8993(03)03327-4; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tran H. S., 2011, THESIS; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	60	7	7	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2019	36	5					735	755		10.1089/neu.2018.5700		OCT 2018	21	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HR2BG	WOS:000446275600001	30136628	Green Published, Green Submitted			2022-02-06	
J	Yuan, WH; Foss, KDB; Dudley, J; Thomas, S; Galloway, R; DiCesare, C; Leach, J; Scheifele, P; Farina, M; Valencia, G; Smith, D; Altaye, M; Rhea, CK; Talavage, T; Myer, GD				Yuan, Weihong; Foss, Kim D. Barber; Dudley, Jonathan; Thomas, Staci; Galloway, Ryan; DiCesare, Christopher; Leach, James; Scheifele, Pete; Farina, Megan; Valencia, Gloria; Smith, David; Altaye, Mekibib; Rhea, Christopher K.; Talavage, Thomas; Myer, Gregory D.			Impact of Low-Level Blast Exposure on Brain Function after a One-Day Tactile Training and the Ameliorating Effect of a Jugular Vein Compression Neck Collar Device	JOURNAL OF NEUROTRAUMA			English	Article						auditory network functional connectivity; blast exposure; fMRI; neck collar; working memory	DEFAULT MODE NETWORK; WORKING-MEMORY LOAD; MILITARY PERSONNEL; INJURY; ACTIVATION; MILD; FMRI; CONNECTIVITY; HEARING; SEASON	Special Weapons and Tactics (SWAT) personnel who conduct breacher exercises are at risk for blast-related head trauma. We aimed to investigate the potential impact of low-level blast exposure during breacher training on the neural functioning of working memory and auditory network connectivity. We also aimed to evaluate the effects of a jugular vein compression collar, designed to internally mitigate slosh energy absorption, preserving neural functioning and connectivity, following blast exposure. A total of 23 SWAT personnel were recruited and randomly assigned to a non-collar (n=11) and collar group (n=12). All participants completed a 1-day breacher training with multiple blast exposure. Prior to and following training, 18 participants (non-collar, n=8; collar, n=10) completed functional magnetic resonance imaging (fMRI) of working memory using N-Back task; 20 participants (non-collar, n=10; collar, n=12) completed resting-state fMRI. Key findings from the working memory analysis include significantly increased fMRI brain activation in the right insular, right superior temporal pole, right inferior frontal gyrus, and pars orbitalis post-training for the non-collar group (p<0.05, threshold-free cluster enhancement corrected), but no changes were noted for the collar group. The elevation in fMRI activation in the non-collar group was found to correlate significantly (n=7, r=0.943, p=0.001) with average peak impulse amplitude experienced during the training. In the resting-state fMRI analysis, significant pre- to post-training increase in connectivity between the auditory network and two discrete regions (left middle frontal gyrus and left superior lateral occipital/angular gyri) was found in the non-collar group, while no change was observed in the collar group. These data provided initial evidence of the impact of low-level blast on working memory and auditory network connectivity as well as the protective effect of collar on brain function following blast exposure, and is congruent with previous collar findings in sport-related traumatic brain injury.	[Yuan, Weihong; Dudley, Jonathan] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Foss, Kim D. Barber; Thomas, Staci; Galloway, Ryan; DiCesare, Christopher; Smith, David; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, SPORT Ctr, Cincinnati, OH 45229 USA; [Leach, James] Cincinnati Childrens Hosp Med Ctr, Div Radiol, Cincinnati, OH 45229 USA; [Altaye, Mekibib] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Scheifele, Pete; Farina, Megan; Valencia, Gloria] Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Rhea, Christopher K.] Univ Cincinnati, Dept Orthoped Surg, Cincinnati, OH USA; [Talavage, Thomas] Univ N Carolina, Dept Kinesiol, Greensboro, NC 27412 USA; [Myer, Gregory D.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Yuan, Weihong; Myer, Gregory D.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Myer, GD (corresponding author), Cincinnati Childrens Hosp, 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA.	greg.myer@cchmc.org	DiCesare, Christopher/ABH-9573-2020; DiCesare, Christopher/AAA-3327-2021; Myer, Gregory/H-6572-2016	DiCesare, Christopher/0000-0002-6576-4904; Dudley, Jonathan/0000-0002-5189-9568; Talavage, Thomas/0000-0003-4977-6398; Myer, Gregory/0000-0002-9983-8422	Q30 Sports Innovations, LLC	The authors would like to thank Hamilton County Police Association (HCPA) SWAT. We appreciate their patience with the testing scheduling, follow-ups, and equipment additions. Their enthusiastic support made this study possible. We would like to thank Chief David Schaefer, SWAT Commander; Sheriff Jim Neil, Hamilton County Sheriff; and Chief Charles R. Lindsey, HCPA president for their help in obtaining approval for the study; we would also like to thank Interim SWAT Commander Tim Chin for helping to coordinate the entire study protocol. Special acknowledgement goes to SWAT Medical Directors, Dustin J. Calhoun, MD, and Edward Otten, MD, and Hamilton County Medical Director Lakshmi Kode Sammarco, MD. Without their time, commitment, and passion for the health and well-being of their team members, this study would not have been possible. We also thank Chief Jim Puthoff, Liaison to HCPA, who supported and presented the research ideas to the SWAT that allowed for the initial discussions to medical directors. We would also like to thank James P. Bailey, Evans Demolition/Excavation Division, who helped secure the bank for explosive breach training. We also thank the Bomb Explosive Ordnance Disposal Technicians Brad Justice and Steve Luensman who coordinated the explosive training and helped ensure the safety of both SWAT members and the research team. Lastly, the authors would like to thank Lacey Haas, Brynne Williams, Kaley Bridgewater, and Matt Lanier in the Imagine Research Center as their support made this study possible. The authors acknowledge funding support from Q30 Sports Innovations, LLC.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Chandler CDW, 2006, ASHA LEAD, V11, P8, DOI DOI 10.1044/LEADER.FTR4.11092006.8; Davies G, 1996, INJURY, V27, P647, DOI 10.1016/S0020-1383(96)00115-5; Defense and Veterans Brain Injury Center, 2015, DOD WORLDW NUMB TBI; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Dundas-Grant J, 1923, Proc R Soc Med, V16, P49; Dundas-Grant J, 1923, Proc R Soc Med, V16, P48; Elsayed NM, 2007, TOXICOL SCI, V95, P289, DOI 10.1093/toxsci/kfl138; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Glasstone S., 1977, EFFECTS NUCL WEAPONS, V3; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Gu M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2075463; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hood L.J., 1998, CLIN APPL AUDITORY B; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kubli LR, 2017, NOISE HEALTH, V19, P227, DOI 10.4103/nah.NAH_58_16; Laumen G, 2016, EAR HEARING, V37, pE276, DOI 10.1097/AUD.0000000000000301; LEVI L, 1990, ISRAEL J MED SCI, V26, P555; Littlefield PD, 2016, J NEUROTRAUM, V33, P71, DOI 10.1089/neu.2014.3824; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Martin F.N., 2015, INTRO AUDIOLOGY, V12; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister T., 2001, J NEUROPSYCHIATRY CL, V13, P141; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mu WY, 2017, J HEAD TRAUMA REHAB, V32, P55, DOI 10.1097/HTR.0000000000000213; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; Newsome MR, 2009, BRAIN IMAGING BEHAV, V3, P298, DOI 10.1007/s11682-009-9072-5; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Queckenstedt PD, 1916, DTSCH Z NERVENHEILKU, V55, P325, DOI [10.1007/BF01733057, DOI 10.1007/BF01733057]; Rhea CK, 2017, MIL MED, V182, P147, DOI 10.7205/MILMED-D-16-00140; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Samuel Glasstone., 1964, EFFECTS NUCL WEAPONS; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schwartz I, 2008, BRAIN INJURY, V22, P255, DOI 10.1080/02699050801941763; Shaffer LA, 2003, EAR HEARING, V24, P367, DOI 10.1097/01.AUD.0000090439.16438.9F; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shenk TE, 2015, DEV NEUROPSYCHOL, V40, P63, DOI 10.1080/87565641.2015.1014088; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Sindelar B, 2017, J NEUROTRAUM, V34, P1703, DOI 10.1089/neu.2016.4648; Sindelar B, 2017, OTOL NEUROTOL, V38, P591, DOI 10.1097/MAO.0000000000001332; Smith DW, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113511588; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Teng C, 2003, BRIT J OPHTHALMOL, V87, P946, DOI 10.1136/bjo.87.8.946; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; United States Department of Defense, 1999, DEP DEF DES CRIT STA; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Walker JJ, 2013, AM FAM PHYSICIAN, V87, P41; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WEIBULL HRW, 1968, ANN NY ACAD SCI, V152, P357, DOI 10.1111/j.1749-6632.1968.tb11987.x; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Wu Y, 2017, SCI REP, P7; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Yuan WH, 2018, J NEUROTRAUM, V35, P1248, DOI 10.1089/neu.2017.5262; Yuan WH, 2017, J NEUROTRAUM, V34, P2432, DOI 10.1089/neu.2016.4834	81	7	7	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2019	36	5					721	734		10.1089/neu.2018.5737		OCT 2018	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HR2BG	WOS:000446276000001	30136637				2022-02-06	
J	Szczygielski, J; Glameanu, C; Muller, A; Klotz, M; Sippl, C; Hubertus, V; Schafer, KH; Mautes, AE; Schwerdtfeger, K; Oertel, J				Szczygielski, Jacek; Glameanu, Cosmin; Mueller, Andreas; Klotz, Markus; Sippl, Christoph; Hubertus, Vanessa; Schaefer, Karl-Herbert; Mautes, Angelika E.; Schwerdtfeger, Karsten; Oertel, Joachim			Changes in Posttraumatic Brain Edema in Craniectomy-Selective Brain Hypothermia Model Are Associated With Modulation of Aquaporin-4 Level	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; decompressive craniectomy; brain edema; hypothermia; aquaporin-4	CLOSED-HEAD INJURY; CONTROLLED CORTICAL IMPACT; DECOMPRESSIVE CRANIECTOMY; INTRACEREBRAL HEMORRHAGE; MILD HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; INTRACRANIAL-PRESSURE; BARRIER DISRUPTION; AQP4 EXPRESSION; CEREBRAL EDEMA	Both hypothermia and decompressive craniectomy have been considered as a treatment for traumatic brain injury. In previous experiments we established a murine model of decompressive craniectomy and we presented attenuated edema formation due to focal brain cooling. Since edema development is regulated via function of water channel proteins, our hypothesis was that the effects of decompressive craniectomy and of hypothermia are associated with a change in aquaporin-4 (AQP4) concentration. Male CD-1 mice were assigned into following groups (n = 5): sham, decompressive craniectomy, trauma, trauma followed by decompressive craniectomy and trauma + decompressive craniectomy followed by focal hypothermia. After 24 h, magnetic resonance imaging with volumetric evaluation of edema and contusion were performed, followed by ELISA analysis of AQP4 concentration in brain homogenates. Additional histopathological analysis of AQP4 immunoreactivity has been performed at more remote time point of 28d. Correlation analysis revealed a relationship between AQP4 level and both volume of edema (r(2) = 0.45, p < 0.01, **) and contusion (r(2) = 0.41, p < 0.01, **) 24 h after injury. Aggregated analysis of AQP4 level (mean +/- SEM) presented increased AQP4 concentration in animals subjected to trauma and decompressive craniectomy (52.1 +/- 5.2 pg/mL, p = 0.01; *), but not to trauma, decompressive craniectomy and hypothermia (45.3 +/- 3.6 pg/mL, p > 0.05; ns) as compared with animals subjected to decompressive craniectomy only (32.8 +/- 2.4 pg/mL). However, semiquantitative histopathological analysis at remote time point revealed no significant difference in AQP4 immunoreactivity across the experimental groups. This suggests that AQP4 is involved in early stages of brain edema formation after surgical decompression. The protective effect of selective brain cooling may be related to change in AQP4 response after decompressive craniectomy. The therapeutic potential of this interaction should be further explored.	[Szczygielski, Jacek; Glameanu, Cosmin; Sippl, Christoph; Hubertus, Vanessa; Mautes, Angelika E.; Schwerdtfeger, Karsten; Oertel, Joachim] Saarland Univ, Med Ctr, Fac Med, Dept Neurosurg, Homburg, Germany; [Szczygielski, Jacek] Saarland Univ, Med Ctr, Fac Med, Inst Neuropathol, Homburg, Germany; [Szczygielski, Jacek] Univ Rzeszow, Fac Med, Rzeszow, Poland; [Mueller, Andreas] Saarland Univ, Med Ctr, Dept Radiol, Fac Med, Homburg, Germany; [Klotz, Markus; Schaefer, Karl-Herbert] Univ Appl Sci Kaiserslautern, Working Grp Enter Nervous Syst AGENS, Kaiserslautern, Germany; [Hubertus, Vanessa] Charite, Dept Neurosurg, Berlin, Germany		Szczygielski, J (corresponding author), Saarland Univ, Med Ctr, Fac Med, Dept Neurosurg, Homburg, Germany.; Szczygielski, J (corresponding author), Saarland Univ, Med Ctr, Fac Med, Inst Neuropathol, Homburg, Germany.; Szczygielski, J (corresponding author), Univ Rzeszow, Fac Med, Rzeszow, Poland.	jacek.szczygielski@uks.eu	Szczygielski, Jacek/AAV-4791-2021; Oertel, Joachim/AAO-5012-2021	Szczygielski, Jacek/0000-0002-3157-2824; Hubertus, Vanessa/0000-0002-2653-5818	voluntary association Friends of Saarland University Medical Center	This work has been supported by financial award of voluntary association Friends of Saarland University Medical Center for JS.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Akdemir G, 2014, NEUROSCI LETT, V574, P70, DOI 10.1016/j.neulet.2014.03.073; Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; Andrews BT, 2016, J CRANIOFAC SURG, V27, P1875, DOI 10.1097/SCS.0000000000002897; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Beaumont A, 2002, ACT NEUR S, V81, P217; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Berger C, 2007, EXP NEUROL, V204, P131, DOI 10.1016/j.expneurol.2006.10.002; Blixt J, 2018, J NEUROTRAUM, V35, P671, DOI 10.1089/neu.2017.5015; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Buhler D, 2015, STROKE, V46, P819, DOI 10.1161/STROKEAHA.114.007703; Calviello L, 2018, NEUROCRIT CARE, V28, P212, DOI 10.1007/s12028-017-0475-7; Chen JQ, 2016, MED SCI MONITOR, V22, DOI 10.12659/MSM.898190; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chieregato A, 2005, ACTA NEUROCHIR SUPPL, V95, P159; Chiu CD, 2013, STROKE, V44, P1682, DOI 10.1161/STROKEAHA.113.675983; Chu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066051; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Coplin WM, 2001, NEUROL RES, V23, P277, DOI 10.1179/016164101101198433; Farag E, 2011, MINERVA ANESTESIOL, V77, P366; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feng JZ, 2017, J TRAUMA ACUTE CARE, V83, P296, DOI 10.1097/TA.0000000000001522; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fujita Y, 2003, NEUROSCI RES, V47, P437, DOI 10.1016/j.neures.2003.08.006; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; GAAB MR, 1990, ACT NEUR S, V51, P326; Gao DP, 2015, MOL MED REP, V11, P3009, DOI 10.3892/mmr.2014.3111; Gatto R, 2015, RESTOR NEUROL NEUROS, V33, P927, DOI 10.3233/RNN-150577; Girisgin AS, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.17(4)2015.21233; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Hsu MS, 2011, NEUROSCIENCE, V178, P21, DOI 10.1016/j.neuroscience.2011.01.020; Hubbard JA, 2015, ASN NEURO, V7, DOI 10.1177/1759091415605486; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; IACUC Committee, 2014, IACUC GUID MOUS AN A; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jin HB, 2016, MED SCI MONITOR, V22, P678, DOI 10.12659/MSM.897201; Jin YC, 2015, J NEUROTRAUM, V32, P1090, DOI 10.1089/neu.2014.3649; Katada R, 2014, FASEB J, V28, P705, DOI 10.1096/fj.13-231274; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Kim JY, 2013, J NEUROTRAUM, V30, P1170, DOI 10.1089/neu.2012.2691; Kim Jong-Heon, 2014, Exp Neurobiol, V23, P115, DOI 10.5607/en.2014.23.2.115; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Koizumi H, 2016, ACTA NEUROCHIR SUPPL, V122, P193, DOI 10.1007/978-3-319-22533-3_39; Kurisu K, 2016, NEUROSURGERY, V79, P125, DOI 10.1227/NEU.0000000000001088; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lazic SE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-5; Lee JH, 2016, NEUROBIOL DIS, V96, P248, DOI 10.1016/j.nbd.2016.09.013; Lin B, 2001, J NEUROTRAUM, V18, P389, DOI 10.1089/089771501750170958; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Lo Pizzo M, 2013, NEUROL SCI, V34, P1309, DOI 10.1007/s10072-012-1233-4; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Lu H, 2011, CHINESE MED J-PEKING, V124, P3148, DOI 10.3760/cma.j.issn.0366-6999.2011.19.034; Maegele M, 2015, ACTA RADIOL OPEN, V4, DOI 10.1177/2047981614555142; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Majdan M, 2014, MINERVA ANESTESIOL, V80, P1261; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou A, 1980, Adv Neurol, V28, P345; Marmarou A, 2000, ACT NEUR S, V76, P349; MCINTOSH TK, 1990, ACT NEUR S, V51, P263; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meng SZ, 2004, EUR J NEUROSCI, V19, P2261, DOI 10.1111/j.0953-816X.2004.03315.x; Nilsson OG, 2006, NEUROSURGERY, V59, P521, DOI 10.1227/01.NEU.0000227521.58701.E5; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; O'Phelan Kristine H, 2015, World J Crit Care Med, V4, P296, DOI 10.5492/wjccm.v4.i4.296; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Popescu C, 2015, J Med Life, V8, P272; Portella G, 2000, ACT NEUR S, V76, P273; Qing WG, 2009, J NEUROSURG, V110, P462, DOI 10.3171/2008.4.JNS17512; Qiu GP, 2015, NEUROSCI LETT, V588, P42, DOI 10.1016/j.neulet.2014.12.053; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Salman MM, 2017, EUR J NEUROSCI, V46, P2542, DOI 10.1111/ejn.13723; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Shima K, 2003, ACT NEUR S, V86, P17; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Soltani Z, 2016, J PHYSIOL BIOCHEM, V72, P33, DOI 10.1007/s13105-015-0453-5; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Szczygielski J, 2017, J NEUROTRAUM, V34, P1623, DOI 10.1089/neu.2016.4615; Szczygielski J, 2016, J NEUROTRAUM, V33, P122, DOI 10.1089/neu.2014.3835; Szczygielski J, 2010, ACTA NEUROCHIR SUPPL, V106, P225, DOI 10.1007/978-3-211-98811-4_42; Tang YP, 2010, EXP NEUROL, V223, P485, DOI 10.1016/j.expneurol.2010.01.015; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Thomas L, 1997, CONSERV BIOL, V11, P276, DOI 10.1046/j.1523-1739.1997.96102.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tian RF, 2015, BRAIN RES, V1622, P339, DOI 10.1016/j.brainres.2015.06.039; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Tourdias T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-143; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Verkman AS, 2014, NAT REV DRUG DISCOV, V13, P259, DOI 10.1038/nrd4226; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Westermaier T, 2017, J NEUROL SURG PART A, V78, P397, DOI 10.1055/s-0036-1596057; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wu JCC, 2013, J SURG RES, V179, P138, DOI 10.1016/j.jss.2012.09.013; Xiao F, 2004, ACAD EMERG MED, V11, P1001, DOI 10.1197/j.aem.2004.05.026; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; Yang J, 2017, SCI REP-UK, V7, DOI 10.1038/srep40358; Yao CP, 2011, J NEUROTRAUM, V28, P1237, DOI 10.1089/neu.2010.1678; Yao XM, 2015, J NEUROTRAUM, V32, P1458, DOI 10.1089/neu.2014.3675; Yao XM, 2015, NEUROSCI LETT, V584, P368, DOI 10.1016/j.neulet.2014.10.040; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725; Zhang CC, 2015, MOL MED REP, V12, P7351, DOI 10.3892/mmr.2015.4372; Zhang MK, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0295-2; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649; Zhong ZH, 2013, NEUROSCI LETT, V555, P24, DOI 10.1016/j.neulet.2013.09.023; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	147	7	7	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 2	2018	9								799	10.3389/fneur.2018.00799			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GV5AQ	WOS:000446113500001	30333785	gold, Green Published			2022-02-06	
J	Bellamkonda, S; Woodward, SJ; Campolettano, E; Gellner, R; Kelley, ME; Jones, DA; Genemaras, A; Beckwith, JG; Greenwald, RM; Maerlender, AC; Rowson, S; Duma, SM; Urban, JE; Stitzel, JD; Crisco, JJ				Bellamkonda, Srinidhi; Woodward, Samantha J.; Campolettano, Eamon; Gellner, Ryan; Kelley, Mireille E.; Jones, Derek A.; Genemaras, Amaris; Beckwith, Jonathan G.; Greenwald, Richard M.; Maerlender, Arthur C.; Rowson, Steven; Duma, Stefan M.; Urban, Jillian E.; Stitzel, Joel D.; Crisco, Joseph J.			Head Impact Exposure in Practices Correlates With Exposure in Games for Youth Football Players	JOURNAL OF APPLIED BIOMECHANICS			English	Article						linear acceleration; rotational acceleration; HIT system; impacts per practice; impacts per game	HIGH-SCHOOL FOOTBALL; TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; UNITED-STATES; NECK STRENGTH; EPIDEMIOLOGY; ACCELERATION; MAGNITUDE; CONTACT; SYSTEM	This study aimed to compare head impact exposures between practices and games in football players ages 9 to 14 years, who account for approximately 70% of all football players in the United States. Over a period of 2 seasons. 136 players were enrolled from 3 youth programs, and 49,847 head impacts were recorded from 345 practices and 137 games. During the study. individual players sustained a median of 211 impacts per season, with a maximum of 1226 impacts. Players sustained 50th (95th) percentile peak linear acceleration of 18.3 (46.9) g. peak rotational acceleration of 1305.4 (3316.6) rad.s(-2). and Head Impact Technology Severity Profile of 13.7 (24.3), respectively. Overall, players with a higher frequency of head impacts at practices recorded a higher frequency of head impacts at games (P < .001, r(2) = .52), and players who sustained a greater average magnitude of head impacts during practice also recorded a greater average magnitude of head impacts during games (P < .001). The youth football head impact data quantified in this study provide valuable insight into the player exposure profile, which should serve as a key baseline in efforts to reduce injury.	[Bellamkonda, Srinidhi; Woodward, Samantha J.; Crisco, Joseph J.] Brown Univ, Warren Alpert Med Sch, Bioengn Lab, Dept Orthopaed,Rhode Isl Hosp, Providence, RI 02912 USA; [Genemaras, Amaris; Beckwith, Jonathan G.; Greenwald, Richard M.] Simbex, Lebanon, NH USA; [Maerlender, Arthur C.] Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE USA; [Campolettano, Eamon; Gellner, Ryan; Rowson, Steven; Duma, Stefan M.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Kelley, Mireille E.; Jones, Derek A.; Urban, Jillian E.; Stitzel, Joel D.] Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, Winston Salem, NC USA		Crisco, JJ (corresponding author), Brown Univ, Warren Alpert Med Sch, Bioengn Lab, Dept Orthopaed,Rhode Isl Hosp, Providence, RI 02912 USA.	joseph_crisco@brown.edu	Stitzel, Joel/B-4045-2012; Rowson, Steven/B-1270-2012	Stitzel, Joel/0000-0001-9762-3033; Rowson, Steven/0000-0002-3227-0596; Crisco, Joseph/0000-0002-8786-0905	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH R01NS094410]; Riddell, Inc (Elyria, OH); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institutes of Health under the Award Number NIH R01NS094410. HIT System technology was developed in part under NIH R44HD40743 and research and development support from Riddell, Inc (Elyria, OH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors appreciate and acknowledge the researchers and institutions from which the data were collected and would also like to thank Bethany Wilcox and Arlene Garcia from Brown University. J.J.C., R.M.G., J.G.B., and Simbex have a financial interest in the instruments (HIT System, Sideline Response System, Riddell, Inc) that were used to collect the biomechanical data reported in this study.	[Anonymous], 2012, BIOMED ENG, V40, P1, DOI [10.1007/s10439-011-0392-4, DOI 10.1007/S10439-011-0392-4]; Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Cantu RC, 2012, SPORTS LEGACY I HIT; Cobb Bryan R, 2014, Biomed Sci Instrum, V50, P285; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Dick R, 2007, J ATHL TRAINING, V42, P262; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kerr ZY, 2018, HEALTH PROMOT PRACT, V19, P184, DOI 10.1177/1524839917700398; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kucera KL, 2017, MMWR-MORBID MORTAL W, V65, P1465, DOI 10.15585/mmwr.mm6552a2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Meeuwisse WH, 1998, CLIN J SPORT MED, V8, P164, DOI 10.1097/00042752-199807000-00003; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; OBrien C, HAZARD SCREENING REP, P2884, DOI [10.1177/0363546513502458, DOI 10.1177/0363546513502458]; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Powell JW, 1999, J ATHL TRAINING, V34, P277; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Rowson S, 2018, ANN, V5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	59	7	7	0	5	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	OCT	2018	34	5					354	360		10.1123/jab.2017-0207			7	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	GX9XI	WOS:000448161700002	29651910	Green Accepted			2022-02-06	
J	Cheng, YJ; Zan, JY; Song, YY; Yang, GY; Shang, HB; Zhao, WG				Cheng, Yijun; Zan, Jieyu; Song, Yaying; Yang, Guoyuan; Shang, Hanbing; Zhao, Weiguo			Evaluation of intestinal injury, inflammatory response and oxidative stress following intracerebral hemorrhage in mice	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						intracerebral hemorrhage; intestinal injury; gut mucosa; barrier dysfunction; small intestinal motility; inflammatory response; oxidative stress	TRAUMATIC BRAIN-INJURY; SYSTEMIC LPS INJECTION; NF-KAPPA-B; POSTOPERATIVE ILEUS; SIGNALING PATHWAY; TIGHT JUNCTION; RATS; DYSFUNCTION; STROKE; ACTIVATION	Intestinal injury is a common complication following intracerebral hemorrhage (ICH), which leads to malnutrition, impaired immunity and unsatisfactory prognosis. Previous studies have revealed the pathogenesis of intestinal injury following traumatic brain injury using ischemic stroke models. However, the effects of ICH on intestinal injury remain unknown. The present study aimed to investigate the pathological alterations and molecular mechanism, as well as the time course of intestinal injury following ICH in mice. Male C57BL/6 mice were randomly divided into the following seven groups (n=6 mice/group): Control group, which underwent a sham operation, and six ICH groups (2, 6, 12 and 24 h, and days 3 and 7). The ICH model was induced by stereotactically injecting autologous blood in two stages into the brain. Subsequently, intestinal tissue was stained with hematoxylin and eosin for histopathological examination. Small intestinal motility was measured by charcoal meal test, and gut barrier dysfunction was evaluated by detecting the plasma levels of endotoxin. Quantitative polymerase chain reaction (qPCR), immunohisto-chemistry and ELISA analysis were performed to evaluate the mRNA and protein expression levels of inflammatory cytokines [interleukin (IL)-1 beta, IL-6, tumor necrosis factor-alpha, intercellular adhesion molecule 1, monocyte chemotactic protein 1 and chemokine (C-C motif) ligand-5] in intestinal tissue and serum. Furthermore, intestinal leukocyte infiltration was detected by measuring myeloperoxidase activity. Oxidative stress was indirectly detected by measuring reactive oxygen species-associated markers (malondialdehyde content and superoxide dismutase activity assays) and the mRNA and protein expression levels of antioxidant genes [nuclear factor (erythroid-derived 2)-like 2, manganese superoxide dismutase and heme oxygenase 1] by qPCR and western blot analysis. The results demonstrated that significant destruction of the gut mucosa, delayed small intestinal motility, intestinal barrier dysfunction, and increased inflammatory responses and oxidative stress occurred rapidly in response to ICH. These symptoms occurred as early as 2 h after ICH and persisted for 7 days. These findings suggested that ICH may induce immediate and persistent damage to gut structure and barrier function, which may be associated with upregulalion of inflammation and oxidative stress markers.	[Cheng, Yijun; Shang, Hanbing; Zhao, Weiguo] Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Neurosurg, Sch Med, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China; [Zan, Jieyu] Nantong First Peoples Hosp, Dept Pediat, Nantong 226001, Jiangsu, Peoples R China; [Song, Yaying; Yang, Guoyuan] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Neurol, Shanghai 200025, Peoples R China; [Yang, Guoyuan] Shanghai Jiao Tong Univ, Med X Res Inst, Neurosci & Neuroengn Res Ctr, Shanghai 200025, Peoples R China		Shang, HB; Zhao, WG (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Neurosurg, Sch Med, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China.	ruijinshb@qq.com; ruijinsjwk@qq.com			Natural Science Fund from the Science and Technology Commission of Shanghai Municipality [14ZR1426000, 16ZR14212000]	The present study was supported by the Natural Science Fund (grant nos. 14ZR1426000 and 16ZR14212000) from the Science and Technology Commission of Shanghai Municipality.	Adeoye O, 2010, NAT REV NEUROL, V6, P593, DOI 10.1038/nrneurol.2010.146; ARNDT H, 1992, INFLAMMATION, V16, P549, DOI 10.1007/BF00918979; Bohatschek M, 2001, EXP NEUROL, V172, P137, DOI 10.1006/exnr.2001.7764; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Giudice A, 2010, METHODS MOL BIOL, V647, P37, DOI 10.1007/978-1-60761-738-9_3; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Jin W, 2009, J SURG RES, V157, P251, DOI 10.1016/j.jss.2008.08.003; Kalff JC, 2000, GASTROENTEROLOGY, V118, P316, DOI 10.1016/S0016-5085(00)70214-9; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Li XL, 2015, SHOCK, V43, P540, DOI 10.1097/SHK.0000000000000353; Liu XH, 2015, WORLD J GASTROENTERO, V21, P13250, DOI 10.3748/wjg.v21.i47.13250; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowa G, 2015, CLIN RADIOL, V70, P898, DOI 10.1016/j.crad.2015.04.001; Lu WY, 1997, NEUROSURGERY, V41, P416, DOI 10.1097/00006123-199708000-00017; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Misra UK, 2003, J NEUROL SCI, V208, P25, DOI 10.1016/S0022-510X(02)00415-X; MOLMENTI EP, 1993, J BIOL CHEM, V268, P14116; National Research Council, 2011, GUIDE CARE USE LAB A, V8th ed., P1, DOI [10.17226/12910, DOI 10.17226/12910]; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nussbaum C, 2013, ANTIOXID REDOX SIGN, V18, P692, DOI 10.1089/ars.2012.4783; Phillips NA, 2015, J PHYSIOL-LONDON, V593, P739, DOI 10.1113/jphysiol.2014.283416; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Shang H, 2013, FREE RADICAL RES, V47, P368, DOI 10.3109/10715762.2013.778403; Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS74, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.005; The FO, 2005, BRIT J PHARMACOL, V146, P252, DOI 10.1038/sj.bjp.0706303; Timmermans K, 2015, SHOCK, V43, P117, DOI 10.1097/SHK.0000000000000284; Turner JR, 2000, SEMIN CELL DEV BIOL, V11, P301, DOI 10.1006/scdb.2000.0180; Wang WJ, 2012, CNS NEUROSCI THER, V18, P773, DOI 10.1111/j.1755-5949.2012.00367.x; Wehner S, 2005, SURGERY, V137, P436, DOI 10.1016/j.surg.2004.11.003; Wehner S, 2012, LANGENBECK ARCH SURG, V397, P591, DOI 10.1007/s00423-012-0915-y; Xu XP, 2012, ANAT REC, V295, P307, DOI 10.1002/ar.21490; Xue B, 2015, NEUROGASTROENT MOTIL, V27, P550, DOI 10.1111/nmo.12531; Yang TC, 2013, AM J MED SCI, V346, P279, DOI 10.1097/MAJ.0b013e318271a621	39	7	9	2	25	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	OCT	2018	42	4					2120	2128		10.3892/ijmm.2018.3755			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GR8JX	WOS:000442971000035	30015849	Bronze			2022-02-06	
J	Feng, GL; Feng, J; Zhang, SJ; Tong, YP; Zhang, Q; Yang, XM; Zhang, HP				Feng, Guilong; Feng, Jie; Zhang, Shaojun; Tong, Yuping; Zhang, Qiang; Yang, Xiaoming; Zhang, Huaping			Altered levels of alpha-melanocyte stimulating hormone in cerebrospinal fluid and plasma of patients with traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury (TBI); Alpha-melanocyte stimulating hormone (alpha-MSH); Tumor necrosis factor-alpha (TNF-alpha); Cerebrospinal fluid (CSF); Intracranial pressure (ICP)	RAT HYPOTHALAMIC SLICES; INFLAMMATORY RESPONSE; HEMORRHAGIC-SHOCK; IN-VIVO; MELANOCORTINS; RELEASE; MSH; RECOVERY; RECEPTOR; PROTEIN	Traumatic brain injury (TBI) is closely associated with marked inflammation. Although alpha-Melanocyte-Stimulating Hormone (alpha-MSH) exerts powerful anti-inflammatory effects, changes in endogenous alpha-MSH levels following TBI remain poorly understood. We investigated the changes of alpha-MSH levels in the cerebrospinal fluid (CSF) and plasma of post-TBI patients and the association of these changes with the severity of TBI and inflammation. TBI severity was assessed by the GCS coma scale from which, patients were separated into three groups. Clinical data were collected on days 1, 3, 5, and 7 including levels of alpha-MSH, tumor necrosis factor (TNF-alpha), and intracranial pressure (ICP). alpha-MSH levels in CSF steadily increased for one week (peak at day 5) but plasma alpha-MSH decreased and remained low. These changes were more substantial in the Severe Group of TBI with lower GCS. TNF-alpha levels were similarly increased in both CSF and plasma (peak at day 3). In the early phase of TBI elevated TNF-alpha and ICP dominated, and CSF alpha-MSH displayed a slow and insufficient increase. In later phases of TBI, TNF-alpha and ICP levels were alleviated concordantly with sustained increases in central alpha-MSH, wherein an anti-inflammatory environment might predominate. The relationship between plasma alpha-MSH and TNF-alpha showed significant negative correlation, and the relationship between CSF alpha-MSH and TNF-alpha showed significant positive correlation with a two-day lag. In conclusion, plasma alpha-MSH levels decreased, but CSF levels increased slowly following TBI. These changes were more substantial in severe patients with a lower GCS. Increases in central alpha-MSH paralleled alleviation of inflammation. (C) 2018 Elsevier B.V. All rights reserved.	[Feng, Guilong; Feng, Jie; Tong, Yuping; Yang, Xiaoming] Shanxi Med Univ, Dept Emergency, Hosp 1, Taiyuan 030001, Shanxi, Peoples R China; [Zhang, Shaojun] Shanxi Prov Peoples Hosp, Dept Endocrinol, Taiyuan, Shanxi, Peoples R China; [Zhang, Qiang] Zhengzhou Univ, Dept Emergency, Zhengzhou Cent Hosp, Zhengzhou, Henan, Peoples R China; [Zhang, Huaping] Shanxi Med Univ, Mol Biol Labs, Taiyuan, Shanxi, Peoples R China		Feng, GL (corresponding author), Shanxi Med Univ, Dept Emergency, Hosp 1, Taiyuan 030001, Shanxi, Peoples R China.	fg12008friend@163.com			Natural Science Foundation of Shanxi Province, ChinaNatural Science Foundation of Shanxi Province [2014011041-2]; National Clinical Specialty Construction Project of China [2013-544]	This work was supported by the Natural Science Foundation of Shanxi Province, China (Grant Number: 2014011041-2) and the National Clinical Specialty Construction Project of China (Grant Number: 2013-544).	Altavilla D, 1998, BRIT J PHARMACOL, V124, P1587, DOI 10.1038/sj.bjp.0702038; BERTOLINI A, 1989, RESUSCITATION, V18, P253, DOI 10.1016/0300-9572(89)90027-0; Bharne AP, 2011, NEUROPEPTIDES, V45, P25, DOI 10.1016/j.npep.2010.10.001; Bitto A, 2012, CRIT CARE MED, V40, P945, DOI 10.1097/CCM.0b013e318236efde; BLASQUEZ C, 1992, BRAIN RES, V596, P163, DOI 10.1016/0006-8993(92)91544-O; Brzoska T, 2008, ENDOCR REV, V29, P581, DOI 10.1210/er.2007-0027; CARR JA, 1991, NEUROENDOCRINOLOGY, V54, P616, DOI 10.1159/000125968; Catania A, 1995, NEUROIMMUNOMODULAT, V2, P258, DOI 10.1159/000097204; Catania A, 2008, TRENDS NEUROSCI, V31, P353, DOI 10.1016/j.tins.2008.04.002; Catania A, 2010, THESCIENTIFICWORLDJO, V10, P1840, DOI 10.1100/tsw.2010.173; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Giuliani D, 2011, ACTA NEUROPATHOL, V122, P443, DOI 10.1007/s00401-011-0873-4; GUARINI S, 1990, CRIT CARE MED, V18, P862, DOI 10.1097/00003246-199008000-00014; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Huang S. Y., 2007, CLIN GUIDELINES MANA, P56; Lasaga M, 2008, PEPTIDES, V29, P1825, DOI 10.1016/j.peptides.2008.06.009; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; MABLEY J, 1991, EUR J PHARMACOL, V209, P127, DOI 10.1016/0014-2999(91)90023-J; Magnoni S, 2003, J NEUROTRAUM, V20, P251, DOI 10.1089/089771503321532833; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Papadopoulos AD, 1999, J NEUROENDOCRINOL, V11, P315; Roth J, 2004, FRONT BIOSCI-LANDMRK, V9, P816, DOI 10.2741/1277; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Scranton RA, 2015, J CLIN MED, V4, P1463, DOI 10.3390/jcm4071463; Sinha PS, 2004, BRAIN RES, V1001, P150, DOI 10.1016/j.brainres.2003.12.007; Squadrito F, 1999, BRIT J PHARMACOL, V128, P816, DOI 10.1038/sj.bjp.0702848; Stein DM, 2012, SHOCK, V37, P563, DOI 10.1097/SHK.0b013e3182534f93; Todd SR, 2009, J TRAUMA, V66, P465, DOI 10.1097/TA.0b013e31818b1e04; Weaver LC, 2015, EXP NEUROL, V271, P409, DOI 10.1016/j.expneurol.2015.07.003; Xiao EN, 2003, ENDOCRINOLOGY, V144, P1736, DOI 10.1210/en.2002-220013; [周强 Zhou Qiang], 2012, [中华急诊医学杂志, Chinese Journal of Emergency Medicine], V21, P189	33	7	8	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 1	2018	1696						22	30		10.1016/j.brainres.2018.05.044			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO6CI	WOS:000440121300003	29859146				2022-02-06	
J	Gutowski, P; Meier, U; Rohde, V; Lemcke, J; von der Brelie, C				Gutowski, Pawel; Meier, Ullrich; Rohde, Veit; Lemcke, Johannes; von der Brelie, Christian			Clinical Outcome of Epidural Hematoma Treated Surgically in the Era of Modern Resuscitation and Trauma Care	WORLD NEUROSURGERY			English	Article						EDH; Isolated EDH; Outcome; Modern resuscitation; Trauma care	ACUTE SUBDURAL-HEMATOMA; EXTRADURAL HEMATOMA; BRAIN-INJURY; PREINJURY WARFARIN; MORTALITY; COMPLICATIONS; MANAGEMENT; COAGULOPATHY; SCORE	OBJECTIVE: Patients from contemporary populations with traumatic brain injury (TBI) resulting from epidural hematoma (EDH) may differ regarding age, comorbidities, and coagulation status. We therefore analyzed predictors for the clinical outcome of patients with EDH treated surgically regarding modern approaches to resuscitation and trauma care. METHODS: A retrospective observational analysis was carried out. All patients included underwent surgery. The indication for surgery followed international guidelines. Retrospective data evaluation considered data reflecting the effectiveness of trauma care, baseline characteristics, and radiologic findings. In this analysis, we divided patients into 2 groups (isolated EDH vs. EDH plus other intracranial traumatic injuries). The neurologic outcome was assessed at discharge using the Glasgow Outcome Scale. RESULTS: Two hundred and sixty-eight patients with epidural hematoma, of whom 131 underwent surgery, were treated between January 1997 and December 2012 in our level-1 trauma center. The overall mortality was 6.8% (mortality for patients with Glasgow Outcome Scale score < 9, 15%). As expected, factors with a highly significant (P < 0.01) impact on outcome were concomitant with other intracranial injuries, brain midline shift, and higher Injury Severity Score. Alcohol intoxication was a significant (P < 0.05) predictor of an unfavorable outcome. Anticoagulants and Glasgow Coma Scale score at admission had no significant impact on the outcome. CONCLUSIONS: The outcome for EDH is more favorable than decades ago, most probably reflecting a well-established chain of trauma care. Therefore, EDH is a treatable disease with a high probability of a favorable outcome.	[Gutowski, Pawel; Meier, Ullrich; Lemcke, Johannes; von der Brelie, Christian] Unfallkrankenhaus Berlin, Dept Neurosurg, Berlin, Germany; [Rohde, Veit; von der Brelie, Christian] Univ Gottingen, Dept Neurosurg, Gottingen, Germany		Gutowski, P (corresponding author), Unfallkrankenhaus Berlin, Dept Neurosurg, Berlin, Germany.	Pawel.Gutowski@ukh.de		Lemcke, Johannes/0000-0002-8073-1625			Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balik V, 2011, CENT EUR NEUROSURG, V72, P169, DOI 10.1055/s-0031-1286261; Basamh M, 2016, CAN J NEUROL SCI, V43, P74, DOI 10.1017/cjn.2015.232; Bershad EM, 2008, J NEUROSURG, V109, P664, DOI 10.3171/JNS/2008/109/10/0664; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; COOK RJ, 1988, ACTA NEUROCHIR, V95, P90, DOI 10.1007/BF01790766; Dubey A, 2004, NEUROL INDIA, V52, P443; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Heinzelmann M, 1996, INJURY, V27, P345, DOI 10.1016/0020-1383(95)00223-5; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JONES NR, 1993, BRIT J NEUROSURG, V7, P465, DOI 10.3109/02688699308995068; Juratli TA, 2015, ANAESTHESIST, V64, P159, DOI 10.1007/s00101-014-2337-4; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Leggate JRS, 1989, BRIT J NEUROSURG, V3, P533, DOI 10.3109/02688698909002844; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P199, DOI 10.1007/s00402-012-1652-y; Lemcke J, 2014, BLOOD COAGUL FIBRIN, V25, P353, DOI 10.1097/MBC.0000000000000042; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mathias JL, 2018, NEUROPSYCHOL REHABIL, V28, P997, DOI 10.1080/09602011.2016.1224190; Meizoso JP, 2015, J TRAUMA ACUTE CARE, V79, P227, DOI 10.1097/TA.0000000000000748; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Paci GM, 2009, J TRAUMA, V67, P531, DOI 10.1097/TA.0b013e3181b840e8; PANG D, 1983, J NEUROSURG, V59, P958, DOI 10.3171/jns.1983.59.6.0958; PARZHUBER A, 1994, UNFALLCHIRURG, V97, P615; Saab M, 1996, J ACCID EMERG MED, V13, P208; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1988, Brain Inj, V2, P87, DOI 10.3109/02699058809150935; Tallon JM, 2008, CAN J SURG, V51, P339; von der Brelie C, 2015, J TRAUMA ACUTE CARE, V79, P295, DOI 10.1097/TA.0000000000000722; Wagner N, 2016, SHOCK, V46, P261, DOI 10.1097/SHK.0000000000000620; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	37	7	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2018	118						E166	E174		10.1016/j.wneu.2018.06.147			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GU1NY	WOS:000445032000024	29959068				2022-02-06	
J	Hammond, FM; Sauve, W; Ledon, F; Davis, C; Formella, AE				Hammond, Flora M.; Sauve, William; Ledon, Fred; Davis, Charles; Formella, Andrea E.			Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM-II Open Label Study	PM&R			English	Article							EMOTIONAL EXPRESSION DISORDER; PATHOLOGICAL LAUGHTER; MULTIPLE-SCLEROSIS; DOUBLE-BLIND; VALIDATION; FLUOXETINE; LABILITY; STROKE; PATHOPHYSIOLOGY; NUEDEXTA(R)	Background: Dextromethorphan 20 mg / quinidine 10 mg (DM/Q) was approved to treat pseudobulbar affect (PBA) based on phase 3 trials conducted in participants with amyotrophic lateral sclerosis or multiple sclerosis. PRISM II evaluated DM/Q effectiveness, safety, and tolerability for PBA following stroke, dementia, or traumatic brain injury (TBI). Objective: To report results from the TBI cohort of PRISM II, including a TBI-specific functional scale. Design: Open-label trial evaluating twice-daily DM/Q over 90 days. Study Participants: Adults (n = 120) with a clinical diagnosis of PBA secondary to nonpenetrating TBI; stable psychiatric medications were allowed. Methods: PRISM II was an open-label, 12-week trial enrolling adults with PBA secondary to dementia, stroke, or TBI (NCT01799941). All study participants received DM/Q 20/10 mg twice daily. Study visits occurred at baseline and at day 30 and day 90. Setting: 150 U.S. centers. Main Outcome Measurements: Primary endpoint was change in Center for Neurologic Study-Lability Scale (CNS-LS) score from baseline to day 90. Secondary outcomes included PBA episode count, Clinical and Patient Global Impression of Change (CGI-C; PGI-C), Quality of Life-Visual Analog Scale (QOL-VAS), treatment satisfaction, Neurobehavioral Functioning Inventory (NFI), Patient Health Questionnaire (PHQ-9), and Mini Mental State Examination (MMSE). Results: DM/Q-treated participants showed significant mean (SD) reductions in CNS-LS from baseline (day 30, -5.6 [5.2]; day 90, -8.5 [5.2]; both, P<.001). Compared with baseline, PBA episodes were reduced by 61.3% and 78.5% at days 30 and 90 (both, P<.001). At day 90, 78% and 73% of study participants had "much improved" or "very much improved" on the CGI-C and PGI-C. QOL-VAS scores were significantly reduced from baseline (-3.7 [3.3], P<.001). Mean (SD) PHQ-9 scores improved compared to baseline at day 30 (-3.2 [5.3], P<.001) and 90 (-5.2 [6.4], P<.001). NFI T scores were significantly improved (P<.001), whereas MMSE scores were unchanged. Adverse events (AEs) were consistent with the known DM/Q safety profile; the most common AE was diarrhea (8.3%). Conclusions: DM/Q was well tolerated, and it significantly reduced PBA episodes in study participants with TBI. Changes in CNS-LS and PBA episode count were similar to changes with DM/Q in phase 3 trials.	[Hammond, Flora M.] Indiana Univ Sch Med, Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Sauve, William] TMS NeuroHlth Ctr, Richmond, VA USA; [Ledon, Fred; Formella, Andrea E.] Avanir Pharmaceut Inc, Aliso Viejo, CA USA; [Davis, Charles] CSD Biostat Inc, Tucson, AZ USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA.	Flora.hammond@rhin.com	Formella, Andrea/AAE-4073-2020; Group, Prescott Medical Communications/AAE-7494-2019	Formella, Andrea/0000-0003-2737-7898; 			ANDERSEN G, 1993, LANCET, V342, P837, DOI 10.1016/0140-6736(93)92696-Q; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Banos JH, 2010, J HEAD TRAUMA REHAB, V25, P357, DOI 10.1097/HTR.0b013e3181d6c715; Brooks BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072232; Brooks BR, 2004, NEUROLOGY, V63, P1364; Brown KW, 1998, ACTA PSYCHIAT SCAND, V98, P455, DOI 10.1111/j.1600-0447.1998.tb10119.x; Burns A, 1999, INT J GERIATR PSYCH, V14, P681, DOI 10.1002/(SICI)1099-1166(199908)14:8<681::AID-GPS49>3.3.CO;2-Q; CODD EE, 1995, J PHARMACOL EXP THER, V274, P1263; Cummings JL, 2006, CNS SPECTRUMS, V11, P1; Doody RS, 2016, CNS SPECTRUMS, V21, P450, DOI 10.1017/S1092852915000620; Engelman W, 2014, NEUROPSYCH DIS TREAT, V10, P1903, DOI 10.2147/NDT.S63304; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fonda JR, 2015, J REHABIL RES DEV, V52, P839, DOI 10.1682/JRRD.2014.08.0191; Guy W., 1976, CLIN GLOBAL IMPRESSI; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammond F, 2016, AM J GERIAT PSYCHIAT, V24, pS146, DOI 10.1016/j.jagp.2016.02.018; Hammond FM, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0679-z; Hernandez SC, 2000, J PHARMACOL EXP THER, V293, P962; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Lauterbach EC, 2013, NEUROSCI BIOBEHAV R, V37, P1893, DOI 10.1016/j.neubiorev.2013.03.002; Lavins BJ, 2009, GASTROENTEROLOGY, V136, pA71; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; Panitch HS, 2006, ANN NEUROL, V59, P780, DOI 10.1002/ana.20828; Parvizi J, 2009, J NEUROPSYCH CLIN N, V21, P75, DOI 10.1176/appi.neuropsych.21.1.75; Pattee GL, 2014, CURR MED RES OPIN, V30, P2255, DOI 10.1185/03007995.2014.940040; Pioro EP, 2014, NEUROL THER, V3, P15, DOI 10.1007/s40120-014-0018-5; Pioro EP, 2011, DRUGS, V71, P1193, DOI 10.2165/11591450-000000000-00000; Pioro EP, 2010, ANN NEUROL, V68, P693, DOI 10.1002/ana.22093; Pope LE, 2004, J CLIN PHARMACOL, V44, P1132, DOI 10.1177/0091270004269521; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; Roy D, 2015, J NEUROPSYCH CLIN N, V27, P299, DOI 10.1176/appi.neuropsych.15030045; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; Smi CK, 2006, STROKE, V37, P156, DOI 10.1161/01.STR.0000190892.93663.e2; Smith RA, 2004, MULT SCLER J, V10, P679, DOI 10.1191/1352458504ms1106oa; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Taylor CP, 2016, PHARMACOL THERAPEUT, V164, P170, DOI 10.1016/j.pharmthera.2016.04.010; Werling LL, 2007, EXP NEUROL, V207, P248, DOI 10.1016/j.expneurol.2007.06.013; Work SS, 2011, ADV THER, V28, P586, DOI 10.1007/s12325-011-0031-3; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160; ZOROWITZ R, 2016, STROKE S1, V47	41	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2018	10	10					993	1003		10.1016/j.pmrj.2018.02.010			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GY0MW	WOS:000448216000001	29477412				2022-02-06	
J	Han, PF; Winkler, N; Hummel, C; Hahner, A; Gerber, J; Hummel, T				Han, Pengfei; Winkler, Nicole; Hummel, Cornelia; Haehner, Antje; Gerber, Johannes; Hummel, Thomas			Impaired brain response to odors in patients with varied severity of olfactory loss after traumatic brain injury	JOURNAL OF NEUROLOGY			English	Article						Traumatic brain injury; Olfaction dysfunction; Odor; Functional magnetic resonance imaging; Time since injury	HEAD-INJURY; TRIGEMINAL FUNCTION; DISCRIMINATION; IDENTIFICATION; ACTIVATION; VOLUME; DYSFUNCTION; STIMULI; TESTS; TASTE	Traumatic brain injury (TBI) as a major public health problem may lead to olfactory dysfunction. However, little is known about brain responses to odors in TBI olfactory loss patients. Nineteen healthy controls and forty TBI olfactory dysfunctional patients (19 with hyposmia and 21 with anosmia) underwent a functional magnetic resonance imaging scan when two odors (peach and coffee) were presented intranasally using a computerized olfactometer. Olfactory performance was measured using the "Sniffin' Sticks" test. TBI patients with hyposmia or anosmia showed decreased odor-induced brain activations in the primary olfactory area and insular cortex as compared to healthy controls (FWE-corrected peak p < 0.05). In addition, negative correlations were found between the time since injury (in month) and odor-induced brain responses in the right primary olfactory area for patients with hyposmia. Similar correlations were seen in the insula and orbitofrontal cortex for patients with anosmia. In conclusion, results from the current study are evidences for the impairment of central nervous processing of odor perception at all levels of the olfactory system among TBI patients with olfactory loss. In addition, the duration after the initial injury may have an impact on the severity of olfactory dysfunction.	[Han, Pengfei; Winkler, Nicole; Hummel, Cornelia; Haehner, Antje; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Dresden, Germany; [Gerber, Johannes] Tech Univ Dresden, Dept Neuroradiol, Dresden, Germany		Han, PF (corresponding author), Tech Univ Dresden, Dept Otorhinolaryngol, Dresden, Germany.	pengfeihan88@gmail.com	Gerber, Johannes/U-4918-2019	Gerber, Johannes/0000-0001-7465-8700; Han, Pengfei/0000-0001-8266-6655	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG HU 411/18 - 1]	We would like to thank Claudia Valder, Frey und Lau, Henstedt-Ulzburg, Germany, for an excellent collaboration and donation of the odors. This research as supported by a Grant from the Deutsche Forschungsgemeinschaft to TH (DFG HU 411/18 - 1).	Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; Bengtsson S, 2001, NEUROREPORT, V12, P2027, DOI 10.1097/00001756-200107030-00048; Boyle JA, 2007, NEUROSCIENCE, V149, P223, DOI 10.1016/j.neuroscience.2007.06.045; Bratt M, 2018, BRAIN INJURY, V32, P1021, DOI 10.1080/02699052.2018.1469043; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P625, DOI 10.1093/chemse/26.6.625; Charland-Verville V, 2012, AM J RHINOL ALLERGY, V26, P222, DOI 10.2500/ajra.2012.26.3769; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; Damm M, 2004, HNO, V52, P112, DOI 10.1007/s00106-003-0877-z; de Guise E, 2015, BRAIN INJURY, V29, P730, DOI 10.3109/02699052.2015.1004748; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fjaeldstad A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42534; Frasnelli J, 2007, INT J PSYCHOPHYSIOL, V65, P177, DOI 10.1016/j.ijpsycho.2007.03.007; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; Frasnelli J, 2007, CEREB CORTEX, V17, P2268, DOI 10.1093/cercor/bhl135; Gardner AJ, 2017, PHYS MED REH CLIN N, V28, P413, DOI 10.1016/j.pmr.2016.12.014; Gottfried JA, 2006, ADV OTO-RHINO-LARYNG, V63, P44, DOI 10.1159/000093750; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Gudziol H, 2007, LARYNGO RHINO OTOL, V86, P640, DOI 10.1055/s-2007-966228; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1996, CHEM SENSES, V21, P75, DOI 10.1093/chemse/21.1.75; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T., 2016, Rhinology, V56, P1, DOI 10.4193/Rhin16.248; Hummel T, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00125; Hummel T, 2015, J NEUROL, V262, P1046, DOI 10.1007/s00415-015-7691-x; Hummel T, 2010, ARCH OTOLARYNGOL, V136, P347, DOI 10.1001/archoto.2010.27; Iannilli E, 2007, BRAIN RES, V1139, P235, DOI 10.1016/j.brainres.2006.12.082; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Kobal G, 1981, ELEKTROPHYSIOLOGISCH; Konstantinidis I, 2013, LARYNGOSCOPE, V123, pE85, DOI 10.1002/lary.24390; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Landis BN, 2010, J NEUROL, V257, P1303, DOI 10.1007/s00415-010-5513-8; Lee VK, 2016, BRAIN INJURY, V30, P1737, DOI 10.1080/02699052.2016.1199895; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lotsch J, 2016, NEUROIMAGE-CLIN, V11, P99, DOI 10.1016/j.nicl.2016.01.011; Lotsch J, 2015, RHINOLOGY, V53, P365, DOI 10.4193/Rhino15.010; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lubke K, 2012, CHEMOSENS PERCEPT, V5, P22, DOI 10.1007/s12078-011-9115-3; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Pellegrino R, 2016, RHINOLOGY, V54, P374, DOI [10.4193/Rhin16.098, 10.4193/Rhino16.098]; Plailly J, 2007, HUM BRAIN MAPP, V28, P363, DOI 10.1002/hbm.20290; Proskynitopoulos Phileas J, 2016, Surg Neurol Int, V7, pS263, DOI 10.4103/2152-7806.181981; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Reichert JL, 2018, NEUROSCIENTIST, V24, P22, DOI 10.1177/1073858417703910; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Roberts Richard J, 2010, Indian J Psychol Med, V32, P93, DOI 10.4103/0253-7176.78504; ROESSLER EB, 1978, J FOOD SCI, V43, P940, DOI 10.1111/j.1365-2621.1978.tb02458.x; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Schriever VA, 2014, CHEM SENSES, V39, P343, DOI 10.1093/chemse/bju005; Seubert J, 2015, HUM BRAIN MAPP, V36, P1662, DOI 10.1002/hbm.22728; Seubert J, 2013, NEUROIMAGE, V66, P333, DOI 10.1016/j.neuroimage.2012.10.030; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9; Sommer JU, 2012, J NEUROSCI METH, V209, P189, DOI 10.1016/j.jneumeth.2012.05.026; Sorokowska A, 2016, NEUROSCIENCE, V324, P62, DOI 10.1016/j.neuroscience.2016.03.008; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Takeda A, 2010, J NEUROL SCI, V289, P36, DOI 10.1016/j.jns.2009.08.041; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vent J, 2010, BRAIN RES, V1320, P1, DOI 10.1016/j.brainres.2010.01.007; Wang JL, 2010, BRAIN RES, V1357, P184, DOI 10.1016/j.brainres.2010.08.018; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Wu KN, 2012, NAT NEUROSCI, V15, P1313, DOI 10.1038/nn.3186; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	76	7	7	1	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	OCT	2018	265	10					2322	2332		10.1007/s00415-018-9003-8			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GV5KG	WOS:000446139800018	30109478				2022-02-06	
J	Hedayatpour, A; Shiasi, M; Famitafreshi, H; Abolhassani, F; Ebrahimnia, P; Mokhtari, T; Hassanzaeh, G; Karimian, M; Nazparvar, B; Marefati, N; Tarzjani, MD				Hedayatpour, Azim; Shiasi, Maryam; Famitafreshi, Hamidreza; Abolhassani, Farid; Ebrahimnia, Parisa; Mokhtari, Tahmineh; Hassanzaeh, Gholamreza; Karimian, Morteza; Nazparvar, Bashir; Marefati, Narges; Tarzjani, Masoomeh Dehghan			Co-Administration of Progesterone and Melatonin Attenuates Ischemia-Induced Hippocampal Damage in Rats	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Global brain ischemia; Progesterone; Melatonin; Apoptosis and neurotrophic factors	BRAIN-INJURY; NEUROTROPHIC FACTOR; PROTECTIVE ROLE; STROKE; NEUROPROTECTION; EXPRESSION; ANTIOXIDANT; IMPAIRMENT; ESTROGEN; BDNF	Stroke is the second leading reason for death worldwide and is one of the fundamental causes of long-term disabilities. The aim of this investigation was to assess the impact of combined administration progesterone (PROG) and melatonin (MEL) on stroke complications. Male Wistar rats (9-10weeks) weighing 250-300g were used as a part of this examination. They were randomly separated into eight groups (nine rats for every group). Common carotid arteries on the two sides clamped (BCCAO model) with non-traumatic clips for 20min. At that point, the rats were treated with 8mg/kg PROG, 10mg/kg MEL, and vehicles (sesamoid and normal saline). Morris water maze testing was performed following 2weeks. At that point, the rats were euthanized, and histological examination was directed. The outcome demonstrated that utilization of PROG and MEL in treatment groups essentially increases the quantity of pyramidal cells and enhances spatial memory compared to non-treatment groups (p<0.05). Moreover, the neuroleptic factor gene expression and protein concentration were significantly enhanced in the treated groups (p<0.05). As indicated by the outcomes, co-administration of PROG and MEL can enhance learning and memory by surviving the pyramidal neurons and diminishing neural death by means of increasing neuroleptic factors in the hippocampal CA1 zone.	[Hedayatpour, Azim; Shiasi, Maryam; Abolhassani, Farid; Ebrahimnia, Parisa; Mokhtari, Tahmineh; Hassanzaeh, Gholamreza] Univ Tehran Med Sci, Dept Anat, Tehran, Iran; [Famitafreshi, Hamidreza; Karimian, Morteza; Marefati, Narges] Univ Tehran Med Sci, Physiol Dept, Tehran, Iran; [Nazparvar, Bashir] Legal Med Org Iran, Tehran, Iran; [Tarzjani, Masoomeh Dehghan] Univ Tehran Med Sci, Tehran, Iran		Hedayatpour, A (corresponding author), Univ Tehran Med Sci, Dept Anat, Tehran, Iran.	Hedayatpour@tums.ac.ir	Famitafreshi, Hamidreza/F-4058-2015; Mokhtari, Tahmineh/E-8308-2017	Mokhtari, Tahmineh/0000-0002-4126-7102; famitafreshi, hamidreza/0000-0003-1457-6361			Chen TY, 2006, J PINEAL RES, V40, P242, DOI 10.1111/j.1600-079X.2005.00307.x; Chesler EJ, 2000, HORM BEHAV, V38, P234, DOI 10.1006/hbeh.2000.1626; Chu SF, 2017, MOL NEUROBIOL, V54, P524, DOI 10.1007/s12035-015-9673-5; Cuzzocrea S, 2000, J PINEAL RES, V29, P217, DOI 10.1034/j.1600-0633.2002.290404.x; Espinosa-Garcia C, 2014, BRAIN RES, V1545, P23, DOI 10.1016/j.brainres.2013.11.030; Gaignard P, 2016, J CEREBR BLOOD F MET, V36, P562, DOI 10.1177/0271678X15610338; Harburger LL, 2007, NEUROBIOL AGING, V28, P602, DOI 10.1016/j.neurobiolaging.2006.02.019; Hassanzadeh P, 2012, IRAN J BASIC MED SCI, V15, P1046; Imbesi M, 2008, J NEURAL TRANSM, V115, P1495, DOI 10.1007/s00702-008-0066-z; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Kondoh T, 2002, LIFE SCI, V72, P583, DOI 10.1016/S0024-3205(02)02256-7; Kuhl NM, 2003, GLIA, V44, P91, DOI 10.1002/glia.10263; Lee EJ, 2005, J PINEAL RES, V38, P42, DOI 10.1111/j.1600-079X.2004.00173.x; Lee MY, 2007, J PINEAL RES, V42, P297, DOI 10.1111/j.1600-079X.2007.00420.x; Letechipia-Vallejo G, 2007, J PINEAL RES, V42, P139, DOI 10.1111/j.1600-079X.2006.00395.x; Lin HW, 2009, NEUROPSYCH DIS TREAT, V5, P157; Manev H, 1996, FASEB J, V10, P1546, DOI 10.1096/fasebj.10.13.8940301; MELCHIORRI D, 1995, FASEB J, V9, P1205, DOI 10.1096/fasebj.9.12.7672513; Mori MA, 2017, PROG NEURO-PSYCHOPH, V75, P94, DOI 10.1016/j.pnpbp.2016.11.005; Movassaghi S, 2012, IRAN J BASIC MED SCI, V15, P1083; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Reiter RJ, 2000, NEWS PHYSIOL SCI, V15, P246; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sharifi ZN, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/809417; Shinozuka K, 2013, INT J MOL SCI, V14, P8924, DOI 10.3390/ijms14058924; Tao RR, 2013, J PINEAL RES, V54, P271, DOI 10.1111/jpi.12009; Tao RR, 2012, CURR DRUG TARGETS, V13, P272, DOI 10.2174/138945012799201649; Tutunculer F, 2005, PEDIATR INT, V47, P434, DOI 10.1111/j.1442-200x.2005.02085.x; Watson N, 2016, CELL TRANSPLANT, V25, P883, DOI 10.3727/096368915X689749; Wong R, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0131-5; Xu Q, 2015, PSYCHOPHARMACOLOGY, V232, P1779, DOI 10.1007/s00213-014-3809-6; Yang Y, 2015, J PINEAL RES, V58, P61, DOI 10.1111/jpi.12193; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Younan N, 2012, MED J CAIRO U, V80; Yousuf S, 2013, NEUROSCIENCE, V239, P92, DOI 10.1016/j.neuroscience.2012.10.017; Yousuf S, 2014, J CEREBR BLOOD F MET, V34, P297, DOI 10.1038/jcbfm.2013.198; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162	38	7	9	0	18	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	OCT	2018	66	2					251	260		10.1007/s12031-018-1163-6			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GV9TM	WOS:000446503500012	30182311				2022-02-06	
J	Hesam, S; Khoshkholgh-Sima, B; Pourbadie, HG; Babapour, V; Zendedel, M; Sayyah, M				Hesam, Soghra; Khoshkholgh-Sima, Baharak; Pourbadie, Hamid Gholami; Babapour, Vahab; Zendedel, Morteza; Sayyah, Mohammad			Monophosphoryl Lipid A and Pam3Cys Prevent the Increase in Seizure Susceptibility and Epileptogenesis in Rats Undergoing Traumatic Brain Injury	NEUROCHEMICAL RESEARCH			English	Article						Kindling; Preconditioning; Toll-like receptors; Trauma; Traumatic epilepsy; TNF-	CEREBRAL ISCHEMIA/REPERFUSION INJURY; TOLL-LIKE RECEPTORS; KINDLING EPILEPTOGENESIS; NEUROPROTECTION; PROTECTION; ACTIVATION; ADJUVANTS	Five percent of all epilepsy cases are attributed to traumatic brain injury (TBI), which are known as post-traumatic epilepsy (PTE). Finding preventive strategies for PTE is valuable. Remarkable feature of TBI is activation of microglia and subsequent neuroinflammation, which provokes epileptogenesis. The toll-like receptor agonists monophosphoryl lipid A (MPL) and tri-palmitoyl-S-glyceryl-cysteine (Pam3Cys) are safe, well-tolerated and effective adjuvants existing in prophylactic human vaccines. We examined the impact of early injection of MPL and Pam3Cys to rats, on the rate of kindled seizures acquisition following TBI. Rats received a single dose (1 mu g/rat) of MPL or Pam3Cys through intracerebroventricular injection. 5days later, trauma was exerted to temporo-parietal cortex of rats by controlled cortical impact device. After 24h, traumatic rats underwent amygdala kindling. Brain level of the inflammatory cytokine tumor necrosis factor-alpha (TNF-) was also measured in traumatic rats by immunoblotting. Compared to non-traumatic (sham-operated) rats, traumatic rats showed three times lower seizure threshold (133 +/- 5 mu A vs. 416.3 +/- 16 mu A, p<0.001); about three times less number of stimuli to become kindled (5 +/- 1 vs. 14 +/- 2, p<0.01); longer duration of kindled seizure parameters including entire seizure behavior, generalized seizures, and afterdischarges (p<0.001); and a two times increase in the TNF- level. MPL and Pam3Cys did not change kindling rate and the seizure parameters in sham-operated rats. The MPL- and Pam3Cys-pretreated traumatic rats displayed seizure threshold, speed of kindling, and duration of kindled seizure parameters, similar to the non-traumatic rats. Pretreatment by MPL and Pam3Cys prevented the increase in TNF- level by trauma. Given that MPL and Pam3Cys currently have clinical use as well-tolerated vaccines with reliable safety, they have the potential to be used in prevention of PTE.	[Hesam, Soghra; Khoshkholgh-Sima, Baharak; Pourbadie, Hamid Gholami; Sayyah, Mohammad] Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran, Iran; [Hesam, Soghra; Babapour, Vahab; Zendedel, Morteza] Univ Tehran, Fac Vet Med, Dept Basic Sci, Tehran, Iran		Sayyah, M (corresponding author), Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran, Iran.	sayyahm2@pasteur.ac.ir	Khoshkholgh-Sima, BAHARAK/ABF-1064-2021; Hesam, Soghra/AAX-5930-2020	Khoshkholgh-Sima, BAHARAK/0000-0002-6262-0462; Hesam, Soghra/0000-0003-2974-1374	Pasteur Institute of Iran	This study is supported by Pasteur Institute of Iran.	Ajmone-Cat MA, 2013, GLIA, V61, P1698, DOI 10.1002/glia.22550; Baldrick P, 2002, REGUL TOXICOL PHARM, V35, P398, DOI 10.1006/rtph.2002.1541; Chilton PM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00154; Davis AEM, 2005, EUR J NEUROSCI, V22, P2441, DOI 10.1111/j.1460-9568.2005.04447.x; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Dowling JK, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.22; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; Ebert S, 2005, J NEUROIMMUNOL, V159, P87, DOI 10.1016/j.jneuroim.2004.10.005; Eslami M, 2016, NEUROL RES, V38, P269, DOI 10.1179/1743132815Y.0000000086; Eslami M, 2015, J NEUROIMMUNOL, V289, P143, DOI 10.1016/j.jneuroim.2015.11.003; Evans Jay T, 2003, Expert Rev Vaccines, V2, P219, DOI 10.1586/14760584.2.2.219; Gesuete R, 2014, J NEUROPATH EXP NEUR, V73, P378, DOI 10.1097/NEN.0000000000000068; Hua F, 2008, J NEUROIMMUNOL, V199, P75, DOI 10.1016/j.jneuroim.2008.05.009; KELLNER J, 1992, BIOL CHEM H-S, V373, P51, DOI 10.1515/bchm3.1992.373.1.51; Larochelle A, 2015, BRAIN BEHAV IMMUN, V46, P221, DOI 10.1016/j.bbi.2015.02.019; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rosewich M, 2013, HUM VACC IMMUNOTHER, V9, P1523, DOI 10.4161/hv.24631; Schaafsma W, 2015, BRAIN BEHAV IMMUN, V48, P205, DOI 10.1016/j.bbi.2015.03.013; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Venezia S, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0195-7; Wang PF, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0301-0; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Yokobori S, 2013, TRANSL STROKE RES, V4, P25, DOI 10.1007/s12975-012-0226-1; Yu ZQ, 2012, ANN CLIN LAB SCI, V42, P26; Zaman M., 2013, FRONT IMMUNOL, V4, P318, DOI [DOI 10.3389/FIMMU.2013.00318, DOI 10.3389/fimmu.2013.00318]	30	7	8	0	7	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	OCT	2018	43	10					1978	1985		10.1007/s11064-018-2619-3			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GV0UP	WOS:000445779800012	30173323				2022-02-06	
J	Hudac, CM; Cortesa, CS; Ledwidge, PS; Molfese, DL				Hudac, Caitlin M.; Cortesa, Cathryn S.; Ledwidge, Patrick S.; Molfese, Dennis L.			History of concussion impacts electrophysiological correlates of working memory	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Concussion; Working memory; Event-related potentials (ERPs); N2; P3; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; EVENT-RELATED POTENTIALS; SPORTS-RELATED CONCUSSION; CLOSED-HEAD-INJURY; PROFESSIONAL FOOTBALL PLAYERS; AUDITORY ODDBALL TASK; COGNITIVE CONTROL; NEUROCOGNITIVE PERFORMANCE; FUNCTIONAL ABNORMALITIES; MULTIPLE CONCUSSIONS	Sports-related concussions occur in approximately 21% of college athletes with implications for long-term cognitive impairments in working memory. Working memory involves the capacity to maintain short-term information and integrate with higher-order cognitive processing for planning and behavior execution, critical skills for optimal cognitive and athletic performance. This study quantified working memory impairments in 36 American football college athletes (18-23 years old) using event-related potentials (ERPs). Despite performing similarly in a standard 2-back working memory task, athletes with history of concussion exhibited larger P1 and P3 amplitudes compared to Controls. Concussion History group latencies were slower for the P1 and faster for the N2. Source estimation analyses indicated that previously concussed athletes engaged different brain regions compared to athletes with no concussion history. These findings suggest that ERPs may be a sensitive and objective measure to detect long-term cognitive consequences of concussion.	[Hudac, Caitlin M.; Cortesa, Cathryn S.; Ledwidge, Patrick S.; Molfese, Dennis L.] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; [Hudac, Caitlin M.] Univ Washington, Dept Psychiat & Behav Sci, CHDD Box 357920, Seattle, WA 98195 USA; [Cortesa, Cathryn S.] Johns Hopkins Univ, Dept Cognit Sci, 237 Krieger Hall,3400 N Charles St, Baltimore, MD 21218 USA; [Ledwidge, Patrick S.; Molfese, Dennis L.] Univ Nebraska, Ctr Brain Biol & Behav, C89 East Stadium, Lincoln, NE 68588 USA; [Ledwidge, Patrick S.] Baldwin Wallace Univ, Dept Psychol, Berea, OH USA		Hudac, CM (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, CHDD Box 357920, Seattle, WA 98195 USA.; Cortesa, CS (corresponding author), Johns Hopkins Univ, Dept Cognit Sci, 237 Krieger Hall,3400 N Charles St, Baltimore, MD 21218 USA.; Molfese, DL (corresponding author), Univ Nebraska, Ctr Brain Biol & Behav, C89 East Stadium, Lincoln, NE 68588 USA.	chudac@uw.edu; ccortes4@jhu.edu; dmolfese2@unl.edu		Hudac, Caitlin/0000-0002-0478-440X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD073202, R01EB007684, HD062072]; University of Nebraska, Lincoln Faculty Seed Grant [UNMC 36-0411-3001-001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD073202] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R43HD062072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB007684] Funding Source: NIH RePORTER	This study was supported by grants from NIH R01 HD073202, R01EB007684, HD062072, University of Nebraska, Lincoln Faculty Seed Grant, UNMC 36-0411-3001-001 to Dennis L. Molfese.	Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Baddeley A.D., 1994, NEUROPSYCHOLOGY, V8, P485, DOI [10.1037/0894-4105.8.4.485, DOI 10.1037/0894-4105.8.4.485]; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2004, STUD NEUROPSYCHOL DE, P71; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chung D, 2007, 2007 3RD INTERNATIONAL IEEE/EMBS CONFERENCE ON NEURAL ENGINEERING, VOLS 1 AND 2, P568, DOI 10.1109/CNE.2007.369736; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Congedo M, 2006, IEEE T BIO-MED ENG, V53, P1624, DOI 10.1109/TBME.2006.878055; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Curran T, 1999, NEUROPSYCHOLOGIA, V37, P771, DOI 10.1016/S0028-3932(98)00133-X; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis DC., 2001, DELIS KAPLAN EXECUTI; Di Russo F, 2010, PSYCHOPHYSIOLOGY, V47, P425, DOI 10.1111/j.1469-8986.2009.00950.x; Dien J, 2005, CLIN NEUROPHYSIOL, V116, P1808, DOI 10.1016/j.clinph.2004.11.025; Dien J, 2005, EVENT RELATED POTENT, P57; Dien J, 2010, PSYCHOPHYSIOLOGY, V47, P170, DOI 10.1111/j.1469-8986.2009.00885.x; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Donchin E, 1986, PSYCHOPHYSIOLOGY SYS, P244; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Duncan CC, 2003, PSYCHOPHYSIOLOGY, V40, P45, DOI 10.1111/1469-8986.00006; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Eimer M, 1996, J EXP PSYCHOL LEARN, V22, P970, DOI 10.1037//0278-7393.22.4.970; Ferree T. C., 2000, SPLINE INTERPOLATION; Ferree TC, 2000, IEEE T BIO-MED ENG, V47, P1584, DOI 10.1109/10.887939; Finnigan S, 2011, PSYCHOPHYSIOLOGY, V48, P601, DOI 10.1111/j.1469-8986.2010.01128.x; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hammeke TA, 2013, J INT NEUROPSYCH SOC, V19, P863, DOI 10.1017/S1355617713000702; Handy TC, 2005, EVENT RELATED POTENT; HEINZE HJ, 1990, ELECTROEN CLIN NEURO, V75, P511, DOI 10.1016/0013-4694(90)90138-A; Hellerstein LF, 2011, UNDERSTANDING AND MANAGING VISION DEFICITS: A GUIDE FOR OCCUPATIONAL THERAPISTS, THIRD EDITION, P189; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hudac CM, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-017-9199-4; Hudac CM, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9118-5; Hudac CM, 2012, EYE BRAIN, V4, P1, DOI 10.2147/EB.S27290; Hux K, 1996, INTERV SCH CLIN, V31, P158, DOI 10.1177/105345129603100305; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kappenman Emily S, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P110; Kayser J, 2003, CLIN NEUROPHYSIOL, V114, P2307, DOI 10.1016/S1388-2457(03)00241-4; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Keil A, 2014, PSYCHOPHYSIOLOGY, V51, P1, DOI 10.1111/psyp.12147; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Klimesch W, 2007, NEUROSCI BIOBEHAV R, V31, P1003, DOI 10.1016/j.neubiorev.2007.03.005; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kota S, 2013, NEUROREPORT, V24, P437, DOI 10.1097/WNR.0b013e3283616512; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Ledwidge PS, 2016, J NEUROTRAUM, V33, P2081, DOI 10.1089/neu.2015.4251; Lovell M. R., 2006, SPORTS NEUROPSYCHOLO, P193; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Missonnier P, 2005, J GERONTOL A-BIOL, V60, P660, DOI 10.1093/gerona/60.5.660; MOLFESE DL, 1976, ANN NY ACAD SCI, V280, P821, DOI 10.1111/j.1749-6632.1976.tb25545.x; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Natale E, 2006, EUR J NEUROSCI, V23, P2511, DOI 10.1111/j.1460-9568.2006.04756.x; Otten L.J., 2005, EVENT RELATED POTENT, P3; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Penkam I, 2004, J COG REHABIL, V2, P13; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ranganath C, 2004, J NEUROSCI, V24, P3917, DOI 10.1523/JNEUROSCI.5053-03.2004; ROSSINI PM, 1981, ELECTROEN CLIN NEURO, V52, P540; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shelton JT, 2009, INTELLIGENCE, V37, P283, DOI 10.1016/j.intell.2008.11.005; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Sohlberg MM, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-14-0128; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; van der Horn HJ, 2016, BRAIN IMAGING BEHAV, V10, P1243, DOI 10.1007/s11682-015-9489-y; Vanrumste B, 2001, BRAIN TOPOGR, V14, P83, DOI 10.1023/A:1012909511833; Webb SJ, 2015, J AUTISM DEV DISORD, V45, P425, DOI 10.1007/s10803-013-1916-6; Wechsler D., 2008, WECHSLER ADULT INTEL; Wild-Wall N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00186; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Yoo SS, 2004, INT J NEUROSCI, V114, P613, DOI 10.1080/00207450490430561	113	7	7	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		135	144		10.1016/j.ijpsycho.2017.09.020			10	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000017	29024682	Green Accepted, Bronze			2022-02-06	
J	Kitya, D; Punchak, M; Abdelgadir, J; Obiga, O; Harborne, D; Haglund, MM				Kitya, David; Punchak, Maria; Abdelgadir, Jihad; Obiga, Oscar; Harborne, Derek; Haglund, Michael M.			Causes, clinical presentation, management, and outcomes of chronic subdural hematoma at Mbarara Regional Referral Hospital	NEUROSURGICAL FOCUS			English	Article						chronic subdural hematoma; low- and middle-income countries; neurosurgical access	TRAUMATIC BRAIN-INJURY; UGANDA; RECURRENCE; PREDICTORS; MORTALITY; DRAINAGE; DISEASE; FUTURE	OBJECTIVE Causes, clinical presentation, management, and outcomes of chronic subdural hematoma (CSDH) in low- and middle-income countries are not well characterized in the literature. Knowledge regarding these factors would be beneficial in the development and implementation of effective preventive and management measures for affected patients. The authors conducted a study to gain a better understanding of these factors in a low- income setting. METHODS This prospective study was performed at Mbarara Regional Referral Hospital (MRRH) in Uganda between January 2014 and June 2017. Patients of any age who presented and were diagnosed with CSDH during the aforementioned time period were included in the study. Variables were collected from patients' files at discharge and follow-up clinic visits. The primary outcome of interest was death. Secondary outcomes of interest included discharge Glasgow Coma Scale (GCS) score, ICU admission, wound infection, and CSDH recurrence. RESULTS Two hundred five patients, the majority of whom were male (147 [72.8%]), were enrolled in the study. The mean patient age was 60.2 years (SD 17.7). Most CSDHs occurred as a result of motor vehicle collisions (MVCs) and falls, 35.6% (73/205) and 24.9% (51/205), respectively. The sex ratio and mean age varied depending on the mechanism of injury. Headache was the most common presenting symptom (89.6%, 173/193), whereas seizures were uncommon (11.5%, 23/200). Presenting symptoms differed by age. A total of 202 patients underwent surgical intervention with burr holes and drainage, and 22.8% (46) were admitted to the ICU. Two patients suffered a recurrence, 5 developed a postoperative wound infection, and 18 died. Admission GCS score was a significant predictor of the discharge GCS score (p = 0.004), ICU admission (p < 0.001), and death (p < 0.001). CONCLUSIONS Trauma from an MVC is the commonest cause of CSDH among the young. For the elderly, falling is common, but the majority have CSDH with no known cause. Although the clinical presentation is broad, there are several pronounced differences based on age. Burr hole surgery plus drainage is a safe and reliable intervention. A low preoperative GCS score is a risk factor for ICU admission and death.	[Kitya, David; Obiga, Oscar] Mbarara Reg Referral Hosp, Dept Neurosurg, Mbarara, Uganda; [Kitya, David; Obiga, Oscar; Harborne, Derek] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Punchak, Maria] UCLA, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Punchak, Maria; Abdelgadir, Jihad; Haglund, Michael M.] Duke Univ, Div Global Neurosurg & Neurosci, Durham, NC USA; [Haglund, Michael M.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA; [Haglund, Michael M.] Duke Univ, Global Hlth Inst, Durham, NC USA		Kitya, D (corresponding author), Mbarara Reg Referral Hosp, Mbarara, Uganda.	dkitya1@hotmail.com			Nuvasive; Lifenet; UCBUCB Pharma SA	Dr. Haglund has received clinical or research support from Nuvasive, Lifenet, and UCB for the study described.	Abdelgadir J, 2018, J CLIN NEUROSCI, V47, P79, DOI 10.1016/j.jocn.2017.10.004; Abdulla AJJ, 1999, AGE AGEING, V28, P582, DOI 10.1093/ageing/28.6.582; Adeolu AA, 2012, BRIT J NEUROSURG, V26, P743, DOI 10.3109/02688697.2012.690912; Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Akbar Ali, 2004, JPMA Journal of the Pakistan Medical Association, V54, P604; Anderson GA, 2017, SURGERY, V161, P1710, DOI 10.1016/j.surg.2017.01.009; Bansal H, 2015, INDIAN J SURG, V77, P532, DOI 10.1007/s12262-015-1323-7; Bennett KS, 2017, PEDIATR CRIT CARE ME, V18, P54, DOI 10.1097/PCC.0000000000000948; CAMERON MM, 1978, J NEUROL NEUROSUR PS, V41, P834, DOI 10.1136/jnnp.41.9.834; Contini Sandro, 2007, Acta Biomed, V78, P4; Dakurah T K, 2005, West Afr J Med, V24, P283; ELLIS G L, 1990, Emergency Medicine Clinics of North America, V8, P281; Eogelholm R, 1975, NEUROSURGERY, V42, P43; Erem G, 2017, AFR HEALTH SCI, V17, P116, DOI 10.4314/ahs.v17i1.15; Haglund MM, 2017, NEUROSURGERY, V80, P656, DOI 10.1093/neuros/nyw159; Idro R., 2015, BRAIN DEGENERATION D, P183; Iliescu I A, 2015, J Med Life, V8, P278; Jones S, 1999, AGE AGEING, V28, P519, DOI 10.1093/ageing/28.6.519; Kageyama H, 2013, J NEUROSURG, V119, P332, DOI 10.3171/2013.3.JNS122162; Kolias AG, 2014, NAT REV NEUROL, V10, P570, DOI 10.1038/nrneurol.2014.163; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Kurabe S, 2010, ACTA NEUROCHIR, V152, P1171, DOI 10.1007/s00701-010-0627-4; Lee KS, 2016, J KOREAN NEUROSURG S, V59, P1, DOI 10.3340/jkns.2016.59.1.1; LUXON LM, 1979, Q J MED, V48, P43; MARKWALDER TM, 1985, NEUROSURGERY, V16, P185, DOI 10.1227/00006123-198502000-00010; Mellergard P, 1996, ACTA NEUROCHIR, V138, P708, DOI 10.1007/BF01411476; Mezue W C, 2011, Afr J Med Med Sci, V40, P373; Ministry of Health, 2012, HLTH FAC INV; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; NAGANUMA H, 1986, NEUROSURGERY, V19, P794, DOI 10.1227/00006123-198611000-00013; Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256; Park BE, 2016, WORLD NEUROSURG, V87, P417, DOI 10.1016/j.wneu.2015.11.077; POTTER JF, 1977, GERIATRICS, V32, P61; Punchak M, 2018, WORLD NEUROSURG, V114, pE396, DOI 10.1016/j.wneu.2018.02.191; Rovlias Aristedis, 2015, Surg Neurol Int, V6, P127, DOI 10.4103/2152-7806.161788; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Sahyouni R, 2017, WORLD NEUROSURG, V104, P418, DOI 10.1016/j.wneu.2017.05.030; Smely C, 1997, ACTA NEUROCHIR, V139, P818, DOI 10.1007/BF01411399; SPALLONE A, 1989, EUR NEUROL, V29, P18, DOI 10.1159/000116370; Sunada Ichiro, 1996, Neurologia Medico-Chirurgica, V36, P99, DOI 10.2176/nmc.36.99; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17; Traynelis V C, 1991, Clin Geriatr Med, V7, P583; Tsutsumi K, 1997, J NEUROSURG, V87, P870, DOI 10.3171/jns.1997.87.6.0870; VanHavenbergh T, 1996, BRIT J NEUROSURG, V10, P35; WALI GM, 1994, J NEUROL NEUROSUR PS, V57, P1144, DOI 10.1136/jnnp.57.9.1144	45	7	7	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	OCT	2018	45	4							E7	10.3171/2018.7.FOCUS18253			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GV6US	WOS:000446253400007	30269586	gold			2022-02-06	
J	Lininger, MR; Leahy, TE; Haug, EC; Bowman, TG				Lininger, Monica R.; Leahy, Theresa E.; Haug, Elise C.; Bowman, Thomas G.			TEST-RETEST RELIABILITY OF THE LIMITS OF STABILITY TEST PERFORMED BY YOUNG ADULTS USING NEUROCOM (R) VSR SPORT	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Balance; clinical test; dynamic postural control; reaction time	ERROR SCORING SYSTEM; NEUROCOGNITIVE FUNCTION; POSTURAL STABILITY; CONCUSSION; RECOVERY; SYMPTOMS; VALIDITY	Background: A reliable measure of dynamic postural control is needed for inclusion in the sports-related concussion assessment battery. Currently, there is not a clinical gold standard. The Limits of Stability (LOS) test has potential to be a useful tool to collect objective data on important dynamic postural stability variables. Psychometric properties of the LOS test with healthy young adults are yet to be established. Hypothesis/Purpose: The purpose of this study was to examine the intra-session and test-retest reliability for the LOS on the NeuroCom (R) VSR Sport when performed by young adults. Study Design: Reliability study Methods: Ttiventy-seven healthy university students completed four trials of the LOS in each of two testing sessions one week apart. Relative reliability was measured within each session with an intraclass correlation coefficient (ICC[3,k]) for Session 1 and Session 2, respectively, on each of the five dependent variables (movement velocity [MVL], directional control [DCL], maximum excursion [MXE], endpoint excursion [EPE], and reaction time [RT]) provided by the Neurocom. Test-retest reliability was assessed using a repeated-measures analysis of variance along with an ICC (3,k) for relative reliability. An ICC value of 0.90 or higher was defined as having a high reliability, moderate reliability for ICC values between 0.80-0.89, and below 0.80 as questionable. Results: The reliability within each session for LOS composite scores for MVL, DCL, and MXE was moderate to high (ICC[3,k] = 0.89-0.95). These same three variables also had high levels of test-retest reliability (ICC[3,k] = 0.95-0.96). EPE and RT had moderate reliability over time (ICC[3,k] = 0.88) but differences for within session reliability. Conclusions: LOS provides a reliable measure of dynamic postural control for young adults. Two trials are recommended at baseline with the first being an adaptation trial to ensure accuracy of findings. Care needs to be taken when interpreting EPE and DCL scores on post-injury tests due to a learning effect for those variables.	[Lininger, Monica R.] No Arizona Univ, Flagstaff, AZ USA; [Leahy, Theresa E.; Haug, Elise C.] Lynchburg Coll, Dept Phys Therapy, Lynchburg, VA 24501 USA; [Bowman, Thomas G.] Lynchburg Coll, Dept Athlet Training, Lynchburg, VA 24501 USA		Lininger, MR (corresponding author), No Arizona Univ, Dept Phys Therapy & Athlet Training, POB 15094, Flagstaff, AZ 86011 USA.	monica.lininger@nau.edu	Bowman, Thomas/AAA-3036-2020; Bowman, Tom/AAU-6473-2020	Bowman, Thomas/0000-0002-0034-2946; 			Alsalaheen B, 2015, ARCH PHYS MED REHAB, V96, P2194, DOI 10.1016/j.apmr.2015.08.418; [Anonymous], 2016, NEUROCOM BAL MAN CLI; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Forth KE, 2011, GAIT POSTURE, V33, P715, DOI 10.1016/j.gaitpost.2010.12.024; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Leahy T, 2013, J NEUROL PHYS THER, P92; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGivern RF, 2002, BRAIN COGNITION, V50, P73, DOI 10.1016/S0278-2626(02)00012-X; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Pickerill ML, 2011, J ATHL TRAINING, V46, P600; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Thomsen MH, 2017, GAIT POSTURE, V51, P10, DOI 10.1016/j.gaitpost.2016.09.018; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Vincent WJ, 2005, STAT KINESIOLOGY, P196; Williams RM, 2017, J SPECTROSC, V2017, P1, DOI 10.1155/2017/6867507	26	7	7	0	1	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	OCT	2018	13	5					800	807		10.26603/ijspt20180800			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	HC6CO	WOS:000451889600004	30276012	Green Published			2022-02-06	
J	Martino, EA; Redaelli, MB; Sardo, S; Lembo, R; Giordano, VF; Winterton, D; Ruggeri, L; Hajjar, LA; Zangrillo, A; Landoni, G				Martino, Enrico A.; Redaelli, Martina Baiardo; Sardo, Salvatore; Lembo, Rosalba; Giordano, Vito F.; Winterton, Dario; Ruggeri, Laura; Hajjar, Ludhmilla A.; Zangrillo, Alberto; Landoni, Giovanni			Steroids and Survival in Critically Ill Adult Patients: A Meta-analysis of 135 Randomized Trials	JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA			English	Article						steroids; corticosteroids; mortality; meta-analysis; critically ill; surgery	COMMUNITY-ACQUIRED PNEUMONIA; LOW-DOSE HYDROCORTISONE; OBSTRUCTIVE PULMONARY-DISEASE; SYSTEMIC INFLAMMATORY RESPONSE; SEVERE ALCOHOLIC HEPATITIS; PLACEBO-CONTROLLED TRIAL; SEVERE HEAD-INJURY; PNEUMOCYSTIS-CARINII PNEUMONIA; RESPIRATORY-DISTRESS-SYNDROME; CARDIOPULMONARY BYPASS SIRS	Objective: Corticosteroids have important effects on intermediate outcomes in critically ill patients, but their effect on survival is unknown. The objective of this meta-analysis was to analyze the effect on mortality of corticosteroids in critical and perioperative settings. Design: A meta-analysis of randomized trials. Setting: PubMed, Embase, BioMed Central, Google Scholar, and the Cochrane Central Register of Controlled Trials were searched to February 1, 2018, for randomized trials comparing corticosteroids with placebo or standard care. Participants: Critically ill or surgical adult patients. Interventions: Corticosteroids compared with placebo or standard care. Measurements and Main Results: A total of 44,553 patients from 135 studies were included. Overall, mortality in the corticosteroid group and in the control group were similar (16% v 16%; p = 0.9). Subanalyses identified a beneficial effect of corticosteroids on survival in patients with respiratory system diseases (9% v 13%; p < 0.001) and bacterial meningitis (28% v 32%; p= 0.04), and a detrimental effect on survival in patients with traumatic brain injury (22% v 19%; p < 0.001). No differences in mortality were found in patients with cardiac diseases (7% v 6%; p = 0.7), in patients undergoing cardiac surgery (2.8% v 3.2% p = 0.14), and when treatment duration or patient age were considered. Conclusions: This meta-analysis documents the safety of corticosteroids in the overall critically ill population with the notable exception of brain injury patients, a setting where the authors confirmed their detrimental effect on survival. A possible beneficial effect of corticosteroids on survival was found among patients with respiratory diseases and in patients with bacterial meningitis. (C) 2018 Elsevier Inc. All rights reserved.	[Martino, Enrico A.; Redaelli, Martina Baiardo; Lembo, Rosalba; Giordano, Vito F.; Winterton, Dario; Ruggeri, Laura; Zangrillo, Alberto; Landoni, Giovanni] IRCCS San Raffaele Sci Inst, Dept Anesthesia & Intens Care, Milan, Italy; [Sardo, Salvatore] Univ Cagliari, Dept Med Sci M Aresu, Cagliari, Italy; [Hajjar, Ludhmilla A.] Univ Sao Paulo, Med Sch, Heart Inst InCor, Sao Paulo, Brazil; [Zangrillo, Alberto; Landoni, Giovanni] Univ Vita Salute San Raffaele, Milan, Italy		Lembo, R (corresponding author), Osped San Raffaele, Dept Anesthesia & Intens Care, Via Olgettina 60, I-20132 Italy, Italy.	lembo.rosalba@hsr.it	Sardo, Salvatore/AAO-9400-2021; Zangrillo, Alberto/AAH-2037-2019; Giovanni, Landoni/AAH-1881-2019; Winterton, Dario/E-9353-2015	Sardo, Salvatore/0000-0001-7664-8928; Zangrillo, Alberto/0000-0002-7687-7648; Giovanni, Landoni/0000-0002-8594-5980; Abrahao Hajjar, Ludhmila/0000-0001-5645-2055; Winterton, Dario/0000-0003-1207-8289			Abbaszadeh M, 2012, REV BRAS CIR CARDIOV, V27, P18, DOI 10.5935/1678-9741.20120005; Abdelmalak BB, 2013, BRIT J ANAESTH, V111, P209, DOI 10.1093/bja/aet050; Abroug F, 2014, EUR RESPIR J, V43, P717, DOI 10.1183/09031936.00002913; ALBERT RK, 1980, ANN INTERN MED, V92, P753, DOI 10.7326/0003-4819-92-6-753; Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; Aldrighetti L, 2006, LIVER TRANSPLANT, V12, P941, DOI 10.1002/lt.20745; Alia I, 2011, ARCH INTERN MED, V171, P1939, DOI 10.1001/archinternmed.2011.530; Alian S, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.16030; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002243.pub3; Arabi YM, 2010, CAN MED ASSOC J, V182, P1971, DOI 10.1503/cmaj.090707; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Azar RR, 2000, EUR HEART J, V21, P2026, DOI 10.1053/euhj.2000.2475; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bingol H, 2005, J CARDIAC SURG, V20, P252, DOI 10.1111/j.1540-8191.2005.200392.x; Biondi-Zoccai G, 2011, HEART LUNG VESSEL, V3, P161; BLITZER BL, 1977, AM J DIG DIS, V22, P477, DOI 10.1007/BF01072499; Blot M, 2016, CLIN MICROBIOL INFEC; Blum CA, 2015, LANCET, V385, P1511, DOI 10.1016/S0140-6736(14)62447-8; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BONE RC, 1987, CHEST, V92, P1032, DOI 10.1378/chest.92.6.1032; Boonen E, 2013, NEW ENGL J MED, V368, P1477, DOI 10.1056/NEJMoa1214969; Bourbon A, 2004, EUR J CARDIO-THORAC, V26, P932, DOI 10.1016/j.ejcts.2004.07.044; BOZZETTE SA, 1990, NEW ENGL J MED, V323, P1451, DOI 10.1056/NEJM199011223232104; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Bullard MJ, 1996, AM J EMERG MED, V14, P139, DOI 10.1016/S0735-6757(96)90120-5; CAMPRA JL, 1973, ANN INTERN MED, V79, P625, DOI 10.7326/0003-4819-79-5-625; CARITHERS RL, 1989, ANN INTERN MED, V110, P685, DOI 10.7326/0003-4819-110-9-685; Celik JB, 2004, PERFUSION-UK, V19, P185, DOI 10.1191/0267659104pf733oa; Chaney MA, 1998, ANESTH ANALG, V87, P27, DOI 10.1097/00000539-199807000-00007; Cicarelli Domingos Dias, 2006, Sao Paulo Med. J., V124, P90, DOI 10.1590/S1516-31802006000200008; Cicarelli DD, 2007, SAO PAULO MED J, V125, P237, DOI 10.1590/S1516-31802007000400009; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Dalay SK, 2012, J INTENSIVE CARE SOC, V13, P352; Davies L, 1999, LANCET, V354, P456, DOI 10.1016/S0140-6736(98)11326-0; De BK, 2014, ANN MED HEALTH SCI R, V4, P810, DOI 10.4103/2141-9248.141562; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; DEPEW W, 1980, GASTROENTEROLOGY, V78, P524; Dieleman JM, 2012, JAMA-J AM MED ASSOC, V308, P1761, DOI 10.1001/jama.2012.14144; Donadon M, 2016, WORLD J SURG, V40, P2202, DOI 10.1007/s00268-016-3506-1; Edwards P, 2005, LANCET, V365, P1957; El Azab SR, 2002, BRIT J ANAESTH, V88, P496, DOI 10.1093/bja/88.4.496; Fernandez-Serrano S, 2011, CRIT CARE, V15, DOI 10.1186/cc10103; Francois B, 2007, LANCET, V369, P1083, DOI 10.1016/S0140-6736(07)60526-1; Fujikura Y, 2017, ARCH BRONCONEUMOL, V53, P55, DOI 10.1016/j.arbres.2016.06.016; Gaab M R, 1994, Zentralbl Neurochir, V55, P135; GAGNON S, 1990, NEW ENGL J MED, V323, P1444, DOI 10.1056/NEJM199011223232103; GIANNOTTA SL, 1984, NEUROSURGERY, V15, P497, DOI 10.1227/00006123-198410000-00004; Gordon AC, 2014, CRIT CARE MED, V42, P1325, DOI 10.1097/CCM.0000000000000212; Greco T, 2013, HEART LUNG VESSEL, V5, P219; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; Hakim JG, 2000, HEART, V84, P183, DOI 10.1136/heart.84.2.183; Halonen J, 2007, JAMA-J AM MED ASSOC, V297, P1562, DOI 10.1001/jama.297.14.1562; Halvorsen P, 2003, ANESTH ANALG, V96, P1578, DOI 10.1213/01.ANE.0000063922.90966.3A; Hayashi Y, 2011, ANN SURG, V253, P50, DOI 10.1097/SLA.0b013e318204b6bb; HELMAN RA, 1971, ANN INTERN MED, V74, P311, DOI 10.7326/0003-4819-74-3-311; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOFFMAN SL, 1984, NEW ENGL J MED, V310, P82, DOI 10.1056/NEJM198401123100203; Horita N, 2015, SCI REP-UK, V5, DOI 10.1038/srep14061; Huang CJ, 2006, AM J RESP CRIT CARE, V173, P276, DOI 10.1164/rccm.200504-545OC; Huang Ruolan, 2014, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V26, P184, DOI 10.3760/cma.j.issn.2095-4352.2014.03.012; JASTREMSKI M, 1989, JAMA-J AM MED ASSOC, V262, P3427, DOI 10.1001/jama.262.24.3427; Katz L, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.797; Kaya E, 2015, WORLD J EMERG MED, V6, P54, DOI 10.5847/wjem.j.1920-8642.2015.01.010; Keh D, 2016, JAMA-J AM MED ASSOC, V316, P1775, DOI 10.1001/jama.2016.14799; Kerr KM, 2012, CHEST, V141, P27, DOI 10.1378/chest.10-2639; Khalid I, 2016, RESP CARE, V61, P340, DOI 10.4187/respcare.04325; Kilger E, 2011, MINERVA ANESTESIOL, V77, P268; Kilger E, 2003, CRIT CARE MED, V31, P1068, DOI 10.1097/01.CCM.0000059646.89546.98; Kirkpatrick J, 1986, J NEUROSURG, V65, P427; Knollmann, 2011, GOODMAN GILMANS PHAR; Laaninen M, 2016, ANN SURG, V264, P696, DOI 10.1097/SLA.0000000000001883; Liakopoulos OJ, 2007, ANN THORAC SURG, V84, P110, DOI 10.1016/j.athoracsur.2007.01.003; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Liu Ling, 2012, Zhonghua Nei Ke Za Zhi, V51, P599; Lomivorotov VV, 2013, HEART LUNG CIRC, V22, P25, DOI 10.1016/j.hlc.2012.08.001; LUCE JM, 1988, AM REV RESPIR DIS, V138, P62, DOI 10.1164/ajrccm/138.1.62; Lv QQ, 2017, AM J EMERG MED, V35, P1810, DOI 10.1016/j.ajem.2017.06.004; MADDREY WC, 1978, GASTROENTEROLOGY, V75, P193; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; Maltais F, 2002, AM J RESP CRIT CARE, V165, P698, DOI 10.1164/ajrccm.165.5.2109093; MARIK P, 1993, CHEST, V104, P389, DOI 10.1378/chest.104.2.389; Mayosi BM, 2014, NEW ENGL J MED, V371, P1121, DOI 10.1056/NEJMoa1407380; Mayumi H, 1997, ANN THORAC SURG, V63, P129; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; Meduri GU, 2016, INTENS CARE MED, V42, P829, DOI 10.1007/s00134-015-4095-4; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7; Mentzelopoulos SD, 2013, JAMA-J AM MED ASSOC, V310, P270, DOI 10.1001/jama.2013.7832; Mentzelopoulos SD, 2009, ARCH INTERN MED, V169, P15, DOI 10.1001/archinternmed.2008.509; Mirhosseini Seyed Jalil, 2011, Acta Med Iran, V49, P288; Moreno R, 2011, INTENS CARE MED, V37, P1765, DOI 10.1007/s00134-011-2334-x; Muratore A, 2003, BRIT J SURG, V90, P17, DOI 10.1002/bjs.4055; Nafae RM, 2013, EGYPT J CHEST DIS TU, V62, P439, DOI 10.1016/j.ejcdt.2013.03.009; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Oliver WC, 2004, ANESTHESIOLOGY, V101, P327, DOI 10.1097/00000542-200408000-00013; Oppert M, 2005, CRIT CARE MED, V33, P2457, DOI 10.1097/01.CCM.0000186370.78639.23; PORTER HP, 1971, NEW ENGL J MED, V284, P1350, DOI 10.1056/NEJM197106172842404; Prasongsukarn K, 2005, J THORAC CARDIOV SUR, V130, P93, DOI 10.1016/j.jtcvs.2004.09.014; RAMOND MJ, 1992, NEW ENGL J MED, V326, P507, DOI 10.1056/NEJM199202203260802; Remmelts HHF, 2012, J INFECTION, V65, P25, DOI 10.1016/j.jinf.2012.03.008; Rezk NA, 2013, EGYPT J CHEST DIS TU, V62, P167, DOI 10.1016/j.ejcdt.2013.02.013; Rinaldi S, 2006, CRIT CARE MED, V34, P2334, DOI 10.1097/01.CCM.0000233872.04706.BB; Rittenhouse DR, 2009, NEW ENGL J MED, V361, P2301, DOI 10.1056/NEJMp0909327; Roberts I, 2000, LANCET, V364, P1321; ROBERTSON CS, 1985, J NEUROSURG, V63, P714, DOI 10.3171/jns.1985.63.5.0714; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Rosseel PM, 2013, JAMA-J AM MED ASSOC, V308, P1761; Roth D, 2016, CRIT CARE MED, V44, pE737, DOI 10.1097/CCM.0000000000001631; Rubens FD, 2005, ANN THORAC SURG, V79, P655, DOI 10.1016/j.athoracsur.2004.07.044; Rumalla V, 2001, ARCH SURG-CHICAGO, V136, P1039, DOI 10.1001/archsurg.136.9.1039; Sabry NA, 2011, PHARM PHARM, V2, P73, DOI DOI 10.4236/PP.2011.22009; Santarpino G, 2009, J CARDIOVASC SURG, V50, P555; Santarpino G, 2009, INT J CLIN PHARM TH, V47, P78; Sato N, 2002, ANN SURG, V236, P184, DOI 10.1097/00000658-200208000-00006; SAUL TG, 1981, J NEUROSURG, V54, P596, DOI 10.3171/jns.1981.54.5.0596; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; SCHONFELD SA, 1983, ANN INTERN MED, V99, P438, DOI 10.7326/0003-4819-99-4-438; SCHUMER W, 1976, ANN SURG, V184, P333, DOI 10.1097/00000658-197609000-00011; Siempos II, 2008, J ANTIMICROB CHEMOTH, V62, P661, DOI 10.1093/jac/dkn283; SLOAN JP, 1992, J AM GERIATR SOC, V40, P1105, DOI 10.1111/j.1532-5415.1992.tb01798.x; Snijders D, 2010, AM J RESP CRIT CARE, V181, P975, DOI 10.1164/rccm.200905-0808OC; Sobieski MA, 2008, ASAIO J, V54, P203, DOI 10.1097/MAT.0b013e3181640331; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; SPRUNG CL, 1984, NEW ENGL J MED, V311, P1137, DOI 10.1056/NEJM198411013111801; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Sterne J, 2001, SYSTEMATIC REV HLTH, V2, P189, DOI DOI 10.1002/9780470693926.CH11; Suezawa T, 2013, GEN THORAC CARDIOVAS, V61, P455, DOI 10.1007/s11748-013-0206-8; THEODOSSI A, 1982, GUT, V23, P75, DOI 10.1136/gut.23.1.75; Thomas R, 1999, INTENS CARE MED, V25, P475, DOI 10.1007/s001340050883; Thursz MR, 2015, NEW ENGL J MED, V372, P1619, DOI 10.1056/NEJMoa1412278; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Tolaj Ilir, 2010, Med Arh, V64, P228; TOLEDOPEREYRA LH, 1980, AM SURGEON, V46, P155; Tongyoo S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1511-2; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88; Turner S, 2008, BRIT J SURG, V95, P50, DOI 10.1002/bjs.5978; Venet F, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0740-0; Venkatesh B, 2018, NEW ENGL J MED, V378, P797, DOI 10.1056/NEJMoa1705835; Vukovic PM, 2011, PERFUSION-UK, V26, P31, DOI 10.1177/0267659110385607; WAGNER HN, 1956, B JOHNS HOPKINS HOSP, V98, P197; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Wan YD, 2016, CHEST, V149, P209, DOI 10.1378/chest.15-1733; Weis F, 2009, CRIT CARE MED, V37, P1685, DOI 10.1097/CCM.0b013e31819fca77; Whitlock RP, 2015, LANCET, V386, P1243, DOI 10.1016/S0140-6736(15)00273-1; Whitlock RP, 2006, J SURG RES, V132, P188, DOI 10.1016/j.jss.2006.02.013; Yano M, 2005, HEPATO-GASTROENTEROL, V52, P481; Yared JP, 2007, J CARDIOTHOR VASC AN, V21, P68, DOI 10.1053/j.jvca.2005.10.014; Yared JP, 2000, ANN THORAC SURG, V69, P1420, DOI 10.1016/S0003-4975(00)01180-2; Yildiz O, 2002, CRIT CARE, V6, P251, DOI 10.1186/cc1498; Yildiz O, 2011, J RES MED SCI, V16, P1410; Zannad F, 2005, HEART FAIL REV, V10, P71, DOI 10.1007/s10741-005-2351-3	155	7	7	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1053-0770	1532-8422		J CARDIOTHOR VASC AN	J. Cardiothorac. Vasc. Anesth.	OCT	2018	32	5					2252	2260		10.1053/j.jvca.2018.04.017			9	Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Cardiovascular System & Cardiology; Respiratory System	GX5UU	WOS:000447817300037	29793761				2022-02-06	
J	Olson, RL; Brush, CJ; Ehmann, PJ; Buckman, JF; Alderman, BL				Olson, Ryan L.; Brush, Christopher J.; Ehmann, Peter J.; Buckman, Jennifer F.; Alderman, Brandon L.			A history of sport-related concussion is associated with sustained deficits in conflict and error monitoring	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Concussion; Cognitive control; ERN; Event-related potential; Sport	TRAUMATIC BRAIN-INJURY; OBSESSIVE-COMPULSIVE DISORDER; ANTERIOR CINGULATE CORTEX; MAJOR DEPRESSIVE DISORDER; COGNITIVE CONTROL; PERSISTENT INFLUENCE; ERP COMPONENTS; ELECTROPHYSIOLOGICAL EVIDENCE; NEUROCOGNITIVE PERFORMANCE; FUNCTIONAL-SIGNIFICANCE	Previous research has demonstrated long-term deficits in neurocognitive function in individuals with a history of sport-related concussion. The purpose of this study was to examine the relationship between a history of concussion and behavioral and event-related potential (ERP) indices of pre- and post-response conflict and error monitoring. A secondary aim was to determine whether years of high risk sport participation were related to impairments in these cognitive control processes. Forty-seven former athletes (age = 20.8 +/- 2.2 years) with (n = 25; 5 females) and without (n = 22; 9 females) a history of concussion completed a modified flanker task while behavioral performance, N2, error-related negativity (ERN), and error positivity (Pe) components were assessed. An increase in post-response error-related (ERN) brain activity and a nonsignificant trend of increased pre-response conflict (N2) was observed in individuals with a prior sport-related concussion relative to non concussed controls; however, no behavioral performance differences were found between groups. No significant associations were found between ERP and behavioral measures and the number of years of high-risk sport participation; however, time since last head injury was associated with shorter N2 latency. Together, these findings suggest a persistent impairment in cognitive control and error-related processing in individuals with a history of concussion. These findings are interpreted within the framework of the compensatory error-monitoring hypothesis.	[Olson, Ryan L.] Univ North Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX USA; [Brush, Christopher J.; Ehmann, Peter J.; Buckman, Jennifer F.; Alderman, Brandon L.] Rutgers State Univ, Dept Kinesiol & Hlth, 70 Lipman Dr, New Brunswick, NJ 08901 USA		Alderman, BL (corresponding author), Rutgers State Univ, Dept Kinesiol & Hlth, 70 Lipman Dr, New Brunswick, NJ 08901 USA.	alderman@rutgers.edu	Olson, Ryan/N-3137-2015; Ehmann, Peter/O-3938-2017	Olson, Ryan/0000-0002-7070-3233; Alderman, Brandon/0000-0003-0101-6533; Ehmann, Peter/0000-0001-8037-5731	NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K02 AA025123] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K02AA025123] Funding Source: NIH RePORTER		Alderman BL, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00269, 10.3389/fnhum.2015.00269]; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Brush CJ, 2018, INT J PSYCHOPHYSIOL, V132, P124, DOI 10.1016/j.ijpsycho.2017.10.006; CHATRIAN GE, 1988, J CLIN NEUROPHYSIOL, V5, P183, DOI 10.1097/00004691-198804000-00005; Clark M., 2016, TRANSLATIONAL RES TR; Clawson A, 2013, PSYCHOPHYSIOLOGY, V50, P711, DOI 10.1111/psyp.12066; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P1209, DOI 10.1111/psyp.12138; De Beaumont L, 2013, J CLIN EXP NEUROPSYC, V35, P596, DOI 10.1080/13803395.2013.800023; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dien J, 2004, PSYCHOPHYSIOLOGY, V41, P665, DOI 10.1111/j.1469-8986.2004.00193.x; Dien J, 2010, J NEUROSCI METH, V187, P138, DOI 10.1016/j.jneumeth.2009.12.009; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Endrass T, 2010, BIOL PSYCHOL, V84, P257, DOI 10.1016/j.biopsycho.2010.02.002; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gosselin N, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12253; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Hajcak G, 2003, BIOL PSYCHOL, V64, P77, DOI 10.1016/S0301-0511(03)00103-0; Hajcak G, 2012, CURR DIR PSYCHOL SCI, V21, P101, DOI 10.1177/0963721412436809; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Holmes AJ, 2010, COGN AFFECT BEHAV NE, V10, P119, DOI 10.3758/CABN.10.1.119; Holroyd CB, 1998, NEUROSCI LETT, V242, P65, DOI 10.1016/S0304-3940(98)00035-4; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; Kappenman, 2012, OXFORD HDB EVENT REL, P231, DOI [10.1093/oxfordhb/9780195374148.013.0120, DOI 10.1093/OXFORDHB/9780195374148.013.0120]; Kappenman ES, 2016, CEREB CORTEX, V26, P1891, DOI 10.1093/cercor/bhu329; Kappenman ES., 2012, OXFORD HDB EVENT REL, P3; Kaufman NL, 2004, KAUFMAN BRIEF INTELL; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Ladouceur CD, 2012, DEV COGN NEUROS-NETH, V2, P351, DOI 10.1016/j.dcn.2012.01.005; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Larson MJ, 2014, INT J PSYCHOPHYSIOL, V93, P283, DOI 10.1016/j.ijpsycho.2014.06.007; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Ledwidge PS, 2016, J NEUROTRAUM, V33, P2081, DOI 10.1089/neu.2015.4251; Leuthold H, 1999, CLIN NEUROPHYSIOL, V110, P342, DOI 10.1016/S1388-2457(98)00058-3; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BR J SPORTS MED; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meyer A, 2013, PSYCHOPHYSIOLOGY, V50, P1220, DOI 10.1111/psyp.12132; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moran T. P, 2015, SOC COGN AFFECT NEUR; Moser JS, 2016, PSYCHOPHYSIOLOGY, V53, P21, DOI 10.1111/psyp.12509; Moser JS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00064; Moser JS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00466; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Olson RL, 2016, NEUROIMAGE, V131, P171, DOI 10.1016/j.neuroimage.2015.10.011; Olvet DM, 2009, PSYCHOPHYSIOLOGY, V46, P957, DOI 10.1111/j.1469-8986.2009.00848.x; Olvet DM, 2008, CLIN PSYCHOL REV, V28, P1343, DOI 10.1016/j.cpr.2008.07.003; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Proudfit GH, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00636; Riesel A, 2013, BIOL PSYCHOL, V93, P377, DOI 10.1016/j.biopsycho.2013.04.007; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Simons RF, 2010, PSYCHOPHYSIOLOGY, V47, P1, DOI 10.1111/j.1469-8986.2009.00929.x; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Tucker D. M., 1994, HUMAN BRAIN MAPPING, V1, P134, DOI DOI 10.1002/HBM.460010206	72	7	7	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		145	154		10.1016/j.ijpsycho.2018.01.006			10	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000018	29355581	Green Accepted			2022-02-06	
J	Rosario, BL; Horvat, CM; Wisniewski, SR; Bell, MJ; Panigrahy, A; Zuccoli, G; Narayanan, S; Balasubramani, GK; Beers, SR; Adelson, PD				Rosario, Bedda L.; Horvat, Christopher M.; Wisniewski, Stephen R.; Bell, Michael J.; Panigrahy, Ashok; Zuccoli, Giulio; Narayanan, Srikala; Balasubramani, Goundappa K.; Beers, Sue R.; Adelson, P. David		Investigators Cool Kids Trial	Presenting Characteristics Associated With Outcome in Children With Severe Traumatic Brain Injury: A Secondary Analysis From a Randomized, Controlled Trial of Therapeutic Hypothermia	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						fixed pupils; outcomes; pediatric traumatic brain injury; phenotype; prediction; subarachnoid hemorrhage	GLASGOW COMA SCALE; COMMON DATA ELEMENTS; SUBARACHNOID HEMORRHAGE; PROGNOSTIC-FACTORS; CLINICAL-TRIAL; MORTALITY; VALIDATION; PREDICTORS; PHENOTYPES; VASOSPASM	Objectives: To identify injury patterns and characteristics associated with severe traumatic brain injury course and outcome, within a well-characterized cohort, which may help guide new research and treatment initiatives. Design: A secondary analysis of a phase 3, randomized, controlled trial that compared therapeutic hypothermia versus normothermia following severe traumatic brain injury in children. Setting: Fifteen sites in the United States, Australia, and New-Zealand. Patients: Children (< 18 yr old) with severe traumatic brain injury. Measurements and Main Results: Baseline, clinical, and CT characteristics of patients (n = 77) were examined for association with mortality and outcome, as measured by the Glasgow Outcome ScaleExtended Pediatric Revision 3 months after traumatic brain injury. Data are presented as odds ratios with 95% CIs. No demographic, clinical, or CT characteristic was associated with mortality in bivariate analysis. Characteristics associated with worse Glasgow Outcome Scale-Extended Pediatric Revision in bivariate analysis were two fixed pupils (14.17 [3.38-59.37]), abdominal Abbreviated Injury Severity score (2.03 [1.19-3.49]), and subarachnoid hemorrhage (3.36 [1.30-8.70]). Forward stepwise regression demonstrated that Abbreviated Injury Severity spine (3.48 [1.14-10.58]) and midline shift on CT (8.35 [1.05-66.59]) were significantly associated with mortality. Number of fixed pupils (one fixed pupil 3.47 [0.79-15.30]; two fixed pupils 13.61 [2.89-64.07]), hypoxia (5.22 [1.02-26.67]), and subarachnoid hemorrhage (3.01 [1.01-9.01]) were independently associated with worse Glasgow Outcome Scale-Extended Pediatric Revision following forward stepwise regression. Conclusions: Severe traumatic brain injury is a clinically heterogeneous disease that can be accompanied by a range of neurologic impairment and a variety of injury patterns at presentation. This secondary analysis of prospectively collected data identifies several characteristics associated with outcome among children with severe traumatic brain injury. Future, larger trials are needed to better characterize phenotypes within this population.	[Rosario, Bedda L.; Wisniewski, Stephen R.; Balasubramani, Goundappa K.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Horvat, Christopher M.; Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Horvat, Christopher M.; Bell, Michael J.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Panigrahy, Ashok; Zuccoli, Giulio; Narayanan, Srikala] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Beers, Sue R.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Adelson, P. David] Phoenix Childrens Hosp, Dept Neurol Surg, Barrow Neurol Inst, Phoenix, AZ USA		Bell, MJ (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA.; Bell, MJ (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.; Bell, MJ (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA.	mbell@childrensnational.org	Adelson, David/W-2083-2019	Figaji, Anthony/0000-0002-3357-6490; Goundappa K, Balasubramani/0000-0001-7221-1825; Edwards, Richard/0000-0001-8415-2180; /0000-0001-9734-8035	National Institutes of Health grants National Institute of Child Health and Human Development [T32 HD40686]; Clinical and Translational Science Award [UL1TR000005]; National Institute of Neurologic Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS052478]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS081041]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS052478, R21NS099546, U01NS081041] Funding Source: NIH RePORTER	Supported, in part, by the National Institutes of Health grants National Institute of Child Health and Human Development T32 HD40686 (to Dr. Horvat), Clinical and Translational Science Award UL1TR000005 (to Dr. Rosario), National Institute of Neurologic Disorders and Stroke (NINDS) U01NS052478 (to Dr. Adelson), NINDS U01 NS081041 (to Dr. Bell).	Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P304, DOI 10.1097/TA.0000000000000300; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Alharfi IM, 2013, J NEUROTRAUM, V30, P361, DOI 10.1089/neu.2012.2410; Alhelali I, 2015, J TRAUMA ACUTE CARE, V78, P1155, DOI 10.1097/TA.0000000000000662; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bandt SK, 2012, J NEUROSURG-PEDIATR, V10, P511, DOI 10.3171/2012.8.PEDS123; Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x; Bos LD, 2017, THORAX, V72, P876, DOI 10.1136/thoraxjnl-2016-209719; Carcillo JA, 2017, PEDIATR CRIT CARE ME, V18, P513, DOI 10.1097/PCC.0000000000001122; Chan M, 2013, SPINAL CORD, V51, P360, DOI 10.1038/sc.2013.6; Teruel GC, 2007, J PEDIATR SURG, V42, P1903, DOI 10.1016/j.jpedsurg.2007.07.020; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Fard SA, 2016, J CLIN NEUROSCI, V33, P63, DOI 10.1016/j.jocn.2016.05.021; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hekking PPW, 2014, J ALLER CL IMM-PRACT, V2, P671, DOI 10.1016/j.jaip.2014.09.007; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Horn EM, 2007, J NEUROSURG-SPINE, V6, P113, DOI 10.3171/spi.2007.6.2.113; Hu CYW, 2015, SCI REP-UK, V5, DOI 10.1038/srep12894; Kannan N, 2016, PEDIATR EMERG CARE, V34, P325; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Leo P., 2016, TRANSLATIONAL RES TR, P1; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Murphy S, 2017, J NEUROTRAUM, V34, P2220, DOI 10.1089/neu.2016.4793; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; O'Brien NF, 2015, CRIT CARE MED, V43, P674, DOI 10.1097/CCM.0000000000000745; O'Brien NF, 2010, INTENS CARE MED, V36, P680, DOI 10.1007/s00134-009-1747-2; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; Ratan Simmi K., 2002, Indian Journal of Pediatrics, V69, P573, DOI 10.1007/BF02722680; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; Varma A, 2010, SPINE, V35, P778, DOI 10.1097/BRS.0b013e3181ba1359; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507	40	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	OCT	2018	19	10					957	964		10.1097/PCC.0000000000001676			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	HD3PQ	WOS:000452430500015	30067578	Green Accepted			2022-02-06	
J	Trevisi, G; Scerrati, A; Peppucci, E; DeWaure, C; Anile, C; Mangiola, A				Trevisi, Gianluca; Scerrati, Alba; Peppucci, Elisabetta; DeWaure, Chiara; Anile, Carmelo; Mangiola, Annunziato			What Is the Best Timing of Repeated CT Scan in Mild Head Trauma with an Initially Positive CT Scan?	WORLD NEUROSURGERY			English	Article						Computed tomography; Glasgow Coma Scale; Intracerebral contusion; Mild head trauma; Subarachnoid hemorrhage; Subdural hematoma	COMPUTED-TOMOGRAPHY; BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; UTILITY	BACKGROUND: Mild traumatic brain injury (MTBI) is among the most common causes of emergency admission. Current guidelines have clearly evidenced risk factors and neurologic signs that should suggest computed tomography (CT) of the head at admission and indications for the first repeated CT scan. However, the role and frequency of further repeated CT scans after an initially positive scan are still unclear. METHODS: We retrospectively analyzed 222 patients admitted in our hospital for clinical observation after an MTBI and a positive initial scan. Repeated CT scans were categorized according to timing from the first scan. All the scans were evaluated for the presence of posttraumatic lesions. We classified the data in 3 groups according to the timing of CT scans: A (CT scans at t0-t12-t24), B (t0-t12-t48), and C (t0-t24-t48). Differences in worsening or stability of posttraumatic lesions were compared by the chi(2) test. RESULTS: 146 CT scans were performed at t12, 81 at t24, and 143 at t48. The initial CT scan was positive for epidural hematoma in 17 cases, subdural hematoma in 106, subdural hygroma in 10, intracerebral contusion in 110, subarachnoid hemorrhage in 109, and intraventricular hemorrhage in 12. None of the posttraumatic lesions showed significant worsening or at the first or second CT scan in any of the 3 groups. CONCLUSIONS: The treatment of patients in clinically stable condition with an MTBI and posttraumatic intracranial lesions at initial CT scan has been shown to minimally benefit from repeated CT scans. Given neurologic stability, a control scan can be safely delayed up to 48 hours to avoid unnecessary scans.	[Trevisi, Gianluca; Anile, Carmelo] Univ Cattolica Sacro Cuore, Inst Neurosurg, Rome, Italy; [Scerrati, Alba] S Anna Univ Hosp, Dept Neurosurg, Ferrara, Italy; [Peppucci, Elisabetta] Santa Maria Hosp Trust, Dept Neurosurg, Terni, Italy; [DeWaure, Chiara] Univ Perugia, Dept Expt Med, Perugia, Italy; [Mangiola, Annunziato] Chieti Univ G DAnnunzio, Santo Spirito Hosp, Dept Neurosurg, Pescara, Italy		Scerrati, A (corresponding author), S Anna Univ Hosp, Dept Neurosurg, Ferrara, Italy.	a.scerrati@gmail.com	Scerrati, Alba/Z-2079-2019; Trevisi, Gianluca/K-9664-2016; Trevisi, Gianluca/ABD-1335-2020; Dewaure, Chiara/K-7192-2016	Scerrati, Alba/0000-0002-8607-5323; Trevisi, Gianluca/0000-0002-2879-8451; Trevisi, Gianluca/0000-0002-2879-8451; Dewaure, Chiara/0000-0002-4346-1494			AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Campiglio L, 2017, NEUROL-CLIN PRACT, V7, P296, DOI 10.1212/CPJ.0000000000000375; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Innocenti F, 2017, INTERN EMERG MED, V12, P81, DOI 10.1007/s11739-016-1421-y; Kreitzer N, 2017, AM J EMERG MED, V35, P875, DOI 10.1016/j.ajem.2017.01.051; National Institute for Health and Care Excellence, 2017, HEAD INJ ASS EARL MA; Reljic T, 2014, J NEUROTRAUM, V31, P78, DOI 10.1089/neu.2013.2873; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	14	7	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2018	118						E316	E322		10.1016/j.wneu.2018.06.185			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GU1NY	WOS:000445032000044	29969739				2022-02-06	
J	Zhang, BL; Fan, YS; Wang, JW; Zhou, ZW; Wu, YG; Yang, MC; Sun, DD; Zhang, JN				Zhang, Bao-Liang; Fan, Yue-Shan; Wang, Ji-Wei; Zhou, Zi-Wei; Wu, Yin-Gang; Yang, Meng-Chen; Sun, Dong-Dong; Zhang, Jian-Ning			Cognitive impairment after traumatic brain injury is associated with reduced long-term depression of excitatory postsynaptic potential in the rat hippocampal dentate gyrus	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; long-term depression; traumatic brain injury; hippocampus; interneurons; excitability; dentate gyrus; parvalbumin; cholecystokinin; electrophysiology; quantification; neural regeneration	TEMPORAL-LOBE EPILEPSY; DEFICITS; NEURONS; MEMORY; CELLS; HYPEREXCITABILITY; CORTEX; MODEL; INTERNEURONS; INHIBITION	Traumatic brain injury can cause loss of neuronal tissue, remote symptomatic epilepsy, and cognitive deficits. However, the mechanisms underlying the effects of traumatic brain injury are not yet clear. Hippocampal excitability is strongly correlated with cognitive dysfunction and remote symptomatic epilepsy. In this study, we examined the relationship between traumatic brain injury-induced neuronal loss and subsequent hippocampal regional excitability. We used hydraulic percussion to generate a rat model of traumatic brain injury. At 7 days after injury, the mean modified neurological severity score was 9.5, suggesting that the neurological function of the rats was remarkably impaired. Electrophysiology and immunocytochemical staining revealed increases in the slope of excitatory postsynaptic potentials and long-term depression (indicating weakened long-term inhibition), and the numbers of cholccystokinin and parvalbumin immunoreactive cells were clearly reduced in the rat hippocampal dentate gyms. These results indicate that interneuronal loss and changes in excitability occurred in the hippocampal dentate gyrus. Thus, traumatic brain injury-induced loss of interneurons appears to be associated with reduced long-term depression in the hippocampal dentate gyms.	[Zhang, Jian-Ning] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; Tianjin Neurol Inst, Tianjin, Peoples R China; Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.	jianningzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81330029, 81501057]; Natural Science Foundation of Tianjin of ChinaNatural Science Foundation of Tianjin [17JCQNJC12000]; Tianjin Medical University General Hospital Funding in China [ZYYFY2016014]	This study was supported by the National Natural Science Foundation of China, No. 81330029, 81501057; the Natural Science Foundation of Tianjin of China, No. 17JCQNJC12000; the Tianjin Medical University General Hospital Funding in China, No. ZYYFY2016014.; This study was supported by the National Natural Science Foundation of China, No. 81330029, 81501057; the Natural Science Foundation of Tianjin of China, No. 17JCQNJC12000; the Tianjin Medical University General Hospital Funding in China, No. ZYYFY2016014. The funders did not participant in the study design, in the collection, analysis and interpretation of data, in the writing of the paper, and in the decision to submit the paper for publication.	Altinbilek B, 2007, EUR J NEUROSCI, V26, P1166, DOI 10.1111/j.1460-9568.2007.05742.x; Alwis DS, 2016, J NEUROTRAUM, V33, P1084, DOI 10.1089/neu.2014.3774; Andrews CJ, 2017, NEURAL REGEN RES, V12, P1405, DOI 10.4103/1673-5374.215242; Andrews CJ, 2017, NEURAL REGEN RES, V12, P677, DOI 10.4103/1673-5374.206636; Ashley MJ, 2012, NEUROREHABILITATION, V31, P31, DOI 10.3233/NRE-2012-0772; Aungst S, 2013, J NEUROPHYSIOL, V109, P813, DOI 10.1152/jn.00869.2012; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bussiere T, 2002, NEUROSCIENCE, V112, P75, DOI 10.1016/S0306-4522(02)00056-8; Casaletto KB, 2017, NEUROLOGY, V89, P1782, DOI 10.1212/WNL.0000000000004569; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; Dymowski AR, 2015, J CLIN EXP NEUROPSYC, V37, P1024, DOI 10.1080/13803395.2015.1074663; Faingold CL, 2015, NEUROSCIENTIST, V21, P460, DOI 10.1177/1073858415592377; Finch E, 2017, BRAIN INJURY, V27, P1; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; HALASY K, 1993, EUR J NEUROSCI, V5, P411, DOI 10.1111/j.1460-9568.1993.tb00508.x; Hamidi S, 2015, NEUROPHARMACOLOGY, V95, P377, DOI 10.1016/j.neuropharm.2015.04.015; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; Hendricks WD, 2017, J NEUROSCI, V37, P5722, DOI 10.1523/JNEUROSCI.0761-17.2017; Hoover S, 2014, INT J PSYCHOPHYSIOL, V91, P139, DOI 10.1016/j.ijpsycho.2013.12.009; Hosseini-Zare MS, 2017, EXP NEUROL, V295, P155, DOI 10.1016/j.expneurol.2017.05.002; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Kamins J, 2016, NEUROSURG CLIN N AM, V27, P441, DOI 10.1016/j.nec.2016.05.005; Levesque M, 2016, NEUROBIOL DIS, V87, P91, DOI 10.1016/j.nbd.2015.12.011; Li SH, 2006, J NEUROSCI RES, V83, P292, DOI 10.1002/jnr.20720; Lin W, 2016, ASIA PAC J CLIN TRIA, V1, P170; Liu TT, 2017, MOL MED REP, V16, P3169, DOI 10.3892/mmr.2017.7017; Losi G, 2016, J NEUROSCI METH, V260, P125, DOI 10.1016/j.jneumeth.2015.04.001; Magagna-Poveda A, 2017, BRAIN STRUCT FUNCT, V222, P4219, DOI 10.1007/s00429-017-1457-4; Mashhadizadeh S, 2017, IRAN J BASIC MED SCI, V20, P399, DOI 10.22038/IJBMS.2017.8581; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McGarity S, 2017, J HEAD TRAUMA REHAB, V32, P34, DOI 10.1097/HTR.0000000000000242; Miki T, 2000, HIPPOCAMPUS, V10, P284, DOI 10.1002/1098-1063(2000)10:3<284::AID-HIPO9>3.0.CO;2-K; Neumann AR, 2017, BRAIN, V140, P2355, DOI 10.1093/brain/awx179; Palmer MJ, 2014, J NEUROPHYSIOL, V112, P2026, DOI 10.1152/jn.00180.2014; Pedachenko E G, 2015, Zh Vopr Neirokhir Im N N Burdenko, V79, P21, DOI 10.17116/neiro201579221-32; Rink E, 2004, NEUROSCIENCE, V127, P147, DOI 10.1016/j.neuroscience.2004.05.004; Rombo DM, 2016, J NEUROCHEM, V139, P1056, DOI 10.1111/jnc.13872; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; Sood S, 2017, MED DOSIM, V42, P375, DOI 10.1016/j.meddos.2017.07.005; Spencer SJ, 2017, NEUROBIOL AGING, V58, P88, DOI 10.1016/j.neurobiolaging.2017.06.014; Spiegel DP, 2015, VISION RES, V109, P38, DOI 10.1016/j.visres.2015.02.020; Su ZJ, 2009, J NEUROTRAUM, V26, P1695, DOI 10.1089/neu.2008.0519; Thomsen GM, 2017, J TRAUMA ACUTE CARE, V82, P1039, DOI 10.1097/TA.0000000000001443; Van KC, 2016, METHODS MOL BIOL, V1462, P231, DOI 10.1007/978-1-4939-3816-2_14; van Zomeren AH, 1998, J NEUROL NEUROSUR PS, V64, P763, DOI 10.1136/jnnp.64.6.763; Vasudevan EVL, 2014, J NEUROL PHYS THER, V38, P172, DOI 10.1097/NPT.0000000000000049; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yamada H, 2016, NEUROSCI RES, V105, P2, DOI 10.1016/j.neures.2015.10.003; Yang L, 2007, J NEUROPHYSIOL, V97, P178, DOI 10.1152/jn.01374.2005; You JC, 2017, NAT MED, V23, P1377, DOI 10.1038/nm.4413	54	7	8	2	9	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	OCT	2018	13	10					1753	1758		10.4103/1673-5374.238618			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	GR6EJ	WOS:000442737900014	30136690	Green Published, gold			2022-02-06	
J	Mang, CS; Whitten, TA; Cosh, MS; Scott, SH; Wiley, JP; Debert, CT; Dukelow, SP; Benson, BW				Mang, Cameron S.; Whitten, Tara A.; Cosh, Madeline S.; Scott, Stephen H.; Wiley, J. Preston; Debert, Chantel T.; Dukelow, Sean P.; Benson, Brian W.			Robotic Assessment of Motor, Sensory, and Cognitive Function in Acute Sport-Related Concussion and Recovery	JOURNAL OF NEUROTRAUMA			English	Article						assessment; concussion; KINARM; robotics; sport	TRAUMATIC BRAIN-INJURY; ASSESSMENT TOOLS; BALANCE CONTROL; HIGH-SCHOOL; GAIT; SENSORIMOTOR; RELIABILITY; PERFORMANCE; COLLEGIATE; VALIDITY	There is a need for better tools to objectively, reliably, and precisely assess neurological function after sport-related concussion (SRC). The aim of this study was to use a robotic device (Kinesiological Instrument for Normal and Altered Reaching Movements; KINARM) to quantify neurological impairments in athletes acutely and when clinically asymptomatic post-SRC. Robotic assessments included five KINARM standard tasks that evaluate aspects of motor, sensory, and cognitive function. We hypothesized that acutely concussed athletes would demonstrate significant rates of impairment on the robotic assessment, and that impairments would be associated with acute symptom severity. Pre-season assessments were conducted from 2011 to 2016 on 1051 athletes. Eighty-four athletes were reassessed acutely (10 days post-injury) and while symptomatic post-SRC and 89 when clinically asymptomatic. Forty-four parameters were measured from the KINARM assessment to characterize neurological function. Reliable change indices (80% confidence interval) identified impairments in healthy and concussed individuals for each parameter. In concussed individuals, impairment rate varied across parameters from 4% to 27% at the acute time point and from 2% to 18% when clinically asymptomatic. Healthy athlete impairment rates were between 2% and 16% across all testing time points. We identified relationships between acute symptom severity and task performance for only two parameters, both of which evaluated attributes of motor function. Overall, the KINARM identified impairments in motor, sensory, and cognitive function in athletes with SRC; however, impairment rates were low and largely did not relate to symptom severity. More complex tasks may be necessary to identify potentially subtle neurological impairments post-SRC.	[Mang, Cameron S.; Whitten, Tara A.; Debert, Chantel T.; Dukelow, Sean P.; Benson, Brian W.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Mang, Cameron S.; Whitten, Tara A.; Debert, Chantel T.; Dukelow, Sean P.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Cosh, Madeline S.; Benson, Brian W.] Winter Sport Inst, WinSport Med Clin, Calgary, AB, Canada; [Scott, Stephen H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Wiley, J. Preston; Dukelow, Sean P.; Benson, Brian W.] Univ Calgary, Fac Kinesiol, Sport Med Ctr, Calgary, AB, Canada; [Benson, Brian W.] Canadian Sport Inst Calgary, Calgary, AB, Canada		Mang, CS (corresponding author), Univ Calgary, Dept Clin Neurosci, Foothills Med Ctr, Room 905,South Tower,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	cameron.mang@ucalgary.ca		Debert, Chantel/0000-0002-2704-0438; Mang, Cameron/0000-0002-3376-5355	Own the Podium Canada; Canadian Academy of Sport and Exercise Medicine Research Fund; Canadian Sport Institute Calgary; Alberta; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions; Mitacs fellowship	This work was funded by Own the Podium Canada, the Canadian Academy of Sport and Exercise Medicine Research Fund, the Canadian Sport Institute Calgary, and Jim Smith of Calgary, Alberta. C.S.M. was funded by post-doctoral fellowships from the Canadian Institutes of Health Research and Alberta Innovates Health Solutions. T.A.W. was funded by a Mitacs fellowship in partnership with Own the Podium Canada. S.H.S. is cofounder and chief scientific officer of BKIN Technologies, Ltd., the company that commercializes the KINARM device used in this study.	Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bourke TC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0201-2; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; BROWN JA, 2015, BMC SPORTS SCI MED R, V7, DOI DOI 10.1186/S13102-015-0019-4; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Coderre AM, 2010, NEUROREHAB NEURAL RE, V24, P528, DOI 10.1177/1545968309356091; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Debert CT, 2012, J NEUROL PHYS THER, V36, P58, DOI 10.1097/NPT.0b013e318254bd4f; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; DUKELOW SP, 2012, J NEUROENG REHABIL, V9, DOI DOI 10.1186/1743-0003-9-72; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; HERTER TM, 2014, J NEUROENG REHABIL, V11, DOI DOI 10.1186/1743-0003-11-43; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; KENZIE JM, 2017, J NEUROENG REHABIL, V14, DOI DOI 10.1186/S12984-017-0329-8; Little CE, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0195-9; Little CE, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0070-0; Logan LM, 2018, J HEAD TRAUMA REHAB, V33, pE61, DOI 10.1097/HTR.0000000000000349; Mang CS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196205; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea MA, 2017, PHYS MED REH CLIN N, V28, P271, DOI 10.1016/j.pmr.2016.12.005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MCLEAN D, 2016, DEXTERIT E 3 6 USER, DOI DOI 10.1016/J.JPEDSURG.2008.10.089; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; MOSTAFAVI SM, 2013, IEEE INT C REH ROB, V2013, DOI DOI 10.1089/NEU.2016.4840; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P159; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Scott SH, 2011, J REHABIL RES DEV, V48, P335, DOI 10.1682/JRRD.2010.04.0057; Simmatis L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188786; Subbian V, 2016, ACAD EMERG MED, V23, P382, DOI 10.1111/acem.12906; Subbian V, 2015, IEEE J TRANSL ENG HE, V3, DOI 10.1109/JTEHM.2015.2424224; TYRYSHKIN K, 2014, J NEUROENG REHABIL, V11, DOI DOI 10.1186/1743-0003-11-47	51	7	7	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					308	321		10.1089/neu.2017.5587		SEP 2018	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000445760500001	30032700				2022-02-06	
J	Suleiman, A; Lithgow, B; Mansouri, B; Moussavi, Z				Suleiman, Abdelbaset; Lithgow, Brian; Mansouri, Behzad; Moussavi, Zahra			Investigating the validity and reliability of Electrovestibulography (EVestG) for detecting post-concussion syndrome (PCS) with and without comorbid depression	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; COMPOUND ACTION-POTENTIALS; SYMPTOMS QUESTIONNAIRE; HEAD-INJURY; POSTCONCUSSION SYNDROME; CONSTRUCT-VALIDITY; QUANTITATIVE EEG; DISORDERS; DIZZINESS; COCHLEA	Features from Electrovestibulography (EVestG) recordings have been used to classify and measure the severity of both persistent post-concussion syndrome (PCS) and major depressive disorder. Herein, we examined the effect of comorbid depression on the detection of persistent PCS using EVestG. To validate our previously developed EVestG classifier for PCS detection, the classifier was tested with a new blind dataset (N = 21). The unbiased accuracy for identifying the new PCS from controls was found to be >90%. Next, the PCS group (N = 59) was divided into three subgroups: PCS with no-depression (n = 18), PCS with mild-depression (n = 27) and PCS with moderate/severe-depression (n = 14). When moderate/severe depression was present, PCS classification accuracy dropped to 83%. By adding an EVestG depression feature from a previous study, separation accuracy of each PCS subgroup from controls was >90%. A four and three-group (excluding mild-depression subgroup) classification, achieved an accuracy of 74% and 81%, respectively. Correlation analysis indicated a significant correlation (R= 0.67) between the depression feature and the MADRS depression score as well as between the PCS-specific feature and Rivermead Post-Concussion Questionnaire (RPQ) (R = -0.48). No significant correlation was found between the PCS-specific feature and the MADRS score (R = 0.20) or between RPQ and the depression feature (R = 0.12). The (PCS-specific and depression-specific) EVestG features used herein have the potential to robustly detect and monitor changes, relatively independently, in both persistent PCS and its depression comorbidity. Clinically, this can be particularly advantageous.	[Suleiman, Abdelbaset; Lithgow, Brian; Mansouri, Behzad; Moussavi, Zahra] Univ Manitoba, Biomed Engn Program, Winnipeg, MB, Canada; [Mansouri, Behzad] Univ Manitoba, Dept Internal Med Neurol, Winnipeg, MB, Canada; [Lithgow, Brian] Monash Univ, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia		Moussavi, Z (corresponding author), Univ Manitoba, Biomed Engn Program, Winnipeg, MB, Canada.	Moussavi@umanitoba.ca			MITACS; Manitoba Public Insurance (MPI); Neural Diagnostics Canada Ltd.; Riverview Health Centre Foundation	This study was supported by MITACS in two separate projects one in partnership with Manitoba Public Insurance (MPI) and the other in partnership with Neural Diagnostics Canada Ltd. and Riverview Health Centre Foundation.	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Ashiri M, 2019, J MED BIOL ENG, V39, P238, DOI 10.1007/s40846-018-0425-7; Blakley B, 2019, J MED BIOL ENG, V39, P213, DOI 10.1007/s40846-018-0398-6; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown DJ, 2010, HEARING RES, V267, P12, DOI 10.1016/j.heares.2010.03.091; DAIGNEAULT EA, 1974, ACTA OTO-LARYNGOL, V77, P405, DOI 10.3109/00016487409124642; DAVIDSON J, 1986, ACTA PSYCHIAT SCAND, V73, P544, DOI 10.1111/j.1600-0447.1986.tb02723.x; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; Jones TA, 1999, HEARING RES, V136, P75, DOI 10.1016/S0378-5955(99)00110-0; Jury MA, 2001, NEW ZEAL MED J, V114, P286; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kisilevski V, 2001, Int Tinnitus J, V7, P118; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lithgow B, 2012, ANN BIOMED ENG, V40, P1835, DOI 10.1007/s10439-012-0526-3; Lithgow BJ, 2019, EUR ARCH PSY CLIN N, V269, P761, DOI 10.1007/s00406-018-0935-x; Lithgow BJ, 2015, WORLD J BIOL PSYCHIA, V16, P334, DOI 10.3109/15622975.2015.1014410; Lithgow BJ, 2015, J NEUROL SCI, V353, P49, DOI 10.1016/j.jns.2015.03.050; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; MARLINSKY VV, 1995, NEUROSCIENCE, V69, P661, DOI 10.1016/0306-4522(95)00231-7; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; McCrory P, 2017, BR J SPORTS MED; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moller A. R, 2000, HEARING ITS PHYSL PA; MOLLER AR, 1983, EXP NEUROL, V80, P633, DOI 10.1016/0014-4886(83)90313-8; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sellick P, 2003, HEARING RES, V176, P42, DOI 10.1016/S0378-5955(02)00716-5; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Suleiman A, 2015, IEEE ENG MED BIO, P3375, DOI 10.1109/EMBC.2015.7319116; Suleiman A, 2019, J MED BIOL ENG, V39, P218, DOI 10.1007/s40846-018-0405-y; Suleiman A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15487-2; Surmeli T, 2017, CLIN EEG NEUROSCI, V48, P217, DOI 10.1177/1550059416654849; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Vaccarino AL, 2008, J AFFECT DISORDERS, V110, P270, DOI 10.1016/j.jad.2008.01.009	51	7	7	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 27	2018	8								14495	10.1038/s41598-018-32808-1			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV1FU	WOS:000445816800009	30262840	gold, Green Published			2022-02-06	
J	Ketharanathan, N; Yamamoto, Y; Rohlwink, UK; Wildschut, ED; Mathot, RA; de Lange, ECM; de Wildt, SN; Argent, AC; Tibboel, D; Figaji, AA				Ketharanathan, Naomi; Yamamoto, Yumi; Rohlwink, Ursula K.; Wildschut, Enno D.; Mathot, Ron A. A.; de Lange, Elizabeth C. M.; de Wildt, Saskia N.; Argent, Andrew C.; Tibboel, Dick; Figaji, Anthony A.			Combining Brain Microdialysis and Translational Pharmacokinetic Modeling to Predict Drug Concentrations in Pediatric Severe Traumatic Brain Injury: The Next Step Toward Evidence-Based Pharmacotherapy?	JOURNAL OF NEUROTRAUMA			English	Article						microdialysis; morphine; pediatric; pharmacokinetics; traumatic brain injury	GUIDELINES; CARE	Evidence-based analgosedation in severe pediatric traumatic brain injury (pTBI) management is lacking, and improved pharmacological understanding is needed. This starts with increased knowledge of factors controlling the pharmacokinetics (PK) of unbound drug at the target site (brain) and related drug effect(s). This prospective, descriptive study tested a pediatric physiology-based pharmacokinetic software model by comparing actual plasma and brain extracellular fluid (brain(ECF)) morphine concentrations with predicted concentration-time profiles in severe pTBI patients (Glasgow Coma Scale [GCS], 8). Plasma and brain(ECF) samples were obtained after legal guardian written consent and were collected from 8 pTBI patients (75% male; median age, 96 months [34.0-155.5]; median weight, 24kg [14.5-55.0]) with a need for intracranial pressure monitoring (GCS, 8) and receiving continuous morphine infusion (10-40g/kg/h). Brain(ECF) samples were obtained by microdialysis. Brain(ECF) samples were taken from injured and uninjured regions as determined by microdialysis catheter location on computed head tomography. A previously developed physiology-based software model to predict morphine concentrations in the brain was adapted to children using pediatric physiological properties. The model predicted plasma morphine concentrations well for individual patients (97% of data points within the 90% prediction interval). In addition, predicted brain(ECF) concentration-time profiles fell within a 90% prediction interval of microdialysis brain(ECF) drug concentrations when sampled from an uninjured area. Prediction was less accurate in injured areas. This approach of translational physiology-based PK modeling allows prediction of morphine concentration-time profiles in uninjured brain of individual patients and opens promising avenues towards evidence-based pharmacotherapies in pTBI.	[Ketharanathan, Naomi; Wildschut, Enno D.; de Wildt, Saskia N.; Tibboel, Dick] Erasmus MC, Sophia Childrens Hosp, Intens Care, Rotterdam, Netherlands; [Ketharanathan, Naomi; Wildschut, Enno D.; de Wildt, Saskia N.; Tibboel, Dick] Erasmus MC, Sophia Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands; [Yamamoto, Yumi; de Lange, Elizabeth C. M.] Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands; [Rohlwink, Ursula K.; Figaji, Anthony A.] Univ Cape Town, Red Cross War Mem Childrens Hosp, Div Neurosurg, Cape Town, South Africa; [Rohlwink, Ursula K.; Figaji, Anthony A.] Univ Cape Town, Red Cross War Mem Childrens Hosp, Neurosci Inst, Cape Town, South Africa; [Mathot, Ron A. A.] Acad Med Ctr, Dept Pharmacol, Amsterdam, Netherlands; [de Wildt, Saskia N.] Radboud Univ Nijmegen, Dept Pharmacol & Toxicol, Nijmegen, Netherlands; [Argent, Andrew C.] Univ Cape Town, Red Cross War Mem Childrens Hosp, Paediat Intens Care, Sch Child & Adolescent Hlth, Cape Town, South Africa		Ketharanathan, N (corresponding author), Erasmus MC, Sophia Childrens Hosp, Wytemaweg 80,Room Sk-3234, NL-3015 CN Rotterdam, Netherlands.	n.ketharanathan@erasmusmc.nl	Rohlwink, Ursula Karin/U-8917-2019; de Wildt, Saskia/A-9589-2008; Argent, Andrew/J-1605-2019; Rohlwink, Ursula/AAE-2513-2020	Rohlwink, Ursula Karin/0000-0002-4469-4935; de Wildt, Saskia/0000-0002-0502-0647; Argent, Andrew/0000-0001-9333-2036; de lange, elizabeth/0000-0001-8303-1117; Figaji, Anthony/0000-0002-3357-6490; mathot, ron/0000-0001-8401-0879	Sophia Children's Hospital Research Fund (SSWO); National Research Foundation SARChI Chair of Clinical Neurosciences	N. Ketharanathan received research funding from Sophia Children's Hospital Research Fund (SSWO). A. Figaji is supported by the National Research Foundation SARChI Chair of Clinical Neurosciences.	Azeredo FJ, 2014, CLIN PHARMACOKINET, V53, P205, DOI 10.1007/s40262-014-0131-8; Bell MJ, 2013, CRIT CARE CLIN, V29, P223, DOI 10.1016/j.ccc.2012.11.004; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; De Cock RFW, 2011, EUR J CLIN PHARMACOL, V67, pS5, DOI 10.1007/s00228-009-0782-9; Ederoth P, 2004, BRIT J CLIN PHARMACO, V57, P427, DOI 10.1046/j.1365-2125.2003.02032.x; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Hammarlund-Udenaes M, 2017, AAPS J, V19, P1294, DOI 10.1208/s12248-017-0108-2; Ketharanathan N, 2017, CHILD NERV SYST, V33, P1703, DOI 10.1007/s00381-017-3520-0; Knibbe CAJ, 2011, INT J PHARMACEUT, V415, P9, DOI 10.1016/j.ijpharm.2011.02.056; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Le Roux P, 2014, NEUROCRIT CARE, V21, P297, DOI 10.1007/s12028-014-0081-x; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Shannon RJ, 2013, J PHARMACOKINET PHAR, V40, P343, DOI 10.1007/s10928-013-9306-4; Starkey ES, 2015, ARCH DIS CHILDHOOD-E, V100, P37, DOI 10.1136/archdischild-2013-304555; Westerhout J, 2012, AAPS J, V14, P543, DOI 10.1208/s12248-012-9366-1; Westerhout J, 2011, J PHARM SCI-US, V100, P3577, DOI 10.1002/jps.22604; Yamamoto Y, 2017, AAPS J, V19, P891, DOI 10.1208/s12248-017-0050-3; Yamamoto Y, 2017, PHARM RES-DORDR, V34, P333, DOI 10.1007/s11095-016-2065-3	20	7	7	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					111	117		10.1089/neu.2017.5588		SEP 2018	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000444017100001	30019622	Green Submitted			2022-02-06	
J	Lillicrap, T; Garcia-Esperon, C; Walker, FR; Ong, LK; Nilsson, M; Spratt, N; Levi, CR; Parsons, M; Isgaard, J; Bivard, A				Lillicrap, Thomas; Garcia-Esperon, Carlos; Walker, Frederick Rohan; Ong, Lin Kooi; Nilsson, Michael; Spratt, Neil; Levi, Christopher R.; Parsons, Mark; Isgaard, Jorgen; Bivard, Andrew			Growth Hormone Deficiency Is Frequent After Recent Stroke	FRONTIERS IN NEUROLOGY			English	Article						ischemic stroke; growth hormone; neuro recovery; rehabilitation; cognition	TRAUMATIC BRAIN-INJURY; RAT	Introduction: The incidence of pituitary dysfunction after severe ischemic stroke is unknown, however given the increasing attention to pituitary dysfunction after neurological injuries such as traumatic brain injury, this may represent a novel area of research in stroke. Methods: We perform an arginine and human growth hormone releasing hormone challenge on ischemic stroke patients within a week of symptom onset. Results: Over the study period, 13 patients were successfully tested within a week of stroke (baseline NIHSS 10, range 7-16). Overall, 9(69%) patients had a poor response, with 7(54%) of these patients meeting the criteria for had human growth hormone deficiency. Other measures of pituitary function were within normal ranges. Conclusion: After major ischemic stroke, low GH levels are common and may play a role in stroke recovery.	[Lillicrap, Thomas; Garcia-Esperon, Carlos; Spratt, Neil; Levi, Christopher R.; Parsons, Mark; Bivard, Andrew] Univ Newcastle, John Hunter Hosp, Dept Neurol, Newcastle, NSW, Australia; [Walker, Frederick Rohan; Ong, Lin Kooi; Nilsson, Michael; Spratt, Neil; Levi, Christopher R.; Parsons, Mark; Isgaard, Jorgen; Bivard, Andrew] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW, Australia; [Isgaard, Jorgen] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, Gothenburg, Sweden		Bivard, A (corresponding author), Univ Newcastle, John Hunter Hosp, Dept Neurol, Newcastle, NSW, Australia.; Bivard, A (corresponding author), Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW, Australia.	abivard@unimelb.edu.au	Lillicrap, Thomas/AAP-2949-2021; Lillicrap, Thomas/V-7131-2019; Spratt, Neil J/K-4208-2012; NILSSON, MICHAEL/ABE-7821-2020; Garcia-Esperon, Carlos/AAY-6810-2020; Ong, Lin Kooi/H-2797-2012	Lillicrap, Thomas/0000-0003-3273-7501; Spratt, Neil J/0000-0002-9023-6177; NILSSON, MICHAEL/0000-0002-8826-1621; Ong, Lin Kooi/0000-0001-8664-0540; Levi, Christopher/0000-0002-9474-796X			Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; ANDERSSON K, 1981, EUR J PHARMACOL, V76, P261, DOI 10.1016/0014-2999(81)90510-0; Bondanelli M, 2010, J CLIN ENDOCR METAB, V95, P4660, DOI 10.1210/jc.2010-0611; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Doulah AH, 2009, NEUROSCI LETT, V466, P47, DOI 10.1016/j.neulet.2009.09.016; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Kargi AY, 2013, NAT REV ENDOCRINOL, V9, P335, DOI 10.1038/nrendo.2013.77; Li E, 2011, ENDOCR J, V58, P257, DOI 10.1507/endocrj.K11E-006; Pathipati P, 2009, BEHAV BRAIN RES, V204, P93, DOI 10.1016/j.bbr.2009.05.023; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Scheepens A, 2001, NEUROSCIENCE, V104, P677, DOI 10.1016/S0306-4522(01)00109-9	12	7	7	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 6	2018	9								713	10.3389/fneur.2018.00713			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GS6UA	WOS:000443833900001	30237782	gold, Green Published			2022-02-06	
J	Zhang, YL; Chopp, M; Rex, CS; Simmon, VF; Sarraf, ST; Zhang, ZG; Mahmood, A; Xiong, Y				Zhang, Yanlu; Chopp, Michael; Rex, Christopher S.; Simmon, Vincent F.; Sarraf, Stella T.; Zhang, Zheng Gang; Mahmood, Asim; Xiong, Ye			A Small Molecule Spinogenic Compound Enhances Functional Outcome and Dendritic Spine Plasticity in a Rat Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						dendritic spine; functional outcome; rat; SPG101; traumatic brain injury	CONTROLLED CORTICAL IMPACT; SYNAPTIC PLASTICITY; SOCIAL-BEHAVIOR; METHYLENE-BLUE; SPATIAL MEMORY; MOUSE MODEL; DYNAMICS; PERFORMANCE; RECOVERY; DEFICITS	The tetra (ethylene glycol) derivative of benzothiazole aniline (SPG101) has been shown to improve dendritic spine density and cognitive memory in the triple transgenic mouse model of Alzheimer disease (AD) when administered intraperitoneally. The present study was designed to investigate the therapeutic effects of SPG101 on dendritic spine density and morphology and sensorimotor and cognitive functional recovery in a rat model of traumatic brain injury (TBI) induced by controlled cortical impact (CCI). Young adult male Wistar rats with CCI were randomly divided into the following two groups (n=7/group): (1) Vehicle, and (2) SPG101. SPG101 (30mg/kg) dissolved in vehicle (1% dimethyl sulfoxide in phosphate buffered saline) or Vehicle were intraperitoneally administered starting at 1h post-injury and once daily for the next 34 days. Sensorimotor deficits were assessed using a modified neurological severity score and adhesive removal and foot fault tests. Cognitive function was measured by Morris water maze, novel object recognition (NOR), and three-chamber social recognition tests. The animals were sacrificed 35 days after injury, and their brains were processed for measurement of dendritic spine density and morphology using ballistic dye labeling. Compared with the vehicle treatment, SPG101 treatment initiated 1h post-injury significantly improved sensorimotor functional recovery (days 7-35, p<0.0001), spatial learning (days 32-35, p<0.0001), NOR (days 14 and 35, p<0.0001), social recognition (days 14 and 35, p<0.0001). Further, treatment significantly increased dendritic spine density in the injured cortex (p<0.05), decreased heterogeneous distribution of spine lengths in the injured cortex and hippocampus (p<0.0001), modifications that are associated with the promotion of spine maturation in these brain regions. In summary, treatment with SPG101 initiated 1h post-injury and continued for an additional 34 days improves both sensorimotor and cognitive functional recovery, indicating that SPG101 acts as a spinogenic agent and may have potential as a novel treatment of TBI.	[Zhang, Yanlu; Mahmood, Asim; Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Rex, Christopher S.] Afraxis Inc, San Diego, CA USA; [Simmon, Vincent F.; Sarraf, Stella T.] Spinogenix Inc, San Diego, CA USA		Xiong, Y (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, E&R Bldg,Room 3096,2799 West Grand Blvd, Detroit, MI 48202 USA.	yxiong1@hfhs.org		Xiong, Ye/0000-0001-9770-6031	Spinogenix; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NOA R43AG056236]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30 NS047101]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R43AG056236] Funding Source: NIH RePORTER	This work was supported by Spinogenix and NIH NOA R43AG056236. Super-resolution microscopy was supported by NINDS P30 NS047101. The authors would like to thank Susan MacPhee-Gray for editorial assistance and Janelle Ilagen, Kimberly St. Aubin, David Chau, and Chase Shankula for technical assistance.	Bengoetxea Xabier, 2015, Front Biosci (Schol Ed), V7, P10; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; CATALA I, 1988, HUM NEUROBIOL, V6, P255; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cheung ZDH, 2011, INT J NEUROPSYCHOPH, V14, P1247, DOI 10.1017/S1461145710001537; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Ebrahimi S, 2014, BBA-BIOMEMBRANES, V1838, P2391, DOI 10.1016/j.bbamem.2014.06.002; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Georgoff PE, 2017, J NEUROTRAUM, V34, P2167, DOI 10.1089/neu.2016.4859; Goldstein FC, 2017, J NEUROTRAUM, V34, P115, DOI 10.1089/neu.2015.4313; Gonzales ELT, 2015, BIOMOL THER, V23, P251, DOI 10.4062/biomolther.2014.120; Grayson B, 2015, BEHAV BRAIN RES, V285, P176, DOI 10.1016/j.bbr.2014.10.025; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hu Q, 2016, MED GAS RES, V6, P102, DOI 10.4103/2045-9912.184720; Kasai Haruo, 2002, Japanese Journal of Neuropsychopharmacology, V22, P159; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Korley FK, 2018, J NEUROTRAUM, V35, P1185, DOI 10.1089/neu.2017.5581; Lee NJ, 2016, BBA-MOL BASIS DIS, V1862, P284, DOI 10.1016/j.bbadis.2015.12.007; Lewis SR, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub5; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Maiti P, 2015, NEUROSCI BIOBEHAV R, V59, P208, DOI 10.1016/j.neubiorev.2015.09.020; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Megill A, 2013, J NEUROSCI, V33, P9306, DOI 10.1523/JNEUROSCI.1615-12.2013; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Nagaoka A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26651; Ota KT, 2014, NAT MED, V20, P535, DOI 10.1038/nm.3513; Patterson MA, 2010, P NATL ACAD SCI USA, V107, P15951, DOI 10.1073/pnas.0913875107; Prangkio P, 2011, BBA-BIOMEMBRANES, V1808, P2877, DOI 10.1016/j.bbamem.2011.08.024; Reilly MP, 2015, HORM BEHAV, V73, P47, DOI 10.1016/j.yhbeh.2015.06.002; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Sheppard CJR, 2013, OPT LETT, V38, P2889, DOI 10.1364/OL.38.002889; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Song JM, 2014, EXP NEUROL, V252, P105, DOI 10.1016/j.expneurol.2013.11.023; Staffend Nancy A, 2011, Curr Protoc Neurosci, VChapter 2, DOI 10.1002/0471142301.ns0213s55; Stuart SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075467; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wang CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37063; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Watts LT, 2016, J NEUROTRAUM, V33, P194, DOI 10.1089/neu.2015.3904; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Waworuntu RV, 2016, INT J DEV NEUROSCI, V55, P28, DOI 10.1016/j.ijdevneu.2016.09.001; Williams A.M., 2018, J NEUROTRAUMA; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008; Zhang Y., 2018, J NEUROSURG; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhang YL, 2017, J NEUROSURG, V126, P782, DOI 10.3171/2016.3.JNS152699; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang YL, 2015, J NEUROSURG, V122, P843, DOI 10.3171/2014.11.JNS14271; Zhang YL, 2013, J NEUROSURG, V118, P1343, DOI 10.3171/2013.3.JNS122061; Zhao S, 2016, MOL NEUROBIOL, V53, P1884, DOI 10.1007/s12035-015-9128-z	73	7	7	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2019	36	4					589	600		10.1089/neu.2018.5790		SEP 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4MQ	WOS:000444014300001	30014757	Green Published			2022-02-06	
J	Bayley, MT; Lamontagne, ME; Kua, A; Marshall, S; Marier-Deschenes, P; Allaire, AS; Kagan, C; Truchon, C; Janzen, S; Teasell, R; Swaine, B				Bayley, Mark Theodore; Lamontagne, Marie-Eve; Kua, Ailene; Marshall, Shawn; Marier-Deschenes, Pascale; Allaire, Anne-Sophie; Kagan, Corinne; Truchon, Catherine; Janzen, Shannon; Teasell, Robert; Swaine, Bonnie			Unique Features of the INESSS-ONF Rehabilitation Guidelines for Moderate to Severe Traumatic Brain Injury: Responding to Users' Needs	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						guidelines; knowledge translation; rehabilitation; therapeutic approaches for the treatment of CNS injury; traumatic brain injury	INCOG RECOMMENDATIONS; MANAGEMENT; THERAPY	Objective: Traumatic brain injury (TBI) clinical practice guidelines are a potential solution to rapidly expanding literature. The project objective was to convene experts to develop a unique set of TBI rehabilitation recommendations incorporating users' priorities for format and implementation tools including indicators of adherence. Methods: The Guidelines Adaptation & Development Cycle informed recommendation development. Published TBI recommendations were identified and tabulated. Experts convened to adapt or, where appropriate, develop new evidence-based recommendations. These draft recommendations were validated by systematically reviewing relevant literature. Surveys of experts and target users were triangulated with strength of evidence to identify priority topics. Results: The final recommendation set included a rationale, implementation tools (algorithms/adherence indicators), key process indicators, and evidence summaries, and were divided in 2 sections: Section I: Components of the Optimal TBI Rehabilitation System (71 recommendations) and Section II: Assessment and Rehabilitation of Brain Injury Sequelae (195 recommendations). The recommendations address top priorities for the TBI rehabilitation system: (1) intensity/frequency of interventions; (2) rehabilitation models; (3) duration of interventions; and (4) continuity-of-care mechanisms. Key sequelae addressed (1) behavioral disorders; (2) cognitive dysfunction; (3) fatigue and sleep disturbances; and (4) mental health. Conclusion: This TBI rehabilitation guideline used a robust development process to address users' priorities.	[Bayley, Mark Theodore] Univ Hlth Network, Brain & Spinal Cord Rehabil Program, Toronto Rehabil Inst, Room 3-131,550 Univ Ave, Toronto, ON M5G 2A2, Canada; [Bayley, Mark Theodore] Univ Toronto, Fac Med, Toronto, ON, Canada; [Lamontagne, Marie-Eve; Marier-Deschenes, Pascale] Univ Laval, Dept Rehabil, CIRRIS, Fac Med, Quebec City, PQ, Canada; [Kua, Ailene] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Marshall, Shawn] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Marshall, Shawn] Univ Ottawa, Ottawa, ON, Canada; [Allaire, Anne-Sophie] CIRRIS, Quebec City, PQ, Canada; [Kagan, Corinne] ONF, Toronto, ON, Canada; [Truchon, Catherine] INESSS, Quebec City, PQ, Canada; [Janzen, Shannon] St Josephs Hlth Care, Lawson Hlth Res Inst, London, ON, Canada; [Teasell, Robert] Univ Western Ontario, St Josephs Hlth Care, London, ON, Canada; [Swaine, Bonnie] Montreal Metropolitain CRIR, Ctr Rech Interdisciplinaire Readaptat, Quebec City, PQ, Canada; [Swaine, Bonnie] Univ Montreal, Quebec City, PQ, Canada		Bayley, MT (corresponding author), Univ Hlth Network, Brain & Spinal Cord Rehabil Program, Toronto Rehabil Inst, Room 3-131,550 Univ Ave, Toronto, ON M5G 2A2, Canada.	mark.bayley@uhn.ca		Bayley, Mark/0000-0001-7860-9463; Lamontagne, Marie-Eve/0000-0002-3301-7429	Institut national d'excellence en sante et en services sociaux (INESSS); Ontario Neurotrauma Foundation (ONF)	The authors gratefully acknowledge the Institut national d'excellence en sante et en services sociaux (INESSS) and the Ontario Neurotrauma Foundation (ONF) for their support of this project. They also thank the group facilitators: Nora Cullen, Scott McCullagh, and Diana Velikonja for their contributions to this project. The authors extend their particular gratitude to the entire expert panel for their expertise, dedication, and support of the INESSS-ONF clinical practice guideline for rehabilitation of moderate to severe traumatic brain injury.; The project described in this manuscript was funded through the Institut national d'excellence en sante et en services sociaux (INESSS) and the Ontario Neurotrauma Foundation (ONF). The authors declare that no competing financial interests exist.	[Anonymous], 2006, TRAUM BRAIN INJ DIAG; [Anonymous], 2016, EVIDENCE BASED REV M; [Anonymous], 2007, ACQUIRED BRAIN INJUR; Arundine A, 2012, J HEAD TRAUMA REHAB, V27, P104, DOI 10.1097/HTR.0b013e3182125591; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Bragge P, 2014, J HEAD TRAUMA REHAB, V29, P277, DOI 10.1097/HTR.0000000000000066; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Field MJ, 1990, CLIN PRACTICE GUIDEL; Gosliz K, 2009, OCCUPATIONAL THERAPY; Graham Ian D, 2005, Evid Based Nurs, V8, P68, DOI 10.1136/ebn.8.3.68; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; Kitson AL, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-1; Lamontagne ME, 2018, J HEAD TRAUMA REHAB, V33, P288, DOI 10.1097/HTR.0000000000000429; Lamontagne ME, 2018, J HEAD TRAUMA REHAB, V33, P306, DOI 10.1097/HTR.0000000000000430; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Salbach NM, 2011, J EVAL CLIN PRACT, V17, P786, DOI 10.1111/j.1365-2753.2010.01456.x; Scottish Intercollegiate Guidelines Network (SIGN), 2013, BRAIN INJ REH AD; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Shekelle P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-62; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069	25	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					296	305		10.1097/HTR.0000000000000428			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500012	30188459				2022-02-06	
J	Ghods, M; Nasiri-Gheidari, Z; Tootoonchian, F; Oraee, H				Ghods, M.; Nasiri-Gheidari, Z.; Tootoonchian, F.; Oraee, H.			Design Improvement of a Small, Outer Rotor, Permanent Magnet Vernier Generator for Supplying Traffic Enforcement Camera	IEEE TRANSACTIONS ON ENERGY CONVERSION			English	Article						Design; road speed camera; traffic enforcement camera; permanent magnet vernier generator (PMVG); 3-D finite element analysis; optimization	MACHINE; MOTORS	Road speed cameras are usually used in photovoltaic power plants, especially in the areas with limited or no access to grid power. However, there are many areas in Iran where wind power is more accessible than solar energy. So, in this study, a small permanent magnet vernier generator is designed to meet power concussion requirements of traffic enforcement camera. The designed generator is optimized to achieve lower harmonic content of no-load induced voltage and lower cogging torque. In this regard, the effect of geometrical dimensions and the configuration of permanent magnets are investigated using three-dimensional time stepping finite element method. Both no-load and full-load performances of the generator are discussed, and finally, a prototype of the optimal generator is built and tested. A close agreement is obtained between simulation and experimental results, validating the success of the design and optimizations.	[Ghods, M.; Nasiri-Gheidari, Z.; Oraee, H.] Sharif Univ Technol, Dept Elect Engn, Tehran 111556393, Iran; [Tootoonchian, F.] Iran Univ Sci & Technol, Dept Elect Engn Dept, Tehran 1684613114, Iran		Tootoonchian, F (corresponding author), Iran Univ Sci & Technol, Dept Elect Engn Dept, Tehran 1684613114, Iran.	znasiri@sharif.edu	tootoonchian, Farid/T-5726-2018; Nasiri-Gheidari, Zahra/Y-3440-2019	Nasiri-Gheidari, Zahra/0000-0003-0744-1442	research office of Sharif University of Technology; Niroo Research Institute	This work was supported in part by the research office of Sharif University of Technology, and in part by the Niroo Research Institute. Paper no. TEC-00501-2017.	Boldea I, 2014, IEEE T IND ELECTRON, V61, P5696, DOI 10.1109/TIE.2014.2301754; Chung SU, 2016, IEEE T IND ELECTRON, V63, P302, DOI 10.1109/TIE.2015.2472375; Dorrell DG, 2012, IEEE T IND ELECTRON, V59, P3690, DOI 10.1109/TIE.2011.2165460; Guo XL, 2016, IEEE T APPL SUPERCON, V26, DOI 10.1109/TASC.2016.2525780; Heller B., 1977, HARMONIC FIELD EFFEC; Ishizaki A., 1995, Seventh International Conference on Electrical Machines and Drives (Conf. Publ. No.412), P208, DOI 10.1049/cp:19950864; Li DW, 2016, IEEE T IND APPL, V52, P125, DOI 10.1109/TIA.2015.2464173; Li DW, 2015, IEEE ENER CONV, P2153, DOI 10.1109/ECCE.2015.7309964; Li JG, 2010, IEEE T MAGN, V46, P1475, DOI 10.1109/TMAG.2010.2044636; Liu GH, 2017, IEEE T MAGN, V53, DOI 10.1109/TMAG.2016.2614791; Liu P, 2018, IEEE T MAGN, V54, DOI 10.1109/TMAG.2018.2848622; More DS, 2010, IET ELECTR POWER APP, V4, P109, DOI 10.1049/iet-epa.2009.0003; Nasiri-Gheidari Z, 2013, IEEE T ENERGY CONVER, V28, P543, DOI 10.1109/TEC.2013.2260826; Nerg J, 2014, IEEE T IND ELECTRON, V61, P4286, DOI 10.1109/TIE.2013.2248340; Pyrhonen J., 2009, DESIGN ROTATING ELEC; Raza M, 2017, IEEE T MAGN, V53, DOI 10.1109/TMAG.2017.2669105; Toba A, 2000, IEEE T IND APPL, V36, P1539, DOI 10.1109/28.887204; Tootoonchian F, 2016, IET ELECTR POWER APP, V10, P667, DOI 10.1049/iet-epa.2015.0575; Wrobel R, 2008, IEEE T ENERGY CONVER, V23, P1, DOI 10.1109/TEC.2007.905073; Wu L., 2017, 2017 IEEE EL DES ADV 2017 IEEE INT EL MAC, P1; Xie KF, 2017, IEEE T MAGN, V53, DOI 10.1109/TMAG.2017.2658634; Xu L, 2017, IEEE T IND ELECTRON, V64, P179, DOI 10.1109/TIE.2016.2610399; Xu L, 2015, IEEE T ENERGY CONVER, V30, P1483, DOI 10.1109/TEC.2015.2434931; Zhao W., 2017, CES T ELECT MACH SYS, V1, P83, DOI DOI 10.23919/TEMS.2017.7911112; Zhao Y, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2014.2300043; Zhu JG, 2011, IEEE T MAGN, V47, P4376, DOI 10.1109/TMAG.2011.2157320; Zou T., 2015, P IEEE EN CONV C EXP, P3906; Zou TJ, 2017, IEEE T IND APPL, V53, P1920, DOI 10.1109/TIA.2017.2657493	28	7	7	1	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-8969	1558-0059		IEEE T ENERGY CONVER	IEEE Trans. Energy Convers.	SEP	2018	33	3					1213	1221		10.1109/TEC.2018.2803058			9	Energy & Fuels; Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED)	Energy & Fuels; Engineering	GR9MC	WOS:000443085800029					2022-02-06	
J	Gray, SE; Hassani-Mahmooei, B; Kendall, E; Cameron, ID; Kenardy, J; Collie, A				Gray, Shannon E.; Hassani-Mahmooei, Behrooz; Kendall, Elizabeth; Cameron, Ian D.; Kenardy, Justin; Collie, Alex			Factors associated with graduated return to work following injury in a road traffic crash	JOURNAL OF TRANSPORT & HEALTH			English	Article						Injury; Road traffic crash; Return to work; Graduated return to work; Work hardening	TRAUMATIC BRAIN-INJURY; LOW-BACK INJURY; TO-WORK; WHIPLASH INJURY; DISABILITY; OUTCOMES; COMPENSATION; DISORDERS; DURATION; COHORT	Return-to-work (RTW) after road traffic crash is an important rehabilitation and recovery step. A possible RTW pathway is to gradually return-to-work (GRTW), or return in a partial capacity before reaching full RTW goals. This study sought to identify those likely to follow a GRTW pathway, and identify factors associated with successful GRTW. Administrative claims data from a state-based compulsory third party transport injury insurer were used. Individuals whose crash occurred from 2003-2012 were included if aged 15-70 years at time of crash, sustained a non-catastrophic injury, had complete data for all variables and attempted a RTW in the three years follow-up. A matrix was created using income payments data, which were used as a proxy for RTW, to map their RTW pattern for up to three years post-crash. Individuals were flagged as attempting GRTW if patterns were detected for receiving full income payments, followed by partial payments, then none. Individuals who resumed full payments after a period of partial payments or resumed any payments after a period of no payments were flagged as having relapsed. In the three years follow-up, 9.6% of individuals followed a GRTW pathway. Of those that attempted GRTW for their first full-time RTW, 55.1% relapsed. Least likely to attempt GRTW were males, individuals with contusions, abrasions, sprains, strains, non-limb fractures and those from the most advantaged socioeconomic group. Conversely, those admitted to hospital were 88% more likely to relapse. Of those that followed a GRTW pathway, those aged 15-24 years were most likely to succeed. Those with whiplash, internal injuries and those admitted to hospital were least likely to succeed. This study may assist regulators, insurers, employers and healthcare professionals to identify opportunities for GRTW (such as using RTW as a recovery tool), and identifies groups that may require additional support to achieve successful employment outcomes.	[Gray, Shannon E.; Hassani-Mahmooei, Behrooz; Collie, Alex] Monash Univ, Sch Publ Hlth & Prevent Med, Insurance Work & Hlth Grp, Clayton, Vic, Australia; [Kendall, Elizabeth] Griffith Univ, Menzies Hlth Inst Queensland, Hopkins Ctr, Nathan, Qld, Australia; [Cameron, Ian D.] Univ Sydney, Kolling Inst, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia; [Kenardy, Justin] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Gray, Shannon E.; Kendall, Elizabeth; Cameron, Ian D.; Kenardy, Justin; Collie, Alex] Ctr Res Excellence Recovery Following Rd Traff In, Brisbane, Qld, Australia		Gray, SE (corresponding author), 553 St Kilda Rd, Melbourne, Vic 3004, Australia.	shannon.gray@monash.edu	Kenardy, Justin A/H-6603-2014; Gray, Shannon/I-3500-2019; Hassani-Mahmooei, Behrooz/U-4317-2019	Kenardy, Justin A/0000-0001-9475-8450; Gray, Shannon/0000-0002-8029-6838; Hassani-Mahmooei, Behrooz/0000-0002-3616-4715; Collie, Alex/0000-0003-2617-9339; Kendall, Elizabeth/0000-0003-2399-1460	Transport Accident Commission through the Institute for Safety, Compensation and Recovery Research (ISCRR)	This project was funded by the Transport Accident Commission through the Institute for Safety, Compensation and Recovery Research (ISCRR).	Adams H, 2007, J OCCUP REHABIL, V17, P305, DOI 10.1007/s10926-007-9082-3; Anstis L, 2014, OCCUP HLTH, V66, P12; Arnetz BB, 2003, J OCCUP ENVIRON MED, V45, P499, DOI 10.1097/01.jom.0000063628.37065.45; Australian Bureau of Statistics, 2013, POST AR IND SEIFA SO; Australian Institute of Health and Welfare, 2015, INJURY RES STAT SERI, V89; Baldwin ML, 1996, AM J IND MED, V29, P632; Berecki-Gisolf J, 2012, J OCCUP REHABIL, V22, P283, DOI 10.1007/s10926-011-9344-y; Bethge M, 2016, SCAND J WORK ENV HEA, V42, P273, DOI 10.5271/sjweh.3562; Burton A.K., 2006, IS WORK GOOD YOUR HL; BUTLER RJ, 1995, IND LABOR RELAT REV, V48, P452, DOI 10.2307/2524774; Canadian Medical Association, 2013, TREAT PHYS ROL HELP; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Collie A, 2018, ANN SURG; Collie A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010910; CORNES P, 1992, INJURY, V23, P256, DOI 10.1016/S0020-1383(05)80011-7; Dasinger LK, 1999, AM J IND MED, V35, P619, DOI 10.1002/(SICI)1097-0274(199906)35:6<619::AID-AJIM9>3.0.CO;2-I; Fitzharris M, 2010, AUST NZ J PUBL HEAL, V34, P153, DOI 10.1111/j.1753-6405.2010.00500.x; Gozzard C, 2001, J BONE JOINT SURG BR, V83B, P506, DOI 10.1302/0301-620X.83B4.11228; Gray SE, 2018, J OCCUP REHABIL, V28, P740, DOI 10.1007/s10926-018-9761-2; Grunert B. K., 1992, ANN PLAST SURG, V29; Hogelund J, 2010, J HEALTH ECON, V29, P158, DOI 10.1016/j.jhealeco.2009.11.009; Holtslag HR, 2007, CLIN REHABIL, V21, P373, DOI 10.1177/0269215507072084; Krause N, 1999, AM J IND MED, V35, P604, DOI 10.1002/(SICI)1097-0274(199906)35:6<604::AID-AJIM8>3.3.CO;2-K; Lilley R, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000400; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McClune T, 2002, EMERG MED J, V19, P499, DOI 10.1136/emj.19.6.499; McLeod CB, 2018, SCAND J WORK ENV HEA, V44, P147, DOI 10.5271/sjweh.3701; Palmer KT, 2012, RHEUMATOLOGY, V51, P230, DOI 10.1093/rheumatology/ker086; Potterton P, 2017, COST ROAD TRAUMA AUS; Prang Khic-Houy, 2016, BMC Res Notes, V9, P456; Pransky G, 2005, J OCCUP REHABIL, V15, P453, DOI 10.1007/s10926-005-8027-y; Pransky G, 2013, HDB WORK DISABILITY; Schneider U, 2016, EUR J HEALTH ECON, V17, P629, DOI 10.1007/s10198-015-0707-8; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Sterling M, 2005, PAIN, V114, P141, DOI 10.1016/j.pain.2004.12.005; Streibelt M, 2018, J OCCUP REHABIL, V28, P180, DOI 10.1007/s10926-017-9709-y; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Transport Accident Commission, 2016, TAC ANN REP 2015 16; Transport Accident Commission, 2014, TAC INF EMPL; Young AE, 2005, J OCCUP REHABIL, V15, P543, DOI 10.1007/s10926-005-8033-0	40	7	7	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2214-1405			J TRANSP HEALTH	J. Transp. Health	SEP	2018	10						167	177		10.1016/j.jth.2018.07.006			11	Public, Environmental & Occupational Health; Transportation	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	GZ8NX	WOS:000449750400018					2022-02-06	
J	Ishai, R; Knoll, RM; Chen, JX; Wong, K; Reinshagen, KL; Nadol, JB; Remenschneider, AK; Jung, DH; Kozin, ED				Ishai, Reuven; Knoll, Renata M.; Chen, Jenny X.; Wong, Kevin; Reinshagen, Katherine L.; Nadol, Joseph B., Jr.; Remenschneider, Aaron K.; Jung, David H.; Kozin, Elliott D.			Otopathologic Changes in the Cochlea following Head Injury without Temporal Bone Fracture	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article						traumatic brain injury; hearing loss; sensorineural hearing loss; conductive hearing loss; inner ear; spiral ganglion cells; hair cells; temporal bone; histopathology	TRAUMATIC BRAIN-INJURY; HEARING-LOSS; LABYRINTHINE CONCUSSION; DEAFNESS; BLAST; HISTOPATHOLOGY; CONSEQUENCES; DYSFUNCTION; PREVALENCE; DISORDERS	Objective Hearing loss following temporal bone (TB) fracture may result from direct transection of the middle and inner ear. The pathophysiology of hearing loss due to head injury without TB fracture, however, is not well understood. Few reports describe otopathologic findings. Herein, we investigate the pathologic findings of patients who sustained a head injury without evidence of a TB fracture. Study Design Otopathology study. Setting Otopathology laboratory. Subjects Subjects with a history of head injury without TB fracture. Methods The TBs of patients with head injury were evaluated by light microscopy. Inner ear anatomy was evaluated, including counts of spiral ganglion cells (SGCs), hair cells, pillar cells, atrophy of the stria vascularis, and the presence of endolymphatic hydrops. SGC counts were compared with those of historical age-matched controls. Results All cases (N = 6 TBs) had evidence of inner ear pathology. Of the 6 cases, 2 (33%) had severe loss of hair cells in all 3 turns of the cochlea, and 4 (67%) cases demonstrated moderate to severe loss at the basal turn of the cochlea. Four cases had scattered atrophy of the stria vascularis, and 3 (50%) had cochlear hydrops. The number of total SGCs was decreased, with an average 53% loss (range, 25%-79%) as compared with controls. The SGC count loss was evenly distributed along Rosenthal's canal. Conclusions Patients with a history of head injury without TB fracture demonstrate inner ear pathology. Further studies are necessary to determine if otopathology findings are directly attributable to trauma.	[Ishai, Reuven; Knoll, Renata M.; Chen, Jenny X.; Wong, Kevin; Nadol, Joseph B., Jr.; Remenschneider, Aaron K.; Jung, David H.; Kozin, Elliott D.] Harvard Med Sch, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA; [Ishai, Reuven; Knoll, Renata M.; Chen, Jenny X.; Wong, Kevin; Nadol, Joseph B., Jr.; Remenschneider, Aaron K.; Jung, David H.; Kozin, Elliott D.] Massachusetts Eye & Ear, Otopathol Lab, Dept Otolaryngol, Boston, MA USA; [Reinshagen, Katherine L.] Massachusetts Eye & Ear, Dept Radiol, Boston, MA USA		Jung, DH; Kozin, ED (corresponding author), Harvard Med Sch, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA.	David_jung@meei.harvard.edu; Elliott_kozin@meei.harvard.edu	Chen, Jenny X./AAR-9523-2021	Remenschneider, Aaron/0000-0003-0989-6264	NIDCD (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [L124DC013983]	NIDCD (NIH) L124DC013983.	Alzahrani M, 2014, INT J PEDIATR OTORHI, V78, P804, DOI 10.1016/j.ijporl.2014.02.018; Arlinger S, 2003, INT J AUDIOL, V42, pS17; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; Brodie HA, 1997, AM J OTOL, V18, P188; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; BROWNING GG, 1982, ARCH OTOLARYNGOL, V108, P474; Brunner H, 1940, LARYNGOSCOPE, V50, P921; CANNON CR, 1983, ARCH OTOLARYNGOL, V109, P285; Ceranic BJ, 1998, J NEUROL NEUROSUR PS, V65, P523, DOI 10.1136/jnnp.65.4.523; Chiaramonte R, 2013, NEURORADIOL J, V26, P52, DOI 10.1177/197140091302600109; Choi Mi Suk, 2013, Korean J Audiol, V17, P13, DOI 10.7874/kja.2013.17.1.13; Corrales CE, 2010, OTOL NEUROTOL, V31, P1508, DOI 10.1097/MAO.0b013e3181f0c848; Cureoglu S, 2004, OTOLARYNG HEAD NECK, V130, P113, DOI 10.1016/j.otohns.2003.09.008; Dahiya R, 1999, J TRAUMA, V47, P1079, DOI 10.1097/00005373-199912000-00014; Dion GR, 2014, J VOICE, V28, P88, DOI 10.1016/j.jvoice.2013.08.005; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; HEALY GB, 1982, NEW ENGL J MED, V306, P1029, DOI 10.1056/NEJM198204293061705; HOWE JR, 1975, NEUROLOGY, V25, P286, DOI 10.1212/WNL.25.3.286; Hu CJ, 1997, NEUROLOGY, V48, P1448, DOI 10.1212/WNL.48.5.1448; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Karch Stephanie J, 2016, US Army Med Dep J, P52; KIMURA RS, 1982, AM J OTOLARYNG, V3, P447, DOI 10.1016/S0196-0709(82)80023-9; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lubinski R, 1997, BRAIN INJURY, V11, P103, DOI 10.1080/026990597123692; Mahmud MR, 2003, ANN OTO RHINOL LARYN, V112, P979, DOI 10.1177/000348940311201111; Maillot O, 2017, J NEURORADIOLOGY, V44, P333, DOI 10.1016/j.neurad.2017.04.001; MAKISHIMA K, 1976, LARYNGOSCOPE, V86, P1303, DOI 10.1288/00005537-197609000-00002; MAKISHIMA K, 1976, LARYNGOSCOPE, V86, P971, DOI 10.1288/00005537-197607000-00010; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MCKENNAN KX, 1992, AM J OTOL, V13, P167; Millspaugh J., 1937, US NAVAL MED B, V35, pe303; NADOL JB, 1991, ANN OTO RHINOL LARYN, V100, P712, DOI 10.1177/000348949110000904; NADOL JB, 1988, AM J OTOLARYNG, V9, P47, DOI 10.1016/S0196-0709(88)80007-3; NADOL JB, 1990, AM J OTOLARYNG, V11, P112, DOI 10.1016/0196-0709(90)90007-I; Nadol JB, 2010, SCHUKNECHTS PATHOLOG; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; OTTE J, 1978, LARYNGOSCOPE, V88, P1231; PAPARELLA MM, 1983, LARYNGOSCOPE, V93, P1004; Penn C, 2009, INT J AUDIOL, V48, P135, DOI 10.1080/14992020802635309; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; Robert ME, 2016, OTOLARYNG HEAD NECK, V154, P157, DOI 10.1177/0194599815603964; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Salt AN, 2018, HEARING RES, V362, P25, DOI 10.1016/j.heares.2017.12.010; Salt AN, 2012, HEARING RES, V283, P14, DOI 10.1016/j.heares.2011.11.012; SCHUKNECHT HF, 1953, AMA ARCH OTOLARYNGOL, V58, P377; SCHUKNECHT HF, 1956, ARCHIV OTOLARYNGOL, V63, P513; SCHUKNECHT HF, 1951, ANN OTO RHINOL LARYN, V60, P273, DOI 10.1177/000348945106000201; SCHUKNECHT HF, 1950, ANN OTO RHINOL LARYN, V59, P331, DOI 10.1177/000348945005900203; Tos M, 1971, J Laryngol Otol, V85, P1147, DOI 10.1017/S0022215100074569; Ulug T, 2006, J OTOLARYNGOL, V35, P380, DOI 10.2310/7070.2006.0069; Vadala R, 2013, NEUROL SCI, V34, P1259, DOI 10.1007/s10072-012-1208-5; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Voss O., 1936, CHIRURG SCHADELBASIS; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wittmaack K., 1932, ARCH F OHRENH, V131, P59; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	70	7	7	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	SEP	2018	159	3					526	534		10.1177/0194599818769861			9	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Otorhinolaryngology; Surgery	GS5UA	WOS:000443735400017	29890895				2022-02-06	
J	Jiang, JP; Dai, C; Niu, XG; Sun, HT; Cheng, SX; Zhang, ZW; Zhu, X; Wang, YT; Zhang, TS; Duan, F; Chen, XY; Zhang, S				Jiang, Jipeng; Dai, Chen; Niu, Xuegang; Sun, Hongtao; Cheng, Shixiang; Zhang, Zhiwen; Zhu, Xu; Wang, Yuting; Zhang, Tongshuo; Duan, Feng; Chen, Xuyi; Zhang, Sai			Establishment of a precise novel brain trauma model in a large animal based on injury of the cerebral motor cortex	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Brain trauma; Cerebral cortex; Model; DTI; Electrophysiology	HYPOTHERMIC CIRCULATORY ARREST; CONTROLLED CORTICAL IMPACT; CENTRAL-NERVOUS-SYSTEM; DIFFUSE AXONAL INJURY; FLUID-PERCUSSION; PROGNOSTIC VALUE; LOCOMOTION; PROTECTS; POSITION; PRIMATE	Background: Animal models are essential in simulating clinical diseases and facilitating relevant studies. New method: We established a precise canine model of traumatic brain injury (TBI) based on cerebral motor cortex injury which was confirmed by neuroimaging, electrophysiology, and a series of motor function assessment methods. Twelve beagles were divided into control, sham, and model groups. The cerebral motor cortex was identified by diffusion tensor imaging (DTI), a simple marker method, and intraoperative electrophysiological measurement. Bony windows were designed by magnetic resonance imaging (MRI) scan and DTI. During the operation, canines in the control group were under general anesthesia. The canines were operated via bony window craniotomy and dura mater opening in the sham group. After opening of the bony window and dura mater, the motor cortex was impacted by a modified electronic cortical contusion impactor (eCCI) in the model group. Results: Postoperative measurements revealed damage to the cerebral motor cortex and functional defects. Comparisons between preoperative and postoperative results demonstrated that the established model was successful. Comparison with existing method(s): Compared with conventional models, this is the first brain trauma model in large animal that was constructed based on injury to the cerebral motor cortex under the guidance of DTI, a simple marker method, and electrophysiology. Conclusion: The method used to establish this model can be standardized to enhance reproducibility and provide a stable and precise large animal model of TBI for clinical and basic research.	[Jiang, Jipeng; Dai, Chen; Niu, Xuegang; Sun, Hongtao; Cheng, Shixiang; Chen, Xuyi; Zhang, Sai] Logist Univ PAP, Inst Brain Trauma & Neurol Dis, Key Lab Neurotrauma Repair Tianjin, Affiliated Hosp, Chenglin Rd 220, Tianjin 300162, Peoples R China; [Zhang, Zhiwen; Duan, Feng] Nankai Univ, Coll Comp & Control Engn, Dept Automat, Tongan Rd 38, Tianjin 300350, Peoples R China; [Zhu, Xu; Wang, Yuting] Tianjin Med Univ, Qixiangtai Rd 22, Tianjin 300070, Peoples R China; [Zhang, Tongshuo] Logist Univ PAP, Affiliated Hosp, Dept Clin Lab, Chenglin Rd 220, Tianjin 300162, Peoples R China		Jiang, JP; Chen, XY; Zhang, S (corresponding author), Logist Univ PAP, Inst Brain Trauma & Neurol Dis, Key Lab Neurotrauma Repair Tianjin, Affiliated Hosp, Chenglin Rd 220, Tianjin 300162, Peoples R China.	13502034360@163.com; chenxuyi1979@126.com; zhangsai718@vip.126.com		Jiang, Jipeng/0000-0002-8954-7277	National Key Research and Development Plan of China [2016YFC1101500]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11672332, 11102235, 31200809]; Science and Technology Program of Tianjin, China [17YFZCSY00620]	This work was supported by the National Key Research and Development Plan of China (2016YFC1101500) and The National Natural Science Foundation of China (11672332, 11102235, 31200809). Science and Technology Program of Tianjin, China (17YFZCSY00620). We would like to acknowledge Dr. He T for the slicing procedure of paraffin -embedded sections and hematoxylin-eosin staining.	Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Balvin Mark J, 2010, Am J Electroneurodiagnostic Technol, V50, P219; Beltran E, 2014, J VET INTERN MED, V28, P1256, DOI 10.1111/jvim.12368; Bosco G, 2001, PHYSIOL REV, V81, P539, DOI 10.1152/physrev.2001.81.2.539; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Castella M, 2005, ANN THORAC SURG, V79, P646, DOI 10.1016/j.athoracsur.2004.07.007; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Courtine G, 2005, J NEUROPHYSIOL, V93, P3127, DOI 10.1152/jn.01073.2004; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Dai JX, 2018, INT J NEUROSCI, V128, P243, DOI 10.1080/00207454.2017.1380008; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Fukuda Satoru, 2011, Masui, V60, P544; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hartl R, 1997, ACT NEUR S, V70, P240; Hayes R L, 1987, Brain Inj, V1, P93, DOI 10.3109/02699058709034449; Hutchinson EB, 2016, SHOCK, V46, P167, DOI 10.1097/SHK.0000000000000659; Ivanenko YP, 2008, J NEUROPHYSIOL, V99, P1890, DOI 10.1152/jn.01308.2007; Kawata M, 2006, J THORAC CARDIOV SUR, V131, P1331, DOI 10.1016/j.jtcvs.2005.10.035; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; Kishikawa J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190213; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lyeth BG, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00217; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLEN JE, 1985, J NEUROSURG, V62, P587, DOI 10.3171/jns.1985.62.4.0587; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; PURDY PD, 1989, STROKE, V20, P1361, DOI 10.1161/01.STR.20.10.1361; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; TORNHEIM PA, 1981, J NEUROSURG, V55, P407, DOI 10.3171/jns.1981.55.3.0407; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Wahab RA, 2015, J NEUROSCI METH, V248, P16, DOI 10.1016/j.jneumeth.2015.03.010; Wei XE, 2011, J TRAUMA, V71, P1645, DOI 10.1097/TA.0b013e31823498eb; Wenger N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008325; Yamamoto T, 2017, ANAESTH INTENSIVE TH, V49, P288, DOI 10.5603/AIT.a2017.0046; Zhang J, 2012, CHIN J TRAUMATOL, V15, P338, DOI 10.3760/cma.j.issn.1008-1275.2012.06.004; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhang Z, 2015, J NEUROTRAUM, V32, P1369, DOI 10.1089/neu.2014.3701	42	7	7	2	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	SEP 1	2018	307						95	105		10.1016/j.jneumeth.2018.06.025			11	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GQ8ZN	WOS:000442055800012	29960029				2022-02-06	
J	McCafferty, RR; Neal, CJ; Marshall, SA; Pamplin, JC; Rivet, D; Hood, BJ; Cooper, PB; Stockinger, Z				McCafferty, Randall R.; Neal, Chris J.; Marshall, Scott A.; Pamplin, Jeremy C.; Rivet, Dennis; Hood, Brian J.; Cooper, Patrick B.; Stockinger, Zsolt			Neurosurgery and Medical Management of Severe Head Injury	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; OUTCOMES; COMBAT; TRIAL; MORTALITY; BLAST	Management of the patient with moderate to severe brain injury in any environment can be time consuming and resource intensive. In the austere or hostile environment, the challenges to deliver care to this patient population are magnified. These guidelines have been developed by acknowledging commonly recognized recommendations for neurosurgical and neuro-critical care patients and augmenting those evaluations and interventions based on the experience of neurosurgeons, trauma surgeons, and intensivists who have delivered care during recent coalition conflicts.	[McCafferty, Randall R.; Neal, Chris J.; Marshall, Scott A.; Pamplin, Jeremy C.; Rivet, Dennis; Hood, Brian J.; Cooper, Patrick B.; Stockinger, Zsolt] Joint Base San Antonio, Joint Trauma Syst, 3698 Chambers Pass, Ft Sam Houston, TX 78234 USA		McCafferty, RR (corresponding author), Joint Base San Antonio, Joint Trauma Syst, 3698 Chambers Pass, Ft Sam Houston, TX 78234 USA.		Pamplin, Jeremy/AAA-9646-2021				[Anonymous], 2016, JOINT TRAUMA SYSTEM; [Anonymous], 2016, BURN CAR CPG; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Brain Trauma Foundation, 2016, GUID SURG MAN TRAUM; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chapleau W, 2012, ADV TRAUMA LIFE SUPP; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490; Edwards P, 2005, LANCET, V365, P1957; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Giannou C, 2013, WAR SURG WORKING LTD, V2, P245; Goodman MD, 2010, J SURG RES, V164, P286, DOI 10.1016/j.jss.2009.07.040; Johannigman JA, 2015, MIL MED, V180, P50, DOI 10.7205/MILMED-D-14-00381; Latronico N, 2008, MINERVA ANESTESIOL, V74, P543; Meyer RM, 2017, J NEUROSURG, V126, P1047, DOI 10.3171/2016.4.JNS16101; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Weisbrod AB, 2012, J TRAUMA ACUTE CARE, V73, P1525, DOI 10.1097/TA.0b013e318270e179; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9	29	7	8	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP-OCT	2018	183			2			67	72		10.1093/milmed/usy071			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5FY	WOS:000443684000015	30189083	hybrid			2022-02-06	
J	Mustafa, AG; Alfaqih, MA; AL-Shboul, O				Mustafa, Ayman G.; Alfaqih, Mahmoud A.; AL-Shboul, Othman			The 4-hydroxynonenal mediated oxidative damage of blood proteins and lipids involves secondary lipid peroxidation reactions	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						thiobarbituric acid reactive substances; reactive oxygen species; oxidative stress; phenelzine; lipid peroxidation	TRAUMATIC BRAIN-INJURY; STRESS; OXYGEN; MECHANISMS; PEROXYNITRITE	Lipid peroxidation is associated with several metabolic diseases. Lipid peroxidation causes cellular damage through reactive aldehyde species such as 4-hydroxyonenal (4-HNE). The exact mechanism(s) by which 4-HNE causes damage in the intravascular compartment is not yet exactly understood. Using an in vitro system, the damage induced by 4-HNE on the blood was investigated by measuring protein carbonyl groups and thiobarbituric acid reactive substances (TBARS) following 4-HNE treatment. The findings demonstrated that treatment with 4-HNE increased the carbonylation of protein and the formation of TBARS in the blood plasma. It was also tested whether phenelzine, a scavenger of aldehyde species, or U-83836E, a scavenger of lipid peroxy radicals, attenuated the damage caused by 4-HNE. It was demonstrated that phenelzine or U-83836E both mitigated the effects of 4-HNE on the proteins and the lipids of the blood plasma. The findings of the current study suggest that phenelzine, U-83836E or functionally similar therapeutics may prevent or treat diseases that involve an increased production of 4-HNE in the intravascular compartment.	[Mustafa, Ayman G.] Jordan Univ Sci & Technol, Sch Med, Dept Basic Med Sci, Irbid 22110, Jordan; [Mustafa, Ayman G.] Qatar Univ, Sch Med, Dept Anat, Doha, Qatar; [Alfaqih, Mahmoud A.; AL-Shboul, Othman] Jordan Univ Sci & Technol, Sch Med, Dept Physiol & Biochem, Hlth Sci Complex,M3L0, Irbid 22110, Jordan		Alfaqih, MA (corresponding author), Jordan Univ Sci & Technol, Sch Med, Dept Physiol & Biochem, Hlth Sci Complex,M3L0, Irbid 22110, Jordan.	maalfaqih@just.edu.jo		Alfaqih, Mahmoud/0000-0002-6383-7014; mustafa, ayman/0000-0002-0341-7149	Jordan University of Science and Technology [301/2014]	The present study was supported by the Deanship of Research at Jordan University of Science and Technology (grant no. 301/2014).	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI DOI 10.1155/2014/360438; Bandyopadhyay U, 1999, CURR SCI INDIA, V77, P658; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Betteridge DJ, 2000, METABOLISM, V49, P3, DOI 10.1016/S0026-0495(00)80077-3; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; DIX TA, 1993, CHEM RES TOXICOL, V6, P2, DOI 10.1021/tx00031a001; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Girotti AW, 1998, J LIPID RES, V39, P1529; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; HALL ED, 1991, J PHARMACOL EXP THER, V258, P688; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Hemnani T, 1998, Indian J Physiol Pharmacol, V42, P440; Huang Y, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-40; Jaganjac M, 2013, FREE RADICAL RES, V47, P39, DOI 10.3109/10715762.2013.789136; Jang EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129244; Jena NR, 2012, J BIOSCIENCES, V37, P503, DOI 10.1007/s12038-012-9218-2; Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011; Mustafa AG, 2018, ARCH PHYSIOL BIOCHEM, V124, P418, DOI 10.1080/13813455.2017.1415939; Mustafa AG, 2015, EXP BIOL MED, V240, P109, DOI 10.1177/1535370214546291; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Mylonas C, 1999, IN VIVO, V13, P295; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Raza H, 2006, TOXICOL APPL PHARM, V216, P309, DOI 10.1016/j.taap.2006.06.001; Reis A, 2012, BBA-BIOMEMBRANES, V1818, P2374, DOI 10.1016/j.bbamem.2012.02.002; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Schaur RJ, 2015, BIOMOLECULES, V5, P2247, DOI 10.3390/biom5042247; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shukla V, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/572634; Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887; Ullah A, 2016, SAUDI PHARM J, V24, P547, DOI 10.1016/j.jsps.2015.03.013; Usatyuk PV, 2004, J BIOL CHEM, V279, P11789, DOI 10.1074/jbc.M311184200; Yang YS, 2003, ACTA BIOCHIM POL, V50, P319; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z; Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011	35	7	7	0	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	SEP	2018	16	3					2132	2137		10.3892/etm.2018.6419			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GS5UZ	WOS:000443738300078	30186450	Green Published, gold			2022-02-06	
J	Nelson, LD; Kramer, MD; Patrick, CJ; McCrea, MA				Nelson, Lindsay D.; Kramer, Mark D.; Patrick, Christopher J.; McCrea, Michael A.			Modeling the Structure of Acute Sport-Related Concussion Symptoms: A Bifactor Approach	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Head injury; Concussion; Sports; Exploratory factor analysis; Confirmatory factor analysis; Bifactor model; Hierarchical model; Higher-order factor model; Psychometric properties; Clinical phenotypes	PERSISTENT POSTCONCUSSIVE SYMPTOMS; TRAUMATIC BRAIN-INJURY; RECOVERY; RELIABILITY; VALIDITY; SCALE; SOMATIZATION; VALIDATION; CHILDREN; CARE	Objectives: Concussions cause diverse symptoms that are often measured through a single symptom severity score. Researchers have postulated distinct dimensions of concussion symptoms, raising the possibility that total scores may not accurately represent their multidimensional nature. This study examined to what degree concussion symptoms, assessed by the Sport Concussion Assessment Tool 3 (SCAT3), reflect a unidimensional versus multidimensional construct to inform how the SCAT3 should be scored and advance efforts to identify distinct phenotypes of concussion. Methods: Data were aggregated across two prospective studies of sport-related concussion, yielding 219 high school and college athletes in the acute (<48 hr) post-injury period. Item-level ratings on the SCAT3 checklist were analyzed through exploratory and confirmatory factor analyses. We specified higher-order and bifactor models and compared their fit, inter-pretability, and external correlates. Results: The best-fitting model was a five-factor bifactor model that included a general factor on which all items loaded and four specific factors reflecting emotional symptoms, torpor, sensory sensitivities, and headache symptoms. The bifactor model demonstrated better discriminant validity than the counterpart higher-order model, in which the factors were highly correlated (r = .55-.91). Conclusions: The SCAT3 contains items that appear unidimensional, suggesting that it is appropriate to quantify concussion symptoms with total scores. However, evidence of multidimensionality was revealed using bifactor modeling. Additional work is needed to clarify the nature of factors identified by this model, explicate their clinical and research utility, and determine to what degree the model applies to other stages of injury recovery and patient subgroups.	[Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Kramer, Mark D.] Univ Texas Austin, Steve Hicks Sch Social Work, Austin, TX 78712 USA; [Patrick, Christopher J.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA		Nelson, LD (corresponding author), 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R03NS100691-01]; U.S. Army Medical Research and Materiel Command (Department of Defense)U.S. Army Medical Research & Materiel Command (USAMRMC)United States Department of Defense [W81XWH-12-1-0004, W81XWH-14-1-0561]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1UL1-RR031973(-01)]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS100691, R01NS110856] Funding Source: NIH RePORTER	We thank Jana Ranson, PhD, for her involvement in discussions about these data. We thank the University of Minnesota Press for permissions to reproduce select MMPI-2-RF and MMPI-2-A sub-scales for use in the study. This secondary data analysis project was funded by National Institutes of Health (NIH) grant 1R03NS100691-01. The studies from which data were obtained for the project were funded by U.S. Army Medical Research and Materiel Command (Department of Defense) under award numbers W81XWH-12-1-0004 and W81XWH-14-1-0561. Study data were collected and managed using REDCap (Harris et al., 2009) electronic data capture tools hosted at the Medical College of Wisconsin's Clinical and Translational Science Institute, supported by NIH grant 1UL1-RR031973(-01). The manuscript's contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH and are not necessarily endorsed by the U.S. Army. The authors have no conflicts of interest to disclose.	Archer R. P, 2014, MMPI A RF MANUAL ADM; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Chen FF, 2012, J PERS, V80, P219, DOI 10.1111/j.1467-6494.2011.00739.x; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Cucina Jeffrey, 2017, J Intell, V5, DOI 10.3390/jintelligence5030027; Derogatis L.R., 1993, BSI BRIEF SYMPTOM IN; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Ebesutani C, 2011, PSYCHOL ASSESSMENT, V23, P679, DOI 10.1037/a0023234; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gignac GE, 2013, MULTIVAR BEHAV RES, V48, P639, DOI 10.1080/00273171.2013.804398; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Helmick K., 2006, DEFENSE VETERANS BRA; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Mansolf M, 2017, INTELLIGENCE, V61, P120, DOI 10.1016/j.intell.2017.01.012; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Muthen B, 2006, ADDICT BEHAV, V31, P1050, DOI 10.1016/j.addbeh.2006.03.026; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Nelson L. D, 2018, HDB PSYCHOPATHY; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Patrick CJ, 2007, J PERS DISORD, V21, P118, DOI 10.1521/pedi.2007.21.2.118; Patrick CJ, 2009, DEV PSYCHOPATHOL, V21, P913, DOI 10.1017/S0954579409000492; Patrick CJ, 2002, PSYCHOL ASSESSMENT, V14, P150, DOI 10.1037//1040-3590.14.2.150; Piland SG, 2003, J ATHL TRAINING, V38, P104; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Reise SP, 2007, QUAL LIFE RES, V16, P19, DOI 10.1007/s11136-007-9183-7; Reise SP, 2012, MULTIVAR BEHAV RES, V47, P667, DOI 10.1080/00273171.2012.715555; Rodriguez A, 2016, PSYCHOL METHODS, V21, P137, DOI 10.1037/met0000045; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Tellegen, 2008, MINNESOTA MULTIPHASI; Thomas ML, 2012, PSYCHOL ASSESSMENT, V24, P101, DOI 10.1037/a0024712; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Waljas M, 2012, BRAIN INJURY, V26, P972, DOI 10.3109/02699052.2012.660511; WechslerD, 2001, WECHSLER TEST ADULT	49	7	7	1	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2018	24	8					793	804		10.1017/S1355617718000462			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	HG6MJ	WOS:000455095800004	30079858	Green Accepted			2022-02-06	
J	Peacock, J; Al Hussaini, M; Greene, NT; Tollin, DJ				Peacock, John; Al Hussaini, Mohamed; Greene, Nathaniel T.; Tollin, Daniel J.			Intracochlear pressure in response to high intensity, low frequency sounds in chinchilla	HEARING RESEARCH			English	Article						Laser Doppler vibrometry; Intracochlear pressure; Blast overpressure; Acoustic shock wave; Stapedial annular ligament	TRAUMATIC BRAIN-INJURY; INNER-EAR CONTRIBUTION; HEARING-LOSS; BONE-CONDUCTION; ACOUSTIC TRAUMA; MIDDLE-EAR; STAPES DISPLACEMENT; MECHANICAL DAMAGE; AUDITORY-SYSTEM; BLAST INJURY	Exposure to high intensity (blast) sounds can result in both conductive and sensorineural damage to hearing. This includes rupture of the tympanic membrane and dislocation of the middle ear ossicles, as well as damage to the inner and outer hair cells in the cochlea. A clearer understanding of how the hearing system responds to blast could help us better prevent auditory trauma, and support those who have been exposed to such sounds. Chinchillas are often used in studies of hearing due to the similarity between the chinchilla and human audiograms. The suitability of their use in research on auditory trauma from blast noise will depend on the extent to which cochlear pressures generated in chinchillas compare to those in humans. In order to gain a more detailed understanding of the response of the ear to high intensity sounds, a custom built sound concentrating horn was used to expose chinchilla cadaveric ears to a series of single frequency tones between 10 and 1280 Hz, with varying intensities from 90 to 194 dB SPL while intracochlear pressures were measured simultaneously in the scala vestibuli and scala tympani. These results were then compared to similar, previously published data from human cadavers. In both human and chinchillas, intracochlear pressures increased with applied sound pressure up to about 120 dB SPL, but began to saturate at higher intensities. The exact saturation point and the saturation pressures showed a strong frequency dependence. Intracochlear pressure magnitudes in chinchillas show some similarities with those measured in humans, but also significant differences, particularly at very high intensity levels such as those found in a blast. These differences should be taken into account when conducting blast studies in chinchillas. (C) 2018 Elsevier B.V. All rights reserved.	[Peacock, John; Tollin, Daniel J.] Univ Colorado, Sch Med, Dept Physiol & Biophys, M-S 8307,Res Complex 1-N,Rm 7401G, Aurora, CO 80045 USA; [Al Hussaini, Mohamed; Greene, Nathaniel T.; Tollin, Daniel J.] Univ Colorado, Sch Med, Dept Otolaryngol, Aurora, CO 80045 USA		Peacock, J (corresponding author), Univ Colorado, Sch Med, Dept Physiol & Biophys, M-S 8307,Res Complex 1-N,Rm 7401G, Aurora, CO 80045 USA.	john.2.peacock@ucdenver.edu		Greene, Nathaniel/0000-0001-5872-9169	DODUnited States Department of Defense [W81XWH-15-2-0002]; NIH NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [T32 DC012280]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 NS041854]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [T32DC012280] Funding Source: NIH RePORTER	Funding for these experiments was provided by DOD grant W81XWH-15-2-0002 and NIH NIDCD T32 DC012280 (NTG). We appreciate the assistance of Dr. Michael Hall in constructing some of the custom experimental equipment (support by NIH grant P30 NS041854).	Binseel M. S., 2009, ARLTR4987; Chandler D W, 1997, J Am Acad Audiol, V8, P81; Chen W, 2013, INT J CLIN EXP PATHO, V6, P375; Chhan D, 2016, HEARING RES, V340, P144, DOI 10.1016/j.heares.2016.02.015; Chhan D, 2013, HEARING RES, V301, P66, DOI 10.1016/j.heares.2012.11.014; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Cooper SP, 2014, MIL MED, V179, P1458, DOI 10.7205/MILMED-D-14-00100; Department of Defense, 2015, MILSTD1474E; DUNN DE, 1991, J ACOUST SOC AM, V90, P1979, DOI 10.1121/1.401677; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fedele P. D., 2013, USING AUDITORY HAZAR; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gan RZ, 2016, HEARING RES, V340, P25, DOI 10.1016/j.heares.2016.01.004; Geckle L., 2004, FORC HLTH PROT C ALB; Gee KL, 2013, J ACOUST SOC AM, V133, pEL88, DOI 10.1121/1.4773225; Greene NT, 2018, HEARING RES, V365, P149, DOI 10.1016/j.heares.2018.05.014; Greene NT, 2017, HEARING RES, V348, P16, DOI 10.1016/j.heares.2017.02.002; Greene NT, 2016, OTOL NEUROTOL, V37, P1541, DOI 10.1097/MAO.0000000000001232; GUINAN JJ, 1967, J ACOUST SOC AM, V41, P1237, DOI 10.1121/1.1910465; HAMERNIK RP, 1993, J ACOUST SOC AM, V93, P2088, DOI 10.1121/1.406695; HAMERNIK RP, 1984, HEARING RES, V13, P229, DOI 10.1016/0378-5955(84)90077-7; Hartl RMB, 2017, OTOL NEUROTOL, V38, P938, DOI 10.1097/MAO.0000000000001474; HEFFNER RS, 1991, HEARING RES, V52, P13, DOI 10.1016/0378-5955(91)90183-A; Huang S, 2012, JARO-J ASSOC RES OTO, V13, P461, DOI 10.1007/s10162-012-0326-3; Koka K, 2011, HEARING RES, V272, P135, DOI 10.1016/j.heares.2010.10.007; Lupo JE, 2011, HEARING RES, V272, P30, DOI 10.1016/j.heares.2010.11.003; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Mattingly JK, 2015, OTOL NEUROTOL, V36, P1403, DOI 10.1097/MAO.0000000000000814; Mayo Ami, 2006, World J Emerg Surg, V1, P33, DOI 10.1186/1749-7922-1-33; MILLER JD, 1970, J ACOUST SOC AM, V48, P513, DOI 10.1121/1.1912166; Nakajima HH, 2009, JARO-J ASSOC RES OTO, V10, P23, DOI 10.1007/s10162-008-0150-y; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Olson ES, 1999, NATURE, V402, P526, DOI 10.1038/990092; Olson ES, 1998, J ACOUST SOC AM, V103, P3445, DOI 10.1121/1.423083; Paakkonen R, 1988, LOW FREQUENCY HIGH L, V7, P42; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Price G., 2011, ARLTR5587; PRICE GR, 1991, J ACOUST SOC AM, V90, P219, DOI 10.1121/1.401291; PRICE GR, 1974, J ACOUST SOC AM, V56, P195, DOI 10.1121/1.1903253; Race N, 2017, J NEUROPHYSIOL, V118, P782, DOI 10.1152/jn.00710.2016; Ravicz ME, 2013, J ACOUST SOC AM, V133, P2208, DOI 10.1121/1.4792139; Ravicz ME, 2010, HEARING RES, V263, P16, DOI 10.1016/j.heares.2009.11.014; REED JW, 1977, J ACOUST SOC AM, V61, P39, DOI 10.1121/1.381266; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; SALVI RJ, 1990, HEARING RES, V50, P245, DOI 10.1016/0378-5955(90)90049-U; Sindelar B, 2017, OTOL NEUROTOL, V38, P1205, DOI 10.1097/MAO.0000000000001500; Slama MCC, 2010, J ACOUST SOC AM, V127, P1397, DOI 10.1121/1.3279830; Smoorenburg G. F., 2003, TR017HFM022, P1; Tufts JB, 2009, J AM ACAD AUDIOL, V20, P539, DOI 10.3766/jaaa.20.9.3; Wightman F.L, 2010, AM I BIOL SCI PEER R, P1; Zagadou B, 2016, HEARING RES, V342, P23, DOI 10.1016/j.heares.2016.02.017	53	7	7	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	SEP	2018	367						213	222		10.1016/j.heares.2018.06.013			10	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	GU5FF	WOS:000445310700020	29945804				2022-02-06	
J	Sadaka, F; Jadhav, A; Miller, M; Saifo, A; O'Brien, J; Trottier, S				Sadaka, Farid; Jadhav, Amar; Miller, Melinda; Saifo, Ammar; O'Brien, Jacklyn; Trottier, Steven			Is it possible to recover from traumatic brain injury and a Glasgow coma scale score of 3 at emergency department presentation?	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Coma; Traumatic brain injury; TBI; Glasgow coma scale; GCS; Glasgow outcome score; GOS; Outcome	SEVERE HEAD-INJURY; ADMISSION; SURVIVAL; CHANCE	Introduction: A Glasgow Coma Scale (GCS) score of 3 on presentation in patients with traumatic brain injury (TBI) portends a poor prognosis. Consequently, there is often a tendency to treat these patients less aggressively because of low expectations for a good outcome. Methods and results: We performed a retrospective review of patients with TBI and a GCS score of 3. Patients were divided into 2 groups based on Glasgow Outcome Scale (GOS): Group 1 (GOS - 1-3) and Group 2 (GOS = 4-5). A total of 62 patients were included. The overall mortality rate was 80.6%. At 6-month, 9 patients (14.5%) achieved a GOS 4-5. Compared to Group 2 (n = 9). Group 1 (n = 53) had higher average APACHE IV score (104 +/- 19 vs 89 +/- 27, p = 0.04), more patients with bilateral fixed pupils (59% vs 22%, p = 0.04), and higher ICP burden (50 +/- 34 vs 0 +/- 0, p = 0.0001). Using the CRASH calculator, the estimated mortality at 14 days was 66% compared to actual mortality of 81%; difference of 15%, (p = 0.05), and the estimated GOS 1-3 was 85.5% compared to actual of 85.5%, (p = 1.0). Conclusions: 14.5% of patients with TBI and a GCS of 3 at presentation achieved a good outcome at 6 months, and 6.9% of patients with GCS of 3 and bilateral fixed pupils on presentation to the ED achieved a good outcome at 6 months. (C) 2018 Elsevier Inc. All rights reserved.	[Sadaka, Farid; Jadhav, Amar; Miller, Melinda; Saifo, Ammar; O'Brien, Jacklyn; Trottier, Steven] St Louis Univ, Mercy Hosp St Louis, St Louis, MO 63103 USA		Sadaka, F (corresponding author), 625 S New Ballas Rd,Suite 7020, St Louis, MO 63141 USA.	farid.sadaka@mercy.net		Sadaka, Farid/0000-0003-1387-2513			Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; KOTWICA Z, 1995, ACTA NEUROCHIR, V133, P56, DOI 10.1007/BF01404948; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237	12	7	7	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	SEP	2018	36	9					1624	1626		10.1016/j.ajem.2018.01.051			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GQ2TH	WOS:000441510000019	29433914				2022-02-06	
J	Shahpar, S; Wong, AWK; Keeshin, S; Eickmeyer, SM; Semik, P; Kocherginsky, M; McCarty, S				Shahpar, Samman; Wong, Alex W. K.; Keeshin, Susan; Eickmeyer, Sarah M.; Semik, Patrick; Kocherginsky, Masha; McCarty, Stacy			Functional Outcomes of an Interdisciplinary Outpatient Rehabilitation Program for Patients with Malignant Brain Tumors	PM&R			English	Article							AUSTRALIAN COMMUNITY COHORT; QUALITY-OF-LIFE; INPATIENT REHABILITATION; ACUTE STROKE; DISABILITY; INJURY; TRIAL	Background: Malignant brain tumors cause significant impairments in function because of the nature of the disease. Nevertheless, patients with malignant brain tumors can make functional gains equivalent to those with stroke and traumatic brain injury in the inpatient rehabilitation setting. However, the efficacy of outpatient rehabilitation in this population has received little study. Objective: To determine if an interdisciplinary outpatient rehabilitation program will improve functional outcomes in patients with malignant brain tumors. Design: Nonrandomized prospective longitudinal study. Setting: Six affiliated outpatient sites of one institution. Patients: Forty-nine adults with malignant brain tumors were enrolled. Methods: Patients received interdisciplinary therapy services, with duration determined by the therapist evaluations. The therapists scored the Day Rehabilitation Outcome Scale (DayROS) and Disability Rating Scale (DRS) on admission and discharge. The caregivers filled out the DRS at discharge, 1 month, and 3 months after discharge. Main Outcome Measurements: The primary study outcome measure was the DayROS, which is a functional measure similar to the Functional Independence Measure. DRS was another functional outcome measure assessing basic self-care, dependence on others, and psychosocial adaptability. Results: Forty-six of 49 enrolled patients (94%) completed the day rehabilitation program. The average length of stay was 76.9 days. There was a significant improvement in total DayROS (P < .001), mobility (P < .001), Activities of Daily Living (P < .001), and communication (P < .001) DayROS subscores from admission to discharge. There were no significant changes over time in the DRS scores. Women had higher DayROS gains (P = .003) and better therapist DRS scores from admission to discharge than men (P = .010). Conclusions: Patients with malignant brain tumors can make functional gains in an interdisciplinary outpatient rehabilitation program. This level of care should be considered in this patient population.	[Shahpar, Samman; Keeshin, Susan; McCarty, Stacy] Northwestern Univ, Feinberg Sch Med, 355 E Erie St, Chicago, IL 60611 USA; [Shahpar, Samman; Keeshin, Susan; McCarty, Stacy] Shirley Ryan AbilityLab, 355 E Erie St, Chicago, IL 60611 USA; [Wong, Alex W. K.] Washington Univ, Sch Med, St Louis, MO USA; [Eickmeyer, Sarah M.] Univ Kansas, Dept Phys Med & Rehabil, Sch Med, Kansas City, KS USA; [Semik, Patrick] Shirley Ryan AbilityLab, Ctr Rehabil Outcomes Res, Chicago, IL USA; [Kocherginsky, Masha] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Div Biostat, Chicago, IL 60611 USA		Shahpar, S (corresponding author), Northwestern Univ, Feinberg Sch Med, 355 E Erie St, Chicago, IL 60611 USA.; Shahpar, S (corresponding author), Shirley Ryan AbilityLab, 355 E Erie St, Chicago, IL 60611 USA.	sshahpar@sralab.org		Semik, Patrick/0000-0002-8955-6501; Wong, Alex/0000-0002-4423-2685	Acorda Neurorehab; American Brain Tumor Association; American Brain Tumor Association Discovery Grant; Foundation for PM& R Acorda Neurologic Rehabilitation Research Grant	S.S. Northwestern University Feinberg School of Medicine, Chicago, IL; and Shirley Ryan AbilityLab, 355 E. Erie Street, Chicago, IL 60611. Address correspondence to: S.S.; e-mail: sshahpar@sralab.org; Disclosures related to this publication: grants, Acorda Neurorehab, American Brain Tumor Association; S.K. Northwestern University Feinberg School of Medicine, Chicago, IL; and Shirley Ryan AbilityLab, Chicago, IL; Disclosures related to this publication: grant, The American Brain Tumor Association; S.M. Northwestern University Feinberg School of Medicine, Chicago, IL; and Shirley Ryan AbilityLab, Chicago, IL; Disclosures related to this publication: grants, Acorda Neurorehab, American Brain Tumor Association.; Supported by the American Brain Tumor Association Discovery Grant and the Foundation for PM& R Acorda Neurologic Rehabilitation Research Grant, principal investigator: S. M.	Central Brain Tumor Registry of the United States, 2016 CBTRUS FACT SHE; Chaichana KL, 2011, J NEUROSURG, V114, P604, DOI 10.3171/2010.4.JNS091340; Cichowski K, 1987, 64 ANN SESS AM C REH; Fu JB, 2010, AM J PHYS MED REHAB, V89, P205, DOI 10.1097/PHM.0b013e3181ca2306; Geler-Kulcu D, 2009, J CLIN NEUROSCI, V16, P74, DOI 10.1016/j.jocn.2008.04.014; Greenberg E, 2006, AM J PHYS MED REHAB, V85, P568, DOI 10.1097/01.phm.0000223218.38152.53; Huang ME, 1998, ARCH PHYS MED REHAB, V79, P1386, DOI 10.1016/S0003-9993(98)90232-5; Huang ME, 2000, AM J PHYS MED REHAB, V79, P327, DOI 10.1097/00002060-200007000-00003; Huang ME, 2001, ARCH PHYS MED REHAB, V82, P1540, DOI 10.1053/apmr.2001.26613; KHAN F, 2013, COCHRANE DB SYST REV, V1; Khan F, 2014, J REHABIL MED, V46, P754, DOI 10.2340/16501977-1840; Khan F, 2013, J REHABIL MED, V45, P434, DOI 10.2340/16501977-1132; Kirshblum S, 2001, CANCER, V92, P1029, DOI 10.1002/1097-0142(20010815)92:4+<1029::AID-CNCR1416>3.0.CO;2-P; Marciniak CM, 2001, ARCH PHYS MED REHAB, V82, P457, DOI 10.1053/apmr.2001.21862; Mukand JA, 2001, AM J PHYS MED REHAB, V80, P346, DOI 10.1097/00002060-200105000-00005; O'Dell MWBK, 1998, ARCH PHYS MED REHAB, V79, P1386; Ostrom QT, 2016, NEURO-ONCOLOGY, V18, pv1, DOI 10.1093/neuonc/now207; Pace A, 2007, J EXP CLIN CANC RES, V26, P297; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sherer M, 1997, CANCER, V80, P250, DOI 10.1002/(SICI)1097-0142(19970715)80:2<250::AID-CNCR13>3.3.CO;2-T; Taphoorn MJB, 2005, LANCET ONCOL, V6, P937, DOI 10.1016/S1470-2045(05)70432-0; Vecht CJ, 2014, ONCOLOGIST, V19, P751, DOI 10.1634/theoncologist.2014-0060	22	7	7	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	SEP	2018	10	9					926	933		10.1016/j.pmrj.2018.03.002			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GT9HH	WOS:000444851100006	29550410				2022-02-06	
J	Thomas, M; Skilbeck, C; Cannan, P; Slatyer, M				Thomas, Matt; Skilbeck, Clive; Cannan, Phillipa; Slatyer, Mark			The Structure of the Rivermead Post-Concussion Symptoms Questionnaire in Australian Adults with Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						Rivermead Post-Concussion Symptoms Questionnaire (RPQ); construct validity; factor structure concussion; mild traumatic brain injury	ROUTINE FOLLOW-UP; CONSTRUCT-VALIDITY; EARLY INTERVENTION; HEAD-INJURY; MILD; PREVALENCE; FIT; DISABILITY; TESTS; TRIAL	Background and aims: Many sustaining traumatic brain injury (TBI) suffer ongoing post-concussion symptoms (PCS). The Rivermead Post-Concussion Symptoms Questionnaire (RPQ) is widely used, although there is disagreement about its structure. This study compared the fit of published RPQ structures with a four-factor structure derived from a large adult sample with TBI in Tasmania. Method: 661 adults with TBI completed the RPQ at approximately one month post injury. Exploratory factor analysis (EFA), using the first half of the sample (n = 330), suggested a four-factor solution. This was compared with models reported in the literature with the second half of the sample (n = 331), using structural equation modelling. Trajectory of recovery across these factors was examined within subsamples at 1, 3, 6 and 12 months following TBI. Results: Inter-correlations between items were strongest for somatic, cognitive and emotional functioning items and the EFA identified a four-factor model. Fit was examined utilising bootstrapping for model comparison. The data at 1 month following TBI best fitted the four-factor model (CFI = .95, RMSEA = .060 (.049-.071) and factors had adequate internal consistency (r = .61-.89). This model appeared a good fit and clinically useful across time points to 12 months post injury. Conclusions: Data best fitted a four-factor model, identified using a rigorous statistical approach. Clinicians and clinical researchers may use this preferred model to provide more specific measurement of the severity of PCS. Future research could attempt replication within international samples.	[Thomas, Matt] Charles Sturt Univ, Sch Psychol, Bathurst, NSW, Australia; [Thomas, Matt; Skilbeck, Clive; Cannan, Phillipa; Slatyer, Mark] Royal Hobart Hosp, Neurotrama Register Tasmania, Hobart, Tas, Australia; [Skilbeck, Clive; Cannan, Phillipa] Univ Tasmania, Sch Psychol, Hobart, Tas, Australia		Thomas, M (corresponding author), Charles Sturt Univ, Sch Psychol, Bathurst, NSW, Australia.	mathomas@csu.edu.au					AIHW, 2007, DIS AUSTR ACQ BRAIN; AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Arbuckle J.L., 2007, AMOS 16 0 USERS GUID; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Browne MW, 1993, ALTERNATIVE WAYS ASS; Byrne BM., 2013, STRUCTURAL EQUATION; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Department of Veterans Affairs and Department of Defense, 2009, CLIN PRACT GUID MAN; Dexheimer JW, 2017, INT J MED INFORM, V97, P163, DOI 10.1016/j.ijmedinf.2016.10.007; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Fidell L.S., 2001, USING MULTIVARIATE S, V4th; FINNEY SJ, 2006, NONNORMAL CATEGORICA; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORTUNE N, 1999, DEFINITION INCIDENCE; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Hadanny A, 2016, EXPERT REV NEUROTHER, V16, P875, DOI 10.1080/14737175.2016.1205487; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hillier SL, 1997, BRAIN INJURY, V11, P649; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kim H, 2014, MULTIVAR BEHAV RES, V49, P581, DOI 10.1080/00273171.2014.947352; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Randall D., 2016, J HEAD TRAUMA REHABI; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Tabachnick L. S., 2013, USING MULTIVARIATE S, V6th; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Tate RL, 2010, COMPENDIUM TESTS SCA; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Thomas MD, 2012, AUST J PSYCHOL, V64, P225, DOI 10.1111/j.1742-9536.2012.00054.x; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Zucchini W., 1986, MODEL SELECTION	61	7	7	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2018	19	2			SI		166	182		10.1017/Brimp.2017.26			17	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	GP2LS	WOS:000440665300005					2022-02-06	
J	Kongwad, LI; Hegde, A; Menon, G; Nair, R				Kongwad, Lakshman, I; Hegde, Ajay; Menon, Girish; Nair, Rajesh			Influence of Admission Blood Glucose in Predicting Outcome in Patients With Spontaneous Intracerebral Hematoma	FRONTIERS IN NEUROLOGY			English	Article						intracerebral hemorrhage; mRS; stroke; admission blood glucose; stroke outcome	SERUM GLUCOSE; INTRAVENTRICULAR HEMORRHAGE; STRESS HYPERGLYCEMIA; NONDIABETIC PATIENTS; DIABETES-MELLITUS; PROGNOSTIC VALUE; STROKE TRIAL; BRAIN-INJURY; RISK; DEATH	Background and Aims: Hyperglycemia or elevated blood glucose levels have been associated with poor outcomes in patients with ischemic stroke yet control of hyperglycemia has not resulted in good outcomes. High admission blood glucose (ABG) values have been mitigated by other poor prognosticators like large hematoma volume, intraventricular extension (IVE) of hematoma and poor GCS. The aim of this study was to evaluate the effects of blood glucose levels at admission, on mortality and functional outcomes at discharge and 3 months follow up. Methods: This was a retrospective observational study conducted at a tertiary care. Patients with spontaneous SICH were enrolled from a prospective SICH register maintained at our hospital. Blood glucose values were recorded on admission. Patients with traumatic hematomas, vascular malformations, aneurysms, and coagulation abnormalities were excluded from our study. Results: A total of 510 patients were included in the study. We dichotomised our cohort into two groups, group A with ABG> 160 mg/dl and group B with ABG< 160 mg/dl. Mean blood glucose levels in these two groups were 220.73 mg/dl and 124.37 mg/dl respectively, with group A having twice the mortality. mRS at discharge and 3 months was better in Group B (p < 0.001) as compared to Group A. Age, GCS, volume of hematoma, ABG, IVE and Hydrocephalus were significant predictors of mortality and poor outcome on univariate analysis with a p < 0.05. The relationship between ABG and mortality (P = 0.249, 95% CI 0.948-1.006) and outcome (P = 0.538, 95% CI 0.997-1.005) failed to reach statistical significance on multivariate logistic regression. Age, Volume of hematoma and GCS were stronger predictors of mortality and morbidity. Conclusion: Admission blood glucose levels was not an independent predictor of mortality in our study when adjusted with age, GCS, and hematoma volume. The effect of high ABG on SICH outcome is probably multifactorial and warrants further research.	[Kongwad, Lakshman, I; Hegde, Ajay; Menon, Girish; Nair, Rajesh] Manipal Acad Higher Educ, Dept Neurosurg, Kasturba Med Coll, Manipal, Karnataka, India		Hegde, A (corresponding author), Manipal Acad Higher Educ, Dept Neurosurg, Kasturba Med Coll, Manipal, Karnataka, India.	dr.ajayhegde@gmail.com	Nair, Rajesh Parameshwaran/AAZ-8676-2020; Hegde, Ajay/N-3334-2017	Nair, Rajesh Parameshwaran/0000-0001-7911-4972; Hegde, Ajay/0000-0001-6970-2260; Menon, Girish/0000-0002-1849-0453			Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Bejot Y, 2012, STROKE, V43, P243, DOI 10.1161/STROKEAHA.111.632950; Bhalla A, 2013, STROKE, V44, P2174, DOI 10.1161/STROKEAHA.113.001263; Bhatia R, 2013, NEUROL INDIA, V61, P244, DOI 10.4103/0028-3886.115062; Bhattathiri PS, 2006, ACTA NEUROCHIR SUPPL, V96, P65; Bilbao G, 2005, ACTA NEUROCHIR, V147, P823, DOI 10.1007/s00701-005-0531-5; Bilotta Federico, 2007, J Neurosurg Anesthesiol, V19, P156, DOI 10.1097/ANA.0b013e3180338e69; Bruno A, 2002, NEUROLOGY, V59, P669, DOI 10.1212/WNL.59.5.669; Bruno A, 2013, CLIN REHABIL, V27, P724, DOI 10.1177/0269215512470674; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Chiu CD, 2013, STROKE, V44, P1682, DOI 10.1161/STROKEAHA.113.675983; Chiu CD, 2012, PROTEOMICS, V12, P113, DOI 10.1002/pmic.201100256; Chuang YC, 2009, INT J QUAL HEALTH C, V21, P441, DOI 10.1093/intqhc/mzp041; Dennis MS, 2003, CEREBROVASC DIS, V16, P9, DOI 10.1159/000069935; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P349, DOI 10.1136/jnnp.2003.034819; FRANKE CL, 1992, J NEUROL NEUROSUR PS, V55, P653, DOI 10.1136/jnnp.55.8.653; Godoy DA, 2008, NEUROCRIT CARE, V9, P217, DOI 10.1007/s12028-008-9063-1; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Guo XM, 2016, MOL NEUROBIOL, V53, P2269, DOI 10.1007/s12035-015-9184-4; Hallevi H, 2009, CRIT CARE MED, V37, P969, DOI 10.1097/CCM.0b013e318198683a; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Kent TA, 2015, NEUROLOGY, V85, P274, DOI 10.1212/WNL.0000000000001757; Kimura K, 2007, J NEUROL SCI, V255, P90, DOI 10.1016/j.jns.2007.02.005; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Krinsley JS, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1784-0; Kurtz P, 2014, CRIT CARE, V18, DOI 10.1186/cc13857; Lee SH, 2010, DIABETOLOGIA, V53, P429, DOI 10.1007/s00125-009-1617-z; Liu J, 2011, NAT MED, V17, P206, DOI 10.1038/nm.2295; Liu RY, 2014, NEUROSCI BULL, V30, P90, DOI 10.1007/s12264-013-1371-6; Mandava P, 2014, TRANSL STROKE RES, V5, P519, DOI 10.1007/s12975-014-0338-x; Mankovsky BN, 1996, J DIABETES COMPLICAT, V10, P228, DOI 10.1016/S1056-8727(96)90006-9; Mankovsky BN, 2004, DIABETES-METAB RES, V20, P268, DOI 10.1002/dmrr.490; MELAMED E, 1976, J NEUROL SCI, V29, P267, DOI 10.1016/0022-510X(76)90176-3; Namani G, 2014, SCH J APP MED SCI, V2, P3005; Narayan SK, 2012, ANN INDIAN ACAD NEUR, V15, P263, DOI 10.4103/0972-2327.104333; Ntaios G, 2010, STROKE, V41, P2366, DOI 10.1161/STROKEAHA.110.592170; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Passero S, 2003, NEUROLOGY, V61, P1351, DOI 10.1212/01.WNL.0000094326.30791.2D; Qureshi AI, 2011, NEUROCRIT CARE, V15, P428, DOI 10.1007/s12028-011-9541-8; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Rosso C, 2012, STROKE, V43, P2343, DOI 10.1161/STROKEAHA.112.657122; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00091; Sacco RL, 1998, NEUROLOGY, V51, pS27, DOI 10.1212/WNL.51.3_Suppl_3.S27; Song EC, 2003, STROKE, V34, P2215, DOI 10.1161/01.STR.0000088060.83709.2C; Stollberger C, 2005, ANN MED, V37, P357, DOI 10.1080/07853890510037356; Sun SC, 2016, SCI REP-UK, V6, DOI 10.1038/srep32342; Tan X, 2014, INTERN MED J, V44, P254, DOI 10.1111/imj.12352; Tapia-Perez JH, 2014, CLIN NEUROL NEUROSUR, V118, P37, DOI 10.1016/j.clineuro.2013.12.018; Tetri S, 2009, J NEUROSURG, V110, P411, DOI 10.3171/2008.8.JNS08445; Uyttenboogaart M, 2007, BRAIN, V130, P1626, DOI 10.1093/brain/awm087; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Won SJ, 2011, ANN NEUROL, V70, P583, DOI 10.1002/ana.22538; Xi GH, 2004, NEUROCRIT CARE, V1, P5, DOI 10.1385/NCC:1:1:5; Yoo DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094364; Zheng J, 2018, WORLD NEUROSURG, V114, pE756, DOI 10.1016/j.wneu.2018.03.077	57	7	7	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 28	2018	9								725	10.3389/fneur.2018.00725			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GR8ES	WOS:000442945900001	30210444	Green Published, gold			2022-02-06	
J	Panchal, H; Sollmann, N; Pasternak, O; Alosco, ML; Kinzel, P; Kaufmann, D; Hartl, E; Forwell, LA; Johnson, AM; Skopelja, EN; Shenton, ME; Koerte, IK; Echlin, PS; Lin, AP				Panchal, Hemali; Sollmann, Nico; Pasternak, Ofer; Alosco, Michael L.; Kinzel, Philipp; Kaufmann, David; Hartl, Elisabeth; Forwell, Lorie A.; Johnson, Andrew M.; Skopelja, Elaine N.; Shenton, Martha E.; Koerte, Inga K.; Echlin, Paul S.; Lin, Alexander P.			Neuro-Metabolite Changes in a Single Season of University Ice Hockey Using Magnetic Resonance Spectroscopy	FRONTIERS IN NEUROLOGY			English	Article						magnetic resonance spectroscopy; ice hockey; sex difference; traumatic brain injury; repetitive head injury	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; DIFFUSE AXONAL INJURY; MR SPECTROSCOPY; HEAD IMPACTS; DESCRIPTIVE EPIDEMIOLOGY; FUNCTIONAL CONNECTIVITY; SURVEILLANCE SYSTEM; GENDER-DIFFERENCES; N-ACETYLASPARTATE	Background: Previous research has shown evidence for transient neuronal loss after repetitive head impacts (RHI) as demonstrated by a decrease in N-acetylaspartate (NAA). However, few studies have investigated other neuro-metabolites that may be altered in the presence of RHI; furthermore, the relationship of neuro-metabolite changes to neurocognitive outcome and potential sex differences remain largely unknown. Objective: The aim of this study was to identify alterations in brain metabolites and their potential association with neurocognitive performance over time as well as to characterize sex-specific differences in response to RHI. Methods: 33 collegiate ice hockey players (17 males and 16 females) underwent 3T magnetic resonance spectroscopy (MRS) and neurocognitive evaluation before and after the Canadian lnteruniversity Sports (CIS) ice hockey season 2011-2012. The MRS voxel was placed in the corpus callosum. Pre- and postseason neurocognitive performances were assessed using the Immediate Post-Concussion Assessment and Cognitive Test (ImPACT). Absolute neuro-metabolite concentrations were then compared between pre- and postseason MRS were (level of statistical significance after correction for multiple comparisons: p < 0.007) and correlated to ImPACT scores for both sexes. Results: A significant decrease in NAA was observed from preseason to postseason (p = 0.001). Furthermore, a trend toward a decrease in total choline (Cho) was observed (p = 0.044). Although no overall effect was observed for glutamate (Glu) over the season, a difference was observed with females showing a decrease in Glu and males showing an increase in Glu, though this was not statistically significant (p = 0.039). In both males and females, a negative correlation was observed between changes in Glu and changes in verbal memory (p = 0.008). Conclusion: The results of this study demonstrate changes in absolute concentrations of neuro-metabolites following exposure to RHI. Results suggest that changes in Glu are correlated with changes in verbal memory. Future studies need to investigate further the association between brain metabolites and clinical outcome as well as sex-specific differences in the brain's response to RHI.	[Panchal, Hemali; Lin, Alexander P.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA; [Panchal, Hemali; Shenton, Martha E.; Lin, Alexander P.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Clin Spect, Boston, MA USA; [Sollmann, Nico; Pasternak, Ofer; Kinzel, Philipp; Kaufmann, David; Hartl, Elisabeth; Shenton, Martha E.; Koerte, Inga K.; Lin, Alexander P.] Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Boston, MA USA; [Sollmann, Nico] Tech Univ Munich, Klinikum Rechts Isar, Dept Neuroradiol, Munich, Germany; [Sollmann, Nico] Tech Univ Munich, Klinikum Rechts Isar, TUM Neuroimaging Ctr, Munich, Germany; [Sollmann, Nico] Tech Univ Munich, Dept Neurosurg, Klinikum Rechts Isar, Munich, Germany; [Pasternak, Ofer; Shenton, Martha E.; Koerte, Inga K.] Harvard Med Sch, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA USA; [Alosco, Michael L.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Alosco, Michael L.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Kinzel, Philipp; Kaufmann, David; Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Hartl, Elisabeth] Ludwig Maximilians Univ Munchen, Dept Neurol, Munich, Germany; [Forwell, Lorie A.] Univ Western Ontario, Ctr 3M, London, ON, Canada; [Johnson, Andrew M.] Univ Western Ontario, Sch Hlth Studies, London, ON, Canada; [Skopelja, Elaine N.] Indiana Univ, Ruth Lilly Med Lib, Indianapolis, IN 46204 USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton, MA USA; [Echlin, Paul S.] Elliott Sports Med Clin, Burlington, ON, Canada		Lin, AP (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA.; Lin, AP (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Ctr Clin Spect, Boston, MA USA.; Lin, AP (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Boston, MA USA.	Aplin@bwh.harvard.edu	Johnson, Andrew M/B-2048-2012; Shenton, Martha/V-8780-2019; Koerte, Inga Katharina/AAW-3031-2021	Sollmann, Nico/0000-0002-8120-2223; Johnson, Andrew M./0000-0002-7269-3016	Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award) [UL1 TR001102]; Harvard University; Ontario Trillium Foundation; Dave Irwin Foundation for Brain Injury; Ontario Neurotrauma Foundation, Air Canada; Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; Ontario Ministry of Tourism Culture and Sport; Ontario Ministry of Education; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 NS 093334: IK, R01 NS 100952: IK]; Veterans Affairs (VA Merit Award)US Department of Veterans Affairs [I01 RX00928: MS]; Department of Defense Congressionally Directed Medical Research ProgramsUnited States Department of Defense [W81XWH-08-2-0159: MS, WX81XWH-15-1-0412: AL]; LMU Munich's Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative; HCEP; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100952, U01NS093334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000928] Funding Source: NIH RePORTER	This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. Funding for this work was also provided to the HCEP and PE by the Ontario Trillium Foundation, The Dave Irwin Foundation for Brain Injury, the Ontario Neurotrauma Foundation, Air Canada, The Ontario Ministry of Health and Long Term Care, The Ontario Ministry of Tourism Culture and Sport and The Ontario Ministry of Education. The authors of this study were supported by the NIH (U01 NS 093334: IK, MS; R01 NS 100952: IK, AL), the Veterans Affairs (VA Merit Award I01 RX00928: MS), and the Department of Defense Congressionally Directed Medical Research Programs (W81XWH-08-2-0159: MS, WX81XWH-15-1-0412: AL). This research project was also partially supported by LMU Munich's Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative (IK). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.	Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P249; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Barth C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00037; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Chang LD, 2013, J NEUROIMMUNE PHARM, V8, P576, DOI 10.1007/s11481-013-9460-x; Croall Iain, 1800, Top Magn Reson Imaging, V24, P267, DOI 10.1097/RMR.0000000000000063; Echemendia RJ, 2016, CLIN NEUROPSYCHOL, V30, P311, DOI 10.1080/13854046.2016.1158320; Echlin PS, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12287; Echlin PS, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12286; Erickson KI, 2012, BRAIN BEHAV, V2, P32, DOI 10.1002/brb3.30; Friedman SD, 2017, NEUROLOGY, V89, P2151, DOI 10.1212/WNL.0000000000004666; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Irick E., 2015, NCAA SPORTS SPONSORS; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lin A, 2012, SEMIN NEUROL, V32, P432, DOI 10.1055/s-0032-1331814; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Maddock RJ, 2016, J NEUROSCI, V36, P2449, DOI 10.1523/JNEUROSCI.3455-15.2016; Mader I, 2008, EUR J RADIOL, V67, P250, DOI 10.1016/j.ejrad.2008.02.033; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; McCrory P MeeuwisseW, 2012, PHYS THER SPORT, V14, pe1, DOI [10.1016/j.ptsp.2013.03.002, DOI 10.1016/J.PTSP.2013.03.002]; Mize AL, 2003, ENDOCRINOLOGY, V144, P306, DOI 10.1210/en.2002-220698; Molinuevo Jose L, 2005, Am J Alzheimers Dis Other Demen, V20, P77, DOI 10.1177/153331750502000206; Nikolova S, 2017, NEUROBIOL AGING, V54, P103, DOI 10.1016/j.neurobiolaging.2017.01.026; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Quadrelli S, 2016, MAGN RESON INSIGHTS, V9, P1, DOI 10.4137/MRI.S32903; Rigotti DJ, 2007, AM J NEURORADIOL, V28, P1843, DOI 10.3174/ajnr.A0774; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wagner G, 2016, CORTEX, V81, P104, DOI 10.1016/j.cortex.2016.03.022; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Yoon SJ, 2005, CLIN REHABIL, V19, P209, DOI 10.1191/0269215505cr813oa; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	58	7	7	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 20	2018	9								616	10.3389/fneur.2018.00616			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GQ9VP	WOS:000442144400001	30177905	Green Published, gold			2022-02-06	
J	Nordgarden, T; Odland, P; Guttormsen, AB; Ugelvik, KS				Nordgarden, Terje; Odland, Peter; Guttormsen, Anne Berit; Ugelvik, Kristina Stolen			Undertriage of major trauma patients at a university hospital: a retrospective cohort study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						American College of Surgeons; Committee on trauma; Guidelines for Field Triage of Injured Patients; Haukeland University Hospital; National Trauma Plan; Norway; Trauma; Trauma team; Undertriage	INJURY SEVERITY SCORE; FIELD TRIAGE GUIDELINES; GLASGOW COMA SCALE; AMERICAN-COLLEGE; BRAIN-INJURY; SURGEONS COMMITTEE; COST-EFFECTIVENESS; DECISION SCHEME; VITAL SIGNS; MORTALITY	Background: Studies show increased mortality among severely injured patients not met by trauma team. Proper triage is important to ensure that all severely injured patients receive vital trauma care. In 2017 a new national trauma plan was implemented in Norway, which recommended the use of a modified version of "Guidelines for Field Triage of Injured Patients" to identify severely injured patients. Methods: A retrospective study of 30,444 patients admitted to Haukeland University Hospital in 2013, with ICD-10 injury codes upon discharge. The exclusion criteria were department affiliation considered irrelevant when identifying trauma, patients with injuries that resulted in Injury Severity Score < 15, patients that did receive trauma team, and patients admitted > 24 h after time of injury. Information from patient records of every severely injured patient admitted in 2013 was obtained in order to investigate the sensitivity of the new guidelines. Results: Trauma team activation was performed in 369 admissions and 85 patients were identified as major trauma. Ten severely injured patients did not receive trauma team resuscitation, resulting in an undertriage of 10.5%. Nine out of ten patients were men, median age 54 years. Five patients were 60 years or older. All of the undertriaged patients experienced fall from low height (< 4 m). Traumatic brain injury was seen in six patients. Six patients had a Glasgow Coma Scale score <= 13. The new trauma activation guidelines had a sensitivity of 95.0% in our 2013 trauma population. The degree of undertriage could have been reduced to 4.0% had the guidelines been implemented and correctly applied. Conclusions: The rate of undertriage at Haukeland University Hospital in 2013 was above the recommendations of less than 5%. Use of the new trauma guidelines showed increased triage precision in the present trauma population.	[Nordgarden, Terje; Odland, Peter] Univ Bergen, Fac Med, Haukelandsveien 28, N-5009 Bergen, Norway; [Guttormsen, Anne Berit] Dept Clin Med 1, Jonas Lies Vei 65, N-5021 Bergen, Norway; [Guttormsen, Anne Berit] Haukeland Hosp, Dept Anaesthesia & Intens Care, Jonas Lies Vei 65, N-5021 Bergen, Norway; [Ugelvik, Kristina Stolen] Haukeland Hosp, Surg Dept, Reg Trauma Ctr, Jonas Lies Vei 65, N-5021 Bergen, Norway		Nordgarden, T (corresponding author), Univ Bergen, Fac Med, Haukelandsveien 28, N-5009 Bergen, Norway.	terje.n@outlook.com		Nordgarden, Terje/0000-0003-1747-6710			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bergeson AG, 2004, CLIN NEUROPSYCHOL, V18, P509, DOI 10.1080/1385404049052414; CHAMPION HR, 1992, ARCH SURG-CHICAGO, V127, P333; CHAMPION HR, 1989, AM J PUBLIC HEALTH, V79, P1278, DOI 10.2105/AJPH.79.9.1278; Cook CH, 2001, ARCH SURG-CHICAGO, V136, P752, DOI 10.1001/archsurg.136.7.752; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dehli T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0295-3; Dehli T, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-18; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; Elliott DC, 1996, SURG CLIN N AM, V76, P47, DOI 10.1016/S0039-6109(05)70421-7; Frankema SPG, 2005, J TRAUMA, V58, P596, DOI 10.1097/01.TA.0000152551.39400.6F; Franklin GA, 2000, J TRAUMA, V48, P1034, DOI 10.1097/00005373-200006000-00006; Gerardo CJ, 2011, J EMERG MED, V40, P586, DOI 10.1016/j.jemermed.2009.08.056; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Haas B, 2012, MORTALITY BENEFIT DI; Haas B, 2012, J TRAUMA ACUTE CARE, V72, P1510, DOI 10.1097/TA.0b013e318252510a; Haas B, 2010, J AM COLL SURGEONS, V211, P804, DOI 10.1016/j.jamcollsurg.2010.08.014; Heffernan DS, 2010, J TRAUMA, V69, P813, DOI 10.1097/TA.0b013e3181f41af8; Henry MC, 1996, AM J EMERG MED, V14, P124, DOI 10.1016/S0735-6757(96)90117-5; Holcomb JB, 2005, J TRAUMA, V59, P821, DOI 10.1097/01.ta.0000188125.44129.7c; Hranjec T, 2012, AM SURGEON, V78, P1369; Kann SH, 2007, ACTA ANAESTH SCAND, V51, P1172, DOI 10.1111/j.1399-6576.2007.01354.x; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; KILBERG L, 1988, J TRAUMA, V28, P1493, DOI 10.1097/00005373-198810000-00017; Lehmann R, 2009, AM J SURG, V197, P571, DOI 10.1016/j.amjsurg.2008.12.037; Lerner EB, 2006, PREHOSP EMERG CARE, V10, P303, DOI 10.1080/10903120600723921; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCoy CE, 2013, WEST J EMERG MED, V14, P69, DOI 10.5811/westjem.2013.1.15981; McDermott FT, 2008, MED J AUSTRALIA, V189, P540, DOI 10.5694/j.1326-5377.2008.tb02174.x; Medicine A.f.t, ABBREVIATED INJURY S; Meldon SW, 2002, J TRAUMA, V52, P79, DOI 10.1097/00005373-200201000-00014; Mohan D, 2011, ARCH SURG-CHICAGO, V146, P786, DOI 10.1001/archsurg.2011.43; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1919, DOI 10.1001/jama.271.24.1919; Mullins RJ, 1998, J TRAUMA, V44, P609, DOI 10.1097/00005373-199804000-00009; Mullins RJ, 1996, J TRAUMA, V40, P536, DOI 10.1097/00005373-199604000-00004; Mullins RJ, 1996, INFLUENCE STATEWIDE; Nakamura Y, 2012, ANN EMERG MED, V60, P335, DOI 10.1016/j.annemergmed.2012.04.006; Newgard CD, 2016, J AM COLL SURGEONS, V222, P1125, DOI 10.1016/j.jamcollsurg.2016.02.014; Newgard CD, 2016, J AM COLL SURGEONS, V222, P146, DOI 10.1016/j.jamcollsurg.2015.10.016; Newgard CD, 2013, HEALTH AFFAIR, V32, P1591, DOI 10.1377/hlthaff.2012.1142; Newgard CD, 2011, J AM COLL SURGEONS, V213, P709, DOI 10.1016/j.jamcollsurg.2011.09.012; NKT-Traume N. K.f.T, 2015, NASJONAL TRAUMEPLAN; NORCROSS ED, 1995, J AM COLL SURGEONS, V181, P539; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Pearson WS, 2012, PREHOSP EMERG CARE, V16, P323, DOI 10.3109/10903127.2012.682701; Pracht EE, 2007, MED CARE RES REV, V64, P83, DOI 10.1177/1077558706296241; Rehn M, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-1; Salehi O, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.20349; Sampalis JS, 1999, J TRAUMA, V46, P565, DOI 10.1097/00005373-199904000-00004; Sampalis JS, 1999, TRAUMA CARE REGIONAL; Sasser SM, 2011, WEST J EMERG MED, V12, P275; Sentralbyra S., 2016, FOLKMENGDE BEFOLKNIN; Soni KD, 2017, BURNS TRAUMA, V5, DOI 10.1186/s41038-017-0087-7; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Staudenmayer KL, 2013, J AM COLL SURGEONS, V217, P569, DOI 10.1016/j.jamcollsurg.2013.06.017; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Strnad M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/983409; Taheri PA, 2004, AM J SURG, V187, P7, DOI 10.1016/j.amjsurg.2003.06.002; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Tinkoff GH, 2002, J TRAUMA, V52, P1153, DOI 10.1097/00005373-200206000-00022; Tinkoff GH, 2002, VALIDATION NEW TRAUM; Trauma C.o, 2014, RES OPT CAR INJ PAT; Vassar MJ, 2003, J AM COLL SURGEONS, V197, P717, DOI 10.1016/S1072-7515(03)00749-X; Wong TH, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0215-6; Xiang HY, 2014, AM J EMERG MED, V32, P997, DOI 10.1016/j.ajem.2014.05.038	68	7	7	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	AUG 14	2018	26								64	10.1186/s13049-018-0524-z			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GQ8TN	WOS:000442032000001	30107855	Green Published, gold			2022-02-06	
J	Guo, QJ; Yin, X; Qiao, M; Jia, YJ; Chen, DD; Shao, J; Lebaron, TW; Gaos, Y; Shi, HS; Jia, B				Guo, Qingjun; Yin, Xi; Qiao, Meng; Jia, Yujiao; Chen, Dandan; Shao, Juan; Lebaron, Tyler W.; Gaos, Yuan; Shi, Haishui; Jia, Bin			Hydrogen-Rich Water Ameliorates Autistic-Like Behavioral Abnormalities in Valproic Acid-Treated Adolescent Mice Offspring	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						molecular hydrogen; autism; valproic acid; inflammation; interleukin 6; tumor necrosis factor-&alpha	SPECTRUM DISORDER; MOLECULAR-HYDROGEN; OXIDATIVE STRESS; MOUSE MODEL; ASSOCIATION; RESPONSES; ANXIETY; METAANALYSIS; ANTIOXIDANT; ACTIVATION	Due to its anti-inflammatory and anti-oxidative effects, recent research has demonstrated that molecular hydrogen can serve as a new medical approach for depression, anxiety and traumatic brain injury. However, its potential effects on neurodevelopmental diseases, such as autism are still elusive. The present study aims to investigate the potential effects of hydrogen-rich water (HRW) administration on valproic acid (VPA)-induced autistic-like behavioral deficits, and the associated underlying mechanism in adolescent mice offspring. Pregnant ICR mice were randomly divided into five groups (n = 6). One group was injected with saline (NAV group) and provided hydrogen-free water. The other four groups were injected with VPA (600 mg/kg, intraperitoneally, i.p.) on pregnant day (PND) 12.5. One group was provided with hydrogen-free water (VEH group) and the other three groups were provided HRW at different segments, postnatal day 1 (PND 1) to PND 21 (PHV group), PND 13 to PND 21 (PVS group) or from PND 13 to postnatal day 42 (PVL group). Behavioral tests, including open field, novelty suppressed feeding (NSF), hot plate, social interaction (SI) and contextual fear memory tests were conducted between postnatal day 35-42. We found that HRW administration significantly reversed the autistic-like behaviors induced by maternal VPA exposure in the adolescent offspring of both male and female adolescent offspring. Furthermore, HRW administration significantly reversed the alternation of serum levels of interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), but without any effects on the BDNF levels in maternal VPA-exposed mice offspring. These data suggest the need for additional research on HRW as a potential preventive strategy for autism and related disorders. Lay Summary: Maternal VPA injection induces autistic-like behavioral deficits in adolescent mice offspring. HRW administration ameliorates autistic-like behavioral deficits. HRW administration reverses the alternation of serum levels of IL-6 and TNF-alpha induced by VPA.	[Guo, Qingjun] Hebei Med Univ, Dept Surg, Shijiazhuang, Hebei, Peoples R China; [Yin, Xi] Hebei Med Univ, Hosp 4, Dept Funct Reg Diag, Shijiazhuang, Hebei, Peoples R China; [Qiao, Meng; Jia, Yujiao; Chen, Dandan] Hebei Med Univ, Coll Basic Med, Shijiazhuang, Hebei, Peoples R China; [Shao, Juan] Hebei Med Univ, Hosp 3, Dept Senile Dis, Shijiazhuang, Hebei, Peoples R China; [Lebaron, Tyler W.] Mol Hydrogen Fdn, Kissimmee, FL USA; [Gaos, Yuan; Shi, Haishui] Hebei Med Univ, Dept Biochem & Mol Biol, Shijiazhuang, Hebei, Peoples R China; [Gaos, Yuan; Shi, Haishui; Jia, Bin] Hebei Med Univ, Neurosci Res Ctr, Shijiazhuang, Hebei, Peoples R China; [Shi, Haishui] Dept Forens Med, Hebei Key Lab Forens Med, Shijiazhuang, Hebei, Peoples R China; [Shi, Haishui] Hebei Med Univ, Collaborat Innovat Ctr Forens Med Mol Identificat, Shijiazhuang, Hebei, Peoples R China; [Jia, Bin] Lingshui Gen Hosp, Lingshui, Peoples R China		Shi, HS (corresponding author), Hebei Med Univ, Dept Biochem & Mol Biol, Shijiazhuang, Hebei, Peoples R China.; Shi, HS; Jia, B (corresponding author), Hebei Med Univ, Neurosci Res Ctr, Shijiazhuang, Hebei, Peoples R China.; Shi, HS (corresponding author), Dept Forens Med, Hebei Key Lab Forens Med, Shijiazhuang, Hebei, Peoples R China.; Shi, HS (corresponding author), Hebei Med Univ, Collaborat Innovat Ctr Forens Med Mol Identificat, Shijiazhuang, Hebei, Peoples R China.; Jia, B (corresponding author), Lingshui Gen Hosp, Lingshui, Peoples R China.	shihs@hebmu.edu.cn; 1006687921@qq.com		LeBaron, Tyler/0000-0001-9164-6728	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771462]; Natural Science Foundation from Hebei province, China [2018206119]; Natural Science Foundation for Heath Science from HFPC of Hebei Province [20170642, 20170469, 20170471]; College Students Innovative Pilot Project in Hebei Medical University [USIP2016033, USIP2016035]	This study was partly financed by the National Natural Science Foundation of China (81771462), Natural Science Foundation from Hebei province, China (No. 2018206119), Natural Science Foundation for Heath Science from HFPC of Hebei Province (20170642, 20170469, 20170471), the College Students Innovative Pilot Project in Hebei Medical University (USIP2016033, USIP2016035).	Al-Amin MM, 2015, BEHAV BRAIN RES, V286, P112, DOI 10.1016/j.bbr.2015.02.041; Al-Ayadhi Laila Y, 2005, Neurosciences (Riyadh), V10, P155; Al-Zaid FS, 2014, SCI REP-UK, V4, DOI 10.1038/srep06478; Ansari MA, 2017, CELL SIGNAL, V36, P14, DOI 10.1016/j.cellsig.2017.04.014; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Bronson SL, 2014, ENDOCRINOLOGY, V155, P2635, DOI 10.1210/en.2014-1040; Careaga M, 2017, BIOL PSYCHIAT, V81, P391, DOI 10.1016/j.biopsych.2016.10.020; Chahrour M, 2016, J NEUROSCI, V36, P11402, DOI 10.1523/JNEUROSCI.2335-16.2016; Chauhan Abha, 2006, Pathophysiology, V13, P171, DOI 10.1016/j.pathophys.2006.05.007; CHRISTIANSON AL, 1994, DEV MED CHILD NEUROL, V36, P361; Courchesne E, 2019, MOL PSYCHIATR, V24, P88, DOI 10.1038/s41380-018-0056-y; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Gao Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10362-6; Ghanizadeh A, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-19; Gong M, 2017, CHEMOSPHERE, V187, P140, DOI 10.1016/j.chemosphere.2017.08.119; Hara Y, 2017, PSYCHOPHARMACOLOGY, V234, P3217, DOI 10.1007/s00213-017-4703-9; Hollocks MJ, 2014, AUTISM RES, V7, P216, DOI 10.1002/aur.1361; Huang L, 2016, MED GAS RES, V6, P219, DOI 10.4103/2045-9912.196904; Ichihara M, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0035-1; Iketani M, 2017, CURR NEUROPHARMACOL, V15, P324, DOI 10.2174/1570159X14666160607205417; Imai K, 2016, FREE RADICAL BIO MED, V91, P154, DOI 10.1016/j.freeradbiomed.2015.12.015; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; Kazlauskas N, 2016, PSYCHONEUROENDOCRINO, V72, P11, DOI 10.1016/j.psyneuen.2016.06.001; Kim S, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0195-5; Lee AS, 2017, BRAIN BEHAV IMMUN, V62, P193, DOI 10.1016/j.bbi.2017.01.019; Lin CP, 2017, WORLD J GASTROENTERO, V23, P4920, DOI 10.3748/wjg.v23.i27.4920; Lombardo MV, 2018, MOL PSYCHIATR, V23, P1001, DOI 10.1038/mp.2017.15; Lucchina L, 2014, AUTISM RES, V7, P273, DOI 10.1002/aur.1338; Martin HGS, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00023; Masi A, 2015, MOL PSYCHIATR, V20, P440, DOI 10.1038/mp.2014.59; Masi A, 2017, NEUROSCI BULL, V33, P194, DOI 10.1007/s12264-017-0103-8; Masuda K, 2017, NEUROPSYCH DIS TREAT, V13, P2357, DOI 10.2147/NDT.S138289; Matsumoto A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03273; Meltzer A, 2017, NEUROPSYCHOPHARMACOL, V42, P284, DOI 10.1038/npp.2016.158; Meng WD, 2017, MOL NEUROBIOL, V54, P1167, DOI 10.1007/s12035-016-9721-9; Nagata K, 2009, NEUROPSYCHOPHARMACOL, V34, P501, DOI 10.1038/npp.2008.95; Nicolini C, 2018, EXP NEUROL, V299, P217, DOI 10.1016/j.expneurol.2017.04.017; Ohno K, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/353152; Ohta Shigeo, 2015, Seikagaku, V87, P82; Ohta S, 2014, PHARMACOL THERAPEUT, V144, P1, DOI 10.1016/j.pharmthera.2014.04.006; Prata J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0938-y; Qin XY, 2016, JAMA PEDIATR, V170, P1079, DOI 10.1001/jamapediatrics.2016.1626; Ross HE, 2013, BRAIN BEHAV IMMUN, V31, P76, DOI 10.1016/j.bbi.2012.12.021; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Shi YJ, 2011, J NEUROCHEM, V119, P124, DOI 10.1111/j.1471-4159.2011.07403.x; Singh K, 2014, P NATL ACAD SCI USA, V111, P15550, DOI 10.1073/pnas.1416940111; Slezak J, 2016, PHYSIOL RES, V65, pS11, DOI 10.33549/physiolres.933414; Suzuki Y, 2017, BIOCHEM BIOPH RES CO, V492, P74, DOI 10.1016/j.bbrc.2017.08.035; Varghese M, 2017, ACTA NEUROPATHOL, V134, P537, DOI 10.1007/s00401-017-1736-4; Wen D, 2017, NEUROPHARMACOLOGY, V118, P199, DOI 10.1016/j.neuropharm.2017.03.029; Wu SH, 2016, BEHAV BRAIN RES, V301, P55, DOI 10.1016/j.bbr.2015.12.030; Yamaguchi H, 2017, BEHAV BRAIN RES, V333, P67, DOI 10.1016/j.bbr.2017.06.035; Yoritaka A, 2013, MOVEMENT DISORD, V28, P836, DOI 10.1002/mds.25375; Zhang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23742	54	7	7	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	AUG 6	2018	12								170	10.3389/fnbeh.2018.00170			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	GP4BF	WOS:000440800700001	30127728	Green Published, gold			2022-02-06	
J	Bahraini, NH; Hostetter, TA; Forster, JE; Schneider, AL; Brenner, LA				Bahraini, Nazanin H.; Hostetter, Trisha A.; Forster, Jeri E.; Schneider, Alexandra L.; Brenner, Lisa A.			A Rasch Analysis of the Neurobehavioral Symptom Inventory in a National Cohort of Operation Enduring and Iraqi Freedom Veterans With Mild Traumatic Brain Injury	PSYCHOLOGICAL ASSESSMENT			English	Article						NSI; postconcussive symptoms; Rasch analysis; Veterans; patient-reported outcomes	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; PARALLEL ANALYSIS; DEPLOYMENT; VALIDITY; AFGHANISTAN; VALIDATION; MECHANISMS; ITEM	This study investigated the dimensionality and measurement properties of the Neurobehavioral Symptom Inventory (NSI), a 22-item questionnaire of postconcussive symptoms, in a national sample of 9,679 Operation Enduring Freedom and Operation Iraqi Freedom (OEF/OIF) Veterans with mild traumatic brain injury. Dimensionality of the NSI was examined using exploratory factor analysis (EFA) and Rasch analysis. Rasch measurement properties, including overall fit, unidimensionality, item level statistics, and category functioning were examined for individual NSI symptom domains identified through EFA. Differential item functioning (DIF) analyses of subgroups based on gender and Posttraumatic Stress Disorder (PTSD) diagnosis were also conducted. Results showed that the NSI items are multidimensional and responses can be differentiated into 3 unidimensional domains reflecting Cognitive, Mood-Behavioral, and Vestibular-Sensory symptoms. All items in each of the 3 subscales demonstrated adequate fit to the Rasch model. In each domain, the item hierarchy was consistent with expectations regarding the theoretical ordering of symptoms. Some problems were observed regarding test targeting for all 3 subscales, such that items were generally concentrated around the mean ability level of the population. As such there were fewer items that differentiated between those at the upper and lower extremes of the scale. Differential item functioning (DIF) based on gender was noted for hearing difficulty. This item on average reflected a higher degree of severity for women than for men. There was no DIF based on PTSD status. Implications for using the NSI as an outcome measure are discussed. Public Significance Statement This study suggests that the Neurobehavioral Symptom Inventory (NSI) is a multidimensional measure, and that the total score should not be used as a global measure of postconcussive symptoms. Instead items should be differentiated into Cognitive, Mood-Behavioral, and Vestibular-Sensory symptom domains. In addition, using Rasch interval scores instead of raw scores may allow for the assessment of interventions at more specific levels, and enhance measurement precision for individuals with different levels of symptom severity.	[Bahraini, Nazanin H.] Dept Vet Affair, Rocky Mt Mental Illness Res Educ & Clin Ctr MIRECC, Denver, CO USA; [Bahraini, Nazanin H.] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Boulder, CO USA; [Bahraini, Nazanin H.; Forster, Jeri E.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Hostetter, Trisha A.; Forster, Jeri E.; Schneider, Alexandra L.; Brenner, Lisa A.] Dept Vet Affair, Rocky Mt MIRECC, 1055 Clermont St, Denver, CO 80220 USA; [Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO USA		Bahraini, NH (corresponding author), Dept Vet Affair, Rocky Mt MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	nazanin.bahraini@va.gov	Brenner, Lisa A./AAG-2442-2019		U.S. Army Office of the Surgeon General (OTSG); Department of Veterans Affairs (VA), Veterans Health Administration, Patient Care Services Program Office; Denver VA Medical Center; Rocky Mountain Mental Illness Research Education and Clinical Center	The research reported here was supported by the U.S. Army Office of the Surgeon General (OTSG) and the Department of Veterans Affairs (VA), Veterans Health Administration, Patient Care Services Program Office. Further support was provided by the Denver VA Medical Center and the Rocky Mountain Mental Illness Research Education and Clinical Center. The views expressed herein are those of the authors and do not necessarily reflect the views or the official policy of the Department of Defense, VA, or US Government.	Abrams TE, 2016, INT J METH PSYCH RES, V25, P22, DOI 10.1002/mpr.1470; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Briggs Derek C, 2003, J Appl Meas, V4, P87; BUJA A, 1992, MULTIVAR BEHAV RES, V27, P509, DOI 10.1207/s15327906mbr2704_2; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Conrad K. J., 2008, GAIN WORKING PAPERS; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Farace E, 2000, Neurosurg Focus, V8, pe6; Fisher W., 1992, RASCH MEAS T, V6, P238; Fitzpatrick R, 2004, QUAL LIFE RES, V13, P331, DOI 10.1023/B:QURE.0000018489.25151.e1; Hayas CL, 2011, INVEST OPHTH VIS SCI, V52, P4800, DOI 10.1167/iovs.10-6132; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Linacre J M, 1998, J Outcome Meas, V2, P266; Linacre J. M, 2012, A USERS GUIDE TO WIN; Linacre J. M., 2012, WINSTEPS RASCH MEASU; Linacre J. M., 2016, WINSTEPS VERSION 3 9; Linacre J.M., 2002, RASCH MEAS T, V16; Linacre JM., 2006, RASCH MEAS T, V1, P1045; Linacre John M, 2002, J Appl Meas, V3, P85; MacDonald P, 2002, EDUC PSYCHOL MEAS, V62, P921, DOI 10.1177/0013164402238082; Meijer RR, 2001, APPL PSYCH MEAS, V25, P107, DOI 10.1177/01466210122031957; MESSICK S, 1995, AM PSYCHOL, V50, P741, DOI 10.1037/0003-066X.50.9.741; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Norquist JM, 2004, MED CARE, V42, P25, DOI 10.1097/01.mlr.0000103530.13056.88; Paulson D, 2015, ARCH CLIN NEUROPSYCH, V30, P207, DOI 10.1093/arclin/acv009; Ponocny I., 2002, PSYCHOL BEITR, V44, P94; Progar S, 2008, HORIZONS PSYCHOL, V17, P5; Rasch G., 1960, PROBABILISTIC MODELS; Rasch Georg, 1980, PROBABILISTIC MODELS; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Smith Everett V Jr, 2002, J Nurs Meas, V10, P189; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stewart J., 2012, SHIKEN RESEARCH BULL, V16, P15; Tanielian T., 2008, INVISIBLE WOUNDS OF; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Wang WC, 2004, PSYCHOL METHODS, V9, P116, DOI 10.1037/1082-989X.9.1.116; Wang WC, 2006, QUAL LIFE RES, V15, P607, DOI 10.1007/s11136-005-4365-7; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wright B., 1999, MEASUREMENT ESSENTIA, V2nd; Wright B., 1982, RATING SCALE ANALYSI; Wright B, 1994, MEASUREMENT T, V8, P370	52	7	7	0	2	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	AUG	2018	30	8					1013	1027		10.1037/pas0000555			15	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GP1HU	WOS:000440566800004	29878819	Bronze			2022-02-06	
J	Cai, HP; Zheng, SF; Cai, B; Yao, PS; Ding, CY; Chen, FX; Kang, DZ				Cai, Hanpei; Zheng, Shufa; Cai, Bin; Yao, Peisen; Ding, Chenyu; Chen, Fuxiang; Kang, Dezhi			Neuroglobin as a Novel Biomarker for Predicting Poor Outcomes in Aneurysmal Subarachnoid Hemorrhage	WORLD NEUROSURGERY			English	Article						Aneurysm; Biomarker; Neuroglobin; Poor outcome; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; MULTIPLE BIOMARKERS; CEREBRAL VASOSPASM; PROGNOSTIC VALUE; NITRIC-OXIDE; IN-VIVO; PROTECTS; EXPRESSION; PATHWAYS; ISCHEMIA	OBJECTIVE: Neuroglobin (Ngb) has a high affinity for oxygen and helps prevent hypoxic-ischemic brain damage. In this study we analyzed the relationship between Ngb levels and clinical outcomes of aneurysmal subarachnoid hemorrhage (aSAH). METHODS: Serum Ngb levels were measured in 58 patients with aSAH and 27 control individuals using the enzyme-linked immunosorbent assay. To continuously assess aSAH, we measured serum Ngb levels on days 1, 2, 3, 5, and 7 after aSAH. Clinical data were collected using the Hunt and Hess Scale, the Glasgow Coma Scale (GCS), the World Federation of Neurological Surgeons (WFNS) Scale, and the modified Fisher Scale. Clinical outcomes included 6-month mortality and 6-month unfavorable outcomes (modified Rankin Scale (mRS) score of 3-6). RESULTS: Serum Ngb levels increased after aSAH, peaked on day 2, and then gradually decreased. Serum Ngb levels on admission were higher in the patient group than in the control group (7.67 +/- 2.56 ng/mL vs. 6.45 +/- 0.88 ng/ml, P < 0.05). Multivariate logistic regression analysis indicated that serum Ngb levels on day 2 after aSAH were independently related to 6-month mortality (odds ratio [011] = 0.265, 95% confidence interval [CI] = 0.094-0.747, P < 0.05) and 6-month unfavorable outcomes (OR = 1.919, 95% CI = 1.158-3.180, P < 0.05), and receiver operating characteristic curve analysis showed that serum Ngb levels on day 2 predicted 6-month mortality and 6-month unfavorable outcomes, with areas under the curve of 0.893 (P < 0.05; 95% CI, 0.812-0.974) and 0.818 (P < 0.05; 95% CI, 0.691-0.954), respectively, based on the best thresholds. CONCLUSIONS: Serum Ngb levels on day 2 after aSAH were strongly associated with poor outcomes in aSAH, suggesting that Ngb may be a novel biomarker for predicting poor outcomes in aSAH.	[Cai, Hanpei; Zheng, Shufa; Cai, Bin; Yao, Peisen; Ding, Chenyu; Chen, Fuxiang; Kang, Dezhi] Fujian Med Univ, Affiliated Hosp 1, Dept Neurosurg, Fuzhou, Fujian, Peoples R China		Kang, DZ (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Neurosurg, Fuzhou, Fujian, Peoples R China.	kdz99988@sina.com					Ayer R, 2010, TURK NEUROSURG, V20, P159, DOI 10.5137/1019-5149.JTN.2714-09.0; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Brunori M, 2006, FASEB J, V20, P2192, DOI 10.1096/fj.06-6643rev; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Carpenter KLH, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00026; Cedzich C, 2005, ZBL NEUROCHIR, V66, P112, DOI 10.1055/s-2005-836477; Chen H, 2015, BIOMARKERS, V20, P495, DOI 10.3109/1354750X.2015.1094138; Chen XD, 2015, THROMB RES, V136, P24, DOI 10.1016/j.thromres.2015.03.025; DRAKE CG, 1988, J NEUROSURG, V68, P985; Emara M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-33; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Jin KL, 2008, NEUROSCI LETT, V430, P135, DOI 10.1016/j.neulet.2007.10.031; Khan AA, 2007, P NATL ACAD SCI USA, V104, P19114, DOI 10.1073/pnas.0706167104; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; Laufs TL, 2004, NEUROSCI LETT, V362, P83, DOI 10.1016/j.neulet.2004.02.072; Lee JY, 2009, BRAIN RES, V1287, P126, DOI 10.1016/j.brainres.2009.06.028; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Li Shi-Qi, 2013, Sichuan Da Xue Xue Bao Yi Xue Ban, V44, P747; Li WD, 2014, CELL MOL NEUROBIOL, V34, P247, DOI 10.1007/s10571-013-0008-7; Lindgren C, 2015, ACTA NEUROL SCAND, V132, P410, DOI 10.1111/ane.12410; Ma CX, 2009, CHINESE MED J-PEKING, V122, P1575, DOI 10.3760/cma.j.issn.0366-6999.2009.13.019; Pluta RM, 2009, NEUROL RES, V31, P151, DOI 10.1179/174313209X393564; Rodriguez-Rodriguez A, 2014, J NEUROL SCI, V341, P119, DOI 10.1016/j.jns.2014.04.020; Schubert GA, 2011, ACTA NEUROCHIR SUPPL, V110, P35, DOI 10.1007/978-3-7091-0353-1_6; Sehba FA, 2011, MOL NEUROBIOL, V43, P27, DOI 10.1007/s12035-010-8155-z; Shang AJ, 2006, BRAIN RES, V1078, P219, DOI 10.1016/j.brainres.2006.01.064; Shen YF, 2015, CLIN CHIM ACTA, V448, P155, DOI 10.1016/j.cca.2015.06.024; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Wang Hang-yan, 2008, Zhonghua Er Ke Za Zhi, V46, P716; Wang Y, 2015, J NEUROL SCI, V356, P72, DOI 10.1016/j.jns.2015.05.038; Xu M, 2013, SLEEP BREATH, V17, P573, DOI 10.1007/s11325-012-0723-1; Yu WH, 2014, CLIN CHIM ACTA, V433, P174, DOI 10.1016/j.cca.2014.03.014; Zhang ZY, 2014, PEPTIDES, V60, P13, DOI 10.1016/j.peptides.2014.07.016	38	7	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2018	116						E258	E265		10.1016/j.wneu.2018.04.184			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GN9GM	WOS:000439498500034	29738858				2022-02-06	
J	Darwazeh, R; Darwazeh, M; Sbeih, I; Yan, Y; Wang, JM; Sun, XC				Darwazeh, Rami; Darwazeh, Mazhar; Sbeih, Ibrahim; Yan, Yi; Wang, Jianmin; Sun, Xiaochuan			Traumatic Brain Injury Caused by Missile Wounds in the North of Palestine: A Single Institution's Experience with 520 Consecutive Civilian Patients	WORLD NEUROSURGERY			English	Article						Civilian; Craniocerebral injury; Missile wounds; Palestine; Palestinian intifada; Traumatic brain injury	CRANIOCEREBRAL GUNSHOT WOUNDS; PROGNOSTIC-FACTORS; HEAD WOUNDS; EPIDEMIOLOGY; PREDICTORS; MANAGEMENT; CONFLICT; SURVIVAL	BACKGROUND: Literature about traumatic brain injury caused by missile wounds is scanty. We shed some light on this field. METHODS: This retrospective study was carried out, between September 2000 and September 2010, on 520 civilian patients who sustained traumatic brain injury from missiles in the north of Palestine. Thorough detailed analyses were made of patients' admission Glasgow Coma Scale (GCS) scores, pupillary reactivity to light, site and mode of injuries, type of injurious agents, missile trajectory, method of treatment, radiologic manifestations, complications, and outcome. The GCS score was used to assess the level of consciousness, whereas the Glasgow Outcome Scale score was used to evaluate the outcome. RESULTS: Patients' age ranged from 6 months to 75 years. Only 50 (9.6%) patients were female. Patients injured by metallic bullets, rubber bullets, and shrapnel from bomb explosions numbered 351, 139, and 30, respectively. Of 384 patients who were treated conservatively, no mortality was detected, whereas of 136 surgically treated patients, 66 (48.5%) died of their injuries. Although our management of patients was not optimal because of many factors, the overall mortality was 12.7% (n = 66). CONCLUSIONS: The promptness of transport to hospital was a decisive factor with a major bearing on decreasing mortality. Brain computed tomography was invaluable in the diagnosis and follow-up of our patients. In addition, age, pupillary reactivity, admission GCS score, missile trajectory, ventricular involvement, and site and mode of injury were important prognostic factors.	[Darwazeh, Rami; Yan, Yi; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China; [Darwazeh, Rami; Darwazeh, Mazhar] Specialized Arab Hosp, Dept Neurosurg, Nablus, Palestine; [Sbeih, Ibrahim] Ibn Al Haytham Hosp, Dept Neurosurg, Amman, Jordan; [Wang, Jianmin] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Chongqing, Peoples R China		Sun, XC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China.	779203374@qq.com	Darwazeh, Rami/AAT-7891-2020	Darwazeh, Rami/0000-0003-3099-8257; sun, xiao chuan/0000-0001-6992-332X			AARABI B, 1989, NEUROSURGERY, V25, P923, DOI 10.1227/00006123-198912000-00011; AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; Ambrosi PB, 2012, NEUROSURG REV, V35, P429, DOI 10.1007/s10143-012-0377-2; Bakir A, 2005, NEUROL MED-CHIR, V45, P281, DOI 10.2176/nmc.45.281; Bayston R, 2000, LANCET, V355, P1813, DOI 10.1016/S0140-6736(00)02275-3; Bizhan Aarabi, 2015, Handb Clin Neurol, V127, P181, DOI 10.1016/B978-0-444-52892-6.00012-X; Bodanapally UK, 2015, RADIOL CLIN N AM, V53, P695, DOI 10.1016/j.rcl.2015.02.011; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Buttram Sandra D W, 2015, Hosp Pediatr, V5, P79, DOI 10.1542/hpeds.2014-0094; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; Cosar A, 2005, MINIM INVAS NEUROSUR, V48, P113, DOI 10.1055/s-2004-830222; Darwazeh R, 2017, WORLD NEUROSURG, V104, P39, DOI 10.1016/j.wneu.2017.04.150; Donnarumma P, 2014, TURK NEUROSURG, V24, P415, DOI 10.5137/1019-5149.JTN.7325-12.1; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Erdogan E, 2004, MIL MED, V169, P691, DOI 10.7205/MILMED.169.9.691; Farhat Hamad Issam, 2012, J Emerg Med, V43, pe111, DOI 10.1016/j.jemermed.2009.10.015; Furlow Bryant, 2006, Radiol Technol, V78, P145; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Izci Y, 2005, EMERG MED J, V22, P409, DOI 10.1136/emj.2004.014704; JENNETT B, 1975, LANCET, V1, P480; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Khan MB, 2014, WORLD NEUROSURG, V82, P14, DOI 10.1016/j.wneu.2013.01.026; Kim TW, 2007, J TRAUMA, V62, P1446, DOI 10.1097/01.ta.0000222909.31666.db; Kong V, 2017, ANZ J SURG, V87, P186, DOI 10.1111/ans.13846; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; Liebenberg WA, 2005, NEUROSURGERY, V57, P293, DOI 10.1227/01.NEU.0000166662.77797.EC; Lolli V, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150849; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Muehlschlegel S, 2016, NEUROLOGY, V87, P2244, DOI 10.1212/WNL.0000000000003355; Nathoo N, 2002, SURG NEUROL, V58, P225, DOI 10.1016/S0090-3019(02)00828-5; Ozkan U, 2002, NEUROSURG REV, V25, P231, DOI 10.1007/s101430100173; Petridis AK, 2011, CENT EUR NEUROSURG, V72, P5, DOI 10.1055/s-0029-1241850; PITLYK PJ, 1970, J NEUROSURG, V33, P19, DOI 10.3171/jns.1970.33.1.0019; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rosenfeld JV, 2002, J CLIN NEUROSCI, V9, P9, DOI 10.1054/jocn.2001.0949; Solmaz I, 2009, TURK NEUROSURG, V19, P216; Turco L, 2017, WORLD NEUROSURG, V104, P653, DOI 10.1016/j.wneu.2017.05.068; Vakil MT, 2017, EMERG RADIOL, V24, P301, DOI 10.1007/s10140-016-1477-z; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wani AA, 2011, J NEUROSURG-PEDIATR, V7, P276, DOI 10.3171/2010.12.PEDS10241	49	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2018	116						E329	E339		10.1016/j.wneu.2018.04.202			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GN9GM	WOS:000439498500043	29738860				2022-02-06	
J	Di, GF; Hu, QX; Liu, DM; Jiang, XC; Chen, J; Liu, HY				Di, Guangfu; Hu, Qianxin; Liu, Dongming; Jiang, Xiaochun; Chen, Jiu; Liu, Hongyi			Risk Factors Predicting Posttraumatic Hydrocephalus After Decompressive Craniectomy in Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Decompressive craniectomy; Posttraumatic hydrocephalus; Risk factor; Traumatic brain injury	POSTOPERATIVE HYDROCEPHALUS; INTERHEMISPHERIC HYGROMA; CLINICAL-FEATURES; SUBDURAL HYGROMA; CRANIOPLASTY; COMPLICATIONS; HEMORRHAGE	OBJECTIVE: To identify risk factors for predicting post-traumatic hydrocephalus (PTH) development after traumatic brain injury in patients who underwent decompressive craniectomy (DC). METHODS: This retrospective study included 121 patients who underwent DC performed by 6 different neuro-surgeons after traumatic brain injury between January 2013 and December 2016 at Yijishan Hospital and were still alive at 6-month follow-up. Patients were divided into PTH group and non-PTH group. Logistic regression analysis was used to identify PTH potential risk factors based on results obtained from univariate analysis. Power of the regression model to discriminate PTH from non-PTH was evaluated using receiver operating characteristic curve. RESULTS: With Glasgow Coma Scale (GCS) score cutoff value of 6, GCS scores <6 on admission, craniectomy site, and intraventricular hemorrhage (IVH) were significant predictors for development of PTH after DC. Receiver operating characteristic curve indicated that a final predictive model composed of these 3 factors (area under the curve [AUC] = 0.866, sensitivity = 0.78, and specificity = 0.83) was significantly better than each single model (AUC = 0.750 for GCS scores on admission, AUC = 0.650 for craniectomy site, AUC = 0.572 for IVH). A significantly positive association was found between patients' Glasgow Outcome Scale Extended scores and GCS scores on admission, whereas a significantly negative association was found between IVH, craniectomy site, and Glasgow Outcome Scale Extended. CONCLUSIONS: GCS scores <6 on admission, presence of IVH on first head computed tomography scan, and need for bilateral DC might be used to predict whether patients with traumatic brain injury after DC will develop PTH. The reliability of this specific combination might be useful for clinicians to make a correct prediction.	[Di, Guangfu; Hu, Qianxin; Jiang, Xiaochun] Wannan Med Coll, Yijishan Hosp, Dept Neurosurg, Wuhu City, Peoples R China; [Liu, Dongming; Liu, Hongyi] Nanjing Med Univ, Affiliated Brain Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Chen, Jiu] Nanjing Med Univ, Affiliated Brain Hosp, Inst Neuropsychiat, Clin Coll 4, Nanjing, Jiangsu, Peoples R China		Liu, HY (corresponding author), Nanjing Med Univ, Affiliated Brain Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.; Chen, J (corresponding author), Nanjing Med Univ, Affiliated Brain Hosp, Inst Neuropsychiat, Clin Coll 4, Nanjing, Jiangsu, Peoples R China.	ericcst@aliyun.com; hyliu18@126.com			Jiangsu Provincial Commission of Health and Family Planning [w201308]; Nanjing Commission of Health and Family Planning [H201540]; Nanjing Medical Science and Technology Development Project [ZKX14044]; Young and Middle-Aged Research Fund Project of Wannan Medical College [WK2017F04]	This study was supported by the Jiangsu Provincial Commission of Health and Family Planning (w201308), Nanjing Commission of Health and Family Planning (H201540), Nanjing Medical Science and Technology Development Project (ZKX14044), and Young and Middle-Aged Research Fund Project of Wannan Medical College (WK2017F04).	Cao Ke, 2015, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V40, P993, DOI 10.11817/j.issn.1672-7347.2015.09.008; Chen H, 2017, METAB BRAIN DIS, V32, P1427, DOI 10.1007/s11011-017-0008-2; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Cho BR, 2012, KOREAN J NEUROTRAUMA, V8, P110; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ding J, 2014, ARQ NEURO-PSIQUIAT, V72, P715, DOI 10.1590/0004-282X20140106; Fotakopoulos G, 2016, J NEUROL SURG PART A, V77, P88, DOI 10.1055/s-0035-1558411; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Ki HJ, 2015, J KOREAN NEUROSURG S, V58, P254, DOI 10.3340/jkns.2015.58.3.254; Kim H, 2017, J KOREAN NEUROSURG S, V60, P730, DOI 10.3340/jkns.2017.0210; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Low CYD, 2013, J CLIN NEUROSCI, V20, P867, DOI 10.1016/j.jocn.2012.06.007; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Manfiotto M, 2017, CHILD NERV SYST, V33, P1751, DOI 10.1007/s00381-017-3542-7; Morton RP, 2018, J NEUROSURG, V128, P1648, DOI 10.3171/2016.11.JNS161917; Nalbach SV, 2012, J CLIN NEUROSCI, V19, P1222, DOI 10.1016/j.jocn.2012.01.016; Rahme R, 2010, NEUROSURGERY, V67, P675, DOI 10.1227/01.NEU.0000383142.10103.0B; Shi SS, 2011, CHINESE J TRAUMATOLO, V16, P243; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Symss NP, 2013, J NEUROSURG-PEDIATR, V11, P170, DOI 10.3171/2012.3.PEDS0934; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Wang QP, 2016, NEUROSCIENCES, V21, P10, DOI 10.17712/nsj.2016.1.20150543; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Yuan Q, 2015, BRAIN INJURY, V29, P971, DOI 10.3109/02699052.2015.1004760	35	7	10	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2018	116						E406	E413		10.1016/j.wneu.2018.04.216			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GN9GM	WOS:000439498500052	29751189				2022-02-06	
J	Hermann, B; Brisson, H; Langeron, O; Pyatigorskaya, N; Paquereau, J; Robert, H; Stender, J; Habert, MO; Naccache, L; Monsel, A				Hermann, Bertrand; Brisson, Helene; Langeron, Olivier; Pyatigorskaya, Nadya; Paquereau, Julie; Robert, Helene; Stender, Johan; Habert, Marie-Odile; Naccache, Lionel; Monsel, Antoine			Unexpected good outcome in severe cerebral fat embolism syndrome	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CONSCIOUSNESS; POTENTIALS; SCALE; STATE; COMA; MRI	In this case study, we report the longitudinal and multimodal follow-up of a catastrophic initial presentation of cerebral fat embolism syndrome. We show that despite the initial severity, the cognitive outcome was ultimately very good but with a highly nonlinear time-course and prolonged loss of consciousness (more than 2months). Repeated clinical assessments and brain-imaging techniques (electroencephalography, event-related potential, (18)-Fluoro-Deoxy-Glucose-PET and magnetic resonance imaging) allowed us to monitor and anticipate this dynamic, providing relevant information to guide decision making in front of withdrawal of life-sustaining therapy discussions. This case illustrates the value of multimodal functional imaging in devastating brain injuries.	[Hermann, Bertrand] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurol, Paris, France; [Hermann, Bertrand; Pyatigorskaya, Nadya; Habert, Marie-Odile; Naccache, Lionel] Inserm U 1127, Paris, France; [Hermann, Bertrand; Pyatigorskaya, Nadya; Habert, Marie-Odile; Naccache, Lionel] ICM, Brain & Spine Inst, Paris, France; [Hermann, Bertrand; Brisson, Helene; Langeron, Olivier; Pyatigorskaya, Nadya; Stender, Johan; Habert, Marie-Odile; Naccache, Lionel; Monsel, Antoine] Sorbonne Univ, Fac Med, Paris, France; [Brisson, Helene; Langeron, Olivier; Monsel, Antoine] Grp Hosp Pitie Salpetriere, AP HP, Multidisciplinary Intens Care Unit, Dept Anesthesia & Crit Care, F-75013 Paris, France; [Pyatigorskaya, Nadya] Grp Hosp Pitie Salpetriere, AP HP, Dept Neuroradiol, Paris, France; [Paquereau, Julie] Hop Raymond Poincare, AP HP, Dept Phys Med & Rehabil, Garches, France; [Robert, Helene] Grp Hosp Pitie Salpetriere, AP HP, Dept Phys Med & Rehabil, Paris, France; [Habert, Marie-Odile] Grp Hosp Pitie Salpetriere, AP HP, Dept Nucl Med, Paris, France; [Habert, Marie-Odile] UPMC Univ Paris 06, Lab Imagerie Biomed, Sorbonne Univ, CNRS,INSERM, F-75013 Paris, France; [Naccache, Lionel] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurophysiol, Paris, France; [Monsel, Antoine] Sorbonne Univ, INSERM, UMR S 959, i3, F-75005 Paris, France; [Monsel, Antoine] Hop La Pitie Salpetriere, AP HP, Biotherapy CIC BTi & Inflammat Immunopathol Bioth, F-75651 Paris, France		Hermann, B (corresponding author), Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, 47-83 Blvd Hop, F-75013 Paris, France.	bertrand.hermann@gmail.com	Pyatigorskaya, Nadya/AAP-8332-2020	Pyatigorskaya, Nadya/0000-0002-2070-1299			Aggarwal R, 2015, INDIAN J CRIT CARE M, V19, P687, DOI 10.4103/0972-5229.169358; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Beretta Luigi, 2008, J Trauma, V65, pE46, DOI 10.1097/01.ta.0000221368.79241.bd; CHRISTIE J, 1995, J BONE JOINT SURG BR, V77B, P450, DOI 10.1302/0301-620X.77B3.7744935; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Faugeras F, 2011, NEUROLOGY, V77, P264, DOI 10.1212/WNL.0b013e3182217ee8; Fernandez-Torre JL, 2015, EPILEPSY BEHAV, V49, P184, DOI 10.1016/j.yebeh.2015.04.045; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Gray AC, 2007, J BONE JOINT SURG AM, V89A, P1092, DOI 10.2106/JBJS.F.00196; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; KANE NM, 1993, LANCET, V341, P688, DOI 10.1016/0140-6736(93)90453-N; Kellogg RG, 2013, J NEUROSURG, V119, P1263, DOI 10.3171/2013.7.JNS13363; King JR, 2013, CURR BIOL, V23, P1914, DOI 10.1016/j.cub.2013.07.075; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Manousakis G, 2012, J STROKE CEREBROVASC, V21, DOI 10.1016/j.jstrokecerebrovasdis.2011.07.006; Meyer N, 2007, J TRAUMA, V63, P1395, DOI 10.1097/01.ta.0000223953.05151.96; Nolan JP, 2015, INTENS CARE MED, V41, P2039, DOI 10.1007/s00134-015-4051-3; Parizel PM, 2001, STROKE, V32, P2942, DOI 10.1161/str.32.12.2942; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Srikanth KP, 2014, INDIAN J ORTHOP, V48, P100, DOI 10.4103/0019-5413.125527; Stender J, 2016, CURR BIOL, V26, P1494, DOI 10.1016/j.cub.2016.04.024; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Takahashi M, 1999, J TRAUMA, V46, P324, DOI 10.1097/00005373-199902000-00021; Tolonen A, 2017, CLIN EEG NEUROSCI; Velly L, 2018, LANCET NEUROL, V17, P317, DOI 10.1016/S1474-4422(18)30027-9	27	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	AUG	2018	5	8					988	995		10.1002/acn3.596			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GQ5QF	WOS:000441741800010	30128324	Green Published, gold			2022-02-06	
J	Jung, JY; Pissarenko, A; Yaraghi, NA; Naleway, SE; Kisailus, D; Meyers, MA; McKittrick, J				Jung, Jae-Young; Pissarenko, Andrei; Yaraghi, Nicholas A.; Naleway, Steven E.; Kisailus, David; Meyers, Marc A.; McKittrick, Joanna			A comparative analysis of the avian skull: Woodpeckers and chickens	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Woodpecker; Chicken; Skull bone; X-ray micro-computed tomography; Scanning electron microscopy; Nanoindentation	MECHANICAL-PROPERTIES; IMAGE-ANALYSIS; GALLUS-GALLUS; BRAIN-INJURY; BONE; MICROSTRUCTURE; MORPHOLOGY; APPARATUS; KINETICS; PECKING	Woodpeckers peck at trees without any reported brain injury despite undergoing high impact loads. Amongst the adaptations allowing this is a highly functionalized impact-absorption system consisting of the head, beak, tongue and hyoid bone. This study aims to examine the anatomical structure, composition, and mechanical properties of the skull to determine its potential role in energy absorption and dissipation. An acorn woodpecker and a domestic chicken are compared through micro-computed tomography to analyze and compare two- and three-dimensional bone morphometry. Optical and scanning electron microscopy with energy dispersive X-ray spectroscopy are used to identify the structural and chemical components. Nanoindentation reveals mechanical properties along the transverse cross-section, normal to the direction of impact. Results show two different strategies: the skull bone of the woodpecker shows a relatively small but uniform level of closed porosity, a higher degree of mineralization, and a higher cortical to skull bone ratio. Conversely, the chicken skull bone shows a wide range of both open and closed porosity (volume fraction), a lower degree of mineralization, and a lower cortical to skull bone ratio. This structural difference affects the mechanical properties: the skull bones of woodpeckers are slightly stiffer than those of chickens. Furthermore, the Young's modulus of the woodpecker frontal bone is significantly higher than that of the parietal bone. These new findings may be useful to potential engineered design applications, as well as future work to understand how woodpeckers avoid brain injury.	[Jung, Jae-Young; Meyers, Marc A.; McKittrick, Joanna] Univ Calif San Diego, Mat Sci & Engn Program, La Jolla, CA 92093 USA; [Pissarenko, Andrei; Meyers, Marc A.; McKittrick, Joanna] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Yaraghi, Nicholas A.; Kisailus, David] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA; [Naleway, Steven E.] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA; [Kisailus, David] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA; [Meyers, Marc A.] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA		Jung, JY (corresponding author), 9500 Gilman Dr MC 0418, La Jolla, CA 92093 USA.	jyjung@ucsd.edu; jmckittrick@eng.ucsd.edu	Kisailus, David/AAW-9736-2021; Naleway, Steven/K-3497-2016; Jung, Jae-Young/J-2677-2014	Naleway, Steven/0000-0001-9413-0399; Jung, Jae-Young/0000-0002-6773-3730	Multi-University Research Initiative through the Air Force Office of Scientific Research [AFOSR-FA9550-15-1-0009]; National Science Foundation, Biomaterials GrantNational Science Foundation (NSF) [1507978]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P41 GM103412]; NSFNational Science Foundation (NSF) [IIS-0208675, DBI-0743460]; National Science FoundationNational Science Foundation (NSF) [ECCS-1542148]; Direct For Mathematical & Physical ScienNational Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS) [1507978] Funding Source: National Science Foundation	The authors thank to Ms. Esther Cory and Dr. Robert L. Sah for mu-CT scans. This work is supported by a Multi-University Research Initiative through the Air Force Office of Scientific Research (AFOSR-FA9550-15-1-0009) (J.J., D.K., J.M., S.E.N., N.Y., M.M., A.P.) and a National Science Foundation, Biomaterials Grant 1507978 (J.M.). Some of the work described here was carried out using shared research resources at the National Center for Microscopy and Imaging Research (NCMIR) at UCSD supported by the NIH under award number P41 GM103412 (M.H. Ellisman). The authors also would like to acknowledge the digimorph.org (Dr. Jessica A. Maisano) and NSF grant IIS-0208675 to T. Rowe (for woodpeckers) and NSF grant DBI-0743460 to B. Dumont (for chicken) for sharing the raw CT data. This work was performed in part at the San Diego Nanotechnology Infrastructure (SDNI) of UCSD, a member of the National Nanotechnology Coordinated Infrastructure, which is supported by the National Science Foundation (Grant ECCS-1542148).	ASHBY MF, 1983, METALL TRANS A, V14, P1755, DOI 10.1007/BF02645546; BENNETT PM, 1985, J ZOOL, V207, P491; Bock W. J., 1959, SCANSORIAL FOOT WOOD, V1931; BOCK WJ, 1964, J MORPHOL, V114, P1, DOI 10.1002/jmor.1051140102; Bock WJ, 1999, OSTRICH, V70, P23, DOI 10.1080/00306525.1999.9639746; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Eliaz N, 2017, MATERIALS, V10, DOI 10.3390/ma10040334; Gibson LJ, 2006, J ZOOL, V270, P462, DOI 10.1111/j.1469-7998.2006.00166.x; Gibson L. J., 1999, CELLULAR SOLIDS STRU; HOMBERGER DG, 1989, AM J ANAT, V186, P217, DOI 10.1002/aja.1001860302; JOLLIE MALCOLM T., 1957, J MORPH, V100, P389, DOI 10.1002/jmor.1051000302; Jung JY, 2016, ACTA BIOMATER, V37, P1, DOI 10.1016/j.actbio.2016.03.030; Lee N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0274; Liu Y, 2015, PLOS ONE, V10; Marbury Robert, 2014, TAXIDERMY ART ROGUES; MAY PRA, 1976, LANCET, V1, P1347; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; McKittrick J, 2010, MAT SCI ENG C-MATER, V30, P331, DOI 10.1016/j.msec.2010.01.011; Mehdizadeh SA, 2015, COMPUT ELECTRON AGR, V114, P88, DOI 10.1016/j.compag.2015.03.017; Meyers M. A., 2014, BIOL MAT SCI BIOL MA; Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854; Oda J, 2006, JSME INT J A-SOLID M, V49, P390, DOI 10.1299/jsmea.49.390; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/NMAT3115, 10.1038/nmat3115]; TOLMAN CW, 1967, BEHAVIOUR, V29, P57, DOI 10.1163/156853967X00262; Van den Heuvel WF, 1998, NETH J ZOOL, V48, P273, DOI 10.1163/156854298X00129; VANDENHEUVEL WF, 1992, NETH J ZOOL, V42, P561, DOI 10.1163/156854292X00071; Wang B, 2016, PROG MATER SCI, V76, P229, DOI 10.1016/j.pmatsci.2015.06.001; WANG L, 2013, WORLD C MED PHYS BIO, P165, DOI DOI 10.1007/978-3-642-29305-4_45; Wang LZ, 2011, SCI CHINA LIFE SCI, V54, P1036, DOI 10.1007/s11427-011-4242-2; Wang LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026490; Wu CW, 2015, J PHYS CONF SER, V628, DOI 10.1088/1742-6596/628/1/012007; Yoon SH, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/1/016003; Zhou P, 2009, J BIONIC ENG, V6, P214, DOI 10.1016/S1672-6529(08)60126-2; Zhu ZD, 2014, J BIONIC ENG, V11, P282, DOI 10.1016/S1672-6529(14)60045-7	37	7	7	4	44	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	AUG	2018	84						273	280		10.1016/j.jmbbm.2018.05.001			8	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	GP7VD	WOS:000441117800030	29852315				2022-02-06	
J	Kang, F; Tang, CL; Han, MM; Chai, XQ; Huang, X; Li, J				Kang, Fang; Tang, ChaoLiang; Han, MingMing; Chai, XiaoQing; Huang, Xiang; Li, Juan			Effects of Dexmedetomidine-Isoflurane versus Isoflurane Anesthesia on Brain Injury After Cardiac Valve Replacement Surgery	JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA			English	Article						dexmedetomidine; isoflurane; brain injury; cardiac surgery	CORONARY-ARTERY-BYPASS; FIBRILLARY ACIDIC PROTEIN; RISK-ADJUSTED MORTALITY; TRAUMATIC BRAIN; OFF-PUMP; MATRIX METALLOPROTEINASES; CEREBRAL-ISCHEMIA; IN-VITRO; NEUROPROTECTION; OUTCOMES	Objectives: To compare dexmedetomidine combined with isoflurane versus isoflurane anesthesia on brain injury after cardiac surgery. Design: A prospective, randomized, single-blind study. Setting: University hospital. Participants: Adult patients undergoing elective valve replacement surgery. Interventions: Ninety-seven patients scheduled for valve replacement surgery were randomly divided into 2 groups: dexmedetomidine and isoflurane (Dex-Iso, n = 50) and isoflurane alone (Iso, n = 47). Dexemedetomidine was infused at 0.6 mu g/kg as a bolus, followed with 0.2 mu g/kg/h until the end of surgery. Measurements and Main Results: Jugular blood samples were drawn for analysis of matrix metalloproteinase-9 (MMP-9) and glial fibrillary acidic protein (GFAP) levels on time points of: Ti (before induction); T2 (5 minutes after cardiopulmonary bypass [CPB] onset); T3 (after CPB off); T4 (the first day after operation); T5 (the second day after operation). Plasma lactate levels in arterial and jugular venous blood also were quantified. The difference between arterial and jugular bulb venous blood lactate levels (AVDL) was calculated. An antisaccadic eye movement (ASEM) test was carried out on the day before the operation and the seventh day postoperatively. In both groups, serum MMP-9 and GFAP concentrations increased after CPB, with the peak values occurring after CPB. At time point T5, MMP-9 and GFAP levels were close to those at Tl. MMP-9 concentrations in the Dex-Iso group were lower than the Iso group at T3 and T4. GFAP concentrations in the Dex-Iso group were lower at T3 but were higher than the Iso group at T2. No significant differences were found in AVDL between the 2 groups perioperatively except at T2. The ASEM scores decreased significantly postoperatively. There was no significant difference in the ASEM scores between the 2 treatment groups before and after the operation. Conclusions: The use of dexmedetomidine decreased the biochemical markers of brain injury but did not improve the neuropsychological test result after cardiac surgery. (C) 2017 Elsevier Inc. All rights reserved.	[Kang, Fang; Tang, ChaoLiang; Han, MingMing; Chai, XiaoQing; Huang, Xiang; Li, Juan] Anhui Med Univ, Anhui Prov Hosp, Dept Anesthesiol, 1 Swan Lake Rd, Hefei 230036, Anhui, Peoples R China		Li, J (corresponding author), Anhui Med Univ, Anhui Prov Hosp, Dept Anesthesiol, 1 Swan Lake Rd, Hefei 230036, Anhui, Peoples R China.	27938758@qq.com					Arom I, 2001, ANN THORAC SURG, V72, P1288; Bekker A, 2005, NEUROSURGERY, V57, P1, DOI 10.1227/01.NEU.0000163476.42034.A1; Bowling AC, 2015, AGING NEUROPSYCHOL C, V22, P201, DOI 10.1080/13825585.2014.901290; Burchell SR, 2013, J INVEST MED, V61, P1078, DOI 10.2310/JIM.0b013e3182a07921; Carollo DS, 2008, CURR OPIN ANESTHESIO, V21, P457, DOI 10.1097/ACO.0b013e328305e3ef; Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5; Dabrowski W, 2012, J CARDIOTHOR VASC AN, V26, P999, DOI 10.1053/j.jvca.2012.07.015; Dabrowski W, 2012, J CARDIOTHOR VASC AN, V26, P395, DOI 10.1053/j.jvca.2011.10.014; de Tournay-Jette E, 2011, J CARDIOTHOR VASC AN, V25, P95, DOI 10.1053/j.jvca.2010.03.019; Dezfulian C, 2013, TRANSL STROKE RES, V4, P19, DOI 10.1007/s12975-012-0224-3; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hernandez F, 2007, ANN THORAC SURG, V84, P1897, DOI 10.1016/j.athoracsur.2007.07.036; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Ishigaki D, 2008, CEREBROVASC DIS, V25, P587, DOI 10.1159/000134375; Jaafari N, 2011, ACTA PSYCHIAT SCAND, V124, P87, DOI 10.1111/j.1600-0447.2011.01721.x; Ji FH, 2013, CIRCULATION, V127, P1576, DOI 10.1161/CIRCULATIONAHA.112.000936; Johnsson P, 1996, J CARDIOTHOR VASC AN, V10, P120, DOI 10.1016/S1053-0770(96)80187-X; Lewis MS, 2006, ANN THORAC SURG, V81, P2097, DOI 10.1016/j.athoracsur.2006.01.044; Mathew JP, 2009, STROKE, V40, P880, DOI 10.1161/STROKEAHA.108.531236; Mohandas BS, 2013, ANN CARD ANAESTH, V16, P102, DOI 10.4103/0971-9784.109740; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Sanders RD, 2010, ACTA ANAESTH SCAND, V54, P710, DOI 10.1111/j.1399-6576.2009.02177.x; Sanders RD, 2009, ANESTHESIOLOGY, V110, P1077, DOI 10.1097/ALN.0b013e31819daedd; Schallner N, 2014, ANESTH ANALG, V119, P1429, DOI 10.1213/ANE.0000000000000488; Schifilliti D, 2010, CNS DRUGS, V24, P893, DOI 10.2165/11584760-000000000-00000; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Su ZY, 2017, NEURAL REGEN RES, V12, P1329, DOI 10.4103/1673-5374.213554; Sulemanji DS, 2007, ACTA ANAESTH SCAND, V51, P1093, DOI 10.1111/j.1399-6576.2007.01377.x; Talke P, 1996, ANESTHESIOLOGY, V85, P551, DOI 10.1097/00000542-199609000-00014; Ulbrich F, 2016, EUR J ANAESTH, V33, P670, DOI 10.1097/EJA.0000000000000449; Wang L, 2008, CURR OPIN PHARMACOL, V8, P104, DOI 10.1016/j.coph.2007.09.005; Wang XN, 2015, INT J CLIN EXP MED, V8, P17281; Wolman RL, 1999, STROKE, V30, P514, DOI 10.1161/01.STR.30.3.514; Yao FSF, 2004, J CARDIOTHOR VASC AN, V18, P552, DOI 10.1053/j.jvca.2004.07.007; Yin YQ, 2007, CHINESE MED J-PEKING, V120, P1951, DOI 10.1097/00029330-200711020-00003; Zheng F, 2013, ANESTH ANALG, V116, P663, DOI 10.1213/ANE.0b013e318277a255; ZORNOW MH, 1990, ANESTH ANALG, V70, P624	39	7	9	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1053-0770	1532-8422		J CARDIOTHOR VASC AN	J. Cardiothorac. Vasc. Anesth.	AUG	2018	32	4					1581	1586		10.1053/j.jvca.2017.11.028			6	Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Cardiovascular System & Cardiology; Respiratory System	GQ5ER	WOS:000441703200006	29277297				2022-02-06	
J	Lantagne, A; Peterson, RL; Kirkwood, MW; Taylor, HG; Stancin, T; Yeates, KO; Wade, SL				Lantagne, Ann; Peterson, Robin L.; Kirkwood, Michael W.; Taylor, H. Gerry; Stancin, Terry; Yeates, Keith Owen; Wade, Shari L.			Featured Article: Interpersonal Stressors and Resources as Predictors of Adolescent Adjustment Following Traumatic Brain Injury	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						adjustment; adolescence; closed head injury; social support; stress	LONG-TERM OUTCOMES; SOCIAL RESOURCES; PSYCHOSOCIAL OUTCOMES; LIFE STRESSORS; CHILDREN; FAMILY; ADAPTATION; BEHAVIOR; SKILLS; DISORDERS	Objective The present study sought to examine adolescents' perceptions of their interpersonal stressors and resources across parent, sibling, friend, and school relationships, and the longitudinal associations with self-reported adjustment after traumatic brain injury (TBI) over a 12-month period. Methods We examined the main effects of stressors and resources on internalizing and externalizing symptoms in 152 adolescents who had sustained complicated mild-to-severe TBI. We also investigated the conjoint effects of stressors and resources and the moderating effects of TBI severity with stressors and resources on outcomes. Results High stressors consistently predicted worse adjustment. High resources were generally only associated with fewer internalizing symptoms. Main effects were qualified by interactions between school stressors and resources in predicting externalizing symptoms and between friend stressors and resources in predicting internalizing and externalizing symptoms. For school stressors, the effects of resources on externalizing symptoms functioned as a buffer. In comparison, the buffering effects of friend resources on internalizing and externalizing symptoms disappeared at moderate-to-high levels of friend stress. Moderating effects of TBI severity were also observed, such that as family resources increased, only adolescents with complicated mild-to-moderate TBI, but not those with severe TBI, experienced decreases in internalizing and eternalizing symptoms. Conclusion Interpersonal stressors and social support have important implications for adolescent adjustment after TBI. Adolescents with low levels of school resources, with high levels of friend stress, and who sustain severe TBI are at greatest risk for difficulties with adjustment.	[Lantagne, Ann; Peterson, Robin L.; Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Rehabil, Aurora, CO 80045 USA; [Lantagne, Ann] Univ Denver, Dept Child Clin Psychol, Denver, CO 80208 USA; [Peterson, Robin L.; Kirkwood, Michael W.] Univ Colorado, Sch Med, Boulder, CO 80309 USA; [Taylor, H. Gerry; Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Stancin, Terry] Metrohlth Med Ctr, Dept Psychiat, 3395 Scranton Rd, Cleveland, OH 44109 USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA		Lantagne, A (corresponding author), Childrens Hosp Colorado, Rehabil Med, 13123 E 16th Ave,B285, Aurora, CO 80045 USA.	ann.lantagne@du.edu	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B090010]; National Institutes of Health/National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683] Funding Source: NIH RePORTER	Supported in part by the National Institute on Disability, Independent Living, and Rehabilitation Research, formerly known as the National Institute on Disability and Rehabilitation Research (grant no. H133B090010), and the National Institutes of Health/National Institute of Child Health and Human Development (grant no. K23HD074683). Clinical Trial Registration No.: NCT01042899.	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Behrens JT, 1997, PSYCHOL METHODS, V2, P131, DOI 10.1037/1082-989X.2.2.131; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Ciccia AH, 2015, INT J LANG COMM DIS, V50, P436, DOI 10.1111/1460-6984.12153; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Farrell SP, 2004, J ADOLESCENT HEALTH, V34, P461, DOI 10.1016/S1054-139X(03)00215-5; Florsheim P, 2008, J ADOLESCENCE, V31, P795, DOI 10.1016/j.adolescence.2007.09.005; Folkman S., 1984, STRESS; Glang A, 2014, JOURNAL OF ADOLESCEN, V56, P91, DOI [10.1016/jadohealth.2014.08.011, DOI 10.1016/JADOHEALTH.2014.08.011]; Grant KE, 2006, CLIN PSYCHOL REV, V26, P257, DOI 10.1016/j.cpr.2005.06.011; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Heverly-Fitt S, 2014, J INT NEUROPSYCH SOC, V20, P684, DOI 10.1017/S1355617714000393; Hung AH, 2017, J DEV BEHAV PEDIATR, V38, P49, DOI 10.1097/DBP.0000000000000366; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; LAGRECA AM, 1995, J PEDIATR PSYCHOL, V20, P449, DOI 10.1093/jpepsy/20.4.449; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Moos RH, 2002, J ADOLESCENT HEALTH, V30, P22, DOI 10.1016/S1054-139X(02)00337-3; MOOS RH, 1988, SOC SCI MED, V27, P999, DOI 10.1016/0277-9536(88)90291-2; Moos RH, 1988, J SUBSTANCE ABUSE, V1, P135, DOI DOI 10.1016/S0899-3289(88)80017-8; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Raudenbush SW, 2004, HLM 6 WINDOWS COMPUT; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; RUBIN C, 1992, AM J ORTHOPSYCHIAT, V62, P430, DOI 10.1037/h0079352; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; SILVERBERG SB, 1987, J YOUTH ADOLESCENCE, V16, P293, DOI 10.1007/BF02139096; Somerville LH, 2013, CURR DIR PSYCHOL SCI, V22, P121, DOI 10.1177/0963721413476512; Swift EE, 2003, J DEV BEHAV PEDIATR, V24, P24, DOI 10.1097/00004703-200302000-00007; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor O, 2015, BRAIN INJURY, V29, P709, DOI 10.3109/02699052.2015.1004739; TIMKO C, 1995, J RES ADOLESCENCE, V5, P361, DOI 10.1207/s15327795jra0503_4; VERNBERG EM, 1990, J ABNORM CHILD PSYCH, V18, P187, DOI 10.1007/BF00910730; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2017, REHABIL PSYCHOL, V62, P290, DOI 10.1037/rep0000160; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Young JF, 2012, SCH MENT HEALTH, V4, P254, DOI 10.1007/s12310-012-9078-9	45	7	7	0	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	AUG	2018	43	7					703	712		10.1093/jpepsy/jsy020			10	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	GP9NJ	WOS:000441243400001	29617953	Green Published, Bronze			2022-02-06	
J	Manderino, LM; Gunstad, J				Manderino, L. M.; Gunstad, J.			Performance of the Immediate Post-Concussion Assessment and Cognitive Testing Protocol Validity Indices	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Head injury; Traumatic brain injury; Malingering/symptom validity testing	TEST-RETEST RELIABILITY; WORD MEMORY TEST; HIGH-SCHOOL; NEUROPSYCHOLOGICAL MEASURES; SYMPTOM VALIDITY; ONLINE VERSION; TEST BATTERY; IMPACT; SPORTS; CONSTRUCT	Objective: Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) is a computerized neuropsychological test battery. Athletes provide preseason baseline ImPACT scores to which post-injury scores can be compared to aid concussion diagnosis. However, if baseline scores are not accurately representative of abilities, the utility of post-injury score comparison is diminished. For this reason, ImPACT includes low score thresholds on five validity indices to identify insufficient effort at baseline, though evidence of these indices' performance is limited. The present study examines the classification accuracy and concurrent validity of the existing ImPACT validity indices and three proposed indices (Word Memory Correct Distractors, Design Memory Correct Distractors, Total Symptom Score). Methods: The ImPACT, Word Memory Test (WMT) and Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) were administered to 242 undergraduate students. Participants were instructed to either give full effort on testing or to simulate SRC. Results: Sensitivity of the existing ImPACT validity indices was marginally improved with adjusted score thresholds while maintaining acceptable specificity (0.90). Alternative score thresholds and novel validity indices demonstrated adequate specificity while improving sensitivity overall. Positive and negative predictive powers are provided to inform use of protocol validity indices across diverse treatment settings. Conclusions: The existing ImPACT indices' high specificity at the expense of lower sensitivity compared to external validity measures may under-identify poor effort, resulting in premature return-to-play decisions for athletes with concussion. Improvements or additions to the existing indices may raise sensitivity while maintaining acceptable specificity, aiding in the protection of athletes and safe athletic participation.	[Manderino, L. M.; Gunstad, J.] Kent State Univ, Dept Psychol Sci, Kent, OH 44224 USA		Gunstad, J (corresponding author), Kent State Univ, 144 Kent Hall, Kent, OH 44224 USA.	jgunstad@kent.edu					Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P., 2003, WORD MEMORY TEST WIN; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Iverson G., 1999, J COGNITIVE REHABILI, V17, P4; Johnson E, 2014, ARCH CLIN NEUROPSYCH, V29, P590; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Lovell M. R., 2015, IMPACT TEST ADM INTE; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Manderino L, 2018, CLIN J SPORT MED, V28, P111, DOI 10.1097/JSM.0000000000000433; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Millis SR, 2009, J NEUROTRAUM, V26, P2409, DOI 10.1089/neu.2008.0530; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Tarescavage AM, 2013, CLIN NEUROPSYCHOL, V27, P313, DOI 10.1080/13854046.2012.744099; Tellegen, 2008, MINNESOTA MULTIPHASI; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X	32	7	7	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2018	33	5					596	605		10.1093/arclin/acx102			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GS3SF	WOS:000443539600008	29088321	Green Published, Bronze			2022-02-06	
J	Vinothkumar, G; Krishnakumar, S; Sureshkumar; Shivashekar, G; Sreedhar, S; Preethikrishnan; Dinesh, S; Sundaram, A; Balakrishnan, D; Riya; Venkataraman, P				Vinothkumar, G.; Krishnakumar, S.; Sureshkumar; Shivashekar, G.; Sreedhar, S.; Preethikrishnan; Dinesh, S.; Sundaram, A.; Balakrishnan, D.; Riya; Venkataraman, P.			Therapeutic impact of rHuEPO on abnormal platelet APP, BACE 1, presenilin 1, ADAM 10 and A beta expressions in chronic kidney disease patients with cognitive dysfunction like Alzheimer's disease: A pilot study	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Chronic kidney disease; Alzheimer's diseases; Cognitive dysfunction; Platelet APP/ A beta; rHuEPO	AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; GAMMA-SECRETASE; HEMODIALYSIS-PATIENTS; LIPID-PEROXIDATION; IN-VITRO; ERYTHROPOIETIN; IMPAIRMENT; ANEMIA	Background: Cognitive dysfunction is reported to be a major cause of morbidity in chronic kidney disease (CKD). The senile plaques (SPs) in the brain are one of the most pathophysiological characteristics of cognitive dysfunction and its major constituent amyloid beta (A beta) released from amyloid precursor protein (APP) by beta (BACE1) and. (presenilin 1) secretases. Platelets contain more than 95% of the circulating APP and implicate as a candidate biomarker for cognitive decline. Recombinant human erythropoietin (rHuEPO) is a standard therapy for anemia in CKD and also acts as a neuroprotective agent. The aim of the study is to determine the impact of rHuEPO therapy on platelet APP processing in CKD with Cognitive Dysfunction. Methods: A total of 60 subjects comprising of 30 CKD without cognitive dysfunction and 30 CKD with cognitive dysfunction based on neuropsychological assessment. APP, BACE1, Presenilin 1, ADAM 10 (a secretase) and A beta expressions in platelets were determined by western blotting and lipid peroxidation (LPO) in platelet rich plasma (PRP) was done by spectrophotometrically. The parameters were statistically compared with Alzheimer's disease (AD), Normocytic normochromic anemic and healthy subjects. Results: Significantly (p < 0.05) decreased APP, ADAM 10 while increased BACE1, Presenilin 1, A beta and LPO were observed in CKD with cognitive dysfunction like AD subjects compared to other groups. The parameters were reassessed in CKD with cognitive dysfunction subjects after rHuEPO (100 IU/kg, weekly twice, 6 months) therapy. All the parameters were retrieved significantly (p < 0.05) along with improved neuropsychological tests scoring after rHuEPO therapy. Conclusions: This study demonstrated that rHuEPO is an effective neuroprotective agent in the context of CKD associated cognitive dysfunction and proved its clinical usefulness.	[Vinothkumar, G.; Sundaram, A.; Balakrishnan, D.; Venkataraman, P.] SRM Univ, SRM Med coll Hosp, Dept Med Res, Madras, Tamil Nadu, India; [Krishnakumar, S.; Sreedhar, S.] SRM Univ, SRM Med coll Hosp, Dept Nephrol, Madras, Tamil Nadu, India; [Preethikrishnan; Dinesh, S.; Riya] SRM Univ, SRM Med coll Hosp, Dept Clin Psychol, Madras, Tamil Nadu, India; [Shivashekar, G.] SRM Univ, SRM Med coll Hosp, Dept Pathol, Madras, Tamil Nadu, India; [Sureshkumar] Balaji Med coll Hosp, Dept Neurol, Madras, Tamil Nadu, India		Venkataraman, P (corresponding author), SRM Univ, Dept Med Res, SRM Med coll Hosp & Res Ctr, Kattankulathur 603203, India.	venkataraman.p@ktr.srmuniv.ac.in	Ganapathy, Shivasekar/AAV-6793-2020; Doraisami, Balakrishnan/AAC-3057-2021; Doraisami, Balakrishnan/AAM-2345-2021	Ganapathy, Shivasekar/0000-0002-5655-2395; Doraisami, Balakrishnan/0000-0002-9608-3423; Doraisami, Balakrishnan/0000-0002-9608-3423	Indian council of Medical Research, New Delhi, IndiaIndian Council of Medical Research (ICMR) [GIA/77/2014-DHR]	This work was financially supported by a grant from the Indian council of Medical Research (No. GIA/77/2014-DHR), New Delhi, India is gratefully acknowledged.	Agarwal S. K., 2006, JIACM, V7, P193; Babitt JL, 2012, J AM SOC NEPHROL, V23, P1631, DOI 10.1681/ASN.2011111078; Bartesaghi S, 2005, NEUROTOXICOLOGY, V26, P923, DOI 10.1016/j.neuro.2005.01.016; Bermejo-Bescos P, 2013, NEUROCHEM RES, V38, P1415, DOI 10.1007/s11064-013-1039-7; Borroni B, 2010, EXP GERONTOL, V45, P53, DOI 10.1016/j.exger.2009.08.004; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Butterfield DA, 1997, CHEM RES TOXICOL, V10, P495, DOI 10.1021/tx960130e; Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516; Chang YK, 2011, J SPORT EXERCISE PSY, V33, P847, DOI 10.1123/jsep.33.6.847; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; Chen LJ, 2008, J NEUROCHEM, V107, P197, DOI 10.1111/j.1471-4159.2008.05603.x; CHEN M, 1995, BIOCHEM BIOPH RES CO, V213, P96, DOI 10.1006/bbrc.1995.2103; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Colciaghi F, 2004, NEUROLOGY, V62, P498, DOI 10.1212/01.WNL.0000106953.49802.9C; Matta Sílvia Mendonça da, 2014, Braz. J. Nephrol., V36, P241, DOI 10.5935/0101-2800.20140035; DEVASAGAYAM TPA, 1987, BIOCHEM BIOPH RES CO, V145, P134, DOI 10.1016/0006-291X(87)91297-6; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Drew DA, 2014, KIDNEY INT, V85, P505, DOI 10.1038/ki.2013.437; ESCHBACH JW, 1989, KIDNEY INT, V35, P134, DOI 10.1038/ki.1989.18; FAZEKAS G, 1995, J NEUROL SCI, V134, P83, DOI 10.1016/0022-510X(95)00226-7; Genc S, 2002, NEUROSCI LETT, V321, P73, DOI 10.1016/S0304-3940(02)00041-1; Humpel C., 2009, HDB NEUROPSYCHIATRIC, P3; Johnston JA, 2008, NEUROBIOL AGING, V29, P661, DOI 10.1016/j.neurobiolaging.2006.11.003; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Katavetin P, 2007, KIDNEY INT, V72, pS10, DOI 10.1038/sj.ki.5002482; Kokjohn TA, 2011, BBA-MOL BASIS DIS, V1812, P1508, DOI 10.1016/j.bbadis.2011.07.004; Krishnaswamy S, 2009, CRIT REV CL LAB SCI, V46, P282, DOI 10.3109/10408360903335821; Kumral A, 2004, BIOL NEONATE, V85, P51, DOI 10.1159/000074958; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1272, DOI 10.1093/ndt/gfg074; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma R, 2009, NEUROPHARMACOLOGY, V56, P1027, DOI 10.1016/j.neuropharm.2009.02.006; McGowan T, 2008, CLIN J AM SOC NEPHRO, V3, P1006, DOI 10.2215/CJN.05671207; Modaresi A, 2015, IRAN J KIDNEY DIS, V9, P165; Nadler Y, 2008, GLIA, V56, P552, DOI 10.1002/glia.20638; Padurariu M, 2010, NEUROSCI LETT, V469, P6, DOI 10.1016/j.neulet.2009.11.033; Pergola PE, 2009, CLIN J AM SOC NEPHRO, V4, P1731, DOI 10.2215/CJN.03470509; Pickett JL, 1999, AM J KIDNEY DIS, V33, P1122, DOI 10.1016/S0272-6386(99)70150-2; Riccio CA, 2004, ARCH CLIN NEUROPSYCH, V19, P661, DOI 10.1016/j.acn.2003.09.001; Ruiz M, 2014, NEUROPHARMACOLOGY, V83, P137, DOI 10.1016/j.neuropharm.2014.04.009; Sehgal AR, 1997, AM J KIDNEY DIS, V30, P41, DOI 10.1016/S0272-6386(97)90563-1; Siems W, 2005, KIDNEY BLOOD PRESS R, V28, P295, DOI 10.1159/000090184; Singh Narinder P, 2006, Hemodial Int, V10, P267, DOI 10.1111/j.1542-4758.2006.00107.x; Smith CCT, 2009, PLATELETS, V20, P29, DOI 10.1080/09537100802334434; Solfrizzi V, 2006, CLIN CHIM ACTA, V364, P91, DOI 10.1016/j.cca.2005.06.015; Srinivasan R, 2016, BIOMED PHARMACOTHER, V82, P44, DOI 10.1016/j.biopha.2016.04.041; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Tamagno E, 2012, NEUROTOX RES, V22, P208, DOI 10.1007/s12640-011-9283-6; Tang K, 2006, J NEUROL SCI, V240, P53, DOI 10.1016/j.jns.2005.09.002; Vinothkumar G, 2017, BBA CLIN, V8, P20, DOI 10.1016/j.bbacli.2017.06.001; Wang HB, 2013, TRENDS PHARMACOL SCI, V34, P215, DOI 10.1016/j.tips.2013.01.008; Wang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03137-6; Wechsler D, 1987, MEMORY SCALE REVISED; Zainaghi IA, 2007, PSYCHOPHARMACOLOGY, V192, P547, DOI 10.1007/s00213-007-0748-5; Zainaghi IA, 2012, J NEURAL TRANSM, V119, P815, DOI 10.1007/s00702-012-0807-x; Zhang DX, 2017, BIOMED PHARMACOTHER, V87, P332, DOI 10.1016/j.biopha.2016.12.115; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zhu L, 2009, BRAIN RES, V1289, P96, DOI 10.1016/j.brainres.2009.07.015	58	7	7	0	5	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	AUG	2018	104						211	222		10.1016/j.biopha.2018.05.028			12	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	GL1BQ	WOS:000436830700025	29775888				2022-02-06	
J	Weykamp, M; Nikolian, VC; Dennahy, IS; Higgins, GA; Georgoff, PE; Remmer, H; Ghandour, MH; Alam, HB				Weykamp, Michael; Nikolian, Vahagn C.; Dennahy, Isabel S.; Higgins, Gerald A.; Georgoff, Patrick E.; Remmer, Henriette; Ghandour, Mohamed H.; Alam, Hasan B.			Rapid valproic acid-induced modulation of the traumatic proteome in a porcine model of traumatic brain injury and hemorrhagic shock	JOURNAL OF SURGICAL RESEARCH			English	Article						Valproic acid; Histone deacetylase inhibitor; Proteomics; Posttranslational modification; Hemorrhage; Traumatic brain injury	HISTONE DEACETYLASE INHIBITION; INDUCED NEURONAL APOPTOSIS; LARGE ANIMAL-MODEL; PHARMACOLOGICAL RESUSCITATION; ACETYLATION; CYTOSKELETON; CELLS; DIFFERENTIATION; EXPRESSION; PREVENTION	Background: Histone deacetylase inhibitors such as valproic acid (VPA) improve survival in lethal models of hemorrhagic shock and polytrauma. Although VPA is known to modulate transcription, its ability to reduce mortality within minutes of administration suggests involvement of a rapid, posttranslational mechanism. We hypothesized that VPA treatment would cause proteomic changes within minutes of treatment including quantitative and/or posttranslational differences in structural and/or effector proteins. Materials and methods: We used a porcine model of traumatic brain injury (computercontrolled cortical impact, 12 mm depth) and hemorrhagic shock (40% hemorrhage). Animals were kept in shock for 2 h and randomized to two groups (n = 3): normal saline (volume = 3:1 hemorrhage volume) or normal saline + VPA (150 mg/kg, single dose). Peripheral blood mononuclear cells were collected at baseline, postshock, and postresuscitation. Intracellular protein profiles were assessed using 1 dimensional gel electrophoresis, liquid chromatography, mass spectrometry, and analyzed with Ingenuity Pathway Analysis software. Results: Animals treated with VPA demonstrated significant proteomic changes. Quantitative differences were found in over 200 proteins including effector, regulatory, and structural proteins in critical cell signaling pathways. Posttranslational modification analysis demonstrated differential VPA-induced acetylation of lysine residues in histone and nonhistone proteins. Pathway analysis correlated these changes with significant increases in numerous prosurvival and cytoskeletal intracellular pathways, including Rho GTPase signaling (P = 1.66E-11), integrin signaling (P = 4.19E-21), and a decrease in Rho guanosine nucleotide dissociation inhibitor signaling (P = 4.83E-12). Conclusions: In a porcine model of severe injuries, a single dose of VPA is associated with protective changes in the proteome that are measurable within minutes of treatment. (C) 2018 Elsevier Inc. All rights reserved.	[Weykamp, Michael; Nikolian, Vahagn C.; Dennahy, Isabel S.; Georgoff, Patrick E.; Ghandour, Mohamed H.; Alam, Hasan B.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA; [Higgins, Gerald A.] Univ Michigan, Dept Computat Med & Bioinformat, Med Sch, Ann Arbor, MI USA; [Remmer, Henriette] Univ Michigan, Dept Biol Chem, Med Sch, Ann Arbor, MI USA		Alam, HB (corresponding author), Univ Michigan Hosp, Surg, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.; Alam, HB (corresponding author), Univ Michigan Hosp, Gen Surg, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Higgins, Gerry/0000-0002-0434-1465	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-1-0520]; Massey Foundation	This research was supported by the US Army Medical Research and Materiel Command [grant number W81XWH-09-1-0520] and the Massey Foundation; these bodies had no involvement in study design, data collection, and analysis, or writing of the report and the decision to publish.	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Arnold TR, 2017, EXP CELL RES, V358, P20, DOI 10.1016/j.yexcr.2017.03.053; Bambakidis T, 2016, J NEUROTRAUM, V33, P1514, DOI 10.1089/neu.2015.4163; Blom M, 2017, EXP CELL RES, V352, P255, DOI 10.1016/j.yexcr.2017.02.013; BOYUM A, 1977, LYMPHOLOGY, V10, P71; Butt MU, 2009, J SURG RES, V156, P290, DOI 10.1016/j.jss.2009.04.012; Causey MW, 2013, J SURG RES, V184, P533, DOI 10.1016/j.jss.2013.03.087; Chang ZG, 2016, J TRAUMA ACUTE CARE, V81, P512, DOI 10.1097/TA.0000000000001137; Cimino G, 2006, CANCER RES, V66, P8903, DOI 10.1158/0008-5472.CAN-05-2726; Das C, 2005, IUBMB LIFE, V57, P137, DOI 10.1080/15216540500090629; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Georgoff PE, 2016, J AM COLL SURGEONS, V223, pS160, DOI 10.1016/j.jamcollsurg.2016.06.347; Georgoff PE, 2016, J TRAUMA ACUTE CARE, V81, P1020, DOI 10.1097/TA.0000000000001249; Gonzales E, 2006, SHOCK, V25, P395, DOI 10.1097/01.shk.0000209522.28120.c8; Gottlicher M, 2004, Ann Hematol, V83 Suppl 1, pS91; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Holmes WR, 2016, PHYS BIOL, V13, DOI 10.1088/1478-3975/13/4/046001; Hoon JL, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020017; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Huang ZS, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0287-6; Hwabejire JO, 2014, J SURG RES, V186, P363, DOI 10.1016/j.jss.2013.09.016; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Ji ZS, 2017, AM J TRANSL RES, V9, P762; Jin G, 2014, SURGERY, V156, P221, DOI 10.1016/j.surg.2014.03.038; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Kuhlmann N, 2016, J BIOL CHEM, V291, P5484, DOI 10.1074/jbc.M115.707091; Li YQ, 2008, J TRAUMA, V64, P863, DOI 10.1097/TA.0b013e318166b822; Li YQ, 2012, ADV EXP MED BIOL, V710, P107, DOI 10.1007/978-1-4419-5638-5_11; Rodriguez-Hernandez Irene, 1800, F1000Res, V5, DOI 10.12688/f1000research.7909.1; Singh BN, 2010, EXPERT REV ANTICANC, V10, P935, DOI [10.1586/era.10.62, 10.1586/ERA.10.62]; Song EH, 2015, J CELL SCI, V128, P913, DOI 10.1242/jcs.158121; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Wen SJ, 2017, ONCOTARGET, V8, P30112, DOI 10.18632/oncotarget.15618; West MA, 2008, J TRAUMA, V64, P870; Zhang C, 2014, BRAIN RES, V1555, P1, DOI 10.1016/j.brainres.2014.01.051	38	7	7	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	AUG	2018	228						84	92		10.1016/j.jss.2018.02.046			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GK8TB	WOS:000436499700013	29907235				2022-02-06	
J	Zhu, SZ; Gao, XY; Huang, KB; Gu, Y; Hu, YF; Wu, YM; Ji, Z; Wang, Q; Pan, SY				Zhu, Shuzhen; Gao, Xiaoya; Huang, Kaibin; Gu, Yong; Hu, Yafang; Wu, Yongming; Ji, Zhong; Wang, Qing; Pan, Suyue			Glibenclamide Enhances the Therapeutic Benefits of Early Hypothermia after Severe Stroke in Rats	AGING AND DISEASE			English	Article						stroke; cerebral edema; glyburide; glibenclamide; therapeutic hypothermia	TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; INFLAMMATORY RESPONSE; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; MILD HYPOTHERMIA; MODEL; IMMUNODEPRESSION; NEUROPROTECTION; OUTCOMES	Glibenclamide (GBC) is an antidiabetic drug that is in a class of medications known as sulfonylureas, which play critical roles in attenuating brain edema and reducing mortality in ischemic stroke patients. Therapeutic hypothermia (TH) is another robust neuroprotectant that prevents brain swelling and improves the neurological outcomes of stroke patients. However, whether the combination of GBC and TH can be used as a reliable neuroprotectant in ischemic stroke remains largely unknown. We used the middle cerebral artery occlusion (MCAO) rat model as well as oxygen and glucose depth ation-reoxygenation (OGD/R) endothelial cells as ischemic stroke models to investigate the efficacy and mechanisms of treating ischemic stroke with the combination of GBC and TH. The serum glucose, mortality rate, neurobehavioral functions, tight junctions, endothelial cells and inflammatory cytokines were evaluated in the stroke models after treatment with GBC, TH or the combination of them. After 5-hour occlusion and subsequent reperfusion, rats exhibited a large volume of hemispheric swelling and a high mortality rate. Stroke rats treated with the combined therapy did not exhibit hypoglycemia. The combination of GBC and TH exhibited synergistic neuroprotective effects in stroke rats that were associated with greater reductions in edema volume, better improvement in neurobehavioral functions, prevention of tight junction loss, and reduction of expression of the inflammatory cytokines COX-2 and iNOS. In OGD/R endothelia cells, the combination reduced endothelial cell death. This study demonstrated that both GBC and TH are neuroprotective after the severe stroke; however, combined therapy with GBC and TH enhanced the efficiency and efficacy of the effects of TH and GBC in the treatment of ischemic. This combined therapy may facilitate the clinical translation of TH management for severe stroke. The combination of GBC and TH seems to be a feasible and promising clinical strategy to alleviate cerebral injury following severe stroke.	[Zhu, Shuzhen; Gao, Xiaoya; Huang, Kaibin; Gu, Yong; Hu, Yafang; Wu, Yongming; Ji, Zhong; Pan, Suyue] Southern Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Zhu, Shuzhen; Gao, Xiaoya; Wang, Qing] Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China		Pan, SY (corresponding author), Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.; Wang, Q (corresponding author), Southern Med Univ, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China.	denniswq@yahoo.com; pansuyue82@126.com	Huang, Kaibin/AAC-6346-2019	Wang, Qing/0000-0002-3882-6540; Huang, Kaibin/0000-0002-3360-7031	Science and Technology Program of Guangdong of China [2016A050502019]; Natural Science Foundations of Guangdong of China [2014A020212068]; Leading Talent in Talents Project; Guangdong High-level Personnel of Special Support Program; Scientific Research Foundation of Guangzhou [2014J4100210]; Medical Scientific Research Foundation of Guangdong Province [A2016074, C1036209]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471339]; National Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2017A030313672, 2015A 030313859]	This work was supported by the Science and Technology Program of Guangdong of China (Grant NO: 2016A050502019), Natural Science Foundations of Guangdong of China (Grant NO: 2014A020212068), Leading Talent in Talents Project, Guangdong High-level Personnel of Special Support Program, and Scientific Research Foundation of Guangzhou (Grant NO: 2014J4100210) to Q.W.; and Medical Scientific Research Foundation of Guangdong Province(Grant NO: A2016074) and National Natural Science Foundation of China (Grant NO: 81471339) to SY, and Medical Scientific Research Foundation of Guangdong Province (Grant NO: C1036209) and National Science Foundation of Guangdong Province (NO: 2017A030313672) to SZ and National Science Foundation of Guangdong Province (NO: 2015A 030313859) to XY.	Atif F, 2013, NEUROPHARMACOLOGY, V67, P78, DOI 10.1016/j.neuropharm.2012.10.004; Chen J, 2015, NEUROL RES, V37, P263, DOI 10.1179/1743132814Y.0000000451; Doll DN, 2014, AGING DIS, V5, P294, DOI 10.14336/AD.2014.0500294; Famakin BM, 2014, AGING DIS, V5, P307, DOI 10.14336/AD.2014.0500307; Gao XY, 2016, CRYOBIOLOGY, V72, P141, DOI 10.1016/j.cryobiol.2016.01.003; Gao XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07091; Gu LJ, 2014, CNS NEUROSCI THER, V20, P67, DOI 10.1111/cns.12160; Ji YB, 2012, NEUROL RES, V34, P657, DOI 10.1179/1743132812Y.0000000061; Koda Y, 2010, BRAIN RES, V1311, P197, DOI 10.1016/j.brainres.2009.11.028; Lee JH, 2016, STROKE, V47, P1907, DOI 10.1161/STROKEAHA.116.013061; Lee YJ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00416; Li X, 2016, NEUROSCI LETT, V614, P55, DOI 10.1016/j.neulet.2015.12.035; Lin ZZ, 2017, NEUROPHARMACOLOGY, V121, P1, DOI 10.1016/j.neuropharm.2017.04.016; Liu X, 2016, NEUROPSYCH DIS TREAT, V12, P219, DOI 10.2147/NDT.S90960; Makar TK, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0432-3; Murtha LA, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00124; Pompermayer K, 2005, KIDNEY INT, V67, P1785, DOI 10.1111/j.1523-1755.2005.00276.x; Schneider H, 2017, INT J STROKE, V12, P732, DOI 10.1177/1747493017694388; Simard JM, 2013, SPINAL CORD, V51, P823, DOI 10.1038/sc.2013.99; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Su YY, 2016, STROKE, V47, P457, DOI 10.1161/STROKEAHA.115.009789; Tokutomi T, 2004, NEUROCRIT CARE, V1, P171, DOI 10.1385/NCC:1:2:171; Tosun C, 2013, STROKE, V44, P3522, DOI 10.1161/STROKEAHA.113.002904; Wang LQ, 2014, CNS NEUROSCI THER, V20, P317, DOI 10.1111/cns.12216; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wei XB, 2016, MOL NEUROBIOL, V53, P5876, DOI 10.1007/s12035-015-9477-7; Wu Z, 2016, BRAIN RES, V1643, P113, DOI 10.1016/j.brainres.2016.04.067; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016; Zhang HF, 2008, BRAIN RES, V1198, P182, DOI 10.1016/j.brainres.2008.01.007; Zhang H, 2008, NEUROL RES, V30, P332, DOI 10.1179/174313208X300279; Zhao HP, 2016, AGING DIS, V7, P295, DOI 10.14336/AD.2015.1009; Zhao H, 2007, J NEUROSURG, V107, P636, DOI 10.3171/JNS-07/09/0636; Zhao H, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/131834; Zhu SZ, 2016, BIOCHEM BIOPH RES CO, V474, P175, DOI 10.1016/j.bbrc.2016.04.095; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	37	7	8	0	6	INT SOC AGING & DISEASE	FORT WORTH	EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA	2152-5250			AGING DIS	Aging Dis.	AUG	2018	9	4					685	695		10.14336/AD.2017.0927			11	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	GP6OT	WOS:000441002200011	30090656	Green Submitted, Green Published, gold			2022-02-06	
J	Paterno, R; Metheny, H; Cohen, AS				Paterno, Rosalia; Metheny, Hannah; Cohen, Akiva S.			Memory Deficit in an Object Location Task after Mild Traumatic Brain Injury Is Associated with Impaired Early Object Exploration and Both Are Restored by Branched Chain Amino Acid Dietary Therapy	JOURNAL OF NEUROTRAUMA			English	Article						BCAA therapy; spatial memory; traumatic brain injury	GLUTAMATE SYNTHESIS; WORKING-MEMORY; THETA RHYTHM; HIPPOCAMPAL; RATS; OSCILLATIONS; DISSOCIATION; NEUROANATOMY; RECOGNITION; NAVIGATION	The relation between traumatic brain injury (TBI) and memory dysfunction is well established, yet imprecise. Here, we investigate whether mild TBI causes a specific deficit in spatial episodic memory. Fifty-eight (29 TBI, 29 sham) mice were run in a spatial recognition task. To determine which phase of memory might be affected in our task, we assessed rodent performance at three different delay times (3 min, 1 h, and 24 h). We found that sham and TBI mice performed equally well at 3 min, but TBI mice had significantly impaired spatial recognition memory after a delay time of 1 h. Neither sham nor injured mice remembered the test object locations after a 24-h delay. In addition, the TBI-specific impairment was accompanied by a decrease in exploratory behavior during the first 3 mins of the initial exposure to the test objects. These memory and exploratory behavioral deficits were linked as branched-chain amino acid (BCAA) dietary therapy restored both memory performance and normal exploratory behavior. Our findings 1) support the use of BCAA therapy as a potential treatment for mild TBI and 2) suggest that poor memory performance post-TBI is associated with a deficit in exploratory behavior that is likely to underlie the encoding needed for memory formation.	[Paterno, Rosalia] Univ Penn, Perelman Sch Med, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA; [Metheny, Hannah; Cohen, Akiva S.] Childrens Hosp Philadelphia, Dept Anesthesiol, Joseph Stokes Res Inst, Philadelphia, PA 19104 USA; [Cohen, Akiva S.] Univ Penn, Dept Anesthesiol, Perelman Sch Med, Philadelphia, PA 19104 USA		Cohen, AS (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Anesthesiol & Crit Care Med,Abramson Res Ctr, 3615 Civ Ctr Blvd,Room 816-h, Philadelphia, PA 19104 USA.	cohena@email.chop.edu			National Institute of Child Health and Human Development at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37-HD059288]; National Institute of Neurological Disease and Stroke at the National Institutes of Health [R21NS096618];  [T32 HL07713]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD059288] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS096618] Funding Source: NIH RePORTER	This work was supported by National Institute of Child Health and Human Development at the National Institutes of Health (R37-HD059288 to A.S.C.), the National Institute of Neurological Disease and Stroke at the National Institutes of Health (R21NS096618 to A.S.C.), and the post-doctoral training grant T32 HL07713. The authors thank Brian N. Johnson and John F. Burke for helpful discussion and input.	Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Dere E, 2005, BRAIN RES PROTOC, V16, P10, DOI 10.1016/j.brainresprot.2005.08.001; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Eichenbaum H., 2004, OXFORD PSYCHOL SERIE, V35; Eldridge LL, 2005, J NEUROSCI, V25, P3280, DOI 10.1523/JNEUROSCI.3420-04.2005; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; GLISKY EL, 1995, NEUROPSYCHOLOGY, V9, P229, DOI 10.1037/0894-4105.9.2.229; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Johnson BN, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00435; Kahana Michael J., 2012, FDN HUMAN MEMORY; Kanamori K, 1998, J NEUROCHEM, V70, P1304; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LAPIDOT A, 1994, J BIOL CHEM, V269, P27198; Lieth E, 2001, J NEUROCHEM, V76, P1712, DOI 10.1046/j.1471-4159.2001.00156.x; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Manns JR, 2009, LEARN MEMORY, V16, P616, DOI 10.1101/lm.1484509; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Moscovitch M, 2008, CAN J EXP PSYCHOL, V62, P62, DOI 10.1037/1196-1961.62.1.62; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; NORMAN DA, 1969, J MATH PSYCHOL, V6, P192, DOI 10.1016/0022-2496(69)90002-9; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Sakai R, 2004, J NEUROCHEM, V88, P612, DOI 10.1111/j.1471-4159.2004.02179.x; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Sweet JA, 2014, HIPPOCAMPUS, V24, P1592, DOI 10.1002/hipo.22338; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; Tulving E., 1972, ORG MEMORY, P381; Tulving E., 1985, ELEMENTS EPISODIC ME; Tulving Endel, 1995, P839; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Whiting MD, 2006, J NEUROTRAUM, V23, P1529, DOI 10.1089/neu.2006.23.1529; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	46	7	7	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2018	35	17					2117	2124		10.1089/neu.2017.5170		JUL 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GQ7LU	WOS:000438171100001	29774776	Green Published			2022-02-06	
J	Verley, DR; Torolira, D; Pulido, B; Gutman, B; Bragin, A; Mayer, A; Harris, NG				Verley, Derek R.; Torolira, Daniel; Pulido, Brandon; Gutman, Boris; Bragin, Anatol; Mayer, Andrew; Harris, Neil G.			Remote Changes in Cortical Excitability after Experimental Traumatic Brain Injury and Functional Reorganization	JOURNAL OF NEUROTRAUMA			English	Article						excitability; fMRI; plasticity; recovery; sensorimotor	LESS-AFFECTED FORELIMB; IMPACT INJURY; STIMULATION; IMPAIRMENT; INCREASES; RECOVERY; NEURONS; CORTEX; FACILITATION; CONCUSSION	Although cognitive and behavioral deficits are well known to occur following traumatic brain injury (TBI), motor deficits that occur even after mild trauma are far less known, yet are equally persistent. This study was aimed at making progress toward determining how the brain reorganizes in response to TBI. We used the adult rat controlled cortical impact injury model to study the ipsilesional forelimb map evoked by electrical stimulation of the affected limb, as well as the contralesional forelimb map evoked by stimulation of the unaffected limb, both before injury and at 1, 2, 3, and 4 weeks after using functional magnetic resonance imaging (fMRI). End-point c-FOS immunohistochemistry data following 1h of constant stimulation of the unaffected limb were acquired in the same rats to avoid any potential confounds due to altered cerebrovascular coupling. Single and paired-pulse sensory evoked potential (SEP) data were recorded from skull electrodes over the contralesional cortex in a parallel series of rats before injury, at 3 days, and at 1, 2, 3, and 4 weeks after injury in order to determine whether alterations in cortical excitability accompanied reorganization of the cortical map. The results show a transient trans-hemispheric shift in the ipsilesional cortical map as indicated by fMRI, remote contralesional increases in cortical excitability that occur in spatially similar regions to altered fMRI activity and greater c-FOS activation, and reduced or absent ipsilesional cortical activity chronically. The contralesional changes also were indicated by reduced SEP latency within 3 days after injury, but not by blood oxygenation level-dependent fMRI until much later. Detailed interrogation of cortical excitability using paired-pulse electrophysiology showed that the contralesional cortex undergoes both an early and a late post-injury period of hyper-excitability in response to injury, interspersed by a period of relatively normal activity. From these data, we postulate a cross-hemispheric mechanism by which remote cortex excitability inhibits ipsilesional activation by rebalanced cortical excitation-inhibition.	[Verley, Derek R.; Torolira, Daniel; Pulido, Brandon; Harris, Neil G.] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA USA; [Bragin, Anatol] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Gutman, Boris] Univ Southern Calif, Keck Univ Southern Calif, Sch Med, Inst Neuroimaging & Informat,Dept Neurol,Imaging, Los Angeles, CA USA; [Mayer, Andrew] Univ New Mexico, MIND Res Network, Albuquerque, NM 87131 USA; [Mayer, Andrew] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA		Harris, NG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, 300 Stein Plaza,Suite 535,Box 956901, Los Angeles, CA 90095 USA.	ngharris@ucla.edu		Torolira, Daniel/0000-0002-7282-6771; Bragin, Anatol/0000-0003-1207-8481	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD087101-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD087101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM055052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091222] Funding Source: NIH RePORTER	NIH NINDS NS091222 & NS065877, The UCLA Brain Injury Research Center. The project described was also supported in part by the MRI Core of the Semel Institute of Neuroscience at UCLA which is supported by Intellectual Development and Disabilities Research Center grant number U54HD087101-01 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health.	Allred RP, 2010, BEHAV NEUROSCI, V124, P124, DOI 10.1037/a0018457; [Anonymous], 2016, R LANG ENV STAT COMP; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Barry MD, 2014, EXP NEUROL, V261, P258, DOI 10.1016/j.expneurol.2014.05.023; Bestmann S, 2010, J NEUROSCI, V30, P11926, DOI 10.1523/JNEUROSCI.5642-09.2010; Black K, 2000, BRAIN INJURY, V14, P141, DOI 10.1080/026990500120808; Brown AW, 2007, BRAIN INJURY, V21, P673, DOI 10.1080/02699050701468925; Butefisch CM, 2003, BRAIN, V126, P470, DOI 10.1093/brain/awg044; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Di Russo F, 2005, J NEUROTRAUM, V22, P297; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Dinov Ivo D, 2009, Front Neuroinform, V3, P22, DOI 10.3389/neuro.11.022.2009; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Eklund A., 2017, FRONT HUM NEUROSCI, V11, P345; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hanell A, 2015, J NEUROTRAUM, V32, P1590, DOI 10.1089/neu.2014.3592; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Harris N.G., 2003, J CEREB METAB BLOOD, V21, P1318; Harris NG, 2013, J NEUROTRAUM, V30, P1257, DOI 10.1089/neu.2012.2737; Harris NG, 2013, J NEUROTRAUM, V30, P1137, DOI 10.1089/neu.2012.2785; Harris NG, 2010, J NEUROTRAUM, V27, P1971, DOI 10.1089/neu.2010.1470; Hillier SL, 1997, BRAIN INJURY, V11, P661; Holschneider DP, 2013, J NEUROTRAUM, V30, P907, DOI 10.1089/neu.2012.2657; Hsu JE, 2006, EXP NEUROL, V201, P479, DOI 10.1016/j.expneurol.2006.05.003; Hsu JE, 2005, EUR J NEUROSCI, V22, P2069, DOI 10.1111/j.1460-9568.2005.04370.x; Hua X, 2011, NEUROIMAGE, V57, P5, DOI 10.1016/j.neuroimage.2011.01.079; Hunt R.F., 2012, REGIONALLY LOCALIZED, V103, P1490; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Imbrosci B, 2015, BRAIN STRUCT FUNCT, V220, P1649, DOI 10.1007/s00429-014-0750-8; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P561, DOI 10.1007/s10237-014-0622-4; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Le Prieult F., 2016, J NEUROTRAUM, V14, P1; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Matthews MA, 1998, BRAIN RES, V794, P1, DOI 10.1016/S0006-8993(98)00107-3; Meintjes EM, 2014, NEUROIMAGE-CLIN, V5, P152, DOI 10.1016/j.nicl.2014.04.001; METHERATE R, 1994, J PHYSIOL-LONDON, V481, P331, DOI 10.1113/jphysiol.1994.sp020443; Moro N, 2011, NEUROSCI LETT, V491, P158, DOI 10.1016/j.neulet.2011.01.029; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Nita DA, 2006, J NEUROPHYSIOL, V95, P902, DOI 10.1152/jn.00742.2005; Porter JT, 2004, J NEUROPHYSIOL, V92, P2762, DOI 10.1152/jn.00196.2004; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; RICHARDS HK, 1995, CHILD NERV SYST, V11, P288, DOI 10.1007/BF00301762; SHAW NA, 1984, AUST J EXP BIOL MED, V62, P361, DOI 10.1038/icb.1984.36; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sonnay S, 2016, J CEREBR BLOOD F MET, V36, P928, DOI 10.1177/0271678X16629482; Stewart TH, 2010, J NEUROPHYSIOL, V104, P3345, DOI 10.1152/jn.00398.2010; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Tustison N.J., 2010, T MED IMAGING, P29; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620; Williams KA, 2010, MAGN RESON IMAGING, V28, P995, DOI 10.1016/j.mri.2010.03.007; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	70	7	7	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2448	2461		10.1089/neu.2017.5536		JUL 2018	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000437806100001	29717625	Green Published			2022-02-06	
J	Temraz, S; Tamim, H; Mailhac, A; Taher, A				Temraz, Sally; Tamim, Hani; Mailhac, Aurelie; Taher, Ali			Could sodium imbalances predispose to postoperative venous thromboembolism? An analysis of the NSQIP database	THROMBOSIS JOURNAL			English	Article						Hypernatremia; Hyponatremia; Mortality; Morbidity; Surgery; Venous thromboembolism	IN-HOSPITAL MORTALITY; ACUTE PULMONARY-EMBOLISM; TRAUMATIC BRAIN-INJURY; DEEP-VEIN THROMBOSIS; INDEPENDENT PREDICTOR; HEART-FAILURE; RISK-FACTORS; ACQUIRED HYPERNATREMIA; ELDERLY-PATIENTS; HYPONATREMIA	Background: Hyponatremia is common among patients with pulmonary embolism, while hypernatremia increases the risk of venous thromboembolism (VTE). Our objective was to evaluate the association between sodium imbalances and the incidence of VTE and other selected perioperative outcomes. Methods: We conducted a retrospective cohort study using the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) and identified 1,108,704 patients undergoing major surgery from 2008 to 2012. We evaluated 30-day perioperative outcomes, including mortality and cardiac, respiratory, neurological, urinary, wound, and VTE outcomes. Multivariate logistic regressions were used to estimate the odds of 30-day perioperative outcomes. Results: Compared with the normal sodium group, in which VTE occurred in 1.0% of patients, 1.8% of patients in the hyponatremia group (unadjusted odds ratio (OR) 1.84) and 2.4% of patients in the hypernatremia group (unadjusted OR 2.49) experienced VTE. Crude mortality was 1.3% in the normal sodium group, 4.9% in the hyponatremia group (unadjusted OR 3.93) and 8.4% in the hypernatremia group (unadjusted OR 7.01). Crude composite morbidity was 7.1% for the normal sodium group, 16.7% for the hyponatremia group (unadjusted OR 2.63) and 20.6% for the hypernatremia group (unadjusted OR 3.43). After adjusting for potential confounders, hyponatremia and hypernatremia remained significantly and independently associated with an increased risk of VTE (adjusted OR 1. 43 and 1.56, respectively), mortality (adjusted OR 1.39 and 1.39, respectively) and composite morbidity (adjusted OR 2. 15 and 3.34, respectively). Conclusions: Pre-operative hyponatremia and hypernatremia are potential prognostic markers for perioperative 30-day morbidity, mortality and VTE.	[Temraz, Sally; Tamim, Hani; Taher, Ali] Amer Univ Beirut, Med Ctr, Dept Internal Med, Riad El Solh 110, Beirut 72020, Lebanon; [Mailhac, Aurelie] Amer Univ Beirut, Med Ctr, Clin Res Inst, Beirut, Lebanon		Taher, A (corresponding author), Amer Univ Beirut, Med Ctr, Dept Internal Med, Riad El Solh 110, Beirut 72020, Lebanon.	ataher@aub.edu.lb		Temraz, Sally/0000-0002-8995-7946			Alharfi IM, 2013, J NEUROTRAUM, V30, P361, DOI 10.1089/neu.2012.2410; Alshayeb HM, 2011, AM J MED SCI, V341, P356, DOI 10.1097/MAJ.0b013e31820a3a90; Arampatzis S, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.04.041; Arinzon Z, 2005, ARCH GERONTOL GERIAT, V40, P317, DOI 10.1016/j.archger.2004.10.004; Ates I, 2016, INTERN EMERG MED, V11, P451, DOI 10.1007/s11739-015-1368-4; Ayus JC, 2010, CLIN J AM SOC NEPHRO, V5, P167, DOI 10.2215/CJN.09281209; Bataille S, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-37; Bhavnani SP, 2014, EUROPACE, V16, P47, DOI 10.1093/europace/eut211; Bohl MA, 2016, NEUROSURGERY, V78, P84, DOI 10.1227/NEU.0000000000001003; Chae YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087813; Chalela R, 2016, RESP MED, V117, P237, DOI 10.1016/j.rmed.2016.05.003; Corona G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124105; De Martino RR, 2012, J VASC SURG, V55, P1035, DOI 10.1016/j.jvs.2011.10.129; De Vecchis R, 2016, J CLIN MED, V5, DOI 10.3390/jcm5100092; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Fink AS, 2002, ANN SURG, V236, P344, DOI 10.1097/00000658-200209000-00011; Frenkel WJ, 2010, J AM GERIATR SOC, V58, P2227, DOI 10.1111/j.1532-5415.2010.03104.x; Guyatt GH, 2012, CHEST, V141, pE185S, DOI 10.1378/chest.11-2289; Hawkins RC, 2003, CLIN CHIM ACTA, V337, P169, DOI 10.1016/j.cccn.2003.08.001; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Heit JA, 2001, MAYO CLIN PROC, V76, P1102, DOI 10.4065/76.11.1102; Higgins PDR, 2015, CLIN GASTROENTEROL H, V13, P316, DOI 10.1016/j.cgh.2014.07.017; Holland-Bill L, 2015, EUR J ENDOCRINOL, V173, P71, DOI 10.1530/EJE-15-0111; Johannesdottir SA, 2013, JAMA INTERN MED, V173, P743, DOI 10.1001/jamainternmed.2013.122; Kantar RS, 2015, EUR J INTERN MED, V26, P528, DOI 10.1016/j.ejim.2015.06.005; Khuri SF, 2007, J AM COLL SURGEONS, V204, P1089, DOI 10.1016/j.jamcollsurg.2007.03.028; Kinsella S, 2010, CLIN J AM SOC NEPHRO, V5, P275, DOI 10.2215/CJN.06120809; Kovesdy CP, 2012, CIRCULATION, V125, P677, DOI 10.1161/CIRCULATIONAHA.111.065391; Kuramatsu JB, 2014, STROKE, V45, P1285, DOI 10.1161/STROKEAHA.113.004136; Lee SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162990; Leung AA, 2013, AM J MED, V126, P877, DOI 10.1016/j.amjmed.2013.02.039; Leung AA, 2012, ARCH INTERN MED, V172, P1474, DOI 10.1001/archinternmed.2012.3992; Liamis G, 2013, AM J MED, V126, P256, DOI 10.1016/j.amjmed.2012.06.037; Lindner G, 2007, AM J KIDNEY DIS, V50, P952, DOI 10.1053/j.ajkd.2007.08.016; Lindner G, 2010, INTENS CARE MED, V36, P1718, DOI 10.1007/s00134-010-1968-4; LONG CA, 1991, POSTGRAD MED J, V67, P643, DOI 10.1136/pgmj.67.789.643; Lyman GH, 2013, J CLIN ONCOL, V31, P2189, DOI 10.1200/JCO.2013.49.1118; Madsen CM, 2016, OSTEOPOROSIS INT, V27, P397, DOI 10.1007/s00198-015-3423-4; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Maggs FG, 2014, CLIN MED, V14, P260, DOI 10.7861/clinmedicine.14-3-260; Mandala M, 2011, ANN ONCOL, V22, pvi85, DOI 10.1093/annonc/mdr392; Mattsson C, 2006, NAT CLIN PRACT NEPHR, V2, P198, DOI 10.1038/ncpneph0151; Mohan S, 2013, AM J MED, V126, P1127, DOI 10.1016/j.amjmed.2013.07.021; Molaschi M, 1997, J Nutr Health Aging, V1, P156; Muratori R, 2017, DIGEST LIVER DIS, V49, P181, DOI 10.1016/j.dld.2016.10.015; Onusko E, 2003, AM FAM PHYSICIAN, V67, P67; Palevsky PM, 1996, ANN INTERN MED, V124, P197, DOI 10.7326/0003-4819-124-2-199601150-00002; Renneboog B, 2006, AM J MED, V119, p71e1, DOI [10.1016/j.amjmed.2005.09.026, DOI 10.1016/J.AMJMED.2005.09.026]; Saepudin S, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0082-5; Salahudeen AK, 2013, SUPPORT CARE CANCER, V21, P1871, DOI 10.1007/s00520-013-1734-6; Sato N, 2013, AM J CARDIOL, V111, P1019, DOI 10.1016/j.amjcard.2012.12.019; Scherz N, 2010, AM J RESP CRIT CARE, V182, P1178, DOI 10.1164/rccm.201003-0481OC; Selmer C, 2016, EUR J INTERN MED, V36, P36, DOI 10.1016/j.ejim.2016.07.028; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; SNYDER NA, 1987, ANN INTERN MED, V107, P309, DOI 10.7326/0003-4819-107-2-309; Streiff MB, 2011, J NATL COMPR CANC NE, V9, P714, DOI 10.6004/jnccn.2011.0062; Sturdik I, 2014, EUR J INTERN MED, V25, P379, DOI 10.1016/j.ejim.2014.02.002; Sun Tongwen, 2014, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V26, P228, DOI 10.3760/cma.j.issn.2095-4352.2014.04.006; Tamizifar B, 2015, J RES MED SCI, V20, P777, DOI 10.4103/1735-1995.168402; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005; Waikar SS, 2009, AM J MED, V122, P857, DOI 10.1016/j.amjmed.2009.01.027; Waite MD, 2013, J CRIT CARE, V28, P405, DOI 10.1016/j.jcrc.2012.11.013; Wald R, 2010, ARCH INTERN MED, V170, P294, DOI 10.1001/archinternmed.2009.513; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Zhou XY, 2017, INT J CARDIOL, V227, P251, DOI 10.1016/j.ijcard.2016.11.120; Zilberberg MD, 2008, CURR MED RES OPIN, V24, P1601, DOI 10.1185/03007990802081675; Zilberberg Marya D, 2008, BMC Pulm Med, V8, P16, DOI 10.1186/1471-2466-8-16	67	7	7	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1477-9560			THROMB J	Thromb. J.	JUL 3	2018	16								11	10.1186/s12959-018-0165-5			12	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	GL9AM	WOS:000437521400001	29988709	Green Published, gold			2022-02-06	
J	Alexis, RJ; Jagdish, S; Sukumar, S; Pandit, VR; Palnivel, C; Antony, MJ				Alexis, R. Joseph; Jagdish, S.; Sukumar, Sanjay; Pandit, Vinay R.; Palnivel, C.; Antony, M. Jency			Clinical Profile and Autopsy Findings in Fatal Head Injuries	JOURNAL OF EMERGENCIES TRAUMA AND SHOCK			English	Article						Antemortem; autopsy; head injury; postmortem; traumatic brain injury	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; PREVENTION; STATES	Aims: This study aims to correlate the autopsy findings with the clinical picture and imaging report in fatal head injury patients. Settings and Design: A descriptive study conducted at tertiary care hospital in South India from July 2015 to December 2016. Patients and Methods: All patients with head injuries who were admitted to our Emergency and Trauma Centre and underwent autopsy were included in the study. A structured pro forma was used for collecting information. Autopsy findings were considered as a gold standard to correlate with antemortem findings in fatal head injury. The data were analyzed with EpiData and OpenEpi statistical analyzing software. Results: Of the 303 fatal head injury patients, a majority were males and age group between 21 and 40 years. Eighty-eight percent (267/303) of fatal head injuries were due to road traffic accidents. Twenty-five of the 303 patients reached our center within 1 h (golden hour) of trauma. Of the 303 fatal head injuries, 153 (50.5%) died within 24 h of reaching our center. The most common autopsy finding in this study was subarachnoid hemorrhage (SAH) (247/303, 81.3%). Diagnostic accuracy of Epi dural hemorrhage (EDH) antcmortem had the highest value (98.35%). SAH had least diagnostic accuracy value (45.72). subdural hemorrhage (SDH) had highest sensitivity (57.02%). EDH had higher specificity (100%). Significant SDH, SA1I, and brain contusions were not detected during antemortem evaluation. Conclusions: Our study revealed that among fatal head injury patients, half of them died within first 24 h after reaching to tertiary care center. Diagnostic accuracy to detect extradural hemorrhage antemortem had the highest value and SAH had least diagnostic accuracy value. Significant subdural hemorrhage, subarachniod hemorrhage, and brain contusion were not detected during antemortem evaluation. Expertise in interpretation of imaging, adequate clinical examination, proper documentation, and early resuscitation may reduce the chances of missed injuries in head injury patients.	[Alexis, R. Joseph; Jagdish, S.; Pandit, Vinay R.; Palnivel, C.] Jawaharlal Inst Postgrad Med Educ & Res, Dept Emergency Med & Trauma, Dhanvantri Nagar 605006, Puducherry, India; [Sukumar, Sanjay] Jawaharlal Inst Postgrad Med Educ & Res, Dept Forens Med & Toxicol, Pondicherry, India; [Antony, M. Jency] Jawaharlal Inst Postgrad Med Educ & Res, Dept Prevent & Social Med, Pondicherry, India		Alexis, RJ (corresponding author), Jawaharlal Inst Postgrad Med Educ & Res, Dept Emergency Med & Trauma, Dhanvantri Nagar 605006, Puducherry, India.	jsphalexis@gmail.com					Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Al-Qazzaz MA, 2014, EGYPTIAN J FORENSIC, V4, P116; Amit M, 2010, J INDIAN ACAD FORENS, V32, P144; Amitabh S, 2013, INT J MED SCI PUBLIC, V2, P287; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Gururaj G, 2005, INJURIES INDIA NATL; Gururaj G, 2005, PUBLICATION NATL I M; Indrayan A, 2002, NATL MED J INDIA, V15, P7; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Muhammad TK, 2011, PAK ARMED FORCES MED, V2, P12; Open Government Data (OGD), OP GOV DAT OGD PLATF; Pathak A., 2006, JIAFM, V28, P971; Pfeifer R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148844; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22	15	7	7	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0974-2700	0974-519X		J EMERG TRAUMA SHOCK	J. Emerg. Trauma Shock	JUL-SEP	2018	11	3					205	210		10.4103/JETS.JETS_127_17			6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	GV8OG	WOS:000446402800012	30429629				2022-02-06	
J	Barnard, EBG; Hunt, PAF; Lewis, PEH; Smith, JE				Barnard, Ed B. G.; Hunt, P. A. F.; Lewis, P. E. H.; Smith, J. E.			The outcome of patients in traumatic cardiac arrest presenting to deployed military medical treatment facilities: data from the UK Joint Theatre Trauma Registry	JOURNAL OF THE ROYAL ARMY MEDICAL CORPS			English	Article							RESUSCITATION COUNCIL GUIDELINES; CARDIORESPIRATORY ARREST; SPECIAL CIRCUMSTANCES; ALGORITHM; MORTALITY; SERVICE	Background The UK military was continuously engaged in armed conflict in Iraq and Afghanistan between 2003 and 2014, resulting in 629 UK fatalities. Traumatic cardiac arrest (TCA) is a precursor to traumatic death, but data on military outcomes are limited. In order to better inform military treatment protocols, the aim of this study was to define the epidemiology of TCA in the military population with a particular focus on survival rates and injury patterns. Methods A retrospective database analysis of the UK Joint Theatre Trauma Registry was undertaken. Patients who were transported to a UK deployed hospital between 2003 and 2014 and suffered TCA were included. Those patients injured by asphyxiation, electrocution, burns without other significant trauma and drowning were excluded. Data included mechanism of injury, Injury Severity Score (ISS), Abbreviated Injury Scale (AIS) for each body region and survival to deployed (Role 3) field hospital discharge. Results 424 TCA patients were identified during the study period; median age was 23 years, with a median ISS of 45. The most common mechanism of injury was explosive (55.7%), followed by gunshot wound (38.9%), road traffic collision (3.5%), crush (1.7%) and fall (0.2%). 45 patients (10.6% (95% CI 8.0% to 13.9%)) survived to deployed (Role 3) hospital discharge. The most prevalent body region with a severe to maximum AIS injury was the head, followed by the lower limbs, thorax and abdomen. Haemorrhage secondary to abdominal and lower limb injury was associated with survival; traumatic brain injury was associated with death. Conclusions This study has shown that short-term survival from TCA in a military population is 10.6%. With appropriate and aggressive early management, although unlikely, survival is still potentially possible in military patients who suffer traumatic cardiac arrest.	[Barnard, Ed B. G.; Hunt, P. A. F.; Lewis, P. E. H.; Smith, J. E.] Royal Ctr Def Med Res & Acad, Acad Dept Mil Emergency Med, Birmingham, W Midlands, England; [Barnard, Ed B. G.] Inst Naval Med, Dept Seconded Med Officers, Gosport, Hants, England; [Hunt, P. A. F.] James Cook Univ Hosp, Emergency Dept, Middlesbrough, Cleveland, England; [Lewis, P. E. H.] Frimley Pk Hosp, Emergency Dept, Frimley, Surrey, England; [Smith, J. E.] Derriford Hosp, Emergency Dept, Plymouth, Devon, England		Barnard, EBG (corresponding author), Royal Ctr Def Med, Acad Dept Mil Emergency Med, Inst Res & Dev, Birmingham B15 2SQ, W Midlands, England.	ukbarnard@gmail.com	Smith, Jason Edward/H-9380-2013	Smith, Jason Edward/0000-0002-6143-0421			Barnard E, 2017, RESUSCITATION, V113, pE23, DOI 10.1016/j.resuscitation.2017.01.004; Barnard E, 2017, RESUSCITATION, V110, P90, DOI 10.1016/j.resuscitation.2016.11.001; Barnard EBG, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002349; Battistella FD, 1999, ARCH SURG-CHICAGO, V134, P742, DOI 10.1001/archsurg.134.7.742; Leis CC, 2013, J TRAUMA ACUTE CARE, V74, P634, DOI 10.1097/TA.0b013e31827d5d3c; Cureton EL, 2012, J TRAUMA ACUTE CARE, V73, P102, DOI 10.1097/TA.0b013e3182569ebc; Huber-Wagner S, 2007, RESUSCITATION, V75, P276, DOI 10.1016/j.resuscitation.2007.04.018; Keene DD, 2016, J ROY ARMY MED CORPS, V162, P355, DOI 10.1136/jramc-2015-000490; Lockey D, 2006, ANN EMERG MED, V48, P240, DOI 10.1016/j.annemergmed.2006.03.015; Lockey DJ, 2013, RESUSCITATION, V84, P738, DOI 10.1016/j.resuscitation.2012.12.003; Morrison JJ, 2014, SHOCK, V41, P388, DOI 10.1097/SHK.0000000000000136; Penn-Barwell JG, 2015, J TRAUMA ACUTE CARE, V78, P1014, DOI 10.1097/TA.0000000000000580; Rago Adam P, 2015, J Spec Oper Med, V15, P39; Rall JM, 2017, J SURG RES, V212, P159, DOI 10.1016/j.jss.2017.01.020; Resuscitation Council UK, CONS PAP OUT OF HOSP; Rhee PM, 2000, J AM COLL SURGEONS, V190, P288, DOI 10.1016/S1072-7515(99)00233-1; ROSEMURGY AS, 1993, J TRAUMA, V35, P468, DOI 10.1097/00005373-199309000-00022; Russell RJ, 2011, PHILOS T R SOC B, V366, P171, DOI 10.1098/rstb.2010.0232; Russell R, 2014, J ROY ARMY MED CORPS, V160, P150, DOI 10.1136/jramc-2013-000215; Sherren PB, 2013, CRIT CARE, V17, DOI 10.1186/cc12504; SHIMAZU S, 1983, J TRAUMA, V23, P213, DOI 10.1097/00005373-198303000-00006; Smith JE, 2015, J ROY SOC MED, V108, P11, DOI 10.1177/0141076814560837; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; Tarmey NT, 2011, RESUSCITATION, V82, P1194, DOI 10.1016/j.resuscitation.2011.04.018; Truhlar A, 2015, RESUSCITATION, V95, P148, DOI 10.1016/j.resuscitation.2015.07.017	25	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0035-8665	2052-0468		J ROY ARMY MED CORPS	J. R. Army Med. Corps	JUL	2018	164	3					150	154		10.1136/jramc-2017-000818			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR2KO	WOS:000442400000004	28988190				2022-02-06	
J	Chatha, H; Sammy, I; Hickey, M; Sattout, A; Hollingsworth, J				Chatha, Hridesh; Sammy, Ian; Hickey, Michael; Sattout, Abdo; Hollingsworth, John			Falling down a flight of stairs: The impact of age and intoxication on injury pattern and severity	TRAUMA-ENGLAND			English	Article						Multiple trauma; wounds and injuries; accidental falls; aged; emergency department; emergency services; hospital	ALCOHOL-INTOXICATION; TRAUMA PATIENTS; OLDER-ADULTS; CRITERIA	Background Falling down a flight of stairs is a common injury mechanism in major trauma patients, but little research has been undertaken into the impact of age and alcohol intoxication on the injury patterns of these patients. The aim of this study was to compare the impact of age and alcohol intoxication on injury pattern and severity in patients who fell down a flight of stairs. Methods This was a retrospective observational study of prospectively collected trauma registry data from a major trauma centre in the United Kingdom comparing older and younger adult patients admitted to the Emergency Department following a fall down a flight of stairs between July 2012 and March 2015. Results Older patients were more likely to suffer injuries to all body regions and sustained more severe injuries to the spine; they were also more likely to suffer polytrauma (23.6% versus 10.6%; p<0.001). Intoxicated patients were more likely to suffer injuries to the head and neck (42.9% versus 30.5%; p=0.006) and were significantly younger than sober patients (53 versus 69 years; p<0.001). Conclusion Older patients who fall down a flight of stairs are significantly different from their younger counterparts, with a different injury pattern and a greater likelihood of polytrauma. In addition, alcohol intoxication also affects injury pattern in people who have fallen down a flight of stairs, increasing the risk of traumatic brain injury. Both age and intoxication should be considered when managing these patients.	[Chatha, Hridesh] Brnsley Dist Gen Hosp, Barnsley, England; [Chatha, Hridesh; Hickey, Michael; Sattout, Abdo; Hollingsworth, John] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Sammy, Ian] Univ Sheffield, Sch Hlth & Related Res, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England		Sammy, I (corresponding author), Univ Sheffield, Sch Hlth & Related Res, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England.	ian.sammy@sheffield.ac.uk		Sammy, Ian/0000-0003-4265-5569			Aitken LM, 2010, J AM GERIATR SOC, V58, P442, DOI 10.1111/j.1532-5415.2010.02728.x; Albrecht-Anoschenko J, 2005, ZBL NEUROCHIR, V66, P59, DOI 10.1055/s-2005-836487; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boye NDA, 2014, INJURY, V45, P1224, DOI 10.1016/j.injury.2014.03.021; Brown JB, 2015, J TRAUMA ACUTE CARE, V78, P352, DOI 10.1097/TA.0000000000000523; Davies RM, 2016, INJURY, V47, P43, DOI 10.1016/j.injury.2015.08.036; Friedland D, 2014, J COMMUN HEALTH, V39, P148, DOI 10.1007/s10900-013-9752-3; HONKANEN R, 1990, INJURY, V21, P353, DOI 10.1016/0020-1383(90)90117-D; Hsiao KH, 2013, EMERG MED AUSTRALAS, V25, P182, DOI 10.1111/1742-6723.12041; Irwin ZN, 2004, SPINE, V29, P796, DOI 10.1097/01.BRS.0000119400.92204.B5; Johnston JJE, 2004, EMERG MED J, V21, P185, DOI 10.1136/emj.2003.006130; Kehoe AD, 2014, EMERG MED J, V31, P775; Malhotra S, 2013, EMERG MED J, V30, P923, DOI 10.1136/emermed-2012-201548; Ragg M., 2000, EMERGEN MED, V12, P45; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; van Hensbroek PB, 2009, INJURY, V40, P884, DOI 10.1016/j.injury.2009.01.105; Yeung JHH, 2008, INJURY, V39, P1034, DOI 10.1016/j.injury.2008.03.017	18	7	7	0	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma	JUL	2018	20	3					169	174		10.1177/1460408617720948			6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	GK3UV	WOS:000436075100002	30008610	hybrid, Green Published, Green Accepted			2022-02-06	
J	Creber, RMM; Dayan, PS; Kuppermann, N; Ballard, DW; Tzimenatos, L; Alessandrini, E; Mistry, RD; Hoffman, J; Vinson, DR; Bakken, S				Creber, Ruth M. Masterson; Dayan, Peter S.; Kuppermann, Nathan; Ballard, Dustin W.; Tzimenatos, Leah; Alessandrini, Evaline; Mistry, Rakesh D.; Hoffman, Jeffrey; Vinson, David R.; Bakken, Suzanne		Pediat Emergency Care Appl Res; Clinical Res Emergency Serv Treatm	Applying the RE-AIM Framework for the Evaluation of a Clinical Decision Support Tool for Pediatric Head Trauma: A Mixed-Methods Study	APPLIED CLINICAL INFORMATICS			English	Article						clinical decision support; clinical trial; blunt head trauma; traumatic brain injury; implementation; child	EMERGENCY-DEPARTMENT; COMPUTED-TOMOGRAPHY; MULTICENTER TRIAL; CHILDREN; IMPLEMENTATION; INTERVENTIONS; SYSTEMS; DESIGN; IMPACT	Background The overuse of cranial computed tomography (CT) to diagnose potential traumatic brain injuries (TBIs) exposes children with minor blunt head trauma to unnecessary ionizing radiation. The Pediatric Emergency Care Applied Research Network and the Clinical Research on Emergency Services and Treatments Network implemented TBI prediction rules via electronic health record (EHR) clinical decision support (CDS) to decrease use of CTs in children with minor blunt head trauma. Objective This article aims to facilitate implementation and dissemination of a CDS alert into emergency departments around the country. Methods We evaluated the EHR CT CDS tool through a mixed-methods analysis of 38 audio-recorded interviews with health care stakeholders and quantitative data sources, using the Reach, Efficacy, Adoption, Implementation, and Maintenance framework. Results Reach-The demographics of participants enrolled in the clinical trial were consistent with national estimates of TBI prevalence. Efficacy-There was a variable and modest reduction in CT rates for the 8,067 children with minor head trauma whose clinicians received CDS. Adoption-The EHR CT CDS tool was well matched with the organizational mission, values, and priorities of the implementation sites. Implementation-The most important predisposing factors for successful implementation were the presence of an approachable clinical champion at each site and belief that the tool was a relevant, reusable knowledge asset. Enabling factors included an effective integration within the clinicalworkflow, organizational investment in user training, and ease of use. Maintenance-Reinforcing factors for the EHR CT CDS tool included a close fit with the institutional culture, belief that it was useful for providers and families, and a good educational and informational tool. As such, the EHR CT CDS tool was maintained in clinical practice long after study completion. Conclusion Data from this mixed-methods study complement findings from the efficacy trial and provide critical components for consideration prior to integration and subsequent dissemination of the EHR CT CDS tool.	[Creber, Ruth M. Masterson] Weill Cornell Med, Dept Healthcare Policy & Res, Div Hlth Informat, 425 East 61st St,Room 323, New York, NY 10065 USA; [Dayan, Peter S.] Columbia Univ, Coll Phys & Surg, Div Pediat Emergency Med, New York, NY USA; [Kuppermann, Nathan; Tzimenatos, Leah] Univ Calif Sacramento, Davis Sch Med, Sacramento, CA USA; [Ballard, Dustin W.] Kaiser Permanente, San Rafael Med Ctr, San Rafael, CA USA; [Ballard, Dustin W.; Vinson, David R.] Kaiser Permanente, Div Res, Oakland, CA USA; [Alessandrini, Evaline] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp & Med Ctr,Dept Pediat, James M Anderson Ctr Hlth Syst Excellence & Emerg, Cincinnati, OH USA; [Mistry, Rakesh D.] Univ Colorado Denver, Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA; [Hoffman, Jeffrey] Nationwide Childrens Hosp, Dept Pediat, Div Emergency Med, Columbus, OH USA; [Vinson, David R.] Kaiser Permanente, Roseville Med Ctr, Roseville, NSW, Australia; [Bakken, Suzanne] Columbia Univ, Sch Nursing, New York, NY USA; [Bakken, Suzanne] Columbia Univ, Dept Biomed Informat, New York, NY USA		Creber, RMM (corresponding author), Weill Cornell Med, Dept Healthcare Policy & Res, Div Hlth Informat, 425 East 61st St,Room 323, New York, NY 10065 USA.	rmc2009@med.cornell.edu	Creber, Ruth Masterson/AAQ-7288-2020; Vinson, David R/AAK-3227-2020; Mistry, Rakesh/ABI-1930-2020	Creber, Ruth Masterson/0000-0002-4238-9902; Vinson, David R/0000-0001-6559-1858; 	American Recovery and Reinvestment Act-Office of the Secretary (ARRA OS) [S02MC19289-01-00]; Health Resources and Services Administration (HRSA)United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA); Maternal and Child Health Bureau (MCHB); Emergency Medical Services for Children (EMSC) Program [U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008, U03MC22684, U03MC22685]; National Institute of Nursing Research (NINR) of the National Institutes of Health (NIH) [K99NR016275, T32NR007969]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R00NR016275, K99NR016275, T32NR007969] Funding Source: NIH RePORTER	This study was funded by the American Recovery and Reinvestment Act-Office of the Secretary (ARRA OS): Grant #S02MC19289-01-00. PECARN is supported by the Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB), and Emergency Medical Services for Children (EMSC) Program through the following cooperative agreements: U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008, U03MC22684, and U03MC22685. The authors also gratefully acknowledge funding for RMC by the National Institute of Nursing Research (NINR) of the National Institutes of Health (NIH) under Award Numbers K99NR016275 and T32NR007969. The content is solely the responsibility of the authors and does not necessarily represent the official views of the federal agencies that funded this study.	[Anonymous], EMR 2016 MARKET ELE; Aronsky D, 2001, J AM MED INFORM ASSN, V8, P473, DOI 10.1136/jamia.2001.0080473; Bakken S, 2009, J AM MED INFORM ASSN, V16, P889, DOI 10.1197/jamia.M3085; Ballard DW, 2016, APPL CLIN INFORM, V7, P883, DOI 10.4338/ACI-2016-05-RA-0073; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Centers for Disease Control and Prevention, 2016, RAT TBI REL EM DEP V; [Communications ET Epic software], 2017, EP FACT SHEET; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Deakyne SJ, 2015, APPL CLIN INFORM, V6, P521, DOI 10.4338/ACI-2015-02-RA-0019; Faul M, 2010, TRAUMATIC BRAIN INJU; Finlayson Marcia, 2014, Int J MS Care, V16, P192, DOI 10.7224/1537-2073.2014-055; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Glasgow RE, 2006, HEALTH EDUC RES, V21, P688, DOI 10.1093/her/cyl081; Goldberg HS, 2016, INT J MED INFORM, V87, P101, DOI 10.1016/j.ijmedinf.2015.12.002; Green L. W., 2005, HLTH PROMOTION PLANN; Hess EP, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-253; Holmes-Rovner Margaret, 2000, Health Expect, V3, P182, DOI 10.1046/j.1369-6513.2000.00093.x; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Marin JR, 2014, ACAD EMERG MED, V21, P987, DOI 10.1111/acem.12458; Meeker D, 2016, JAMA-J AM MED ASSOC, V315, P562, DOI 10.1001/jama.2016.0275; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Miller A, 2015, INT J MED INFORM, V84, P1009, DOI 10.1016/j.ijmedinf.2015.09.005; Monegain B, 2016, KALORAMA CERNER MCKE; Rogers RL, 2015, AM J EMERG MED, V33, P1505, DOI 10.1016/j.ajem.2015.07.039; Sheehan B, 2013, J BIOMED INFORM, V46, P905, DOI 10.1016/j.jbi.2013.07.005; Sittig DF, 2008, J BIOMED INFORM, V41, P387, DOI 10.1016/j.jbi.2007.09.003; Tham E, 2016, APPL CLIN INFORM, V7, P534, DOI 10.4338/ACI-2015-10-CR-0144	29	7	7	0	4	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	1869-0327			APPL CLIN INFORM	Appl. Clin. Inform.	JUL	2018	9	3					693	703		10.1055/s-0038-1669460			11	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Medical Informatics	GT4AZ	WOS:000444447400003	30184559	hybrid, Green Published, Green Submitted			2022-02-06	
J	Olivares-Hernandez, JD; Garcia-Garcia, F; Camacho-Abrego, I; Flores, G; Juarez-Aguilar, E				David Olivares-Hernandez, Juan; Garcia-Garcia, Fabio; Camacho-Abrego, Israel; Flores, Gonzalo; Juarez-Aguilar, Enrique			Intracerebroventricular administration of growth hormone induces morphological changes in pyramidal neurons of the hippocampus and prefrontal cortex in adult rats	SYNAPSE			English	Article						dendritic morphology; Golgi-Cox staining; somatotropin; structural plasticity	EXCITATORY SYNAPTIC-TRANSMISSION; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; DENDRITIC SPINES; STRUCTURAL PLASTICITY; HYPOPHYSECTOMIZED RATS; CELL-PROLIFERATION; GH REPLACEMENT; IN-VIVO; MEMORY	A growing body of evidence suggests that growth hormone (GH) affects synaptic plasticity at both the molecular and electrophysiological levels. However, unclear is whether plasticity that is stimulated by GH is associated with changes in neuron structure. This study investigated the effect of intracerebroventricular (ICV) administration of GH on the morphology of pyramidal neurons of the CA1 region of the dorsal hippocampus and layer III of the prefrontal cortex. Male Wistar rats received daily ICV injections of GH (120 ng) for 7 days, and they were euthanized 21 days later. Changes in neuronal morphology were evaluated using Golgi-Cox staining and subsequent Sholl analysis. GH administration increased total dendritic length in the CA1 region of the dorsal hippocampus and prefrontal cortex. The Sholl analysis revealed an increase in dendritic length of the third to eighth branch orders in the hippocampus and from the third to sixth branch orders in the prefrontal cortex. Interestingly, GH treatment increased the density of dendritic spines in both brain regions, favoring the presence of mushroom-like spines only in the CA1 hippocampal region. Our results indicated that GH induces changes in the length of dendritic trees and the density of dendritic spines in two high-plasticity brain regions, suggesting that GH-induced synaptic plasticity at the molecular and electrophysiological levels may be associated with these structural changes in neurons.	[David Olivares-Hernandez, Juan; Garcia-Garcia, Fabio; Juarez-Aguilar, Enrique] Univ Veracruzana, Hlth Sci Inst, Dept Biomed, Dr Luis Castelazo Ayala S-N, Xalapa 91190, Veracruz, Mexico; [David Olivares-Hernandez, Juan] Univ Veracruzana, PhD Hlth Sci Program, Hlth Sci Inst, Dr Luis Castelazo Ayala S-N, Xalapa 91190, Veracruz, Mexico; [Camacho-Abrego, Israel; Flores, Gonzalo] Benemerita Univ Autonoma Puebla, Inst Fisiol, Lab Neuropsychiat, 14 Sur 6301,CU San Manuel, Puebla 72570, Puebla, Mexico		Juarez-Aguilar, E (corresponding author), Univ Veracruzana, Hlth Sci Inst, Dept Biomed, Ave Dr Luis Castelazo Ayala S-N, Xalapa 91190, Veracruz, Mexico.	enjuarez@uv.mx	Garcia-Garcia, Fabio/U-5755-2018	Garcia-Garcia, Fabio/0000-0002-3756-9845; Juarez Aguilar, Enrique/0000-0003-3010-4364; Flores, Gonzalo/0000-0002-4100-2104	CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [254264]	CONACYT, Grant/Award Number: 254264.	Aberg ND, 2010, GROWTH HORM IGF RES, V20, P264, DOI 10.1016/j.ghir.2009.12.003; Aberg ND, 2009, J ENDOCRINOL, V201, P141, DOI 10.1677/JOE-08-0495; Bello-Medina PC, 2016, P NATL ACAD SCI USA, V113, pE6516, DOI 10.1073/pnas.1613680113; Bhagia V, 2010, BRAIN INJURY, V24, P560, DOI 10.3109/02699051003601705; Bhagya VR, 2017, J NEUROSCI RES, V95, P1602, DOI 10.1002/jnr.23992; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Brooks AJ, 2010, NAT REV ENDOCRINOL, V6, P515, DOI 10.1038/nrendo.2010.123; Bruel-Jungerman E, 2007, NEUROSCIENTIST, V13, P492, DOI 10.1177/1073858407302725; Brusco J, 2010, NEUROSCI LETT, V483, P152, DOI 10.1016/j.neulet.2010.07.083; Chen CJ, 2015, J BIOL CHEM, V290, P6010, DOI 10.1074/jbc.M114.603795; Davson H., 1970, TXB GEN PHYSL, P55; Devesa J, 2015, INT J MOL SCI, V16, P30470, DOI 10.3390/ijms161226244; Devesa J, 2013, HORM BEHAV, V63, P331, DOI 10.1016/j.yhbeh.2012.02.022; Elbornsson M, 2017, EUR J ENDOCRINOL, V176, P99, DOI 10.1530/EJE-16-0875; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Flores G., 2014, PHARM PHARM, V5, P691; Flores G, 2016, BEHAV BRAIN RES, V301, P190, DOI 10.1016/j.bbr.2015.12.034; Glasper ER, 2010, HIPPOCAMPUS, V20, P706, DOI 10.1002/hipo.20672; Goh ELK, 1998, ENDOCRINOLOGY, V139, P4364, DOI 10.1210/en.139.10.4364; Goh ELK, 1997, ENDOCRINOLOGY, V138, P3207, DOI 10.1210/en.138.8.3207; Harvey S, 2009, ANN NY ACAD SCI, V1163, P414, DOI 10.1111/j.1749-6632.2008.03641.x; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Laroche S, 2000, HIPPOCAMPUS, V10, P438; Le Greves M, 2006, EXP BRAIN RES, V173, P267, DOI 10.1007/s00221-006-0438-2; Mahmoud GS, 2006, J NEUROPHYSIOL, V95, P2962, DOI 10.1152/jn.00947.2005; Maures TJ, 2007, TRENDS ENDOCRIN MET, V18, P38, DOI 10.1016/j.tem.2006.11.007; Molina DP, 2012, NEUROBIOL AGING, V33, P1938, DOI 10.1016/j.neurobiolaging.2011.09.014; Nagaraja TN, 2005, FLUIDS BARRIERS CNS, V2, DOI 10.1186/1743-8454-2-5; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Ramis M, 2013, PROG NEURO-PSYCHOPH, V45, P11, DOI 10.1016/j.pnpbp.2013.04.005; Rasin MR, 2011, COLLEGIUM ANTROPOL, V35, P253; Regalado-Santiago C, 2013, GROWTH HORM IGF RES, V23, P179, DOI 10.1016/j.ghir.2013.07.002; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; Ruffino C, 2017, NEUROSCIENCE, V341, P61, DOI 10.1016/j.neuroscience.2016.11.023; Schaefer AT, 2003, J NEUROPHYSIOL, V89, P3143, DOI 10.1152/jn.00046.2003; Scheepens A, 2001, NEUROSCIENCE, V104, P677, DOI 10.1016/S0306-4522(01)00109-9; SHOLL DA, 1953, J ANAT, V87, P387; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Trivino-Paredes J, 2016, FRONT NEUROENDOCRIN, V41, P23, DOI 10.1016/j.yfrne.2016.03.001; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; Wamstad JB, 2013, BRAIN INJURY, V27, P200, DOI 10.3109/02699052.2012.672786; Waters M J, 2011, Pediatr Endocrinol Rev, V9, P549; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010; Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108518; Zhu T, 1998, J BIOL CHEM, V273, P33864, DOI 10.1074/jbc.273.50.33864	47	7	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-4476	1098-2396		SYNAPSE	Synapse	JUL	2018	72	7							e22030	10.1002/syn.22030			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GI2CC	WOS:000434176200001	29405381				2022-02-06	
J	Fink, EL; Andre-von Arnim, AV; Kumar, R; Wilson, PT; Bacha, T; Aklilu, AT; Teklemariam, TL; Hooli, S; Tuyisenge, L; Otupiri, E; Fabio, A; Gianakas, J; Kochanek, PM; Angus, DC; Tasker, RC				Fink, Ericka L.; Andre-von Arnim, Amelie von Saint; Kumar, Rashmi; Wilson, Patrick T.; Bacha, Tigist; Aklilu, Abenezer Tirsit; Teklemariam, Tsegazeab Laeke; Hooli, Shubhada; Tuyisenge, Lisine; Otupiri, Easmon; Fabio, Anthony; Gianakas, John; Kochanek, Patrick M.; Angus, Derek C.; Tasker, Robert C.		Pediat Acute Lung Injury & Se; PALISI Global Hlth Subgrp; Global Epidemiological Asse	Traumatic Brain Injury and Infectious Encephalopathy in Children From Four Resource-Limited Settings in Africa	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						central nervous system infection; child; epidemiology; traumatic brain injury; low-resource setting	PEDIATRIC TRAUMA; GLOBAL BURDEN; BACTERIAL-MENINGITIS; FALCIPARUM-MALARIA; RISK-FACTORS; CARE; EPIDEMIOLOGY; IMPACT; DEATH; COUNTRIES	Objectives: To assess the frequency, interventions, and outcomes of children presenting with traumatic brain injury or infectious encephalopathy in low-resource settings. Design: Prospective study. Setting: Four hospitals in Sub-Saharan Africa. Patients: Children age 1 day to 17 years old evaluated at the hospital with traumatic brain injury or infectious encephalopathy. Interventions: None. Measurements and Main Results: We evaluated the frequency and outcomes of children presenting consecutively over 4 weeks to any hospital department with traumatic brain injury or infectious encephalopathy. Pediatric Cerebral Performance Category score was assessed pre morbidity and at hospital discharge. Overall, 130 children were studied (58 [45%] had traumatic brain injury) from hospitals in Ethiopia (n = 51), Kenya (n = 50), Rwanda (n = 20), and Ghana (n = 7). Forty-six percent had no prehospital care, and 64% required interhospital transport over 18 km (1-521 km). On comparing traumatic brain injury with infectious encephalopathy, there was no difference in presentation with altered mental state (80% vs 82%), but a greater proportion of traumatic brain injury cases had loss of consciousness (80% vs 53%; p = 0.004). Traumatic brain injury patients were older (median [range], 120 mo [6-204 mo] vs 13 mo [0.3-204 mo]), p value of less than 0.001, and more likely male (73% vs 51%), p value of less than 0.01. In 78% of infectious encephalopathy cases, cause was unknown. More infectious encephalopathy cases had a seizure (69% vs 12%; p < 0.001). In regard to outcome, infectious encephalopathy versus traumatic brain injury: hospital lengths of stay were longer for infectious encephalopathy (8 d [2-30 d] vs 4 d [1-36 d]; p = 0.003), discharge rate to home, or for inpatient rehabilitation, or death differed between infectious encephalopathy (85%, 1%, and 13%) and traumatic brain injury (79%, 12%, and 1%), respectively, p value equals to 0.044. There was no difference in the proportion of children surviving with normal or mild disability (73% traumatic brain injury vs 79% infectious encephalopathy; p = 0.526). Conclusions: The epidemiology and outcomes of pediatric traumatic brain injury and infectious encephalopathy varied by center and disease. To improve outcomes of these conditions in low-resource setting, focus should be on neurocritical care protocols for pre-hospital, hospital, and rehabilitative care.	[Fink, Ericka L.; Kochanek, Patrick M.] UPMC, Childrens Hosp Pittsburgh, Dept Crit Care Med, Div Pediat Crit Care, Pittsburgh, PA 15213 USA; [Fink, Ericka L.; Kochanek, Patrick M.] Univ Pittsburgh, Med Ctr, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Andre-von Arnim, Amelie von Saint] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Andre-von Arnim, Amelie von Saint] Seattle Childrens Hosp, Seattle, WA USA; [Kumar, Rashmi] Univ Nairobi, Kenyatta Hosp, Dept Paediat & Child Hlth, Nairobi, Kenya; [Wilson, Patrick T.] Columbia Univ, Med Ctr, Dept Pediat, Div Pediat Crit Care Med, New York, NY USA; [Bacha, Tigist] Addis Ababa Univ, Dept Pediat, Addis Ababa, Ethiopia; [Aklilu, Abenezer Tirsit; Teklemariam, Tsegazeab Laeke] Addis Ababa Univ, Dept Surg, Addis Ababa, Ethiopia; [Hooli, Shubhada] Baylor Coll Med, Dept Pediat, Sect Emergency Med, Houston, TX 77030 USA; [Hooli, Shubhada] Texas Childrens Hosp, Houston, TX 77030 USA; [Tuyisenge, Lisine] Univ Teaching Hosp Kigali, Dept Paediat, Kigali, Rwanda; [Otupiri, Easmon] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Dept Community Hlth, Kumas, Ghana; [Fabio, Anthony; Gianakas, John] Univ Pittsburgh, Grad Sch Publ Hlth, Epidemiol Data Ctr, Pittsburgh, PA USA; [Angus, Derek C.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Angus, Derek C.] Univ Pittsburgh, Med Ctr, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness Ctr, Pittsburgh, PA USA; [Tasker, Robert C.] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Tasker, Robert C.] Harvard Med Sch, Dept Anaesthesia Pediat, Boston, MA USA		Fink, EL (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Crit Care Med, Div Pediat Crit Care, Pittsburgh, PA 15213 USA.	finkel@ccm.upmc.edu	Tasker, Robert C/R-5837-2019; Fink, Ericka/AAU-9792-2021; Angus, Derek C/E-9671-2012	Scholefield, Barney/0000-0002-6198-4985; Bacha, Tigist/0000-0002-8322-1612; Gianakas, John/0000-0002-8913-7972	Laerdal Foundation; Laerdal grant; University of PittsburghUniversity of Pittsburgh; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; U.S. Department of DefenseUnited States Department of Defense; Society of Critical Care Medicine; World Federation of Pediatric Intensive and Critical Care Societies	Drs. Fink's, Bacha's, and Kochanek's institutions received funding from the Laerdal Foundation. Dr. Kumar received support for article research from a Laerdal grant. Dr. Wilson's institution received funding from the University of Pittsburgh. Dr. Kochanek disclosed that he holds several patents/provisional patents in the field of acute brain injury, and his research is funded by the National Institutes of Health and the U.S. Department of Defense (although this study was not supported by those grants nor are the patents relevant to the current study); he received funding from the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies as Editor-in-Chief of Pediatric Critical Care Medicine; and he has served as an expert witness on a number of cases in the field of neurocritical care and resuscitation. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Abdur-Rahman LO, 2012, SEMIN PEDIATR SURG, V21, P111, DOI 10.1053/j.sempedsurg.2012.01.003; Alonge O, 2014, ARCH DIS CHILD, V99, P62, DOI 10.1136/archdischild-2013-304177; Carter JA, 2005, TROP MED INT HEALTH, V10, P3, DOI 10.1111/j.1365-3156.2004.01345.x; Christensen SS, 2015, T ROY SOC TROP MED H, V109, P233, DOI 10.1093/trstmh/trv005; Crouse HL, 2016, PAEDIATR INT CHILD H, V36, P219, DOI 10.1179/2046905515Y.0000000026; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Fink Ericka L, 2017, Pediatr Crit Care Med, V18, P330, DOI 10.1097/PCC.0000000000001093; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Gatera M, 2016, VACCINE, V34, P5321, DOI 10.1016/j.vaccine.2016.08.084; Gwer S, 2013, PAEDIATR INT CHILD H, V33, P129, DOI 10.1179/2046905513Y.0000000068; HALLER JA, 1983, JAMA-J AM MED ASSOC, V249, P47, DOI 10.1001/jama.249.1.47; Hatherill M, 2003, INTENS CARE MED, V29, P1547, DOI 10.1007/s00134-003-1888-7; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Kassebaum N, 2017, JAMA PEDIATR, V171, P573, DOI 10.1001/jamapediatrics.2017.0250; Kiragu AW, 2017, J PEDIATR INTENSIVE, V6, P52, DOI 10.1055/s-0036-1584676; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276; Malaria S, 2014, TROP MED INT HEALTH, V19, P7, DOI [10.1111/tmi.12313, 10.1111/tmi.12313_2]; Mwangi I, 2002, PEDIATR INFECT DIS J, V21, P1042, DOI 10.1097/00006454-200211000-00013; Newgard CD, 2015, ANN EMERG MED, V66, P30, DOI 10.1016/j.annemergmed.2014.12.004; Nicolette NB, 2014, AFR HEALTH SCI, V14, P143, DOI 10.4314/ahs.v14i1.22; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Odebode TO, 2004, PEDIATR SURG INT, V20, P348, DOI 10.1007/s00383-004-1196-5; Olness K, 2003, J DEV BEHAV PEDIATR, V24, P120, DOI 10.1097/00004703-200304000-00009; Osifo OD, 2012, INJURY, V43, P1861, DOI 10.1016/j.injury.2011.07.016; Peden M, 2008, WORLD REPORT CHILD I; Pelkonen T, 2009, CLIN INFECT DIS, V48, P1107, DOI 10.1086/597463; Rubiano AM, 2013, BRAIN INJURY, V27, P262, DOI 10.3109/02699052.2012.750742; Sasser SM, 2006, B WORLD HEALTH ORGAN, V84, P507, DOI 10.2471/BLT.06.033605; Schrieff L E, 2013, SAMJ, S. Afr. med. j., V103, P616, DOI 10.7196/samj.7137; Seydel KB, 2015, NEW ENGL J MED, V372, P1126, DOI 10.1056/NEJMoa1400116; TEASDALE G, 1974, LANCET, V2, P81; United Nations, 2016, UN SUST DEV GOALS; Vavilala MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166478; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI [10.2471/BLT.07.045120, 10.1371/journal.pmed.0040296]; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; WHO Guidelines Approved by the Guidelines Review Committee, 2016, GUID UPD PAED EM TRI; World Health Organization, 2005, EM TRIAG ASS TREATM	39	7	7	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2018	19	7					649	657		10.1097/PCC.0000000000001554			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	GL8HM	WOS:000437459400013	29664874				2022-02-06	
J	Liang, CY; Yang, Y; Shen, CS; Wang, HJ; Liu, NM; Wang, ZW; Zhu, FL; Xu, RX				Liang, Chun-yang; Yang, Yang; Shen, Chun-sen; Wang, Hai-jiang; Liu, Nai-Ming; Wang, Zhi-wen; Zhu, Feng-lei; Xu, Ru-xiang			Chinese Military Evaluation of a Portable Near-Infrared Detector of Traumatic Intracranial Hematomas	MILITARY MEDICINE			English	Article							BRAIN-INJURY; DEVICE; INFRASCANNER; EPIDEMIOLOGY	Introduction: Secondary brain injury is the main cause of mortality from traumatic brain injury (TBI). One hallmark of TBI is intracranial hemorrhage, which occurs in 40-50% of severe TBI cases. Early identification of intracranial hematomas in TBI patients allows early surgical evacuation and can reduce the case fatality rate of TBI. As pre-hospital care is the weakest part of Chinese emergency care, there is an urgent need for a capability to detect brain hematomas early. In China, in addition to preventing injuries and diseases in military staff and in enhancing the military armed forces during war, military medicine participates in actions such as emergency public health crises, natural disasters, emerging conflicts, and anti-terrorist campaigns during peacetime. The purpose of this observational study is to evaluate in the Chinese military general hospital the performance of a near-infrared (NIR)-based portable device, developed for US Military, in the detection of traumatic intracranial hematomas. The endpoint of the study was a description of the test characteristics (sensitivity, specificity, and positive and negative predictive values [NPV]) of the portable NIR-based device in identification of hematomas within its detection limits (volume > 3.5 mL and depth < 2.5 cm) compared with computed tomography (CT) scans as the gold standard. Materials and Methods: The Infrascanner Model 2000 NIR device (InfraScan, Inc., Philadelphia, PA, USA) was used for hematoma detection in patients sustaining TBI. Data were collected in the People's Liberation Army General Hospital in Beijing using the NIR device at the time of CT scans, which were performed to evaluate suspected TBI. One hundred and twenty seven patients were screened, and 102 patients were included in the per protocol population. Of the 102 patients, 24 were determined by CT scan to have intracranial hemorrhage. The CT scans were read by an independent neuroradiologist who was blinded to the NIR measurements. Results: The NIR device demonstrated sensitivity of 100% (95% confidence intervals [CI] 82.8-100%) and specificity of 93.6% (95% CI 85-97.6%) in detecting intracranial hematomas larger than 3.5 mL in volume and that were less than 2.5 cm from the surface of the brain. Blood contained within scalp hematomas was found to be a major cause of false-positive results with this technology. Conclusion: The study showed that the Infrascanner is a suitable portable device in Chinese population for detecting preoperative intracranial hematomas in remote locations, emergency rooms, and intensive care units. It could aid military medics, physicians, and hospital staff, permitting better triage decisions, earlier treatment, and reducing secondary brain injury caused by acute and delayed hematomas.	[Liang, Chun-yang; Yang, Yang; Shen, Chun-sen; Wang, Hai-jiang; Liu, Nai-Ming; Wang, Zhi-wen; Zhu, Feng-lei; Xu, Ru-xiang] PLA Army Gen Hosp, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China		Liang, CY (corresponding author), PLA Army Gen Hosp, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China.		Yang, Yang/AAL-1670-2020	Yang, Yang/0000-0001-6645-2454	Beijing Scientific Association [Z171100001017165]	The study was supported by a grant from Beijing Scientific Association (project number: Z171100001017165).	Ayaz Hasan, 2011, Journal of Medical Devices, V5, DOI 10.1115/1.3591407; Bressan S, 2014, CHILD NERV SYST, V30, P477, DOI [10.1007/s00381-014-2368-9, 10.1007/s00381-013-2314-2]; Chambers JA, 2011, MIL MED, V176, P1043, DOI 10.7205/MILMED-D-11-00030; Cope M, 1991, THESIS; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Fu XB, 2014, MILITARY MED RES, V1, DOI 10.1186/2054-9369-1-2; Kou K, 2014, WORLD J EMERG MED, V5, P245, DOI 10.5847/wjem.j.issn.1920-8642.2014.04.001; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Li YM, 2015, BRAIN INJURY, V29, P981, DOI 10.3109/02699052.2014.989405; Liu BY, 2015, CHIN J TRAUMATOL, V18, P135, DOI 10.1016/j.cjtee.2015.04.002; Marion DW, 2006, NEUROSURGERY, V58, P655; Robertson C S, 1997, J Biomed Opt, V2, P31, DOI 10.1117/12.261680; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Skotnicka-Klonowicz G, 2014, STANDARDY MED PROBLE, V4, P42; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Tyzo B, 2014, NEUROL PRAKTYCZNA, V2, P13; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; Zhao YD, 2001, WORLD J SURG, V25, P1202	18	7	7	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL-AUG	2018	183	7-8					E318	E323		10.1093/milmed/usx088			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL3EI	WOS:000437011100020	29420761	Bronze			2022-02-06	
J	Massingale, S; Alexander, A; Erickson, S; McQueary, E; Gerkin, R; Kisana, H; Silvestri, B; Schodrof, S; Nalepa, B; Pardini, J				Massingale, Shelly; Alexander, Amy; Erickson, Steven; McQueary, Elizabeth; Gerkin, Richard; Kisana, Haroon; Silvestri, Briana; Schodrof, Sarah; Nalepa, Bryce; Pardini, Jamie			Comparison of Uninjured and Concussed Adolescent Athletes on the Concussion Balance Test (COBALT)	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						balance; dizziness; postural control; sports; vestibular therapy	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; RELIABILITY; ADULTS; SCALE	Background and Purpose: Dizziness and balance problems are common symptoms following sports-related concussion (SRC). Most sports require high-level balance skills that integrate the sensory inputs used for balance. Thus, a comprehensive assessment of postural control following SRC is recommended as an integral part of evaluation and management of the injury. The purpose of this exploratory study was to examine performance differences between uninjured and concussed athletes on the Concussion Balance Test (COBALT), as well as complete preliminary analyses of criterion-related validity and reliability of COBALT. Methods: COBALT is an 8 condition test developed for both preseason and postinjury assessment using force plate technology to measure sway velocity under dynamic postural conditions that challenge the vestibular system. Retrospective COBALT data obtained through chart review for 132 uninjured athletes and 106 concussed age-matched athletes were compared. Results: All uninjured athletes were able to complete the assessment, compared with only 55% of concussed athletes. Concussed athletes committed significantly more errors than uninjured athletes. Sway velocity for concussed athletes was higher (worse) than that for uninjured athletes on 2 conditions in COBALT. Discussion and Conclusions: By examining an athlete's ability to complete the protocol, error rate, and sway velocity on COBALT postinjury, the clinician can identify balance function impairment, which may help the medical team develop a more targeted treatment plan, and provide objective input regarding recovery of balance function following SRC. Video Abstract available for more insights from the authors (see Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A204).	[Massingale, Shelly; Alexander, Amy; Erickson, Steven; McQueary, Elizabeth; Kisana, Haroon; Silvestri, Briana; Schodrof, Sarah; Nalepa, Bryce; Pardini, Jamie] Banner Univ, Sports Med & Concuss Specialists, 1320 N 10th St,Ste B, Phoenix, AZ 85006 USA; [Gerkin, Richard] Banner Univ, Med Ctr Phoenix, Phoenix, AZ USA		McQueary, E (corresponding author), Banner Univ, Sports Med & Concuss Specialists, 1320 N 10th St,Ste B, Phoenix, AZ 85006 USA.	elizabeth.mcqueary@bannerhealth.com	Gerkin, Richard/AAM-5406-2020; Erickson, Steven/ABH-3918-2020	Gerkin, Richard/0000-0002-6389-8888; Schodrof, Sarah/0000-0002-3844-0277			Berme N, 2005, US patent, Patent No. [US 6,936,016 B2, 6936016]; Davlin CD, 2004, PERCEPT MOTOR SKILL, V98, P1171, DOI 10.2466/pms.98.3c.1171-1176; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Honaker JA, 2009, AM J AUDIOL, V18, P108, DOI 10.1044/1059-0889(2009/09-0012); King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Li Z, 2016, J PHYS THER SCI, V28, P1364, DOI 10.1589/jpts.28.1364; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Mackey DC, 2005, CLIN BIOMECH, V20, P776, DOI 10.1016/j.clinbiomech.2005.05.002; Massingale S, INT J ATHL THER TRAI, DOI [10. 1123/ijatt. 2017-0042. 7., DOI 10.1123/IJATT.2017-0042.7]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; WINTER DA, 1990, MED PROG TECHNOL, V16, P31	21	7	7	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JUL	2018	42	3			SI		149	154		10.1097/NPT.0000000000000225			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	GL1OM	WOS:000436873100006	29864102	Bronze			2022-02-06	
J	McGowan, AL; Bretzin, AC; Savage, JL; Petit, KM; Parks, AC; Covassin, T; Pontifex, MB				McGowan, Amanda L.; Bretzin, Abigail C.; Savage, Jennifer L.; Petit, Kyle M.; Parks, Andrew C.; Covassin, Tracey; Pontifex, Matthew B.			Preliminary Evidence for Differential Trajectories of Recovery for Cognitive Flexibility Following Sports-Related Concussion	NEUROPSYCHOLOGY			English	Article						sports-related concussion; task switch; executive function; cognitive control; neuropsychological tests	TRAUMATIC BRAIN-INJURY; VISUOSPATIAL ATTENTION DEFICITS; PERSISTENT INFLUENCE; HIGH-SCHOOL; PLAY; EPIDEMIOLOGY; ASSOCIATION; PERFORMANCE; HISTORY; IMPACT	Objective: A critical barrier to the understanding of disruptions to cognitive flexibility following sports-related concussion is the use of assessments that conflate shifts of visuospatial attention and contextual rules. Because these dissociable forms of cognitive flexibility are subserved by distinct neural networks, the utility of a cognitive flexibility assessment following concussion may be reduced, depending upon the extent to which the task requires shifting visuospatial attention relative to shifting contextual rules. Accordingly, the current investigation examined the extent to which these aspects of cognitive flexibility exhibit differential trajectories of recovery following a sports-related concussion. Method: Twenty-two athletes with sports-related concussions were assessed on a cognitive flexibility task with 2 switch conditions (i.e., perceptual-based and contextual rule-based) within 72 hr of injury, after return to play, and within 1 month following return to play. Thirty-three healthy control athletes were tested at the same intervals. Results: Findings revealed that concussed athletes demonstrated protracted disruptions in task performance on a visuospatial attention-based cognitive flexibility task relative to healthy controls, whereas disruptions in task performance on a contextual rule-based cognitive flexibility task resolved after the acute phase of injury. These findings suggest that dissociable forms of cognitive flexibility exhibit differential trajectories of recovery. Conclusions: Therefore, evaluations detecting sports-related concussion disruptions in cognitive flexibility may be reduced depending on the extent to which they rely on contextual rule-based decisions. Test batteries focusing on visuospatial attention-based demands may be useful additions to aid in the objective assessment and follow-up management of athletes following the acute phase of injury. General Scientific Summary Disruptions to cognitive flexibility are common following sports-related concussion, yet present test batteries conflate dissociable forms of cognitive flexibility, thereby limiting the ability to detect distinct recovery patterns. This study provides evidence that disruptions to visuospatial attention exhibit protracted recovery up to one month following the return to full sport participation, whereas disruptions to rule-response mappings recover by the return to play period. Given the growing interest in enhancing the clinical management of concussed athletes, such findings may be particularly important for guiding interpretations of performance on neuropsychological batteries.	[McGowan, Amanda L.; Bretzin, Abigail C.; Savage, Jennifer L.; Petit, Kyle M.; Parks, Andrew C.; Covassin, Tracey; Pontifex, Matthew B.] Michigan State Univ, Dept Kinesiol, 126E IM Sports Circle, E Lansing, MI 48824 USA		Pontifex, MB (corresponding author), Michigan State Univ, Dept Kinesiol, 126E IM Sports Circle, E Lansing, MI 48824 USA.	pontifex@msu.edu	Parks, Andrew/T-3480-2019; McGowan, Amanda L/G-9746-2016; Pontifex, Matthew B/A-4474-2009; Parks, Andrew/ABB-2724-2021	McGowan, Amanda L/0000-0003-3422-0135; Pontifex, Matthew B/0000-0001-9819-9625; Bretzin, Abigail/0000-0003-3730-2849	U.S. Navy (Naval Health Research Center) [W911QY-14-C-0098]	This study was funded in part by U.S. Navy (Naval Health Research Center) Contract W911QY-14-C-0098 to BrainScope Company.l	BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; DeRenzo E G, 1998, J Health Care Law Policy, V1, P66; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; MARSH NV, 1995, BRAIN INJURY, V9, P553, DOI 10.3109/02699059509008214; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Pontifex MB, 2012, RES Q EXERCISE SPORT, V83, P553; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; R Core Team, 2017, R LANG ENV STAT COMP; Ravizza SM, 2008, NEUROPSYCHOLOGIA, V46, P2924, DOI 10.1016/j.neuropsychologia.2008.06.006; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537	40	7	7	1	15	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2018	32	5					564	574		10.1037/neu0000475			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GK8VT	WOS:000436509600005	29952610	Bronze			2022-02-06	
J	Pandit, V; Khan, M; Zakaria, E; Largent-Milnes, TM; Hamidi, M; O'Keeffe, T; Vanderah, TW; Joseph, B				Pandit, Viraj; Khan, Muhammad; Zakaria, El Rasheid; Largent-Milnes, Tally M.; Hamidi, Mohammad; O'Keeffe, Terence; Vanderah, Todd W.; Joseph, Bellal			Continuous remote ischemic conditioning attenuates cognitive and motor deficits from moderate traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	31st Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma(EAST)	JAN 09-13, 2018	Lake Buena Vista, FL	Eastern Assoc Surg Trauma		Traumatic brain injury; remote ischemic conditioning; cognition; motor coordination	CEREBROSPINAL-FLUID; REPERFUSION INJURY; MICE; HEMORRHAGE; MODELS; BLOOD	BACKGROUND While studies show that single-dose remote ischemic conditioning (RIC) improves outcomes, the effect of continuous (daily) RIC is unknown. Thus, we aimed to investigate the role of continuous RIC on cognitive and motor function following traumatic brain injury (TBI). METHODS We subjected 24 male C57BL mice to a cortical-controlled TBI. Two hours after TBI, the animals were randomly allocated to the RIC group (n = 12) or the sham group (n = 12). Remote ischemic conditioning was induced by noninvasive external compression of the hind limb using an occlusive band (six 4-minute cycles/24 hours) for six consecutive days. Before TBI, a baseline rotarod test and novel object recognition were performed. Post-TBI rotarod and novel object recognition tests were performed on Days 1 to 5, 7, 14, and 21. After the animals were sacrificed on Day 21, brain sections were analyzed using hematoxylin and eosin and glial fibrillary acidic protein staining to evaluate the hippocampal CA1 area for neuronal injury. RESULTS Both the RIC and sham groups had lower latency to fall compared with the baseline post-TBI. The RIC animals had a higher latency to fall compared with the sham animals at all time points, statistically significant after Day 3, until Day 21 post-TBI. Both the RIC and sham groups had lower recognition index compared with the baseline post-TBI. The RIC animals had a significantly higher recognition index than the sham animals after Day 1, until Day 21 post-TBI. Hematoxylin and eosin and glial fibrillary acidic protein staining of the brain samples of the sham group revealed that more neurons in the hippocampal CA1 area appeared shrunken with eosinophilic cytoplasm and pyknotic nuclei compared with the brain samples of the RIC group. CONCLUSION Postinjury continuous RIC resulted in improved cognitive functions and motor coordination in a mouse model of moderate TBI. Further studies are required to determine optimum dosage and frequency of this novel therapy to maximize its beneficial effects following TBI.	[Pandit, Viraj; Khan, Muhammad; Zakaria, El Rasheid; Hamidi, Mohammad; O'Keeffe, Terence; Joseph, Bellal] Univ Arizona, Coll Med, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ USA; [Largent-Milnes, Tally M.; Vanderah, Todd W.] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, Room 5411,1501N,Campbell Ave,POB 245063, Tucson, AZ 85727 USA.	bjoseph@surgery.arizona.edu	Zakaria, EL Rasheid/E-4506-2018	Zakaria, EL Rasheid/0000-0003-3230-073X			Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; ANDERSSON M, 1994, J NEUROL NEUROSUR PS, V57, P897, DOI 10.1136/jnnp.57.8.897; [Anonymous], 2017, INJURY PREVENTION CO; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brevoord D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042179; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Gonzalez NR, 2013, ACTA NEUROCHIR SUPPL, V115, P193, DOI 10.1007/978-3-7091-1192-5_36; Heusch G, 2015, J AM COLL CARDIOL, V65, P177, DOI 10.1016/j.jacc.2014.10.031; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Ibanez B, 2015, J AM COLL CARDIOL, V65, P1455, DOI 10.1016/j.jacc.2015.02.032; Jehan F, 2017, J TRAUMA ACUTE CARE, V83, P1148, DOI 10.1097/TA.0000000000001658; Jensen HA, 2011, CIRCULATION, V123, P714, DOI 10.1161/CIRCULATIONAHA.110.986497; Ji XR, 2017, BRAIN RES, V1659, P88, DOI 10.1016/j.brainres.2016.12.031; Jia JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121972; Joseph B, 2017, J NEUROSCI RES; Joseph B, 2015, J TRAUMA ACUTE CARE, V78, P698, DOI 10.1097/TA.0000000000000584; Kanoria S, 2006, BRIT J SURG, V93, P762, DOI 10.1002/bjs.5331; Konstantinov IE, 2005, J THORAC CARDIOV SUR, V130, P1326, DOI 10.1016/j.jtcvs.2005.03.050; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lokhandwala A, 2017, J AM COLL SURGEONS, V225, pS62, DOI 10.1016/j.jamcollsurg.2017.07.125; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Moojen VKM, 2012, BRAIN RES, V1466, P82, DOI 10.1016/j.brainres.2012.05.041; Moses MA, 2005, AM J PHYSIOL-REG I, V289, pR1609, DOI 10.1152/ajpregu.00395.2005; Perez-Pinzon MA, 1999, NEUROREPORT, V10, P2951, DOI 10.1097/00001756-199909290-00014; Popescu C, 2015, J Med Life, V8, P272; Prevention CfDCa, 2017, INJURY PREVENTION C; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Sandweiss AJ, 2017, J TRAUMA ACUTE CARE, V83, P1074, DOI 10.1097/TA.0000000000001626; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Song T, 2007, COMPARATIVE MED, V57, P200; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vanderah TW, 2008, EUR J PHARMACOL, V583, P62, DOI 10.1016/j.ejphar.2008.01.011; Wang HC, 2014, BRAIN INJURY, V28, P1491, DOI 10.3109/02699052.2014.943288; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	38	7	7	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2018	85	1					48	53		10.1097/TA.0000000000001835			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	GL8GZ	WOS:000437457000008	29443855				2022-02-06	
J	Seguin, M; Lahaie, A; Matte-Gagne, C; Beauchamp, MH				Seguin, Marilou; Lahaie, Annie; Matte-Gagne, Celia; Beauchamp, Miriam H.			Ready! Set? Let's Train! : Feasibility of an intensive attention training program and its beneficial effect after childhood traumatic brain injury	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Cognitive rehabilitation program; Traumatic brain injury; Children; Attention; Executive functions	COGNITIVE REHABILITATION; EXECUTIVE FUNCTION; CHILDREN; REMEDIATION; INHIBITION; IMPAIRMENT; DEFICITS; MEMORY	Background: Attention deficits are common after pediatric Traumatic Brain Injury (TBI); they complicate return to activities of daily living and disrupt socioacademic reintegration. Yet, clinicians in rehabilitation settings have limited access to cognitive remediation protocols for which feasibility has been demonstrated. Objective: The aim of this study was to evaluate the feasibility of intensive attention process training program Ready! Set? Let's Train! (RST), based on an adaptation of the Attention Process Training-I program. Materials and methods: In a randomized controlled trial, participants with attention deficits were assigned to receive the attention process training intervention (RST) or Homework Assistance (HWA). Pre- and post-intervention assessments consisted of standardized attentional and executive tests and a behavior checklist. Results: Analyses conducted for 17 participants (RST, n = 8; HWA, n = 9; mean age 14.70 +/- 2.17 years, 11 males) indicated the study was successful in that it showed improvements in working memory (F(14) = 5.44, P = 0.04; eta(2) = 0.19), inhibition (F(14) = 10.18, P = 0.007; eta(2) = 0.75) and cognitive flexibility (F(14) = 5.36, P = 0.04; eta(2) = 0.57). Conclusions: These findings indicate positive support for combined process-specific and metacognitive strategy training for attention and executive functions. (C) 2017 Elsevier Masson SAS. All rights reserved.	[Seguin, Marilou; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Vile, Montreal, PQ H3C 3J7, Canada; [Seguin, Marilou; Beauchamp, Miriam H.] St Justine Hosp Res Ctr, Montreal, PQ, Canada; [Seguin, Marilou; Lahaie, Annie] Le Bouclier Rehabil Ctr, St Jerome, PQ, Canada; [Matte-Gagne, Celia] Laval Univ, Dept Psychol, Quebec City, PQ, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Vile, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca		Matte-Gagne, Celia/0000-0001-5999-2129			Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2012, J HEAD TRAUMA REHAB, V27, P199, DOI 10.1097/HTR.0b013e31821a9d2b; Benedict R., 1997, PROFESSIONAL MANUAL; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen J., 1988, STAT POWER ANAL BEHA, V2, P284; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Demetriou A, 2009, LEARN INDIVID DIFFER, V19, P181, DOI 10.1016/j.lindif.2008.10.007; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Hoare P, 2003, EUR J EMERG MED, V10, P98, DOI 10.1097/01.mej.0000072631.17469.71; Kaplan E, 2004, TRAUMATISME CRANIOEN; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2001, NEUROPSYCHOLOGY, V15, P557, DOI 10.1037//0894-4105.15.4.557; Lyons KE, 2011, ADV CHILD DEV BEHAV, V40, P379; Mateer, 1987, ATTENTION PROCESS TR; Nolin P., 2000, Annales de Readaptation et de Medecine Physique, V43, P236, DOI 10.1016/S0168-6054(00)89087-X; Paquette C., 2009, GUIDE MEILLEURES PRA, P120; Pearson, 2008, CONNERS MANUAL; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Seguin M, 2012, C ET HOP STE JUST MO; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Sorrentino RM, 2001, TRENDS PROSPECTS MOT, P297, DOI [DOI 10.1007/0-306-47676-2, DOI 10.1007/0-306-47676-2_16]; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; Suzman KB, 1997, J BEHAV THER EXP PSY, V28, P203, DOI 10.1016/S0005-7916(97)00023-2; Tamm L, 2009, J ATTEN DISORD; Thomson JB, 1994, ASS NEUROPSYCHOL RES; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Vanier M., 1991, TRAUMATISME CRANIOEN, P1; Vernescu RM, 2008, SUSTAINED ATTENTION; Wechsler D., 1999, PEARSON ASSESSMENT	39	7	7	1	5	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	JUL	2018	61	4					189	196		10.1016/j.rehab.2017.05.001			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GY7DW	WOS:000448765700002	28673512	Bronze			2022-02-06	
J	Trautz, F; Dressler, J; Stassart, R; Muller, W; Ondruschka, B				Trautz, Florian; Dressler, Jan; Stassart, Ruth; Mueller, Wolf; Ondruschka, Benjamin			Proposals for best-quality immunohistochemical staining of paraffin-embedded brain tissue slides in forensics	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Biomarker; Evaluation; Forensic neuropathology; GFAP; Immunohistochemistry; Traumatic brain injury	QUANTITATIVE-ANALYSIS; INJURY; NEURONS; S100; NSE	Immunohistochemistry (IHC) has become an integral part in forensic histopathology over the last decades. However, the underlying methods for IHC vary greatly depending on the institution, creating a lack of comparability. The aim of this study was to assess the optimal approach for different technical aspects of IHC, in order to improve and standardize this procedure. Therefore, qualitative results from manual and automatic IHC staining of brain samples were compared, as well as potential differences in suitability of common IHC glass slides. Further, possibilities of image digitalization and connected issues were investigated. In our study, automatic staining showed more consistent staining results, compared to manual staining procedures. Digitalization and digital post-processing facilitated direct analysis and analysis for reproducibility considerably. No differences were found for different commercially available microscopic glass slides regarding suitability of IHC brain researches, but a certain rate of tissue loss should be expected during the staining process.	[Trautz, Florian; Dressler, Jan; Ondruschka, Benjamin] Univ Leipzig, Inst Legal Med, Fac Med, Leipzig, Germany; [Stassart, Ruth; Mueller, Wolf] Univ Leipzig, Univ Hosp, Dept Neuropathol, Leipzig, Germany		Ondruschka, B (corresponding author), Univ Leipzig, Inst Legal Med, Fac Med, Leipzig, Germany.	benjamin.ondruschka@medizin.uni-leipzig.de	Stassart, Ruth M/T-7093-2019				Bremicker K, 2013, RECHTSMEDIZIN, V23, P327, DOI [10.1007/s00194-013-0903-8, DOI 10.1007/s00194-013-0903-8]; Buttner Andreas, 2006, Forensic Sci Med Pathol, V2, P115, DOI 10.1385/FSMP:2:2:115; Cates JMM, 2015, APPL IMMUNOHISTO M M, V23, P471, DOI 10.1097/PAI.0000000000000111; Conway C, 2008, HISTOCHEM CELL BIOL, V130, P447, DOI 10.1007/s00418-008-0480-1; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Franke H, 2013, PURINERG SIGNAL, V9, P451, DOI 10.1007/s11302-013-9366-3; Goede A, 2015, RECHTSMEDIZIN, V25, P261, DOI 10.1007/s00194-015-0040-7; Hausmann R, 2000, INT J LEGAL MED, V113, P288, DOI 10.1007/s004149900126; Hausmann R, 2001, INT J LEGAL MED, V114, P338, DOI 10.1007/s004140000199; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Li DR, 2009, HISTOL HISTOPATHOL, V24, P1113, DOI 10.14670/HH-24.1113; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; Lin F, 2014, ARCH PATHOL LAB MED, V138, P1564, DOI 10.5858/arpa.2014-0074-RA; O'Hurley G, 2014, MOL ONCOL, V8, P783, DOI 10.1016/j.molonc.2014.03.008; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Sabatasso S, 2017, INT J LEGAL MED, V131, P1643, DOI 10.1007/s00414-017-1575-9; Sabattini E, 1998, J CLIN PATHOL, V51, P506, DOI 10.1136/jcp.51.7.506; Weber M, 2013, BRAIN RES, V1500, P72, DOI 10.1016/j.brainres.2012.12.048	18	7	7	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JUL	2018	132	4					1103	1109		10.1007/s00414-017-1767-3			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	GJ4VI	WOS:000435379900020	29299666	Green Accepted			2022-02-06	
J	Zhao, LW; Liu, Q; Ma, SY; Zhang, Y; Liang, P				Zhao, Liwei; Liu, Qing; Ma, Shuyin; Zhang, Yue; Liang, Peng			TPEN Attenuates Neural Autophagy Induced by Synaptically-released Zinc Translocation and Improves Histological Outcomes after Traumatic Brain Injury in Rats	ANNALS OF CLINICAL AND LABORATORY SCIENCE			English	Article						autophagy; zinc translocation; TPEN; traumatic brain injury	INDUCED CELL-DEATH; IN-VITRO; CONTRIBUTES; IMPACT; MICE; VIVO	Objectives. Previous studies have demonstrated that the inhibition of autophagy could reduce traumatic brain injury (TBI)-induced cell injury and attenuate behavioural outcomes. Meanwhile, synaptically released zinc translocation is found in the hippocampus of rats, and excessive release of chelatable zinc from excitatory synaptic vesicles is involved in the pathophysiological processes of TBI. We speculated that the release of zinc is closely connected with autophagy and that treatment with the zinc chelator N,N,N',N'-tetrakis-(2-pyridylmethyl) ethylenediamine (TPEN) could attenuate autophagy and thus improve histologic outcomes after TBI in rats. Methods. Rats were randomly divided into three groups: sham group, CCI+vehicle group and CCI+TPEN group. TPEN (20 mg/kg/12 h, i.p) or vehicle (DMSO) was injected into the rats immediately after TBI, then given twice a day until the animals were sacrificed. Morphological changes associated with autophagy were tested by TEM. Zinc autometallography staining was used to evaluate chelatable zinc accumulation. Western blot analysis was used to detect protein expression. Results. In our study, we found that treatment with TPEN reduced zinc translocation, reduced excito-toxicity and also partially reduced levels of LC3-II, Beclin-1 and the ratio of Beclin-1/Bcl-2 in injured hippocampal neurons of rats, partially improving histologic outcomes after TBI. Conclusion. These data show that the zinc chelator TPEN plays a protective role in TBI, suggesting the possible involvement of autophagy.	[Zhao, Liwei; Zhang, Yue] Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, Harbin, Heilongjiang, Peoples R China; [Liu, Qing] First Hosp Harbin, Dept Neurosurg, Harbin, Heilongjiang, Peoples R China; [Ma, Shuyin] Harbin Med Univ, Affiliated Hosp 1, Dept Rehabil, Harbin, Heilongjiang, Peoples R China; [Liang, Peng] Harbin Med Univ, Affiliated Hosp 3, Dept Neurosurg, 150 Haping St, Harbin 150040, Heilongjiang, Peoples R China		Liang, P (corresponding author), Harbin Med Univ, Affiliated Hosp 3, Dept Neurosurg, 150 Haping St, Harbin 150040, Heilongjiang, Peoples R China.	liangpeng2017@sohu.com			Natural Scientific Foundation Program of Heilongjiang Province [201104]	This research is supported by the Natural Scientific Foundation Program of Heilongjiang Province (201104).	Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li Y, 2010, BRAIN RES, V1330, P131, DOI 10.1016/j.brainres.2010.03.034; Liang XH, 2001, CANCER RES, V61, P3443; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Pozuelo-Rubio M, 2011, AUTOPHAGY, V7, P240, DOI 10.4161/auto.7.2.14286; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sun KJ, 2013, BRAIN RES, V1506, P132, DOI 10.1016/j.brainres.2013.02.011; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Zhang LH, 2010, NEUROBIOL AGING, V31, P74, DOI 10.1016/j.neurobiolaging.2008.02.018; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zhu L, 2009, BRAIN RES, V1289, P96, DOI 10.1016/j.brainres.2009.07.015	20	7	7	0	1	ASSOC CLINICAL SCIENTISTS	MIDDLEBURY	PO BOX 1287, MIDDLEBURY, VT 05753 USA	0091-7370	1550-8080		ANN CLIN LAB SCI	Ann. Clin. Lab. Sci.	JUL-AUG	2018	48	4					446	452					7	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	GR4MA	WOS:000442583100004	30143485				2022-02-06	
J	Dang, T; Suchy, M; Truong, YJ; Oakden, W; Lam, WW; Lazurko, C; Facey, G; Stanisz, GJ; Shuhendler, AJ				Dang, Trina; Suchy, Mojmir; Truong, Yen J.; Oakden, Wendy; Lam, Wilfred W.; Lazurko, Caitlin; Facey, Glenn; Stanisz, Greg J.; Shuhendler, Adam J.			Hydrazo-CEST: Hydrazone-Dependent Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Contrast Agents	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						aldehydes; chemical exchange saturation transfer; contrast agents; hydrazones; magnetic resonance imaging	TRAUMATIC BRAIN-INJURY; GADOLINIUM DEPOSITION; BIOLOGICAL-ACTIVITIES; ALDEHYDE LOAD; TRANSFER MRI; PH; MECHANISMS; DERIVATIVES; PRODUCTS; SHIFT	The rapid formation of hydrazones under physiological conditions was exploited for the detection of aldehydes through chemical exchange saturation transfer magnetic resonance imaging (CEST-MRI). A metal-free, diamagnetic contrast agent derived from N-amino anthranilic acid was introduced, which selectively turned-on upon hydrazone formation through an effect termed Hydrazo-CEST. While the hydrazine form of the probe produced no CEST-MRI signal enhancement, the formation of the aryl hydrazone resulted in >20% intensity decrease in the bulk water signal through the CEST effect, as measured by 300MHz (HNMR)-H-1, 3T and 7T MRI. Both the electronic contributions of the N-amino anthranilate and the aldehyde binding partner were shown to directly impact the exchange rate of the proton on the ring-proximal nitrogen, and thus the imaging signal. Additionally, the presence of the carboxylic acid moiety ortho to the hydrazine was necessary not only for contrast production, but also for rapid hydrazone formation and prolonged hydrazone product stability under physiological conditions. This work provided the first example of an MRI-based contrast agent capable of a turn on response upon reaction with bioactive aldehydes, and outlined both the structural and electronic requirements to expand on Hydrazo-CEST, a novel, hydrazone-dependent subtype of diamagnetic CEST-MRI.	[Dang, Trina; Suchy, Mojmir; Truong, Yen J.; Lazurko, Caitlin; Facey, Glenn; Shuhendler, Adam J.] Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON, Canada; [Suchy, Mojmir; Shuhendler, Adam J.] Univ Ottawa, Heart Inst, Ottawa, ON, Canada; [Oakden, Wendy; Lam, Wilfred W.; Stanisz, Greg J.] Sunnybrook Res Inst, Dept Phys Sci, Toronto, ON, Canada; [Stanisz, Greg J.] Univ Toronto, Dept Biomed Phys, Toronto, ON, Canada; [Stanisz, Greg J.] Med Univ, Dept Neurosurg & Pediat Neurosurg, Lublin, Poland		Shuhendler, AJ (corresponding author), Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON, Canada.; Shuhendler, AJ (corresponding author), Univ Ottawa, Heart Inst, Ottawa, ON, Canada.	adam.shuhendler@uottawa.ca	, stanisz@sri.utoronto.ca/A-4943-2013; Shuhendler, Adam/B-6333-2014	, stanisz@sri.utoronto.ca/0000-0002-9488-7612; Lazurko, Caitlin/0000-0002-4856-3553; Shuhendler, Adam/0000-0001-6952-5217	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 2015-05796]; Canada Research Chairs ProgramCanada Research Chairs [950-230754]; Canadian Foundation for InnovationCanada Foundation for Innovation; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [PJT376892]	This work was supported by an NSERC Discovery Grant RGPIN 2015-05796 (A.J.S.), the Canada Research Chairs Program 950-230754 (A.J.S.), the Canadian Foundation for Innovation (A.J.S.), and the Canadian Institutes of Health Research PJT376892 (A.J.S.).	Aime S, 2002, MAGN RESON MED, V47, P639, DOI 10.1002/mrm.10106; Anderson DG, 2016, CHEM RES TOXICOL, V29, P1098, DOI 10.1021/acs.chemrestox.5b00528; Bar-Shir A, 2015, ACS CHEM BIOL, V10, P1160, DOI 10.1021/cb500923v; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Chen HH, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91506; Daryaei I, 2016, ACS SENSORS, V1, P857, DOI 10.1021/acssensors.6b00203; Desogere P, 2017, J NUCL MED, V58, P1991, DOI 10.2967/jnumed.117.193532; Di Domenico F, 2017, FREE RADICAL BIO MED, V111, P253, DOI 10.1016/j.freeradbiomed.2016.10.490; Dixon WT, 2010, MAGN RESON MED, V63, P625, DOI 10.1002/mrm.22242; Fernandez-Cuervo G, 2016, BIOCONJUGATE CHEM, V27, P2549, DOI 10.1021/acs.bioconjchem.6b00482; Halstrom A, 2017, J CLIN NEUROSCI, V35, P104, DOI 10.1016/j.jocn.2016.09.006; Haris M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0659-x; Hingorani DV, 2016, CONTRAST MEDIA MOL I, V11, P130, DOI 10.1002/cmmi.1672; Ivanova S, 1998, J EXP MED, V188, P327, DOI 10.1084/jem.188.2.327; Kanda T, 2016, JPN J RADIOL, V34, P3, DOI 10.1007/s11604-015-0503-5; Kool ET, 2014, ORG LETT, V16, P1454, DOI 10.1021/ol500262y; Kool ET, 2013, J AM CHEM SOC, V135, P17663, DOI 10.1021/ja407407h; Kovacs D, 2015, SYNTHETIC COMMUN, V45, P1675, DOI 10.1080/00397911.2015.1040511; Landge SM, 2011, J AM CHEM SOC, V133, P9812, DOI 10.1021/ja200699v; Liu GS, 2013, NMR BIOMED, V26, P810, DOI 10.1002/nbm.2899; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; McDonald RJ, 2017, RADIOLOGY, V285, P546, DOI 10.1148/radiol.2017161595; McDonald RJ, 2015, RADIOLOGY, V275, P772, DOI 10.1148/radiol.15150025; Narang R, 2012, CURR MED CHEM, V19, P569, DOI 10.2174/092986712798918789; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; Popiolek L, 2017, MED CHEM RES, V26, P287, DOI 10.1007/s00044-016-1756-y; Rajca A, 2012, J AM CHEM SOC, V134, P15724, DOI 10.1021/ja3079829; Sherry AD, 2009, J MAGN RESON IMAGING, V30, P1240, DOI 10.1002/jmri.21966; Shuhendler AJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14759; Sinharay S, 2017, MAGN RESON MED, V77, P2005, DOI 10.1002/mrm.26278; Song XL, 2016, J CEREBR BLOOD F MET, V36, P1186, DOI 10.1177/0271678X16637882; Song XL, 2015, CONTRAST MEDIA MOL I, V10, P74, DOI 10.1002/cmmi.1597; Theeraladanon C, 2004, TETRAHEDRON, V60, P3017, DOI 10.1016/j.tet.2004.01.084; van Zijl PCM, 2018, NEUROIMAGE, V168, P222, DOI 10.1016/j.neuroimage.2017.04.045; Verma G, 2014, J PHARM BIOALLIED SC, V6, P69, DOI 10.4103/0975-7406.129170; Waghorn PA, 2017, ANGEW CHEM, V129, P9957; Waghorn PA, 2017, ANGEW CHEM INT EDIT, V56, P9825, DOI 10.1002/anie.201704773; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Ward KM, 2000, MAGN RESON MED, V44, P799, DOI 10.1002/1522-2594(200011)44:5<799::AID-MRM18>3.0.CO;2-S; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004; Wood PL, 2006, BRAIN RES, V1122, P184, DOI 10.1016/j.brainres.2006.09.003; Young MB, 2004, J MED CHEM, V47, P2995, DOI 10.1021/jm030303e; ZELLNER H, 1949, MONATSH CHEM, V80, P330, DOI 10.1007/BF00897765; Zhang L, 2017, CHEM-EUR J, V23, P1752, DOI 10.1002/chem.201604558; Zielinski ZAM, 2017, J ORG CHEM, V82, P2817, DOI 10.1021/acs.joc.7b00152	45	7	7	1	16	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	JUN 26	2018	24	36					9148	9156		10.1002/chem.201801671			9	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Chemistry	GK5VB	WOS:000436245300027	29645309				2022-02-06	
J	Kelley, KD; Checkoway, H; Hall, DA; Reich, SG; Cunningham, C; Litvan, I				Kelley, Kristen D.; Checkoway, Harvey; Hall, Deborah A.; Reich, Stephen G.; Cunningham, Chris; Litvan, Irene			Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans	FRONTIERS IN NEUROLOGY			English	Article						PSP; case-control study; military; firearms; traumatic brain injury	INDOOR FIRING RANGES; MINI-MENTAL-STATE; LEAD-EXPOSURE; ALZHEIMERS-DISEASE; HEAD-INJURY; DEVELOPMENTAL EXPOSURE; BLOOD LEAD; TAU; PB; AD	Background: Progressive supranuclear palsy (PSP) is a tauopathy that has a multifactorial etiology. Numerous studies that have investigated lead exposure and traumatic brain injury (TBI) as risk factors for other tauopathies, such as Alzheimer's disease, but not for PSP. Objective: We sought to investigate the role of firearm usage, as a possible indicator of lead exposure, and TBI as risk factors for PSP in a population of military veterans. Methods: We included participants from a larger case-control study who reported previous military service. Our sample included 67 PSP cases and 68 controls. Participants were administered a questionnaire to characterize firearm use in the military and occurrence of TBI. Results: Cases were significantly less educated than controls. In unadjusted analyses, the proportion of PSP cases (80.6%) and controls (64.7%) who reported use of firearms as part of their military job was positively associated with PSP, odds ratio (OR) 2.2 (95% Cl: 1-5.0). There were no significant case -control differences in mean service duration. There was only a weak association with history of TBI, OR 1.6 (95% CI: 0.8-3.4). In multivariate models, firearm usage (OR 3.7, 95% Cl: 1.5, 9.8) remained significantly associated with PSP. Conclusions: Our findings show a positive association between firearm usage and PSP and an inverse association between education and PSP. The former suggests a possible etiologic role of lead. Further studies are needed to confirm the potential etiologic effects of metals on PSP.	[Kelley, Kristen D.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Checkoway, Harvey] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Hall, Deborah A.] Rush Univ, Med Ctr, Dept Neurol, Chicago, IL 60612 USA; [Reich, Stephen G.] Univ Maryland, Dept Neurol, Baltimore, MD 21201 USA; [Cunningham, Chris] Univ Louisville, Clin Trials Unit, Louisville, KY 40292 USA; [Litvan, Irene] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA		Litvan, I (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	ilitvan@ucsd.edu	Litvan, Irene/X-9319-2018	Litvan, Irene/0000-0002-3485-3445	National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [5R01AG024040]; National Institutes of Health of CTSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001443]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Environmental Health SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS); National Multiple Sclerosis SocietyNational Multiple Sclerosis Society; Parkinson Foundation; Shapiro Foundation; PfizerPfizer; Neurocrine; NIH-NINDS/ORDR-NCATS; Parkinson Study Group; Michael J Fox Foundation; AVID Pharmaceuticals; C2N Diagnostics; Bristol-Myers and Squibb;  [5P50 AG005131-31];  [5T35HL007491];  [1U01NS086659];  [1U54NS092089-01]	This study was funded by National Institute of Aging 5R01AG024040. Additionally, the project described was partially supported by the National Institutes of Health, Grant TL1TR001443 of CTSA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. KK has received funding from the National Institute of Health. HC has received research funding from the National Institute of Environmental Health Sciences and the National Multiple Sclerosis Society. DH has received funding from the National Institute of Health, the Parkinson Foundation, the Shapiro Foundation, Pfizer, and Neurocrine. SR received research funding from NIH-NINDS/ORDR-NCATS. He received royalties from Informa and from being a reviewer of UpToDate. CC has no financial disclosures. IL is also an investigator in studies funded by 5P50 AG005131-31, 5T35HL007491, 1U01NS086659, 1U54NS092089-01, Parkinson Study Group, Michael J Fox Foundation, AVID Pharmaceuticals, C2N Diagnostics and Bristol-Myers and Squibb. She receives her salary from the University of California San Diego. She is member of the Biotie/Michael J Fox Foundation Advisory Board and was member of the Biogen and Bristol-Myers and Squibb Advisories Boards. Dr. Riley has received honoraria from Allergan, Lundbeck, and Teva. Dr. Bordelon received speaker honoraria from Teva and Lundbeck.	Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Beaucham C, 2014, MMWR-MORBID MORTAL W, V63, P347; Bihaqi SW, 2014, NEUROTOXICOLOGY, V44, P114, DOI 10.1016/j.neuro.2014.06.008; Bihaqi SW, 2013, NEUROTOXICOLOGY, V39, P95, DOI 10.1016/j.neuro.2013.07.010; Caparros-Lefebvre D, 2015, NEUROLOGY, V85, P1293, DOI 10.1212/WNL.0000000000001997; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Dash M, 2016, NEUROTOXICOLOGY, V55, P154, DOI 10.1016/j.neuro.2016.06.001; Duff K, 2015, J GERIATR PSYCH NEUR, V28, P193, DOI 10.1177/0891988715573532; FISHERFISCHBEIN J, 1987, JAMA-J AM MED ASSOC, V257, P803, DOI 10.1001/jama.257.6.803; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Golbe LI, 1996, NEUROLOGY, V47, P148, DOI 10.1212/WNL.47.1.148; GOLDBERG RL, 1991, J OCCUP ENVIRON MED, V33, P718, DOI 10.1097/00043764-199106000-00013; Houghton DJ, 2007, PARKINSONISM RELAT D, V13, pS341, DOI 10.1016/S1353-8020(08)70028-2; Litvan I, 2003, MOVEMENT DISORD, V18, pS43, DOI 10.1002/mds.10562; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Litvan I, 2016, MOVEMENT DISORD, V31, P644, DOI 10.1002/mds.26512; Ludolph AC, 2009, EUR J NEUROL, V16, P297, DOI 10.1111/j.1468-1331.2008.02513.x; NIKLOWITZ WJ, 1975, J NEUROPATH EXP NEUR, V34, P445, DOI 10.1097/00005072-197509000-00006; NOVOTNY T, 1987, AM J PUBLIC HEALTH, V77, P1225, DOI 10.2105/AJPH.77.9.1225; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Payton M, 1998, NEUROTOXICOL TERATOL, V20, P19, DOI 10.1016/S0892-0362(97)00075-5; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; R Core Team, 2018, R LANGUAGE ENV STAT; Rocca WA, 1998, J CLIN EPIDEMIOL, V51, P517, DOI 10.1016/S0895-4356(98)00017-1; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Stewart PA, 1996, INT J EPIDEMIOL, V25, P744, DOI 10.1093/ije/25.4.744; SVENSSON BG, 1992, INT ARCH OCC ENV HEA, V64, P219, DOI 10.1007/BF00378278; Swerdlow RH, 2000, J NEUROCHEM, V75, P1681, DOI 10.1046/j.1471-4159.2000.0751681.x; Vidal JS, 2009, J NEUROL NEUROSUR PS, V80, P1271, DOI 10.1136/jnnp.2008.149849; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Weisskopf MG, 2004, AM J EPIDEMIOL, V160, P1184, DOI 10.1093/aje/kwh333; Wright K, 2018, TOXICOL LETT, V284, P63, DOI 10.1016/j.toxlet.2017.11.041; Wu J, 2008, J NEUROSCI, V28, P3, DOI 10.1523/JNEUROSCI.4405-07.2008	34	7	7	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 20	2018	9								474	10.3389/fneur.2018.00474			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GK0UU	WOS:000435828300001	29973911	gold, Green Published			2022-02-06	
J	Yu, J; Hong, JH; Park, JY; Hwang, JH; Cho, SS; Kim, YK				Yu, Jihion; Hong, Jun Hyuk; Park, Jun-Young; Hwang, Jai-Hyun; Cho, Seong-Sik; Kim, Young-Kug			Propofol attenuates the increase of sonographic optic nerve sheath diameter during robot-assisted laparoscopic prostatectomy: a randomized clinical trial	BMC ANESTHESIOLOGY			English	Article						Propofol; Sevoflurane; Sonographic optic nerve sheath diameter; Robot-assisted laparoscopic prostatectomy	CEREBRAL-BLOOD-FLOW; ELEVATED INTRACRANIAL-PRESSURE; TRAUMATIC BRAIN INJURY; TRENDELENBURG POSITION; RADICAL PROSTATECTOMY; NONINVASIVE METHODS; HEAD-INJURY; SEVOFLURANE; PNEUMOPERITONEUM; ANESTHESIA	Background: Robot-assisted laparoscopic prostatectomy (RALP) requires pneumoperitoneum and the Trendelenburg position to optimize surgical exposure, which can increase intracranial pressure (ICP). Anesthetic agents also influence ICP. We compared the effects of propofol and sevoflurane on sonographic optic nerve sheath diameter (ONSD) as a surrogate for ICP in prostate cancer patients who underwent RALP. Methods: Thirty-six patients were randomly allocated to groups receiving propofol (propofol group, n = 18) or sevoflurane (sevoflurane group, n = 18) anesthesia. The ONSD was measured 10 min after induction of anesthesia in the supine position (T1); 5 min (T2), 30 min (T3), and 60 min (T4) after establishing pneumoperitoneum and the Trendelenburg position; and at the end of surgery after desufflation in the supine position (T5). Respiratory and hemodynamic variables were also evaluated. Results: The ONSD was significantly different between the propofol group and the sevoflurane group at T4 (5.27 +/- 0.35 mm vs. 5.57 +/- 0.28 mm, P = 0.007), but not at other time points. The ONSDs at T2, T3, T4, and T5 were significantly greater than at T1 in both groups (all P < 0.001). Arterial carbon dioxide partial pressure, arterial oxygen partial pressure, peak airway pressure, plateau airway pressure, systolic blood pressure, pulse pressure variation, body temperature and regional cerebral oxygen saturation, except heart rate, were not significantly different between the two groups. Conclusions: The ONSD was significantly lower during propofol anesthesia than during sevoflurane anesthesia 60 min after pneumoperitoneum and the Trendelenburg position, suggesting that propofol anesthesia may help minimize ICP changes in robotic prostatectomy patients.	[Yu, Jihion; Park, Jun-Young; Hwang, Jai-Hyun; Kim, Young-Kug] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea; [Hong, Jun Hyuk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul 05505, South Korea; [Cho, Seong-Sik] Hallym Univ, Sacred Heart Hosp, Dept Occupat & Environm Med, 22,Kwanpying Ro 170 Gil, Anyang 14068, South Korea		Kim, YK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.; Cho, SS (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Occupat & Environm Med, 22,Kwanpying Ro 170 Gil, Anyang 14068, South Korea.	sscho@hallym.or.kr; kyk@amc.seoul.kr	Kim, Young-Kug/V-4877-2018	Kim, Young-Kug/0000-0002-1982-3053; Cho, Seong-Sik/0000-0002-1875-1377			ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; Berryhill R, 2008, UROLOGY, V72, P15, DOI 10.1016/j.urology.2007.12.038; Binder J, 2001, BJU INT, V87, P408, DOI 10.1046/j.1464-410x.2001.00115.x; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; Blecha S, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0333-3; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bundgaard H, 1998, ACTA ANAESTH SCAND, V42, P621, DOI 10.1111/j.1399-6576.1998.tb05292.x; Chin JH, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0025-9; Chui J, 2014, CAN J ANESTH, V61, P347, DOI 10.1007/s12630-014-0118-9; Dubost C, 2012, ANESTHESIOLOGY, V116, P1066, DOI 10.1097/ALN.0b013e318246ea1a; Fahy BG, 1996, J CLIN ANESTH, V8, P236, DOI 10.1016/0952-8180(96)00017-7; FARLING PA, 1989, ANAESTHESIA, V44, P222, DOI 10.1111/j.1365-2044.1989.tb11228.x; Gainsburg DM, 2012, MINERVA ANESTESIOL, V78, P596; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; GUERCI AD, 1985, CIRC RES, V56, P20, DOI 10.1161/01.RES.56.1.20; Halverson A, 1998, SURG ENDOSC, V12, P266, DOI 10.1007/s004649900648; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; HARPER AM, 1965, BRIT J ANAESTH, V37, P225; HARPER AM, 1965, J NEUROL NEUROSUR PS, V28, P449, DOI 10.1136/jnnp.28.5.449; ILLIEVICH UM, 1993, ANESTH ANALG, V77, P155; Jun IJ, 2018, J ENDOUROL, V32, P608, DOI 10.1089/end.2017.0828; Kahveci FS, 2001, SURG NEUROL, V56, P206, DOI 10.1016/S0090-3019(01)00555-9; Kim MS, 2014, J ENDOUROL, V28, P801, DOI 10.1089/end.2014.0019; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; LASSEN NA, 1976, BRIT J ANAESTH, V48, P719, DOI 10.1093/bja/48.8.719; Mangez J F, 1987, Ann Fr Anesth Reanim, V6, P336, DOI 10.1016/S0750-7658(87)80055-2; MARSH B, 1991, BRIT J ANAESTH, V67, P41, DOI 10.1093/bja/67.1.41; Matta BF, 1999, ANESTHESIOLOGY, V91, P677, DOI 10.1097/00000542-199909000-00019; Minto CF, 1997, ANESTHESIOLOGY, V86, P10, DOI 10.1097/00000542-199701000-00004; Moretti R, 2009, J NEUROSURG ANESTHES; MOSS E, 1990, BRIT J ANAESTH, V65, P823, DOI 10.1093/bja/65.6.823; Oshima T, 2002, ACTA ANAESTH SCAND, V46, P831, DOI 10.1034/j.1399-6576.2002.460713.x; Park EY, 2009, ACTA ANAESTH SCAND, V53, P895, DOI 10.1111/j.1399-6576.2009.01991.x; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Rassweiler J, 2006, EUR UROL, V49, P612, DOI 10.1016/j.eururo.2005.12.054; Rehberg B, 1999, ANESTHESIOLOGY, V91, P397, DOI 10.1097/00000542-199908000-00013; Robba C, 2016, BRIT J ANAESTH, V117, P783, DOI 10.1093/bja/aew356; Saghaei Mahmood, 2004, BMC Med Res Methodol, V4, P26, DOI 10.1186/1471-2288-4-26; Strumwasser A, 2011, J SURG RES, V170, P265, DOI 10.1016/j.jss.2011.03.009; Talke P, 1999, ANESTHESIOLOGY, V91, P127, DOI 10.1097/00000542-199907000-00020; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Van Hemelrijck J, 1989, Acta Anaesthesiol Belg, V40, P95; Whiteley JR, 2015, J NEUROSURG ANESTH, V27, P155, DOI 10.1097/ANA.0000000000000106	43	7	8	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2253			BMC ANESTHESIOL	BMC Anesthesiol.	JUN 20	2018	18								72	10.1186/s12871-018-0523-7			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	GK0WE	WOS:000435832000002	29925316	gold, Green Published			2022-02-06	
J	Adjorlolo, S				Adjorlolo, Samuel			Diagnostic Accuracy, Sensitivity, and Specificity of Executive Function Tests in Moderate Traumatic Brain Injury in Ghana	ASSESSMENT			English	Article						executive function tests; diagnostic accuracy; sensitivity; specificity; brain injury; Ghana; Africa; cross-cultural neuropsychology	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; VERBAL FLUENCY PERFORMANCE; MILD COGNITIVE IMPAIRMENT; MENTAL-STATE-EXAMINATION; FRONTAL LOBES; ECOLOGICAL VALIDITY; AFRICAN-AMERICANS; SCREENING-TEST; METAANALYSIS	The sociocultural differences between Western and sub-Saharan African countries make it imperative to standardize neuropsychological tests in the latter. However, Western-normed tests are frequently administered in sub-Saharan Africa because of challenges hampering standardization efforts. Yet a salient topical issue in the cross-cultural neuropsychology literature relates to the utility of Western-normed neuropsychological tests in minority groups, non-Caucasians, and by extension Ghanaians. Consequently, this study investigates the diagnostic accuracy, sensitivity, and specificity of executive function (EF) tests (The Stroop Test, Trail Making Test, and Controlled Oral Word Association Test), and a Revised Quick Cognitive Screening Test (RQCST) in a sample of 50 patients diagnosed with moderate traumatic brain injury and 50 healthy controls in Ghana. The EF test scores showed good diagnostic accuracy, with area under the curve (AUC) values of the Trail Making Test scores ranging from .746 to .902. With respect to the Stroop Test scores, the AUC values ranged from .793 to .898, while Controlled Oral Word Association Test had AUC value of .787. The RQCST scores discriminated between the groups, with AUC values ranging from .674 to .912. The AUC values of composite EF score and a neuropsychological score created from EF and RQCST scores were .936 and. 942, respectively. Additionally, the Stroop Test, Trail Making Test, EF composite score, and RQCST scores showed good to excellent sensitivities and specificities. In general, this study has shown that commonly used EF tests in Western countries have diagnostic accuracy, sensitivity, and specificity when administered in Ghanaian samples. The findings and implications of the study are discussed.	[Adjorlolo, Samuel] City Univ Hong Kong, Kowloon, Hong Kong, Peoples R China		Adjorlolo, S (corresponding author), City Univ Hong Kong, Dept Appl Social Sci, Kowloon, Hong Kong, Peoples R China.	sadjorlol2-c@my.cityu.edu.hk	Adjorlolo, Samuel/AAL-1009-2020				Adjorlolo S, 2017, INT J PSYCHOL, V52, P9, DOI 10.1002/ijop.12248; Adjorlolo S, 2016, CLIN NEUROPSYCHOL, V30, P1517, DOI 10.1080/13854046.2016.1172667; Adjorlolo S, 2016, J FORENSIC PSYCHI PS, V27, P349, DOI 10.1080/14789949.2016.1141431; Adjorlolo S, 2015, APPL NEUROPSYCH-ADUL, V22, P388, DOI 10.1080/23279095.2014.949718; Akolo C, 2014, J NEUROVIROL, V20, P380, DOI 10.1007/s13365-014-0254-6; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; [Anonymous], 2002, Am Psychol, V57, P1060; Benton AL, 1994, MULTILINGUAL APHASIA; Boivin MJ, 2002, J DEV BEHAV PEDIATR, V23, P353, DOI 10.1097/00004703-200210000-00010; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; Brickman AM, 2006, APPL NEUROPSYCHOL, V13, P91, DOI 10.1207/s15324826an1302_4; Carter JA, 2005, J NEUROL NEUROSUR PS, V76, P476, DOI 10.1136/jnnp.2004.043893; Casey ER, 2012, INT J EMERG MED, V5, DOI 10.1186/1865-1380-5-28; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Crawford J. R., 2005, CLIN NEUROPSYCHOLOGY, DOI [10.1002/0470013338.ch6, DOI 10.1002/0470013338.CH6]; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; European Asylum Support Office, LAT AS TRENDS 2015 O; Field A., 2011, DISCOVERING STAT USI; Gerstenbrand F, 2001, BRAIN INJURY, V15, P95; Gibbons LE, 2012, BRAIN IMAGING BEHAV, V6, P517, DOI 10.1007/s11682-012-9176-1; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; Golden CJ, 1978, STROOP COLOR WORD TE; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; HELMS JE, 1992, AM PSYCHOL, V47, P1083, DOI 10.1037/0003-066X.47.9.1083; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Hestad KA, 2012, J NERV MENT DIS, V200, P336, DOI 10.1097/NMD.0b013e31824cc225; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; Iverson G., 2011, ENCY CLIN NEUROPSYCH, P2459, DOI DOI 10.1007/978-0-387-79948-3_1254; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kashala E, 2005, PEDIATR NEUROL, V33, P357, DOI 10.1016/j.pediatrneurol.2005.05.013; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Kim J, 2005, J INT NEUROPSYCH SOC, V11, P434, DOI 10.1017/S1355617705050563; Kriegler S. M., 1996, PERSPECTIVES LEARNIN, P109; Lansbergen MM, 2007, NEUROPSYCHOLOGY, V21, P251, DOI 10.1037/0894-4105.21.2.251; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lucas JA, 2005, CLIN NEUROPSYCHOL, V19, P243, DOI 10.1080/13854040590945337; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Manly JJ, 2005, CLIN NEUROPSYCHOL, V19, P270, DOI 10.1080/13854040590945346; Mate-Kole CC, 2009, ARCH PHYS MED REHAB, V90, P1469, DOI 10.1016/j.apmr.2009.02.007; MATEKOLE CC, 1994, ARCH PHYS MED REHAB, V75, P867; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; National Road Safety Commission, 2013, REG MONTHL MON; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Ramlall S, 2014, SAJP-S AFR J PSYCHI, V20, P153, DOI [10.7196/sajp.558, 10.7196/SAJP.558]; Ramlall S, 2013, DEMENT GERIATR COGN, V36, P119, DOI 10.1159/000350768; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Roebuck-Spencer T, 2008, TXB CLIN NEUROPSYCHO, P411; Roos A, 2010, COMPR PSYCHIAT, V51, P207, DOI 10.1016/j.comppsych.2009.03.007; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosselli N, 2003, BRAIN COGNITION, V52, P326, DOI 10.1016/S0278-2626(03)00170-2; Sacktor N, 2013, J NEUROVIROL, V19, P48, DOI 10.1007/s13365-012-0139-5; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; TEASDALE G, 1974, LANCET, V2, P81; Van der Elst W, 2008, ARCH CLIN NEUROPSYCH, V23, P787, DOI 10.1016/j.acn.2008.09.002; van Mourik R, 2005, J CHILD PSYCHOL PSYC, V46, P150, DOI 10.1111/j.1469-7610.2004.00345.x; Ylvisaker M, 2000, TOP LANG DISORD, V20, P29, DOI 10.1097/00011363-200020020-00005; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27	74	7	7	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	JUN	2018	25	4					498	512		10.1177/1073191116646445			15	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GF8ZW	WOS:000432266200007	27121081				2022-02-06	
J	Clark, RA; Pua, YH				Clark, Ross A.; Pua, Yong-Hao			SeeSway - A free web-based system for analysing and exploring standing balance data	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						Posturography; Balance; Force platform; Center of pressure; Falls	CRUCIATE LIGAMENT RECONSTRUCTION; TOTAL KNEE ARTHROPLASTY; DWELLING OLDER-ADULTS; POSTURAL CONTROL; NECK-PAIN; VALIDITY; BOARD; RELIABILITY; PERFORMANCE; CONCUSSION	Background and objectives: Computerised posturography can be used to assess standing balance, and can predict poor functional outcomes in many clinical populations. A key limitation is the disparate signal filtering and analysis techniques, with many methods requiring custom computer programs. This paper discusses the creation of a freely available web-based software program, SeeSway (www.rehabtools.org/seesway), which was designed to provide powerful tools for pre-processing, analysing and visualising standing balance data in an easy to use and platform independent website. Methods: SeeSway links an interactive web platform with file upload capability to software systems including LabVIEW, Matlab, Python and R to perform the data filtering, analysis and visualisation of standing balance data. Input data can consist of any signal that comprises an anterior-posterior and medial-lateral coordinate trace such as center of pressure or mass displacement. This allows it to be used with systems including criterion reference commercial force platforms and three dimensional motion analysis, smartphones, accelerometers and low-cost technology such as Nintendo Wii Balance Board and Microsoft Kinect. Filtering options include Butterworth, weighted and unweighted moving average, and discrete wavelet transforms. Analysis methods include standard techniques such as path length, amplitude, and root mean square in addition to less common but potentially promising methods such as sample entropy, detrended fluctuation analysis and multiresolution wavelet analysis. These data are visualised using scalo-grams, which chart the change in frequency content over time, scatterplots and standard line charts. This provides the user with a detailed understanding of their results, and how their different pre-processing and analysis method selections affect their findings. Results: An example of the data analysis techniques is provided in the paper, with graphical representation of how advanced analysis methods can better discriminate between someone with neurological impairment and a healthy control. Conclusions: The goal of SeeSway is to provide a simple yet powerful educational and research tool to explore how standing balance is affected in aging and clinical populations. (c) 2018 Elsevier B.V. All rights reserved.	[Clark, Ross A.] Univ Sunshine Coast, Sch Hlth & Sports Sci, Sippy Downs, Qld, Australia; [Pua, Yong-Hao] Singapore Gen Hosp, Dept Physiotherapy, Singapore, Singapore		Clark, RA (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld 4556, Australia.	rclark@usc.edu.au	Clark, Ross A/R-5664-2018; Clark, Ross/K-7613-2019	Clark, Ross A/0000-0002-7291-8553; Clark, Ross/0000-0002-7291-8553; Pua, Yong-Hao/0000-0003-2313-9665			Abramoff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI [DOI 10.1117/1.3589100, DOI 10.1201/9781420005615.AX4]; Borg FG, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-38; Clark RA, 2017, OSTEOARTHR CARTILAGE, V25, P42, DOI 10.1016/j.joca.2016.08.009; Clark RA, 2018, GAIT POSTURE, V61, P40, DOI 10.1016/j.gaitpost.2017.12.022; Clark RA, 2015, GAIT POSTURE, V42, P210, DOI 10.1016/j.gaitpost.2015.03.005; Clark RA, 2014, J BIOMECH, V47, P1134, DOI 10.1016/j.jbiomech.2013.12.015; Clark RA, 2012, GAIT POSTURE, V36, P372, DOI 10.1016/j.gaitpost.2012.03.033; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Duarte M, 2001, PHYS LETT A, V283, P124, DOI 10.1016/S0375-9601(01)00188-8; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hatton AL, 2017, GAIT POSTURE, V52, P22, DOI 10.1016/j.gaitpost.2016.11.013; Hatton AL, 2014, ARTHRIT CARE RES, V66, P709, DOI 10.1002/acr.22193; Holmes JD, 2013, CLIN REHABIL, V27, P361, DOI 10.1177/0269215512458684; Kwok BC, 2015, CLIN BIOMECH, V30, P481, DOI 10.1016/j.clinbiomech.2015.03.006; Liang ZQ, 2014, GAIT POSTURE, V39, P397, DOI 10.1016/j.gaitpost.2013.08.007; Lorefice LE, 2015, DEV MED CHILD NEUROL, V57, P175, DOI 10.1111/dmcn.12550; Merchant-Borna K, 2017, J ATHL TRAINING, V52, P245, DOI 10.4085/1062-6050-52.1.13; Oliveira CC., 2017, COPD, P1; Pajala S, 2008, J GERONTOL A-BIOL, V63, P171, DOI 10.1093/gerona/63.2.171; Patterson JA, 2014, INT J SPORTS PHYS TH, V9, P135; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; PRINCE F, 1994, GAIT POSTURE, V2, P19, DOI 10.1016/0966-6362(94)90013-2; Pua YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117124; Pua YH, 2013, ARCH PHYS MED REHAB, V94, P503, DOI 10.1016/j.apmr.2012.10.008; Quek J, 2018, GAIT POSTURE, V60, P93, DOI 10.1016/j.gaitpost.2017.11.016; Quek J, 2014, GAIT POSTURE, V39, P1069, DOI 10.1016/j.gaitpost.2014.01.009; Quenneville B, 2009, COMPUT STAT DATA AN, V53, P3386, DOI 10.1016/j.csda.2009.02.021; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Rhine T, 2017, J HEAD TRAUMA REHAB, V32, pE18, DOI 10.1097/HTR.0000000000000192; Rhine TD, 2016, CLIN J SPORT MED, V26, P221, DOI 10.1097/JSM.0000000000000234; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; Schmitt AC, 2017, CLIN BIOMECH, V50, P1, DOI 10.1016/j.clinbiomech.2017.09.010; Scott D, 2015, J MUSCULOSKEL NEURON, V15, P350; SMITH G, 1989, J BIOMECH, V22, P967, DOI 10.1016/0021-9290(89)90082-1; van der Kooij H, 2011, GAIT POSTURE, V34, P19, DOI 10.1016/j.gaitpost.2011.02.025; Visser JE, 2008, CLIN NEUROPHYSIOL, V119, P2424, DOI 10.1016/j.clinph.2008.07.220; Vitkovic J, 2016, AUDIOL NEURO-OTOL, V21, P195, DOI 10.1159/000445100	38	7	7	0	21	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	JUN	2018	159						31	36		10.1016/j.cmpb.2018.02.019			6	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	GC2DU	WOS:000429593200005	29650316				2022-02-06	
J	Kent, WT; Shelton, TJ; Eastman, J				Kent, William T.; Shelton, Trevor J.; Eastman, Jonathan			Heterotopic ossification around the knee after tibial nailing and ipsilateral antegrade and retrograde femoral nailing in the treatment of floating knee injuries	INTERNATIONAL ORTHOPAEDICS			English	Article						Heterotopic ossification; Floating knee injury; Retrograde nail; Antegrade nail	TRAUMATIC BRAIN-INJURY; FEMUR; FRACTURES; EXTREMITY	Purpose Floating knee injuries are relatively uncommon injuries. We report the prevalence, location, and severity of heterotopic ossification (HO) around the knee in patients treated with antegrade tibial intramedullary nailing and ipsilateral antegrade versus retrograde femoral intramedullary nailing as well as how the severity of HO around the knee affects knee range of motion (ROM). Methods From 2004 to 2014, 26 floating knee injuries were included. Radiographs were reviewed to determine presence, location, and severity of HO. Post-operative knee ROM was determined. Results A significantly higher prevalence of HO around the knee was detected in the retrograde group (90%) compared to the antegrade group (43%) (p = 0.028). There was a trend for more HO into the patellar tendon occurring in 29% of patients in the antegrade group and 74% in the retrograde group (p = 0.069). The severity of HO was higher for the retrograde group 1.6 +/- 1.0 compared to the antegrade group 0.4 +/- 0.5 (p = 0 .004). There was poor correlation between HO severity and knee ROM. Conclusions Treatment of floating knee injuries with a retrograde femoral nail was demonstrated to result in a greater likelihood of developing HO and a greater severity of HO around the knee than if treated with an antegrade femoral nail. However, this increased severity of HO is unlikely to affect ROM.	[Kent, William T.] Univ Calif San Diego, Dept Orthopaed, 200 West Arbor Dr, San Diego, CA 92103 USA; [Shelton, Trevor J.; Eastman, Jonathan] Univ Calif Davis, Dept Orthopaed, 4860 Y St,Suite 3800, Sacramento, CA 95817 USA		Shelton, TJ (corresponding author), Univ Calif Davis, Dept Orthopaed, 4860 Y St,Suite 3800, Sacramento, CA 95817 USA.	kentbt@gmail.com; tjshelton@ucdavis.edu; jgeastman@ucdavis.edu	Shelton, Trevor/Y-7273-2019	Shelton, Trevor/0000-0002-2032-3371			Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Elmrini A, 2006, INT ORTHOP, V30, P325, DOI 10.1007/s00264-006-0084-0; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; FRASER RD, 1978, J BONE JOINT SURG BR, V60, P510, DOI 10.1302/0301-620X.60B4.711798; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; GOSSELIN RA, 1993, J TRAUMA, V34, P161, DOI 10.1097/00005373-199301000-00033; Horne LT, 1999, J ORTHOP TRAUMA, V13, P385, DOI 10.1097/00005131-199906000-00013; Howell RD, 2011, ORTHOPEDICS, V34, DOI 10.3928/01477447-20110124-32; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Kuhn Kevin M, 2013, J Surg Orthop Adv, V22, P263; Lundy D W, 2001, J Am Acad Orthop Surg, V9, P238; Mills WJ, 2003, J ORTHOP TRAUMA, V17, P338, DOI 10.1097/00005131-200305000-00004; Mitchell EJ, 2010, J ORTHOP TRAUMA, V24, P530, DOI 10.1097/BOT.0b013e3181ed147b; Nauth A, 2012, J ORTHOP TRAUMA, V26, P684, DOI 10.1097/BOT.0b013e3182724624; Nouraei MH, 2013, J RES MED SCI, V18, P1087; OMER GE, 1968, J TRAUM, V8, P1026, DOI 10.1097/00005373-196811000-00004; Paul G R, 1990, J Orthop Trauma, V4, P309; Ricci WM, 2001, J ORTHOP TRAUMA, V15, P161, DOI 10.1097/00005131-200103000-00003; Shehab D, 2002, J NUCL MED, V43, P346; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Stannard JP, 2002, ARTHROSCOPY, V18, P835, DOI 10.1053/jars.2002.32842; Takemoto RC, 2011, J ORTHOP TRAUMA, V25, pE77, DOI 10.1097/BOT.0b013e3181f981e1; Tornetta P, 2000, J BONE JOINT SURG BR, V82B, P652, DOI 10.1302/0301-620X.82B5.10038; WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215, DOI 10.1302/0301-620X.74B2.1544955	24	7	7	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	JUN	2018	42	6					1379	1385		10.1007/s00264-018-3845-7			7	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	GG1AQ	WOS:000432412100024	29470598				2022-02-06	
J	Krishnamoorthy, V; Vavilala, MS; Chaikittisilpa, N; Rivara, FP; Temkin, NR; Lele, AV; Gibbons, EF; Rowhani-Rahbar, A				Krishnamoorthy, Vijay; Vavilala, Monica S.; Chaikittisilpa, Nophanan; Rivara, Frederick P.; Temkin, Nancy R.; Lele, Abhijit V.; Gibbons, Edward F.; Rowhani-Rahbar, Ali			Association of Early Myocardial Workload and Mortality Following Severe Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						hemodynamics; myocardial workload; trauma; traumatic brain injury	GLASGOW COMA SCALE; OXYGEN-CONSUMPTION; CARDIAC-OUTPUT; BLOOD-PRESSURE; BETA-BLOCKERS; HEART-RATE; DYSFUNCTION; SURVIVAL; OUTCOMES; RISK	Objectives: To examine the impact of early myocardial workload on in-hospital mortality following isolated severe traumatic brain injury. Design: Retrospective cohort study. Setting: Data from the National Trauma Databank, a multicenter trauma registry operated by the American College of Surgeons, from 2007 to 2014. Patients: Adult patients with isolated severe traumatic brain injury (defined as admission Glasgow Coma Scale < 8 and head Abbreviated Injury Score 4). Interventions: Admission rate-pressure product, categorized into five levels based on published low, normal, and submaximal human thresholds: less than 5,000; 5,000-9,999; 10,000-14,999; 15,000-19,999; and greater than 20,000. Measurements and Main Results: Data from 26,412 patients were analyzed. Most patients had a normal rate-pressure product (43%), 35% had elevated rate-pressure product, and 22% had depressed rate-pressure product at hospital admission. Compared with the normal rate-pressure product group, in-hospital mortality was 22 percentage points higher in the lowest rate-pressure product group (cumulative mortality, 50.2%; 95% CI, 43.6-56.9%) and 11 percentage points higher in the highest rate-pressure product group (cumulative mortality, 39.2%; 95% CI, 37.4-40.9%). The lowest rate-pressure product group was associated with a 50% increased risk of mortality, compared with the normal rate-pressure product group (adjusted relative risk, 1.50; 95% CI, 1.31-1.76%; p < 0.0001), and the highest rate-pressure product group was associated with a 25% increased risk of mortality, compared with the normal rate-pressure product group (adjusted relative risk, 1.25; 95% CI, 1.18-1.92%; p < 0.0001). This relationship was blunted with increasing age. Among patients with normotension, those with depressed and elevated rate-pressure products experienced increased mortality. Conclusions: Adults with severe traumatic brain injury experience heterogeneous myocardial workload profiles that have a U-shaped relationship with mortality, even in the presence of a normal blood pressure. Our findings are novel and suggest that cardiac performance is important following severe traumatic brain injury.	[Krishnamoorthy, Vijay] Duke Univ, Dept Anesthesiol, Durham, NC 27708 USA; [Krishnamoorthy, Vijay; Vavilala, Monica S.; Chaikittisilpa, Nophanan; Rivara, Frederick P.; Temkin, Nancy R.; Lele, Abhijit V.; Gibbons, Edward F.; Rowhani-Rahbar, Ali] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Vavilala, Monica S.; Chaikittisilpa, Nophanan; Lele, Abhijit V.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Rivara, Frederick P.; Rowhani-Rahbar, Ali] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Gibbons, Edward F.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA		Krishnamoorthy, V (corresponding author), Duke Univ, Dept Anesthesiol, Durham, NC 27708 USA.; Krishnamoorthy, V (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA.	vijay.krishnamoorthy@duke.edu		Rowhani-Rahbar, Ali/0000-0002-2705-4485	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EDGE therapeutics, NEWTON clinical trial; ASSESSED clinical trial, Aqueduct critical care; NIH/National Institute of Neurologic Disorders and Stroke, ATACHII clinical trial	Dr. Krishnamoorthy received funding from the National Institutes of Health (NIH). Drs. Krishnamoorthy and Vavilala received support for article research from the NIH. Dr. Lele's institution received funding from EDGE therapeutics, NEWTON clinical trial (research support); ASSESSED clinical trial, Aqueduct critical care; and the NIH/National Institute of Neurologic Disorders and Stroke, ATACHII clinical trial. The remaining authors have disclosed that they do not have any potential conflicts of interest	Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; EBSTEIN RP, 1985, ISRAEL J MED SCI, V21, P302; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Haider AH, 2014, J TRAUMA ACUTE CARE, V76, P1061, DOI 10.1097/TA.0000000000000182; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Hui SC, 2000, MED SCI SPORT EXER, V32, P1520, DOI 10.1097/00005768-200008000-00023; Jorgensen C R, 1977, Ann N Y Acad Sci, V301, P213, DOI 10.1111/j.1749-6632.1977.tb38200.x; KENDALL MJ, 1982, BRIT J CLIN PHARMACO, V14, P821, DOI 10.1111/j.1365-2125.1982.tb02043.x; KITAMURA K, 1972, J APPL PHYSIOL, V32, P516, DOI 10.1152/jappl.1972.32.4.516; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Mason RP, 2009, J CARDIOVASC PHARM, V54, P123, DOI 10.1097/FJC.0b013e3181ad207b; Meng LZ, 2015, ANESTHESIOLOGY, V123, P1198, DOI 10.1097/ALN.0000000000000872; Mohseni S, 2015, WORLD J SURG, V39, P2076, DOI 10.1007/s00268-015-3039-z; NELSON RR, 1974, CIRCULATION, V50, P1179, DOI 10.1161/01.CIR.50.6.1179; Nguyen H, 2009, CURR NEUROL NEUROSCI, V9, P486, DOI 10.1007/s11910-009-0071-0; OPPENHEIMER SM, 1994, CURR OPIN NEUROL, V7, P20, DOI 10.1097/00019052-199402000-00005; Rebet O, 2016, EUR J ANAESTH, V33, P638, DOI 10.1097/EJA.0000000000000470; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Someya Fujiko, 2015, BMC Res Notes, V8, P355, DOI 10.1186/s13104-015-1331-5; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; The Brain Trauma Foundation, 2007, J NEUROTRAUM, V24, P7; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9; White WB, 1999, AM J HYPERTENS, V12, p50S, DOI 10.1016/S0895-7061(98)00280-5; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38; Zangbar B, 2016, J SURG RES, V200, P586, DOI 10.1016/j.jss.2015.08.020	30	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUN	2018	46	6					965	971		10.1097/CCM.0000000000003052			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN9ZS	WOS:000439575100047	29509569	Green Accepted			2022-02-06	
J	Kurowski, BG; Stancin, T; Taylor, HG; McNally, KA; Kirkwood, MW; Cassedy, A; King, E; Sklut, M; Narad, ME; Wade, SL				Kurowski, Brad G.; Stancin, Terry; Taylor, H. Gerry; McNally, Kelly A.; Kirkwood, Michael W.; Cassedy, Amy; King, Eileen; Sklut, McKenna; Narad, Megan E.; Wade, Shari L.			Comparative effectiveness of family problem-solving therapy (F-PST) for adolescents after traumatic brain injury: Protocol for a randomized, multicenter, clinical trial	CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS			English	Article						Pediatric traumatic brain injury; Telehealth; Problem solving; Behavior; Executive function	QUALITY-OF-LIFE; TBI IDENTIFICATION METHOD; TERM BEHAVIOR PROBLEMS; DIFFICULTIES QUESTIONNAIRE; PSYCHIATRIC-DISORDERS; PRELIMINARY EFFICACY; EXECUTIVE FUNCTION; CHILDREN; VALIDITY; RELIABILITY	Introduction: The objective of this manuscript is to describe the methodology that will be used to test the comparative effectiveness, feasibility, and acceptability of three formats of family problem solving therapy (FPST) for improving functional outcomes of complicated mild to severe adolescent TBI. Methods: Three-arm comparative effectiveness, randomized clinical trial (RCT) design. We describe the protocol of a three-arm RCT comparing the effectiveness of three modalities of F-PST to reduce executive dysfunction and behavior problems following TBI in adolescence. The RCT will compare the relative effectiveness among face-to-face; online and self-directed; and therapist-supported online modes of treatment.	[Kurowski, Brad G.; Cassedy, Amy; King, Eileen; Sklut, McKenna; Narad, Megan E.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Stancin, Terry] Cleveland Med Ctr, MetroHlth Med Ctr, Cleveland, OH USA; [Taylor, H. Gerry] Ohio State Univ, Biobehav Hlth Ctr, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43210 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA; [McNally, Kelly A.] Ohio State Univ, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Aurora, CO USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Pediat & Neurol & Rehabil Med, Cincinnati, OH USA		Kurowski, BG (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	brad.kurowski@cchme.org	Stancin, Terry/L-7993-2019	McNally, Kelly/0000-0001-9278-9413	Patient Center Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI; Patient-Centered Outcomes Research Institute (PCORI) AwardPatient-Centered Outcomes Research Institute - PCORI [PCORI-CER-1306-02435]	Funding for this study was provided by the Patient Center Outcomes Research Institute. Information reported in this work/publication was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (PCORI-CER-1306-02435). The views, statements, opinions in this work/publication are solely the responsibility of the authors and do not necessarily represent the views of the Patient Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; Baum F, 2006, J EPIDEMIOL COMMUN H, V60, P854, DOI 10.1136/jech.2004.028662; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Corrigan J. D., 2017, INJ PREV; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Dams-O'Connor K, 2017, J HEAD TRAUMA REHAB, V32, P147, DOI 10.1097/HTR.0000000000000263; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; Faul M, 2010, TRAUMATIC BRAIN INJU; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gioia G.A., 2000, BRIEF BEHAV RATING I; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Hauser RM, 1997, SOCIOL METHODOL, V27, P177, DOI 10.1111/1467-9531.271028; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Holmbeck GN, 1997, J CONSULT CLIN PSYCH, V65, P599, DOI 10.1037/0022-006X.65.4.599; Johnson JG, 2002, J ADOLESCENT HEALTH, V30, P196, DOI 10.1016/S1054-139X(01)00333-0; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; King M., 2009, JAMA-J AM MED ASSOC, V293, P1089; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1998, BRAIN INJURY, V12, P41; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Newman MG, 2004, J CLIN PSYCHOL, V60, P141, DOI 10.1002/jclp.10240; Oregon Social Learning Center (OSLC, 1996, OSLC PROJ LIFT PROBL; Owens PL, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200206000-00013; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Schafer JL, 1997, ANAL INCOMPLETE MULT; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Thomas KM, 2004, J COGNITIVE NEUROSCI, V16, P1339, DOI 10.1162/0898929042304688; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; [No title captured]	73	7	8	0	5	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	2451-8654			CONT CLIN TRIAL COMM	Contemp. Clin. Trials Commun.	JUN	2018	10						111	120		10.1016/j.conctc.2018.04.001			10	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	GH3PQ	WOS:000433315000017	30023445	Green Published			2022-02-06	
J	Milroy, JJ; Hebard, S; Kroshus, E; Wyrick, DL				Milroy, Jeffrey J.; Hebard, Stephen; Kroshus, Emily; Wyrick, David L.			Sport-Related Concussion Reporting and Coach-Athlete Attachment Among Collegiate Student-Athletes	JOURNAL OF CLINICAL SPORT PSYCHOLOGY			English	Article						athlete wellness; coach-athlete attachment; concussion reporting	QUALITY-OF-LIFE; HIGH-SCHOOL; ICE HOCKEY; SYMPTOMS; ASSOCIATION; STATEMENT; EMOTION; NORMS	Between 2001 and 2015, 3.4 million traumatic brain injury (TBI) occurrences in the U.S. were accounted for by sport participation. It is estimated between 12% and 60% of athletes delay seeking care after sustaining a concussion. Differences in sport-related concussion (SRC) reporting have been attributed to several different factors. Whereas prior research related to SRC reporting behavior focus on normative and competitive pressures to continue play, less attention is given to the interpersonal context in which reporting takes place. Grounded in attachment theory, this study investigated relationships between coach-athlete attachment and help-seeking behavior. Findings suggest that as coach-athlete anxiousness increases, not reporting increases. and as coach-athlete secureness increases, not reporting decreases. Logistic regression analyses indicate that secure coach attachment significantly predicts greater likelihood of SRC reporting. These findings underscore the important role coach-athlete relationships may have on care-seeking behaviors of student-athletes and can inform individual and group interventions promoting SRC reporting.	[Milroy, Jeffrey J.; Wyrick, David L.] Univ North Carolina Greensboro, Greensboro, NC 27412 USA; [Milroy, Jeffrey J.; Wyrick, David L.] UNC Greensboro Inst Promote Athlete Hlth & Wellne, Greensboro, NC USA; [Hebard, Stephen] Univ Alabama Birmingham, Birmingham, AL USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Kroshus, Emily] Harborview Injury Prevent Res Ctr, Seattle, WA USA		Milroy, JJ (corresponding author), Univ North Carolina Greensboro, Greensboro, NC 27412 USA.; Milroy, JJ (corresponding author), UNC Greensboro Inst Promote Athlete Hlth & Wellne, Greensboro, NC USA.	jjmilroy@uncg.edu					AINSWORT.MD, 1970, CHILD DEV, V41, P49, DOI 10.1111/j.1467-8624.1970.tb00975.x; AINSWORTH MDS, 1989, AM PSYCHOL, V44, P709, DOI 10.1037/0003-066X.44.4.709; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belsley D. A., 1980, REGRESSION DIAGNOSTI, P46; Berry T. R., 2000, Journal of Sport Behavior, V23, P207; Bowlby J., 1973, ATTACHMENT LOSS; Bowlby J., 1969, ATTACHMENT LOSS VOL; Brennan KA., 1998, ATTACHMENT THEORY CL, P46; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Cassidy J., 1995, ROCHESTER S DEVELOPM, P343; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Cote J., 2002, PSYCHOL FDN SPORT, P520; Davis L, 2014, J SPORT SCI, V32, P1454, DOI 10.1080/02640414.2014.898183; Davis L, 2010, J CLIN SPORT PSYCHOL, V4, P112, DOI 10.1123/jcsp.4.2.112; Diamond LM, 2003, MOTIV EMOTION, V27, P125, DOI 10.1023/A:1024521920068; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Felton L, 2015, SCAND J MED SCI SPOR, V25, P289, DOI 10.1111/sms.12196; Fox NA, 2003, MOTIV EMOTION, V27, P7, DOI 10.1023/A:1023622324898; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hamilton CE, 2000, CHILD DEV, V71, P690, DOI 10.1111/1467-8624.00177; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Institute of Medicine & National Research Council, 2014, SPORTS RELATED CONCU; Jones M., 2005, PSYCHOL COACHING, P14, DOI DOI 10.1016/J.JSAMS.2014.07.008; Jowett S, 2003, SPORT PSYCHOL, V17, P444, DOI 10.1123/tsp.17.4.444; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mikulincer M, 2003, ADV EXP SOC PSYCHOL, V35, P53, DOI 10.1016/S0065-2601(03)01002-5; Mikulincer M., 2008, HDB ATTACHMENT THEOR, P503; Mikulincer M., 1998, ATTACHMENT THEORY CL, P143; National Collegiate Athletic Association, 2014, NCAA SPORTS MED HDB, P56; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Smoll F. L., 2007, SPORT ED, P165, DOI 10.14195/978-989-26-0474-9J4; Smoll F. L., 2002, EXPLORING SPORT EXER, P341; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279	48	7	7	3	7	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1932-9261	1932-927X		J CLIN SPORT PSYCHOL	J. Clin. Sport Psychol.	JUN	2018	12	2					268	281		10.1123/jcsp.2017-0029			14	Psychology, Applied	Social Science Citation Index (SSCI)	Psychology	GM5BR	WOS:000438143600010		Green Submitted			2022-02-06	
J	Ohlin, M; Kjeldgard, L; Elrud, R; Stigson, H; Alexanderson, K; Friberg, E				Ohlin, Maria; Kjeldgard, Linnea; Elrud, Rasmus; Stigson, Helena; Alexanderson, Kristina; Friberg, Emilie			Duration of sickness absence following a bicycle crash, by injury type and injured body region: A nationwide register-based study	JOURNAL OF TRANSPORT & HEALTH			English	Article; Proceedings Paper	Active-Living-Research (ALR) Conference on Active Living across the Life Span	FEB 26-MAR 01, 2017	Clearwater, FL			Bicycle; Crash; Injuries; Sickness absence; Sick leave	PHYSICAL-ACTIVITY; ACCIDENTS; DISABILITY; WALKING; WORK; CONSEQUENCES; METAANALYSIS; POPULATION; MORTALITY; SWEDEN	In recent years, bicycle injuries have increased but little is known about the relation of such injures to sickness absence (SA). The aim of this study was to investigate duration of SA > 14 days after a bicycle crash, in general and by injury type and injured body region. A population-based study was conducted, including all individuals living in Sweden, aged 16-64 years, who in 2009-2011 had in-or specialized outpatient medical care due to a new injury from a bicycle crash (n = 22,045), excluding those already on SA or full-time disability pension at the time of the crash. Crude and adjusted odds ratios (OR) and 95% confidence intervals (CI) for a new SA were estimated by logistic regression. In total, 4387 (20%) had new SA in connection to the crash. SA was most common among individuals aged 55-64 years (32%), and more common among women (23%) than men (18%). Fractures was the injury type with the highest OR for SA across all durations, but highest for 30-89 days (8.09; CI 6.30-10.39). Spine and back was the body region with the highest OR for SA >= 90 days (11.98; CI 7.38-19.46), followed by Traumatic Brain Injuries (6.64; CI 4.01-10.98), and injuries to lower extremities (5.28; CI 3.58-7.78). For 235 individuals (5%) the SA spell lasted >= 180 days. Among those cases, the most commonly injured body regions were lower leg (21%) followed by shoulder and upper arm (17%), and Traumatic Brain Injuries (15%). In conclusion, the duration of SA varied with type of injury and injured body region. Among the very long SA spells, common injuries were injuries to the lower leg, to the shoulder and upper arm, and traumatic brain injuries.	[Ohlin, Maria] Univ Gothenburg, Dept Food & Nutr & Sport Sci, Gothenburg, Sweden; [Ohlin, Maria] Chalmers Univ Technol, Vehicle Engn & Autonomous Syst Div, Dept Appl Mech, Gothenburg, Sweden; [Kjeldgard, Linnea; Elrud, Rasmus; Stigson, Helena; Alexanderson, Kristina; Friberg, Emilie] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, SE-17177 Stockholm, Sweden; [Stigson, Helena] Chalmers Univ Technol, Vehicle Safety Div, Dept Appl Mech, Gothenburg, Sweden; [Stigson, Helena] Folksam Res, Stockholm, Sweden		Ohlin, M (corresponding author), Univ Gothenburg, Dept Food & Nutr & Sport Sci, Gothenburg, Sweden.	maria.ohlin@gu.se; linnea.kjeldgard@ki.se; rasmus.elrud@ki.se; helena.stigson@folksam.se; kristina.alexanderson@ki.se; emilie.friberg@ki.se	Stigson, Helena/AAZ-6786-2020	Stigson, Helena/0000-0002-2409-1379; Rizzi, Maria/0000-0003-1155-3519; Friberg, Emilie/0000-0001-7874-4243; Kjeldgard, Linnea/0000-0002-4575-7483	Swedish Transport Administration [TRV 2017/13132, TRV 2014/77216]; Folksam's Research Fund [2015:33]; Swedish Research Council for Health, Working Life and WelfareSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte) [2007-1762, 2009-1758]	This work was supported by the Swedish Transport Administration (Grant numbers TRV 2017/13132 & TRV 2014/77216), Folksam's Research Fund (Grant number 2015:33), and Swedish Research Council for Health, Working Life and Welfare (Grant numbers 2007-1762 & 2009-1758).	Aertsens J., 2014, P INT CYCL SAF C GOT; Aertsens J, 2010, ACCIDENT ANAL PREV, V42, P2149, DOI 10.1016/j.aap.2010.07.008; Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Berecki-Gisolf J, 2013, ACCIDENT ANAL PREV, V51, P129, DOI 10.1016/j.aap.2012.11.010; Berg HY, 2016, TRANSPORT RES F-TRAF, V38, P1, DOI 10.1016/j.trf.2015.12.007; BJORNSTIG U, 1984, ACTA CHIR SCAND, V150, P353; Bylund PO, 1998, SPINE, V23, P1023, DOI 10.1097/00007632-199805010-00012; de Geus B, 2012, ACCIDENT ANAL PREV, V45, P683, DOI 10.1016/j.aap.2011.09.045; de Hartog JJ, 2011, CIENC SAUDE COLETIVA, V16, P4731, DOI 10.1590/S1413-81232011001300022; HANSSON PG, 1976, SCAND J SOC MED, V4, P103; Holm AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001135; Kelly P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0132-x; Lindstrom M, 2008, PREV MED, V46, P22, DOI 10.1016/j.ypmed.2007.07.012; Malm Sigrun, 2008, Ann Adv Automot Med, V52, P93; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; Ohlin M., 2016, J TRANSP HLTH; Oja P, 1998, PATIENT EDUC COUNS, V33, pS87, DOI 10.1016/S0738-3991(98)00013-5; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Olivier J., 2016, INT J EPIDEMIOL; OLKKONEN S, 1993, SCAND J SOC MED, V21, P98, DOI 10.1177/140349489302100207; Rizzi M., 2013, CYCLIST INJURIES LEA, V46; Rojas-Rueda D, 2013, PREV MED, V57, P573, DOI 10.1016/j.ypmed.2013.07.021; Sahlqvist S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003797; Social insurance in figures 2016, 2016, SOC INS FIG 2016; Swedish Transport Administration, 2015, STA PUBL, P103; The National Board of Health and Welfare, 2011, INT STAT CLASS DIS R; World Health Organization, 2007, INT CLASS FUNCT DIS	28	7	7	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2214-1405			J TRANSP HEALTH	J. Transp. Health	JUN	2018	9						275	281		10.1016/j.jth.2018.01.011			7	Public, Environmental & Occupational Health; Transportation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Public, Environmental & Occupational Health; Transportation	GL4EE	WOS:000437100900032					2022-02-06	
J	Pierce, JD; Gupte, R; Thimmesch, A; Shen, QH; Hiebert, JB; Brooks, WM; Clancy, RL; Diaz, FJ; Harris, JL				Pierce, Janet D.; Gupte, Raeesa; Thimmesch, Amanda; Shen, Qiuhua; Hiebert, John B.; Brooks, William M.; Clancy, Richard L.; Diaz, Francisco J.; Harris, Janna L.			Ubiquinol treatment for TBI in male rats: Effects on mitochondrial integrity, injury severity, and neurometabolism	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						apoptosis; biomarkers; magnetic resonance spectroscopy; mitochondria; RRID: SCR_003792; RRID: SCR_014051; RRID: SCR_011417; RRID: SCR_008988; RRID: SCR_004515; RRID: SCR_008635; RRID: SCR_014455; RRID: SCR_012763	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE SPECTROSCOPY; FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE-L1; STRESS-INDUCED APOPTOSIS; OXIDATIVE STRESS; NEUROCHEMICAL PROFILE; CORTICAL CONTUSION; CEREBRAL-ISCHEMIA; NEUROPROTECTION	Following traumatic brain injury (TBI), there is significant secondary damage to cerebral tissue from increased free radicals and impaired mitochondrial function. This imbalance between reactive oxygen species (ROS) production and the effectiveness of cellular antioxidant defenses is termed oxidative stress. Often there are insufficient antioxidants to scavenge ROS, leading to alterations in cerebral structure and function. Attenuating oxidative stress following a TBI by administering an antioxidant may decrease secondary brain injury, and currently many drugs and supplements are being investigated. We explored an over-the-counter supplement called ubiquinol (reduced form of coenzyme Q10), a potent antioxidant naturally produced in brain mitochondria. We administered intra-arterial ubiquinol to rats to determine if it would reduce mitochondrial damage, apoptosis, and severity of a contusive TBI. Adult male F344 rats were randomly assigned to one of three groups: (1) Saline-TBI, (2) ubiquinol 30 minutes before TBI (UB-PreTBI), or (3) ubiquinol 30 minutes after TBI (UB-PostTBI). We found when ubiquinol was administered before or after TBI, rats had an acute reduction in brain mitochondrial damage, apoptosis, and two serum biomarkers of TBI severity, glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase-L1 (UCH-L1). However, in vivo neurometabolic assessment with proton magnetic resonance spectroscopy did not show attenuated injury-induced changes. These findings are the first to show that ubiquinol preserves mitochondria and reduces cellular injury severity after TBI, and support further study of ubiquinol as a promising adjunct therapy for TBI.	[Pierce, Janet D.; Thimmesch, Amanda; Shen, Qiuhua; Hiebert, John B.; Clancy, Richard L.] Univ Kansas, Med Ctr, Sch Nursing, Lawrence, KS 66045 USA; [Gupte, Raeesa] Univ Kansas, Med Ctr, Hoglund Brain Inst, Lawrence, KS 66045 USA; [Brooks, William M.] Univ Kansas, Med Ctr, Dept Neurol, Hoglund Brain Imaging Ctr, Lawrence, KS 66045 USA; [Diaz, Francisco J.] Univ Kansas, Med Ctr, Dept Biostat, Lawrence, KS 66045 USA; [Harris, Janna L.] Univ Kansas Med, Dept Anat & Cell Biol, Hoglund Brain Imaging Ctr, Lawrence, KS USA		Pierce, JD (corresponding author), Univ Kansas, Med Ctr, Sch Nursing, Lawrence, KS 66045 USA.	jpierce@kumc.edu	Gupte, Raeesa/AAZ-1152-2021; Brooks, William/AAF-8299-2019	Brooks, William/0000-0001-6227-7636; Shen, Qiuhua/0000-0002-1236-0244	TriService Nursing Research Program, Uniformed Services University of the Health Sciences; Uniformed Services University of the Health Sciences (USU) [HU0001-14-1-TS03]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG035982] Funding Source: NIH RePORTER	This research was sponsored by the TriService Nursing Research Program, Uniformed Services University of the Health Sciences and The Uniformed Services University of the Health Sciences (USU), grant number: HU0001-14-1-TS03	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Brooks JCW, 2001, CEREB CORTEX, V11, P598, DOI 10.1093/cercor/11.7.598; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Centers for Disease Control and Prevention, 2017, TBI GET THE FACTS; Cervellati R, 2016, HELV CHIM ACTA, V99, P41, DOI 10.1002/hlca.201500124; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cikriklar HI, 2016, TURK NEUROSURG, V26, P878, DOI 10.5137/1019-5149.JTN.13946-15.2; Coimbra-Costa D, 2017, REDOX BIOL, V12, P216, DOI 10.1016/j.redox.2017.02.014; Csilla A., 2017, METABOLOMICS, V13; Defense and Veterans Brain Injury Center, 2017, TBI THE MIL; Desbats MA, 2015, J INHERIT METAB DIS, V38, P145, DOI 10.1007/s10545-014-9749-9; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Ferreira T., 2012, IMAGEJ USER GUIDE; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Fitzpatrick M., 2014, MEASURING CELL FLUOR; Flippo KH, 2017, J CELL SCI, V130, P671, DOI 10.1242/jcs.171017; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Gao YY, 2017, AM J TRANSL RES, V9, P887; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Goodyear-Bruch Caryl, 2005, Biol Res Nurs, V6, P180, DOI 10.1177/1099800404271869; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Haar CV, 2016, BRAIN RES, V1640, P114, DOI 10.1016/j.brainres.2015.12.030; Harris JL, 2015, FRONT AGING NEUROSCI, V7, DOI [10.5589/fnagi.2015.00202, 10.3389/fnagi.2015.00202]; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Jou MJ, 2004, J PINEAL RES, V37, P55, DOI 10.1111/j.1600-079X.2004.00140.x; Jou MJ, 2002, J BIOMED SCI, V9, P507; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kalayci M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-75; Kawashima C., 2016, CIRCULATION S1, V134; Kisser J, 2017, BRAIN INJURY, V31, P620, DOI 10.1080/02699052.2017.1283057; Lee P, 2012, EXP NEUROL, V234, P50, DOI 10.1016/j.expneurol.2011.12.016; Lee YB, 2000, BRAIN RES, V864, P220, DOI 10.1016/S0006-8993(00)02180-6; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lu CJ, 2017, PATHOL RES PRACT, V213, P1191, DOI 10.1016/j.prp.2017.06.005; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Matthews RT, 1998, P NATL ACAD SCI USA, V95, P8892, DOI 10.1073/pnas.95.15.8892; Meirelles LD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051082; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Neergheen Viruna, 2017, J. inborn errors metab. screen., V5, pe160063, DOI 10.1177/2326409817707771; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nowak E, 2006, RADIAT RES, V165, P155, DOI 10.1667/RR3496.1; Oz G, 2014, RADIOLOGY, V270, P658, DOI 10.1148/radiol.13130531; Papa L, 2017, J NEUROTRAUM, V34, P2187, DOI 10.1089/neu.2017.5030; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Pfeuffer J, 1999, J MAGN RESON, V141, P104, DOI 10.1006/jmre.1999.1895; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Salo AB, 2017, J PHYS CHEM B, V121, P1771, DOI 10.1021/acs.jpcb.6b10403; Shen Q, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12199; Singh K, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3764; Suenobu T, 2016, INORG CHEM, V55, P7747, DOI 10.1021/acs.inorgchem.6b01220; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; Vekaria HJ, 2017, NEUROCHEM INT, V109, P117, DOI 10.1016/j.neuint.2017.04.004; Wang JF, 2014, NEUROCHEM INT, V64, P37, DOI 10.1016/j.neuint.2013.11.002; Wang KK, 2017, EXPERT OPIN THER TAR, V21, P627, DOI 10.1080/14728222.2017.1321635; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Woodward M., 2005, EPIDEMIOLOGY STUDY D; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Xu Z, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0257-8; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yokobori S, 2014, CNS NEUROL DISORD-DR, V13, P606, DOI 10.2174/187152731304140702112805; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762	79	7	7	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2018	96	6					1080	1092		10.1002/jnr.24210			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC9IT	WOS:000430111400012	29380912				2022-02-06	
J	Rosenberg, H; McDonald, S; Rosenberg, J; Westbrook, RF				Rosenberg, Hannah; McDonald, Skye; Rosenberg, Jacob; Westbrook, R. Frederick			Amused, flirting or simply baffled? Is recognition of all emotions affected by traumatic brain injury?	JOURNAL OF NEUROPSYCHOLOGY			English	Article						traumatic brain injury; emotion recognition; working memory; abstract reasoning; processing speed	CLOSED-HEAD-INJURY; FACIAL AFFECT RECOGNITION; SOCIAL-PERCEPTION; NONVERBAL-COMMUNICATION; BEHAVIORAL-CHANGES; DEFICITS; EXPRESSIONS; RECOVERY; AWARENESS; LESIONS	ObjectiveThis study examined whether people with moderate-severe traumatic brain injury (TBI) display a specific or a general impairment in emotion recognition compared with matched controls, whether these deficits might be accounted for by deficits in other cognitive processes, and whether emotion recognition predicts social functioning following TBI. ParticipantsThirty-two participants with TBI and 32 matched controls took part in this study. DesignParticipants completed the Complex Audio-Visual Emotion Assessment Task (CAVEAT), a novel measure of emotion recognition, alongside measures of neuropsychological functioning. The TBI group also completed selected self-report measures of psychosocial functioning. ResultsTraumatic brain injury participants performed more poorly than controls in recognizing all emotions, rather than displaying a selective impairment in recognizing some emotions (e.g., negative vs. positive) compared with others. Although abstract reasoning, working memory, and processing speed were associated with emotion recognition, injury severity and abstract reasoning were the sole predictors of emotion recognition as measured by the CAVEAT. Emotion recognition accuracy in the TBI group was associated with number of friends and self-reported apathy. ConclusionEmotion recognition deficits are a direct consequence of TBI and have a direct effect on the social dysfunction which is a common outcome of TBI, strengthening the need for targeted remediation.	[Rosenberg, Hannah; McDonald, Skye; Rosenberg, Jacob; Westbrook, R. Frederick] Univ New South Wales, Sch Psychol, Mathews Bldg, Sydney, NSW 2052, Australia		Rosenberg, H (corresponding author), Univ New South Wales, Sch Psychol, Mathews Bldg, Sydney, NSW 2052, Australia.	hannah.rosenberg@unsw.edu.au					Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Banerjee M., 1997, DEV SOCIAL COGNITION, P241; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BUCK R, 1980, CORTEX, V16, P351, DOI 10.1016/S0010-9452(80)80037-2; Darwin C., 1872, EXPRESSION EMOTIONS; EKMAN P, 1992, PHILOS T ROY SOC B, V335, P63, DOI 10.1098/rstb.1992.0008; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; Ekman P., 1999, HDB COGNITION EMOTIO, P45, DOI 10.1002/0470013494.ch3; Ekman P., 1976, PICTURES FACIAL AFFE; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; ESLINGER PJ, 1995, NEUROREHABILITATION, V5, P161, DOI 10.3233/NRE-1995-5206; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Grattan L. M., 2002, REHABILITATION NEURO, Vxiv; Green DP, 1999, PSYCHOL SCI, V10, P304, DOI 10.1111/1467-9280.00158; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Izard C. E., 1971, FACE EMOTION; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovibond SH, 1995, MANUAL DEPRESSION AN, P2; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rosenberg H., 2016, MEASURING EMOT UNPUB, DOI 10.1080/09602011.2016.1273118; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Russell J.A., 1980, J PERSONALITY SOCIAL; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; RUSSELL JA, 1985, J PERS SOC PSYCHOL, V48, P1290, DOI 10.1037/0022-3514.48.5.1290; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Watson D, 1999, J PERS SOC PSYCHOL, V76, P820, DOI 10.1037/0022-3514.76.5.820; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Yates PJ, 2003, NEUROPSYCHOL REHABIL, V13, P291, DOI 10.1080/09602010244000408; Yim J, 2013, BRAIN INJURY, V27, P1155, DOI 10.3109/02699052.2013.804203; Ylvisaker M, 2000, APHASIOLOGY, V14, P407, DOI 10.1080/026870300401432; Zupan B., 2013, J HEAD TRAUMA REHAB, V29, pE1	61	7	7	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	JUN	2018	12	2					145	164		10.1111/jnp.12109			20	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GI2TO	WOS:000434225000001	27353568				2022-02-06	
J	Rowley, DA; Rogish, M; Alexander, T; Riggs, KJ				Rowley, Dane A.; Rogish, Miles; Alexander, Timothy; Riggs, Kevin J.			Counter-intuitive moral judgement following traumatic brain injury	JOURNAL OF NEUROPSYCHOLOGY			English	Article						moral judgement; social cognition; emotion; traumatic brain injury; decision-making	PREFRONTAL CORTEX; DECISION-MAKING; NEURAL SYSTEMS; MIND; COGNITION; AVERSION; EMOTION; DAMAGE; FMRI	Several neurological patient populations, including traumatic brain injury (TBI), appear to produce an abnormally utilitarian' pattern of judgements to moral dilemmas; they tend to make judgements that maximize the welfare of the majority, rather than deontological judgements based on the following of moral rules (e.g., do not harm others). However, this patient research has always used extreme dilemmas with highly valued moral rules (e.g., do not kill). Data from healthy participants, however, suggest that when a wider range of dilemmas are employed, involving less valued moral rules (e.g., do not lie), moral judgements demonstrate sensitivity to the psychological intuitiveness of the judgements, rather than their deontological or utilitarian content (Kahane etal., Social Cognitive and Affective Neuroscience, 7, 2011, 393). We sought the moral judgements of 30 TBI participants and 30 controls on moral dilemmas where content (utilitarian/deontological) and intuition (intuitive/counter-intuitive) were measured concurrently. Overall TBI participants made utilitarian judgements in equal proportions to controls; disproportionately favouring utilitarian judgements only when they were counter-intuitive, and deontological judgements only when they were counter-intuitive. These results speak against the view that TBI causes a specific utilitarian bias, suggesting instead that moral intuition is broadly disrupted following TBI.	[Rowley, Dane A.; Alexander, Timothy] Univ Hull, Clin Psychol Programme, Kingston Upon Hull, N Humberside, England; [Rogish, Miles] Disabil Trust, Brain Injury Rehabil Trust, Burgess Hill, W Sussex, England; [Riggs, Kevin J.] Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England		Riggs, KJ (corresponding author), Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England.	k.riggs.@hull.ac.uk					Apperly Ian, 2010, MINDREADERS COGNITIV; Avramova YR, 2013, WIRES COGN SCI, V4, P169, DOI 10.1002/wcs.1216; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Choe SY, 2011, JUDGM DECIS MAK, V6, P580; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Crockett MJ, 2010, P NATL ACAD SCI USA, V107, P17433, DOI 10.1073/pnas.1009396107; Cushman F, 2012, EMOTION, V12, P2, DOI 10.1037/a0025071; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Gleichgerrcht E, 2013, SOC COGN AFFECT NEUR, V8, P780, DOI 10.1093/scan/nss067; Gleichgerrcht E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060418; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; JONES C, 1979, AM J NURS, V79, P1551; Kahane G, 2012, SOC COGN AFFECT NEUR, V7, P393, DOI 10.1093/scan/nsr005; Kant I., 1959, FDN METAPHYSICS MORA; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koenigs M, 2012, SOC COGN AFFECT NEUR, V7, P708, DOI 10.1093/scan/nsr048; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Martins AT, 2012, JUDGM DECIS MAK, V7, P478; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mendez MF, 2005, COGN BEHAV NEUROL, V18, P193, DOI 10.1097/01.wnn.0000191292.17964.bb; Mitchell DGV, 2006, NEUROCASE, V12, P164, DOI 10.1080/13554790600611288; Moretto G, 2010, J COGNITIVE NEUROSCI, V22, P1888, DOI 10.1162/jocn.2009.21367; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Muller JL, 2003, PSYCHIAT PRAX, V30, pS221; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Nummenmaa L, 2008, NEUROIMAGE, V43, P571, DOI 10.1016/j.neuroimage.2008.08.014; Paxton JM, 2014, SOC COGN AFFECT NEUR, V9, P1368, DOI 10.1093/scan/nst102; Pitman I, 2014, NEUROPSYCHOL REHABIL, V25, P763; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rosas A, 2014, SOC NEUROSCI-UK, V9, P661, DOI 10.1080/17470919.2014.937506; Shamay-Tsoory SG, 2006, SOC NEUROSCI-UK, V1, P149, DOI 10.1080/17470910600985589; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Tversky B, 2009, COGNITION, V110, P124, DOI 10.1016/j.cognition.2008.10.008; Wechsler D., 2011, WECHSLER ABBREVIATED; Wiech K, 2013, COGNITION, V126, P364, DOI 10.1016/j.cognition.2012.11.002; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	49	7	7	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	JUN	2018	12	2					200	215		10.1111/jnp.12117			16	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GI2TO	WOS:000434225000004	28168820	Green Accepted			2022-02-06	
J	Shewring, DJ; Trickett, RW; Smith, A				Shewring, David J.; Trickett, Ryan W.; Smith, Adam			Fractures at the junction of diaphysis and nnetaphysis of the proxinnal phalanges in adults	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Article						Proximal phalanx fracture; metaphyseal; Kirschner wire	PROXIMAL INTERPHALANGEAL JOINT; HEMI-HAMATE ARTHROPLASTY; OPEN REDUCTION; INTERNAL-FIXATION; SCREW FIXATION; DISLOCATIONS; FINGER	We describe the treatment of 101 patients with 113 fractures of the proximal phalanx at the junction of the diaphysis with the proximal metaphysis. Fractures were stabilized using a single extra-articular percutaneous Kirschner wire passed lateral to the metacarpal head into the base of the phalanx base and across the fracture to engage the lateral cortex. Patients were treated semi-electively on a day surgery unit. The metacarpophalangeal joint was splinted in flexion with mobilization of the proximal inter-phalangeal joints, until the wire was removed at 24 days and the hand then freely mobilized. The mean total active movement was 230' and no patients experienced problems with significant pain. There were two pin site infections. There were no cases of angular or rotational malunion. These injuries can be successfully and safely treated using this simple technique, negating the need for close monitoring for angular displacement of the fracture, which is frequently seen with non-surgical management.	[Shewring, David J.; Trickett, Ryan W.; Smith, Adam] Univ Hosp Wales, Dept Trauma & Orthopaed Surg, Heath Pk, Cardiff CF14 4XW, S Glam, Wales		Shewring, DJ (corresponding author), Univ Hosp Wales, Dept Trauma & Orthopaed Surg, Heath Pk, Cardiff CF14 4XW, S Glam, Wales.	davidshewring@me.com	Trickett, Ryan/I-4415-2019	Trickett, Ryan/0000-0002-0688-0630			Abou Elatta MM, 2017, J HAND SURG-EUR VOL, V42, P182, DOI 10.1177/1753193416674155; Aladin A, 2005, J HAND SURG-BRIT EUR, V30B, P120, DOI 10.1016/j.jhsb.2004.10.011; Armstrong MB, 1997, PLAST RECONSTR SURG, V99, P2096; Burnier M, 2017, J HAND SURG-EUR VOL, V42, P188, DOI 10.1177/1753193416671886; Calfee RP, 2009, J HAND SURG-AM, V34A, P1232, DOI 10.1016/j.jhsa.2009.04.027; Deitch MA, 1999, J HAND SURG-AM, V24A, P914; Elfar J, 2013, J AM ACAD ORTHOP SUR, V21, P88, DOI 10.5435/JAAOS-21-02-88; FREELAND AE, 1994, HAND CLIN, V10, P239; Glickel SZ, 2000, HAND CLIN, V16, P333; Grant I, 2005, J HAND SURG-BRIT EUR, V30B, P492, DOI 10.1016/j.jhsb.2005.05.006; Hamilton SC, 2006, J HAND SURG-AM, V31A, P1349, DOI 10.1016/j.jhsa.2006.07.011; Kang R, 2002, J AM SOC SURG HAND, V2, P47; Lee JJ, 2013, ARCH PLAST SURG-APS, V40, P397, DOI 10.5999/aps.2013.40.4.397; Lee JYL, 2006, J HAND SURG-BRIT EUR, V31B, P138, DOI 10.1016/j.jhsb.2005.09.019; Mousavi SJ, 2008, CLIN REHABIL, V22, P749, DOI 10.1177/0269215508085821; Sinclair VF, 2017, J HAND SURG-EUR VOL, V42, P199, DOI 10.1177/1753193415617936; Thomas BP, 2017, J HAND SURG-EUR VOL, V42, P799, DOI 10.1177/1753193417707381; Williams RMM, 2003, J HAND SURG-AM, V28A, P856, DOI 10.1016/S0363-5023(03)00304-6; WILSON JN, 1966, J BONE JOINT SURG AM, VA 48, P493, DOI 10.2106/00004623-196648030-00008	19	7	7	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	JUN	2018	43	5					506	512		10.1177/1753193418766973			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	GG2NT	WOS:000432530300007	29587603				2022-02-06	
J	Shi, XD; Zhang, GD; Sun, HJ; Bai, YN; Liu, YG; Zhang, W; Xiao, H				Shi, Xiaodong; Zhang, Guodong; Sun, Huijuan; Bai, Yunan; Liu, Yuguang; Zhang, Wei; Xiao, Hang			Effects of over-expression of HIF-1alpha in bone marrow-derived mesenchymal stem cells on traumatic brain injury	ENGINEERING IN LIFE SCIENCES			English	Article						Bone marrow derived mesenchymal stem cell (BM-MSC); Hypoxia inducible factor (HIF)-1alpha; Therapeutic effect; Traumatic brain injury (TBI)	ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1; FOCAL CEREBRAL-ISCHEMIA; STROMAL CELLS; ADULT RATS; DENTATE GYRUS; IN-VITRO; NEUROGENESIS; RECOVERY; ERYTHROPOIETIN	Mesenchymal stem cells (MSCs) have been shown to play therapeutic effect in traumatic brain injury (TBI). To augment the therapeutic effect, MSCs could be engineered to over-express genes that are beneficial for treatment. In the present study, we over-expressed hypoxia inducible factor (HIF)-1alpha in bone marrow derived MSCs (BM-MSCs) and sought to investigate whether HIF-1alpha could enhance the therapeutic effect of MSCs in a mouse model of TBI. Balb/c mice were subjected to controlled cortical impact injury and MSCs were transplanted intravenously at 6 h after injury. The lesion volume and brain water content were measured and the neurological function was assessed by modified neurologic severity score tests. Double-labeled immunofluorescence for BrdU and NeuU was performed to determine angiogenesis and neurogenesis. The expression of erythropoietin (EPO) and vascular endothelial growth factor (VEGF) was measured by quantitative RT-PCR and western blotting. After TBI, mice received BM-MSCs over-expressing HIF-1alpha showed significantly more functional recovery, reduced brain damage, increased angiogenesis and neurogenesis and increased expression of VEGF and EPO, compared with control mice or mice treated with non-transduced BM-MSCs. Over-expression of HIF-1alpha enhanced BM-MSCs induced improvement of neurological recovery after TBI, by stimulating angiogenesis and neurogenesis.	[Shi, Xiaodong; Liu, Yuguang] Shandong Univ, Qilu Hosp, Wenhuaxi Rd, Jinan 250014, Shandong, Peoples R China; [Shi, Xiaodong; Zhang, Guodong; Sun, Huijuan; Bai, Yunan; Zhang, Wei; Xiao, Hang] Weifang Yidu Cent Hosp, 4138 Linglongshan Rd, Qingzhou 262500, Shandong, Peoples R China		Liu, YG (corresponding author), Shandong Univ, Qilu Hosp, Wenhuaxi Rd, Jinan 250014, Shandong, Peoples R China.; Zhang, W (corresponding author), Weifang Yidu Cent Hosp, 4138 Linglongshan Rd, Qingzhou 262500, Shandong, Peoples R China.	liuyuguangs-ddx@163.com; zhangweiydzx@163.com			Development Plan of Shandong Medical and Health Technology [2015WS0070, 2015WS0069]	This study was supported by the Development Plan of Shandong Medical and Health Technology (2015WS0069, 2015WS0070).	Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Freret T, 2006, EUR J NEUROSCI, V23, P1757, DOI 10.1111/j.1460-9568.2006.04699.x; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A., 2003, NEUROSURGERY, V53, P702; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Nico B, 2011, J NEURO-ONCOL, V102, P51, DOI 10.1007/s11060-010-0294-6; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Sen T, 2016, NEUROPHARMACOLOGY, V107, P79, DOI 10.1016/j.neuropharm.2016.03.009; Shi HL, 2009, CURR MED CHEM, V16, P4593, DOI 10.2174/092986709789760779; Souvenir R, 2014, TRANSL STROKE RES, V5, P118, DOI 10.1007/s12975-013-0312-z; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; van Velthoven CTJ, 2013, STROKE, V44, P1426, DOI 10.1161/STROKEAHA.111.000326; Wang ZT, 2013, J MOL NEUROSCI, V49, P409, DOI 10.1007/s12031-012-9908-0; Xiguang S., 2016, ANN CLIN BIOCHEM, V54, P584; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Zhang Y., 2014, VASCULAR MECH CNS TR, P141	28	7	7	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1618-0240	1618-2863		ENG LIFE SCI	Eng. Life Sci.	JUN	2018	18	6					401	407		10.1002/elsc.201800015			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	GI4PE	WOS:000434352900007	32624920	Green Published			2022-02-06	
J	Song, HJ; Chen, X; Yu, YL; Zhang, L				Song, Hujie; Chen, Xiao; Yu, Yalan; Zhang, Ling			Xingnao Kaiqiao acupuncture combined with Angong Niuhuang Wan for a patient under persistent vegetative state: a case report	FRONTIERS OF MEDICINE			English	Article						PVS; stubborn disease; Xingnao Kaiqiao; Angong Niuhuang Wan; TCM; acupuncture		Persistent vegetative state (PVS) is a clinical condition wherein the cerebral cortex loses its function although brain stem function remains relatively intact. It has high mortality and disability rates. Although treatment for PVS is extensively studied in developed countries, little breakthrough has been made. In China, many PVS patients who were treated with traditional Chinese medicine (TCM) and acupuncture therapy were reported to have regained consciousness. In our department, we have been investigating TCM diagnosis and treatment methods for PVS for many years and have summarized a set of curative programs. Our patient is a male and 5 years and 3 months of age. He had traumatic brain injury and had been unconscious for three months on admission. Considering his condition, we adopted Xingnao Kaiqiao acupuncture, oral Angong Niuhuang Wan, and Xingnaojing intravenous drip. After the 50-day treatment, his health significantly improved and is nearly similar to that of a healthy child, indicating that the treatment is effective for PVS. Therefore, we decided to report the case and treatment methods.	[Song, Hujie; Chen, Xiao; Yu, Yalan; Zhang, Ling] Xian Encephalopathy Hosp Tradit Chinese Med, PVS Consciousness Promoted Ctr, Xian 710032, Shaanxi, Peoples R China		Yu, YL (corresponding author), Xian Encephalopathy Hosp Tradit Chinese Med, PVS Consciousness Promoted Ctr, Xian 710032, Shaanxi, Peoples R China.	yalan96@qq.com					Chen L., 2008, FUJIAN MED J, V30, P6; Chen X, 2012, ACTA CHIN MED PHARM, V40, P71; Hu GQ, 1996, CHIN CRIT CARE MED, V8, P5; Huang Xh, 2009, J INF TRADIT CHIN ME, V16, P71; Li YH, 1993, CHIN ACUPUNCT MOXIBU, V13, P37; Li ZR, 1990, JIANGSU J TRADIT CHI, V11, P27; Liu HZ, 2011, CHIN J EXPT TRADIT M, V17, P248; Lu SJ, 2013, CHIN HLTH CARE NUTR, V2, P167; Qiao DC, 1998, NATL MED J CHINA, V78, P167; Shi YH, 2005, CHIN J REHABIL THEOR, V11, P137; The Academic Committee of Clinical Medicine of Institute of Hospital Management of the Ministry of Health, 2001, ADV REV PERF DIAGN S; Wang JD, 1994, SHANGHAI J ACUPUNCT, V13, P12; Wang QS, 2003, CHIN J NEUROSURGI DI, V2, P175; Wu WB, 2002, CHIN J CLIN REHABIL, V7, P421; [张志斌 Zhang Zhibin], 2006, [中医杂志, Journal of Traditional Chinese Medicine], V47, P483; Zhang ZL, 1995, CHIN ACUPUNCT MOXIBU, V15, P123; Zheng TJ, 2012, J EMERG TRADIT CHIN, V21, P294; Zhou YQ, 1998, CHIN ACUPUNCT MOXIBU, V18, P3995; Zhu CT, 2008, SHANGHAI J ACUPUNCT, V27, P15	19	7	7	0	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2095-0217	2095-0225		FRONT MED-PRC	Front. Med.	JUN	2018	12	3					334	339		10.1007/s11684-017-0539-2			6	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	GF9ZB	WOS:000432336500012	28791670				2022-02-06	
J	Zhang, HS; Zhang, DD; Li, H; Yan, HY; Zhang, ZH; Zhou, CH; Chen, Q; Ye, ZN; Hang, CH				Zhang, Huasheng; Zhang, Dingding; Li, Hua; Yan, Huiying; Zhang, Zihuan; Zhou, Chenhui; Chen, Qiang; Ye, Zhennan; Hang, Chunhua			Biphasic activation of nuclear factor-B and expression of p65 and c-Rel following traumatic neuronal injury	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						inflammatory response; nuclear factor-B; traumatic neuronal injury; biphasic activation	NF-KAPPA-B; BRAIN-INJURY; TRANSCRIPTION FACTOR; INDUCED APOPTOSIS; OXIDATIVE STRESS; IN-VITRO; PROTEINS; SURVIVAL; NEUROPROTECTION; DIFFERENTIATION	The transcription factor nuclear factor-B (NF-B) has been shown to function as a key regulator of cell death or survival in neuronal cells. Previous studies indicate that the biphasic activation of NF-B occurs following experimental neonatal hypoxia-ischemia and subarachnoid hemorrhage. However, the comprehensive understanding of NF-B activity following traumatic brain injury (TBI) is incomplete. In the current study, an in vitro model of TBI was designed to investigate the NF-B activity and expression of p65 and c-Rel subunits following traumatic neuronal injury. Primary cultured neurons were assigned to control and transected groups. NF-B activity was detected by electrophoretic mobility shift assay. Western blotting and immunofluorescence were used to investigate the expression and distribution of p65 and c-Rel. Reverse transcription-quantitative polymerase chain reaction was performed to assess the downstream genes of NF-B. Lactate dehydrogenase (LDH) quantification and trypan blue staining were used to estimate the neuronal injury. Double peaks of elevated NF-B activity were observed at 1 and 24 h following transection. The expression levels of downstream genes exhibited similar changes. The protein levels of p65 also presented double peaks while c-Rel was elevated significantly in the late stage. The results of the trypan blue staining and LDH leakage assays indicated there was no sustained neuronal injury during the late peak of NF-B activity. In conclusion, biphasic activation of NF-B is induced following experimental traumatic neuronal injury. The elevation of p65 and c-Rel levels at different time periods suggests that within a single neuron, NF-B may participate in different pathophysiological processes.	[Zhang, Huasheng; Zhang, Dingding; Li, Hua; Yan, Huiying; Zhou, Chenhui; Hang, Chunhua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Zhang, Zihuan] Zhongdu Hosp, Dept Neurosurg, Bengbu 233004, Anhui, Peoples R China; [Chen, Qiang; Ye, Zhennan; Hang, Chunhua] Southern Med Univ Guangzhou, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China		Hang, CH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hang_neurosurgery@163.com			National Natural Science Foundation, ChinaNational Natural Science Foundation of China (NSFC) [81171170, 81371294]; Nature Science Foundation of Jiangsu Province, ChinaNatural Science Foundation of Jiangsu Province [BK2010459]	The present study was supported by the National Natural Science Foundation, China (grant nos. 81171170 and 81371294) and the Nature Science Foundation of Jiangsu Province, China (grant no. BK2010459).	BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Basu S, 2012, J BIOL CHEM, V287, P8384, DOI 10.1074/jbc.M112.341586; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Biscetti F, 2011, CURR VASC PHARMACOL, V9, P677, DOI 10.2174/157016111797484125; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Clemens JA, 1997, MOL BRAIN RES, V48, P187, DOI 10.1016/S0169-328X(97)00092-2; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Hatic H, 2012, J NEUROTRAUM, V29, P1188, DOI 10.1089/neu.2011.1806; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lescot T, 2007, PRESSE MED, V36, P1117, DOI 10.1016/j.lpm.2007.01.017; Lezoualc'h F, 1998, J NEUROSCI, V18, P3224; Lin SC, 1998, MOL CELL BIOL, V18, P5523, DOI 10.1128/MCB.18.9.5523; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Nijboer CH, 2008, STROKE, V39, P2578, DOI 10.1161/STROKEAHA.108.516401; Perkins ND, 1997, INT J BIOCHEM CELL B, V29, P1433, DOI 10.1016/S1357-2725(97)00088-5; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Qin ZH, 1998, MOL PHARMACOL, V53, P33, DOI 10.1124/mol.53.1.33; Rogers B, 2003, FREE RADICAL BIO MED, V35, P872, DOI 10.1016/S0891-5849(03)00431-3; Roshak AK, 1996, J BIOL CHEM, V271, P31496, DOI 10.1074/jbc.271.49.31496; Shimada M, 2001, DEV GROWTH DIFFER, V43, P145; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; You WC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/786242; Youssef S, 2006, NAT IMMUNOL, V7, P901, DOI 10.1038/ni0906-901; Zhang R, 2006, NEUROBIOL DIS, V24, P345, DOI 10.1016/j.nbd.2006.07.012; Zhang YG, 2012, STEM CELLS, V30, P510, DOI 10.1002/stem.1006; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhou ML, 2007, J CEREBR BLOOD F MET, V27, P1583, DOI 10.1038/sj.jcbfm.9600456	40	7	7	0	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JUN	2018	41	6					3203	3210		10.3892/ijmm.2018.3567			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GD5OM	WOS:000430556300011	29568960	hybrid, Green Published, Green Submitted			2022-02-06	
J	Handforth, A; Parker, GA				Handforth, Adrian; Parker, Gail A.			Conditions Associated with Essential Tremor in Veterans: A Potential Role for Chronic Stress8	TREMOR AND OTHER HYPERKINETIC MOVEMENTS			English	Article						Essential tremor; affective disorders; epidemiology; personality disorder; drug abuse	CARDIOVASCULAR RISK-FACTORS; TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE PATIENTS; SUBSTANCE USE DISORDERS; D PERSONALITY; HEARING IMPAIRMENT; CIGARETTE-SMOKING; PSYCHIATRIC DISEASES; ANXIETY DISORDERS; LIFE-STYLE	Background: Increased depression, hearing loss, dementia, alcoholism, and mortality in essential tremor patients remain unexplained. We investigated whether conditions associated with tremor are linked to chronic stress. Methods: The FY2013 Veterans Affairs database was queried for 38 selected dual diagnosis combinations in 5,854,223 veterans aged 21-95 years. Results: Post-traumatic stress disorder, anxiety, and depression were the most common psychiatric diagnoses in tremor patients, with the odds ratio exceeding 2 in all 15-year cohorts. Depending on age, patients with essential tremor were more likely than those without to have obsessive-compulsive disorder, bipolar illness, schizophrenia, use tobacco and abuse alcohol, have hypertension, obesity, hyperlipidemia, diabetes, vitamin D deficiency, coronary and cerebrovascular diseases, congestive heart failure, stroke, asthma, hypothyroidism, irritable bowel syndrome, renal insufficiency, alcoholic liver disease, hearing loss, glaucoma, macular degeneration, migraine, epilepsy, idiopathic polyneuropathy, history of head trauma, and 'Alzheimer's dementia. In contrast, lung and colorectal cancer, amyotrophic lateral sclerosis, psychostimulant abuse, and rheumatoid arthritis were not more common. Discussion: Post-traumatic stress disorder, anxiety, and depression, strongly associated with essential tremor, are known risk factors for poor health habits, tobacco use and alcohol abuse; collectively these are risk factors for vascular disease, with further negative health consequences for multiple organ systems. As essential tremor is associated with all these conditions, we propose that chronic stress is not only responsible for the conditions associated with tremor but in some cases itself directly and indirectly induces essential tremor, so that tremor and poor health share a common cause.	[Handforth, Adrian] Vet Affairs Greater Los Angeles Healthcare Syst, Neurol Serv, Los Angeles, CA 90012 USA; [Parker, Gail A.] Vet Affairs Greater Los Angeles Healthcare Syst, Knowledge Management, Los Angeles, CA USA		Handforth, A (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Neurol Serv, Los Angeles, CA 90012 USA.	Charles.Handforth@va.gov			Veterans AffairsUS Department of Veterans Affairs	The authors were supported by Veterans Affairs.	Akdeniz C, 2014, SOC PSYCH PSYCH EPID, V49, P507, DOI 10.1007/s00127-014-0858-4; Anthenelli RM, 2010, ALCOHOL RES HEALTH, V33, P109; Baena R, 2015, MATURITAS, V80, P258, DOI 10.1016/j.maturitas.2014.12.017; Baldereschi M, 2013, NEUROL SCI, V34, P955, DOI 10.1007/s10072-012-1167-x; Bartoli F, 2015, J CLIN PSYCHIAT, V76, pE1253, DOI 10.4088/JCP.14r09199; Benito-Leon J, 2008, MOVEMENT DISORD, V23, P246, DOI 10.1002/mds.21810; Benito-Leon J, 2007, NEUROEPIDEMIOLOGY, V29, P213, DOI 10.1159/000112463; Benito-Leon J, 2015, J NEUROL SCI, V353, P116, DOI 10.1016/j.jns.2015.04.030; Bermejo-Pareja F, 2007, MOVEMENT DISORD, V22, P1573, DOI 10.1002/mds.21553; Berthon BS, 2015, NUTRIENTS, V7, P1618, DOI 10.3390/nu7031618; Bhatt H, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0541-5; Blaine B, 2008, J HEALTH PSYCHOL, V13, P1190, DOI 10.1177/1359105308095977; Bohnert KM, 2014, ADDICT BEHAV, V39, P1414, DOI 10.1016/j.addbeh.2014.05.022; Booth L, 2015, J HEALTH PSYCHOL, V20, P921, DOI 10.1177/1359105315573433; Brady KT, 2013, SOC WORK PUBLIC HLTH, V28, P407, DOI 10.1080/19371918.2013.774675; Bruce G, 2013, J STUD ALCOHOL DRUGS, V74, P120, DOI 10.15288/jsad.2013.74.120; Brudey C, 2015, AM J PHYSIOL-REG I, V309, pR315, DOI 10.1152/ajpregu.00343.2014; Buse DC, 2013, J NEUROL, V260, P1960, DOI 10.1007/s00415-012-6725-x; Carle A, 2012, CLIN ENDOCRINOL, V77, P764, DOI 10.1111/j.1365-2265.2012.04455.x; Catala-Lopez F, 2014, PSYCHOTHER PSYCHOSOM, V83, P89, DOI 10.1159/000356498; Soriano LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159179; Cereda E, 2012, CLIN NUTR, V31, P699, DOI 10.1016/j.clnu.2012.02.004; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chan YLE, 2017, AM J GERIAT PSYCHIAT, V25, P917, DOI 10.1016/j.jagp.2017.03.012; Chatterjee A, 2004, J NEUROL NEUROSUR PS, V75, P958, DOI 10.1136/jnnp.2004.037176; Chen Y, 2013, CURR DIABETES REV, V9, P350, DOI 10.2174/15733998113099990060; Chou KL, 2011, J CLIN PSYCHIAT, V72, P144, DOI 10.4088/JCP.09m05618gry; Cohen BE, 2009, JAMA-J AM MED ASSOC, V302, P489, DOI 10.1001/jama.2009.1084; Crippa JA, 2009, HUM PSYCHOPHARM CLIN, V24, P515, DOI 10.1002/hup.1048; Cuffee Y, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0483-3; Cuzick J, 2014, LANCET ONCOL, V15, pE484, DOI 10.1016/S1470-2045(14)70211-6; de Bruijn RFAG, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0130-5; Deckers K, 2015, INT J GERIATR PSYCH, V30, P234, DOI 10.1002/gps.4245; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Dodd JW, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0116-3; Dworetzky BA, 2010, EPILEPSIA, V51, P198, DOI 10.1111/j.1528-1167.2009.02268.x; Dykshoorn KL, 2014, HEALTH PSYCHOL BEHAV, V2, P517, DOI 10.1080/21642850.2014.905207; Ersoy L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/413150; Evans AH, 2006, J NEUROL NEUROSUR PS, V77, P317, DOI 10.1136/jnnp.2005.065417; Feddersen B, 2014, EPILEPSY RES, V108, P349, DOI 10.1016/j.eplepsyres.2013.11.013; Fontenelle LF, 2012, J ANXIETY DISORD, V26, P377, DOI 10.1016/j.janxdis.2011.12.001; Ginzburg K, 2010, J AFFECT DISORDERS, V123, P249, DOI 10.1016/j.jad.2009.08.006; Godfrey KM, 2013, ANN GEN PSYCHIATR, V12, DOI 10.1186/1744-859X-12-30; Gounko NV, 2013, MOL PSYCHIATR, V18, P86, DOI 10.1038/mp.2012.43; Gragnoli C, 2014, APPL CLIN GENET, V7, P43, DOI 10.2147/TACG.S39993; Grant BF, 2009, MOL PSYCHIATR, V14, P1051, DOI 10.1038/mp.2008.41; Harbishettar V, 2005, PARKINSONISM RELAT D, V11, P85, DOI 10.1016/j.parkreldis.2004.07.006; Harper S, 2015, SOC PSYCH PSYCH EPID, V50, P1471, DOI 10.1007/s00127-015-1081-7; Heppner PS, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-1; Hesdorffer DC, 1996, NEUROLOGY, V46, P727, DOI 10.1212/WNL.46.3.727; Hesdorffer DC, 2006, ANN NEUROL, V59, P35, DOI 10.1002/ana.20685; Hesdorffer DC, 2000, ANN NEUROL, V47, P246, DOI 10.1002/1531-8249(200002)47:2<246::AID-ANA17>3.3.CO;2-5; Hochmuth F, 2016, EUR J CANCER PREV, V25, P259, DOI 10.1097/CEJ.0000000000000176; Hu YQ, 2014, CEPHALALGIA, V34, P1142, DOI 10.1177/0333102414531153; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Carod-Artal FJ, 2014, J PAIN RES, V7, P185, DOI 10.2147/JPR.S61819; Kahl KG, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.306; Kiefer MM, 2015, MED CLIN N AM, V99, P935, DOI 10.1016/j.mcna.2015.05.003; Klimek P, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004125; Konitsiotis S, 2014, J NEUROL SCI, V343, P36, DOI 10.1016/j.jns.2014.05.003; Kuklina EV, 2012, EXPERT REV NEUROTHER, V12, P199, DOI [10.1586/ern.11.99, 10.1586/ERN.11.99]; Kupper N, 2007, PSYCHOSOM MED, V69, P675, DOI 10.1097/PSY.0b013e318149f4a7; Kupper N, 2011, PSYCHOSOM MED, V73, P75, DOI 10.1097/PSY.0b013e3181fdce54; Leuner B, 2013, NEUROSCIENCE, V251, P108, DOI 10.1016/j.neuroscience.2012.04.021; Levine AB, 2014, CARDIOLOGY, V127, P1, DOI 10.1159/000354910; LEVINE RL, 1992, STROKE, V23, P839, DOI 10.1161/01.STR.23.6.839; Lidfeldt J, 2005, DIABETES CARE, V28, P2531, DOI 10.2337/diacare.28.10.2531; Lin CY, 2014, BRAIN, V137, P3149, DOI 10.1093/brain/awu281; Lin HL, 2014, ANN EPIDEMIOL, V24, P206, DOI 10.1016/j.annepidem.2013.12.010; Lin PH, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0234-y; Longinetti E, 2017, NEUROLOGY, V89, P578, DOI 10.1212/WNL.0000000000004179; Lorenz D, 2011, EUR J NEUROL, V18, P972, DOI 10.1111/j.1468-1331.2010.03295.x; Louis ED, 2007, EUR J NEUROL, V14, P1138, DOI 10.1111/j.1468-1331.2007.01923.x; Louis ED, 2009, J NEUROL NEUROSUR PS, V80, P494, DOI 10.1136/jnnp.2008.162701; Louis ED, 2008, MOVEMENT DISORD, V23, P1747, DOI 10.1002/mds.22084; Louis ED, 2008, NEUROLOGY, V70, P1682, DOI 10.1212/01.wnl.0000311271.42596.32; Louis ED, 2007, NEUROLOGY, V69, P1982, DOI 10.1212/01.wnl.0000279339.87987.d7; Louis ED, 2007, NEUROEPIDEMIOLOGY, V28, P181, DOI 10.1159/000104096; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Minichino A, 2013, INT J ENV RES PUB HE, V10, P4790, DOI 10.3390/ijerph10104790; Mishima T, 2017, J PARKINSON DIS, V7, P353, DOI 10.3233/JPD-160982; Mitchell CS, 2015, NEURODEGENER DIS, V15, P109, DOI 10.1159/000369812; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Molloy GJ, 2008, PSYCHOSOM MED, V70, P863, DOI 10.1097/PSY.0b013e3181842e0c; Moylan S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-123; Munhoz RP, 2004, PARKINSONISM RELAT D, V10, P381, DOI 10.1016/j.parkreldis.2004.03.008; Muscatello MRA, 2014, WORLD J GASTROENTERO, V20, P7570, DOI 10.3748/wjg.v20.i24.7570; Nataraj A, 2005, MOVEMENT DISORD, V20, P1476, DOI 10.1002/mds.20608; Nayor M, 2015, CURR OPIN CARDIOL, V30, P543, DOI 10.1097/HCO.0000000000000206; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; NG SKC, 1993, NEUROLOGY, V43, P425, DOI 10.1212/WNL.43.2.425; Nicoletti A, 2010, MOVEMENT DISORD, V25, P2387, DOI 10.1002/mds.23297; Nunes JC, 2014, NEUROL SCI, V35, P595, DOI 10.1007/s10072-013-1571-x; Ondo WG, 2003, NEUROLOGY, V61, P1093, DOI 10.1212/01.WNL.0000086376.40750.AF; Oron Y, 2014, AUDIOL NEURO-OTOL, V19, P256, DOI 10.1159/000363215; Player MS, 2011, INT J PSYCHIAT MED, V41, P365, DOI 10.2190/PM.41.4.f; Postma DS, 2015, LANCET, V385, P899, DOI 10.1016/S0140-6736(14)60446-3; Qin HY, 2014, WORLD J GASTROENTERO, V20, P14126, DOI 10.3748/wjg.v20.i39.14126; Querques G, 2014, SURV OPHTHALMOL, V59, P532, DOI 10.1016/j.survophthal.2014.01.001; Rasul A, 2013, ARCH DERMATOL RES, V305, P407, DOI 10.1007/s00403-013-1325-x; Sacco S, 2015, CEPHALALGIA, V35, P146, DOI 10.1177/0333102414559551; Samokhvalov AV, 2010, EPILEPSIA, V51, P1177, DOI 10.1111/j.1528-1167.2009.02426.x; Sargent PA, 2000, ARCH GEN PSYCHIAT, V57, P174, DOI 10.1001/archpsyc.57.2.174; Scarmeas N, 2007, NEUROEPIDEMIOLOGY, V29, P170, DOI 10.1159/000111579; So EL, 1996, NEUROLOGY, V46, P350, DOI 10.1212/WNL.46.2.350; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strike PC, 2004, PROG CARDIOVASC DIS, V46, P337, DOI 10.1016/j.pcad.2003.09.001; STRUCK LK, 1990, STROKE, V21, P1395, DOI 10.1161/01.STR.21.10.1395; Sugiyama D, 2010, ANN RHEUM DIS, V69, P70, DOI 10.1136/ard.2008.096487; Svansdottir E, 2013, EUR J PREV CARDIOL, V20, P322, DOI 10.1177/2047487312441723; Tan DJ, 2015, EXPERT REV RESP MED, V9, P109, DOI 10.1586/17476348.2015.1000311; Teunissen LL, 2002, J NEUROL NEUROSUR PS, V72, P590, DOI 10.1136/jnnp.72.5.590; Thawani SP, 2009, NEUROLOGY, V73, P621, DOI 10.1212/WNL.0b013e3181b389f1; Thenganatt MA, 2012, PARKINSONISM RELAT D, V18, P1042, DOI 10.1016/j.parkreldis.2012.05.015; Tully PJ, 2013, PSYCHOL HEALTH MED, V18, P627, DOI 10.1080/13548506.2012.749355; Velilla S, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/895147; Visser NA, 2013, DIABETES CARE, V36, P817, DOI 10.2337/dc12-0469; Vitale C, 2012, MOVEMENT DISORD, V27, P1530, DOI 10.1002/mds.25149; Wiltink J, 2011, J AFFECT DISORDERS, V130, P429, DOI 10.1016/j.jad.2010.10.041; Woods SP, 2008, COGN BEHAV NEUROL, V21, P28, DOI 10.1097/WNN.0b013e3181684414; Wranicz Julia, 2014, Rocz Panstw Zakl Hig, V65, P273; Wu YL, 2014, INT J MED SCI, V11, P1185, DOI 10.7150/ijms.10001; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Yang H, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000222; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zesiewicz TA, 2004, PARKINSONISM RELAT D, V10, P417, DOI 10.1016/j.parkreldis.2004.04.001; Zhao Y, 2013, NUTRITION, V29, P828, DOI 10.1016/j.nut.2012.11.018; Zis P, 2017, J NEUROL SCI, V378, P204, DOI 10.1016/j.jns.2017.05.023	128	7	7	0	8	COLUMBIA UNIV LIBRARIES, CENTER DIGITAL RESEARCH & SCHOLARSHIP	NEW YORK	201 LEHMAN LIBRARY, INT AFFAIRS BLDG-SIPA, NEW YORK, NY 10027 USA	2160-8288			TREMOR OTHER HYPERK	Tremor Other Hyperkinetic Mov.	MAY 17	2018	8								8	10.7916/D8VD8FF5			14	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	GK5AT	WOS:000436183900001	29971194				2022-02-06	
J	Silver, D; Brown, N; Gissane, C				Silver, David; Brown, Nicola; Gissane, Conor			Reported concussion incidence in youth community Rugby Union and parental assessment of post head injury cognitive recovery using the King-Devick test	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						King-Devick test; Eye-movement; Occulo-motor; Sports-related concussion; Rugby union	VISUAL SCREENING TOOL; EYE-MOVEMENTS; MANAGEMENT; LEAGUE; METAANALYSIS; PLAYERS; TACKLE; SPORT; BAN	Aim: To assess the frequency of reported head injuries in youth community Rugby Union and determine whether the King-Devick (K-D) test could be used by parents as a means to chart cognitive recovery following head injury. Methods: A prospective cohort study of 489 junior players (U9-U18) conducted at a community level Rugby Union club over four seasons. All players undertook a baseline K-D test at the start of each season. Players identified with suspected concussion performed the K-D test post injury and results were compared to their most recent baseline assessment. Parent/Guardians of the player then oversaw repeated daily testing until baseline scores were surpassed. Results: 49 players were sent for assessment after suspected head injury. 46 parents oversaw daily repeated K-D testing (93.8% engagement). The median reduction in K-D test performance speed post-injury from baseline was 7.32 s (IQR 2.46 - 7.98). A median of 5.1 days/tests were taken for players to surpass baseline performance. No correlation was found between initial post-injury test and cognitive recovery time. 38 head injuries were reported from match play with an incidence rate of 12.7 per 1000 match hours (95% CI 9.2-17.5). Conclusion: The K-D test is a practical tool for baseline, post injury and parentally supervised repeated testing within youth community Rugby Union. Incidence of reported head injuries following match play is higher than previously reported. Parental engagement was high. Post-Injury K-D test performance should not be used as a means to predict symptom recovery.	[Silver, David; Brown, Nicola; Gissane, Conor] St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, Middx, England		Silver, D (corresponding author), St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, Middx, England.	Physio@cobhamrugby.co.uk	Gissane, Conor/I-3661-2019	Gissane, Conor/0000-0003-4677-3853; Brown, Nicola/0000-0001-5538-2171; Silver, David/0000-0002-9347-121X			Anderson E., 2010, SPORT THEORY SOCIAL, DOI [10.4324/9780203857434, DOI 10.4324/9780203857434]; Batten J, 2016, BRIT J SPORT MED, V50, P1293, DOI 10.1136/bjsports-2015-095949; Clacy A, 2017, J SPORT SCI, V35, P2232, DOI 10.1080/02640414.2016.1265140; Davidson R. M., 1969, MED J AUSTRALIA, V147, P119; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Dhawan PSA, 2014, NEUROL CLIN PRACT, V82, pS11; Duenas M, 2014, SURG NEUROL INT, V5, P91, DOI DOI 10.4103/2152-7806.134364; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Howitt Scott, 2016, J Can Chiropr Assoc, V60, P322; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Kroshus E, 2017, HEALTH EDUC BEHAV, P1, DOI [10.1177/10901981177115669, DOI 10.1177/10901981177115669]; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Pollock AM, 2017, BRIT J SPORT MED, V51, P1113, DOI 10.1136/bjsports-2016-096996; Qualsafe Ltd, QA LEV 3 AW EM 1 AID; R. F. U. (RFU), SEAS REP ENGL PROF R; R. F. U. (RFU), 2016, CONC HEADC ENGL RUGB; RFU, 2016, SAFE GUID PROV 1 AID; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Roberts SP, 2017, AM J SPORT MED, V45, P480, DOI 10.1177/0363546516668296; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Tucker R, 2016, BRIT J SPORT MED, V50, P921, DOI 10.1136/bjsports-2016-096322; Weerdenburg K, 2016, PAED CHILD HEALT-CAN, V21, pE22, DOI 10.1093/pch/21.3.e22; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	43	7	7	2	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	MAY 15	2018	388						40	46		10.1016/j.jns.2018.02.046			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GE0JI	WOS:000430899700011	29627029	Green Accepted			2022-02-06	
J	Christie, S; Chan, V; Mollayeva, T; Colantonio, A				Christie, Shanice; Chan, Vincy; Mollayeva, Tatyana; Colantonio, Angela			Systematic review of rehabilitation intervention outcomes of adult and paediatric patients with infectious encephalitis	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; HERPES-SIMPLEX ENCEPHALITIS; LONG-TERM OUTCOMES; COGNITIVE REHABILITATION; UNITED-STATES; INPATIENT REHABILITATION; FUNCTIONAL INDEPENDENCE; CHILDHOOD ENCEPHALITIS; VIRUS ENCEPHALITIS; CHILDREN	Objective Although a range of rehabilitation interventions have been applied to restore function after infectious encephalitis, there is a lack of literature summarising the benefits of these interventions. This systematic review aims to synthesise current scientific knowledge on outcome measures following rehabilitative interventions among children and adults with infectious encephalitis, with a specific focus on the influence of the age, sex, baseline status and intervention type. Search strategy Five scholarly databases (MEDLINE, Embase, PsycINFO, CINAHL and Cochrane Central Register of Controlled Trials), three sources of grey literature (Google, Google Scholar and Grey Matters) and reference lists of included publications were systematically searched. Literature published before 15 December 2017 and focused on patients with infectious encephalitis in any rehabilitation setting were included. Quality assessment was completed using the Downs and Black rating scale. Results Of the 12737 reference titles screened, 20 studies were included in this review. All of the studies had sample sizes of less than 25 patients and received a score of less than 15 out of 31 points on the Downs and Black rating scale. Findings showed a variety of interventions has been applied to alleviate sequelae from infectious encephalitis, including using cognitive therapy (nine studies), behavioural therapy (five studies), physical therapy (two studies) or two or more therapies (four studies). There was inconclusive evidence on the effect of sex, age and baseline functional abilities on outcomes. Due to clinical and methodological heterogeneity between studies, meta-analyses were not performed. Conclusion Evidence suggests the potential for a beneficial effect of rehabilitation interventions in patients with infectious encephalitis. Future research is required to identify all effect modifiers and to determine the effect of time in the natural course of recovery. An enhanced set of known effect modifiers will support the process of future evaluation of a client-centred rehabilitation intervention.	[Christie, Shanice; Chan, Vincy; Mollayeva, Tatyana] Univ Toronto, Acquired Brain Injury Res Lab, Toronto, ON, Canada; [Christie, Shanice] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Christie, Shanice; Chan, Vincy; Mollayeva, Tatyana; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Chan, Vincy; Mollayeva, Tatyana; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Christie, S (corresponding author), Univ Toronto, Acquired Brain Injury Res Lab, Toronto, ON, Canada.; Christie, S (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Christie, S (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada.	shanice.christie@mail.utoronto.ca	Chan, Vincy/AAA-7813-2020; , Mollayeva/A-4522-2018	Chan, Vincy/0000-0002-6884-044X; Colantonio, Angela/0000-0003-2094-4765	AC through the Canadian Institute of Health Research (CIHR) Chair in Gender Work and HealthCanadian Institutes of Health Research (CIHR) [CWG-126580]; CIHR and Pediatric Oncology Group of Ontario for a Doctoral Research AwardCanadian Institutes of Health Research (CIHR); Brain Canada; CIBC; Ontario Neurotrauma Foundation; Alzheimer's Association research fellowship grant [AARF-16-442937]	This work was supported by AC through the Canadian Institute of Health Research (CIHR) Chair in Gender Work and Health (#CWG-126580). VC received support from the CIHR and Pediatric Oncology Group of Ontario for a Doctoral Research Award, Brain Canada and CIBC for a Brain Cancer Training Award and the Ontario Neurotrauma Foundation for the Jane Gillett Pediatric ABI Studentship. TM received support by the Alzheimer's Association research fellowship grant (AARF-16-442937).	Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Andrewes D, 1999, NEUROPSYCHOL REHABIL, V9, P77, DOI 10.1080/713755591; [Anonymous], 1999, 4 INT C GREY LIT NEW, P4; Association of American Medical Colleges, INF DIS INT MED; Barikroo A, 2011, DYSPHAGIA, V26, P418, DOI 10.1007/s00455-011-9329-1; Berner Y, 2005, ARCH GERONTOL GERIAT, V41, P15, DOI 10.1016/j.archger.2004.10.006; Berry E, 2007, NEUROPSYCHOL REHABIL, V17, P582, DOI 10.1080/09602010601029780; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P1044; Chen AQ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-85; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Christie S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010754; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; Dewar BK, 2005, BRAIN INJURY, V19, P1285, DOI 10.1080/02699050500309536; Dewar BK, 2007, NEUROPSYCHOL REHABIL, V17, P602, DOI 10.1080/09602010601051610; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Emslie H, 2007, NEUROPSYCHOL REHABIL, V17, P567, DOI 10.1080/09602010701381933; Eng Janice J, 2007, Top Spinal Cord Inj Rehabil, V13, P1, DOI 10.1310/sci1301-1; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fowler A, 2013, J PEDIATR-US, V163, P555, DOI 10.1016/j.jpeds.2013.01.037; Fowler A, 2010, PEDIATRICS, V126, pE828, DOI 10.1542/peds.2009-3188; Friberg IO, 2016, SCAND J PUBLIC HEALT, V44, P264, DOI 10.1177/1403494815618843; George BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104169; GILES GM, 1989, J CLIN EXP NEUROPSYC, V11, P311, DOI 10.1080/01688638908400891; Giustini Alessandro, 2013, Handb Clin Neurol, V110, P401, DOI 10.1016/B978-0-444-52901-5.00034-4; Granerod J, 2007, NEUROPSYCHOL REHABIL, V17, P406, DOI 10.1080/09602010600989620; Granerod J, 2013, EMERG INFECT DIS, V19, P1455, DOI 10.3201/eid1909.130064; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Ilias A, 2006, J CHILD NEUROL, V21, P910, DOI 10.1177/08830738060210101701; Institute of Medicine, 2011, COGN REH THER TRAUM; Jimenez N, 2015, ARCH PHYS MED REHAB, V96, P1255, DOI 10.1016/j.apmr.2015.02.019; Kappus RM, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0046-6; KATZMANN S, 1994, AM J OCCUP THER, V48, P259, DOI 10.5014/ajot.48.3.259; Khandaker G, 2016, DEV MED CHILD NEUROL, V58, P1108, DOI 10.1111/dmcn.13197; Khetsuriani N, 2002, CLIN INFECT DIS, V35, P175, DOI 10.1086/341301; Khuu W, 2015, SYST REV-LONDON, V4, DOI 10.1186/2046-4053-4-14; Kolski H, 1998, CLIN INFECT DIS, V26, P398, DOI 10.1086/516301; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Kulkarni MA, 2013, EPIDEMIOL INFECT, V141, P2243, DOI 10.1017/S095026881200252X; Lowry PW, 1997, J LAB CLIN MED, V129, P405, DOI 10.1016/S0022-2143(97)90073-1; Mailles A, 2012, CLIN INFECT DIS, V54, P1455, DOI 10.1093/cid/cis226; MCMILLAN T M, 1990, Brain Injury, V4, P399, DOI 10.3109/02699059009026193; Mehndiratta P, 2015, CEREBROVASC DIS, V39, P302, DOI 10.1159/000381832; Miotto EC, 2002, ARQ NEURO-PSIQUIAT, V60, P21, DOI 10.1590/S0004-282X2002000100005; Miotto EC, 2007, NEUROPSYCHOL REHABIL, V17, P551, DOI 10.1080/09602010701202188; Modi S, 2017, J NEUROL, V264, P1204, DOI 10.1007/s00415-017-8516-x; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Moorthi S, 1999, BRAIN INJURY, V13, P139, DOI 10.1080/026990599121809; Morris P., 1995, CLIN REHABIL, V9, P267, DOI [10.1177/026921559500900315, DOI 10.1177/026921559500900315]; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; National Institute of Neurological Disorders and Stroke (NINDS), MEN ENC FACT SHEET; Olson, 1982, EDUC TREAT CHILD, V5, P261; Parkin AJ, 1998, COGNITIVE NEUROPSYCH, V15, P361, DOI 10.1080/026432998381131; Peterson BL, 2015, BEHAV BRAIN RES, V286, P152, DOI 10.1016/j.bbr.2015.03.005; Ponfick M, 2012, EUR J NEUROL, V19, P776, DOI 10.1111/j.1468-1331.2011.03651.x; RAO N, 1991, AM J PHYS MED REHAB, V70, P73, DOI 10.1097/00002060-199104000-00004; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; SLAVIN RE, 1995, J CLIN EPIDEMIOL, V48, P9, DOI 10.1016/0895-4356(94)00097-A; Tailor YI, 2013, J PEDIATR REHAB MED, V6, P163, DOI 10.3233/PRM-130248; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Tong CYW, 1997, LANCET, V349, P470, DOI 10.1016/S0140-6736(96)09320-8; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; Vora NM, 2014, NEUROLOGY, V82, P443, DOI 10.1212/WNL.0000000000000086; Wang IJ, 2007, EUR J PAEDIATR NEURO, V11, P63, DOI 10.1016/j.ejpn.2006.09.010; Whyte J, 2002, ARCH PHYS MED REHAB, V83, P1320, DOI 10.1053/apmr.2002.34807; WONG V, 1987, AUST PAEDIATR J, V23, P339; World Health Organization, DEF KEY TERMS; World Health Organization, REH HLTH; World Health Organization. (WHO), ADOLESCENT HEALTH; Yamamoto Eiko, 2000, Tokai Journal of Experimental and Clinical Medicine, V25, P173; Zhao WJ, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0045-7; Zhou YH, 2016, FRONT NEUROENDOCRIN, V40, P24, DOI 10.1016/j.yfrne.2015.07.001; Zifroni A, 1997, LANCET, V349, P1328, DOI 10.1016/S0140-6736(05)62546-9	80	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAY	2018	8	5							e015928	10.1136/bmjopen-2017-015928			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GJ7KZ	WOS:000435567200007	29764868	gold, Green Published			2022-02-06	
J	Dingman, AL; Stence, NV; O'Neill, BR; Sillau, SH; Chapman, KE				Dingman, Andra L.; Stence, Nicholas, V; O'Neill, Brent R.; Sillau, Stefan H.; Chapman, Kevin E.			Seizure Severity Is Correlated With Severity of Hypoxic-Ischemic Injury in Abusive Head Trauma	PEDIATRIC NEUROLOGY			English	Article						Traumatic brain injury; Abusive head trauma; Acute seizures; Status epilepticus; Hypoxic-ischemic injury	DIFFUSE AXONAL INJURY; SHAKEN BABY SYNDROME; NEONATAL SEIZURES; BRAIN-DAMAGE; PERINATAL ASPHYXIA; YOUNG-CHILDREN; TERM NEWBORNS; ENCEPHALOPATHY; RAT; MECHANISMS	Background: The objective of this study was to characterize hypoxic-ischemic injury and seizures in abusive head trauma. Methods: We studied 58 children with moderate or severe traumatic brain injury due to abusive head trauma. Continuous electroencephalograms and magnetic resonance images were scored. Results: Electrographic seizures (51.2%) and hypoxic-ischemic injury (77.4%) were common in our cohort. Younger age was associated with electrographic seizures (no seizures: median age 13.5 months, interquartile range five to 25 months, versus seizures: 4.5 months, interquartile range 3 to 9.5 months; P = 0.001). Severity of hypoxic-ischemic injury was also associated with seizures (no seizures: median injury score 1.0, interquartile range 0 to 3, versus seizures: 4.5, interquartile range 3 to 8; P = 0.01), but traumatic injury severity was not associated with seizures (no seizures: mean injury score 3.78 +/- 1.68 versus seizures: mean injury score 3.83 +/- 0.95, P = 0.89). There was a correlation between hypoxic-ischemic injury severity and seizure burden when controlling for patient age (r(s)=0.61, P < 0.001). The ratio of restricted diffusion volume to total brain volume (restricted diffusion ratio) was smaller on magnetic resonance imaging done early (median restricted diffusion ratio 0.03, interquartile range 0 to 0.23 on magnetic resonance imaging done within two days versus median restricted diffusion ratio 0.13, interquartile range 0.01 to 0.43 on magnetic resonance imaging done after two days, P = 0.03 ). Conclusions: Electrographic seizures are common in children with moderate to severe traumatic brain injury from abusive head trauma, and therefore children with suspected abusive head trauma should be monitored with continuous electroencephalogram. Severity of hypoxic-ischemic brain injury is correlated with severity of seizures, and evidence of hypoxic-ischemic injury on magnetic resonance imaging may evolve over time. Therefore children with a high seizure burden should be reimaged to evaluate for evolving hypoxic-ischemic injury. Published by Elsevier Inc.	[Dingman, Andra L.; Chapman, Kevin E.] Univ Colorado, Dept Pediat, Div Child Neurol, Anschuts Med Campus, Aurora, CO 80045 USA; [Stence, Nicholas, V] Univ Colorado, Dept Radiol, Div Pediat Radiol, Anschuts Med Campus, Aurora, CO USA; [O'Neill, Brent R.] Univ Colorado, Dept Neurosurg, Div Pediat Neurosurg, Anschuts Med Campus, Aurora, CO USA; [Sillau, Stefan H.] Univ Colorado, Dept Neurol, Anschuts Med Campus, Aurora, CO USA		Dingman, AL (corresponding author), Univ Colorado, Dept Pediat, Div Child Neurol, Anschuts Med Campus, Aurora, CO 80045 USA.	andra.dingman@childrenscolorado.org					Abend NS, 2011, J PEDIATR-US, V159, P479, DOI 10.1016/j.jpeds.2011.02.004; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Bednarek N, 2012, NEUROLOGY, V78, P1420, DOI 10.1212/WNL.0b013e318253d589; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Bourgeois M, 2008, CHILD NERV SYST, V24, P169, DOI 10.1007/s00381-007-0493-4; Campbell C, 2002, NEUROLOGY, V59, P1119, DOI 10.1212/WNL.59.7.1119; Canas N, 2010, EPILEPSY RES, V91, P240, DOI 10.1016/j.eplepsyres.2010.07.019; EVANS M, 1983, NEUROPATH APPL NEURO, V9, P39, DOI 10.1111/j.1365-2990.1983.tb00322.x; Fox CK, 2016, NEUROLOGY, V86, P2179, DOI 10.1212/WNL.0000000000002739; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Glass HC, 2009, J PEDIATR-US, V155, P318, DOI 10.1016/j.jpeds.2009.03.040; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; Hasbani DM, 2013, PEDIATR CRIT CARE ME, V14, P709, DOI 10.1097/PCC.0b013e3182917b83; Huang YC, 2009, EPILEPSY RES, V86, P72, DOI 10.1016/j.eplepsyres.2009.05.011; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Kadom N, 2014, PEDIATR RADIOL, V44, P839, DOI 10.1007/s00247-014-2874-7; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; Kranz PG, 2009, AM J NEURORADIOL, V30, P1206, DOI 10.3174/ajnr.A1547; Labeyrie MA, 2012, STROKE, V43, P2986, DOI 10.1161/STROKEAHA.112.661009; Lynch NE, 2012, EPILEPSIA, V53, P549, DOI 10.1111/j.1528-1167.2011.03401.x; Matschke J, 2015, INT J LEGAL MED, V129, P105, DOI 10.1007/s00414-014-1060-7; McCabe BK, 2001, J NEUROSCI, V21, P2094, DOI 10.1523/JNEUROSCI.21-06-02094.2001; McKinney AM, 2008, PEDIATR RADIOL, V38, P164, DOI 10.1007/s00247-007-0673-0; McLean C, 2004, SEMIN PERINATOL, V28, P425, DOI 10.1053/j.semperi.2004.10.005; Miller SP, 2002, NEUROLOGY, V58, P542, DOI 10.1212/WNL.58.4.542; Oehmichen M, 2008, ACTA NEUROPATHOL, V116, P317, DOI 10.1007/s00401-008-0356-4; Olivot JM, 2009, STROKE, V40, P1692, DOI 10.1161/STROKEAHA.108.538082; Pinard E, 2002, STROKE, V33, P606, DOI 10.1161/hs0202.102738; Sanchez RM, 2001, EPILEPSIA, V42, P577, DOI 10.1046/j.1528-1157.2001.12000.x; Shanahan ME, 2013, PEDIATRICS, V132, pE1546, DOI 10.1542/peds.2013-2049; Wang Y, 1996, EPILEPSIA, V37, P1000, DOI 10.1111/j.1528-1157.1996.tb00539.x; Wirrell EC, 2001, PEDIATR RES, V50, P445, DOI 10.1203/00006450-200110000-00005; Yager JY, 2002, DEV NEUROSCI-BASEL, V24, P367, DOI 10.1159/000069049; Zanelli S, 2014, NEUROBIOL DIS, V68, P37, DOI 10.1016/j.nbd.2014.03.005	37	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	MAY	2018	82						29	35		10.1016/j.pediatrneurol.2017.12.003			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	GH4OL	WOS:000433383000008	29625848				2022-02-06	
J	Gerritsen, H; Samim, M; Peters, H; Schers, H; van de Laar, F				Gerritsen, Herman; Samim, Mariam; Peters, Hans; Schers, Henk; van de Laar, Floris			Incidence, course and risk factors of head injury: a retrospective cohort study	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; SPECTRUM; BIAS; RULE	Objectives To assess the incidence of head injury and predictors of complication across the care continuum. Design Retrospective cohort study using data from a research network. We calculated the incidence of overall head injury in a longitudinal cohort covering 1-year interval (31 369 patient-years), and the incidence of complicated head injury in a longitudinal cohort covering 10 years interval (220 352 patient-ears). Incidence rates were calculated per 1000 patient-years with 95% CI using the Mid-P exact test. We calculated ORs to assess potential risk factors for a complicated head injury. Setting A practice-based research network covering a population of >30 000 patients. Participants All patients listed in practices within the research network during the years 2005-2014. Main outcome measures Incidence of (complicated) head injury and predictors for clinical complications. Results The incidence of overall head injury was 22.1 per 1000 person-years and the incidence of a complicated course following head injury was 0.16 per 1000 person-years. The following determinants were risk factors for a complicated course: high energy trauma, bicycle accident, traffic accident in general, use of anticoagulants, alcohol intoxication, age above 60 years and low Glasgow Coma Scale at initial presentation. A complicated course was very unlikely when the patients' first encounter with a healthcare professional was in primary care (OR 0.03, 95% CI 0.01 to 0.07). Conclusions Complication after head injury are rarely seen in general practice. Patients who do experience complications are often easily identifiable as requiring specialist care. A more reserved referral policy for general practice may be desirable, suggesting that current guidelines are too defensive.	[Gerritsen, Herman] Geert Groote Huisartsengroepspraktijk, Primary Care Ctr, Zwolle, Netherlands; [Samim, Mariam; Peters, Hans; Schers, Henk; van de Laar, Floris] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands		van de Laar, F (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands.	Floris.vandeLaar@radboudumc.nl	Schers, H.J./L-4631-2015; van de Laar, F.A./L-4467-2015	Schers, H.J./0000-0002-9362-9451; 	Hein Hogerzeil foundation	The Hein Hogerzeil foundation funded the article publishing fee in the form of a grant.	[Anonymous], 1998, NIH Consens Statement, V16, P1; [Anonymous], 2015, HUISARTS WET, V58, P82; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; de Kruijk Jelle R, 2012, Ned Tijdschr Geneeskd, V156, pA4195; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Draijer L Willem, 2015, Ned Tijdschr Geneeskd, V159, pA8992; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Gerritsen H, 2015, HUISARTS WET, V58, P80; Jelinek Michael, 2008, Evid Based Med, V13, P132, DOI 10.1136/ebm.13.5.132; KNOTTNERUS JA, 1985, J ROY COLL GEN PRACT, V35, P270; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; National Clinical Guideline C, 2014, NAT I HLTH CLIN EXC; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Opstelten Wim, 2012, Ned Tijdschr Geneeskd, V156, pA4474; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rose VL, 1999, AM FAM PHYSICIAN, V59, P1051; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; van den Brand Crispijn L, 2014, Ned Tijdschr Geneeskd, V158, pA6973; Van der Kruijk RA, 2015, TIJDSCHR NEUROLOG NE, V116, P154; van Weel C, 2012, J AM BOARD FAM MED, V25, pS12, DOI 10.3122/jabfm.2012.02.110212; Whiting PF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008155; Willis BH, 2008, FAM PRACT, V25, P390, DOI 10.1093/fampra/cmn051	31	7	7	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAY	2018	8	5							e020364	10.1136/bmjopen-2017-020364			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ7KZ	WOS:000435567200093	29858414	Green Published, gold			2022-02-06	
J	Hayes, DM; Nickell, CG; Chen, KY; McClain, JA; Heath, MM; Deeny, MA; Nixon, K				Hayes, Dayna M.; Nickell, Chelsea G.; Chen, Kevin Y.; McClain, Justin A.; Heath, Megan M.; Deeny, M. Ayumi; Nixon, Kimberly			Activation of neural stem cells from quiescence drives reactive hippocampal neurogenesis after alcohol dependence	NEUROPHARMACOLOGY			English	Article						Alcoholism; Ethanol; Adult neurogenesis; Hippocampus; Progenitor cell; Neurodegeneration	TRAUMATIC BRAIN-INJURY; ADULT-RAT HIPPOCAMPUS; BINGE ETHANOL EXPOSURE; MAGNETIC-RESONANCE; COGNITIVE RECOVERY; PROLIFERATING CELLS; PATTERN SEPARATION; PROGENITOR CELLS; ANALYSIS REVEALS; NEWBORN NEURONS	Neural stem cell-driven adult neurogenesis contributes to the integrity of the hippocampus. Excessive alcohol consumption in alcoholism results in hippocampal degeneration that may recover with abstinence. Reactive, increased adult neurogenesis during abstinence following alcohol dependence may contribute to recovery, but the mechanism driving reactive neurogenesis is not known. Therefore, adult, male rats were exposed to alcohol for four days and various markers were used to examine cell cycle dynamics, the percentage and number of neural progenitor cell subtypes, and the percentage of quiescent versus activated progenitors. Using a screen for cell cycle perturbation, we showed that the cell cycle is not likely altered at 7 days in abstinence. As the vast majority of Bromodeoxyuridine-positive (+) cells were co-labeled with progenitor cell marker, Sox2, we then developed a quadruple fluorescent labeling scheme to examine Type-1,-2a,-2b and -3 progenitor cells simultaneously. Prior alcohol dependence indiscriminately increased all subtypes at 7 days, the peak of the reactive proliferation. An evaluation of the time course of reactive cell proliferation revealed that cells begin proliferating at 5 days post alcohol, where only actively dividing Type 2 progenitors were increased by alcohol. Furthermore, prior alcohol increased the percentage of actively dividing Sox2+ progenitors, which supported that reactive neurogenesis is likely due to the activation of progenitors out of quiescence. These observations were associated with granule cell number returning to normal at 28 days. Therefore, activating stem and progenitor cells out of quiescence may be the mechanism underlying hippocampal recovery in abstinence Kfollowing alcohol dependence. (C) 2018 Elsevier Ltd. All rights reserved.	[Hayes, Dayna M.; Nickell, Chelsea G.; Chen, Kevin Y.; McClain, Justin A.; Heath, Megan M.; Deeny, M. Ayumi; Nixon, Kimberly] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 789 S Limestone,TODD 473, Lexington, KY 40536 USA; [Hayes, Dayna M.] Radford Univ, Dept Psychol, POB 6946,5127 CHBS, Radford, VA 24142 USA; [McClain, Justin A.] Gwynedd Mercy Univ, Div Nat & Computat Sci, Sch Arts & Sci, 1325 Sumneytown Pike, Gwynedd Valley, PA 19437 USA		Nixon, K (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 789 S Limestone,TODD 473, Lexington, KY 40536 USA.	dhayes4@radford.edu; chelsea.geil@uky.edu; kevin.chen@uky.edu; mcclain.j@gmercyu.edu; megan.heath@nortonhealthcare.org; margot.deeny@duke.edu; kim-nixon@uky.edu	Nixon, Kimberly/Y-9270-2019	Nixon, Kimberly/0000-0002-3466-9912; Chen, Kevin/0000-0002-8134-3376	National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA016959, F31AA023459]; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA007304, T32DA016176]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA016959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA007304, T32DA016176] Funding Source: NIH RePORTER	The authors gratefully acknowledge support of this work by the National Institute on Alcohol Abuse and Alcoholism grants R01AA016959 (KN), and F31AA023459 (CRGN), and the National Institute on Drug Abuse grants T32DA007304 (DMH) and T32DA016176 (CRGN; JAM).	ALTMAN J, 1969, J COMP NEUROL, V136, P269, DOI 10.1002/cne.901360303; Bartels C, 2007, ALCOHOL ALCOHOLISM, V42, P92, DOI 10.1093/alcalc/agl104; Belujon P, 2008, J NEUROSCI, V28, P9797, DOI 10.1523/JNEUROSCI.2200-08.2008; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Beresford TP, 2006, ALCOHOL CLIN EXP RES, V30, P1866, DOI 10.1111/j.1530-0277.2006.00223.x; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Broadwater MA, 2014, DEV NEUROSCI-BASEL, V36, P297, DOI 10.1159/000362874; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; CARLEN PL, 1978, SCIENCE, V200, P1076, DOI 10.1126/science.653357; Chanraud S, 2007, NEUROPSYCHOPHARMACOL, V32, P429, DOI 10.1038/sj.npp.1301219; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Collins MA, 1996, ALCOHOL CLIN EXP RES, V20, P284, DOI 10.1111/j.1530-0277.1996.tb01641.x; Contet C, 2014, ADDICT BIOL, V19, P770, DOI 10.1111/adb.12040; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; Crews FT, 2004, ALCOHOL, V33, P63, DOI 10.1016/j.alcohol.2004.04.005; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Deschaux O, 2014, ADDICT BIOL, V19, P562, DOI 10.1111/adb.12019; Diaz F, 2013, J NEUROSCI, V33, P6278, DOI 10.1523/JNEUROSCI.5885-12.2013; Ehlers CL, 2013, NEUROSCIENCE, V244, P1, DOI 10.1016/j.neuroscience.2013.03.058; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Fisher WP, 2017, SPR SER MEAS SCI TEC, P1, DOI 10.1007/978-3-319-67304-2_1; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Galinato MH, 2018, MOL PSYCHIATR, V23, P629, DOI 10.1038/mp.2017.46; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Gazdzinski S, 2008, ALCOHOL, V42, P67, DOI 10.1016/j.alcohol.2008.01.002; Geil CR, 2014, PROG NEURO-PSYCHOPH, V54, P103, DOI 10.1016/j.pnpbp.2014.05.003; Godsil BP, 2013, EUR NEUROPSYCHOPHARM, V23, P1165, DOI 10.1016/j.euroneuro.2012.10.018; Golub HM, 2015, ALCOHOL CLIN EXP RES, V39, P1967, DOI 10.1111/acer.12843; Gomez R, 2015, NICOTINE TOB RES, V17, P1442, DOI 10.1093/ntr/ntv051; Gomez-Nicola D, 2014, BRAIN, V137, P2312, DOI 10.1093/brain/awu155; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Hansson AC, 2010, INT J NEUROPSYCHOPH, V13, P583, DOI 10.1017/S1461145710000246; He J, 2005, EUR J NEUROSCI, V21, P2711, DOI 10.1111/j.1460-9568.2005.04120.x; He J, 2009, ALCOHOL CLIN EXP RES, V33, P129, DOI 10.1111/j.1530-0277.2008.00823.x; Herrera DG, 2003, P NATL ACAD SCI USA, V100, P7919, DOI 10.1073/pnas.1230907100; HUNT WA, 1993, ALCOHOL, V10, P559, DOI 10.1016/0741-8329(93)90083-Z; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jhaveri DJ, 2012, DEV NEUROBIOL, V72, P1044, DOI 10.1002/dneu.22027; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kelso ML, 2011, NEUROSCIENCE, V197, P381, DOI 10.1016/j.neuroscience.2011.09.019; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kunze A, 2006, NEUROBIOL DIS, V21, P324, DOI 10.1016/j.nbd.2005.07.013; Leasure JL, 2010, ALCOHOL CLIN EXP RES, V34, P404, DOI 10.1111/j.1530-0277.2009.01105.x; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Liu JL, 1998, J NEUROSCI, V18, P7768; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; MAJCHROWICZ E, 1975, PSYCHOPHARMACOLOGIA, V43, P245, DOI 10.1007/BF00429258; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Mandyam Chitra D, 2013, Front Psychiatry, V4, P61, DOI 10.3389/fpsyt.2013.00061; Mandyam CD, 2012, TRENDS NEUROSCI, V35, P250, DOI 10.1016/j.tins.2011.12.005; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; Mattiesen WRC, 2009, ACTA NEUROPATHOL, V117, P525, DOI 10.1007/s00401-009-0509-0; McClain JA, 2014, ADDICT BIOL, V19, P687, DOI 10.1111/adb.12075; McClain JA, 2011, J COMP NEUROL, V519, P2697, DOI 10.1002/cne.22647; Mhatre MC, 2001, PHARMACOL BIOCHEM BE, V68, P339, DOI 10.1016/S0091-3057(00)00481-0; Morris SA, 2010, ALCOHOL, V44, P89, DOI 10.1016/j.alcohol.2009.10.017; Morris SA, 2010, HIPPOCAMPUS, V20, P596, DOI 10.1002/hipo.20665; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Ninkovic J, 2007, CURR OPIN NEUROBIOL, V17, P338, DOI 10.1016/j.conb.2007.04.006; Nixon K, 2008, NEUROBIOL DIS, V31, P218, DOI 10.1016/j.nbd.2008.04.009; Nixon K, 2006, HIPPOCAMPUS, V16, P287, DOI 10.1002/hipo.20162; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; Noori HR, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00140; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; NRC, 2011, GUIDE CARE USE LAB A; Obernier JA, 2002, PHARMACOL BIOCHEM BE, V72, P521, DOI 10.1016/S0091-3057(02)00715-3; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Olsufka R., 2018, STEM CELLS TOXICOLOG; Ozsoy S, 2013, ALCOHOL, V47, P9, DOI 10.1016/j.alcohol.2012.09.002; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Parent JM, 1997, J NEUROSCI, V17, P3727; Paxinos G, 2009, RAT BRAIN STEREOTAXI; Peng H, 2017, ALCOHOL, V62, P29, DOI 10.1016/j.alcohol.2017.02.175; Penland S, 2001, ALCOHOL, V24, P45, DOI 10.1016/S0741-8329(01)00142-2; PFEFFERBAUM A, 1995, ALCOHOL CLIN EXP RES, V19, P1177, DOI 10.1111/j.1530-0277.1995.tb01598.x; Prendergast MA, 2012, ADDICT BIOL, V17, P209, DOI 10.1111/j.1369-1600.2011.00375.x; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Richardson HN, 2009, NEUROBIOL DIS, V36, P1, DOI 10.1016/j.nbd.2009.05.021; RILEY JN, 1978, SCIENCE, V201, P646, DOI 10.1126/science.566953; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sakharkar AJ, 2016, BRAIN STRUCT FUNCT, V221, P4691, DOI 10.1007/s00429-016-1196-y; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Segi-Nishida E, 2008, P NATL ACAD SCI USA, V105, P11352, DOI 10.1073/pnas.0710858105; Sgubin D, 2007, J NEUROSCI RES, V85, P1647, DOI 10.1002/jnr.21303; Somkuwar SS, 2016, BRAIN STRUCT FUNCT, V221, P4319, DOI 10.1007/s00429-015-1163-z; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; SULLIVAN EV, 1995, ALCOHOL CLIN EXP RES, V19, P110, DOI 10.1111/j.1530-0277.1995.tb01478.x; Sun CR, 2013, J NEUROSCI, V33, P17314, DOI 10.1523/JNEUROSCI.2129-13.2013; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Taffe MA, 2010, P NATL ACAD SCI USA, V107, P11104, DOI 10.1073/pnas.0912810107; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yoneyama M, 2011, J PHARMACOL SCI, V115, P425, DOI 10.1254/jphs.11R02CP; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Yun S, 2016, NAT MED, V22, P1239, DOI 10.1038/nm.4218; Zahr NM, 2010, BIOL PSYCHIAT, V67, P846, DOI 10.1016/j.biopsych.2009.10.028	110	7	7	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	MAY 1	2018	133						276	288		10.1016/j.neuropharm.2018.01.032			13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	GC6HX	WOS:000429891800026	29378214	Green Accepted			2022-02-06	
J	Hohne, J; Werzmirzowsky, K; Ott, C; Hohenberger, C; Hassanin, BG; Brawanski, A; Schebesch, KM				Hoehne, Julius; Werzmirzowsky, Korbinian; Ott, Christian; Hohenberger, Christoph; Hassanin, Bahaa Ghareb; Brawanski, Alexander; Schebesch, Karl-Michael			Outcomes of Cranioplasty with Preformed Titanium versus Freehand Molded Polymethylmethacrylate Implants	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						cranioplasty; craniectomy; titanium; polymethylmethacrylate; outcome	MIDDLE-CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; MALIGNANT INFARCTION; CONTROLLED-TRIAL; MULTICENTER; HEMICRANIECTOMY; COMPLICATIONS; EXPERIENCE; INFECTION	Objective Cranioplasty reshapes the neurocranium and viscerocranium after craniectomy. Different materials have been used for cranioplasty. However, no consistent data are yet available comparing these different materials regarding indications, complications, and outcome. We report our experience with preformed titanium implants and freehand molded polymethylmethacrylate (PMMA) implants for cranioplasty. Methods This retrospective single-center analysis included 120 consecutive cranioplasty patients who had been operated between 2006 and 2013. A total of 60 patients (27 women, 33 men; mean age: 54 years) had received a preformed titanium implant and 60 patients (22 women, 38 men; mean age: 46 years) a freehand molded PMMA implant. We evaluated all demographic and procedure-related data, indications, and outcome. The longest follow-up was 5.5 years. Results The most frequent indications for cranioplasty were trauma (n = 48 [40%]), malignant infarction (n = 27 [23%]), tumor (n = 22 [18%]), spontaneous intracerebral or aneurysmal subarachnoid hemorrhage (n = 16 [13%]), revision surgery (n = 5 [4%]), and empyema (n = 2 [2%]). PMMA implants were more often associated with wound-healing disorders (p < 0.023; odds ratio [OR]: 10.53) and epidural hematoma (p < 0.03; OR: 8.46), resulting in a significantly higher re-operation rate (p < 0.005). Precise fitting was radiologically confirmed in 98% of titanium implants but in only 71% of PMMA implants (p < 0.001). Magnetic resonance imaging of patients with titanium implants (n = 4) did not show any relevant artifacts. Conclusion Cranioplasty with preformed titanium implants seems to be superior to freehand molded PMMA implants regarding surgical morbidity, revision rate, and aesthetic results.	[Hoehne, Julius; Werzmirzowsky, Korbinian; Ott, Christian; Hohenberger, Christoph; Hassanin, Bahaa Ghareb; Brawanski, Alexander; Schebesch, Karl-Michael] Univ Med Ctr Regensburg, Dept Neurosurg, Franz Josef Strauss Allee 11, D-93051 Regensburg, Germany; [Hassanin, Bahaa Ghareb] Sohag Univ, Fac Med, Dept Neurosurg, Sohag, Egypt		Hohne, J (corresponding author), Univ Med Ctr Regensburg, Dept Neurosurg, Franz Josef Strauss Allee 11, D-93051 Regensburg, Germany.	julius.hoehne@ukr.de	Hoehne, Julius/M-4210-2019; Hohne, Julius/J-6159-2015	Hoehne, Julius/0000-0002-8238-2211; Hohne, Julius/0000-0002-8238-2211			Adeoye O, 2011, J STROKE CEREBROVASC, V20, P251, DOI 10.1016/j.jstrokecerebrovasdis.2010.01.006; Al-Tamimi YZ, 2012, BRIT J NEUROSURG, V26, P510, DOI 10.3109/02688697.2011.633640; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; CHANDLER CL, 1994, BRIT J NEUROSURG, V8, P409, DOI 10.3109/02688699408995107; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coulter IC, 2014, ACTA NEUROCHIR, V156, P1361, DOI 10.1007/s00701-014-2081-1; Giese H, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009273; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Hill CS, 2012, BRIT J NEUROSURG, V26, P832, DOI 10.3109/02688697.2012.692839; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hohne Julius, 2013, Surg Neurol Int, V4, P88, DOI 10.4103/2152-7806.114811; Honeybul S, 2017, J NEUROSURG, V126, P81, DOI 10.3171/2015.12.JNS152004; Honeybul S, 2013, J NEUROSURG, V119, P1566, DOI 10.3171/2013.8.JNS13857; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Im SH, 2012, J KOREAN NEUROSURG S, V52, P396, DOI 10.3340/jkns.2012.52.4.396; Jaberi J, 2013, J ORAL MAXIL SURG, V71, pE81, DOI 10.1016/j.joms.2012.09.023; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Joffe J, 1999, BRIT J NEUROSURG, V13, P576, DOI 10.1080/02688699943088; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kim H, 2013, ACTA NEUROCHIR, V155, P2171, DOI 10.1007/s00701-013-1877-8; Lee L, 2013, BRIT J NEUROSURG, V27, P629, DOI 10.3109/02688697.2013.815313; Lindner D, 2017, J NEUROSURG, V126, P175, DOI 10.3171/2015.10.JNS151245; Luo JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.2.FOCUS129; Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055; Park JS, 2007, J KOREAN NEUROSURG S, V42, P89; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; Reddy S, 2014, PLAST RECONSTR SURG, V133, P864, DOI 10.1097/PRS.0000000000000013; Schebesch KM, 2013, J CRANIO MAXILL SURG, V41, P803, DOI 10.1016/j.jcms.2013.01.030; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Schwarz F, 2016, J NEUROSURG, V124, P710, DOI 10.3171/2015.4.JNS159; Sobani Zain A, 2011, Surg Neurol Int, V2, P123, DOI 10.4103/2152-7806.85055; Thavarajah D, 2012, BRIT J NEUROSURG, V26, P78, DOI 10.3109/02688697.2011.603850; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Wiggins A, 2013, NEUROSURGERY, V72, P248, DOI 10.1227/NEU.0b013e31827b98f3; Zanaty M, 2015, J NEUROSURG, V123, P182, DOI 10.3171/2014.9.JNS14405	42	7	9	0	6	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	MAY	2018	79	3					200	205		10.1055/s-0037-1604362			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GB8RU	WOS:000429343800003	28800664				2022-02-06	
J	Hunt, C; Michalak, A; Johnston, E; Lefkimmiatis, C; Macumber, L; Jocko, T; Ouchterlony, D				Hunt, Cindy; Michalak, Alicja; Johnston, Elaine; Lefkimmiatis, Chrissy; Macumber, Leila; Jocko, Tony; Ouchterlony, Donna			Knowledge, Attitudes and Concussion Information Sources Among First Nations in Ontario	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Brain injury-traumatic; Brain injury-pediatric; Education; Head trauma	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; CONSENSUS STATEMENT; NORTH-AMERICAN; HEAD-INJURY; IMPACT; PREVENTION; MANAGEMENT; CHILDREN; SPORTS	Objective: Hockey is a popular sport played by many First Nation youth. Concussion frequently goes unrecognized and unreported in youth hockey. Unintentional injuries among Indigenous youth occur at rates three to four times the national Canadian average. The study sought to examine knowledge, attitudes and sources of concussion information among First Nations people attending a provincial hockey tournament. Methods: A cross-sectional survey was undertaken. The survey by Mzazik et al. were modified to use in this study. Participants included youth (6-18 years) hockey players (n = 75), parents (n = 248) and coaches (n = 68). The main outcome measure was total knowledge index (TKI) which consisted of the sum of correct responses to 15 multiple choice questions. Additional data gathered included demographics, concussion history, attitudes toward concussion and sources of information. Descriptive statistics included proportion comparisons. Variables were tested using chi(2) and analysis of variance. Results: Overall TKI scores (out of a total of 15) were low; players (5.9 +/- 2.8), parents (7.5 +/- 2.6) and coaches (7.9 +/- 2.6). Participants with higher knowledge scores reported more appreciation of the seriousness of concussion. Sources of information about concussion differed by study group, suggesting the need for multiple knowledge translation strategies to reach youth, parents and coaches. Conclusions: Future initiatives are urgently needed to improve education and prevention of concussion in First Nations youth hockey. Collaborating and engaging with communities can help to ensure an Indigenous lens for culturally safe interventions.	[Hunt, Cindy; Michalak, Alicja; Lefkimmiatis, Chrissy; Ouchterlony, Donna] St Michaels Hosp, Trauma & Neurosurg Program, Head Injury Clin, 193 Yonge St,3rd Floor, Toronto, ON M5B 1M8, Canada; [Johnston, Elaine] Serpent River First Nation, Cutler, ON, Canada; [Macumber, Leila] Serpent River First Nation, Kenabutch Hlth Ctr, Cutler, ON, Canada; [Jocko, Tony] Union Ontario Indians, North Bay, ON, Canada		Hunt, C (corresponding author), St Michaels Hosp, Trauma & Neurosurg Program, Head Injury Clin, 193 Yonge St,3rd Floor, Toronto, ON M5B 1M8, Canada.	huntci@smh.ca					Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Banerji A, 2012, PAED CHILD HEALT-CAN, V17, P393, DOI 10.1093/pch/17.7.393; BC Research and Injury Prevention, CONC AW TRAIN TOOLK; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Blackmer J, 1999, BRAIN INJURY, V13, P627; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Burke MJ, 2012, CAN J NEUROL SCI, V39, P763, DOI 10.1017/S0317167100015584; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Cusimano Michael D, 2011, Open Med, V5, pe57; Dudley RW, 2012, CAN J NEUROL SCI S3, V39, pS20, DOI DOI 10.1017/S0317167100018138; Eagles ME, 2016, CAN J NEUROL SCI, V43, P659, DOI 10.1017/cjn.2016.263; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis MJ, 2017, CAN J NEUROL SCI, V44, P24, DOI 10.1017/cjn.2016.312; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Giles AR, 2015, PUBLIC HEALTH NURS, V32, P543, DOI 10.1111/phn.12210; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Harrop AR, 2007, PUBLIC HEALTH REP, V122, P339, DOI 10.1177/003335490712200307; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hunt C, 2016, CONCUSSION, V1; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Latimer Margot, 2014, CMAJ Open, V2, pE133, DOI 10.9778/cmajo.20130086; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P1557, DOI 10.1136/bjsports-2017-098065; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Mrazik M, 2015, J HEAD TRAUMA REHAB, V30, P219, DOI 10.1097/HTR.0000000000000018; National Steering Committee of the First Nations and Inuit Regional Longitudinal Health Survey, 2015, 1 NAT PRINC OWN CONT; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Parachute Canada, CAN GUID CONC SPORT; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Ross A, 2015, ADDICT BEHAV, V51, P184, DOI 10.1016/j.addbeh.2015.07.014; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Smylie J, 2009, HEALTH PROMOT PRACT, V10, P436, DOI 10.1177/1524839907307993; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Zeiler KJ, 2017, CAN J NEUROL SCI, V44, P525, DOI 10.1017/cjn.2017.49	45	7	7	0	5	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2018	45	3					283	289		10.1017/cjn.2017.299			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GF8MQ	WOS:000432227200006	29552994	Bronze			2022-02-06	
J	Kannan, N; Wang, J; Mink, RB; Wainwright, MS; Groner, JI; Bell, MJ; Giza, CC; Zatzick, DF; Ellenbogen, RG; Boyle, LN; Mitchell, PH; Rivara, FP; Rowhani-Rahbar, A; Vavilala, MS				Kannan, Nithya; Wang, Jin; Mink, Richard B.; Wainwright, Mark S.; Groner, Jonathan I.; Bell, Michael J.; Giza, Christopher C.; Zatzick, Douglas F.; Ellenbogen, Richard G.; Boyle, Linda Ng; Mitchell, Pamela H.; Rivara, Frederick P.; Rowhani-Rahbar, Ali; Vavilala, Monica S.		PEGASUS Pediat Guideline Adhe	Timely Hemodynamic Resuscitation and Outcomes in Severe Pediatric Traumatic Brain Injury Preliminary Findings	PEDIATRIC EMERGENCY CARE			English	Article						timely; resuscitation; traumatic brain injury; hypotension	SEVERE HEAD-INJURY; CHILDREN; HYPOTENSION; IMPACT	Objectives: Early resuscitation may improve outcomes in pediatric traumatic brain injury (TBI). We examined the association between timely treatment of hypotension and hypoxia during early care (prehospital or emergency department locations) and discharge outcomes in children with severe TBI. Methods: Hypotension was defined as systolic blood pressure less than 70 + 2 (age in years), and hypoxia was defined as Pao(2) less than 60 mm Hg or oxygen saturation less than 90% in accordance with the 2003 Brain Trauma Foundation guidelines. Timely treatment of hypotension and hypoxia during early care was defined as the treatment within 30 minutes of a documented respective episode. Two hundred thirty-six medical records of children younger than 18 years with severe TBI from 5 regional pediatric trauma centers were examined. Main outcomes were in-hospital mortality and discharge Glasgow Outcome Scale (GOS) score. Results: Hypotension occurred in 26% (60/234) during early care and was associated with in-hospital mortality (23.3% vs 8.6%; P = 0.01). Timely treatment of hypotension during early care occurred in 92% (55/60) by use of intravenous fluids, blood products, or vasopressors and was associated with reduced in-hospital mortality [adjusted relative risk (aRR), 0.46; 95% confidence interval, 0.24-0.90] and less likelihood of poor discharge GOS (aRR, 0.54; 95% confidence interval, 0.39-0.76) when compared to children with hypotension who were not treated in a timely manner. Early hypoxia occurred in 17% (41/236) and all patients received timely oxygen treatment. Conclusions: Timely resuscitation during early care was common and associated with lower in-hospital mortality and favorable discharge GOS in severe pediatric TBI.	[Kannan, Nithya; Rivara, Frederick P.; Rowhani-Rahbar, Ali] Univ Washington, Epidemiol, Seattle, WA 98195 USA; [Wang, Jin; Rivara, Frederick P.; Vavilala, Monica S.] Univ Washington, Pediat, Seattle, WA 98195 USA; [Mink, Richard B.] Harbor UCLA, Dept Pediat, Torrance, CA USA; [Ellenbogen, Richard G.] Los Angeles BioMed Res Inst, Torrance, CA USA; [Wainwright, Mark S.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL 60611 USA; [Groner, Jonathan I.] Ohio State Univ, Coll Med, Dept Surg, Columbus, OH 43210 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Dept Neurosurg, Mattel Childrens Hosp, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Div Pediat Neurol, Mattel Childrens Hosp, Los Angeles, CA USA; [Zatzick, Douglas F.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Ellenbogen, Richard G.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Ellenbogen, Richard G.] Univ Washington, Dept Global Hlth Med, Seattle, WA 98195 USA; [Boyle, Linda Ng] Univ Washington, Dept Ind & Syst Engn, Seattle, WA 98195 USA; [Mitchell, Pamela H.] Univ Washington, Sch Nursing, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Pain Med, Seattle, WA 98195 USA		Vavilala, MS (corresponding author), Harborview Injury Prevent & Res Ctr, 401 Broadway,Box 359960, Seattle, WA 98104 USA.	vavilala@u.washington.edu		Rowhani-Rahbar, Ali/0000-0002-2705-4485	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS072308-05]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	The source of support for this work including design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript was NINDS R01 NS072308-05.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Altman D.G., 1990, PRACTICAL STAT MED R; Buck CJ, 2010, INT CLASSIFICATION D; Chiaretti A, 2002, CHILD NERV SYST, V18, P54, DOI 10.1007/s00381-001-0533-4; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleiss JH., 1981, STAT METHODS RATES P; JENNETT B, 1976, LANCET, V1, P1031; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; MAYER TA, 1985, ANN EMERG MED, V14, P1178, DOI 10.1016/S0196-0644(85)81025-8; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; StataCorp, 2009, STAT STAT SOFTW COMP; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	22	7	7	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAY	2018	34	5					325	329		10.1097/PEC.0000000000000803			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	GF8AJ	WOS:000432189400013	27387972	Green Accepted			2022-02-06	
J	Lee, CJ; Felix, ER; Levitt, RC; Eddy, C; Vanner, EA; Feuer, WJ; Sarantopoulos, CD; Galor, A				Lee, Charity J.; Felix, Elizabeth R.; Levitt, Roy C.; Eddy, Christopher; Vanner, Elizabeth A.; Feuer, William J.; Sarantopoulos, Constantine D.; Galor, Anat			Traumatic brain injury, dry eye and comorbid pain diagnoses in US veterans	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; UNITED-STATES; RETROSPECTIVE ANALYSIS; NEUROPATHIC PAIN; OCULAR SURFACE; WORKSHOP 2007; SYMPTOMS; DISEASE; PATHOPHYSIOLOGY	Aims The purpose of the study is to evaluate the relationship between dry eye (DE) and pain diagnoses in US veterans with and without traumatic brain injury (TBI). Methods Retrospective cohort study of veterans who were seen in the Veterans Administration Hospital (VA) between 1 January 2010 and 31 December 2014. Veterans were separated into two groups by the presence or absence of an International Classification of Diseases, Ninth Revision diagnosis of TBI and assessed for DE and other comorbidities. A dendrogram was used to investigate the linkage between TBI, DE, chronic pain and other comorbid conditions. Results Of the 3 265 894 veterans seen during the 5-year period, 3.97% carried a diagnosis of TBI. Veterans with TBI were more likely to have a diagnosis of DE compared with their counterparts without TBI (37.2% vs 29.1%, p<0.0005). The association was stronger between TBI and ocular pain (OR 3.08; 95% CI 3.03 to 3.13) compared with tear film dysfunction (OR 1.09; 95% CI 1.07 to 1.10). Those with TBI were also about twice as likely to have a diagnosis of chronic pain, headache, depression or post-traumatic stress disorder compared with their counterparts without TBI. Cluster analysis of TBI, DE and pain diagnoses of interest revealed that central pain syndrome, cluster headache, sicca syndrome, keratoconjunctivitis sicca and late effect of injury to the nervous system (as can be seen after TBI) were all closely clustered together. Conclusions DE and pain disorders occur at higher frequencies in patients with a diagnosis of TBI, suggesting a common underlying pathophysiology.	[Lee, Charity J.; Felix, Elizabeth R.; Levitt, Roy C.; Galor, Anat] Miami VA Med Ctr, Dept Ophthalmol, Miami, FL 33125 USA; [Lee, Charity J.; Vanner, Elizabeth A.; Feuer, William J.; Galor, Anat] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA; [Felix, Elizabeth R.] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, Miami, FL 33136 USA; [Levitt, Roy C.; Eddy, Christopher; Sarantopoulos, Constantine D.] Univ Miami, Miller Sch Med, Dept Anesthesiol Perioperat Med & Pain Management, Miami, FL 33136 USA; [Levitt, Roy C.] Univ Miami, Miller Sch Med, Inst Human Genom, Miami, FL 33136 USA; [Levitt, Roy C.] Univ Miami, Miller Sch Med, Dept Human Genet, Miami, FL 33136 USA		Galor, A (corresponding author), Miami VA Med Ctr, Dept Ophthalmol, Miami, FL 33125 USA.	agalor@med.miami.edu	Felix, Elizabeth/AAD-6356-2021	Feuer, William/0000-0002-9442-3076; Vanner, Elizabeth/0000-0003-1875-4524; Felix, Elizabeth/0000-0002-6239-715X	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences ResearchUS Department of Veterans Affairs [EPID-006-15S]; NIH Center Core GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30EY014801, R01EY026174]; Research to Prevent Blindness Unrestricted GrantResearch to Prevent Blindness (RPB); Department of Anesthesiology, Perioperative Medicine, and Pain Management, University of Miami Miller School of Medicine, Miami, Florida; NIH NIDCRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [RO1 DE022903]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY014801, R01EY026174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE022903] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001089] Funding Source: NIH RePORTER	Supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences Research EPID-006-15S (AG), NIH Center Core Grant P30EY014801, R01EY026174 (AG), Research to Prevent Blindness Unrestricted Grant, NIH NIDCR RO1 DE022903 (RCL and Martin), Department of Anesthesiology, Perioperative Medicine, and Pain Management, University of Miami Miller School of Medicine, Miami, Florida.	Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cockerham GC, 2013, OCUL SURF, V11, P25, DOI 10.1016/j.jtos.2012.09.004; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Formisano R, 2009, MED SCI MONITOR, V15, pCR101; Galor A, 2017, EYE CONTACT LENS, P1; Galor A, 2016, JAMA OPHTHALMOL, V134, P1290, DOI 10.1001/jamaophthalmol.2016.3642; Galor A, 2016, J PAIN, V17, P310, DOI 10.1016/j.jpain.2015.10.019; Galor A, 2015, BRIT J OPHTHALMOL, V99, P1126, DOI 10.1136/bjophthalmol-2014-306481; Galor A, 2012, CORNEA, V31, P1403, DOI 10.1097/ICO.0b013e31823cc0b7; Galor A, 2012, AM J OPHTHALMOL, V154, P340, DOI 10.1016/j.ajo.2012.02.009; Kalangara JP, 2017, EYE CONTACT LENS, V43, P192, DOI 10.1097/ICL.0000000000000249; Katz BJ, 2016, SURV OPHTHALMOL, V61, P466, DOI 10.1016/j.survophthal.2016.02.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee V, 2004, EYE, V18, P1225, DOI 10.1038/sj.eye.6701383; Lemp MA, 2007, OCUL SURF, V5, P75; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Martinez JD, 2016, CLIN OPHTHALMOL, V10, P1335, DOI 10.2147/OPTH.S106451; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Moshourab RA, 2015, BRAIN NEUROTRAUMA MO; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Pekel E, 2016, AM J OPHTHALMOL, V166, P203, DOI 10.1016/j.ajo.2016.03.022; Pouyeh B, 2012, AM J OPHTHALMOL, V153, P1061, DOI 10.1016/j.ajo.2011.11.030; Rosenthal P, 2016, BRIT J OPHTHALMOL, V100, P128, DOI 10.1136/bjophthalmol-2014-306280; Rosenthal P, 2012, OCUL SURF, V10, P2, DOI 10.1016/j.jtos.2012.01.002; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Rutner D, 2006, BRAIN INJURY, V20, P1079, DOI 10.1080/02699050600909904; Sarantopoulos C, 2013, REGION ANESTH PAIN M, V38, P378, DOI 10.1097/AAP.0b013e3182a3922b; Schein OD, 1997, OPHTHALMOLOGY, V104, P1395, DOI 10.1016/S0161-6420(97)30125-0; Smith JA, 2007, OCUL SURF, V5, P93; Takahashi Courtney, 2015, Handb Clin Neurol, V128, P539, DOI 10.1016/B978-0-444-63521-1.00034-0; Truong JQ, 2014, BRAIN INJURY, V28, P1283, DOI 10.3109/02699052.2014.915989; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Yu JH, 2011, CORNEA, V30, P379, DOI 10.1097/ICO.0b013e3181f7f363; Yunus MB, 2008, SEMIN ARTHRITIS RHEU, V37, P339, DOI 10.1016/j.semarthrit.2007.09.003; Yunus MB, 2015, CURR RHEUMATOL REV, V11, P70, DOI 10.2174/157339711102150702112236; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	42	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	MAY	2018	102	5					667	673		10.1136/bjophthalmol-2017-310509			7	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	GD3YN	WOS:000430439800015	28844048				2022-02-06	
J	Leon-Espinosa, G; Regalado-Reyes, M; DeFelipe, J; Munoz, A				Leon-Espinosa, Gonzalo; Regalado-Reyes, Mamen; DeFelipe, Javier; Munoz, Alberto			Changes in neocortical and hippocampal microglial cells during hibernation	BRAIN STRUCTURE & FUNCTION			English	Article						Resting microglia; Activated microglia; Dystrophic microglia; Syrian hamster; Torpor; Iba-1	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; IMMUNE-SYSTEM; DYSTROPHIC MICROGLIA; TAU PHOSPHORYLATION; REACTIVE MICROGLIA; GROUND-SQUIRRELS; NITRIC-OXIDE; DYNAMICS; HYPOTHERMIA	Mammalian hibernation proceeds alongside a wide range of complex brain adaptive changes that appear to protect the brain from extreme hypoxia and hypothermia. Using immunofluorescence, confocal microscopy, quantitative analysis methods and intracellular injections, we have characterized microglia morphological changes that occur in the neocortex and hippocampus of the Syrian hamster during hibernation. In euthermic hamsters, microglial cells showed the typical ramified/resting morphology with multiple long, thin and highly-branched processes homogeneously immunostained for Iba-1. However, during torpor, microglial cell process numbers increase significantly accompanied by a shortening of the Iba-1 immunoreactive processes, which show a fragmented appearance. Adaptative changes of microglial cells during torpor coursed with no expression of microglial cell activation markers. We discuss the possibility that these morphological changes may contribute to neuronal damage prevention during hibernation.	[Leon-Espinosa, Gonzalo; DeFelipe, Javier; Munoz, Alberto] CSIC, Inst Cajal, Madrid, Spain; [Leon-Espinosa, Gonzalo; Regalado-Reyes, Mamen; DeFelipe, Javier; Munoz, Alberto] Univ Politecn Madrid, Ctr Tecnol Biomed, Lab Cajal Circuitos Cort CTB, Madrid 28223, Spain; [DeFelipe, Javier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, CIBERNED, Madrid, Spain; [Munoz, Alberto] Univ Complutense Complutense, Dept Biol Celular, Madrid, Spain; [Leon-Espinosa, Gonzalo] Univ San Pablo CEU, Fac Farm, Madrid, Spain		Munoz, A (corresponding author), CSIC, Inst Cajal, Madrid, Spain.; Munoz, A (corresponding author), Univ Politecn Madrid, Ctr Tecnol Biomed, Lab Cajal Circuitos Cort CTB, Madrid 28223, Spain.; Munoz, A (corresponding author), Univ Complutense Complutense, Dept Biol Celular, Madrid, Spain.	amunozc@bio.ucm.es	DEFELIPE, JAVIER/D-1195-2014; Munoz, Alberto/D-4225-2014; ESPINOSA, GONZALO LEON/I-4135-2015	DEFELIPE, JAVIER/0000-0001-5484-0660; Munoz, Alberto/0000-0003-4607-3398; ESPINOSA, GONZALO LEON/0000-0002-9921-2614	Ministerio de Economia y CompetitividadSpanish Government [SAF 2015-66603-P]; Centro de Investigacion en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain) [CB06/05/0066]; Alzheimer's AssociationAlzheimer's Association [ZEN-15-321663]	This work was supported by grants from the following entities: SAF 2015-66603-P from the Ministerio de Economia y Competitividad; Centro de Investigacion en Red sobre Enfermedades Neurodegenerativas (CIBERNED, CB06/05/0066, Spain); and a grant from the Alzheimer's Association (ZEN-15-321663). We thank Soledad Martinez for technical help with the surgical procedures in middle cerebral artery occlusion experiments and Natalia Yanguas for providing antibodies for CD16/32 and CD64.	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Anton-Fernandez A, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00157; Arendt T, 2003, J NEUROSCI, V23, P6972, DOI 10.1523/JNEUROSCI.23-18-06972.2003; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Bachstetter AD, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0209-z; Bechade C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00032; Bellucci A, 2004, AM J PATHOL, V165, P1643, DOI 10.1016/S0002-9440(10)63421-9; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Bouma HR, 2010, VET IMMUNOL IMMUNOP, V136, P319, DOI 10.1016/j.vetimm.2010.03.016; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Bullmann T, 2016, HIPPOCAMPUS, V26, P301, DOI 10.1002/hipo.22522; BUZADZIC B, 1990, FREE RADICAL BIO MED, V9, P407, DOI 10.1016/0891-5849(90)90017-D; Cogut V, 2017, BRAIN BEHAV IMMUN; Colak G, 2011, JOVE-J VIS EXP, DOI 10.3791/3039; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Davidson JO, 2016, SCI REP-UK, V6, DOI 10.1038/srep25178; Davidson JO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00198; Davies DS, 2016, BRAIN PATHOL; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Fendrick SE, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-9; Flanary BE, 2007, REJUV RES, V10, P61, DOI 10.1089/rej.2006.9096; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 2013, CURR BIOL, V23, pR188, DOI 10.1016/j.cub.2013.01.062; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gyoneva S, 2016, NEUROSCIENCE, V330, P410, DOI 10.1016/j.neuroscience.2016.05.061; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Ikeda M, 2005, AM J PATHOL, V166, P521, DOI 10.1016/S0002-9440(10)62274-2; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Wang JY, 2007, CHINESE J PHYSIOL, V50, P127; Kierdorf K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00044; Krabbe G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060921; Leon-Espinosa G, 2016, NEUROSCIENCE, V333, P181, DOI 10.1016/j.neuroscience.2016.07.016; Leon-Espinosa G, 2013, J NEUROSCI RES, V91, P954, DOI 10.1002/jnr.23220; Lim SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081218; Lopes KO, 2008, GLIA, V56, P1048, DOI 10.1002/glia.20678; Ma L, 2003, GLIA, V43, P274, DOI 10.1002/glia.10261; Mallard C, 2014, PEDIATR RES, V75, P234, DOI 10.1038/pr.2013.188; Maphis N, 2015, BRAIN, V138, P1738, DOI 10.1093/brain/awv081; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsui H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.479; Matsui T, 2014, FOLIA NEUROPATHOL, V52, P151, DOI 10.5114/fn.2014.43786; Matsui T, 2014, NEUROCRIT CARE, V20, P301, DOI 10.1007/s12028-013-9911-5; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Miyamoto A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00070; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Moskowitz MA, 2010, STROKE, V41, pS85, DOI 10.1161/STROKEAHA.110.598458; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Popov VI, 2007, NEUROSCIENCE, V149, P549, DOI 10.1016/j.neuroscience.2007.07.059; POPOV VI, 1992, NEUROSCIENCE, V48, P53, DOI 10.1016/0306-4522(92)90337-2; POPOV VI, 1992, NEUROSCIENCE, V48, P45, DOI 10.1016/0306-4522(92)90336-Z; Popov VI, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/867525; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; Rubio-Perez J. M., 2012, THESCIENTIFICWORLDJO, V2012, P2012, DOI DOI 10.1100/2012/756357; Ruf T, 2015, BIOL REV, V90, P891, DOI 10.1111/brv.12137; Sanchez-Mejias E, 2016, ACTA NEUROPATHOL, V132, P897, DOI 10.1007/s00401-016-1630-5; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Seo JW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-164; Sheng JG, 1997, ACTA NEUROPATHOL, V94, P1, DOI 10.1007/s004010050664; Sierra A, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/610343; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Streit WJ, 2004, GLIA, V45, P208, DOI 10.1002/glia.10319; Streit WJ, 2005, BRAIN RES REV, V48, P234, DOI 10.1016/j.brainresrev.2004.12.013; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Streit WJ, 2014, CURR OPIN IMMUNOL, V29, P93, DOI 10.1016/j.coi.2014.05.005; Streit WJ, 2009, J NEUROIMMUNE PHARM, V4, P371, DOI 10.1007/s11481-009-9163-5; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Tischer J, 2016, GLIA, V64, P1562, DOI 10.1002/glia.23024; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Tremblay Marie-Eve, 2011, Commun Integr Biol, V4, P220, DOI 10.4161/cib.4.2.14506; UEDA S, 1995, PHYSIOL BEHAV, V58, P653, DOI 10.1016/0031-9384(95)00095-Z; von der Ohe CG, 2007, J NEUROSCI, V27, P84, DOI 10.1523/JNEUROSCI.4385-06.2007; von der Ohe CG, 2006, J NEUROSCI, V26, P10590, DOI 10.1523/JNEUROSCI.2874-06.2006; Zhou F, 2001, AM J PATHOL, V158, P2145, DOI 10.1016/S0002-9440(10)64686-X; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	89	7	7	1	13	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2653	1863-2661		BRAIN STRUCT FUNCT	Brain Struct. Funct.	MAY	2018	223	4					1881	1895		10.1007/s00429-017-1596-7			15	Anatomy & Morphology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Neurosciences & Neurology	GB6RO	WOS:000429200400019	29260372				2022-02-06	
J	Moll, J; de Oliveira-Souza, R; Basilio, R; Bramati, IE; Gordon, B; Rodriguez-Nieto, G; Zahn, R; Krueger, F; Grafman, J				Moll, Jorge; de Oliveira-Souza, Ricardo; Basilio, Rodrigo; Bramati, Ivanei Edson; Gordon, Barry; Rodriguez-Nieto, Geraldine; Zahn, Roland; Krueger, Frank; Grafman, Jordan			Altruistic decisions following penetrating traumatic brain injury	BRAIN			English	Article						altruism; costly donation; costly punishment; penetrating traumatic brain injury; selfishness	RIGHT TEMPOROPARIETAL JUNCTION; PREFRONTAL CORTEX; 3RD-PARTY PUNISHMENT; MORAL JUDGMENT; FRONTOTEMPORAL DEMENTIA; NEURAL BASIS; SELF-CONTROL; DAMAGE; NETWORKS; LESIONS	The cerebral correlates of altruistic decisions have increasingly attracted the interest of neuroscientists. To date, investigations on the neural underpinnings of altruistic decisions have primarily been conducted in healthy adults undergoing functional neuroimaging as they engaged in decisions to punish third parties. The chief purpose of the present study was to investigate altruistic decisions following focal brain damage with a novel altruistic decision task. In contrast to studies that have focused either on altruistic punishment or donation, the Altruistic Decision Task allows players to anonymously punish or donate to 30 charitable organizations involved with salient societal issues such as abortion, nuclear energy and civil rights. Ninety-four Vietnam War veterans with variable patterns of penetrating traumatic brain injury and 28 healthy veterans who also served in combat participated in the study as normal controls. Participants were asked to invest $ 1 to punish or reward real societal organizations, or keep the money for themselves. Associations between lesion distribution and performance on the task were analysed with multivariate support vector regression, which enables the assessment of the joint contribution of multiple regions in the determination of a given behaviour of interest. Our main findings were: (i) bilateral dorsomedial prefrontal lesions increased altruistic punishment, whereas lesions of the right perisylvian region and left temporo-insular cortex decreased punishment; (ii) altruistic donations were increased by bilateral lesions of the dorsomedial parietal cortex, whereas lesions of the right posterior superior temporal sulcus and middle temporal gyri decreased donations; (iii) altruistic punishment and donation were only weakly correlated, emphasizing their dissociable neuroanatomical associations; and (iv) altruistic decisions were not related to post-traumatic personality changes. These findings indicate that altruistic punishment and donation are determined by largely non-overlapping cerebral regions, which have previously been implicated in social cognition and moral experience such as evaluations of intentionality and intuitions of justice and morality.	[Moll, Jorge; de Oliveira-Souza, Ricardo; Basilio, Rodrigo; Bramati, Ivanei Edson] DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil; [de Oliveira-Souza, Ricardo] Fed Univ State Rio de Janeiro, Rio De Janeiro, Brazil; [Gordon, Barry] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gordon, Barry] Johns Hopkins Univ, Dept Cognit Sci, Baltimore, MD 21218 USA; [Rodriguez-Nieto, Geraldine] Univ Nacl Autonoma Mexico, Inst Neurobiol, Mexico City, DF, Mexico; [Zahn, Roland] Kings Coll London, London, England; [Krueger, Frank] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA; [Grafman, Jordan] Shirley Ryan AbilityLab, Brain Injury Res Program, Chicago, IL USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		de Oliveira-Souza, R (corresponding author), DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.	rdeoliveira@gmail.com; jgrafman@northwestern.edu	Moll, Jorge/AAF-8388-2021; Zahn, Roland/O-8944-2019	Moll, Jorge/0000-0002-4297-591X; Zahn, Roland/0000-0002-8447-1453	U.S. National Institute of Neurological Disorders and Stroke Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Therapeutic Cognitive Neuroscience Fund	This research was conducted at the National Institutes of Health Clinical Research Center and supported by U.S. National Institute of Neurological Disorders and Stroke Intramural Research Program. It was also partly supported by the Therapeutic Cognitive Neuroscience Fund (B.G., J.G.). The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the US Government.	Baumgartner T, 2014, SOC COGN AFFECT NEUR, V9, P653, DOI 10.1093/scan/nst023; Buckholtz JW, 2012, NAT NEUROSCI, V15, P655, DOI 10.1038/nn.3087; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Bzdok D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00232; Chakroff A., 2015, SOCIAL COGNITIVE AFF, V11, P476; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Cristofori I, 2015, NEUROLOGY, V84, P1394, DOI 10.1212/WNL.0000000000001446; de Oliveira-Souza R., 2016, MORAL BRAINS, P203, DOI [10.1093/acprof:oso/9780199357666.003.0010, DOI 10.1093/ACPROF:OSO/9780199357666.003.0010]; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Delis DC., 2001, DELIS KAPLAN EXECUTI; Driscoll DM, 2012, COGN BEHAV NEUROL, V25, P160, DOI 10.1097/WNN.0b013e318280cf4e; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Gao JS, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00023; Ginther MR, 2016, J NEUROSCI, V36, P9420, DOI 10.1523/JNEUROSCI.4499-15.2016; Glass L, 2016, SOC COGN AFFECT NEUR, V11, P253, DOI 10.1093/scan/nsv105; Gluth S, 2016, SCIENCE, V351, P1028, DOI 10.1126/science.aaf4688; Green C.D., 2003, EARLY PSYCHOL THOUGH; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Harenski CL, 2008, SOC COGN AFFECT NEUR, V3, P313, DOI 10.1093/scan/nsn026; Haushofer J, 2008, NEURON, V60, P738, DOI 10.1016/j.neuron.2008.11.019; Hayashi T, 2013, P NATL ACAD SCI USA, V110, P4422, DOI 10.1073/pnas.1212185110; Heberlein AS, 2004, J COGNITIVE NEUROSCI, V16, P1143, DOI 10.1162/0898929041920423; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Hoffman M. B., 2014, PUNISHERS BRAIN EVOL; Jenkins AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105341; Karim AA, 2010, CEREB CORTEX, V20, P205, DOI 10.1093/cercor/bhp090; KIMURA D, 1992, SCI AM, V267, P119; Knoch D, 2009, P NATL ACAD SCI USA, V106, P20895, DOI 10.1073/pnas.0911619106; Koenigs M., 2006, ORBITOFRONTAL CORTEX, P597; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; Krueger F, 2016, TRENDS NEUROSCI, V39, P499, DOI 10.1016/j.tins.2016.06.004; Krueger F, 2014, SOC COGN AFFECT NEUR, V9, P1143, DOI 10.1093/scan/nst092; Krueger F, 2009, P NATL ACAD SCI USA, V106, P22486, DOI 10.1073/pnas.0912568106; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Mars RB, 2012, CEREB CORTEX, V22, P1894, DOI 10.1093/cercor/bhr268; McCrae RR, 1985, PSYCHOL ASSESSMENT R; Mendez MF, 2017, J NEUROPSYCH CLIN N, V29, P86, DOI 10.1176/appi.neuropsych.16030051; Miller MB, 2010, NEUROPSYCHOLOGIA, V48, P2215, DOI 10.1016/j.neuropsychologia.2010.02.021; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; Moll J, 2002, NEUROIMAGE, V16, P696, DOI 10.1006/nimg.2002.1118; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moll J., 2016, HDB VALUE PERSPECTIV, P119; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Moll J, 2011, NEUROIMAGE, V54, P1735, DOI 10.1016/j.neuroimage.2010.08.026; Moretto G, 2010, J COGNITIVE NEUROSCI, V22, P1888, DOI 10.1162/jocn.2009.21367; Morishima Y, 2012, NEURON, V75, P73, DOI 10.1016/j.neuron.2012.05.021; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Prevost C, 2010, J NEUROSCI, V30, P14080, DOI 10.1523/JNEUROSCI.2752-10.2010; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Robinson PH, 2007, MINN LAW REV, V91, P1829; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Ruff CC, 2013, SCIENCE, V342, P482, DOI 10.1126/science.1241399; Schroeter ML, 2015, J NEUROL NEUROSUR PS, V86, P700, DOI 10.1136/jnnp-2014-308387; Smith DV, 2013, P NATL ACAD SCI USA, V110, P1518, DOI 10.1073/pnas.1210126110; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stefanacci L, 1996, J COMP NEUROL, V375, P552; Tassy S, 2012, SOC COGN AFFECT NEUR, V7, P282, DOI 10.1093/scan/nsr008; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Young L, 2010, NEURON, V65, P845, DOI 10.1016/j.neuron.2010.03.003; Younga L, 2008, NEUROIMAGE, V40, P1912, DOI 10.1016/j.neuroimage.2008.01.057; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104; Zhang YS, 2014, HUM BRAIN MAPP, V35, P5861, DOI 10.1002/hbm.22590; Zhu LS, 2014, NAT NEUROSCI, V17, P1319, DOI 10.1038/nn.3798	67	7	7	3	21	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	MAY	2018	141		5				1558	1569		10.1093/brain/awy064			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GF7VS	WOS:000432177000033	29590314	Green Published, hybrid			2022-02-06	
J	Nyam, TTE; Ho, CH; Wang, YL; Lim, SW; Wang, JJ; Chio, CC; Kuo, JR; Wang, CC				Nyam, Tee-Tau Eric; Ho, Chung-Han; Wang, Yu-Lin; Lim, Sher-Wei; Wang, Jhi-Joung; Chio, Chung-Ching; Kuo, Jinn-Rung; Wang, Che-Chuan			The Risk of Traumatic Brain Injury Occurring Among Patients with Parkinson Disease: A 14-Year Population-Based Study	WORLD NEUROSURGERY			English	Article						National Health Insurance Research Database; Parkinson disease; Propensity score; Traumatic brain injury	HEAD-INJURY; FALLS; BURDEN; PREVALENCE; DISABILITY; NATIONWIDE; IMPACT	BACKGROUND: Previous studies have implicated traumatic brain injury (TBI) as a risk factor for Parkinson disease (PD). However, the incidence risk of new-onset TBI among patients with PD is not well established. This study investigated the contribution of PD to new-onset TBI associations. METHODS: The study selected 6076 patients with PD and using 1:2 propensity score matching 12,152 general population cohorts in a longitudinal population database in Taiwan. The Cox proportional hazard regression model was used to estimate the hazard ratio of TBI adjusted with the potential confounding factors. RESULTS: The incidence of TBI in patients with PD (2.57%) and compared cohorts (1.81%) was significantly different (P = 0.0007). Patients with PD had a higher risk of TBI (hazard ratio, 1.63; 95% confidence interval, 1.32-2.01) compared with the general population. Patients with PD with TBI incidence had a higher Charlson Comorbidity Index than did the general population with TBI (P < 0.0001). Fall is the major cause of TBI in patients with PD. CONCLUSIONS: This study shows that patients with PD have a high risk of TBI, and the major cause of TBI in patients with PD is fall.	[Nyam, Tee-Tau Eric; Chio, Chung-Ching; Kuo, Jinn-Rung; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wang, Yu-Lin] Chi Mei Med Ctr, Dept Rehabil, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Lim, Sher-Wei] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Ctr Gen Educ, Tainan, Taiwan; [Lim, Sher-Wei] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan		Kuo, JR; Wang, CC (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.; Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.; Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.; Wang, CC (corresponding author), Southern Taiwan Univ Sci & Technol, Ctr Gen Educ, Tainan, Taiwan.	kuojinnrung@gmail.com; wangchechuan@gmail.com		Ho, Chung-Han/0000-0001-5925-8477	Chi Mei Medical Center [CMFHR10640]	This research had funding support from Chi Mei Medical Center (project number CMFHR10640).	Arbouw MEL, 2011, OSTEOPOROSIS INT, V22, P2197, DOI 10.1007/s00198-010-1455-3; Ashburn A, 2001, AGE AGEING, V30, P47, DOI 10.1093/ageing/30.1.47; Balash Y, 2005, J NEUROL, V252, P1310, DOI 10.1007/s00415-005-0855-3; Benzinger P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097073; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Crouse JJ, 2016, REV NEUROSCIENCE, V27, P549, DOI 10.1515/revneuro-2016-0002; Faul M, 2010, TRAUMATIC BRAIN INJU; Gao X, 2008, MOVEMENT DISORD, V23, P613, DOI 10.1002/mds.21919; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Huang CLC, 2016, PSYCHIAT RES, V244, P382, DOI 10.1016/j.psychres.2016.08.023; Hwang HF, 2015, J HEAD TRAUMA REHAB, V30, pE9, DOI 10.1097/HTR.0000000000000093; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jagnoor J, 2012, INJURY, V43, P1996, DOI 10.1016/j.injury.2011.08.004; JOHNELL O, 1992, AGE AGEING, V21, P32, DOI 10.1093/ageing/21.1.32; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leibson CL, 2006, MOVEMENT DISORD, V21, P446, DOI 10.1002/mds.20685; Liu WM, 2016, J FORMOS MED ASSOC, V115, P531, DOI 10.1016/j.jfma.2015.05.014; Macleod AD, 2016, PARKINSONISM RELAT D, V28, P124, DOI 10.1016/j.parkreldis.2016.05.013; Michatowska M, 2005, FUNCT NEUROL, V20, P163; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Pohar SL, 2009, ARCH GERONTOL GERIAT, V49, P317, DOI 10.1016/j.archger.2008.11.006; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Rugbjerg K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2494; Rumalla K, 2017, INT J NEUROSCI, V127, P326, DOI 10.1080/00207454.2016.1239196; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Wang HC, 2014, EUR J NEUROL, V21, P907, DOI 10.1111/ene.12410	29	7	7	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2018	113						E328	E335		10.1016/j.wneu.2018.02.027			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8JD	WOS:000432942700040	29452320				2022-02-06	
J	Ott, SD; Bailey, CM; Broshek, DK				Ott, Summer D.; Bailey, Christopher M.; Broshek, Donna K.			An Interdisciplinary Approach to Sports Concussion Evaluation and Management: The Role of a Neuropsychologist	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Sports concussion; Neuropsychological assessment; Interdisciplinary team; Consultant	TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; POSITION STATEMENT; ZURICH; IMPACT	Sports neuropsychology is a rapidly emerging field that affords neuropsychologists, the opportunity to work with a diverse group of individuals in terms of age, gender, sports, ethnicity, and language and sports has a way of bringing diverse communities together. Although working with athletes can be associated with unique challenges, neuropsychological assessment with this population and being part of an interdisciplinary sports medicine team is both exciting and rewarding and can merge a passion for sports with professional interests. This paper is intended to highlight the contribution of neuropsychology to the evaluation and management of sport-related concussion as well as describe the neuropsychologist's role as an integral member of interdisciplinary sports medicine teams. Clinical model, special considerations, assessment strategy, and administrative aspects of practice are discussed.	[Ott, Summer D.] Univ Texas Houston, McGovern Med Sch, Dept Orthopaed Surg, 6400 Fannin St,Suite 1620, Houston, TX 77030 USA; [Ott, Summer D.] Mem Hermann Ironman Sports Med Inst, Houston, TX USA; [Bailey, Christopher M.] Univ Hosp Cleveland Med Ctr, Cleveland, OH USA; [Bailey, Christopher M.] Case Western Reserve Univ, Sch Med, Dept Neurol, Cleveland, OH 44106 USA; [Broshek, Donna K.] Univ Virginia Hlth Syst, Dept Psychiat & Neurobehav Sci, Charlottesville, VA USA		Ott, SD (corresponding author), Univ Texas Houston, McGovern Med Sch, Dept Orthopaed Surg, 6400 Fannin St,Suite 1620, Houston, TX 77030 USA.	summer.d.ott@uth.tmc.edu	Broshek, Donna/ABA-4208-2021	Broshek, Donna/0000-0002-7175-7815			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailey CM, 2009, J HEAD TRAUMA REHAB, V24, P123, DOI 10.1097/HTR.0b013e31819c1caa; Barth JT, 2001, J ATHL TRAINING, V36, P253; Barth JT, 1989, MILD HEAD INJURY, P257; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Centers for Disease Control and Prevention (CDC), 2011, MORBIDITY MORTALITY; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2012, ARCH CLIN NEUROPSYCH, V27, P119, DOI 10.1093/arclin/acr077; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; ImPACT Applications Inc, 2007, IMM POSTC ASS TEST I; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P721, DOI 10.1007/978-0-387-76978-3_23; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Love S, 2015, AM J SPORT MED, V43, P1260, DOI 10.1177/0363546514535187; Lovell M. R., 2006, SPORTS NEUROPSYCHOLO, P193; Lovell M. R., 2004, TRAUMATIC BRAIN INJU; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 1999, SPORTS-RELATED CONCUSSION, P200; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Ott S. D., 2017, NATL PSYCHOL, V26, P13; Petraglia A, 2015, HDB NEUROLOGICAL SPO; Webbe F., 2011, HDB SPORT NEUROPSYCH	32	7	7	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2018	33	3			SI		319	329		10.1093/arclin/acx132			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GE3UE	WOS:000431137600009	29300847				2022-02-06	
J	Spaw, AJ; Lundine, JP; Johnson, SA; Peng, J; Wheeler, KK; Shi, JX; Yang, G; Haley, KJ; Groner, JI; Xiang, H				Spaw, Alexandra J.; Lundine, Jennifer P.; Johnson, Sarah A.; Peng, Jin; Wheeler, Krista K.; Shi, Junxin; Yang, Ginger; Haley, Kathy J.; Groner, Jonathan I.; Xiang, Henry			Follow-Up Care Adherence After Hospital Discharge in Children With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						pediatric; rehabilitation; service utilization; traumatic brain injury	CONCUSSION; PREDICTORS; CHILDHOOD; SYMPTOMS; BEHAVIOR; NEEDS	Objective: To investigate factors associated with follow-up care adherence in children hospitalized because of traumatic brain injury (TBI). Design: An urban level 1 children's hospital trauma registry was queried to identify patients (2-18 years) hospitalized with a TBI in 2013 to 2014. Chart reviewers assessed discharge summaries and follow-up instructions in 4 departments. Main Measures: Three levels of adherencenonadherence, partial adherence, and full adherenceand their associations with care delivery, patient, and injury factors. Results: In our population, 80% were instructed to follow up within the hospital network. These children were older and had more severe TBIs than those without follow-up instructions and those referred to outside providers. Of the 352 eligible patients, 19.9% were nonadherent, 27.3% were partially adherent, and 52.8% were fully adherent. Those recommended to follow up with more than 1 department had higher odds of partial adherence over nonadherence (adjusted odds ratio [AOR] = 5.8, 95% CI: 1.9-17.9); however, these patients were less likely to be fully adherent (AOR = 0.1; 95% CI: 0.1-0.3). Privately insured patients had a higher AOR of full adherence. Conclusions: Nearly 20% of children hospitalized for TBI never returned for outpatient follow-up and 27% missed appointments. Care providers need to educate families, coordinate service provision, and promote long-term monitoring.	[Spaw, Alexandra J.; Yang, Ginger; Groner, Jonathan I.; Xiang, Henry] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Div Clin Therapies, Columbus, OH USA; [Johnson, Sarah A.; Peng, Jin; Wheeler, Krista K.; Shi, Junxin; Yang, Ginger; Haley, Kathy J.; Groner, Jonathan I.; Xiang, Henry] Nationwide Childrens Hosp, Res Inst, Ctr Pediat Trauma Res, Columbus, OH USA; [Johnson, Sarah A.; Peng, Jin; Wheeler, Krista K.; Shi, Junxin; Yang, Ginger; Xiang, Henry] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA; [Peng, Jin] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Haley, Kathy J.; Groner, Jonathan I.] Nationwide Childrens Hosp, Trauma Program, Columbus, OH USA		Xiang, H (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	Henry.Xiang@NationwideChildrens.org	Lundine, Jennifer P/P-5184-2018	Lundine, Jennifer P/0000-0002-9113-7875	Ohio State University College of Medicine's Bennet Research Scholarship; Nationwide Children's HospitalOhio State University	This study was funded in part by The Ohio State University College of Medicine's Bennet Research Scholarship awarded to Alexandra Spaw, and an internal fund of Nationwide Children's Hospital.	Aaland MO, 2012, J TRAUMA ACUTE CARE, V73, P1507, DOI 10.1097/TA.0b013e31826fc928; Alexander J, 2005, PEDIATRICS, V116, P1238, DOI 10.1542/peds.2005-2070; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Bachrach A., 2011, PEDIAT MED HOMES LAY; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Cameron C, 1996, J ADV NURS, V24, P244, DOI 10.1046/j.1365-2648.1996.01993.x; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Di Battista A, 2015, BRAIN INJURY, P1; Faul M, 2010, TRAUMATIC BRAIN INJU; Gordon M, 2010, PSYCHIAT SERV, V61, P657, DOI 10.1176/ps.2010.61.7.657; Greenspan AI, 2000, BRAIN INJURY, V14, P417; IRWIN CE, 1993, PEDIATRICS, V92, P20; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McPherson ML, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e94; Pratt KJ, 2015, FAM SYST HEALTH, V33, P55, DOI 10.1037/fsh0000103; Robert Wood Johnson Foundation, 2016, LAWATLAS POL SURV PO; Schneiderman JU, 2015, 19 ANN C SOC SOC WOR; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Walz NC, 2012, J NEUROPSYCHOL, V6, P143, DOI 10.1111/j.1748-6653.2011.02020.x; Willemse-van Son AHP, 2009, J REHABIL MED, V41, P59, DOI 10.2340/16501977-0294; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	31	7	7	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2018	33	3					E1	E10		10.1097/HTR.0000000000000314			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ7HA	WOS:000435555500001	28520664				2022-02-06	
J	Truesdale, DM; Pell, MD				Truesdale, Deirdre M.; Pell, Marc D.			The sound of Passion and Indifference	SPEECH COMMUNICATION			English	Article						Arousal; Spontaneous speech; Neutral speech; Podcast; Acoustic cues; Vocal affect	TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; EMOTION; COMMUNICATION; EXPRESSION; SPEECH; APATHY; MODEL; PERCEPTION; PRAGMATICS	Extending affective speech communication research in the context of authentic, spontaneous utterances, the present study investigates two signals of affect defined by extreme levels of physiological arousal-Passion and Indifference. Exemplars were mined from podcasts conducted in informal, unstructured contexts to examine communication at extreme levels of perceived hyper- and hypo-arousal. Utterances from twenty native speakers of Canadian/American English were submitted for perceptual validation for judgments of affective meaning (Passion, Indifference, or Neutrality) and level of arousal ("Not At All" to "Very Much"). Arousal ratings, acoustic patterns, and linguistic cues (affect/emotion words and expletives) were analyzed. In comparison to neutral utterances, Passion was communicated with the highest maximum pitch and pitch range, and highest maximum and mean amplitude, while Indifference was communicated via decreases in these measures in comparison to neutral affect. Interestingly, Passion and Neutrality were expressed with comparable absolute ranges of amplitude, while the minimum amplitudes of both Passion and Indifference were greater than those of Neutral expressions. Linguistically, Indifference was marked by significantly greater use of explicit expressions of affect (e.g. I don't care...), suggesting a linguistic encoding preference in this context. Passion was expressed with greater use of expletives; yet, their presence was not necessary to facilitate perception of a speaker's level of arousal. These findings shed new light upon the paralinguistic and linguistic features of spontaneous expressions at the extremes of the arousal continuum, highlighting key distinctions between Indifference and Neutrality with implications for vocal communication research in healthy and clinical populations.	[Truesdale, Deirdre M.; Pell, Marc D.] McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ, Canada		Truesdale, DM (corresponding author), McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ, Canada.	deirdre.truesdale@mail.mcgill.ca	Pell, Marc D./AAL-3121-2021	Pell, Marc D./0000-0002-9947-1552	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [RGPIN203708-16]	This work was supported by the Natural Sciences and Engineering Research Council of Canada [Grant no.: RGPIN203708-16].	ARNDT H, 1991, J PRAGMATICS, V15, P521, DOI 10.1016/0378-2166(91)90110-J; Bachorowski JA, 2003, ANN NY ACAD SCI, V1000, P244, DOI 10.1196/annals.1280.012; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Banziger T, 2005, SPEECH COMMUN, V46, P252, DOI 10.1016/j.specom.2005.02.016; Bonner MR, 1943, AM J PSYCHOL, V56, P262, DOI 10.2307/1417508; Burgoon J. K., 2017, SOCIAL SIGNAL PROCES, P78; BURGOON JK, 1989, HUM COMMUN RES, V16, P217, DOI 10.1111/j.1468-2958.1989.tb00210.x; CACIOPPO JT, 1994, PSYCHOL BULL, V115, P401, DOI 10.1037/0033-2909.115.3.401; CAFFI C, 1994, J PRAGMATICS, V22, P325, DOI 10.1016/0378-2166(94)90115-5; Cheang HS, 2008, SPEECH COMMUN, V50, P366, DOI 10.1016/j.specom.2007.11.003; Cowie R, 2003, SPEECH COMMUN, V40, P5, DOI 10.1016/S0167-6393(02)00071-7; de Ziga HG, 2010, J INF TECHNOL POLITI, V7, P36, DOI 10.1080/19331680903316742; Du Bois JW, 2012, TEXT TALK, V32, P433, DOI 10.1515/text-2012-0021; Du Bois John W, 2007, STANCETAKING DISCOUR, P139, DOI [10.1075/pbns.164.07du, DOI 10.1075/PBNS.164.07DU]; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ekman P., 1972, EMOTION HUMAN FACE G, P25, DOI [10.1016/B978-0-08-016643-8.50012-4, DOI 10.1016/B978-0-08-016643-8.50012-4]; Ekman Paul, 1969, SEMIOTICA, V1, P49, DOI [10.1515/semi.1969.1.1.49, DOI 10.1515/SEMI.1969.1.1.49]; Englebretson Robert, 2007, STANCETAKING DISCOUR; Fontaine JRJ, 2007, PSYCHOL SCI, V18, P1050, DOI 10.1111/j.1467-9280.2007.02024.x; Foolen Ad., 2012, MOVING OURSELVES MOV, P349, DOI DOI 10.1075/CEB.6; Freeman V, 2014, J PHONETICS, V45, P1, DOI 10.1016/j.wocn.2014.03.002; FRICK RW, 1985, PSYCHOL BULL, V97, P412, DOI 10.1037/0033-2909.97.3.412; FRIJDA NH, 1989, J PERS SOC PSYCHOL, V57, P212, DOI 10.1037/0022-3514.57.2.212; Gasiorek J., 2016, COMMUNICATION ACCOMM, P60, DOI [10.1017/CBO9781316226537.005, DOI 10.1017/CBO9781316226537.005]; Gasiorek J, 2016, COMMUNICATION ACCOMMODATION THEORY: NEGOTIATING PERSONAL RELATIONSHIPS AND SOCIAL IDENTITIES ACROSS CONTEXTS, P13; Gasiorek J, 2012, HUM COMMUN RES, V38, DOI 10.1111/j.1468-2958.2012.01426.x; Gussenhoven C, 2002, SPEECH PROSODY, P1; Hatfield E., 1985, A NEW LOOK AT LOVE; HEILMAN KM, 1978, NEUROLOGY, V28, P229, DOI 10.1212/WNL.28.3.229; Heilman KM., 2011, CLIN NEUROPSYCHOLOGY, P466; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Jay T, 2008, J POLITENESS RES-LAN, V4, P267, DOI 10.1515/JPLR.2008.013; Jaywant A, 2010, J INT NEUROPSYCH SOC, V16, P49, DOI 10.1017/S1355617709990919; Johnstone T., 2001, APPRAISAL PROCESSES, P271; Johnstone T, 2007, PSYCHOPHYSIOLOGY, V44, P827, DOI 10.1111/j.1469-8986.2007.00552.x; Jurgens R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00111; Jurgens R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00180; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; KAPLAN KJ, 1972, PSYCHOL BULL, V77, P361, DOI 10.1037/h0032590; Landes AM, 2001, J AM GERIATR SOC, V49, P1700, DOI 10.1046/j.1532-5415.2001.49282.x; Laukka P, 2011, COMPUT SPEECH LANG, V25, P84, DOI 10.1016/j.csl.2010.03.004; LAZARUS RS, 1991, AM PSYCHOL, V46, P352, DOI 10.1037/0003-066X.46.4.352; Leander N. P, 2009, LOSING WILL AUTOMATI; Lemke J. L., 2012, 2 INT HDB SCI ED, DOI DOI 10.1007/978-1-4020-9041-7_94; Levenson RW, 2014, ANNU REV CLIN PSYCHO, V10, P581, DOI 10.1146/annurev-clinpsy-032813-153653; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Martin JR, 2008, EMOTION TALK ACROSS CORPORA, P27; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Pagonabarraga J, 2015, LANCET NEUROL, V14, P518, DOI 10.1016/S1474-4422(15)00019-8; Paulmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017694; Pell MD, 2009, J PHONETICS, V37, P417, DOI 10.1016/j.wocn.2009.07.005; Pell MD, 2006, BRAIN LANG, V97, P123, DOI 10.1016/j.bandl.2005.08.010; Pell MD, 2002, BRAIN COGNITION, V48, P499, DOI 10.1006/brxg.2001.1406; Pluck GC, 2002, J NEUROL NEUROSUR PS, V73, P636, DOI 10.1136/jnnp.73.6.636; Russell JA, 2003, ANNU REV PSYCHOL, V54, P329, DOI 10.1146/annurev.psych.54.101601.145102; Scherer K. R., 1989, HDB SOCIAL PSYCHOPHY, P165; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; SCHERER KR, 1991, MOTIV EMOTION, V15, P123, DOI 10.1007/BF00995674; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; SCHERER KR, 1979, EMOTIONS PERSONALITY, P493, DOI DOI 10.1007/978-1-4613-2892-6_18; Schieffelin B., 1989, TEXT, V9, P7; Schneider IK, 2016, EMOTION, V16, P426, DOI 10.1037/emo0000164; Selting M, 2010, PRAGMATICS, V20, P229, DOI 10.1075/prag.20.2.06sel; Stuss D. T., 2000, NEUROPSYCHOLOGY EMOT, P239; Sundherg J., 2010, SPEECH PROSODY, P4; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Turner JR, 2013, ENCY BEHAV MED, DOI [10.1007/978-1-4419-1005-9, DOI 10.1007/978-1-4419-1005-9]; Vallerand RJ, 2003, J PERS SOC PSYCHOL, V85, P756, DOI 10.1037/0022-3514.85.4.756; Vallerand RJ, 2010, ADV EXP SOC PSYCHOL, V42, P97, DOI 10.1016/S0065-2601(10)42003-1; Ward, 2006, HDB PRAGMATICS, P604, DOI DOI 10.1002/9780470756959.CH27; Weenink D., 2015, PRAAT DOING PHONETIC; WILLIAMS CE, 1972, J ACOUST SOC AM, V52, P1238, DOI 10.1121/1.1913238	74	7	7	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-6393	1872-7182		SPEECH COMMUN	Speech Commun.	MAY	2018	99						124	134		10.1016/j.specom.2018.03.007			11	Acoustics; Computer Science, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Acoustics; Computer Science	GP4YI	WOS:000440877900013					2022-02-06	
J	Wrede, AH; Shah, A; McNamara, MC; Montazami, R; Hashemi, NN				Wrede, Alex H.; Shah, Aarthy; McNamara, Marilyn C.; Montazami, Reza; Hashemi, Nicole N.			Controlled positioning of microbubbles and induced cavitation using a dual-frequency transducer and microfiber adhesion techniques	ULTRASONICS SONOCHEMISTRY			English	Article						Cavitation; Microbubbles; Traumatic brain injuries; Microfibers	TRAUMATIC BRAIN-INJURY; ULTRASOUND; GRAPHENE; BUBBLES	We report a study on two methods that enable spatial control and induced cavitation on targeted microbubbles (MBs). Cavitation is known to be present in many situations throughout nature. This phenomena has been proven to have the energy to erode alloys, like steel, in propellers and turbines. It is recently theorized that cavitation occurs inside the skull during a traumatic-brain injury (TBI) situation. Controlled cavitation methods could help better understand TBIs and explain how neurons respond at moments of trauma. Both of our approaches involve an ultrasonic transducer and bio-compatible Polycaprolactone (PCL) microfibers. These methods are reproducible as well as affordable, providing more control and efficiency compared to previous techniques found in literature. We specifically model three-dimensional spatial control of individual MBs using a 1.6 MHz transducer. Using a 100 kHz transducer, we also illustrate induced cavitation on an individual MB that is adhered to the surface of a PCL microfiber. The goal of future studies will involve characterization of neuronal response to cavitation and seek to unmask its linkage with TBIs.	[Wrede, Alex H.; Shah, Aarthy; McNamara, Marilyn C.; Montazami, Reza; Hashemi, Nicole N.] Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA; [Montazami, Reza; Hashemi, Nicole N.] Iowa State Univ, Ctr Adv Host Def Immunobiot & Translat Comparat M, Ames, IA 50011 USA		Hashemi, NN (corresponding author), Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA.	nastaran@iastate.edu	Montazami, Reza/A-6115-2012; Hashemi, Nicole/AAW-1384-2021	Montazami, Reza/0000-0002-8827-0026; Hashemi, Nicole/0000-0001-8921-7588; Wrede, Alex/0000-0001-9509-924X	Office of Naval Research (ONR)Office of Naval Research [N000141612246, N000141712620]; U.S. Department of Energy Office of Science under the Science Undergraduate Laboratory Internship (SULI) Program at Ames Laboratory; Iowa State University	We thank Timothy Bigelow for his help with ultrasound logistics, Dan Barnard for his help with ultrasonic transducer, Travis Sippel for his help with imaging, and Hannah Rhoads. This work was partially supported by the Office of Naval Research (ONR) Grant N000141612246, ONR Grant N000141712620, U.S. Department of Energy Office of Science under the Science Undergraduate Laboratory Internship (SULI) Program at Ames Laboratory, and Iowa State University.	Ashokkumar M, 2011, ULTRASON SONOCHEM, V18, P864, DOI 10.1016/j.ultsonch.2010.11.016; Bai ZH, 2014, J MATER CHEM A, V2, P4878, DOI 10.1039/c3ta14573e; Brennen CE, 2014, CAVITATION AND BUBBLE DYNAMICS, P1; Buckey JC, 2005, ACTA ASTRONAUT, V56, P1041, DOI 10.1016/j.actaastro.2005.01.032; Canchi S, 2017, J MECH BEHAV BIOMED, V74, P261, DOI 10.1016/j.jmbbm.2017.06.018; Cartagena CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158576; Chernin L, 2017, RENEW ENERG, V113, P688, DOI 10.1016/j.renene.2017.06.037; Gai YZ, 2018, ULTRASON SONOCHEM, V41, P181, DOI 10.1016/j.ultsonch.2017.09.007; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Gogate PR, 2009, BIOCHEM ENG J, V44, P60, DOI 10.1016/j.bej.2008.10.006; Gogate PR, 2005, ULTRASON SONOCHEM, V12, P21, DOI 10.1016/j.ultsonch.2004.03.007; Haniff S, 2017, SHOCK WAVES, V27, P929, DOI 10.1007/s00193-017-0765-1; Ji B, 2014, J MECH SCI TECHNOL, V28, P1339, DOI 10.1007/s12206-013-1166-8; Khismatullin DB, 2004, J ACOUST SOC AM, V116, P1463, DOI 10.1121/1.1778835; Kuiper G, 1998, APPL SCI RES, V58, P33; Lauterborn W, 1997, ULTRASON SONOCHEM, V4, P65, DOI 10.1016/S1350-4177(97)00009-6; Li FF, 2018, P NATL ACAD SCI USA, V115, pE353, DOI 10.1073/pnas.1713905115; Newman CMH, 2007, GENE THER, V14, P465, DOI 10.1038/sj.gt.3302925; Philipp A, 1998, J FLUID MECH, V361, P75, DOI 10.1017/S0022112098008738; Postema M, 2004, ULTRASOUND MED BIOL, V30, P827, DOI 10.1016/j.ultrasmedbio.2004.02.010; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Schoellhammer CM, 2016, EXPERT OPIN DRUG DEL, V13, P1045, DOI 10.1517/17425247.2016.1171841; Sharifi F, 2016, BIOMACROMOLECULES, V17, P3287, DOI 10.1021/acs.biomac.6b01028; Sharifi F, 2016, J MECH BEHAV BIOMED, V61, P530, DOI 10.1016/j.jmbbm.2016.04.005; Stride EP, 2010, P I MECH ENG H, V224, P171, DOI 10.1243/09544119JEIM622; Tan RKL, 2017, J MATER CHEM A, V5, P17777, DOI 10.1039/c7ta05759h; Zhou Y, 2012, J CONTROL RELEASE, V157, P103, DOI 10.1016/j.jconrel.2011.09.068	27	7	7	1	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1350-4177	1873-2828		ULTRASON SONOCHEM	Ultrason. Sonochem.	MAY	2018	43						114	119		10.1016/j.ultsonch.2018.01.006			6	Acoustics; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics; Chemistry	GC1BO	WOS:000429511800014	29555266	Green Submitted, hybrid			2022-02-06	
J	Xu, LW; Vaca, SD; Nalwanga, J; Muhumuza, C; Vail, D; Lerman, BJ; Kiryabwire, J; Ssenyonjo, H; Mukasa, J; Muhumuza, M; Haglund, MM; Grant, G				Xu, Linda W.; Vaca, Silvia D.; Nalwanga, Juliet; Muhumuza, Christine; Vail, Daniel; Lerman, Benjamin J.; Kiryabwire, Joel; Ssenyonjo, Hussein; Mukasa, John; Muhumuza, Michael; Haglund, Michael M.; Grant, Gerald			Life After the Neurosurgical Ward in Sub-Saharan Africa: Neurosurgical Treatment and Outpatient Outcomes in Uganda	WORLD NEUROSURGERY			English	Article						Follow-up; Global neurosurgery; Neurosurgical outcomes; Sub-Saharan Africa; Uganda	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; INFANTS; MYELOMENINGOCELE; SURVIVAL; TUMORS	BACKGROUND: In the past decade, neurosurgery in Uganda experienced increasing surgical volume and a new residency training program. Although research has examined surgical capacity, minimal data exist on the patient population treated by neurosurgery and their eventual outcomes in sub-Saharan Africa. METHODS: Patients admitted to Mulago National Referral Hospital neurosurgical ward over 2 years (2014 and 2015) were documented in a prospective database. In total, 1167 were discharged with documented phone numbers and thus eligible for follow-up. Phone surveys were developed and conducted in the participant's language to assess mortality, neurologic outcomes, and follow-up health care. RESULTS: During the study period, 2032 patients were admitted to the neurosurgical ward, 80% for traumatic brain injury. A total of 7.8% received surgical intervention. The in-hospital mortality rate was 18%. A total of 870 patients were reached for phone follow-up, a 75% response rate, and 30-day and 1-year mortality were 4% and 8%, respectively. Almost one-half of patients had not had subsequent health care after the initial encounter. Most patients had Glasgow Outcome Scale-Extended scores consistent with good recovery and mild disability, with patients experiencing trauma faring best and patients with tumor faring worst. A total of 85% felt they returned to baseline work performance, and 76% of guardians felt that children returned to baseline school performance. CONCLUSIONS: The neurosurgical service provided health care to a large proportion of nonoperative patients. Phone surveys captured data on patients in whom nearly one-half would be lost to subsequent health care. Although mortality during initial hospitalization was high, more than 90% of those discharged survived at 1-year follow up, and the vast majority returned to work and school.	[Xu, Linda W.; Vaca, Silvia D.; Vail, Daniel; Lerman, Benjamin J.; Grant, Gerald] Stanford Univ, Dept Neurosurg, Palo Alto, CA 94304 USA; [Xu, Linda W.; Vaca, Silvia D.; Vail, Daniel; Lerman, Benjamin J.; Grant, Gerald] Stanford Ctr Global Hlth Innovat, Palo Alto, CA 94304 USA; [Nalwanga, Juliet; Kiryabwire, Joel; Ssenyonjo, Hussein; Mukasa, John; Muhumuza, Michael] Mulago Natl Referral Hosp, Dept Neurosurg, Kampala, Uganda; [Muhumuza, Christine] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Haglund, Michael M.] Duke Univ, Dept Neurosurg, Durham, NC USA; [Haglund, Michael M.] Duke Univ, Div Global Neurosurg & Neurol, Durham, NC USA		Xu, LW (corresponding author), Stanford Univ, Dept Neurosurg, Palo Alto, CA 94304 USA.; Xu, LW (corresponding author), Stanford Ctr Global Hlth Innovat, Palo Alto, CA 94304 USA.	lindawxu@stanford.edu	Lerman, Benjamin/O-7731-2018	Lerman, Benjamin/0000-0001-9973-6779; Vail, Daniel/0000-0001-8769-2369			Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Cell Phones in Africa. Communication Lifeline j Pew Research Center, CELL PHON AFR COMM L; Donoho DA, 2017, J NEUROSURG-PEDIATR, V20, P149, DOI 10.3171/2017.1.PEDS16527; Ghroubi S, 2016, ANN PHYS REHABIL MED, V59, P87, DOI 10.1016/j.rehab.2016.01.005; Haglund MM, 2011, WORLD J SURG, V35, P1175, DOI 10.1007/s00268-011-1080-0; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McAllister S, 2018, INT J HEALTH PLAN M, V33, pE57, DOI 10.1002/hpm.2408; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Sims-Williams HJ, 2017, J NEUROSURG-PEDIATR, V19, P70, DOI 10.3171/2016.7.PEDS16296; Stagno V, 2014, CHILD NERV SYST, V30, P137, DOI 10.1007/s00381-013-2297-z; Sutiono AB, 2018, INT J HEALTH PLAN M, V33, pE49, DOI 10.1002/hpm.2406; Teasdale TW, 2005, BRAIN INJURY, V19, P1049, DOI 10.1080/02699050500110421; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Walther AE, 2016, J PEDIATR SURG, V51, P1346, DOI 10.1016/j.jpedsurg.2016.03.016; Warf BC, 2012, J NEUROSURG-PEDIATR, V10, P108, DOI 10.3171/2012.4.PEDS1253; Warf BC, 2011, J NEUROSURG-PEDIATR, V7, P127, DOI 10.3171/2010.11.PEDS10428; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137	20	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2018	113						E153	E160		10.1016/j.wneu.2018.01.204			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8JD	WOS:000432942700021	29427813				2022-02-06	
J	Zhao, WX; Wu, RH; Wang, SH; Qi, HH; Qian, YT; Wang, SN				Zhao, Weixiang; Wu, Ruhong; Wang, Suhong; Qi, Haihui; Qian, Yitao; Wang, Suinuan			Behavioral and neurophysiological abnormalities during cued continuous performance tasks in patients with mild traumatic brain injury	BRAIN AND BEHAVIOR			English	Article						conflict monitoring; mild traumatic brain injury; response inhibition; sustained attention	EVENT-RELATED POTENTIALS; RESPONSE-INHIBITION; WORKING-MEMORY; GO/NOGO TASK; ATTENTION; OSCILLATIONS; SYNCHRONY; ALPHA; ERP; CONNECTIVITY	Objective: This study's aim was to investigate the features and neural mechanisms of sustained attention in patients with mild traumatic brain injury (mTBI) by comparing and analyzing neuropsychological, behavioral, event-related potentials, and event-related desynchronization and synchronization between mTBI patients and healthy controls. Methods: Twenty mTBI patients with mTBI and 20 healthy controls underwent the Mini-Mental State Examination (MMSE) and a cued continuous performance task (AX-CPT). Neuropsychological, behavioral, and electroencephalogram (EEG) data were collected and analyzed. Results: There were significant differences between the mTBI group and the control group in their MMSE total scores, attention, and calculation, but there were no significant differences in orientation, memory, recall, and verbal scores. There were significant differences between the mTBI group and the control group in hitting the number, reaction time, and the number of errors of omission, but there were no significant differences in the number of false errors. The amplitude of Go-N2 and Nogo-N2 was significantly smaller for the mTBI group than that for the control group. The amplitude of Go-P3 was significantly smaller for the mTBI group than that for the control group, but not for the amplitude of Nogo-P3. The Go-ERS were significantly less for the mTBI group than for the control group during the 0-200 ms after the stimulus onset. The Go-ERD and Nogo-ERD were significantly less for the mTBI group than for the control group during the 600-1,000 ms after the stimulus onset. The Go-ERS were significantly less for the mTBI group than for the control group during the 200-400ms after the stimulus onset. There were no significant differences in the Nogo-ERS and Nogo-ERD/ERS between the mTBI group and the control group. Conclusion: Patients with mTBI exhibited impairments in sustained attention and conflict monitoring, while response inhibition may have been spared.	[Zhao, Weixiang; Wu, Ruhong; Qi, Haihui; Qian, Yitao; Wang, Suinuan] Soochow Univ, Dept Neurosurg, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China; [Wang, Suhong] Soochow Univ, Dept Neurosci, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China		Wang, SN (corresponding author), Soochow Univ, Dept Neurosurg, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China.	wsuinuanedu@163.com			National Natural Science of Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81101018]; Jiangsu Science and Technology Fifth 333 Project [BRA201711]; Changzhou Science and Technology Application Project [CJ20160458]; Changzhou High-Level Medical Talents Training Project [2016CZBJ005]	National Natural Science of Foundation of China, Grant/Award Number: 81101018; Jiangsu Science and Technology Fifth 333 Project, Grant/Award Number: BRA201711; Changzhou Science and Technology Application Project, Grant/Award Number: CJ20160458; Changzhou High-Level Medical Talents Training Project, Grant/Award Number: 2016CZBJ005	Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bryden DW, 2016, NEUROPSYCHOPHARMACOL, V41, P716, DOI 10.1038/npp.2015.197; Chikazoe J, 2010, CURR OPIN PSYCHIATR, V23, P267, DOI 10.1097/YCO.0b013e3283387a9f; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Dymowski AR, 2016, NEUROPSYCHOL REHABIL, V26, P866, DOI 10.1080/09602011.2015.1102746; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Guan MZ, 2015, NEUROSCI LETT, V603, P1, DOI 10.1016/j.neulet.2015.06.062; Halperin JM, 2002, J AM ACAD CHILD PSY, V41, P245, DOI 10.1097/00004583-200203000-00003; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Huang LY, 2013, INT J PSYCHOPHYSIOL, V90, P172, DOI 10.1016/j.ijpsycho.2013.07.001; Iwanaga M, 2015, BRAIN INJURY, V29, P1252, DOI 10.3109/02699052.2015.1035332; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Johnstone SJ, 2013, CLIN NEUROPHYSIOL, V124, P644, DOI 10.1016/j.clinph.2012.09.006; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Lee Chung Nam, 2015, Korean J Neurotrauma, V11, P6, DOI 10.13004/kjnt.2015.11.1.6; Lee JY, 2017, FRONT HUM NEUROSCI, V11, P1, DOI 10.3389/fnhum.2017.00133; Mannarelli D, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/410785; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Meeuwissen EB, 2011, HUM BRAIN MAPP, V32, P2045, DOI 10.1002/hbm.21167; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Nam CS, 2011, CLIN NEUROPHYSIOL, V122, P567, DOI 10.1016/j.clinph.2010.08.002; Nicholls C, 2015, BIOL PSYCHOL, V110, P115, DOI 10.1016/j.biopsycho.2015.07.013; Olofsson JK, 2007, BIOL PSYCHOL, V75, P101, DOI 10.1016/j.biopsycho.2006.12.006; Padrao G, 2015, NEUROPSYCHOLOGIA, V75, P458, DOI 10.1016/j.neuropsychologia.2015.07.004; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Poch C, 2014, EUR J NEUROSCI, V40, P2399, DOI 10.1111/ejn.12589; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Schmitter-Edgecombe M, 2015, J CLIN EXP NEUROPSYC, V37, P162, DOI 10.1080/13803395.2014.998170; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; von Stein A, 1999, CEREB CORTEX, V9, P137, DOI 10.1093/cercor/9.2.137; Wen Hong-Bo, 2008, Zhonghua Nei Ke Za Zhi, V47, P36; Wu JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep08844; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zygierewicz J, 2005, J NEUROSCI METH, V145, P267, DOI 10.1016/j.jneumeth.2005.01.013	49	7	8	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	MAY	2018	8	5							e00966	10.1002/brb3.966			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	GF4YN	WOS:000431970500017	29761018	Green Published, gold			2022-02-06	
J	Kobayashi, M; Tamari, K; Al Salihi, MO; Nishida, K; Takeuchi, K				Kobayashi, Masayoshi; Tamari, Kengo; Al Salihi, Mohammed Omar; Nishida, Kohei; Takeuchi, Kazuhiko			Anti-high mobility group box 1 antibody suppresses local inflammatory reaction and facilitates olfactory nerve recovery following injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Astrocyte; Cycloheximide; Field potential recording; Head injury; HMGB1; Macrophage; Olfactory bulb; Olfactory nerve; Olfactory marker protein (OMP); Regeneration	SEVERE HEAD-INJURY; POST-TRAUMATIC ANOSMIA; BRAIN-INJURY; THERAPEUTIC TARGET; HMGB1; DEXAMETHASONE; ALPHA; DISTURBANCE; PROTEIN; RATS	Background: Refractory olfactory dysfunction is a common finding in head trauma due to olfactory nerve injury. Anti-inflammatory treatment using steroids is known to contribute to functional recovery of the central and peripheral nervous systems in injury models, while there is a concern that steroids can induce side effects. The present study examines if the inhibition of proinflammatory cytokine, high mobility group box 1 (HMGB1), can facilitate olfactory functional recovery following injury. Methods: Olfactory nerve transection (NTx) was performed in OMP-tau-lacZ mice to establish injury models. We measured HMGB1 gene expression in the olfactory bulb using semi-quantitative polymerase chain reaction (PCR) assays and examined HMGB1 protein localization in the olfactory bulb using immunohistochemical staining. Anti-HMGB1 antibody was intraperitoneally injected immediately after the NTx and histological assessment of recovery within the olfactory bulb was performed at 5, 14, 42, and 100 days after the drug injection. X-gal staining labeled OMP in the degenerating and regenerating olfactory nerve fibers, and immunohistochemical staining detected the presence of reactive astrocytes and macrophages/microglia. Olfactory function was assessed using both an olfactory avoidance behavioral test and evoked potential recording. Results: HMGB1 gene and protein were significantly expressed in the olfactory bulb 12 h after NTx. Anti-HMGB1 antibody-injected mice showed significantly smaller areas of injury-associated tissue, fewer astrocytes and macrophages/microglia and an increase in regenerating nerve fibers. Both an olfactory avoidance behavioral test and evoked potential recordings showed improved functional recovery in the anti-HMGB1 antibody-injected mice. Conclusions: These findings suggest that inhibition of HMGB1 could provide a new therapeutic strategy for the treatment of olfactory dysfunction following head injuries.	[Kobayashi, Masayoshi; Tamari, Kengo; Al Salihi, Mohammed Omar; Nishida, Kohei; Takeuchi, Kazuhiko] Mie Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan		Kobayashi, M (corresponding author), Mie Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	m-koba@doc.medic.mie-u.ac.jp			JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [16K11211]	This work was supported by JSPS KAKENHI grant number 16K11211.	Al Salihi MO, 2017, AURIS NASUS LARYNX, V44, P70, DOI 10.1016/j.anl.2016.05.009; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; Costanzo RM, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P794; Costanzo RM, 1986, CLIN MEASUREMENTS TA, P565; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; Delank K.-W., 1998, Rhinology (Utrecht), V36, P15; Dogra S, 2013, INDIAN J DERMATOL VE, V79, pS35, DOI 10.4103/0378-6323.115526; Esposito E, 2009, CURR MED CHEM, V16, P3152, DOI 10.2174/092986709788803024; Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; Haruma J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37755; Jimenez D F, 1997, J Craniomaxillofac Trauma, V3, P8; Kawabata H, 2010, SPINE, V35, P1109, DOI 10.1097/BRS.0b013e3181bd14b6; Kikuchi K, 2011, EXP THER MED, V2, P767, DOI 10.3892/etm.2011.310; Kobayashi M, 2013, NEUROSCI RES, V76, P125, DOI 10.1016/j.neures.2013.03.015; Kobayashi Masayoshi, 2005, Nihon Jibiinkoka Gakkai Kaiho, V108, P986; Kobayashi M, 2009, CHEM SENSES, V34, P573, DOI 10.1093/chemse/bjp038; London B, 2008, ANN NEUROL, V63, P159, DOI 10.1002/ana.21293; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Miwa T, 2005, CHEM SENSES, V30, pI214, DOI 10.1093/chemse/bjh190; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Ren PC, 2012, BRAIN RES BULL, V88, P332, DOI 10.1016/j.brainresbull.2012.03.002; Santos DV, 2004, ARCH OTOLARYNGOL, V130, P317, DOI 10.1001/archotol.130.3.317; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wang Haichao, 2007, Novartis Found Symp, V280, P73; Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768, DOI 10.1164/ajrccm.164.10.2106117; Xu M, 2016, INFLAMMATION, V39, P1594, DOI 10.1007/s10753-016-0395-2; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	37	7	7	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	APR 26	2018	15								124	10.1186/s12974-018-1168-7			11	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	GE1JY	WOS:000430973800002	29699567	gold, Green Published			2022-02-06	
J	Wahlin, RR; Nelson, DW; Bellander, BM; Svensson, M; Helmy, A; Thelin, EP				Wahlin, Rebecka Rubenson; Nelson, David W.; Bellander, Bo-Michael; Svensson, Mikael; Helmy, Adel; Thelin, Eric Peter			Prehospital Intubation and Outcome in Traumatic Brain Injury-Assessing Intervention Efficacy in a Modern Trauma Cohort	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; advanced airway management; prehospital trauma care; human; emergency medical services	RAPID-SEQUENCE INTUBATION; ENDOTRACHEAL INTUBATION; HEAD-INJURY; GOLDEN HOUR; HEMODYNAMIC-RESPONSE; TRANSIENT HYPOXIA; SECONDARY INSULTS; SEVERITY SCORE; MATURE URBAN; MANAGEMENT	Background: Prehospital intubation in traumatic brain injury (TBI) focuses on limiting the effects of secondary insults such as hypoxia, but no indisputable evidence has been presented that it is beneficial for outcome. The aim of this study was to explore the characteristics of patients who undergo prehospital intubation and, in turn, if these parameters affect outcome. Material and methods: Patients >= 15 years admitted to the Department of Neurosurgery, Stockholm, Sweden with TBI from 2008 through 2014 were included. Data were extracted from prehospital and hospital charts, including prospectively collected Glasgow Outcome Score (GOS) after 12 months. Univariate and multivariable logistic regression models were employed to examine parameters independently correlated to prehospital intubation and outcome. Results: A total of 458 patients were included (n = 178 unconscious, among them, n = 61 intubated). Multivariable analyses indicated that high energy trauma, prehospital hypotension, pupil unresponsiveness, mode of transportation, and distance to the hospital were independently correlated with intubation, and among them, only pupil responsiveness was independently associated with outcome. Prehospital intubation did not add independent information in a step-up model versus GOS (p = 0.154). Prehospital reports revealed that hypoxia was not the primary cause of prehospital intubation, and that the procedure did not improve oxygen saturation during transport, while an increasing distance from the hospital increased the intubation frequency. Conclusion: In this modern trauma cohort, prehospital intubation was not independently associated with outcome; however, hypoxia was not a common reason for prehospital intubation. Prospective trials to assess efficacy of prehospital airway intubation will be difficult due to logistical and ethical considerations.	[Wahlin, Rebecka Rubenson] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Wahlin, Rebecka Rubenson] Soder Sjukhuset, Dept Anesthesia & Intens Care, Stockholm, Sweden; [Nelson, David W.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Anesthesiol & Intens Care, Stockholm, Sweden; [Bellander, Bo-Michael; Svensson, Mikael; Thelin, Eric Peter] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Bellander, Bo-Michael; Svensson, Mikael] Karolinska Univ Hosp Solna, Dept Neurosurg, Stockholm, Sweden; [Helmy, Adel; Thelin, Eric Peter] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England		Thelin, EP (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.; Thelin, EP (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England.	eric.thelin@ki.se	Svensson, Mikael/F-8662-2012; Helmy, Adel/AAS-3084-2020; Wahlin, Rebecka/AAH-6519-2020; Thelin, Eric Peter/K-2144-2012	Svensson, Mikael/0000-0003-1179-7003; Helmy, Adel/0000-0002-0531-0556; Thelin, Eric Peter/0000-0002-2338-4364; Nelson, David/0000-0003-2530-8207; Rubenson Wahlin, Rebecka/0000-0003-3890-8236	Stockholm County Council (ALF project)Stockholm County Council [20140349]; Swedish Society of Medicine [SLS-587221]; Swedish Society for Medical Research; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G1002277]; Cambridge Biomedical Research Centre, Royal College of Surgeons of England [G0802251]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1002277, G0600986] Funding Source: UKRI	RW was supported by grants provided by the Stockholm County Council (ALF project) project number; 20140349. ET is funded by Swedish Society of Medicine (Grant no. SLS-587221) and Swedish Society for Medical Research. AH was funded by Medical Research Council (Grant no: G0600986 and G1002277), Cambridge Biomedical Research Centre, Royal College of Surgeons of England (Grant no: G0802251).	*AM COLL SURG COMM, 2006, RES OPT CAR INJ PAT; [Anonymous], 2017, 20170717 HSN; [Anonymous], 2012, ADV TRAUM LIF SUPP P; [Anonymous], 2006, MED RIKTL AMB; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bellander Bo-Michael, 2008, Lakartidningen, V105, P1834; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Blow O, 1999, J TRAUMA, V47, P964, DOI 10.1097/00005373-199911000-00028; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; BOIDIN MP, 1985, BRIT J ANAESTH, V57, P306, DOI 10.1093/bja/57.3.306; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brown JB, 2016, J TRAUMA ACUTE CARE, V81, P93, DOI 10.1097/TA.0000000000000999; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Cudnik MT, 2008, PREHOSP EMERG CARE, V12, P459, DOI 10.1080/10903120802290745; Davis DP, 2011, CRIT CARE, V15, DOI 10.1186/cc10039; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Deakin CD, 2005, EMERG MED J, V22, P64, DOI 10.1136/emj.2004.017178; Denninghoff KR, 2017, PREHOSP EMERG CARE, V21, P539, DOI 10.1080/10903127.2017.1315201; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gonzalez RP, 2006, J TRAUMA, V61, P404, DOI 10.1097/01.ta.0000229816.16305.94; Goodhart CAE, 1975, PAPERS MONETARY EC R; Grossman DC, 1997, J TRAUMA, V42, P723, DOI 10.1097/00005373-199704000-00024; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Hasegawa K, 2013, JAMA-J AM MED ASSOC, V309, P257, DOI 10.1001/jama.2012.187612; Helm M, 2006, BRIT J ANAESTH, V96, P67, DOI 10.1093/bja/aei275; Helm M, 2013, ACTA ANAESTH SCAND, V57, P199, DOI 10.1111/aas.12032; Hoogmartens O, 2014, PREHOSP EMERG CARE, V18, P265, DOI 10.3109/10903127.2013.856506; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jacobs LM, 1997, ARCH SURG-CHICAGO, V132, P381; Jivall L, 2000, EUREF S TROMS; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; Lockey DJ, 1999, ANAESTHESIA, V54, P1097, DOI 10.1046/j.1365-2044.1999.00754.x; Lossius HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11189; Lossius HM, 2011, CRIT CARE, V15, DOI 10.1186/cc9973; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marshall A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-7; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Mohseni S, 2016, BRAIN INJURY, V30, P1256, DOI 10.1080/02699052.2016.1183823; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Newgard CD, 2015, ANN EMERG MED, V66, P30, DOI 10.1016/j.annemergmed.2014.12.004; Nicholl J, 2007, EMERG MED J, V24, P665, DOI 10.1136/emj.2007.047654; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Pakkanen T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0256-x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perkins ZB, 2013, INJURY, V44, P618, DOI 10.1016/j.injury.2012.03.019; Perkins ZB, 2013, J TRAUMA ACUTE CARE, V74, P1074, DOI 10.1097/TA.0b013e3182827305; R Development Core Team, 2008, R LANG ENV STAT COMP; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Rogers FB, 1997, ARCH SURG-CHICAGO, V132, P376; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-58; S. County Council, 2013, EMS MED STAT CAK NET; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Sollid SJM, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-58; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Spaite DW, 2003, ANN EMERG MED, V42, P729, DOI 10.1016/S0196-0644(03)00822-9; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Thelin EP, 2016, EUR J TRAUMA EMERG S, V42, P617, DOI 10.1007/s00068-015-0583-z; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Thelin EP, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00023; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Timmermann A, 2007, ANESTH ANALG, V104, P619, DOI 10.1213/01.ane.0000253523.80050.e9; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; von Vopelius-Feldt J, 2013, EUR J EMERG MED, V20, P382, DOI 10.1097/MEJ.0b013e32835b08b7; Whitaker Iveth Y, 2003, Annu Proc Assoc Adv Automot Med, V47, P301; Wirtz DD, 2007, PREHOSP EMERG CARE, V11, P213, DOI 10.1080/10903120701205935	79	7	7	1	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 10	2018	9								194	10.3389/fneur.2018.00194			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC2DJ	WOS:000429592100001	29692755	Green Published, gold			2022-02-06	
J	Abutarboush, R; Mullah, SH; Saha, BK; Haque, A; Walker, PB; Aligbe, C; Pappas, G; Ho, LTVT; Arnaud, FG; Auker, CR; McCarron, RM; Scultetus, AH; Moon-Massat, P				Abutarboush, Rania; Mullah, Saad H.; Saha, Biswajit K.; Haque, Ashraful; Walker, Peter B.; Aligbe, Chioma; Pappas, Georgina; Lam Thuy Vi Tran Ho; Arnaud, Francoise G.; Auker, Charles R.; McCarron, Richard M.; Scultetus, Anke H.; Moon-Massat, Paula			Brain oxygenation with a non-vasoactive perfluorocarbon emulsion in a rat model of traumatic brain injury	MICROCIRCULATION			English	Article						controlled cortical impact; intravital microscopy; oxygen therapeutic; phosphorescence quenching method; pial microcirculation	IMPAIRED CEREBRAL AUTOREGULATION; CELL-FREE HEMOGLOBIN; SPINAL-CORD-INJURY; DECOMPRESSION-SICKNESS; PERFLUBRON EMULSION; PIAL ARTERIOLES; SWINE MODEL; MOUSE-BRAIN; FLUOSOL-DA; BLOOD-FLOW	ObjectiveThe aim of this study was to assess, in two experiments, the safety and efficacy of the PFC emulsion Oxycyte as an oxygen therapeutic for TBI to test the hypothesis that early administration of this oxygen-carrying fluid post-TBI would improve brain tissue oxygenation (PbtO2). MethodsThe first experiment assessed the effects of Oxycyte on cerebral vasoactivity in healthy, uninjured rats using intravital microscopy. The second experiment investigated the effect of Oxycyte on cerebral PbtO2 using the PQM in TBI model. Animals in the Oxycyte group received a single injection of Oxycyte (6mL/kg) shortly after TBI, while NON animals received no treatment. ResultsOxycyte did not cause vasoconstriction in small- (<50m) or medium- (50-100m) sized pial arterioles nor did it cause a significant change in blood pressure. Treatment with Oxycyte while breathing 100% O-2 did not improve PbtO2. However, in rats ventilated with 40% O-2, PbtO2 improved to near pre-TBI values within 105minutes after Oxycyte injection. ConclusionsAlthough Oxycyte did not cause cerebral vasoconstriction, its use at the dose tested while breathing 100% O-2 did not improve PbtO2 following TBI. However, Oxycyte treatment while breathing a lower enriched oxygen concentration may improve PbtO2 after TBI.	[Abutarboush, Rania; Mullah, Saad H.; Saha, Biswajit K.; Haque, Ashraful; Walker, Peter B.; Lam Thuy Vi Tran Ho; Arnaud, Francoise G.; Auker, Charles R.; McCarron, Richard M.; Scultetus, Anke H.; Moon-Massat, Paula] Naval Med Res Ctr, NeuroTrauma Dept, Silver Spring, MD 20910 USA; [Aligbe, Chioma; Pappas, Georgina; Arnaud, Francoise G.; McCarron, Richard M.; Scultetus, Anke H.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Abutarboush, R (corresponding author), Naval Med Res Ctr, NeuroTrauma Dept, Silver Spring, MD 20910 USA.	rania.abutarboush.ctr@mail.mil			Defense Health Program (DHP) [603115HP.3730.001.A1247]	The work was supported by Defense Health Program (DHP) work unit number 603115HP.3730.001.A1247	Abutarboush R, 2014, J FUNCT BIOMATER, V5, P246, DOI 10.3390/jfb5040246; Abutarboush Rania, 2013, Curr Drug Discov Technol, V10, P315; Arnaud F, 2016, INT J HEMATOL, V103, P584, DOI 10.1007/s12185-016-1955-9; Blick G, 1909, BRIT MED J, V1909, P1796, DOI 10.1136/bmj.2.2556.1796; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Cabrales P, 2011, ANESTHESIOLOGY, V114, P901, DOI 10.1097/ALN.0b013e31820efb36; Centers for Disease Control and Prevention, 2001, RAT TBI REL EM DEP V; Clark D.D., 1999, BASIC NEUROCHEMISTRY; Cortes DO, 2015, MICROVASC RES, V98, P23, DOI 10.1016/j.mvr.2014.11.006; Daugherty WP, 2004, NEUROSURGERY, V54, P1223, DOI 10.1227/01.NEU.0000119238.68938.5D; Dunphy I, 2002, ANAL BIOCHEM, V310, P191, DOI 10.1016/S0003-2697(02)00384-6; Eckmann DM, 2013, J APPL PHYSIOL, V115, P868, DOI 10.1152/japplphysiol.01382.2012; Esipova TV, 2011, ANAL CHEM, V83, P8756, DOI 10.1021/ac2022234; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; GUO J, 1995, NEUROSURGERY, V36, P350, DOI 10.1227/00006123-199502000-00015; Hoffman WE, 1997, BRIT J ANAESTH, V78, P169, DOI 10.1093/bja/78.2.169; KERINS DM, 1994, AM J MED SCI, V307, P218, DOI 10.1097/00000441-199403000-00009; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Mahon RT, 2013, SPINAL CORD, V51, P188, DOI 10.1038/sc.2012.135; Mahon RT, 2010, AVIAT SPACE ENVIR MD, V81, P555, DOI 10.3357/ASEM.2745.2010; Mahon RT, 2006, AVIAT SPACE ENVIR MD, V77, P8; Mahonand RT, 2014, COMPR PHYSIOL, V4, P1157, DOI 10.1002/cphy.c130039; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Moon-Massat P, 2017, J NEUROTRAUM, V34, P2812, DOI 10.1089/neu.2015.3908; Muizelaar JP, 1986, INTRACRANIAL PRESSUR, P758; Mullah SH, 2016, MICROVASC RES, V107, P83, DOI 10.1016/j.mvr.2016.06.001; Mullah SH, 2016, BRAIN RES, V1634, P132, DOI 10.1016/j.brainres.2016.01.012; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; PEERLESS SJ, 1981, STROKE, V12, P558, DOI 10.1161/01.STR.12.5.558; Rebel A, 2006, AM J PHYSIOL-HEART C, V290, pH1027, DOI 10.1152/ajpheart.00500.2005; Rebel A, 2003, AM J PHYSIOL-HEART C, V285, pH1600, DOI 10.1152/ajpheart.00077.2003; REINHART K, 1991, CHEST, V99, P690, DOI 10.1378/chest.99.3.690; Riess JG, 2005, ARTIF CELL BLOOD SUB, V33, P47, DOI 10.1081/BIO-200046659; ROSENBLUM WI, 1976, STROKE, V7, P283, DOI 10.1161/01.STR.7.3.283; ROSENBLUM WI, 1963, ARCH NEUROL-CHICAGO, V9, P414, DOI 10.1001/archneur.1963.00460100102012; Rosenblum WI, 1971, STROKE, V2, P429, DOI 10.1161/01.STR.2.5.429; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Schroeder JL, 2008, J NEUROSURG-SPINE, V9, P213, DOI 10.3171/SPI/2008/9/8/213; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Spahn DR, 2002, ANESTHESIOLOGY, V97, P1338, DOI 10.1097/00000542-200212000-00004; Spiess BD, 2009, J APPL PHYSIOL, V106, P1444, DOI 10.1152/japplphysiol.90995.2008; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; SUZUKI J, 1984, STROKE, V15, P672, DOI 10.1161/01.STR.15.4.672; Torres IP, 2014, J BIOMED MATER RES A, V102, P2105, DOI 10.1002/jbm.a.34885; Torres LN, 2014, J SURG RES, V187, P324, DOI 10.1016/j.jss.2013.08.011; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; VERCELLOTTI GM, 1982, BLOOD, V59, P1299, DOI 10.1182/blood.V59.6.1299.1299; Vinogradov SA, 2002, COMP BIOCHEM PHYS A, V132, P147, DOI 10.1016/S1095-6433(01)00541-4; Vinogradov SA, 2001, REV SCI INSTRUM, V72, P3396, DOI 10.1063/1.1386634; WILSON DF, 1988, J BIOL CHEM, V263, P2712; Woitzik J, 2005, NEUROL RES, V27, P509, DOI 10.1179/016164105X15677; Yacoub A, 2014, J NEUROTRAUM, V31, P256, DOI 10.1089/neu.2013.3037; Yang ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002010; Zhou ZW, 2008, NEUROSURGERY, V63, P799, DOI 10.1227/01.NEU.0000325493.51900.53	61	7	7	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1073-9688	1549-8719		MICROCIRCULATION	Microcirculation	APR	2018	25	3							e12441	10.1111/micc.12441			13	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	GC3XP	WOS:000429717300003	29356218	Green Published			2022-02-06	
J	Avesani, R; Dambruoso, F; Scandola, M; Formisano, R; De Tanti, A; Ferro, S; Smania, N; Roncari, L; Rossato, E				Avesani, Renato; Dambruoso, Francesca; Scandola, Michele; Formisano, Rita; De Tanti, Antonio; Ferro, Salvatore; Smania, Nicola; Roncari, Laura; Rossato, Elena			Epidemiological and clinical characteristics of 492 patients in a vegetative state in 29 Italian rehabilitation units. What about outcome?	FUNCTIONAL NEUROLOGY			English	Article						acquired brain injury; disorders of consciousness; outcome; rehabilitation	TRAUMATIC BRAIN-INJURY; DISABILITY RATING-SCALE; WAKEFULNESS SYNDROME; PROLONGED DISORDERS; RECOVERY; CONSCIOUSNESS; COMA; VALIDATION	Recent studies on recovery of consciousness of subjects in a vegetative state(VS)admitted to rehabilitation units have focused mainly on the identification of prognostic factors,whereas few studies have focused on outcome. The aim of this study was to compare demographic and clinical data and report functional outcome of patients in a VS due to severe acquired brain injury (ARI) of different aetiologies. The study was a retrospective multicentre cohort study and involved 492 patients in a VS due to traumatic(TBI) or non-traumatic (NTBI) severe ABI admitted to 29 Italian rehabilitation units. Demographic and clinical data recorded included age, gender, aetiology, Glasgow Coma Scale score; onset-to-admission interval; length of stay in the rehabilitation unit; the department from which they were referred; and the presence of percutaneous endoscopic gastrostomy or tracheostomy. Recovery of consciousness and disability were evaluated using a discharge Disability Rating Scale. At discharge, 53.11% patients had emerged from VS, with TBI subjects significantly more likely to recover consciousness than NTBI ones. Subjects with NTBI had a significantly worse prognosis than those with TBI, and within the NTBI group, subjects with a cere- brovascular aetiology had a better outcome than those with an anoxic aetiology. Among the patients who emerged from VS, 71.30% of TBI and 83.06% of NTBI subjects presented extremely severe disability. Only 37.93% of subjects affected by TBI and 17.44% of those affected by NTBI who presented extremely severe disability returned home after their rehabilitation stay. Even though almost a half of the patients emerged from VS, a large number of these subjects showed severe disability, after making it impossible for them to return home.This situation has a major impact on the healthcare system.	[Avesani, Renato; Dambruoso, Francesca; Rossato, Elena] Sacro Cuore Don Calabria Hosp, Dept Rehabil, Verona, Italy; [Scandola, Michele; Smania, Nicola] Univ Verona, Dept Human Sci, Lab Neuropsychol, NPSY Lab VR, Verona, Italy; [Formisano, Rita] IRCCS, Dept Rehabil, Rome, Italy; [De Tanti, Antonio] Cardinal Ferrari Hosp, Parma, Italy; [Ferro, Salvatore] Hlth Agcy Emilia Romagna Reg, Hosp Serv, Bologna, Italy; [Roncari, Laura] Univ Verona, Dept Neurol & Movement Sci, Neuromotor & Cognit Rehabil Res Ctr, Verona, Italy		Dambruoso, F (corresponding author), Sacro Cuore Don Calabria Hosp, Dept Rehabil, Verona, Italy.	fr.dambruoso@gmail.com	Scandola, Michele/D-8107-2013	Scandola, Michele/0000-0003-0853-8975			Avesani R, 2013, EUR J PHYS REHAB MED, V49, P611; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Bagnato S, 2014, CLIN NEUROPHYSIOL, V1, pS1388; Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Baricich A, 2017, FUNCT NEUROL, V32, P131; Boccagni C, 2011, J CLIN NEUROPHYSIOL, V28, P489, DOI 10.1097/WNP.0b013e318231c8c8; Bodart O, 2014, CRIT CARE, V18, DOI 10.1186/cc13831; De Tanti A, 2015, EUR J PHYS REHAB MED, V51, P89; DeFina PA, 2010, RESTOR NEUROL NEUROS, V28, P769, DOI 10.3233/RNN-2010-0548; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Faugeras F, 2011, NEUROLOGY, V77, P264, DOI 10.1212/WNL.0b013e3182217ee8; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gigli G, 2008, STATO VEGETATIVO MIN; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Gosseries O, 2011, FUNCT NEUROL, V26, P25; Goudarzi F, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.23571; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hammond FM, 2010, EUR J PHYS REHAB MED, V46, P545; Howell K, 2013, RESUSCITATION, V84, P1409, DOI 10.1016/j.resuscitation.2013.05.015; Kang XG, 2014, CRIT CARE, V18, DOI 10.1186/cc13745; Klein AM, 2013, CLIN NEUROL NEUROSUR, V115, P2136, DOI 10.1016/j.clineuro.2013.08.004; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Lupi A, 2014, CURR RADIOPHARM, V7, P57, DOI 10.2174/1874471007666140411103819; Ng YS, 2005, NEUROREHABILITATION, V20, P97; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Pisa FE, 2014, J HEAD TRAUMA REHAB, V29, pE23, DOI 10.1097/HTR.0b013e3182a4469f; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sacco S, 2011, BRAIN INJURY, V25, P488, DOI 10.3109/02699052.2011.558043; Sattin D, 2014, EUR J PHYS REHAB MED, V50, P309; Smania N, 2013, J HEAD TRAUMA REHAB, V28, P131, DOI 10.1097/HTR.0b013e31823c0127; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Steppacher I, 2013, ANN NEUROL, V73, P594, DOI 10.1002/ana.23835; Tang QL, 2017, NEUROREHABILITATION, V40, P23, DOI 10.3233/NRE-161387; Vogel D, 2013, ARCH PHYS MED REHAB, V94, P1891, DOI 10.1016/j.apmr.2012.11.053; von Wild K, 2012, J Med Life, V5, P3; Wheatley-Smith L, 2013, DISABIL REHABIL, V35, P1006, DOI 10.3109/09638288.2012.720355; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Zafonte RD, 1966, AM J PHYS REHABIL, V75, P346	40	7	8	0	1	C I C-EDIZIONI INT SRL	ROME	CORSO TRIESTE, 42, 00198 ROME, ITALY	0393-5264	1971-3274		FUNCT NEUROL	Funct. Neurol.	APR-JUN	2018	33	2					97	103					7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	GL5UC	WOS:000437236000006	29984687				2022-02-06	
J	Bogoslovsky, T; Bernstock, JD; Bull, G; Gouty, S; Cox, BM; Hallenbeck, JM; Maric, D				Bogoslovsky, Tanya; Bernstock, Joshua D.; Bull, Greg; Gouty, Shawn; Cox, Brian M.; Hallenbeck, John M.; Maric, Dragan			Development of a systems-based in situ multiplex biomarker screening approach for the assessment of immunopathology and neural tissue plasticity in male rats after traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						controlled cortical impact (CCI); immunopathology; multiplex immunohistology; neural plasticity; systems biology; traumatic brain injury (TBI)	DIFFUSE AXONAL INJURY; SURROGATE END-POINTS; EPIDEMIOLOGY; PATHOPHYSIOLOGY; NEUROGENESIS; BIOMECHANICS; PROGNOSIS; DIAGNOSIS; RECOVERY; NEURONS	Traumatic brain injuries (TBIs) pose a massive burden of disease and continue to be a leading cause of morbidity and mortality throughout the world. A major obstacle in developing effective treatments is the lack of comprehensive understanding of the underlying mechanisms that mediate tissue damage and recovery after TBI. As such, our work aims to highlight the development of a novel experimental platform capable of fully characterizing the underlying pathobiology that unfolds after TBI. This platform encompasses an empirically optimized multiplex immunohistochemistry staining and imaging system customized to screen for a myriad of biomarkers required to comprehensively evaluate the extent of neuroinflammation, neural tissue damage, and repair in response to TBI. Herein, we demonstrate that our multiplex biomarker screening platform is capable of evaluating changes in both the topographical location and functional states of resident and infiltrating cell types that play a role in neuropathology after controlled cortical impact injury to the brain in male Sprague-Dawley rats. Our results demonstrate that our multiplex biomarker screening platform lays the groundwork for the comprehensive characterization of changes that occur within the brain after TBI. Such work may ultimately lead to the understanding of the governing pathobiology of TBI, thereby fostering the development of novel therapeutic interventions tailored to produce optimal tissue protection, repair, and/or regeneration with minimal side effects, and may ultimately find utility in a wide variety of other neurological injuries, diseases, and disorders that share components of TBI pathobiology.	[Bogoslovsky, Tanya; Bull, Greg; Gouty, Shawn; Cox, Brian M.] Uniformed Serv Univ Hlth Sci CNRM USUHS, Ctr Neurosci & Regenerat Med, Rockville, MD USA; [Bernstock, Joshua D.; Hallenbeck, John M.] NINDS, Stroke Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Bernstock, Joshua D.] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Div Stem Cell Neurobiol, Dept Clin Neurosci, Cambridge, England; [Bull, Greg; Gouty, Shawn; Cox, Brian M.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Maric, Dragan] NINDS, Flow & Imaging Cytometry Core Facil, NIH, 10 Ctr Dr,Bldg 10,Room 5S241, Bethesda, MD 20892 USA		Maric, D (corresponding author), NINDS, Flow & Imaging Cytometry Core Facil, NIH, 10 Ctr Dr,Bldg 10,Room 5S241, Bethesda, MD 20892 USA.	maricd@ninds.nih.gov		Bernstock, Joshua/0000-0002-7814-3867	CNRM/USUHS; NINDS/NIH intramural research programs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002856, ZIANS002924] Funding Source: NIH RePORTER	This work was supported by the CNRM/USUHS and NINDS/NIH intramural research programs.	Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMI.S20062, 10.4137/BMIMI.S20062]; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Bjornsson CS, 2008, J NEUROSCI METH, V170, P165, DOI 10.1016/j.jneumeth.2007.12.024; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Budinich CS, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/378307; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Fontana ACK, 2016, J NEUROTRAUM, V33, P1073, DOI 10.1089/neu.2015.4079; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hallbergson AF, 2003, J CLIN INVEST, V112, P1128, DOI 10.1172/JCI200320098; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lesko LJ, 2001, ANNU REV PHARMACOL, V41, P347, DOI 10.1146/annurev.pharmtox.41.1.347; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Lizhnyak PN, 2015, EXPERT REV PROTEOMIC, V12, P75, DOI 10.1586/14789450.2015.1000869; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mannix R, 2014, J NEUROSURG, V121, P1337, DOI 10.3171/2014.8.JNS14715; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meaney DF, 2001, J NEUROSURG, V95, P1108; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Namjoshi DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146540; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; NITSCH R, 1993, HIPPOCAMPUS, V3, P481, DOI 10.1002/hipo.450030409; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Robb MA, 2016, JAMA-J AM MED ASSOC, V315, P1107, DOI 10.1001/jama.2016.2240; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005	49	7	7	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		487	500		10.1002/jnr.24054			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV2DK	WOS:000424374300002	28463430	Green Accepted, Bronze			2022-02-06	
J	Easom, LR; Wang, K; Moore, RH; Wang, HQ; Bauer, L				Easom, Leisa R.; Wang, Ke; Moore, Renee H.; Wang, Heqiong; Bauer, Laura			Operation family caregiver: Problem-solving training for military caregivers in a community setting	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURIES; HEALTH-CARE UTILIZATION; SPINAL-CORD INJURIES; SECONDARY TRAUMATIZATION; VETERANS; DEPRESSION; BURDEN; WAR	ObjectiveThis study, conducted over a 2-year period at 9 sites, describes the outcomes of an evidence-based support program, Operation Family Caregiver, to gain an understanding of how a tailored, problem-solving training could assist military caregivers, who provide care and assistance to those injured, ill, or disabled as a result of war. MethodA pre-post research design was employed to examine caregiver burden, depression, health complaints, satisfaction with life, children's anxiety, and problem solving among a convenience sample of caregivers of 128 military service members and veterans. ResultsAnalysis revealed a decrease in depression, burden, and health complaints and an increase in satisfaction of life and positive problem-solving skills (p<.001). ConclusionThis program may be beneficial to caregiving families of military service and veterans living with posttraumatic stress, traumatic brain injury, and/or a physical disability.	[Easom, Leisa R.; Wang, Ke; Bauer, Laura] Georgia Southwestern State Univ, Americus, GA USA; [Moore, Renee H.; Wang, Heqiong] Emory Univ, Atlanta, GA 30322 USA		Easom, LR (corresponding author), Georgia Southwestern State Univ, Rosalynn Carter Inst Caregiving, 800 GSW State Univ Dr, Americus, GA 31709 USA.	Leisa.easom@gsw.edu	WANG, HEQIONG/ABI-7893-2020				Arean PA, 2010, AM J PSYCHIAT, V167, P1391, DOI 10.1176/appi.ajp.2010.09091327; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Berry JW, 2012, REHABIL PSYCHOL, V57, P98, DOI 10.1037/a0028229; Carter R., 2013, HELPING YOURSELF HEL; Cohen CA, 2002, INT J GERIATR PSYCH, V17, P184, DOI 10.1002/gps.561; D'Zurilla T.J., 2002, SOCIAL PROBLEM SOLVI; Dekel R, 2005, FAM RELAT, V54, P24, DOI 10.1111/j.0197-6664.2005.00003.x; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dirkzwager AJE, 2005, J FAM PSYCHOL, V19, P217, DOI 10.1037/0893-3200.19.2.217; Elliott TR, 2008, BEHAV RES THER, V46, P1220, DOI 10.1016/j.brat.2008.08.004; Elliott TR, 2009, BEHAV RES THER, V47, P548, DOI 10.1016/j.brat.2009.03.006; Elliott TR, 2009, J CLIN PSYCHOL, V65, P406, DOI 10.1002/jclp.20527; Filipkowski KB, 2010, INT J BEHAV MED, V17, P182, DOI 10.1007/s12529-009-9058-0; Fixsen D.L., 2005, IMPLEMENTATION RES S; Franciskovic T, 2007, CROAT MED J, V48, P177; Garcia A, 2015, MATERN CHILD HLTH J, V19, P459, DOI 10.1007/s10995-014-1525-9; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; Grant J S, 1999, Rehabil Nurs, V24, P254; Griffin JM, 2014, MILITARY DEPLOYMENT; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Knowles M. S., 1984, ANDRAGOGY ACTION APP; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kurylo MF, 2001, J COUNS DEV, V79, P275, DOI 10.1002/j.1556-6676.2001.tb01972.x; Lavela S., 2013, WOMEN HEALTH ISS, V23, P225; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; Lilly CL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130249; Michelson IR, 2017, CARING FOR THE MILITARY: A GUIDE FOR HELPING PROFESSIONALS, P111; Morera OF, 2006, PERS INDIV DIFFER, V41, P307, DOI 10.1016/j.paid.2005.08.016; National Alliance for Caregiving, 2010, CAR VET SERV HOM; National Alliance for Caregiving AARP Public Policy Institute, 2015, CAR US; Nauta MH, 2004, BEHAV RES THER, V42, P813, DOI 10.1016/S0005-7967(03)00200-6; Nichols L., 2014, GERONTOLOGIST, V56, P135; Olszewski-Kubilius P., 2012, UNLOCKING EMERGENT T; Ozakinci G, 2011, BEHAV MED, V37, P35, DOI 10.1080/08964289.2011.552925; Patel BR, 2015, SOC WORK, V60, P9, DOI 10.1093/sw/swu043; Pennebaker JW., 1982, PSYCHOL PHYS SYMPTOM; Pennebaker JW, 1999, SCI SELF REPORT IMPL, P299; Pinciotti CM, 2017, J NERV MENT DIS, V205, P106, DOI 10.1097/NMD.0000000000000560; Pinquart M, 2000, PSYCHOL AGING, V15, P187, DOI 10.1037//0882-7974.15.2.187; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramchand R., 2014, HIDDEN HEROES AM MIL; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Snyder C. R., 2001, COPING STRESS EFFECT; Tanielian R., 2013, MILITARY CAREGIVERS; U S Department of Veteran Affairs, 2017, VA CAR SUPP; Uberlacker S., 2013, ROLE PLAYING HELPS C; Varvogli L., 2011, HLTH SCI J, V5, P74, DOI DOI 10.1080/02699930302287; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26; Yambo TW, 2016, J NURS SCHOLARSHIP, V48, P543, DOI 10.1111/jnu.12237; Yip Kam-Shing, 2003, American Journal of Psychotherapy, V57, P109	51	7	7	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9762	1097-4679		J CLIN PSYCHOL	J. Clin. Psychol.	APR	2018	74	4					536	553		10.1002/jclp.22536			18	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GA4VC	WOS:000428330400003	29139114				2022-02-06	
J	Irvine, KA; Bishop, RK; Won, SJ; Xu, JG; Hamel, KA; Coppes, V; Singh, P; Sondag, A; Rome, E; Basu, J; Cittolin-Santos, GF; Panter, SS; Swanson, RA				Irvine, Karen-Amanda; Bishop, Robin K.; Won, Seok Joon; Xu, Jianguo; Hamel, Katherine A.; Coppes, Valerie; Singh, Pardeep; Sondag, Andrew; Rome, Eric; Basu, Jayinee; Cittolin-Santos, Giordano Fabricio; Panter, S. Scott; Swanson, Raymond A.			Effects of Veliparib on Microglial Activation and Functional Outcomes after Traumatic Brain Injury in the Rat and Pig	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; IL1-beta; MMP9; TNF alpha	POLY(ADP-RIBOSE) POLYMERASE INHIBITOR; NAD(+) DEPLETION; GENE-EXPRESSION; SWINE MODEL; NEURODEGENERATION; INFLAMMATION; TRANSCRIPTION; NEUROBIOLOGY; DEFICIENT; RECOVERY	The inflammation response induced by brain trauma can impair recovery. This response requires several hours to develop fully and thus provides a clinically relevant therapeutic window of opportunity. Poly(ADP-ribose) polymerase inhibitors suppress inflammatory responses, including brain microglial activation. We evaluated delayed treatment with veliparib, a poly(ADPribose) polymerase inhibitor, currently in clinical trials as a cancer therapeutic, in rats and pigs subjected to controlled cortical impact (CCI). In rats, CCI induced a robust inflammatory response at the lesion margins, scattered cell death in the dentate gyrus, and a delayed, progressive loss of corpus callosum axons. Pre-determined measures of cognitive and motor function showed evidence of attentional deficits that resolved after three weeks and motor deficits that recovered only partially over eight weeks. Veliparib was administered beginning 2 or 24 h after CCI and continued for up to 12 days. Veliparib suppressed CCI-induced microglial activation at doses of 3mg/kg or higher and reduced reactive astrocytosis and cell death in the dentate gyrus, but had no significant effect on delayed axonal loss or functional recovery. In pigs, CCI similarly induced a perilesional microglial activation that was attenuated by veliparib. CCI in the pig did not, however, induce detectable persisting cognitive or motor impairment. Our results showed veliparib suppression of CCI-induced microglial activation with a delay-to-treatment interval of at least 24 h in both rats and pigs, but with no associated functional improvement. The lack of improvement in long-term recovery underscores the complexities in translating anti-inflammatory effects to clinically relevant outcomes.	[Irvine, Karen-Amanda; Bishop, Robin K.; Won, Seok Joon; Xu, Jianguo; Singh, Pardeep; Sondag, Andrew; Rome, Eric; Basu, Jayinee; Cittolin-Santos, Giordano Fabricio; Swanson, Raymond A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Irvine, Karen-Amanda; Bishop, Robin K.; Won, Seok Joon; Xu, Jianguo; Hamel, Katherine A.; Coppes, Valerie; Singh, Pardeep; Sondag, Andrew; Rome, Eric; Basu, Jayinee; Cittolin-Santos, Giordano Fabricio; Panter, S. Scott; Swanson, Raymond A.] San Francisco VA Med Ctr, San Francisco, CA USA; [Xu, Jianguo] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Hamel, Katherine A.; Coppes, Valerie; Panter, S. Scott] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Cittolin-Santos, Giordano Fabricio] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil; [Cittolin-Santos, Giordano Fabricio] CNPq, Sci Borders, Brasilia, DF, Brazil; [Irvine, Karen-Amanda] VA Palo Alto Hlth Care Syst, Anesthesiol Serv, Palo Alto, CA USA; [Irvine, Karen-Amanda] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA		Swanson, RA (corresponding author), San Francisco VA Med Ctr, Neurol 127, 4150 Clement St, San Francisco, CA 94121 USA.	raymond.swanson@ucsf.edu		Hamel, Katherine/0000-0001-8294-2285; kumbara, arya/0000-0002-0395-1245	U.S. Dept. of DefenseUnited States Department of Defense [W81XWH-13-2-0091]; Dept. of Veterans AffairsUS Department of Veterans Affairs	This work was supported by a grant from the U.S. Dept. of Defense (W81XWH-13-2-0091) and by the Dept. of Veterans Affairs. We thank Autumn Sorrels (UCSF) for advice with the pig behavioral studies, and Preeti Mann, Anna Conti, Peter Swanson, and Owen Jansen for technical assistance.	Alam HB, 2002, SURGERY, V132, P278, DOI 10.1067/msy.2002.125787; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Bai P, 2012, FEBS LETT, V586, P3771, DOI 10.1016/j.febslet.2012.09.026; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brochier C, 2015, P NATL ACAD SCI USA, V112, P15220, DOI 10.1073/pnas.1509754112; Byrne AB, 2016, ELIFE, V5, DOI 10.7554/eLife.12734; CHAO CC, 1992, J IMMUNOL, V149, P2736; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Ha HC, 2002, P NATL ACAD SCI USA, V99, P3270, DOI 10.1073/pnas.052712399; Haddad M, 2006, BRIT J PHARMACOL, V149, P23, DOI 10.1038/sj.bjp.0706837; Hu XM, 2014, PROG NEUROBIOL, V119, P60, DOI 10.1016/j.pneurobio.2014.06.002; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Irvine K. A., 2010, J VIS EXP, V46; Irvine KA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00116; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kamboj A, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-49; Kauppinen TM, 2009, J CEREBR BLOOD F MET, V29, P820, DOI 10.1038/jcbfm.2009.9; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Liu Y, 1999, J NEUROSCI, V19, P4370; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Martinez-Zamudio RI, 2014, BRAIN BEHAV, V4, P552, DOI 10.1002/brb3.239; Odland RM, 2012, NEUROSURGERY, V70, P445, DOI 10.1227/NEU.0b013e318230ee5e; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Phulwani NK, 2008, J NEUROCHEM, V106, P578, DOI 10.1111/j.1471-4159.2008.05403.x; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Vuong B, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0448-8; Wagner LM, 2015, ONCOTARGETS THER, V8, P1931, DOI 10.2147/OTT.S69935; Wang XX, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0270-16.2016; WELTIN D, 1995, INT J IMMUNOPHARMACO, V17, P265, DOI 10.1016/0192-0561(95)00007-O; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Xu JG, 2016, GLIA, V64, P1869, DOI 10.1002/glia.23026	59	7	7	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	7					918	929		10.1089/neu.2017.5044			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GC0NF	WOS:000429473300004	29285982	Green Submitted			2022-02-06	
J	Jones, S; Davis, N; Tyson, SF				Jones, Samantha; Davis, Naomi; Tyson, Sarah F.			A scoping review of the needs of children and other family members after a child's traumatic injury	CLINICAL REHABILITATION			English	Article						Traumatic brain injury; unmet needs; traumatic physical injury; rehabilitation	BRAIN-INJURY; HEALTH-CARE; STROKE PATIENTS; LONG-TERM; PARENTS; ADOLESCENTS; INFORMATION; MANAGEMENT; SERVICES; SUPPORT	Objective: To review children's and their families' needs after a child's traumatic injury and assessment tools to measure needs. Data sources: Medline, Embase, CINAHL and PsycINFO databases (2005-September 2017) were searched and screened for papers (of any design) investigating children's and families' needs after a child's traumatic physical injury. Review methods: Data regarding children's and families' needs were extracted by two independent raters. Methodological quality of the identified papers was not assessed. Thematic content analysis drew out the key needs. Results: A total of 12 studies were identified, involving 932 participants including 105 injured adolescents and 827 family members or professionals. The needs of children under 12 years were identified indirectly from families or professionals. Most studies focussed on traumatic brain injuries. Two groups of needs were identified: person-related and service-related. Person-related needs were categorized into adolescent-specific needs, need for support with cognitive, emotional, social and physical problems and help with practical problems. Service-related needs were categorized into the need for information, educational needs and support during care transitions (specifically access to community-based services). These needs were largely unmet, particularly regarding information, emotional support and care transitions, which were compounded by professionals' limited understanding of the children's difficulties. We found no published measurement tools to assess children's and families' needs after a child's traumatic injury. Conclusion: The evidence about children's and families' needs following a child's traumatic injury was limited, but needs for information, emotional support and access to community-based services were consistently unmet.	[Jones, Samantha; Davis, Naomi] Royal Manchester Childrens Hosp, Dept Trauma & Orthopaed, Manchester M13 9WL, Lancs, England; [Jones, Samantha; Tyson, Sarah F.] Univ Manchester, Sch Hlth Sci, Div Nursing Midwifery & Social Work, Manchester, Lancs, England; [Jones, Samantha; Davis, Naomi; Tyson, Sarah F.] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England		Jones, S (corresponding author), Royal Manchester Childrens Hosp, Dept Trauma & Orthopaed, Manchester M13 9WL, Lancs, England.	Samantha.Jones@mft.nhs.uk		Jones, samantha/0000-0001-6393-5274	part-time Trauma and Orthopaedic Research Secondment - Royal Manchester Children's Hospital Charities; National Institute for Health Research (HEE/NIHR ICA Programme Clinical Doctoral Research Fellowship) [ICA-CDRF-2016-02-021]; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ICA-CDRF-2016-02-021] Funding Source: researchfish	The author(s) declared the following potential conflicts of interest with respect to the research, authorship and/or publication of this article: S.J.'s work on this project was partially supported by a part-time Trauma and Orthopaedic Research Secondment, funded by the Royal Manchester Children's Hospital Charities. This manuscript is independent research supported by the National Institute for Health Research (HEE/NIHR ICA Programme Clinical Doctoral Research Fellowship, Miss Samantha Jones, ICA-CDRF-2016-02-021). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.	ACHESON RM, 1978, J EPIDEMIOL COMMUN H, V32, P10, DOI 10.1136/jech.32.1.10; ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; Asadi-Lari Mohsen, 2003, Health Qual Life Outcomes, V1, P34, DOI 10.1186/1477-7525-1-34; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; British Society of Rehabilitation Medicine, 2013, SPEC REH TRAUM PATHW; Bugel Mary Jo, 2014, Pediatr Nurs, V40, P179; Burton LJ, 2015, PSYCHOL MED, V45, P29, DOI 10.1017/S0033291714000336; Burton L, 2015, J REHABIL MED, V47, P193, DOI 10.2340/16501977-1930; Butcher HK, 2001, RES NURS HEALTH, V24, P470, DOI 10.1002/nur.10005; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Falk AC, 2008, PATIENT EDUC COUNS, V70, P251, DOI 10.1016/j.pec.2007.10.001; Forster A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001919.pub3; Foster K, 2017, INJURY, V48, P114, DOI 10.1016/j.injury.2016.09.034; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Glang A, 2008, NEUROREHABILITATION, V23, P477; Hafsteinsdottir TB, 2011, PATIENT EDUC COUNS, V85, P14, DOI 10.1016/j.pec.2010.07.046; Harrison JD, 2013, INT J HEALTH SERV, V43, P567, DOI 10.2190/HS.43.3.l; Hemmingsson H, 2017, DISABIL REHABIL, V39, P1059, DOI 10.1080/09638288.2016.1189603; Karver CL, 2014, ARCH PHYS MED REHAB, V95, P1556, DOI 10.1016/j.apmr.2014.03.030; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Langhorne P, 2005, LANCET, V365, P501; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Lloyd DA, 2001, ANN ROY COLL SURG, V83, P15; McColl MA, 2010, DISABIL SOC, V25, P205, DOI 10.1080/09687590903537406; National Audit Office, 2010, MAJ TRAUM CAR ENGL R; National Confidential Enquiry into Patient Outcome and Death, 2007, TRAUM WHO CAR REP NA; Rajmil L, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-101; Roscigno CI, 2015, DISABIL REHABIL, V37, P523, DOI 10.3109/09638288.2014.933896; Royal College of Surgeons of England and the British Orthopaedic Society, 2000, BETT CAR SEV INJ; Sabin JA, 2006, PEDIATRICS, V117, P130, DOI 10.1542/peds.2005-1042; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Smith J, 2009, CLIN REHABIL, V23, P195, DOI 10.1177/0269215508092820; Swaine BR, 2008, BRAIN INJURY, V22, P581, DOI 10.1080/02699050802189701; TARN: Trauma and Audit Research Network, 2012, SEV INJ CHILDR 2012; Thorogood N, 2004, QUALITATIVE METHODS; Wolfe I., 2014, WHY CHILDREN DIE D A	38	7	7	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	APR	2018	32	4					501	511		10.1177/0269215517736672			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GC4TL	WOS:000429777600009	29082778	hybrid, Green Published			2022-02-06	
J	Dong, DB; Park, SK; Moon, BH; Cho, BR; Jang, DK; Jang, KS				Kim, Dong Bin; Park, Sang Kyu; Moon, Byeong Hoo; Cho, Byeong Rae; Jang, Dong Kyu; Jang, Kyeong Sool			Comparison of craniotomy and decompressive craniectomy in large supratentorial intracerebral hemorrhage	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Intracerebral hemorrhage; Mortality; Morbidity; Craniotomy; Decompressive craniectomy	ASSOCIATION/AMERICAN-STROKE-ASSOCIATION; TRAUMATIC BRAIN-INJURY; INITIAL CONSERVATIVE TREATMENT; CEREBRAL VENOUS THROMBOSIS; ACUTE SUBDURAL HEMATOMAS; SINGLE-CENTER EXPERIENCE; QUALITY-OF-CARE; SURGICAL-TREATMENT; RANDOMIZED-TRIAL; EARLY SURGERY	Intracerebral hemorrhage (ICH) is devastating disease with high mortality and morbidity rates. Most ICH is evacuated by either craniotomy (CR) or decompressive craniectomy (DC) although optimal treatment has not been established yet. The objective of this study was to compare clinical outcomes of spontaneous ICH patients between CR and DC groups and determine clinical factors affecting clinical prognosis. We retrospectively analyzed our single-center experience with large supratentorial ICH. From January 2011 to December 2016, 286 consecutive supratentorial large ICH patients underwent surgery in our institute. We compared CR group and DC group with regard to age, sex, GCS score, hematoma volume, midline shift, ICH score, and time from ictus to surgery. Statistical analysis was done using the t-test or x(2) test, and odds ratio was calculated. During study period, CR was performed in 139 patients while DC was performed in 125 patients. There were no significant difference in 30-day mortality between the CR group and the DC group (13.7% vs 15.2%, p = 0.729). However, 12-month functional survival was 46.0% in the CR group, which was significantly (p = 0.014) higher than that (32.0%) of the DC group. In conclusion, the 30-day mortality of CR group was not inferior to that of the DC group while its 12-month functional survival was superior to that of the DC group. This suggests better functional outcome might be obtained for selected large ICH patients with CR than with DC. (C) 2018 Elsevier Ltd. All rights reserved.	[Kim, Dong Bin; Park, Sang Kyu; Moon, Byeong Hoo; Cho, Byeong Rae; Jang, Dong Kyu; Jang, Kyeong Sool] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea		Park, SK (corresponding author), Catholic Univ Korea, Incheon St Marys Hosp, Dept Neurosurg, 222 Banpo Daero, Seoul 137701, South Korea.	skparkns@gmail.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aaron S, 2013, J NEUROL NEUROSUR PS, V84, P995, DOI 10.1136/jnnp-2012-303356; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; ANDERSON CS, 1994, J NEUROL NEUROSUR PS, V57, P936, DOI 10.1136/jnnp.57.8.936; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; BRODERICK JP, 1992, NEW ENGL J MED, V326, P733, DOI 10.1056/NEJM199203123261103; Chan S, 2014, CRIT CARE CLIN, V30, P699, DOI 10.1016/j.ccc.2014.06.003; Ferro JM, 2011, STROKE, V42, P2825, DOI 10.1161/STROKEAHA.111.615393; Gebel JM, 2002, STROKE, V33, P2631, DOI 10.1161/01.STR.0000035284.12699.84; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Hayes SB, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12422; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Keep RF, 2005, STROKE, V36, P1594, DOI 10.1161/01.STR.0000170701.41507.e1; Kim JY, 2017, J STROKE, V19, P28, DOI 10.5853/jos.2016.01935; Kirkman MA, 2008, BRIT J NEUROSURG, V22, P739, DOI 10.1080/02688690802346091; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Li Q, 2013, BRIT J NEUROSURG, V27, P617, DOI 10.3109/02688697.2013.765938; Malmivaara K, 2011, EUR J NEUROL, V18, P402, DOI 10.1111/j.1468-1331.2010.03162.x; Marinkovic I, 2009, NEUROSURGERY, V65, P780, DOI 10.1227/01.NEU.0000351775.30702.A9; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mendelow AD, 2005, LANCET, V365, P387; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Otani N, 2008, CEREBROVASC DIS, V26, P612, DOI 10.1159/000165115; Pantazis G, 2006, SURG NEUROL, V66, P492, DOI 10.1016/j.surneu.2006.05.054; RANKIN J, 1957, Scott Med J, V2, P200; Rincon F, 2010, CURR OPIN NEUROL, V23, P59, DOI 10.1097/WCO.0b013e3283352c01; Ruiz-Sandoval JL, 2012, J STROKE CEREBROVASC, V21, P395, DOI 10.1016/j.jstrokecerebrovasdis.2011.01.001; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Shimamura N, 2011, ACTA NEUROCHIR SUPPL, V111, P415, DOI 10.1007/978-3-7091-0693-8_71; Takeuchi S, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12424; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Vermeer SE, 2002, NEUROLOGY, V59, P205, DOI 10.1212/WNL.59.2.205; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2004, NEUROCRIT CARE, V1, P5, DOI 10.1385/NCC:1:1:5; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Zuurbier SM, 2012, J NEUROL, V259, P1099, DOI 10.1007/s00415-011-6307-3	46	7	10	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	APR	2018	50						208	213		10.1016/j.jocn.2018.01.066			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC1DT	WOS:000429519400050	29428269				2022-02-06	
J	Kim, YH; Fu, AH; Tucker, LB; Liu, J; McCabe, JT				Kim, Yeonho; Fu, Amanda H.; Tucker, Laura B.; Liu, Jiong; McCabe, Joseph T.			Characterization of controlled cortical impact devices by high-speed image analysis	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						brain injuries; calibration; models; animal; instrumentation; reproducibility	TRAUMATIC BRAIN-INJURY; MODEL; MOUSE	As a consequence of their commercial availability, ease of use, and reproducibility, controlled cortical impact (CCI) devices have attained significant prevalence in preclinical traumatic brain injury research. With a CCI, the severity of injury is controlled by varying the impact depth, velocity, and duration, but the actual performance of the device is not well appreciated, partly because of the velocity and short travel distance to impact. This study used a high-speed video digital camera to investigate the performance of five electromagnetically driven CCI devices of the same model. Videography indicated that the impactor tip made a series of distinctive vertical advances and retractions before it attained the desired preset depth; this was also observed in male mouse CCI tests. The impactor tip was also observed to move in the horizontal direction by .8-1.6 mm. On the first advance, the tip extended a distance that was shorter than the preset depth and the velocity of impactor tip was slightly faster than the preset values for three of the five machines. One of the devices was evaluated on four separate occasions over a 14-month period and was found to operate consistently over time. Overall, differences in impact depth and velocity between the devices were modest, suggesting that comparisons of experimental results from different laboratories will generally be informative, particularly if reports provide relevant descriptions of neuropathology. However, the repetitive extension and retraction and horizontal movement of the tip suggests caution in modeling CCI as a single injurious event.	[Kim, Yeonho; Fu, Amanda H.; Tucker, Laura B.; Liu, Jiong; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Kim, Yeonho; Fu, Amanda H.; Tucker, Laura B.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Ctr Neurosci & Regenerat Med, Preclin Studies Core, Bethesda, MD 20814 USA		McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	Joseph.McCabe@usuhs.edu	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442; Tucker, Laura/0000-0002-5984-6399	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855-300600-7.01]	This work was supported by the Center for Neuroscience and Regenerative Medicine, grant number: 60855-300600-7.01.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Budinich CS, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/378307; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Hua Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/272976; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; myNeuroLab, 2008, BENCHM STER IMP INST, P6; Osier ND, 2015, BRAIN NEUROTRAUMA MO, P177; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Weissgerber TL, 2016, J NEUROSCI RES, V94, P859, DOI 10.1002/jnr.23785	19	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		501	511		10.1002/jnr.24099			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV2DK	WOS:000424374300003	28675644				2022-02-06	
J	Negrini, S; Cantista, P; Ceravolo, MG; Christodoulou, N; Delarque, A; Gutenbrunner, C; Kiekens, C; Moslavac, S; Varela-Donoso, E; Ward, AB; Zampolini, M; Basaglia, N; Didier, JP; Frontera, W; Haig, AJ; Laxe, S; Li, JN; Li, L; Michel, C; Padua, L; Paysant, J; Perennou, D; Rode, G; Rossetti, Y; Tederko, P; Ward, AB				Negrini, Stefano; Cantista, Pedro; Ceravolo, Maria Gabriella; Christodoulou, Nicolas; Delarque, Alain; Gutenbrunner, Christoph; Kiekens, Carlotte; Moslavac, Sasa; Varela-Donoso, Enrique; Ward, Anthony B.; Zampolini, Mauro; Basaglia, Nino; Didier, Jean-Pierre; Frontera, Walter; Haig, Andrew J.; Laxe, Sara; Li, Jianan; Li, Leonard; Michel, Carine; Padua, Luca; Paysant, Jean; Perennou, Dominic; Rode, Gilles; Rossetti, Yves; Tederko, Piotr; Ward, Anthony B.		EARM; ESPRM; European Union Med Specialists PRM; ECPRM	White Book on Physical and Rehabilitation Medicine (PRM) in Europe. Chapter 6. Knowledge and skills of PRM physicians	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Physical and rehabilitation medicine; Europe; Learning; Recovery of function; Case management; Communication	SPINAL-CORD-INJURY; ENERGY-CONSERVATION COURSE; TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; PRISM ADAPTATION; INTERNATIONAL CLASSIFICATION; NEUROPATHIC PAIN; PRESSURE ULCERS; MOTOR RECOVERY; BACK-PAIN	In the context of the White Book of Physical and Rehabilitation Medicine (PRM) in Europe, this paper deals with the fundamentals of PRM from a physiological perspective, looking at the human mechanisms both physical and behavioral which are at the base of PRM physicians' work. After a discussion on the development and evolution of PRM that leads to its unique and specific approach. the mechanisms considered include: - repairing processes (and potential of recovery evaluation): repairing processes are mainly related to the quantity and natural history of diseases and impairments, while potential of recovery is also linked to the individual and environmental factors; PRM physicians work on impairments to favor healing or recovery, and propose rehabilitation if there is a potential of recovery: this is related to the prognostic role of PRM physicians; - learning processes: PRM is the specialty of teaching new physical ways and behavioral approaches to make patients participate at best through improvement of impairments and modification of activities; in this perspective, during repair and rehabilitation processes, PRM physicians and the rehabilitation team are teachers of new motor and behavioral strategies; - compensatory processes (adaptation/habilitation/rehabilitation): PRM physicians teach patients how to adapt to the new (acquired) health condition using compensatory mechanisms based on other body structures/functions, behavioral changes and/or assistive devices (or technical aids) (prosthesis and orthosis); during growth PRM physicians aim at allowing a complete (and compensatory) development of the intact function, not to be impaired by the original disease; compensatory processes are related to activities; - management skills: PRM physicians are managers of people and resources; they manage patients and their caregivers, to teach and allow them to reach the best possible participation, also focusing on maintenance; they lead the team. with the aim to make it function at best for the sake of the patient; finally, they manage resource allocation for the functioning of patients and team; - communication skills: PRM physicians need to develop very good communication skills, so to teach, inform and educate patients and their caregivers: this will allow the proper behavioural changes and also the correct physical compensations.					Kiekens, Carlotte/V-7545-2018; Negrini, Stefano/B-6667-2013; Padua, Luca/K-5398-2016; Tederko, Piotr/U-7928-2018	Kiekens, Carlotte/0000-0001-8500-7751; Negrini, Stefano/0000-0002-1878-2747; Padua, Luca/0000-0003-2570-9326; Tederko, Piotr/0000-0002-2008-0357; MICHEL COLENT, Carine/0000-0002-4307-5593			Alford VM, 2015, DISABIL REHABIL, V37, P655, DOI 10.3109/09638288.2014.935875; Allen NJ, 2004, J OCCUP ORGAN PSYCH, V77, P439, DOI 10.1348/0963179042596469; ANDERSON TP, 1983, ARCH PHYS MED REHAB, V64, P314; Andre J, 1999, TRAITE MED PHYS READ; ANDRE JM, 1994, B ACAD NAT MED PARIS, V178, P1301; Andre JM, 1994, B ACAD NATL MED, V178, P1316; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Baker NA, 2001, AM J OCCUP THER, V55, P324, DOI 10.5014/ajot.55.3.324; Boyd LA, 2003, PHYS THER, V83, P976, DOI 10.1093/ptj/83.11.976; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; BRILLHART B, 1989, NURS CLIN N AM, V24, P675; Budh CN, 2006, J REHABIL MED, V38, P172, DOI 10.1080/16501970500476258; Cardenas DD, 2004, J SPINAL CORD MED, V27, P47, DOI 10.1080/10790268.2004.11753730; Cooper H, 2001, PATIENT EDUC COUNS, V44, P107, DOI 10.1016/S0738-3991(00)00182-8; Coster S, 2009, INT J NURS STUD, V46, P508, DOI 10.1016/j.ijnurstu.2008.09.009; Cox RJ, 2001, CLIN REHABIL, V15, P600, DOI 10.1191/0269215501cr453oa; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; de Haes H, 2009, PATIENT EDUC COUNS, V74, P287, DOI 10.1016/j.pec.2008.12.006; DeLisa's Physical Medicine & Rehabilitation, PRINCIPLES PRACTICE, VV; Desrosiers J, 2007, ARCH PHYS MED REHAB, V88, P1095, DOI 10.1016/j.apmr.2007.06.017; Didier J, 2004, PLASTICITE FONCTION, VXII; Didier JP, 2004, PLASTICITE FONCTION, P15; Draaistra Harriett, 2012, Can J Neurosci Nurs, V34, P22; Elliott Timothy R, 2008, Bienn Rev Couns Psychol, V1, P295; Escorpizo R, 2015, PHYSIOTHER RES INT, V20, P200, DOI 10.1002/pri.1578; European Board of PRM physician, TRAIN CURR; EVANS RL, 1988, STROKE, V19, P1243, DOI 10.1161/01.STR.19.10.1243; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Friston K, 2011, NEURON, V72, P488, DOI 10.1016/j.neuron.2011.10.018; Ganguly K, 2013, NEURON, V80, P729, DOI 10.1016/j.neuron.2013.10.028; Garber SL, 2002, J REHABIL RES DEV, V39, P575; Gay RE, INTEGRATIVE MED REHA, P483; Gelis A., 2011, Annals of Physical and Rehabilitation Medicine, V54, P189, DOI 10.1016/j.rehab.2011.03.004; Geuze R.H., 2005, NEURAL PLAST, V12, P263; Geuze Reint H., 2005, Neural Plasticity, V12, P183, DOI 10.1155/NP.2005.183; Gollhofer A., 2013, ROUTLEDGE HDB MOTOR; Gonzalo JD, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1714-x; Gremeaux V., 2010, Annals of Physical and Rehabilitation Medicine, V53, P669, DOI 10.1016/j.rehab.2010.09.003; HAGGLUND KJ, 2005, TOPICS SPINAL CORD I, V10, P53; Harber MP, 2012, J APPL PHYSIOL, V113, P1495, DOI 10.1152/japplphysiol.00786.2012; Hearn JH, 2015, DISABIL REHABIL, V37, P2203, DOI 10.3109/09638288.2014.1002579; Herson L, 1999, Rehabil Nurs, V24, P148; Hetherington R, 2004, CHILD NEUROPSYCHOL, V10, P117, DOI 10.1080/09297040490911122; Hirano T, 2013, P JPN ACAD B-PHYS, V89, P183, DOI 10.2183/pjab.89.183; Iosa M, 2013, EUR J PHYS REHAB MED, V49, P291; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Jacquin-Courtois S, 2013, NEUROSCI BIOBEHAV R, V37, P594, DOI 10.1016/j.neubiorev.2013.02.007; JAKOBSON LS, 1989, EXP BRAIN RES, V78, P575; Joiner WM, 2008, J NEUROPHYSIOL, V100, P2948, DOI 10.1152/jn.90706.2008; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P399, DOI 10.1016/S0003-9993(95)80567-2; King RB, 2008, REHABIL NURS, V33, P154, DOI 10.1002/j.2048-7940.2008.tb00221.x; Kitago T, 2013, MOTOR LEARNI1G PRINC; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; Lefebvre H, 2006, BRAIN INJURY, V20, P711, DOI 10.1080/02699050600744244; Levin MF, 2002, EXP BRAIN RES, V143, P171, DOI 10.1007/s00221-001-0976-6; Lexell J, 2015, NEUROREHABILITATION, V36, P5, DOI 10.3233/NRE-141184; Lexell J, 2012, PM&R, V4, P331, DOI 10.1016/j.pmrj.2012.03.009; Li YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117037; Liddle SD, 2007, MANUAL THER, V12, P310, DOI 10.1016/j.math.2006.12.009; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Little P, 2008, BRIT J SPORT MED, V42, P965; Magasi S, 2015, ARCH PHYS MED REHAB, V96, P569, DOI 10.1016/j.apmr.2014.12.002; Mateo S, 2013, SPINAL CORD, V51, P144, DOI 10.1038/sc.2012.101; Mathiowetz V, 2001, ARCH PHYS MED REHAB, V82, P449, DOI 10.1053/apmr.2001.22192; Mathiowetz VG, 2005, MULT SCLER J, V11, P592, DOI 10.1191/1352458505ms1198oa; MEYER D, 1985, HEALTH PSYCHOL, V4, P115, DOI 10.1037/0278-6133.4.2.115; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Michel C, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01979; Michel C, 2013, CORTEX, V49, P2249, DOI 10.1016/j.cortex.2012.11.008; Morison M J, 1989, Prof Nurse, V5, ppassim; Morison MJ, 1989, PROF NURS, V5, P136; Morison MJ, 1989, PROF NURS, V5, P138; Mouillie JM, 2010, REHABILITATION NORMS, P53; North NT, 1999, SPINAL CORD, V37, P671, DOI 10.1038/sj.sc.3100913; Pellerito Joseph M Jr, 2003, Occup Ther Int, V10, P1, DOI 10.1002/oti.174; Plant SE, 2016, CLIN REHABIL, V30, P921, DOI 10.1177/0269215516655856; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Poquet N, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008325.pub2; Powell-Cope G, 2015, REHABIL NURS, V40, P100, DOI 10.1002/rnj.134; Rehabilitation Team Function and Prescriptions, REHABILITATION TEAM; Rehabilitation Team Function and Prescriptions, REHABILITATION TEAM; Rintala DH, 2008, ARCH PHYS MED REHAB, V89, P1429, DOI 10.1016/j.apmr.2008.01.015; Robertson JV, 2010, AUGMENTED FEEDBACK V; Rode G, 2015, ANN PHYS REHABIL MED, V58, P40, DOI 10.1016/j.rehab.2014.10.004; Rode G, 1996, NEUROPSYCHOLOGIA, V34, P87, DOI 10.1016/0028-3932(95)00065-8; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; Rossetti Y, 2015, TESTING COGNITION RE; Schubart J, 2012, OSTOMY WOUND MANAG, V58, P38; Schulz R, 2015, BRAIN, V138, P1949, DOI 10.1093/brain/awv100; Sheppard R, 2006, J CLIN PSYCHOL MED S; Stewart R, 1999, DISABIL REHABIL, V21, P338; Stinear C. M., 2014, Annals of Physical and Rehabilitation Medicine, V57, P489, DOI 10.1016/j.rehab.2014.08.006; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Taylor JA, 2012, ANN NY ACAD SCI, V1251, P1, DOI 10.1111/j.1749-6632.2011.06430.x; van Tulder MW, 2006, EUR SPINE J, V15, pS64, DOI 10.1007/s00586-005-1048-6; Vanage SM, 2003, AM J OCCUP THER, V57, P315, DOI 10.5014/ajot.57.3.315; Viehbeck M, 1995, SCI Nurs, V12, P73; Voogt J, 2016, INT J QUAL HLTH CARE; Waddell G, 2004, INFORM ADVICE PATIEN, P323; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; WILKINSON DA, 1971, J EXP PSYCHOL, V89, P250, DOI 10.1037/h0031162; Zientz J, 2007, J MED SPEECH LANG PA	102	7	7	0	5	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	APR	2018	54	2					214	229		10.23736/S1973-9087.18.05150-X			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	GU4ZD	WOS:000445293100007	29565107				2022-02-06	
J	Nie, JP; Chen, J; Yang, JG; Pei, QQ; Li, J; Liu, J; Xu, LX; Li, N; Chen, YH; Chen, XH; Luo, H; Sun, TS				Nie, Jiping; Chen, Jian; Yang, Jianguo; Pei, Qinqin; Li, Jing; Liu, Jia; Xu, Lixin; Li, Nan; Chen, Youhao; Chen, Xiaohua; Luo, Hao; Sun, Tiansheng			Inhibition of mammalian target of rapamycin complex 1 signaling by n-3 polyunsaturated fatty acids promotes locomotor recovery after spinal cord injury	MOLECULAR MEDICINE REPORTS			English	Article						polyunsaturated fatty acids; spinal cord injury; mammalian target of rapamycin; autophagy; locomotor recovery	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; NEURAL TISSUE-DAMAGE; FUNCTIONAL RECOVERY; TRANSGENIC MICE; MESSENGER-RNA; AUTOPHAGY; OMEGA-3-FATTY-ACIDS; RATS; MTOR	The present study aimed to explore the effects of n-3 polyunsaturated fatty acids (PUFAs) on autophagy and their potential for promoting locomotor recovery after spinal cord injury (SCI). Primary neurons were isolated and cultured. Sprague-Dawley rats were randomly divided into three groups and fed diets with different amounts of n-3 PUFAs. A model of spinal cord contusion was created at the T10 spinal segment and the composition of PUFAs was analyzed using gas chromatography. Spinal repair and motor function were evaluated postoperatively. Assessment of the effects of n-3 PUFAs on autophagy and mammalian target of rapamycin complex 1 (mTORC1) was performed using immunofluorescence staining and western blotting. In vitro, n-3 PUFAs inhibited mTORC1 and enhanced autophagy. The n-3 PUFA levels and the ratio of n-3 PUFA to n-6 PUFA in the spinal cord and serum of rats fed a high-n-3 PUFA diet were higher before and after operation (P<0.05). Additionally, rats in the high-n-3 PUFA group showed improved motor function recovery, spinal cord repair-related protein expression level (MBP, Galc and GFAP). Expression levels if these protiens in the high-n-3 PUFA diet group expressed the highest levels, followed by the low-n-3 PUFA diet group and finally the control group (P<0.05). high-n-3 PUFA diet promoted autophagy ability and inhibited activity of the mTORC1 signaling pathway compared with the low-n-3 PUFA diet group or the control group (P<0.05). These results suggest that exogenous dietary n-3 PUFAs can inhibit mTORC1 signaling and enhance autophagy, promoting functional recovery of rats with SCI.	[Nie, Jiping; Sun, Tiansheng] Southern Med Univ, Guangzhou 510515, Guangdong, Peoples R China; [Nie, Jiping] Inner Mongolia Med Univ, Dept Orthoped, Affiliated Hosp 2, Hohhot 010050, Inner Mongolia, Peoples R China; [Chen, Jian; Pei, Qinqin; Li, Jing; Xu, Lixin; Li, Nan; Chen, Youhao; Chen, Xiaohua; Luo, Hao] Three Gorges Cent Hosp Chongqing, Dept Orthoped, 165 New City Rd, Chongqing 404000, Peoples R China; [Yang, Jianguo] Huhhot First Hosp, Dept Orthoped, Hohhot 010020, Inner Mongolia, Peoples R China; [Liu, Jia] Youjiang Med Coll Nationalities, Dept Orthoped, Affiliated Hosp, Baise 533000, Guangxi, Peoples R China; [Sun, Tiansheng] Beijing Army Gen Hosp, Dept Orthoped, 5 Nanmengcang, Beijing 100700, Peoples R China		Luo, H (corresponding author), Three Gorges Cent Hosp Chongqing, Dept Orthoped, 165 New City Rd, Chongqing 404000, Peoples R China.; Sun, TS (corresponding author), Beijing Army Gen Hosp, Dept Orthoped, 5 Nanmengcang, Beijing 100700, Peoples R China.	yueer327@126.com; 2381049996@qq.com			National Natural Sciences Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81560213]; Chongqing Three Gorges Central Hospital PhD Research Startup Fund [2017BSKYQDJJ02]; Chongqing Postdoctoral Research Special Fund [Xm2017181]; North Sichuan Medical College and Chongqing Three Gorges Central Hospital Cooperation Fund [2016XY01]	The present study was supported by National Natural Sciences Foundation of China (grant no. 81560213), Chongqing Three Gorges Central Hospital PhD Research Startup Fund (grant no. 2017BSKYQDJJ02), Chongqing Postdoctoral Research Special Fund (grant no. Xm2017181), and North Sichuan Medical College and Chongqing Three Gorges Central Hospital Cooperation Fund (grant no. 2016XY01).	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Berquin IM, 2008, CANCER LETT, V269, P363, DOI 10.1016/j.canlet.2008.03.044; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Chen KB, 2011, SPINE, V36, P1350, DOI 10.1097/BRS.0b013e3181f014ec; Chen Z, 2014, ONCOGENE, V33, P4548, DOI 10.1038/onc.2013.402; Chen Z, 2014, MOL MED REP, V9, P2091, DOI 10.3892/mmr.2014.2124; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Dyall SC, 2007, NEUROBIOL AGING, V28, P424, DOI 10.1016/j.neurobiolaging.2006.01.002; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Figueroa JD, 2014, MOL NEUROBIOL, V50, P197, DOI 10.1007/s12035-014-8701-1; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fry EJ, 2001, CLIN EXP PHARMACOL P, V28, P253, DOI 10.1046/j.1440-1681.2001.03417.x; Gao K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/260161; Gerber M, 2012, BRIT J NUTR, V107, pS228, DOI 10.1017/S0007114512001614; Grau JW, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00100; Guo J, 2015, MOL MED REP, V12, P37, DOI 10.3892/mmr.2015.3390; Guo YJ, 2015, LAB INVEST, V95, P1439, DOI 10.1038/labinvest.2015.120; Hao HH, 2013, NEUROSCI BULL, V29, P484, DOI 10.1007/s12264-013-1355-6; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; Hou HP, 2014, J NEUROSURG-SPINE, V20, P568, DOI 10.3171/2014.1.SPINE13237; Huang MJ, 2014, ANN RHEUM DIS, V73, P1719, DOI 10.1136/annrheumdis-2013-203231; Jiang WQ, 2012, CANCER RES, V72, P3795, DOI 10.1158/0008-5472.CAN-12-1047; Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273; Kang JX, 2008, J NUTRIGENET NUTRIGE, V1, P172, DOI 10.1159/000119714; Kanki T, 2010, MOL MICROBIOL, V75, P795, DOI 10.1111/j.1365-2958.2009.07035.x; Kanno H, 2012, CELL CYCLE, V11, P3175, DOI 10.4161/cc.21262; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002; Laplante M, 2012, COLD SPRING HARB PER, V4; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Lim SN, 2013, NEUROBIOL DIS, V51, P104, DOI 10.1016/j.nbd.2012.10.021; Liu GM, 2016, MOL MED REP, V13, P4431, DOI 10.3892/mmr.2016.5072; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lotz MK, 2011, NAT REV RHEUMATOL, V7, P579, DOI 10.1038/nrrheum.2011.109; Lu Y, 2014, PAIN, V155, P2618, DOI 10.1016/j.pain.2014.09.027; MANKU MS, 1983, LIPIDS, V18, P906, DOI 10.1007/BF02534572; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Ribatti D, 2003, BRAIN RES, V989, P9, DOI 10.1016/S0006-8993(03)03225-6; Ritfeld GJ, 2012, CELL TRANSPLANT, V21, P1561, DOI 10.3727/096368912X640484; Schwab ME, 1998, NEWS PHYSIOL SCI, V13, P294; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Su M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7263736; Wang CX, 1997, BRAIN RES, V759, P190, DOI 10.1016/S0006-8993(97)00254-0; Wang ZY, 2014, APOPTOSIS, V19, P933, DOI 10.1007/s10495-014-0976-1; Wei D, 2010, DIABETES, V59, P471, DOI 10.2337/db09-0284; Wen ZH, 2013, ONCOGENE, V32, P160, DOI 10.1038/onc.2012.47; Zeman M, 2012, NEUROENDOCRINOL LETT, V33, P736; Zhang XY, 2012, J BIOMED MATER RES A, V100A, P578, DOI 10.1002/jbm.a.33237; Zhou KL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17130; Zhou YL, 2016, NEUROCHEM RES, V41, P813, DOI 10.1007/s11064-015-1756-1; Zurita M, 2005, NEUROREPORT, V16, P505, DOI 10.1097/00001756-200504040-00017	55	7	7	1	5	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	APR	2018	17	4					5894	5902		10.3892/mmr.2018.8583			9	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	GA9PA	WOS:000428672100130	29436695	hybrid, Green Published			2022-02-06	
J	Oyesanya, TO; Bowers, BJ; Royer, HR; Turkstra, LS				Oyesanya, Tolu O.; Bowers, Barbara J.; Royer, Heather R.; Turkstra, Lyn S.			Nurses' concerns about caring for patients with acute and chronic traumatic brain injury	JOURNAL OF CLINICAL NURSING			English	Article						brain injury; content analysis; nurses; nursing education	QUALITATIVE CONTENT-ANALYSIS; METAANALYSIS; STATEMENT; RECOVERY; CARE	Aims and objectives: As a first step in developing traumatic brain injury-specific nursing education, the purpose of this study was to investigate nurses' concerns about caring for patients with moderate-to-severe traumatic brain injury. Background: Patients with moderate-to-severe traumatic brain injury typically have significant immediate and chronic cognitive impairments. These cognitive impairments can negatively affect their inpatient stay after an acute traumatic brain injury and affect their health care later in life when seeking care for other acute health conditions during the chronic phase of traumatic brain injury. Nurses must be knowledgeable about modifying care to accommodate the cognitive impairments of these patients throughout the continuum of care. Yet, current guidelines focus exclusively on acute care and do not address nurses' central role in dealing with residual cognitive impairments of these patients. Thus, educational and training interventions are needed to ensure nurses have adequate knowledge to care for these patients. Design: We conducted a cross-sectional, exploratory survey of 692 nurses across hospital departments at three hospitals between October 2014-August 2015. Nurses answered the following qualitative open-ended question: "What are your primary concerns about providing care to patients with moderate-to-severe traumatic brain injury?" Methods: Conventional qualitative content analysis was used to analyse nurses' responses. Results: Findings showed nurses reported multiple concerns about caring for patients in the acute phase after traumatic brain injury, but few concerns about caring for patients in the chronic phase. Some of the concerns nurses reported included: (i) preventing physical injury; (ii) missing changes in condition; (iii) providing adequate education; (iv) providing support; and (v) promoting recovery. Barriers to providing adequate care were as follows: (i) lack of knowledge; (ii) limited staffing; and (iii) inadequate resources. Conclusions: Findings have implications for education of nurses and development of nursing guidelines for management of patients with traumatic brain injury, including providing direction for nurses on development of care plans for patients in the chronic phase after a moderate-to-severe traumatic brain injury.	[Oyesanya, Tolu O.] Shepherd Ctr, Atlanta, GA USA; [Bowers, Barbara J.] Univ Wisconsin, Sch Nursing, Madison, WI USA; [Royer, Heather R.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Turkstra, Lyn S.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada		Oyesanya, TO (corresponding author), Crawford Res Inst, Atlanta, GA 30309 USA.	tolu_oyesanya@shepherd.org	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921; Oyesanya, Tolu/0000-0001-8821-4510	NIH/NIGMS Initiative for Maximizing Student Development [R25GM083252]; University of Wisconsin-Madison, School of Nursing (Eckburg and Eckburg Dissertation Awards); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER	This research was supported by the NIH/NIGMS Initiative for Maximizing Student Development (PI, M. Carnes) Grant# R25GM083252 and the University of Wisconsin-Madison, School of Nursing (Eckburg and Eckburg Dissertation Awards).	American Association of Neuroscience Nurses, 2008, NURS MAN AD SEV TRAU; Blease CR, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01170; Centers for Disease Control and Prevention, 2016, TBI DAT STAT; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Defense and Veterans Brain Injury Center, 2014, TBI THE MIL; Defense Medical Surveillance System (DMSS)  Theater Medical Data Store (TMDS)  & Armed Forces Health Surveillance Center (AFHSC), 2014, DOD WORLDW NUMB TBI; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Green REA, 2006, BRAIN COGNITION, V60, P199; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jaglal SB, 2014, BMC HEALTH SERV RES, V14, P1; Lehman C, 2015, SPECIALTY PRACTICE R, P511; Lentz J, 2016, CONTEMP CLIN TRIALS, V49, P65, DOI 10.1016/j.cct.2016.06.005; Long AF, 2002, J ADV NURS, V37, P70, DOI 10.1046/j.1365-2648.2002.02059.x; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McQuillan K. A., 2002, TRAUMA NURSING RESUS, P394; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller EL, 2010, STROKE, V41, P2402, DOI 10.1161/STR.0b013e3181e7512b; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; Oyesanya TO, 2017, J CLIN NURS, V26, P1562, DOI 10.1111/jocn.13457; Oyesanya TO, 2016, WESTERN J NURS RES, V38, P1114, DOI 10.1177/0193945916636629; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Ryan DL., 2009, AM NURSE TODAY, V4, P18; Scharf D.M., 2015, PUBLIC PRIVATE PARTN; Shih TH, 2009, EDUC RES REV-NETH, V4, P26, DOI 10.1016/j.edurev.2008.01.003; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	35	7	7	6	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	APR	2018	27	7-8					1408	1419		10.1111/jocn.14298			12	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	GD9HZ	WOS:000430825100049	29399908	Green Accepted			2022-02-06	
J	Wallace, J; Covassin, T; Lefevor, M				Wallace, Jessica; Covassin, Tracey; Lefevor, Meghan			Use of the stepwise progression return-to-play protocol following concussion among practicing athletic trainers	JOURNAL OF SPORT AND HEALTH SCIENCE			English	Article						Athletic trainers; Concussion; Concussion management; Graduate degree; Return to play; Sports medicine; Stepwise progression	SPORT-RELATED CONCUSSION; MANAGEMENT; GUIDELINES; PATTERNS	Purpose: The purpose of this study was to determine whether practicing athletic trainers (ATs) were using the stepwise progression to make return-to-play (RTP) decisions after concussion and to determine what factors influenced their decision to use the stepwise progression. Methods: A total of 166 ATs (response rate-16.6%) completed a 21-item questionnaire that evaluated participant demographics, methods of concussion management, and RTP decision-making using the stepwise progression. Descriptive statistics and a logistic regression were completed to analyze data. Results: Factors such as education level (p = 0.05) and number of concussions treated (p = 0.05) predicted use of the stepwise progression, whereas sex (p = 0.17), employment setting (p = 0.17), state law (p = 0.86), and years practicing (p = 0.17) did not predict whether ATs were following the stepwise progression. Conclusion: The majority of the ATs from this study are employing the stepwise progression to safely return athletes to play after sustaining a concussion. This demonstrates that ATs are providing a standard of care for concussed athletes across various athletic training settings; however, having a graduate degree and treating more concussions per year are predictors of whether an AT follows all steps of the stepwise progression. (C) 2018 Published by Elsevier B.V. on behalf of Shanghai University of Sport.	[Wallace, Jessica; Covassin, Tracey; Lefevor, Meghan] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Wallace, Jessica] Youngstown State Univ, Human Performance & Exercise Sci Dept, Youngstown, OH 44555 USA		Wallace, J (corresponding author), Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA.; Wallace, J (corresponding author), Youngstown State Univ, Human Performance & Exercise Sci Dept, Youngstown, OH 44555 USA.	Jwallace02@ysu.edu					Almasi Stephen J, 2012, WMJ, V111, P21; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; d'Hemecourt P, 2011, CLIN SPORT MED, V30, P63, DOI 10.1016/j.csm.2010.08.008; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Echemendia RJ, 2015, BRAIN INJURY, V29, P185, DOI 10.3109/02699052.2014.965212; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz Kevin, 2014, Neurosurgery, V75 Suppl 4, pS113, DOI 10.1227/NEU.0000000000000494; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Rigby J, 2013, J ATHL TRAINING, V48, P636, DOI 10.4085/1062-6050-48.3.10; Sarris CE, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12224; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612	23	7	7	0	1	SHANGHAI UNIV SPORT	SHANGHAI	EDITORIAL BOARD, 650 QINGYUANHUAN RD, SHANGHAI, 200438, PEOPLES R CHINA	2095-2546	2213-2961		J SPORT HEALTH SCI	J. Sport Health Sci.	APR	2018	7	2					204	209		10.1016/j.jshs.2016.11.002			6	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	GG1ZH	WOS:000432488500012	30356457	gold, Green Published			2022-02-06	
J	Yen, TL; Chang, CC; Chung, CL; Ko, WC; Yang, CH; Hsieh, CY				Yen, Ting-Lin; Chang, Chao-Chien; Chung, Chi-Li; Ko, Wen-Chin; Yang, Chih-Hao; Hsieh, Cheng-Ying			Neuroprotective Effects of Platonin, a Therapeutic Immunomodulating Medicine, on Traumatic Brain Injury in Mice after Controlled Cortical Impact	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; platonin; neuroinflammation; microglial activation; free radical	PHOTOSENSITIZING DYE; INHIBITORY CONTROL; ISCHEMIC-STROKE; APOPTOSIS; INFLAMMATION; ACTIVATION; BEHAVIOR; DEFICITS; MODELS; CELLS	Traumatic brain injury (TBI) is one of the leading causes of mortality worldwide and leads to persistent cognitive, sensory, motor dysfunction, and emotional disorders. TBI-caused primary injury results in structural damage to brain tissues. Following the primary injury, secondary injuries which are accompanied by neuroinflammation, microglial activation, and additional cell death subsequently occur. Platonin, a cyanine photosensitizing dye, has been used to treat trauma, ulcers, and some types of acute inflammation. In the present study, the neuroprotective effects of platonin against TBI were explored in a controlled cortical impact (CCI) injury model in mice. Treatment with platonin ( 200 mu g/kg) significantly reduced the neurological severity score, general locomotor activity, and anxiety-related behavior, and improved the rotarod performance of CCI-injured mice. In addition, platonin reduced lesion volumes, the expression of cleaved caspase-3, and microglial activation in TBI-insulted brains. Platonin also suppressed messenger (m)RNA levels of caspase-3, caspase-1, cyclooxygenase-2, tumor necrosis factor-alpha, interleukin-6, and interleukin-1 alpha. On the other hand, free radical production after TBI was obviously attenuated in platonin-treated mice. Treatment with platonin exhibited prominent neuroprotective properties against TBI in a CCI mouse model through its anti-inflammatory, anti-apoptotic, and anti-free radical capabilities. This evidence collectively indicates that platonin may be a potential therapeutic medicine for use with TBIs.	[Yen, Ting-Lin] Cathay Gen Hosp, Dept Med Res, Taipei 22174, Taiwan; [Yen, Ting-Lin; Chang, Chao-Chien; Yang, Chih-Hao; Hsieh, Cheng-Ying] Taipei Med Univ, Coll Med, Dept Pharmacol, Taipei 11031, Taiwan; [Chang, Chao-Chien; Ko, Wen-Chin] Cathay Gen Hosp, Dept Cardiol, Taipei 10630, Taiwan; [Chung, Chi-Li] Taipei Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taipei 11031, Taiwan; [Chung, Chi-Li] Taipei Med Univ, Coll Med, Dept Internal Med, Sch Resp Therapy,Div Thorac Med,Sch Med, Taipei 11031, Taiwan		Hsieh, CY (corresponding author), Taipei Med Univ, Coll Med, Dept Pharmacol, Taipei 11031, Taiwan.	d119096015@tmu.edu.tw; change@seed.net.tw; cichung@tmu.edu.tw; wckcgh@ms17.hinet.net; chyang@tmu.edu.tw; hsiehcy@tmu.edu.tw	Chung, Chi-Li/AAB-7219-2020; Ko, Wen-chin/ABI-3879-2020	Chung, Chi-Li/0000-0003-0656-976X; Ko, Wen-chin/0000-0002-7109-832X; Yen, Ting-Lin/0000-0002-1454-0521	Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST-105-2320-B-038-015, MOST-106-2320-B-038-060-MY2]; Taipei Medical University (TMU)-TMU Hospital [105 TMU-TMUH-02-02]; Cathay General Hospital [CGH-MR-A106020]	This work was supported by grants provided by the Ministry of Science and Technology of Taiwan (MOST-105-2320-B-038-015, MOST-106-2320-B-038-060-MY2), the Taipei Medical University (TMU)-TMU Hospital (105 TMU-TMUH-02-02), and Cathay General Hospital (CGH-MR-A106020).	Abdul-Muneer PM, 2017, MOL NEUROBIOL, V54, P3964, DOI 10.1007/s12035-016-9949-4; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Centers for Disease Control, 2016, TRAUM BRAIN INJ US F; Chen CY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092271, 10.1371/journal.pone.0108021, 10.1371/journal.pone.0106248]; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen WW, 2016, MOL MED REP, V13, P3391, DOI 10.3892/mmr.2016.4948; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Elliott MR, 2016, DEV CELL, V38, P147, DOI 10.1016/j.devcel.2016.06.029; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Glushakov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113689; Guadagno J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.151; Guadagno J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.59; Hsiao G, 2002, BIOL PHARM BULL, V25, P995, DOI 10.1248/bpb.25.995; Ishihara M, 2006, IN VIVO, V20, P845; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Komori T., 1984, KOUSHYOKAISHI, V8, P43; Konrad KN, 2000, BRAIN INJURY, V14, P859; Larcher T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110371; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Lee J, 2014, J TRAUMA ACUTE CARE, V77, P709, DOI 10.1097/TA.0000000000000445; Lee JJ, 2003, J PHARMACOL SCI, V93, P376, DOI 10.1254/jphs.93.376; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; McAllister, 1998, Semin Clin Neuropsychiatry, V3, P158; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MOTOYOSHI F, 1991, BIOTHERAPY, V3, P241, DOI 10.1007/BF02171687; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rodgers KM, 2014, J NEUROTRAUM, V31, P487, DOI [10.1089/NEU.2013.3090, 10.1089/neu.2013.3090]; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Shah ZA, 2010, J CEREBR BLOOD F MET, V30, P1951, DOI 10.1038/jcbfm.2010.53; Sheu JR, 2017, SCI REP-UK, V7, DOI 10.1038/srep42277; Sinopoli KJ, 2012, INT J DEV NEUROSCI, V30, P207, DOI 10.1016/j.ijdevneu.2011.08.006; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wong CHY, 2008, CURR MED CHEM, V15, P1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yeh Chia-Tse, 2015, Acta Anaesthesiol Taiwan, V53, P12, DOI 10.1016/j.aat.2015.02.001; Yen TL, 2016, TRANSL RES, V170, P57, DOI 10.1016/j.trsl.2015.12.002	46	7	7	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	APR	2018	19	4							1100	10.3390/ijms19041100			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	GJ0XU	WOS:000434978700179	29642394	Green Published, Green Submitted, gold			2022-02-06	
J	Awwad, HO; Durand, CD; Gonzalez, LP; Tompkins, P; Zhang, Y; Lerner, MR; Brackett, DJ; Sherry, DM; Awasthi, V; Standifer, KM				Awwad, Hibah O.; Durand, Cindy D.; Gonzalez, Larry P.; Tompkins, Paul; Zhang, Yong; Lerner, Megan R.; Brackett, Daniel J.; Sherry, David M.; Awasthi, Vibhudutta; Standifer, Kelly M.			Post-blast treatment with Nociceptin/Orphanin FQ peptide (NOP) receptor antagonist reduces brain injury-induced hypoxia and signaling proteins in vestibulomotor-related brain regions	BEHAVIOURAL BRAIN RESEARCH			English	Article						Nociceptin/Orphanin FQ peptide receptor; Blast traumatic brain injury; Vestibulomotor; Rotarod; PET imaging; Hypoxia	BLAST EXPOSURE; PHARMACOLOGICAL CHARACTERIZATION; HYPERCAPNIC CEREBROVASODILATION; DIFFERENTIAL ACTIVATION; SERUM BIOMARKERS; RAT MODEL; P38 MAPK; IN-VITRO; KAPPA-B; NOC/OFQ	Mild traumatic brain injury (mTBI) diagnoses have increased due to aggressive sports and blast related injuries, but the cellular mechanisms and pathology underlying mTBI are not completely understood. Previous reports indicate that Nociceptin Orphanin/FQ (N/OFQ), an endogenous neuropeptide, contributes to post injury ischemia following mechanical brain injury, yet its specific role in cerebral hypoxia, vestibulomotor function and injury marker expression following blast induced TBI is not known. This study is the first to identify a direct association of N/OFQ and its N/OFQ peptide (NOP) receptor with TBI-induced changes following a single 80 psi head blast exposure in male rats. N/OFQ and NOP receptor expression increased in brain tissue and plasma following TBI, concurrent with vestibular dysfunction but preceding hypoxia and appearance of injury markers compared to sham rats. A single post-blast treatment with the NOP receptor antagonist, SB-612111, transiently improved acute vestibulomotor performance. It also prevented increases in markers of TBI-induced hypoxia, proapoptotic proteins and injury seen 8-10 days post-blast. This study reveals an apparent role for the N/OFQ-NOP receptor system in blast TBI and suggests potential therapeutic utility of NOP receptor antagonists for mTBI. (C)2016 Elsevier B.V. All rights reserved.	[Awwad, Hibah O.; Durand, Cindy D.; Zhang, Yong; Sherry, David M.; Awasthi, Vibhudutta; Standifer, Kelly M.] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, 1110 N Stonewall Ave,Suite 315, Oklahoma City, OK 73117 USA; [Awwad, Hibah O.; Gonzalez, Larry P.; Zhang, Yong; Sherry, David M.; Standifer, Kelly M.] Oklahoma Ctr Neurosci, Oklahoma City, OK USA; [Gonzalez, Larry P.] Univ Oklahoma, Hlth Sci Ctr, Dept Psychiat & Behav Sci, Oklahoma City, OK 73190 USA; [Tompkins, Paul] Univ Oklahoma, Hlth Sci Ctr, Dept Neurosurg, Oklahoma City, OK USA; [Lerner, Megan R.; Brackett, Daniel J.] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK USA; [Sherry, David M.; Standifer, Kelly M.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Cell Biol, Oklahoma City, OK 73190 USA; [Lerner, Megan R.] Oklahoma City VA Med Ctr, Oklahoma City, OK 73117 USA		Awwad, HO (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, 1110 N Stonewall Ave,Suite 315, Oklahoma City, OK 73117 USA.	hawwad@ouhsc.edu	Gonzalez, Larry P/A-4362-2008		Department of the Army [W81XWH-09-1-0443]	This work was supported by the Department of the Army [W81XWH-09-1-0443 to KMS].	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Armstead WA, 2006, EUR J PHARMACOL, V529, P129, DOI 10.1016/j.ejphar.2005.08.059; Armstead WM, 2000, J NEUROTRAUM, V17, P751, DOI 10.1089/neu.2000.17.751; Armstead WM, 2000, BRAIN RES, V869, P231, DOI 10.1016/S0006-8993(00)02367-2; Armstead WM, 2003, EUR J PHARMACOL, V474, P249, DOI 10.1016/S0014-2999(03)02012-0; Armstead WM, 2000, AM J PHYSIOL-HEART C, V278, pH477, DOI 10.1152/ajpheart.2000.278.2.H477; Armstead WM, 2000, BRAIN RES, V868, P48, DOI 10.1016/S0006-8993(00)02262-9; Awasthi V, 2010, NUCL MED COMMUN, V31, P152, DOI 10.1097/MNM.0b013e3283339f92; Awwad H. O., 2016, METHODS MOL BIOL; Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; DeLellis Stephen M, 2009, J Spec Oper Med, V9, P36; Desai A, 2010, NEUROCHEM INT, V57, P876, DOI 10.1016/j.neuint.2010.09.006; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Donica CL, 2013, MOL PHARMACOL, V83, P907, DOI 10.1124/mol.112.084632; Donica CL, 2011, J NEUROIMMUNE PHARM, V6, P617, DOI 10.1007/s11481-011-9279-2; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Glenn Thomas C, 2012, Acta Neurochir Suppl, V114, P11, DOI 10.1007/978-3-7091-0956-4_3; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Irwin R J, 1998, J Okla State Med Assoc, V91, P387; Irwin RJ, 1997, J TRAUMA, V43, P650, DOI 10.1097/00005373-199710000-00015; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; Jagolino A, 2001, BRAIN RES BULL, V55, P465, DOI 10.1016/S0361-9230(01)00542-1; Jagolino AL, 2003, AM J PHYSIOL-HEART C, V284, pH101, DOI 10.1152/ajpheart.00457.2002; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mollereau C, 2000, PEPTIDES, V21, P907, DOI 10.1016/S0196-9781(00)00227-8; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Paxinos G, 2006, RAT BRAIN STEREOTAXI; Post A, 2016, NEUROPSYCHOPHARMACOL, V41, P1803, DOI 10.1038/npp.2015.348; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Risling M., 2012, FRONT NEUROL, V3; Rizzi A, 2007, J PHARMACOL EXP THER, V321, P968, DOI 10.1124/jpet.106.116780; Ross J, 2005, BRAIN RES, V1054, P95, DOI 10.1016/j.brainres.2005.06.065; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Spagnolo B, 2007, J PHARMACOL EXP THER, V321, P961, DOI 10.1124/jpet.106.116764; Spratt NJ, 2009, BRAIN RES, V1288, P135, DOI 10.1016/j.brainres.2009.06.102; Stein DM, 2012, SHOCK, V37, P563, DOI 10.1097/SHK.0b013e3182534f93; Sulaiman MR, 1999, BRAIN RES, V828, P74, DOI 10.1016/S0006-8993(99)01331-1; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Witta J, 2004, BRAIN RES, V997, P24, DOI 10.1016/j.brainres.2003.08.066; Witta J, 2003, J NEUROTRAUM, V20, P523, DOI 10.1089/089771503767168456; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Zaratin PF, 2004, J PHARMACOL EXP THER, V308, P454, DOI 10.1124/jpet.103.055848; Zhang Y, 2015, BRIT J PHARMACOL, V172, P571, DOI 10.1111/bph.12701; Zhang Y, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-76	56	7	7	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		183	194		10.1016/j.bbr.2016.10.041			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400022	27793733				2022-02-06	
J	Romaus-Sanjurjo, D; Valle-Maroto, SM; Barreiro-Iglesias, A; Fernandez-Lopez, B; Rodicio, MC				Romaus-Sanjurjo, D.; Valle-Maroto, S. M.; Barreiro-Iglesias, A.; Fernandez-Lopez, B.; Rodicio, M. C.			Anatomical recovery of the GABAergic system after a complete spinal cord injury in lampreys	NEUROPHARMACOLOGY			English	Article						GABA; GABAB; Complete spinal cord injury; Cerebrospinal fluid contacting-cell; Sea lamprey; Spinal cord plasticity	GAMMA-AMINOBUTYRIC-ACID; PROMOTES AXON REGENERATION; GABA-IMMUNOREACTIVE CELLS; LARVAL SEA LAMPREY; BRAIN-STEM; DORSAL-HORN; NEUROPATHIC PAIN; NEUROTRANSMITTER COLOCALIZATION; PATTERN GENERATORS; PETROMYZON-MARINUS	Lampreys recover locomotion spontaneously several weeks after a complete spinal cord injury. Dysfunction of the GABAergic system following SCI has been reported in mammalian models. So, it is of great interest to understand how the GABAergic system of lampreys adapts to the post-injury situation and how this relates to spontaneous recovery. The spinal cord of lampreys contains 3 populations of GABAergic neurons and most of the GABAergic innervation of the spinal cord comes from these local cells. GABAB receptors are expressed in the spinal cord of lampreys and they play important roles in the control of locomotion. The aims of the present study were to quantify: 1) the changes in the number of GABAergic neurons and innervation of the spinal cord and 2) the changes in the expression of the gabab receptor subunits b1 and b2 in the spinal cord of the sea lamprey after SCI. We performed complete spinal cord transections at the level of the fifth gill of mature larval lampreys and GABA immunohistochemistry or gabab in situ hybridization experiments. Animals were analysed up to 10 weeks post lesion (wpl), when behavioural analyses showed that they recovered normal appearing locomotion (stage 6 in the Ayer's scale of locomotor recovery). We observed a significant decrease in the number of GABA-ir cells and fibres 1 h after lesion both rostral and caudal to the lesion site. GABA-ir cell numbers and innervation were recovered to control levels 1 to 2 wpl. At 1, 4 and 10 wpl the expression of gabab1 and gabab2 transcripts was significantly decreased in the spinal cord compared to control un-lesioned animals. This is the first study reporting the quantitative long-term changes in the number of GABAergic cells and fibres and in the expression of gabab receptors in the spinal cord of any vertebrate following a traumatic SCI. Our results show that in lampreys there is a full recovery of the GABAergic neurons and a decrease in the expression of gabab receptors when functional recovery is achieved. (C) 2018 Elsevier Ltd. All rights reserved.	[Romaus-Sanjurjo, D.; Valle-Maroto, S. M.; Barreiro-Iglesias, A.; Fernandez-Lopez, B.; Rodicio, M. C.] Univ Santiago de Compostela, Fac Biol, CIBUS, Dept Funct Biol, Santiago De Compostela 15782, Spain; [Fernandez-Lopez, B.] Univ Helsinki, Dev Biol Program, Inst Biotechnol, Bioctr 3,Viikinkaari 1,POB 65, FIN-00014 Helsinki, Finland		Rodicio, MC (corresponding author), Univ Santiago de Compostela, Dept Biol Func, Edificio CIBUS,Campus Vida, Santiago De Compostela 15782, A Coruna, Spain.	mcelina.rodicio@usc.es	Romaus-Sanjurjo, Daniel/ABB-9692-2021; Barreiro-Iglesias, Anton/G-5281-2010; Rodicio, Maria Celina/K-1883-2014	Romaus-Sanjurjo, Daniel/0000-0001-7715-1956; Barreiro-Iglesias, Anton/0000-0002-7507-080X; Rodicio, Maria Celina/0000-0002-7267-3285; Fernandez-Lopez, Blanca/0000-0003-4691-8346	Spanish Ministry of Science and InnovationSpanish Government [BFU2010-17174<bold>, </bold>]; European Regional Development FundEuropean Commission [</bold>, BFU2010-17174, BFU2014-56300-P<bold>]; Spanish Ministry of Economy and CompetitivenessSpanish Government [</bold>, BFU2014-56300-P<bold>]; Xunta de GaliciaXunta de GaliciaEuropean Commission [</bold>, GPC2014/030, 2016-PG008, <bold>]	Grant sponsors: Spanish Ministry of Science and Innovation and the European Regional Development Fund 2007-2013, Grant number: BFU2010-17174; Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund 2007-2013, Grant number: BFU2014-56300-P and Xunta de Galicia, Grant number: GPC2014/030. ABI was supported by a grant from the Xunta de Galicia (Grant number: 2016-PG008). The authors thank the staff of Ximonde Biological Station for providing the lampreys used in this study, and the Microscopy Service (University of Santiago de Compostela) and Dr. Mercedes Rivas Cascallar for confocal microscope facilities and help.	Alam T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10388; ALFORD S, 1991, EUR J NEUROSCI, V3, P107, DOI 10.1111/j.1460-9568.1991.tb00071.x; ALFORD S, 1991, J NEUROSCI, V11, P3718; Antal M, 1996, NEUROSCIENCE, V73, P509, DOI 10.1016/0306-4522(96)00063-2; Ayers J., 1989, CELLULAR NEURONAL OS, P349; BARBER RP, 1982, BRAIN RES, V238, P305, DOI 10.1016/0006-8993(82)90107-X; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Barreiro-Iglesias A, 2015, NEURAL REGEN RES, V10, P25, DOI 10.4103/1673-5374.150642; Barreiro-Iglesias A, 2014, JOVE-J VIS EXP, DOI 10.3791/51494; Barreiro-Iglesias A, 2012, BRAIN BEHAV EVOLUT, V79, P1, DOI 10.1159/000334187; Barreiro-Iglesias A, 2009, J ANAT, V215, P601, DOI 10.1111/j.1469-7580.2009.01159.x; Barreiro-Iglesias A, 2009, J ANAT, V215, P435, DOI 10.1111/j.1469-7580.2009.01119.x; BATUEVA IV, 1990, J HIRNFORSCH, V31, P739; Becker MI, 2015, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00148; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; BRODIN L, 1990, BRAIN RES, V508, P172, DOI 10.1016/0006-8993(90)91134-3; Castro A, 2007, J COMP NEUROL, V503, P642, DOI 10.1002/cne.21421; Castro A, 2011, BIOCHEM BIOPH RES CO, V412, P26, DOI 10.1016/j.bbrc.2011.07.026; CASTROLOPES JM, 1995, BRAIN RES, V679, P289, DOI 10.1016/0006-8993(95)00262-O; CAZALETS JR, 1994, J PHYSIOL-LONDON, V474, P173, DOI 10.1113/jphysiol.1994.sp020011; Rodicio MC, 2008, BRAIN RES BULL, V76, P45, DOI 10.1016/j.brainresbull.2007.10.062; Rodicio MC, 2012, REV NEUROLOGIA, V55, P157, DOI 10.33588/rn.5503.2012136; Cohen AH, 2005, J NEUROTRAUM, V22, P172, DOI 10.1089/neu.2005.22.172; Cooke RM, 2009, J NEUROTRAUM, V26, P597, DOI 10.1089/neu.2008.0660; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; DALE N, 1987, PROC R SOC SER B-BIO, V232, P193, DOI 10.1098/rspb.1987.0068; DALE N, 1987, PROC R SOC SER B-BIO, V232, P205, DOI 10.1098/rspb.1987.0069; Drew GM, 2004, PAIN, V109, P379, DOI 10.1016/j.pain.2004.02.007; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; DUFFY MT, 1990, J COMP NEUROL, V293, P208, DOI 10.1002/cne.902930205; ElManira A, 1996, J COMP NEUROL, V369, P533, DOI 10.1002/(SICI)1096-9861(19960610)369:4<533::AID-CNE4>3.0.CO;2-5; ElManira A, 1997, J NEUROPHYSIOL, V78, P1334; Cornide-Petronio ME, 2014, NEUROPHARMACOLOGY, V77, P369, DOI 10.1016/j.neuropharm.2013.10.017; Cornide-Petronio ME, 2011, J NEUROTRAUM, V28, P2535, DOI 10.1089/neu.2011.1766; Fernandez-Lopez B., 2014, CONFOCAL MULTIPHOTON, V11, P239; Fernandez-Lopez B, 2016, SCI REP-UK, V6, DOI 10.1038/srep37786; Fernandez-Lopez B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/350750; Fernandez-Lopez B, 2014, GLIA, V62, P1254, DOI 10.1002/glia.22678; Fernandez-Lopez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047898; Fink AJP, 2014, NATURE, V509, P43, DOI 10.1038/nature13276; Francois A, 2017, NEURON, V93, P822, DOI 10.1016/j.neuron.2017.01.008; Grasso R, 2004, BRAIN, V127, P1019, DOI 10.1093/brain/awh115; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Gwak YS, 2011, NEUROPHARMACOLOGY, V60, P799, DOI 10.1016/j.neuropharm.2010.12.030; Gwak YS, 2008, PAIN, V138, P410, DOI 10.1016/j.pain.2008.01.021; Gwak YS, 2006, J NEUROTRAUM, V23, P1111, DOI 10.1089/neu.2006.23.1111; HARPER CE, 1993, PHILOS T ROY SOC B, V340, P141, DOI 10.1098/rstb.1993.0053; Higashijima S, 2004, J COMP NEUROL, V480, P19, DOI 10.1002/cne.20279; Hoffman N, 2011, NEUROSCIENCE, V199, P563, DOI 10.1016/j.neuroscience.2011.09.021; HOMMA S, 1978, J PHYSIOL-LONDON, V279, P231, DOI 10.1113/jphysiol.1978.sp012342; Hossaini M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035293; Hwang JH, 1997, PAIN, V70, P15, DOI 10.1016/S0304-3959(96)03249-6; Jacobs AJ, 1997, J NEUROSCI, V17, P5206; Jalalvand E, 2014, J COMP NEUROL, V522, P1753, DOI 10.1002/cne.23542; Jin LQ, 2009, J COMP NEUROL, V515, P295, DOI 10.1002/cne.22057; Kobayashi M, 2012, J NEUROPHYSIOL, V107, P1431, DOI 10.1152/jn.00813.2011; Lambert TD, 2004, J COMP PHYSIOL A, V190, P331, DOI 10.1007/s00359-004-0505-8; Lau BYB, 2013, EXP NEUROL, V250, P31, DOI 10.1016/j.expneurol.2013.09.004; Li WC, 2003, J COMP PHYSIOL A, V189, P29, DOI 10.1007/s00359-002-0372-0; Liu J, 2004, MOL THER, V10, P57, DOI 10.1016/j.ymthe.2004.04.017; MAGOUL R, 1987, NEUROSCIENCE, V20, P1001, DOI 10.1016/0306-4522(87)90258-2; Marchenko V, 2015, AM J PHYSIOL-REG I, V308, pR916, DOI 10.1152/ajpregu.00244.2014; MATSUSHIMA T, 1993, J NEUROPHYSIOL, V70, P2606, DOI 10.1152/jn.1993.70.6.2606; Meisner JG, 2010, J NEUROTRAUM, V27, P729, DOI 10.1089/neu.2009.1166; Mele M, 2016, J NEUROCHEM, V139, P997, DOI 10.1111/jnc.13742; Melendez-Ferro M, 2003, J COMP NEUROL, V464, P17, DOI 10.1002/cne.10773; Melendez-Ferro M, 2002, J COMP NEUROL, V446, P360, DOI 10.1002/cne.10209; Mowery TM, 2015, BRAIN RES, V1611, P44, DOI 10.1016/j.brainres.2015.03.010; Munro G, 2008, J PHARMACOL EXP THER, V327, P969, DOI 10.1124/jpet.108.144568; Nieuwenhuys R., 1998, P397; Padgett CL, 2010, ADV PHARMACOL, V58, P123, DOI 10.1016/S1054-3589(10)58006-2; Parker D, 1998, EUR J NEUROSCI, V10, P2856, DOI 10.1046/j.1460-9568.1998.00295.x; REICHLING DB, 1990, J COMP NEUROL, V302, P370, DOI 10.1002/cne.903020213; Retzius G., 1893, BIOL UNTERSUCH STOCK, V5, P15; ROBERTS A, 1987, J COMP NEUROL, V261, P435, DOI 10.1002/cne.902610308; Robertson B, 2007, J COMP NEUROL, V503, P47, DOI 10.1002/cne.21348; ROMAUSSANJURJO D, 2016, FRONT NEUROANAT, V10; ROVAINEN CM, 1976, J COMP NEUROL, V168, P545, DOI 10.1002/cne.901680407; Ruiz Y, 2004, J COMP NEUROL, V470, P151, DOI 10.1002/cne.11032; Schmitt DE, 2004, J NEUROPHYSIOL, V92, P2357, DOI 10.1152/jn.00233.2004; SELZER ME, 1978, J PHYSIOL-LONDON, V277, P395, DOI 10.1113/jphysiol.1978.sp012280; Shifman Michael I., 2007, P229; STELZNER DJ, 1991, EXP NEUROL, V114, P193, DOI 10.1016/0014-4886(91)90036-C; Sueiro C, 2004, J COMP NEUROL, V478, P189, DOI 10.1002/cne.20285; Svensson E, 2013, NEUROSCIENCE, V235, P109, DOI 10.1016/j.neuroscience.2013.01.017; TEGNER J, 1993, J NEUROPHYSIOL, V69, P647, DOI 10.1152/jn.1993.69.3.647; Tillakaratne NJK, 2000, J NEUROSCI RES, V60, P219, DOI 10.1002/(SICI)1097-4547(20000415)60:2<219::AID-JNR11>3.0.CO;2-F; Valle-Maroto SM, 2011, NEUROSCIENCE, V194, P1, DOI 10.1016/j.neuroscience.2011.08.017; Villar-Cervino V, 2008, J COMP NEUROL, V508, P112, DOI 10.1002/cne.21661; Villar-Cervino V, 2008, BRAIN RES BULL, V75, P246, DOI 10.1016/j.brainresbull.2007.10.022; Villar-Cervino V, 2008, J COMP NEUROL, V507, P1441, DOI 10.1002/cne.21634; Villar-Cervino V, 2006, J COMP NEUROL, V499, P810, DOI 10.1002/cne.21136; Villar-Cervino V, 2014, J COMP NEUROL, V522, P1209, DOI 10.1002/cne.23493; Wang XL, 2011, NEUROSCI LETT, V490, P112, DOI 10.1016/j.neulet.2010.12.038; Wikstrom MA, 1998, EUR J NEUROSCI, V10, P1528; WOOD MR, 1979, SCIENCE, V206, P344, DOI 10.1126/science.482943; ZHANG AL, 1994, BRAIN RES, V656, P187, DOI 10.1016/0006-8993(94)91383-8; Zhang GX, 2014, J COMP NEUROL, V522, P1316, DOI 10.1002/cne.23485	98	7	7	3	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	MAR 15	2018	131						389	402		10.1016/j.neuropharm.2018.01.006			14	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	FZ1DK	WOS:000427316000034	29317225				2022-02-06	
J	Rubenstein, R; Wang, KK; Chiu, A; Grinkina, N; Sharma, DR; Agarwal, S; Lin, F; Yang, ZH				Rubenstein, Richard; Wang, Kevin K.; Chiu, Allen; Grinkina, Natalia; Sharma, Deep R.; Agarwal, Sanjeev; Lin, Fan; Yang, Zhihui			PrPc expression and calpain activity independently mediate the effects of closed head injury in mice	BEHAVIOURAL BRAIN RESEARCH			English	Article						Cellular prion protein; Calpain; Closed head injury; Traumatic brain injury; SNJ-1945	TRAUMATIC BRAIN-INJURY; CELLULAR PRION PROTEIN; FIBRILLARY ACIDIC PROTEIN; SPECTRIN BREAKDOWN PRODUCTS; ALPHA-II-SPECTRIN; CEREBROSPINAL-FLUID; 5-METHOXY-3-OXAPENTYL ESTER; INHIBITOR SNJ-1945; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS	The normal cellular prion protein (PrPc) is a sialoglycoprotein with a glycophosphatidylinositol anchor and expressed in highest levels within the CNS particularly at neuronal synapses. This membrane-bound protein is involved with many cell functions including cell signaling and neuroprotection. Calpains are calcium-activated cysteine proteases that typically undergo controlled activation. PrPc is a calpain substrate and is neurotoxic if it undergoes aberrant processing with cytosol accumulation. Following traumatic brain injury (TBI), there is an abnormal influx of Ca+2 and overactivation of calpains resulting in neuronal dysfunction and cell death. We investigated whether PrPc expression and calpain activity have an effect on, or are affected by, TBI. PrPc expression in the hippocampus, cortex and cerebellum of WT and Tga20 (PrPc overexpression) mice were unchanged after closed head injury (CHI). Further, PrPc in WT and Tga20 mice was resistant to TBI-induced calpain proteolysis. CHI-induced calpain activation resulted in breakdown products (BDPs) of alpha II-spectrin (SBDPs) and GFAP (GBDP-44 K) in all brain regions and mouse lines. CHI caused significant increases in SBDP145, GFAP and GBDP-44 K when compared to sham. With few exceptions, the calpain inhibitor, SNJ-1945, reduced SBDP145 and GBDP-44K levels. Behavioral studies suggested that PrPc and calpain independently affect learning and memory. Overall, we conclude that: (i) there is SNJ-1945-sensitive calpain activation in both neuron and glial cells following CHI, (ii) closed head trauma is not affected by, nor does it have an influence on, PrPc expression, and (iii) PrPc expression plays a minor role, if any, in CHI-induced calpain activation in vivo. (C) 2016 Elsevier B.V. All rights reserved.	[Rubenstein, Richard; Chiu, Allen; Sharma, Deep R.] Suny Downstate Med Ctr, Dept Neurol & Physiol, Lab Neurodegenerat Dis & CNS Biomarker Discovery, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA; [Rubenstein, Richard; Chiu, Allen; Sharma, Deep R.] Suny Downstate Med Ctr, Dept Pharmacol, Lab Neurodegenerat Dis & CNS Biomarker Discovery, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA; [Wang, Kevin K.; Lin, Fan; Yang, Zhihui] Univ Florida, Dept Psychiat, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL 32611 USA; [Wang, Kevin K.; Lin, Fan; Yang, Zhihui] Univ Florida, Dept Neurosci, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL 32611 USA; [Grinkina, Natalia] Suny Downstate Med Ctr, Dept Physiol Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA; [Agarwal, Sanjeev] Suny Downstate Med Ctr, Dept Orthopaed Surg & Rehabil Med, 450 Clarkson Ave, Brooklyn, NY 11203 USA		Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Dept Neurol & Physiol, Lab Neurodegenerat Dis & CNS Biomarker Discovery, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA.; Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Dept Pharmacol, Lab Neurodegenerat Dis & CNS Biomarker Discovery, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA.; Wang, KK (corresponding author), Univ Florida, Dept Psychiat, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL 32611 USA.; Wang, KK (corresponding author), Univ Florida, Dept Neurosci, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL 32611 USA.	Richard.Rubenstein@Downstate.edu; Kwang@ufl.edu		Sharma, Deep/0000-0002-2971-5013; Wang, Kevin/0000-0002-9343-6473	U.S. Army Medical Research Acquisition Activity, Fort Detrick MD; Office of the Assistant Secretary of Defense for Health Affairs through the Department of Defense Broad Agency Announcement [W81XWH-11-2-0069, W81XWH-14-2-0166]; SUNY Downstate Medical Center	The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported, in part, by the Office of the Assistant Secretary of Defense for Health Affairs through the Department of Defense Broad Agency Announcement under Award numbers W81XWH-11-2-0069 and W81XWH-14-2-0166. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. This work was also supported, in part, by the SUNY Downstate Medical Center.	Agoston D. V., 2012, FRONT NEUROL, V3, P1; Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Bains M, 2013, J NEUROCHEM, V125, P125, DOI 10.1111/jnc.12118; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Baydas G, 2003, EUR J PHARMACOL, V462, P67, DOI 10.1016/S0014-2999(03)01294-9; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; DEARMOND SJ, 1983, BRAIN RES, V262, P275, DOI 10.1016/0006-8993(83)91018-1; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Guingab-Cagmat JD, 2012, ELECTROPHORESIS, V33, P3786, DOI 10.1002/elps.201200326; Huang SH, 2007, P NATL ACAD SCI USA, V104, P6800, DOI 10.1073/pnas.0608885104; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; KASCSAK RJ, 1986, J VIROL, V59, P676, DOI 10.1128/JVI.59.3.676-683.1986; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Koumura A, 2008, NEUROSCIENCE, V157, P309, DOI 10.1016/j.neuroscience.2008.09.007; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Ma H, 2009, J OCUL PHARMACOL TH, V25, P409, DOI 10.1089/jop.2009.0030; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Pham N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117286; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Paitel E, 2004, J BIOL CHEM, V279, P612, DOI 10.1074/jbc.M310453200; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Rubenstein R, 2012, ELECTROPHORESIS, V33, P3720, DOI 10.1002/elps.201200384; Shanab AY, 2012, NEUROBIOL DIS, V48, P556, DOI 10.1016/j.nbd.2012.07.025; Shimazawa M, 2010, J PHARMACOL EXP THER, V332, P380, DOI 10.1124/jpet.109.156612; Shirasaki Y, 2008, BIOORG MED CHEM LETT, V18, P5174, DOI 10.1016/j.bmcl.2008.08.089; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Wang K., 2015, MOL NEUROBIOL; Weise J, 2004, NEUROSCI LETT, V372, P146, DOI 10.1016/j.neulet.2004.09.030; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Wong BS, 2001, J NEUROCHEM, V76, P565, DOI 10.1046/j.1471-4159.2001.00028.x; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yusa S, 2012, VIRUSES-BASEL, V4, P3109, DOI 10.3390/v4113109; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762	55	7	7	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		29	40		10.1016/j.bbr.2016.04.041			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400004	27188531				2022-02-06	
J	Sozbilen, MC; Ozturk, M; Kaftan, G; Dagci, T; Ozyalcin, H; Armagan, G				Sozbilen, Murat Celal; Ozturk, Murat; Kaftan, Gizem; Dagci, Taner; Ozyalcin, Halit; Armagan, Guliz			Neuroprotective Effects of C-terminal Domain of Tetanus Toxin on Rat Brain Against Motorneuron Damages After Experimental Spinal Cord Injury	SPINE			English	Article						apoptosis; autophagy; cell death mechanisms; C-terminal domain of tetanus toxin; spinal cord injury; tetanus toxin	FRAGMENT-C; HEAVY-CHAIN; RETROGRADE TRANSPORT; CEREBRAL-ISCHEMIA; AUTOPHAGY; PROTEIN; EXPRESSION; MODEL; METHYLPREDNISOLONE; DEGENERATION	Study Design. Experimental animal study investigating the efficacy of C-terminal domain of tetanus toxin application as neuroprotective effects on rat brain in a model of spinal cord injury (SCI). Objective. The aim of the present study was to investigate the possible role of C-terminal domain of tetanus toxin (Hc-TeTx) on cell death mechanisms including apoptosis and autophagy following SCI. Summary of Background Data. Traumatic SCI can lead to posttraumatic inflammation, oxidative stress, motor neuron apoptosis, necrosis, and autophagy of tissue. To promote and enhance recovery after SCI, recent development of devices and therapeutic interventions are needed. Methods. Twenty-eight adult rats were divided into four groups (n = 7 each) as follows: sham, trauma (SCI), SCI thorn Hc-TeTx, and SCI thorn methylprednisolone groups. The functional neurological deficits due to the SCI were assessed by behavioral analysis using the Basso, Beattie and Bresnahan (BBB) open-field locomotor test. The alterations in pro-/anti-apoptotic and autophagy related-protein levels were measured by Western blotting technique. Results. In this study, Hc-TeTx promotes locomotor recovery and motor neuron survival of SCI rats. Hc-TeTx also decreased expression of bax, bad, bak, cleaved caspase-3, Ask1, and autophagy-related proteins including Atg5 and LC3II in brain. Our study provides an evidence that cell death mechanisms play critical roles in SCI and that the nontoxic peptides including Hc-TeTx may exert protective effect and decrease cell death following SCI. Conclusion. Our preliminary findings suggest a possible therapeutic agent to improve survival after spinal cord trauma, but further analysis are still needed to evaluate the difference between acute and chronic injuries.	[Sozbilen, Murat Celal] Dr Behcet Uz Child Dis & Surg Res & Training Hosp, Dept Orthopaed & Traumatol, Konak Izmir, Turkey; [Ozturk, Murat; Ozyalcin, Halit] Ege Univ, Sch Med Hosp, Dept Orthopaed Surg, Izmir, Turkey; [Kaftan, Gizem; Armagan, Guliz] Ege Univ, Dept Biochem, Fac Pharm, Izmir, Turkey; [Dagci, Taner] Ege Univ, Sch Med, Dept Physiol, Izmir, Turkey; [Dagci, Taner] Ege Univ, Ctr Brain Res, Izmir, Turkey		Sozbilen, MC (corresponding author), Dr Behcet Uz Hosp, Dept Orthopaed, Izmir, Turkey.	muratcelal@hotmail.com	Armagan, Guliz/ABI-5508-2020; OZTURK, ANIL MURAT/AAF-3747-2021; Ozturk, Anil Murat/AAG-9834-2019; Dagci, Taner/A-9827-2008	OZTURK, ANIL MURAT/0000-0001-8674-8877; Dagci, Taner/0000-0002-2786-6141; sozbilen, murat celal/0000-0001-7128-6227; ARMAGAN, GULIZ/0000-0001-6466-2263; KAFTAN, Gizem/0000-0002-6085-189X	The Turkish Orthopedic Research Council (TORC/TOAK), a branch of the Turkish Society of Orthopedics and Traumatology (TSOT/TOTBID) [07.09.2015-30]	The Turkish Orthopedic Research Council (TORC/TOAK), a branch of the Turkish Society of Orthopedics and Traumatology (TSOT/TOTBID) (07.09.2015-30) grant funds were received in support of this work.	Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Benson MA, 2011, J BIOL CHEM, V286, P34015, DOI 10.1074/jbc.M111.272054; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Calvo AC, 2012, INT J MOL SCI, V13, P6883, DOI 10.3390/ijms13066883; Carlton E, 2008, NEUROSURGERY, V63, P1175, DOI 10.1227/01.NEU.0000334415.45003.EA; Chaib-Oukadour I, 2004, J NEUROCHEM, V90, P1227, DOI 10.1111/j.1471-4159.2004.02586.x; Chaib-Oukadour I, 2009, MOL CELL NEUROSCI, V41, P297, DOI 10.1016/j.mcn.2009.03.006; Chen HC, 2012, SPINE, V37, P470, DOI 10.1097/BRS.0b013e318221e859; Dagci T, 2009, PHYSIOL RES, V58, P427, DOI 10.33549/physiolres.931388; Dayan K, 2012, LIFE SCI, V90, P360, DOI 10.1016/j.lfs.2011.12.005; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Gil C, 2003, BIOCHEM J, V373, P613, DOI 10.1042/BJ20030333; Grimes ML, 1996, J NEUROSCI, V16, P7950; Gunay H, 2014, MICROSURG, V34, P384, DOI 10.1002/micr.22249; Herrando-Grabulosa M, 2013, J NEUROCHEM, V124, P36, DOI 10.1111/jnc.12062; Herreros J, 2000, BIOCHEM J, V347, P199, DOI 10.1042/0264-6021:3470199; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Kanno H, 2009, NEUROBIOL DIS, V33, P143, DOI 10.1016/j.nbd.2008.09.009; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lalli G, 2002, J CELL BIOL, V156, P233, DOI 10.1083/jcb.200106142; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; MAKOFF AJ, 1989, BIO-TECHNOL, V7, P1043; Mendieta L, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw021; Mendieta L, 2012, NEUROSCI RES, V74, P156, DOI 10.1016/j.neures.2012.08.006; Mendieta L, 2009, NEUROSCI RES, V65, P98, DOI 10.1016/j.neures.2009.06.001; Moreno-Igoa M, 2012, RESTOR NEUROL NEUROS, V30, P69, DOI 10.3233/RNN-2011-0621; Moreno-Igoa M, 2010, J MOL MED, V88, P297, DOI 10.1007/s00109-009-0556-y; Olivan S, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00076; Poon PC, 2007, SPINE, V32, P2853, DOI 10.1097/BRS.0b013e31815b7e6b; Radenovic L, 2014, BRAIN RES BULL, V101, P37, DOI 10.1016/j.brainresbull.2013.11.006; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Roux S, 2005, MOL CELL NEUROSCI, V30, P79, DOI 10.1016/j.mcn.2005.05.008; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Seo JY, 2015, SPINE, V40, P883, DOI 10.1097/BRS.0000000000000845; Simpson LL, 1989, J PHYSL, V84, P143; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Toivonen JM, 2010, TOXINS, V2, P2622, DOI 10.3390/toxins2112622; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Yan XL, 2017, PHARM BIOL, V55, P1171, DOI 10.1080/13880209.2017.1288262	42	7	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	MAR 15	2018	43	6					E327	E333		10.1097/BRS.0000000000002357			7	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	GP0NZ	WOS:000440508500002	28767631				2022-02-06	
J	Cinelli, I; Destrade, M; Duffy, M; McHugh, P				Cinelli, I.; Destrade, M.; Duffy, M.; McHugh, P.			Electro-mechanical response of a 3D nerve bundle model to mechanical loads leading to axonal injury	INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING			English	Article						coupled electro-mechanical modelling; diffuse axonal injury; equivalences; finite element modelling; trauma	TRAUMATIC BRAIN-INJURY; SQUID GIANT-AXON; STRETCH-INJURY; STRAIN; COMPRESSION; MAGNITUDE; SYSTEM; DAMAGE	Traumatic brain injuries and damage are major causes of death and disability. We propose a 3D fully coupled electro-mechanical model of a nerve bundle to investigate the electrophysiological impairments due to trauma at the cellular level. The coupling is based on a thermal analogy of the neural electrical activity by using the finite element software Abaqus CAE 6.13-3. The model includes a real-time coupling, modulated threshold for spiking activation, and independent alteration of the electrical properties for each 3-layer fibre within a nerve bundle as a function of strain. Results of the coupled electro-mechanical model are validated with previously published experimental results of damaged axons. Here, the cases of compression and tension are simulated to induce (mild, moderate, and severe) damage at the nerve membrane of a nerve bundle, made of 4 fibres. Changes in strain, stress distribution, and neural activity are investigated for myelinated and unmyelinated nerve fibres, by considering the cases of an intact and of a traumatised nerve membrane. A fully coupled electro-mechanical modelling approach is established to provide insights into crucial aspects of neural activity at the cellular level due to traumatic brain injury. One of the key findings is the 3D distribution of residual stresses and strains at the membrane of each fibre due to mechanically induced electrophysiological impairments, and its impact on signal transmission.	[Cinelli, I.; Duffy, M.; McHugh, P.] NUI Galway, Discipline Biomed Engn, Univ Rd, Galway H91 TK33, Ireland; [Destrade, M.] NUI Galway, Sch Math Stat & Appl Math, Univ Rd, Galway H91 TK33, Ireland; [Cinelli, I.] NUI Galway, Discipline Elect & Elect Engn, Galway H91 TK33, Ireland		Cinelli, I (corresponding author), Natl Univ Ireland Galway, Galway, Ireland.	i.cinelli1@nuigalway.ie	Destrade, Michel/O-5825-2019; McHugh, Peter Edward/AAR-2574-2021; Cinelli, Ilaria/AAR-8760-2020	Destrade, Michel/0000-0002-6266-1221; McHugh, Peter Edward/0000-0001-9147-3652; Cinelli, Ilaria/0000-0003-1302-1188	Galway University Foundation; Biomechanics Research Centre; Power Electronics Research Centre	Galway University Foundation; Biomechanics Research Centre; Power Electronics Research Centre	ALVAREZ O, 1978, BIOPHYS J, V21, P1, DOI 10.1016/S0006-3495(78)85505-2; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; Cao C., 2012, INT J ARCHITECTURE E, V1, P14, DOI DOI 10.7492/IJAEC.2012.002; Cinelli I, 2017, ENG MED BIOL EMBC 20, P1; Cinelli I, 2017, IEEE T BIOMED ENG, V9294, P1; Cinelli I, 2017, NEUR ENG NER 2017 8, P2; Delisi LE, 2010, HDB NEUROCHEM MOL NE, V27, P107; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Duffy CI, 2015, IEEE ENG MED BIO, P3969, DOI 10.1109/EMBC.2015.7319263; Einziger PD, 2003, 1 INT IEEE EMBS C NE, V52, P1632; El Hady A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7697; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gallant PE, 1997, J NEUROTRAUM, V14, P811, DOI 10.1089/neu.1997.14.811; GALLANT PE, 1992, J NEUROPATH EXP NEUR, V51, P220, DOI 10.1097/00005072-199203000-00011; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hosmane S, 2011, LAB CHIP, V11, P3888, DOI 10.1039/c1lc20549h; Jerusalem A, 2014, BIOMECH MODEL MECHAN, V13, P883, DOI 10.1007/s10237-013-0543-7; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Meffin H, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/065005; Mosgaard LD, 2015, SOFT MATTER, V11, P7899, DOI 10.1039/c5sm01519g; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Platkiewicz J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000850; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Tahayori B, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/065006; Tawfik SA, 2011, COMPOS PART A-APPL S, V42, P748, DOI 10.1016/j.compositesa.2011.03.001; Uhl, 2008, MECHANICS, V27, P161; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yu N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002664; Zhang PC, 2001, NATURE, V413, P428, DOI 10.1038/35096578; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0	37	7	7	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-7939	2040-7947		INT J NUMER METH BIO	Int. J. Numer. Meth. Biomed.	MAR	2018	34	3							e2942	10.1002/cnm.2942			15	Engineering, Biomedical; Mathematical & Computational Biology; Mathematics, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematical & Computational Biology; Mathematics	FY1ZF	WOS:000426612100011	29160926	Green Submitted			2022-02-06	
J	Henninger, N; Compton, RA; Khan, MW; Carandang, R; Hall, W; Muehlschlegel, S				Henninger, Nils; Compton, Rebecca A.; Khan, Muhammad W.; Carandang, Raphael; Hall, Wiley; Muehlschlegel, Susanne			"Don't lose hope early": Hemorrhagic diffuse axonal injury on head computed tomography is not associated with poor outcome in moderate to severe traumatic brain injury patients	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; diffuse axonal injury; traumatic axonal injury; computed tomography; prognosis; patient outcomes; outcome prognostication; critical care	PROGNOSTIC VALUE; DECISION-MAKING; ACUTE-PHASE; MRI; WITHDRAWAL; CARE; CLASSIFICATION; GUIDELINES; DIAGNOSIS; IMPACT	BACKGROUND Diffuse axonal injury (DAI) on magnetic resonance imaging has been associated with poor functional outcome after moderate-severe traumatic brain injury (msTBI). Yet, DAI assessment with highly sensitive magnetic resonance imaging techniques is unfeasible in the acute trauma setting, and computed tomography (CT) remains the key diagnostic modality despite its lower sensitivity. We sought to determine whether CT-defined hemorrhagic DAI (hDAI) is associated with discharge and favorable 3- and 12-month functional outcome (Glasgow Coma Scale score 4) after msTBI. METHODS We analyzed 361 msTBI patients from the single-center longitudinal Outcome Prognostication in Traumatic Brain Injury study collected over 6 years (November 2009 to November 2015) with prospective outcome assessments at 3 months and 12 months. Patients with microhemorrhages on CT were designated CT-hDAI-positive and those without as CT-hDAI-negative. For secondary analyses CT-hDAI-positive was stratified into two phenotypes according to presence (associated) versus absence (predominant) of concomitant large acute traumatic lesions to determine whether presence versus absence of additional focal mass lesions portends a different prognosis. RESULTS Seventy (19%) patients were CT-hDAI-positive (n = 36 predominant; n = 34 associated hDAI). In univariate analyses, CT-hDAI-positive status was associated with discharge survival (p = 0.004) and favorable outcome at 3 months (p = 0.003) and 12 months (p = 0.005). After multivariable adjustment, CT-hDAI positivity was no longer associated with discharge survival and functional outcome (all ps > 0.05). Stratified by hDAI phenotype, predominant hDAI patients had worse trauma severity, longer intensive care unit stays, and more systemic medical complications. Predominant hDAI, but not associated hDAI, was an independent predictor of discharge survival (adjusted odds ratio, 24.7; 95% confidence interval [CI], 3.2-192.6; p = 0.002) and favorable 12-month outcome (adjusted odds ratio, 4.7; 95% CI, 1.5-15.2; p = 0.01). Sensitivity analyses using Cox regression confirmed this finding for 1-year survival (adjusted hazard ratio, 5.6; 95% CI, 1.3-23; p = 0.048). CONCLUSION The CT-defined hDAI was not an independent predictor of unfavorable short- and long-term outcomes and should not be used for acute prognostication in msTBI patients. Predominant hDAI patients had good clinical outcomes when supported to intensive care unit discharge and beyond. LEVEL OF EVIDENCE Prognostic study, level III.	[Henninger, Nils; Compton, Rebecca A.; Khan, Muhammad W.; Carandang, Raphael; Hall, Wiley; Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Neurol Neurocrit Care, Worcester, MA USA; [Henninger, Nils] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Carandang, Raphael; Hall, Wiley; Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA USA; [Carandang, Raphael; Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Anesthesia Crit Care, Worcester, MA USA		Muehlschlegel, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol Neurocrit Care, Anesthesiol Crit Care & Surg, 55 Lake Ave North,S-5, Worcester, MA 01655 USA.	susanne.muehlschlegel@umassmemorial.org			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5K08NS091499]; NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K23HD080971]; University of Massachusetts Medical School Center for Clinical and Translational Science - NIH Clinical and Translational Science Award [UL1TR000161]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD080971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS091499] Funding Source: NIH RePORTER	Dr. Henninger serves on the advisory board of Omniox, Inc. Dr. Henninger is supported by 5K08NS091499 from the NIH/NINDS. Dr. Muehlschlegel is supported by NIH/NICHD grant 5K23HD080971. This project was supported by the University of Massachusetts Medical School Center for Clinical and Translational Science which is funded by the NIH Clinical and Translational Science Award to the University of Massachusetts Medical School (UL1TR000161).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Center for Disease Control, 2016, TRAUM BRAIN INJ STAT; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GENTRY LR, 1994, RADIOLOGY, V191, P1; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones NR, 1998, J CLIN NEUROSCI, V5, P73, DOI 10.1016/S0967-5868(98)90207-7; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lin C-M, 2015, BIOMED RES INT, V2015; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mac Donald CL, 2016, J NEUROTRAUMA; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Muehlschlegel S, 2013, NEUROCRIT CARE, V18, P318, DOI 10.1007/s12028-013-9817-2; Nath R, 1997, BIOCHEM MOL BIOL INT, V43, P197; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Ong CJ, 2016, NEUROCRIT CARE, V25, P258, DOI 10.1007/s12028-016-0275-5; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Wasserman JR, 2016, DIFFUSE AXONAL INJUR; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	39	7	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2018	84	3					473	482		10.1097/TA.0000000000001733			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	FY1DU	WOS:000426552800010	29140952	Green Accepted			2022-02-06	
J	Hu, W; Dang, XB; Wang, G; Li, S; Zhang, YL				Hu, Wei; Dang, Xing-Bo; Wang, Gang; Li, Shuai; Zhang, Yue-Lin			Peroxiredoxin-3 attenuates traumatic neuronal injury through preservation of mitochondrial function	NEUROCHEMISTRY INTERNATIONAL			English	Article						TBI; PRDX3; Mitochondrial dysfunction; Mitochondrial biogenesis	OXIDATIVE STRESS; BRAIN-INJURY; ANTIOXIDANT DEFENSE; CELL-DEATH; BIOGENESIS; EXPRESSION; MANAGEMENT; ISCHEMIA; PROTEIN; DAMAGE	Peroxiredoxins (PRDXs) are a highly conserved family of thiol peroxidases that scavenge peroxides in cells. PRDX3 is one member of PRDXs localized in the mitochondria, and has been shown to be involved in antioxidant defense and redox signaling. In this study, we investigated the role of PRDX3 in neuronal trauma using a traumatic neuronal injury (TNI) model in primary cultured cortical neurons. We found that TNI significantly decreased the expression of PRDX3 at both mRNA and protein levels. Over expression of PRDX3 by lentivirus (LV-PRDX3) transfection attenuated lactate dehydrogenase (LDH) release and neuronal apoptosis after TNI. The results of immunostaining showed that LV-PRDX3 transfection markedly reduced TNI-induced intracellular ROS production, protein radical formation and lipid peroxidation. In addition, overexpression of PRDX3 preserved mitochondrial membrane potential (MMP) levels and ATP generation, and inhibited mitochondrial cytochrome c release in TNI-injured neurons. The results of polymerase chain reaction (PCR) showed that PRDX3 overexpression also increased mitochondrial DNA (mtDNA) content and upregulated the expression of mitochondrial biogenesis-related factors. Taken together, our data demonstrate that PRDX3 protects against TNI insult by preserving mitochondrial function and mitochondrial biogenesis, and may have potential therapeutic value for traumatic brain injury (TBI). (C) 2018 Elsevier Ltd. All rights reserved.	[Hu, Wei; Zhang, Yue-Lin] Xi An Jiao Tong Univ, Hlth Sci Ctr, 76 Yanta West Rd, Xian 710061, Shannxi, Peoples R China; [Zhang, Yue-Lin] Xi An Jiao Tong Univ, Dept Neurosurg, Shaanxi Prov Peoples Hosp, Affiliated Hosp 3,Sch Med, Xian 710068, Shaanxi, Peoples R China; [Hu, Wei; Dang, Xing-Bo; Wang, Gang; Li, Shuai] Xi An Jiao Tong Univ, Sch Med, Shaanxi Prov Peoples Hosp, Affiliated Hosp 3,Dept Emergency, Xian 710068, Shaanxi, Peoples R China		Zhang, YL (corresponding author), Xi An Jiao Tong Univ, Dept Neurosurg, Shaanxi Prov Peoples Hosp, Affiliated Hosp 3,Sch Med, Xian 710068, Shaanxi, Peoples R China.	zhangyuelin_xjtu@163.com					Abboud A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00342; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Candelario-Jalil E, 2001, J APPL TOXICOL, V21, P403, DOI 10.1002/jat.768; Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x; Chen T, 2018, REDOX BIOL, V14, P229, DOI 10.1016/j.redox.2017.09.016; Chen T, 2017, CELL MOL NEUROBIOL, V37, P43, DOI 10.1007/s10571-016-0341-8; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080816; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; De Simoni S, 2013, J NEUROCHEM, V125, P473, DOI 10.1111/jnc.12117; Duberley KE, 2014, INT J BIOCHEM CELL B, V50, P60, DOI 10.1016/j.biocel.2014.02.003; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Huh JY, 2012, ANTIOXID REDOX SIGN, V16, P229, DOI [10.1089/ars.2011.3952, 10.1089/ars.2010.3766]; Ishaq GM, 2013, J NEUROSCI RURAL PRA, V4, P292, DOI 10.4103/0976-3147.118784; Kaila VRI, 2014, P NATL ACAD SCI USA, V111, P6988, DOI 10.1073/pnas.1319156111; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; Li LQ, 2007, BIOCHEM BIOPH RES CO, V355, P715, DOI 10.1016/j.bbrc.2007.02.022; Mason RP, 2004, FREE RADICAL BIO MED, V36, P1214, DOI 10.1016/j.freeradbiomed.2004.02.077; McLeod CJ, 2005, TRENDS CARDIOVAS MED, V15, P118, DOI 10.1016/j.tcm.2005.05.001; Mitsumoto A, 2001, FREE RADICAL BIO MED, V30, P625, DOI 10.1016/S0891-5849(00)00503-7; Mukhopadhyay SS, 2006, J CELL BIOL, V175, P225, DOI 10.1083/jcb.200607061; Nonn L, 2003, MOL CANCER RES, V1, P682; Normoyle KP, 2015, TRANSL NEUROSCI, V6, P179, DOI 10.1515/tnsci-2015-0019; Onyango IG, 2010, BBA-MOL BASIS DIS, V1802, P228, DOI 10.1016/j.bbadis.2009.07.014; Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200; Rhee SG, 2016, MOL CELLS, V39, P1, DOI 10.14348/molcells.2016.2368; Shih SF, 2001, J BIOL CHEM, V276, P21870, DOI 10.1074/jbc.M100571200; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Wood-Allum CA, 2006, BRAIN, V129, P1693, DOI 10.1093/brain/awl118	34	7	7	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	MAR	2018	114						120	126		10.1016/j.neuint.2018.02.004			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GA7CE	WOS:000428491400014	29427714				2022-02-06	
J	Jang, SH; Chang, CH; Jung, YJ; Kim, SH; Seo, JP				Jang, Sung Ho; Chang, Chul Hoon; Jung, Young Jin; Kim, Seong Ho; Seo, Jeong Pyo			Optic radiation injury in patients with aneurismal subarachnoid hemorrhage: a preliminary diffusion tensor imaging report	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; diffusion tensor imaging; optic radiation; subarachnoid hemorrhage; visual field defect; neural regeneration	TRAUMATIC BRAIN-INJURY; FUNCTIONAL MAGNETIC-RESONANCE; HOMONYMOUS HEMIANOPIA; CORTICOSPINAL TRACT; ANEURYSM; TRACKING; STROKE	Visual field defect is one of the various clinical manifestations in patients with subarachnoid hemorrhage (SAH). Little is known about the pathogenic mechanism of visual field defect in SAH. In the current study, we investigated the diffusion tensor imaging (DTI) finding of the optic radiation in patients with SAH following rupture of a cerebral artery aneurysm. We recruited 21 patients with aneurismal SAH (12 males, 9 females, mean age, 52.67 years; range, 41-68 years) who showed no definite lesion along the visual pathway. Twenty-one age-and sex-matched normal control subjects were also recruited. DTI data were acquired at an average of 5.9 weeks (range: 3-12 weeks) after onset and reconstruction of the optic radiation was performed using DTI-Studio software. The fractional anisotropy value, apparent diffusion coefficient value, and fiber number of the optic radiation were measured. The fractional anisotropy value of the optic radiation was significantly decreased, and the apparent diffusion coefficient value was significantly increased, in patients with aneurismal SAH than in normal control subjects. However, there was no significant difference in the fiber number of the optic radiation between patients with aneurismal SAH and normal control subjects. The decrement of fractional anisotropy value and increment of apparent diffusion coefficient value of the optic radiation in patients with aneurismal SAH suggest optic radiation injury. Therefore, we recommend a thorough evaluation for optic radiation injury in patient with aneurismal SAH.	[Jang, Sung Ho; Seo, Jeong Pyo] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Daegu, South Korea; [Chang, Chul Hoon; Jung, Young Jin; Kim, Seong Ho] Yeungnam Univ, Coll Med, Dept Neurosurg, Daegu, South Korea		Seo, JP (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Daegu, South Korea.	raphael0905@hanmail.net			National Research Foundation (NRF) of Korea - Korean Government (MSIP) [2015R1A2A2A01004073]	This work was supported by the National Research Foundation (NRF) of Korea Grant funded by the Korean Government (MSIP) (2015R1A2A2A01004073).	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Berman JI, 2009, AM J NEURORADIOL, V30, P120, DOI 10.3174/ajnr.A1304; Chan JW, 1997, NEUROLOGY, V48, P680, DOI 10.1212/WNL.48.3.680; Chua CO, 2009, STROKE, V40, P3369, DOI 10.1161/STROKEAHA.109.549212; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gall C, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-33; Glass HC, 2010, AM J NEURORADIOL, V31, P1424, DOI 10.3174/ajnr.A2110; Hara N, 2003, OPHTHALMOLOGICA, V217, P79, DOI 10.1159/000068247; Hofer S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00015; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002620; Jang SH, 2015, J NEURO-OPHTHALMOL, V35, P270, DOI 10.1097/WNO.0000000000000249; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; KAN S, 1978, NEURORADIOLOGY, V16, P299, DOI 10.1007/BF00395280; Liu YW, 2007, RADIOLOGY, V242, P518, DOI 10.1148/radiol.2422051698; Mizrachi IBB, 2005, J NEURO-OPHTHALMOL, V25, P193, DOI 10.1097/01.wno.0000179357.20858.22; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Obuchowska I, 2011, ACTA NEUROCHIR, V153, P2127, DOI 10.1007/s00701-011-1161-8; Obuchowska Iwona, 2010, Klin Oczna, V112, P120; Polonara Gabriele, 2011, International Ophthalmology, V31, P129, DOI 10.1007/s10792-011-9420-5; Rabinstein AA, 2013, NEUROLOGY, V80, pE56, DOI 10.1212/WNL.0b013e3182834b22; SARNER M, 1967, J NEUROL NEUROSUR PS, V30, P67, DOI 10.1136/jnnp.30.1.67; Schweizer TA, 2012, CLIN NEUROL NEUROSUR, V114, P798, DOI 10.1016/j.clineuro.2011.12.045; Seo JP, 2013, EUR NEUROL, V69, P236, DOI 10.1159/000345271; Seo YS, 2015, AM J PHYS MED REHAB, V94, pE116, DOI 10.1097/PHM.0000000000000349; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; TSEMENTZIS SA, 1984, NEUROCHIRURGIA, V27, P133; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; VANGIJN J, 1985, NEUROLOGY, V35, P493, DOI 10.1212/WNL.35.4.493; Walkden A, 2012, SUDDEN ONSET LOSS VI; Werring DJ, 1999, NEUROIMAGE, V9, P352, DOI 10.1006/nimg.1999.0421; Xie S, 2007, AM J OPHTHALMOL, V143, P642, DOI 10.1016/j.ajo.2006.12.009; Yamada K, 2009, P NATL ACAD SCI USA, V106, pE14, DOI 10.1073/pnas.0812352106; Yeo SS, 2012, STROKE, V43, P2239, DOI 10.1161/STROKEAHA.112.661116; Yeo SS, 2012, BRAIN INJURY, V26, P891, DOI 10.3109/02699052.2012.661119; Yoshida M, 2006, J NEURO-OPHTHALMOL, V26, P11, DOI 10.1097/01.wno.0000205620.60510.01; Zhang XJ, 2006, J NEURO-OPHTHALMOL, V26, P180, DOI 10.1097/01.wno.0000235587.41040.39	36	7	7	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAR	2018	13	3					563	566		10.4103/1673-5374.228763			4	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	GB9DL	WOS:000429374200034	29623945	Green Published, gold			2022-02-06	
J	Kulas, JF; Rosenheck, RA				Kulas, Joseph F.; Rosenheck, Robert A.			A Comparison of Veterans with Post-traumatic Stress Disorder, with Mild Traumatic Brain Injury and with Both Disorders: Understanding Multimorbidity	MILITARY MEDICINE			English	Article							WAR VETERANS; SOLDIERS; PREVALENCE; MORBIDITY; SEQUELAE; BLAST; CARE	Introduction: Mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) are common military service-related conditions diagnosed both singly and together in veterans returning from recent military conflicts overseas. The impact of these disorders in real-world Veterans Health Administration practice has not been studied extensively, and few studies have examined the association of these disorders both by themselves and together with sociodemographic characteristics, psychiatric and medical comorbidities, health service utilization, and psychotropic medication fills. This study aims to add to the broader study of multimorbidity and the impact it has on patient care. Materials and Methods: This study used a national Veterans Health Administration sample (N = 164,884) to compare characteristics of veterans diagnosed with mTBI, PTSD, and with both disorders. Relative rates of diagnosis with psychiatric and medical disorders, utilization of medical and psychiatric services, and prescription rates of psychotropic medication fills were examined to determine the impact that the disorders had on these rates, both in isolation and together. Results: With few exceptions, diagnosis with PTSD, both alone and in the presence of mTBI, was associated with greater risk of comorbid psychiatric diagnosis, higher service utilization, and greater psychotropic medication fills. Notable correlates specific to mTBI included headache, seizure disorder, paraplegia, and cerebrovascular accident. Conclusion: PTSD thus plays the dominant role in the development of psychiatric difficulties and service use independently of mTBI. The recognition of the central importance of psychiatric difficulties in the functional outcomes of individuals who have experienced an mTBI suggests a need to assure access of veterans to psychiatric treatment services.	[Kulas, Joseph F.; Rosenheck, Robert A.] Connecticut Healthcare Syst, Vet Affairs, 950 Campbell Ave, West Haven, CT 06516 USA; [Kulas, Joseph F.; Rosenheck, Robert A.] Yale Sch Med, 333 Cedar St, New Haven, CT 06510 USA		Kulas, JF (corresponding author), Connecticut Healthcare Syst, Vet Affairs, 950 Campbell Ave, West Haven, CT 06516 USA.; Kulas, JF (corresponding author), Yale Sch Med, 333 Cedar St, New Haven, CT 06510 USA.						Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Boyd C. M., 2010, PUBLIC HLTH REV, V32, P1; Bradford LS, 2015, REHABIL PSYCHOL, V60, P344, DOI 10.1037/rep0000057; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen J., 2013, STAT POWER ANAL BEHA; Difede J, 2010, ANN NY ACAD SCI, V1208, P1, DOI 10.1111/j.1749-6632.2010.05795.x; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McNally RJ, 2013, J ANXIETY DISORD, V27, P520, DOI 10.1016/j.janxdis.2013.07.002; Melek S, 2014, EC IMPACT INTEGRATED; North CS, 2016, ANN CLIN PSYCHIATRY, V28, P182; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Petrakis IL, SOCIODEMOGRAPHIC DIA; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Skopp Nancy A, 2012, MSMR, V19, P7; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thorpe K, 2017, HEALTH AFFAIR, V36, P124, DOI 10.1377/hlthaff.2016.0875; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265	27	7	7	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2018	183	3-4					E114	E122		10.1093/milmed/usx050			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF9BF	WOS:000432270400005	29514340	hybrid			2022-02-06	
J	Li, T; Luo, ZQ; Liu, Y; Wang, MJ; Yu, XH; Cao, CD; Liao, ZC; Ding, Y; Yue, SJ				Li, Ting; Luo, Ziqiang; Liu, Yang; Wang, Mingjie; Yu, Xiaohe; Cao, Chuanding; Liao, Zhengchang; Ding, Ying; Yue, Shaojie			Excessive Activation of NMDA Receptors Induced Neurodevelopmental Brain Damage and Cognitive Deficits in Rats Exposed to Intrauterine Hypoxia	NEUROCHEMICAL RESEARCH			English	Article						NMDA receptors; Glutamate antagonist; Memantine; Intrauterine hypoxia; Neurodevelopment	METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; ISCHEMIC REPERFUSION INJURY; FETAL-GROWTH RESTRICTION; FOCAL CEREBRAL-ISCHEMIA; MATERNAL HYPOXIA; WATER-MAZE; TRANSIENT MODEL; DENTATE GYRUS; MEMANTINE	Intrauterine hypoxia is one of the most common stressors in fetuses, which can lead to abnormal brain development and permanent neurological deficits in adulthood. Neurological disorder excitotoxicity induced by hypoxia or ischemia may involve N-methyl-d-aspartate receptors (NMDARs), which are known to participate in the maturation and plasticity of developmental neurons. Inhibition of NMDARs has been reported to improve neurological outcomes in traumatic brain injuries and Alzheimer's disease. Here, we investigated if antenatal blockade of NMDARs induced by memantine could alleviate neurodevelopmental brain damage and long-term cognitive deficits in intrauterine hypoxia rats. Pregnant rats were assigned to four groups: air control, air + memantine, hypoxia, and hypoxia + memantine. The rats were exposed to hypoxic conditions (FiO(2) = 0.095-0.115) for 8 h/day (hypoxia group) or given a daily memantine injection (5 mg/kg, i.p.) before hypoxia exposure from pregnant day 19 (G19) to G20 (hypoxia + memantine group).The influence of NMDARs antenatal blockade by memantine on intrauterine hypoxia-induced brain developmental damage and cognitive function was then studied. Intrauterine hypoxia resulted in decreased fetal body weight, brain weight, cognitive function, hippocampal neuron numbers, and Ki-67 proliferation index in the hippocampus. Memantine preventive treatment in pregnant rats before hypoxia exposure alleviated the aforementioned damage in vivo. Excessive activation of NMDARs contributes to fetal brain developmental damage and cognitive ability impairment induced by intrauterine hypoxia, which could be alleviated by antenatal memantine preventative treatment.	[Li, Ting; Liu, Yang; Wang, Mingjie; Yu, Xiaohe; Cao, Chuanding; Liao, Zhengchang; Ding, Ying; Yue, Shaojie] Cent S Univ, Xiangya Hosp, Dept Pediat, Changsha 410008, Hunan, Peoples R China; [Luo, Ziqiang] Cent S Univ, Xiangya Med Sch, Dept Physiol, Changsha 410008, Hunan, Peoples R China		Yue, SJ (corresponding author), Cent S Univ, Xiangya Hosp, Dept Pediat, Changsha 410008, Hunan, Peoples R China.	shaojieyue@163.com	luo, ziqiang/AAO-8299-2020		National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81270121]	Funding was provided by National Science Foundation of China (Grant No. 81270121).	Aboutaleb N, 2014, INT J PEPT RES THER, V20, P127, DOI 10.1007/s10989-013-9374-8; ALBERT DJ, 1975, PHYSIOL BEHAV, V15, P339, DOI 10.1016/0031-9384(75)90102-X; BALAZS R, 1990, INT J DEV NEUROSCI, V8, P347, DOI 10.1016/0736-5748(90)90068-D; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bromley-Brits K, 2011, JOVE-J VIS EXP, DOI 10.3791/2920; BROOKS WJ, 1991, SYNAPSE, V8, P41, DOI 10.1002/syn.890080107; Burd I, 2016, ADV PHARMACOL, V76, P85, DOI 10.1016/bs.apha.2016.02.003; Chen HJ, 2003, CHINESE MED J-PEKING, V116, P558; Chen HSV, 1998, NEUROSCIENCE, V86, P1121, DOI 10.1016/S0306-4522(98)00163-8; Dulloo AG, 2008, BEST PRACT RES CL EN, V22, P155, DOI 10.1016/j.beem.2007.08.001; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Gao Ying, 2006, Zhongguo Dang Dai Er Ke Za Zhi, V8, P38; Gheibi S, 2014, J MOL NEUROSCI, V54, P264, DOI 10.1007/s12031-014-0284-9; Golan H, 2004, J NEUROSCI RES, V78, P430, DOI 10.1002/jnr.20269; Golan H, 2004, DEV NEUROSCI-BASEL, V26, P24, DOI 10.1159/000080708; Gould E, 1997, BEHAV NEUROSCI, V111, P49; GOULD E, 1994, J COMP NEUROL, V340, P551, DOI 10.1002/cne.903400408; Heidrich A, 1997, FORTSCHR NEUROL PSYC, V65, P108, DOI 10.1055/s-2007-996315; Herlenius E, 2001, EARLY HUM DEV, V65, P21, DOI 10.1016/S0378-3782(01)00189-X; Jang EA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00176; JEFFERY KJ, 1993, HIPPOCAMPUS, V3, P133, DOI 10.1002/hipo.450030205; Kalynchuk LE, 1998, NEUROSCIENCE, V85, P1311, DOI 10.1016/S0306-4522(98)00003-7; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Khalaf-Nazzal R, 2013, NEUROSCIENCE, V248, P225, DOI 10.1016/j.neuroscience.2013.05.061; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Liao Z., 2016, BIOMED RES INT, V2016; Lipton SA, 1999, NAT MED, V5, P270, DOI 10.1038/6481; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Luscher C, 2012, COLD SPRING HARB PER, V4, P997; Mach Mojmir, 2009, Interdiscip Toxicol, V2, P28, DOI 10.2478/v10102-009-0005-3; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; Miller SL, 2016, J PHYSIOL-LONDON, V594, P807, DOI 10.1113/JP271402; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Murray E, 2015, BJOG-INT J OBSTET GY, V122, P1062, DOI 10.1111/1471-0528.13435; Myseros JS, 1995, ANN NY ACAD SCI, V765, P262, DOI 10.1111/j.1749-6632.1995.tb16583.x; Ojeda NB, 2008, ADV CHRONIC KIDNEY D, V15, P101, DOI 10.1053/j.ackd.2008.01.001; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Portera-Cailliau C, 2015, J COMP NEUROL, V378, P10; Rakic P, 1998, Am J Psychiatry, V155, P1150; Rao VLR, 2001, BRAIN RES, V911, P96; Ritter LM, 2001, DEV BRAIN RES, V127, P123, DOI 10.1016/S0165-3806(01)00126-2; SOMBATI S, 1991, BRAIN RES, V566, P316, DOI 10.1016/0006-8993(91)91716-E; Stocker CJ, 2005, P NUTR SOC, V64, P143, DOI 10.1079/PNS2005417; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Waters KA, 2004, NEUROSIGNALS, V13, P162, DOI 10.1159/000077523; Yue S, 1994, FOREIGN MED SCI SECT, V4, P205	51	7	7	0	6	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAR	2018	43	3					566	580		10.1007/s11064-017-2451-1			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FY6GG	WOS:000426940700005	29260492				2022-02-06	
J	Martin, GE; Carroll, CP; Plummer, ZJ; Millar, DA; Pritts, TA; Makley, AT; Joseph, BA; Ngwenya, LB; Goodman, MD				Martin, Grace E.; Carroll, Christopher P.; Plummer, Zachary J.; Millar, D. A.; Pritts, Timothy A.; Makley, Amy T.; Joseph, Bellal A.; Ngwenya, Laura B.; Goodman, Michael D.			Safety and efficacy of brain injury guidelines at a Level III trauma center	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Level III trauma center; traumatic brain injury; brain injury guidelines	SECONDARY OVERTRIAGE; NEUROSURGICAL CONSULTATION; MANAGEMENT; CARE; HEMORRHAGE; TRANSFERS; SURGEONS; SYSTEM; RISK	BACKGROUND Patients with mild to moderate traumatic brain injury (TBI) are often primarily managed by emergency medicine and trauma/acute care physicians. The Brain Injury Guidelines (BIG) were developed at an American College of Surgeons-accredited Level 1 trauma center to triage mild to moderate TBI patients and help identify patients who warrant neurosurgical consultation. The BIG have not been validated at a Level III trauma center. We hypothesized that BIG criteria can be safely adapted to an American College of Surgeons-accredited Level III trauma center to guide transfers to a higher echelon of care. METHODS We reviewed the trauma registry at a Level III trauma center to identify TBI patients who presented with an Abbreviated Injury Severity-Head score greater than zero. Demographic data, injury details, and clinical outcomes were abstracted with primary outcome measures of worsening on second computed tomography of the head, neurosurgical intervention, transfer to a Level I trauma center, and in-hospital mortality. Patients were classified using the BIG criteria. After validating the BIG in our cohort, we reclassified patients using updated BIG criteria. Updated criteria included mechanism of injury, reclassification of anticoagulation or antiplatelet use, and replacement of the neurologic examination component with stratification by admission Glasgow Coma Scale (GCS) score. RESULTS From July 2013 to June 2016, 332 TBI patients were identified: 115 BIG-1, 25 BIG-2, and 192 BIG-3. Patients requiring neurosurgical intervention (n = 30) or who died (n = 29) were BIG-3 with one exception. Patients with GCS score of less than 12 had worse outcomes than those with a GCS score of 12 or greater, regardless of BIG classification. Anticoagulant or antiplatelet use was not associated with worsened outcomes in patients not meeting other BIG-3 criteria. The updated BIG resulted in more patients in BIG-1 (n = 109) and BIG-2 (n = 100) without negatively affecting outcomes. CONCLUSION The BIG can be applied in the Level III trauma center setting. Updated BIG criteria can aid triage of mild to moderate TBI patients to a Level I trauma center and may reduce secondary overtriage. LEVEL OF EVIDENCE Care management, level IV.	[Martin, Grace E.; Millar, D. A.; Pritts, Timothy A.; Makley, Amy T.; Goodman, Michael D.] Univ Cincinnati, Coll Med, Dept Surg, Div Trauma Crit Care & Acute Care Surg, Cincinnati, OH USA; [Carroll, Christopher P.; Plummer, Zachary J.; Ngwenya, Laura B.] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA; [Joseph, Bellal A.] Univ Arizona, Coll Med, Dept Surg, Div Trauma Crit Care Burn & Emergency Surg, Tucson, AZ USA		Goodman, MD (corresponding author), Univ Cincinnati, Div Trauma Crit Care, Dept Surg, 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA.	goodmamd@ucmail.uc.edu	Carroll, Christopher P./AAK-5502-2020	Carroll, Christopher P./0000-0001-5833-7405; Ngwenya, Laura/0000-0001-7103-971X; Pritts, Timothy/0000-0003-2495-3255			Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, C TRAUM BRAIN INJ US; Ciesla DJ, 2008, J AM COLL SURGEONS, V206, P131, DOI 10.1016/j.jamcollsurg.2007.06.285; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Harbrecht BG, 2010, J TRAUMA, V68, P1367, DOI 10.1097/TA.0b013e3181d990da; Joseph B, 2015, ANN SURG, V262, P440, DOI 10.1097/SLA.0000000000001418; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Lewis Paul R, 2017, J Trauma Acute Care Surg, V82, P776, DOI 10.1097/TA.0000000000001388; Lynch KT, 2016, J SURG RES, V204, P460, DOI 10.1016/j.jss.2016.05.035; Mohan D, 2011, ARCH SURG-CHICAGO, V146, P786, DOI 10.1001/archsurg.2011.43; Osen HB, 2010, J TRAUMA, V69, P602, DOI 10.1097/TA.0b013e3181e7db37; Reljic T, 2014, J NEUROTRAUM, V31, P78, DOI 10.1089/neu.2013.2873; RHODES M, 1993, J TRAUMA, V35, P384, DOI 10.1097/00005373-199309000-00009; Rotondo MF, 2014, RESOURCES OPTIMAL CA, P28; Rotono M., 2014, RESOURCES OPTIMAL CA, P31; Sorensen MJ, 2013, JAMA SURG, V148, P763, DOI 10.1001/jamasurg.2013.2132; Tang A, 2014, J TRAUMA ACUTE CARE, V77, P969, DOI 10.1097/TA.0000000000000462; TEASDALE G, 1974, LANCET, V2, P81; Wu C, 2012, J TRAUMA ACUTE CARE, V73, P1247, DOI 10.1097/TA.0b013e318265d24e; Yun BJ, 2017, AM J EMERG MED, V35, P1281, DOI 10.1016/j.ajem.2017.03.071	24	7	7	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2018	84	3					483	489		10.1097/TA.0000000000001767			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	FY1DU	WOS:000426552800011	29251702				2022-02-06	
J	Orito, K; Hirohata, M; Nakamura, Y; Yamamoto, M; Takeshige, N; Aoki, T; Hattori, G; Sakata, K; Takeuchi, Y; Uzu, H; Takasu, O; Abe, T; Uchiyama, Y; Morioka, M				Orito, Kimihiko; Hirohata, Masaru; Nakamura, Yukihiko; Yamamoto, Masafumi; Takeshige, Nobuyuki; Aoki, Takachika; Hattori, Gohsuke; Sakata, Kiyohiko; Takeuchi, Yasuharu; Uzu, Hideaki; Takasu, Osamu; Abe, Toshi; Uchiyama, Yusuke; Morioka, Motohiro			Predictive Value of Leakage Signs for Pure Brain Contusional Hematoma Expansion	JOURNAL OF NEUROTRAUMA			English	Article						hematoma expansion; leakage sign; traumatic brain contusions	PRIMARY INTRACEREBRAL HEMORRHAGE; ANGIOGRAPHY SPOT SIGN; CONTRAST EXTRAVASATION; MORTALITY; INJURY; GROWTH; MANAGEMENT; COMPLEX	Hematoma expansion is an important consideration in patients with traumatic brain injury (TBI). No precise methods are available, however, for predicting the expansion of TBI-related hematoma. We aimed to establish a more sensitive predictor for contusional hematoma expansion based on the presence of leakage signs on computed tomography angiography (CTA). Thirty-three patients with pure contusion were included in the analysis (age: 64.1 +/- 20.6 years; 24 men and 7 women). We compared Hounsfield unit (HU) values within set regions of interest (diameter, 10 mm) between serial CTA phase and delayed-phase CT images (5 min after CTA phase). Positive leakage signs were defined as >10% increases in HU value. Hematoma expansion was determined using plain CT at 24 h in patients who did not undergo emergent surgery. Glasgow Coma Scale (GCS) scores measured at admission and 24 h after admission were also compared. Leakage signs predicted hematoma expansion with high specificity (100%) and sensitivity (92.8%). Patients with positive leakage signs had significant decreases in GCS scores 24 h after the scan (GCS change: positive group, -0.92 +/- 0.59; negative group, 1.14 +/- 0.82). Positive leakage signs were clearly associated with surgical hematoma removal. Five patients without hematoma who had positive leakage signs at admission exhibited significant expansion of hematomas 24 h later. Our results indicate that leakage signs had high sensitivity in the prediction of contusional hematoma expansion and were significantly associated with delayed neurological deterioration and the necessity of surgical removal.	[Orito, Kimihiko; Hirohata, Masaru; Nakamura, Yukihiko; Yamamoto, Masafumi; Takeshige, Nobuyuki; Aoki, Takachika; Hattori, Gohsuke; Sakata, Kiyohiko; Takeuchi, Yasuharu; Morioka, Motohiro] Kurume Univ, Sch Med, Dept Neurosurg, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan; [Abe, Toshi; Uchiyama, Yusuke] Kurume Univ, Sch Med, Dept Radiol, Fukuoka, Japan; [Uzu, Hideaki; Takasu, Osamu] Kurume Univ, Sch Med, Dept Emergency & Acute Intens Care Med, Fukuoka, Japan		Orito, K (corresponding author), Kurume Univ, Sch Med, Dept Neurosurg, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	orito_kimihiko@kurume-u.ac.jp					Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Almandoz JED, 2012, J NEUROINTERV SURG, V4, P442, DOI 10.1136/neurintsurg-2011-010061; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Brouwers HB, 2014, JAMA NEUROL, V71, P158, DOI 10.1001/jamaneurol.2013.5433; Brouwers HB, 2012, STROKE, V43, P3427, DOI 10.1161/STROKEAHA.112.664003; Dowlatshahi D, 2016, STROKE, V47, P695, DOI 10.1161/STROKEAHA.115.012012; Dowlatshahi D, 2014, STROKE, V45, P277, DOI 10.1161/STROKEAHA.113.003387; Du FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115777; Gao L, 2013, WORLD NEUROSURG, V80, P879, DOI 10.1016/j.wneu.2013.01.020; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Kim J, 2008, AM J NEURORADIOL, V29, P520, DOI 10.3174/ajnr.A0859; Orito K, 2016, STROKE, V47, P958, DOI 10.1161/STROKEAHA.115.011578; Rehmani R, 2017, EMERG RADIOL, V24, P241, DOI 10.1007/s10140-016-1464-4; Rosa M, 2015, J COMPUT ASSIST TOMO, V39, P217, DOI 10.1097/RCT.0000000000000182; Rosa M, 2016, J NEUROTRAUM, V33, P1015, DOI 10.1089/neu.2015.4062; Thompson AL, 2009, CAN J NEUROL SCI, V36, P456, DOI 10.1017/S0317167100007782; Wan XY, 2017, ACTA NEUROCHIR, V159, P227, DOI 10.1007/s00701-016-3043-6; Yuan Q, 2017, NEUROSCIENCE, V348, P114, DOI 10.1016/j.neuroscience.2017.02.020	19	7	7	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2018	35	5					760	766		10.1089/neu.2017.5247			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FX4ZY	WOS:000426088600006	28967295				2022-02-06	
J	Tallapragada, K; Peddada, RS; Dexter, M				Tallapragada, Krishna; Peddada, Ratna Soundarya; Dexter, Mark			Paediatric mild head injury: is routine admission to a tertiary trauma hospital necessary?	ANZ JOURNAL OF SURGERY			English	Article						paediatric epidural haematoma; paediatric mild head injury; paediatric skull fracture(s); paediatric traumatic brain injury	DEPRESSED SKULL FRACTURES; MANAGEMENT; CHILDREN; OUTCOMES	Background: Previous studies have shown that children with isolated linear skull fractures have excellent clinical outcomes and low risk of surgery. We wish to identify other injury patterns within the spectrum of paediatric mild head injury, which need only conservative management. Children with low risk of evolving neurosurgical lesions could be safely managed in primary hospitals. Methods: We retrospectively analysed all children with mild head injury (i.e. admission Glasgow coma score 13-15) and skull fracture or haematoma on a head computed tomography scan admitted to Westmead Children's Hospital, Sydney over the years 2009-2014. Data were collected regarding demographics, clinical findings, mechanism of injury, head computed tomography scan findings, neurosurgical intervention, outcome and length of admission. Wilcoxon paired test was used with P value < 0.05 considered significant. Results: Four hundred and ten children were analysed. Three hundred and eighty-one (93%) children were managed conservatively, 18 (4%) underwent evacuation of extradural haematoma (TBI surgery) and 11 (3%) needed fracture repair surgery. Two children evolved a surgical lesion 24 h post-admission. Only 17 of 214 children transferred from peripheral hospitals needed neurosurgery. Overall outcomes: zero deaths, one needed brain injury rehabilitation and 63 needed child protection unit intervention. Seventy-five percentage of children with non-surgical lesions were discharged within 2 days. Eighty-three percentage of road transfers were discharged within 3 days. Conclusions: Children with small intracranial haematomas and/or skull fractures who need no surgery only require brief inpatient symptomatic treatment and could be safely managed in primary hospitals. Improved tertiary hospital transfer guidelines with protocols to manage clinical deterioration could have cost benefit without risking patient safety.	[Tallapragada, Krishna; Peddada, Ratna Soundarya] NSW Hlth, Childrens Hosp Westmead, Dept Neurosurg, Sydney, NSW, Australia; [Dexter, Mark] Westmead Publ Hosp, Childrens Hosp, Dept Neurosurg, Sydney, NSW, Australia; [Dexter, Mark] Westmead Private Hosp, Childrens Hosp, Dept Neurosurg, Sydney, NSW, Australia		Tallapragada, K (corresponding author), Childrens Hosp Westmead, Dept Neurosurg, 170 Hawkesbury Rd, Westmead, NSW 2145, Australia.	krishna.tallapragada@gmail.com					Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Arrey EN, 2015, J NEUROSURG-PEDIATR, V16, P703, DOI 10.3171/2015.4.PEDS1545; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Australian Bureau of Statistics, 2015, 3101 0 AUSTR DEM STA; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Flaherty BF, 2017, J PEDIATR SURG, V52, P334, DOI 10.1016/j.jpedsurg.2016.09.005; Holsti M, 2005, PEDIATR EMERG CARE, V21, P639, DOI 10.1097/01.pec.0000181426.25342.a9; Hung KL, 2005, J NEUROSURG, V103, P69, DOI 10.3171/ped.2005.103.1.0069; Liu XS, 2012, J NEUROSURG-PEDIATR, V9, P670, DOI 10.3171/2012.2.PEDS11538; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; McCutcheon BA, 2013, OTOLARYNG HEAD NECK, V149, P931, DOI 10.1177/0194599813508539; Ministry of Health New South Wales, 2011, CHILDR INF AC MAN HE; Pointer S., 2014, INJURY RES STAT SERI, V91; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Savitsky EA, 2000, AM J EMERG MED, V18, P96, DOI 10.1016/S0735-6757(00)90060-3; Schaller Alexandra L, 2015, S D Med, V68, P457; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; STEINBOK P, 1987, J NEUROSURG, V66, P506, DOI 10.3171/jns.1987.66.4.0506; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Tunik MG, 2016, ANN EMERG MED, V68, P431, DOI 10.1016/j.annemergmed.2016.04.058; White IK, 2016, J NEUROSURG-PEDIATR, V17, P602, DOI 10.3171/2015.9.PEDS15352	23	7	7	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1445-1433	1445-2197		ANZ J SURG	ANZ J. Surg.	MAR	2018	88	3					202	206		10.1111/ans.14175			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FY4BB	WOS:000426764700054	28922710				2022-02-06	
J	Witiw, CD; Byrne, JP; Nassiri, F; Badhiwala, JH; Nathens, AB; da Costa, LB				Witiw, Christopher D.; Byrne, James P.; Nassiri, Farshad; Badhiwala, Jetan H.; Nathens, Avery B.; da Costa, Leodante B.			Isolated Traumatic Subarachnoid Hemorrhage: An Evaluation of Critical Care Unit Admission Practices and Outcomes From a North American Perspective	CRITICAL CARE MEDICINE			English	Article						health policy; healthcare reform; intensive care unit; mild traumatic brain injury; traumatic subarachnoid hemorrhage	BRIEF CONCEPTUAL TUTORIAL; MULTILEVEL LOGISTIC-REGRESSION; BRAIN-INJURY; SOCIAL EPIDEMIOLOGY; CLINICAL-SIGNIFICANCE; CONTEXTUAL PHENOMENA; INDIVIDUAL HEALTH; MANAGEMENT; DETERIORATION; DIAGNOSIS	Objectives: Traumatic subarachnoid hemorrhage is a common radiographic finding associated with traumatic brain injury. The objective of this investigation is to evaluate the association between hospital-level ICU admission practices and clinically important outcomes for patients with isolated traumatic subarachnoid hemorrhage and mild clinical traumatic brain injury. Design: Multicenter observational cohort. Setting: Trauma centers participating in the American College of Surgeons Trauma Quality Improvement Program spanning January 2012 to March 2014. Patients: A total of 14,146 subjects, 16 years old and older, admitted to 215 trauma centers with isolated traumatic subarachnoid hemorrhage and Glasgow Coma Scale score 13 or greater. Patients with concurrent intracranial injuries, severe injury to other body regions, or tests positive for alcohol or illicit substances were excluded. Intervention: ICU admission. Measurements and Main Results: The primary outcome was need for neurosurgical intervention, defined as insertion of an intracranial monitor/drain or craniectomy/craniotomy. Secondary outcomes describing the clinical course included hospital discharge disposition, in-hospital mortality, and length of stay. Admission to ICU was common within the cohort (44.6%), yet the need for neurosurgical intervention was rare (0.24%). Variability was high between centers and remained so after adjusting for differences in case-mix and hospital-level characteristics (median odds ratio, 4.1). No significant differences in neurosurgical interventions, mortality, or discharge disposition to home under self-care were observed between groups of the highest and lowest ICU admitting hospitals. However, those in highest admitting group stayed in hospital 1.13 (95% CI, 1.07-1.20; p < 0.001) times that of the lowest admitting group. Conclusions: Critical care admission for mild traumatic brain injury patients with isolated traumatic subarachnoid hemorrhage is frequent and highly variable despite low probability of requiring neurosurgical intervention. Reevaluation of hospital-level practices may represent an opportunity for resource optimization when managing patients with mild clinical traumatic brain injury and associated isolated traumatic subarachnoid hemorrhage.	[Witiw, Christopher D.; Nassiri, Farshad; Badhiwala, Jetan H.; da Costa, Leodante B.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Byrne, James P.; Nathens, Avery B.] Univ Toronto, Dept Surg, Div Gen Surg, Toronto, ON, Canada; [Byrne, James P.; Nathens, Avery B.; da Costa, Leodante B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Byrne, James P.; Nathens, Avery B.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Clin Epidemiol Program, Toronto, ON, Canada; [Nathens, Avery B.; da Costa, Leodante B.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada		da Costa, LB (corresponding author), Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada.; da Costa, LB (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada.; da Costa, LB (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada.	leo.dacosta@sunnybrook.ca		Byrne, James/0000-0002-3760-8509			Albertine P, 2016, EMERG RADIOL, V23, P207, DOI 10.1007/s10140-016-1377-2; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Ditty BJ, 2015, J NEUROSURG, V123, P649, DOI 10.3171/2014.10.JNS132713; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Nathens AB, 2003, J TRAUMA, V55, P444, DOI 10.1097/01.TA.0000047809.64699.59; Newgard CD, 2013, J AM COLL SURGEONS, V216, P147, DOI 10.1016/j.jamcollsurg.2012.08.017; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Sanagou M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-28; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; von der Brelie C, 2015, J TRAUMA ACUTE CARE, V79, P295, DOI 10.1097/TA.0000000000000722; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	21	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAR	2018	46	3					430	436		10.1097/CCM.0000000000002931			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX7WE	WOS:000426301500030	29271842				2022-02-06	
J	Won, YD; Na, MK; Ryu, JI; Cheong, JH; Kim, JM; Kim, CH; Han, MH				Won, Yu Deok; Na, Min Kyun; Ryu, Je-Il; Cheong, Jin-Hwan; Kim, Jae-Min; Kim, Choong-Hyun; Han, Myung-Hoon			Radiologic Factors Predicting Deterioration of Mental Status in Patients with Acute Traumatic Subdural Hematoma	WORLD NEUROSURGERY			English	Article						Acute traumatic subdural hematoma; Midline shift; Sylvian fissure ratio	COMPUTED-TOMOGRAPHY; BRAIN-INJURY; 3D SLICER; SUBARACHNOID HEMORRHAGE; PROGNOSTIC-FACTORS; MIDLINE SHIFT; MANAGEMENT; SCAN	OBJECTIVE: To evaluate whether subdural hematoma (SDH) volume and other radiologic factors predict deterioration of mental status in patients with acute traumatic SDH. METHODS: SDH volumes were measured with a semi-automated tool. The area under the receiver operating characteristic curve was used to determine optimal cutoff values for mental deterioration, including the variables midline shift, SDH volume, hematoma thickness, and Sylvian fissure ratio. Multivariate logistic regression was used to calculate the odds ratio for mental deterioration based on several predictive factors. RESULTS: We enrolled 103 consecutive patients admitted to our hospital with acute traumatic SDH over an 8-year period. We observed an increase in SDH volume of approximately 7.2 mL as SDH thickness increased by 1 mm. A steeper slope for midline shift was observed in patients with SDH volumes of approximately 75 mL in the younger age group compared with patients in the older age group. When comparing cutoff values used to predict poor mental status at time of admission between the 2 age groups, we observed smaller midline shifts in the older patients. CONCLUSIONS: Among younger patients, an overall tendency for more rapid midline shift progression was observed in patients with relatively low SDH volumes compared with older patients. Older patients seem to tolerate larger hematoma volumes owing to brain atrophy compared with younger patients. When there is a midline shift, older patients seem to be more vulnerable to mental deterioration than younger patients.	[Won, Yu Deok; Na, Min Kyun; Ryu, Je-Il; Cheong, Jin-Hwan; Kim, Jae-Min; Kim, Choong-Hyun; Han, Myung-Hoon] Hanyang Univ, Guri Hosp, Dept Neurosurg, Gyonggi Do, South Korea		Han, MH (corresponding author), Hanyang Univ, Guri Hosp, Dept Neurosurg, Gyonggi Do, South Korea.	gksmh80@gmail.com		Won, Yu Deok/0000-0002-8822-6631			Aminmansour B, 2009, J RES MED SCI, V14, P343; Barnes CA, 2003, PHILOS T R SOC B, V358, P765, DOI 10.1098/rstb.2002.1244; Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Cheng GZ, 2016, CHEST, V149, P1136, DOI 10.1016/j.chest.2016.03.001; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Huang MC, 2017, YOUMANS WINN NEUROLO; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Ma ZL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15653; Marion DW, 2006, NEUROSURGERY, V58, P655; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Mukherjee J, 2002, SYNAPSE, V46, P170, DOI 10.1002/syn.10128; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Sander IM, 2017, ANAT SCI EDUC, V10, P383, DOI 10.1002/ase.1682; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Son S, 2013, J KOREAN NEUROSURG S, V54, P211, DOI 10.3340/jkns.2013.54.3.211; Thomas HMT, 2017, J MED IMAGING, V4, DOI 10.1117/1.JMI.4.1.011009; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495; Vilcinis R, 2017, WORLD NEUROSURG, V101, P335, DOI 10.1016/j.wneu.2017.02.010	25	7	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2018	111						E120	E134		10.1016/j.wneu.2017.12.025			15	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	GG7WI	WOS:000432908700017	29248778				2022-02-06	
J	Leung, JYK; Bennett, WR; King, AE; Chung, RS				Leung, Jacqueline Y. K.; Bennett, William R.; King, Anna E.; Chung, Roger S.			The impact of metallothionein-II on microglial response to tumor necrosis factor-alpha (TNF alpha) and downstream effects on neuronal regeneration	JOURNAL OF NEUROINFLAMMATION			English	Article						Metallothionein; Microglia; Low-density lipoprotein receptor-related protein-1; Low-density lipoprotein receptor-related protein-2; Axon regeneration; Traumatic brain injury	BRAIN-INJURY; CHONDROITINASE ABC; CNS; EXPRESSION	Background: The extracellular environment plays an important role in supporting the regeneration of axons after injury. Metallothionein-II (MTII) is a metal-binding protein known for its neuroprotective effect by directly stimulating the growth of axons after injury. Previous studies have shown that MTII also modulates the response of astrocytes and microglia after injury. However, a detailed analysis describing how MTII modulates the interaction between microglia and neurons is lacking. Methods: We introduced fluorescently labelled MTII into the cortex at the time of needlestick injury to investigate the cellular uptake of MTII using immunohistochemistry with antibodies against cell-type-specific markers. The role of MTII in modulating the effect of microglia on axon outgrowth following an inflammatory response is further investigated using a co-culture model involving primary rodent microglia pre-treated with TNF alpha and primary rodent cortical neurons. The axon lengths were assessed 24 h after the plating of the neurons onto treated microglia. We also utilised siRNA to knockdown the expression of LRP1, which allows us to investigate the role of LRP1 receptors in the MTII-mediated effect of microglia on axon outgrowth. Results: Fluorescently labelled MTII was found to be associated with neurons, astrocytes and microglia following injury in vivo. Microglia-neuron co-culture experiments demonstrated that exogenous MTII altered the response of microglia to TNF alpha. The neurons plated onto the TNF alpha-stimulated microglia pre-treated with MTII have shown a significantly longer axonal length compare to the TNF alpha-stimulated microglia without the MTII treatment. This suggested that MTII reduce cytokine-stimulated activation of microglia, which would ordinarily impair neurite outgrowth. This inhibitory effect of MTII on activated microglia was blocked by siRNA-mediated downregulation of LRP1 receptor expression in microglia, suggesting that MTII acts via the LRP1 receptor on microglia. Conclusions: This study demonstrates that exogenous MTII acts via the LRP1 receptor to alter the inflammatory response of microglia following TNF alpha stimulation, providing a more supportive environment for axon growth.	[Leung, Jacqueline Y. K.; Bennett, William R.; King, Anna E.] Univ Tasmania, Coll Hlth & Med, Wicking Dementia Res & Educ Ctr, Med Sci Precinct 1,17 Liverpool St, Hobart, Tas 7000, Australia; [Chung, Roger S.] Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, 2 Technol Pl, Sydney, NSW 2109, Australia		Leung, JYK (corresponding author), Univ Tasmania, Coll Hlth & Med, Wicking Dementia Res & Educ Ctr, Med Sci Precinct 1,17 Liverpool St, Hobart, Tas 7000, Australia.	Jacqueline.Leung@utas.edu.au	Chung, Roger/ABF-8395-2020; King, Anna/J-7927-2014	King, Anna/0000-0003-1792-0965; Chung, Roger/0000-0002-9286-947X	Bill Gole Postdoctoral Research Fellowship from the Motor Neuron Disease Research Institute of Australia (MNDRIA); Research Enhancement Grant Scheme, Faculty of Health, University of Tasmania	The first author (Dr. Leung) is supported by the Bill Gole Postdoctoral Research Fellowship from the Motor Neuron Disease Research Institute of Australia (MNDRIA). This project is also supported by the Research Enhancement Grant Scheme, Faculty of Health, University of Tasmania.	Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Chen XR, 2014, BRAIN RES, V1543, P324, DOI 10.1016/j.brainres.2013.12.002; Chung RS, 2009, NEUROTOX RES, V15, P381, DOI 10.1007/s12640-009-9044-y; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Chung RS, 2003, J NEUROSCI, V23, P3336; DAvila JC, 2012, J NEUROINFLAMM, V31, P638; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Guillemin GJ, 2003, ADV EXP MED BIOL, V527, P105; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Ji K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-159; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Landowski LM, 2016, J BIOL CHEM, V291, P1092, DOI 10.1074/jbc.M115.668996; Leung YKJ, 2010, EXP NEUROL, V221, P98, DOI 10.1016/j.expneurol.2009.10.006; Penkowa M, 1999, J NEUROSCI, V19, P2535; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Yang LY, 2017, NAT PROD RES, V31, P487, DOI 10.1080/14786419.2016.1190719; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	24	7	7	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	FEB 22	2018	15								56	10.1186/s12974-018-1070-3			9	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	FX3MD	WOS:000425975200002	29471847	Green Published, Green Accepted, gold			2022-02-06	
J	Arakaki, X; Shoga, M; Li, LY; Zouridakis, G; Tran, T; Fonteh, AN; Dawlaty, J; Goldweber, R; Pogoda, JM; Harrington, MG				Arakaki, Xianghong; Shoga, Michael; Li, Lianyang; Zouridakis, George; Thao Tran; Fonteh, Alfred N.; Dawlaty, Jessica; Goldweber, Robert; Pogoda, Janice M.; Harrington, Michael G.			Alpha desynchronization/synchronization during working memory testing is compromised in acute mild traumatic brain injury (mTBI)	PLOS ONE			English	Article							4TH INTERNATIONAL-CONFERENCE; NEURAL OSCILLATIONS; CONSENSUS STATEMENT; SPORT HELD; EEG; CONCUSSION; ATTENTION; PHASE; PERFORMANCE; THETA	Diagnosing and monitoring recovery of patients with mild traumatic brain injury (mTBI) is challenging because of the lack of objective, quantitative measures. Diagnosis is based on description of injuries often not witnessed, subtle neurocognitive symptoms, and neuropsychological testing. Since working memory (WM) is at the center of cognitive functions impaired in mTBI, this study was designed to define objective quantitative electroencephalographic (qEEG) measures of WM processing that may correlate with cognitive changes associated with acute mTBI. First-time mTBI patients and mild peripheral (limb) trauma controls without head injury were recruited from the emergency department. WM was assessed by a continuous performance task (N-back). EEG recordings were obtained during N-back testing on three occasions: within five days, two weeks, and one month after injury. Compared with controls, mTBI patients showed abnormal induced and evoked alpha activity including event-related desynchronization (ERD) and synchronization (ERS). For induced alpha power, TBI patients had excessive frontal ERD on their first and third visit. For evoked alpha, mTBI patients had lower parietal ERD/ERS at the second and third visits. These exploratory qEEG findings offer new and non-invasive candidate measures to characterize the evolution of injury over the first month, with potential to provide much-needed objective measures of brain dysfunction to diagnose and monitor the consequences of mTBI.	[Arakaki, Xianghong; Shoga, Michael; Thao Tran; Fonteh, Alfred N.; Dawlaty, Jessica; Harrington, Michael G.] Huntington Med Res Inst, Neurosci, Pasadena, CA 91101 USA; [Li, Lianyang; Zouridakis, George] Univ Houston, Biomed Imaging Lab, Houston, TX USA; [Goldweber, Robert] Huntington Hosp, Emergency Dept, Pasadena, CA USA; [Pogoda, Janice M.] Columbus Biometr LLC, Reno, NV USA		Arakaki, X (corresponding author), Huntington Med Res Inst, Neurosci, Pasadena, CA 91101 USA.	xianghong@hmri.org	Zouridakis, George/R-8876-2019	Zouridakis, George/0000-0002-7770-9857; Harrington, Michael/0000-0002-7923-8032	Department of the army, USAMRAA, military medical research and development [DoD: W81XWH-13-1-0005]; HMRI; Columbus Biometrics	This research was funded by a grant from the DoD: W81XWH-13-1-0005, Department of the army, USAMRAA, military medical research and development. HMRI provided additional financial support. Columbus Biometrics provided support in the form of salaries for author JMP but did not have any additional role in the study design, data collection or decision to publish of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Columbus Biometrics was a paid independent consultant, and Columbus Biometrics assisted in statistical analyses and manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by a grant from the DoD: W81XWH-13-1-0005, Department of the army, USAMRAA, military medical research and development. HMRI provided additional financial support.	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Axmacher N, 2010, EUR J NEUROSCI, V31, P177, DOI 10.1111/j.1460-9568.2009.07041.x; Ayaz H, 2012, NEUROIMAGE, V59, P36, DOI 10.1016/j.neuroimage.2011.06.023; Bastiaansen M, 2003, CORTEX, V39, P967, DOI 10.1016/S0010-9452(08)70873-6; Bauer M, 2012, CURR BIOL, V22, P397, DOI 10.1016/j.cub.2012.01.022; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beauregard M, 2009, RESUSCITATION, V80, P1006, DOI 10.1016/j.resuscitation.2009.05.006; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; Brincat SL, 2016, J NEUROSCI, V36, P9739, DOI 10.1523/JNEUROSCI.0274-16.2016; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Cohen MX, 2013, J NEUROPHYSIOL, V110, P2752, DOI 10.1152/jn.00479.2013; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cooper NR, 2006, NEUROREPORT, V17, P205, DOI 10.1097/01.wnr.0000198433.29389.54; Darowski ES, 2008, NEUROPSYCHOLOGY, V22, P638, DOI 10.1037/0894-4105.22.5.638; Deiber MP, 2007, J COGNITIVE NEUROSCI, V19, P158, DOI 10.1162/jocn.2007.19.1.158; Deiber MP, 2009, NEUROBIOL AGING, V30, P1444, DOI 10.1016/j.neurobiolaging.2007.11.021; Del Percio C, 2009, HUM BRAIN MAPP, V30, P3527, DOI 10.1002/hbm.20776; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dipoppa M, 2013, P NATL ACAD SCI USA, V110, P12828, DOI 10.1073/pnas.1303270110; Dong SS, 2015, BRAIN RES, V1616, P146, DOI 10.1016/j.brainres.2015.05.003; Doppelmayr M, 2005, NEUROSCI LETT, V381, P309, DOI 10.1016/j.neulet.2005.02.037; Eckart C, 2016, NEUROIMAGE, V137, P61, DOI 10.1016/j.neuroimage.2016.05.049; Ergen M, 2014, INT J PSYCHOPHYSIOL, V94, P463, DOI 10.1016/j.ijpsycho.2014.08.177; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Foster JJ, 2016, J NEUROPHYSIOL, V115, P168, DOI 10.1152/jn.00860.2015; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Grabner RH, 2006, BRAIN RES BULL, V69, P422, DOI 10.1016/j.brainresbull.2006.02.009; Grabner RH, 2004, COGNITIVE BRAIN RES, V20, P212, DOI 10.1016/j.cogbrainres.2004.02.010; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitland I, 2013, BEHAV BRAIN RES, V249, P55, DOI 10.1016/j.bbr.2013.04.013; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hsueh JJ, 2016, HUM BRAIN MAPP, V37, P2662, DOI 10.1002/hbm.23201; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Ishibashi K, 2014, EUR J NEUROSCI, V40, P2701, DOI 10.1111/ejn.12633; Jensen O, 2014, TRENDS NEUROSCI, V37, P357, DOI 10.1016/j.tins.2014.04.001; Jonassen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030564; Junghofer M, 1999, CLIN NEUROPHYSIOL, V110, P1149, DOI 10.1016/S1388-2457(99)00044-9; Khader P, 2007, COGN AFFECT BEHAV NE, V7, P212, DOI 10.3758/CABN.7.3.212; Klimesch W, 2006, CEREB CORTEX, V16, P280, DOI 10.1093/cercor/bhi107; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Lee RR, 2014, PROG NEUROL SURG, V28, P94, DOI 10.1159/000358768; Lei SG, 2011, HUM FACTORS, V53, P168, DOI 10.1177/0018720811400601; Lenartowicz A, 2016, NEUROIMAGE-CLIN, V11, P210, DOI 10.1016/j.nicl.2016.01.023; Lenartowicz A, 2014, J NEUROSCI, V34, P1171, DOI 10.1523/JNEUROSCI.1765-13.2014; Li LY, 2016, IEEE ENG MED BIO, P1862, DOI 10.1109/EMBC.2016.7591083; Li LY, 2015, IEEE ENG MED BIO, P6963, DOI 10.1109/EMBC.2015.7319994; Liguori C, 2016, EUR J NUCL MED MOL I, V43, P2040, DOI 10.1007/s00259-016-3417-2; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Manza P, 2014, J NEUROSCI, V34, P5998, DOI 10.1523/JNEUROSCI.4641-13.2014; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Masurkar AV, 2014, CURR GERIATR REP, V3, P91, DOI 10.1007/s13670-014-0080-y; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Medaglia JD, 2015, BRAIN IMAGING BEHAV, V9, P285, DOI 10.1007/s11682-014-9306-z; Muhl C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00114; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pesonen M, 2007, BRAIN RES, V1138, P171, DOI 10.1016/j.brainres.2006.12.076; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Ridley RM, 2006, BEHAV BRAIN RES, V166, P253, DOI 10.1016/j.bbr.2005.08.007; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; ROUX F, 2014, SCI ENG ETHICS, V18, P16, DOI DOI 10.1016/J.TICS.2013.10.010; Sadaghiani S, 2012, J NEUROSCI, V32, P14305, DOI 10.1523/JNEUROSCI.1358-12.2012; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Sauseng P, 2012, CURR BIOL, V22, pR306, DOI 10.1016/j.cub.2012.03.029; Schack B, 2005, INT J PSYCHOPHYSIOL, V57, P105, DOI 10.1016/j.ijpsycho.2005.03.016; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142; Takahashi M, 2010, NEUROSCI LETT, V477, P72, DOI 10.1016/j.neulet.2010.04.031; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; van der Horn H. J., 2015, BRAIN IMAGING BEHAV; Vorobyov S, 2002, BIOL CYBERN, V86, P293, DOI 10.1007/s00422-001-0298-6; Wang C, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00015; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Yao DZ, 2005, PHYSIOL MEAS, V26, P173, DOI 10.1088/0967-3334/26/3/003; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Zhang GH, 2015, J VISION, V15, DOI 10.1167/15.10.8	88	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0188101	10.1371/journal.pone.0188101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	WOS:000425183500002	29444081	Green Published, Green Submitted, gold			2022-02-06	
J	Zong, ZW; Zhang, LY; Qin, H; Chen, SX; Zhang, L; Yang, L; Li, XX; Bao, QW; Liu, DC; He, SH; Shen, Y; Zhang, R; Zhao, YF; Zhong, XZ				Zong, Zhao-wen; Zhang, Lian-yang; Qin, Hao; Chen, Si-xu; Zhang, Lin; Yang, Lei; Li, Xiao-xue; Bao, Quan-wei; Liu, Dao-cheng; He, Si-hao; Shen, Yue; Zhang, Rong; Zhao, Yu-feng; Zhong, Xiao-zheng		Representing PLA Professional Comm	Expert consensus on the evaluation and diagnosis of combat injuries of the Chinese People's Liberation Army	MILITARY MEDICAL RESEARCH			English	Article						Combat injuries; Assessment; Diagnosis; Expert consensus	TRAUMATIC BRAIN-INJURY; SEVERITY SCORE; MASSIVE TRANSFUSION; FIELD TRIAGE; LIMB LOSS; CASUALTIES; WAR; COAGULOPATHY; AFGHANISTAN; VALIDATION	The accurate assessment and diagnosis of combat injuries are the basis for triage and treatment of combat casualties. A consensus on the assessment and diagnosis of combat injuries was made and discussed at the second annual meeting of the Professional Committee on Disaster Medicine of the Chinese People's Liberation Army (PLA). In this consensus agreement, the massive hemorrhage, airway, respiration, circulation and hypothermia (MARCH) algorithm, which is a simple triage and rapid treatment and field triage score, was recommended to assess combat casualties during the first-aid stage, whereas the abbreviated scoring method for combat casualty and the MARCH algorithm were recommended to assess combat casualties in level II facilities. In level III facilities, combined measures, including a history inquiry, thorough physical examination, laboratory examination, X-ray, and ultrasound examination, were recommended for the diagnosis of combat casualties. In addition, corresponding methods were recommended for the recognition of casualties needing massive transfusions, assessment of firearm wounds, evaluation of mangled extremities, and assessment of injury severity in this consensus.	[Zong, Zhao-wen; Zhang, Lian-yang; Qin, Hao; Chen, Si-xu; Yang, Lei; Bao, Quan-wei; Liu, Dao-cheng; He, Si-hao; Shen, Yue; Zhao, Yu-feng; Zhong, Xiao-zheng] Army Med Univ, Daping Hosp, Dept Trauma Surg, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Zhang, Lin] Bethune Med Profess Sergeant Sch, Special Slin Dept, Shijiazhuang, Hebei, Peoples R China; [Li, Xiao-xue] Gen Hosp Chinese Peoples Armed Police Forces, Res Inst Disaster Med, Beijing, Peoples R China; [Zhang, Rong] Mil Med Training Brigade Chinese Peoples Liberat, Xinjiang, Uygur Autonomou, Peoples R China		Zong, ZW (corresponding author), Army Med Univ, Daping Hosp, Dept Trauma Surg, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China.	zongzhaowen@163.com			Special Project in Military Logistics Scientific Program [AWS14L012]; Innovation Project of Military Medicine [16CXZ017]	Special Project in Military Logistics Scientific Program during the Twelfth Five-year Plan Period (AWS14L012); Innovation Project of Military Medicine (16CXZ017).	Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bahadur S, 2016, J ROY ARMY MED CORPS, V162, P120, DOI 10.1136/jramc-2014-000393; Benson M, 1996, Prehosp Disaster Med, V11, P117; Bhalla MC, 2015, AM J EMERG MED, V33, P1687, DOI 10.1016/j.ajem.2015.08.021; Blackbourne LH, 2008, CRIT CARE MED, V36, pS304, DOI 10.1097/CCM.0b013e31817e2854; BOWYER GW, 1993, INJURY, V24, P597, DOI 10.1016/0020-1383(93)90121-L; Brooks A J, 2004, J R Army Med Corps, V150, P78; Busic Z, 2006, MIL MED, V171, P55; Byers Rachel, 2010, Int Emerg Nurs, V18, P221, DOI 10.1016/j.ienj.2010.01.002; Camanho GL, 2015, REV BRAS ORTOP, V44; Cartwright MS, 2015, MED HYPOTHESES, V85, P262, DOI 10.1016/j.mehy.2015.05.012; Champion HR, 2010, J TRAUMA, V68, P1139, DOI 10.1097/TA.0b013e3181d86a0d; Champion HR, 1996, J TRAUMA, V40, P42, DOI 10.1097/00005373-199601000-00009; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cotte Jean, 2013, J Spec Oper Med, V13, P59; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Cotton BA, 2010, J TRAUMA, V69, pS33, DOI 10.1097/TA.0b013e3181e42411; Dawes R, 2009, CURR OPIN CRIT CARE, V15, P527, DOI 10.1097/MCC.0b013e32833190c3; Doran CM, 2010, J TRAUMA, V69, pS40, DOI 10.1097/TA.0b013e3181e4257b; Dougherty PJ, 2012, J TRAUMA ACUTE CARE, V73, P1590, DOI 10.1097/TA.0b013e318265fe64; Dougherty PJ, 2010, J REHABIL RES DEV, V47, P333, DOI 10.1682/JRRD.2009.04.0043; Dunn JC, 2016, ANN VASC SURG, V35, P30, DOI 10.1016/j.avsg.2016.01.040; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Eastridge BJ, 2010, AM J SURG, V200, P724, DOI 10.1016/j.amjsurg.2010.08.006; Ege T, 2015, INDIAN J ORTHOP, V49, P656, DOI 10.4103/0019-5413.168759; EMERMAN CL, 1991, J TRAUMA, V31, P1369, DOI 10.1097/00005373-199110000-00009; Falzone E, 2017, ANAESTH CRIT CARE PA, V36, P43, DOI 10.1016/j.accpm.2016.05.004; Farkash U, 2002, INJURY, V33, P103, DOI 10.1016/S0020-1383(01)00149-8; GORMICAN SP, 1982, ANN EMERG MED, V11, P132, DOI 10.1016/S0196-0644(82)80237-0; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Howick J., 2011, OXFORD CTR EVIDENCE; Ketola E, 2007, QUAL SAF HEALTH CARE, V16, P308, DOI 10.1136/qshc.2006.019752; Kolkebeck TE, 2006, ANN EMERG MED, V48, pS87; Larson CR, 2010, J TRAUMA, V69, pS26, DOI 10.1097/TA.0b013e3181e423f4; Lawnick MM, 2013, J TRAUMA ACUTE CARE, V75, P573, DOI 10.1097/TA.0b013e3182a53bc6; Laytin AD, 2017, J SURG RES, V215, P60, DOI 10.1016/j.jss.2017.03.032; Le TD, 2016, J TRAUMA ACUTE CARE, V81, P114, DOI 10.1097/TA.0000000000001032; Martin MJ, 2017, FRONT LINE SURG PRAC; McLaughlin DF, 2008, J TRAUMA, V64, pS57, DOI 10.1097/TA.0b013e318160a566; Mierzwa AP, 2016, STUD HEALTH TECHNOL, V220, P241, DOI 10.3233/978-1-61499-625-5-241; Ministry of health of General Logistics Department of PLA, 2016, RUL COMB CAS CAR; Mitkovic Milorad, 2013, Acta Chir Iugosl, V60, P41; Penn-Barwell JG, 2015, J TRAUMA ACUTE CARE, V78, P1014, DOI 10.1097/TA.0000000000000580; Qin H, 2015, J PRACT MED, V31, P3099; Shin E, 2013, J ORTHOP TRAUMA, V27, P419, DOI 10.1097/BOT.0b013e318279fa4f; Smith JK, 2016, MUSCLE NERVE, V54, P1139, DOI 10.1002/mus.25216; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Trauma ACoSCo, 2004, ATLS ADV TRAUM LIF S; Turco L, 2017, WORLD NEUROSURG, V104, P653, DOI 10.1016/j.wneu.2017.05.068; Zhang LY, 2010, J TRAU SURG, V12, P96	51	7	13	2	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2095-7467	2054-9369		MILITARY MED RES	MILITARY MED. RES.	FEB 13	2018	5								6	10.1186/s40779-018-0152-y			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW7SV	WOS:000425525800001	29502527	Green Published, gold			2022-02-06	
J	Cacace, AT; Hu, JN; Romero, S; Xuan, Y; Burkard, RF; Tyler, RS				Cacace, Anthony T.; Hu, Jiani; Romero, Stephen; Xuan, Yang; Burkard, Robert F.; Tyler, Richard S.			Glutamate is down-regulated and tinnitus loudness-levels decreased following rTMS over auditory cortex of the left hemisphere: A prospective randomized single-blinded sham-controlled cross-over study	HEARING RESEARCH			English	Article						Tinnitus; Repetitive transcranial magnetic stimulation; Magnetic resonance imaging; Magnetic resonance spectroscopy; Loudness scaling; Metabolites	TRANSCRANIAL MAGNETIC STIMULATION; BLAST-INDUCED NEUROTRAUMA; HOMEOSTATIC PLASTICITY; ACOUSTIC TRAUMA; NOISE; HYPERACTIVITY; NEUROSCIENCE; MODELS; ACID	Using a prospective randomized single-blinded sham-controlled cross-over design, we studied the efficacy of low frequency (1-Hz) repetitive transcranial magnetic stimulation (rTMS) over auditory cortex of the left temporal lobe as an experimental treatment modality for noise-induced tinnitus. Pre/post outcome measures for sham vs. active rTMS conditions included differential changes in tinnitus loudness, self-perceived changes in the Tinnitus Handicap Questionnaire (THQ), and neurochemical changes of brain metabolite concentrations using single voxel proton magnetic resonance spectroscopy (H-1-MRS) obtained from left and right auditory cortical areas. While no subject in our sample had complete abatement of their tinnitus percept, active but not sham rTMS significantly reduced the loudness level of the tinnitus perception on the order of 4.5 dB; improved subscales in several content areas on the THQ and down regulated (reduced) glutamate concentrations specific to the auditory cortex of the left temporal lobe that was stimulated. In addition, significant pair-wise correlations were observed among questionnaire variables, metabolite variables, questionnaire-metabolite variables, and metabolite-loudness variables. As part of this correlation analysis, we demonstrate for the first time that active rTMS produced a down regulation in the excitatory neurotransmitter glutamate that was highly correlated (r = 0.77, p < 0.05) with a reduction in tinnitus loudness levels measured psychoacoustically with a magnitude estimation procedure. Overall, this study provides unique information on neurochemical, psychoacoustic, and questionnaire-related profiles which emphasizes the emerging fields of perceptual and cognitive MRS and provides a perspective on a new frontier in auditory and tinnitus-related research. (C) 2017 Elsevier B.V. All rights reserved.	[Cacace, Anthony T.] Wayne State Univ, Dept Commun Sci & Disorders, 207 Rackham,60 Farnsworth, Detroit, MI 48202 USA; [Hu, Jiani; Xuan, Yang] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA; [Romero, Stephen] Union Coll, Dept Psychol, Schenectady, NY 12308 USA; [Burkard, Robert F.] SUNY Buffalo, Dept Rehabil Sci, Buffalo, NY USA; [Tyler, Richard S.] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Tyler, Richard S.] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA USA		Cacace, AT (corresponding author), Wayne State Univ, Dept Commun Sci & Disorders, 207 Rackham,60 Farnsworth, Detroit, MI 48202 USA.	cacacea@wayne.edu		tyler, richard/0000-0002-2101-4714			Brozoski T, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00009; Cacace A. T., 2009, 3 TINN RES IN M CLIN; CACACE AT, 1988, HEARING RES, V34, P225, DOI 10.1016/0378-5955(88)90002-0; Charter RA, 2003, J GEN PSYCHOL, V130, P290, DOI 10.1080/00221300309601160; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cheung SW, 2010, NEUROSCIENCE, V169, P1768, DOI 10.1016/j.neuroscience.2010.06.007; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; COUNTER SA, 1991, ELECTROEN CLIN NEURO, V78, P173, DOI 10.1016/0013-4694(91)90031-X; COUNTER SA, 1992, ELECTROEN CLIN NEURO, V85, P280, DOI 10.1016/0168-5597(92)90117-T; COUNTER SA, 1993, ACTA OTO-LARYNGOL, V113, P699, DOI 10.3109/00016489309135888; COUNTER SA, 1993, ACTA OTO-LARYNGOL, V113, P483, DOI 10.3109/00016489309135850; COUNTER SA, 1993, SCAND AUDIOL, V22, P1; De Ridder D, 2017, NEUROMODULATION, V20, P206, DOI 10.1111/ner.12593; De Ridder D, 2014, NEUROMODULATION, V17, P170, DOI 10.1111/ner.12127; Dhamne SC, 2014, BRAIN STIMUL, V7, P432, DOI 10.1016/j.brs.2014.01.056; Dong SY, 2010, EUR J NEUROSCI, V31, P1616, DOI 10.1111/j.1460-9568.2010.07183.x; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; FELDMANN H, 1971, AUDIOLOGY, V10, P138; Godfrey DA, 2012, J NEUROSCI RES, V90, P2214, DOI 10.1002/jnr.23095; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Henderson D, 2011, TEXTBOOK OF TINNITUS, P301, DOI 10.1007/978-1-60761-145-5_37; Hu JN, 2007, J MAGN RESON, V185, P204, DOI 10.1016/j.jmr.2006.12.010; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; KUK FK, 1990, EAR HEARING, V11, P434, DOI 10.1097/00003446-199012000-00005; Langguth B, 2006, BRAIN TOPOGR, V18, P241, DOI 10.1007/s10548-006-0002-1; Lee AC, 2015, NEURAL REGEN RES, V10, P368, DOI 10.4103/1673-5374.153680; Lee SL, 2008, OTOLARYNG HEAD NECK, V138, P398, DOI 10.1016/j.otohns.2007.11.035; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; Meng Z., 2011, COCHRANE DB SYST REV, V10, P1; Middleton JW, 2011, P NATL ACAD SCI USA, V108, P7601, DOI 10.1073/pnas.1100223108; Muller PA, 2012, BRAIN STIMUL, V5, P320, DOI 10.1016/j.brs.2011.05.003; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Newman C W, 1998, J Am Acad Audiol, V9, P153; Newman C. W., 2006, TINNITUS THEORY MANA, P237; NEWMAN CW, 1995, ANN OTO RHINOL LARYN, V104, P718, DOI 10.1177/000348949510400910; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Peng Z, 2012, OTOLARYNG HEAD NECK, V147, P817, DOI 10.1177/0194599812458771; Peterchev AV, 2015, IEEE ENG MED BIO, P226, DOI 10.1109/EMBC.2015.7318341; Piccirillo JF, 2011, ARCH OTOLARYNGOL, V137, P221, DOI 10.1001/archoto.2011.3; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Roberts LE, 2007, PROG BRAIN RES, V166, P487, DOI 10.1016/S0079-6123(07)66047-6; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Ruttiger L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057247; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Schaette R, 2006, EUR J NEUROSCI, V23, P3124, DOI 10.1111/j.1460-9568.2006.04774.x; Sedley W, 2015, J NEUROSCI, V35, P14822, DOI 10.1523/JNEUROSCI.2695-15.2015; Shellock F. G., 2011, REFERENCE MANUAL MAG, P43; Tringali S, 2012, OTOL NEUROTOL, V33, P1156, DOI 10.1097/MAO.0b013e318263d37d; Tyler R. S., 1984, J LARYNGOLOGY OTO S9, P38; Tyler R. S., 1982, USES COMPUTERS AIDIN, P249; Tyler R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12178-w; TYLER RS, 1984, J LARYNGOL OTOL S, V9, P150, DOI DOI 10.1017/S1755146300090363; Vanneste S, 2012, NEUROMODULATION, V15, P350, DOI 10.1111/j.1525-1403.2012.00447.x; Vernon J., 1980, AM J OTOLARYNG, V11, P44; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wang H, 1996, NEUROREPORT, V7, P521, DOI 10.1097/00001756-199601310-00035; Wang HN, 2011, HEARING RES, V279, P111, DOI 10.1016/j.heares.2011.04.004; Yang S., 2007, J MAG RESON, V185, P204; Yang SC, 2011, P NATL ACAD SCI USA, V108, P14974, DOI 10.1073/pnas.1107998108	63	7	7	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	FEB	2018	358						59	73		10.1016/j.heares.2017.10.017			15	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	FV8QZ	WOS:000424853200008	29150051				2022-02-06	
J	Fuller, AT; Corley, J; Tran, TM; Butler, EK; Vissoci, JR; Andrade, L; Makumbi, F; Luboga, S; Muhumuza, C; Ssennono, VF; Chipman, JG; Galukande, M; Haglund, MM; Smith, ER				Fuller, Anthony T.; Corley, Jacquelyn; Tran, Tu M.; Butler, Elissa K.; Vissoci, Joao Ricardo; Andrade, Luciano; Makumbi, Fredrick; Luboga, Samuel; Muhumuza, Christine; Ssennono, Vincent F.; Chipman, Jeffrey G.; Galukande, Moses; Haglund, Michael M.; Smith, Emily R.			Prevalence of Surgically Untreated Face, Head, and Neck Conditions in Uganda: A Cross-Sectional Nationwide Household Survey	WORLD NEUROSURGERY			English	Article						Disease burden; Global surgery; Head and neck injury; Low- and middle-income countries	TRAUMATIC BRAIN-INJURY; SURGERY WORLDWIDE; MODELING STRATEGY; GLOBAL BURDEN; SIERRA-LEONE; LOW-INCOME; DISEASE; HEALTH; CARE; NEED	BACKGROUND: The Surgeons OverSeas Assessment of Surgical Need tool (SOSAS) was created to evaluate the burden of surgically treatable conditions in low-and middle-income countries. The goal of our study is to describe the face, head, and neck (FHN) conditions that need surgical care in Uganda, along with barriers to that care and disability from these conditions. METHODS: A 2-stage cluster randomized SOSAS survey was administered in a cross-sectional manner between August and September 2014. Participants included randomly selected persons in 105 enumeration areas in 74 districts throughout Uganda with 24 households in each cluster. The SOSAS survey collected demographic and clinical data on all respondents. Univariate and multivariate logistic models evaluated associations of demographic characteristics and clinical characteristics of the FHN conditions and outcomes of whether health care was sought or surgical care was received. RESULTS: Of the 4428 respondents, 331 (7.8%) reported having FHN conditions. The most common types of conditions were injury-related wounds. Of those who reported an FHN condition, 36% reported receiving no surgical care whereas 82.5% reported seeking health care. In the multivariate model, literacy and type of condition were significant predictors of seeking health care whereas village type, literacy, and type of condition remained significant predictors of receiving surgical care. CONCLUSIONS: Many individuals in Uganda are not receiving surgical care and barriers include costs, rural residency, and literacy. Our study highlights the need for targeted interventions in various parts of Uganda to increase human resources for surgery and expand surgical capacity.	[Fuller, Anthony T.; Corley, Jacquelyn; Tran, Tu M.; Vissoci, Joao Ricardo; Muhumuza, Christine; Haglund, Michael M.; Smith, Emily R.] Duke Univ, Div Global Neurosurg & Neurosci, Durham, NC 27706 USA; [Fuller, Anthony T.; Haglund, Michael M.] Duke Univ, Sch Med, Durham, NC 27708 USA; [Corley, Jacquelyn; Haglund, Michael M.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27710 USA; [Butler, Elissa K.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Vissoci, Joao Ricardo; Smith, Emily R.] Duke Univ, Med Ctr, Global Hlth Inst, Durham, NC USA; [Andrade, Luciano] State Univ West Parana, Unioeste, Foz Do Iguacu, Brazil; [Andrade, Luciano] Unioeste, Publ Hlth Res Grp, Toledo, Brazil; [Makumbi, Fredrick; Muhumuza, Christine] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Luboga, Samuel] Makerere Univ, Sch Med, Dept Anat, Kampala, Uganda; [Ssennono, Vincent F.] Govt Uganda, Minist Hlth, Kampala, Uganda; [Chipman, Jeffrey G.] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [Galukande, Moses] Makerere Univ, Coll Hlth Sci, Dept Surg, Kampala, Uganda		Haglund, MM (corresponding author), Duke Univ, Div Global Neurosurg & Neurosci, Durham, NC 27706 USA.; Haglund, MM (corresponding author), Duke Univ, Sch Med, Durham, NC 27708 USA.; Haglund, MM (corresponding author), Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27710 USA.	michael.haglund@duke.edu		Smith, Emily/0000-0002-1745-5728			Bhattacharyya N, 2001, ARCH OTOLARYNGOL, V127, P127, DOI 10.1001/archotol.127.2.127; Brinda EM, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-5; El Khamlichi A, 2001, NEUROSURGERY, V48, P1344, DOI 10.1097/00006123-200106000-00034; Elliott IS, 2015, CLIN ORTHOP RELAT R, V473, P380, DOI 10.1007/s11999-014-4017-8; Eskander A, 2016, CURR ONCOL REP, V18, DOI 10.1007/s11912-016-0500-6; Fagan JJ, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1932; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Fuller Anthony, 2016, eNeurologicalSci, V3, P1, DOI 10.1016/j.ensci.2015.10.003; Fuller AT, 2015, WORLD J SURG, V39, P2900, DOI 10.1007/s00268-015-3191-5; Groen RS, 2012, LANCET, V380, P1082, DOI 10.1016/S0140-6736(12)61081-2; Gupta S, 2015, BRIT J SURG, V102, P700, DOI 10.1002/bjs.9807; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hamid SA, 2014, APPL HEALTH ECON HEA, V12, P421, DOI 10.1007/s40258-014-0100-2; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Musoke D, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.36; Onywera VO, 2013, GLOB HEALTH PROMOT, V20, P52, DOI 10.1177/1757975913502688; Petroze RT, 2013, SURGERY, V153, P457, DOI 10.1016/j.surg.2012.10.001; Pulte D, 2010, ONCOLOGIST, V15, P994, DOI 10.1634/theoncologist.2009-0289; Roehler DR, 2013, GLOB HEALTH PROMOT, V20, P37, DOI 10.1177/1757975913509657; Rose J, 2015, LANCET GLOB HEALTH, V3, pS13, DOI 10.1016/S2214-109X(15)70087-2; Rose J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089693; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS8, DOI 10.1016/S2214-109X(14)70384-5; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS38, DOI 10.1016/S2214-109X(15)70085-9; Staton C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150150; Team QD, QGIS GEOGR INF SYST; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Van Buren NC, 2014, OTOLARYNG HEAD NECK, V151, P638, DOI 10.1177/0194599814542587; Verguet S, 2015, LANCET GLOB HEALTH, V3, pS28, DOI 10.1016/S2214-109X(15)70086-0; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Zogg CK, 2015, INT J SURG, V13, P1, DOI 10.1016/j.ijsu.2014.11.026	32	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2018	110						E747	E754		10.1016/j.wneu.2017.11.099			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FX1ZT	WOS:000425856900098	29180091				2022-02-06	
J	Kerr, ZY; Lincoln, AE; Dodge, T; Yeargin, SW; Covassin, TM; Nittoli, VC; Mensch, J; Roos, KG; Dompier, TP; Caswell, SV				Kerr, Zachary Y.; Lincoln, Andrew E.; Dodge, Thomas; Yeargin, Susan W.; Covassin, Tracey M.; Nittoli, Vincent C.; Mensch, James; Roos, Karen G.; Dompier, Thomas P.; Caswell, Shane V.			Epidemiology of Youth Boys' and Girls' Lacrosse Injuries in the 2015 to 2016 Seasons	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						RECREATIONAL YOUTH SPORTS LEAGUES; EQUIPMENT; INJURY PREVENTION; LACROSSE	UNITED-STATES; WOMENS LACROSSE; ACADEMIC YEARS; HEAD-INJURIES; EYE INJURIES; SURVEILLANCE; PLAYERS; CONCUSSION; RATES; MENS	Purpose Examinations of injury among younger populations of lacrosse players that are beginning their development is limited. This study describes the epidemiology of youth boys' and girls' lacrosse injuries during the 2015 to 2016 seasons. Methods Surveillance data originated from a convenience sample of 10 leagues in five states with 1090 boy lacrosse players and 408 girl lacrosse players from the U9-U15 divisions. Athletic trainers reported injury and exposure data at games and practices. Time loss (TL) injuries were defined as resulting in 24 h of participation restriction time. Injury counts and rates per 1000 athlete games/practices were calculated. Injury rate ratios (IRR) with 95% confidence intervals (CI) compared rates by sex and age division. Results Overall, 241 and 59 injuries were reported in boys' and girls' youth lacrosse, respectively, of which 17.0% and 18.6% were TL. Compared with girls, boys had a higher overall injury rate (12.7 vs 8.7/1000 athlete games/practices; IRR, 1.5; 95% CI, 1.1-1.9). U13/U15 boys had a higher TL injury rate than U9/U11 boys (2.6 vs 1.0/1000 athlete game/practices; IRR, 2.6; 95% CI, 1.1-6.1). Most injuries were diagnosed as contusions (boys, 53.7%; girls, 47.2%) and resulted from stick contact (boys, 34.1%; girls, 30.6%) and ball contact (boys, 17.1%; girls, 25.0%). Among girls, ball contact contributed to 75.0% (n = 9) of all head/face injuries. Among the 14 concussions reported in boys, player contact was the most common injury mechanism (50.0%, n = 7), followed by stick contact (35.7%, n = 5). Conclusions Boys' lacrosse has a higher injury incidence than girls' lacrosse, reflecting the contact nature of the boys' game. The high incidence of stick- and ball-related injuries suggests the need for youth-specific rules to better protect youth players.	[Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA; [Lincoln, Andrew E.] MedStar Sports Med Res Ctr, Baltimore, MD USA; [Dodge, Thomas] Springfield Coll, Dept Exercise Sci & Sport Studies, Springfield, MA USA; [Yeargin, Susan W.; Mensch, James] Univ South Carolina, Dept Exercise Sci, Columbia, SC USA; [Covassin, Tracey M.] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Nittoli, Vincent C.] St Vincent Sports Performance, Indianapolis, IN USA; [Roos, Karen G.] Calif State Univ Long Beach, Dept Kinesiol, Long Beach, CA 90840 USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Caswell, Shane V.] George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, Manassas, VA USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu			National Operating Committee on Standards for Athletic Equipment (NOCSAE)	This project was funded by National Operating Committee on Standards for Athletic Equipment (NOCSAE). The content of this report is solely the responsibility of the authors and does not necessarily reflect the views of NOCSAE. This study would not be possible without the assistance of the AT and youth lacrosse leagues who participated in the program.	Boone C, 2015, TELEMEDICINE PROGRAM; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick R, 2007, J ATHL TRAINING, V42, P255; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Farrey T, 2016, YOUTH FOOTBALL PARTI; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Kerr Zachary Y, 2017, Inj Epidemiol, V4, P6, DOI 10.1186/s40621-017-0104-0; Kerr ZY, 2018, J SPORT REHABIL, V27, P118, DOI 10.1123/jsr.2016-0124; Kerr Zachary Y, 2016, Inj Epidemiol, V3, P3; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2014, CLIN J SPORT MED, V24, P355, DOI 10.1097/JSM.0000000000000011; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; Schiff MA, 2010, J ATHL TRAINING, V45, P238, DOI 10.4085/1062-6050-45.3.238; Stovitz SD, 2012, BRIT J SPORT MED, V46, P960, DOI 10.1136/bjsports-2011-090693; US Lacrosse, 2017, 2017 YOUTH BOYS RUL; US Lacrosse, 2016, PART SURV 2015; US Lacrosse, 2015, 2015 RUL BOYS YOUTH; US Lacrosse, 2017, COACH ED PROGR; US Lacrosse, 2017, ATHL DEV MOD; US Lacrosse, 2017, 2017 YOUTH GIRLS RUL; US Lacrosse, 2017, OFF ED PROGR; US Lacrosse, 2015, WOM LACR HEADG FAQ; US Lacrosse, 2016, PEARL GUARD NAM OFF; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914; Yard EE, 2006, J ATHL TRAINING, V41, P441	32	7	8	0	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	FEB	2018	50	2					284	291		10.1249/MSS.0000000000001422			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FS6VM	WOS:000419936500013	28902125	Bronze			2022-02-06	
J	Poulsen, I; Kreiner, S; Engberg, AW				Poulsen, Ingrid; Kreiner, Svend; Engberg, Aase W.			VALIDATION OF THE EARLY FUNCTIONAL ABILITIES SCALE: AN ASSESSMENT OF FOUR DIMENSIONS IN EARLY RECOVERY AFTER TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						construct validity; loglinear Rasch model; Rasch model; rehabilitation; traumatic brain injury; validation; Early Functional Abilities	INDEPENDENCE MEASURE; RASCH ANALYSIS; REHABILITATION; VALIDITY; FIM(TM); COMA; EFA; FIM	Objective: The Early Functional Abilities scale assesses the restoration of brain function after brain injury, based on 4 dimensions. The primary objective of this study was to evaluate the validity, objectivity, reliability and measurement precision of the Early Functional Abilities scale by Rasch model item analysis. A secondary objective was to examine the relationship between the Early Functional Abilities scale and the Functional Independence Measurement T, in order to establish the criterion validity of the Early Functional Abilities scale and to compare the sensitivity of measurements using the 2 instruments. Methods: The Rasch analysis was based on the assessment of 408 adult patients at admission to subacute rehabilitation in Copenhagen, Denmark after traumatic brain injury. Results: The Early Functional Abilities scale provides valid and objective measurement of vegetative (autonomic), facio-oral, sensorimotor and communicative/cognitive functions. Removal of one item from the sensorimotor scale confirmed unidimensionality for each of the 4 subscales, but not for the entire scale. The Early Functional Abilities subscales are sensitive to differences between patients in ranges in which the Functional Independence Measurement T has a floor effect. Conclusion: The Early Functional Abilities scale assesses the early recovery of important aspects of brain function after traumatic brain injury, but is not unidimensional. We recommend removal of the "standing" item and calculation of summary subscales for the separate dimensions.	[Poulsen, Ingrid; Engberg, Aase W.] Rigshosp, Traumat Brain Injury, Dept Neurorehabil, Copenhagen, Denmark; [Kreiner, Svend] Univ Copenhagen, Sect Biostat, Copenhagen, Denmark; [Poulsen, Ingrid] Aarhus Univ, Sect Nursing Sci, Hlth, Aarhus, Denmark		Poulsen, I (corresponding author), Rigshosp, Dept Neurorehabil, Traumat Brain Injury, Kettegaard 30, DK-2650 Hvidovre, Denmark.	Ingrid.Poulsen@regionh.dk	Poulsen, ingrid/AAH-2052-2019	Poulsen, ingrid/0000-0002-0342-017X			Alvsaker K, 2011, J REHABIL MED, V43, P892, DOI 10.2340/16501977-0855; ANDERSEN EB, 1970, J ROY STAT SOC B, V32, P283; Andrich D., 1988, RASCH MODELS MEASURE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Christensen KB, 2013, RASCH MODELS HLTH, P83; COOK L, 1994, ARCH PHYS MED REHAB, V75, P390, DOI 10.1016/0003-9993(94)90160-0; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Hankemeier A, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0469-z; Hart T, 2014, ARCH PHYS MED REHAB, V95, P2103, DOI 10.1016/j.apmr.2014.07.001; Heck G, 2000, NEUROL REHABIL, V6, P125; KELDERMAN H, 1984, PSYCHOMETRIKA, V49, P223, DOI 10.1007/BF02294174; Kreiner S, 2006, ITEM ANAL DIGRAM GUI; Kreiner S., 2003, INTRO DIGRAM; Kreiner S, 2007, STAT SOC BEHAV SC, P329, DOI 10.1007/978-0-387-49839-3_21; Maneesriwongul W, 2004, J ADV NURS, V48, P175, DOI 10.1111/j.1365-2648.2004.03185.x; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; Mesbah M., 2013, RASCH MODELS HLTH; Nilsson AL, 2005, ACTA NEUROL SCAND, V111, P264, DOI 10.1111/j.1600-0404.2005.00404.x; Nilsson AL, 2011, J REHABIL MED, V43, P884, DOI 10.2340/16501977-0871; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; ROSENBAUM PR, 1989, PSYCHOMETRIKA, V54, P625, DOI 10.1007/BF02296400; Stubbs PW, 2014, DISABIL REHABIL, V36, P2278, DOI 10.3109/09638288.2014.904935; TEASDALE G, 1974, LANCET, V2, P81; WARM TA, 1989, PSYCHOMETRIKA, V54, P427, DOI 10.1007/BF02294627; Yamada S, 2006, J REHABIL MED, V38, P50, DOI 10.1080/16501970510044034; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	30	7	7	1	1	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	FEB	2018	50	2					165	172		10.2340/16501977-2300			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FW3VM	WOS:000425239300005	29313872	gold, Green Published, Green Submitted			2022-02-06	
J	Rau, CS; Wu, SC; Chien, PC; Kuo, PJ; Chen, YC; Hsieh, HY; Hsieh, CH; Liu, HT				Rau, Cheng-Shyuan; Wu, Shao-Chun; Chien, Peng-Chen; Kuo, Pao-Jen; Chen, Yi-Chun; Hsieh, Hsiao-Yun; Hsieh, Ching-Hua; Liu, Hang-Tsung			Identification of Pancreatic Injury in Patients with Elevated Amylase or Lipase Level Using a Decision Tree Classifier: A Cross-Sectional Retrospective Analysis in a Level I Trauma Center	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						decision tree; pancreatic injury; amylase; lipase; abdominal injury; shock; traumatic brain injury; mandible fracture; maxilla fracture	SHOCK-INDEX; SERUM AMYLASE; MASSIVE TRANSFUSION; ENZYME LEVELS; BLUNT TRAUMA; MANAGEMENT; UTILITY; FAILURE; HYPERAMYLASEMIA; PREDICTION	Background: In trauma patients, pancreatic injury is rare; however, if undiagnosed, it is associated with high morbidity and mortality rates. Few predictive models are available for the identification of pancreatic injury in trauma patients with elevated serum pancreatic enzymes. In this study, we aimed to construct a model for predicting pancreatic injury using a decision tree (DT) algorithm, along with data obtained from a population-based trauma registry in a Level I trauma center. Methods: A total of 991 patients with elevated serum levels of amylase (> 137 U/L) or lipase (> 51 U/L), including 46 patients with pancreatic injury and 865 without pancreatic injury between January 2009 and December 2016, were allocated in a ratio of 7: 3 to training (n = 642) or test (n = 269) sets. Using the data on patient and injury characteristics as well as laboratory data, the DT algorithm with Classification and Regression Tree (CART) analysis was performed based on the Gini impurity index, using the rpart function in the rpart package in R. Results: Among the trauma patients with elevated amylase or lipase levels, three groups of patients were identified as having a high risk of pancreatic injury, using the DT model. These included (1) 69% of the patients with lipase level >= 306 U/L; (2) 79% of the patients with lipase level between 154 U/L and 305 U/L and shock index (SI) >= 0.72; and (3) 80% of the patients with lipase level <154 U/L with abdomen injury, glucose level <158 mg/dL, amylase level <90 U/L, and neutrophil percentage >= 76%; they had all sustained pancreatic injury. With all variables in the model, the DT achieved an accuracy of 97.9% (sensitivity of 91.4% and specificity of 98.3%) for the training set. In the test set, the DT achieved an accuracy of 93.3%, sensitivity of 72.7%, and specificity of 94.2%. Conclusions: We established a DT model using lipase, SI, and additional conditions (injury to the abdomen, glucose level <158 mg/dL, amylase level <90 U/L, and neutrophils >= 76%) as important nodes to predict three groups of patients with a high risk of pancreatic injury. The proposed decision-making algorithm may help in identifying pancreatic injury among trauma patients with elevated serum amylase or lipase levels.	[Rau, Cheng-Shyuan] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 83301, Taiwan; [Wu, Shao-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung 83301, Taiwan; [Chien, Peng-Chen; Kuo, Pao-Jen; Chen, Yi-Chun; Hsieh, Hsiao-Yun; Hsieh, Ching-Hua] Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Kaohsiung 83301, Taiwan; [Liu, Hang-Tsung] Kaohsiung Chang Gung Mem Hosp, Dept Trauma Surg, Kaohsiung 83301, Taiwan		Hsieh, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Kaohsiung 83301, Taiwan.; Liu, HT (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Trauma Surg, Kaohsiung 83301, Taiwan.	ersh2127@cloud.cgmh.org.tw; shaochunwu@gmail.com; venu_chien@hotmail.com; bow110470@gmail.com; libe320@yahoo.com.tw; sylvia19870714@hotmail.com; m93chinghua@gmail.com; htl1688@yahoo.com.tw		Hsieh, Ching-Hua/0000-0002-0945-2746; WU, Shaochun/0000-0002-0984-6921	 [CMRPG8F1861]	We appreciate help with the statistical analysis extended by the Biostatistics Center, Kaohsiung Chang Gung Memorial Hospital. This research was supported by a grant from CMRPG8F1861.	ALLGOWER M, 1967, DEUT MED WOCHENSCHR, V92, P1947, DOI 10.1055/s-0028-1106070; Birkhahn RH, 2005, AM J EMERG MED, V23, P323, DOI 10.1016/j.ajem.2005.02.029; BOULANGER BR, 1993, CAN J SURG, V36, P63; BOUWMAN DL, 1983, SURGERY, V94, P318; BUECHTER KJ, 1990, AM SURGEON, V56, P204; Chang LY, 2006, ACCIDENT ANAL PREV, V38, P1019, DOI 10.1016/j.aap.2006.04.009; Chen CC, 2010, J CHIN MED ASSOC, V73, P129, DOI 10.1016/S1726-4901(10)70026-5; Ciccone MM, 2010, VASC HEALTH RISK MAN, V6, P297; Cirillo RL, 2002, J GASTROINTEST SURG, V6, P587, DOI 10.1016/S1091-255X(01)00028-2; DeMuro JP, 2013, AM J EMERG MED, V31, P1260, DOI 10.1016/j.ajem.2013.05.027; Dente C, 2011, J TRAUMA, V70, P388; Farion K, 2010, J MED SYST, V34, P551, DOI 10.1007/s10916-009-9268-7; Frank B, 1999, AM J GASTROENTEROL, V94, P463, DOI 10.1016/S0002-9270(98)00759-X; Guilbault RWR, 2017, J INTENSIVE CARE MED, V32, P333, DOI 10.1177/0885066616686924; GUMASTE VV, 1993, AM J GASTROENTEROL, V88, P2051; Hsieh CH, 2017, BIOMED J, V40, P113, DOI 10.1016/j.bj.2016.10.005; Hsieh CH, 2017, BIOMED J, V40, P121, DOI 10.1016/j.bj.2016.10.006; JURKOVICH GJ, 1990, SURG CLIN N AM, V70, P575; Kasbekar PU, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00025; Keller MS, 2004, AM J SURG, V188, P671, DOI 10.1016/j.amjsurg.2004.08.056; Kumar Subodh, 2012, J Emerg Trauma Shock, V5, P135, DOI 10.4103/0974-2700.96482; Lee CC, 2010, J CHIN MED ASSOC, V73, P8, DOI 10.1016/S1726-4901(10)70015-0; Lin BC, 2004, J TRAUMA, V56, P774, DOI 10.1097/01.TA.0000087644.90727.DF; Liu KJM, 2001, AM SURGEON, V67, P215; Mahajan A, 2014, INJURY, V45, P1384, DOI 10.1016/j.injury.2014.02.014; Malinoski DJ, 2009, J TRAUMA, V67, P445, DOI 10.1097/TA.0b013e3181b5dc11; Mansour A, 2001, AM SURGEON, V67, P219; Matsuno WC, 2009, INJURY, V40, P66, DOI 10.1016/j.injury.2008.10.003; Mitra B, 2014, INJURY, V45, P61, DOI 10.1016/j.injury.2013.01.010; MORETZ JA, 1975, AM J SURG, V130, P739, DOI 10.1016/0002-9610(75)90432-8; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12851; Nadler EP, 1999, J TRAUMA, V47, P1098, DOI 10.1097/00005373-199912000-00020; Patton JH, 1997, J TRAUMA, V43, P234, DOI 10.1097/00005373-199708000-00005; Pezzilli Raffaele, 2002, JOP, V3, P139; PIEPERBIGELOW C, 1990, GASTROENTEROL CLIN N, V19, P793; Rassameehiran S, 2017, SOUTH MED J, V110, P738, DOI 10.14423/SMJ.0000000000000729; Rau CS, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070683; Ripley B., 2013, TREE CLASSIFICATION; Sakorafas GH, 2000, DIGEST SURG, V17, P3, DOI 10.1159/000018793; Schmid-Schonbein GW, 2005, MICROCIRCULATION, V12, P71, DOI 10.1080/10739680590896009; Shi KQ, 2017, J VIRAL HEPATITIS, V24, P132, DOI 10.1111/jvh.12617; SKUDE G, 1973, SCAND J PLAST RECONS, V7, P105, DOI 10.3109/02844317309056418; SMEGO DR, 1985, J TRAUMA, V25, P771, DOI 10.1097/00005373-198508000-00007; Stawicki SP, 2008, AM SURGEON, V74, P1133; TAKAHASHI M, 1980, J TRAUMA, V20, P951, DOI 10.1097/00005373-198011000-00008; Tietz NW, 1997, CLIN CHIM ACTA, V257, P85, DOI 10.1016/S0009-8981(96)06435-2; Vandromme MJ, 2011, J TRAUMA, V70, P384, DOI 10.1097/TA.0b013e3182095a0a; WISNER DH, 1990, ARCH SURG-CHICAGO, V125, P1109; Zimmerman RK, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1839-x; Zintzaras E, 2007, COMPUT BIOL MED, V37, P637, DOI 10.1016/j.compbiomed.2006.06.001	50	7	7	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	FEB	2018	15	2							277	10.3390/ijerph15020277			12	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	FY3LM	WOS:000426721400102	29415489	gold, Green Published, Green Submitted			2022-02-06	
J	Sando, MJ; Grieshober, JA; Kim, H; Dreese, JC; Henn, RF				Sando, Mark J.; Grieshober, Jason A.; Kim, Hyunchul; Dreese, James C.; Henn, R. Frank, III			Evaluation of Risk to the Suprascapular Nerve During Arthroscopic SLAP Repair: Is a Posterior Portal Safer?	ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY			English	Article							SUPERIOR LABRAL ANTERIOR; GLENOID LABRUM; LONG HEAD; LESIONS; SHOULDER; OUTCOMES; INJURY; TEARS; PATHOGENESIS; SURGERY	Purpose: The purpose of this study was to compare the risk of glenoid perforation during SLAP repair for suture anchors placed through an anterolateral portal versus a posterolateral portal of Wilmington. Methods: Ten bilateral cadaveric shoulders were randomized to suture anchor placement through an anterolateral portal on one shoulder and a posterolateral portal on the contralateral shoulder. Anchors were placed into anterior, posterior, and far posterior positions on the glenoid rim (1 o'clock, 11 o'clock, and 10 o'clock positions for right shoulders). The shoulder was then dissected, and the distance from the suture anchor tip to the nerve was measured if perforation occurred. The maximum load and failure mechanism of each anchor was assessed with a materials testing system machine. Results: Only 2 of 20 anchors placed in the posterosuperior glenoid through the posterolateral portal perforated compared with 16 of 20 of the anchors placed through the anterolateral portal (P < .05). The mean distance from the perforated anchor tip to the suprascapular nerve was 2.5 +/- 1.4 mm for the anterolateral portal and 4.4 +/- 0.6 mm for the posterolateral portal (P = .18). We did not observe a significant difference in biomechanical strength (P > .05). Conclusions: There is a high rate of glenoid perforation in close proximity to the suprascapular nerve when placing anchors in the posterosuperior glenoid through an anterolateral portal. Use of the posterolateral portal results in a much lower incidence of glenoid perforation for anchors placed in the posterosuperior glenoid, but there is a higher risk of glenoid perforation for an anchor placed in the anterosuperior glenoid from the posterolateral portal.	[Sando, Mark J.; Grieshober, Jason A.; Kim, Hyunchul; Dreese, James C.; Henn, R. Frank, III] Univ Maryland, Sch Med, Dept Orthopaed, Baltimore, MD 21201 USA		Henn, RF (corresponding author), Univ Maryland, Dept Orthopaed, 2200 Kernan Dr,Suite 1154, Baltimore, MD 21201 USA.	Frank_Henn@yahoo.com			Zimmer Biomet	J.C.D. is a paid consultant for Zimmer Biomet.	Alpert JM, 2010, AM J SPORT MED, V38, P2299, DOI 10.1177/0363546510377741; ANDREWS JR, 1985, AM J SPORT MED, V13, P337, DOI 10.1177/036354658501300508; Bouliane M, 2015, KNEE SURG SPORT TR A, V23, P517, DOI 10.1007/s00167-013-2415-1; Brockmeier SF, 2009, J BONE JOINT SURG AM, V91A, P1595, DOI 10.2106/JBJS.H.00205; Burkhart SS, 2003, ARTHROSCOPY, V19, P404, DOI 10.1053/jars.2003.50128; Chan H, 2010, J SHOULDER ELB SURG, V19, P709, DOI 10.1016/j.jse.2009.12.007; Clavert P, 2004, J SHOULDER ELB SURG, V13, P45, DOI 10.1016/j.jse.2003.09.008; Denard Patrick J, 2017, Am J Orthop (Belle Mead NJ), V46, pE60; Gumina S, 2011, J SHOULDER ELB SURG, V20, P1; Keener JD, 2009, J AM ACAD ORTHOP SUR, V17, P627, DOI 10.5435/00124635-200910000-00005; Kim SH, 2010, ARTHROSCOPY, V26, P1005, DOI 10.1016/j.arthro.2010.01.005; Koh KH, 2011, J SHOULDER ELB SURG, V20, P245, DOI 10.1016/j.jse.2010.06.004; Leedle BP, 2005, ARTHROSCOPY, V21, P81, DOI 10.1016/j.arthro.2004.08.011; Morgan CD, 1998, ARTHROSCOPY, V14, P553, DOI 10.1016/S0749-8063(98)70049-0; Morgan RT, 2014, ARTHROSCOPY, V30, P1418, DOI 10.1016/j.arthro.2014.06.006; O'Brien SJ, 2002, ARTHROSCOPY, V18, P372, DOI 10.1053/jars.2002.30646; Oh JH, 2008, AM J SPORT MED, V36, P1913, DOI 10.1177/0363546508317414; RODOSKY MW, 1994, AM J SPORT MED, V22, P121, DOI 10.1177/036354659402200119; Shishido H, 2001, J SHOULDER ELB SURG, V10, P372, DOI 10.1067/mse.2001.115988; SNYDER S J, 1990, Arthroscopy, V6, P274, DOI 10.1016/0749-8063(90)90056-J; Weber SC, 2012, AM J SPORT MED, V40, P1538, DOI 10.1177/0363546512447785; Yoo JC, 2008, J SHOULDER ELB SURG, V17, P144, DOI 10.1016/j.jse.2007.03.025; Yoo Jae Chul, 2009, J Shoulder Elbow Surg, V18, pe27, DOI 10.1016/j.jse.2008.10.006	23	7	7	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-8063	1526-3231		ARTHROSCOPY	Arthroscopy	FEB	2018	34	2					389	395		10.1016/j.arthro.2017.07.037			7	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	FV8FG	WOS:000424820500009	28935431				2022-02-06	
J	Scherer, MR; Weightman, MM; Radomski, MV; Smith, L; Finkelstein, M; Cecchini, A; Heaton, KJ; McCulloch, K				Scherer, Matthew R.; Weightman, Margaret M.; Radomski, Mary Vining; Smith, Laurel; Finkelstein, Marsha; Cecchini, Amy; Heaton, Kristin Jensen; McCulloch, Karen			Measuring Soldier Performance During the Patrol-Exertion Multitask: Preliminary Validation of a Postconcussive Functional Return-to-Duty Metric	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain concussion; Mild traumatic brain injury; Military personnel; Multitask; Outcome measures; Performance-based assessment; Rehabilitation; Return to duty; Return to work; Validation	TRAUMATIC BRAIN-INJURY; DIVIDED ATTENTION; CONCUSSION; RECOVERY; DEFICITS; BALANCE; GAIT; REHABILITATION	Objective: To assess the discriminant validity of the Patrol-Exertion Multitask (PEMT), a novel, multidomain, functional return-to-duty clinical assessment for active duty military personnel. Design: Measurement development study. Setting: Nonclinical indoor testing facility. Participants: Participants (N=84) were healthy control (HC) service members (SMs; n=51) and military personnel (n=33) with persistent postconcussive symptoms receiving rehabilitation (mild traumatic brain injury [mTBI]). Interventions: Not applicable. Main Outcome Measures: Known-groups discriminant validity was evaluated by comparing performance on the PEMT in 2 groups of active duty SMs: HCs and personnel with mTBI residual symptoms. Participant PEMT performance was based on responses in 4 subtasks during a 12-minute patrolling scenario: (1) accuracy in identifying virtual improvised explosive device (lED) markers and responses to scenario-derived questions from a computer-simulated foot patrol; (2) auditory reaction time responses; (3) rating of perceived exertion during stepping; and (4) self-reported visual clarity (ie, gaze stability) during vertical head-in-space translation while stepping. Results: Significant between-group differences for the PEMT were observed in 2 of 4 performance domains. Postpatrol lED identification task/question responses (P = .179) and rating of perceived exertion (P = .133) did not discriminate between groups. Participant self-report of visual clarity during stepping revealed significant (P<.001) between-group differences. SM reaction time responses to scenario-based auditory cues were significantly delayed in the mTBI group in both the early (P = .013) and late (P = .002) stages of the PEMT. Conclusions: Findings from this study support the use of a naturalistic, multidomain, complex clinical assessment to discriminate between healthy SMs and personnel with mTBI residual symptoms. Based on this preliminary study, additional research to further refine the PEMT and extend its application to return-to-work outcomes in military and civilian environments is warranted. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Scherer, Matthew R.] Med Res & Mat Command, Clin & Rehabil Med Res Program, 504 Scott St,Bldg 722, Ft Detrick, MD 21702 USA; [Weightman, Margaret M.; Radomski, Mary Vining; Finkelstein, Marsha; Cecchini, Amy] Allina Hlth, Courage Kenny Res Ctr, Minneapolis, MN USA; [Smith, Laurel; Heaton, Kristin Jensen] US Army Res Inst Environm Med, Natick, MA USA; [Cecchini, Amy] Def & Vet Brain Injury Ctr, Ft Bragg, NC USA; [Heaton, Kristin Jensen] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [McCulloch, Karen] Univ N Carolina, Div Phys Therapy, Chapel Hill, NC USA		Scherer, MR (corresponding author), Med Res & Mat Command, Clin & Rehabil Med Res Program, 504 Scott St,Bldg 722, Ft Detrick, MD 21702 USA.	matthew.r.scherer2.mil@mail.mil		McCulloch, Karen/0000-0003-4228-0517	United States Army Medical Research Materiel Command [W81XWH-12-2-0070]	Support for the Assessment of Military Multitasking Performance validation study was provided by the United States Army Medical Research Materiel Command (award no. W81XWH-12-2-0070) The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.	Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigsby K, 2014, INT J SPORTS PHYS TH, V9, P436; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Coolican H., 2009, RES METHODS STAT PSY, V5th; Darling KA, 2014, EXP BRAIN RES, V232, P1367, DOI 10.1007/s00221-014-3855-7; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Defense and Veterans Brain Injury Center, 2015, CONC MAN ALG POCK CA; Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury, 2012, CONC MAN DEPL SETT V; Editors of the American Heritage Dictionaries, 2011, AM HERITAGE DICT ENG; Edwards J, 2014, APPL NEUROPSYCH-ADUL, V21, P220, DOI 10.1080/09084282.2013.796554; Epling SL, 2016, EXP BRAIN RES, V234, P2979, DOI 10.1007/s00221-016-4700-y; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Guzman JF, 2016, EUR J SPORT SCI, V16, P1197, DOI 10.1080/17461391.2016.1186744; Hall Courtney D, 2006, J Neurol Phys Ther, V30, P74; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Herdman SJ, 2003, ARCH OTOLARYNGOL, V129, P819, DOI 10.1001/archotol.129.8.819; Hettich Thomas, 2010, J Spec Oper Med, V10, P48; Hinds A, 2016, J NEUROL NEUROPHYSIO, V7, P388, DOI DOI 10.4172/2155-9562.1000388; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kelley AM, 2015, J HEAD TRAUMA REHAB, V30, pE11, DOI 10.1097/HTR.0000000000000060; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Radomski MV, 2013, MIL MED, V178, P246, DOI 10.7205/MILMED-D-12-00144; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Robitaille N, 2016, DISABIL REHABIL ASSI; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Scherer MR, 2013, PHYS THER, V93, P1; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Siu KC, 2009, BRAIN RES, V1248, P59, DOI 10.1016/j.brainres.2008.10.078; Smith LB, 2014, AM J OCCUP THER, V68, P439, DOI 10.5014/ajot.2014.012393; Tapper A, 2017, J SPORT SCI, V35, P231, DOI 10.1080/02640414.2016.1161214; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; van Donkelaar P, 2006, EXERC SPORT SCI REV, V34, P77, DOI 10.1249/00003677-200604000-00007; Weightman MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169104; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME	50	7	7	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2		1			S79	S85		10.1016/j.apmr.2017.04.012			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FU7YY	WOS:000424069900011	28499856	Green Submitted			2022-02-06	
J	Wen, PS; Waid-Ebbs, JK; Graham, DP; Helmer, DA				Wen, Pey-Shan; Waid-Ebbs, J. Kay; Graham, David P.; Helmer, Drew A.			Psychometric Properties of 2 Participation Measures in Veterans With Mild Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Community integration; Rehabilitation; Veterans	COMMUNITY INTEGRATION; REINTEGRATION; IRAQ; SOLDIERS; OUTCOMES; SAMPLE; CARE	Objective: To compare the psychometric properties of 2 commonly used participation measures: the Community Reintegration of Service "Members (CRIS) and the Participation Assessment with Recombined Tools-Objective (PART-O) in veterans with mild traumatic brain injury (mTBI). Design: Data were collected from 2 cross-sectional observation studies conducted in 2 Veterans Affairs medical centers. Setting: Questionnaires were completed in-person or by mail. Participants: Veterans with mTBI (N=201) were recruited from the Michael E. DeBakey Veterans Affairs Medical Center in Houston (n=94) and the Malcom Randall North Florida/South Georgia Veterans Health System (n=107). Interventions: Not applicable. Main Outcome Measures: CRIS and PART-O. Results: We conducted Rasch analysis on the PART-O and on 3 subscales of the CRIS (extent of participation, perceived limitation, and satisfaction). For PART-O, results showed PART-O has questionable unidimensionality. For both instruments, some rating categories were underused, and rating scales did not advance accordingly. Compared with PART-O, the CRIS was able to distinguish more categories of person's ability (>5 vs 2 for PART-O) and had better internal consistency as indicated by higher Cronbach alpha (.96-98 vs.65 for PART-O). Conclusions: To capture participation unique to veterans with mTBI, CRIS has greater potential to detect a change in participation and is therefore recommended over PART-O. Rating scales of both instruments, however, need further refinement. We suggest future studies examine collapsed rating categories and use qualitative methods to redefine categories. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Wen, Pey-Shan] Georgia State Univ, Occupat Therapy Dept, Atlanta, GA 30303 USA; [Waid-Ebbs, J. Kay] North Florida South Georgia Vet Hlth Syst, Brain Rehabil Res Ctr Excellence, Gainesville, FL USA; [Graham, David P.] Michael E DeBakey VA Med Ctr, Traumat Brain Injury Ctr Excellence, Neurorehabil Neurons Network, Houston, TX USA; [Graham, David P.] Baylor Coll Med, Menninger Dept Psychiat, Houston, TX 77030 USA; [Graham, David P.] Baylor Coll Med, Menninger Dept Behav Sci, Houston, TX 77030 USA; [Graham, David P.] Vet Affairs South Cent Mental Illness Res Educ &, Houston, TX USA; [Helmer, Drew A.] Vet Affairs New Jersey Hlth Care Syst, War Related Illness & Injury Study Ctr, E Orange, NJ USA; [Helmer, Drew A.] Rutgers Univ New Jersey, Sch Med, Newark, NJ USA		Wen, PS (corresponding author), 140 Decatur St,Urban Life Bldg,Room 1250, Atlanta, GA 30303 USA.	pwen@gsu.edu		Wen, Pey-Shan/0000-0002-8921-8801	Eunice Kennedy Shriver National Institute of Child Health and Human Development, as part of the Medical Rehabilitation Research Infrastructure Network (Boston Rehabilitation Outcome Center) [5R24HD065688-05]; Department of Veterans Affairs Rehabilitation Research and DevelopmentUS Department of Veterans Affairs [B0902-W]	Supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, as part of the Medical Rehabilitation Research Infrastructure Network (Boston Rehabilitation Outcome Center) (grant no. 5R24HD065688-05) and in part by the Department of Veterans Affairs Rehabilitation Research and Development (grant no. B0902-W).	Bagalman E, 2013, MENTAL DISORDERS OEF; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Gaines KD, 2016, APPL NEUROPSYCH-ADUL, V23, P115, DOI 10.1080/23279095.2015.1012762; Heinemann AW, 2010, ARCH PHYS MED REHAB, V91, pS72, DOI 10.1016/j.apmr.2009.11.031; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kean J, 2013, ARCH PHYS MED REHAB, V94, P2417, DOI 10.1016/j.apmr.2013.08.006; Lequerica AH, 2013, J HEAD TRAUMA REHAB, V28, pE14, DOI 10.1097/HTR.0b013e31826e3ca8; Linacre J, 1994, RASCH MEAS T, V7, P328; Linacre J.M., RELIABILITY SEPARATI; Linacre J. M., 2016, WINSTEPS RASCH MEASU; Linacre JM, 2008, RASCH MEAS T, V22, P1164; Linacre John M, 2002, J Appl Meas, V3, P85; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Nelson KM, 2007, PUBLIC HEALTH REP, V122, P93, DOI 10.1177/003335490712200113; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Wang WC, 2005, EDUC PSYCHOL MEAS, V65, P376, DOI 10.1177/0013164404268673; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; World Health Organization, 2007, INT CLASS FUNCT DIS; Wright B, 1982, RATING SCALE ANAL RA; Wright B, 1994, MEASUREMENT T, V8, P370	28	7	7	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2		1			S86	S93		10.1016/j.apmr.2017.04.026			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FU7YY	WOS:000424069900012	28583464				2022-02-06	
J	Ho, CH; Liang, FW; Wang, JJ; Chio, CC; Kuo, JR				Ho, Chung-Han; Liang, Fu-Wen; Wang, Jhi-Joung; Chio, Chung-Ching; Kuo, Jinn-Rung			Impact of grouping complications on mortality in traumatic brain injury: A nationwide population-based study	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; ACUTE MYOCARDIAL-INFARCTION; ARTIFICIAL NEURAL-NETWORK; IN-HOSPITAL MORTALITY; RISK-FACTORS; SLEEP DISORDERS; ISCHEMIC-STROKE; TAIWAN; CARE; EPIDEMIOLOGY	Traumatic brain injury (TBI) is an important health issue with high mortality. Various complications of physiological and cognitive impairment may result in disability or death after TBI. Grouping of these complications could be treated as integrated post-TBI syndromes. To improve risk estimation, grouping TBI complications should be investigated, to better predict TBI mortality. This study aimed to estimate mortality risk based on grouping of complications among TBI patients. Taiwan's National Health Insurance Research Database was used in this study. TBI was defined according to the International Classification of Diseases, Ninth Revision, Clinical Modification codes: 801-804 and 850-854. The association rule data mining method was used to analyze coexisting complications after TBI. The mortality risk of post-TBI complication sets with the potential risk factors was estimated using Cox regression. A total 139,254 TBI patients were enrolled in this study. Intracerebral hemorrhage was the most common complication among TBI patients. After frequent item set mining, the most common post-TBI grouping of complications comprised pneumonia caused by acute respiratory failure (ARF) and urinary tract infection, with mortality risk 1.55 (95% C. I.: 1.51-1.60), compared with those without the selected combinations. TBI patients with the combined combinations have high mortality risk, especially those aged < 20 years with septicemia, pneumonia, and ARF (HR: 4.95, 95% C. I.: 3.55-6.88). We used post-TBI complication sets to estimate mortality risk among TBI patients. According to the combinations determined by mining, especially the combination of septicemia with pneumonia and ARF, TBI patients have a 1.73-fold increased mortality risk, after controlling for potential demographic and clinical confounders. TBI patients aged<20 years with each combination of complications also have increased mortality risk. These results could provide physicians and caregivers with important information to increase their awareness about sequences of clinical syndromes among TBI patients, to prevent possible deaths among these patients.	[Ho, Chung-Han; Wang, Jhi-Joung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp Hlth Care Adm, Tainan, Taiwan; [Liang, Fu-Wen] Natl Cheng Kung Univ, Coll Med, Res Ctr Hlth Data, Tainan, Taiwan; [Liang, Fu-Wen] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan, Taiwan; [Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.; Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.; Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	kuojinnrung@gmail.com		Ho, Chung-Han/0000-0001-5925-8477; Liang, Fu-Wen/0000-0002-3396-037X	Ministry of Science and Technology (MOST), Executive Yuan, Taiwan [MOST 104-2314-6-384-006]	This study was supported by grants (MOST 104-2314-6-384-006) from the Ministry of Science and Technology (MOST), Executive Yuan, Taiwan to author CHH, JRK and JJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaranta H, 1946, WIEN MED WOCHENSCHR, V150, P444; Arabi Y, 2002, INT J QUAL HEALTH C, V14, P403, DOI 10.1093/intqhc/14.5.403; Calderon-Larranaga A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659295; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen TJ, 2003, CLIN THER, V25, P2453, DOI 10.1016/S0149-2918(03)80287-4; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng T-M, 2009, TAIWANS NATL HLTH IN, P171; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; DuGoff EH, 2014, MED CARE, V52, P688, DOI 10.1097/MLR.0000000000000166; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Faul M, 2010, TRAUMATIC BRAIN INJU, V2, P1; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Hamele M, 2016, J NEUROTRAUM, V33, P832, DOI 10.1089/neu.2015.4004; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P287, DOI 10.1016/j.apmr.2011.08.041; Howle AA, 2011, BRAIN IMPAIR, V12, P179; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hung L-C, 2016, J EPIDEMIOLOGY; Jawad I, 2012, POPULATION, V2, P4; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Launey Y, 2014, CRITICAL CARE, V18, P1; Liao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084941; Liesemer K, 2014, PEDIAT CRITICAL CARE; Lockey DJ, 1999, ANAESTHESIA, V54, P1097, DOI 10.1046/j.1365-2044.1999.00754.x; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pasquier N, 1999, LECT NOTES COMPUT SC, V1540, P398; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Piatetsky-Shapiro G., 1991, Knowledge discovery in databases, P229; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rothen HU, 2007, INTENS CARE MED, V33, P1329, DOI 10.1007/s00134-007-0690-3; Rughani AI, 2010, J NEUROSURG, V113, P585, DOI 10.3171/2009.11.JNS09857; Sanchez-Olmedo J, 2005, TRANSPLANTATION P; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Shultz SR, 2016, NEUROSCIENCE BIOBEHA; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Tu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014824; van Oostrom SH, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-61; Venturi L, 2009, J NEUROTRAUM, V26, P1547, DOI [10.1089/neu.2008.0723, 10.1089/neu.2008-0723]; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Wang LL, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-016-0580-x; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wee HY, 2016, J CLIN PSYCHIAT, V77, P505, DOI 10.4088/JCP.14m09749; Weissman C, 2000, INTENS CARE MED, V26, P1319, DOI 10.1007/s001340000612; Wu MP, 2014, STROKE, V45, P1349, DOI 10.1161/STROKEAHA.113.003675; Yasseen B, 2008, BRAIN INJURY, V22, P752, DOI 10.1080/02699050802320132	59	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e190683	10.1371/journal.pone.0190683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BJ	WOS:000419952400047	29324771	Green Published, gold, Green Submitted			2022-02-06	
J	Guay, S; De Beaumont, L; Drisdelle, BL; Lina, JM; Jolicoeur, P				Guay, Samuel; De Beaumont, Louis; Drisdelle, Brandi Lee; Lina, Jean-Marc; Jolicoeur, Pierre			Electrophysiological impact of multiple concussions in asymptomatic athletes: A re-analysis based on alpha activity during a visual-spatial attention task	NEUROPSYCHOLOGIA			English	Article						Concussion; Long-term effects; Cumulative effects; EEG; Alpha; Event-related spectral perturbations	TRAUMATIC BRAIN-INJURY; EVENT-RELATED DESYNCHRONIZATION; SPORT-RELATED CONCUSSION; WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; FOOTBALL PLAYERS; EEG ALPHA; OSCILLATIONS; FREQUENCY; BAND	Most EEG studies used event-related potentials to assess long-term and cumulative effects of sport-related concussions on brain activity. Time-frequency methods provide another approach that allows the detection of subtle shifts in types and patterns of brain oscillations. We sought to discover whether event-related alpha activity would be significantly affected in asymptomatic multi-concussed athletes. We measured the amplitude of alpha activity (8-12 Hz) from the EEG recorded during a visual-spatial attention task to compare event-related alpha perturbations in 13 multi-concussed athletes and 14 age-equivalent, non-concussed teammates. Relative to non-concussed athletes, multi-concussed athletes showed significantly less event-related perturbations time locked to stimulus presentation. Alpha activity alterations were closely related to the number of concussions sustained. Event-related alpha activity differed in asymptomatic multi-concussed athletes when compared to controls. Our study suggests that low-level neurophysiological underpinnings of the deployment of visual-spatial attention are affected in multi-concussed athletes even though their last concussion occurred on average 30 months prior to testing.	[Guay, Samuel] Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ, Canada; [Guay, Samuel; De Beaumont, Louis; Lina, Jean-Marc] Hop Sacre Coeur Montreal, Ctr Rech, Montreal, PQ, Canada; [De Beaumont, Louis] Univ Montreal, Dept Surg, Montreal, PQ, Canada; [Drisdelle, Brandi Lee; Jolicoeur, Pierre] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Drisdelle, Brandi Lee; Jolicoeur, Pierre] Univ Montreal, Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [Lina, Jean-Marc] Montreal Polytech, Montreal, PQ, Canada; [Jolicoeur, Pierre] Inst Univ Geriat Montreal, Ctr Rech, Montreal, PQ, Canada		Jolicoeur, P (corresponding author), Univ Montreal, Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	pierre.jolicoeur@umontreal.ca		Guay, Samuel/0000-0001-6990-839X			Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Babiloni C, 2010, BRAIN RES BULL, V81, P149, DOI 10.1016/j.brainresbull.2009.10.014; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Bastos AM, 2015, NEURON, V85, P390, DOI 10.1016/j.neuron.2014.12.018; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Brookes MJ, 2005, NEUROIMAGE, V26, P302, DOI 10.1016/j.neuroimage.2005.01.050; Caravaglios G, 2015, J NEURAL TRANSM, V122, P441, DOI 10.1007/s00702-014-1262-7; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Chen LZ, 2016, NEUROSCI BIOBEHAV R, V68, P838, DOI 10.1016/j.neubiorev.2016.07.022; Chiang AKI, 2011, CLIN NEUROPHYSIOL, V122, P1505, DOI 10.1016/j.clinph.2011.01.040; Chu CJ, 2015, NEUROIMAGE, V108, P23, DOI 10.1016/j.neuroimage.2014.12.033; Ciulla C, 1999, BRAIN TOPOGR, V11, P211, DOI 10.1023/A:1022233828999; Cortese S, 2012, CURR PSYCHIAT REP, V14, P568, DOI 10.1007/s11920-012-0310-y; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2013, J CLIN EXP NEUROPSYC, V35, P596, DOI 10.1080/13803395.2013.800023; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Deiber MP, 2015, J ALZHEIMERS DIS, V47, P335, DOI 10.3233/JAD-150111; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Drisdelle BL, 2017, PSYCHOPHYSIOLOGY, V54, P83, DOI 10.1111/psyp.12675; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Feher KD, 2016, JOVE-J VIS EXP, DOI 10.3791/53527; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Frey JN, 2015, BRAIN RES, V1626, P183, DOI 10.1016/j.brainres.2015.02.017; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gomarus HK, 2009, CLIN NEUROPHYSIOL, V120, P73, DOI 10.1016/j.clinph.2008.10.017; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haegens S, 2014, NEUROIMAGE, V92, P46, DOI 10.1016/j.neuroimage.2014.01.049; Haenschel C, 2009, J NEUROSCI, V29, P9481, DOI 10.1523/JNEUROSCI.1428-09.2009; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Heida T, 2014, CLIN NEUROPHYSIOL, V125, P1819, DOI 10.1016/j.clinph.2014.01.016; Helfrich RF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002031; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Henry LC, 2016, NEUROSCIENTIST; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hindriks R, 2015, NEUROIMAGE, V106, P328, DOI 10.1016/j.neuroimage.2014.10.057; Hogan MJ, 2003, INT J PSYCHOPHYSIOL, V49, P147, DOI 10.1016/S0167-8760(03)00118-1; Jann K, 2012, BRAIN CONNECT, V2, P11, DOI 10.1089/brain.2011.0063; Kelly JP, 1997, NEUROLOGY, V48, P581; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Ledwidge P. S., 2016, J NEUROTRAUMA; Lilly JM, 2017, P ROY SOC A-MATH PHY, V473, DOI 10.1098/rspa.2016.0776; Lilly JM, 2010, IEEE T INFORM THEORY, V57, P4135, DOI 10.1109/TIT.2010.2050935; Limbach K., 2016, PSYCHOPHYSIOLOGY, V53, P1154; MacLean MH, 2011, BRAIN RES, V1387, P99, DOI 10.1016/j.brainres.2011.02.069; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2017, BR J SPORTS MED; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Missonnier P, 2013, NEUROSCIENCE, V241, P135, DOI 10.1016/j.neuroscience.2013.03.011; Molfese DL, 2015, DEV NEUROPSYCHOL, V40, P1, DOI 10.1080/87565641.2015.1006479; Monto S, 2007, CEREB CORTEX, V17, P1386, DOI 10.1093/cercor/bhl049; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Nunez PL, 2015, CLIN NEUROPHYSIOL, V126, P110, DOI 10.1016/j.clinph.2014.04.003; Nunez PL, 2014, BRAIN RES, V1542, P138, DOI 10.1016/j.brainres.2013.10.036; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Olhede SC, 2002, IEEE T SIGNAL PROCES, V50, P2661, DOI 10.1109/TSP.2002.804066; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Paloyelis Yannis, 2007, Expert Rev Neurother, V7, P1337, DOI 10.1586/14737175.7.10.1337; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Peng WW, 2015, BEHAV BRAIN RES, V295, P71, DOI 10.1016/j.bbr.2015.04.051; Peng WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034163; Pfurtscheller G, 2003, EPILEPSIA, V44, P2, DOI 10.1111/j.0013-9580.2003.12001.x; PFURTSCHELLER G, 1994, INT J PSYCHOPHYSIOL, V16, P147, DOI 10.1016/0167-8760(89)90041-X; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Popescu M, 2016, CLIN NEUROPHYSIOL, V127, P3075, DOI 10.1016/j.clinph.2016.06.004; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Scholvinck ML, 2013, NEUROIMAGE, V80, P297, DOI 10.1016/j.neuroimage.2013.04.010; Schutter DJLG, 2016, NEUROPSYCHOLOGIA, V86, P110, DOI 10.1016/j.neuropsychologia.2016.04.011; SERGEANT J, 1987, PSYCHOPHYSIOLOGY, V24, P272, DOI 10.1111/j.1469-8986.1987.tb00294.x; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tenke CE, 2015, INT J PSYCHOPHYSIOL, V97, P299, DOI 10.1016/j.ijpsycho.2015.05.011; ter Huurne N, 2013, BIOL PSYCHIAT, V74, P227, DOI 10.1016/j.biopsych.2013.02.001; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Thut G, 2011, CURR BIOL, V21, P1176, DOI 10.1016/j.cub.2011.05.049; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; van Albada SJ, 2010, CLIN NEUROPHYSIOL, V121, P21, DOI 10.1016/j.clinph.2009.09.021; van Diepen RM, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0204-16.2016; Veniero D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00477; Vossen A, 2015, BRAIN STIMUL, V8, P499, DOI 10.1016/j.brs.2014.12.004; Vosskuhl J, 2015, NEUROIMAGE; White RD, 2014, SPORTS HEALTH, V6, P149, DOI 10.1177/1941738113484679; Wu ZM, 2017, NEUROPSYCHOPHARMACOL, V42, P572, DOI 10.1038/npp.2016.223; Yordanova J, 2001, PSYCHOPHYSIOLOGY, V38, P143, DOI 10.1017/S0048577201990079	111	7	8	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JAN 8	2018	108						42	49		10.1016/j.neuropsychologia.2017.11.022			8	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	FU1YD	WOS:000423644500006	29162458	Green Accepted			2022-02-06	
J	Poiani, GDR; Zaninotto, AL; Carneiro, AMC; Zangaro, RA; Salgado, ASI; Parreira, RB; de Andrade, AF; Teixeira, MJ; Paiva, WS				Ribeiro Poiani, Guilherme da Cruz; Zaninotto, Ana Luiza; Costa Carneiro, Ana Maria; Zangaro, Renato Amaro; Inoue Salgado, Afonso Shiguemi; Parreira, Rodolfo Borges; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva			Photobiomodulation using low-level laser therapy (LLLT) for patients with chronic traumatic brain injury: a randomized controlled trial study protocol	TRIALS			English	Article						Traumatic brain injury; Cognition; Memory; Depression; Anxiety; Photobiomodulation; Rehabilitation	LIGHT THERAPY; COGNITIVE IMPAIRMENT; ISCHEMIC-STROKE; VERBAL FLUENCY; NITRIC-OXIDE; LED THERAPY; EPIDEMIOLOGY; STIMULATION; MEMORY; DISSOCIATION	Background: Photobiomodulation using low-level laser therapy (LLLT) has been tested as a new technique to optimize recovery of patients with traumatic brain injury (TBI). The aim of this study is to evaluate inhibitory attentional control after 18 sessions of active LLLT and compare with the placebo group (sham LLLT). Our exploratory analysis will evaluate the efficacy of the active LLLT on verbal and visuospatial episodic memory, executive functions (working memory, verbal and visuospatial fluency, attentional processes), and anxiety and depressive symptoms compared to the sham group. Methods/Design: A randomized double-blinded trial will be made in 36 patients with moderate and severe TBI. The active LLLT will use an optical device composed of LEDs emitting 632 nm of radiation at the site with full potency of 830 mW. The cranial region with an area of 400 cm(2) will be irradiated for 30 min, giving a total dose per session of 3. 74 J/cm(2). The sham LLLT group contains only an LED device with power < 1 mW, only serving to simulate the irradiation. Each patient will be irradiated three times per week for six weeks, totaling 18 sessions. Neuropsychological assessments will be held one week before the beginning of the sessions, after one week, and three months after the end of LLLT sessions. Memory domain, attention, executive functioning, and visual construction will be evaluated, in addition to symptoms of depression, anxiety, and social demographics. Discussion: LLLT has been demonstrated as a safe and effective technique in significantly improving the memory, attention, and mood performance in healthy and neurologic patients. We expect that our trial can complement previous finds, as an effective low-cost therapy to improve cognitive sequel after TBI.	[Zaninotto, Ana Luiza] Univ Sao Paulo, Div Psychol, Hosp Clin, Med Sch, Sao Paulo, Brazil; [Ribeiro Poiani, Guilherme da Cruz; Zaninotto, Ana Luiza; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Div Neurosurg, Med Sch, Ave Dr Arnaldo,455 Cerqueira Cesar, BR-01246903 Sao Paulo, SP, Brazil; [Costa Carneiro, Ana Maria; Zangaro, Renato Amaro] Anhembi Morumbi Univ, Inst Biomed Engn, Sao Jose Dos Campos, SP, Brazil; [Inoue Salgado, Afonso Shiguemi; Parreira, Rodolfo Borges] Salgado Inst Integral Hlth, Sch Postural & Manual Therapy, Londrina, Parana, Brazil; [Zangaro, Renato Amaro] Ctr Innovat Technol & Educ CTE, Sao Jose Dos Campos, SP, Brazil		Poiani, GDR (corresponding author), Univ Sao Paulo, Div Neurosurg, Med Sch, Ave Dr Arnaldo,455 Cerqueira Cesar, BR-01246903 Sao Paulo, SP, Brazil.	comporta.saude@gmail.com	Parreira, Rodolfo/AAH-6459-2019; Zaninotto, Ana Luiza C./I-4095-2016; Paiva, Wellingson S/G-5517-2013; Zangaro, Renato/K-5961-2015	Parreira, Rodolfo/0000-0003-2597-1172; Zaninotto, Ana Luiza C./0000-0003-0639-0612; Paiva, Wellingson S/0000-0002-5165-7040; Zangaro, Renato/0000-0001-6962-3001			Antunes F, 2004, P NATL ACAD SCI USA, V101, P16774, DOI 10.1073/pnas.0405368101; Barrett DW, 2013, NEUROSCIENCE, V230, P13, DOI 10.1016/j.neuroscience.2012.11.016; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck AT, 1993, BECK ANXIETY INVENTO; Burik TE, 1950, J PSYCHOL, V30, P33, DOI 10.1080/00223980.1950.9916049; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Costa TL, 2015, NEUROPSYCHOLOGIA, V78, P142, DOI 10.1016/j.neuropsychologia.2015.10.008; de Andrade AF, 2009, REV ASSOC MED BRAS, V55, P75, DOI 10.1590/S0104-42302009000100020; Esbjornsson E, 2013, BRAIN INJURY, V27, P521, DOI 10.3109/02699052.2012.743179; Fitzgerald PB, 2011, J ECT, V27, P38, DOI 10.1097/YCT.0b013e3181eb30c6; Haeussinger FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026377; Hennessy M, 2017, J OPTICS-UK, V19, DOI 10.1088/2040-8986/19/1/013003; Huang YY, 2012, J BIOPHOTONICS, V5, P827, DOI 10.1002/jbio.201200077; Kamal VK, 2016, J NEUROSCI RURAL PRA, V7, P515, DOI 10.4103/0976-3147.188637; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; KARU TI, 1986, DOKL AKAD NAUK SSSR+, V291, P1245; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kushner DS, 2014, J REHABIL RES DEV, V51, P1057, DOI 10.1682/JRRD.2014.01.0002; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Lavery LA, 2008, DIABETES CARE, V31, P316, DOI 10.2337/dc07-1794; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; Leung MCP, 2002, LASER SURG MED, V31, P283, DOI 10.1002/lsm.10096; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816; Malloy-Diniz LF, 2007, REV BRAS PSIQUIATR, V29, P324, DOI 10.1590/S1516-44462006005000053; MCLEOD DR, 1982, BEHAV RES METH INSTR, V14, P463, DOI 10.3758/BF03203313; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Naeser M, 2012, PROCD SOC BEHV, V61, P138, DOI 10.1016/j.sbspro.2012.10.116; Naeser MA, 2016, PHOTOMED LASER SURG, V34, P610, DOI 10.1089/pho.2015.4037; Naeser MA, 2015, PHOTOMED LASER SURG, V33, P443, DOI 10.1089/pho.2015.3986; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Nascimento E, 2005, ESCALA INTELIGENCIA; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; NISSAN M, 1986, LASER SURG MED, V6, P435, DOI 10.1002/lsm.1900060502; Oron U, 2001, CIRCULATION, V103, P296; Peeters S, 2017, WORLD NEUROSURG, V97, P580, DOI 10.1016/j.wneu.2016.09.127; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Rey A., 2010, FIGURAS COMPLEXAS RE; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rojas JC, 2013, BIOCHEM PHARMACOL, V86, P447, DOI 10.1016/j.bcp.2013.06.012; Rojas JC, 2012, J ALZHEIMERS DIS, V32, P741, DOI 10.3233/JAD-2012-120817; de Almeida CER, 2016, WORLD NEUROSURG, V87, P540, DOI 10.1016/j.wneu.2015.10.020; Saltmarche AE, 2017, PHOTOMED LASER SURG, V35, P432, DOI 10.1089/pho.2016.4227; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Smith KC, 2005, PHOTOMED LASER SURG, V23, P78, DOI 10.1089/pho.2005.23.78; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Thunshelle C, 2016, PHOTOMED LASER SURG, V34, P587, DOI 10.1089/pho.2015.4051; TOMBAUGH TN, 1992, J CLIN EXP NEUROPSYC, V14, P647, DOI 10.1080/01688639208402853; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Zaninotto AL, 2017, ACTA NEUROPSYCHIATR, V29, P35, DOI 10.1017/neu.2016.29; Zaninotto AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00095; Zaninotto AL, 2014, NEUROPSYCH DIS TREAT, V10, P1155, DOI 10.2147/NDT.S62728; Zhang Q, 2000, J BIOMED OPT, V5, P206, DOI 10.1117/1.429988	63	7	9	0	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	JAN 8	2018	19								17	10.1186/s13063-017-2414-5			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	FS2KT	WOS:000419608100007	29310710	gold, Green Published			2022-02-06	
J	Ilie, G; Adlaf, EM; Mann, RE; Ialomiteanu, A; Hamilton, H; Rehm, J; Asbridge, M; Cusimano, MD				Ilie, Gabriela; Adlaf, Edward M.; Mann, Robert E.; Ialomiteanu, Anca; Hamilton, Hayley; Rehm, Jurgen; Asbridge, Mark; Cusimano, Michael D.			Associations between self-reported lifetime history of traumatic brain injuries and current disability assessment in a population sample of Canadian adults	PLOS ONE			English	Article							LONG-TERM DISABILITY; UNITED-STATES; PREVALENCE; DISORDERS; WORK	Objective This study describes the association between history of lifetime traumatic brain injury (TBI) and current disabling functional restrictions among Ontario adults. Setting and design A two-stage rolling cross-sectional sample of 6,048 adults aged 18 to 93 were interviewed by computer assisted telephone interviewing between 2011-2013 regarding their mental health and substance use in Ontario, Canada. TBI criteria were defined by loss of consciousness for minimum five minutes or at least one overnight hospitalization. Dimensions of functionality restrictions in the last 30 days were measured with the WHO Disability Assessment Schedule (WHODAS). Results The estimated mean for global disability in this sample of Ontario adults was 2.75 (SD = 5.4, range 0-40). The estimated means of global disability for individuals who reported a history of lifetime TBI was 4.16 (SD = 7.12) and compared with 2.46 (SD = 4.98) for individuals who never had a TBI (p < 0.001). Adults with a history of lifetime TBI had greater odds of global and item disability including restricted cognition, decreased self-care, difficulties with social relationships, fewer life activities and reduced participation in society compared to adults without a history of TBI (p < 0.001), even after adjusting for values of age, sex, marital status, household income and education. Conclusion The co-occurrence of history of lifetime TBI with self-reported disability within the past 30 days provide evidence that careful consideration, planning and understanding of short and long term health needs of TBI survivors are critical.	[Ilie, Gabriela; Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Ilie, Gabriela; Adlaf, Edward M.; Mann, Robert E.; Ialomiteanu, Anca; Hamilton, Hayley; Rehm, Jurgen] Ctr Addict & Mental Hlth, Social & Epidemiol Res, Toronto, ON, Canada; [Adlaf, Edward M.; Mann, Robert E.; Hamilton, Hayley; Rehm, Jurgen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cusimano, Michael D.] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada		Ilie, G (corresponding author), Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada.; Ilie, G (corresponding author), Ctr Addict & Mental Hlth, Social & Epidemiol Res, Toronto, ON, Canada.	Gabriela.Ilie@dal.ca	Ilie, Gabriela/AAM-9122-2021; Cusimano, Michael/X-4059-2019; Ilie, Gabriela/J-6066-2014	Ilie, Gabriela/0000-0002-1602-6374	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation; AUTO21; Natural Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC); Social Sciences and Humanities Research CouncilSocial Sciences and Humanities Research Council of Canada (SSHRC); Industry Canada; Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario	This work was financially supported by a STAIR Team Grant from the Canadian Institutes of Health Research (# TIR-103946; MC, RM, MA, GI) and by the Ontario Neurotrauma Foundation. Additional funding was obtained from a grant from AUTO21, a member of the Networks of Centres of Excellence program that is administered and funded by the Natural Sciences and Engineering Research Council, the Social Sciences and Humanities Research Council, in partnership with Industry Canada, and ongoing funding support from the Ontario Ministry of Health and Long-Term Care (RM). The funding agencies had no role in design and conduct of the study, the collection, management, analysis and interpretation of the data, or the preparation, review or approval of the manuscript.	Aharony L, 1993, Med Care Rev, V50, P49, DOI 10.1177/002570879305000104; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Bayona N, 2008, EVIDENCE BASED REV M; Richmond Jonathan Y, 2002, MMWR Recomm Rep, V51, P1; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; De Wolf AC, 2012, J REHABIL MED, V44, P747, DOI 10.2340/16501977-1016; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Ialomiteanu A., 2014, CAMH MONITOR 2013 ME; Ialomiteanu AR., 2014, CAMH RES DOCUMENT SE, V40; Ilie G, 2014, BULLYING OTHER CONDU, V9, P10, DOI DOI 10.1371/J0URNAL.P0NE.0094936; Ilie G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135860; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Ilie G, 2015, ACCIDENT ANAL PREV, V81, P1, DOI 10.1016/j.aap.2015.04.021; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Korn E.L., 1999, ANAL HLTH SURVEYS; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; Luciano JV, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-45; Morrell R.F., 1998, J OFFENDER REHABIL, V27, P1, DOI [DOI 10.1300/J076V27N03_01, https://doi.org/10.1300/J076v27n03_01]; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Scott SG, 2005, FEDERAL PRACTITIONER, V22, P67; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sjonnesen K, 2016, CAN J PSYCHIAT, V61, P227, DOI 10.1177/0706743716632514; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Svestkova O, 2010, DISABIL REHABIL, V32, pS68, DOI 10.3109/09638288.2010.511690; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Toft AMH, 2010, J TRAUMA, V69, P26, DOI 10.1097/TA.0b013e3181d3cbf2; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; World Health Organization, WHO DISABILITY ASSES; Yen CF, 2014, J FORMOS MED ASSOC, V113, P839, DOI 10.1016/j.jfma.2014.08.008; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2018	13	1							e0188908	10.1371/journal.pone.0188908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR9OU	WOS:000419403800014	29304117	gold, Green Published, Green Submitted			2022-02-06	
J	Chiampas, GT; Kirkendall, DT				Chiampas, George T.; Kirkendall, Donald T.			Point-counterpoint: should heading be restricted in youth football? Yes, heading should be restricted in youth football	SCIENCE AND MEDICINE IN FOOTBALL			English	Article						Concussion; heading; restriction		There is probably no issue in sports that is more divisive than head injury. The first report of chronic traumatic encephalopathy (CTE) in a retired National Football League player12 showed us a reason for the memory loss, confusion, impaired judgment, impulse control problems, aggression, depression, suicidality, Parkinsonism, and eventually progressive dementia described by the families of (mostly) retired contact or collision sport athletes. Hardly a week goes by without some media outlet asking whether a child or adolescent is going to develop CTE after a concussive injury in sports. Parents of children interested in playing sports are left to choose between prohibiting their children from playing some sports or moving them to sports they believe is safer.	[Chiampas, George T.; Kirkendall, Donald T.] US Soccer, Chicago, IL 60616 USA; [Kirkendall, Donald T.] Sports Med Res Educ & Advisory Comm, Chicago, IL USA		Chiampas, GT (corresponding author), US Soccer, Chicago, IL 60616 USA.	GChiampas@ussoccer.org					Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Beaudouin F, 2017, BR J SPORTS MED; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Faude O, 2017, SCAND J MED SCI SPOR, V27, P1986, DOI 10.1111/sms.12839; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hrysomallis C, 2016, SPORTS MED, V46, P1111, DOI 10.1007/s40279-016-0490-4; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Lisman P., 2012, INT J SPORTS SCI ENG, V6, P131; Mansell J, 2005, J ATHL TRAINING, V40, P310; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Rossler R, 2016, AM J SPORT MED, V44, P309, DOI 10.1177/0363546515614816; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA	25	7	7	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2473-3938	2473-4446		SCI MED FOOTBALL	Sci. Med. Football	JAN 2	2018	2	1					80	82		10.1080/24733938.2017.1421771			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	VJ2RA	WOS:000562857700014					2022-02-06	
J	Aalling, N; Hageman, I; Miskowiak, K; Orlowski, D; Wegener, G; Wortwein, G				Aalling, Nadia; Hageman, Ida; Miskowiak, Kamilla; Orlowski, Dariusz; Wegener, Gregers; Wortwein, Gitta			Erythropoietin prevents the effect of chronic restraint stress on the number of hippocampal CA3c dendritic terminalsrelation to expression of genes involved in synaptic plasticity, angiogenesis, inflammation, and oxidative stress in male rats	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						depression; animal model; allostatic load; novelty-suppressed feeding; RRID:SCR_002865	TRAUMATIC BRAIN-INJURY; APICAL DENDRITES; GLUCOCORTICOID-RECEPTOR; ADULT NEUROGENESIS; PYRAMIDAL NEURONS; INDUCED ATROPHY; MOOD DISORDERS; DEPRESSION; BEHAVIOR; HYPOXIA	Stress-induced allostatic load affects a variety of biological processes including synaptic plasticity, angiogenesis, oxidative stress, and inflammation in the brain, especially in the hippocampus. Erythropoietin (EPO) is a pleiotropic cytokine that has shown promising neuroprotective effects. Recombinant human EPO is currently highlighted as a new candidate treatment for cognitive impairment in neuropsychiatric disorders. Because EPO enhances synaptic plasticity, attenuates oxidative stress, and inhibits generation of proinflammatory cytokines, EPO may be able to modulate the effects of stress-induced allostatic load at the molecular level. The aim of this study was therefore to investigate how EPO and repeated restraint stress, separately and combined, influence (i) behavior in the novelty-suppressed feeding test of depression/anxiety-related behavior; (ii) mRNA levels of genes encoding proteins involved in synaptic plasticity, angiogenesis, oxidative stress, and inflammation; and (iii) remodeling of the dendritic structure of the CA3c area of the hippocampus in male rats. As expected, chronic restraint stress lowered the number of CA3c apical dendritic terminals, and EPO treatment reversed this effect. Interestingly, these effects seemed to be mechanistically distinct, as stress and EPO had differential effects on gene expression. While chronic restraint stress lowered the expression of spinophilin, tumor necrosis factor , and heat shock protein 72, EPO increased expression of hypoxia-inducible factor-2 and lowered the expression of vascular endothelial growth factor in hippocampus. These findings indicate that the effects of treatment with EPO follow different molecular pathways and do not directly counteract the effects of stress in the hippocampus.	[Aalling, Nadia; Hageman, Ida; Wortwein, Gitta] Rigshosp, Psychiat Ctr Copenhagen, Lab Neuropsychiat, Copenhagen, Denmark; [Aalling, Nadia; Hageman, Ida; Wortwein, Gitta] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Miskowiak, Kamilla] Copenhagen Univ Hosp, Rigshosp, Psychiat Ctr Copenhagen, Copenhagen Affect Disorder Res Ctr, Copenhagen, Denmark; [Miskowiak, Kamilla] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Orlowski, Dariusz] Univ Aarhus, Dept Clin Med, Ctr Expt Neurosci Cense, Aarhus, Denmark; [Wegener, Gregers] Univ Aarhus, Dept Clin Med, Translat Neuropsychiat Unit, Aarhus, Denmark; [Wegener, Gregers] North West Univ, Ctr Excellence Pharmaceut Sci, Potchefstroom Campus, Potchefstroom, South Africa; [Wortwein, Gitta] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark		Wortwein, G (corresponding author), Rigshosp 6102, Lab Neuropsychiat, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	giwo@sund.ku.dk	Aalling, Nadia/AAG-5669-2020; Wegener, Gregers/A-1019-2011; Wegener, Gregers/Z-3945-2019	Wegener, Gregers/0000-0002-0081-0068; Miskowiak, Kamilla/0000-0003-2572-1384; Wortwein, Gitta/0000-0001-6981-7885; Aalling, Nadia/0000-0001-6995-1590	Lundbeck FoundationLundbeckfonden; Psychiatric Center Copenhagen Research Foundation; Ivan Nielsen Foundation; Savvaerksejer Jeppe Juhl & Hustru Ovita Juhls Mindelegat; Ideas Initiative (eMOOD) of the University of Aarhus; Weimann Foundation	Financial support for the study was provided by the Lundbeck Foundation, the Psychiatric Center Copenhagen Research Foundation, the Ivan Nielsen Foundation, Savvaerksejer Jeppe Juhl & Hustru Ovita Juhls Mindelegat, and the Ideas Initiative (eMOOD) of the University of Aarhus. Half of K.M.'s salary was provided by the Lundbeck Foundation from 2012 to 2015 and by the Weimann Foundation from 2015 to present.	Adamcio B, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-37; Alnaeeli Mawadda, 2012, Anat Res Int, V2012, P953264, DOI 10.1155/2012/953264; Ampuero E, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv038; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bang ML, 2013, NEUROCHEM RES, V38, P1174, DOI 10.1007/s11064-013-1029-9; Bartolomucci A, 2003, BRAIN RES BULL, V62, P173, DOI 10.1016/j.brainresbull.2003.09.009; Beleslin-Cokic BB, 2004, BLOOD, V104, P2073, DOI 10.1182/blood-2004-02-0744; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; BRADLEY BP, 1995, BEHAV RES THER, V33, P755, DOI 10.1016/0005-7967(95)00029-W; Brines M, 2012, MOL MED, V18, P486, DOI 10.2119/molmed.2011.00414; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; Calabrese V, 2004, MECH AGEING DEV, V125, P325, DOI 10.1016/j.mad.2004.01.003; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; El-Kordi A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-37; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Girgenti MJ, 2009, BIOL PSYCHIAT, V66, P267, DOI 10.1016/j.biopsych.2008.12.005; Gray JD, 2014, MOL PSYCHIATR, V19, P1171, DOI 10.1038/mp.2013.175; Grippo AJ, 2005, PHYSIOL BEHAV, V84, P697, DOI 10.1016/j.physbeh.2005.02.011; Guidotti G, 2013, NEUROPSYCHOPHARMACOL, V38, P616, DOI 10.1038/npp.2012.225; Hageman I, 2008, STRESS, V11, P282, DOI 10.1080/10253890701783794; Hageman I, 2009, BEHAV BRAIN RES, V196, P71, DOI 10.1016/j.bbr.2008.07.037; Harmer CJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0407; Hassouna I, 2016, MOL PSYCHIATR, V21, P1752, DOI 10.1038/mp.2015.212; Hayley S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00218; Law AJ, 2004, AM J PSYCHIAT, V161, P1848, DOI 10.1176/appi.ajp.161.10.1848; Leconte C, 2011, NEUROPHARMACOLOGY, V60, P354, DOI 10.1016/j.neuropharm.2010.09.025; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Luine Victoria, 1996, Physiology and Behavior, V59, P27, DOI 10.1016/0031-9384(95)02016-0; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; McEwen BS, 2010, HORM BEHAV, V57, P105, DOI 10.1016/j.yhbeh.2009.09.011; Mengozzi M, 2012, P NATL ACAD SCI USA, V109, P9617, DOI 10.1073/pnas.1200554109; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Miskowiak KW, 2014, NEUROPSYCHOPHARMACOL, V39, P1399, DOI 10.1038/npp.2013.335; Miskowiak KW, 2012, PSYCHOPHARMACOLOGY, V219, P687, DOI 10.1007/s00213-011-2511-1; Miu AC, 2004, BEHAV BRAIN RES, V155, P223, DOI 10.1016/j.bbr.2004.04.019; Nakano M, 2007, CIRC RES, V100, P662, DOI 10.1161/01.RES.0000260179.43672.fe; Newton SS, 2013, CELL MOL LIFE SCI, V70, P1739, DOI 10.1007/s00018-013-1281-9; Orlowski D, 2012, STRESS, V15, P514, DOI 10.3109/10253890.2011.643516; Orlowski D, 2009, HISTOCHEM CELL BIOL, V132, P369, DOI 10.1007/s00418-009-0611-3; Osborn M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072813; Rao A, 2000, NAT NEUROSCI, V3, P747, DOI 10.1038/77636; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Sargin D, 2010, BEST PRACT RES-CLIN, V24, P573, DOI 10.1016/j.bpa.2010.10.005; Sato M, 2002, AM J RESP CELL MOL, V26, P127, DOI 10.1165/ajrcmb.26.1.4319; Sattler MB, 2004, CELL DEATH DIFFER, V11, pS181, DOI 10.1038/sj.cdd.4401504; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Sriram K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042958; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; Wang B, 2016, NEUROTHERAPEUTICS, V13, P418, DOI 10.1007/s13311-015-0418-y; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WEN D, 1993, BLOOD, V82, P1507; You ZL, 2011, BEHAV BRAIN RES, V225, P135, DOI 10.1016/j.bbr.2011.07.006	72	7	9	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JAN	2018	96	1					103	116		10.1002/jnr.24107			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FX1KZ	WOS:000425811000011	28752903				2022-02-06	
J	Adams, SM; Conley, YP; Ren, DX; Okonkwo, DO; Puccio, AM; Dixon, CE; Clark, RSB; Kochanek, PM; Empey, PE				Adams, Solomon M.; Conley, Yvette P.; Ren, Dianxu; Okonkwo, David O.; Puccio, Ava M.; Dixon, C. Edward; Clark, Robert S. B.; Kochanek, Patrick M.; Empey, Philip E.			ABCG2 c.421C > A Is Associated with Outcomes after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; genetic factors; human studies; outcome measures; traumatic brain injury	SINGLE NUCLEOTIDE POLYMORPHISMS; URIC-ACID LEVELS; TRANSPORTERS; MICROGLIA; DISEASE; VARIANT; SERUM	Traumatic brain injury (TBI) is a leading cause of death with no pharmacological treatments that improve outcomes. Transporter proteins participate in TBI recovery by maintaining the central nervous system (CNS) biochemical milieu. Genetic variations in transporters that alter expression and/or function have been associated with TBI outcomes. The ATP-binding cassette transporter, ABCG2, is a uric acid (UA) transporter that effluxes UA from cells in the CNS and is responsible for systemic UA clearance. Uric acid is a CNS antioxidant and/or a biomarker that might support TBI recovery. Our objective was to investigate the impact of ABCG2 SNP: c.421C>A on TBI outcomes. Two cohorts (discovery [N=270] and replication [N=166]) were genotyped for ABCG2 c.421C>A. Glasgow Outcome Scale (GOS) scores were collected at 3, 6, 12, and 24 months post-injury and compared with mixed-effects multiple ordinal regression controlled for time post-injury, age, sex, time, post-injury imaging determined hemorrhage types, and Glasgow Coma Scale score. Variant alleles (genotype) were associated with better GOS scores (p=0.01 [discovery] and p=0.02 [replication]), whereas genotype*age interaction was associated with worse GOS scores (p=0.03 [discovery] and p=0.01 [replication]). Reversed coefficient directionality suggests variant allele(s) are protective up to approximately age 34 years. Overall, variant alleles at ABCG2 c.421C>A associate with better GOS scores post-injury in two independently sampled cohorts. This finding is mitigated by increasing subject age. This suggests that ABCG2 might have an age-dependent effect on TBI recovery and should be explored in future mechanistic studies.	[Adams, Solomon M.] Univ Pittsburgh, Sch Pharm, Pharmaceut Sci, Pittsburgh, PA USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Hlth Promot & Dev, Pittsburgh, PA 15261 USA; [Conley, Yvette P.] Univ Pittsburgh, Grad Sch Publ Hlth, Human Genet, Pittsburgh, PA USA; [Ren, Dianxu] Univ Pittsburgh, Sch Nursing, Hlth & Community Syst, Pittsburgh, PA 15261 USA; [Okonkwo, David O.; Puccio, Ava M.; Dixon, C. Edward] Univ Pittsburgh, Sch Med, Neurol Surg, Pittsburgh, PA USA; [Dixon, C. Edward; Clark, Robert S. B.; Kochanek, Patrick M.; Empey, Philip E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Empey, Philip E.] Univ Pittsburgh, Sch Pharm, Pharm & Therapeut, 205 Salk Pavil,335 Sutherland Dr, Pittsburgh, PA 15261 USA		Empey, PE (corresponding author), Univ Pittsburgh, Sch Pharm, Pharm & Therapeut, 205 Salk Pavil,335 Sutherland Dr, Pittsburgh, PA 15261 USA.	pempey@pitt.edu	Empey, Philip/L-9604-2019; Adams, Solomon/AAX-6743-2021	Empey, Philip/0000-0001-7474-2339; Adams, Solomon/0000-0002-5583-0322; Conley, Yvette/0000-0002-1784-6067	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1TL1 TR001858-01, R01 NR013342, KL2 TR000146]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001858] Funding Source: NIH RePORTER	Support for this research from grants from the National Institutes of Health 1TL1 TR001858-01 (to S.M.A.), R01 NR013342 (to Y.P.C.), and KL2 TR000146 (to P.E.E.) for grant support. We also acknowledge the contribution of Sandra Deslouches for running the TaqMan assays and abstracting data from the CoreExome panel and the University of Pittsburgh Genomics Research Core for running the Core Exome panel.	Abuznait AH, 2012, ACS CHEM NEUROSCI, V3, P820, DOI 10.1021/cn300077c; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Chamorro A, 2014, LANCET NEUROL, V13, P453, DOI 10.1016/S1474-4422(14)70054-7; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Christensen R.H.B., ORDINAL REGRESSION M, P6, DOI DOI 10.1016/S0022-5371(72)80001-X; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cousar JL, 2013, NEUROCRIT CARE, V19, P192, DOI 10.1007/s12028-013-9881-7; Crain JM, 2013, J NEUROSCI RES, V91, P1143, DOI 10.1002/jnr.23242; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; Fang Pu, 2013, Brain Disord Ther, V2, P109; Feher A, 2013, NEUROSCI LETT, V550, P51, DOI 10.1016/j.neulet.2013.06.044; Furukawa T, 2009, PHARM RES-DORDR, V26, P469, DOI 10.1007/s11095-008-9752-7; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jackson EK, 2016, J NEUROCHEM, V137, P142, DOI 10.1111/jnc.13551; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jha RM, 2017, NEUROCRIT CARE, V26, P213, DOI 10.1007/s12028-016-0309-z; Jullienne A, 2014, J CEREBR BLOOD F MET, V34, P1637, DOI 10.1038/jcbfm.2014.124; Kuzuya M, 2002, J GERONTOL A-BIOL, V57, pM660, DOI 10.1093/gerona/57.10.M660; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lu J, 2012, J NEUROTRAUM, V29, P719, DOI 10.1089/neu.2010.1746; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Maetzler W, 2011, J ALZHEIMERS DIS, V27, P119, DOI 10.3233/JAD-2011-110587; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Mahringer A, 2016, EXPERT OPIN DRUG MET, V12, P499, DOI 10.1517/17425255.2016.1168804; Matsuo H, 2015, ANN CLIN TRANSL NEUR, V2, P302, DOI 10.1002/acn3.167; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Sanchez-Covarrubias L, 2014, CURR PHARM DESIGN, V20, P1422, DOI 10.2174/13816128113199990463; Tamura A, 2007, CANCER SCI, V98, P231, DOI 10.1111/j.1349-7006.2006.00371.x; Tayag EC, 1996, BRAIN RES, V733, P287, DOI 10.1016/0006-8993(96)00669-5; Tomioka NH, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0046-x	34	7	8	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					48	53		10.1089/neu.2017.5000			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000419569700007	28747144	Green Published			2022-02-06	
J	Aidinoff, E; Groswasser, Z; Bierman, U; Gelernter, I; Catz, A; Gur-Pollack, R				Aidinoff, Elena; Groswasser, Zeev; Bierman, Uri; Gelernter, Ilana; Catz, Amiram; Gur-Pollack, Rotem			Vegetative state outcomes improved over the last two decades	BRAIN INJURY			English	Article						Unawareness; brain injury; disorders of consciousness	MINIMALLY CONSCIOUS STATE; PROLONGED POSTTRAUMATIC UNAWARENESS; TRAUMATIC BRAIN-INJURY; FUNCTIONAL OUTCOMES; LATE RECOVERY; REHABILITATION; PROGNOSIS; MORTALITY; ETIOLOGY; DAMAGE	Objective: To describe late outcomes in patients with prolonged unawareness, and factors affecting them.Design: A retrospective study of 154 patients with traumatic brain injury (TBI) and 52 with non-traumatic brain injury (NTBI), admitted for intensive care and consciousness rehabilitation (ICCR), in a vegetative state (VS) lasting over 1 month.Results: Survival rate (67% total) was higher than in past studies carried out at the same facility (p<0.01). Consciousness recovery rate (54% total) was higher in NTBI VS patients (p<0.01) than in earlier cohorts, and similar in TBI VS patients, despite their older age than that of earlier cohorts. No meaningful differences were found in characteristics or in outcomes between the TBI and NTBI groups. Age, length of stay in ICCR, and hydrocephalus were found to affect survival (p<0.001). Younger age, absence of hydrocephalus, and anti-Parkinsonian medication contributed to consciousness recovery after VS (p<0.05).Conclusions: The present study demonstrated an improvement in survival and recovery of consciousness in VS patients over the last two decades, and similar outcomes for both TBI and NTBI VS. Outcomes suggest that acute medical care and ICCR have contributed to advances in VS care.	[Aidinoff, Elena; Groswasser, Zeev; Bierman, Uri; Catz, Amiram; Gur-Pollack, Rotem] Loewenstein Hosp & Rehabil Ctr, Raanana, Israel; [Aidinoff, Elena; Groswasser, Zeev; Gelernter, Ilana; Catz, Amiram] Tel Aviv Univ, Dept Rehabil, Tel Aviv, Israel; [Aidinoff, Elena; Groswasser, Zeev; Gelernter, Ilana; Catz, Amiram] Tel Aviv Univ, Stat Lab, Tel Aviv, Israel		Aidinoff, E (corresponding author), Loewenstein Hosp & Rehabil Ctr, Intens Care & Consciousness Rehabil Dept, 278 Achuza St, IL-43100 Raanana, Israel.	aidinofe@clalit.org.il		Catz, Amiram/0000-0002-7879-2015			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Bender A, 2015, DTSCH ARZTEBL INT, V112, P235, DOI 10.3238/arztebl.2015.0235; Borer-Alafi N, 2002, BRAIN INJURY, V16, P593, DOI 10.1080/02699050110119484; Christensen AL, 1994, BRAIN INJURY NEUROPS; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; Deininger MH, 2007, NEUROCRIT CARE, V7, P27, DOI 10.1007/s12028-007-0013-0; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Georgiopoulos M, 2010, STEREOT FUNCT NEUROS, V88, P199, DOI 10.1159/000314354; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GROSWASSER Z, 1989, ARCH PHYS MED REHAB, V70, P186; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Horsting MWB, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0041-9; JENNETT B, 1972, LANCET, V1, P734; Kim JY, 2006, J KOR NEUROTRAUMATOL, V2, P101; Krimchansky BZ, 2006, ISR MED ASSOC J, V8, P819; Krimchansky BZ, 2004, BRAIN INJURY, V18, P1099, DOI 10.1080/02699050310001646206; Levy D E, 1978, Ann N Y Acad Sci, V315, P293, DOI 10.1111/j.1749-6632.1978.tb50347.x; Liberati G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00865; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Nirel N., 2011, HAREFUAH, V78, P209; Nirel Nurit, 2011, Harefuah, V150, P72; Pagani M, 2014, J NEUROL, V261, P1144, DOI 10.1007/s00415-014-7309-8; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; SAZBON L, 1991, J NEUROL NEUROSUR PS, V54, P149, DOI 10.1136/jnnp.54.2.149; SAZBON L, 1991, ACTA NEUROCHIR, V112, P110, DOI 10.1007/BF01405137; SAZBON L, 1993, J NEUROL NEUROSUR PS, V56, P407, DOI 10.1136/jnnp.56.4.407; Schmidt JG, 1997, J NEUROL REHABIL, V11, P189; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Ugoya SO, 2010, CLIN NEUROPHARMACOL, V33, P279, DOI 10.1097/WNF.0b013e3182011070; Wu X, 2015, INT J CLIN EXP MED, V8, P19775	34	7	8	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	3					297	302		10.1080/02699052.2017.1418535			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FU3PV	WOS:000423764700002	29265938				2022-02-06	
J	Bayen, E; Jourdan, C; Ghout, I; Pradat-Diehl, P; Darnoux, E; Nelson, G; Vallat-Azouvi, C; Charenton, J; Aegerter, P; Ruet, A; Azouvi, P				Bayen, Eleonore; Jourdan, Claire; Ghout, Idir; Pradat-Diehl, Pascale; Darnoux, Emmanuelle; Nelson, Gaelle; Vallat-Azouvi, Claire; Charenton, James; Aegerter, Philippe; Ruet, Alexis; Azouvi, Philippe			Negative impact of litigation procedures on patient outcomes four years after severe traumatic brain injury: results from the PariS-traumatic brain injury study	DISABILITY AND REHABILITATION			English	Article						Severe traumatic brain injury; road traffic accident; litigation procedure; financial compensation; prognosis; PariS-traumatic brain injury study	HEAD-INJURY; COMPENSATION-SEEKING; HEALTH-STATUS; FOLLOW-UP; TBI; RECOVERY; VALIDITY; SCALE; WHIPLASH; PEOPLE	Purpose: To analyze the effect of litigation procedures on long-term outcomes in severe traumatic brain injury.Materials and methods: Prospective observational follow-up of an inception cohort including 504 adults with severe traumatic brain injury recruited in 2005-2007 in the Parisian area, France, with initial, one- and four-year outcomes measures.Results: Four years after the traumatic brain injury, 147 patients, out of 257 who survived the acute phase, were assessed. Among these patients, 53 patients declared being litigants and 78 nonlitigants (litigation status was unknown in 16 cases). Sociodemographic characteristics, type of injury and initial severity did not differ significantly between litigants and nonlitigants, except for Injury Severity Score (worse in litigants) and the proportion of road traffic accidents (higher in litigants). One- and four-year outcomes were significantly worse in litigants for autonomy, participation, psychiatric and cognitive function but not quality of life (measured with the Glasgow Outcome Scale-Extended, the working activity status, the Brain Injury Community Rehabilitation Outcome, the Hospital Anxiety and Depression scale, the Neurobehavioral Rating Scale-revised and the Quality of Life after Brain Injury, respectively). Multivariate analyses highlighted litigation procedure as an independent significant predictor of lower autonomy, participation and psychiatric function and tended to predict lower cognitive function, but not lower quality of life, after adjustment for pretrauma characteristics, Injury Severity Score, road traffic accidents and work-related accident status.Conclusions: Patients with severe traumatic brain injury have a worse prognosis when involved in a litigation procedure and require special attention in clinical practice.Implications for rehabilitationThe influence of litigation procedure on health and social outcomes in severe traumatic brain injury is a major issue that entail numerous levels of complexities.A wide range of interactions and factors related to the prolonged process of litigation against a third party may influence recovery.Results from the PariS-Traumatic Brain Injury study suggest that patients with a severe Traumatic Brain Injury who are involved in a litigation procedure within French jurisdiction compensation scheme have a worse prognosis than patients who do not.Health professionals should be aware of the potential adverse effects of litigation procedures on recovery, and provide appropriate interventions and information to patients and families in such cases.	[Bayen, Eleonore; Pradat-Diehl, Pascale] Hop La Pitie Salpetriere, AP HP, Phys Med & Rehabil Dept, Paris, France; [Bayen, Eleonore] Univ Paris 09, Hlth Econ Dept LEDa LEGOS, Paris, France; [Jourdan, Claire] CHRU, Lapeyronie Hosp, Phys Med & Rehabil Dept, Montpellier, France; [Ghout, Idir; Darnoux, Emmanuelle; Nelson, Gaelle; Aegerter, Philippe] Ambroise Pare Hosp, AP HP, Dept Biostat, UVSQ, Boulogne, France; [Ghout, Idir; Darnoux, Emmanuelle; Nelson, Gaelle; Vallat-Azouvi, Claire; Aegerter, Philippe; Azouvi, Philippe] Univ Versailles St Quentin, EA4047, Versailles, France; [Pradat-Diehl, Pascale] Univ Paris 06, Sorbonne Univ, Lab Imagerie Biomed, INSERM,U1146,UMCR2,CNRS,UMR7371, Paris, France; [Vallat-Azouvi, Claire; Azouvi, Philippe] Hop Raymond Poincare, AP HP, Phys Med & Rehabil Dept, Garches, France; [Charenton, James] CRFTC, Reg Reference Ctr Bain Injury Parisan Area, Paris, France; [Ruet, Alexis] CHU Caen, Phys Med & Rehabil Dept, Caen, France; [Ruet, Alexis] INSERM, U1077, Paris, France		Bayen, E (corresponding author), Hop La Pitie Salpetriere, Phys Med & Rehabil Dept, 47 Bd Hop, F-75013 Paris, France.	bayen.eleonore@gmail.com	AEGERTER, Philippe/AAY-6003-2021; RUET, Alexis/L-8726-2015	AEGERTER, Philippe/0000-0002-9156-5028; RUET, Alexis/0000-0002-5080-5734			Aghababian V, 2010, ENCEPHALE, V36, P139, DOI 10.1016/j.encep.2009.06.002; Azouvi P, 2015, NEUROPSYCHOL REHABIL, V25, P864, DOI 10.1080/09602011.2014.990907; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bryant B, 1997, MED SCI LAW, V37, P326, DOI 10.1177/002580249703700408; Cameron ID, 2008, SPINE, V33, P250, DOI 10.1097/BRS.0b013e31816244ed; Cameron P, 2009, INJURY, V40, P905, DOI 10.1016/j.injury.2009.06.309; Cassidy JD, 2011, INJURY, V42, P428, DOI 10.1016/j.injury.2010.11.027; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Cunningham-Hill S, 2015, CIVIL LITIGATION 201; Grant GM, 2014, JAMA PSYCHIAT, V71, P446, DOI 10.1001/jamapsychiatry.2013.4023; Hall RCW, 2012, J AM ACAD PSYCHIATRY, V40, P390; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Harrington R, 2015, BRAIN INJURY, V29, P1561, DOI 10.3109/02699052.2015.1075142; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; LEVY A, 1992, Brain Injury, V6, P401, DOI 10.3109/02699059209008136; Littleton SM, 2012, INJURY, V43, P1586, DOI 10.1016/j.injury.2011.03.002; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; Miller H., 1992, BRAIN INJURY, V6, P401; Murgatroyd DF, 2011, INJURY PREV, V17, P222, DOI 10.1136/ip.2010.029546; O'Donnell ML, 2010, MED J AUSTRALIA, V192, P328, DOI 10.5694/j.1326-5377.2010.tb03532.x; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Schaafsma FG, 2013, J REHABIL MED, V45, P446, DOI 10.2340/16501977-1135; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Spearing NM, 2012, J LAW MED, V20, P82; Spearing NM, 2011, INJURY, V42, P15, DOI 10.1016/j.injury.2009.12.009; Stulemeijer M, 2007, BRAIN INJURY, V21, P309, DOI 10.1080/02699050701209980; Suter PB, 2002, PAIN, V100, P249, DOI 10.1016/S0304-3959(02)00238-5; Sweet JJ, 2013, BEHAV SCI LAW, V31, P756, DOI 10.1002/bsl.2088; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P239, DOI 10.1016/j.acn.2005.12.004; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	7	7	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	17					2040	2047		10.1080/09638288.2017.1325522			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GI3HT	WOS:000434263100009	28508698				2022-02-06	
J	Bernstein, J; Calamia, M				Bernstein, John; Calamia, Matthew			Characteristics of a Mild Traumatic Brain Injury Sample Recruited Using Amazon's Mechanical Turk	PM&R			English	Article							HEAD-INJURY; FOOTBALL PLAYERS; CONCUSSION; KNOWLEDGE; US; PERFORMANCE; PREVENTION; RECOVERY; VALIDITY; STUDENTS	Background: Several barriers exist in the recruitment of individuals with a history of mild traumatic brain injury (mTBI). The current study is the first to examine whether crowdsourcing, which has been used in other clinical populations, is useful in the recruitment of those with mTBI. Objective: To examine whether Amazon's Mechanical Turk (MTurk), an online crowdsourcing platform, is a useful tool in the recruitment of individuals with a history of mTBI and to examine the injury and psychological characteristics of individuals who report a history of mTBI. Design: Retrospective, cross-sectional study. Setting: Online. Participants: A total of 468 MTurk workers (215 who reported mTBI history on the screener, 253 who did not). Methods: Comparison of MTurk participants ("workers") who report a history of mTBI on a one-item screener and/or a more comprehensive mTBI assessment tool (ie, the Ohio State University Traumatic Brain Injury Identification Method [OSU TBI-ID]) with workers who do not report mTBI history. Main Outcome Measures: Prevalence rates of mTBI in the MTurk sample (one-item screener and/or OSU TBI-ID), associations between self-reported mTBI with history of psychological disorders and current psychological symptoms (ie, selected Patient-Reported Outcomes Measurement Information System scales). Results: Of workers who reported a history of mTBI on the screener, 169 (79%) met mTBI criteria on the OSU TBI-ID. Compared with those who denied history of mTBI on both the screener and OSU TBI-ID, workers who reported a history of mTBI on both measures were more likely to have a history of diagnosed depression (P =.008), anxiety (P =.007) or attention deficithy-peractivity disorder (P =.04), and were more likely to currently experience cognitive (P =.01) and sleep disorder symptoms (P =.003). Conclusions: Workers recruited via MTurk with history of mTBI show similar rates of psychological disorder history and current symptoms to samples recruited via noncrowdsourcing methods in previous studies. MTurk may be a useful recruitment tool in the mTBI population and should be used in future studies of outcomes after mTBI.	[Bernstein, John; Calamia, Matthew] Louisiana State Univ, Dept Psychol, 226 Audubon Hall, Baton Rouge, LA 70803 USA		Bernstein, J (corresponding author), Louisiana State Univ, Dept Psychol, 226 Audubon Hall, Baton Rouge, LA 70803 USA.	jberns3@lsu.edu		Calamia, Matthew/0000-0002-7252-7181			Andover MS, 2014, PSYCHIAT RES, V219, P305, DOI 10.1016/j.psychres.2014.06.001; Arditte KA, 2016, PSYCHOL ASSESSMENT, V28, P684, DOI 10.1037/pas0000217; Bardeen JR, 2013, BEHAV THER, V44, P459, DOI 10.1016/j.beth.2013.04.001; Behrend TS, 2011, BEHAV RES METHODS, V43, P800, DOI 10.3758/s13428-011-0081-0; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chilton, 2010, P 11 ACM C EL COMM; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dick RW, 2012, BRIT J SPORT MED, V43, P46; Faul M, 2010, TRAUMATIC BRAIN INJU; Gordon KE, 2010, PEDIATR NEUROL, V43, P253, DOI 10.1016/j.pediatrneurol.2010.05.012; Grills CE, 2016, APPL NEUROPSYCH-ADUL, V23, P295, DOI 10.1080/23279095.2015.1079713; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; Litman L, 2015, BEHAV RES METHODS, V47, P519, DOI 10.3758/s13428-014-0483-x; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McKinlay A, 2017, DISABIL REHABIL, V39, P1296, DOI 10.1080/09638288.2016.1193905; Miller SC, 2015, OCCUP ENV MED; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Mrazik M, 2015, J HEAD TRAUMA REHAB, V30, P219, DOI 10.1097/HTR.0000000000000018; Papa A, 2014, J AFFECT DISORDERS, V161, P136, DOI 10.1016/j.jad.2014.03.018; Perry BN, BRIAN INJ 2014; Pescatore AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131618; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Preece M.H.W., 2016, BRAIN INJURY, V3, P1; Raugust J, 2013, PM&R, V5, pS129; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shapiro DN, 2013, CLIN PSYCHOL SCI, V1, P213, DOI 10.1177/2167702612469015; Shirk SD, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt94; Strickland JC, 2015, DRUG ALCOHOL DEPEN, V156, P304, DOI 10.1016/j.drugalcdep.2015.09.029; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Wymbs BT, 2015, J ATTEN DISORD	59	7	7	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	JAN	2018	10	1					45	55		10.1016/j.pmrj.2017.06.010			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FU4XF	WOS:000423855200006	28633999				2022-02-06	
S	Bragina, OA; Lara, DA; Nemoto, EM; Shuttleworth, CW; Semyachkina-Glushkovskaya, OV; Bragin, DE		Thews, O; LaManna, JC; Harrison, DK		Bragina, O. A.; Lara, D. A.; Nemoto, E. M.; Shuttleworth, C. W.; Semyachkina-Glushkovskaya, O. V.; Bragin, D. E.			Increases in Microvascular Perfusion and Tissue Oxygenation via Vasodilatation After Anodal Transcranial Direct Current Stimulation in the Healthy and Traumatized Mouse Brain	OXYGEN TRANSPORT TO TISSUE XL	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	45th Annual Meeting of the International-Society-on-Oxygen-Transport-to-Tissue (ISOTT)	AUG 19-23, 2017	Martin Luther Univ, Med Fac, Halle, GERMANY	Int Soc Oxygen Transport Tissue, Oxford Optronix, Hamamatsu Photon, Univ Hosp Halle	Martin Luther Univ, Med Fac			Traumatic brain injury (TBI), causing neurological deficit in 70% of survivors, still lacks a clinically proven effective therapy. Transcranial direct current stimulation (tDCS) has emerged as a promising electroceutical therapeutic intervention possibly suitable for TBI; however, due to limited animal studies the mechanisms and optimal parameters are unknown. Using a mouse model of TBI we evaluated the acute effects of the anodal tDCS on cerebral blood flow (CBF) and tissue oxygenation, and assessed its efficacy in long-term neurologic recovery. TBI was induced by controlled cortical impact leading to cortical and hippocampal lesions with reduced CBF and developed hypoxia in pericontusion area. Sham animals were subjected to craniotomy only. Repetitive anodal tDCS (0.1 mA/15 min) or sham stimulation was done over 4 weeks for four consecutive days with 3-day intervals, beginning 1 or 3 weeks after TBI. Laser speckle contrast imaging (LSCI) revealed that anodal tDCS causes an increase in regional cortical CBF in both traumatized and Sham animals. On microvascular level, using in-vivo two-photon microscopy (2PLSM), we have shown that anodal tDCS induces arteriolar dilatation leading to an increase in capillary flow velocity and tissue oxygenation in both traumatized and Sham animals. Repetitive anodal tDCS significantly improved motor and cognitive neurologic outcome. The group with stimulation starting 3 weeks after TBI showed better recovery compared with stimulation starting 1 week after TBI, suggesting that the late post-traumatic period is more optimal for anodal tDCS.	[Bragina, O. A.; Lara, D. A.; Nemoto, E. M.; Bragin, D. E.] Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA; [Shuttleworth, C. W.] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Semyachkina-Glushkovskaya, O. V.] Saratov NG Chernyshevskii State Univ, Dept Human & Anim Physiol, Saratov, Russia		Bragina, OA (corresponding author), Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA.	dbragin@salud.unm.edu	Glushkovskaya, Oxana V/D-5190-2013; Bragin, Denis/E-5494-2016; Bragina, Olga A/H-6696-2016	Glushkovskaya, Oxana V/0000-0001-6753-7513; Bragin, Denis/0000-0003-4894-0061; Bragina, Olga A/0000-0003-2810-9764	NIH-NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089]; RSFRussian Science Foundation (RSF) [17-75-20069]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089] Funding Source: NIH RePORTER	Supported by NIH-NIGMS P20GM109089 and RSF No 17-75-20069.	Bragin DE, 2015, J NEUROSURG, V122, P1239, DOI 10.3171/2014.8.JNS132083; Chohan MO, 2015, NEUROSURGERY, V76, P201, DOI 10.1227/NEU.0000000000000577; Clayton E, 2016, BRAIN RES, V1640, P130, DOI 10.1016/j.brainres.2016.01.056; Faul M, 2010, TRAUMATIC BRAIN INJU; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Wachter D, 2011, EXP NEUROL, V227, P322, DOI 10.1016/j.expneurol.2010.12.005	8	7	8	1	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-319-91287-5; 978-3-319-91285-1	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2018	1072						27	31		10.1007/978-3-319-91287-5_5			5	Medicine, Research & Experimental; Physiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Physiology	BL6LR	WOS:000454396400006	30178319	Green Accepted			2022-02-06	
J	Bustamante, MC; Singh, D; Cronin, DS				Bustamante, M. C.; Singh, D.; Cronin, D. S.			Polymeric Hopkinson Bar-Confinement Chamber Apparatus to Evaluate Fluid Cavitation	EXPERIMENTAL MECHANICS			English	Article						Cavitation; Polymer split Hopkinson pressure bar; PMMA modelling; Mild traumatic brain injury; Negative pressure	TRAUMATIC BRAIN-INJURY; PRESSURE-TENSION CYCLES; GAS-BODY ACTIVATION; ULTRASONIC CAVITATION; FREE-SURFACE; STRENGTH; LIQUIDS; WATER; TISSUE; WAVES	Mild traumatic brain injury associated with blast exposure is an important issue, and cavitation of the cerebrospinal fluid (CSF) has been suggested as a potential injury mechanism; however, physical measurements are required to evaluate cavitation thresholds. Modifications to a Split Hopkinson Pressure Bar (SHPB) apparatus were investigated with the aim to generate localized fluid cavitation and measure the cavitation threshold of fluids. The proposed design incorporated a novel closed cavitation chamber to generate localized cavitation resulting from a reflected compression pulse, which was generated by a spherical steel striker and Polymethyl methacrylate (PMMA) incident bar. A numerical model of the incident bar was developed and validated with 24 independent tests (cross-correlation: 0.970-0.997), and this was extended to a numerical model of the apparatus including the chamber, validated with 27 independent tests (cross-correlation: 0.921) to predict the tensile fluid pressure in the chamber. Tests on distilled water were performed with comparable numerical results for the chamber strain (R-2: 0.875) and chamber end-wall velocity (R-2: 0.992). The pressure in the chamber was determined from the model to avoid introducing a nucleation site via a pressure gauge, and was verified with a first-order approximation showing good agreement (R-2: 0.892). The 50% probability of cavitation for distilled water was -3.32 MPa +/- 3%, comparable to values in the literature. This novel apparatus, including a closed confinement chamber integrated with a polymeric SHPB apparatus was able to create localized fluid cavitation with loading comparable to blast exposure. Future studies will include the measurement of CSF cavitation pressure.	[Bustamante, M. C.; Singh, D.; Cronin, D. S.] Univ Waterloo, Dept Mech Engn, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada		Cronin, DS (corresponding author), Univ Waterloo, Dept Mech Engn, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	duane.cronin@uwaterloo.ca					Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; [Anonymous], 2014, 18506 ISOTS; Bir C., 2011, MEASURING BLAST RELA; Bo C, 2011, EUR PHYS J-APPL PHYS, V55, DOI 10.1051/epjap/2011110052; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Brennen C.E., 1995, ANNU REV FLUID MECH, DOI [10.1017/CBO9781107338760, DOI 10.1017/CBO9781107338760]; Bustamante M, 2016, C PROC SOC EXP MECH, P43, DOI 10.1007/978-3-319-22452-7_8; Caupin F, 2003, PHYSICA B, V329, P356, DOI 10.1016/S0921-4526(02)02103-8; Caupin F, 2006, CR PHYS, V7, P1000, DOI 10.1016/j.crhy.2006.10.015; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chahine K.K.G., 2014, ADV EXPT NUMERICAL T, V106, P71, DOI [10.1007/978-94-017-8539-6, DOI 10.1007/978-94-017-8539-6]; CHESTERMAN WD, 1952, P PHYS SOC LOND B, V65, P846, DOI 10.1088/0370-1301/65/11/302; Collins J. A., 2009, MECH DESIGN MACHINE; COUZENS DCF, 1969, NATURE, V222, P473, DOI 10.1038/222473a0; COUZENS DCF, 1974, J PHYS D APPL PHYS, V7, P2277, DOI 10.1088/0022-3727/7/16/315; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; FRY FJ, 1995, ULTRASOUND MED BIOL, V21, P1227, DOI 10.1016/0301-5629(96)89519-6; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Ganpule S., 2009, ASME 2009 INT MECH E, P8; Gehre C., 2009, OBJECTIVE RATING SIG; Ginsberg HJ, 2001, ULTRASON, P1381, DOI 10.1109/ULTSYM.2001.991978; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Gray III GT., 2000, ASM HDB, V8, P488; Grujicic M, 2010, MULTIDISCIP MODEL MA, V6, P335, DOI 10.1108/15736101011080097; HANSSON I, 1982, J PHYS D APPL PHYS, V15, P1725, DOI 10.1088/0022-3727/15/9/017; HARVEY EN, 1947, J APPL PHYS, V18, P162, DOI 10.1063/1.1697598; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Herbert E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041603; Hong Y, 2016, EXP MECH, V56, P97, DOI 10.1007/s11340-015-0024-2; Hong Y, 2012, AM SOC BIOMECH GAINE, P2; Hua Y, 2014, J COMPUT NONLIN DYN, V9, DOI 10.1115/1.4026156; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; KENNER VH, 1978, INT J MECH SCI, V20, P373, DOI 10.1016/0020-7403(78)90040-1; KENNER VH, 1980, J BIOMECH ENG-T ASME, V102, P151, DOI 10.1115/1.3138212; Kolsky H., 1949, Proceedings of the Physical Society. Section B, V62, P676, DOI 10.1088/0370-1301/62/11/302; LEE CS, 1988, ULTRASOUND MED BIOL, V14, P735, DOI 10.1016/0301-5629(88)90029-4; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; LSDYNA, 2013, LS DYNA KEYW US MAN; MILLER DL, 1987, ULTRASOUND MED BIOL, V13, P443, DOI 10.1016/0301-5629(87)90110-4; Miller DL, 2007, PROG BIOPHYS MOL BIO, V93, P314, DOI 10.1016/j.pbiomolbio.2006.07.027; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nie X, 2013, INT J IMPACT ENG, V53, P56, DOI 10.1016/j.ijimpeng.2012.07.012; OVERTON GDN, 1981, J PHYS D APPL PHYS, V14, P241, DOI 10.1088/0022-3727/14/2/016; OVERTON GDN, 1984, J PHYS D APPL PHYS, V17, P979, DOI 10.1088/0022-3727/17/5/012; Panzer M.B., 2010, PERS ARM SYST S QUEB, P11; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Plesset M. S., 1970, EFFECT DISSOLVED GAS; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Salisbury C., 2015, J DYN BEHAV MAT, V1, P237, DOI DOI 10.1007/S40870-015-0026-2; Salisbury C, 2015, J DYNAM BEHAV MAT, V1, P249; Sarntinoranont M, 2012, J NEUROTRAUM, V29, P418, DOI 10.1089/neu.2011.1772; Sarvghad-Moghaddam H, 2015, COMPUT METHOD BIOMEC, V18, P1846, DOI 10.1080/10255842.2014.977878; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; SEDGEWICK SA, 1976, J PHYS D APPL PHYS, V9, P1983, DOI 10.1088/0022-3727/9/14/008; Singh D, 2015, INVESTIGATION PRIMAR; Singh D, 2015, C P SOC EXP MECH SER, V65, P177, DOI [10.1007/978-3-319-06995-1_27, DOI 10.1007/978-3-319-06995-1_27]; Singh D, 2014, INT J NUMER METH BIO, V30, P470, DOI 10.1002/cnm.2612; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Strand O., 2004, SPIE P, V5580, P593, DOI [10.1063/5.0004363, DOI 10.1063/5.0004363]; Strand OT, 2005, NOVEL SYSTEM HIGH SP; TEMPERLEY HNV, 1977, P ROY SOC LOND A MAT, V357, P395, DOI 10.1098/rspa.1977.0175; TEMPERLEY HNV, 1987, J PHYS D APPL PHYS, V20, P1080, DOI 10.1088/0022-3727/20/8/018; Thiruvengadam A., 1974, HDB CAVITATION EROSI; Thunert C., 2012, CORA RELEASE 36 USER; TREVENA DH, 1984, J PHYS D APPL PHYS, V17, P2139, DOI 10.1088/0022-3727/17/11/003; Tsaklis P, 2010, HUMAN MOV SCI, V11, P91, DOI [10.2478/v10038-009-0025-z, DOI 10.2478/V10038-009-0025-Z]; Van Sligtenhorst C, 2006, J BIOMECH, V39, P1852, DOI 10.1016/j.jbiomech.2005.05.015; WARD JW, 1948, SCIENCE, V107, P349, DOI 10.1126/science.107.2779.349; Willams PR, 2000, P ROY SOC A-MATH PHY, V456, P1321, DOI 10.1098/rspa.2000.0564; Williams PR, 1999, P ROY SOC A-MATH PHY, V455, P3311, DOI 10.1098/rspa.1999.0452; Williams PR, 2004, MOL PHYS, V102, P2091, DOI 10.1080/00268970412331292786; Williams PR, 1997, J PHYS D APPL PHYS, V30, P1197, DOI 10.1088/0022-3727/30/8/007; Williams PR, 1996, J PHYS D APPL PHYS, V29, P1904, DOI 10.1088/0022-3727/29/7/026; Williams PR, 1998, MEAS SCI TECHNOL, V9, P976, DOI 10.1088/0957-0233/9/6/015; Williams PR, 1998, PHYS MED BIOL, V43, P3101, DOI 10.1088/0031-9155/43/10/028; Zhang C, 2014, CANCER LETT, V347, P105, DOI 10.1016/j.canlet.2014.01.022; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088; Zhu Feng, 2010, Stapp Car Crash J, V54, P211	81	7	9	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4851	1741-2765		EXP MECH	Exp. Mech.	JAN	2018	58	1					55	74		10.1007/s11340-017-0323-x			20	Materials Science, Multidisciplinary; Mechanics; Materials Science, Characterization & Testing	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Mechanics	FR1BE	WOS:000418799700005		hybrid			2022-02-06	
J	Candrian, G; Muller, A; Dall'Acqua, P; Kompatsiari, K; Baschera, GM; Mica, L; Simmen, HP; Glaab, R; Fandino, J; Schwendinger, M; Meier, C; Ulbrich, EJ; Johannes, S				Candrian, Gian; Muller, Andreas; Dall'Acqua, Patrizia; Kompatsiari, Kyveli; Baschera, Gian-Marco; Mica, Ladislav; Simmen, Hans-Peter; Glaab, Richard; Fandino, Javier; Schwendinger, Markus; Meier, Christoph; Ulbrich, Erika Jasmin; Johannes, Sonke			Longitudinal study of a NoGo-P3 event-related potential component following mild traumatic brain injury in adults	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Mild traumatic brain injury; Event-related potentials; Independent component analysis; Longitudinal	CONCUSSION SYMPTOMS QUESTIONNAIRE; TEST-RETEST RELIABILITY; VISUAL GO/NOGO TASK; INDEPENDENT COMPONENTS; HEAD-INJURY; ERP COMPONENTS; P300; INSTRUCTIONS; NEUROSCIENCE; PROGNOSIS	Background: Event-related potentials have repeatedly revealed electrophysiological markers of cognitive dysfunction associated with Mild Traumatic Brain Injury (MTBI) and may represent a sensitive tool to guide cognitive rehabilitative interventions. We previously found patients with symptomatic MTBI characterized by smaller P300 (or P3) wave amplitudes in a NoGo-P3 subcomponent in the acute phase of the injury. The goal of this longitudinal study was to investigate whether this early NoGo-P3 subcomponent differs over time in symptomatic MTBI patients and healthy controls. Methods: We included adults with a diagnosis of MTBI and individually matched healthy controls tested at 1 week, 3 months, and 1 year after the MTBI. Symptoms were assessed by the Rivermead Post-Concussion Symptoms Questionnaire. NoGo-P3 was collected by using a cued Go/NoGo task and the relevant subcomponent was extracted by independent component analysis. Results: Among 53 adults with a diagnosis of MTBI and 53 controls, we included 35 with symptomatic MTBI and 35 matched healthy controls (18 females each group; mean age 34.06 +/- 13.15 and 34.26 +/- 12.98 years). Amplitudes for the early NoGo-P3 subcomponent were lower for symptomatic MTBI patients than controls (P < 0.05) at 1 week post-injury. Furthermore, mixed ANOVA revealed a significant time by group interaction (P < 0.05), so the effect of time differed for symptomatic MTBI patients and healthy controls. The amplitudes for MTBI patients normalized from 1 week to 3 months post-injury and were comparable to those of controls from 3 months to 1 year post-injury. However, amplitudes for 3 MTBI patients with particularly severe complaints 1 year post-injury did not normalize and were lower than those for the remaining MTBI sample (P < 0.05). Conclusions: Selected event-related potentials can be used as a sensitive and objective tool to illustrate the cognitive consequences of and recovery after MTBI. (C) 2017 Elsevier Masson SAS. All rights reserved.	[Candrian, Gian; Muller, Andreas; Kompatsiari, Kyveli; Baschera, Gian-Marco] Brain & Trauma Fdn Grisons, Poststr 22, CH-7000 Chur, Switzerland; [Dall'Acqua, Patrizia; Johannes, Sonke] Bellikon Rehabil Clin, CH-5454 Bellikon, Switzerland; [Dall'Acqua, Patrizia] Univ Zurich, Dept Psychol, Div Neuropsychol, CH-8050 Zurich, Switzerland; [Mica, Ladislav; Simmen, Hans-Peter] Univ Hosp Zurich, Div Trauma Surg, CH-8091 Zurich, Switzerland; [Glaab, Richard] Cantonal Hosp Aarau, Dept Traumatol, CH-5001 Aarau, Switzerland; [Fandino, Javier] Cantonal Hosp Aarau, Dept Neurosurg, CH-5001 Aarau, Switzerland; [Schwendinger, Markus] Baden Cantonal Hosp, Interdisciplinary Emergency Ctr, CH-5404 Baden, Switzerland; [Meier, Christoph] Waid City Hosp, Dept Surg, CH-8037 Zurich, Switzerland; [Ulbrich, Erika Jasmin] Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland		Candrian, G (corresponding author), Brain & Trauma Fdn Grisons, Poststr 22, CH-7000 Chur, Switzerland.	giancan@bluewin.ch		Simmen, Hans-Peter/0000-0002-5201-4549	Research Fund of SUVA	This work was supported by the Research Fund of SUVA. The authors thank Ludwig Coray for the management-related aspects of the study. They also thank Serafina Dima, Denise Long and Karoline Wurmitzer for taking care of participants and for their assistance in executing the tests.	Aasen IE, 2016, PSYCHOPHYSIOLOGY, V53, P171, DOI 10.1111/psyp.12563; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Brunner JF, 2015, NEUROPSYCHOLOGIA, V66, P144, DOI 10.1016/j.neuropsychologia.2014.11.019; Brunner JF, 2013, INT J PSYCHOPHYSIOL, V89, P106, DOI 10.1016/j.ijpsycho.2013.06.005; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carrillo-de-la-Pena MT, 2000, NEUROPHYSIOL CLIN, V30, P232, DOI 10.1016/S0987-7053(00)00220-3; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CASSIDY JD, 2014, ARCH PHYS MED REHAB, V95, P132; Castellan N. J, 1988, NONPARAMETRIC STAT B; Chen DYT, 2016, RADIOLOGY, V278, P854, DOI 10.1148/radiol.2015150612; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; de Guise E, 2016, APPL NEUROPSYCH-ADUL, V23, P213, DOI 10.1080/23279095.2015.1038747; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Hautzinger M., 2006, BDI 2 BECK DEPRESSIO; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koerte IK, 2016, TRANSLATIONAL RES TR, V2016; Kompatsiari K, 2016, NEUROSCI LETT, V617, P166, DOI 10.1016/j.neulet.2016.02.012; Kropotov JD, 2011, NEUROIMAGE, V57, P565, DOI 10.1016/j.neuroimage.2011.04.060; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Muller A, 2015, NEUROREPORT, V26, P952, DOI 10.1097/WNR.0000000000000447; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Raggi A, 2012, REV NEUROSCIENCE, V23, P311, DOI 10.1515/revneuro-2012-0027; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Solbakk AK, 2000, J CLIN EXP NEUROPSYC, V22, P743, DOI 10.1076/jcen.22.6.743.953; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695	47	7	10	0	15	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	JAN	2018	61	1					18	26		10.1016/j.rehab.2017.07.246			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FS0MX	WOS:000419469300004	28882543	Bronze			2022-02-06	
J	Childs, C; Barker, LA; Gage, AMD; Loosemore, M				Childs, Charmaine; Barker, Lynne A.; Gage, Alex M. D.; Loosemore, Mike			Investigating possible retinal biomarkers of head trauma in Olympic boxers using optical coherence tomography	EYE AND BRAIN			English	Article						optical coherence tomography; OCT; mild traumatic brain injury; macula; retinal nerve fiber layer; imaging; concussion; eye; biomarkers; chronic traumatic encephalopathy; CTE	FIBER LAYER THICKNESS; BRAIN-INJURY; ABNORMALITIES; IMPAIRMENT; OCT	Purpose: Changes to retina have been reported after a number of neurodegenerative conditions. The purpose of this study was to investigate retinal structures in Olympic boxers exposed to frequent head blows. Methods: Retinal imaging offers potential as a non-invasive biomarker of neuropathology. Macula and retinal nerve fiber layer (RNFL) thickness was measured using optical coherence tomography (OCT) in UK Olympic boxers attending two mandatory eye screening programs, 18 months apart. Data from the two eye screenings provide longitudinal data of retinal change over time. Sedentary healthy subjects (controls) without past or present history of concussion were also screened at the time of the second boxer screening to provide comparison of cross-sectional data. Results: Sixteen Olympic boxers aged 20-33 years and 20 sedentary healthy controls, aged 24-45 years, were recruited. Significant macula thickening was observed over time (18 months) in 75% of right and 50% of left eye sectors. For RNFL, left eye quadrants thickened. For right eye RNFL quadrants, thickening and thinning of this layer were observed. Cross-sectional results showed thinner macula sectors and RNFL quadrants in Olympic boxers compared to controls. Conclusion: Significant change to macula and RNFL densities, occurring over an 18 month interval is an unexpected finding in otherwise heathy elite sportsmen. In addition, macula and RNFL were thinner than healthy sedentary controls. OCT may prove clinically useful as a candidate retinal biomarker of neuropathological change after mild traumatic brain injury and/or repeat head blows.	[Childs, Charmaine] Sheffield Hallam Univ, Fac Hlth & Wellbeing, Montgomery House,32 Collegiate Crescent, Sheffield S10 2BP, S Yorkshire, England; [Barker, Lynne A.] Sheffield Hallam Univ, Ctr Behav Sci & Appl Psychol, Sheffield, S Yorkshire, England; [Gage, Alex M. D.] Alex Gage Family Optometrist, Sheffield, S Yorkshire, England; [Loosemore, Mike] ISEH, London, England		Childs, C (corresponding author), Sheffield Hallam Univ, Fac Hlth & Wellbeing, Montgomery House,32 Collegiate Crescent, Sheffield S10 2BP, S Yorkshire, England.	c.childs@shu.ac.uk		Loosemore, Michael/0000-0002-4855-0744; CHILDS, Charmaine/0000-0002-1558-5633			Abegg M, 2014, OPHTHALMOLOGY, V121, P142, DOI 10.1016/j.ophtha.2013.08.045; Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; Bernick C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt177; Bodis-Wollner I, 2009, J NEURAL TRANSM, V116, P1493, DOI 10.1007/s00702-009-0292-z; Childs C, 2014, EUR J EMERG MED, V21, P388, DOI 10.1097/MEJ.0000000000000169; Cohen J., 2013, STAT POWER ANAL BEHA; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Denniss R, 2016, EFFECT MICRONUTRIENT; Ellis MJ, 2016, CURR SPORT MED REP, V15, P27, DOI 10.1249/JSR.0000000000000223; Evanson NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197346; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Hondur G, 2018, CLIN OPHTHALMOL, V12, P401, DOI 10.2147/OPTH.S157429; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Jang Sun Young, 2018, Korean J Neurotrauma, V14, P1, DOI 10.13004/kjnt.2018.14.1.1; Kanamori A, 2003, OPHTHALMOLOGICA, V217, P273, DOI 10.1159/000070634; Kanamori A, 2012, ARCH OPHTHALMOL-CHIC, V130, P1067, DOI 10.1001/archophthalmol.2012.470; Leong D, 2018, J NEURO-OPHTHALMOL, V38, P285, DOI 10.1097/WNO.0000000000000572; Leveillard T, 2017, CELL MOL LIFE SCI, V74, P3649, DOI 10.1007/s00018-016-2318-7; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mammadova N, 2017, AM J PATHOL, V187, P1459, DOI 10.1016/j.ajpath.2017.03.005; Matser EJT, 2000, PHYSICIAN SPORTSMED, V28, P87, DOI 10.3810/psm.2000.01.645; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Mrejen S, 2013, SURV OPHTHALMOL, V58, P387, DOI 10.1016/j.survophthal.2012.12.001; Ozevren H, 2017, INT J MORPHOL, V35, P840; Parisi V, 1999, INVEST OPHTH VIS SCI, V40, P2520; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Pierro L, 2012, INVEST OPHTH VIS SCI, V53, P5912, DOI 10.1167/iovs.11-8644; Rebolleda G, 2015, SAUDI J OPHTHALMOL, V29, P9, DOI 10.1016/j.sjopt.2014.09.016; Rossetto JD, 2017, ARQ BRAS OFTALMOL, V80, P390, DOI 10.5935/0004-2749.20170095; Sarkies N, 2004, EYE, V18, P1122, DOI 10.1038/sj.eye.6701571; Sharifipour Farideh, 2016, J Ophthalmic Vis Res, V11, P42, DOI 10.4103/2008-322X.180708; Singman EL, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0069-2; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234	35	7	7	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-2744			EYE BRAIN	EYE BRAIN		2018	10						101	110		10.2147/EB.S183042			10	Ophthalmology	Emerging Sources Citation Index (ESCI)	Ophthalmology	HF4OJ	WOS:000454212300001	30588143	Green Published, Green Submitted, Green Accepted, gold			2022-02-06	
J	Cho, HB; Bueler, CE; DiMuzio, J; Hicks-Little, C; McGlade, E; Lyoo, IK; Yurgelun-Todd, D				Cho, Han Byul; Bueler, Charles Elliott; DiMuzio, Jennifer; Hicks-Little, Charlie; McGlade, Erin; Lyoo, In Kyoon; Yurgelun-Todd, Deborah			Negative Mood States Correlate with Laterobasal Amygdala in Collegiate Football Players	BIOMED RESEARCH INTERNATIONAL			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; BRAIN-INJURY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; EMOTIONAL STIMULI; MAJOR DEPRESSION; CONCUSSION; SPORT; CORTEX; SYMPTOMS	A number of studies have suggested that sports-related concussion (SRC) may place individuals at increased risk for depression and negative outcomes including suicide. However, the mechanisms underlying a potential relationship between brain integrity and mood remain unclear. The current study is aimed at examining the association between amygdala shape, mood state, and postconcussion symptoms in collegiate football players. Thirty members of 1 football team completed the Profile of Mood States (POMS), the postconcussion symptom scale (PCSS), and an MRI protocol during preseason camp. T1-weighted images were acquired and three-dimensional amygdala and probabilistic maps were created for shape analysis. Correlation analyses between POMS and PCSS and the relationship between POMS and amygdala shape were completed. In the amygdala, the left laterobasal subregion showed a positive relationship with the POMS total score and subscales scores. No significant relationship between PCSS and amygdala shape was found. Significant positive correlations were found between POMS subscales and PCSS. These results indicate that amygdala structure may be more closely associated with negative mood states than postconcussion symptoms. These findings suggest that premorbid individual differences in effect may provide critical insight into the relationship between negative mood and outcomes in collegiate football players with SRC.	[Cho, Han Byul; Bueler, Charles Elliott; DiMuzio, Jennifer; McGlade, Erin; Lyoo, In Kyoon; Yurgelun-Todd, Deborah] Univ Utah, Brain Inst, 383 Colorow Dr, Salt Lake City, UT 84108 USA; [Cho, Han Byul; Bueler, Charles Elliott; DiMuzio, Jennifer; McGlade, Erin; Yurgelun-Todd, Deborah] Univ Utah, Diagnost Neuroimaging Lab, 501 Chipeta Way, Salt Lake City, UT 84108 USA; [Cho, Han Byul; McGlade, Erin; Lyoo, In Kyoon; Yurgelun-Todd, Deborah] Sch Med, Dept Psychiat, 501 Chipeta Way, Salt Lake City, UT 84108 USA; [Hicks-Little, Charlie] Univ Utah, Dept Phys Therapy & Athlet Training, 520 Wakara Way, Salt Lake City, UT 84108 USA; [McGlade, Erin; Yurgelun-Todd, Deborah] US Dept Vet Affairs, Rocky Mt MIRECC, 500 Foothill Dr, Salt Lake City, UT 84148 USA; [Lyoo, In Kyoon] EwhaWomans Univ, Ewha Brain Inst, 150 Bugahyeon Ro, Seoul 03759, South Korea; [Lyoo, In Kyoon] Ewha Womans Univ, Dept Brain & Cognit Sci, 150 Bugahyeon Ro, Seoul 03759, South Korea; [Lyoo, In Kyoon] Ewha Womans Univ, Grad Sch Pharmaceut Sci, 52 Ewhayeodae Gil, Seoul 03760, South Korea		Yurgelun-Todd, D (corresponding author), Univ Utah, Brain Inst, 383 Colorow Dr, Salt Lake City, UT 84108 USA.; Yurgelun-Todd, D (corresponding author), Univ Utah, Diagnost Neuroimaging Lab, 501 Chipeta Way, Salt Lake City, UT 84108 USA.; Yurgelun-Todd, D (corresponding author), Sch Med, Dept Psychiat, 501 Chipeta Way, Salt Lake City, UT 84108 USA.; Yurgelun-Todd, D (corresponding author), US Dept Vet Affairs, Rocky Mt MIRECC, 500 Foothill Dr, Salt Lake City, UT 84148 USA.	deborah.yurgelun-todd@hsc.utah.edu	McGlade, Erin C/K-1157-2016	McGlade, Erin C/0000-0003-2234-1984	Pac-12 Student-Athlete Health and Well-Being Grant Program; Utah Science Technology and Research Initiative (USTAR); National Research Foundation of KoreaNational Research Foundation of Korea [2015M3C7A1028373]	The authors would like to thank Dr. In Kyoon Lyoo for his comments and suggestions. This work was supported by the Pac-12 Student-Athlete Health and Well-Being Grant Program (Drs. D. A. Yurgelun-Todd and C. Hicks-Little), the Utah Science Technology and Research Initiative (USTAR) (Dr. D. A. Yurgelun-Todd), and the National Research Foundation of Korea (2015M3C7A1028373) (Dr. I. K. Lyoo).	Aggleton E.J., 2000, AMYGDALA FUNCTIONAL; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Bailey R, 2006, J SCHOOL HEALTH, V76, P397, DOI 10.1111/j.1746-1561.2006.00132.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Cahill L, 2003, PROG NEURO-PSYCHOPH, V27, P1235, DOI 10.1016/j.pnpbp.2003.09.019; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis M, 2000, CURR BIOL, V10, pR131, DOI 10.1016/S0960-9822(00)00345-6; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; Droppleman, 1992, REVISED MANUAL PROFI; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frodl T, 2002, BIOL PSYCHIAT, V51, P708, DOI 10.1016/S0006-3223(01)01359-2; Fusar-Poli P, 2009, NEUROSCI LETT, V452, P262, DOI 10.1016/j.neulet.2009.01.065; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Glascher J, 2003, J NEUROSCI, V23, P10274; Goossens L, 2009, HUM BRAIN MAPP, V30, P3332, DOI 10.1002/hbm.20755; Hosking JG, 2014, NEUROPSYCHOPHARMACOL, V39, P1558, DOI 10.1038/npp.2014.27; Hwang J, 2006, AM J PSYCHIAT, V163, P276, DOI 10.1176/appi.ajp.163.2.276; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Kim JE, 2010, ARCH GEN PSYCHIAT, V67, P1187, DOI 10.1001/archgenpsychiatry.2010.148; Kim N, 2011, NEUROSCI LETT, V488, P65, DOI 10.1016/j.neulet.2010.11.005; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Leaver A, 2015, BIOL PSYCHIAT, V77, p295S; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Lorensen W., 1987, COMPUT GRAPH, V87, P163, DOI [10.1145/37401.37422, 10.1145/37402.37422, DOI 10.1145/37402.37422]; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Resch J. E. B., 2013, ATHLETIC TRAINING SP, V5, P272; Rosso IM, 2005, BIOL PSYCHIAT, V57, P21, DOI 10.1016/j.biopsych.2004.10.027; Rubinow MJ, 2016, BRAIN STRUCT FUNCT, V221, P171, DOI 10.1007/s00429-014-0900-z; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Striedter GF, 2006, BEHAV BRAIN SCI, V29, P1, DOI 10.1017/S0140525X06009010; Suzuki M, 2004, BRIT J SPORT MED, V38, P436, DOI 10.1136/bjsm.2002.004309; Switzer R, 1999, HDB CHEM NEUROANATOM, P57; Terry PC, 2000, J APPL SPORT PSYCHOL, V12, P93, DOI 10.1080/10413200008404215; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Wilson MA, 2015, NEUROBIOL STRESS, V1, P195, DOI 10.1016/j.ynstr.2015.06.001; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Zald DH, 2002, NEUROIMAGE, V16, P746, DOI 10.1006/nimg.2002.1115	56	7	7	0	8	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2018	2018								8142631	10.1155/2018/8142631			11	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	FV7FI	WOS:000424748500001	29581986	gold, Green Published, Green Submitted			2022-02-06	
J	Cook, S; Hung, V; Duncan, KA				Cook, Samarah; Hung, Vanessa; Duncan, Kelli A.			Crosstalk between Estrogen Withdrawal and NF kappa B Signaling following Penetrating Brain Injury	NEUROIMMUNOMODULATION			English	Article						Steroids; Avian brain; Neuroprotection	INDUCED INFLAMMATORY RESPONSE; NECROSIS-FACTOR-ALPHA; TRANSCRIPTION FACTOR; GLIAL AROMATIZATION; EXPRESSION; AROMATASE; RECEPTOR; INVOLVEMENT; NEUROGENESIS; INHIBITION	Objectives: Characterized by neuroinflammation, traumatic brain injury (TBI) induces neuropathological changes and cognitive deficits. Estrogens are neuroprotective by increasing cell survival and this increase is mediated by a decrease in neuroinflammation. To further explore the relationship between estrogens, brain injury, and neuroinflammation, we examined the expression of the IKK/NF kappa B complex. The IKK/NF kappa B complex is a pleiotropic regulator of many cellular signaling pathways linked to inflammation, as well as three major cytokines (IL-1 beta, IL-6, and TNF-alpha). We hypothesized that NF kappa B expression would be upregulated following injury and that this increase would be exacerbated when circulating estrogens were decreased with fadrozole (aromatase inhibitor). Methods: Using adult zebra finches, we first determined the expression of major components of the NF kappa B complex (NF kappa B, IkB-alpha, and IkB-beta) following injury using qPCR. Next, male and female finches were collected at 2 time points (2 or 24 h after injury) and brain tissue was analyzed to determine whether NF kappa B expression was differentially expressed in males and females at either time point. Finally, we examined how the expression of NF kappa B changed when estrogen levels were decreased immediately after injury. Results: Our study documented an increase in the expression of the major components of the NF kappa B complex (NF kappa B, IkB-alpha, and IkB-beta) following injury. Decreasing estrogen levels resulted in a surprising decrease in the NF kappa B complex studied here. Discussion: These data further expand the model of how estrogens and other steroid hormones interact with the inflammatory pathways following injury and may prove beneficial when developing therapies for treatment of TBI. (C) 2018 S. Karger AG, Basel	[Cook, Samarah; Hung, Vanessa; Duncan, Kelli A.] Vassar Coll, Program Neurosci & Behav, Poughkeepsie, NY 12601 USA; [Duncan, Kelli A.] Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA		Duncan, KA (corresponding author), Vassar Coll, 124 Raymond Ave, Poughkeepsie, NY 12604 USA.	keduncan@vassar.edu			Vassar College	This work was supported by Vassar College.	Abou-Abbass H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005342; Ahn HJ, 2008, LEARN MEMORY, V15, P539, DOI 10.1101/lm.866408; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Brown K, 1993, MUTUAL REGULATION TR; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; DEMARTIN R, 1993, EMBO J, V12, P2773, DOI 10.1002/j.1460-2075.1993.tb05938.x; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Duncan KA, 2013, J NEUROTRAUM, V30, P1919, DOI 10.1089/neu.2013.2951; Duncan KA, 2013, HORM BEHAV, V63, P208, DOI 10.1016/j.yhbeh.2012.02.026; Duncan KA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-81; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; KALTSCHMIDT B, 1993, MOL ASPECTS MED, V14, P171, DOI 10.1016/0098-2997(93)90004-W; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Khorooshi R, 2008, J IMMUNOL, V181, P7284, DOI 10.4049/jimmunol.181.10.7284; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Klores M, 2017, J CHEM NEUROANAT, V79, P32, DOI 10.1016/j.jchemneu.2016.11.002; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Levenson JM, 2004, J NEUROSCI, V24, P3933, DOI 10.1523/JNEUROSCI.5646-03.2004; Mehos CJ, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12348; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Norata GD, 2006, J CLIN ENDOCR METAB, V91, P546, DOI 10.1210/jc.2005-1664; O'Riordan KJ, 2006, J NEUROSCI, V26, P4870, DOI 10.1523/JNEUROSCI.4527-05.2006; Pan MH, 2010, FOOD FUNCT, V1, P15, DOI 10.1039/c0fo00103a; Pedersen AL, 2016, ENDOCRINOLOGY, V157, P2041, DOI 10.1210/en.2015-1991; Peterson RS, 2004, J COMP NEUROL, V475, P261, DOI 10.1002/cne.20157; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; ROTHWELL NJ, 1995, INT J DEV NEUROSCI, V13, P179, DOI 10.1016/0736-5748(95)00018-C; Saldanha CJ, 2013, J NEUROENDOCRINOL, V25, P1032, DOI 10.1111/jne.12067; Saldanha CJ, 2000, J COMP NEUROL, V423, P619, DOI 10.1002/1096-9861(20000807)423:4<619::AID-CNE7>3.0.CO;2-U; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; SHEN P, 1995, J COMP NEUROL, V360, P172, DOI 10.1002/cne.903600113; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Vegeto E, 2001, J NEUROSCI, V21, P1809, DOI 10.1523/JNEUROSCI.21-06-01809.2001; WADE J, 1994, GEN COMP ENDOCR, V94, P53, DOI 10.1006/gcen.1994.1059; Walters BJ, 2011, DEV NEUROBIOL, V71, P170, DOI 10.1002/dneu.20839; Wynne RD, 2004, J NEUROENDOCRINOL, V16, P676, DOI 10.1111/j.1365-2826.2004.01217.x; Wynne RD, 2008, GLIA, V56, P97, DOI 10.1002/glia.20594; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhao Y, 1996, MOL ENDOCRINOL, V10, P1350, DOI 10.1210/me.10.11.1350; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	48	7	7	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2018	25	4					193	200		10.1159/000493506			8	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	HI5AB	WOS:000456463300002	30423555				2022-02-06	
J	De Koning, ME; Scheenen, ME; Van Der Horn, HJ; Spikman, JM; Van Der Naalt, J				De Koning, M. E.; Scheenen, M. E.; Van Der Horn, H. J.; Spikman, J. M.; Van Der Naalt, J.			From "miserable minority' to the "fortunate few': the other end of the mild traumatic brain injury spectrum	BRAIN INJURY			English	Article						Traumatic brain injury; posttraumatic complaints; hospital anxiety and depression scale; outcome	OUTCOME PREDICTION; TRACK-TBI; VALIDATION; SYMPTOMS; SCALE	Objectives: This study, as part of the UPFRONT-study, aimed to study the patients that report zero complaints early after injury, a group that we named the fortunate few'. We focused on their demographic, clinical and premorbid characteristics, and examined whether they would remain asymptomatic. Moreover, we investigated the influence of anxiety and depression (HADS), and determined outcome (GOS-E) and quality of life (WHOQOL-BREF) 1 year after injury.Methods: Patients with MTBI (Glasgow Coma Scale score 13-15), without complaints 2weeks after injury were included. Follow-up took place at 3, 6 and 12months after injury.Results: Of the entire UPFRONT-cohort (n=1151), 10% (n=119) reported zero complaints 2weeks after injury. More than half of these patients (57%) developed complaints at a later stage (M=2, p<.001). Patients with secondary complaints had higher anxiety (p=.004) and depression (p=.002) scores, leading to less favourable outcome (p=.014) and a lower quality of life (p=.006) 1 year after injury compared to patients that remained asymptomatic.Conclusion: One in 10 patients with mTBI report zero complaints early after injury. Although they seem fully recovered early after injury, a substantial part may develop secondary complaints leading to less favourable outcome and lower quality of life, warranting further research of this interesting group.	[De Koning, M. E.; Van Der Horn, H. J.; Van Der Naalt, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [Scheenen, M. E.; Spikman, J. M.] Univ Groningen, Univ Med Ctr Groningen, Neuropsychol, Groningen, Netherlands		Van Der Naalt, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	j.van.der.naalt@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418	Dutch Brain Foundation [Ps2012-06]	The study was funded by the Dutch Brain Foundation (Grant no. Ps2012-06).	de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; DeVries J, 1997, EUR J PSYCHOL ASSESS, V13, P164, DOI 10.1027/1015-5759.13.3.164; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	15	7	7	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					540	543		10.1080/02699052.2018.1431844			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200002	29388851	Bronze			2022-02-06	
J	Downing, M; Ponsford, J				Downing, Marina; Ponsford, Jennie			Sexuality in individuals with traumatic brain injury and their partners	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; sexuality; partners; close-other	HEAD-INJURY; FOLLOW-UP; MODEL; MULTICENTER; ORGASM; TBI; ADJUSTMENT	Whilst previous research has detailed the impact of TBI on an individual's sexuality, few studies have investigated couples' sexuality where one partner has sustained a TBI. The study assessed sexual function in individuals with TBI and their partners. Fifty five individuals who had sustained TBI and their partners completed the Derogatis Interview for Sexual FunctionSelf Report (DISF-SR). All participants scored below the 50th percentile in relation to norms. Whilst participants with TBI obtained lower T-scores than partners on all subscales (except for sexual behaviour/experiences where scores were equivalent), as well as the total score, none of these differences was significant. Item analysis indicated that female participants with TBI reported significantly lower scores than female partners on frequency of having normal lubrication. Normative comparisons revealed that approximately one-third of individuals with TBI and one-fifth of their partners scored below the second percentile. Given the high frequency of sexual problems in individuals with TBI, which also impact their partners, addressing sexual problems should be a priority in rehabilitation and beyond.	[Downing, Marina; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Clayton, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Downing, Marina/AAX-2380-2020; Ponsford, Jennie/H-8341-2014	Downing, Marina/0000-0002-3126-6632; Ponsford, Jennie/0000-0003-0430-125X	Transport Accident Commission through the Institute for Safety, Compensation and Recovery Research (ISCRR)	This research was funded by the Transport Accident Commission through the Institute for Safety, Compensation and Recovery Research (ISCRR).	Aloni R., 2003, SEXUAL DIFFICULTIES; Alwaal A, 2015, FERTIL STERIL, V104, P1051, DOI 10.1016/j.fertnstert.2015.08.033; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bivona U, 2016, BRAIN INJURY, V30, P1082, DOI 10.3109/02699052.2016.1165867; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Derogatis L, 1987, DEROGATIS INTERVIEW; Derogatis LR, 1997, J SEX MARITAL THER, V23, P291; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Gosling J, 1999, BRAIN INJURY, V13, P785; Hanks RA, 2013, J HEAD TRAUMA REHAB, V28, P179, DOI 10.1097/HTR.0b013e31828b4fae; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Jha S, 2010, EUR J OBSTET GYN R B, V153, P117, DOI 10.1016/j.ejogrb.2010.06.010; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Levin RJ, 2014, PHARMACOL BIOCHEM BE, V121, P62, DOI 10.1016/j.pbb.2014.02.010; Medlar T. M., 1993, SEX DISABIL, V11, P57, DOI DOI 10.1007/BF01102309; Meston CM, 2004, ANN REV SEX RES, V15, P173; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Penna S, 2010, J HEAD TRAUMA REHAB, V25, P52, DOI 10.1097/HTR.0b013e3181c29952; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford J, 2014, BRAIN INJURY, V28, P146, DOI 10.3109/02699052.2013.859733; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ponsford JL, 2013, J HEAD TRAUMA REHAB, V28, P195, DOI 10.1097/HTR.0b013e31828b4f7b; Salonia A, 2010, J SEX MED, V7, P2637, DOI 10.1111/j.1743-6109.2010.01810.x; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Sander A.M., 2011, SEXUAL FUNCTIONING S; Sander AM, 2016, ARCH PHYS MED REHAB, V97, P753, DOI 10.1016/j.apmr.2016.01.009; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Stejkal T.M., 2011, INTIMACY SEXUALITY S; Stolwyk RJ, 2013, J HEAD TRAUMA REHAB, V28, P164, DOI 10.1097/HTR.0b013e31828197d1; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778	36	7	7	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2018	28	6					1028	1037		10.1080/09602011.2016.1236732			10	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GJ1KR	WOS:000435015100009	27677345				2022-02-06	
J	Driver, S; Reynolds, M; Douglas, M; Bennett, M				Driver, Simon; Reynolds, Megan; Douglas, Megan; Bennett, Monica			Describing Weight Loss Attempts and Physical Activity Among Individuals With TBI Prior to Participation in a Weight-Loss Program	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; health promotion; physical activity; weight loss history	TRAUMATIC BRAIN-INJURY; DIABETES PREVENTION PROGRAM; ADULTS; HEALTH; EXERCISE; MODEL; RELIABILITY; MEDICINE; BENEFITS; VALIDITY	Objective: Describe (1) weight loss history, (2) perceptions about lifestyle changes, and (3) physical activity among a sample of individuals with traumatic brain injury prior to a 12-month lifestyle change program. Setting: Community-based. Participants: Individuals enrolled in a lifestyle change program, 6 months or more post-traumatic brain injury, body mass index of 25 or greater, 18 to 64 years of age, with physician's clearance to participate. Design: Convenience sample. Main Measures: Self-report data were collected before beginning the lifestyle change program including descriptive, weight loss history and physical activity behavior using the Modifiable Activity Questionnaire. Results: The final sample included 22 participants (M age = 46 years) injured a median of 8 years ago. Mean weight was 208.5 lb (SD = 40.2), with average body mass index of 31.84 (SD = 4.4). Since injury, 72.7% reported prior weight loss attempts, with 50% gaining 10 lb or more. All participants indicated high motivation for lifestyle changes. Perceived benefits included feeling better, improving overall health, and increased energy. Barriers included physical health complications. Types of physical activity completed included walking (68%, 180 min/mo) and swimming (32%, 79 min/mo). Conclusion: Results indicate that many individuals gained weight since injury and attempted weight loss, demonstrating a need for evidence-based lifestyle interventions. Future research is needed to determine whether individuals with traumatic brain injury are able to achieve and maintain weigh loss through intervention.	[Driver, Simon; Reynolds, Megan] Baylor Inst Rehabil, Phys Med & Rehabil, 909 N Washington Ave, Dallas, TX 75246 USA; [Douglas, Megan] Univ North Texas, Dept Psychol, Denton, TX USA; [Bennett, Monica] Baylor Scott & White Hlth, Ctr Clin Effectiveness, Dallas, TX USA		Driver, S (corresponding author), Baylor Inst Rehabil, Phys Med & Rehabil, 909 N Washington Ave, Dallas, TX 75246 USA.	simon.driver@BWSHealth.org		Douglas, Megan/0000-0002-1522-7991; driver, simon/0000-0003-2356-432X			Bellon K, 2015, BRAIN INJURY, V29, P313, DOI 10.3109/02699052.2014.974670; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; CDC, AB AD BMI; Centers for Disease Control and Prevention (CDC), CDC VIT SIGNS AD DIS; Centers for Disease Control and Prevention (CDC), TBI GET THE FACTS; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Cowan RE, 2016, ARCH PHYS MED REHAB, V97, pS232, DOI 10.1016/j.apmr.2016.01.040; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Driver S, BRAIN INJ IN PRESS; Driver S, 2008, ADAPT PHYS ACT Q, V25, P289, DOI 10.1123/apaq.25.4.289; Driver S, 2016, ARCH PHYS MED REHAB, V97, pS194, DOI 10.1016/j.apmr.2015.06.023; Driver S, 2013, BRAIN INJURY, V27, P1173, DOI 10.3109/02699052.2013.804197; Driver S, 2012, BRAIN INJURY, V26, P1482, DOI 10.3109/02699052.2012.694568; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Faul M, 2010, TRAUMATIC BRAIN INJU; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Guercio J, 1999, BRAIN INJURY, V13, P729; Hamilton M, 2016, BRAIN INJURY, V30, P819, DOI 10.3109/02699052.2016.1146962; Hamilton M, 2015, BRAIN INJURY, V29, P1572, DOI 10.3109/02699052.2015.1075145; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hassett L, 2016, BRAIN IMPAIR, V17, P43, DOI 10.1017/BrImp.2015.28; Hassett L, 2015, J HEAD TRAUMA REHAB, V30, pE55, DOI 10.1097/HTR.0000000000000047; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS245, DOI 10.1016/j.apmr.2014.06.024; Jones TM, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0039-x; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kramer MK, 2015, J OCCUP ENVIRON MED, V57, P284, DOI 10.1097/JOM.0000000000000350; Kramer MK, 2009, AM J PREV MED, V37, P505, DOI 10.1016/j.amepre.2009.07.020; KRISKA AM, 1990, DIABETES CARE, V13, P401, DOI 10.2337/diacare.13.4.401; Le D, 2015, AM J PHYS MED REHAB, V94, P627, DOI 10.1097/PHM.0000000000000222; Ma J, 2013, JAMA INTERN MED, V173, P113, DOI 10.1001/2013.jamainternmed.987; National Institutes of Health-National Institute of Neurological Disorders and Stroke, TRAUM BRAIN INJ HOP; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; Self M, 2013, ADAPT PHYS ACT Q, V30, P20, DOI 10.1123/apaq.30.1.20; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2015, NAT DAT 2015 PROF PE; Williams G, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318279536d; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009	44	7	7	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2018	33	1					E36	E43		10.1097/HTR.0000000000000327			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GB0QS	WOS:000428752300005	28520676				2022-02-06	
J	Durish, CL; Yeates, KO; Stancin, T; Taylor, HG; Walz, NC; Wade, SL				Durish, Christianne Laliberte; Yeates, Keith Owen; Stancin, Terry; Taylor, H. Gerry; Walz, Nicolay C.; Wade, Shari L.			Home Environment as a Predictor of Long-Term Executive Functioning following Early Childhood Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Preschool; Neuropsychology; Attention; Problem solving; Parenting; family	FAMILY OUTCOMES; SOCIAL OUTCOMES; BEHAVIOR; RELIABILITY; DYSFUNCTION; INVENTORY; MODERATOR	Objectives: This study examined the relationship of the home environment to long-term executive functioning (EF) following early childhood traumatic brain injury (TBI). Methods: Participants (N = 134) were drawn from a larger parent study of 3- to 6-year-old children hospitalized for severe TBI (n = 16), complicated mild/moderate TBI (n = 44), or orthopedic injury (OI; n = 74), recruited prospectively at four tertiary care hospitals in the United States and followed for an average of 6.8 years post-injury. Quality of the home environment, caregiver psychological distress, and general family functioning were assessed shortly after injury (i.e., early home) and again at follow-up (i.e., late home). Participants completed several performance-based measures of EF at follow-up. Hierarchical regression analyses examined the early and late home environment measures as predictors of EF, both as main effects and as moderators of group differences. Results: The early and late home environment were inconsistent predictors of long-term EF across groups. Group differences in EF were significant for only the TEA-Ch Walk/Don't Walk subtest, with poorer performance in the severe TBI group. However, several significant interactions suggested that the home environment moderated group differences in EF, particularly after complicated mild/moderate TBI. Conclusions: The home environment is not a consistent predictor of long-term EF in children with early TBI and OI, but may moderate the effects of TBI on EF. The findings suggest that interventions designed to improve the quality of stimulation in children's home environments might reduce the long-term effects of early childhood TBI on EF.	[Durish, Christianne Laliberte] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst,Cumming Sch Med, Calgary, AB, Canada; [Stancin, Terry] Case Western Reserve Univ, Dept Psychiat, Div Child & Adolescent Psychiat & Psychol, Cleveland, OH 44106 USA; [Stancin, Terry] MetroHlth Med Ctr, Cleveland, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Univ Hosp Cleveland Med Ctr, 2101 Adelbert Rd, Cleveland, OH 44106 USA; [Walz, Nicolay C.] Dept Pediat, Div Behav Med & Clin Psychol, Cincinnati, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Durish, CL (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	christianne.lalibert@ucalgary.ca	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729, K02 HD44099]; USPHS NIHUnited States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA [M01 RR 08084]; State of Ohio Emergency Medical Services; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077-04]; Alberta Innovates-Health Solutions; Alberta Innovates [201500100] Funding Source: researchfish	This research was supported by Grant R01 HD42729 from NICHD, in part by USPHS NIH Grant M01 RR 08084, Trauma Research grants from the State of Ohio Emergency Medical Services, as well as the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 8 UL1 TR000077-04. Dr. Yeates received support from career development Grant K02 HD44099 from NICHD. The authors wish to acknowledge the contributions of Christine Abraham, Andrea Beebe, Lori Bernard, Anne Birnbaum, Beth Bishop, Tammy Matecun, Karen Oberjohn, Elizabeth Roth, and Elizabeth Shaver in data collection. The Cincinnati Children's Medical Center Trauma Registry, Rainbow Pediatric Trauma Center, Rainbow Babies & Children's Hospital, Nationwide Children's Hospital Trauma Program, and MetroHealth Center Department of Pediatrics and Trauma Registry provided assistance with recruitment. Finally, Ms. Laliberte Durish received funding from Alberta Innovates-Health Solutions and the Alberta Children's Hospital Research Institute in the form of a graduate studentship. The authors do not declare any conflicts of interest.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bigler ED, 2015, BRAIN INJURY, V29, P1062, DOI 10.3109/02699052.2015.1011234; Blair C, 2014, DEV PSYCHOL, V50, P554, DOI 10.1037/a0033647; BRADLEY RH, 1984, DEV PSYCHOL, V20, P315, DOI 10.1037/0012-1649.20.2.315; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Caldwell B., 1984, HOME OBSERVATION MEA; Camerota M, 2015, J ABNORM CHILD PSYCH, V43, P1551, DOI 10.1007/s10802-015-0032-9; Crowe LM, 2014, J HEAD TRAUMA REHAB, V29, P217, DOI 10.1097/HTR.0b013e31829babfd; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Culbertson WC, 1998, ARCH CLIN NEUROPSYCH, V13, P285, DOI 10.1016/S0887-6177(97)00033-4; Derogatis L.R., 2000, BRIEF SYMPTOM INVENT; Derogatis L. R., 1994, USE PSYCHOL TESTING, P217; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Faul M, 2010, TRAUMATIC BRAIN INJU; Garcia D, 2015, J PEDIATR PSYCHOL, V40, P391, DOI 10.1093/jpepsy/jsu093; Hayes A. F., 2013, INTRO MEDICATION MOD; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Mangeot S., 2010, CHILD NEUROPSYCHOL, V8, P271; Manly T., 1999, TEA CH THE TEST OF E; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Papoutsis J, 2014, DEV NEUROPSYCHOL, V39, P638, DOI 10.1080/87565641.2014.979926; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Roskam I, 2014, J EXP CHILD PSYCHOL, V122, P166, DOI 10.1016/j.jecp.2014.01.003; Sarsour K, 2011, J INT NEUROPSYCH SOC, V17, P120, DOI 10.1017/S1355617710001335; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393	42	7	7	0	20	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2018	24	1					11	21		10.1017/S1355617717000595			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	FR6BL	WOS:000419150300002	28724466	Green Accepted			2022-02-06	
S	Echemendia, RJ; Gioia, GA		Hainline, B; Stern, RA		Echemendia, Ruben J.; Gioia, Gerard A.			The role of neuropsychologists in concussion evaluation and management	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							SPORT-RELATED CONCUSSION; TEST-RETEST RELIABILITY; TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; EARLY INTERVENTION; VIDEO ANALYSIS; TEST BATTERY; IMPACT	Sport-related concussions are complex injuries of the brain. Since concussions can only be diagnosed clinically and manifest in different ways among athletes, diagnosis and management often require a multidisciplinary team approach. Sports neuropsychologists contribute to the team through their ability to assess cognitive, behavioral, and social-emotional domains that may or may not be a direct effect of the injury. This chapter describes the new field of sports neuropsychology and articulates how neuropsychologists can contribute to assessment and management. The strengths and weaknesses of neuropsychological assessment are reviewed, including traditional paper-and-pencil testing and computer-administered tests, both as baseline and postinjury evaluations. Neuropsychologists can provide biopsychosocial evaluation and treatment services to athletes, including postinjury education and emotional reassurance, guiding symptom management and emotional support, and assisting with return-to-play and return-to-school processes. They also provide important insight for decisions regarding retirement, including articulating the relevant factors and supporting athletes in their decision process. Given the varying and behavioral responses that can accompany concussion, neuropsychologists can provide unique support to athletes to help them cope with their injury and its effects.	[Echemendia, Ruben J.] Univ Orthoped Ctr, Concuss Care Clin, State Coll, PA USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Div Pediat Neuropsychol, Rockville, MD USA		Gioia, GA (corresponding author), George Washington Univ, Sch Med, 15245 Shady Grove Rd,Suite 350, Rockville, MD 20850 USA.	GGioia@childrensnational.org					Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barth JT, 1989, MILD HEAD INJURY; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Benedict R. H., 1997, PSYCHOL ASSESSMENT R; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Bruce J, 2016, APPL NEUROPSYCH-ADUL, V23, P336, DOI 10.1080/23279095.2015.1064002; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Bruce JM, 2017, CLIN NEUROPSYCHOL, V31, P1329, DOI 10.1080/13854046.2017.1311375; Cantu RC, 2013, JAMA NEUROL, V70, P1481, DOI 10.1001/jamaneurol.2013.3231; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Cantu RC, 2009, CURR SPORT MED REP, V8, P6, DOI 10.1249/JSR.0b013e31819677db; Centers for Disease Control and Prevention, 2017, REP PED MILD TRAUM B; Centers for Disease Control and Prevention, 2010, HEADS SCH KNOW CONC; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Childers C, 2016, J POSTSECOND EDUC DI, V29, P389; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, NEUROPSYCHOLOGICAL P; Echemendia RJ, 2010, B NATL ACAD NEUROPSY, V25, P5; Echemendia RJ, 2015, PSYCHOL INJ LAW, V8, P289, DOI 10.1007/s12207-015-9241-3; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Echemendia RJ, 2016, CLIN NEUROPSYCHOL, V30, P311, DOI 10.1080/13854046.2016.1158320; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, J CLIN SPORT PSYCHOL, V6, P207, DOI 10.1123/jcsp.6.3.207; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; English T, 2017, EMOTION, V17, P1, DOI 10.1037/emo0000235; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-017-0117-9; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Gioia GA, 2017, CLIN PEDIATR EMERG M, V18, P42; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GRONWALL D, 1974, LANCET, V2, P605; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guskiewicz K, 2009, ORTHOPAEDIC KNOWLEDG, P285; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hamsher K., 1989, MULTILINGUAL APHASIA; Harris P, 2015, KNOWLEDGEABLE ARE AM; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Lovell M, 2000, IMPACT IMMEDIATE POS; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCarty CA, 2017, PEDIATRICS, V138, P1; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Neuropsychology Society Sports, 2014, SPORTS NEUR PSYCH DE; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Purcell L, 2018, BR J SPORTS MED; Quinlan Patricia, 2013, HSS J, V9, P42, DOI 10.1007/s11420-012-9308-6; Rabinowitz AR, 2015, DEV NEUROPSYCHOL, V40, P29, DOI 10.1080/87565641.2014.1001066; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Ransom DM, 2016, J INT NEUROPSYCH SOC, V22, P1038, DOI 10.1017/S1355617716000916; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2014, OXFORD HDB SPORTS RE; Schatz P, 2012, OXFORD HDB SPORT REL; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Smith A., 1982, SYMBOL DIGIT MODALIT; Subotic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183092; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Walsh K. W., 1978, NEUROPSYCHOLOGY CLIN; Wechsler D, 2001, WECHSLER TEST ADULT; Wechsler D., 2011, TEST PREMORBID FUNCT; White T., 1996, COLOR TRAILS TEST PR; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	109	7	8	0	0	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						179	191		10.1016/B978-0-444-63954-7.00018-5			13	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100020	30482345				2022-02-06	
J	El Husseini, N; Hoffman, BM; Bennett, ER; Li, YW; Taylor, RAW; Hailey, CE; Richardson, K; Li, YJ; Laskowitz, DT; James, ML				El Husseini, Nada; Hoffman, Benjamin M.; Bennett, Ellen R.; Li, Yen-Wei; Taylor, Rachel A. Williamson; Hailey, Claire E.; Richardson, Kara; Li, Yi-Ju; Laskowitz, Daniel T.; James, Michael L.			Association of IL6ST (gp130) Polymorphism with Functional Outcome Following Spontaneous Intracerebral Hemorrhage	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Intracerebral hemorrhage; neurological outcome; single nucleotide polymorphism; gp130; IL6ST	TRAUMATIC BRAIN-INJURY; POLY(ADP-RIBOSE) POLYMERASE; CEREBRAL-ISCHEMIA; SIGNAL TRANSDUCER; ADP-RIBOSYLATION; APOLIPOPROTEIN-E; BLOOD-PRESSURE; APOE GENOTYPE; MICE; ACTIVATION	Background and Purpose: Genes associated with the inflammatory response and cytostructural integrity may influence recovery following a brain injury. To examine this in the setting of spontaneous intracerebral hemorrhage (ICH), selected single nucleotide polymorphisms (SNPs) were assessed for associations with patient outcome. Methods: A cohort of 54 patients with supratentorial ICH were enrolled. Based on known involvement with neuroinflammation and cytostructural integrity, 10 preselected SNPs from 6 candidate genes were tested for associations with 6-month functional outcome (modified Rankin Scale [mRS] >= 3), mortality, and in-hospital deterioration (Glasgow Coma Scale decrease by >2 within 7 days of admission) following ICH. Fisher's exact test and logistic regression with adjustment for race and ICH score were performed. Results: SNP rs10940495 (gp130 G/A) within the gp130 gene was the only SNP significantly associated with lower odds of an unfavorable 6-month functional outcome (odds ratio = .16 for mRS >= 3; 95% confidence interval,.03-.87, P =.03). Compared with major allele (A) homozygotes, minor allele (G) carriers in the IL6 signal transducer gene (gp130) locus were 84% less likely to have a poor outcome (mRS >= 3) at 6 months following spontaneous ICH. The SNP rs10940495 (gp130 G/A) and SNP rs3219119 (PARP-1 A/T) were associated with 6-month mortality (P = .02 and .04, respectively) only on univariate analysis. None of the SNPs examined were associated with in-hospital deterioration. Conclusion: In this exploratory study, SNP rs10940495 in the gp130 locus was associated with functional outcome at 6 months following spontaneous ICH. These findings, which should be validated through a larger study, suggest that inflammation plays an important role in mediating outcomes after ICH.	[El Husseini, Nada; Bennett, Ellen R.; Richardson, Kara; Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Dept Neurol, Durham, NC USA; [El Husseini, Nada; Hoffman, Benjamin M.] Wake Forest Baptist Med Ctr, Dept Neurol, Winston Salem, NC 27157 USA; [Bennett, Ellen R.; Richardson, Kara; Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Dept Anesthesiol, Durham, NC USA; [Li, Yen-Wei; Li, Yi-Ju] Duke Univ, Brain Injury Translat Res Ctr, Durham, NC USA; [Taylor, Rachel A. Williamson; Hailey, Claire E.; Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA		El Husseini, N (corresponding author), Wake Forest Baptist Med Ctr, Dept Neurol, Div Vasc Neurol, 6th Floor Janeway Tower,Med Ctr Blvd, Winston Salem, NC 27157 USA.	nelhusse@wakehealth.edu	James, Michael L./AAJ-5592-2020	James, Michael L./0000-0002-8715-5210; Li, Yi-Ju/0000-0001-6996-4834	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Hospira; Cephalogics; Baxter; American Heart AssociationAmerican Heart Association	Dr. Laskowitz served as a consultant and holds stock options for Astute Medical. Dr. James has received personal compensation for activities with Hospira and Cephalogics. Dr. James has received research support from the National Institutes of Health, American Heart Association, Baxter, Cephalogics, and Hospira.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson CS, 2010, STROKE, V41, P307, DOI 10.1161/STROKEAHA.109.561795; Benrick A, 2008, REGUL PEPTIDES, V146, P189, DOI 10.1016/j.regpep.2007.09.031; Biffi A, 2011, LANCET NEUROL, V10, P702, DOI 10.1016/S1474-4422(11)70148-X; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Endres M, 1998, NEUROSCI LETT, V248, P41, DOI 10.1016/S0304-3940(98)00224-9; Gallek MJ, 2009, BIOL RES NURS, V10, P205, DOI 10.1177/1099800408323221; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gottardo L, 2008, OBESITY, V16, P205, DOI 10.1038/oby.2007.28; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hirano Toshio, 1997, Cytokine and Growth Factor Reviews, V8, P241, DOI 10.1016/S1359-6101(98)80005-1; Inta I, 2009, J HYPERTENS, V27, P527, DOI 10.1097/HJH.0b013e32831e9948; James ML, 2012, ANESTHESIOLOGY, V116, P1299, DOI 10.1097/ALN.0b013e318253a02a; James ML, 2010, J NEUROTRAUM, V27, P217, DOI 10.1089/neu.2009.1022; James ML, 2009, BIOMARKERS, V14, P388, DOI 10.1080/13547500903015784; James ML, 2009, J STROKE CEREBROVASC, V18, P144, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.012; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; Kao HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132115; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Laskowitz DT, 2012, NEUROCRIT CARE, V16, P316, DOI 10.1007/s12028-011-9641-5; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li X, 2013, MOL MED REP, V7, P1261, DOI 10.3892/mmr.2013.1332; Luchtefeld M, 2007, J EXP MED, V204, P1935, DOI 10.1084/jem.20070120; MAYER SA, 1994, NEUROLOGY, V44, P1379, DOI 10.1212/WNL.44.8.1379; Mayer SA, 2007, STROKE, V38, P763, DOI 10.1161/01.STR.0000254499.46122.22; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qureshi Adnan I, 2005, J Intensive Care Med, V20, P34, DOI 10.1177/0885066604271619; Qureshi AI, 2014, NEUROCRIT CARE, V20, P470, DOI 10.1007/s12028-013-9842-1; Ritschel VN, 2016, J AM HEART ASSOC, V5, P5; Sarnaik AA, 2010, J NEUROTRAUM, V27, P465, DOI 10.1089/neu.2009.1171; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Sorimachi T, 2010, J CLIN NEUROSCI, V17, P1367, DOI 10.1016/j.jocn.2010.02.024; Sun W, 2012, J CLIN NEUROSCI, V19, P1096, DOI 10.1016/j.jocn.2011.11.020; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Vespa PM, 2013, STROKE, V44, pS79, DOI 10.1161/STROKEAHA.113.001494; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Waters RJ, 2005, CURR OPIN CRIT CARE, V11, P105, DOI 10.1097/01.ccx.0000155354.78617.91; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Wonnerth A, 2014, METABOLISM, V63, P647, DOI 10.1016/j.metabol.2014.02.005; Yeatts SD, 2013, NEUROCRIT CARE, V19, P257, DOI 10.1007/s12028-013-9861-y	47	7	7	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2018	27	1					125	131		10.1016/j.jstrokecerebrovasdis.2017.08.017			7	Neurosciences; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	FS2BZ	WOS:000419584400019	28964648				2022-02-06	
S	Fernandes, FAO; de Sousa, RJA; Ptak, M	Fernandes, FAO; DeSousa, RJA; Ptak, M			Fernandes, Fabio A. O.; Alves de Sousa, Ricardo J.; Ptak, Mariusz	Fernandes, FAO; DeSousa, RJA; Ptak, M		Finite Element Head Modelling and Head Injury Predictors	HEAD INJURY SIMULATION IN ROAD TRAFFIC ACCIDENTS	Springerbriefs in Applied Sciences and Technology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; MECHANICAL-PROPERTIES; DYNAMIC-RESPONSE; BRIDGING VEINS; SKULL FRACTURE; STRAIN-RATE; IMPACT; VALIDATION; BIOMECHANICS		[Fernandes, Fabio A. O.; Alves de Sousa, Ricardo J.] Univ Aveiro, Ctr Mech Technol & Automat TEMA, Aveiro, Portugal; [Ptak, Mariusz] Wroclaw Univ Sci & Technol, Wroclaw, Poland		Fernandes, FAO (corresponding author), Univ Aveiro, Ctr Mech Technol & Automat TEMA, Aveiro, Portugal.		de Sousa, Ricardo Alves/E-4405-2010; Fernandes, Fabio A.O./H-2680-2012; Ptak, Mariusz/B-1493-2013	de Sousa, Ricardo Alves/0000-0002-5848-6424; Fernandes, Fabio A.O./0000-0001-9751-8807; Ptak, Mariusz/0000-0001-8081-8336			Aare M., 2003, INT RES COUNC BIOM I, P349; Aare M., 2003, PREVENTION HEAD INJU; Advani S, 1975, P INT C BIOM SER TRA, P153; Advani SH, 1982, HUMAN BODY DYNAMICS; Aiello M, 2007, INT J CRASHWORTHINES, V12, P1, DOI 10.1533/ijcr.2006.0134; AlBsharat A. S., 1999, P 43 STAPP CAR CRASH, P321; Allsop D., 1991, P 35 STAPP CAR CRASH, P139; Allsop D, 1988, P 32 STAPP CAR CRASH; Andaluz N., 2016, TRAUMATIC BRAIN INJU; ANDERSON R, 2000, THESIS U ADELAIDE; [Anonymous], 2001, COST327 EUR COMM; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F.A., 2001, P 17 INT TECHN C ENH; Bandak F.A., 1994, 38 STAPP CAR CRASH C, P145; BANDAK FA, 1995, J NEUROTRAUM, V12, P635, DOI 10.1089/neu.1995.12.635; Bandak FA, 1997, RES LEG MED, V17, P59; Bandak FA, 1997, NATO ADV SCI I E-APP, V332, P53; Baumgartner D., 2001, P IRCOBI C ISL MAN U; BAUMGARTNER D, 2001, THESIS U L PASTEUR S; Belingardi G., 2005, 050441 POL TOR DIP M; BRANDS DWA, 2002, P 46 STAPP CAR CRASH, P103; Canaple B, 2003, INT J CRASHWORTHINES, V8, P41; Canaple B, 2002, INT J CRASHWORTHINES, V7, P307; Cardamone L., 2005, ANALISI NUMERICA TRA; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Claessens M., 1997, 973338 SAE, P3829; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Cloots R.J.H., 2010, P IRCOBI C HANN GERM, P119; Darvish K. K., 2002, P IRCOBI C MUN GERM; Deck C, 2003, STRUCT MAT, V13, P319; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Deck C., 2009, P 7 EUR LS DYNA C; DiMasi F., 1991, P 12 INT TECHN C EXP, V2, P617; DiMasi F. P., 1995, P 39 STAPP CAR CRASH; Dirisala V, 2012, INT J NUMER METH BIO, V28, P472, DOI 10.1002/cnm.1480; Dokko Y., 2003, P 18 INT TECHN C ENH; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Fernandes FAO, 2017, PROCEDIA MANUF, V13, P227, DOI 10.1016/j.promfg.2017.09.055; Fernandes FAO, 2017, PROCEDIA MANUF, V13, P219, DOI 10.1016/j.promfg.2017.09.052; Fernandes FAO, 2015, MATER DESIGN, V82, P335, DOI 10.1016/j.matdes.2015.06.004; Fernandes F. A. O., 2013, P IRCOBI C GOTH, P431; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Fernandes FAO, 2013, STRUCT ENG MECH, V48, P661, DOI 10.12989/sem.2013.48.5.661; FRANKLYN M, 2003, P 18 INT TECHN C ENH; Gilchrist MD, 2000, COMPUT MECH, V26, P229, DOI 10.1007/s004660000179; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Gurdjian ES, 1966, CLIN NEUROSURG, V12, P112; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hartmann ULRICH, 1999, Comput Methods Biomech Biomed Engin, V2, P49, DOI 10.1080/10255849908907978; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Ho J, 2009, INT J CRASHWORTHINES, V14, P555, DOI 10.1080/13588260902895708; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Hodgson V. R., 1971, BREAKING STRENGTH HU; Hodgson VR, 1970, P 14 STAPP CAR CRASH; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hosey R. R., 1982, FINITE ELEMENTS BIOM, P379; Ipek H., 2009, COUPLING STRASBOURG, P1; Iwamoto M., 2003, LS DYNA JMAG US C JA; Iwamoto M, 2007, 6 EUR LS DYNA US C, P47; Iwamoto M., 2002, P IRCOBI C MUN GERM; KANG H, 1997, SAE T, V41, P849; KHALIL TB, 1977, J BIOMECH, V10, P119, DOI 10.1016/0021-9290(77)90075-6; KHALIL TB, 1982, P 26 STAPP CAR CRASH, P87; Kim J. E., 2005, 17 IMACS WORLD C SCI; Kimpara H., 2006, P 50 STAPP CAR CRASH, P509; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S., 2007, HEAD INJURY BIOMECHA; Kleiven S., 2006, SCAND J FORENS SCI, V2, P73; Kleiven S., 2001, P INT C BIOM IMP IRC, P161; KLEIVEN S, 2002, THESIS ROYAL I TECHN; Kleiven S., 2002, P 45 STAPP CAR CRASH; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; KRABBEL G, 1996, VIS HUM PROJ C NAT I, P71; Lauret C, 2009, MED ENG PHYS, V31, P392, DOI 10.1016/j.medengphy.2008.05.004; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; Li XG, 2011, ACTA NEUROCHIR, V153, P2057, DOI 10.1007/s00701-011-1078-2; Liu D. S., 1998, P INT CRASHW C DEAR; LOWENHIELM P, 1974, Z RECHTSMED, V75, P131, DOI 10.1007/BF02114709; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; MCLEAN AJ, 1995, J NEUROTRAUM, V12, P621, DOI 10.1089/neu.1995.12.621; Melvin J. W., 1970, P 14 STAPP CAR CRASH; Mendis K, 1992, THESIS OHIO STATE U; Miller R.T., 1998, STAPP CAR CRASH J, P155; Mills N.J., 1995, 1995 IRCOBI C BRUNN, P217; Monea AG, 2014, J MECH BEHAV BIOMED, V33, P3, DOI 10.1016/j.jmbbm.2013.06.011; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Morrison III B., 2003, P 47 STAPP CAR CRASH; Motherway J, 2009, Leg Med (Tokyo), V11 Suppl 1, pS220, DOI 10.1016/j.legalmed.2009.01.072; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; NAHUM AM, 1968, P 12 STAPP CAR CRASH; Nakadate H., 2014, JBSE, V9, DOI [10.1299/jbse.14-00136, DOI 10.1299/JBSE.14-00136]; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Ptak M, 2017, INT J IMPACT ENG, V106, P238, DOI 10.1016/j.ijimpeng.2017.04.014; Ptak M., 2017, P 13 INT SCI C RESRB; Raul JS, 2008, INT J LEGAL MED, V122, P359, DOI 10.1007/s00414-008-0248-0; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; ROBBINS DH, 1969, EXP MECH, V9, P236, DOI 10.1007/BF02326542; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; RUAN JS, 1993, P 37 STAPP CAR C; Sahoo D, 2014, 2014 IRCOBI C BERL G, P106; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Sahoo D, 2016, J MECH BEHAV BIOMED, V57, P24, DOI 10.1016/j.jmbbm.2015.11.014; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Sahoo D, 2013, J MECH BEHAV BIOMED, V28, P340, DOI 10.1016/j.jmbbm.2013.08.010; Schneider DC, 1972, P 16 STAPP CAR CRASH, P186; Schwartz D, 2015, TRAFFIC INJ PREV, V16, pS49, DOI 10.1080/15389588.2015.1021418; Shreiber D. I., 1997, P 41 STAPP CAR CRASH, P177; Shugar T. A., 1977, 2893550TA DOT HS; SHUGAR TA, 1975, J ENG MECH DIV-ASCE, V101, P223; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Suh CM, 2005, J MECH SCI TECHNOL, V19, P1424, DOI 10.1007/BF03023901; Takhounts EG, 2008, STAPP CAR C, V52, P1; Takhounts GE, 2003, STAPP CAR CRASH J, V47, P107; Tchepel D., 2016, WHAT ARE FORENSIC SC, P3542; Thamburaj VA, 2012, TXB CONT NEUROSURGER; Thibault L.E., 1990, P INT C BIOM IMP LYO, P191; Thibault L. E., 1993, P IRCOBI C EINDH NET, P3; Tse K.M., 2014, AM J ENG TECHNOL SOC, V1, P28; Turquier F, 1996, P 40 STAPP CAR CRASH, P1912; van den Bosch H.L.A., 2006, THESIS TU EINDHOVEN; van Dommelen J.A.W., 2008, J BIOMECH ENG, V130, P663; Vezin P., 2004, P IRCOBI C GRAZ AUST, P319; Viano D. C., 1999, J CRASH PREVENTION I, V1, P35; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Voo L., 1994, 941725 SAE, P178; Ward C., 1980, P 8 ANN INT WORKSH H; Ward C, 1980, P 24 STAPP CAR CRASH; WARD CC, 1975, P 19 STAPP CAR CRASH, P641; Willinger R, 2000, J SOUND VIB, V235, P611, DOI 10.1006/jsvi.1999.2931; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Willinger R, 1999, CR ACAD SCI II B, V327, P125, DOI 10.1016/S1287-4620(99)80021-0; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Willinger R, 2000, INT J CRASHWORTHINES, V5, P249; Willinger Rm, 2000, P INT RES COUNCIL BI, P209; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Yang J, 2011, COMPUTATIONAL BIOMEC; Yao JF, 2006, P IRCOBI MADR SPAIN, P241; Yao JF, 2008, SAFETY SCI, V46, P1103, DOI 10.1016/j.ssci.2007.06.021; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Yoganandan N., 1994, 94172 SAE, P184; Zhang J., 2007, 070352 DEP NEUR MED; Zhang JJ, 2008, PACIIA: 2008 PACIFIC-ASIA WORKSHOP ON COMPUTATIONAL INTELLIGENCE AND INDUSTRIAL APPLICATION, VOLS 1-3, PROCEEDINGS, P123; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang L., 2003, ASME BIOENG C P FLOR, P25; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; ZHOU C, 1996, P ADV GROUP AER RES, P81; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714; Ziejewski M., 2009, P 21 INT C ENH SAF V	162	7	7	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	2191-530X	2191-5318	978-3-319-89926-8; 978-3-319-89925-1	SPRINGERBR APPL SCI			2018							1	23		10.1007/978-3-319-89926-8_1	10.1007/978-3-319-89926-8		23	Engineering, Biomedical; Transportation Science & Technology	Book Citation Index – Science (BKCI-S)	Engineering; Transportation	BL0JP	WOS:000446010400001					2022-02-06	
J	Figueiredo, TH; Harbert, CL; Pidoplichko, V; Almeida-Suhett, CP; Pan, HN; Rossetti, K; Braga, MFM; Marini, AM				Figueiredo, Taiza H.; Harbert, Carolina L.; Pidoplichko, Volodymyr; Almeida-Suhett, Camila P.; Pan, Hongna; Rossetti, Katia; Braga, Maria F. M.; Marini, Ann M.			Alpha-Linolenic Acid Treatment Reduces the Contusion and Prevents the Development of Anxiety-Like Behavior Induced by a Mild Traumatic Brain Injury in Rats	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Anxiety disorders; Controlled cortical impact; Rat; Alpha-linolenic acid	POLYUNSATURATED FATTY-ACIDS; FACTOR-KAPPA-B; PSYCHIATRIC-DISORDERS; UNITED-STATES; NEUROPROTECTIVE EFFICACY; LIPID RAFTS; SOMAN; MODERATE; TRANSCRIPTION; EPIDEMIOLOGY	Approximately, 1.7 million Americans suffer a TBI annually and TBI is a major cause of death and disability. The majority of the TBI cases are of the mild type and while most patients recover completely from mild TBI (mTBI) about 10% result in persistent symptoms and some result in lifelong disability. Anxiety disorders are the second most common diagnosis post-TBI. Of note, TBI-induced anxiety disorders are difficult to treat and remain a chronic condition suggesting that new therapies are needed. Previous work from our laboratory demonstrated that a mild TBI induced an anxiety-like phenotype, a key feature of the human condition, associated with loss of GABAergic interneurons and hyperexcitability in the basolateral amygdala (BLA) in rodents 7 and 30 days after a controlled cortical impact (CCI) injury. We now confirm that animals display significantly increased anxiety-like behavior 30 days after CCI. The anxiety-like behavior was associated with a significant loss of GABAergic interneurons and significant reductions in the frequency and amplitude of spontaneous and miniature GABA(A)-receptor-mediated inhibitory postsynaptic currents (IPSCs) in the BLA. Significantly, subchronic treatment with alpha-linolenic acid (ALA) after CCI prevents the development of anxiety-like behavior, the loss of GABAergic interneurons, hyperexcitability in the BLA and reduces the impact injury. Taken together, administration of ALA after CCI is a potent therapy against the neuropathology and pathophysiological effects of mTBI in the BLA.	[Figueiredo, Taiza H.; Harbert, Carolina L.; Pidoplichko, Volodymyr; Almeida-Suhett, Camila P.; Rossetti, Katia; Braga, Maria F. M.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Pan, Hongna; Marini, Ann M.] Uniformed Serv Univ Hlth Sci, Dept Neurol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Pan, Hongna; Marini, Ann M.] Uniformed Serv Univ Hlth Sci, Program Neurosci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Marini, AM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.; Marini, AM (corresponding author), Uniformed Serv Univ Hlth Sci, Program Neurosci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	ann.marini@usuhs.edu	Almeida-Suhett, Camila/I-8045-2016	Almeida-Suhett, Camila/0000-0002-7588-9487	US Army Research Office; Defense Advanced Research Projects Agency (DARPA)United States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [W911NF-14-2-0100]	Research was sponsored by the US Army Research Office and the Defense Advanced Research Projects Agency (DARPA) and was accomplished under Cooperative Agreement Number W911NF-14-2-0100.	ADAM O, 1986, J LIPID RES, V27, P421; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; ANDING RH, 1986, LIPIDS, V21, P697, DOI 10.1007/BF02537243; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Aroniadou-Anderjaska V, 2012, NEUROSCIENCE, V221, P157, DOI 10.1016/j.neuroscience.2012.07.006; Basiouni S, 2012, CELL IMMUNOL, V275, P42, DOI 10.1016/j.cellimm.2012.03.004; Bay Esther H, 2009, Res Theory Nurs Pract, V23, P42; Besshoh S, 2007, J NEUROSCI RES, V85, P1876, DOI 10.1002/jnr.21336; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; Blondeau N, 2016, BIOCHIMIE, V120, P49, DOI 10.1016/j.biochi.2015.06.005; Blondeau N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/519830; Blondeau N, 2009, NEUROPSYCHOPHARMACOL, V34, P2548, DOI 10.1038/npp.2009.84; Bourourou M, 2016, NEUROPHARMACOLOGY, V108, P60, DOI 10.1016/j.neuropharm.2016.04.040; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; CUNNANE SC, 1993, BRIT J NUTR, V69, P443, DOI 10.1079/BJN19930046; de Goede J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017967; Deb S, 1999, AM J PSYCHIAT, V156, P374; Desai A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0714-4; Egawa J, 2016, J PHYSIOL-LONDON, V594, P4565, DOI 10.1113/JP270590; Epstein Richard S., 1994, P285; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Faraday MM, 2001, PHARMACOL BIOCHEM BE, V70, P475, DOI 10.1016/S0091-3057(01)00642-6; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Figueiredo TH, 2011, BRIT J PHARMACOL, V164, P1495, DOI 10.1111/j.1476-5381.2011.01427.x; Figueiredo TH, 2011, J PHARMACOL EXP THER, V336, P303, DOI 10.1124/jpet.110.171835; Golub T, 2004, CURR OPIN NEUROBIOL, V14, P542, DOI 10.1016/j.conb.2004.08.003; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOLMAN RT, 1982, AM J CLIN NUTR, V35, P617, DOI 10.1093/ajcn/35.3.617; Holzschneider Kathrin, 2011, Dialogues Clin Neurosci, V13, P453; Hung HC, 2015, EUR NEUROPSYCHOPHARM, V25, P1723, DOI 10.1016/j.euroneuro.2015.07.005; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jiang XY, 2008, J NEUROSCI, V28, P1118, DOI 10.1523/JNEUROSCI.2262-07.2008; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S; Lang-Lazdunski L, 2003, J VASC SURG, V38, P564, DOI 10.1016/S0741-5214(03)00473-7; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lin YH, 2007, J LIPID RES, V48, P2709, DOI 10.1194/jlr.M700369-JLR200; Lipsky RH, 2001, J NEUROCHEM, V78, P254, DOI 10.1046/j.1471-4159.2001.00386.x; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Marini AM, 2007, AMINO ACIDS, V32, P299, DOI 10.1007/s00726-006-0414-y; Marini AM, 1998, J BIOL CHEM, V273, P29394, DOI 10.1074/jbc.273.45.29394; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Mutoh T, 2000, GLYCOCONJUGATE J, V17, P233, DOI 10.1023/A:1026597408790; Nguemeni C, 2010, PHARMACOL RES, V61, P226, DOI 10.1016/j.phrs.2009.12.007; OWREN PA, 1964, LANCET, V2, P975; Pan H, 2015, NEUROTOXICOLOGY, V51, P38, DOI 10.1016/j.neuro.2015.09.006; Pan HN, 2012, NEUROTOXICOLOGY, V33, P1219, DOI 10.1016/j.neuro.2012.07.001; Park K, 2007, BIOCHEM BIOPH RES CO, V361, P718, DOI 10.1016/j.bbrc.2007.07.064; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; Pidoplichko VI, 2013, J NEUROPHYSIOL, V110, P2358, DOI 10.1152/jn.01030.2012; Piermartiri T, 2015, MOLECULES, V20, P20355, DOI 10.3390/molecules201119698; Piermartiri TCB, 2015, NEUROMOL MED, V17, P251, DOI 10.1007/s12017-015-8353-y; Prager EM, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00038; Prince DA, 2016, PROG BRAIN RES, V226, P209, DOI 10.1016/bs.pbr.2016.03.013; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sala-Vila A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002543; SANDERS TAB, 1983, CLIN SCI, V64, P91, DOI 10.1042/cs0640091; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simopoulos Artemis P., 1999, Annals of Nutrition and Metabolism, V43, P127, DOI 10.1159/000012777; SINGER P, 1986, PROSTAG LEUKOTR ESS, V24, P173, DOI 10.1016/0262-1746(86)90125-3; SINGER P, 1984, PROSTA LEUKOTR MED, V15, P159, DOI 10.1016/0262-1746(84)90173-2; Sosin DM, 1996, BRAIN INJURY, V10, P47; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Virtanen JK, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000305; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Watson C., 2005, RAT BRAIN STEROTAXIC; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Zaninotto AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00095	85	7	7	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2018	55	1					187	200		10.1007/s12035-017-0732-y			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV6PC	WOS:000424702600020	28844093				2022-02-06	
J	Genet, GF; Bentzer, P; Hansen, MB; Ostrowski, SR; Johansson, PI				Genet, Gustav Folmer; Bentzer, Peter; Hansen, Morten Bagge; Ostrowski, Sisse Rye; Johansson, Par Ingemar			Effects of propranolol and clonidine on brain edema, blood-brain barrier permeability, and endothelial glycocalyx disruption after fluid percussion brain injury in the rat	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Blood-brain barrier breakdown; brain water content; clonidine; glycocalyx; propranolol	DECREASES PLASMA-CATECHOLAMINES; HEMORRHAGIC-SHOCK; CEREBRAL PERFUSION; BETA-BLOCKERS; RODENT MODEL; TRAUMA; COAGULOPATHY; PATHOPHYSIOLOGY; RESUSCITATION; INFLAMMATION	BACKGROUND Traumatic brain injury causes a disruption of the vascular endothelial glycocalyx layer that is associated with an overactivation of the sympathoadrenal system. We hypothesized that early and unselective beta-blockade with propranolol alone or in combination with the alfa(2)-agonist clonidine would decrease brain edema, blood-brain barrier permeability, and glycocalyx disruption at 24 hours after trauma. METHODS We subjected 53 adult male Sprague-Dawley rats to lateral fluid percussion brain injury and randomized infusion with propranolol (n = 16), propranolol + clonidine (n = 16), vehicle (n = 16), or sham (n = 5) for 24 hours. Primary outcome was brain water content at 24 hours. Secondary outcomes were blood-brain barrier permeability and plasma levels of syndecan-1 (glycocalyx disruption), cell damage (histone-complexed DNA fragments), epinephrine, norepinephrine, and animal motor function. RESULTS We found no difference in brain water content (mean SD) between propranolol (80.8 +/- 0.3%; 95% confidence interval [CI], 80.7-81.0) and vehicle (81.1 +/- 0.6%; 95% CI, 80.8-81.4) (p = 0.668) or between propranolol/clonidine (80.8 +/- 0.3%; 95% CI, 80.7-81.0) and vehicle (p = 0.555). We found no effect of propranolol and propranolol/clonidine on blood-brain barrier permeability and animal motor scores. Unexpectedly, propranolol and propranolol/clonidine caused an increase in epinephrine and syndecan-1 levels. CONCLUSION This study does not provide any support for unselective beta-blockade with propranolol or the combination of propranolol and the alfa(2)-agonist clonidine on brain water content. The novel finding of an increase in plasma concentrations of epinephrine and syndecan-1 after propranolol treatment in traumatic brain injury is of unclear significance and should be investigated further.	[Genet, Gustav Folmer; Hansen, Morten Bagge; Ostrowski, Sisse Rye; Johansson, Par Ingemar] Univ Copenhagen, Rigshosp, Capital Reg Blood Bank, Transfus Med Sect, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Bentzer, Peter] Helsingborg Hosp, Dept Anesthesia & Intens Care, Helsingborg, Sweden; Lund Univ, Lund, Sweden; [Johansson, Par Ingemar] Univ Texas Houston, Sch Med, Ctr Translat Injury Res, Dept Surg,CeTIR, Houston, TX USA		Genet, GF (corresponding author), Univ Copenhagen, Rigshosp, Capital Reg Blood Bank, Transfus Med Sect, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	gustav.folmer.genet@regionh.dk	Ostrowski, Sisse R/E-7423-2011	Ostrowski, Sisse R/0000-0001-5288-3851; Johansson, Par Ingemar/0000-0001-9778-5964	A.P. Moller Foundation for Medical Sciences; Augustinus Foundation; King Christian X Foundation; University of Copenhagen Faculty of Health and Medical Sciences	We thank Helen Axelberg, B.A. (Technician, Department of Anesthesiology and Intensive Care, Lund University, Lund, Sweden), for skilled technical assistance regarding surgical preparation and pathology methods. Marten Jungner, MD, PhD (Department of Anesthesiology and Intensive Care, Lund University, Lund, Sweden) for skilled advices regarding the model. Gustav Mattiasson, MD, PhD, Associate Professor (Anesthesia & Intensive Care, Lund University Hospital, Lund, Sweden) for skilled advices regarding the composite neuroscore test and Line Gronkjaer Hansen (Laboratory technician, Department of Clinical Immunology, Section for Transfusion Medicine, Rigshospitalet, Copenhagen, Denmark) for skilled technical assistance regarding ELISA analysis. We would also like to thank the following foundations for providing unrestricted research grants: A.P. Moller Foundation for Medical Sciences, Augustinus Foundation, King Christian X Foundation and the University of Copenhagen Faculty of Health and Medical Sciences.	Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P347, DOI 10.1111/j.1399-6576.1995.tb04075.x; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; Bentzer P, 2016, NEUROCRIT CARE; Bentzer P, 2015, CLIN CHEST MED, V36, P521, DOI 10.1016/j.ccm.2015.05.009; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Genet GF, 2017, J NEUROTRAUM, V34, P1054, DOI 10.1089/neu.2016.4574; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; HOFFMAN WE, 1991, ANESTH ANALG, V73, P460; Jepsen CH, 2014, J TRAUMA ACUTE CARE, V77, P292, DOI 10.1097/TA.0000000000000333; Johansson PI, 2010, MED HYPOTHESES, V75, P564, DOI 10.1016/j.mehy.2010.07.031; Johansson Par I, 2013, J Emerg Trauma Shock, V6, P171, DOI 10.4103/0974-2700.115327; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Johansson PI, 2012, J TRAUMA ACUTE CARE, V72, P428, DOI 10.1097/TA.0b013e31821e0f93; Johansson P, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1605-5; Jungner M, 2010, ANESTHESIOLOGY, V112, P1194, DOI 10.1097/ALN.0b013e3181d94d6e; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Lewis PR, 2016, J TRAUMA ACUTE CARE, V80, P643, DOI 10.1097/TA.0000000000000957; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; Luchette FA, 1999, J TRAUMA, V46, P873, DOI 10.1097/00005373-199905000-00017; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; PAYEN D, 1990, CRIT CARE MED, V18, P392, DOI 10.1097/00003246-199004000-00008; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; SUGAWARA K, 1980, EUR J PHARMACOL, V62, P287, DOI 10.1016/0014-2999(80)90096-5; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515; Yoon JH, 2017, J VASC RES, V54, P59, DOI 10.1159/000457799	41	7	7	2	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2018	84	1					89	96		10.1097/TA.0000000000001708			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	FS0JG	WOS:000419459600013	28930945				2022-02-06	
J	Haltmeier, T; Benjamin, E; Gruen, JP; Shulman, IA; Lam, L; Inaba, K; Demetriades, D				Haltmeier, Tobias; Benjamin, Elizabeth; Gruen, John Peter; Shulman, Ira A.; Lam, Lydia; Inaba, Kenji; Demetriades, Demetrios			Decreased mortality in patients with isolated severe blunt traumatic brain injury receiving higher plasma to packed red blood cells transfusion ratios	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Brain injury; Blood component transfusion; Transfusion ratio; Mortality; Coagulopathy	INTRACRANIAL HEMORRHAGE; COAGULOPATHY; ASSOCIATION; PROGRESSION; PLATELETS; MARKER; IMPACT; TESTS	Introduction: Higher transfusion ratios of plasma to packed red blood cells (PRBC) and platelets (PLT)to PRBC have been shown to be associated with decreased mortality in major trauma patients. However, little is known about the effect of transfusion ratios on mortality in patients with isolated severe traumatic brain injury (TBI). The aim of this study was to investigate the effect of transfusion ratios on mortality in patients with isolated severe blunt TBI. We hypothesized that higher transfusion ratios of plasma to PRBC and PLT to PRBC are associated with a lower mortality rate in these patients. Methods: Retrospective observational study. Patients with isolated severe blunt TBI (AIS head >= 3, AIS extracranial <3) admitted to an urban level I trauma centre were included. Clinical data were extracted from the institution's trauma registry, blood transfusion data from the blood bank database. The effect of higher transfusion ratios on in-hospital mortality was analysed using univariate and multivariable regression analysis. Results: A total of 385 patients were included. Median age was 32 years (IQR 2-50), 71.4% were male, and 76.6% had an ISS >= 16. Plasma: PRBC transfusion ratios >= 1 were identified as an independent predictor for decreased in-hospital mortality (adjusted OR 0.43 [CI 0.22-0.81]). PLT: PRBC transfusion ratios >= 1 were not significantly associated with mortality (adjusted OR 0.39 [CI 0.08-1.92]). Conclusion: This study revealed plasma to PRBC transfusion ratios >= 1 as an independent predictor for decreased in-hospital mortality in patients with isolated severe blunt TBI. (C) 2017 Elsevier Ltd. All rights reserved.	[Haltmeier, Tobias; Benjamin, Elizabeth; Lam, Lydia; Inaba, Kenji; Demetriades, Demetrios] Los Angeles Cty & Univ Southern Calif Med Ctr, Dept Surg, Div Acute Care Surg & Surg Crit Care, Los Angeles, CA USA; [Gruen, John Peter] Los Angeles Cty & Univ Southern Calif Med Ctr, Dept Neurol Surg, Los Angeles, CA USA; [Shulman, Ira A.] Los Angeles Cty & Univ Southern Calif Med Ctr, Dept Pathol, Los Angeles, CA USA		Benjamin, E (corresponding author), Univ Southern Calif, LA Cty USC Med Ctr, Dept Surg, Div Acute Care Surg & Surg Crit Care, 1200 N State St,Inpatient Tower C Rm C5L100, Los Angeles, CA 90033 USA.	Elizabeth.Benjamin@med.usc.edu	Benjamin, Elizabeth/AAD-2457-2020; INABA, KENJI/AAC-8532-2020	Haltmeier, Tobias/0000-0001-6049-9235			Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; [Anonymous], 2011 NATL BLOOD COLL; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Duchesne JC, 2013, J TRAUMA ACUTE CARE, V75, P76, DOI 10.1097/TA.0b013e3182987df3; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Inaba K, 2010, J AM COLL SURGEONS, V211, P573, DOI 10.1016/j.jamcollsurg.2010.06.392; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; LeonCarrion J, 2006, STUD NEUROPSYCH DEV, P1; Liu J, 2016, CHIN J TRAUMATOL, V19, P172, DOI 10.1016/j.cjtee.2016.01.011; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Shander A, 2014, ADV THER, V31, P66, DOI 10.1007/s12325-013-0083-7; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Spinella PC, 2011, J TRAUMA, V71, pS343, DOI 10.1097/TA.0b013e318227ef2d; Takahashi H, 1997, J NEUROSURG, V86, P768, DOI 10.3171/jns.1997.86.5.0768; Wu X, 2014, J TRAUMA ACUTE CARE, V76, P114, DOI 10.1097/TA.0b013e3182a8fe48; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	26	7	7	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2018	49	1					62	66		10.1016/j.injury.2017.07.035			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FS9VT	WOS:000422767800010	28807428				2022-02-06	
J	Hylin, MJ; Holden, RC; Smith, AC; Logsdon, AF; Qaiser, R; Lucke-Wold, BP				Hylin, Michael J.; Holden, Ryan C.; Smith, Aidan C.; Logsdon, Aric F.; Qaiser, Rabia; Lucke-Wold, Brandon P.			Juvenile Traumatic Brain Injury Results in Cognitive Deficits Associated with Impaired Endoplasmic Reticulum Stress and Early Tauopathy	DEVELOPMENTAL NEUROSCIENCE			English	Article						Controlled cortical impact; Endoplasmic reticulum stress; Novel object recognition; Elevated plus maze; Morris water maze; Tau oligomers	CORTICAL IMPACT MODEL; NEONATAL HYPOXIA-ISCHEMIA; EMERGENCY-DEPARTMENT; OXIDATIVE STRESS; DECISION-MAKING; UNIQUE FEATURES; PEDIATRIC SKULL; ER STRESS; DAMAGE; MATURATION	The leading cause of death in the juvenile population is trauma, and in particular neurotrauma. The juvenile brain response to neurotrauma is not completely understood. Endoplasmic reticulum (ER) stress has been shown to contribute to injury expansion and behavioral deficits in adult rodents and furthermore has been seen in adult postmortem human brains diagnosed with chronic traumatic encephalopathy. Whether endoplasmic reticulum stress is increased in juveniles with traumatic brain injury (TBI) is poorly delineated. We investigated this important topic using a juvenile rat controlled cortical impact (CCI) model. We proposed that ER stress would be significantly increased in juvenile rats following TBI and that this would correlate with behavioral deficits using a juvenile rat model. A juvenile rat (postnatal day 28) CCI model was used. Binding immunoglobulin protein (BiP) and C/EBP homologous protein (CHOP) were measured at 4 h in the ipsilateral pericontusion cortex. Hypoxia-inducible factor (HIF)-1 alpha was measured at 48 h and tau kinase measured at 1 week and 30 days. At 4 h following injury, BiP and CHOP (markers of ER stress) were significantly elevated in rats exposed to TBI. We also found that HIF-1 alpha was significantly upregulated 48 h following TBI showing delayed hypoxia. The early ER stress activation was additionally associated with the activation of a known tau kinase, glycogen synthase kinase-3 beta (GSK-3 beta), by 1 week. Tau oligomers measured by R23 were significantly increased by 30 days following TBI. The biochemical changes following TBI were associated with increased impulsive-like or anti-anxiety behavior measured with the elevated plus maze, deficits in short-term memory measured with novel object recognition, and deficits in spatial memory measured with the Morris water maze in juvenile rats exposed to TBI. These results show that ER stress was increased early in juvenile rats exposed to TBI, that these rats developed tau oligomers over the course of 30 days, and that they had significant short-term and spatial memory deficits following injury. (C) 2018 S. Karger AG, Basel	[Hylin, Michael J.; Holden, Ryan C.; Smith, Aidan C.] Southern Illinois Univ, Dept Psychol, Neurotrauma & Rehabil Lab, Carbondale, IL 62901 USA; [Logsdon, Aric F.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Qaiser, Rabia; Lucke-Wold, Brandon P.] West Virginia Univ, Sch Med, Dept Neurosurg, Morgantown, WV USA		Hylin, MJ (corresponding author), Southern Illinois Univ, Dept Psychol, Neurotrauma & Rehabil Lab, Carbondale, IL 62901 USA.	mhylin@siu.edu	Lucke-Wold, Brandon/AAW-3525-2021; Lucke-Wold, Brandon/AAW-1881-2021; Hylin, Michael/U-2878-2019	Lucke-Wold, Brandon/0000-0001-6577-4080; Hylin, Michael/0000-0002-8600-3047	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32 AG052354] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54 GM104942] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG052354] Funding Source: NIH RePORTER		Begum G, 2013, TRANSL STROKE RES, V4, P635, DOI 10.1007/s12975-013-0282-1; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Bueter W, 2009, PEDIATR RES, V66, P487, DOI 10.1203/PDR.0b013e3181baa083; Cai XH, 2014, EXP NEUROL, V257, P148, DOI 10.1016/j.expneurol.2014.04.029; Chavez-Valdez R, 2016, INT J DEV NEUROSCI, V48, P58, DOI 10.1016/j.ijdevneu.2015.11.007; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA; d'Abramo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062402; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; Dash PK, 2015, J NEUROTRAUM, V32, P1608, DOI 10.1089/neu.2014.3772; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Gaudet CM, 2016, BEHAV BRAIN RES, V302, P88, DOI 10.1016/j.bbr.2016.01.016; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Golpich M, 2015, PHARMACOL RES, V97, P16, DOI 10.1016/j.phrs.2015.03.010; Gordon WA, 2017, J HEAD TRAUMA REHAB, V32, P393, DOI 10.1097/HTR.0000000000000274; Han Y, 2015, NEUROSCI LETT, V585, P126, DOI 10.1016/j.neulet.2014.11.040; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Harris NG, 2010, J NEUROTRAUM, V27, P1971, DOI 10.1089/neu.2010.1470; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1294, DOI 10.1097/00004647-200009000-00003; Jantzie LL, 2015, CEREB CORTEX, V25, P482, DOI 10.1093/cercor/bht246; Komada Munekazu, 2008, J Vis Exp, DOI 10.3791/1088; Kovacs K, 2016, MOL CANCER THER, V15, P264, DOI 10.1158/1535-7163.MCT-14-0315; Kriegel J, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024059; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Licht-Murava A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aah7102; Logsdon AF, 2014, J NEUROL DISORD STRO, V2, P1074; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Lucke-Wold BP, 2015, TRANSL RES, V166, P509, DOI 10.1016/j.trsl.2015.08.005; Lucke-Wold BP, 2016, J NEUROSURG, V124, P687, DOI 10.3171/2015.3.JNS141802; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Maria NSS, 2017, J NEUROTRAUM, V34, P1692, DOI 10.1089/neu.2016.4747; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1998, BRAIN INJURY, V12, P41; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Meares GP, 2011, EXP CELL RES, V317, P1621, DOI 10.1016/j.yexcr.2011.02.012; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Pikstra ARA, 2017, EUR J PAEDIATR NEURO, V21, P344, DOI 10.1016/j.ejpn.2016.09.005; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Plourde V, 2017, J INT NEUROPSYCH SOC, V23, P304, DOI 10.1017/S1355617717000066; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Rong Lin-lin, 2005, Beijing Da Xue Xue Bao Yi Xue Ban, V37, P378; Salomon-Zimri S, 2016, J ALZHEIMERS DIS, V53, P1443, DOI 10.3233/JAD-160182; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Tatebayashi Y, 2004, J CELL SCI, V117, P1653, DOI 10.1242/jcs.01018; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953	64	7	8	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2018	40	2					175	188		10.1159/000488343			14	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	GJ6IF	WOS:000435486800007	29788004	Green Accepted			2022-02-06	
J	Kanchan, A; Singh, AR; Khan, NA; Jahan, M; Raman, R; Rao, TSS				Kanchan, Amrita; Singh, Amool Ranjan; Khan, Nawab Akhtar; Jahan, Masroor; Raman, Rajesh; Rao, T. S. Sathyanarayana			Impact of neuropsychological rehabilitation on activities of daily living and community reintegration of patients with traumatic brain injury	INDIAN JOURNAL OF PSYCHIATRY			English	Article						Cognition; Cognitive Symptom Checklist; Luria-Nebraska Neuropsychological Battery for Adults; neuropsychological deficits	COGNITIVE REHABILITATION; FUNCTIONAL ABILITY; RATING-SCALE; INTEGRATION; STROKE; IMPAIRMENT; RECOVERY; MODERATE; PEOPLE	Objectives: The present study was targeted to observe the impact of neuropsychological rehabilitation on activities of daily living (ADL) and community reintegration of patients with traumatic brain injury (TBI). Settings and Participants: Based on purposive sampling technique, ten patients with TBI falling in the age range of 20-40 years and fulfilling the inclusion and exclusion criteria were chosen from All India Institute of Speech and Hearing, Mysuru, India. Design: A quasi-experimental design, i.e., nonequivalent control group design was chosen for the study. Materials and Methods: Patients were assessed on Luria-Nebraska Neuropsychological Battery for Adults, Cognitive Symptoms Checklist, and Community Integration Questionnaire. Patients in experimental group were given neuropsychological rehabilitation for 6 months. Brainwave-R and Talking Pen were used as rehabilitative tools. Results: Patients with TBI have significant neuropsychological deficits observed in memory, visuo-spatial organization, arithmetic, spelling, writing, fine motor coordination, and executive functioning. Neuropsychological deficits have a major impact on ADL and community reintegration. Neuropsychological rehabilitation is effective in rehabilitating neuropsychological deficits, which in turn leads to improvement in ADL and community reintegration. Conclusion: Neuropsychological rehabilitation should be one of the major goals in rehabilitation procedures for patients with TBI in order to bring overall improvement in them.	[Kanchan, Amrita] All India Inst Speech & Hearing, Dept Clin Psychol, Mysuru, Karnataka, India; [Singh, Amool Ranjan; Jahan, Masroor] Ranchi Inst Neuropsychiat & Allied Sci, Dept Clin Psychol, Ranchi, Jharkhand, India; [Khan, Nawab Akhtar] JSS Univ, JSS Med Coll & Hosp, Dept Clin Psychol, JSS Acad Higher Educ & Res, Mysore, Karnataka, India; [Raman, Rajesh; Rao, T. S. Sathyanarayana] JSS Univ, JSS Acad Higher Educ & Res, JSS Med Coll, Dept Psychiat, Mysore, Karnataka, India		Khan, NA (corresponding author), JSS Univ, JSS Acad Higher Educ & Res, JSS Med Coll, Dept Clin Psychol, Mysore, Karnataka, India.	nawab409@gmail.com	Rao, T.S. Sathyanarayana/AAF-9930-2019	Rao, T.S. Sathyanarayana/0000-0002-5727-944X			Adamovich BL, 1991, COGNITIVE REHABILITA, P75; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; Brain Injury Association of America, 2011, DEF TRAUM BRAIN INJ; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; ECRI Institute, 2010, PLYM M PA ECRI I HLT; Golden C, 1981, DIAGNOSIS REHABILITA; Gontkovsky ST, 2009, NEUROREHABILITATION, V24, P185, DOI 10.3233/NRE-2009-0467; Gouveia PA, 2004, NEUROPSICOLOGIA HOJE, P297; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Ho MR, 1997, ARCH CLIN NEUROPSYCH, V12, P1; Hoffmann T, 2010, TOP STROKE REHABIL, V17, P99, DOI 10.1310/tsr1702-99; KAPLAN CP, 1994, ARCH PHYS MED REHAB, V75, P643, DOI 10.1016/0003-9993(94)90186-4; Kathleen M, 1998, WILLARD SPACKMANS OC, P260; Koizumi MS, 2000, ARQ NEURO-PSIQUIAT, V58, P81, DOI 10.1590/S0004-282X2000000100013; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Luria A., 1963, RECOVERY FUNCTIONS B; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Malia KB, 2002, COGNITIVE STRATEGIES; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; Millis S R, 1994, Int J Neurosci, V79, P165; Mokashi S.P., 2005, INDIAN J OCCUP THER, V37, P3; OHARA C, 1993, COGNITIVE SYMPTOM CH; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pedersen PM, 1996, ARCH PHYS MED REHAB, V77, P336, DOI 10.1016/S0003-9993(96)90080-5; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P1, DOI 10.1097/HTR.0b013e3182068588; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Smith LM, 1995, FAMILY SUPPORT PROGR, P191; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Walker C.M., 2016, BRIT J OCCUP THER, V66, P263, DOI [10.1177/030802260306600605, DOI 10.1177/030802260306600605]; Walker CM, 2004, J NEUROL NEUROSUR PS, V75, P43; Wayne Engineering, 1974, THE TALK PEN; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002	42	7	7	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0019-5545	1998-3794		INDIAN J PSYCHIAT	Indian J. Psychiatry	JAN-MAR	2018	60	1					38	48		10.4103/psychiatry.IndianJPsychiatry_118_17			11	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	GD2SG	WOS:000430350500008	29736061	Green Published, gold			2022-02-06	
J	Katiyar, KS; Winter, CC; Gordian-Velez, WJ; O'Donnell, JC; Song, YJ; Hernandez, NS; Struzyna, LA; Cullen, DK				Katiyar, Kritika S.; Winter, Carla C.; Gordian-Velez, Wisberty J.; O'Donnell, John C.; Song, Yeri J.; Hernandez, Nicole S.; Struzyna, Laura A.; Cullen, D. Kacy			Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System Regeneration	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Bioengineering; Issue 131; Neural tissue engineering; living scaffolds; neurotrauma; neuroregeneration; cell migration; axon pathfinding; astrocyte networks; neural stem cells	SPINAL-CORD REGENERATION; GLIAL SCAR FORMATION; IMMATURE ASTROCYTES; SUBSTRATE CURVATURE; AXONAL REGENERATION; SUBVENTRICULAR ZONE; NEURITE OUTGROWTH; LIVING SCAFFOLDS; BRAIN; NEURONS	Neurotrauma and neurodegenerative disease often result in lasting neurological deficits due to the limited capacity of the central nervous system (CNS) to replace lost neurons and regenerate axonal pathways. However, during nervous system development, neuronal migration and axonal extension often occur along pathways formed by other cells, referred to as "living scaffolds". Seeking to emulate these mechanisms and to design a strategy that circumvents the inhibitory environment of the CNS, this manuscript presents a protocol to fabricate tissue engineered astrocyte-based "living scaffolds". To create these constructs, we employed a novel biomaterial encasement scheme to induce astrocytes to self-assemble into dense three-dimensional bundles of bipolar longitudinally-aligned somata and processes. First, hollow hydrogel microcolumns were assembled, and the inner lumen was coated with collagen extracellular-matrix. Dissociated cerebral cortical astrocytes were then delivered into the lumen of the cylindrical micro-column and, at a critical inner diameter of <350 mu m, spontaneously self-aligned and contracted to produce long fiber-like cables consisting of dense bundles of astrocyte processes and collagen fibrils measuring <150 mu m in diameter yet extending several cm in length. These engineered living scaffolds exhibited >97% cell viability and were virtually exclusively comprised of astrocytes expressing a combination of the intermediate filament proteins glial-fibrillary acidic protein (GFAP), vimentin, and nestin. These aligned astrocyte networks were found to provide a permissive substrate for neuronal attachment and aligned neurite extension. Moreover, these constructs maintain integrity and alignment when extracted from the hydrogel encasement, making them suitable for CNS implantation. These preformed constructs structurally emulate key cytoarchitectural elements of naturally occurring glial-based "living scaffolds" in vivo. As such, these engineered living scaffolds may serve as test-beds to study neurodevelopmental mechanisms in vitro or facilitate neuroregeneration by directing neuronal migration and/or axonal pathfinding following CNS degeneration in vivo.	[Katiyar, Kritika S.; Winter, Carla C.; Gordian-Velez, Wisberty J.; O'Donnell, John C.; Song, Yeri J.; Hernandez, Nicole S.; Struzyna, Laura A.; Cullen, D. Kacy] Univ Penn, Perelman Sch Med, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Katiyar, Kritika S.; Winter, Carla C.; Gordian-Velez, Wisberty J.; O'Donnell, John C.; Struzyna, Laura A.; Cullen, D. Kacy] Michael J Crescenz Vet Affairs Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA 19104 USA; [Katiyar, Kritika S.] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA; [Winter, Carla C.; Gordian-Velez, Wisberty J.; Struzyna, Laura A.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Song, Yeri J.; Hernandez, Nicole S.; Cullen, D. Kacy] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA		Cullen, DK (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA.; Cullen, DK (corresponding author), Michael J Crescenz Vet Affairs Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA 19104 USA.; Cullen, DK (corresponding author), Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA.	dkacy@mail.med.upenn.edu		O'Donnell, John/0000-0001-8101-3783	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01-NS094340, F31-NS090746]; Michael J. Fox Foundation [Therapeutic Pipeline Program] [9998]; Penn Medicine Neuroscience Center Pilot Award (Cullen); National Science Foundation [Graduate Research Fellowships]National Science Foundation (NSF) [DGE-1321851]; Department of Veterans Affairs [RRD Merit Review] [B1097-I]; U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-207004, W81XWH-15-1-0466]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS094340, F31NS090746] Funding Source: NIH RePORTER	Financial support was provided by the National Institutes of Health [U01-NS094340 (Cullen) & F31-NS090746 (Katiyar)], Michael J. Fox Foundation [Therapeutic Pipeline Program #9998 (Cullen)], Penn Medicine Neuroscience Center Pilot Award (Cullen), National Science Foundation [Graduate Research Fellowships DGE-1321851 (Struzyna)], Department of Veterans Affairs [RR&D Merit Review # B1097-I (Cullen)], and the U.S. Army Medical Research and Materiel Command [# W81XWH-13-207004 (Cullen) & W81XWH-15-1-0466 (Cullen)].	Akesson E, 2009, STEM CELL RES, V2, P56, DOI 10.1016/j.scr.2008.06.002; Alexander JK, 2006, NEURON GLIA BIOL, V2, P93, DOI 10.1017/S1740925X0600010X; Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1; Barry D, 2005, GLIA, V50, P187, DOI 10.1002/glia.20166; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; Benowitz LI, 2007, DEV NEUROBIOL, V67, P1148, DOI 10.1002/dneu.20515; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Chotard C, 2004, TRENDS NEUROSCI, V27, P655, DOI 10.1016/j.tins.2004.09.001; Chwalek K, 2015, NAT PROTOC, V10, P1362, DOI 10.1038/nprot.2015.091; Conway A, 2014, STEM CELLS, V32, P1220, DOI 10.1002/stem.1650; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Cullen DK, 2007, J NEUROSCI RES, V85, P3642, DOI 10.1002/jnr.21434; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z; Cullen DK, 2012, TISSUE ENG PT A, V18, P2280, DOI [10.1089/ten.tea.2011.0534, 10.1089/ten.TEA.2011.0534]; Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P201; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; East E, 2010, TISSUE ENG PT A, V16, P3173, DOI 10.1089/ten.tea.2010.0017; Filous AR, 2010, DEV NEUROBIOL, V70, P826, DOI 10.1002/dneu.20820; Fry EJ, 2010, GLIA, V58, P423, DOI 10.1002/glia.20934; Gao YD, 2016, REGEN BIOMATER, V3, P115, DOI 10.1093/rb/rbw004; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Harris JP, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016019; Hidalgo A, 2000, DEVELOPMENT, V127, P393; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hsiao TW, 2015, BIOMATERIALS, V39, P124, DOI 10.1016/j.biomaterials.2014.10.062; Hsiao TW, 2013, ACTA BIOMATER, V9, P7200, DOI 10.1016/j.actbio.2013.02.047; Huang JH, 2009, TISSUE ENG PT A, V15, P1677, DOI 10.1089/ten.tea.2008.0294; Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19; Irons HR, 2008, J NEURAL ENG, V5, P333, DOI 10.1088/1741-2560/5/3/006; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Jiang ZP, 2014, CELL MOL IMMUNOL, V11, P17, DOI 10.1038/cmi.2013.62; Johansson S, 2002, J COMP NEUROL, V443, P237, DOI 10.1002/cne.10119; Kaneko N, 2010, NEURON, V67, P213, DOI 10.1016/j.neuron.2010.06.018; Katiyar K. S., 2016, J TISSUE ENG REGEN M; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; KIM SU, 1983, BRAIN RES, V274, P79, DOI 10.1016/0006-8993(83)90522-X; LaPlaca M. C., 2010, METHODS BIOENG 3D TI; Lee-Liu D, 2013, GENESIS, V51, P529, DOI 10.1002/dvg.22406; Li XW, 2012, PROG POLYM SCI, V37, P1105, DOI 10.1016/j.progpolymsci.2012.02.004; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lin B, 2014, EXP THER MED, V7, P66, DOI 10.3892/etm.2013.1371; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Montani L, 2014, J NEUROSCI, V34, P4443, DOI 10.1523/JNEUROSCI.0320-14.2014; Morrison B, 2011, STUD MECHANOBIOL TIS, V3, P247, DOI 10.1007/8415_2011_79; MORRISON RS, 1981, P NATL ACAD SCI-BIOL, V78, P7205, DOI 10.1073/pnas.78.11.7205; Nishimura Y, 2013, CELL TRANSPLANT, V22, P2187, DOI 10.3727/096368912X657882; Pacifici M., 2012, J VIS EXP, V63; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Peretto P, 2005, J COMP NEUROL, V487, P407, DOI 10.1002/cne.20576; Pertusa M, 2007, J NEUROCHEM, V101, P794, DOI 10.1111/j.1471-4159.2006.04369.x; Phillips JB, 2005, TISSUE ENG, V11, P1611, DOI 10.1089/ten.2005.11.1611; REIER PJ, 1979, BRAIN RES, V164, P61, DOI 10.1016/0006-8993(79)90006-4; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Smeal RM, 2005, ANN BIOMED ENG, V33, P376, DOI 10.1007/s10439-005-1740-z; Smeal RM, 2008, EXP NEUROL, V213, P281, DOI 10.1016/j.expneurol.2008.05.026; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sorensen A, 2007, BIOMATERIALS, V28, P5498, DOI 10.1016/j.biomaterials.2007.08.034; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8; Struzyna LA, 2015, TISSUE ENG PT A, V21, P2744, DOI [10.1089/ten.tea.2014.0557, 10.1089/ten.TEA.2014.0557]; Struzyna LA, 2015, NEURAL REGEN RES, V10, P679, DOI 10.4103/1673-5374.156943; Struzyna LA, 2014, CURR OPIN SOLID ST M, V18, P308, DOI 10.1016/j.cossms.2014.07.004; Tam RY, 2014, NEUROPSYCHOPHARMACOL, V39, P169, DOI 10.1038/npp.2013.237; Toy Dana, 2013, Exp Neurobiol, V22, P68, DOI 10.5607/en.2013.22.2.68; Vadivelu S, 2015, STEM CELL TRANSL MED, V4, P401, DOI 10.5966/sctm.2014-0107; Vukasinovic J, 2009, BIOMED MICRODEVICES, V11, P1155, DOI 10.1007/s10544-009-9332-6; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Wang L., 2015, CELL DISCOV, V1; Winter CC, 2016, ACTA BIOMATER, V38, P44, DOI 10.1016/j.actbio.2016.04.021; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zukor KA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-1	75	7	7	0	15	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JAN	2018		131							e55848	10.3791/55848			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX5CM	WOS:000426095700012	29364269	Green Published			2022-02-06	
J	Kuo, KW; Bacek, LM; Taylor, AR				Kuo, Kendon W.; Bacek, Lenore M.; Taylor, Amanda R.			Head Trauma	VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE			English	Article						Head trauma; Traumatic brain injury; Intracranial pressure; Dog; Cat	CEREBROSPINAL-FLUID PRESSURE; THORACIC FOCUSED ASSESSMENT; CEREBRAL BLOOD-VOLUME; BRAIN-INJURY; INTRACRANIAL-PRESSURE; HYPERTONIC SALINE; PROGNOSTIC VALUE; MANAGEMENT; DOGS; DEXMEDETOMIDINE	Head trauma is a common cause of significant morbidity and mortality in dogs and cats. Traumatic brain injury may occur after head trauma. Understanding the pathophysiology of primary and secondary injury after head trauma is essential for management. This article reviews the pathophysiology of head trauma, patient assessment and diagnostics, and treatment recommendations.	[Kuo, Kendon W.; Bacek, Lenore M.] Auburn Univ, Emergency & Crit Care, Dept Clin Sci, Coll Vet Med, 1220 Wire Rd, Auburn, AL 36849 USA; [Taylor, Amanda R.] Auburn Univ, Coll Vet Med, Dept Clin Sci, Neurol Neurosurg, 1220 Wire Rd, Auburn, AL 36849 USA		Kuo, KW (corresponding author), Auburn Univ, Emergency & Crit Care, Dept Clin Sci, Coll Vet Med, 1220 Wire Rd, Auburn, AL 36849 USA.	kwk0003@auburn.edu	Ragle, Claude/W-2248-2019; Agarwal, Amit K/F-8184-2012; Bacek, Lenore/P-1884-2019; Ragle, Claude/P-5504-2017	Agarwal, Amit K/0000-0001-9139-8007; Bacek, Lenore/0000-0002-1046-9297; Kuo, Kendon/0000-0003-4279-1966; Taylor, Amanda/0000-0003-1971-2764			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Angle N, 1998, SHOCK, V9, P164, DOI 10.1097/00024382-199803000-00002; Armitage-Chan EA, 2007, J VET EMERG CRIT CAR, V17, P5, DOI 10.1111/j.1476-4431.2006.00194.x; ARTRU AA, 1984, ANESTHESIOLOGY, V60, P575, DOI 10.1097/00000542-198406000-00010; Aryan H, 2009, BRAIN INJURY, V20, P791; BAGLEY RS, 1995, J AM VET MED ASSOC, V207, P588; Beltran E, 2014, J VET INTERN MED, V28, P1256, DOI 10.1111/jvim.12368; Boysen SR, 2004, JAVMA-J AM VET MED A, V225, P1198, DOI 10.2460/javma.2004.225.1198; Caputo ND, 2014, J TRAUMA ACUTE CARE, V77, P534, DOI 10.1097/TA.0000000000000414; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cenic A, 2002, ANESTH ANALG, V94, P661, DOI 10.1097/00000539-200203000-00033; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cosar M, 2009, SURG NEUROL, V71, P54, DOI 10.1016/j.surneu.2007.08.020; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Dewey C. W., 1997, Journal of Veterinary Emergency & Critical Care, V7, P20; Dewey CW, 2000, VET CLIN N AM-SMALL, V30, P207, DOI 10.1016/S0195-5616(00)50010-2; Dewey CW, 1993, VET COMP ORTHOPAED T, V6, P29; Dewey CW, 2012, VET SURG SMALL ANIMA, P508; DiFazio J, 2013, VET CLIN N AM-SMALL, V43, P915, DOI 10.1016/j.cvsm.2013.03.002; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Edwards P, 2005, LANCET, V365, P1957; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fink Matthew E, 2012, Continuum (Minneap Minn), V18, P640, DOI 10.1212/01.CON.0000415432.84147.1e; Friedenberg SG, 2012, JAVMA-J AM VET MED A, V241, P1479, DOI 10.2460/javma.241.11.1479; GARDNER AE, 1971, ANESTHESIOLOGY, V35, P226, DOI 10.1097/00000542-197108000-00029; Green DM, 2010, NEUROCRIT CARE, V13, P299, DOI 10.1007/s12028-010-9417-3; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Hall KE, 2014, JAVMA-J AM VET MED A, V244, P300, DOI 10.2460/javma.244.3.300; Hans P, 2006, CURR OPIN ANESTHESIO, V19, P498, DOI 10.1097/01.aco.0000245274.69292.ad; Hayes GM, 2009, J VET EMERG CRIT CAR, V19, P629, DOI 10.1111/j.1476-4431.2009.00478.x; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Holzer A, 2003, ANAESTHESIA, V58, P217, DOI 10.1046/j.1365-2044.2003.03041.x; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Ilie LA, 2015, AM J VET RES, V76, P724, DOI 10.2460/ajvr.76.8.724; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; KAMADA T, 1977, J TRAUMA, V17, P44, DOI 10.1097/00005373-197701000-00006; KEEGAN RD, 1995, AM J VET RES, V56, P193; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kolenda H, 1996, ACTA NEUROCHIR, V138, P1193, DOI 10.1007/BF01809750; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Levine PB, 1997, J AM ANIM HOSP ASSOC, V33, P405, DOI 10.5326/15473317-33-5-405; Li M, 2015, MEDICINE, V94; Lisciandro GR, 2008, J VET EMERG CRIT CAR, V18, P258, DOI 10.1111/j.1476-4431.2008.00312.x; Lisciandro GR, 2011, J VET EMERG CRIT CAR, V21, P104, DOI 10.1111/j.1476-4431.2011.00626.x; LIST WF, 1972, ANESTHESIOLOGY, V36, P98, DOI 10.1097/00000542-197201000-00023; Liu B, 2015, CRIT CARE, V19, P1; MAIER C, 1993, ANESTHESIOLOGY, V79, P306, DOI 10.1097/00000542-199308000-00016; Marcolini EG, 2015, EMERG MED CLIN N AM, V33, P519, DOI 10.1016/j.emc.2015.04.003; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; MAXWELL RE, 1971, J NEUROSURG, V34, P477, DOI 10.3171/jns.1971.34.4.0477; McCarthy Paul, 2013, Pathophysiology, V20, P5, DOI 10.1016/j.pathophys.2012.03.002; McCulloch TJ, 2000, ANESTHESIOLOGY, V93, P1205, DOI 10.1097/00000542-200011000-00012; Misra UK, 2005, J NEUROL SCI, V234, P41, DOI 10.1016/j.jns.2005.03.038; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Myburgh J, 2007, NEW ENGL J MED, V357, P874; NEWBERG LA, 1983, ANESTHESIOLOGY, V59, P23, DOI 10.1097/00000542-198307000-00005; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Olan NV, 2015, J VET EMERG CRIT CAR, V25, P405, DOI 10.1111/vec.12306; Pajoumand M, 2016, J TRAUMA ACUTE CARE, V81, P345, DOI 10.1097/TA.0000000000001069; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Platt SR, 2002, VET REC, V151, P243, DOI 10.1136/vr.151.8.243; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; ROBERTS PA, 1987, J NEUROSURG, V66, P440, DOI 10.3171/jns.1987.66.3.0440; Robinson R, 2015, VET ANAESTH ANALG, V42, P493, DOI 10.1111/vaa.12244; Robinson R, 2013, VET ANAESTH ANALG, V40, P455, DOI 10.1111/vaa.12052; Rockar R. A., 1994, Journal of Veterinary Emergency & Critical Care, V4, P77, DOI 10.1111/j.1476-4431.1994.tb00118.x; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Schmittner MD, 2007, J NEUROSURG ANESTH, V19, P257, DOI 10.1097/ANA.0b013e31811f3feb; SHACKFORD SR, 1994, J TRAUMA, V37, P899, DOI 10.1097/00005373-199412000-00005; SHAPIRO HM, 1972, BRIT J ANAESTH, V44, P1200, DOI 10.1093/bja/44.11.1200; Sharma D, 2015, J VET EMERG CRIT CAR, V25, P631, DOI 10.1111/vec.12328; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Simpson SA, 2009, J VET EMERG CRIT CAR, V19, P588, DOI 10.1111/j.1476-4431.2009.00468.x; SMITH GJ, 1985, J SURG RES, V39, P517, DOI 10.1016/0022-4804(85)90120-9; Sorjonen D. C., 1991, Progress in Veterinary Neurology, V2, P225; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Streeter EM, 2009, J AM VET MED ASSOC, V235; Syring RS, 2001, J AM VET MED ASSOC, V218, P1124, DOI 10.2460/javma.2001.218.1124; Syring RS, 2005, VET CLIN N AM-SMALL, V35, P343, DOI 10.1016/j.cvsm.2004.10.007; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Todd MM, 2006, ANESTHESIOLOGY, V105, P1176, DOI 10.1097/00000542-200612000-00017; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Tsaousi GG, 2016, CLIN NEUROPHARMACOL, V39, P144, DOI 10.1097/WNF.0000000000000151; van der Jagt M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1309-2; WYTE SR, 1972, ANESTHESIOLOGY, V36, P174, DOI 10.1097/00000542-197202000-00021; Yundt KD, 1997, CRIT CARE CLIN, V13, P163, DOI 10.1016/S0749-0704(05)70300-6; Zeiler FA, 2014, NEUROCRIT CARE, V21, P163, DOI 10.1007/s12028-013-9950-y; ZORNOW MH, 1992, ANESTH ANALG, V75, P232; ZORNOW MH, 1990, ANESTH ANALG, V70, P624	96	7	7	2	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0195-5616	1878-1306		VET CLIN N AM-SMALL	Vet. Clin. N. Am.-Small Anim. Pract.	JAN	2018	48	1					111	+		10.1016/j.cvsm.2017.08.005			19	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	FR0DE	WOS:000418730500010	28985897				2022-02-06	
J	Larson, EB				Larson, Eric B.			Sleep disturbance and cognition in people with TBI	NEUROREHABILITATION			English	Article						Traumatic brain injury; neuropsychological assessment; memory; sleep	TRAUMATIC BRAIN-INJURY; OLDER-ADULTS; DISORDERS; MEMORY; IMPAIRMENT; DURATION; INSOMNIA; CONSOLIDATION; PREVALENCE; RECOVERY	BACKGROUND: Sleep disturbance plays a significant role in cognitive impairment following traumatic brain injury (TBI). OBJECTIVE: To summarize recent findings that examine sleep disturbance and cognition in TBI. METHODS: Epidemiological information on sleep disorders in people with TBI is presented. A simple introduction to the role of sleep in normal cognition provides context for the literature on clinical populations. Current theory on the mechanisms underlying cognitive problems in people with sleep disorder is briefly described. Findings on the relationship between sleep disorder and cognitive problems in TBI is examined in more detail. RESULTS: Consistent reports of an association between sleep duration and cognition include several studies noting positive associations (shorter sleep duration accompanies cognitive impairment) and others observing negative associations (longer sleep duration accompanies cognitive problems). Both insomnia and hypersomnolence are forms of sleep disturbance that disrupt key mental processes such as memory consolidation. Obstructive sleep apnea, cerebral structural abnormalities, neurochemical changes and psychiatric pathology are implicated. CONCLUSIONS: Additional information is needed on how severity of injury impacts sleep and cognition. Hypothesized mechanisms underlying the effects of sleep on cognition in TBI should be empirically tested. Further, discrepancies between objective and subjective measures of sleep and cognition must be explored.	[Larson, Eric B.] Marianjoy Rehabil Hosp, 26W171 Roosevelt Rd, Wheaton, IL 60187 USA		Larson, EB (corresponding author), Marianjoy Rehabil Hosp, 26W171 Roosevelt Rd, Wheaton, IL 60187 USA.	Eric.Larson@nm.org	Larson, Eric/AAD-9567-2021		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P2CHD086844] Funding Source: NIH RePORTER		Barshikar S, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0792-4; Beaulieu-Bonneau S, 2017, NEUROPSYCHOL REHABIL, V27, P216, DOI 10.1080/09602011.2015.1077145; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Blackwell T, 2006, J GERONTOL A-BIOL, V61, P405, DOI 10.1093/gerona/61.4.405; Blackwell T, 2011, SLEEP, V34, P1347, DOI 10.5665/SLEEP.1276; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chambers AM, 2017, WIRES COGN SCI, V8, DOI 10.1002/wcs.1433; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Durrant SJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00379; Elwood PC, 2011, J EPIDEMIOL COMMUN H, V65, P820, DOI 10.1136/jech.2009.100503; Ferrie JE, 2011, SLEEP, V34, P565, DOI 10.1093/sleep/34.5.565; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Grima NA, 2017, CURR OPIN PULM MED, V23, P493, DOI 10.1097/MCP.0000000000000429; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P108, DOI 10.1097/HTR.0000000000000206; Hou L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076087, DOI 10.1371/J0URNAL.P0NE.0076087]; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Jelicic M, 2002, INT J GERIATR PSYCH, V17, P73, DOI 10.1002/gps.529; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; Lequerica AH, 2017, NEUROPSYCHOL REHABIL, V27, P1019, DOI 10.1080/09602011.2016.1231120; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Mander BA, 2011, CURR BIOL, V21, pR183, DOI 10.1016/j.cub.2011.01.019; Mantua J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00328; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Mollayeva T, 2016, SLEEP MED, V20, P157, DOI 10.1016/j.sleep.2015.09.008; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Payne JD, 2015, EMOTION, V15, P176, DOI 10.1037/a0038683; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Potvin O, 2012, SLEEP, V35, P491, DOI 10.5665/sleep.1732; Rosanova M, 2005, J NEUROSCI, V25, P9398, DOI 10.1523/JNEUROSCI.2149-05.2005; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sterniczuk R, 2013, ALZHEIMERS DEMENTI S, V9, DOI [10.1016/j.jalz.2013.04.294, DOI 10.1016/J.JALZ.2013.04.294]; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Tang NKY, 2004, BEHAV RES THER, V42, P27, DOI 10.1016/S0005-7967(03)00068-8; Valko PO, 2016, SLEEP, V39, P1249, DOI 10.5665/sleep.5844; Van Den Berg JF, 2008, J SLEEP RES, V17, P295, DOI 10.1111/j.1365-2869.2008.00638.x; Virta JJ, 2013, SLEEP, V36, P1533, DOI 10.5665/sleep.3052; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; Xu L, 2011, SLEEP, V34, P575, DOI 10.1093/sleep/34.5.575; Yaffe K, 2014, LANCET NEUROL, V13, P1017, DOI 10.1016/S1474-4422(14)70172-3; Zollman FS, 2012, J HEAD TRAUMA REHAB, V27, P135, DOI 10.1097/HTR.0b013e3182051397; Zunzunegui C, 2011, SLEEP MED, V12, DOI [10.1016/s1389-9457(11)70344-6, DOI 10.1016/S1389-9457(11)70344-6]	54	7	7	2	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	43	3					297	306		10.3233/NRE-182534			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HA8FK	WOS:000450524200006	30347628				2022-02-06	
S	Lin, A; Charney, M; Shenton, ME; Koerte, IK		Hainline, B; Stern, RA		Lin, Alexander; Charney, Molly; Shenton, Martha E.; Koerte, Inga Katharina			Chronic traumatic encephalopathy: neuroimaging biomarkers	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							PROFESSIONAL SOCCER PLAYERS; SMALLER THALAMIC VOLUMES; WHITE-MATTER INTEGRITY; CHRONIC BRAIN-DAMAGE; RETIRED NFL PLAYERS; MICROSTRUCTURAL DAMAGE; 1ST EXPOSURE; FOOTBALL; DIFFUSION; BOXERS	Chronic traumatic encephalopathy (CTE) is a neurodegenerative disorder associated with repetitive head impact exposure, such as that resulting from sports-related concussive and subconcussive brain trauma. Currently, the only way to diagnose CTE is by using neuropathologic markers obtained postmortem. To diagnose CTE earlier, so that possible treatment interventions may be employed, there is a need to develop noninvasive in vivo biomarkers of CTE. Neuroimaging provides promising biomarkers for the diagnosis of CTE and may also help elucidate pathophysiologic changes that occur with chronic sports-related brain injury. To describe the use of neuroimaging as presumed biomarkers of CTE, this chapter focuses on only those studies that report the chronic stages of sports-related brain injury, as opposed to previous chapters that described neuroimaging in the context of acute and subacute injury. Studies using positron emission tomography and magnetic resonance imaging and spectroscopy will be discussed for contact/collision sports such as American football, boxing, mixed martial arts, rugby, and soccer, in which repetitive head impacts are common.	[Lin, Alexander; Charney, Molly] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Ctr Clin Spect, Boston, MA 02115 USA; [Shenton, Martha E.; Koerte, Inga Katharina] Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Boston, MA USA; [Koerte, Inga Katharina] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany		Koerte, IK (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02215 USA.	ikoerte@bwh.harvard.edu	Koerte, Inga Katharina/AAW-3031-2021				Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Alosco ML, 2017, SEMIN NEUROL, V37, P503, DOI 10.1055/s-0037-1608764; Alosco ML, 2017, P INT MAGN RESON MED, P2385; Aviv RI, 2010, CAN ASSOC RADIOL J, V61, P29, DOI 10.1016/j.carj.2009.09.002; Bang SA, 2016, J NEUROTRAUM, V33, P1005, DOI 10.1089/neu.2015.4051; Banks SJ, 2014, J NEUROPSYCH CLIN N, V26, P44, DOI 10.1176/appi.neuropsych.12070185; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; Bhidayasiri R, 2012, PARKINSONISM RELAT D, V18, P694, DOI 10.1016/j.parkreldis.2012.01.010; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Chappell MH, 2008, MAGN RESON IMAGING, V26, P1398, DOI 10.1016/j.mri.2008.04.004; Clark MD, 2018, RADIOLOGY, V286, P975, DOI 10.1148/radiol.2017170539; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; DAVIE CA, 1995, J NEUROL NEUROSUR PS, V58, P688, DOI 10.1136/jnnp.58.6.688; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P297; Hall B, 2017, AGEING RES REV, V36, P50, DOI 10.1016/j.arr.2017.03.002; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kornguth S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120164; Lepage C, 2019, BRAIN IMAGING BEHAV, V13, P725, DOI 10.1007/s11682-018-9895-z; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Martland H., 1928, JAMA-J AM MED ASSOC, V91, P1103, DOI DOI 10.1001/JAMA.1928.02700150029009; Mathis CA, 2017, SEMIN NUCL MED, V47, P553, DOI 10.1053/j.semnuclmed.2017.06.003; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Mishra VR, 2017, RADIOLOGY, V285, P555, DOI 10.1148/radiol.2017162403; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Shoghi-Jadid K, 2002, AM J GERIAT PSYCHIAT, V10, P24, DOI 10.1176/appi.ajgp.10.1.24; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Terry DP, 2018, BRAIN IMAGING BEHAV, V12, P631, DOI 10.1007/s11682-017-9719-6; Tremblay S, 2017, EUR J NEUROSCI, V46, P1956, DOI 10.1111/ejn.13583; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Villemagne VL, 2018, NAT REV NEUROL, V14, P225, DOI 10.1038/nrneurol.2018.9; Wilde EA, 2016, J NEUROTRAUM, V33, P672, DOI 10.1089/neu.2015.4035; Wojtowicz M, 2018, NEUROIMAGE-CLIN, V18, P377, DOI 10.1016/j.nicl.2018.01.005; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	67	7	7	0	3	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						309	322		10.1016/B978-0-444-63954-7.00029-X			14	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100031	30482359				2022-02-06	
J	Linton, KF; Kim, BJ				Linton, Kristen F.; Kim, Bum Jung			A pilot study of Trabajadora de salud, a lay health worker intervention for Latinas/os with traumatic brain injuries and their caregivers	DISABILITY AND HEALTH JOURNAL			English	Article						Latino; Hispanic; Brain injury; Traumatic brain injury; Trabajadora; Lay health worker	FAMILY-MEMBERS; AMERICANS; MODEL	Background: Latinas/os with traumatic brain injuries (TBIs) and their caregivers experience worse outcomes than others. Objective: The study aimed to assess the acceptability and promise of Trabajadora de Salud on the functional abilities, hospital readmission, rehabilitation, employment, depression, somatic symptoms, and caregiver burden among Latinas/os with TBIs and their caregivers. Methods: A pre-posttest experimental pilot study was conducted. A total of eight Latina/o adult patients (50% female) with mild or moderate TBI and six of their caregivers (66.7% female) were randomized to receive Trabajadora de Salud or a telephone only control group. Trabajadora de Salud, a three-month, inhome intervention administered by bilingual lay health workers, focused on: 1) providing empathy and validation of TBI symptoms, 2) addressing basic needs, 3) goal setting, and 4) improving communication with healthcare providers. Results: Trabajadora de Salud was widely accepted by patients, caregivers, and health professionals. The functional, depression, and somatic symptoms of the patients as well as the somatic symptoms and caregiver burden of the caregivers improved more for participants in the intervention group than the control group. Conclusions: Trabajadora de Salud demonstrated promise in improving outcomes of Latinas/os with TBIs and their caregivers and should be further studied. (C) 2017 Elsevier Inc. All rights reserved.	[Linton, Kristen F.] Calif State Univ Channel Isl, Hlth Sci Program, One Univ Dr,Solano Hall 1120, Camarillo, CA 93012 USA; [Kim, Bum Jung] Univ Hawaii Manoa, Sch Social Work, Honolulu, HI 96822 USA		Linton, KF (corresponding author), Calif State Univ Channel Isl, Hlth Sci Program, One Univ Dr,Solano Hall 1120, Camarillo, CA 93012 USA.	Kristen.linton@csuci.edu			Solution Focused Brief Therapy Association	This study was funded by the Solution Focused Brief Therapy Association.	Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Armengol CG, 1999, J HEAD TRAUMA REHAB, V14, P233, DOI 10.1097/00001199-199906000-00004; Ayala GX, 2010, HEALTH EDUC RES, V25, P815, DOI 10.1093/her/cyq035; Burnett DM, 2000, BRAIN INJURY, V14, P713; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Marsiglia FF, 2010, J HEALTH CARE POOR U, V21, P119, DOI 10.1353/hpu.0.0355; Perrin PB, 2010, J REHABIL RES DEV, V47, P605, DOI 10.1682/JRRD.2009.10.0170; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Vincent D, 2007, BIOL RES NURS, V9, P130, DOI 10.1177/1099800407304980	15	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-6574	1876-7583		DISABIL HEALTH J	Disabil. Health J.	JAN	2018	11	1					161	164		10.1016/j.dhjo.2017.04.009			4	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	FP4ZY	WOS:000417627400028	28456615				2022-02-06	
B	Mao, HJ		Yang, KH		Mao, Haojie			Modeling the Head for Impact Scenarios	BASIC FINITE ELEMENT METHOD AS APPLIED TO INJURY BIOMECHANICS			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; IN-VITRO; VALIDATION; BIOMECHANICS; DEFORMATION; STRAIN		[Mao, Haojie] Western Univ, London, ON, Canada		Mao, HJ (corresponding author), Western Univ, London, ON, Canada.		Mao, Haojie/Q-7514-2018	Mao, Haojie/0000-0002-7563-9234			Allsop D, 1988, P 32 STAPP CAR CRASH; Bass CR, 2015, SKULL FACIAL BONE IN, P203; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Franklyn M., 2005, 49 STAPP CAR CRASH C; FUNG YCB, 1967, AM J PHYSIOL, V213, P1532, DOI 10.1152/ajplegacy.1967.213.6.1532; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gent AN, 1996, RUBBER CHEM TECHNOL, V69, P59, DOI 10.5254/1.3538357; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Hodgson VR., 1970, 14 STAPP CAR CRASH C; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Ji Songbai, 2004, Stapp Car Crash J, V48, P227; Jin Xin, 2006, Stapp Car Crash J, V50, P637; Jin X, 2011, J BIOMECH, V44, P467, DOI 10.1016/j.jbiomech.2010.09.035; Jin X, 2007, STAPP CAR CRASH JO, V51, P115; Kleiven, 2002, FINITE ELEMENT MODEL; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2013, J NEUROTRAUM, V30, P1521, DOI 10.1089/neu.2012.2520; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Meaney D. F., 1991, BIOMECHANICS ACUTE S, P583; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Mooney M, 1940, J APPL PHYS, V11, P582, DOI 10.1063/1.1712836; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nahum AM, 1977, P 21 STAPP CAR CRASH; Nyquist G. W., 1986, P 30 STAPP CAR CRASH; Ogden, 1984, NONLINEAR ELASTIC DE; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parnaik Yednesh, 2004, Stapp Car Crash J, V48, P259; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Sanchez EJ, 2017, J NEUROTRAUM, V34, P2410, DOI 10.1089/neu.2016.4681; Stitzel J. D., 1999, SAE C P, P81; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Trosseille X., 1992, P 36 STAPP CAR CRASH; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Yang KH, 2011, STUD MECHANOBIOL TIS, V3, P69, DOI 10.1007/8415_2010_62; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhu F, 2016, J NEUROTRAUM, V33, P859, DOI 10.1089/neu.2015.4007	45	7	7	1	1	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			978-0-12-809832-5; 978-0-12-809831-8				2018							469	502		10.1016/B978-0-12-809831-8.00012-X			34	Engineering, Biomedical; Engineering, Mechanical	Book Citation Index – Science (BKCI-S)	Engineering	BJ4AB	WOS:000424737600015					2022-02-06	
J	Mathias, JL; Osborn, AJ				Mathias, J. L.; Osborn, A. J.			Impact of day-of-injury alcohol consumption on outcomes after traumatic brain injury: A meta-analysis	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; blood alcohol; alcohol consumption; intoxication; outcome; meta-analysis	GLASGOW COMA SCALE; ACUTE ETHANOL INTOXICATION; BLOOD-ALCOHOL; SUBSTANCE-ABUSE; HEAD-INJURY; MODERATE; LEVEL; MORTALITY; HETEROGENEITY; INVOLVEMENT	Although a known risk factor for traumatic brain injury (TBI), alcohol has been found to both promote and protect against secondary brain damage. However, it is presently unclear whether the cognitive, psychological and medical/functional outcomes of adults who have consumed alcohol prior to sustaining a TBI differ from those who have not. This meta-analysis examined the outcomes of groups that differed in terms of their day-of-injury (DOI) blood alcohol levels (BALs) by comparing positive with zero BAL (BAL(+)/BAL(-)) and high with low BAL (BAL(high)/BAL(low)) samples. The PubMed, PsycINFO, EMBASE, and Scopus databases were searched from inception until the end of March 2015. Hedge's g effects (continuous data) and odds ratios (categorical data) were calculated for 27 studies that compared either the outcomes of BAL(+) and BAL(-) groups or BAL(high) and BAL(low) groups. BAL(+) was associated with significantly poorer cognitive outcomes (overall and on general tests) and higher levels of disability, and BAL(high) was associated with shorter stays in intensive care. More generally, however, most effect sizes were small to low-moderate in size, non-significant and inconsistent in their direction. Although DOI alcohol consumption increases the risk of sustaining a TBI, it is not consistently associated with better or worse outcomes, other than subtle cognitive deficits; the source of which remains to be determined.	[Mathias, J. L.; Osborn, A. J.] Univ Adelaide, Sch Psychol, Adelaide, SA, Australia		Mathias, JL (corresponding author), Univ Adelaide, Sch Psychol, Adelaide, SA, Australia.	jane.mathias@adelaide.edu.au		Mathias, Jane/0000-0001-8957-8594	School of Psychology, University of Adelaide, Adelaide, South Australia	This study was funded by a small research grant from the School of Psychology, University of Adelaide, Adelaide, South Australia.	Albrecht-Anoschenko J, 2005, ZBL NEUROCHIR, V66, P59, DOI 10.1055/s-2005-836487; Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Asmaro K, 2013, CURR DRUG TARGETS, V14, P74, DOI 10.2174/138945013804806505; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; BENNETT RH, 1993, ALCOHOL CLIN EXP RES, V17, P740, DOI 10.1111/j.1530-0277.1993.tb00832.x; Berry C, 2011, AM SURGEON, V77, P1416; Berry C, 2010, AM SURGEON, V76, P1067; Bjork JM, 2014, NEUROPHARMACOLOGY, V84, P101, DOI 10.1016/j.neuropharm.2013.07.039; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Borenstein M., 2011, INTRO META ANAL, DOI DOI 10.1002/9780470743386; Boyles AL, 2011, EPIDEMIOLOGY, V22, P746, DOI 10.1097/EDE.0b013e318225ba48; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Chapital Alyssa D, 2007, Hawaii Med J, V66, P318; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Choi Y, 2009, AM J EMERG MED, V27, P956, DOI 10.1016/j.ajem.2008.07.035; Christensen M A, 2001, J Neurosci Nurs, V33, P184; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Dinh MM, 2014, EMERG MED J, V31, P390, DOI 10.1136/emermed-2012-202076; Ferris J, 2013, ACCIDENT ANAL PREV, V60, P181, DOI 10.1016/j.aap.2013.08.018; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Gururaj G, 2004, J Indian Med Assoc, V102, P157; Hsieh CH, 2013, AM SURGEON, V79, P1289; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Is M, 2005, NEUROSURG QUART, V15, P60, DOI 10.1097/01.wnq.0000152407.39871.c7; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Jones A. W., 2001, ENCY DRUGS ALCOHOL A, P185; Joseph B, 2015, J TRAUMA ACUTE CARE, V78, P403, DOI 10.1097/TA.0000000000000504; Kanbak G, 2013, GENE, V512, P492, DOI 10.1016/j.gene.2012.10.012; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; KELLY DF, 1995, J NEUROTRAUM, V12, P883, DOI 10.1089/neu.1995.12.883; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kong LM, 2012, AM J NEURORADIOL, V33, P928, DOI 10.3174/ajnr.A2873; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Kushner MG, 2000, CLIN PSYCHOL REV, V20, P149, DOI 10.1016/S0272-7358(99)00027-6; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P478, DOI 10.1093/arclin/acu027; Lange RT, 2008, ARCH CLIN NEUROPSYCH, V23, P809, DOI 10.1016/j.acn.2008.07.004; Levy DT, 2004, MED SCI MONITOR, V10, pCR17; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; Matsukawa H, 2013, BRAIN INJURY, V27, P1409, DOI 10.3109/02699052.2013.823655; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; NARANJO CA, 1993, ADDICTION, V88, P25; NATH FP, 1986, INJURY, V17, P150, DOI 10.1016/0020-1383(86)90320-7; Olkin, 1985, STAT METHODS METAANA, DOI DOI 10.1016/J.PHYTOCHEM.2011.03.026; Orwin R.G., 1983, J EDUC STAT, V8, P157, DOI [10.2307/1164923, DOI 10.2307/1164923]; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Pidd K, 2014, ACCIDENT ANAL PREV, V71, P154, DOI 10.1016/j.aap.2014.05.012; Puljula J, 2013, ACTA NEUROL SCAND, V127, P192, DOI 10.1111/j.1600-0404.2012.01697.x; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Tate PS, 1999, BRAIN INJURY, V13, P767; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Turner AP, 2006, REHABIL PSYCHOL, V51, P78, DOI 10.1037/0090-5550.51.1.78; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Vonghia L, 2008, EUR J INTERN MED, V19, P561, DOI 10.1016/j.ejim.2007.06.033; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson, 2001, PRACTICAL METAANALYS; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397; Ylioja S, 2010, CLIN NEUROPSYCHOL, V24, P1097, DOI 10.1080/13854046.2010.516021	85	7	7	1	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2018	28	6					997	1018		10.1080/09602011.2016.1224190			22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GJ1KR	WOS:000435015100007	27585824	Green Published, hybrid			2022-02-06	
J	Najmon, JC; Jacob, DJ; Wood, ZM; Tovar, A				Najmon, Joel C.; Jacob, DeHart J.; Wood, Zebulun M.; Tovar, Andres			Cellular Helmet Liner Design through Bio-inspired Structures and Topology Optimization of Compliant Mechanism Lattices	SAE INTERNATIONAL JOURNAL OF TRANSPORTATION SAFETY			English	Article						Bio-inspired design; Structural optimization; Simulation; Finite element analysis; Energy absorption; Passive safety; Elastomers	ENERGY-ABSORPTION; STRAIN; INJURY; HEAD	The continuous development of sport technologies constantly demands advancements in protective headgear to reduce the risk of head injuries. This article introduces new cellular helmet liner designs through two approaches. The first approach is the study of energy-absorbing biological materials. The second approach is the study of lattices comprised of force-diverting compliant mechanisms. On the one hand, bio-inspired liners are generated through the study of biological, hierarchical materials. An emphasis is given on structures in nature that serve similar concussion-reducing functions as a helmet liner. Inspiration is drawn from organic and skeletal structures. On the other hand, compliant mechanism lattice (CML)-based liners use topology optimization to synthesize rubber cellular unit cells with effective positive and negative Poisson's ratios. Three lattices are designed using different cellular unit cell arrangements, namely, all positive, all negative, and alternating effective Poisson's ratios. The proposed cellular (bio-inspired and CML-based) liners are embedded between two polycarbonate shells, thereby, replacing the traditional expanded polypropylene foam liner used in standard sport helmets. The cellular liners are analyzed through a series of 2D extruded ballistic impact simulations to determine the best performing liner topology and its corresponding rubber hardness. The cellular design with the best performance is compared against an expanded polypropylene foam liner in a 3D simulation to appraise its protection capabilities and verify that the 2D extruded design simulations scale to an effective 3D design.	[Najmon, Joel C.; Jacob, DeHart J.; Wood, Zebulun M.; Tovar, Andres] Indiana Univ Purdue Univ Indianapolis, Indianapolis, IN 46202 USA		Najmon, JC (corresponding author), Indiana Univ Purdue Univ Indianapolis, Indianapolis, IN 46202 USA.				Sports Innovation Institute at Indiana University-Purdue University Indianapolis (IUPUI)	This research was supported by a grant from the Sports Innovation Institute at Indiana University-Purdue University Indianapolis (IUPUI). The authors want to thank Darin Grice, President of Turtle Shell Protective Systems, LLC, for feedback on helmet design and simulation.	Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; B. H. S. I, 2017, BIC HELM LIN FOAM OT; Blanco DH, 2014, P I MECH ENG P-J SPO, V228, P95, DOI 10.1177/1754337113518748; Bouix R, 2009, INT J IMPACT ENG, V36, P329, DOI 10.1016/j.ijimpeng.2007.11.007; Buhrig-Polaczek A, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/4/045002; Chakrabarti A, 2005, AI EDAM, V19, P113, DOI 10.1017/S0890060405050109; Chintapalli RK, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036005; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Fu K, 2014, J MECH DESIGN, V136, DOI 10.1115/1.4028289; Gibson L. J., 2010, CELLULAR MAT NATURE; Gibson L.J., 1997, CELLULAR SOLIDS STRU, P309; Goehler H, 2014, ADV ENG MATER, V16, P335, DOI 10.1002/adem.201300057; Gokhale V. V., 2016, 2016011538 SAE, DOI [10.4271/2016-01-1538, DOI 10.4271/2016-01-1538]; Gokhale V, 2017, PROC ASME DES ENG TE; Halimi MT, 2012, INT J SUSTAIN ENG, V5, P128, DOI 10.1080/19397038.2011.602438; Hallquist JO, 2006, LS DYNA THEORY MANUA; Helmets. org, 2016, HELM MAN ACT; Jiang CG, 2014, COMPUT GRAPH FORUM, V33, P185, DOI 10.1111/cgf.12444; Johnson K., 2013, PRINCETON SCH BECOME; Johnson KL, 2016, MATER DESIGN, V111, P108, DOI 10.1016/j.matdes.2016.08.064; Landman N.H., 2010, NAUTILUS, P249, DOI [10.1007/978-90-481-3299-7_17, DOI 10.1007/978-90-481-3299-7_17]; Li MZ, 2011, ADV ENG MATER, V13, P33, DOI 10.1002/adem.201000165; Liu K, 2014, STRUCT MULTIDISCIP O, V50, P1175, DOI 10.1007/s00158-014-1107-x; Looyrach J., 2015, 8 INT C MAT SCI TECH; Lu G., 2003, ENERGY ABSORPTION ST, P25; Luo YH, 2017, BIO-MED MATER ENG, V28, P279, DOI 10.3233/BME-171674; Mackay M, 2007, SADHANA-ACAD P ENG S, V32, P397, DOI 10.1007/s12046-007-0031-9; Mchenry B.G., 2004, HEAD INJURY CRITERIO; Mehta P.S., 2016, SAE TECH PAP, DOI [10.4271/2016-01-0396, DOI 10.4271/2016-01-0396]; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mills NJ, 2006, P I MECH ENG L-J MAT, V220, P167, DOI 10.1243/14644207JMDA100; Moss WC, 2014, COMPUT METHOD BIOMEC, V17, P1173, DOI 10.1080/10255842.2012.739162; Nagel J. K. S., 2013, ASME 2013 INT DES EN; Najmon J. C., 2017, DESIGN COMPLIANT MEC; Naleway SE, 2015, ADV MATER, V27, P5455, DOI 10.1002/adma.201502403; NOCSAE, 2017, STAND TEST METH EQ U; Oda J, 2006, JSME INT J A-SOLID M, V49, P390, DOI 10.1299/jsmea.49.390; Pinto P, 2014, J MATER PROCESS TECH, V214, P571, DOI 10.1016/j.jmatprotec.2013.11.011; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Saaty T.L., 2008, SORT-STAT OPER RES T, V102, P251; Schaedler TA, 2016, ANNU REV MATER RES, V46, P187, DOI 10.1146/annurev-matsci-070115-031624; Schaedler TA, 2014, ADV ENG MATER, V16, P276, DOI 10.1002/adem.201300206; Schwizer P, 2017, P I MECH ENG P-J SPO, V231, P336, DOI 10.1177/1754337117703839; Shuaeib FM, 2007, MATER DESIGN, V28, P182, DOI 10.1016/j.matdes.2005.04.015; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Soe SP, 2015, INT J ADV MANUF TECH, V79, P1975, DOI 10.1007/s00170-015-6972-y; Soe SP, 2014, POLYM TEST, V34, P103, DOI 10.1016/j.polymertesting.2014.01.004; Srinivasan V., 2010, 2009 ASME INT DES EN; Stephani G, 2006, ADV ENG MATER, V8, P847, DOI 10.1002/adem.200600078; SVANBERG K, 1987, INT J NUMER METH ENG, V24, P359, DOI 10.1002/nme.1620240207; Tay YY, 2014, INT J CRASHWORTHINES, V19, P288, DOI 10.1080/13588265.2014.893789; Teng TL, 2014, P I MECH ENG L-J MAT, V228, P341, DOI 10.1177/1464420713493590; Thielen M., 2013, BIOMIMETIC ENG LEARN; Thielen M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140322; Tinsley A., 2008, 19 INT C DES THEOR M; Vattam S., 2011, DANE FOSTERING CREAT; Vincent JFV, 2002, PHILOS T ROY SOC A, V360, P159, DOI 10.1098/rsta.2001.0923; Wang B, 2018, MATER DESIGN, V137, P305, DOI 10.1016/j.matdes.2017.10.038; Wang B, 2016, PROG MATER SCI, V76, P229, DOI 10.1016/j.pmatsci.2015.06.001; Wang J., 2016, 28 INT C DES THEOR M; Wang LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026490; Warner B, 2005, ANAL HYPERELASTIC MA; Wohlers T., 2016, HIST ADDITIVE MANUFA; Wu YH, 2017, COMPOS PART B-ENG, V121, P122, DOI 10.1016/j.compositesb.2017.03.030; Yoon SH, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/3/035501; Zhang YB, 2017, RAPID PROTOTYPING J, V23, P1136, DOI 10.1108/RPJ-08-2016-0129	66	7	7	1	13	SAE INT	WARRENDALE	400 COMMONWEALTH DR, WARRENDALE, PA 15096 USA	2327-5626	2327-5634		SAE INT J TRANSP SAF	SAE Int. J. Transp. Saf.		2018	6	3					217	235	UNSP 2018-01-1057	10.4271/2018-01-1057			19	Transportation Science & Technology	Emerging Sources Citation Index (ESCI)	Transportation	HK1UW	WOS:000457693300003		Green Published			2022-02-06	
S	Nauman, EA; Talavage, TM		Hainline, B; Stern, RA		Nauman, Eric A.; Talavage, Thomas M.			Subconcussive trauma	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							DEFAULT MODE NETWORK; SPORTS-RELATED CONCUSSION; HEAD IMPACT BIOMECHANICS; SMALLER THALAMIC VOLUMES; PROFESSIONAL FOOTBALL; BRAIN-INJURY; RECURRENT CONCUSSION; SOCCER PLAYERS; 1ST EXPOSURE; SEASON	Even impacts that do not immediately elicit symptoms of a concussion can induce changes in neural integrity. Because these so-called "subconcussive" head acceleration events, or head impact exposures, do not elicit identifiable symptoms, athletes continue to participate with unclear consequences. Neuroimaging studies reveal that neurologic changes, including inflammation, are associated with repetitive head impact exposures. Given that brain changes have been observed in athletes following repetitive head impact exposure, it is important to understand better and mitigate against this phenomenon. It is important to transition from the metric of concussion alone to one that includes repetitive head impact exposure, including the development of models that address why brain integrity may be compromised, who is at risk, and how to mitigate the risk of such exposure. Future work can include a health-monitoring framework to effect change and promote athlete safety.	[Nauman, Eric A.] Purdue Univ, Sch Mech Engn, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Talavage, Thomas M.] Purdue Univ, Sch Elect & Comp Engn, Weldon Sch Biomed Engn, 465 Northwestern Ave, W Lafayette, IN 47907 USA		Talavage, TM (corresponding author), Purdue Univ, Sch Elect & Comp Engn, Weldon Sch Biomed Engn, 465 Northwestern Ave, W Lafayette, IN 47907 USA.	tmt@purdue.edu		Talavage, Thomas/0000-0003-4977-6398			Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bari S, 2019, BRAIN IMAGING BEHAV, V13, P735, DOI 10.1007/s11682-018-9861-9; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Brooks SH, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00261; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cherry JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185079; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Epstein D, 2010, SPORTS ILLUSTRATED, V113, P42; Farrey T, 2016, YOUTH FOOTBALL PARTI; Galle B, 2007, J BIOMECH, V40, P3029, DOI 10.1016/j.jbiomech.2007.03.014; Giza C, 2016, GRIZ1 SOME CLOSEUPS; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Haacke EM, 2013, CEREBRAL BLOOD FLOW; Hui OY, 2008, J NEUROTRAUM, V25, P19, DOI 10.1089/neu.2007.0340; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kashyap P, 2017, BIOM ENG SOC 2017 AN; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Lee T, 2017, BIOM ENG SOC 2017 AN; Livengood SL, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00136; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Park K, 2013, FUTUR NEUROL, V8, P555, DOI 10.2217/FNL.13.35; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Reynolds BB, 2018, BRAIN IMAGING BEHAV, V12, P1332, DOI 10.1007/s11682-017-9790-z; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Shenk TE, 2015, DEV NEUROPSYCHOL, V40, P63, DOI 10.1080/87565641.2015.1014088; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Svaldi DO, 2016, CEREBROVASCULAR REAC; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Talavage TM, 2016, MED IMAGING RECHARAC; Tweardy M, 2017, BIOM ENG SOC 2017 AN; Wallerson R, 2014, WALL STREET J   0131; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	72	7	7	2	5	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						245	255		10.1016/B978-0-444-63954-7.00024-0			11	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100026	30482352				2022-02-06	
J	Newsome, MR; Wilde, EA; Bigler, ED; Liu, QS; Mayer, AR; Taylor, BA; Steinberg, JL; Tate, DF; Abildskov, TJ; Scheibel, RS; Walker, WC; Levin, HS				Newsome, Mary R.; Wilde, Elisabeth A.; Bigler, Erin D.; Liu, Qisheng; Mayer, Andrew R.; Taylor, Brian A.; Steinberg, Joel L.; Tate, David F.; Abildskov, Tracy J.; Scheibel, Randall S.; Walker, William C.; Levin, Harvey S.			Functional brain connectivity and cortical thickness in relation to chronic pain in post-911 veterans and service members with mTBI	BRAIN INJURY			English	Article						Traumatic brain injury; pain; imaging; functional connectivity; cortical thickness	POSTTRAUMATIC-STRESS-DISORDER; AFGHANISTAN VETERANS; PHYSICAL PAIN; DEFAULT-MODE; BACK-PAIN; INJURY; IRAQ; NETWORK; PTSD; TBI	Objectives: Investigate the relation of chronic pain interference to functional connectivity (FC) of brain regions and to cortical thickness in post-911 Veterans and Service Members (SMs) who sustained a mild traumatic brain injury (mTBI).Methods: This is an observational study with cross-sectional analyses. A sample of 65 enrollees completing initial evaluation at a single site of the Chronic Effects of Neurotrauma Consortium (CENC) reported pain interference ratings on the TBI QOL. Functional connectivity and cortical thickness were measured.Results: Severity of pain interference was negatively related to FC of the default mode network (DMN), i.e., participants who reported more severe pain interference had less FC between mesial prefrontal cortex and posterior regions of the DMN including posterior cingulate cortex and precuneus. Cortical thickness of specific regions was positively related to severity of pain interference.Conclusion: The more that pain was perceived to interfere with daily life, the less the FC between regions in a network associated with self-referential thought and mind wandering. Although cortical thickness in specific brain regions was positively related to severity of pain interference, follow-up longitudinal data, control group data, and study of individual differences in this cohort will expand this initial report and replicate these findings.	[Newsome, Mary R.; Wilde, Elisabeth A.; Liu, Qisheng; Scheibel, Randall S.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Michael DeBakey VA Med Ctr & H Ben Taub, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Bigler, Erin D.; Abildskov, Tracy J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Mind Res Network, Albuquerque, NM 87131 USA; [Taylor, Brian A.] Virginia Commonwealth Univ, Coll Engn, Richmond, VA USA; [Steinberg, Joel L.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA		Newsome, MR (corresponding author), Baylor Coll Med, 1 Baylor Plaza,BCM637, Houston, TX 77030 USA.	mnewsome@bcm.edu	Tate, David F/I-3963-2013	Tate, David F/0000-0003-0213-1920	Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC)	This material is based upon work supported with resources and the use of facilities at: Hunter Holmes McGuire Veterans Affairs Medical Center (VAMC) in Richmond, VA; James A. Haley Veterans Hospital (VH), Tampa, FL; Audie L. Murphy Memorial VH, San Antonio, TX; and Michael E. DeBakey VA Medical Center, Houston, TX and is based upon work supported in part by the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC).	Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Ashby FG, 2011, STAT ANAL MRI DATA; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Bansal R, 2018, MOL PSYCHIATR, V23, P375, DOI 10.1038/mp.2017.34; Borsook D, 2013, EXPERT REV NEUROTHER, V13, P1221, DOI 10.1586/14737175.2013.846218; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buttner MM, 2017, PSYCHIAT RES, V257, P7, DOI 10.1016/j.psychres.2017.07.001; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Clewett DV, 2018, J NEUROSCI, V38, P1558, DOI 10.1523/JNEUROSCI.2097-17.2017; Coppieters I, 2018, HUM BRAIN MAPP, V39, P1721, DOI 10.1002/hbm.23947; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fox KCR, 2015, NEUROIMAGE, V111, P611, DOI 10.1016/j.neuroimage.2015.02.039; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gupta A, 2017, J NEUROSCI RES, V95, P604, DOI 10.1002/jnr.23856; Hubbard CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156545; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Kumbhare DA, 2017, CLIN J PAIN, V33, P281, DOI 10.1097/AJP.0000000000000415; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Loggia ML, 2014, ARTHRITIS RHEUMATOL, V66, P203, DOI [10.1002/art.38191, 10.1002/art.38396]; Martucci Katherine T, 2016, Anesthesiol Clin, V34, P255, DOI 10.1016/j.anclin.2016.01.001; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Meerwijk EL, 2013, BRAIN IMAGING BEHAV, V7, P1, DOI 10.1007/s11682-012-9179-y; Morton DL, 2016, J PAIN RES, V9, P613, DOI 10.2147/JPR.S60433; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; Polomano RC, 2016, PAIN MED, V17, P1505, DOI 10.1093/pm/pnw105; Porro CA, 2002, J NEUROSCI, V22, P3206, DOI 10.1523/JNEUROSCI.22-08-03206.2002; Preissler S, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00319; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rizvi SJ, 2017, CURR OPIN PSYCHIATR, V30, P159, DOI 10.1097/YCO.0000000000000314; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Stratton KJ, 2014, J REHABIL RES DEV, V51, P1189, DOI 10.1682/JRRD.2014.04.0111; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thompson SJ, 2012, NEUROSCI LETT, V520, P131, DOI 10.1016/j.neulet.2012.03.015; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Wang S, 2017, NEUROSCIENCE; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; Wiech K, 2016, SCIENCE, V354, P584, DOI 10.1126/science.aaf8934; Wiech K, 2009, NEUROIMAGE, V47, P987, DOI 10.1016/j.neuroimage.2009.05.059; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Wrocklage KM, 2017, EUR NEUROPSYCHOPHARM, V27, P515, DOI 10.1016/j.euroneuro.2017.02.010; Yang Q, 2017, HUM BRAIN MAPP, V38, P1815, DOI 10.1002/hbm.23484	51	7	7	2	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	10			SI		1236	1244		10.1080/02699052.2018.1494853			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GS6YO	WOS:000443846200010	30047797				2022-02-06	
J	Ngwenya, LB; Mazumder, S; Porter, ZR; Minnema, A; Oswald, DJ; Farhadi, HF				Ngwenya, Laura B.; Mazumder, Sarmistha; Porter, Zachary R.; Minnema, Amy; Oswald, Duane J.; Farhadi, H. Francis			Implantation of Neuronal Stem Cells Enhances Object Recognition without Increasing Neurogenesis after Lateral Fluid Percussion Injury in Mice	STEM CELLS INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; DENTATE GYRUS; HIPPOCAMPAL NEUROGENESIS; COGNITIVE RECOVERY; UNITED-STATES; TRANSPLANTATION; MOUSE; ACTIVATION; MECHANISMS; PATTERNS	Cognitive deficits after traumatic brain injury (TBI) are debilitating and contribute to the morbidity and loss of productivity of over 10 million people worldwide. Cell transplantation has been linked to enhanced cognitive function after experimental traumatic brain injury, yet the mechanism of recovery is poorly understood. Since the hippocampus is a critical structure for learning and memory, supports adult neurogenesis, and is particularly vulnerable after TBI, we hypothesized that stem cell transplantation after TBI enhances cognitive recovery by modulation of endogenous hippocampal neurogenesis. We performed lateral fluid percussion injury (LFPI) in adult mice and transplanted embryonic stem cell-derived neural progenitor cells (NPC). Our data confirm an injury-induced cognitive deficit in novel object recognition, a hippocampal-dependent learning task, which is reversed one week after NPC transplantation. While LFPI alone promotes hippocampal neurogenesis, as revealed by doublecortin immunolabeling of immature neurons, subsequent NPC transplantation prevents increased neurogenesis and is not associated with morphological maturation of endogenous injury-induced immature neurons. Thus, NPC transplantation enhances cognitive recovery early after LFPI without a concomitant increase in neuron numbers or maturation.	[Ngwenya, Laura B.; Mazumder, Sarmistha; Minnema, Amy; Oswald, Duane J.; Farhadi, H. Francis] Ohio State Univ, Wexner Med Ctr, Dept Neurol Surg, 410 W 10th Ave,N1021 Doan Hall, Columbus, OH 43210 USA; [Ngwenya, Laura B.; Porter, Zachary R.] Univ Cincinnati, Dept Neurosurg, 231 Albert Sabin Way,MSB 5209,ML 0517, Cincinnati, OH 45267 USA		Farhadi, HF (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Neurol Surg, 410 W 10th Ave,N1021 Doan Hall, Columbus, OH 43210 USA.	francis.farhadi@osumc.edu		Ngwenya, Laura/0000-0001-7103-971X; Farhadi, H Francis/0000-0002-4668-8512	Ohio State University Neurosignature Program; Center for Clinical and Translational Science [UL1TR000090]; P30 Core Grant NINDS [P30-NS045758]; University of Cincinnati Gardner Neuroscience Institute Research Pilot grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS045758, P30NS104177] Funding Source: NIH RePORTER	The authors acknowledge Drs. Ashley Fenn and Jonathan Godbout for establishing the fluid percussion injury model at The Ohio State University. The authors would like to thank Amy Tovar and members of the laboratories of Drs. Philip Popovich and Dana McTigue for helpful discussions and input in designing and administering the behavioral studies. The authors thank the Center for Brain and Spinal Cord Repair at The Ohio State University for use of surgical and behavioral equipment and resources. The authors also thank Lesley Fisher and the laboratory of Dr. Michelle Basso for allowing use of the Stereo Investigator Microscopy and Software. Confocal images were acquired using the Campus Microscopy and Imaging Facility at The Ohio State University. HFF received funding support from The Ohio State University Neurosignature Program, Center for Clinical and Translational Science (UL1TR000090), and a P30 Core Grant NINDS P30-NS045758. Funding support was in part also provided through a University of Cincinnati Gardner Neuroscience Institute Research Pilot grant (to Laura B. Ngwenya).	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Amrein I., 2015, COLD SPRING HARBOR P, V7; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dorsett CR, 2017, J NEUROTRAUM, V34, P220, DOI 10.1089/neu.2015.4372; Dunkerson J, 2014, RESTOR NEUROL NEUROS, V32, P675, DOI 10.3233/RNN-140408; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Griesbach GS, 2015, J NEUROTRAUM, V32, P704, DOI 10.1089/neu.2014.3754; Harrison JL, 2014, EXP BRAIN RES, V232, P2709, DOI 10.1007/s00221-014-3948-3; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Kesner RP, 2013, BEHAV BRAIN RES, V254, P1, DOI 10.1016/j.bbr.2013.01.012; Lam PK, 2016, ACTA NEUROCHIR SUPPL, V122, P21, DOI 10.1007/978-3-319-22533-3_4; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morris AM, 2012, NEUROBIOL LEARN MEM, V97, P326, DOI 10.1016/j.nlm.2012.02.005; Ngwenya LB, 2005, J HISTOCHEM CYTOCHEM, V53, P821, DOI 10.1369/jhc.4A6605.2005; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Ferreira APO, 2014, PSYCHOPHARMACOLOGY, V231, P1935, DOI 10.1007/s00213-013-3336-x; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Reis C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6392592; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Robertson E J, 1990, Methods Mol Biol, V5, P223, DOI 10.1385/0-89603-150-0:223; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shapiro LA, 2006, EPILEPSY RES, V69, P53, DOI 10.1016/j.eplepsyres.2005.12.003; Shapiro LA, 2017, CELL TRANSPLANT, V26, P1314, DOI 10.1177/0963689717714099; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Sullivan GM, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/9342534; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Sun D, 2011, J NEUROTRAUM, V28, P961, DOI 10.1089/neu.2010.1697; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Witgen BM, 2006, J NEUROTRAUM, V23, P1320, DOI 10.1089/neu.2006.23.1320; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	64	7	7	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-966X	1687-9678		STEM CELLS INT	Stem Cells Int.		2018	2018								4209821	10.1155/2018/4209821			11	Cell & Tissue Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FW6ES	WOS:000425411600001	29531536	Green Published, gold, Green Submitted			2022-02-06	
J	Osei, J; Kelly, W; Toffolo, K; Donahue, K; Levy, B; Bard, J; Wang, JX; Levy, E; Nowak, N; Poulsen, D				Osei, Jennifer; Kelly, William; Toffolo, Kathryn; Donahue, Kaitlynn; Levy, Bennet; Bard, Jonathan; Wang, Jianxin; Levy, Elad; Nowak, Norma; Poulsen, David			Thymosin beta 4 induces significant changes in the plasma miRNA profile following severe traumatic brain injury in the rat lateral fluid percussion injury model	EXPERT OPINION ON BIOLOGICAL THERAPY			English	Article						Microrna; plasma; thymosin beta 4; traumatic brain injury	NONCODING RNAS; EMERGING ROLES; MICRORNAS; EXPRESSION; STROKE	Objectives: Thymosin beta 4 (T4) has demonstrated neuroprotective potential in models of neurlogical injury. The neuroprotective potential of T4 has been associated with increased miR-200a and miR-200b within the brain following stroke. Here we tested the hypothesis that T4 treatment could also alter miRNA profiles within the plasma following severe traumatic brain injury (TBI).Methods: We used the rat lateral fluid percusion injury model of severe TBI to test this hypothesis. Highly sensitive and quantitative droplet digital polymerase chain reaction (ddPCR) was used to measure the plasma concentrations of miR-200 family members. In addition, we conducted RNAseq analysis of plasma miRNA to further identify changes associated with TBI and treatment with T4.Results: ddPCR demonstrated that miR-200a-3p andmiR-200b-3p were both significantly increased in plasma following treatment with T4 after severe TBI. RNAseq analysis suggested that miR-300-3p and miR-598-3p increased while miR-450-3p and miR-194-5p significantly decreased following TBI. In contrast, miR-194-5p significantly increased in T4 treated rats following TBI. In addition, we identified nine plasma miRNAs whose expression significantly changed following treatment with T4.Conclusions: T4 treatment significantly increased plasma levels of miR-200a-3p and miR-200b-3p, while RNAseq analysis identified miR-194-5p as a candidate miRNA that may be critical for neuroprotection.	[Osei, Jennifer; Kelly, William; Toffolo, Kathryn; Donahue, Kaitlynn; Levy, Bennet; Levy, Elad; Poulsen, David] SUNY Buffalo, Jacobs Sch Med & Biomed Sceinces, Dept Neurosurg, Buffalo, NY USA; [Bard, Jonathan; Nowak, Norma] SUNY Buffalo, New York State Ctr Bioinformat & Life Sci, Buffalo, NY USA; [Wang, Jianxin] SUNY Buffalo, Ctr Computat Res, Buffalo, NY USA; [Nowak, Norma] SUNY Buffalo, Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY USA		Poulsen, D (corresponding author), SUNY Buffalo, Dept Neurosurg, 875 Ellicott St, Buffalo, NY 14203 USA.	davidpou@buffalo.edu		Toffolo, Kathryn/0000-0002-5728-3174; Bard, Jonathan/0000-0001-7433-0086	New York State Center of Excellence in Bioinformatics and Life Sciences at the University of Buffalo; Department of Neurosurgery, State University of New York at Buffalo; SciClone Pharmaceuticals	This work was supported in part by the New York State Center of Excellence in Bioinformatics and Life Sciences at the University of Buffalo and by the Department of Neurosurgery, State University of New York at Buffalo. This paper has been published as part of a supplement issue covering the proceedings of the Fifth International Symposium on Thymosins in Health and Disease and is funded by SciClone Pharmaceuticals.	Bhalala OG, 2013, NAT REV NEUROL, V9, P328, DOI 10.1038/nrneurol.2013.67; Cheng P, 2014, NEUROPHARMACOLOGY, V85, P408, DOI 10.1016/j.neuropharm.2014.06.004; Lee ST, 2010, STROKE, V41, P1646, DOI 10.1161/STROKEAHA.110.579649; Morris DC, 2014, J NEUROL SCI, V345, P61, DOI 10.1016/j.jns.2014.07.006; Morris DC, 2012, ANN NY ACAD SCI, V1269, P110, DOI 10.1111/j.1749-6632.2012.06651.x; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Rau TF, 2014, EXP NEUROL, V253, P31, DOI 10.1016/j.expneurol.2013.12.001; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; Rau TF, 2011, NEUROPHARMACOLOGY, V61, P677, DOI 10.1016/j.neuropharm.2011.05.010; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rink C, 2011, PHYSIOL GENOMICS, V43, P521, DOI 10.1152/physiolgenomics.00158.2010; Salta E, 2012, LANCET NEUROL, V11, P189, DOI 10.1016/S1474-4422(11)70286-1; Santra M, 2016, J NEUROCHEM, V136, P118, DOI 10.1111/jnc.13394; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Sorensen SS, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0053-5; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Xin HQ, 2013, STEM CELLS, V31, P2737, DOI 10.1002/stem.1409; Xiong Y, 2012, ANN NY ACAD SCI, V1270, P51, DOI 10.1111/j.1749-6632.2012.06683.x; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118	21	7	7	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1471-2598	1744-7682		EXPERT OPIN BIOL TH	Expert Opin. Biol. Ther.		2018	18			1			159	164		10.1080/14712598.2018.1484102			6	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	GP1QR	WOS:000440592000023	29873258				2022-02-06	
S	Ozkizilcik, A; Williams, R; Tian, ZR; Muresanu, DF; Sharma, A; Sharma, HS		Skaper, SD		Ozkizilcik, Asya; Williams, Roger; Tian, Z. Ryan; Muresanu, Dafin F.; Sharma, Aruna; Sharma, Hari S.			Synthesis of Biocompatible Titanate Nanofibers for Effective Delivery of Neuroprotective Agents	NEUROTROPHIC FACTORS: METHODS AND PROTOCOLS, 2ND EDITION	Methods in Molecular Biology		English	Article; Book Chapter						Drug delivery; Nanofibers; Nanocarriers; Neuroprotection; Central nervous system diseases; Blood-brain barrier; Traumatic brain injury; Cerebrolysin	BLOOD-BRAIN-BARRIER; SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; HYPERTHERMIA-INDUCED NEUROTOXICITY; NANOWIRED DRUG-DELIVERY; NEUROTROPHIC FACTORS; CEREBROLYSIN; NANOPARTICLES; REPAIR; RAT	Nanoscience provides us with new opportunities to develop nanotechnologies for treating, in particular, central nervous system disorders such as Alzheimer disease and multiple sclerosis. From a methodological point of view, it is challenging to deliver drugs effectively across the blood-brain barrier and blood-cerebrospinal fluid barrier. Our 10-year data and reports from both in vivo and in vitro studies, however, have consistently proved that therapeutic drugs of different types can be generally loaded in/on the nanocarriers for targeted and programmable deliveries to the central nervous system with a high degree of efficacy. This chapter presents a protocol for the synthesis of biocompatible titanate nanofibers as low-cost drug delivery cargos. In addition, a procedure for loading the neuroprotective agent Cerebrolysin onto the nanofibers is briefly described. Finally, experimental observations on the use of nanodrug delivery for superior neuroprotective effects of Cerebrolysin in traumatic brain injury are given as a proof of concept as compared to normal drug alone.	[Ozkizilcik, Asya] Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA; [Ozkizilcik, Asya; Williams, Roger; Tian, Z. Ryan] Univ Arkansas, Inst Nanosci & Engn, Fayetteville, AR 72701 USA; [Williams, Roger; Tian, Z. Ryan] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Muresanu, Dafin F.] Univ Med & Pharm, Dept Clin Neurosci, Cluj Napoca, Romania; [Muresanu, Dafin F.] RoNeuro Inst Neurol Res & Diagnost, Cluj Napoca, Romania; [Sharma, Aruna; Sharma, Hari S.] Uppsala Univ, Univ Uppsala Hosp, Dept Surg Sci Anesthesiol & Intens Care Med, Int Expt Cent Nervous Syst Injury & Repair IECNSI, Uppsala, Sweden		Ozkizilcik, A (corresponding author), Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA.; Ozkizilcik, A (corresponding author), Univ Arkansas, Inst Nanosci & Engn, Fayetteville, AR 72701 USA.		Muresanu, Fior-Dafin/AAI-8120-2021	Ozkizilcik, Asya/0000-0002-6261-9533	Howard Hughes Medical InstituteHoward Hughes Medical Institute Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG028679] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG028679] Funding Source: NIH RePORTER		Kim MS, 2016, ACS APPL MATER INTER, V8, P18741, DOI 10.1021/acsami.6b06889; Kumar P, 2014, NANOMEDICINE-UK, V9, P331, DOI 10.2217/nnm.13.203; Li AJ, 2015, MOL MED REP, V11, P3078, DOI 10.3892/mmr.2014.3017; Li C, 2015, POLYM CHEM-UK, V6, P2740, DOI 10.1039/c4py01422g; Menon PK, 2012, CNS NEUROL DISORD-DR, V11, P40; Misra A, 2003, J PHARM PHARM SCI, V6, P252; Muresanu DF, 2012, CNS NEUROL DISORD-DR, V11, P50, DOI 10.2174/187152712799960736; Pathan Shadab A, 2009, Recent Pat Drug Deliv Formul, V3, P71; Saraiva C, 2016, J CONTROL RELEASE, V235, P34, DOI 10.1016/j.jconrel.2016.05.044; Sharma A, 2016, CNS NEUROL DISORD-DR, V15, P1092, DOI 10.2174/1871527315666160819123059; Sharma G, 2014, PHARM RES-DORDR, V31, P1194, DOI 10.1007/s11095-013-1242-x; Sharma HS, 2006, ACTA NEUROCHIR SUPPL, V96, P288; Sharma HS, 2016, NEURODEGENER DIS MAN, V6, P453, DOI 10.2217/nmt-2016-0037; Sharma HS, 2015, CNS NEUROL DISORD-DR, V14, P386, DOI 10.2174/1871527314666150318114335; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5014, DOI 10.1166/jnn.2009.GR04; Sharma HS, 2007, PROG BRAIN RES, V162, P173, DOI 10.1016/S0079-6123(06)62010-4; Sharma HS, 2016, CNS NEUROL DISORD-DR, V15, P1045, DOI 10.2174/1871527315666160902145145; Sharma HS, 2014, J NANOSCI NANOTECHNO, V14, P577, DOI 10.1166/jnn.2014.9213; Sharma HS, 2012, INT REV NEUROBIOL, V102, P249, DOI 10.1016/B978-0-12-386986-9.00010-7; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wu W, 2014, BIOMATERIALS, V35, P2355, DOI 10.1016/j.biomaterials.2013.11.074; Ye D, 2013, NANOSCALE, V5, P11153, DOI 10.1039/c3nr02905k; Zhu SP, 2016, MOL NEUROBIOL, V53, P4375, DOI 10.1007/s12035-015-9372-2	24	7	7	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-7571-6; 978-1-4939-7570-9	METHODS MOL BIOL	Methods Mol. Biol.		2018	1727						433	442		10.1007/978-1-4939-7571-6_35	10.1007/978-1-4939-7571-6		10	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BK2PH	WOS:000433438800036	29222803				2022-02-06	
J	Roy, D; Koliatsos, V; Vaishnavi, S; Han, DF; Rao, V				Roy, Durga; Koliatsos, Vassilis; Vaishnavi, Sandeep; Han, Dingfen; Rao, Vani			Risk Factors for New-Onset Depression After First-Time Traumatic Brain Injury	PSYCHOSOMATICS			English	Article						Traumatic brain injury; Neuropsychiatry; Depression	QUALITY-OF-LIFE; MAJOR DEPRESSION; PSYCHIATRIC-DISORDERS; SOCIAL IMPAIRMENT; CONNECTIVITY; INDIVIDUALS; OUTCOMES; HISTORY; STROKE; SCALE	Background: Major depression after traumatic brain injury (TBI) has devastating consequences as it increases the risk of suicide, impairs overall quality of life, and affects interpersonal, occupational, and social functioning. Although the literature has reported factors associated with depression after TBI, very few studies have examined the prevalence and correlates focused on the development of new-onset depression (NOD) after first-time TBI. Our study aimed to identify TBI- and non-TBI-related factors associated with the development of NOD in the first year after TBI. Methods: A total of 103 subjects with first-time TBI were seen within 12 months postinjury and evaluated for the development of NOD at 3, 6, and 12 months. Results: Frontal lobe functioning, frontal lesions, and pre-TBI/early post-TBI social impairment were not found to be predictors of development of NOD within the first year after injury. Decreased post-TBI social functioning as perceived by the subject at 3, 6, and 12 months was found to be associated with NOD at each of these time points, respectively. Conclusion: The study findings highlight the importance of psychotherapeutic interventions to address the individuals' overall perception of their social impairment in the early-TBI period. This may help decrease the progression of major depression within the first year after injury.	[Roy, Durga; Koliatsos, Vassilis; Han, Dingfen; Rao, Vani] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, 5300 Alpha Commons Dr,Suite 446B, Baltimore, MD 21224 USA; [Koliatsos, Vassilis] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21224 USA; [Vaishnavi, Sandeep] Duke Univ, Sch Med, Dept Community & Family Med, Durham, NC USA; [Vaishnavi, Sandeep] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA; Welch Ctr Prevent Epidemiol & Clin Res, GIM Welch Ctr Methods Core, 2024 E Monument St, Baltimore, MD 21287 USA		Roy, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, 5300 Alpha Commons Dr,Suite 446B, Baltimore, MD 21224 USA.	droy4@jhmi.edu			National Institute of Mental Health, United StatesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23 MH 066894]; U.S. Department of Defense, United States [W81XWH-13-1-0469]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH066894] Funding Source: NIH RePORTER	This study was supported by Grant K23 MH 066894 to Dr. Vani Rao from the National Institute of Mental Health, United States. This literature review was supported, in part, by a Grant to Dr. Vani Rao, W81XWH-13-1-0469 from the U.S. Department of Defense, United States.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Chen S, 2016, BIOMETRICS, V72, P596, DOI 10.1111/biom.12433; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Daggett V, 2009, J NEUROSCI NURS, V41, P59, DOI 10.1097/JNN.0b013e31819a7133; Diaz AP, 2014, REV BRAS PSIQUIATR, V36, P213, DOI 10.1590/1516-4446-2013-1303; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; First M., 1997, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Golden J. C., 1978, STROOP COLOR WORD TE; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hyatt KS, 2014, AM J NURS, V114, P36, DOI 10.1097/01.NAJ.0000456426.79527.9b; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Jorge Ricardo E, 2015, Handb Clin Neurol, V128, P613, DOI 10.1016/B978-0-444-63521-1.00038-8; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennedy MRT, 2014, BRAIN INJURY, V28, P1748, DOI 10.3109/02699052.2014.955883; Kreutzer JS, 2001, J HEAD TRAUMA REHAB, V16, pV, DOI 10.1097/00001199-200108000-00001; Lengenfelder J, 2015, APPL NEUROPSYCH-ADUL, V22, P7, DOI 10.1080/23279095.2013.816703; Macaden AS, 2010, DISABIL REHABIL, V32, P1140, DOI 10.3109/09638280903311594; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Nelson H.E., 1982, NATL ADULT READING T; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rapoport MJ, 2003, AM J GERIAT PSYCHIAT, V11, P365, DOI 10.1176/appi.ajgp.11.3.365; Schretlen D., 1996, BRIEF TEST ATTENTION; Shimoda K, 1998, PSYCHIATRY, V61, P101, DOI 10.1080/00332747.1998.11024821; STARR LB, 1983, EXP AGING RES, V9, P101, DOI 10.1080/03610738308258434; TEASDALE G, 1974, LANCET, V2, P81; Testa SM, 2011, EPILEPSIA, V52, pE84, DOI 10.1111/j.1528-1167.2011.03141.x; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Vogler J, 2014, BRAIN INJURY, V28, P1381, DOI 10.3109/02699052.2014.919536; Wee HY, 2016, J CLIN PSYCHIAT, V77, P505, DOI 10.4088/JCP.14m09749; Wolfson D, 1985, HALSTEAD REITAN NEUR	48	7	7	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	JAN-FEB	2018	59	1					47	57		10.1016/j.psym.2017.07.008			11	Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	FQ9XV	WOS:000418715900005	28844451	Green Accepted			2022-02-06	
J	Sabella, SA; Andrzejewski, JH; Wallgren, A				Sabella, Scott A.; Andrzejewski, Joshua H.; Wallgren, Alexandrea			Financial hardship after traumatic brain injury: a brief scale for family caregivers	BRAIN INJURY			English	Article						Traumatic brain injury; brain injury; family caregivers; financial hardship; disability adjustment	EXPLORATORY FACTOR-ANALYSIS; LIFE SATISFACTION; UNITED-STATES; POVERTY; NEEDS; INDIVIDUALS; INCOME; DISTRESS; WORKING; QUALITY	Objective: Financial hardship is frequently posited as a significant factor influencing family health and adjustment after brain injury, though traditional methods of measurement have shown limited usefulness. The purpose of this study was to adapt and test the utility of a brief scale of financial hardship (BSFH-BI) for use with family caregivers after TBI. Methods: The researchers constructed the BSFH-BI using financial well-being items adapted from three survey instruments. The BSFH-BI questionnaire was completed by 136 family caregivers of individuals with TBIs. Scale utility was evaluated through reliability analysis, factor analysis, and correlations with a measure of life satisfaction. Results: The factor analysis revealed that the BSFH-BI had a meaningful two factor structure consisting of items related to (a) meeting essential living expenses and (b) financial changes after the injury. The scale showed high internal consistency (=0.92) and moderate negative correlations with life satisfaction (r(s)=-0.58). Conclusions: The preliminary findings indicate that the BSFH-BI can be a reliable and valid scale for use with family caregivers after TBI. The authors recommend further study of financial hardship within models of adaptation to TBI using psychometrically validated instruments such as the BSFH-BI.	[Sabella, Scott A.; Andrzejewski, Joshua H.; Wallgren, Alexandrea] Univ Buffalo, Dept Counseling Sch & Educ Psychol, 419 Baldy Hall, Buffalo, NY 14260 USA		Sabella, SA (corresponding author), Univ Buffalo, Dept Counseling Sch & Educ Psychol, 419 Baldy Hall, Buffalo, NY 14260 USA.	sasabell@buffalo.edu					Arber S, 2014, SOC SCI MED, V100, P12, DOI 10.1016/j.socscimed.2013.10.016; Asselin L, 2009, ANAL MULTIDIMENSIONA, P228; Baek E, 2010, FAM RELAT, V59, P358, DOI 10.1111/j.1741-3729.2010.00608.x; Butterworth P, 2009, SOC SCI MED, V69, P229, DOI 10.1016/j.socscimed.2009.05.008; Chronister J, 2016, REHABIL COUNS BULL, V59, P235, DOI 10.1177/0034355215601072; Coley RL, 2000, SOC SERV REV, V74, P380, DOI 10.1086/516410; Conway JM, 2003, ORGAN RES METHODS, V6, P147, DOI 10.1177/1094428103251541; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Corrigan JD, 2013, J HEAD TRAUMA REHAB, V28, P489, DOI 10.1097/HTR.0000000000000004; Corso PS., 2006, INCIDENCE EC BURDEN, P208; Cramer D, 2004, SAGE DICT STAT PRACT, P208; Degeneffe CE, 2011, REHABIL PSYCHOL, V56, P243, DOI 10.1037/a0024465; Diener E, 2002, SOC INDIC RES, V57, P119, DOI 10.1023/A:1014411319119; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Fekete C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090130; Gall MD, 2007, ED RES; GIVEN CW, 1992, RES NURS HEALTH, V15, P271, DOI 10.1002/nur.4770150406; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Heflin C, 2011, SOCIOL INQ, V81, P223, DOI 10.1111/j.1475-682X.2011.00369.x; Hick R, 2015, BRIT J SOCIOL, V66, P163, DOI 10.1111/1468-4446.12100; Hollingworth W, 2007, MED CARE, V45, P702, DOI 10.1097/MLR.0b013e318041f765; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Kitter B, 2015, BRAIN INJURY, V29, P1082, DOI 10.3109/02699052.2015.1018323; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer JS, 2002, J HEAD TRAUMA REHAB, V17, P349, DOI 10.1097/00001199-200208000-00008; MOEN P, 1980, J FAM ISSUES, V1, P5, DOI 10.1177/0192513X8000100102; Neukrug E., 2015, ESSENTIALS TESTING A, V3rd ed.; Novemsky N, 2005, J MARKETING RES, V42, P119, DOI 10.1509/jmkr.42.2.119.62292; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Rector RE, 1999, REV SOC ECON, V57, P351, DOI 10.1080/00346769900000007; Ruff R, 2013, NEUROREHABILITATION, V32, P771, DOI 10.3233/NRE-130901; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; She PY, 2007, SOC SCI QUART, V88, P970, DOI 10.1111/j.1540-6237.2007.00513.x; Shigaki CL, 2009, DISABIL REHABIL, V31, P484, DOI 10.1080/09638280802240449; Umeasiegbu VI, 2013, AUST J REHABIL COUNS, V19, P155, DOI 10.1017/jrc.2013.18; United States Department of Health and Human Services, 2004, MEAS MAT HARDSH FIN; US Bureau of Labor Statistics. U.S. Department of Labor, 2018, CPI INFL CALC; US Census Bureau: Censusgov [Internet], 2015, QUICKFACTS COL 2011; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Whelan CT, 2001, EUR SOCIOL REV, V17, P357, DOI 10.1093/esr/17.4.357; Yong AG, 2013, TUTOR QUANT METHODS, V9, P79, DOI 10.20982/tqmp.09.2.p079	44	7	7	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	7					926	932		10.1080/02699052.2018.1469168			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GH6GT	WOS:000433542900014	29718729				2022-02-06	
S	Salvador, E; Burek, M; Forster, CY		Tharakan, B		Salvador, Ellaine; Burek, Malgorzata; Foerster, Carola Y.			An In Vitro Model of Traumatic Brain Injury	TRAUMATIC AND ISCHEMIC INJURY: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						In vitro model; Traumatic brain injury; Stretch injury; Murine cerebrovascular endothelial cells; cEND	STRETCH-INDUCED INJURY; ENDOTHELIAL-CELLS; SYSTEM	Traumatic brain injury (TBI) is a significant problem causing high mortality globally. Methods to increase possibilities for treatment and prevention of secondary injuries resulting from the initial physical insult are thus much needed. TBI affects the central nervous system (CNS) and the neurovascular unit as a whole in numerous ways but one of the primarily compromised components is the blood-brain barrier (BBB). In this chapter, we present a detailed procedure on how stretch injury and oxygen-glucose deprivation (OGD) are applied to brain microvascular endothelial cells of the BBB in order to replicate the actual impact they receive during TBI.	[Salvador, Ellaine; Burek, Malgorzata; Foerster, Carola Y.] Univ Wurzburg, Dept Anaesthesia & Crit Care, Wurzburg, Germany		Salvador, E (corresponding author), Univ Wurzburg, Dept Anaesthesia & Crit Care, Wurzburg, Germany.		Burek, Malgorzata/AAF-3283-2021	Burek, Malgorzata/0000-0001-6148-2195			Abbruscato TJ, 1999, J PHARMACOL EXP THER, V289, P668; Berrout J, 2012, BRAIN RES, V1436, P1, DOI 10.1016/j.brainres.2011.11.044; Burek M, 2012, JOVE-J VIS EXP, V66; DEMBINSKI TC, 1985, CANCER RES, V45, P3083; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Forster C, 2005, J PHYSIOL-LONDON, V565, P475, DOI 10.1113/jphysiol.2005.084038; Kleinschnitz C, 2011, STROKE, V42, P1081, DOI 10.1161/STROKEAHA.110.592238; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Salvador E, 2013, JOVE, V80; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Webster Gregory D, 2008, Biomed Sci Instrum, V44, P483	13	7	7	2	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-7526-6; 978-1-4939-7524-2	METHODS MOL BIOL	Methods Mol. Biol.		2018	1717						219	227		10.1007/978-1-4939-7526-6_17	10.1007/978-1-4939-7526-6		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Research & Experimental Medicine	BK3CS	WOS:000434764100018	29468595				2022-02-06	
J	Samuel, S; Lee, M; Brown, RJ; Choi, HA; Baguley, IJ				Samuel, Sophie; Lee, Monica; Brown, Robert J.; Choi, Huimahn A.; Baguley, Ian J.			Incidence of paroxysmal sympathetic hyperactivity following traumatic brain injury using assessment tools	BRAIN INJURY			English	Article						Paroxysmal sympathetic hyperactivity; traumatic brain injury; autonomic dysregulation; brain storming; diencephalic autonomic seizures	PHARMACOLOGICAL MANAGEMENT; RECEPTOR ENCEPHALITIS; DIENCEPHALIC SEIZURES; DIAGNOSTIC-CRITERIA; RISK-FACTORS; HEAD-INJURY; CASE SERIES; DYSAUTONOMIA; FEVER; HEMORRHAGE	Introduction: A consensus statement proposed a diagnostic framework to systematise the identification of paroxysmal sympathetic hyperactivity (PSH) using the PSH-Assessment Measure (PSH-AM).Methods: This retrospective study identified adult patients with a primary diagnosis of traumatic brain injury and a hospital length of stay >14days. Based on PSH-AM scores, patients were grouped into unlikely', possible', or probable' PSH. For this study, possible' and probable' PSH patients were collapsed into a single group (PSH+), and resultant data were compared with unlikely' diagnoses (PSH-). PSH-AM data were assessed against clinical diagnoses to establish sensitivity and specificity data.Results: Sixty five patients met inclusion criteria, with 45/65 (69%) categorised as either possible' or probable' PSH on the PSH-AM. Only 16 of these patients were diagnosed by clinicians. The most common symptoms triggering clinical diagnosis were tachycardia, fever and posturing. Increased respiratory rate, blood pressure or the presence of diaphoresis were not used in diagnosing PSH if the PSH-AM was not utilised. Assuming clinical assessment as the current gold standard, the PSH-AM yielded a sensitivity of 94% and a specificity of 35% when used retrospectively. Patients clinically diagnosed with PSH were discharged 5days earlier compared to those identified by the PSH-AM.Conclusions: The recently proposed diagnostic framework may reduce misdiagnosis, length of stay and hospitalisation costs.	[Samuel, Sophie] Mem Hermann Texas Med Ctr, Dept Pharm, 6411 Fannin St, Houston, TX 77030 USA; [Lee, Monica] Houston Methodist West Hosp, Dept Pharm, Houston, TX USA; [Brown, Robert J.; Choi, Huimahn A.] Univ Texas Houston, Med Sch Houston, Dept Neurosurg & Neurol, Houston, TX USA; [Baguley, Ian J.] Univ Sydney, Western Med Sch, Sydney, NSW, Australia		Samuel, S (corresponding author), Mem Hermann Texas Med Ctr, Dept Pharm, 6411 Fannin St, Houston, TX 77030 USA.	Sophie.samuel@memorialhermann.org	Baguley, Ian/AAM-5828-2021				Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Choi HA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0370-3; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Deepika A, 2015, ACTA NEUROCHIR, V157, P2033, DOI 10.1007/s00701-015-2575-5; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fernandez A, 2007, NEUROLOGY, V68, P1013, DOI 10.1212/01.wnl.0000258543.45879.f5; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Ko SB, 2010, NEUROLOGIST, V16, P384, DOI 10.1097/NRL.0b013e3181b1cdff; Lv LQ, 2011, J TRAUMA, V71, P538, DOI 10.1097/TA.0b013e31820ebee1; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Nazif TM, 2012, EUROPACE, V14, P1188, DOI 10.1093/europace/eus014; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Samuel S, 2016, J NEUROSCI NURS, V48, P82, DOI 10.1097/JNN.0000000000000207; SNEED RC, 1995, ARCH PHYS MED REHAB, V76, P101, DOI 10.1016/S0003-9993(95)80051-4; TEASDALE G, 1974, LANCET, V2, P81	33	7	8	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	9					1115	1121		10.1080/02699052.2018.1482002			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GL0ZJ	WOS:000436823600008	29856656				2022-02-06	
J	Sawyer, TW; Ritzel, DV; Wang, YS; Josey, T; Villanueva, M; Nelson, P; Song, YF; Shei, YM; Hennes, G; Vair, C; Parks, S; Fan, CY; McLaws, L				Sawyer, Thomas W.; Ritzel, David V.; Wang, Yushan; Josey, Tyson; Villanueva, Mercy; Nelson, Peggy; Song, Yanfeng; Shei, Yimin; Hennes, Grant; Vair, Cory; Parks, Steve; Fan, Changyang; McLaws, Lori			Primary Blast Causes Delayed Effects without Cell Death in Shell-Encased Brain Cell Aggregates	JOURNAL OF NEUROTRAUMA			English	Article						Advanced Blast Simulator (ABS); Akt (protein kinase B); blast-induced traumatic brain injury (bTBI); primary blast; vascular endothelial growth factor (VEGF)	ENDOTHELIAL GROWTH-FACTOR; FIBRILLARY ACIDIC PROTEIN; MEDIATED UP-REGULATION; IN-VITRO; SPECTROPHOTOMETRIC ASSAY; PI3K/AKT/MTOR PATHWAY; NEURONAL SURVIVAL; INJURY; AKT; PHOSPHORYLATION	Previous work in this laboratory used underwater explosive exposures to isolate the effects of shock-induced principle stress without shear on rat brain aggregate cultures. The current study has utilized simulated air blast to expose aggregates in suspension and enclosed within a spherical shell, enabling the examination of a much more complex biomechanical insult. Culture medium-filled spheres were exposed to single pulse overpressures of 15-30psi (approximate to 6-7msec duration) and measurements within the sphere at defined sites showed complex and spatially dependent pressure changes. When brain aggregates were exposed to similar conditions, no cell death was observed and no changes in several commonly used biomarkers of traumatic brain injury (TBI) were noted. However, similarly to underwater blast, immediate and transient increases in the protein kinase B signaling pathway were observed at early time-points (3 days). In contrast, the oligodendrocyte marker 2,3-cyclic nucleotide 3-phosphodiesterase, as well as vascular endothelial growth factor, both displayed markedly delayed (14-28 days) and pressure-dependent responses. The imposition of a spherical shell between the single pulse shock wave and the target brain tissue introduces greatly increased complexity to the insult. This work shows that brain tissue can not only discriminate the nature of the pressure changes it experiences, but that a portion of its response is significantly delayed. These results have mechanistic implications for the study of primary blast-induced TBI and also highlight the importance of rigorously characterizing the actual pressure variations experienced by target tissue in primary blast studies.	[Sawyer, Thomas W.; Wang, Yushan; Josey, Tyson; Villanueva, Mercy; Nelson, Peggy; Song, Yanfeng; Shei, Yimin; Hennes, Grant; Vair, Cory; McLaws, Lori] Def Res & Dev Canada, Suffield Res Ctr, Box 4000, Medicine Hat, AB T1A 8K6, Canada; [Ritzel, David V.] Dyn Fx Consulting Ltd, Amherstburg, ON, Canada; [Parks, Steve] ORA Inc, Marion, NC USA; [Fan, Changyang] Canada West Biosci, Camrose, AB, Canada		Sawyer, TW (corresponding author), Def Res & Dev Canada, Suffield Res Ctr, Box 4000, Medicine Hat, AB T1A 8K6, Canada.	Thomas.sawyer@drdc-rddc.gc.ca					Ahn Jee-Yin, 2014, Exp Neurobiol, V23, P200, DOI 10.5607/en.2014.23.3.200; Appelboom G, 2012, ACTA NEUROCHIR, V154, P131, DOI 10.1007/s00701-011-1210-3; Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Carvalho AF, 2015, PSYCHONEUROENDOCRINO, V62, P18, DOI 10.1016/j.psyneuen.2015.07.002; Cernak I, 2010, MED DATA REV, V2, P297; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chandra N., 2015, BRAIN NEUROTRAUMA MO; CHAO LP, 1972, ANAL BIOCHEM, V46, P114, DOI 10.1016/0003-2697(72)90401-0; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Cudahy E., 2001, 1162 NSMRL, P1; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dienstmann R, 2014, MOL CANCER THER, V13, P1021, DOI 10.1158/1535-7163.MCT-13-0639; DREILING CE, 1980, ANAL BIOCHEM, V102, P304, DOI 10.1016/0003-2697(80)90157-8; Effgen G.B., 2016, J NEUROTRAUMA; Effgen G. B., 2012, FRONT NEUROL, V3, P1; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Evans I., 2015, VEGF SIGNALING METHO; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gawronski JD, 2004, ANAL BIOCHEM, V327, P114, DOI 10.1016/j.ab.2003.12.024; Greenberg DA, 2013, CELL MOL LIFE SCI, V70, P1753, DOI 10.1007/s00018-013-1282-8; Guy R J, 2000, J R Nav Med Serv, V86, P27; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hohman TJ, 2015, JAMA NEUROL, V72, P520, DOI 10.1001/jamaneurol.2014.4761; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Honegger P., 2011, METHODS MOL BIOL, V758; Honegger P., 2003, CURRENT PROTOCOLS IN; Hue CD, 2015, J CEREBR BLOOD F MET, V35, P1191, DOI 10.1038/jcbfm.2015.38; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Jackson EK, 2016, J NEUROCHEM, V137, P142, DOI 10.1111/jnc.13551; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Josey T., 2016, P MIL ASP BLAST SHOC; Kane MJ, 2012, NEUROSCI LETT, V522, P47, DOI 10.1016/j.neulet.2012.06.012; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Lange C, 2016, NAT REV NEUROL, V12, P439, DOI 10.1038/nrneurol.2016.88; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Li T., 2014, INT J MOL SCI; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Llado J, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00181; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; Moreira IS, 2007, ANTI-CANCER AGENT ME, V7, P223; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Mott FW, 1916, LANCET, V1, P331; Myllykoski M, 2016, BRAIN RES, V1641, P64, DOI 10.1016/j.brainres.2015.09.004; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Polivka J, 2014, PHARMACOL THERAPEUT, V142, P164, DOI 10.1016/j.pharmthera.2013.12.004; Raasakka A, 2014, NEUROSCI BULL, V30, P956, DOI 10.1007/s12264-013-1437-5; Ravin R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25713; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Ritzel DV, 2011, 207 NATO HFM; Santos SS, 2007, J NEUROSCI RES, V85, P3386, DOI 10.1002/jnr.21409; Sawyer TW, 2017, J NEUROTRAUM, V34, P517, DOI 10.1089/neu.2016.4430; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shibuya M, 2013, J BIOCHEM, V153, P13, DOI 10.1093/jb/mvs136; Smith GA, 2015, J INHERIT METAB DIS, V38, P753, DOI 10.1007/s10545-015-9838-4; Storkebaum E, 2004, J CLIN INVEST, V113, P14, DOI 10.1172/JCI200420682; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Toker Alex, 2014, Advances in Biological Regulation, V55, P28, DOI 10.1016/j.jbior.2014.04.001; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Yilmaz S, 2007, AM J EMERG MED, V25, P97, DOI 10.1016/j.ajem.2006.04.014; Zander NE, 2016, ANAL BIOCHEM, V504, P4, DOI 10.1016/j.ab.2016.03.009; Zander NE, 2015, J NEUROSCI RES, V93, P1353, DOI 10.1002/jnr.23594; Zheng WH, 2012, BRAIN RES, V1470, P145, DOI 10.1016/j.brainres.2012.06.032	89	7	7	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					174	186		10.1089/neu.2016.4961			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000419569700019	28726571				2022-02-06	
J	Singh, N; Vijayanti, S; Saha, L				Singh, Neha; Vijayanti, Sheekha; Saha, Lekha			Targeting crosstalk between Nuclear factor (erythroid-derived 2)-like 2 and Nuclear factor kappa beta pathway by Nrf2 activator dimethyl fumarate in epileptogenesis	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						Epileptogenesis; Nrf2; NF-kappa B; dimethyl fumarate (DMF); oxidative stress	OXIDATIVE STRESS; THERAPEUTIC TARGET; ACID ESTERS; B-ALPHA; DISEASE; NF-KAPPA-B/P65; SUPPRESSION; MECHANISMS; EXPRESSION; EPILEPSY	Purpose/Aim: Epilepsy is a complex, chronic neurological disorder characterized by increased and abnormal synchronization of neuronal electrical activity, which is manifested as seizures. It is associated with many comorbid conditions such as depression, anxiety, sleep disorder, psychiatric disorder etc., which consequently causes higher mortality rate. The understanding of its cellular and molecular mechanism is partial, because of which it remains an ongoing health problem, despite the increasing availability of newer antiepileptic drugs. Although recurrent seizures are the clinical indication of epilepsy, the disease process (epileptogenesis) begins before the onset of the first seizure. This dormant phase before the onset of first seizure provides an opportune time window for modifying the epileptogenic process by intervening in its progression with an appropriate treatment. Material and Methods: Studies have shown that in epilepsy, there is a chronic state of oxidative stress and inflammation, which plays a key role in epileptic pathogenesis. Various antioxidant mechanisms maintain the redox balance in the body by either scavenging or regulating the generation of free radicals. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway is a well-established antioxidant pathway in various diseases such as diabetes, renal disease, various neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis, traumatic brain injury, etc. Results: It has been observed that single-target therapies are inefficient in providing anticonvulsant and disease-modifying effects in epilepsy. Conclusions: So, preventing the progression of epilepsy by targeting Nrf2-activated antioxidant pathway along with the other established antiepileptic pathways can prove beneficial in epilepsy treatment.	[Singh, Neha; Vijayanti, Sheekha; Saha, Lekha] Post Grad Inst Med Educ & Res, Dept Pharmacol, Chandigarh, India		Saha, L (corresponding author), Post Grad Inst Med Educ & Res, Dept Pharmacol, Chandigarh, India.	saha.lekha@pgimer.edu.in		Singh, Neha/0000-0002-9389-8715			Ahuja M, 2016, J NEUROSCI, V36, P6332, DOI 10.1523/JNEUROSCI.0426-16.2016; Al-Jaderi Z, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00278; Albrecht P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-163; Ameen D, 2017, INT J PHARMACEUT, V529, P465, DOI 10.1016/j.ijpharm.2017.07.031; Becher B, 2000, GLIA, V29, P293; Behr C, 2016, REV NEUROL-FRANCE, V172, P27, DOI 10.1016/j.neurol.2015.11.003; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Bromfield EB, 2006, INTRO EPILEPSY, P1; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Carmona-Aparicio L, 2015, INT J MOL SCI, V16, P18348, DOI 10.3390/ijms160818348; Chen H, 2014, J CLIN INVEST, V124, P2188, DOI 10.1172/JCI72151; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cuadrado Antonio, 2016, Current Opinion in Toxicology, V1, P46, DOI 10.1016/j.cotox.2016.09.004; Cuadrado A, 2014, J BIOL CHEM, V289, P15244, DOI 10.1074/jbc.M113.540633; de Paula CZ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/198612; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; Ellrichmann G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016172; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Guo YS, 2013, LAB INVEST, V93, P825, DOI 10.1038/labinvest.2013.73; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Jo C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4496; Kastrati I, 2016, J BIOL CHEM, V291, P3639, DOI 10.1074/jbc.M115.679704; Keum YS, 2003, PHARM RES-DORDR, V20, P1351, DOI 10.1023/A:1025737622815; Kim JE, 2010, CELL SIGNAL, V22, P1645, DOI 10.1016/j.cellsig.2010.06.004; Kraft AD, 2006, J NEUROCHEM, V98, P1852, DOI 10.1111/j.1471-4159.2006.04019.x; Kunze R, 2015, EXP NEUROL, V266, P99, DOI 10.1016/j.expneurol.2015.02.022; Latimer M, 1998, MOL CELL BIOL, V18, P2640, DOI 10.1128/MCB.18.5.2640; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Loewe R, 2002, J IMMUNOL, V168, P4781, DOI 10.4049/jimmunol.168.9.4781; Longo D, 2013, HARRISONS MANUAL INT, P1199; Lubin FD, 2007, J NEUROCHEM, V103, P1381, DOI 10.1111/j.1471-4159.2007.04863.x; Maguire J, 2016, EPILEPSY CURR, V16, P31, DOI 10.5698/1535-7597-16.1.31; Martinc B, 2012, CURR NEUROPHARMACOL, V10, P328, DOI 10.2174/157015912804143504; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mazzuferi M, 2013, ANN NEUROL, V74, P560, DOI 10.1002/ana.23940; Mertsch K, 2001, NEUROSCI LETT, V314, P135, DOI 10.1016/S0304-3940(01)02299-6; O'Mahony A, 2006, MOL CELL BIOL, V26, P7283, DOI 10.1128/MCB.00510-06; Ockenfels HM, 1998, BRIT J DERMATOL, V139, P390; OH SM, 1991, STROKE, V22, P915, DOI 10.1161/01.STR.22.7.915; Pan H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/217580; Pauletti A, 2017, BRAIN, V140, P1885, DOI 10.1093/brain/awx117; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; Rong Y, 2002, J NEUROCHEM, V67, P662, DOI [10.1046/j.1471-4159.1996.67020662.x, DOI 10.1046/J.1471-4159.1996.67020662.X]; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Schmidt MM, 2010, NEUROCHEM INT, V57, P460, DOI 10.1016/j.neuint.2010.01.006; Schulze-Topphoff U, 2016, P NATL ACAD SCI USA, V113, P4777, DOI 10.1073/pnas.1603907113; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; Sun Z, 2011, MOL CELL BIOL, V31, P1800, DOI 10.1128/MCB.05036-11; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vego H, 2016, CELL MOL IMMUNOL, V13, P57, DOI 10.1038/cmi.2014.114; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Waldbaum S, 2010, J BIOENERG BIOMEMBR, V42, P449, DOI 10.1007/s10863-010-9320-9; Walker L, 2012, EPILEPSY CURR, V12, P8, DOI 10.5698/1535-7511-12.1.8; Wang W, 2013, NEUROSCI LETT, V543, P58, DOI 10.1016/j.neulet.2013.03.038; Wardyn JD, 2015, BIOCHEM SOC T, V43, P621, DOI 10.1042/BST20150014; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Yu NA, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/670613; Zhang HQ, 2017, INT J CLIN EXP PATHO, V10, P1847	63	7	8	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.		2018	128	10					987	994		10.1080/00207454.2018.1441149			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU3IC	WOS:000445168800012	29447051				2022-02-06	
S	Srivastava, AK; Cox, CS		Srivastava, AK; Cox, CS		Srivastava, Amit K.; Cox, Charles S., Jr.			Traumatic Brain Injury	PRE-CLINICAL AND CLINICAL METHODS IN BRAIN TRAUMA RESEARCH	Neuromethods		English	Article; Book Chapter						Brain injury; Trauma; TBI-classification; Diagnosis; Prediction		Traumatic brain injury (TBI) is a common, complex, and costly condition. It is a multidimensional and highly complex condition and an important cause of disability and mortality all around the world. To date, there are no effective treatments available that are able to mitigate subacute injuries and improve long-term functional recovery in TBI. A major reason that several experimental treatments for TBI have failed in the past is the appreciation that TBI is not a single acute event but chronic and progressive tissue damage. Better understanding of the anatomy and pathophysiology of brain injuries, new biomarkers, advanced neuroimaging, and the reorganization of trauma systems have led to a significant reduction in deaths and disability resulting from TBI. In this chapter, we discuss the pathophysiology, classification, clinical presentation, and diagnosis of this condition.	[Srivastava, Amit K.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, Houston, TX 77030 USA		Srivastava, AK (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, Houston, TX 77030 USA.						[Anonymous], 2000, J NEUROTRAUMA, V17, P597, DOI DOI 10.1089/NEU.2000.17.597; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bodanapally UK, 2014, J NEUROSURG, V121, P1275, DOI 10.3171/2014.7.JNS132688; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Cox CS, 2018, PEDIATR RES, V83, P325, DOI 10.1038/pr.2017.253; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Edwards P, 2005, LANCET, V365, P1957; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jackson ML, 2017, J SURG RES, V214, P38, DOI 10.1016/j.jss.2017.02.078; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Laureys S, 2014, LANCET NEUROL, V13, P755, DOI 10.1016/S1474-4422(14)70152-8; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; Munakomi S, 2016, CHIN J TRAUMATOL, V19, P25, DOI 10.1016/j.cjtee.2015.12.005; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pellman E.J., 2003, NEUROSURGERY, V53, P812, DOI [DOI 10.1227/01.N1'17.0000083559.68424.31;, DOI 10.1093/NEUROSURGERY/53.3.799]; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schmid Kara E, 2012, Front Neurol, V3, P90, DOI 10.3389/fneur.2012.00090; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Walsh S, 2017, NEUROTOXICOLOGY, V61, P64, DOI 10.1016/j.neuro.2016.03.011; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	63	7	7	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-4939-8564-7; 978-1-4939-8563-0	NEUROMETHODS	Neuromethods		2018	139						1	14		10.1007/978-1-4939-8564-7_1	10.1007/978-1-4939-8564-7		14	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BL5CO	WOS:000451267100003					2022-02-06	
J	Stephens, JA; Salorio, CF; Barber, AD; Risen, SR; Mostofsky, SH; Suskauer, SJ				Stephens, Jaclyn A.; Salorio, Cynthia F.; Barber, Anita D.; Risen, Sarah R.; Mostofsky, Stewart H.; Suskauer, Stacy J.			Preliminary findings of altered functional connectivity of the default mode network linked to functional outcomes one year after pediatric traumatic brain injury	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Functional neuroimaging; mild traumatic brain injury; moderate traumatic brain injury; neural networks; response inhibition	RESPONSE-INHIBITION; RESTING STATE; WORKING-MEMORY; MILD; CHILDREN; RECOVERY; FMRI; ATTENTION; CHILDHOOD; TBI	Purpose and Method: This study examined functional connectivity of the default mode network (DMN) and examined brain-behavior relationships in a pilot cohort of children with chronic mild to moderate traumatic brain injury (TBI). Results: Compared to uninjured peers, children with TBI demonstrated less anti-correlated functional connectivity between DMN and right Brodmann Area 40 (BA 40). In children with TBI, more anomalous less anti-correlated) connectivity between DMN and right BA 40 was linked to poorer performance on response inhibition tasks. Conclusion: Collectively, these preliminary findings suggest that functional connectivity between DMN and BA 40 may relate to longterm functional outcomes in chronic pediatric TBI.	[Stephens, Jaclyn A.; Salorio, Cynthia F.; Mostofsky, Stewart H.; Suskauer, Stacy J.] Johns Hopkins Sch Med, Kennedy Krieger Inst, Baltimore, MD USA; [Stephens, Jaclyn A.; Salorio, Cynthia F.; Suskauer, Stacy J.] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Barber, Anita D.; Suskauer, Stacy J.] Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY USA; [Risen, Sarah R.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat Neurol, Houston, TX 77030 USA; [Mostofsky, Stewart H.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA; [Mostofsky, Stewart H.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA		Stephens, JA (corresponding author), Kennedy Krieger Inst, 716 N Broadway,Off 306, Baltimore, MD 21205 USA.; Stephens, JA (corresponding author), Johns Hopkins Sch Med, 716 N Broadway,Off 306, Baltimore, MD 21205 USA.	jaclynanne09@gmail.com	Barber, Anita D/P-7010-2016	Barber, Anita D/0000-0001-8766-3103	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001079] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54 HD079123, T32 HD007414, K23 HD061611] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH078160, R01 MH085328] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS063956, R01 NS097511, L40 NS098410] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007414, U54HD079123, K23HD061611] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH085328, R01MH078160] Funding Source: NIH RePORTER		Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Barber AD, 2013, J COGNITIVE NEUROSCI, V25, P1235, DOI 10.1162/jocn_a_00394; Barber AD, 2013, NEUROPSYCHOLOGIA, V51, P156, DOI 10.1016/j.neuropsychologia.2012.11.011; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Dahl E, 2013, J REHABIL MED, V45, P729, DOI 10.2340/16501977-1188; DENCKLA MB, 1985, PSYCHOPHARMACOL BULL, V21, P773; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; Kriegeskorte N, 2010, J CEREBR BLOOD F MET, V30, P1551, DOI 10.1038/jcbfm.2010.86; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Lindquist MA, 2015, PSYCHOSOM MED, V77, P114, DOI 10.1097/PSY.0000000000000148; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Milner TE, 2007, NEUROIMAGE, V36, P388, DOI 10.1016/j.neuroimage.2007.01.057; Mostofsky SH, 2003, COGNITIVE BRAIN RES, V17, P419, DOI 10.1016/S0926-6410(03)00144-7; Muschelli J, 2014, NEUROIMAGE, V96, P22, DOI 10.1016/j.neuroimage.2014.03.028; Ornstein TJ, 2013, J NEUROPSYCHOL, V7, P1, DOI 10.1111/j.1748-6653.2012.02027.x; Reed CL, 2004, HUM BRAIN MAPP, V21, P236, DOI 10.1002/hbm.10162; Rhine T, 2017, J HEAD TRAUMA REHAB, V32, pE18, DOI 10.1097/HTR.0000000000000192; Risen SR, 2015, J PEDIATR REHAB MED, V8, P309, DOI 10.3233/PRM-150349; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Semrud-Clikeman M, 2010, APPL NEUROPSYCHOL, V17, P116, DOI 10.1080/09084281003708985; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; SHUE KL, 1992, BRAIN COGNITION, V20, P104, DOI 10.1016/0278-2626(92)90064-S; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Sinopoli KJ, 2012, INT J DEV NEUROSCI, V30, P207, DOI 10.1016/j.ijdevneu.2011.08.006; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Stephens J, 2017, J MOTOR BEHAV, V49, P20, DOI 10.1080/00222895.2016.1204267; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; VITIELLO B, 1989, J AM ACAD CHILD PSY, V28, P749, DOI 10.1097/00004583-198909000-00017; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	49	7	7	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2018	21	7			SI		423	430		10.1080/17518423.2017.1338777			8	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	GR1HR	WOS:000442284100001	28692408	Green Accepted			2022-02-06	
J	Stigen, L; Bjork, E; Lund, A; Smastuen, MC				Stigen, Linda; Bjork, Evastina; Lund, Anne; Smastuen, Milada Cvancarova			Assessment of clients with cognitive impairments: A survey of Norwegian occupational therapists in municipal practice	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Cognition; municipal rehabilitation; occupational therapy; standardized assessment tools	TRAUMATIC BRAIN-INJURY; STANDARDIZED ASSESSMENTS; STROKE REHABILITATION; OUTCOME MEASURES; PERFORM SYSTEM; TASK-ANALYSIS; POSTSTROKE; PERCEIVE; RECALL; PLAN	Background: With the Coordination Reform Act initiated in 2012, Norwegian loccupational therapists in municipal practice have been given responsibilities concerning clients with cognitive impairments. With emphasis on supporting best practice, the aim was to investigate the practice of Norwegian municipal occupational therapists (OTs) in their assessment of clients with cognitive impairments. Method: An online questionnaire was used to collect data from 4971 of 1367 OTs inl Norwegian municipalities (RR = 36%) Results: The most frequently used methods were informal interviews (91%), observations (91%) and standardized assessments (73%). The most frequently used standardized assessments were the Clock Drawing test (60%) and the Mini Mental State Examination (MMSE 59%). The most common reasons for using standardized assessments were to get a better foundation for initiating interventions (74%), to get more reliable results (64%) and to measure the effect of interventions (47%). The most common reasons for not using standardized assessments were that they did not have competence (49%) or that they did not have access to the materials (40%). Conclusion: The results indicate that there are challenges when it comes to the methods and standardized assessments used. These findings invite further research on enabling municipal OTs to move further towards evidence-based practice.	[Stigen, Linda; Bjork, Evastina] Norwegian Univ Sci & Technol, NTNU, Dept Hlth Sci, Campus Gjovik,Teknol Veien 22, N-2815 Gjovik, Norway; [Lund, Anne] Oslo & Akershus Univ Coll, Dept Occupat Therapy Prosthet & Orthot, Oslo, Norway; [Smastuen, Milada Cvancarova] Oslo & Akershus Univ Coll, Dept Hlth Sci, Oslo, Norway		Stigen, L (corresponding author), Norwegian Univ Sci & Technol, NTNU, Dept Hlth Sci, Campus Gjovik,Teknol Veien 22, N-2815 Gjovik, Norway.	lindastigen@hotmail.com	Lund, Anne/W-2558-2019	Lund, Anne/0000-0003-3180-8013			Allen C. K., 2007, ALLEN COGNITIVE LEVE; Alotaibi NM, 2009, OCCUP THER HEALTH CA, V23, P302, DOI 10.3109/07380570903222583; [Anonymous], 2011, LOV KOMMUNALE HELSE; Arnadottir G, 2008, AM J OCCUP THER, V62, P51, DOI 10.5014/ajot.62.1.51; Arnadottir G, 2009, NEUROREHAB NEURAL RE, V23, P579, DOI 10.1177/1545968308324223; Bathen T., 2003, SUNNAAS SYKEHUS KJOK; Bowling A, 2009, RES METHODS HLTH; Burns SC, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.016543; BURNS T, 1994, J GERIATR PSYCH NEUR, V7, P46, DOI 10.1177/089198879400700109; Chapparo C, OPM MONOLOG 1 OPM A; Chapparo C, 2015, PERCEIVE RECALL PLAN; Corp I, 2013, IBM SPSS STAT WIND V; DeJong G, 2005, ARCH PHYS MED REHAB, V86, pS1, DOI 10.1016/j.apmr.2005.09.003; Doble S E, 1997, Int Psychogeriatr, V9, P25, DOI 10.1017/S1041610297004171; Douglas A, 2009, PHYS OCCUP THER GERI, V27, P273, DOI 10.1080/02703180902733183; Douglas A, 2008, PHYS OCCUP THER GERI, V26, P13, DOI 10.1080/02703180801963758; Douglas Alison, 2007, Can J Occup Ther, V74, P370; Fawcett AL, 2008, PRINCIPLES ASSESSMEN; Field A., 2017, DISCOVERING STAT USI, V5th; Fisher AG., 2003, ASSESSMENT MOTOR PRO, V5th ed.; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Furr R. M., 2008, PSYCHOMETRICS INTRO; Geneau Taillefer D., 1995, 1 C PSYCH CCFP ST HY; Grieve J., 2008, NEUROPSYCHOLOGY OCCU; Hagby C, 2014, BRUKER NORSKE ERGOTE, V57, P22; Hammell KRW, 2015, SCAND J OCCUP THER, V22, P237, DOI 10.3109/11038128.2015.1004103; Hammell KRW, 2012, SCAND J OCCUP THER, V19, P385, DOI 10.3109/11038128.2011.611821; Health A, 2015, DEM ASS TOOL PRIM HL; Helse-og omsorgsdepartementet, 2005, OMS 2015; Holmqvist K, 2014, BRAIN INJURY, V28, P1365, DOI 10.3109/02699052.2014.919529; Holmqvist K, 2009, SCAND J OCCUP THER, V16, P13, DOI 10.1080/11038120802123520; Katz N., 2000, LOEWENSTEIN OCCUPATI; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Koh CL, 2009, AUST OCCUP THER J, V56, P324, DOI 10.1111/j.1440-1630.2008.00764.x; Korner-Bitensky N, 2011, AUST OCCUP THER J, V58, P241, DOI 10.1111/j.1440-1630.2011.00943.x; Laver FA., 2008, PRINCIPLES ASSESSMEN; Law M, 2005, MEASURING OCCUPATION, P375; Law M, 2005, MEASURING OCCUPATION; Nott MT, 2008, AUST OCCUP THER J, V55, P188, DOI 10.1111/j.1440-1630.2007.00685.x; Nott MT, 2012, BRIT J OCCUP THER, V75, P256, DOI 10.4276/030802212X13383757345067; Nott MT, 2009, AUST OCCUP THER J, V56, P307, DOI 10.1111/j.1440-1630.2008.00763.x; NYGARD L, 1994, AM J OCCUP THER, V48, P689, DOI 10.5014/ajot.48.8.689; Perry A, 2004, INT J QUAL HEALTH C, V16, P285, DOI 10.1093/intqhc/mzh059; Piernik-Yoder B, 2012, OCCUP THER HEALTH CA, V26, P97, DOI 10.3109/07380577.2012.695103; Pilegaard M, 2014, INT J THER REHABIL, V21, P280, DOI 10.12968/ijtr.2014.21.6.280; Robertson L, 2013, SCAND J OCCUP THER, V20, P127, DOI 10.3109/11038128.2012.737369; ROGERS JC, 1989, AOTA SELF STUDY SERI; Romoren TI, 2006, RAPPORTSERIE HOGSKOL, V2006, P8; Sansonetti D, 2013, AUST OCCUP THER J, V60, P334, DOI 10.1111/1440-1630.12069; Smedslund G, 2015, 16 NASJ KUNNSK HELS; Sonn U, 1999, SCAND J OCCUP THER, V6, P11, DOI DOI 10.1080/110381299443807; Sorensen L., 1989, COGNITIVE SENSIBILIT; SSB Scb, 2014, NORW OCC THER 2014; Stapleton T, 2009, BRIT J OCCUP THER, V72, P55, DOI 10.1177/030802260907200203; Steultjens EMJ, 2012, INT PSYCHOGERIATR, V24, P659, DOI 10.1017/S1041610211002249; Swinson T, 2016, BRIT J OCCUP THER, V79, P85, DOI 10.1177/0308022615624447; Taylor M. C., 2007, EVIDENCE BASED PRACT; TOGLIA JP, 2005, COGNITION OCCUPATION; Turner Ann, 2002, OCCUPATIONAL THERAPY; WILLIAMS JH, 1991, GERONTOLOGIST, V31, P84, DOI 10.1093/geront/31.1.84; Wilson BA, 1999, RIVERMEAD BEHAV MEMO	61	7	7	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1103-8128	1651-2014		SCAND J OCCUP THER	Scand. J. Occup. Ther.		2018	25	2					88	98		10.1080/11038128.2016.1272633			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GC0HL	WOS:000429458100002	28049384				2022-02-06	
S	Sussulini, A; Hauser-Davis, RA		Arruda, MAZ		Sussulini, Alessandra; Hauser-Davis, Rachel Ann			Metallomics Applied to the Study of Neurodegenerative and Mental Diseases	METALLOMICS: THE SCIENCE OF BIOMETALS	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Metallomics; Brain; Mass spectrometry imaging; ICP-MS; Neurodegenerative diseases; Mental disorders; Metalloproteins; Metalloenzymes; Oxidative stress	SERUM SUPEROXIDE-DISMUTASE; CEREBROSPINAL-FLUID LEVELS; PLASMA-MASS SPECTROMETRY; ACID REACTIVE SUBSTANCES; BETA-AMYLOID PEPTIDE; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; WILSONS-DISEASE; ALPHA-SYNUCLEIN; CERULOPLASMIN LEVELS	Biochemical imbalances, provoked by aging or a secondary illness, might directly affect the brain, causing severe problems, such as loss of memory or alteration of behavior patterns. Brain disorders are usually classified as injuries (such as stroke, hematomas, and concussions), tumors, and neurodegenerative (such as Parkinson's and Alzheimer's diseases) and mental (such as depression, bipolar disorder, schizophrenia) diseases. As the pathophysiology of these illnesses is not completely established and multiple factors are involved, metallomics, a bioanalytical strategy that allows the detection of metal ions and metalloproteins in diverse biological matrices, is of extreme relevance in identifying which elements are affected by a disease and/or treatment. Thus, determining which element ions suffer disturbances in their homeostasis during the disease progress is relevant to understand the biochemical changes and propose new drug targets. In addition, it is well known that oxidative stress plays an important role in the development of pathological neurodegenerative and mental diseases, which may be caused by metal ion dyshomeostasis, so it is also important to understand endogenous antioxidant metalloprotein and metalloenzyme mechanisms in this regard. In this context, recent applications of metallomics in the study of neurodegenerative and mental disorders are discussed in this chapter, as well as future trends in this research area.	[Sussulini, Alessandra] Univ Campinas UNICAMP, Dept Analyt Chem, Inst Chem, Lab Bioanalyt & Integrated Om LaBIOm, Campinas, SP, Brazil; [Sussulini, Alessandra] Univ Campinas UNICAMP, Inst Chem, Dept Analyt Chem, Spectrometry Sample Preparat & Mechanizat Grp GEP, Campinas, SP, Brazil; [Sussulini, Alessandra] Univ Campinas UNICAMP, Inst Chem, Natl Inst Sci & Technol Bioanalyt INCTBio, Campinas, SP, Brazil; [Hauser-Davis, Rachel Ann] Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca ENSP, Ctr Estudos Saude Trabalho & Ecol Humana CESTEH, Rua Leopoldo Bulhoes, Rio De Janeiro, Brazil		Sussulini, A (corresponding author), Univ Campinas UNICAMP, Dept Analyt Chem, Inst Chem, Lab Bioanalyt & Integrated Om LaBIOm, Campinas, SP, Brazil.; Sussulini, A (corresponding author), Univ Campinas UNICAMP, Inst Chem, Dept Analyt Chem, Spectrometry Sample Preparat & Mechanizat Grp GEP, Campinas, SP, Brazil.; Sussulini, A (corresponding author), Univ Campinas UNICAMP, Inst Chem, Natl Inst Sci & Technol Bioanalyt INCTBio, Campinas, SP, Brazil.	sussulini@iqm.unicamp.br	Hauser-Davis, Rachel Ann/C-7970-2013; Sussulini, Alessandra/B-1700-2009	Hauser-Davis, Rachel Ann/0000-0002-9451-471X; Sussulini, Alessandra/0000-0002-5092-5867			ABDALLA DSP, 1986, CLIN CHEM, V32, P805; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Arinola G, 2010, J RES MED SCI, V15, P245; Arnal N, 2010, BRAIN RES, V1319, P118, DOI 10.1016/j.brainres.2009.11.085; Aschner M, 1996, FASEB J, V10, P1129, DOI 10.1096/fasebj.10.10.8751715; Ayton S, 2013, ANN NEUROL, V73, P554, DOI 10.1002/ana.23817; Barbariga M, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0055-2; Barnham KJ, 2014, CHEM SOC REV, V43, P6727, DOI 10.1039/c4cs00138a; BASUN H, 1991, J NEURAL TRANSM-PARK, V3, P231; Bharucha KJ, 2008, J NEUROL, V255, P1957, DOI 10.1007/s00415-009-0063-7; Blennow K, 2009, J ALZHEIMERS DIS, V18, P413, DOI 10.3233/JAD-2009-1177; Blom ES, 2009, DEMENT GERIATR COGN, V27, P458, DOI 10.1159/000216841; Boaru SG, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-98; Bocca B, 2004, SPECTROCHIM ACTA B, V59, P559, DOI 10.1016/j.sab.2004.02.007; Bolann BJ, 2007, SCAND J CLIN LAB INV, V67, P353, DOI 10.1080/00365510601095281; Boll MC, 2008, NEUROCHEM RES, V33, P1717, DOI 10.1007/s11064-008-9610-3; BONILLA E, 1991, NEUROSCI LETT, V129, P22, DOI 10.1016/0304-3940(91)90711-2; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BROWN JS, 1994, SCHIZOPHRENIA BULL, V20, P387, DOI 10.1093/schbul/20.2.387; Chahine Lama M, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS99, DOI 10.1016/S1353-8020(13)70025-7; Cristovao JS, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9812178; Crouch PJ, 2012, ACCOUNTS CHEM RES, V45, P1604, DOI 10.1021/ar300074t; Ebadi M, 2006, EXP BIOL MED, V231, P1576, DOI 10.1177/153537020623100919; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Fattal O, 2006, PSYCHOSOMATICS, V47, P1, DOI 10.1176/appi.psy.47.1.1; Ferenci P, 2004, ALIMENT PHARM THER, V19, P157, DOI 10.1046/j.1365-2036.2003.01813.x; Forte G, 2004, J NEURAL TRANSM, V111, P1031, DOI 10.1007/s00702-004-0124-0; Fukushima Tetsuhito, 2013, Fukushima J Med Sci, V59, P76; Gama CS, 2006, PROG NEURO-PSYCHOPH, V30, P512, DOI 10.1016/j.pnpbp.2005.11.009; Gerhardsson L, 2008, DEMENT GERIATR COGN, V25, P508, DOI 10.1159/000129365; GOLDFISCHER S, 1968, AM J PATHOL, V53, P883; Gonzalez-Dominguez R, 2014, METALLOMICS, V6, P292, DOI 10.1039/c3mt00301a; Gonzalez-Estecha M, 2011, J TRACE ELEM MED BIO, V25, pS78, DOI 10.1016/j.jtemb.2010.10.015; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Halliwell B, 2006, TRENDS BIOCHEM SCI, V31, P509, DOI 10.1016/j.tibs.2006.07.005; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006; Hands SL, 2010, BIOCHEM SOC T, V38, P552, DOI 10.1042/BST0380552; Hare DJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55042; He J, 2013, CURR ALZHEIMER RES, V10, P979; Hutchinson RW, 2005, ANAL BIOCHEM, V346, P225, DOI 10.1016/j.ab.2005.08.024; Ihara Y, 1999, J NEUROL SCI, V170, P90, DOI 10.1016/S0022-510X(99)00192-6; Jin LR, 2011, BRAIN, V134, P50, DOI 10.1093/brain/awq319; Kim Han-Joon, 2013, Exp Neurobiol, V22, P77, DOI 10.5607/en.2013.22.2.77; Kosaka T, 1997, NEUROLOGY, V48, P741, DOI 10.1212/WNL.48.3.741; Kunz M, 2008, PROG NEURO-PSYCHOPH, V32, P1677, DOI 10.1016/j.pnpbp.2008.07.001; Lee JY, 2012, TOX RESEARCH, V28, P93, DOI 10.5487/TR.2012.28.2.093; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Lee YH, 2009, AM J DENT, V22, P241; Li Q, 2007, EXP NEUROL, V204, P840, DOI 10.1016/j.expneurol.2007.01.005; LOEFFLER DA, 1995, J NEUROCHEM, V65, P710; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Manto M, 2014, TOXICS, V2, P327, DOI 10.3390/toxics2020327; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Martinez-Hernandez R, 2011, NEUROCHEM RES, V36, P2111, DOI 10.1007/s11064-011-0535-x; Matusch A, 2012, ANAL CHEM, V84, P3170, DOI 10.1021/ac203112c; Matusch A, 2010, J AM SOC MASS SPECTR, V21, P161, DOI 10.1016/j.jasms.2009.09.022; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Michael GJ, 2011, NEUROGENETICS, V12, P295, DOI 10.1007/s10048-011-0294-5; Molina JA, 1998, J NEURAL TRANSM, V105, P479, DOI 10.1007/s007020050071; MORRISON PJ, 1994, IRISH J MED SCI, V163, P236, DOI 10.1007/BF02943258; Mukherjee S, 1996, SCHIZOPHR RES, V19, P19, DOI 10.1016/0920-9964(95)00048-8; MULDER TPJ, 1992, J HEPATOL, V16, P346, DOI 10.1016/S0168-8278(05)80667-1; Muller M, 2014, J NEUROCHEM, V130, P328, DOI 10.1111/jnc.12739; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; NARTEY NO, 1987, LAB INVEST, V57, P397; Nawaz R, 2014, J NEUROSCI, V4, P450; OGIHARA H, 1995, PEDIATR RES, V37, P219, DOI 10.1203/00006450-199502000-00016; OLATUNBOSUN DA, 1975, BRIT J PSYCHIAT, V127, P119, DOI 10.1192/bjp.127.2.119; Orisakwe OE, 2014, N AM J MED SCI, V6, P370, DOI 10.4103/1947-2714.139283; Park JH, 2014, ASIA-PAC PSYCHIAT, V6, P38, DOI 10.1111/appy.12077; Pomara N, 2005, AM J GERIAT PSYCHIAT, V13, P914; Prakash A, 2017, INT J NEUROSCI, V127, P99, DOI 10.3109/00207454.2016.1174118; Ranjekar PK, 2003, PSYCHIAT RES, V121, P109, DOI 10.1016/S0165-1781(03)00220-8; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Rodriguez-Castro KI, 2015, WORLD J HEPATOL, V7, P2859; Rohani M, 2013, MOVEMENT DISORD, V28, pS319; Samgard K, 2010, INT J GERIATR PSYCH, V25, P403, DOI 10.1002/gps.2353; Sanyal J, 2016, SCI REP-UK, V6, DOI 10.1038/srep35097; Sas K, 2007, J NEUROL SCI, V257, P221, DOI 10.1016/j.jns.2007.01.033; Savas HA, 2006, WORLD J BIOL PSYCHIA, V7, P51, DOI 10.1080/15622970510029993; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schneider P, 2009, CNS NEUROSCI THER, V15, P358, DOI 10.1111/j.1755-5949.2009.00104.x; Schupf N, 2008, P NATL ACAD SCI USA, V105, P14052, DOI 10.1073/pnas.0805902105; Selek S, 2008, J AFFECT DISORDERS, V107, P89, DOI 10.1016/j.jad.2007.08.006; Sharma SK, 2013, SRI LANKA J PSYCHIAT, V5, P14; Shekhar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159099; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Siwek M, 2017, PSYCHIATR POL, V51, P469, DOI 10.12740/PP/OnlineFirst/65250; Southwell AL, 2015, SCI REP-UK, V5, DOI 10.1038/srep12166; Squitti R, 2002, NEUROLOGY, V59, P1153, DOI 10.1212/WNL.59.8.1153; Squitti Rosanna, 2013, Am J Neurodegener Dis, V2, P46; Steinacker P, 2010, AM J PATHOL, V176, P1409, DOI 10.2353/ajpath.2010.090355; Subramanian KS, 1996, SPECTROCHIM ACTA B, V51, P291, DOI 10.1016/0584-8547(95)01425-X; Sussulini A, 2017, MASS SPECTROM REV, V36, P47, DOI 10.1002/mas.21481; Sussulini A, 2012, BIOMED SPECTROSC IMA, V1, P125, DOI 10.3233/BSI-2012-0011; Sussulini A, 2010, ANAL CHEM, V82, P5859, DOI 10.1021/ac101063t; Torsdottir G, 1999, PHARMACOL TOXICOL, V85, P239, DOI 10.1111/j.1600-0773.1999.tb02015.x; TYRER SP, 1979, AM J PSYCHIAT, V136, P937; van Oijen M, 2006, LANCET NEUROL, V5, P655, DOI 10.1016/S1474-4422(06)70501-4; Ventriglia M, 2012, J ALZHEIMERS DIS, V30, P981, DOI 10.3233/JAD-2012-120244; Virit O, 2008, KLIN PSIKOFARMAKOL B, V18, P282; Wisnieff C, 2015, MAGN RESON MED, V74, P564, DOI 10.1002/mrm.25420; Wu JQ, 2013, PROG NEURO-PSYCHOPH, V46, P200, DOI 10.1016/j.pnpbp.2013.02.015; Yanik M, 2004, BIOL TRACE ELEM RES, V98, P109, DOI 10.1385/BTER:98:2:109; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163	105	7	7	2	18	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-319-90143-5; 978-3-319-90142-8	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2018	1055						21	37		10.1007/978-3-319-90143-5_2	10.1007/978-3-319-90143-5		17	Biology; Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Research & Experimental Medicine	BL2DR	WOS:000448876600003	29884960				2022-02-06	
S	Trofimov, AO; Kalentiev, G; Karelsky, M; Ksenofontova, C; Ruzavina, A; Yuriev, M; Bragin, DE		Thews, O; LaManna, JC; Harrison, DK		Trofimov, Alexey O.; Kalentiev, George; Karelsky, Michael; Ksenofontova, Cristina; Ruzavina, Alevtina; Yuriev, Michail; Bragin, Denis E.			Cerebral Hemodynamics After Transcranial Direct Current Stimulation (tDCS) in Patients with Consequences of Traumatic Brain Injury	OXYGEN TRANSPORT TO TISSUE XL	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	45th Annual Meeting of the International-Society-on-Oxygen-Transport-to-Tissue (ISOTT)	AUG 19-23, 2017	Martin Luther Univ, Med Fac, Halle, GERMANY	Int Soc Oxygen Transport Tissue, Oxford Optronix, Hamamatsu Photon, Univ Hosp Halle	Martin Luther Univ, Med Fac			In recent years, hopes for better treatment of traumatic brain injury (TBI) have focused on non-pharmacologic transcranial electrical brain stimulation; however, studies of perfusion changes after stimulation are few and contradictory. Therefore, the aim of this study was to assess cerebral perfusion after high-definition transcranial direct current stimulation (HD-tDCS) in patients with posttraumatic encephalopathy (PTE). Methods. Twenty patients with PTE (16 men and 4 women, aged 35.5 +/- 14.8 years) underwent perfusion computed tomography (PCT), followed by anodal HD-tDCS and post-stimulation tomography at 21 days after TBI. The Westermark perfusion maps were constructed and quantitative perfusion parameters calculated. Significance was preset to P < 0.05. Results. Qualitative analysis revealed that all patients had areas with reduced cerebral blood flow (CBF) and increased average mean transit time (MTT). HD-tDCS was accompanied by a significant decrease in the number of zones of both hypoperfusion and ischemia (p < 0.05). Quantitative analysis showed that, in all patients, HD-tDCS caused a significant increase in CBF (p < 0.001), cerebral blood volume (CBV) (p < 0.01) and MTT shortening (p < 0.05) in the frontotemporal region on the anode side. In the basal ganglia, a significant increase in CBF was found only in the five patients in whom this was initially reduced (p < 0.01) and only with an anode placed on the same side. Conclusions. In patients with complications due to PTE TBI, HD-tDCS causes a significant increase in CBV, CBF and a decrease in the average MTT, suggesting better oxygen delivery to tissue.	[Trofimov, Alexey O.; Kalentiev, George; Karelsky, Michael; Ksenofontova, Cristina; Ruzavina, Alevtina; Yuriev, Michail] Privolzhsky Res Med Univ, Dept Neurosurg, Nizhnii Novgorod, Russia; [Bragin, Denis E.] Univ New Mexico, Sch Med, Div Neurosurg, Albuquerque, NM 87131 USA		Trofimov, AO (corresponding author), Privolzhsky Res Med Univ, Dept Neurosurg, Nizhnii Novgorod, Russia.		Bragin, Denis/E-5494-2016; Trofimov, Alex/T-5805-2017	Bragin, Denis/0000-0003-4894-0061; 	RSFRussian Science Foundation (RSF) [17-15-01263]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089] Funding Source: NIH RePORTER; Russian Science FoundationRussian Science Foundation (RSF) [17-15-01263] Funding Source: Russian Science Foundation	DB was supported by RSF No 17-15-01263.	Filosa JA, 2013, AM J PHYSIOL-HEART C, V305, pH609, DOI 10.1152/ajpheart.00359.2013; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Kochanek PM, 2017, J NEUROTRAUM, V34, P3067, DOI 10.1089/neu.2017.5159; Long HY, 2011, CELL BIOCHEM BIOPHYS, V61, P481, DOI 10.1007/s12013-011-9231-3; Miles KA, 2007, CT PERFUSION IMAGING; Monai H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11100; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931	9	7	7	0	1	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-319-91287-5; 978-3-319-91285-1	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2018	1072						59	62		10.1007/978-3-319-91287-5_10			4	Medicine, Research & Experimental; Physiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Physiology	BL6LR	WOS:000454396400011	30178324	Green Accepted			2022-02-06	
J	Tsushima, WT; Siu, AM; Yamashita, N; Oshiro, RS; Murata, NM				Tsushima, William T.; Siu, Andrea M.; Yamashita, Nozomi; Oshiro, Ross S.; Murata, Nathan M.			Comparison of neuropsychological test scores of high school athletes in high and low contact sports: A replication study	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Concussion; ImPACT; repetitive head trauma	CHRONIC TRAUMATIC ENCEPHALOPATHY; COLLEGIATE FOOTBALL PLAYERS; SOCCER PLAYERS; BRAIN TRAUMA; WHITE-MATTER; CONCUSSION; IMPACT; IMPAIRMENT; RISK; EPIDEMIOLOGY	This replication study re-examined the neuropsychological effects of participation in high and low contact youth sports. Modeled after a recently published investigation, two contact sport groups of participants ages 12 to 18 were formed based on the rate of concussion in their respective sport, with the assumption that more head impacts and neuropsychological effects occur in high contact sports that have a greater number of reported concussions as compared with low contact sports. The preseason baseline ImPACT neuropsychological test scores and symptom scores of nonconcussed youth athletes in a High Contact Sport (football, n = 139) and a Low Contact Sport (basketball, baseball, soccer, wrestling, volleyball, paddling, and cheerleading, n = 57) were compared. The results revealed significantly poorer ImPACT test performances in visual motor speed and reaction time among high contact sport athletes compared to low contact sport athletes. No differences were found between the two groups in Verbal Memory, Visual Memory, and Total Symptom. These findings were identical to a recent study in which nonconcussed youth athletes in a high contact sport, that is, football, exhibited poorer neuropsychological test performance than their peers in low contact sports, that is, basketball, baseball, soccer, wrestling, and judo. This research replication verified the results of the prior study, and raises concerns that youth athletes exposed to repetitive head trauma may be at risk for lowered neuropsychological functioning, even without a reported concussive event.	[Tsushima, William T.] Straub Clin & Hosp, Dept Psychiat & Psychol, 888 South King St, Honolulu, HI 96813 USA; [Siu, Andrea M.] Hawaii Pacific Hlth, Res Inst, Honolulu, HI USA; [Yamashita, Nozomi] Tulane Univ, Dept Neurosci, Honolulu, HI USA; [Oshiro, Ross S.] Queens Ctr Sports Med, POB III, Honolulu, HI USA; [Murata, Nathan M.] Univ Hawaii Manoa, Dept Kinesiol & Rehabil Sci, Honolulu, HI 96822 USA		Tsushima, WT (corresponding author), Straub Clin & Hosp, Dept Psychiat & Psychol, 888 South King St, Honolulu, HI 96813 USA.	wtsushima@straub.net			Hawaii Concussion Awareness and Management Program	The authors wish to acknowledge the support of the Hawaii Concussion Awareness and Management Program. The third author, NY, participated in the Hawaii Pacific Health Summer Student Research Program while she assisted in this research project.	Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2004, STUD NEUROPSYCHOL DE, P45; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Krueger J, 2001, AM PSYCHOL, V56, P16, DOI 10.1037//0003-066X.56.1.16; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell M. R., 2006, SPORTS NEUROPSYCHOLO, P193; Lovell M. R., 2012, CLIN INTERPRETATION; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Maxwell SE, 2015, AM PSYCHOL, V70, P487, DOI 10.1037/a0039400; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Randolph C, 2005, J ATHL TRAINING, V40, P139; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; Weiner I.B., 2003, HDB PSYCHOL, V2; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	42	7	7	1	18	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2018	7	1					14	20		10.1080/21622965.2016.1220860			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GE0RZ	WOS:000430924700002	27561090				2022-02-06	
J	Vavilala, MS; Farr, CK; Watanitanon, A; Clark-Bell, BSC; Chandee, T; Moore, A; Armstead, W				Vavilala, Monica S.; Farr, Carly K.; Watanitanon, Arraya; Clark-Bell, B. S. Crystalyn; Chandee, Theerada; Moore, Anne; Armstead, William			Early changes in cerebral autoregulation among youth hospitalized after sports-related traumatic brain injury	BRAIN INJURY			English	Article						Sports-related concussion; traumatic brain injury	BLOOD-FLOW ALTERATIONS; TRANSCRANIAL DOPPLER; CEREBROVASCULAR PATHOPHYSIOLOGY; CONCUSSION; CHILDREN; MODERATE; MILD; CARE; ANESTHESIA; SYMPTOMS	Objective: To examine early cerebral haemodynamic changes among youth hospitalized with sports-related traumatic brain injury (TBI). Study design: Youth 0-18 years admitted to a level one trauma centre with sports-related TBI were enrolled. Daily measures included clinical symptoms and Glasgow Coma Scale (GCS) score. Using Transcranial Doppler (TCD) ultrasonography and tilt testing, we measured middle cerebral artery flow velocity (Vmca) and cerebral autoregulation index (ARI). Results: Six previously healthy males age 14 (IQR 12-16) years with headache and abnormal head CT were admitted with median admission GCS 15. Six patients underwent 12 TCD examinations between hospital days 0-9. Low Vmca occurred in 3/6 patients and on the side of TBI, whereas high Vmca occurred in 2/6 patients. Five patients had at least one measurement of impaired and five patients had absent cerebral autoregulation of at least one hemisphere; all these five patients had GCS 15 and headache during TCD examinations. Three patients were discharged with absent cerebral autoregulation. Five (83%) patients were discharged to home and one patient was discharged to a rehabilitation facility. Conclusion: Headache, abnormal Vmca and impaired cerebral autoregulation occur after sports-related TBI, despite normal GCS. Headache may signal underlying neurovascular abnormality in sports-related TBI.	[Vavilala, Monica S.; Farr, Carly K.; Watanitanon, Arraya; Clark-Bell, B. S. Crystalyn; Chandee, Theerada] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Vavilala, Monica S.; Farr, Carly K.; Watanitanon, Arraya; Clark-Bell, B. S. Crystalyn; Chandee, Theerada] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Moore, Anne] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, 325 9Th Ave, Seattle, WA 98104 USA; [Armstead, William] Univ Penn, Dept Anesthesiol, Philadelphia, PA 19104 USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Anesthesiol & Pediat, 325 Ninth Avenue,Box 359724, Seattle, WA 98104 USA.; Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, 325 Ninth Avenue,Box 359724, Seattle, WA 98104 USA.	Vavilala@uw.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS095321]; Seattle Paediatric Concussion Collaborative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS095321] Funding Source: NIH RePORTER	This work was financially supported by NINDS R21NS095321 (PI: Vavilala) and The Seattle Paediatric Concussion Collaborative (PI: Rivara).	ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; BODE H, 1988, ARCH DIS CHILD, V63, P606, DOI 10.1136/adc.63.6.606; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; D'Andrea A, 2016, J CARDIOVASC ECHOGR, V26, P28, DOI 10.4103/2211-4122.183746; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Garrett ZK, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13150; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Ma L, 2014, PEDIATR CRIT CARE ME, V15, P742, DOI 10.1097/PCC.0000000000000197; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mora CF, 2017, J CEREBR BLOOD F MET, V37, P2414, DOI 10.1177/0271678X16667524; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; Philip S, 2009, J TRAUMA, V67, pS128, DOI 10.1097/TA.0b013e3181ad32c7; Prabhu SP, 2011, CLIN SPORT MED, V30, P103, DOI 10.1016/j.csm.2010.09.003; Rigamonti A, 2008, CAN J ANAESTH, V55, P112, DOI 10.1007/BF03016323; Rochefort C, 2017, J SCI MED SPORT, V20, P970, DOI 10.1016/j.jsams.2017.04.008; Rochefort C, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117695507; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2017, ANESTH ANALG, V125, P1053, DOI 10.1213/ANE.0000000000002080; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Vavilala MS, 2003, BRIT J ANAESTH, V90, P636, DOI 10.1093/bja/aeg119; Verlhac S, 2011, PEDIATR RADIOL, V41, pS153, DOI 10.1007/s00247-011-2038-y; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612; Zollman, 2016, MANUAL TRAUMATIC BRA	35	7	7	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	2					269	275		10.1080/02699052.2017.1408145			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WF	WOS:000427073600014	29182378	Green Accepted			2022-02-06	
J	Vincent, AS; Roebuck-Spencer, TM; Cox-Fuenzalida, LE; Block, C; Scott, JG; Kane, R				Vincent, Andrea S.; Roebuck-Spencer, Tresa M.; Cox-Fuenzalida, L. Eugenia; Block, Cady; Scott, James G.; Kane, Robert			Validation of ANAM for cognitive screening in a mixed clinical sample	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						ANAM; cognitive screening; computerized testing; neuropsychology	TRAUMATIC BRAIN-INJURY; ASSESSMENT METRICS ANAM; NEUROPSYCHOLOGICAL ASSESSMENT; PRIMARY-CARE; ACUTE CONCUSSION; IMPAIRMENT; TESTS; PERFORMANCE; RELIABILITY; DYSFUNCTION	The Automated Neuropsychological Assessment Metrics (ANAM) is a library of computer based tests designed to measure cognitive function at a single time-point or longitudinally for detection of cognitive change. This study sought to validate ANAM as a cognitive screening tool for presence of confirmed neuropsychological diagnosis in an outpatient setting. Retrospective data analysis was conducted for 139 patients referred for outpatient neuropsychological assessment. Clinical diagnosis was made independent of ANAM test results and resulted in a diagnostic mix of both neurologic and psychologic etiologies. ANAM scores predictive of presence of confirmed diagnosis were identified using multiple logistic regression and the predictive ability of the resulting model was quantified using receiver operator characteristic analysis. Sensitivity and specificity for the ANAM when combined with anger and depressive symptom scores were 71% and 91%, respectively, with a positive predictive value of 97.5 and negative predictive value of 40.4. This combined approach provided the greatest accuracy for individual tests as well as the composite score of the ANAM in identifying those who received a subsequent clinical diagnosis. Although data should be replicated in larger samples, these results suggest that ANAM may have predictive value and may be a useful screening tool for identifying those who would likely benefit from neuropsychological services.	[Vincent, Andrea S.; Roebuck-Spencer, Tresa M.; Cox-Fuenzalida, L. Eugenia] Univ Oklahoma, Cognit Sci Res Ctr, Norman, OK 73019 USA; [Block, Cady; Scott, James G.] Univ Oklahoma, Hlth Sci Ctr, Dept Psychiat & Behav Sci, Oklahoma City, OK 73190 USA; [Kane, Robert] Georgetown Univ, Dept Neurol, Washington, DC USA		Vincent, AS (corresponding author), 350 David L Boren Blvd,Suite 1910, Norman, OK 73019 USA.	avincent@ou.edu	Block, Cady/I-3078-2014	Block, Cady/0000-0001-7168-6116			[Anonymous], 2013, ANAM TECHN MAN; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Borson S, 2006, INT J GERIATR PSYCH, V21, P349, DOI 10.1002/gps.1470; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Cordell CB, 2013, ALZHEIMERS DEMENT, V9, P141, DOI 10.1016/j.jalz.2012.09.011; CSRC, 2013, ANAM GNS BATT ADM MA; Cullen B, 2007, J NEUROL NEUROSUR PS, V78, P790, DOI 10.1136/jnnp.2006.095414; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Lowe M, 2007, ARCH CLIN NEUROPSYCH, V22, pS89, DOI 10.1016/j.acn.2006.10.010; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; McCarten JR, 2012, J AM GERIATR SOC, V60, P210, DOI 10.1111/j.1532-5415.2011.03841.x; McDiarmid Melissa A, 2002, Mil Med, V167, P123; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; Moyer VA, 2014, ANN INTERN MED, V160, P791, DOI 10.7326/M14-0496; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Rahill AA, 1996, AVIAT SPACE ENVIR MD, V67, P640; Ringman JM, 2015, BRAIN, V138, P1036, DOI 10.1093/brain/awv004; Roebuck-Spencer TM, 2006, ARTHRIT RHEUM-ARTHR, V55, P434, DOI 10.1002/art.21992; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Short P, 2007, ARCH CLIN NEUROPSYCH, V22, pS63, DOI 10.1016/j.acn.2006.10.012; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; White RF, 2003, ASSESSMENT, V10, P86, DOI 10.1177/1073191102250185; White RF, 1996, NEUROTOXICOL TERATOL, V18, P441, DOI 10.1016/0892-0362(96)00021-9; Wilken JA, 2003, MULT SCLER, V9, P119, DOI 10.1191/1352458503ms893oa; Wilken JA, 2007, ARCH CLIN NEUROPSYCH, V22, pS127, DOI 10.1016/j.acn.2006.10.007; Woodhouse J, 2013, CLIN NEUROPSYCHOL, V27, P376, DOI 10.1080/13854046.2012.762427; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	45	7	7	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2018	25	4			SI		366	375		10.1080/23279095.2017.1314967			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GG4SF	WOS:000432685800012	28448160				2022-02-06	
J	Wilmoth, K; LoBue, C; Clem, MA; Reddy, R; Hynan, LS; Didehbani, N; Bell, K; Womack, KB; Hart, J; Batjer, H; Cullum, CM				Wilmoth, Kristin; LoBue, Christian; Clem, Matthew A.; Reddy, Rajadhar; Hynan, Linda S.; Didehbani, Nyaz; Bell, Kathleen; Womack, Kyle B.; Hart, John, Jr.; Batjer, Hunt; Cullum, C. Munro			Consistency of traumatic brain injury reporting in older adults with and without cognitive impairment	CLINICAL NEUROPSYCHOLOGIST			English	Article						Traumatic brain injury; concussion; Alzheimer's disease; cognitive impairment; dementia	ALZHEIMERS-DISEASE; CONCUSSION HISTORY; RISK; RELIABILITY; AGREEMENT; AGE	Objective: Medical history information regarding prior traumatic brain injury (TBI) usually relies on self-report, although little is known about the reliability of this information with regard to injuries sustained years or decades earlier. Even less is known about the reliability of self-reported medical history information in older individuals with cognitive impairment. To this end, we assessed the test-retest reliability of self-reported TBI history in a large, national sample. Methods: Participants (n=4309) were older adults with intact cognition, mild cognitive impairment (MCI) and Alzheimer's disease (AD) from the National Alzheimer's Coordinating Center. Subjects provided TBI history information at baseline and one annual follow-up visit. Consistency of self-reported history of TBI with<5minutes loss of consciousness (mLOC) and TBI with5 mLOC reported at time 1 and 2 was analyzed across diagnostic groups. Results: Overall, subjects provided reports of TBI history at follow-up that were highly consistent with baseline reports (97.8-99.6% agreement), and Cohen's kappa coefficients were all larger than .80 and statistically significant, maximum p<.001. Furthermore, level of cognitive impairment was not a significant predictor of consistency in reporting. Conclusions: These data are some of the first to suggest that self-report may be a consistent method of obtaining remote TBI history in the absence of medical records for older individuals, regardless of cognitive impairment.	[Wilmoth, Kristin; LoBue, Christian; Clem, Matthew A.; Reddy, Rajadhar; Hynan, Linda S.; Didehbani, Nyaz; Womack, Kyle B.; Hart, John, Jr.; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Hynan, Linda S.] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Bell, Kathleen] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Womack, Kyle B.; Hart, John, Jr.; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Batjer, Hunt; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA		Wilmoth, K (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	Kristin.Wilmoth@UTSouthwestern.edu	Hynan, Linda S/P-6473-2016; Womack, Kyle/O-5422-2018; Cullum, C. Munro/AAC-2496-2019; Wilmoth, Kristin/ABB-4014-2020	Womack, Kyle/0000-0002-6060-9075; Cullum, C. Munro/0000-0001-9706-5465; Wilmoth, Kristin/0000-0003-4192-8756; Didehbani, Nyaz/0000-0001-6121-5759; Bell, Kathleen/0000-0002-0928-2046	Texas Alzheimer's Research and Care Consortium (TARCC); NIA/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01 AG016976]; Texas Institute for Brain Injury and Repair at the University of Texas Southwestern Medical Center; UT Southwestern's Alzheimer's Disease Center [NIA] [P3012300-19]; Darrell K Royal Texas Alzheimer's Initiative; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG019610, P30 AG013846, P50 AG008702, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146, P50 AG005134, P50 AG016574, P50 AG005138, P30 AG008051, P30 AG013854, P30 AG008017, P30 AG010161, P50 AG047366, P30 AG010129, P50 AG016573, P50 AG005131, P50 AG023501, P30 AG035982, P30 AG028383, P30 AG053760, P30 AG010124, P50 AG005133, P50 AG005142, P30 AG012300, P30 AG049638, P50 AG005136, P50 AG033514, P50 AG005681, P50 AG047270]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005681, P50AG047366, P30AG013846, P50AG047266, P30AG019610, P50AG005136, P50AG005138, P30AG049638, P30AG035982, P30AG010161, P30AG013854, P50AG033514, P50AG008702, P50AG016573, P30AG010124, P50AG005134, P50AG025688, P50AG005142, P50AG005133, P30AG053760, P30AG010129, U01AG016976, P30AG028383, P30AG012300, P30AG010133, P50AG016574, P50AG005146, P50AG047270, P30AG008051, P50AG005131, P50AG023501, P30AG008017] Funding Source: NIH RePORTER	This work was supported in part by the Texas Institute for Brain Injury and Repair at the University of Texas Southwestern Medical Center and UT Southwestern's Alzheimer's Disease Center [NIA grant number P3012300-19]. Additional support was provided by the Texas Alzheimer's Research and Care Consortium (TARCC) and the Darrell K Royal Texas Alzheimer's Initiative, directed by the Texas Council on Alzheimer's Disease and Related Disorders. The NACC database is funded by NIA/NIH grant number U01 AG016976. NACC data are contributed by the NIA-funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134 (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Thomas Wisniewski, MD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG005131 (PI James Brewer, MD, PhD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG053760 (PI Henry Paulson, MD, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P30 AG049638 (PI Suzanne Craft, PhD), P50 AG005136 (PI Thomas Grabowski, MD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), P50 AG047270 (PI Stephen Strittmatter, MD, PhD).	Daly JM, 2010, ARCH GERONTOL GERIAT, V50, P341, DOI 10.1016/j.archger.2009.05.017; Deutsch MB, 2015, DEMENT GERIATR COGN, V39, P143, DOI 10.1159/000369787; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Donato F, 1998, EUR J EPIDEMIOL, V14, P259, DOI 10.1023/A:1007463620130; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; LoBue C, 2016, J NEUROL NEUROSUR PS, V87, P817, DOI 10.1136/jnnp-2015-311438; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Simpson CF, 2004, J AM GERIATR SOC, V52, P123, DOI 10.1111/j.1532-5415.2004.52021.x; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Xu W, 2015, J NEUROL NEUROSUR PS, V86, P1299, DOI 10.1136/jnnp-2015-310548	18	7	7	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2018	32	3					524	529		10.1080/13854046.2017.1378371			6	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FZ4KL	WOS:000427561000013	28988512	Green Accepted			2022-02-06	
J	Yucel, N; Demir, TO; Derya, S; Oguzturk, H; Bicakcioglu, M; Yetkin, F				Yucel, Neslihan; Demir, Tuba Ozturk; Derya, Serdar; Oguzturk, Hakan; Bicakcioglu, Murat; Yetkin, Funda			Potential Risk Factors for In-Hospital Mortality in Patients with Moderate-to-Severe Blunt Multiple Trauma Who Survive Initial Resuscitation	EMERGENCY MEDICINE INTERNATIONAL			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ORGAN FAILURE; BASE DEFICIT; EARLY COAGULOPATHY; END-POINTS; INJURY; SCORE; EPIDEMIOLOGY; PREDICTORS; LACTATE	Introduction. The aim was to identify risk factors that influence in-hospital mortality for patients with moderate-to-severe blunt multiple trauma (BMT) who survive initial resuscitation. Methods. The prospective study involved 195 adult patients with BMT who were admitted to a referral hospital's emergency department (ED) betweenMay 1, 2015, and May 31, 2016. Results. Forty-three (22%) of the 195 patients died in hospital. Multivariate analysis identified low blood pH (odds ratio [OR] 6.580, 95% confidence interval [CI] 1.12-38.51), high serumlactate level (OR 1.041, 95% CI 1.01-1.07), high ISS (OR 1.109, 95% CI 1.06-1.16), high APACHE II score (OR 1.189, 95% CI 1.07-1.33), traumatic brain injury (TBI) (OR 4.358, 95% CI 0.76-24.86), severe hemorrhage (OR 5.314, 95% CI 1.07-26.49), and coagulopathy (OR 5.916, 95% CI 1.17-29.90) as useful predictors of acute in-hospital mortality. High ISS (OR 1.047, 95% CI 1.02-1.08), TBI (OR 8.922, 95% CI 2.57-31.00), sepsis (OR 4.956, 95% CI 1.99-12.36), acute respiratory distress syndrome (ARDS) (OR 8.036, 95% CI 1.85-34.84), respiratory failure (OR 9.630, 95% CI 2.64-35.14), renal failure (OR 74.803, 95% CI 11.34-493.43), and multiple organ failure [MOF] (OR 10.415, 95% CI 4.48-24.24) were risk factors for late in-hospital mortality. High Glasgow Coma Scale (GCS) was a good predictor for survival at 2, 7, and 28 or more days of hospitalization (OR 0.708 and 95% CI 0.56-0.09; OR 0.835 and 95% CI 0.73-0.95; OR 0.798 and 95% CI 0.71-0.90, resp.). Conclusion. Several factors signal poor short-term outcome for patients who present to the ED with moderate-to-severe BMT: low blood pH, high serum lactate level, presence of TBI, severe hemorrhage, coagulopathy, organ failure (respiratory, renal, and MOF), and ARDS. For this patient group, ISS and APACHE II scores might be helpful for stratifying by mortality risk, and GCS might be a good predictor for survival.	[Yucel, Neslihan; Demir, Tuba Ozturk; Derya, Serdar; Oguzturk, Hakan] Inonu Univ, Sch Med, Dept Emergency Med, Malatya, Turkey; [Bicakcioglu, Murat] Inonu Univ, Sch Med, Dept Anesthesiol & Reanimat, Malatya, Turkey; [Yetkin, Funda] Inonu Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Malatya, Turkey		Yucel, N (corresponding author), Inonu Univ, Sch Med, Dept Emergency Med, Malatya, Turkey.	nesyucel@hotmail.com	bicakcioglu, murat/ABB-5579-2020; Oguzturk, Hakan/AAC-3915-2021; oguzturk, hakan/Q-6242-2019; Yucel, Neslihan/ABI-3412-2020; memisoglu, funda/AAA-4392-2021	Oguzturk, Hakan/0000-0002-9800-1428; Yucel, Neslihan/0000-0001-5845-2614; memisoglu, funda/0000-0003-3905-1182			American College of Surgeons Committee on Trauma, 2012, ADV TRAUM LIF SUPP A; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baltas I, 1998, J Neurosurg Sci, V42, P85; Bidgoli HH, 2011, INJURY, V42, P879, DOI 10.1016/j.injury.2010.04.024; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Carley S, 2001, RESUSCITATION, V48, P47, DOI 10.1016/S0300-9572(00)00317-8; Ciesla DJ, 2005, SURGERY, V138, P749, DOI 10.1016/j.surg.2005.07.020; Ciesla DJ, 2005, ARCH SURG-CHICAGO, V140, P432, DOI 10.1001/archsurg.140.5.432; Costa Carlos Dario da Silva, 2012, Rev. Col. Bras. Cir., V39, P249; DALAL SA, 1989, J TRAUMA, V29, P981, DOI 10.1097/00005373-198907000-00012; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; DeLoughery TG, 2004, CRIT CARE CLIN, V20, P13, DOI 10.1016/S0749-0704(03)00089-7; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Devin L., 2007, INFORM HEALTHCARE, V1, P59; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Freitas AD, 2015, ABCD-ARQ BRAS CIR DI, V28, P163, DOI 10.1590/S0102-67202015000300004; Frohlich M, 2014, J TRAUMA ACUTE CARE, V76, P921, DOI 10.1097/TA.0000000000000199; Guzzo JL, 2005, J AM COLL SURGEONS, V201, P891, DOI 10.1016/j.jamcollsurg.2005.07.013; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hoyt DB, 2008, J TRAUMA, V65, P755, DOI 10.1097/TA.0b013e318185fa9f; HOYT DB, 1993, J TRAUMA, V35, P524, DOI 10.1097/00005373-199310000-00005; Husain FA, 2003, AM J SURG, V185, P485, DOI 10.1016/S0002-9610(03)00044-8; Ingraham AM, 2010, ANN SURG, V252, P358, DOI 10.1097/SLA.0b013e3181e623bf; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1989, CRIT CARE CLIN, V5, P221; Kuhls DA, 2002, J AM COLL SURGEONS, V194, P695, DOI 10.1016/S1072-7515(02)01211-5; Lausevic Z, 2008, CAN J SURG, V51, P97; Lichtveld RA, 2007, EUR J TRAUMA EMERG S, V33, P46, DOI 10.1007/s00068-007-6097-6; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; MacLeod JBA, 2004, AM SURGEON, V70, P805; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; MANIKIS P, 1995, AM J EMERG MED, V13, P619, DOI 10.1016/0735-6757(95)90043-8; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Miller PR, 2002, AM SURGEON, V68, P845; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12555; Odom SR, 2013, J TRAUMA ACUTE CARE, V74, P999, DOI 10.1097/TA.0b013e3182858a3e; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Papia G, 1999, J TRAUMA, V47, P923, DOI 10.1097/00005373-199911000-00018; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Porter JM, 1998, J TRAUMA, V44, P908, DOI 10.1097/00005373-199805000-00028; Prin M., 2016, INJ EPIDEMIOL, V3, P18; Probst C, 2009, J TRAUMA, V66, P1212, DOI 10.1097/TA.0b013e318197b97c; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rating the severity of tissue damage. I, 1971, JAMA-J AM MED ASSOC, V215, P277; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; TEASDALE G, 1974, LANCET, V2, P81; Tisherman SA, 2004, J TRAUMA, V57, P898, DOI 10.1097/01.TA.0000133577.25793.E5; Ustundag M, 2010, HONG KONG J EMERG ME, V17, P471, DOI 10.1177/102490791001700507; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wafaisade A, 2011, CRIT CARE MED, V39, P621, DOI 10.1097/CCM.0b013e318206d3df	56	7	8	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2840	2090-2859		EMERG MED INT	Emerg. Med. Int.		2018	2018								6461072	10.1155/2018/6461072			12	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HE3JW	WOS:000453252200001	30595921	Green Submitted, gold, Green Published			2022-02-06	
J	Sebastian, F; Fu, QS; Santello, M; Polygerinos, P				Sebastian, Frederick; Fu, Qiushi; Santello, Marco; Polygerinos, Panagiotis			Soft Robotic Haptic Interface with Variable Stiffness for Rehabilitation of Neurologically Impaired Hand Function	FRONTIERS IN ROBOTICS AND AI			English	Article						soft robotics; stroke; rehabilitation; variable stiffness; haptic interface	NEURAL PLASTICITY; STROKE PATIENTS; RECOVERY; PERCEPTION; DESIGN; COST	The human hand comprises complex sensorimotor functions that can be impaired by neurological diseases and traumatic injuries. Effective rehabilitation can bring the impaired hand back to a functional state because of the plasticity of the central nervous system to relearn and remodel the lost synapses in the brain. Current rehabilitation therapies focus on strengthening motor skills, such as grasping, employ multiple objects of varying stiffness so that affected persons can experience a wide range of strength training. These devices have limited range of stiffness due to the rigid mechanisms employed in their variable stiffness actuators. This paper presents a novel soft robotic haptic device for neuromuscular rehabilitation of the hand, which is designed to offer adjustable stiffness and can be utilized in both clinical and home settings. The device eliminates the need for multiple objects by employing a pneumatic soft structure made with highly compliant materials that act as the actuator of the haptic interface. It is made with interchangeable sleeves that can be customized to include materials of varying stiffness to increase the upper limit of the stiffness range. The device is fabricated using existing 3D printing technologies, and polymer molding and casting techniques, thus keeping the cost low and throughput high. The haptic interface is linked to either an open-loop system that allows for an increased pressure during usage or closed-loop system that provides pressure regulation in accordance to the stiffness the user specifies. Preliminary evaluation is performed to characterize the effective controllable region of variance in stiffness. It was found that the region of controllable stiffness was between points 3 and 7, where the stiffness appeared to plateau with each increase in pressure. The two control systems are tested to derive relationships between internal pressure, grasping force exertion on the surface, and displacement using multiple probing points on the haptic device. Additional quantitative evaluation is performed with study participants and juxtaposed to a qualitative analysis to ensure adequate perception in compliance variance. The qualitative evaluation showed that greater than 60% of the trials resulted in the correct perception of stiffness in the haptic device.	[Sebastian, Frederick; Polygerinos, Panagiotis] Arizona State Univ, Ira A Fulton Schools Engn, Polytech Sch, Bio Inspired Mechatron Lab, Mesa, AZ 85212 USA; [Sebastian, Frederick; Fu, Qiushi; Santello, Marco] Arizona State Univ, Ira A Fulton Schools Engn, Sch Biol Hlth Syst Engn, Neural Control Movement Lab, Tempe, AZ 85287 USA; [Fu, Qiushi] Univ Cent Florida, Mech & Aerosp Engn, Orlando, FL 32816 USA		Polygerinos, P (corresponding author), Arizona State Univ, Ira A Fulton Schools Engn, Polytech Sch, Bio Inspired Mechatron Lab, Mesa, AZ 85212 USA.	polygerinos@asu.edu	Polygerinos, Panagiotis/ABC-7505-2021	Polygerinos, Panagiotis/0000-0002-1976-8728	National Science Foundation (NSF)National Science Foundation (NSF) [BCS-1455866]	This research was partially supported by a Collaborative Research Grant BCS-1455866 from the National Science Foundation (NSF) to MS. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NSF.	Balasubramanian S, 2010, CURR OPIN NEUROL, V23, P661, DOI 10.1097/WCO.0b013e32833e99a4; Bishop-Moser J, 2015, IEEE T ROBOT, V31, P536, DOI 10.1109/TRO.2015.2409452; Deimel R, 2013, IEEE INT CONF ROBOT, P2047, DOI 10.1109/ICRA.2013.6630851; DUNCAN PW, 1994, STROKE, V25, P1181, DOI 10.1161/01.STR.25.6.1181; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; Geetha G N, 2015, J Clin Diagn Res, V9, pHC01, DOI 10.7860/JCDR/2015/13777.6582; Genecov AM, 2014, IEEE HAPTICS SYM, P333, DOI 10.1109/HAPTICS.2014.6775477; Godwin KM, 2011, TOP STROKE REHABIL, V18, P676, DOI 10.1310/tsr18s01-676; Hankey GJ, 2017, LANCET, V389, P641, DOI 10.1016/S0140-6736(16)30962-X; JONES LA, 1990, EXP BRAIN RES, V79, P150; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P27, DOI 10.1016/S0003-9993(95)80038-7; Khademi M., 2012, 2012 IEEE EMBS Conference on Biomedical Engineering and Sciences (IECBES 2012), P892, DOI 10.1109/IECBES.2012.6498168; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Lambercy O, 2009, INT C REHAB ROBOT, P26; Legg L, 2007, BMJ-BRIT MED J, V335, P922, DOI 10.1136/bmj.39343.466863.55; Mace M., 2015, P INT C REH ROB ICOR; Mace M, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160961; Majidi C, 2014, SOFT ROBOT, V1, P5, DOI 10.1089/soro.2013.0001; Malosio Matteo, 2016, J Rehabil Assist Technol Eng, V3, p2055668316680980, DOI 10.1177/2055668316680980; Masia L., 2006, BIOMED ROBOT BIOMECH, P1085; NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P394, DOI 10.1016/0003-9993(94)90161-9; Polygerinos P, 2017, ADV ENG MATER, V19, DOI 10.1002/adem.201700016; Polygerinos P, 2015, IEEE T ROBOT, V31, P778, DOI 10.1109/TRO.2015.2428504; Polygerinos P, 2015, ROBOT AUTON SYST, V73, P135, DOI 10.1016/j.robot.2014.08.014; Popovic Dejan B, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2146; Seo NJ, 2008, HUM FACTORS, V50, P734, DOI 10.1518/001872008X354192; Spagnuolo G, 2017, MECH MACH THEORY, V110, P85, DOI 10.1016/j.mechmachtheory.2016.11.002; Stanley AA, 2013, 2013 WORLD HAPTICS CONFERENCE (WHC), P25, DOI 10.1109/WHC.2013.6548379; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; Tiest WMB, 2010, VISION RES, V50, P2775, DOI 10.1016/j.visres.2010.10.005; Tiest WMB, 2009, IEEE T HAPTICS, V2, P189, DOI [10.1109/TOH.2009.16, 10.1109/ToH.2009.16]; Warraich Z, 2010, PM&R, V2, pS208, DOI 10.1016/j.pmrj.2010.10.016; Wilkinson PR, 1997, STROKE, V28, P507, DOI 10.1161/01.STR.28.3.507; Winstein CJ, 2004, ARCH PHYS MED REHAB, V85, P620, DOI 10.1016/j.apmr.2003.06.027; Yap HK, 2017, INT C REHAB ROBOT, P1465, DOI 10.1109/ICORR.2017.8009454	35	7	7	2	17	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-9144			FRONT ROBOT AI	Front. Robot. AI	DEC 20	2017	4								69	10.3389/frobt.2017.00069			9	Robotics	Emerging Sources Citation Index (ESCI)	Robotics	FQ4NN	WOS:000418334500001		Green Published, gold			2022-02-06	
J	Bartley, JH; Murray, MF; Kraeutler, MJ; Pierpoint, LA; Welton, KL; McCarty, EC; Comstock, RD				Bartley, Justin H.; Murray, Monica F.; Kraeutler, Matthew J.; Pierpoint, Lauren A.; Welton, K. Linnea; McCarty, Eric C.; Comstock, R. Dawn			Epidemiology of Injuries Sustained as a Result of Intentional Player Contact in High School Football, Ice Hockey, and Lacrosse: 2005-2006 Through 2015-2016	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						High School RIO; injury; football; ice hockey; lacrosse	UNITED-STATES; SURVEILLANCE SYSTEM; ACADEMIC YEARS; SOCCER; RISK	Background: Lacrosse and ice hockey are quickly growing in popularity, while football remains the most popular sport among high school student-athletes. Injuries remain a concern, given the physical nature of these contact sports. Purpose: To describe the rates and patterns of injuries sustained as a result of intentional player contact in United States high school boys' football, ice hockey, and lacrosse. Study Design: Descriptive epidemiology study. Methods: We conducted a secondary analysis of High School RIO (Reporting Information Online) data, including exposure and injury data collected from a large sample of high schools in the United States from 2005-2006 through 2015-2016. Data were analyzed to calculate rates, assess patterns, and evaluate potential risk factors for player-to-player contact injuries. Results: A total of 34,532 injuries in boys' football, ice hockey, and lacrosse occurred during 9,078,902 athlete-exposures (AEs), for a rate of 3.80 injuries per 1000 AEs in the 3 contact sports of interest. The risk of injuries was found to be greater in competition compared with practice for all 3 sports, with the largest difference in ice hockey (rate ratio, 8.28) and the smallest difference in lacrosse (rate ratio, 3.72). In all 3 contact sports, the most commonly injured body site in competition and practice caused by both tackling/checking and being tackled/checked was the head/face. However, a significantly greater proportion of concussions sustained in football were the result of tackling compared with being tackled (28.2% vs 24.1%, respectively). In addition, a significantly greater proportion of concussions were sustained in competition compared with practice for all 3 sports. Conclusion: This study is the first to collectively compare injury rates and injury patterns sustained from intentional player-to-player contact in boys' high school football, ice hockey, and lacrosse. Notably, there was a relatively high risk of injuries and concussions during football practices.	[Bartley, Justin H.; Murray, Monica F.; Kraeutler, Matthew J.; Pierpoint, Lauren A.; Welton, K. Linnea; McCarty, Eric C.; Comstock, R. Dawn] Univ Colorado, Sch Med, Invest Performed CU Sports Med & Performance Ctr, Dept Orthoped, Boulder, CO 80309 USA; [Murray, Monica F.; Pierpoint, Lauren A.; Comstock, R. Dawn] Seton Hall Hackensack Meridian Sch Med, Dept Orthopaed Surg, 400 South Orange Ave, S Orange, NJ 07079 USA; [Murray, Monica F.; Welton, K. Linnea; McCarty, Eric C.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Murray, Monica F.; Pierpoint, Lauren A.; Comstock, R. Dawn] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA		Kraeutler, MJ (corresponding author), Seton Hall Hackensack Meridian Sch Med, Dept Orthopaed Surg, 400 South Orange Ave, S Orange, NJ 07079 USA.	matthewkraeutlermd@gmail.com	mccarty, eric/AAA-1821-2019	mccarty, eric/0000-0002-8948-5862	Biomet; Mitek; Smith Nephew; Stryker; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01, R49/CE002106-01]; NFHS; NOCSAE; DonJoy Orthotics; EyeBlack; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001172, R49CE000674, R49CE002106] Funding Source: NIH RePORTER	The content of this study is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. One or more of the authors has declared the following potential conflict of interest or source of funding: E.C.M. receives royalties from Biomet and Elsevier; is a paid consultant for Biomet; and receives research support from Biomet, Mitek, Smith & Nephew, and Stryker. The HS RIO surveillance study was funded in part by the Centers for Disease Control and Prevention (grant Nos. R49/CE000674-01, R49/CE001172-01, R49/CE002106-01) as well as research funding contributions of the NFHS, NOCSAE, DonJoy Orthotics, and EyeBlack.	Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Currie DW, 2017, AM J SPORT MED, V45, P3368, DOI 10.1177/0363546517725068; Dick R, 2007, J ATHL TRAINING, V42, P255; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Froholdt A, 2009, AM J SPORT MED, V37, P1155, DOI 10.1177/0363546508330132; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Kraeutler MJ, 2018, SPORTS HEALTH, V10, P85, DOI 10.1177/1941738117709764; Latinis B, 1983, Issues Compr Pediatr Nurs, V6, P167, DOI 10.3109/01460868309062485; Matic GT, 2015, PHYSICIAN SPORTSMED, V43, P119, DOI 10.1080/00913847.2015.1035210; National Federation of State High School Associations, HIGH SCH SPORTS PART; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Tirabassi J, 2016, AM J SPORT MED, V44, P2925, DOI 10.1177/0363546516644604; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914	16	7	7	2	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	DEC 12	2017	5	12							2325967117740887	10.1177/2325967117740887			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FP7ZK	WOS:000417858600001	29270440	gold, Green Published			2022-02-06	
J	Duan, L; Di, Q				Duan, Lei; Di, Qing			Acetazolamide Suppresses Multi-Drug Resistance-Related Protein 1 and P-Glycoprotein Expression by Inhibiting Aquaporins Expression in a Mesial Temporal Epilepsy Rat Model	MEDICAL SCIENCE MONITOR			English	Article						Acetazolamide; Aquaporins; Epilepsy, Temporal Lobe; Tuberculosis, Multidrug-Resistant	TRAUMATIC BRAIN-INJURY; LOBE EPILEPSY; REFRACTORY EPILEPSY; DRUG-RESISTANCE; HIPPOCAMPAL SCLEROSIS; PILOCARPINE MODEL; FOCAL EPILEPSY; EDEMA; FLUID; GENES	Background: Mesial temporal epilepsy (MTLE) is the most common type of focal epilepsy in adults, and is often drug-resistant. This study investigated the effects of aquaporins (AQP) inhibitor on multi-drug-resistant protein expression in an MTLE rat model. Material/Methods: The MTLE rat model was established by injecting pilocarpine into rats. The MTLE rats were divided into an MTLE-6 h group, an MTLE-12 h group, and an MTLE-24 h group, together with a normal saline group (NS), to examine the AQP4 expression by using Western blot assay and immunohistochemistry assay. The other 18 MTLE model rats were used to observe the effects of the AQP4 inhibitor, acetazolamide, on the multi-drug-resistant protein 1 (MRP1) and P-glycoprotein (Pgp) by using Western blot and immunohistochemistry assays, respectively. Results: AQP4 expression was enhanced in hippocampal tissues of MTLE model rats compared to NS rats (P<0.05). More positively stained AQP4 was discovered in hippocampal tissues of MTLE model rats. AQP4 inhibitor significantly decreased multi-drug-resistant protein MRP1 and Pgp expression in the AQP4 inhibitor Interfere group and the AQP4 inhibitor Therapy group compared to the TMLE model group (P<0.05). Conclusions: The present findings confirm that the AQP4 inhibitor, acetazolamide, effectively inhibits the multi-drug-resistant protein, MRP1, and Pgp, in the MTLE rat model.	[Duan, Lei; Di, Qing] Nanjing Med Univ, Nanjing Brain Hosp, Nanjing, Jiangsu, Peoples R China		Di, Q (corresponding author), Nanjing Med Univ, Nanjing Brain Hosp, Nanjing, Jiangsu, Peoples R China.	diqing@medmail.com.cn					Alvestad S, 2013, EPILEPSY RES, V105, P30, DOI 10.1016/j.eplepsyres.2013.01.006; Ameli PA, 2012, ACTA NEUROCHIR SUPPL, V113, P59, DOI 10.1007/978-3-7091-0923-6_13; Baik EJ, 1999, BRAIN RES, V843, P118, DOI 10.1016/S0006-8993(99)01797-7; Balan S, 2013, GENE, V526, P449, DOI 10.1016/j.gene.2013.05.067; Bebek N, 2013, J CLIN NEUROSCI, V20, P1564, DOI 10.1016/j.jocn.2012.12.023; Chen JQ, 2016, MED SCI MONITOR, V22, DOI 10.12659/MSM.898190; Chen L, 2013, J MOL NEUROSCI, V51, P1, DOI 10.1007/s12031-012-9935-x; Chen YH, 2013, ACTA PHARMACOL SIN, V34, P473, DOI 10.1038/aps.2012.183; Nguyen DK, 2015, EPILEPSIA, V56, P1098, DOI 10.1111/epi.13042; Dixit AB, 2016, GENOMICS, V107, P178, DOI 10.1016/j.ygeno.2016.04.001; Dombrowski SM, 2001, EPILEPSIA, V42, P1501, DOI 10.1046/j.1528-1157.2001.12301.x; Eid T, 2005, P NATL ACAD SCI USA, V102, P1193, DOI 10.1073/pnas.0409308102; Feldmann M, 2012, EPILEPSIA, V53, P60, DOI 10.1111/j.1528-1167.2012.03704.x; Garcia-Hernandez A, 2010, EXP NEUROL, V222, P86, DOI 10.1016/j.expneurol.2009.12.010; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; Hsu MS, 2007, NEURON GLIA BIOL, V3, P287, DOI 10.1017/S1740925X08000112; Jin HB, 2016, MED SCI MONITOR, V22, P678, DOI 10.12659/MSM.897201; Jin SH, 2015, EPILEPSIA, V56, P772, DOI 10.1111/epi.12966; Kahane P, 2010, EPILEPSIA, V51, P59, DOI 10.1111/j.1528-1167.2009.02448.x; Katada R, 2012, AM J PATHOL, V180, P17, DOI 10.1016/j.ajpath.2011.09.011; Kutsy RL, 1999, J NEUROL SCI, V166, P1, DOI 10.1016/S0022-510X(99)00107-0; Lee EM, 2012, EPILEPSIA, V53, P860, DOI 10.1111/j.1528-1167.2012.03432.x; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Medici V, 2011, BRAIN RES, V1367, P330, DOI 10.1016/j.brainres.2010.10.005; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; Pedersen M, 2015, NEUROIMAGE-CLIN, V8, P536, DOI 10.1016/j.nicl.2015.05.009; RACINE R, 1972, ELECTROEN CLIN NEURO, V32, P295, DOI 10.1016/0013-4694(72)90178-2; Regesta G, 1999, EPILEPSY RES, V34, P109, DOI 10.1016/S0920-1211(98)00106-5; Shi WZ, 2012, NEUROSCI BULL, V28, P680, DOI 10.1007/s12264-012-1281-z; Shi ZF, 2015, BIOMED ENVIRON SCI, V28, P199, DOI 10.3967/bes2015.026; Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002; Sisodiya SM, 2003, CURR OPIN NEUROL, V16, P197, DOI 10.1097/00019052-200304000-00013; Song YC, 2015, ASIAN PAC J TROP MED, V8, P791, DOI 10.1016/j.apjtm.2015.09.006; Song ZX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119296; Soussi R, 2015, BRAIN STRUCT FUNCT, V220, P2449, DOI 10.1007/s00429-014-0800-2; Sturdivant NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33330; Sun YQ, 2016, INT J NEUROSCI, V126, P308, DOI 10.3109/00207454.2015.1015724; Tang XH, 2013, CHINESE MED J-PEKING, V126, P1900, DOI 10.3760/cma.j.issn.0366-6999.20122710; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; van der Deen M, 2006, VIRCHOWS ARCH, V449, P682, DOI 10.1007/s00428-006-0240-3; Wieser HG, 2004, EPILEPSIA, V45, P32; Yu WH, 2014, J MOL NEUROSCI, V54, P1, DOI 10.1007/s12031-014-0237-3	44	7	8	2	14	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	DEC 8	2017	23						5818	5825		10.12659/MSM.903855			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FP9GH	WOS:000417955000001	29217817	Green Submitted, Green Published			2022-02-06	
J	Mohammadipour, A; Alemi, A				Mohammadipour, Amir; Alemi, Alireza			Micromechanical analysis of brain's diffuse axonal injury	JOURNAL OF BIOMECHANICS			English	Article						Lattice; Traumatic brain injury; Diffuse axonal injury; Diffusion tensor imaging; Micromechanics; Finite element	WHITE-MATTER; TISSUE; TENSOR; ORIENTATION; COMPUTATION; ANISOTROPY; BEHAVIOR; FRACTURE; MODELS; STRAIN	Computational models are important tools which help researchers understand traumatic brain injury (TBI). A mechanistic multi-scale numerical approach is introduced to quantify diffuse axonal injury (DAI), the most important mechanism of TBI, induced by a mechanical insult at micro-scale regions of the white matter or voxels where fiber orientations are the same. Using the mechanical properties of a single axon with a viscoelastic constitutive relation and its functional failure in terms of electrophysio-logical impairment, a numerical 2D micro-level lattice method is implemented to directly analyze the percentage of injured axons in a voxel containing a bundle of axons all with the same orientation under biaxial stretches. Reference micro-injury maps are then developed with the input parameters based on the principal strain or stretch values and their direction with respect to axons, which provide the percentage of injured axons in the voxel of interest as the output. The methodology is independent of any statistical analyses of the accident data and medical reports to derive probabilistic injury risk curves for DAI. Avoiding a structurally detailed full finite element head model, this study proposes a micro mechanical approach which considers the anatomical structure of neural axons in the white matter together with their mechanical properties using a numerical lattice method to analyze the brain's diffuse axonal injury. This work has the potential to help develop safer prevention tools and more effective diagnosis methods for DAI. (C) 2017 Elsevier Ltd. All rights reserved.	[Mohammadipour, Amir] Univ Houston, Dept Civil & Environm Engn, 4726 Calhoun Rd,Room N107, Houston, TX 77204 USA; [Alemi, Alireza] ENS, Lab Neurosci Cognit, Grp Neural Theory, 29 Rue Ulm, F-75005 Paris, France		Mohammadipour, A (corresponding author), Univ Houston, Dept Civil & Environm Engn, 4726 Calhoun Rd,Room N107, Houston, TX 77204 USA.; Mohammadipour, A (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Ct, Davis, CA 95618 USA.	amohammadipour@uh.edu; alireza.alemi@ens.fr	Alemi, Alireza/AAM-1076-2020	Alemi, Alireza/0000-0002-5811-775X			Alberts B., 2002, MOL BIOL CELL, V4th; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Bartsch H, 2012, BRAIN CONNECT, V2, P284, DOI 10.1089/brain.2012.0096; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bernal R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018301; Bolander JE, 1998, ENG FRACT MECH, V61, P569, DOI 10.1016/S0013-7944(98)00069-1; Chinn B., 2001, COST 327 MOTORCYCLE; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Deck C, 2008, P 7 EUR LS DYNA C; DENNERLL TJ, 1989, J CELL BIOL, V109, P3073, DOI 10.1083/jcb.109.6.3073; Dyson RJ, 2016, J MATH BIOL, V72, P1775, DOI 10.1007/s00285-015-0927-7; Efremov Y.M., 2011, ACTA NAT, V33, P10; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng Y, 2017, J MECH BEHAV BIOMED, V65, P490, DOI 10.1016/j.jmbbm.2016.09.020; Feng Y, 2016, J MECH BEHAV BIOMED, V61, P554, DOI 10.1016/j.jmbbm.2016.04.024; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Heidemann RM, 2012, NEUROIMAGE, V60, P967, DOI 10.1016/j.neuroimage.2011.12.081; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Herkowitz H.N, 2011, ROTHMAN SIMEONE SPLI, V1; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hosey R. R., 1982, FINITE ELEMENTS BIOM, P379; HRENNIKOFF A, 1941, J APPL MECH, V8, P169; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kang H.S., 1997, VALIDATION 3D ANATOM; Karami G, 2009, J MECH BEHAV BIOMED, V2, P243, DOI 10.1016/j.jmbbm.2008.08.003; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Liu WJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121250; MATLAB, 2014, MATLAB VERS 8 3 0 53; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; Mendis K, 1992, THESIS; Mohammadipour A, 2015, THESIS; Mohammadipour A, 2016, 9 INT C FRACT MECH C, P1; Mohammadipour A, 2017, J APPL MECH-T ASME, V84, DOI 10.1115/1.4035181; Mohammadipour A, 2017, INT J SOLIDS STRUCT, V106, P152, DOI 10.1016/j.ijsolstr.2016.11.024; Mohammadipour A, 2016, J APPL MECH-T ASME, V83, DOI 10.1115/1.4033306; Mohammadipour A, 2016, THEOR APPL FRACT MEC, V82, P152, DOI 10.1016/j.tafmec.2016.01.002; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Pan Y, 2011, MRS P, V1301, P87; Pan Yi, 2013, Front Bioeng Biotechnol, V1, P19, DOI 10.3389/fbioe.2013.00019; Patton D. A., 2014, THESIS; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Prange M T, 2000, Stapp Car Crash J, V44, P205; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Shugar T, 1977, FINITE ELEMENT HEAD; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Takhounts EG, 2008, STAPP CAR C, V52, P1; Van Mier J.G.M., 2012, CONCRETE FRACTURE MU; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Ward C. C., 1975, DEV DETAILED FINITE; Ward CC., 1977, INTRACRANIAL PRESSUR; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1	57	7	7	0	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	DEC 8	2017	65						61	74		10.1016/j.jbiomech.2017.09.029			14	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	FP5NE	WOS:000417665400007	29074287				2022-02-06	
J	Park, J; Masaki, T; Mezaki, Y; Yokoyama, H; Nakamura, M; Maehashi, H; Fujimi, TJ; Gouraud, SS; Nagatsuma, K; Nakagomi, M; Kimura, N; Matsuura, T				Park, Jonghyuk; Masaki, Takahiro; Mezaki, Yoshihiro; Yokoyama, Hiroshi; Nakamura, Mariko; Maehashi, Haruka; Fujimi, Takahiko J.; Gouraud, Sabine S.; Nagatsuma, Keisuke; Nakagomi, Madoka; Kimura, Naofumi; Matsuura, Tomokazu			Alpha-1 antichymotrypsin is involved in astrocyte injury in concert with arginine-vasopressin during the development of acute hepatic encephalopathy	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; TRAUMATIC BRAIN-INJURY; AQUAPORIN-4 EXPRESSION; ALZHEIMERS-DISEASE; HEPATOCELLULAR-CARCINOMA; PORTACAVAL ANASTOMOSIS; CULTURED ASTROCYTES; EDEMA; AMMONIA; ALPHA-1-ANTICHYMOTRYPSIN	Background and aims We developed a bio-artificial liver (BAL) using a radial-flow bioreactor and rescued mini-pig models with lethal acute liver failure (ALF). The point of the rescue is the recovery from hepatic encephalopathy (HE). HE on ALF has sometimes resulted in brain death following brain edema with astrocyte swelling. Several factors, including ammonia and glutamine, have been reported to induce astrocyte swelling and injury. However, many clinicians believe that there are any other factors involved in the development of HE. Therefore, the aim of this study was to identify novel HE-inducible factors, particularly those inducing astrocyte dysfunction. Methods Mini-pig plasma samples were collected at three time points: before the administration of toxins (a-amanitin and LPS), when HE occurred after the administration of toxins, and after treatment with extracorporeal circulation (EC) by the BAL. To identify the causative factors of HE, each plasma sample was subjected to a comparative proteome analysis with two-dimensional gel electrophoresis and mass spectrometry. To assess the direct effects of candidate factors on the astrocyte function and injury, in vitro experiments with human astrocytes were performed. Results Using a proteome analysis, we identified alpha-1 antichymotrypsin (ACT), which was increased in plasma samples from mini-pigs with HE and decreased in those after treatment with EC by BAL. In in vitro experiments with human astrocytes, ACT showed growth-inhibitory and cytotoxic effects on astrocytes. In addition, the expression of water channel protein aquaporin-4, which is induced in injured astrocytes, was increased following ACT treatment. Interestingly, these effects of ACT were additively enhanced by adding argininevasopressin (AVP) and were canceled by adding an AVP receptor antagonist. Conclusions These results suggest that ACT is involved in astrocyte injury and dysfunction in concert with AVP during the development of acute HE.	[Park, Jonghyuk; Masaki, Takahiro; Mezaki, Yoshihiro; Yokoyama, Hiroshi; Nakamura, Mariko; Maehashi, Haruka; Nagatsuma, Keisuke; Matsuura, Tomokazu] Jikei Univ, Sch Med, Dept Lab Med, Minato Ku, Tokyo, Japan; [Fujimi, Takahiko J.] Bunkyo Univ, Fac Hlth & Nutr, Chigasaki, Kanagawa, Japan; [Gouraud, Sabine S.] Ochanomizu Univ, Fac Sci, Dept Biol, Bunkyo Ku, Tokyo, Japan; [Nakagomi, Madoka] Hatano Res Inst, Food & Drug Safety Ctr, Kanagawa, Japan; [Kimura, Naofumi] Jikei Univ, Sch Med, Dept Pharmacol, Minato Ku, Tokyo, Japan		Matsuura, T (corresponding author), Jikei Univ, Sch Med, Dept Lab Med, Minato Ku, Tokyo, Japan.	matsuurat@jikei.ac.jp	Gouraud, Sabine S. S/N-3395-2018	Gouraud, Sabine S. S/0000-0002-4917-0647; Fujimi, Takahiko/0000-0003-1768-9695; Yokoyama, Hiroshi/0000-0003-4559-030X; Mezaki, Yoshihiro/0000-0003-4914-0541	Jikei University Research Fund for Graduate Students; Otsuka Toshimi Scholarship FoundationOtsuka Pharmaceutical; Atsumi International Foundation; Japan Agency for Medical Research and DevelopmentJapan Agency for Medical Research and Development (AMED) [17fk0310112h0001]	This work was supported by the Jikei University Research Fund for Graduate Students and Otsuka Toshimi Scholarship Foundation and Atsumi International Foundation, and the Research on the Innovative Development and the Practical Application of New Drugs for Hepatitis B (principal investigator: Soichi Kojima;17fk0310112h0001) provided by Japan Agency for Medical Research and Development.	Abraham CR, 2001, NEUROBIOL AGING, V22, P931, DOI 10.1016/S0197-4580(01)00302-5; Aldridge DR, 2015, J CLIN EXP HEPATOL, V5, pS7, DOI 10.1016/j.jceh.2014.06.004; Asai H, 2013, CELL MOL NEUROBIOL, V33, P393, DOI 10.1007/s10571-013-9905-z; Baker C, 2007, FRONT BIOSCI, V12, P2821, DOI 10.2741/2275; Braghin E, 2009, NEUROSCI LETT, V467, P40, DOI 10.1016/j.neulet.2009.09.057; Chung CH, 2003, J HEPATOL, V39, P193, DOI 10.1016/S0168-8278(03)00185-5; Ciecko-Michalska I, 2012, GASTROENT RES PRACT, V2012; Cordoba J, 1998, J HEPATOL, V29, P589, DOI 10.1016/S0168-8278(98)80154-2; Decaux G, 2008, LANCET, V371, P1624, DOI 10.1016/S0140-6736(08)60695-9; Ding T, 2011, INT J ONCOL, V38, P1521, DOI 10.3892/ijo.2011.983; Ferrin G, 2014, LIVER INT, V34, P438, DOI 10.1111/liv.12277; Ianni Manuela, 2010, Immun Ageing, V7 Suppl 1, pS6, DOI 10.1186/1742-4933-7-S1-S6; Iwasa M, 2015, HEPATOL RES, V45, P1155, DOI 10.1111/hepr.12495; Jia SW, 2016, J STROKE CEREBROVASC, V25, P1289, DOI 10.1016/j.jstrokecerebrovasdis.2016.02.002; Kanai H, 2007, ARTIF ORGANS, V31, P148, DOI 10.1111/j.1525-1594.2007.00354.x; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Liang FY, 2015, NEUROSCI LETT, V598, P29, DOI 10.1016/j.neulet.2015.05.006; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; Mehta PD, 2001, NEUROSCI LETT, V304, P102, DOI 10.1016/S0304-3940(01)01754-2; Mihara T, 1999, BRAIN RES BULL, V49, P343, DOI 10.1016/S0361-9230(99)00064-7; Montana V, 2014, CURR NEUROPHARMACOL, V12, P324, DOI 10.2174/1570159X12666140903094700; Padmanabhan J, 2006, BRAIN, V129, P3020, DOI 10.1093/brain/awl255; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Rabinstein AA, 2010, CURR TREAT OPTION NE, V12, P129, DOI 10.1007/s11940-010-0062-0; Rao KVR, 2007, METAB BRAIN DIS, V22, P265, DOI 10.1007/s11011-007-9063-4; Rao KVR, 2014, NEUROBIOL DIS, V63, P222, DOI 10.1016/j.nbd.2013.11.018; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Rao KVR, 2010, J NEUROPATH EXP NEUR, V69, P869, DOI 10.1097/NEN.0b013e3181ebe581; Rao KVR, 2003, NEUROREPORT, V14, P2379, DOI 10.1097/01.wnr.0000099610.19426.a6; Rauen K, 2013, J NEUROTRAUM, V30, P1442, DOI 10.1089/neu.2012.2807; Ritchie A, 2004, MOL BRAIN RES, V131, P88, DOI 10.1016/j.molbrainres.2004.08.012; Tan XF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-274; Thumburu KK, 2014, J NEUROCHEM, V128, P617, DOI 10.1111/jnc.12511; Wendon J, 2008, NEUROCRIT CARE, V9, P97, DOI 10.1007/s12028-008-9123-6; Wijdicks EFM, 2016, NEW ENGL J MED, V375, P1660, DOI 10.1056/NEJMra1600561; Yang MH, 2007, ANAL BIOANAL CHEM, V388, P637, DOI 10.1007/s00216-007-1263-6; Yang W, 2012, MOL CELL NEUROSCI, V49, P406, DOI 10.1016/j.mcn.2012.02.002; Yi MH, 2013, CELL MOL NEUROBIOL, V33, P223, DOI 10.1007/s10571-012-9889-0; Yin C, 2017, RES VET SCI, V111, P140, DOI 10.1016/j.rvsc.2017.02.016; Zhang B, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-30; Zhang R, 2014, BRAIN RES, V1583, P23, DOI 10.1016/j.brainres.2014.08.016	42	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189346	10.1371/journal.pone.0189346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	WOS:000417337800120	29216295	gold, Green Submitted, Green Published			2022-02-06	
J	Albrecht, JS; O'Hara, LM; Moser, KA; Mullins, CD; Rao, V				Albrecht, Jennifer S.; O'Hara, Lyndsay M.; Moser, Kara A.; Mullins, C. Daniel; Rao, Vani			Perception of Barriers to the Diagnosis and Receipt of Treatment for Neuropsychiatric Disturbances After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							MEDICARE BENEFICIARIES; DEPRESSION	Objective: To explore perceptions of barriers and facilitators to the diagnosis and receipt of treatment for neuropsychiatric disturbances (NPDs) after traumatic brain injury (TBI). Design: Qualitative study using semistructured interviews and focus groups. Setting: A clinic specializing in the treatment of TBI NPDs, an urban trauma center, and a large urban academic hospital. Participants: A sample (N=33) of health care providers (n=10) who treat individuals with TBI, persons with TBI (n=18), and caregivers (n = 5). Interventions: Not applicable. Main Outcome Measures: Topic guides for the interviews and focus groups were guided by previous literature, clinical experience, and the goals of the project and focused on the 3 most common TBI NPDs: depression, anxiety, and posttraumatic stress disorder. The interviews and focus groups were audio-recorded and transcribed verbatim. We performed a conventional content analysis on the transcripts and grouped concepts into overall themes, incorporating feedback from stakeholders. Results: Patient education, insurance, provider type, time since TBI, caregiver support, and recognition or screening for TBI NPDs were the most frequently mentioned barriers or facilitators to the diagnosis and treatment of TBI NPDs by both interview and focus group participants. We grouped these and other frequently mentioned concepts into 3 broad themes: education, access, and support. Each of these themes is explored in depth and supported with direct quotations. Conclusions: This study explored patient, caregiver, and health care provider and identified barriers and facilitators to the diagnosis and receipt of treatment for TBI NPDs. Barriers included poor provider education on TBI NPDs and limited access to care due to lack of insurance, transportation, and income. Facilitators included patient education on TBI NPDs and strong caregiver support. Future studies should develop and pilot interventions aimed at quality of care that address the identified barriers and facilitators. (C) 2017 by the American Congress of Rehabilitation Medicine	[Albrecht, Jennifer S.; O'Hara, Lyndsay M.; Moser, Kara A.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA; [Mullins, C. Daniel] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Rao, Vani] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA		Albrecht, JS (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA.	jalbrecht@epi.umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274; Mullins, C. Daniel/0000-0003-4322-2490	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1K01HS024560]; Department of DefenseUnited States Department of Defense [W81XWH-13-1-0469]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560] Funding Source: NIH RePORTER	Supported by the Agency for Healthcare Research and Quality (grant no. 1K01HS024560) and the Department of Defense (grant no. W81XWH-13-1-0469).	Albrecht JS, 2017, AM J GERIAT PSYCHIAT, V25, P415, DOI 10.1016/j.jagp.2016.11.018; Albrecht JS, 2015, J NEUROTRAUM, V32, P1223, DOI 10.1089/neu.2014.3651; Bishop TF, 2014, JAMA-J AM MED ASSOC, V71, P76; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Faul M, 2010, TRAUMATIC BRAIN INJU; Fujii DE, 2014, PSYCHIAT CLIN N AM, V37, P113, DOI 10.1016/j.psc.2013.11.006; Hansen LO, 2013, J HOSP MED, V8, P421, DOI 10.1002/jhm.2054; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547	27	7	7	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2017	98	12					2548	2552		10.1016/j.apmr.2017.06.007			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FO5FK	WOS:000416878700027	28688786	Green Accepted			2022-02-06	
J	Genrikhs, EE; Voronkov, DN; Kapkaeva, MR; Isaev, NK; Stelmashook, EV				Genrikhs, E. E.; Voronkov, D. N.; Kapkaeva, M. R.; Isaev, N. K.; Stelmashook, E. V.			Focal Unilateral Traumatic brain injury Causes Delayed Neurodegenerative Changes in the Brain of Rats	BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						traumatic brain injury; alpha-synuclein; APP protein	GLUTAMINE-SYNTHETASE; ALZHEIMERS-DISEASE; IMPAIRMENT; ISCHEMIA	A cascade of pathological changes in the intact hemisphere developed in rats 6 months after focal unilateral traumatic brain injury: neuronal degeneration, hyperexpression of alpha-synuclein, APP (beta-amyloid peptide precursor) protein, and glutamine synthetase in cells other than astrocytes. The development of these changes in the contralateral hemisphere indicated the emergence of extensive delayed neurodegenerative processes in the brain after traumatic brain injury, which were characteristic of diseases associated with pathological aging.	[Genrikhs, E. E.; Voronkov, D. N.; Kapkaeva, M. R.; Isaev, N. K.; Stelmashook, E. V.] Moscow MV Lomonosov State Univ, Res Ctr Neurol, Moscow, Russia; [Isaev, N. K.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Isaev, N. K.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia		Stelmashook, EV (corresponding author), Moscow MV Lomonosov State Univ, Res Ctr Neurol, Moscow, Russia.	estelmash@mail.ru	Genrikhs, Elizaveta E/C-3854-2012; Kapkaeva, Marina/AAO-1646-2020; Stelmashook, Elena V/B-4442-2012; Isaev, Nikolay K/B-4194-2012; Voronkov, Dmitry N/B-3910-2012	Voronkov, Dmitry N/0000-0001-5222-5322; Genrikhs, Elizaveta/0000-0002-3203-0250; Kapkaeva, Marina/0000-0002-2833-2897	Russian Science FoundationRussian Science Foundation (RSF) [16-15-10108]	The study was supported by the Russian Science Foundation (grant No. 16-15-10108).	Davis A E, 2000, Crit Care Nurs Q, V23, P1; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Genrikhs EE, 2015, J DRUG TARGET, V23, P347, DOI 10.3109/1061186X.2014.997736; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; Robinson SR, 2000, NEUROCHEM INT, V36, P471, DOI 10.1016/S0197-0186(99)00150-3; Robinson SR, 2001, J NEUROSCI RES, V66, P972, DOI 10.1002/jnr.10057; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Silachev DN, 2009, B EXP BIOL MED+, V147, P269, DOI 10.1007/s10517-009-0489-z; Stelmashook EV, 2015, INT J NEUROSCI, V125, P375, DOI 10.3109/00207454.2014.935376	13	7	7	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4888	1573-8221		B EXP BIOL MED+	Bull. Exp. Biol. Med.	DEC	2017	164	2					211	213		10.1007/s10517-017-3960-2			3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FO4GQ	WOS:000416800400024	29177900				2022-02-06	
J	Li, J; Zhao, C; Rao, JS; Yang, FX; Wang, ZJ; Lei, JF; Yang, ZY; Li, XG				Li, Jing; Zhao, Can; Rao, Jia-Sheng; Yang, Fei-Xiang; Wang, Zhan-Jing; Lei, Jian-Feng; Yang, Zhao-Yang; Li, Xiao-Guang			Structural and metabolic changes in the traumatically injured rat brain: high-resolution in vivo proton magnetic resonance spectroscopy at 7 T	NEURORADIOLOGY			English	Article						Traumatic brain injury; Diffusion tensor imaging; Proton magnetic resonance spectroscopy; Rat	DIFFUSION TENSOR TRACTOGRAPHY; PATHOLOGICAL CORRELATION; AXONAL DAMAGE; MOUSE MODEL; MRI; MODERATE; REPAIR	The understanding of microstructural and metabolic changes in the post-traumatic brain injury is the key to brain damage suppression and repair in clinics. Ten female Wistar rats were traumatically injured in the brain CA1 region and above the cortex. Next, diffusion tensor magnetic resonance imaging (DTI) and proton magnetic resonance spectroscopy (H-1 MRS) were used to analyze the microstructural and metabolic changes in the brain within the following 2 weeks. Anisotropy fraction (FA) and axial diffusivity (AD) of the corpus callosum (CC) began to decrease significantly at day 1, whereas radial diffusivity (RD) significantly increased immediately after injury, reflecting the loss of white matter integrity. Compared with day 3, RD decreased significantly at day 7, implicating the angioedema reduction. In the hippocampus, FA significantly increased at day 7; the choline-containing compounds (Cho) and myo-inositol (MI) remarkably increased at day 7 compared with those at day 3, indicating the proliferation of astrocytes and radial glial cells after day 7. No significant differences between DTI and H-1 MRS parameters were observed between day 1 and day 3. Day 1-3 after traumatic brain injury (TBI) may serve as a relatively appropriate time window for treatment planning and the following nerve repair.	[Li, Jing; Zhao, Can; Rao, Jia-Sheng; Li, Xiao-Guang] Beihang Univ, Beijing Key Lab Biomat & Neural Regenerat, Sch Biol Sci & Med Engn, Beijing, Peoples R China; [Yang, Fei-Xiang; Yang, Zhao-Yang; Li, Xiao-Guang] Capital Med Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China; [Wang, Zhan-Jing; Lei, Jian-Feng] Capital Med Univ, Med Expt & Test Ctr, Beijing 100069, Peoples R China		Li, XG (corresponding author), Beihang Univ, Beijing Key Lab Biomat & Neural Regenerat, Sch Biol Sci & Med Engn, Beijing, Peoples R China.; Li, XG (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China.	bhbmeuniversity@gmail.com		Rao, Jia-Sheng/0000-0002-5196-0912; Li, Xiao-Guang/0000-0002-6557-9688	Special Funds for Beijing Base Construction & Talent Cultivation [Z171100002217066]; Double First-Rate Special Funds of Beihang University [ZG216S17C8]; State Key Program of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31320103903, 31271037]; International Science & Technology Cooperation Program of China [2014DFA30640]; the 111 ProjectMinistry of Education, China - 111 Project [B13003]	This work was funded by the Special Funds for Beijing Base Construction & Talent Cultivation (Grant no. Z171100002217066), the Double First-Rate Special Funds of Beihang University (Grant no. ZG216S17C8), the State Key Program of the National Natural Science Foundation of China (Grants nos. 31320103903 and 31271037), the International Science & Technology Cooperation Program of China (Grant no. 2014DFA30640), and the 111 Project (Grant no. B13003).	Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Bates TE, 1996, NEUROREPORT, V7, P1397, DOI 10.1097/00001756-199605310-00014; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Chan KC, 2009, J MAGN RESON IMAGING, V29, P1013, DOI 10.1002/jmri.21736; Chan KC, 2009, EXP EYE RES, V88, P61, DOI 10.1016/j.exer.2008.10.002; Kumar BSH, 2014, NEUROSCIENCE, V275, P12, DOI 10.1016/j.neuroscience.2014.05.037; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; MANSOUR H, 1990, J NEUROSCI RES, V25, P300, DOI 10.1002/jnr.490250306; Mo LH, 2010, BIOMATERIALS, V31, P2184, DOI 10.1016/j.biomaterials.2009.11.078; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Rao JS, 2013, J NEURORADIOLOGY, V40, P181, DOI 10.1016/j.neurad.2012.08.008; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2004, NEUROBIOL DIS, V15, P640, DOI 10.1016/j.nbd.2003.12.003; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Tu TW, 2017, J NEUROTRAUM, V34, P248, DOI 10.1089/neu.2015.4355; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Tu TW, 2014, J NEUROPATH EXP NEUR, V73, P1152, DOI 10.1097/NEN.0000000000000140; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721; VIDEEN JS, 1995, J CLIN INVEST, V95, P788, DOI 10.1172/JCI117728; Wang SL, 2008, STROKE, V39, P2348, DOI 10.1161/STROKEAHA.107.509927; Xi GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028686; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zhao C., 2017, J MED PRIMATOL, P1; Zhao C, 2016, NEURORADIOLOGY, V58, P607, DOI 10.1007/s00234-016-1660-7; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	38	7	9	1	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	DEC	2017	59	12					1203	1212		10.1007/s00234-017-1915-y			10	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FM8DR	WOS:000415316300005	28856389				2022-02-06	
J	Marciniak, C; McAllister, P; Walker, H; Brashear, A; Edgley, S; Deltombe, T; Khatkova, S; Banach, M; Gul, F; Vilain, C; Picaut, P; Grandoulier, AS; Gracies, JM				Marciniak, Christina; McAllister, Peter; Walker, Heather; Brashear, Allison; Edgley, Steven; Deltombe, Thierry; Khatkova, Svetlana; Banach, Marta; Gul, Fatma; Vilain, Claire; Picaut, Philippe; Grandoulier, Anne-Sophie; Gracies, Jean-Michel		Int AbobotulinumtoxinA Adult	Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial	PM&R			English	Article							ASHWORTH SCALE; STROKE; RELIABILITY; PARESIS; PATHOPHYSIOLOGY; OVERACTIVITY; NEUROTOXIN; INTERRATER; DISABILITY; INJECTION	Objective: To assess the efficacy and safety of abobotulinumtoxinA in adults with upper limb spasticity previously treated with botulinum toxin A (BoNT-A). Design: A post hoc analysis from a Phase 3, prospective, double-blind, randomized, placebo-controlled study (NCT01313299). Setting: A total of 34 neurology or rehabilitation clinics in 9 countries. Participants: Adults aged 18-80 years with hemiparesis, >= 6 months after stroke or traumatic brain injury. This analysis focused on a subgroup of subjects with previous onabotulinumtoxinA or incobotulinumtoxinA treatment (n = 105 of 243 in the total trial population) in the affected limb. The mean age was 52 years, and 62% were male. Intervention: Study subjects were randomized 1: 1: 1 to receive a single injection session with abobotulinumtoxinA 500 or 1000 U or with placebo in the most hypertonic muscle group among the elbow, wrist, or finger flexors (primary target muscle group [PTMG]), and >= 2 additional muscle groups from the upper limb. Main Outcome Measurements: Efficacy and safety measures were assessed, including muscle tone (Modified Ashworth Scale [MAS] in the PTMG), Physician Global Assessment (PGA), perceived function, spasticity, active movement, and treatment-emergent adverse events. Results: At week 4, more subjects had >= 1 grade improvement in MAS for the PTMG with abobotulinumtoxinA versus placebo (abobotulinumtoxinA 500 U, 81.1%; abobotulinumtoxinA 1000 U, 75.0%; placebo, 25.0%). PGA scores >= 1 were achieved by 75.7% and 87.5% of abobotulinumtoxinA 500 and 1000 U subjects versus 41.7% with placebo. Perceived function (Disability Assessment Scale), spasticity angle (Tardieu Scale), and active movement were also improved with abobotulinumtoxinA. There were no treatment-related deaths or serious adverse events. Conclusions: The efficacy and safety of abobotulinumtoxinA in subjects previously treated with BoNT-A were consistent with those in the total trial population. Hence, abobotulinumtoxinA is a treatment option in these patients, and no difference in initial dosing appears to be required compared to that in individuals not treated previously.	[Marciniak, Christina] Shirley Ryan AbilityLab, 355 East Erie St, Chicago, IL 60611 USA; [Marciniak, Christina] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Med Sch, Chicago, IL 60611 USA; [Marciniak, Christina] Northwestern Univ, Dept Neurol, Feinberg Med Sch, Chicago, IL 60611 USA; [McAllister, Peter] New England Inst Neurol & Headache, Stamford, CT USA; [Walker, Heather] Univ N Carolina, Frank Porter Graham Child Dev Inst, Chapel Hill, NC USA; [Brashear, Allison] Wake Forest Univ, Dept Neurol, Baptist Med Ctr, Winston Salem, NC 27109 USA; [Edgley, Steven] Univ Utah, Sch Med, Div Phys Med & Rehabil, Salt Lake City, UT USA; [Deltombe, Thierry] Ctr Hosp Univ UCL Namur Site Mt Godinne, Serv Med Phys & Readaptat, Yvoir, Belgium; [Khatkova, Svetlana] Minist Hlth & Social Dev Russian Federat, Fed State Hosp, Treatments & Rehabil Ctr, Neurol Dept, Moscow, Russia; [Banach, Marta] Jagiellonian Univ, Med Coll, Dept Neurol, Krakow, Poland; [Gul, Fatma] Univ Texas Southwestern Med Ctr Dallas, Phys Med & Rehabil, Dallas, TX 75390 USA; [Vilain, Claire; Picaut, Philippe; Grandoulier, Anne-Sophie] Ipsen Innovat, Les Ulis, France; [Gracies, Jean-Michel] Univ Paris Est Creteil, Serv Reeduc Neurolocomotrice, Hop Univ Henri Mondor, EA BIOTN 7377, Creteil, France		Marciniak, C (corresponding author), Shirley Ryan AbilityLab, 355 East Erie St, Chicago, IL 60611 USA.; Marciniak, C (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Med Sch, Chicago, IL 60611 USA.; Marciniak, C (corresponding author), Northwestern Univ, Dept Neurol, Feinberg Med Sch, Chicago, IL 60611 USA.	cmarciniak@sralab.org	Boyer, Francois Constant/P-4544-2016	Boyer, Francois Constant/0000-0003-1035-9108; Vecchio, Michele/0000-0001-5254-3283; Marciniak, Christina/0000-0003-3300-0050; Lejeune, Thierry/0000-0001-5741-7753; Jech, Robert/0000-0002-9732-8947	IpsenIpsen	The authors thank Dr Timothy Ryder from Watermeadow Medical, funded by Ipsen, for editorial assistance in developing the manuscript.	Bhakta BB, 2000, J NEUROL NEUROSUR PS, V69, P217, DOI 10.1136/jnnp.69.2.217; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Brashear A, 2002, ARCH PHYS MED REHAB, V83, P1349, DOI 10.1053/apmr.2002.35474; Dashtipour K, 2015, AM J PHYS MED REHAB, V94, P229, DOI 10.1097/PHM.0000000000000208; Electronic Medicines Compendium, 2016, DYSP 300 UN SUMM PRO; Esquenazi A, 2013, TOXICON, V67, P115, DOI 10.1016/j.toxicon.2012.11.025; Foley N, 2013, ARCH PHYS MED REHAB, V94, P977, DOI 10.1016/j.apmr.2012.12.006; Gracies JM, 2010, EUR J PHYS REHAB MED, V46, P411; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Gracies JM, 2010, ARCH PHYS MED REHAB, V91, P421, DOI 10.1016/j.apmr.2009.11.017; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Ipsen Biopharm Ltd, 2016, DYSP FULL PRESCR INF; McCrory P, 2009, J REHABIL MED, V41, P536, DOI 10.2340/16501977-0366; Picelli A, 2014, CLIN REHABIL, V28, P232, DOI 10.1177/0269215513497735; Royal College of Physicians British Society of Rehabilitation Medicine Chartered Society of Physiotherapy, 2009, SPAST AD MAN US BOT; Sheean G, 2010, EUR J NEUROL, V17, P74, DOI 10.1111/j.1468-1331.2010.03129.x; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Suputtitada A, 2005, DISABIL REHABIL, V27, P176, DOI 10.1080/09638280400009360; Wissel J, 2009, J REHABIL MED, V41, P13, DOI 10.2340/16501977-0303	21	7	8	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	DEC	2017	9	12					1181	1190		10.1016/j.pmrj.2017.06.007			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FQ7CT	WOS:000418521100001	28625615	hybrid, Green Published			2022-02-06	
J	Sim, SY; Kim, HG; Yoon, SH; Choi, JW; Cho, SM; Choi, MS				Sim, Sook Young; Kim, Hyun Gi; Yoon, Soo Han; Choi, Jong Wook; Cho, Sung Min; Choi, Mi Sun			Reappraisal of Pediatric Diastatic Skull Fractures in the 3-Dimensional CT Era: Clinical Characteristics and Comparison of Diagnostic Accuracy of Simple Skull X-Ray, 2-Dimensional CT, and 3-Dimensional CT	WORLD NEUROSURGERY			English	Article						CT; Diagnosis; Diastatic fracture; Head trauma; Pediatric; Skull fracture	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; CHILDREN; INFANTS; SUTURE; BASE; COMPLICATIONS; ALGORITHM; IMAGES	BACKGROUND: Diastatic skull fractures (DSFs) in children are difficult to detect in skull radiographs before they develop into growing skull fractures; therefore, little information is available on this topic. However, recent advances in 3-dimensional (3D) computed tomography (CT) imaging technology have enabled more accurate diagnoses of almost all forms of skull fracture. The present study was undertaken to document the clinical characteristics of DSFs in children and to determine whether 3D CT enhances diagnostic accuracy. METHODS: Two hundred and ninety-two children younger than 12 years with skull fractures underwent simple skull radiography, 2-dimensional (2D) CT, and 3DCT. Results were compared with respect to fracture type, location, associated lesions, and accuracy of diagnosis. RESULTS: DSFs were diagnosed in 44 (15.7%) of children with skull fractures. Twenty-two patients had DSFs only, and the other 22 had DSFs combined with compound or mixed skull fractures. The most common fracture locations were the occipitomastoid (25%) and lambdoid (15.9%). Accompanying lesions consisted of subgaleal hemorrhages (42/44), epidural hemorrhages (32/44), pneumocephalus (17/44), and subdural hemorrhages (3/44). A total of 17 surgical procedures were performed on 15 of the 44 patients. Fourteen and 19 patients were confirmed to have DSFs by skull radiography and 2D CT, respectively, but 3D CT detected DSFs in 43 of the 44 children (P < 0.001). CONCLUSION: 3D CT was found to be markedly superior to skull radiography or 2D CT for detecting DSFs. This finding indicates that 3D CT should be used routinely rather than 2D CT for the assessment of pediatric head trauma.	[Sim, Sook Young; Choi, Mi Sun] Inje Univ, Dept Neurosurg, Seoul Paik Hosp, Seoul, South Korea; [Kim, Hyun Gi] Ajou Univ, Dept Radiol, Sch Med, Suwon, South Korea; [Yoon, Soo Han] Ajou Univ, Dept Neurosurg, Sch Med, Suwon, South Korea; [Choi, Jong Wook; Cho, Sung Min] Yonsei Univ, Dept Neurosurg, Wonju Severance Christian Hosp, Wonju Coll Med, Wonju, South Korea		Cho, SM (corresponding author), Yonsei Univ, Dept Neurosurg, Wonju Severance Christian Hosp, Wonju Coll Med, Wonju, South Korea.	ns1287@hanmail.net		Kim, Hyun Gi/0000-0002-0086-543X; Choi, Jongwook/0000-0003-2593-3870			Al-Otibi M, 2007, J NEUROSURG, V107, P508, DOI 10.3171/PED-07/12/508; Boice J. D. Jr., 2015, Annals of the ICRP, V44, P236, DOI 10.1177/0146645315575877; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Choudhary AK, 2010, SURG RADIOL ANAT, V32, P807, DOI 10.1007/s00276-010-0633-5; Connor SEJ, 2005, CLIN RADIOL, V60, P878, DOI 10.1016/j.crad.2005.04.003; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; FURUYA Y, 1984, J NEUROSURG, V61, P53, DOI 10.3171/jns.1984.61.1.0053; Glass RBJ, 2004, RADIOGRAPHICS, V24, P507, DOI 10.1148/rg.242035105; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; GROSSART K W, 1961, Clin Radiol, V12, P164, DOI 10.1016/S0009-9260(61)80003-2; Kim YI, 2012, J KOREAN NEUROSURG S, V52, P528, DOI 10.3340/jkns.2012.52.6.528; Li ZD, 2015, FORENSIC SCI INT, V255, P106, DOI 10.1016/j.forsciint.2015.07.012; Mann SS, 2000, NEUROIMAG CLIN N AM, V10, P1; Mitchell LA, 2011, AM J NEURORADIOL, V32, P1801, DOI 10.3174/ajnr.A2673; Mulroy MH, 2012, FORENSIC SCI INT, V214, P167, DOI 10.1016/j.forsciint.2011.07.050; Nimkin K, 2001, RADIOL CLIN N AM, V39, P843, DOI 10.1016/S0033-8389(05)70314-6; Ochalski PG, 2011, J NEUROSURG-PEDIATR, V7, P261, DOI 10.3171/2010.12.PEDS10190; Oh CK, 2010, MED HYPOTHESES, V74, P898, DOI 10.1016/j.mehy.2009.11.014; Orman G, 2015, J NEUROSURG-PEDIATR, V16, P426, DOI 10.3171/2015.3.PEDS1553; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pekcevik Y, 2016, J NEUROSURG-PEDIATR, V17, P630, DOI 10.3171/2015.8.PEDS15463; Pekcevik Y, 2013, DIAGN INTERV RADIOL, V19, P488, DOI 10.5152/dir.2013.13140; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; PUDENZ RH, 1961, CALIF MED, V94, P66; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Ringl H, 2010, RADIOLOGY, V255, P553, DOI 10.1148/radiol.10091096; Sarkar K, 2014, J NEUROSURG-PEDIATR, V13, P307, DOI 10.3171/2013.12.PEDS13223; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Sim SY, 2012, J KOREAN NEUROSURG S, V51, P31, DOI 10.3340/jkns.2012.51.1.31; TAVERAS JM, 1953, J NEUROSURG, V10, P233, DOI 10.3171/jns.1953.10.3.0233; THOMPSON JB, 1973, J NEUROSURG, V39, P493, DOI 10.3171/jns.1973.39.4.0493; WEBBER RL, 1976, J TRAUMA, V16, P115, DOI 10.1097/00005373-197602000-00007; Zacharia TT, 2010, EMERG RADIOL, V17, P97, DOI 10.1007/s10140-009-0842-6; Zulfiqar M, 2017, AM J SURG, V214, P483, DOI 10.1016/j.amjsurg.2016.07.020	34	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2017	108						399	406		10.1016/j.wneu.2017.08.107			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN3CU	WOS:000415874900053	28844920				2022-02-06	
J	Teramoto, M; Cushman, DM; Cross, CL; Curtiss, HM; Willick, SE				Teramoto, Masaru; Cushman, Daniel M.; Cross, Chad L.; Curtiss, Heather M.; Willick, Stuart E.			Game Schedules and Rate of Concussions in the National Football League	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						National Football League (NFL); concussion; game schedules; days of rest; game location; epidemiology	SPORT-RELATED CONCUSSION; SYSTEMATIC VIDEO ANALYSIS; INJURY SURVEILLANCE; RISK; PERFORMANCE; PLAYERS; IMPACT; NHL	Background: Concussion prevention in the National Football League (NFL) is an important priority for player safety. The NFL now has modified game schedules, and one concern is that unconventional game schedules, such as a shortened rest period due to playing on a Thursday rather than during the weekend, may lead to an increased risk of injuries. Hypothesis: Unconventional game schedules in the NFL are associated with an increased rate of concussion. Study Design: Descriptive epidemiological study. Methods: This study analyzed concussions and game schedules over the NFL regular seasons from 2012 to 2015 (4 years). Documented numbers of concussions, identified by use of the online database PBS Frontline Concussion Watch, were summarized by regular-season weeks. Association of days of rest and game location (home, away, or overseas) with the rate of concussion was examined by use of the (2) test. Logistic regression analysis was performed to examine the relationships of days of rest and home/away games to the risk of repeated concussions, with adjustment for player position. Results: A total of 582 concussions were analyzed in this study. A significantly greater number of concussions occurred in the second half of the season (P < .01). No significant association was found between the rate of concussion and the days of rest, game location, or timing of the bye week by the team or the opponent (P > .05). Game schedules were not significantly associated with the occurrence of repeat concussions (P > .05). Conclusion: Unconventional game schedules in the NFL, including playing on Thursday and playing overseas, do not seem to put players at increased risk of concussions.	[Teramoto, Masaru; Cushman, Daniel M.; Cross, Chad L.; Curtiss, Heather M.; Willick, Stuart E.] Univ Utah, Salt Lake City, UT 84108 USA; [Teramoto, Masaru; Cushman, Daniel M.; Curtiss, Heather M.; Willick, Stuart E.] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84108 USA; [Cross, Chad L.] Univ Nevada, Sch Med, Dept Radiat Oncol, Las Vegas, NV 89154 USA; [Cross, Chad L.] Univ Nevada, Sch Community Hlth Sci, Dept Environm & Occupat Hlth, Las Vegas, NV 89154 USA		Teramoto, M (corresponding author), Univ Utah, Sch Med, Div Phys Med & Rehabil, 590 Wakara Way, Salt Lake City, UT 84108 USA.; Teramoto, M (corresponding author), Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84108 USA.	Masaru.Teramoto@hsc.utah.edu		Cushman, Daniel/0000-0002-4580-1173			Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Breslow JM, BS FRONTLINE CONCUSS; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Daniel WW, 2013, BIOSTATISTICS FDN AN, VTenth; Ekegren CL, 2016, SPORTS MED, V46, P49, DOI 10.1007/s40279-015-0410-z; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Jann B, 2008, STATA J, V8, P147, DOI 10.1177/1536867X0800800201; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Lawrence DW, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116639222; Lipsky B, 2008, FORDHAM INTELLECTUAL, V18; Luke A, 2011, CLIN J SPORT MED, V21, P307, DOI 10.1097/JSM.0b013e3182218f71; Malhotra RK, 2017, NEUROL CLIN, V35, P547, DOI 10.1016/j.ncl.2017.03.002; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Matava MJ, 2016, J KNEE SURG, V29, P370, DOI 10.1055/s-0036-1584313; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; NFL, NFL 2015 INJ DAT; NFL and NFL Players Association, COLL BARG AGR; NFL Football Operations, CREAT NFL SCHED; Orentlicher David, 2012, FIU L REV, V8, P23; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Sessler M, NFL R GOODELL SAYS I; Smith RS, 2013, SLEEP, V36, P1999, DOI 10.5665/sleep.3248; Stevens Sean T, 2008, Res Sports Med, V16, P68, DOI 10.1080/15438620701879020; Stites A, SB NATION R SHERMAN; Taheri M, 2012, J SPORTS MED, V3, P15, DOI DOI 10.5812/ASJSM.34719; Teramoto M, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115620365; Underwood E, 2013, SCIENCE, V339, P1367, DOI 10.1126/science.339.6126.1367; Vos BC, 2018, CLIN J SPORT MED, V28, P91, DOI 10.1097/JSM.0000000000000432; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211	37	7	7	1	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	NOV 28	2017	5	11							2325967117740862	10.1177/2325967117740862			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FO0KG	WOS:000416432400001	29226165	Green Published, gold			2022-02-06	
J	Lanfranco, MF; Loane, DJ; Mocchetti, I; Burns, MP; Villapol, S				Lanfranco, Maria Fe; Loane, David J.; Mocchetti, Italo; Burns, Mark P.; Villapol, Sonia			Combination of Fluorescent in situ Hybridization (FISH) and Immunofluorescence Imaging for Detection of Cytokine Expression in Microglia/Macrophage Cells	BIO-PROTOCOL			English	Article						in situ hybridization; RNAscope; Traumatic brain injury (TBI); Macrophages; Immunofluorescence; Microglia cells; Neuroinflammation; Cytokines		Microglia and macrophage cells are the primary producers of cytokines in response to neuroinflammatory processes. But these cytokines are also produced by other glial cells, endothelial cells, and neurons. It is essential to identify the cells that produce these cytokines to target their different levels of activation. We used dual RNAscope (R) fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) techniques to visualize the mRNA expression pattern of pro- and anti-inflammatory cytokines in microglia/macrophages cells. Using these methods, we can associate one mRNA to specific cell types when combining with different cellular markers by immunofluorescence. Results from RNAscope probes IL-1 beta, TNF alpha, TGF beta, IL-10 or Arg1, showed colocalization with antibodies for microglia/macrophage cells. These target probes showed adequate sensitivity and specificity to detect mRNA expression. New FISH detection techniques combined with immunohistochemical techniques will help to jointly determine the protein and mRNA localization, as well as provide reliable quantification of the mRNA expression levels.	[Lanfranco, Maria Fe; Mocchetti, Italo; Burns, Mark P.; Villapol, Sonia] Georgetown Univ, Dept Neurosci, Washington, DC USA; [Loane, David J.] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Dept Anesthesiol, Baltimore, MD 21201 USA		Villapol, S (corresponding author), Georgetown Univ, Dept Neurosci, Washington, DC USA.	sonia.villapol@georgetown.edu	Loane, David/ABD-5177-2021	Loane, David/0000-0003-0393-3503; Burns, Mark P/0000-0003-4750-2000	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03NS095038, R01NS067417]; Georgetown University Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS081068, R21NS102121, R03NS095038, R01NS082308] Funding Source: NIH RePORTER	This work was supported by NIH grants R03NS095038 (S. Villapol), R01NS067417 (M.P. Burns), and the Dean of Biomedical Research (Toulmin pilot project) provided by the Georgetown University Medical Center (I. Mocchetti). We would like to say thanks to Dr. Kathy Maguire-Zeiss for letting us use her fluorescence microscope, and to Lucas Djavaherian for his help recording the video. This protocol has been adapted from (Barrett et al., 2017, Villapol et al., 2017). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Allen M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35497; Barrett JP, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0843-4; Grabinski TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120120; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002	5	7	7	2	11	BIO-PROTOCOL	SUNNYVALE	PO BOX 2073, SUNNYVALE, CA 94087 USA		2331-8325		BIO-PROTOCOL	Bio-protocol	NOV 20	2017	7	22							e2608	10.21769/BioProtoc.2608			12	Biology	Emerging Sources Citation Index (ESCI)	Life Sciences & Biomedicine - Other Topics	VH9MU	WOS:000457909700006	29238736	Green Published, Green Accepted			2022-02-06	
J	Tu, M; Zhu, PL; Hu, SB; Wang, W; Su, ZP; Guan, JQ; Sun, CR; Zheng, WM				Tu, Ming; Zhu, Penglei; Hu, Shaobo; Wang, Wei; Su, Zhipeng; Guan, Jiaqing; Sun, Chongran; Zheng, Weiming			Notch1 Signaling Activation Contributes to Adult Hippocampal Neurogenesis Following Traumatic Brain Injury	MEDICAL SCIENCE MONITOR			English	Article						Brain Injuries; Neurogenesis; Receptor, Notch1	NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; PATHWAY; RAT; MAINTENANCE; MODEL; HES1	Background: Neural stem cells are reported to exist in the hippocampus of adult mammals and are important sources of neurons for repair. The Notch1 signaling pathway is considered as one of the important regulators of neural stem cells, but its role in adult brains is unclear. We aimed to describe the role of Notch1 signaling in the adult rat hippocampus after traumatic brain injury. Material/Methods: The model rats were randomly divided into 4 groups as follows: sham, sham-TBI, sham-Ad-TBI, and NICD-Ad-TBI. We used adenovirus-mediated gene transfection to upregulate endogenous NICD in vivo. Firstly, a TBI rat model was constructed with lateral fluid percussion. Then, the hippocampus was collected to detect the expression of Notch1 markers and stem cell markers (DCX) by Western blot analysis, immunohistochemistry, and immunofluorescence. The prognosis after TBI treatment was evaluated by the Morris Water Maze test. Results: First, we found the expression of NICD in vivo was significantly increased by adenovirus-mediated gene transfection as assessed by Notch1 immunofluorescence and Western blot analysis. Second, enhancing NICD stimulated the regeneration of neural stem cells in the DG of the adult rat brain following traumatic brain injury, as evaluated by DCX and NeuN double-staining. Furthermore, Notch1 signaling activation can promote behavioral improvement after traumatic brain injury, including spatial learning and memory capacity. Conclusions: Our findings suggest that targeted regulation of Notch1 signaling may have a useful effect on stem cell transformation. Notch1 signaling may have a potential brain-protection effect, which may result from neurogenesis.	[Tu, Ming; Hu, Shaobo; Su, Zhipeng; Guan, Jiaqing; Zheng, Weiming] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Wenzhou, Zhejiang, Peoples R China; [Zhu, Penglei] Wenzhou Peoples Hosp, Dept Neurosurg, Wenzhou, Zhejiang, Peoples R China; [Wang, Wei] Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, Wenzhou, Zhejiang, Peoples R China; [Sun, Chongran] Zhejiang Univ Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China		Zheng, WM (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Wenzhou, Zhejiang, Peoples R China.; Sun, CR (corresponding author), Zhejiang Univ Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China.	2307010@zju.edu.cn; zhwm61@126.com			Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [LY13H090009]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [80371370]	This project was supported by grants from the Zhejiang Provincial Natural Science Foundation of China (LY13H090009) and the National Natural Science Foundation of China (80371370)	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Baik SH, 2015, ANN NEUROL, V77, P504, DOI 10.1002/ana.24347; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Calik MW, 2016, J NEGAT RESULTS BIOM, V15, DOI 10.1186/s12952-016-0052-1; Dhingra D, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/357368; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Hellstrom M, 2007, CELL ADHES MIGR, V1, P133, DOI 10.4161/cam.1.3.4978; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Imayoshi T, 2014, TRENDS NEUROSCI, V37, P531, DOI 10.1016/j.tins.2014.07.006; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jurynczyk M, 2010, J NEUROIMMUNOL, V218, P3, DOI 10.1016/j.jneuroim.2009.08.010; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Peters M, 2009, GENES BRAIN BEHAV, V8, P320, DOI 10.1111/j.1601-183X.2009.00474.x; Reinecke K, 2013, BEHAV BRAIN RES, V245, P88, DOI 10.1016/j.bbr.2013.02.013; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt A, 2007, STEM CELLS, V25, P2910, DOI 10.1634/stemcells.2007-0238; Schuster-Gossler K, 2016, GENETICS, V202, P1119, DOI 10.1534/genetics.115.184515; Sha LZ, 2014, MOL NEUROBIOL, V49, P633, DOI 10.1007/s12035-013-8545-0; Song YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013743; Su EJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00385; Wang XM, 2009, J CEREBR BLOOD F MET, V29, P1644, DOI 10.1038/jcbfm.2009.83; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Yagi H, 2012, J BIOL CHEM, V287, P24356, DOI 10.1074/jbc.M112.365643; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhang Z, 2014, BRAIN RES, V1583, P65, DOI 10.1016/j.brainres.2014.07.037; Zong DD, 2016, THER ADV RESPIR DIS, V10, P468, DOI 10.1177/1753465816654873	28	7	9	1	5	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	NOV 18	2017	23						5480	5487		10.12659/MSM.907160			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FN2LM	WOS:000415823800001	29150595	Green Published, Green Submitted			2022-02-06	
J	Akbik, OS; Krasberg, M; Nemoto, EM; Yonas, H				Akbik, Omar S.; Krasberg, Mark; Nemoto, Edwin M.; Yonas, Howard			Effect of Cerebrospinal Fluid Drainage on Brain Tissue Oxygenation in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain tissue oxygenation; cerebrospinal fluid; traumatic brain injury	THERAPY	The effectiveness of cerebrospinal fluid (CSF) drainage in lowering high intracranial pressure (ICP) is well established in severe traumatic brain injury (TBI). Recently, however, the use of external ventricular drains (EVDs) and ICP monitors in TBI has come under question. The aim of this retrospective study was to investigate the effect of CSF drainage on brain tissue oxygenation (PbtO(2)). Using a multi-modality monitoring system, we continuously monitored PbtO(2) and parenchymal ICP during CSF drainage events via a ventriculostomy in 40 patients with severe TBI. Measurements were time-locked continuous recordings on a Component Neuromonitoring Systemin a neuroscience intensive care unit. We further selected for therapeutic CSF drainage events initiated at ICP values above 25 mm Hg and analyzed the 4-min periods before and after drainage for the physiologic variables ICP, cerebral perfusion pressure (CPP), and PbtO(2). We retrospectively identified 204 CSF drainage events for ICP EVD-opening values greater than 25 mm Hg in 23 patients. During the 4 min of opened EVD, ICP decreased by 5.7 +/- 0.6 mm Hg, CPP increased by 4.1 +/- 1.2 mm Hg, and PbtO2 increased by 1.15 +/- 0.26 mm Hg. ICP, CPP, and PbtO(2) all improved with CSF drainage at ICP EVD-opening values above 25 mm Hg. Although the average PbtO2 changes were small, a clinically significant change in PbtO(2) of 5 mm Hg or greater occurred in 12% of CSF drainage events, which was correlated with larger decreases in ICP, displaying a complex relationship between ICP and PbtO(2) that warrants further studies.	[Akbik, Omar S.; Krasberg, Mark; Nemoto, Edwin M.; Yonas, Howard] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA		Akbik, OS (corresponding author), Ctr Ambulatory Care, 2nd Floor,2211 Lomas Blvd NE, Albuquerque, NM 87131 USA.	osakbik@salud.unm.edu					Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; Kerr M E, 2001, Neurosurg Focus, V11, pE1; Kinoshita K, 2006, ACTA NEUROCHIR SUPPL, V96, P37; Liu H, 2015, WORLD NEUROSURG, V83, P794, DOI 10.1016/j.wneu.2014.12.040; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506	11	7	8	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2017	34	22					3153	3157		10.1089/neu.2016.4912			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FL9GC	WOS:000414560000011	28614970				2022-02-06	
J	Kriz, PK; Mannix, R; Taylor, AM; Ruggieri, D; Meehan, WP				Kriz, Peter K.; Mannix, Rebekah; Taylor, Alex M.; Ruggieri, Danielle; Meehan, William P., III			Neurocognitive Deficits of Concussed Adolescent Athletes at Self-reported Symptom Resolution in the Zurich Guidelines Era	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; symptoms; ImPACT; adolescent; neurocognitive impairment	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; PROLONGED RECOVERY; FOOTBALL; CHILDREN; PLAYERS; AGE	Background: Previous studies have evaluated high school and collegiate athletes in the pre-Zurich guidelines era; whether adolescent athletes demonstrate similar neurocognitive decrements in the current concussion management era remains unclear. Purpose: To assess for the presence of neurocognitive deficits in adolescents with a sport-related concussion at the time of self-reported symptom resolution. Study Design: Cross-sectional study; Level of evidence, 3. Methods: We conducted a prospective cohort study of 32 patients, aged 13 to 18 years, who sustained concussions during ice hockey and who were referred to 3 sports medicine clinics between September 1, 2012, and March 31, 2015. Demographic, anthropometric, and injury data were collected at the time of the initial postconcussion evaluation. To document symptoms, patients completed the Post-Concussion Symptom Scale (PCSS) at initial and follow-up visits. Baseline and postinjury neurocognitive function were assessed using computerized neurocognitive testing (Immediate Post-Concussion Assessment and Cognitive Test [ImPACT]), and a reliable change index was used to determine significant changes in composite scores. Statistical comparisons were conducted using the Student t test and Mann-Whitney U test. Results: A total of 9 of 32 athletes (28.1%; 95% CI, 14.8%-46.9%) demonstrated continued neurocognitive impairment on 1 composite score when no longer reporting concussion-related symptoms, while only 2 of 32 athletes (6.3%; 95% CI, 1.4%-23.2%) demonstrated continued neurocognitive impairment on 2 composite scores. Conclusion: Neurocognitive deficits persist in adolescent athletes who no longer report concussion-related symptoms, at rates similar to those of collegiate athletes but at longer time intervals. This finding provides further evidence that adolescent athletes with a sport-related concussion demonstrate a protracted recovery and resolution of neurocognitive deficits compared with collegiate and professional athletes. Computer-based neurocognitive testing as part of a multifaceted approach continues to play an important role in return-to-play decision making after a sport-related concussion in adolescent athletes. Test-taking strategies may erroneously identify asymptomatic athletes as exhibiting neurocognitive impairment.				Peter_Kriz@brown.edu	Mannix, Rebekah/AAD-8702-2020		Rhode Island Foundation [20113642]; National Federation of State High School Associations Foundation [701-5917]; National Football League Players Association; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament	One or more of the authors has declared the following potential conflict of interest or source of funding: This research was funded in part by the Rhode Island Foundation (grant No. 20113642) and the National Federation of State High School Associations Foundation (grant No. 701-5917). W.P.M. receives royalties from ABC-CLIO and Wolters Kluwer, and his research is funded, in part, by a grant from the National Football League Players Association and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Centers for Disease Control and Prevention Injury Center, HEADS YOUTH SPORTS; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Institute of Medicine and National Research Council, 2014, SPORTS RELATED CONCU; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kriz PK, 2016, J PEDIATR-US, V171, P234, DOI 10.1016/j.jpeds.2015.12.006; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2005, BRIT J SPORT MED, V39, pI58, DOI 10.1136/bjsm.2005.020776; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Rohan T., YOUNG ATHL WORLD PAI; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Taylor KA, 2014, BRIT J SPORT MED, V48, P664; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	27	7	7	1	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	NOV 6	2017	5	11							2325967117737307	10.1177/2325967117737307			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FM0ML	WOS:000414660700001	29164163	Green Published, gold			2022-02-06	
J	Shahidi, B; Shah, SB; Esparza, M; Head, BP; Ward, S				Shahidi, Bahar; Shah, Sameer B.; Esparza, Mary; Head, Brian P.; Ward, Sam			Skeletal Muscle Atrophy and Degeneration in a Mouse Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						atrophy; controlled cortical impact; degeneration; regeneration; skeletal muscle; traumatic brain injury	DENERVATION; CARDIOTOXIN; REGENERATION; MECHANISMS; SLOW	Atrophy is thought to be a primary mode of muscle loss in neuromuscular injuries. The differential effects of central and peripheral injuries on atrophy and degeneration/regeneration in skeletal muscle tissue have not been well described. This study investigated skeletal muscle atrophy and degeneration/regeneration in an animal model of traumatic brain injury (TBI). Eight 8-month-old wild-type C57BL6 mice underwent either a sham craniotomy or TBI targeting the motor cortex. Atrophy (fiber area; FA) and degeneration/regeneration (centralized nuclei proportions; CN) of the soleus and tibialis anterior (TA) muscles were measured 2 months post-injury. Injured soleus FAs were smaller than sham soleus (p = 0.02) and injured TA (p < 0.001). Mean CNs were higher in the TBI-injured TA than in other muscles. Differential TBI-induced atrophy and degeneration/regeneration in lower limb muscles suggests that muscle responses to cortical injury involve more complex changes than those observed with simple disuse atrophy.	[Shahidi, Bahar; Shah, Sameer B.; Esparza, Mary; Ward, Sam] Univ Calif San Diego, Dept Orthoped Surg, San Diego, CA 92103 USA; [Head, Brian P.] Univ Calif San Diego, Dept Anesthesiol, San Diego, CA 92103 USA		Head, BP (corresponding author), Univ Calif San Diego, 9500 Gilman Dr 9125, La Jolla, CA 92093 USA.; Ward, S (corresponding author), Univ Calif San Diego, ACTRI Lower Level 2,Rm 401,9452 Med Ctr Dr, La Jolla, CA 92037 USA.	bhead@ucsd.edu; srward@ucsd.edu	Shahidi, Bahar/AAV-3212-2021	Esparza, Mary/0000-0002-7891-8925	 [BX003671];  [NS073653];  [TL1TR001443]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS073653] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003671] Funding Source: NIH RePORTER	This work was funded by BX003671 and NS073653 awarded to BPH, and TL1TR001443 awarded to BS.	Biral D, 2008, NEUROL RES, V30, P137, DOI 10.1179/174313208X281145; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Carlson BM, 2014, EUR J TRANSL MYOL, V24, P5, DOI 10.4081/ejtm.2014.3293; Castro MJ, 1999, J APPL PHYSIOL, V86, P350, DOI 10.1152/jappl.1999.86.1.350; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Clark BC, 2009, MED SCI SPORT EXER, V41, P1869, DOI 10.1249/MSS.0b013e3181a645a6; Daemen MARC, 1998, NEUROSCI LETT, V247, P204, DOI 10.1016/S0304-3940(98)00304-8; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; Egawa J, 2017, FASEB J, V31, P3403, DOI 10.1096/fj.201601288RRR; Eng CM, 2008, J EXP BIOL, V211, P2336, DOI 10.1242/jeb.017640; English C, 2010, INT J STROKE, V5, P395, DOI 10.1111/j.1747-4949.2010.00467.x; FRIDEN J, 1992, MED SCI SPORT EXER, V24, P521; Garry GA, 2016, METHODS MOL BIOL, V1460, P61, DOI 10.1007/978-1-4939-3810-0_6; Gibbons MC, 2017, J BONE JOINT SURG AM, V99, DOI 10.2106/JBJS.16.00335; Hardy D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147198; Jamall AA, 2000, MUSCLE NERVE, V23, P851, DOI 10.1002/(SICI)1097-4598(200006)23:6<851::AID-MUS3>3.0.CO;2-A; Lieber R L, 1999, J Sci Med Sport, V2, P253, DOI 10.1016/S1440-2440(99)80177-7; Mathevon L, 2015, ANN PHYS REHABIL MED, V58, P343, DOI 10.1016/j.rehab.2015.06.002; Minamoto VB, 2007, DEV MED CHILD NEUROL, V49, P907, DOI 10.1111/j.1469-8749.2007.00907.x; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Patterson MF, 2006, AM J PHYSIOL-CELL PH, V291, pC518, DOI 10.1152/ajpcell.00013.2006; Phipps HW, 2016, METHODS MOL BIOL, V1462, P61, DOI 10.1007/978-1-4939-3816-2_5; SCELSI R, 1984, ACTA NEUROPATHOL, V62, P324, DOI 10.1007/BF00687615; SHIAU SYL, 1976, J PHARMACOL EXP THER, V196, P758; Shields RK, 2002, J ORTHOP SPORT PHYS, V32, P65, DOI 10.2519/jospt.2002.32.2.65; Siu PM, 2009, FRONT BIOSCI-LANDMRK, V14, P432, DOI 10.2741/3253; Urso ML, 2009, MED SCI SPORT EXER, V41, P1860, DOI 10.1249/MSS.0b013e3181a6458a; Vignaud A, 2007, NEUROSCI RES, V58, P317, DOI 10.1016/j.neures.2007.04.001; von Walden F, 2012, MUSCLE NERVE, V46, P785, DOI 10.1002/mus.23387	30	7	8	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					398	401		10.1089/neu.2017.5172		NOV 2017	4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000414582600001	28895461	Green Published			2022-02-06	
J	Abbott, EF; Thompson, W; Pandian, TK; Zendejas, B; Farley, DR; Cook, DA				Abbott, Eduardo F.; Thompson, Whitney; Pandian, T. K.; Zendejas, Benjamin; Farley, David R.; Cook, David A.			Personalized Video Feedback and Repeated Task Practice Improve Laparoscopic Knot-Tying Skills: Two Controlled Trials	ACADEMIC MEDICINE			English	Article; Proceedings Paper	56th Annual Research in Medical Education Sessions (RIME) of the Association-of-American-Medical-Colleges (AAMC)	NOV 03-07, 2017	Boston, MA	Assoc Amer Med Coll			HEALTH-PROFESSIONS EDUCATION; TRAUMATIC BRAIN-INJURY; MENTAL WORKLOAD; RETRIEVAL PRACTICE; MEDICAL-EDUCATION; RANDOMIZED-TRIAL; SIMULATION; ACQUISITION; PERFORMANCE; MAINTENANCE	Purpose Compare the effect of personalized feedback (PF) vs. task demonstration (TD), both delivered via video, on laparoscopic knot-tying skills and perceived workload; and evaluate the effect of repeated practice. Method General surgery interns and research fellows completed four repetitions of a simulated laparoscopic knot-tying task at one-month intervals. Midway between repetitions, participants received via e-mail either a TD video (demonstration by an expert) or a PF video (video of their own performance with voiceover from a blinded senior surgeon). Each participant received at least one video per format, with sequence randomly assigned. Outcomes included performance scores and NASA Task Load Index (NASA-TLX) scores. To evaluate the effectiveness of repeated practice, scores from these trainees on a separate delayed retention test were compared against historical controls who did not have scheduled repetitions. Results Twenty-one trainees completed the randomized study. Mean change in performance scores was significantly greater for those receiving PF (difference = 23.1 of 150 [95% confidence interval (CI): 0, 46.2], P = .05). Perceived workload was also significantly reduced (difference = -3.0 of 20 [95% CI: -5.8, -0.3], P = .04). Compared with historical controls (N = 93), the 21 with scheduled repeated practice had higher scores on the laparoscopic knot-tying assessment two weeks after the final repetition (difference = 1.5 of 10 [95% CI: 0.2, 2.8], P = .02). Conclusions Personalized video feedback improves trainees' procedural performance and perceived workload compared with a task demonstration video. Brief monthly practice sessions support skill acquisition and retention.	[Cook, David A.] Mayo Clin, Coll Med, Div Gen Internal Med, Mayo 17,200 First St SW, Rochester, MN 55905 USA; [Abbott, Eduardo F.] Mayo Clin, Coll Med, Multidisciplinary Simulat Ctr, Rochester, MN USA; [Abbott, Eduardo F.] Pontificia Univ Catolica Chile, Escuela Med, Dept Internal Med, Internal Med, Santiago, Chile; [Thompson, Whitney] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Pandian, T. K.; Farley, David R.] Mayo Clin, Coll Med, Dept Surg, Rochester, MN USA; [Zendejas, Benjamin] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA; [Farley, David R.] Mayo Clin, Coll Med, Surg, Rochester, MN USA; [Cook, David A.] Mayo Clin, Multidisciplinary Simulat Ctr, Med, Rochester, MN USA; [Cook, David A.] Mayo Clin, Multidisciplinary Simulat Ctr, Med Educ, Rochester, MN USA; [Cook, David A.] Mayo Clin, Multidisciplinary Simulat Ctr, Rochester, MN USA; [Cook, David A.] Mayo Clin, Coll Med, Off Appl Scholarship & Educ Sci, Res, Rochester, MN USA; [Cook, David A.] Mayo Clin, Coll Med, Div Gen Internal Med, Rochester, MN USA		Cook, DA (corresponding author), Mayo Clin, Coll Med, Div Gen Internal Med, Mayo 17,200 First St SW, Rochester, MN 55905 USA.	cook.david33@mayo.edu					Aiken CA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00338; Altman DG, 1999, BRIT MED J, V319, P703, DOI 10.1136/bmj.319.7211.703; Auerbach M, 2011, PEDIATR EMERG CARE, V27, P29, DOI 10.1097/PEC.0b013e3182043f3b; Augustin Marc, 2014, Yale Journal of Biology and Medicine, V87, P207; Backstein D, 2004, AM J SURG, V187, P427, DOI 10.1016/j.amjsurg.2003.12.011; Backstein D, 2005, CAN J SURG, V48, P195; Brydges R, MED ED; Brydges R, 2015, MED EDUC, V49, P368, DOI 10.1111/medu.12649; Byrne A, 2014, MED EDUC, V48, P262, DOI 10.1111/medu.12387; Caban AM, 2013, JSLS-J SOC LAPAROEND, V17, P440, DOI 10.4293/108680813X13693422521430; Cook DA, SIMUL HEALTHC; Cook DA, 2014, MED TEACH, V36, P965, DOI 10.3109/0142159X.2014.917284; Cook DA, 2013, MED TEACH, V35, pE844, DOI 10.3109/0142159X.2012.714886; Cook DA, 2011, JAMA-J AM MED ASSOC, V306, P978, DOI 10.1001/jama.2011.1234; Cook DA, 2010, ACAD MED, V85, P909, DOI 10.1097/ACM.0b013e3181d6c319; DiDomenico A, 2008, INT J IND ERGONOM, V38, P977, DOI 10.1016/j.ergon.2008.01.012; Ericsson KA, 2004, ACAD MED, V79, pS70, DOI 10.1097/00001888-200410001-00022; Farquharson AL, 2013, BRIT J SURG, V100, P1448, DOI 10.1002/bjs.9237; Fundamentals of Laparoscopic Surgery, FLS PROGR DESCR; HART S G, 1988, P139; Hart SG., 2006, P HUM FACT ERG SOC A, V50, P904, DOI DOI 10.1177/154193120605000909; Hatala R, 2014, ADV HEALTH SCI EDUC, V19, P251, DOI 10.1007/s10459-013-9462-8; Hu JSL, 2016, SURG ENDOSC, V30, P1742, DOI 10.1007/s00464-015-4410-8; Kerfoot BP, 2012, J AM COLL SURGEONS, V214, P367, DOI 10.1016/j.jamcollsurg.2011.11.009; Kerfoot BP, 2009, J UROLOGY, V181, P2671, DOI 10.1016/j.juro.2009.02.024; Kerfoot BP, J GEN INTERN MED; Kobayashi SA, 2011, J SURG EDUC, V68, P105, DOI 10.1016/j.jsurg.2010.09.014; Larsen DP, 2008, MED EDUC, V42, P959, DOI 10.1111/j.1365-2923.2008.03124.x; Maloney S, 2017, MED EDUC, V51, P246, DOI 10.1111/medu.13139; Mazur LM, 2012, INT J RADIAT ONCOL, V83, pE571, DOI 10.1016/j.ijrobp.2012.01.063; McGaghie WC, DOES SIMULATION BASE; McGaghie WC, 2010, MED EDUC, V44, P50, DOI 10.1111/j.1365-2923.2009.03547.x; McGraw-Hunter M, 2006, BRAIN INJURY, V20, P1061, DOI 10.1080/02699050600912163; Mundell WC, 2013, RESUSCITATION, V84, P1174, DOI 10.1016/j.resuscitation.2013.04.016; Muresan C, 2010, AM J SURG, V200, P537, DOI 10.1016/j.amjsurg.2009.12.018; Naismith LM, 2015, ACAD MED, V90, pS24, DOI 10.1097/ACM.0000000000000893; Nesbitt CI, 2015, J SURG EDUC, V72, P697, DOI 10.1016/j.jsurg.2014.12.013; Oermann MH, 2011, RESUSCITATION, V82, P447, DOI 10.1016/j.resuscitation.2010.11.022; Okuda Y, 2009, MT SINAI J MED, V76, P330, DOI 10.1002/msj.20127; Roediger HL, 2011, TRENDS COGN SCI, V15, P20, DOI 10.1016/j.tics.2010.09.003; Rohrer D, ED RES; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Stefanidis D, 2006, J AM COLL SURGEONS, V202, P599, DOI 10.1016/j.jamcollsurg.2005.12.018; Stefanidis D, 2012, ANN SURG, V255, P30, DOI 10.1097/SLA.0b013e318220ef31; Storm BC, 2010, MEM COGNITION, V38, P244, DOI 10.3758/MC.38.2.244; Supe A, 2012, J SURG EDUC, V69, P624, DOI 10.1016/j.jsurg.2012.05.002; Thinggaard E, 2017, SURG ENDOSC, V31, P1738, DOI 10.1007/s00464-016-5166-5; van Merrienboer JJG, 2005, EDUC PSYCHOL REV, V17, P147, DOI 10.1007/s10648-005-3951-0; WINFREY ML, 1993, PERCEPT MOTOR SKILL, V77, P907, DOI 10.2466/pms.1993.77.3.907; Yurko YY, 2010, SIMUL HEALTHC, V5, P267, DOI 10.1097/SIH.0b013e3181e3f329; Zendejas B, 2013, SURGERY, V153, P160, DOI 10.1016/j.surg.2012.06.025	51	7	7	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-2446	1938-808X		ACAD MED	Acad. Med.	NOV	2017	92	11		S			S26	S32		10.1097/ACM.0000000000001924			7	Education, Scientific Disciplines; Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Education & Educational Research; Health Care Sciences & Services	GL9RT	WOS:000437675300006	29065020	Bronze			2022-02-06	
J	Godoy, DA; Videtta, W; Di Napoli, M				Agustin Godoy, Daniel; Videtta, Walter; Di Napoli, Mario			Practical Approach to Posttraumatic Intracranial Hypertension According to Pathophysiologic Reasoning	NEUROLOGIC CLINICS			English	Article						Intracranial pressure; Intracranial hypertension; Acute brain injury; Cerebral perfusion pressure; Multimodal monitoring; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; RANDOMIZED CONTROLLED-TRIALS; HYPERTONIC SODIUM SOLUTIONS; VOLUME-TARGETED THERAPY; BLOOD-FLOW; DECOMPRESSIVE CRANIECTOMY; ACUTE MANAGEMENT; LUMBAR DRAINAGE	Intracranial hypertension is one of leading causes of mortality after acute brain injury. Its causes and origins are multiple. The approach should be based on the underlying pathophysiology. There are different therapeutic modalities to control increase intracranial pressure (ICP), but all share the objective of normalizing basic physiologic variables. ICP control should be combined with adequate cerebral perfusion pressure. The classic approach to ICP control is unidirectional and sequential escalation of therapy. The nonresponse to classic therapy signaled a refractory condition. Multimodal monitoring has emerged as a useful tool, taking into account the analysis of ICP, oxygenation, and cerebral metabolism.	[Agustin Godoy, Daniel] San Juan Bautista Hosp, Intens Care Unit, Catamarca, Argentina; [Agustin Godoy, Daniel] Sanat Pasteur, Neurointens Care Unit, Chacabuco 675, RA-4700 Catamarca, Argentina; [Videtta, Walter] Natl Hosp, Intens Care Unit, Buenos Aires, DF, Argentina; [Videtta, Walter] Eva Peron Hosp, Intens Care Unit, Buenos Aires, DF, Argentina; [Di Napoli, Mario] San Camillo de Lellis Gen Hosp, Neurol Serv, Rieti, Italy; [Di Napoli, Mario] SMDN Ctr Cardiovasc Med & Cerebrovasc Dis Prevent, Neurol Sect, Laquila, Italy		Godoy, DA (corresponding author), Sanat Pasteur, Neurointens Care Unit, Chacabuco 675, RA-4700 Catamarca, Argentina.	dagodoytorres@yahoo.com.ar	Di Napoli, Mario/J-6418-2014	Di Napoli, Mario/0000-0001-9609-4926			AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Abadal-Centellas JM, 2007, J TRAUMA, V62, P282, DOI 10.1097/01.ta.0000199422.01949.78; Albeck MJ, 1998, J NEUROSURG, V89, P275, DOI 10.3171/jns.1998.89.2.0275; ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Andrews PJD, 2004, INTENS CARE MED, V30, P1730, DOI 10.1007/s00134-004-2376-4; Aramendi I, 2016, MED INTENSIVA, V40, P113, DOI 10.1016/j.medin.2015.09.002; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bassin SL, 2008, CRIT CARE, V12, DOI 10.1186/cc7020; Bellemare P, 2007, INTENS CARE MED, V33, P2004, DOI 10.1007/s00134-007-0842-5; Berger-Pelleiter E, 2016, CAN J EMERG MED, V18, P112, DOI 10.1017/cem.2016.12; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bloomfield GL, 1997, CRIT CARE MED, V25, P496, DOI 10.1097/00003246-199703000-00020; Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burgess S, 2016, ANN PHARMACOTHER, V50, P291, DOI 10.1177/1060028016628893; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Celis-Rodriguez E, 2013, MED INTENSIVA, V37, P519, DOI 10.1016/j.medin.2013.04.001; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P99, DOI 10.1111/nyas.12483; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; Citerio G, 2004, INTENS CARE MED, V30, P1882, DOI 10.1007/s00134-004-2377-3; Citerio G, 2001, CRIT CARE MED, V29, P1466, DOI 10.1097/00003246-200107000-00027; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; Diringer MN, 2013, CURR OPIN CRIT CARE, V19, P77, DOI 10.1097/MCC.0b013e32835eba30; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Gantner D, 2014, CURR OPIN CRIT CARE, V20, P385, DOI 10.1097/MCC.0000000000000114; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Gillman LM, 2014, CASE REP CRIT CARE, V2014; Godoy DA, 2015, MED INTENSIVA, V39, P445, DOI 10.1016/j.medin.2014.10.009; Godoy DA, 2005, ACTA ANAESTH SCAND, V49, P1577, DOI 10.1111/j.1399-6576.2005.00885_49_10.x; Godoy DA, 2014, NEUROCRIT CARE, V141, P616; Godoy DA, 2013, NEUROLOGIC INTENSIVE, P196; Godoy DA, 2013, INTENSIVE CARE NEURO, V1, P53; Godoy DA, 2014, GREEN BOOK CUIDADOS, P19; Godoy DA, 2012, NEUROSURGERY, V71, P245, DOI 10.1227/NEU.0b013e318256b9f5; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; GUERCI AD, 1985, CIRC RES, V56, P20, DOI 10.1161/01.RES.56.1.20; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Harrigan MR, 1997, J NEUROTRAUM, V14, P637, DOI 10.1089/neu.1997.14.637; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kerr M E, 1998, Am J Crit Care, V7, P205; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kirkman MA, 2014, BRIT J ANAESTH, V112, P35, DOI 10.1093/bja/aet418; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; Latronico N, 2011, LANCET NEUROL, V10, P931, DOI 10.1016/S1474-4422(11)70178-8; Lauerman MH, 2014, CURR OPIN ANESTHESIO, V27, P219, DOI 10.1097/ACO.0000000000000044; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Le Roux P, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0331-2; Lee TT, 1997, SURG NEUROL, V48, P333, DOI 10.1016/S0090-3019(96)00483-1; Li M, 2015, MEDICINE, V94; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; LYONS MK, 1990, MAYO CLIN PROC, V65, P684, DOI 10.1016/S0025-6196(12)65131-3; Makarenko S, 2016, J CLIN NEUROSCI, V26, P8, DOI 10.1016/j.jocn.2015.05.065; Malbrain MLNG, 2011, AM SURGEON, V77, pS6; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marion DW, 2014, CRIT CARE, V18, DOI 10.1186/cc13955; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Mirski MA, 2008, SEMIN NEUROL, V28, P611, DOI 10.1055/s-0028-1105970; Monro A., 1823, OBSERVATIONS STRUCTU, P5; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Munch EC, 2001, CRIT CARE MED, V29, P976; Murad A, 2008, ACT NEUR S, V102, P89, DOI 10.1007/978-3-211-85578-2_18; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Perez-Barcena J, 2014, CRIT CARE CLIN, V30, P735, DOI 10.1016/j.ccc.2014.06.005; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; Poca MA, 1998, ACT NEUR S, V71, P27; Puppo C, 2007, ACTA NEUROCHIR, V149, P139, DOI 10.1007/s00701-006-1074-0; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Roberts R G, 2002, Crit Care Resusc, V4, P271; Ortega MAR, 2014, MED INTENSIVA, V38, P41, DOI 10.1016/j.medin.2013.03.008; Rosenthal R J, 1998, J Gastrointest Surg, V2, P415, DOI 10.1016/S1091-255X(98)80031-0; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Rosner MJ, 1989, INTRACRANIAL PRESSUR, P611; Sader N, 2015, NEUROCRIT CARE, V22, P437, DOI 10.1007/s12028-014-0088-3; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sandestig A, 2014, THER HYPOTHERMIA TEM, V4, P10, DOI 10.1089/ther.2013.0024; Sanfilippo F, 2015, NEUROCRIT CARE, V22, P325, DOI 10.1007/s12028-014-0061-1; SATO M, 1984, STROKE, V15, P91, DOI 10.1161/01.STR.15.1.91; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Sauquillo J, 2002, NEUROCIRUGIA, V13, P78; Scalea TM, 2007, J TRAUMA, V62, P647, DOI 10.1097/TA.0b013e31802ee542; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; SMITH AL, 1972, ANESTHESIOLOGY, V36, P378, DOI 10.1097/00000542-197204000-00015; Souter MJ, 2009, MILLERS ANESTHESIA, P2899; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steingrub JS, 2014, CRIT CARE MED, V42, P90, DOI 10.1097/CCM.0b013e31829eb7c9; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Stocchetti N, 2013, CRIT CARE, V17, DOI 10.1186/cc11513; Tang JF, 2011, NEUROCRIT CARE, V15, P175, DOI 10.1007/s12028-009-9315-8; Thongrong C, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.02.027; Tuettenberg J, 2009, J NEUROSURG, V110, P1200, DOI 10.3171/2008.10.JNS08293; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; Willemse RB, 1998, ACT NEUR S, V71, P37; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054; Woodman T, 1996, NEUROTRAUMA, P519	129	7	7	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	NOV	2017	35	4					613	+		10.1016/j.ncl.2017.06.002			29	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL6UU	WOS:000414382500003	28962804				2022-02-06	
J	Bernard, CO; Ponsford, JL; McKinlay, A; McKenzie, D; Krieser, D				Bernard, Coco O.; Ponsford, Jennie L.; McKinlay, Audrey; McKenzie, Dean; Krieser, David			Do Concussive Symptoms Really Resolve in Young Children?	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						behavior; child; concussion; mild traumatic brain injury; outcome; pediatric; postconcussive symptoms	TRAUMATIC BRAIN-INJURY; CATECHOL-O-METHYLTRANSFERASE; GENE-ENVIRONMENT INTERACTION; MESSENGER-RNA EXPRESSION; DOPAMINE-RECEPTOR D4; APOLIPOPROTEIN-E; FUNCTIONAL POLYMORPHISM; EXECUTIVE DYSFUNCTION; PREFRONTAL CORTEX; COMT GENE	Objectives: To examine the frequency and nature of postconcussive symptoms (PCSs) and behavioral outcomes in young children following mild traumatic brain injury (mTBI) or concussion. Setting: Emergency department. Participants: Children aged 2 to 12 years presenting with either a concussion or minor bodily injury (control). Outcome Measurement: Parent ratings of PCS were obtained within 72 hours of injury, at 1 week, and 1, 2, and 3 months postinjury using a comprehensive PCS checklist. Preinjury behavior was examined at baseline using the Clinical Assessment of Behavior, which was readministered 1 and 3 months postinjury. Results: PCS burden following mTBI peaked in the acute phase postinjury but reduced significantly from 1 week to 1 month postinjury. Parents of children with mTBI reported more persistent PCSs up to 3 months postinjury than trauma controls, characterized mostly by behavioral and sleep-related symptoms. Subtle increases in problematic behaviors were observed from baseline (preinjury) to 1 month postinjury and persisted at 3 months postinjury; however, scores were not classified as clinically "at risk." Conclusions: A significantminority of young children experienced persistent PCS and problematic behavior following mTBI. Care must be taken when assessing PCS in younger children as method of PCS assessment may influence parental reporting.	[Bernard, Coco O.; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [McKenzie, Dean] Monash Univ, Epworth HealthCare, Melbourne, Vic, Australia; [McKenzie, Dean] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Krieser, David] Sunshine Hosp, Emergency Dept, Melbourne, Vic, Australia		Bernard, CO (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	coco.bernard@monash.edu	Krieser, David/AAA-1370-2021	Krieser, David/0000-0002-7173-6993; McKinlay, Audrey/0000-0001-9846-8514	Jack Brockoff Foundation; Monash University Doctoral Research Fund	Research funding was awarded to Professor Jennie L. Ponsford and Dr Audrey McKinlay by the Jack Brockoff Foundation, and to Coco O. Bernard from the Monash University Doctoral Research Fund. This research was conducted as part of Coco O. Bernard's Doctoral Thesis (Doctorate of Clinical Neuropsychology).	Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Ashley EA, 2015, JAMA-J AM MED ASSOC, V313, P2119, DOI 10.1001/jama.2015.3595; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Batty RA, 2013, BRAIN IMPAIR, V14, P21, DOI 10.1017/BrImp.2013.10; BAUMRIND D, 1966, CHILD DEV, V37, P887, DOI 10.1111/j.1467-8624.1966.tb05416.x; BAUMRIND D, 1967, GENET PSYCHOL MONOGR, V75, P43; Beaver KM, 2012, PSYCHIAT QUART, V83, P29, DOI 10.1007/s11126-011-9180-4; Berry D, 2014, DEV PSYCHOBIOL, V56, P373, DOI 10.1002/dev.21105; Berry D, 2013, DEV PSYCHOPATHOL, V25, P291, DOI 10.1017/S095457941200106X; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Blanco NJ, 2015, NEUROBIOL LEARN MEM, V123, P84, DOI 10.1016/j.nlm.2015.05.004; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; CDC, GET STATS TRAUM BRAI; Chen H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026661, 10.1093/ecam/neq002]; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cicchetti D, 2012, DEV PSYCHOPATHOL, V24, P411, DOI 10.1017/S0954579412000077; Das D, 2011, AM J MED GENET B, V156B, P346, DOI 10.1002/ajmg.b.31169; Derogatis LR., 1982, BRIEF SYMPTOM INVENT; Diaz-Asper Catherine M, 2006, NeuroRx, V3, P97, DOI 10.1016/j.nurx.2005.12.010; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gioia G.A., 2000, BRIEF BEHAV RATING I; Gioia G.A., 2003, BRIEF P BEHAV RATING; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Goldberg X, 2013, J PSYCHIATR RES, V47, P989, DOI 10.1016/j.jpsychires.2013.02.002; Guillin O, 2004, INT REV NEUROBIOL, V59, P425; Hayden EP, 2010, PSYCHIAT GENET, V20, P304, DOI 10.1097/YPG.0b013e32833adccb; HOLM S, 1979, SCAND J STAT, V6, P65; Hygen BW, 2015, DEV PSYCHOL, V51, P1098, DOI 10.1037/dev0000020; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keenan HT, 2006, PEDIATRICS, V117, P1291, DOI 10.1542/peds.2005-1883; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Khoury MJ, 2015, JAMA-J AM MED ASSOC, V313, P2117, DOI 10.1001/jama.2015.3382; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000162; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lavigne JV, 2013, DEV PSYCHOPATHOL, V25, P555, DOI 10.1017/S0954579412001241; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Lo TYM, 2009, CHILD NERV SYST, V25, P47, DOI 10.1007/s00381-008-0723-4; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Martel MM, 2011, J ABNORM CHILD PSYCH, V39, P1, DOI 10.1007/s10802-010-9439-5; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; Matsumoto M, 2003, NEUROPSYCHOPHARMACOL, V28, P1521, DOI 10.1038/sj.npp.1300218; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Nussbaum R. L., 2007, THOMPSON THOMPSON GE, P151; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Quinn TJ, 2004, NEUROPATH APPL NEURO, V30, P569, DOI 10.1111/j.1365-2990.2004.00581.x; ROBINSON CC, 1995, PSYCHOL REP, V77, P819, DOI 10.2466/pr0.1995.77.3.819; Rosa A, 2004, AM J PSYCHIAT, V161, P1110, DOI 10.1176/appi.ajp.161.6.1110; Schellekens AFA, 2013, ADDICT BIOL, V18, P344, DOI 10.1111/j.1369-1600.2012.00438.x; Sweitzer MM, 2013, SOC COGN AFFECT NEUR, V8, P499, DOI 10.1093/scan/nss020; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; van Roekel E, 2011, J CHILD PSYCHOL PSYC, V52, P1044, DOI 10.1111/j.1469-7610.2011.02424.x; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Weinberger DR, 2001, BIOL PSYCHIAT, V50, P825, DOI 10.1016/S0006-3223(01)01252-5; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	78	7	7	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					413	424		10.1097/HTR.0000000000000298			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100097	28422893				2022-02-06	
J	Chevignard, M; Kerrouche, B; Krasny-Pacini, A; Mariller, A; Pineau-Chardon, E; Notteghem, P; Prodhomme, J; Le Gall, D; Roulin, JL; Fournet, N; Roy, A				Chevignard, Mathilde; Kerrouche, Bernadette; Krasny-Pacini, Agata; Mariller, Aude; Pineau-Chardon, Emmanuelle; Notteghem, Pauline; Prodhomme, Julie; Le Gall, Didier; Roulin, Jean-Luc; Fournet, Nathalie; Roy, Arnaud			Ecological Assessment of Everyday Executive Functioning at Home and at School Following Childhood Traumatic Brain Injury Using the BRIEF Questionnaire	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescent; behavior rating; brain injuries; child; cognitive deficit; ecological assessment; everyday life; executive function; school; surveys and questionnaires; traumatic brain injury	BEHAVIOR RATING INVENTORY; YOUNG-CHILDREN; NEUROPSYCHOLOGICAL ASSESSMENT; PEDIATRIC TBI; OUTCOMES; RECOVERY; DYSFUNCTION; PREDICTORS; VALIDITY; REHABILITATION	Objectives: To describe dysexecutive symptoms in children with traumatic brain injury (TBI) using the Behavior Rating Inventory of Executive Function (BRIEF); to compare parent- and teacher-ratings, to analyze the differential impairment in the BRIEF subscales, and factors influencing outcome. Participants: Children aged 5 to 18 years 11 months, referred to a rehabilitation department following TBI. Outcome Measures: Parent- and teacher reports of the BRIEF. Results: A total of 194 patients participated in the study: mild (n = 13), moderate (n = 12), severe (n = 169); mean 4.92 (standard deviation = 3.94) years post-injury. According to parent ratings (n = 193), all BRIEF subscales and indices were significantly elevated (23.8%-48% in the clinical range). The Working Memory subscale score was significantly higher than all other subscales. Results of teacher ratings (n = 28) indicated similar significantly elevated scores in all subscales (39.3%-57.2% in the clinical range). No significant difference was found between parent and teacher ratings, which were significantly correlated. Regression analyses indicated that, in children with severe TBI, parental BRIEF overall and metacognition indices were significantly predicted by younger age at injury and older age at assessment, whereas no significant predictor of behavioral regulation index was identified. Discussion and Conclusion: This study highlights significant executive dysfunction in everyday life several years after childhood TBI, evident in home and school environments.	[Chevignard, Mathilde; Mariller, Aude; Pineau-Chardon, Emmanuelle; Notteghem, Pauline] St Maurice Hosp, Rehabil Dept Children Acquired Neurol Injury, St Maurice, France; [Chevignard, Mathilde; Krasny-Pacini, Agata] UPMC Univ Paris 06, Sorbonne Univ, CNRS, Inserm,LIB, Paris, France; [Chevignard, Mathilde] Grp Rech Clin 18 Handicap Cognitif & Readaptat, Paris, France; [Kerrouche, Bernadette; Prodhomme, Julie] St Maurice Hosp, Outreach Team Children & Adolescents Acquired Bra, St Maurice, France; [Krasny-Pacini, Agata] Inst Univ Readaptat Clemenceau, Strasbourg, France; [Krasny-Pacini, Agata] CHU Strasbourg, Hautepierre, Serv Chirurg Pediat, Strasbourg, France; [Prodhomme, Julie] Necker Enfants Malad Hosp, Neurosurg Dept, Paris, France; [Le Gall, Didier; Roy, Arnaud] Angers Univ, Psychol Lab Pays Loire, Angers, France; [Roulin, Jean-Luc; Fournet, Nathalie] Univ Savoie, Chambery, France; [Roulin, Jean-Luc; Fournet, Nathalie] LPNC, CNRS, Grenoble, France; [Roy, Arnaud] Nantes Univ Hosp, Neurofibromatosis Clin, Nantes, France; [Roy, Arnaud] Nantes Univ Hosp, Learning Disabil Reference Ctr, Nantes, France		Chevignard, M (corresponding author), St Maurice Hosp, Rehabil Dept Children Acquired Neurol Injury, St Maurice, France.	m.chevignard@hopitaux-st-maurice.fr			Saint Maurice Hospitals	There was no specific funding for this study, performed in a clinical rehabilitation department devoted to children with acquired neurological injury. Most of the authors are part of the team of this department, thus funded by the Saint Maurice Hospitals.	Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2001, Pediatr Rehabil, V4, P119, DOI 10.1080/13638490110091347; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Campiglia M, 2014, EPILEPSY BEHAV, V39, P12, DOI 10.1016/j.yebeh.2014.07.023; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; Chevignard MP, 2010, CURR OPIN NEUROL, V23, P695, DOI 10.1097/WCO.0b013e328340296f; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Fournet N, 2015, CHILD NEUROPSYCHOL, V21, P379, DOI 10.1080/09297049.2014.906569; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Garth J, 1997, Pediatr Rehabil, V1, P99; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gioia GA, 2010, J HEAD TRAUMA REHAB, V25, P433, DOI 10.1097/HTR.0b013e3181fbc272; HOLM S, 1979, SCAND J STAT, V6, P65; INSEE, 2003, NOM PROF CAT SOC; Krasny-Pacini A, 2014, J HEAD TRAUMA REHAB, V29, pE49, DOI 10.1097/HTR.0000000000000015; Kurowski BG, 2014, JAMA PEDIATR, V168, P523, DOI 10.1001/jamapediatrics.2013.5070; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Longaud-Vales A, 2016, NEUROPSYCHOL REHABIL, V26, P558, DOI 10.1080/09602011.2015.1048253; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Osorio MB, 2013, PM&R, V5, P554, DOI 10.1016/j.pmrj.2012.11.006; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; PRICE BH, 1990, BRAIN, V113, P1383, DOI 10.1093/brain/113.5.1383; Roy A, 2012, BEHAV RATING INVENTO; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Treble-Barna A, 2016, J HEAD TRAUMA REHAB, V31, P407, DOI 10.1097/HTR.0000000000000200; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Ward Platt MP, 1998, INJURY IN THE YOUNG, P263; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Wochos GC, 2014, CLIN NEUROPSYCHOL, V28, P1243, DOI 10.1080/13854046.2014.971875; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P247	64	7	7	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					E1	E12		10.1097/HTR.0000000000000295			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100001	28195957				2022-02-06	
J	Crosson, B; Hampstead, BM; Krishnamurthy, LC; Krishnamurthy, V; McGregor, KM; Nocera, JR; Roberts, S; Rodriguez, AD; Tran, SM				Crosson, Bruce; Hampstead, Benjamin M.; Krishnamurthy, Lisa C.; Krishnamurthy, Venkatagiri; McGregor, Keith M.; Nocera, Joe R.; Roberts, Simone; Rodriguez, Amy D.; Tran, Stella M.			Advances in Neurocognitive Rehabilitation Research From 1992 to 2017: The Ascension of Neural Plasticity	NEUROPSYCHOLOGY			English	Article						neural plasticity; neurorehabilitation; neuroimaging; noninvasive brain stimulation; aerobic exercise	DIRECT-CURRENT STIMULATION; MILD COGNITIVE IMPAIRMENT; PRIMARY PROGRESSIVE APHASIA; TRAUMATIC BRAIN-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; VOXEL-BASED MORPHOMETRY; ALZHEIMERS ASSOCIATION WORKGROUPS; NETWORK STRENGTHENING TREATMENT; HEALTHY OLDER-ADULTS; AEROBIC EXERCISE	Objective: The last 25 years have seen profound changes in neurocognitive rehabilitation that continue to motivate its evolution. Although the concept of nervous system plasticity was discussed by William James (1890), the foundation for experience-based plasticity had not reached the critical empirical mass to seriously impact rehabilitation research until after 1992. The objective of this review is to describe how the emergence of neural plasticity has changed neurocognitive rehabilitation research. Method: The important developments included (a) introduction of a widely available tool that could measure brain plasticity (i.e., functional MRI); (b) development of new structural imaging techniques that could define limits of and opportunities for neural plasticity; (c) deployment of noninvasive brain stimulation to leverage neural plasticity for rehabilitation; (d) growth of a literature indicating that exercise has positively impacts neural plasticity, especially for older persons; and (e) enhancement of neural plasticity by creating interventions that generalize beyond the boundaries of treatment activities. Given the massive literature, each of these areas is developed by example. Results: The expanding influence of neural plasticity has provided new models and tools for neurocognitive rehabilitation in neural injuries and disorders, as well as methods for measuring neural plasticity and predicting its limits and opportunities. Early clinical trials have provided very encouraging results. Conclusion: Now that neural plasticity has gained a firm foothold, it will continue to influence the evolution of neurocognitive rehabilitation research for the next 25 years and advance rehabilitation for neural injuries and disease. General Scientific Summary Neural plasticity refers to the ability of the nervous system to change in response to experience, and because it is responsible for our ability to learn new facts and procedures, it is the foundation for all neurorehabilitation. This review describes how the concept of neural plasticity, the application of its principles, and the ability to induce it and measure it have revolutionized neurocognitive rehabilitation research for neural injuries and disorders over the last 25 years. Developments in this area have given us a greater understanding of brain-behavior changes underlying rehabilitation, which is allowing rehabilitation scientists to devise exciting new approaches.	[Crosson, Bruce] Atlanta Vet Affairs Med Ctr, Vet Affairs Rehabil Res & Dev Ctr Visual & Neuroc, Decatur, GA USA; [Crosson, Bruce] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Crosson, Bruce; Roberts, Simone; Tran, Stella M.] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Hampstead, Benjamin M.] Vet Affairs Ann Arbor Healthcare Syst, Dept Mental Hlth Serv, Neuropsychol Sect, Ann Arbor, MI USA; [Hampstead, Benjamin M.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Hampstead, Benjamin M.] Univ Michigan, Michigan Alzheimers Dis Core Ctr, Ann Arbor, MI 48109 USA; [Hampstead, Benjamin M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Krishnamurthy, Lisa C.] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30303 USA; [Krishnamurthy, Lisa C.; Krishnamurthy, Venkatagiri; McGregor, Keith M.; Nocera, Joe R.; Rodriguez, Amy D.] Atlanta Vet Affairs Med Ctr, Vet Affairs Rehabil Res, Decatur, GA USA; [Krishnamurthy, Lisa C.; Krishnamurthy, Venkatagiri; McGregor, Keith M.; Nocera, Joe R.; Rodriguez, Amy D.] Atlanta Vet Affairs Med Ctr, Dev Ctr Visual & Neurocognit Rehabil, Decatur, GA USA; [Krishnamurthy, Venkatagiri; McGregor, Keith M.; Nocera, Joe R.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA		Crosson, B (corresponding author), Atlanta VA Med Ctr, Ctr Visual & Neurocognit Rehabil, 1670 Clairmont Rd 151R, Decatur, GA 30033 USA.	bruce.crosson@emory.edu	McGregor, Keith/X-1162-2018; Rodriguez, Amy/ABH-8007-2020	McGregor, Keith/0000-0003-3654-351X; Krishnamurthy, Lisa/0000-0003-3899-9510	Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [C9246C, B6364L, E0956W, B8034W, C2238P, IRX001534]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG053760]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG053760] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2RX000956, I01RX001534] Funding Source: NIH RePORTER	Work on this review was supported by the Veterans Affairs Rehabilitation Research and Development Service (Grants C9246C, B6364L, E0956W, B8034W, C2238P, IRX001534) and the National Institute on Aging (Grant P30AG053760).	Agarwal M, 2016, ASIAN J PSYCHIATR, V21, P31, DOI 10.1016/j.ajp.2016.02.007; Ailion AS, 2016, J INT NEUROPSYCH SOC, V22, P501, DOI 10.1017/S1355617716000138; ALBERT DJ, 1966, NEUROPSYCHOLOGIA, V4, P65, DOI 10.1016/0028-3932(66)90021-2; ALBERT DJ, 1966, NEUROPSYCHOLOGIA, V4, P49, DOI 10.1016/0028-3932(66)90020-0; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; Altmann LJP, 2014, J SPEECH LANG HEAR R, V57, P439, DOI 10.1044/1092-4388(2013/12-0224); Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BARKER AT, 1985, LANCET, V1, P1106; Basso Anna, 2013, Handb Clin Neurol, V110, P325, DOI 10.1016/B978-0-444-52901-5.00027-7; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Belleville S, 2011, BRAIN, V134, P1623, DOI 10.1093/brain/awr037; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; Benjamin ML, 2014, NEUROREHAB NEURAL RE, V28, P545, DOI 10.1177/1545968313517754; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Beschin N, 1997, CORTEX, V33, P379, DOI 10.1016/S0010-9452(08)70013-3; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; BISIACH E, 1978, CORTEX, V14, P129, DOI 10.1016/S0010-9452(78)80016-1; Bislick L. P., 2014, J MED SPEECH-LANG PA, V21, P15; Blanchet S, 2016, INT J REHABIL RES, V39, P153, DOI 10.1097/MRR.0000000000000161; BLUMENTHAL JA, 1989, J GERONTOL, V44, pM147, DOI 10.1093/geronj/44.5.M147; Boggio PS, 2009, J NEUROL NEUROSUR PS, V80, P444, DOI 10.1136/jnnp.2007.141853; Boggio PS, 2012, BRAIN STIMUL, V5, P223, DOI 10.1016/j.brs.2011.06.006; Bonelli SB, 2012, EPILEPSIA, V53, P639, DOI 10.1111/j.1528-1167.2012.03433.x; Bonilha L, 2016, NEUROREHAB NEURAL RE, V30, P266, DOI 10.1177/1545968315593808; Bott NT, 2014, NEURODEGENER DIS MAN, V4, P439, DOI [10.2217/NMT.14.34, 10.2217/nmt.14.34]; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brookshire CE, 2014, AM J SPEECH-LANG PAT, V23, P300, DOI 10.1044/2014_AJSLP-13-0083; Bystad M, 2016, BRAIN STIMUL, V9, P634, DOI 10.1016/j.brs.2016.04.018; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Chetelat G, 2002, NEUROREPORT, V13, P1939; Clark VP, 2011, NEUROSCI LETT, V500, P67, DOI 10.1016/j.neulet.2011.05.244; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Grecco LAC, 2014, RES DEV DISABIL, V35, P2840, DOI 10.1016/j.ridd.2014.07.030; Cotelli M, 2016, BRAIN TOPOGR, V29, P738, DOI 10.1007/s10548-016-0494-2; Cotelli M, 2014, J ALZHEIMERS DIS, V39, P799, DOI 10.3233/JAD-131427; Crinion JT, 2015, CURR OPIN NEUROL, V28, P330, DOI 10.1097/WCO.0000000000000217; Crinion JT, 2007, CURR OPIN NEUROL, V20, P667, DOI 10.1097/WCO.0b013e3282f1c6fa; Crosson B, 2007, NEUROPSYCHOL REV, V17, P157, DOI 10.1007/s11065-007-9024-z; Crosson B, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00307; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Dhaliwal SK, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00119; Doppelmayr M, 2016, J INT NEUROPSYCH SOC, V22, P928, DOI 10.1017/S1355617716000345; Doricchi F, 2003, NEUROREPORT, V14, P2239, DOI 10.1097/00001756-200312020-00021; DOYLE PJ, 1989, J APPL BEHAV ANAL, V22, P157, DOI 10.1901/jaba.1989.22-157; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Duncan ES, 2016, BRAIN CONNECT, V6, P524, DOI 10.1089/brain.2016.0437; DUSTMAN RE, 1984, NEUROBIOL AGING, V5, P35, DOI 10.1016/0197-4580(84)90083-6; Dustman RE, 1996, BRAIN COGNITION, V30, P109, DOI 10.1006/brcg.1996.0007; Edmonds LA, 2016, TOP LANG DISORD, V36, P123, DOI 10.1097/TLD.0000000000000088; Edmonds LA, 2014, AM J SPEECH-LANG PAT, V23, P312, DOI 10.1044/2014_AJSLP-13-0098; Edmonds LA, 2011, AM J SPEECH-LANG PAT, V20, P131, DOI 10.1044/1058-0360(2011/10-0036); Edmonds LA, 2009, APHASIOLOGY, V23, P402, DOI 10.1080/02687030802291339; ELSAYED M, 1980, J GERONTOL, V35, P383, DOI 10.1093/geronj/35.3.383; Endo H, 2006, EXP BRAIN RES, V174, P426, DOI 10.1007/s00221-006-0477-8; Erickson KI, 2009, BRIT J SPORT MED, V43, P22, DOI 10.1136/bjsm.2008.052498; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; FREEDMAN M, 1984, NEUROLOGY, V34, P409, DOI 10.1212/WNL.34.4.409; Fridriksson J, 2015, CORTEX, V69, P68, DOI 10.1016/j.cortex.2015.04.013; Fridriksson J, 2010, J NEUROSCI, V30, P11558, DOI 10.1523/JNEUROSCI.2227-10.2010; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; Fyock Courtney A, 2015, Alzheimers Dement (Amst), V1, P242; Gervits F, 2016, BRAIN LANG, V162, P35, DOI 10.1016/j.bandl.2016.05.007; GLISKY EL, 1992, NEUROPSYCHOLOGIA, V30, P899, DOI 10.1016/0028-3932(92)90034-J; Goldstein K, 1942, EFFECTS BRAIN INJURY; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Hampstead B. M., 2017, NTC01958437; Hampstead B. M., 2017, NTC02155946; Hampstead BM, 2014, BRAIN STIMUL, V7, P314, DOI 10.1016/j.brs.2013.12.006; Hampstead BM, 2012, HIPPOCAMPUS, V22, P1652, DOI 10.1002/hipo.22006; Hampstead BM, 2012, NEUROPSYCHOLOGY, V26, P385, DOI 10.1037/a0027545; Hampstead BM, 2011, NEUROREHAB NEURAL RE, V25, P210, DOI 10.1177/1545968310382424; HASSMEN P, 1992, EUR J APPL PHYSIOL, V64, P460, DOI 10.1007/BF00625068; HAWKINS HL, 1992, PSYCHOL AGING, V7, P643, DOI 10.1037/0882-7974.7.4.643; Hays CC, 2016, CELL MOL NEUROBIOL, V36, P167, DOI 10.1007/s10571-015-0261-z; HEILMAN KM, 1990, NEUROPSYCHOLOGIA, V28, P161, DOI 10.1016/0028-3932(90)90098-9; Holzschneider K, 2012, NEUROIMAGE, V59, P3003, DOI 10.1016/j.neuroimage.2011.10.021; Hsu WY, 2015, NEUROBIOL AGING, V36, P2348, DOI 10.1016/j.neurobiolaging.2015.04.016; Huey ED, 2007, CLIN NEUROPHYSIOL, V118, P1417, DOI 10.1016/j.clinph.2007.02.026; HUGHES JR, 1984, PREV MED, V13, P66, DOI 10.1016/0091-7435(84)90041-0; Hyodo K, 2012, NEUROBIOL AGING, V33, P2621, DOI 10.1016/j.neurobiolaging.2011.12.022; Jackson MP, 2016, CLIN NEUROPHYSIOL, V127, P3425, DOI 10.1016/j.clinph.2016.08.016; James W., 1890, PRINCIPLES PSYCHOL; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Jennett B, 1981, MANAGEMENT HEAD INJU; Karnath HO, 2011, BRAIN, V134, P903, DOI 10.1093/brain/awq355; Karnath HO, 2009, CEREB CORTEX, V19, P2331, DOI 10.1093/cercor/bhn250; Kelley AS, 2015, ANN INTERN MED, V163, P729, DOI 10.7326/M15-0381; Kendall DL, 2008, BRAIN LANG, V105, P1, DOI 10.1016/j.bandl.2007.11.007; Kendall DL, 2006, J REHABIL RES DEV, V43, P409, DOI 10.1682/JRRD.2005.11.0175; Kendall DL, 2015, J SPEECH LANG HEAR R, V58, P798, DOI 10.1044/2015_JSLHR-L-14-0131; Kendall DL, 2003, APHASIOLOGY, V17, P1073, DOI 10.1080/02687030344000355; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Khedr EM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00275; KINSELLA G, 1993, CORTEX, V29, P135, DOI 10.1016/S0010-9452(13)80217-1; Kiran S, 2003, J SPEECH LANG HEAR R, V46, P773, DOI 10.1044/1092-4388(2003/061); Kiran S, 2009, APHASIOLOGY, V23, P835, DOI 10.1080/02687030802588866; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kozyrev V, 2014, P NATL ACAD SCI USA, V111, P13553, DOI 10.1073/pnas.1405508111; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lardon MT, 1996, BIOL PSYCHOL, V44, P19, DOI 10.1016/S0301-0511(96)05198-8; Lee J, 2010, APHASIOLOGY, V24, P449, DOI 10.1080/02687030802714157; Lenz M, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00096; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; Lezak M. D., 2012, NEUROLOGICAL ASSESSM; Lithfous S, 2013, AGEING RES REV, V12, P201, DOI 10.1016/j.arr.2012.04.007; Luria A. R, 1962, HIGHER CORTICAL FUNC; MADDEN DJ, 1989, PSYCHOL AGING, V4, P307, DOI 10.1037/0882-7974.4.3.307; Manenti R, 2016, MOVEMENT DISORD, V31, P715, DOI 10.1002/mds.26561; Marceglia S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00134; Marzolini S, 2013, NEUROREHAB NEURAL RE, V27, P392, DOI 10.1177/1545968312465192; McClung JS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00183; McDonald CR, 2001, NEUROCASE, V7, P407, DOI 10.1076/neur.7.5.407.16250; McGregor KM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00066; McGregor KM, 2011, BEHAV BRAIN RES, V222, P158, DOI 10.1016/j.bbr.2011.03.042; McGregor KM, 2009, BRAIN IMAGING BEHAV, V3, P317, DOI 10.1007/s11682-009-9074-3; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meinzer M, 2015, ALZHEIMERS DEMENT, V11, P1032, DOI 10.1016/j.jalz.2014.07.159; Meinzer M, 2013, NEUROIMAGE, V73, P215, DOI 10.1016/j.neuroimage.2012.02.058; Meinzer M, 2011, APHASIOLOGY, V25, P271, DOI 10.1080/02687038.2010.530672; Meinzer M, 2010, NEUROIMAGE, V53, P283, DOI 10.1016/j.neuroimage.2010.06.004; Menke R, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-118; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Moffat SD, 2009, NEUROPSYCHOL REV, V19, P478, DOI 10.1007/s11065-009-9120-3; Moliadze V, 2015, CLIN NEUROPHYSIOL, V126, P1392, DOI 10.1016/j.clinph.2014.10.142; Moss A, 2006, STROKE, V37, P3043, DOI 10.1161/01.STR.0000249427.74970.15; Na DL, 1998, J NEUROL NEUROSUR PS, V64, P331, DOI 10.1136/jnnp.64.3.331; Nadeau S. E., 2008, LANGUAGE INTERVENTIO, P689; Naeser MA, 1998, ARCH NEUROL-CHICAGO, V55, P1438, DOI 10.1001/archneur.55.11.1438; NAESER MA, 1989, BRAIN, V112, P1, DOI 10.1093/brain/112.1.1; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Neumann K, 2005, J FLUENCY DISORD, V30, P23, DOI 10.1016/j.jfludis.2004.12.002; Nickels L, 2002, APHASIOLOGY, V16, P935, DOI 10.1080/02687030244000563; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Nocera JR, 2015, J AGING PHYS ACTIV, V23, P90, DOI [10.1123/JAPA.2013-0107, 10.1123/japa.2013-0107]; NUDO RJ, 1990, SOMATOSENS MOT RES, V7, P463, DOI 10.3109/08990229009144720; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Odegard TN, 2008, ANN DYSLEXIA, V58, P1, DOI 10.1007/s11881-008-0014-5; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; PASCUALLEONE A, 1991, NEUROLOGY, V41, P697, DOI 10.1212/WNL.41.5.697; Pennanen C, 2005, J NEUROL NEUROSUR PS, V76, P11, DOI 10.1136/jnnp.2004.035600; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; PIZZAMIGLIO L, 1992, J CLIN EXP NEUROPSYC, V14, P901, DOI 10.1080/01688639208402543; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Ploughman M, 2015, TRANSL STROKE RES, V6, P13, DOI 10.1007/s12975-014-0357-7; Poldrack RA, 2012, NEUROIMAGE, V62, P1216, DOI 10.1016/j.neuroimage.2011.08.007; Prakash RS, 2015, ANNU REV PSYCHOL, V66, P769, DOI 10.1146/annurev-psych-010814-015249; Prakash RS, 2011, J INT NEUROPSYCH SOC, V17, P986, DOI 10.1017/S1355617711001093; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Quaney BM, 2009, NEUROREHAB NEURAL RE, V23, P879, DOI 10.1177/1545968309338193; Rabin ML, 2004, BRAIN, V127, P2286, DOI 10.1093/brain/awh281; Rahman-Filipiak A., PRACTICAL GUIDE TRAN; Rapp B, 2013, NEUROIMAGE, V73, P200, DOI 10.1016/j.neuroimage.2012.09.007; ROBEY RR, 1994, BRAIN LANG, V47, P582, DOI 10.1006/brln.1994.1060; Robey RR, 1998, APHASIOLOGY, V12, P787, DOI 10.1080/02687039808249573; ROSSI PW, 1990, NEUROLOGY, V40, P1597, DOI 10.1212/WNL.40.10.1597; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Sandberg CW, 2015, BRAIN LANG, V150, P103, DOI 10.1016/j.bandl.2015.09.002; Sathian, 2015, COGNITIVE PLASTICITY, P61; Saykin A. J., 2014, CLIN NEUROPSYCHOLOGY, P266; Schwartz MF, 1999, NEUROPSYCHOLOGIA, V37, P51; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; SHAY KA, 1992, PSYCHOL AGING, V7, P15, DOI 10.1037/0882-7974.7.1.15; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Singh AM, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-23; Smith JC, 2011, NEUROIMAGE, V54, P635, DOI 10.1016/j.neuroimage.2010.07.070; Society for Neuroscience, 2017, ANN M ATT STAT; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; SPIRDUSO WW, 1975, J GERONTOL, V30, P435, DOI 10.1093/geronj/30.4.435; Suarez RO, 2014, EPILEPSY RES, V108, P1874, DOI 10.1016/j.eplepsyres.2014.09.016; Suemoto CK, 2014, BRAIN STIMUL, V7, P308, DOI 10.1016/j.brs.2013.10.003; Tang A, 2016, J REHABIL MED, V48, P841, DOI 10.2340/16501977-2163; Teichmann M, 2016, ANN NEUROL, V80, P693, DOI 10.1002/ana.24766; Thompson CK, 2003, J SPEECH LANG HEAR R, V46, P591, DOI 10.1044/1092-4388(2003/047); Tipton CM, 2014, ADV PHYSIOL EDUC, V38, P109, DOI 10.1152/advan.00136.2013; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Tsapkini K, 2014, APHASIOLOGY, V28, P1112, DOI 10.1080/02687038.2014.930410; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Valenstein, 2012, CLIN NEUROPSYCHOLOGY, P296; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Verdon V, 2010, BRAIN, V133, P880, DOI 10.1093/brain/awp305; Voss MW, 2013, BRAIN BEHAV IMMUN, V28, P90, DOI 10.1016/j.bbi.2012.10.021; WAMBAUGH JL, 1989, J SPEECH HEAR DISORD, V54, P509, DOI 10.1044/jshd.5404.509; Wang J, 2013, NEUROSCI LETT, V549, P29, DOI 10.1016/j.neulet.2013.06.019; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wasylyshyn C, 2011, PSYCHOL AGING, V26, P15, DOI 10.1037/a0020912; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Wierenga CE, 2008, NEUROBIOL AGING, V29, P436, DOI 10.1016/j.neurobiolaging.2006.10.024; Wilson BA, 1991, NEUROPSYCHOL REHABIL, V1, P5, DOI DOI 10.1080/09602019108401377; ZANGWILL OL, 1945, BRIT MED J, V2, P248, DOI 10.1136/bmj.2.4416.248; Zheng GH, 2016, J STROKE CEREBROVASC, V25, P2780, DOI 10.1016/j.jstrokecerebrovasdis.2016.07.035; Zlatar ZZ, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00005; Zlatar ZZ, 2013, J INT NEUROPSYCH SOC, V19, P625, DOI 10.1017/S1355617713000246	210	7	7	1	20	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	NOV	2017	31	8			SI		900	920		10.1037/neu0000396			21	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FT6JH	WOS:000423259900005	28857600	Green Accepted, Bronze			2022-02-06	
J	Dhillon, NK; Ko, A; Smith, EJT; Kharabi, M; Castongia, J; Nurok, M; Gewertz, BL; Ley, EJ				Dhillon, Navpreet K.; Ko, Ara; Smith, Eric J. T.; Kharabi, Mayumi; Castongia, Joseph; Nurok, Michael; Gewertz, Bruce L.; Ley, Eric J.			Potentially Avoidable Surgical Intensive Care Unit Admissions and Disposition Delays	JAMA SURGERY			English	Article							PALLIATIVE CARE; COST; END; PERCEPTIONS; SAVINGS; WASTE	IMPORTANCE High health care costs encourage initiatives that avoid overuse of resources and identify opportunities to promote appropriate care. OBJECTIVE To investigate the causes of potentially avoidable surgical intensive care unit (SICU) admissions and disposition delays to determine whether targeted interventions could decrease these stays. DESIGN, SETTING, AND PARTICIPANTS This prospective, observational study focused on potentially avoidable SICU days, as determined by observers with input from the rounding intensivists at a 24-bed open SICU at an urban, academic hospital. The preintervention phase occurred from April 6 through June 21, 2015; after implementation of targeted interventions, the postintervention phase occurred from April 4 through June 28, 2016. Data collected included demographic characteristics, reason for admission, and length of stay. All patients admitted to the SICU during the preintervention and postintervention phases were included in the analysis. INTERVENTIONS Based on results collected in the preintervention phase, targeted interventions were designed and implemented from July 1, 2015, through March 31, 2016, including (1) reducing SICU care for minor traumatic brain injury, (2) optimizing postoperative airway management, (3) enhancing communication between services regarding transfers to the SICU, (4) identifying and facilitating more timely end-of-life conversations and supportive care consultations, and (5) encouraging early disposition of patients to floor beds. MAIN OUTCOMES AND MEASURES Changes in the proportion of potentially avoidable SICU days owing to potentially avoidable admissions and/or disposition delays. RESULTS A total of 459 patients (253 men [55.1%] and 206 women [44.9%]; median age, 62 years [interquartile range, 46-75 years]) were admitted during the preintervention and postintervention phases. Of 261 patients admitted during the preintervention period and 245 during the postintervention period, median SICU and hospital length of stay remained unchanged. A reduction was noted in the percentage of postintervention SICU days owing to potentially avoidable admissions (152 of 1168 days [13%] vs 118 of 1338 days [8.8%]; P =.001) and disposition delays (138 of 1168 days [11.8%] vs 97 of 1338 days [7.2%]; P <.001). During the postintervention period, decreases were noted in the SICU days related to the most common sources of potentially avoidable admissions (SICU stay <= 24 hours, airway concerns, and somnolence) and disposition delays (end-of-life decisions and floor bed unavailable) as well as in the overall rate of potentially avoidable days (269 of 1168 days [23%] vs 205 of 1338 days [15.3%]; P <.001). CONCLUSIONS AND RELEVANCE Nearly one-fourth of SICU days could be categorized as potentially avoidable. Targeted interventions resulted in a significant reduction of potentially avoidable SICU days.	[Dhillon, Navpreet K.; Ko, Ara; Smith, Eric J. T.; Nurok, Michael; Gewertz, Bruce L.; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, 8700 Beverly Blvd,Ste 8215NT, Los Angeles, CA 90048 USA; [Kharabi, Mayumi; Castongia, Joseph] Cedars Sinai Med Ctr, Human Ctr Design Team, Los Angeles, CA 90048 USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, 8700 Beverly Blvd,Ste 8215NT, Los Angeles, CA 90048 USA.	eric.ley@cshs.org					Almoosa KF, 2016, J HEALTHC QUAL, V38, pe29, DOI 10.1097/JHQ.0000000000000040; BAIGELMAN W, 1985, INTENS CARE MED, V11, P304, DOI 10.1007/BF00273541; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Bramley T, 2016, J MED ECON, V19, P1075, DOI 10.1080/13696998.2016.1197130; Chaix C, 1999, PHARMACOECONOMICS, V15, P573, DOI 10.2165/00019053-199915060-00005; Chang DW, 2016, JAMA INTERN MED, V176, P1492, DOI 10.1001/jamainternmed.2016.4298; Colla CH, 2016, AM J MANAG CARE, V22, P337; Daly B, 2016, J ONCOL PRACT, V12, pE901, DOI 10.1200/JOP.2016.012823; DAVISON G, 1990, J GEN INTERN MED, V5, P474, DOI 10.1007/BF02600872; Fenton SJ, 2016, J PEDIATR SURG, V51, P1688, DOI 10.1016/j.jpedsurg.2016.05.022; Giannini A, 2006, BRIT J ANAESTH, V96, P57, DOI 10.1093/bja/aei276; Hammond DA, 2017, PHARMACOTHERAPY, V37, P43, DOI 10.1002/phar.1859; Hernu R, 2016, INTENS CARE MED, V42, P1312, DOI 10.1007/s00134-016-4409-1; Huynh TN, 2014, CRIT CARE MED, V42, P1977, DOI 10.1097/CCM.0000000000000402; Johnson DW, 2013, CRIT CARE, V17, DOI 10.1186/cc12807; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Khandelwal N, 2016, J PALLIAT MED, V19, P1171, DOI 10.1089/jpm.2016.0133; Kirton OC, 1996, SURG CLIN N AM, V76, P175, DOI 10.1016/S0039-6109(05)70430-8; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Luce JM, 2002, AM J RESP CRIT CARE, V165, P750, DOI 10.1164/ajrccm.165.6.2109045; Maltoni M, 2016, EUR J CANCER, V69, P110, DOI 10.1016/j.ejca.2016.10.004; Mirghani HM, 2004, INT J OBSTET ANESTH, V13, P82, DOI 10.1016/j.ijoa.2003.10.004; Morgan DJ, 2016, JAMA INTERN MED, V176, P1687, DOI 10.1001/jamainternmed.2016.5381; Osinaike BB, 2016, NIGER J CLIN PRACT, V19, P721, DOI 10.4103/1119-3077.181354; Peltonen LM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/868653; Shine NP, 2006, ANAESTH INTENS CARE, V34, P724, DOI 10.1177/0310057X0603400607; SWANN D, 1993, CAN J ANAESTH, V40, P137, DOI 10.1007/BF03011311; Vlayen Annemie, 2011, JBI Libr Syst Rev, V9, P925; Waite K, 2017, AM J HOSP PALLIAT ME, V34, P977, DOI 10.1177/1049909116673300; Zalenski RJ, 2017, J PAIN SYMPTOM MANAG, V53, P5, DOI 10.1016/j.jpainsymman.2016.08.003	32	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6254	2168-6262		JAMA SURG	JAMA Surg.	NOV	2017	152	11					1015	1022		10.1001/jamasurg.2017.2165			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FN0II	WOS:000415661100007	28724143	Green Published			2022-02-06	
J	Eisenried, A; Meidahl, ACN; Klukinov, M; Tzabazis, AZ; Sabbadini, RA; Clark, JD; Yeomans, DC				Eisenried, Andreas; Meidahl, Anders C. N.; Klukinov, Michael; Tzabazis, Alexander Z.; Sabbadini, Roger A.; Clark, J. David; Yeomans, David C.			Nervous system delivery of antilysophosphatidic acid antibody by nasal application attenuates mechanical allodynia after traumatic brain injury in rats	PAIN			English	Article						Naso-cerebral; Trigeminal pain; Monoclonal antibody; Intranasal	INDUCED NEUROPATHIC PAIN; CLOSED HEAD-INJURY; LYSOPHOSPHATIDIC ACID; MOLECULAR-MECHANISMS; SPINAL-CORD; MICE; NEUROINFLAMMATION; EXPRESSION; BARRIER; FLUID	Lysophosphatidic acid (LPA) is a bioactive lipid that impacts neurological outcomes after neurotrauma by inhibiting neuroregeneration, promoting inflammation, and contributing to behavioral deficits. Blocking LPA signaling with a novel anti-LPA monoclonal antibody (mAb) is neuroprotective after traumatic brain injury (TBI) if given to injured animals whose blood-brain barrier (BBB) has been compromised. It is hypothesized that the anti-LPA mAb could improve chronic pain initiated by TBI. However, poor brain penetration after systemic application of the antibody makes access to the central nervous system (CNS) problematic in situations where the BBB is intact. Our experiments investigated whether intranasal delivery of the anti-LPA mAb could bypass the BBB, allowing for direct entry of the antibody to certain areas of the CNS. When the humanized anti-LPA mAb, LT3114, was intranasally applied to injured rats within 30 minutes after mild TBI using the central lateral percussion model, enzyme-linked immunospecific assay and immunohistochemistry demonstrated antibody uptake to several areas in the CNS, including the area of cortical injury, the corpus callosum, cerebellum, and the subventricular region. Compared with control rats that received LT3114 but no TBI, TBI rats demonstrated significantly higher concentrations of intranasally administered LT3114 antibody in some tissues. In behavioral studies, a significant attenuation of mechanical allodynia after TBI was observed in the anti-LPA treatment group (P = 0.0079), when compared with vehicle controls within 14 days after TBI. These results suggest that intranasal application of the anti-LPA antibody directly accesses CNS sites involved in TBI-related pain and that this access attenuates pain sequelae to the neurotrauma.	[Eisenried, Andreas; Meidahl, Anders C. N.; Klukinov, Michael; Tzabazis, Alexander Z.; Sabbadini, Roger A.; Clark, J. David; Yeomans, David C.] Stanford Univ, Dept Anesthesia Pain & Perioperat Med, 300 Pasteur Dr, Stanford, CA 94305 USA; [Eisenried, Andreas] Univ Klinikum Erlangen, Klin Anasthesiol, Erlangen, Germany		Yeomans, DC (corresponding author), Stanford Univ, Dept Anesthesia Pain & Perioperat Med, 300 Pasteur Dr, Stanford, CA 94305 USA.	dcyeomans@stanford.edu		Meidahl, Anders Christian/0000-0002-8404-4742	Department of Defense (CDMRP)United States Department of Defense [MR141271]; Department of Anesthesia, Pain and Perioperative Medicine, Stanford University, USA; Veterans AffairsUS Department of Veterans Affairs [I01RX001776] Funding Source: NIH RePORTER	Supported by Grant number MR141271 from the Department of Defense (CDMRP) and by the Department of Anesthesia, Pain and Perioperative Medicine, Stanford University, USA. In addition, the antibodies used in this study were provided by Lpath Inc.	Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Crack PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-37; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; Digicaylioglu M, 2010, EXPERT OPIN BIOL TH, V10, P937, DOI 10.1517/14712598.2010.481435; Ellis A, 2013, BRIT J ANAESTH, V111, P26, DOI 10.1093/bja/aet128; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Francis G, 2009, DIABETES, V58, P934, DOI 10.2337/db08-1287; Frey WH, 2014, treatment of central nervous system disorders by intranasal administration of immunoglobulin g, Patent No. [US 2014/0242067 A1, 20140242067]; Frisca F, 2012, INT REV CEL MOL BIO, V296, P273, DOI 10.1016/B978-0-12-394307-1.00005-9; Frugier T, 2011, CELL MOL NEUROBIOL, V31, P569, DOI 10.1007/s10571-011-9650-0; Fujita R, 2008, J NEUROCHEM, V107, P152, DOI 10.1111/j.1471-4159.2008.05599.x; Furrer E, 2009, J NEUROIMMUNOL, V215, P65, DOI 10.1016/j.jneuroim.2009.08.005; Goldshmit Y, 2012, AM J PATHOL, V181, P978, DOI 10.1016/j.ajpath.2012.06.007; Goldshmit Y, 2010, CELL TISSUE RES, V341, P23, DOI 10.1007/s00441-010-0977-5; Halder SK, 2013, NEUROSCIENCE, V235, P10, DOI 10.1016/j.neuroscience.2013.01.005; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Inoue M, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-6; Johnson NJ, 2010, MOL PHARMACEUT, V7, P884, DOI 10.1021/mp100029t; Ling G.S., 2004, CURR PROTOC NEUROSCI; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Ma L, 2009, J NEUROCHEM, V109, P603, DOI 10.1111/j.1471-4159.2009.05987.x; Ma MM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-117; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nirogi R, 2009, J NEUROSCI METH, V178, P116, DOI 10.1016/j.jneumeth.2008.12.001; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; Savaskan NE, 2007, CELL MOL LIFE SCI, V64, P230, DOI 10.1007/s00018-006-6412-0; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Schwedt TJ, 2011, CEPHALALGIA, V31, P6, DOI 10.1177/0333102410365108; Scranton RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018711; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Uchida H, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-71; Ueda H, 2006, PHARMACOL THERAPEUT, V109, P57, DOI 10.1016/j.pharmthera.2005.06.003; Xiao C, 2013, J ALZHEIMERS DIS, V35, P777, DOI 10.3233/JAD-122419; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yano R, 2013, CELL MOL NEUROBIOL, V33, P1033, DOI 10.1007/s10571-013-9970-3; Zhuo M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-31	46	7	7	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0304-3959	1872-6623		PAIN	Pain	NOV	2017	158	11					2181	2188		10.1097/j.pain.0000000000001019			8	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	FL9FV	WOS:000414559100016	29028747				2022-02-06	
J	Erlebach, R; Pagnamenta, A; Klinzing, S; Stretti, F; Cottini, S; Schupbach, R; Steiger, P; Brandi, G				Erlebach, Rolf; Pagnamenta, Alberto; Klinzing, Stephanie; Stretti, Federica; Cottini, Silvia; Schupbach, Reto; Steiger, Peter; Brandi, Giovanna			A ge-related outcome of patients after traumatic brain injury: a single-center observation	MINERVA ANESTESIOLOGICA			English	Article						Traumatic brain injury; Epidemiology; Aged; Intensive care units; Mortality; Glasgow Outcome Scale	PREINJURY WARFARIN; ELDERLY-PATIENTS; EPIDEMIOLOGY; MORTALITY; SEVERITY; FALLS; AGE; ANTICOAGULATION; CLASSIFICATION; POPULATION	BACKGROUND: The purpose of the present study was to analyze clinical features of patients with traumatic brain injury (TBI), their age-related outcomes and determinants of long-term outcome. METHODS: This retrospective cohort study was conducted in a level I University Swiss trauma center. Consecutive patients with moderate to severe TBI admitted for more than 48 hours to the Intensive Care Unit (ICU) were included. Patients' and trauma characteristics, management during ICU stay, prognostic scores and long-term outcomes were analyzed. RESULTS: Hundred-seventy-four patients (72% males, mean age 49 years) were divided in three age groups: young (<= 39 years, N.=69, 39.7%), middle aged (40-64 years, N.=55, 31.6%), and elderly (>= 65 years, N.=50, 28.7%). In elderly patients, falls (62%) were the most common cause of TBI. Overall ICU mortality was 15% with no difference among age groups. Within six-months after TBI, 80% of elderly patients presented unfavorable outcomes. Age, pre-existing cardiovascular disease, use of anticoagulants and/or antiplatelet agents, abnormal pupillary reactivity, a high score in Marshall CT classification, and a higher glucose level were associated with unfavorable outcomes in a univariable logistic regression. In a multivariable logistic regression, age and abnormal pupillary reactivity were identified as independent risk factors for unfavorable outcomes, while presence of epidural hematoma and higher hemoglobin levels were predictors for favorable outcomes. CONCLUSIONS: Older patients are at higher risk for long-term unfavorable outcomes than younger patients. Use of anticoagulants and/or antiplatelet agents and lower hemoglobin levels during rescue phase are associated with unfavorable long-term outcomes. Fall prevention in the elderly should be a key target of intervention programs.	[Erlebach, Rolf; Klinzing, Stephanie; Stretti, Federica; Cottini, Silvia; Schupbach, Reto; Steiger, Peter; Brandi, Giovanna] Univ Zurich Hosp, Unit Surg Intens Care, Ramistr 100, CH-8091 Zurich, Switzerland; [Pagnamenta, Alberto] Ente Osped Cantonale, Clin Epidemiol Unit, Bellinzona, Switzerland; [Stretti, Federica] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy		Brandi, G (corresponding author), Univ Zurich Hosp, Unit Surg Intens Care, Ramistr 100, CH-8091 Zurich, Switzerland.	giovanna.brandi@usz.ch	Schuepbach, Reto/AAO-6360-2020; Schuepbach, Reto A/J-9737-2012	Schuepbach, Reto/0000-0002-7058-4377; Schuepbach, Reto A/0000-0002-7058-4377			Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; [Anonymous], 2012, LANCET NEUROL, V11, P651, DOI 10.1016/S1474-4422(12)70166-7; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boutin A, 2016, TRANSFUS MED REV, V30, P15, DOI 10.1016/j.tmrv.2015.08.004; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cadotte DW, 2011, J NEUROSURG, V114, P1502, DOI 10.3171/2010.12.JNS10808; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Ernstberger A, 2015, INJURY, V46, pS135, DOI 10.1016/S0020-1383(15)30033-4; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gargett S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-270; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Howard JL, 2009, J TRAUMA, V66, P1518, DOI 10.1097/TA.0b013e3181a59728; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kool B, 2009, INJURY PREV, V15, P341, DOI 10.1136/ip.2008.021303; Litofsky NS, 2016, WORLD NEUROSURG, V90, P82, DOI 10.1016/j.wneu.2016.02.076; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Popescu C, 2015, J Med Life, V8, P272; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	37	7	7	0	2	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	NOV	2017	83	11					1169	1177		10.23736/S0375-9393.17.11837-7			9	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	FQ6IU	WOS:000418469000010	28643996				2022-02-06	
J	Gordon, WA; Spielman, LA; Hahn-Ketter, AE; Sy, KTL				Gordon, Wayne A.; Spielman, Lisa A.; Hahn-Ketter, Amanda E.; Sy, Karla Therese L.			The Relationship Between Traumatic Brain Injury and Criminality in Juvenile Offenders	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescents; juvenile offense; traumatic brain injury	HEALTH-CARE UTILIZATION; BEHAVIOR PROBLEMS; CHILDREN; PRACTITIONERS; PEDIATRICIAN	Objective: To examine the relationship between traumatic brain injury (TBI) and criminal behavior in youth who are incarcerated or on probation in Texas. Setting: Seven juvenile justice facilities. Participants: Juvenile offenders in state or county correctional facilities or on probation. Design: Screening for TBI was conducted among adolescents at 7 juvenile justice centers. Main Measures: Participants were administered the Brain Injury Screening Questionnaire, and results were linked to participants' offense history and psychiatric diagnoses. Results: One in 4 juvenile offenders met criteria for TBI, and the majority of injuries occurred prior to the adolescents' criminal offenses. A history of TBI was related to more violent crimes, as well asmoremental health diagnoses and symptoms. Conclusion: The high rates of TBI and levels of distress found in juvenile offenders suggest a need for preventive actions, interventions to compensate for challenges related to TBI, and programs to assist individuals' transitions into the community.	[Gordon, Wayne A.; Spielman, Lisa A.; Hahn-Ketter, Amanda E.; Sy, Karla Therese L.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave L Levy Pl,Box 1240, New York, NY 10029 USA		Gordon, WA (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave L Levy Pl,Box 1240, New York, NY 10029 USA.	wayne.gordon@mountsinai.org	Sy, Karla Therese/AAV-3945-2021	Sy, Karla Therese/0000-0003-0608-9811; Hahn-Ketter, Amanda/0000-0002-0226-3598	Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [H21MC16375]; Center for Disease Control and Prevention [5R49CE002092]	This project was supported by the Health Resources and Services Administration (grant #H21MC16375), and preparation of this article was supported in part by the Center for Disease Control and Prevention (grant #5R49CE002092). The authors acknowledge Bettie Peebles Beckworth, MEd, former director of the Office of Acquired Brain Injury, for her contributions to the grant and assistance with the preparation of the manuscript. The authors also acknowledge Princess Katana, MD, MEd, of the Texas Department of Health and Human Services for her support.	American Academy of Pediatrics DoHSR, 2014, 85 AM AC PED DOHSR; Association for the Advancement of Automotive Medicine; Committee on Injury Scaling, 1990, THE ABBREVIATED INJU; Attar Mohammad A, 2005, J Perinatol, V25, P36, DOI 10.1038/sj.jp.7211203; Beatty PC, 2007, PUBLIC OPIN QUART, V71, P287, DOI 10.1093/poq/nfm006; Centers for Disease Control and Prevention NCfIPaC, 2013, CONC MILD TBI; Centers for Disease ControlNational Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Dillman D., 2008, INTERNET MAIL MIXED; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Foy Jane Meschan, 2010, Pediatrics, V125 Suppl 3, pS69, DOI 10.1542/peds.2010-0788C; Glang A, 2008, NEUROREHABILITATION, V23, P477; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Groves R., 2004, SURVEY METHODOLOGY; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harden RM, 2005, J CONTIN EDUC HEALTH, V25, P43, DOI 10.1002/chp.8; Houtrow A, 2011, PM&R, V3, P45, DOI 10.1016/j.pmrj.2010.08.013; Iverson GL, 2012, REHABIL RES PRACT, V2012, P415; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Keenan HT, 2013, J HEAD TRAUMA REHAB, V28, P426, DOI 10.1097/HTR.0b013e31825935b8; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lewis CW, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.6.e84; Marcin JP, 2016, PEDIATR RES, V79, P169, DOI 10.1038/pr.2015.192; Myers K, 2015, J AM ACAD CHILD PSY, V54, P263, DOI 10.1016/j.jaac.2015.01.009; O'Rourke C, 2016, BRAIN INJURY, V30, P839, DOI 10.3109/02699052.2016.1146967; Papoutsis J, 2014, DEV NEUROPSYCHOL, V39, P638, DOI 10.1080/87565641.2014.979926; Pit SW, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-76; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Sneed RC, 2002, ARCH PHYS MED REHAB, V83, P416, DOI 10.1053/apmr.2002.29650; Stein REK, 2008, AMBUL PEDIATR, V8, P11, DOI 10.1016/j.ambp.2007.10.006; Stein REK, 2016, ACAD PEDIATR, V16, P115, DOI 10.1016/j.acap.2015.08.012; Stevens PK, 2010, BRAIN INJURY, V17, P178; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; TEASDALE G, 1974, LANCET, V2, P81; Vogt DS, 2004, PSYCHOL ASSESSMENT, V16, P231, DOI 10.1037/1040-3590.16.3.231	36	7	7	1	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					393	403		10.1097/HTR.0000000000000274			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100095	28060202				2022-02-06	
J	Kasamatsu, TM; McLeod, TCV; Register-Mihalik, JK; Bacon, CEW				Kasamatsu, Tricia M.; McLeod, Tamara C. Valovich; Register-Mihalik, Johna K.; Bacon, Cailee E. Welch			Teachers' beliefs and practices regarding academic support following concussion	TEACHING AND TEACHER EDUCATION			English	Article						Head injuries; Adolescents; Academic accommodations	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; PLANNED BEHAVIOR; HIGH-SCHOOL; SELF-EFFICACY; KNOWLEDGE; STUDENTS; ACCOMMODATIONS; ADOLESCENTS; PERCEPTIONS	Teachers play an important role in supporting students' return to school after concussion. This online cross sectional survey examined teachers' beliefs and practices regarding concussion and academic support strategies, or academic adjustments (AA). Most teachers (99.1%) agreed-to-strongly agreed concussions affect school performance, and many (71.6%) have worked with a student who received AA after concussion. Teachers who participated in concussion education and observed a decline in a student's academic performance after concussion were more familiar with and recommended AA more often. Professional development is recommended to provide teachers with practical and timely resources to enhance support for students after concussion. (C) 2017 Elsevier Ltd. All rights reserved.	[Kasamatsu, Tricia M.] Calif State Univ Fullerton, 800 N State Coll Blvd, Fullerton, CA 92831 USA; [McLeod, Tamara C. Valovich; Bacon, Cailee E. Welch] AT Still Univ, 5850 E Still Circle, Mesa, AZ 85206 USA; [Register-Mihalik, Johna K.] Univ North Carolina Chapel Hill, 209 Fetzer Hall, Chapel Hill, NC 27515 USA		Kasamatsu, TM (corresponding author), Calif State Univ Fullerton, 800 N State Coll Blvd, Fullerton, CA 92831 USA.	tkasamatsu@fullerton.edu; tmcleod@atsu.edu; johnakay@email.unc.edu; cwelch@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Kasamatsu, Tricia M./0000-0002-6911-6955	A.T. Still University Strategic Research Fund, Mesa, AZ [SRF_501-426]	This study was funded by the A.T. Still University Strategic Research Fund (SRF_501-426), Mesa, AZ.	Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Arroyos-Jurado E, 2008, INTERV SCH CLIN, V43, P252, DOI 10.1177/1053451208314907; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Birman BF, 2000, EDUC LEADERSHIP, V57, P28; Carson J. D., 2017, BRIT J SPORT MED, V51, pA83; Carzoo SA., 2015, ATHL TRAIN SPORTS HL, V7, P144; Chomitz VR, 2009, J SCHOOL HEALTH, V79, P30, DOI 10.1111/j.1746-1561.2008.00371.x; Cohen J., 2013, STAT POWER ANAL BEHA; Cook BG, 2000, EXCEPT CHILDREN, V67, P115, DOI 10.1177/001440290006700108; deBettencourt L. U., 2002, TEACHING EXCEPTIONAL, V34, P16, DOI DOI 10.1177/; Dreer L. E., 2017, HLTH PROMOTION PRACT, V18, P1; Egan J, 2002, J SCI TEACHER ED, V13, P71, DOI DOI 10.1023/A:1016565016116; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; FEISTRITZER CE, 2011, PROFILE TEACHERS US; Fives H, 2008, CONTEMP EDUC PSYCHOL, V33, P134, DOI 10.1016/j.cedpsych.2008.01.001; Frost JH, 2010, TEACH TEACH EDUC, V26, P225, DOI 10.1016/j.tate.2009.03.020; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Graff DM, 2016, J CHILD NEUROL, V31, P1569, DOI 10.1177/0883073816666205; Guskey T.R., 1986, EDUC RESEARCHER, V15, P5, DOI [10.3102/0013189X0150050054, DOI 10.3102/0013189X015005005]; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Haney JJ, 2002, SCI EDUC, V86, P783, DOI 10.1002/sce.10038; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; KAGAN DM, 1992, EDUC PSYCHOL, V27, P65, DOI 10.1207/s15326985ep2701_6; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; Lumpe AT, 2007, J SCI TEACH EDUC, V18, P125, DOI 10.1007/s10972-006-9018-3; Lyons VH, 2017, J SCHOOL HEALTH, V87, P416, DOI 10.1111/josh.12510; Makki Ali Y, 2016, Glob Pediatr Health, V3, p2333794X16630493, DOI 10.1177/2333794X16630493; McAvoy K., 2013, REAP BENEFITS GOOD C; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; NESPOR J, 1987, J CURRICULUM STUD, V19, P317, DOI 10.1080/0022027870190403; PAJARES MF, 1992, REV EDUC RES, V62, P307, DOI 10.2307/1170741; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rigby J, 2013, J ATHL TRAINING, V48, P636, DOI 10.4085/1062-6050-48.3.10; ROBINSON S, 2002, J SCI TEACHER ED, V13, P13, DOI DOI 10.1023/A:1015177609052; Romm K., 2016, J ATHL TRAINING, V51, pS223; Sinclair M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-132; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	48	7	7	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0742-051X			TEACH TEACH EDUC	Teach. Teach. Educ.	NOV	2017	68						181	189		10.1016/j.tate.2017.09.005			9	Education & Educational Research	Social Science Citation Index (SSCI)	Education & Educational Research	FM2OM	WOS:000414824100018					2022-02-06	
J	Magasi, S; Harniss, M; Tulsky, DS; Cohen, ML; Heaton, RK; Heinemann, AW				Magasi, Susan; Harniss, Mark; Tulsky, David S.; Cohen, Matthew L.; Heaton, Robert K.; Heinemann, Allen W.			Test Accommodations for Individuals With Neurological Conditions Completing the NIH Toolbox-Cognition Battery: An Evaluation of Frequency and Appropriateness	REHABILITATION PSYCHOLOGY			English	Article						neuropsychological tests cognition; spinal cord injuries; brain injuries; stroke	OF-THE-LITERATURE; BEHAVIORAL FUNCTION; VALIDITY; REHABILITATION; DISABILITIES; VALIDATION; PEOPLE; CB	Objectives: First, to evaluate the frequency with which individuals with neurological conditions require test administration accommodations for the NIH Toolbox-Cognition Battery (NIHTB-CB). Second, to evaluate the appropriateness of accommodations provided by administrators, including adherence to NIHTB-CB Reasonable Accommodations Guidelines. Method: Adults with traumatic brain injury, spinal cord injury, or stroke (n = 604) completed the NIHTB-CB and other assessments as part of a multisite study. We provide a descriptive, secondary analysis of test administrator notes to determine use and appropriateness of accommodations. Results: Of the 604 participants, 450 (75%) completed the NIHTB-CB using standard administration procedures, but 137 (22.6%) encountered accessibility challenges that required accommodations. Participants with motor function impairments were most likely to receive at least 1 of 3 kinds of accommodations: (a) use of nonstandard methods of entering responses using standard input devices, (b) use of alternate input devices, or (c) help from the test administrator to enter a response. Fatigue and/or impulsivity led to nonstandard administration by 48 (7.9%) individuals. Post hoc audit of test administrator notes revealed that despite careful instructions and supervision, 49 (56.3%) of the accommodated administrations breached standardization and scores could not be interpreted using test norms. Conclusion: Although the NIHTB-CB was developed for individuals without neurological impairment, most individuals with neurological conditions completed the standardized administration without accommodations. When accommodations were needed, administrators did not adhere to the official Reasonable Accommodations Guidelines in more than half of the cases.	[Magasi, Susan] Univ Illinois, Dept Occupat Therapy, 1919 West Taylor St, Chicago, IL 60612 USA; [Magasi, Susan] Univ Illinois, Dept Disabil Studies, 1919 West Taylor St, Chicago, IL 60612 USA; [Harniss, Mark] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Tulsky, David S.] Univ Delaware, Ctr Assessment Res & Translat, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE 19716 USA; [Tulsky, David S.; Cohen, Matthew L.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA; [Cohen, Matthew L.] Univ Delaware, Dept Commun Sci & Disorders, Newark, DE 19716 USA; [Cohen, Matthew L.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE 19716 USA; [Heaton, Robert K.] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA; [Heinemann, Allen W.] Northwestern Univ, Dept Phys Med & Rehabil, Evanston, IL 60208 USA; [Heinemann, Allen W.] Shirley Ryan AbilityLab, Chicago, IL USA		Magasi, S (corresponding author), Univ Illinois, Dept Occupat Therapy, 1919 West Taylor St, Chicago, IL 60612 USA.; Magasi, S (corresponding author), Univ Illinois, Dept Disabil Studies, 1919 West Taylor St, Chicago, IL 60612 USA.	smagas1@uic.edu	Cohen, Mathew/W-3982-2019; Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Tulsky, David/0000-0002-4335-4509; Cohen, Matthew/0000-0001-9609-2461	National Institute on Disability, Independent Living, and Research Rehabilitation Grant [H133B090024]; Psychosocial Research Postdoctoral Fellowship Grant from Craig H. Neilsen Foundation [364962]; Institutional Development Award from National Institute of General Medical Sciences of the National Institutes of Health [U54-GM104941]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH062512] Funding Source: NIH RePORTER	This research was supported by National Institute on Disability, Independent Living, and Research Rehabilitation Grant H133B090024 (principle investigator [PI]: Allen W. Heinemann), as well as Psychosocial Research Postdoctoral Fellowship Grant 364962 from the Craig H. Neilsen Foundation (PI: Matthew L. Cohen). Salary support for Matthew L. Cohen was also provided by an Institutional Development Award from the National Institute of General Medical Sciences of the National Institutes of Health under Grant U54-GM104941 (PI: S. A. Binder-Macleod). We thank these talented and dedicated research staff members: Ana Miskovic, Arielle Goldsmith, Sara Jerousek, Sue Tucker, Jessica Dashner, Cathy Crawley, Ben Aziz, Julie Grech, Livia Vanden Belt, and Angela Miciura. We thank Noelle Carlozzi for her expert review of the coded data and Kimberley The for her editorial support.	American Educational Research Association American Psychological Association & National Council on Measurement in Education, 2014, STAND ED PSYCH TEST; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Braden J. P., 2003, CLIN INTERPRETATION, P451; BRADEN JP, 1994, DEAFNESS DEPRIVATION; Brucker DL, 2015, ARCH PHYS MED REHAB, V96, P771, DOI 10.1016/j.apmr.2015.02.024; Carlozzi N. E., 2017, REHABILITATION PSYCH; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Fuchs LS, 2000, EXCEPT CHILDREN, V67, P67, DOI 10.1177/001440290006700105; Fuchs LS, 2005, FOCUS EXCEPT CHILD, V37, P1; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Haladyna T.M., 2004, EDUC MEAS-ISSUES PRA, V23, P17, DOI [10.1111/j.1745-3992.2004.tb00149.x, DOI 10.1111/J.1745-3992.2004.TB00149.X]; Hansen E. G., 2005, SYSTEM, V33, P107, DOI [10.1016/j.system.2004.11.002, DOI 10.1016/J.SYSTEM.2004.11.002]; Heaton RK, 2014, J INT NEUROPSYCH SOC, V20, P588, DOI 10.1017/S1355617714000241; Hill-Briggs F, 2007, ARCH CLIN NEUROPSYCH, V22, P389, DOI 10.1016/j.acn.2007.01.013; Hollenbeck K, 2005, ASSES EFF INTERV, V31, P7, DOI 10.1177/073724770503100102; Kettler R. J., 2009, PEABODY J EDUC, V84, P529, DOI [10.1080/01619560903240996, DOI 10.1080/01619560903240996]; Kettler RJ, 2012, INT J DISABIL DEV ED, V59, P53, DOI 10.1080/1034912X.2012.654952; Khubchandani A, 2012, AM PSYCHOL, V67, P43, DOI 10.1037/a0025892; Lai SA, 2012, LEARN DISABILITY Q, V35, P158, DOI 10.1177/0731948711433874; Magasi S., 2017, ARCH PHYS MED REHABI; MESSICK S, 1995, AM PSYCHOL, V50, P741, DOI 10.1037/0003-066X.50.9.741; Messick S, 1998, SOC INDIC RES, V45, P35, DOI 10.1023/A:1006964925094; Meyers AR, 2000, ARCH PHYS MED REHAB, V81, pS5, DOI 10.1053/apmr.2000.20618; Mislevy RJ, 2013, EDUC RES EVAL, V19, P121, DOI 10.1080/13803611.2013.767614; NIH Toolbox, 2012, NIH TOOLB REAS ACC G; Quatrano LA, 2011, ARCH PHYS MED REHAB, V92, pS7, DOI 10.1016/j.apmr.2010.08.032; Rios D, 2016, AM J PUBLIC HEALTH, V106, P2137, DOI 10.2105/AJPH.2016.303448; Saldana J, 2013, CODING MANUAL QUALIT; SHERMAN SW, 1982, ABILITY TESTING HAND; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P413, DOI 10.1037/rep0000174; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P409, DOI 10.1037/rep0000201; United States Department of Justice, 2014, ADA REQ TEST ACC; Victorson D, 2013, NEUROLOGY, V80, pS13, DOI 10.1212/WNL.0b013e3182872e26; Warschausky S, 2012, ASSESSMENT, V19, P472, DOI 10.1177/1073191111402458; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Zhu JJ, 2000, CLIN NEUROPSYCHOL, V14, P461, DOI 10.1076/clin.14.4.461.7197; [No title captured]	40	7	7	0	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2017	62	4					455	463		10.1037/rep0000191			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FT1CK	WOS:000422871400006	29265866	Green Accepted			2022-02-06	
J	Singh, D; Cronin, DS				Singh, D.; Cronin, D. S.			Efficacy of visor and helmet for blast protection assessed using a computational head model	SHOCK WAVES			English	Article						Blast injury; mTBI; Finite element head model; Helmet protection; Visor	TRAUMATIC BRAIN-INJURY; EXPOSURE	Head injury resulting from blast exposure has been identified as a challenge that may be addressed, in part, through improved protective systems. Existing detailed head models validated for blast loading were applied to investigate the influence of helmet visor configuration, liner properties, and shell material stiffness. Response metrics including head acceleration and intracranial pressures (ICPs) generated in brain tissue during primary blast exposure were used to assess and compare helmet configurations. The addition of a visor was found to reduce peak head acceleration and positive ICPs. However, negative ICPs associated with a potential for injury were increased when a visor and a foam liner were present. In general, the foam liner material was found to be more significant in affecting the negative ICP response than positive ICP or acceleration. Shell stiffness was found to have relatively small effects on either metric. A strap suspension system, modeled as an air gap between the head and helmet, was more effective in reducing response metrics compared to a foam liner. In cases with a foam liner, lower-density foam offered a greater reduction of negative ICPs. The models demonstrated the "underwash" effect in cases where no foam liner was present; however, the reflected pressures generated between the helmet and head did not translate to significant ICPs in adjacent tissue, when compared to peak ICPs from initial blast wave interaction. This study demonstrated that the efficacy of head protection can be expressed in terms of load transmission pathways when assessed with a detailed computational model.	[Singh, D.; Cronin, D. S.] Univ Waterloo, Waterloo, ON, Canada		Cronin, DS (corresponding author), Univ Waterloo, Waterloo, ON, Canada.	dscronin@uwaterloo.ca			Natural Sciences and Engineering Research Council and Compute Canada	The authors would like to acknowledge the support of the Natural Sciences and Engineering Research Council and Compute Canada.	Bir C, 2011, W81XWH0910498 US ARM; Bouamoul A., 2012, CTTSO TSWG PPE S FLO; Connolly TJM, 2010, SAFETY SCI, V48, P1387, DOI 10.1016/j.ssci.2010.05.013; Cronin D. S., 2008, P PERS ARM SYST S, P84; Dionne JP, 2002, REDUCTION BLAST INDU; Effgen GB, 2016, J NEUROTRAUM, V33, P1901, DOI 10.1089/neu.2015.4327; Fournier E., 2007, BLAST HEAD FORM DEV; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Gower HL, 2008, INT J IMPACT ENG, V35, P1000, DOI 10.1016/j.ijimpeng.2007.07.007; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Hallquist JO, 2006, LS DYNA THEORY MANUA; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lockhart P, 2011, J TRAUMA, V70, pE29, DOI 10.1097/TA.0b013e3181de3f4b; Lockhart PA, 2015, COMPUT METHOD BIOMEC, V18, P635, DOI 10.1080/10255842.2013.829460; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Ouellet S., 2014, DRDCRDDC2014P113; Ouellet S, 2006, POLYM TEST, V25, P731, DOI 10.1016/j.polymertesting.2006.05.005; Panzer M. B., 2010, P PERS ARM SYST S QU; Panzer MB, 2013, COMPUT METHOD BIOMEC, V16, P612, DOI 10.1080/10255842.2011.629615; Pham N, 2015, J NEUROTRAUM, V32, P58, DOI 10.1089/neu.2014.3471; Sarvghad-Moghaddam H, 2015, COMPUT METHOD BIOMEC, V18, P1846, DOI 10.1080/10255842.2014.977878; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; Singh D, 2015, THESIS; Singh D, 2014, INT J NUMER METH BIO, V30, P470, DOI 10.1002/cnm.2612; Souli M, 2004, MATER SCI FORUM, V465-466, P143, DOI 10.4028/www.scientific.net/MSF.465-466.143; Spitzer V, 1996, J AM MED INFORM ASSN, V3, P118, DOI 10.1136/jamia.1996.96236280; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Thom C., 2009, THESIS; Vogel E., 2014, IRCOBI C 2014 BERL G; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Yang K. H., 2011, TISSUE ENG BIOMATER, V3, P69, DOI [10.1007/8415_2010_62, DOI 10.1007/8415_2010_62]; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088	34	7	7	1	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	NOV	2017	27	6					905	918		10.1007/s00193-017-0732-x			14	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	FN4BE	WOS:000415946600008					2022-02-06	
J	Tripathi, BB; Espindola, D; Pinton, GF				Tripathi, B. B.; Espindola, D.; Pinton, G. F.			Piecewise parabolic method for simulating one-dimensional shear shock wave propagation in tissue-mimicking phantoms	SHOCK WAVES			English	Article						Shear shock waves; Traumatic brain injury; Piecewise parabolic method; Nonlinear shear waves	SOFT SOLIDS; NUMERICAL-SIMULATION; BRAIN-TISSUE; NONLINEARITY; DEFORMATION; ELASTICITY; INJURY; RUBBER	The recent discovery of shear shock wave generation and propagation in the porcine brain suggests that this new shock phenomenology may be responsible for a broad range of traumatic injuries. Blast-induced head movement can indirectly lead to shear wave generation in the brain, which could be a primary mechanism for injury. Shear shock waves amplify the local acceleration deep in the brain by up to a factor of 8.5, which may tear and damage neurons. Currently, there are numerical methods that can model compressional shock waves, such as comparatively well-studied blast waves, but there are no numerical full-wave solvers that can simulate nonlinear shear shock waves in soft solids. Unlike simplified representations, e.g., retarded time, full-wave representations describe fundamental physical behavior such as reflection and heterogeneities. Here we present a piecewise parabolic method-based solver for one-dimensional linearly polarized nonlinear shear wave in a homogeneous medium and with empirical frequency-dependent attenuation. This method has the advantage of being higher order and more directly extendable to multiple dimensions and heterogeneous media. The proposed numerical scheme is validated analytically and experimentally and compared to other shock capturing methods. A Riemann step-shock problem is used to characterize the numerical dissipation. This dissipation is then tuned to be negligible with respect to the physical attenuation by choosing an appropriate grid spacing. The numerical results are compared to ultrasound-based experiments that measure planar polarized shear shock wave propagation in a tissue-mimicking gelatin phantom. Good agreement is found between numerical results and experiment across a 40 mm propagation distance. We anticipate that the proposed method will be a starting point for the development of a two- and three-dimensional full-wave code for the propagation of nonlinear shear waves in heterogeneous media.	[Tripathi, B. B.; Espindola, D.; Pinton, G. F.] Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, 109 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Tripathi, B. B.; Espindola, D.; Pinton, G. F.] North Carolina State Univ, 109 Mason Farm Rd, Chapel Hill, NC 27599 USA		Pinton, GF (corresponding author), Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, 109 Mason Farm Rd, Chapel Hill, NC 27599 USA.; Pinton, GF (corresponding author), North Carolina State Univ, 109 Mason Farm Rd, Chapel Hill, NC 27599 USA.	bharat25@email.unc.edu; david.espindola@unc.edu; gia@email.unc.edu	Espindola, DAVID/M-9318-2019	Espindola, DAVID/0000-0001-6675-9560; Tripathi, Bharat/0000-0001-6757-0735	 [NIH R01 NS091195]	This work is done under the framework of Project: NIH R01 NS091195.	Almgren AS, 2010, ASTROPHYS J, V715, P1221, DOI 10.1088/0004-637X/715/2/1221; Catheline S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.164301; Catheline S, 2003, J ACOUST SOC AM, V114, P3087, DOI 10.1121/1.1610457; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; COLELLA P, 1984, J COMPUT PHYS, V54, P174, DOI 10.1016/0021-9991(84)90143-8; Dagrau F, 2011, J ACOUST SOC AM, V130, P20, DOI 10.1121/1.3583549; DAI WL, 1994, J COMPUT PHYS, V115, P485, DOI 10.1006/jcph.1994.1212; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Duck FA., 2013, PHYS PROPERTIES TISS; Espindola D., 2017, 170510672 ARXIV; FUNG YC, 1979, AM J PHYSIOL, V237, pH620, DOI 10.1152/ajpheart.1979.237.5.H620; Fung YC., 1981, BIOMECHANICS MECH PR, DOI [10.1007/978-1-4757-1752-5, DOI 10.1007/978-1-4757-1752-5]; Gadd CW, 1966, SAE TECHNICAL PAPER, DOI [10.4271/660793, DOI 10.4271/660793]; Gent AN, 1996, RUBBER CHEM TECHNOL, V69, P59, DOI 10.5254/1.3538357; Giammarinaro B, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4032643; Goriely A, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.138001; Guskiewicz K. M., 2007, INJURY PREV, V61, P1244, DOI [10.1227/01.neu.0000306103.68635.1a, DOI 10.1227/01.NEU.0000306103.68635.1A]; Hamilton M. F., 1997, NONLINEAR ACOUSTICS; Hosey R. R., 1982, FINITE ELEMENTS BIOM, P379; Lifshitz E, 1986, COURSE THEORETICAL P, V7, P3; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; MCDONALD BE, 1984, J COMPUT PHYS, V56, P448, DOI 10.1016/0021-9991(84)90106-2; Mendis K, 1992, THESIS; Mignone A, 2005, ASTROPHYS J SUPPL S, V160, P199, DOI 10.1086/430905; Miller GH, 2002, J COMPUT PHYS, V183, P26, DOI 10.1006/jcph.2002.7158; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Pinton G, 2014, IEEE T ULTRASON FERR, V61, P1489, DOI 10.1109/TUFFC.2014.3063; Pinton G, 2010, J ACOUST SOC AM, V127, P683, DOI 10.1121/1.3277202; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Renier M, 2008, AIP CONF PROC, V1022, P303, DOI 10.1063/1.2956214; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Shugar T. A., 1977, TECHNICAL REPORT; Smoller J, 1994, SHOCK WAVES REACTION, DOI [10.1007/978-1-4612-0873-0, DOI 10.1007/978-1-4612-0873-0]; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Sytine IV, 2000, J COMPUT PHYS, V158, P225, DOI 10.1006/jcph.1999.6416; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; TRANGENSTEIN JA, 2009, NUMERICAL SOLUTION H; VAN LEER B, 1979, J COMPUT PHYS, V32, P101, DOI 10.1016/0021-9991(79)90145-1; WALKER WF, 1995, IEEE T ULTRASON FERR, V42, P301, DOI 10.1109/58.365243; Wochner MS, 2008, J ACOUST SOC AM, V123, P2488, DOI 10.1121/1.2890739; WOODWARD P, 1984, J COMPUT PHYS, V54, P115, DOI 10.1016/0021-9991(84)90142-6; YANG HQ, 1992, J COMPUT PHYS, V102, P139, DOI 10.1016/S0021-9991(05)80012-9; Zabolotskaya EA, 2004, J ACOUST SOC AM, V116, P2807, DOI 10.1121/1.1802533; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	48	7	7	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	NOV	2017	27	6					879	888		10.1007/s00193-017-0734-8			10	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	FN4BE	WOS:000415946600006					2022-02-06	
J	Wiri, S; Ritter, AC; Bailie, JM; Needham, C; Duckworth, JL				Wiri, S.; Ritter, A. C.; Bailie, J. M.; Needham, C.; Duckworth, J. L.			Computational modeling of blast exposure associated with recoilless weapons combat training	SHOCK WAVES			English	Article						Computational fluid dynamics; SHAMRC; Recoilless weapons; Traumatic brain injury; Blast exposure	TRAUMATIC BRAIN-INJURY; LOW-LEVEL BLAST; EXTRACELLULAR-MATRIX; MECHANOTRANSDUCTION; SIMULATION; ECM	Military personnel are exposed to blast as part of routine combat training with shoulder-fired recoilless rifles. These weapons fire large-caliber ammunitions capable of disabling structures and uparmored vehicles (e.g., tanks). Scientific, medical, and military leaders are beginning to recognize the blast overpressure from these shoulder-fired weapons may result in acute and even long-term physiological effects to military personnel. However, the back blast generated from the Carl Gustav and Shoulder-launched Multipurpose Assault Weapon (SMAW) shoulder-fired weapons on the weapon operator has not been quantified. By quantifying and modeling the full-body blast exposure from these weapons, better injury correlations can be constructed. Blast exposure data from the Carl Gustav and SMAW were used to calibrate a propellant burn source term for computational simulations of blast exposure on operators of these shoulder-mounted weapon systems. A propellant burn model provided the source term for each weapon to capture blast effects. Blast data from personnel-mounted gauges during weapon firing were used to create initial, high-fidelity 3D computational fluid dynamic simulations using SHAMRC (Second-order Hydrodynamic Automatic Mesh Refinement Code). These models were then improved upon using data collected from static blast sensors positioned around the military personnel while weapons were utilized in actual combat training. The final simulation models for both the Carl Gustav and SMAW were in good agreement with the data collected from the personnel-mounted and static pressure gauges. Using the final simulation results, contour maps were created for peak overpressure and peak overpressure impulse experienced by military personnel firing the weapon as well as those assisting with firing of those weapons. Reconstruction of the full-body blast loading enables a more accurate assessment of the cause of potential mechanisms of injury due to air blast even for subjects not wearing blast gauges themselves. By accurately understanding the blast exposure and its variations across an individual, more meaningful correlations with physiologic response including potential TBI spectrum physiology associated with sub-concussive blast exposure can be established. As blast injury thresholds become better defined, results from these reconstructions can provide important insights into approaches for reducing possible risk of injury to personnel operating shoulder-launched weapons.	[Wiri, S.; Needham, C.] Appl Res Associates Inc, Albuquerque, NM 87110 USA; [Ritter, A. C.; Duckworth, J. L.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Ritter, A. C.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Bailie, J. M.] Def & Vet Brain Injury Ctr, Camp Pendleton, CA USA; [Bailie, J. M.] Naval Hosp Camp Pendleton, Camp Pendleton, CA USA; [Bailie, J. M.] Gen Dynam Hlth Solut, Fairfax, VA USA		Wiri, S (corresponding author), Appl Res Associates Inc, Albuquerque, NM 87110 USA.	swiri@ara.com			Defense Advanced Research Projects AgencyUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [HU0001-14-1-0022]	Defense Advanced Research Projects Agency HU0001-14-1-0022, PI: JD. The views expressed herein are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of the Army, Department of Defense, or the United States government.	Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; [Anonymous], 1987, TXB BALLISTICS GUNNE, V1; Baker W. E., 1971, BLAST FIELDS ROCKETS; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Crepeau J. E., 2010, TECHNICAL REPORT, V2; Doan L., 1963, AFWLTM632; Erdik A, 2016, SHOCK WAVES, V26, P449, DOI 10.1007/s00193-015-0576-1; Gieni RS, 2008, J CELL BIOCHEM, V104, P1964, DOI 10.1002/jcb.21364; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Huang Y, 2012, FASEB J, V26, P3351, DOI 10.1096/fj.11-199240; Hunt F.R.W., 1951, INTERNAL BALLISTICS; Jalali S, 2001, P NATL ACAD SCI USA, V98, P1042, DOI 10.1073/pnas.031562998; Johnson D. L., 1993, BLAST OVER PRESSURE; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; McWhorter FY, 2015, CELL MOL LIFE SCI, V72, P1303, DOI 10.1007/s00018-014-1796-8; Merickel B., 1997, BLAST OVERPRESSURE 2; Nogueira ML, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00197; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; Pelosi P, 2008, INTENS CARE MED, V34, P631, DOI 10.1007/s00134-007-0964-9; Price G. R., 1991, TECH MEMO, P20; Rhea CK, 2017, MIL MED, V182, P147, DOI 10.7205/MILMED-D-16-00140; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; St Onge Paul, 2011, US Army Med Dep J, P97; TAN X, 2011, ASME 2011 INT MECH E, P71, DOI DOI 10.1115/IMECE2011-64331; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Wang X, 2017, SHOCK WAVES, V27, P409, DOI 10.1007/s00193-016-0680-x; Willcox MA, 2007, J PROPUL POWER, V23, P575, DOI 10.2514/1.22971; Wiri S, 2016, SHOCK WAVES, V26, P279, DOI 10.1007/s00193-016-0644-1	33	7	7	1	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	NOV	2017	27	6					849	862		10.1007/s00193-017-0755-3			14	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	FN4BE	WOS:000415946600004					2022-02-06	
J	Alali, AS; McCredie, VA; Mainprize, TG; Gomez, D; Nathens, AB				Alali, Aziz S.; McCredie, Victoria A.; Mainprize, Todd G.; Gomez, David; Nathens, Avery B.			Structure, Process, and Culture of Intensive Care Units Treating Patients with Severe Traumatic Brain Injury: Survey of Centers Participating in the American College of Surgeons Trauma Quality Improvement Program	JOURNAL OF NEUROTRAUMA			English	Article						clinical protocol; comparative effectiveness research; intensive care units; organizational structure; traumatic brain injury	COMMUNICATION; PATTERNS; MEDICINE; IMPACT	Outcome after severe traumatic brain injury (TBI) differs substantially between hospitals. Explaining this variation begins with understanding the differences in structures and processes of care, particularly at intensive care units (ICUs) where acute TBI care takes place. We invited trauma medical directors (TMDs) from 187 centers participating in the American College of Surgeons Trauma Quality Improvement Program (ACS TQIP) to complete a survey. The survey domains included ICU model, type, availability of specialized units, staff, training programs, standard protocols and order sets, approach to withdrawal of life support, and perceived level of neurosurgeons' engagement in the ICU management of TBI. One hundred forty-two TMDs (76%) completed the survey. Severe TBI patients are admitted to dedicated neurocritical care units in 52 hospitals (37%), trauma ICUs in 44 hospitals (31%), general ICUs in 34 hospitals (24%), and surgical ICUs in 11 hospitals (8%). Fifty-seven percent are closed units. Board-certified intensivists directed 89% of ICUs, whereas 17% were led by neurointensivists. Sixty percent of ICU directors were general surgeons. Thirty-nine percent of hospitals had critical care fellowships and 11% had neurocritical care fellowships. Fifty-nine percent of ICUs had standard order sets and 61% had standard protocols specific for TBI, with the most common protocol relating to intracranial pressure management (53%). Only 43% of TMDs were satisfied with the current level of neurosurgeons' engagement in the ICU management of TBI; 46% believed that neurosurgeons should be more engaged; 11% believed they should be less engaged. In the largest survey of North American ICUs caring for TBI patients, there is substantial variation in the current approaches to ICU care for TBI, highlighting multiple opportunities for comparative effectiveness research.	[Alali, Aziz S.; Nathens, Avery B.] Sunnybrook Res Inst, Toronto, ON, Canada; [Nathens, Avery B.] Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada; [Alali, Aziz S.; McCredie, Victoria A.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Nathens, Avery B.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Mainprize, Todd G.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Gomez, David; Nathens, Avery B.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [McCredie, Victoria A.] Univ Hlth Network, Dept Crit Care, Toronto, ON, Canada		Alali, AS (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, 2075 Bayview Ave,Room D-574, Toronto, ON M4N 3M5, Canada.	aziz.alali@mail.utoronto.ca		Gomez, David/0000-0002-0926-2547	Physicians' Services Inc. Foundation; De Souza Chair in Trauma Research	This work was supported, in part, by funds from Physicians' Services Inc. Foundation (to A.S.A.) and De Souza Chair in Trauma Research (to A.B.N.).	Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Baldock G, 2001, INTENS CARE MED, V27, P865, DOI 10.1007/s001340100938; Bernard H.R., 2010, ANAL QUALITATIVE DAT; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Checkley W, 2014, CRIT CARE MED, V42, P344, DOI 10.1097/CCM.0b013e3182a275d7; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Conn LG, 2016, QUAL HEALTH RES, V26, P895, DOI 10.1177/1049732315609901; Conn LG, 2009, QUAL HEALTH RES, V19, P943, DOI 10.1177/1049732309338282; Copay AG, 2007, SPINE J, V7, P541, DOI 10.1016/j.spinee.2007.01.008; Enblad P, 2004, INTENS CARE MED, V30, P1058, DOI 10.1007/s00134-004-2206-8; Finkelstein E., 2006, INCIDENCE EC BURDEN; Galesic M, 2009, PUBLIC OPIN QUART, V73, P349, DOI 10.1093/poq/nfp031; Ghorra S, 1999, ANN SURG, V229, P163, DOI 10.1097/00000658-199902000-00001; Goldszmidt M, 2014, MED EDUC, V48, P301, DOI 10.1111/medu.12376; HALPERN NA, 1994, CRIT CARE MED, V22, P2008; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Lingard Lorelei, 2007, J Interprof Care, V21, P657, DOI 10.1080/13561820701731817; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; McCredie VA, 2016, J TRAUMA ACUTE CARE, V80, P484, DOI 10.1097/TA.0000000000000922; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	28	7	7	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2760	2767		10.1089/neu.2017.4997			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700011	28437224				2022-02-06	
J	Bacon, CEW; Kay, MC; McLeod, TCV				Bacon, Cailee E. Welch; Kay, Melissa C.; McLeod, Tamara C. Valovich			Athletic Trainers' Roles and Responsibilities Regarding Academic Adjustments as Part of the Concussion-Management Process in the Secondary School Setting	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; return to learn; adolescents; professional responsibility; academic accommodation	SPORT-RELATED CONCUSSION; CONSENSUAL QUALITATIVE RESEARCH; ACCOMMODATIONS; PERCEPTIONS; STATEMENT; FAMILIARITY; KNOWLEDGE; ENHANCE; POLICY	Context: Athletic trainers (ATs) play a vital role in managing the care of student-athletes after a sport-related concussion, yet little is known about their specific involvement in the implementation of academic adjustments as part of the concussion-management plan. Objective: To explore ATs' perceived roles and responsibilities regarding the implementation of academic adjustments for concussed student-athletes. Design: Qualitative study. Setting: Individual telephone interviews. Patients or Other Participants: Sixteen ATs employed in the secondary school setting (8 women, 8 men; age = 39.6 +/- 6 7.9 years; athletic training experience = 15.1 +/- 5.6 years), representing 12 states, were interviewed. Data Collection and Analysis: One telephone interview was conducted with each participant. After the interviews were transcribed, the data were analyzed and coded into themes and categories, which were determined via consensus of a 4-person research team. To decrease researcher bias, triangulation occurred through participant member checking, the inclusion of multiple researchers, and an internal auditor. Results: Several categories related to participants' perceptions regarding their roles and responsibilities within the academic-adjustments process emerged from data analysis: (1) understanding of academic adjustments, (2) perceptions of their roles in academic adjustments, (3) initiation of academic adjustments, (4) facilitation of academic adjustments, and (5) lack of a role in the academic-adjustments process. Although most ATs perceived that they had a role in the initiation and facilitation of academic adjustments for concussed student-athletes, some reported they did not want a role in the process. Regardless, participants frequently suggested the need for further education. Conclusions: These findings highlight that ATs either wanted to be involved in the implementation of academic adjustments but felt further education was needed or they did not want to be involved because they felt that it was not in their area of expertise. To create a cohesive concussion-management team, it is vital that ATs understand their individual and collaborative roles in the secondary school setting.	[Bacon, Cailee E. Welch; McLeod, Tamara C. Valovich] AT Still Univ, 5850 East Still Circle, Mesa, AZ 85206 USA; [Kay, Melissa C.] Univ N Carolina, Chapel Hill, NC USA		Bacon, CEW (corresponding author), AT Still Univ, 5850 East Still Circle, Mesa, AZ 85206 USA.	cwelch@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722	Cantu/Guskiewicz Endowment for Sport Concussion	The Cantu/Guskiewicz Endowment for Sport Concussion provided financial support for this investigation. We thank Casey D. Erickson, MS, ATC, and Alyssa J. Wagner, MS, ATC, for their contributions to the data analysis for this qualitative inquiry.	Almquist J, 2008, J ATHL TRAINING, V43, P416, DOI 10.4085/1062-6050-43.4.416; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Gioia GA, 2009, TOP LANG DISORD, V29, P266, DOI 10.1097/TLD.0b013e3181b5322b; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hill CE, 2005, J COUNS PSYCHOL, V52, P196, DOI 10.1037/0022-0167.52.2.196; Hill CE, 1997, COUNS PSYCHOL, V25, P517, DOI 10.1177/0011000097254001; McAvoy K., REAP BENEFITS GOOD C; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; National Athletic Trainers' Association, 2011, ATHL TRAIN ED COMP; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Phan K, 2012, ATHL TRAIN ED J, V7, P103; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sirmon-Taylor B., 2012, ASHA PERSPECTIVES, V13, P70; Sleight AJ, 2015, J ATHL TRAINING, V50; Thrasher AB, 2015, J ATHL TRAINING, V50, P321, DOI 10.4085/1062-6050-49.3.67; Valovich McLeod TC, 2015, KINESIOL REV, V4, P131, DOI DOI 10.1123/KR.2015-0007; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Weber ML, 2015, J ATHL TRAINING, V50, pS178; Welch CE, 2014, J ATHL TRAINING, V49, P220, DOI 10.4085/1062-6050-49.2.14; Welch CE, 2014, J ATHL TRAINING, V49, P234, DOI 10.4085/1062-6050-49.2.15; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482	32	7	7	0	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT	2017	52	10					937	945		10.4085/1062-6050-52.7.02			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FN2LV	WOS:000415824700006	28796530	Green Published, Bronze			2022-02-06	
J	Elgeidi, A; El Negery, A; Abdellatif, MS; El Moghazy, N				Elgeidi, Adham; El Negery, Abed; Abdellatif, M. Serry; El Moghazy, Nabil			Dynamic hip screw and fibular strut graft for fixation of fresh femoral neck fracture with posterior comminution	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Fracture neck femur; Posterior comminution; Garden III; Garden IV; DHS; Fibular strut graft	YOUNG-ADULTS; INTRACAPSULAR FRACTURES; PROXIMAL FEMUR; MANAGEMENT	Posterior comminution of the femoral neck fracture is a major cause of delayed and non-union owing to the loss of the buttressing effect against the posterior rotation. When a femoral neck fracture with posterior comminution is anatomically reduced, only the anterior portions of the femoral neck fracture surfaces are brought into contact leaving a posterior defect. The purpose of this study was to evaluate the use of fibular strut grafting and dynamic hip screw (DHS) for fresh femoral neck fractures with posterior comminution in young patient less than 50 years. Between October 2012 and March 2016, 35 patients aged 20-50 years, 30 men and 5 women underwent fixation using DHS and fibular strut grafts for Garden grades III (25 patients) and IV (10 patients) femoral neck fractures with posterior comminution. All fractures were reduced by closed methods, and no hip was aspirated. Clinical and radiological outcomes were evaluated. All patients were in the age group of 20-50 years (mean 37 years). The mean delay in presentation after injury was 1 day. The mean final follow-up for these 35 patients was 27.2 months. Healing of the femoral neck was attained in 34 cases, with an average time to union of 4.8 months (range 4-8 months). One patient underwent arthroplasty due to failure of fixation. According to the Harris hip score, outcome was good to excellent in 30 patients, fair in 4, and poor in 1. In our study, only one patient developed non-union and no patients had avascular necrosis of the femoral head. Closed reduction, fibular strut grafts, and DHS fixation is a reliable procedure for femoral neck fractures with posterior comminution in young adults.	[Elgeidi, Adham; El Negery, Abed; Abdellatif, M. Serry; El Moghazy, Nabil] Mansoura Univ, Mansoura Sch Med, POB 95, Mansoura 35516, Egypt		Elgeidi, A (corresponding author), Mansoura Univ, Mansoura Sch Med, POB 95, Mansoura 35516, Egypt.	elgeidi@doctors.org.uk					ASNIS SE, 1994, J BONE JOINT SURG AM, V76A, P1793, DOI 10.2106/00004623-199412000-00005; Boraiah S, 2010, J TRAUMA, V69, P142, DOI 10.1097/TA.0b013e3181bba236; Bosch U, 2002, CLIN ORTHOP RELAT R, P59; BRAY TJ, 1997, CLIN ORTHOP RELAT R, V339, P20, DOI DOI 10.1097/00003086-199706000-00004; DEDRICK DK, 1986, J TRAUMA, V26, P932, DOI 10.1097/00005373-198610000-00013; Gautam VK, 1998, INJURY, V29, P215, DOI 10.1016/S0020-1383(97)00184-8; HUANG CH, 1986, CLIN ORTHOP RELAT R, P117; Jaiswal Atin, 2013, J Clin Orthop Trauma, V4, P58, DOI 10.1016/j.jcot.2013.04.003; Lazaro LE, 2016, J ORTHOP TRAUMA, V30, P81, DOI 10.1097/BOT.0000000000000452; LEUNG PC, 1993, CLIN ORTHOP RELAT R, P156; Lifeso R, 1990, J Orthop Trauma, V4, P287, DOI 10.1097/00005131-199004030-00009; Lorich D, 2013, MASTER TECHNIQUE ORT; Mittal Ravi, 2012, J Clin Orthop Trauma, V3, P15, DOI 10.1016/j.jcot.2012.04.001; Nagi ON, 2003, CURR ORTHOPAED, V17, P394, DOI 10.1016/S0268-0890(03)00046-X; PARKER MJ, 1994, INJURY, V25, P383, DOI 10.1016/0020-1383(94)90131-7; Parker MJ, 2000, J BONE JOINT SURG BR, V82B, P937, DOI 10.1302/0301-620X.82B7.11595; PROTZMAN RR, 1976, J BONE JOINT SURG AM, V58, P689, DOI 10.2106/00004623-197658050-00020; ROBINSON CM, 1995, CLIN ORTHOP RELAT R, P238; SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P837, DOI 10.2106/00004623-198466060-00003; Weil YA, 2012, J ORTHOP TRAUMA, V26, P19, DOI 10.1097/BOT.0b013e318214f321; Wendt Matthew C, 2013, HSS J, V9, P113, DOI 10.1007/s11420-012-9325-5; Ye Y, 2015, ORTHOPEDICS, V38, P625, DOI 10.3928/01477447-20151002-05	22	7	11	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	OCT	2017	137	10					1363	1369		10.1007/s00402-017-2758-z			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	FG9TC	WOS:000410781400008	28730395				2022-02-06	
J	Kerr, ZY; Yeargin, SW; Djoko, A; Dalton, SL; Baker, MM; Dompier, TP				Kerr, Zachary Y.; Yeargin, Susan W.; Djoko, Aristarque; Dalton, Sara L.; Baker, Melissa M.; Dompier, Thomas P.			Examining Play Counts and Measurements of Injury Incidence in Youth Football	JOURNAL OF ATHLETIC TRAINING			English	Article						epidemiology; exposure; risk	HEAD IMPACT EXPOSURE; SPORTS-RELATED INJURIES; BASEBALL PITCHERS; SHOULDER PAIN; RISK; CONCUSSION; STATEMENT; POSITION; OUTCOMES; LEAGUE	Context: Whereas researchers have provided estimates for the number of head impacts sustained within a youth football season, less is known about the number of plays across which such impact exposure occurs. Objective: To estimate the number of plays in which youth football players participated during the 2013 season and to estimate injury incidence through play-based injury rates. Design: Descriptive epidemiology study. Setting: Youth football. Patients or Other Participants: Youth football players (N-2098; age range, 5-15 years) from 105 teams in 12 recreational leagues across 6 states. Main Outcome Measure(s):We calculated the average number of athlete-plays per season and per game using independent-samples t tests to compare age groups (5-10 years old versus 11-15 years old) and squad sizes (<20 versus >= 20 players); game injury rates per 1000 athlete-exposures (AEs) and per 10 000 athlete-plays; and injury rate ratios (IRRs) with 95% confidence intervals (CIs) to compare age groups. Results: On average, youth football players participated in 333.9 +/- 178.5 plays per season and 43.9 +/- 24.0 plays per game. Age groups (5- to 10-year-olds versus 11- to 15-year-olds) did not differ in the average number of plays per season (335.8 versus 332.3, respectively; t(2086.4) = 0.45, P = .65) or per game (44.1 versus 43.7, respectively; t(2092.3) = 0.38, P = .71). However, players from smaller teams participated in more plays per season (373.7 versus 308.0; t(1611.4) = 8.15, P < .001) and per game (47.7 versus 41.4; t(1523.5) - 5.67, P < .001). Older players had a greater game injury rate than younger players when injury rates were calculated per 1000 AEs (23.03 versus 17.86/1000 AEs; IRR = 1.29; 95% CI = 1.04, 1.60) or per 10 000 athlete-plays (5.30 versus 4.18/10 000 athlete-plays; IRR = 1.27; 95% CI = 1.02, 1.57). Conclusions: A larger squad size was associated with a lower average number of plays per season and per game. Increasing youth football squad sizes may help reduce head-impact exposure for individual players. The AE-based injury rates yielded effect estimates similar to those of play-based injury rates.	[Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA; [Yeargin, Susan W.] Univ South Carolina, Athlet Training Educ Program, Columbia, SC USA; [Djoko, Aristarque; Dalton, Sara L.; Baker, Melissa M.; Dompier, Thomas P.] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu			USA Football, Inc.	Funding for the data used in this study was provided by USA Football, Inc. However, this study was the exclusive creation of the authors and not of USA Football, Inc. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of USA Football, Inc.	[Anonymous], 2015, POP WARN COACH RISK, P25; [Anonymous], 2012, USA FOOTB YOUTH FOOT; [Anonymous], 2012 2013 NCAA FOOTB; [Anonymous], 2013 14 HIGH SCH ATH; [Anonymous], 2016, COLL FOOTB STATS; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Beachy G, 2014, J ATHL TRAINING, V49, P493, DOI 10.4085/1062-6050-49.2.19; Berry JW, 2013, RES SPORTS MED, V21, P159, DOI 10.1080/15438627.2012.757229; Casa DJ, 2015, J ATHL TRAINING, V50, P986, DOI 10.4085/1062-6050-50.9.07; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Dompier TP, 2007, J ATHL TRAINING, V42, P395; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Epstein DM, 2013, AM J SPORT MED, V41, P343, DOI 10.1177/0363546512467612; Football Outsiders, NFL SNAP COUNTS; Gordon A., 2013, NFL NUMBERS 2013; Gutierrez GM, 2007, J SPORT REHABIL, V16, P295, DOI 10.1123/jsr.16.4.295; Irick E., STUDENT ATHLETE PART; Ispirlidis I, 2008, CLIN J SPORT MED, V18, P423, DOI 10.1097/JSM.0b013e3181818e0b; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kerr ZY, 2015, J NEUROTRAUM, V32, P1083, DOI 10.1089/neu.2014.3666; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Luke A, 2011, CLIN J SPORT MED, V21, P307, DOI 10.1097/JSM.0b013e3182218f71; Lyman S, 2002, AM J SPORT MED, V30, P463, DOI 10.1177/03635465020300040201; Lyman S, 2001, MED SCI SPORT EXER, V33, P1803, DOI 10.1097/00005768-200111000-00002; Malina RM, 2006, CLIN J SPORT MED, V16, P214, DOI 10.1097/00042752-200605000-00005; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Messina DF, 1999, AM J SPORT MED, V27, P294, DOI 10.1177/03635465990270030401; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; National Federation of State High School Associations, 2015, 2015 FOOTB RUL TOP; NICHOLAS JA, 1988, JAMA-J AM MED ASSOC, V260, P939, DOI 10.1001/jama.260.7.939; Reilly T, 2005, J SPORT SCI, V23, P619, DOI 10.1080/02640410400021302; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stephensen S, 1996, BRIT J SPORT MED, V30, P331, DOI 10.1136/bjsm.30.4.331; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Tukey J., 1977, EXPLORATOR DATA ANAL; USA Baseball Medical & Safety Advisory Committee, YOUTH BAS PITCH INJ; Wesley CA, 2015, J ATHL TRAINING, V50, P914, DOI 10.4085/1062-6050-50.8.03; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	46	7	7	1	6	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT	2017	52	10					955	965		10.4085/1062-6050-52.7.06			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FN2LV	WOS:000415824700008	28880572	Green Published, Bronze			2022-02-06	
J	Manet, R; Payen, JF; Guerin, R; Martinez, O; Hautefeuille, S; Francony, G; Gergele, L				Manet, Romain; Payen, Jean-Francois; Guerin, Romain; Martinez, Orianne; Hautefeuille, Serge; Francony, Gilles; Gergele, Laurent			Using external lumbar CSF drainage to treat communicating external hydrocephalus in adult patients after acute traumatic or non-traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Post traumatic hydrocephalus; Intracranial hypertension; Lumbar cerebrospinal fluid drainage; Traumatic brain injury; Subarachnoid haemorrhage	CEREBROSPINAL-FLUID DRAINAGE; INCREASED INTRACRANIAL-PRESSURE; SUBARACHNOID HEMORRHAGE; SUBDURAL HYGROMA; HYPERTENSION; GUIDELINES; MANAGEMENT	Despite various treatments to control intracranial pressure (ICP) after brain injury, patients may present a late onset of high ICP or a poor response to medications. External lumbar drainage (ELD) can be considered a therapeutic option if high ICP is due to communicating external hydrocephalus. We aimed at describing the efficacy and safety of ELD used in a cohort of traumatic or non-traumatic brain-injured patients. In this multicentre retrospective analysis, patients had a delayed onset of high ICP after the initial injury and/or a poor response to ICP treatments. ELD was considered in the presence of radiological signs of communicating external hydrocephalus. Changes in ICP values and side effects following the ELD procedure were reported. Thirty-three patients with a median age of 51 years (25-75th percentile: 34-61 years) were admitted after traumatic (n = 22) or non-traumatic (n = 11) brain injuries. Their initial Glasgow Coma Scale score was 8 (4-11). Eight patients underwent external ventricular drainage prior to ELD. Median time to ELD insertion was 5 days (4-8) after brain insult. In all patients, ELD was dramatically effective in lowering ICP: 25 mmHg (20-31) before versus 7 mmHg (3-10) after (p < 0.001). None of the patients showed adverse effects such as pupil changes or intracranial bleeding after the procedure. One patient developed an ELD-related infection. These findings indicate that ELD may be considered potentially effective in controlling ICP, remaining safe if a firm diagnosis of communicating external hydrocephalus has been made.	[Manet, Romain] Ctr Hosp Univ Lyon, Hop Neurol & Neurochirurg Wertheimer, Serv Neurochirurg B, 59 Bd Pinel, F-69677 Lyon, France; [Manet, Romain] Clin Mutualiste Chirurg, Serv Neurochirurg, St Etienne, France; [Payen, Jean-Francois] Univ Grenoble Alpes, GIN, F-38000 Grenoble, France; [Payen, Jean-Francois; Guerin, Romain; Francony, Gilles] CHU Grenoble Alpes, Pole Anesthesie Reanimat, F-38000 Grenoble, France; [Payen, Jean-Francois] INSERM, U1216, F-38000 Grenoble, France; [Martinez, Orianne] CHU Montpellier, Hop Lapeyronie, Serv Reanimat, Montpellier, France; [Hautefeuille, Serge] Ctr Hosp Annecy Genevois, Serv Reanimat, Annecy, France; [Gergele, Laurent] CHU St Etienne, Dept Anesthesie Reanimat, St Priest En Jarez, France		Manet, R (corresponding author), Ctr Hosp Univ Lyon, Hop Neurol & Neurochirurg Wertheimer, Serv Neurochirurg B, 59 Bd Pinel, F-69677 Lyon, France.; Manet, R (corresponding author), Clin Mutualiste Chirurg, Serv Neurochirurg, St Etienne, France.	romain.manet@neurochirurgie.fr	Payen, Jean-Francois/L-6667-2014; MANET, Romain/AAK-1751-2020	GERGELE, Laurent/0000-0002-7283-6793			Abadal-Centellas JM, 2007, J TRAUMA, V62, P282, DOI 10.1097/01.ta.0000199422.01949.78; Akil H, 2007, J TRAUMA, V63, P720, DOI 10.1097/TA.0b013e318141fe4d; Al-Tamimi YZ, 2012, STROKE, V43, P677, DOI 10.1161/STROKEAHA.111.625731; ANDERSSON H, 1984, CHILD BRAIN, V11, P398; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; BALDWIN HZ, 1992, PEDIATR NEUROSURG, V17, P115, DOI 10.1159/000120579; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Cardoso ER, 1996, J NEUROSURG, V85, P1143, DOI 10.3171/jns.1996.85.6.1143; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chapman PH, 1983, CONCEPTS PEDIATR NEU, V4, P102; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; GJERRIS F, 1985, ANN NEUROL, V17, P158, DOI 10.1002/ana.410170209; Grady MS, 2009, J NEUROSURG, V110, P1198, DOI 10.3171/2008.11.JNS081336; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Huh PW, 2006, J NEUROSURG, V105, P65, DOI 10.3171/jns.2006.105.1.65; Ishibashi Akira, 1994, Kurume Medical Journal, V41, P81; Joffe Ari R, 2007, J Intensive Care Med, V22, P194, DOI 10.1177/0885066607299516; Klimo P, 2004, J NEUROSURG, V100, P215, DOI 10.3171/jns.2004.100.2.0215; Llompart-Pou JA, 2011, ANAESTH INTENS CARE, V39, P79, DOI 10.1177/0310057X1103900113; Manet R, 2016, ACTA NEUROCHIR SUPPL, V122, P55, DOI 10.1007/978-3-319-22533-3_11; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Munch EC, 2001, CRIT CARE MED, V29, P976; Murad A, 2012, WORLD NEUROSURG, V77, P160, DOI 10.1016/j.wneu.2011.06.018; Payr E, 1916, MED KLIN, V12, P841; REKATE HL, 1988, PEDIATR NEUROSCI, V14, P77, DOI 10.1159/000120367; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; STONE JL, 1981, NEUROSURGERY, V8, P542, DOI 10.1227/00006123-198105000-00005; Tuettenberg J, 2009, J NEUROSURG, V110, P1200, DOI 10.3171/2008.10.JNS08293; Yoshimoto Y, 1998, J NEUROSURG, V88, P485, DOI 10.3171/jns.1998.88.3.0485	29	7	8	0	6	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2017	159	10					2003	2009		10.1007/s00701-017-3290-1			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FG2GK	WOS:000409907500025	28791479				2022-02-06	
J	McLellan, J; Marshman, LAG; Hennessy, M				McLellan, Jessica; Marshman, Laurence A. G.; Hennessy, Maria			Anterograde amnesia and disorientation are associated with in-patients without traumatic brain injury taking opioids. Retrograde amnesia (RA) is absent. RA assessment should be integral to post-traumatic amnesia testing	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Retrograde amnesia; Opioids; Disorientation; Anterograde amnesia	HEAD-INJURY; PRACTICAL SCALE; MEMORY	The Glasgow Coma Scale (GCS) only assesses orientation after traumatic brain injury (TBI). 'Post-traumatic amnesia' (PTA) comprises orientation, anterograde amnesia (AA) and retrograde amnesia (RA). However, RA is often disregarded in formalized PTA assessment. Drugs can potentially confound PTA assessment: e.g. midazolam can cause AA. However, potential drug confounders are also often disregarded in formalized PTA testing. One study of medium-stay elective-surgery orthopaedic patients (without TBI) demonstrated AA in 80% taking opiates after general anesthesia. However, RA was not assessed. Opiates/opioids are frequently administered after TBI. We compared AA and RA in short-stay orthopaedic surgery in-patients (without TBI) taking post-operative opioids after opiate/opioid/benzodia zepine-free spinal anesthesia. In a prospective cohort, the Westmead PTA Scale (WPTAS) was used to assess AA (WPTAS < 12), whilst RA was assessed using the Galveston Orientation and Amnesia Test RA item. Results were obtained in n = 25 (60 +/- 14 yrs, M:F 17:8). Surgery was uncomplicated: all were discharged by Day-4. All were taking regular oxycodone as a new post-operative prescription. Only one co-administered non-opioid was potentially confounding (temezepam, n = 4). Of 25, 14 (56%) demonstrated AA: five (20%) were simultaneously disorientated. Mean WPTAS was 11.08 +/- 1.22. RA occurred in 0%. Conclusions: AA and disorientation, but not RA, were associated with in-patients (without TBI) taking opioids. Caution should therefore be applied in assessing AA/orientation in TBI in-patients taking opioids. By contrast, retrograde memory was robust and more reliable: even in older patients with iatrogenic AA and disorientation. RA assessment should therefore be integral to assessing TBI severity in all formalized PTA and GCS testing. Crown Copyright (C) 2017 Published by Elsevier Ltd. All rights reserved.	[McLellan, Jessica; Hennessy, Maria] James Cook Univ, Dept Psychol, Townsville, Qld 4810, Australia; [Marshman, Laurence A. G.] Townsville Hosp, Dept Neurosurg, Townsville, Qld 4810, Australia; [Marshman, Laurence A. G.] James Cook Univ, Sch Med & Dent, Townsville, Qld 4810, Australia		Marshman, LAG (corresponding author), Townsville Hosp, Dept Neurosurg, Townsville, Qld 4810, Australia.	l.a.g.marshman@btinternet.com	Hennessy, Maria J/K-6241-2016	Hennessy, Maria J/0000-0002-3500-7128			[Anonymous], 1942, Proc R Soc Med, V35, P601; Cohen J., 2013, STAT POWER ANAL BEHA; FORTUNE N, 1999, DEFINITION INCIDENCE; Hong YJ, 2015, CLIN NEUROPHARMACOL, V38, P47, DOI 10.1097/WNF.0000000000000067; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lowe JMS, 2008, GREENFIELDS NEUROPAT, V8, P1031; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McCarter RJ, 2007, BRAIN INJURY, V21, P1393, DOI 10.1080/02699050701793793; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Salmon P, 2013, CLIN REHABIL, V27, P854, DOI 10.1177/0269215513481686; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Symonds C.P., 1940, INJURIES SKULL BRAIN, P69; Symonds CP, 1943, LANCET, V1, P7; Symonds CP, 1935, LANCET, V1, P486; Symonds CP, 1937, P ROY SOC MED, V30, P34; Symonds CP, 1935, LANCET, V226, P1217, DOI [10.1016/S0140-6736(00)47408-8, DOI 10.1016/S0140-6736(00)47408-8]; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; TEASDALE G, 1974, LANCET, V2, P81	19	7	7	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	OCT	2017	44						184	187		10.1016/j.jocn.2017.06.027			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FJ3CW	WOS:000412609100031	28676317				2022-02-06	
J	Park, E; Park, K; Liu, E; Jiang, RC; Zhang, JN; Baker, AJ				Park, Eugene; Park, Katya; Liu, Elaine; Jiang, Rongcai; Zhang, Jianning; Baker, Andrew J.			Bone-Marrow-Derived Endothelial Progenitor Cell Treatment in a Model of Lateral Fluid Percussion Injury in Rats: Evaluation of Acute and Subacute Outcome Measures	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; cell therapy; endothelial progenitor cells; fluid percussion injury; neuroprotection; traumatic brain injury	TRAUMATIC BRAIN-INJURY; GROWTH-FACTOR; ANGIOGENESIS; RECOVERY; TRANSPLANTATION; NEUROGENESIS; THERAPY; BLOOD; EPCS	Traumatic brain injury (TBI) continues to be a serious health care issue while therapies to treat TBI remain elusive. Promising results from the use of endothelial progenitor cells (EPCs) in numerous disease states highlight the pleiotropic capacity of this cell type. We have previously demonstrated that EPC-conditioned media reduces axonal degeneration subsequent to in vitro oxygen-glucose deprivation insult and concurrently improves white matter and microvascular outcome in vivo after mid-line fluid percussion injury. In the current study, we evaluated the effectiveness of allogeneic endothelial cells derived from rat bone marrow on microvascular recovery and neuronal sparing after lateral fluid percussion injury. We observed reduced expression of activated caspase-3 and poly (ADP-ribose) polymerase cleavage at 72 h post-injury. Subacute injury assessments at 30 days post-injury using immunohistochemistry indicated nonsignificant effects on microvascular outcome and neuronal cell density in the hippocampus. Behavioral testing using the Morris Water Maze and rotarod demonstrated significant improvement in locomotor function, as measured by the rotarod task, but no significant differences in spatial memory ability. The data suggest that EPCs contribute to improvements in the early phase of secondary injury through inhibition of apoptosis whereas the effects on longer-term recovery were less clearly defined. There is potential in the use of EPCs to treat secondary injury post-TBI; however, optimization of their effects through increased duration or homing capacities remains to be examined.	[Park, Eugene; Park, Katya; Liu, Elaine; Baker, Andrew J.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurosurg, Tianjin, Peoples R China; [Baker, Andrew J.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, Dept Surg, Toronto, ON, Canada		Park, E (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 209 Victoria St LKSKI W, Room 6-656, Toronto, ON M5B 1T8, Canada.	parke@smh.ca			Ontario-China Research Innovation Fund through Government of Ontari, Ministry of Economic Development and Innovation	This study was funded by the Ontario-China Research Innovation Fund provided through the Government of Ontario, Ministry of Economic Development and Innovation.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Carenza E, 2014, NANOMED-NANOTECHNOL, V10, P225, DOI 10.1016/j.nano.2013.06.005; Chen H, 2014, HEART LUNG CIRC, V23, P595, DOI 10.1016/j.hlc.2014.02.007; Chen JB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041125, 10.1371/journal.pone.0046878]; Chen X, 2013, ACTA RADIOL, V54, P313, DOI 10.1258/ar.2012.120605; Cho HJ, 2003, CIRCULATION, V108, P2918, DOI 10.1161/01.CIR.0000097001.79750.78; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; Gong DS, 2012, BRAIN INJURY, V26, P291, DOI 10.3109/02699052.2011.648710; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gu YL, 2014, NEUROSCI LETT, V570, P86, DOI 10.1016/j.neulet.2014.04.004; Haar CV, 2012, RESTOR NEUROL NEUROS, V30, P291, DOI 10.3233/RNN-2012-110196; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hu YH, 2003, CIRCULATION, V108, P3122, DOI 10.1161/01.CIR.0000105722.96112.67; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jacobs SA, 2013, CELL TRANSPLANT, V22, P1915, DOI 10.3727/096368912X657369; Kienstra Kirsten A, 2012, Methods Mol Biol, V904, P155, DOI 10.1007/978-1-61779-943-3_13; King Thomas F J, 2014, J Stem Cells, V9, P93, DOI jsc.2014.9.2.93; Ladhoff J, 2010, CARDIOVASC RES, V88, P121, DOI 10.1093/cvr/cvq109; Li QY, 2013, BIOMATERIALS, V34, P4982, DOI 10.1016/j.biomaterials.2013.03.030; Li YF, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0130-8; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Park KJ, 2014, J CEREBR BLOOD F MET, V34, P357, DOI 10.1038/jcbfm.2013.216; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pula G, 2009, CIRC RES, V104, P32, DOI 10.1161/CIRCRESAHA.108.182261; Resch T, 2012, STEM CELL REV REP, V8, P926, DOI 10.1007/s12015-011-9332-9; Rosell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073244; Siddiq I, 2012, J NEUROTRAUM, V29, P2647, DOI 10.1089/neu.2012.2444; Stauffer BL, 2008, ARTERY RES, V2, P156, DOI 10.1016/j.artres.2008.10.001; Thau-Zuchman O, 2012, NEUROSCIENCE, V202, P334, DOI 10.1016/j.neuroscience.2011.11.071; Thau-Zuchman O, 2012, J MOL NEUROSCI, V47, P166, DOI 10.1007/s12031-012-9706-8; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Wang B, 2012, J NEUROL SCI, V319, P117, DOI 10.1016/j.jns.2012.04.015; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035; Zhang YQ, 2013, J SURG RES, V185, P441, DOI 10.1016/j.jss.2013.05.073; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739	39	7	7	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2801	2811		10.1089/neu.2016.4560			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700014	28335684				2022-02-06	
J	Penasco, Y; Gonzalez-Castro, A; Borregan, JCR; Ortiz-Lasa, M; Solorzano, RJ; Arguiano, MJS; Acha, PE				Penasco, Y.; Gonzalez-Castro, A.; Rodriguez Borregan, J. C.; Ortiz-Lasa, M.; Jauregui Solorzano, R.; Sanchez Arguiano, M. J.; Escudero Acha, P.			Limitation of life-sustaining treatment in severe trauma in the elderly after admission to an intensive care unit	MEDICINA INTENSIVA			Spanish	Article						Polytrauma; Geriatric trauma; Elderly; Limitation of life-sustaining treatment	OF-LIFE; GERIATRIC TRAUMA; MULTIPLE INJURIES; RISK-FACTORS; END; POPULATION; MORTALITY; STATEMENT; RECOMMENDATIONS; CHALLENGES	Objective: To analyze the factors associated to limitation of life -sustaining treatment (LLST) measures in elderly patients admitted to an intensive care unit (ICU) due to trauma. Design: A retrospective, descriptive, observational study was carried out. Setting: ICU. Patients: A total of 149 patients aged 65 years or older admitted to the ICU due to trauma. Hospital mortality, the decision to limit life -sustaining treatment and the factors associated to these measures were analyzed. Interventions: None. Results: The mean patient age was 76.3 +/- 6.36 years. The average APACHE a and ISS scores were 15.9 +/- 7.4 and 19.6 +/- 11.4 points, respectively. LLST were used in 37 patients (24.8%). Factors associated to the use of these measures were patient age (OR 1.16; 95% CI 1.08 to 1.25], APACHE score (OR 1.11; 95% CI 1.05-1.67), ISS score (OR 1.03; 95% CI 1.01 to 1.06), admission due to neurological impairment (OR 19.17; 95% CI 2.33 to 157.83) and traumatic brain injury (OR 2.89; 95% CI 1.05 to 7.96). Conclusions: LLST is frequently established in elderly patients admitted to the ICU due to trauma, and is associated to hospital mortality. Factors associated with the use of these measures are patient age, higher APACHE n and ISS scores, admission due to neurological impairment, and the presence of head injuries.(C) 2017 Elsevier Espana, S.L.U. y SEMICYUC. All rights reserved.	[Penasco, Y.; Gonzalez-Castro, A.; Rodriguez Borregan, J. C.; Ortiz-Lasa, M.; Jauregui Solorzano, R.; Sanchez Arguiano, M. J.; Escudero Acha, P.] Hosp Univ Marques Valdecilla, Serv Med Intens, Santander, Spain		Penasco, Y (corresponding author), Hosp Univ Marques Valdecilla, Serv Med Intens, Santander, Spain.	metalkender@yahoo.es	Castro, Alejandro Gonzalez/AAL-7674-2020; Escudero, Patricia/AAL-4344-2020; Castro, Alejandro Gonzalez/AAX-3553-2020	Castro, Alejandro Gonzalez/0000-0001-5927-336X; Escudero, Patricia/0000-0002-1968-265X; Castro, Alejandro Gonzalez/0000-0001-5927-336X			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bodi MA, 2015, MED INTENSIVA, V39, P337, DOI 10.1016/j.medin.2014.07.010; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Carlet J, 2004, INTENS CARE MED, V30, P770, DOI 10.1007/s00134-004-2241-5; Chochinov HM, 2002, LANCET, V360, P2026, DOI 10.1016/S0140-6736(02)12022-8; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Elizari FJ, 2007, COLECCION 10 PALABRA, P245; Esteban A, 2001, INTENS CARE MED, V27, P1744, DOI 10.1007/s00134-001-1111-7; Fernandez R, 2005, MED INTENSIVA, V29, P338, DOI DOI 10.1016/S0210-5691(05)74255-8; Giannoudis PV, 2009, INJURY, V40, P362, DOI 10.1016/j.injury.2008.10.016; Gomez Rubi J. A., 2002, ETICA MED CRITICA; Gonzalez-Castro A, 2016, REV CALID ASSIST, V31, P262, DOI 10.1016/j.cali.2015.12.007; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P196, DOI 10.1097/TA.0b013e3182a833ac; Joyce MF, 2015, CURR OPIN ANESTHESIO, V28, P145, DOI 10.1097/ACO.0000000000000173; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kon AA, 2016, CRIT CARE MED, V44, P1769, DOI 10.1097/CCM.0000000000001965; Labib N, 2011, J TRAUMA, V71, P1908, DOI 10.1097/TA.0b013e31820989ed; Lopez-Soto Alfonso, 2009, Rev Esp Geriatr Gerontol, V44 Suppl 1, P27, DOI 10.1016/j.regg.2009.03.013; McKinley BA, 2000, ARCH SURG-CHICAGO, V135, P688, DOI 10.1001/archsurg.135.6.688; Monedero P, 2010, REV ESP ANEST REANIM, V57, P586, DOI 10.1016/S0034-9356(10)70286-3; Marin JLM, 2008, MED INTENSIVA, V32, P121, DOI 10.1016/S0210-5691(08)70922-7; O'Neill S, 2012, ARCH GERONTOL GERIAT, V54, pE426, DOI 10.1016/j.archger.2012.01.007; Pintado MC, 2016, MED INTENSIVA, V40, P289, DOI 10.1016/j.medin.2015.08.002; RANKIN J, 1957, Scott Med J, V2, P200; Goixart LS, 2014, MED INTENSIVA, V38, P1, DOI 10.1016/j.medin.2012.10.008; Shifflette VK, 2010, J TRAUMA, V69, P88, DOI 10.1097/TA.0b013e3181e291e9; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Trunkey DD, 2000, ARCH SURG-CHICAGO, V135, P34, DOI 10.1001/archsurg.135.1.34; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096	29	7	7	0	1	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	OCT	2017	41	7					394	400		10.1016/j.medin.2017.03.009			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI0YP	WOS:000411656100002	28528969				2022-02-06	
J	Ressel, V; Tuura, RO; Scheer, I; van Hedel, HJA				Ressel, Volker; Tuura, Ruth O'Gorman; Scheer, Ianina; van Hedel, Hubertus J. A.			Diffusion tensor imaging predicts motor outcome in children with acquired brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						DTI; WeeFIM; Paediatric; Stroke and TBI; Corticospinal-tracts	SPATIAL STATISTICS; STROKE; MECHANISMS; MRI	Background: Rehabilitation in children with acquired brain injury is a challenging endeavour. There is a large variability in motor recovery between patients, and a need to optimize therapies by exploiting cerebral plasticity and recovery mechanisms. This retrospective study aims to identify tract-based markers that could serve as predictors of functional outcome following rehabilitation. Methods: Twenty-nine children with traumatic brain injury (n = 14) or stroke (n = 15) underwent a 3 T Magnetic Resonance Imaging (MRI) measurement, including Diffusion Tensor Imaging (DTI) between admission to the Hospital and onset of rehabilitation therapy at the Rehabilitation Centre. The Functional Independence Measure for Children (WeeFIM) was routinely applied at admission and discharge from the Rehabilitation Centre. Distinguishing between children with good versus poor functional independence was performed using ROC-analysis. A non-parametric partial correlation analysis between the DTI and WeeFIM motor scores was performed with age, time in rehabilitation, and time of MRI scan after injury as covariates. Results: Mean fractional anisotropy (FA) from the DTI in the ipsilesional corticospinal-tract provided the highest predictive accuracy (sensitivity = 95 %, specificity = 78 %, Youden Index = 0.73, Area under the curve = 0.9), in comparison to the lesion volume or other clinical variables. Mean FA of the ipsilesional corticospinal-tract correlated positively with the WeeFIM discharge motor scores (rho = 0.547, p = 0.004). Prediction was poorer for the lesion volume or Glasgow Coma Scale. Conclusion: The results suggest that DTI data could improve the prediction of functional outcome after rehabilitation in children and adolescents with stroke or traumatic brain injury. Specifically, mean FA shows the highest predictive accuracy in comparison to lesion volume or clinical scales.	[Ressel, Volker; van Hedel, Hubertus J. A.] Univ Childrens Hosp, Rehabil Ctr, CH-8910 Affoltern Am Albis, Switzerland; [Ressel, Volker; Tuura, Ruth O'Gorman] Univ Childrens Hosp, Ctr MR Res, CH-8032 Zurich, Switzerland; [Scheer, Ianina] Univ Childrens Hosp, Diagnost Imaging, CH-8032 Zurich, Switzerland		Ressel, V (corresponding author), Univ Childrens Hosp, Rehabil Ctr, CH-8910 Affoltern Am Albis, Switzerland.; Ressel, V (corresponding author), Univ Childrens Hosp, Ctr MR Res, CH-8032 Zurich, Switzerland.	volker.ressel@kispi.uzh.ch	Ressel, Volker/E-7657-2012; van Hedel, Hubertus/AAL-3818-2021	van Hedel, Hubertus/0000-0002-9577-5049; Ressel, Volker/0000-0002-2378-830X; O'Gorman, Ruth/0000-0001-5932-7786	Clinical Research Priority Programs Neurorehabilitation of the University of Zurich (Switzerland); Maxi-Foundation (Zurich, Switzerland); Anna Muller Grocholsky Foundation (Zurich, Switzerland)	The authors would like to thank the participants and their parents to provide the written consent for this retrospective study, Corinna Gerber to approach the participants and parents for their written consent, Nicole Iten for help with the Functional Independence Measure for Children (WeeFIM), Dr. med. Annette Hackenberg for the neuropediatric support, Dr. med. Vincenzo Cannizzaro for help in the intensive medicine and neonatology unit, and Prof. Dr. med. Barbara Plecko and PD Dr. Andreas Meyer-Heim for expert comments. We also acknowledge the Neuroscience Center Zurich (ZNZ). This work was funded by the Clinical Research Priority Programs Neurorehabilitation of the University of Zurich (Switzerland), the Maxi-Foundation (Zurich, Switzerland), and the Anna Muller Grocholsky Foundation (Zurich, Switzerland). Last but not least, we would like to thank the anonymous reviewers for their helpful comments.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; BROUWER B, 1990, ELECTROEN CLIN NEURO, V76, P509, DOI 10.1016/0013-4694(90)90002-2; DAVIDOFF RA, 1990, NEUROLOGY, V40, P332; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Jang SH, 2011, NEUROREHABILITATION, V28, P345, DOI 10.3233/NRE-2011-0662; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kusano Y, 2009, AM J NEURORADIOL, V30, P1561, DOI 10.3174/ajnr.A1639; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Ma CC, 2014, J CLIN NEUROSCI, V21, P1388, DOI 10.1016/j.jocn.2013.11.032; Maraka S, 2014, ANN CLIN TRANSL NEUR, V1, P891, DOI 10.1002/acn3.132; McNett Molly, 2007, J Neurosci Nurs, V39, P68; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; O'Gorman RL, 2015, BRAIN, V138, P388, DOI 10.1093/brain/awu363; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Park JH, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0112045, 10.1371/journal.pone.0141010]; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Rabinowitz AR, 2014, ANNU REV PSYCHOL, V65, P301, DOI 10.1146/annurev-psych-010213-115103; Rocca MA, 2013, NEUROTHERAPEUTICS, V10, P511, DOI 10.1007/s13311-013-0189-2; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Simonetti BG, 2012, THER UMSCH, V69, P536, DOI 10.1024/0040-5930/a000326; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smitherman E., 2015, J NEUROTRAUM, V32, P1; Stinear CM, 2007, BRAIN, V130, P170, DOI 10.1093/brain/awl333; Sztriha LK, 2012, STROKE, V43, P3124, DOI 10.1161/STROKEAHA.111.649244; Takeuchi N, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/128641; TEASDALE G, 1974, LANCET, V2, P81; van Hedel HJA, 2010, RESTOR NEUROL NEUROS, V28, P123, DOI 10.3233/RNN-2010-0508; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Xu D, 2013, PEDIATR RADIOL, V43, P55, DOI 10.1007/s00247-012-2481-4; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	40	7	8	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	OCT	2017	11	5					1373	1384		10.1007/s11682-016-9637-z			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FK8VP	WOS:000413789300002	27734299				2022-02-06	
J	Rostami, R; Salamati, P; Yarandi, KK; Khoshnevisan, A; Saadat, S; Kamali, ZS; Ghiasi, S; Zaryabi, A; Saeid, SSGM; Arjipour, M; Rezaee-Zavareh, MS; Rahimi-Movaghar, V				Rostami, Reza; Salamati, Payman; Yarandi, Kourosh Karimi; Khoshnevisan, Alireza; Saadat, Soheil; Kamali, Zeynab Sadat; Ghiasi, Somaie; Zaryabi, Atefeh; Saeid, Seyed Shahab Ghazi Mir; Arjipour, Mehdi; Rezaee-Zavareh, Mohammad Saeid; Rahimi-Movaghar, Vafa			Effects of neurofeedback on the short-term memory and continuous attention of patients with moderate traumatic brain injury: A preliminary randomized controlled clinical trial	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Neurofeedback; Brain injuries; Attention; Short-term memory	ADHD; IRAN	Purpose: There are some studies which showed neurofeedback therapy (NFT) can be effective in clients with traumatic brain injury (TBI) history. However, randomized controlled clinical trials are still needed for evaluation of this treatment as a standard option. This preliminary study was aimed to evaluate the effect of NFT on continuous attention (CA) and short-term memory (STM) of clients with moderate TBI using a randomized controlled clinical trial (RCT). Methods: In this preliminary RCT, seventeen eligible patients with moderate TBI were randomly allocated in two intervention and control groups. All the patients were evaluated for CA and STM using the visual continuous attention test and Wechsler memory scale-4th edition (WMS-IV) test, respectively, both at the time of inclusion to the project and four weeks later. The intervention group participated in 20 sessions of NFT through the first four weeks. Conversely, the control group participated in the same NF sessions from the fifth week to eighth week of the project. Results: Eight subjects in the intervention group and five subjects in the control group completed the study. The mean and standard deviation of participants' age were (26.75 +/- 15.16) years and (27.60 +/- 8.17) years in experiment and control groups, respectively. All of the subjects were male. No significant improvement was observed in any variables of the visual continuous attention test and WMS-IV test between two groups (p >= 0.05). Conclusion: Based on our literature review, it seems that our study is the only study performed on the effect of NFT on TBI patients with control group. NFT has no effect on CA and STM in patients with moderate TBI. More RCTs with large sample sizes, more sessions of treatment, longer time of follow-up and different protocols are recommended. (C) 2017 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University. Production and hosting by Elsevier B.V.	[Rostami, Reza; Kamali, Zeynab Sadat] Univ Tehran, Dept Psychol, Tehran, Iran; [Salamati, Payman; Yarandi, Kourosh Karimi; Saadat, Soheil; Saeid, Seyed Shahab Ghazi Mir; Rezaee-Zavareh, Mohammad Saeid; Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Khoshnevisan, Alireza; Arjipour, Mehdi] Univ Tehran Med Sci, Sch Med, Shariati Hosp, Dept Neurosurg, Tehran, Iran; [Ghiasi, Somaie] Kharazmi Univ, Dept Psychol, Tehran, Iran; [Zaryabi, Atefeh] Allame Tabatabaei Univ, Dept Clin Psychol, Tehran, Iran; [Rezaee-Zavareh, Mohammad Saeid] Baqiyatallah Univ Med Sci, Students Res Comm, Tehran, Iran		Rezaee-Zavareh, MS (corresponding author), Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran.	Dr_Rezaee@Live.com	Rezaee-Zavareh, Mohammad Saeid/E-8022-2010; arjipour/S-2347-2017; yarandi, kourosh karimi/P-5504-2019; Rahimi-Movaghar, Vafa/L-6339-2019; Saadat, Soheil/J-1595-2014; arjipour/AAC-3753-2020; Salamati, Payman/AAK-7086-2020; Rahimi-Movaghar, Vafa/T-7816-2017	Rezaee-Zavareh, Mohammad Saeid/0000-0003-0447-6607; arjipour/0000-0002-0261-1492; yarandi, kourosh karimi/0000-0001-6004-402X; Saadat, Soheil/0000-0002-2744-7983; arjipour/0000-0002-0261-1492; Salamati, Payman/0000-0001-9313-3977; Rahimi-Movaghar, Vafa/0000-0001-7347-8767; ghiasi, somaie/0000-0002-7677-7276	Sina Trauma and Surgery Research Center [167]	This study was financially supported by the Sina Trauma and Surgery Research Center affiliated to Tehran University of Medical Sciences under contract number 167.	[Anonymous], 1998, NIH Consens Statement, V16, P1; Arns M, 2014, BIOL PSYCHOL, V95, P108, DOI 10.1016/j.biopsycho.2013.11.013; Arns M, 2009, CLIN EEG NEUROSCI, V40, P180, DOI 10.1177/155005940904000311; Astrand E, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00144; Carson HJ, 2009, J FORENSIC LEG MED, V16, P115, DOI 10.1016/j.jflm.2008.08.013; Cree Claire, 2003, Nurs Stand, V18, P45; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; Ghodsi S, 2002, TEHRAN J MED COUNC I, V20, P193; Koprivova J, 2013, NEUROPSYCHOBIOLOGY, V67, P210, DOI 10.1159/000347087; LANTZ D, 1988, EPILEPSIA, V29, P163, DOI 10.1111/j.1528-1157.1988.tb04414.x; May G, 2013, ANN CLIN PSYCHIATRY, V25, P289; Munivenkatappa A, 2014, NEUROREHABILITATION, V35, P481, DOI 10.3233/NRE-141140; Nelson DV, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0049-y; Peper E, 2008, APPL PSYCHOPHYS BIOF, V33, P239, DOI 10.1007/s10484-008-9068-8; Rahimi-Movaghar V, 2011, AM SURGEON, V77, pE112; Reddy RP, 2009, INDIAN J NEUROTRAUM, V6, P87, DOI 10.1016/S0973-0508(09)80037-3; Reddy RP, 2014, INDIAN J PSYCHOL MED, V36, P40, DOI 10.4103/0253-7176.127246; Saadat S, 2011, ULUS TRAVMA ACIL CER, V17, P149, DOI 10.5505/tjtes.2011.26043; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Shorooei MH, 2010, IRAN CHIN J TRAUMATO, V13, P345; Sumec R, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/620674; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wing K, 2001, Top Stroke Rehabil, V8, P45; Yan HQ, 2015, BRAIN NEUROTRAUMA MO, P33; Yousefzadeh-Chabok Shahrokh, 2015, Asian J Neurosurg, V10, P173, DOI 10.4103/1793-5482.161165	25	7	7	0	2	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	OCT	2017	20	5					278	282		10.1016/j.cjtee.2016.11.007			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	GQ9RK	WOS:000442124100006	28552331	Green Published, gold			2022-02-06	
J	Shibahashi, K; Sugiyama, K; Hoda, H; Hamabe, Y				Shibahashi, Keita; Sugiyama, Kazuhiro; Hoda, Hidenori; Hamabe, Yuichi			Skeletal Muscle as a Factor Contributing to Better Stratification of Older Patients with Traumatic Brain Injury: A Retrospective Cohort Study	WORLD NEUROSURGERY			English	Article						Muscle; Risk factor; Sarcopenia; Traumatic brain injury	HEAD-INJURY; WHOLE-BODY; BED REST; SARCOPENIA; OUTCOMES; ADULTS; TOMOGRAPHY; MORTALITY; RESECTION; IMPACT	BACKGROUND: Traumatic brain injury (TBI) in older patients is becoming an increasing problem, and methods that help predict outcomes in this population are needed. The objective of this study was to evaluate skeletal muscle mass as a predictive marker for TBI outcome in older patients. METHODS: Older patients (age >= 60 years) with TBI were included in this study. Clinical outcomes were assessed using the Glasgow Outcome Scale (GOS) at 6 months postinjury. Patients were classified according to their GOS score as having a good outcome (GOS 3-5) or a poor outcome (GOS 1 OR 2). Skeletal muscle mass was estimated, and the relationship with outcome was analyzed. A multivariable logistic regression model was used to quantify the independent effects of sarcopenia on the risk of poor outcome. RESULTS: Seventy-four patients (median age, 74 years; 53 males) were included. Outcomes at 6 months postinjury were good in 38 patients and poor in 36 patients. The skeletal muscle area was significantly larger in the good outcome group compared with the poor outcome group (57.3 cm(2) vs. 47.6 cm(2); P < 0.001). The rate of poor outcome was significantly higher in the patients with sarcopenia compared with those without sarcopenia (0.70 vs. 0.24; relative risk, 2.98; 95% confidence interval [CI], 1.57-5.64). The difference was statistically significant, and the odds ratio was 3.88 (95% CI, 1.14-13.2; P = 0.031). CONCLUSION: Reduced skeletal muscle mass was associated with poorer outcome after TBI in our cohort of older patients. Our results suggest that identifying patients with low muscularity may contribute to better stratification in this population.	[Shibahashi, Keita] Tokyo Metropolitan Bokutoh Hosp, Dept Emergency, Tokyo, Japan; Tokyo Metropolitan Bokutoh Hosp, Intens Care Ctr, Tokyo, Japan		Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Dept Emergency, Tokyo, Japan.	kshibahashi@yahoo.co.jp		Sugiyama, Kazuhiro/0000-0003-4543-3064			Benjamin ER, 2015, JAMA SURG, V150, P1194, DOI 10.1001/jamasurg.2015.1649; Blaha MJ, 2008, OBESITY, V16, P869, DOI 10.1038/oby.2008.12; Blanc S, 2000, J CLIN ENDOCR METAB, V85, P2223, DOI 10.1210/jc.85.6.2223; Brandt C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/520258; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; GRIMBY G, 1983, CLIN PHYSIOL, V3, P209, DOI 10.1111/j.1475-097X.1983.tb00704.x; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kimura A, 2013, J TRAUMA ACUTE CARE, V75, P202, DOI 10.1097/TA.0b013e3182905ef7; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; MIKINES KJ, 1991, J APPL PHYSIOL, V70, P1245, DOI 10.1152/jappl.1991.70.3.1245; Moisey LL, 2013, CRIT CARE, V17, DOI 10.1186/cc12901; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5; Peng PD, 2011, HPB, V13, P439, DOI 10.1111/j.1477-2574.2011.00301.x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Peters ME, 2016, INT PSYCHOGERIATR, V28, P1931, DOI 10.1017/S1041610216001666; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Shibahashi K, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0205-9; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P537; Thompson Hilaire J, 2006, Crit Care Nurs Clin North Am, V18, P419, DOI 10.1016/j.ccell.2006.05.008; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Zeng X, 2012, CURR GERIATR REP, V1, P167, DOI 10.1007/s13670-012-0018-1	31	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2017	106						589	594		10.1016/j.wneu.2017.07.025			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN2UP	WOS:000415850400074	28712907				2022-02-06	
J	Wang, HF; Cao, HS; Zhang, XH; Ge, L; Bie, L				Wang, Haifeng; Cao, Hongshi; Zhang, Xiaohong; Ge, Liang; Bie, Li			The effect of hypertonic saline and mannitol on coagulation in moderate traumatic brain injury patients	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Hypertonic saline; Mannitol; Coagulation; Rotational thromboelastometry	WHOLE-BLOOD COAGULATION; PLATELET-FUNCTION; COAGULOPATHY	Background: Hyperosmolar therapy, using either hypertonic saline (HTS) or mannitol (MT), is considered the treatment of choice for intracranial hypertension, a disorder characterized by high intracranial pressure (ICP). However, hyperosmolar agents have been postulated to impair coagulation and platelet function. The aim of this study was to identify whether HTS and MT could affect coagulation in moderate traumatic brain injury (TBI) patients. Methods: In this prospective and randomized double-blind study, we included adult patients withmoderate TBI. Patients were divided into two groups according to the type of hypertonic solution administered. Group A patients received 20% MT and group B patients received 3% HTS. Rotational thromboelastometry (ROTEM) parameters were used to assess coagulation and platelet function. Results: ROTEM parameters included CT (clotting time), CFT (clot formation time), maximum clot firmness (MCF) measured byMCF (EXTEM and INTEM), MCF (FIBTEM) and standard coagulation tests (p > 0.05). No significant differenceswere found between the two groups. Moreover, ROTEM parameters did not show significant changes at different timepoints after administration of the hyperosmolar solutions (p > 0.05). Conclusions Overall, use of 3% HTS and 20% MT for the control of ICP did not significantly affect patients' coagulation function. Therefore, hyperosmotic solution is safe and does not increase the risk of intracranial rebleeding. (C) 2017 Elsevier Inc. All rights reserved.	[Wang, Haifeng; Cao, Hongshi; Zhang, Xiaohong; Ge, Liang; Bie, Li] Jilin Univ, Clin Hosp 1, Dept Neurosurg, Changchun, Jilin, Peoples R China; [Bie, Li] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA		Bie, L (corresponding author), My Hospital, 71 Xinmin St, Changchun 130021, Jilin, Peoples R China.	hfwangjl@sina.com; hscaoneuro@126.com; jlxiaohong@yeah.net; lianggedr@sina.com; bieli@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201980, 81572476]; Natural Science Foundation of Jilin Province, China [20130522028JH]	This work was worked supported by the National Natural Science Foundation of China (No. 81201980, No. 81572476) and Natural Science Foundation of Jilin Province, China (No. 20130522028JH).	Adamik KN, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0555-x; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Delano MJ, 2015, SHOCK, V44, P25, DOI 10.1097/SHK.0000000000000368; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Ganter MT, 2008, ANESTH ANALG, V106, P1366, DOI 10.1213/ane.0b013e318168b367; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hanke AA, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-12; Lindroos AC, 2010, J NEUROSURG ANESTH, V22, P16, DOI 10.1097/ANA.0b013e3181bd4ede; Luostarinen T, 2011, NEUROCRIT CARE, V14, P238, DOI 10.1007/s12028-010-9475-6; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; McMichael MA, 2011, VET CLIN PATH, V40, P140, DOI 10.1111/j.1939-165X.2011.00302.x; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Tan TS, 2002, ANAESTHESIA, V57, P644, DOI 10.1046/j.1365-2044.2002.02603.x; Wurlod VA, 2015, J VET EMERG CRIT CAR, V25, P474, DOI 10.1111/vec.12320; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	18	7	9	1	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	OCT	2017	35	10					1404	1407		10.1016/j.ajem.2017.04.020			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FM6RG	WOS:000415183400004	28431870				2022-02-06	
J	Webster, NJ; Moore, N; Stewart, F				Webster, Nathaniel John; Moore, Nathan; Stewart, Felicia			Reducing Unnecessary Head Computed Tomography in Mild Traumatic Brain Injury	ADVANCED EMERGENCY NURSING JOURNAL			English	Article						decision tool; head CT; head trauma; mTBI; unnecessary	NEW-ORLEANS CRITERIA; INTRACRANIAL INJURY; RULE; PHYSICIANS; ADULT	There is growing concern about the frequency of computed tomographic (CT) scans performed for evaluation of adults with suspected mild traumatic brain injury. The Canadian CT Head Rule and the New Orleans Criteria are the most studied head CT decision tools that aid providers in determining which patients do not require a CT scan. This article examines recent research to determine which of these tools has proven to be the most effective at safely reducing the use of head CT scans. The reviewed studies concluded that both the Canadian CT Head Rule and the New Orleans Criteria had similar sensitivities, but the Canadian CT Head Rule showed superior specificity in predicting the presence of a clinically significant brain injury. The authors of this article recommend that the Canadian CT Head Rule be used in the evaluation of minor head injury to reduce unnecessary CT scans.	[Webster, Nathaniel John] Med Associates LLP, Emergency Dept, Community Hlth Network, Indianapolis, IN USA; [Moore, Nathan] Gulf Coast Internists, Palm Harbor, FL USA; [Stewart, Felicia] Indiana State Univ, Adv Practice Nursing Dept, Terre Haute, IN 47809 USA		Webster, NJ (corresponding author), Med Associates, 1500 N Ritter Ave, Indianapolis, IN 46219 USA.	johnw7127@gmail.com					Alonso JV, 2016, MED CLIN-BARCELONA, V147, P523, DOI 10.1016/j.medcli.2016.07.024; American Board of Internal Medicine Foundation, 2014, BRAIN SCANS HEAD INJ; [Anonymous], 2017, WHAT AR RAD RISKS CT; Bishop TF, 2010, ARCH INTERN MED, V170, P1081, DOI 10.1001/archinternmed.2010.155; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Centers for Disease Control and Prevention, 2016, INJ PREV CONTR TRAUM; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Faul M, 2010, TRAUMATIC BRAIN INJU; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kavalci C, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-31; Koppenheffer M., 2015, NEW EVIDENCE HEAD CT; Li SH, 2017, J AM COLL RADIOL, V14, P149, DOI 10.1016/j.jacr.2016.10.002; Mata-Mbemba D, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1781-9; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Schaffer AC, 2017, JAMA INTERN MED, V177, P710, DOI 10.1001/jamainternmed.2017.0311; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	17	7	7	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1931-4485	1931-4493		ADV EMERG NURS J	Adv. Emerg. Nurs. J.	OCT-DEC	2017	39	4					300	308		10.1097/TME.0000000000000169			9	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	FM5MD	WOS:000415078600010	29095182				2022-02-06	
J	Yengo-Kahn, AM; Gardner, RM; Kuhn, AW; Solomon, GS; Bonfield, CM; Zuckerman, SL				Yengo-Kahn, Aaron M.; Gardner, Ryan M.; Kuhn, Andrew W.; Solomon, Gary S.; Bonfield, Christopher M.; Zuckerman, Scott L.			Sport-Related Structural Brain Injury: 3 Cases of Subdural Hemorrhage in American High School Football	WORLD NEUROSURGERY			English	Article						Football; Structural brain injury; Subdural hemorrhage; Traumatic brain injury	2ND IMPACT SYNDROME; CONCUSSION; FATALITIES; PLAYERS	BACKGROUND: The risk of sport-related concussion (SRC) has emerged as a major public health concern. In rare instances, sport-related head injuries can be even more severe, such as subdural hemorrhage, epidural hemorrhage, or malignant cerebral edema. Unlike SRCs, sport-related structural brain injury (SRSBI) is rare, may require neurosurgical intervention, and can lead to permanent neurologic deficit or death. Data characterizing SRSBI are limited, and many have recognized the need to better understand these catastrophic brain injuries. The goal of the current series is to describe, in detail, the presentation, management, and outcomes of examples of these rare injuries. CASE DESCRIPTION: During the fall of 2015, three high school football players presented with acute subdural hemorrhages following in-game collisions and were treated at our institution within a span of 2 months. For the 2 athletes who required surgical intervention, a previous SRC was sustained within 4 weeks before the catastrophic event. One year after injury, 2 players have returned to school, though with persistent deficits. One patient remains nonverbal and wheelchair bound. None of the athletes has returned to sports. CONCLUSIONS: Acute subdural hemorrhage resultant from an in-game football collision is rare. The temporal proximity of the reported SRSBIs to recent SRCs emphasizes the importance of return-to-play protocols and raises questions regarding the possibility of second impact syndrome. Although epidemiologic conclusions cannot be drawn from this small sample, these cases provide a unique opportunity to demonstrate the presentation, management, and long-term outcomes of SRSBI in American high school football.	[Yengo-Kahn, Aaron M.; Gardner, Ryan M.; Kuhn, Andrew W.; Solomon, Gary S.; Bonfield, Christopher M.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Yengo-Kahn, Aaron M.; Solomon, Gary S.; Bonfield, Christopher M.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA.; Zuckerman, SL (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA.	scott.zuckerman@vanderbilt.edu	Solomon, Gary/K-9011-2019; Yengo-Kahn, Aaron/AAV-7647-2020; Kuhn, Andrew W/AAM-4820-2020	Yengo-Kahn, Aaron/0000-0002-5989-3064; Kuhn, Andrew W/0000-0003-1836-7575			Bailes JE, 2017, J NEUROSURG-PEDIATR, V19, P116, DOI 10.3171/2016.8.PEDS16355; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Cantu RC, 2000, NEUROSURGERY, V47, P673, DOI 10.1097/00006123-200009000-00029; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Kucera K.L., 2017, ANN SURVEY FOOTBALL; Kucera KL, 2017, MMWR-MORBID MORTAL W, V65, P1465, DOI 10.15585/mmwr.mm6552a2; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; MUELLER FO, 1990, MED SCI SPORT EXER, V22, P737, DOI 10.1249/00005768-199012000-00001; Mueller FO, 2012, ANN SURVEY CATASTROP; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Schneider RC., 1973, HEAD NECK INJURIES F; Surgeons ACo, 2017, NTDB RES DAT SET NAT; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Tator Charles H, 2014, Neurosurgery, V75 Suppl 4, pS106, DOI 10.1227/NEU.0000000000000484; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Zuckerman SL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12257	21	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2017	106								PMID 1055.e5	10.1016/J.WNEU.2017.07.072			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN2UP	WOS:000415850400162					2022-02-06	
J	Osteras, O; Heltne, JK; Vikenes, BC; Assmus, J; Brattebo, G				Osteras, Oyvind; Heltne, Jon-Kenneth; Vikenes, Bjorn-Christian; Assmus, Jorg; Brattebo, Guttorm			Factors influencing on-scene time in a rural Norwegian helicopter emergency medical service: a retrospective observational study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						On-scene time; Scene time; Helicopter; Hems; Air ambulances; Emergency medical services; First hour quintet; Norway	TRAUMATIC BRAIN-INJURY; GOLDEN HOUR; PREHOSPITAL INTERVENTIONS; NONTECHNICAL SKILLS; MORTALITY; CARE; ASSOCIATION; PHYSICIANS; INTERVALS; SEVERITY	Background: Critically ill patients need to be immediately identified, properly managed, and rapidly transported to definitive care. Extensive prehospital times may increase mortality in selected patient groups. The on-scene time is a part of the prehospital interval that can be decreased, as transport times are determined mostly by the distance to the hospital. Identifying factors that affect on-scene time can improve training, protocols, and decision making. Our objectives were to assess on-scene time in the Helicopter Emergency Medical Service (HEMS) in our region and selected factors that may affect it in specific and severe conditions. Methods: This retrospective cohort study evaluated on-scene time and factors that may affect it for 9757 emergency primary missions by the three HEMSs in western Norway between 2009 and 2013, using graphics and descriptive statistics. Results: The overall median on-scene time was 10 minutes (IQR 5-16). The median on-scene time in patients with penetrating torso injuries was 5 minutes (IQR 3-10), whereas in cardiac arrest patients it was 20 minutes (IQR 13-28). Based on multivariate linear regression analysis, the severity of the patient's condition, advanced interventions performed, mode of transport, and trauma missions increased the on-scene time. Endotracheal intubation increased the OST by almost 10 minutes. Treatment prior to HEMS arrival reduced the on-scene time in patients suffering from acute myocardial infarction. Discussion: We found a short OST in preselected conditions compared to other studies. For the various patient subgroups, the strength of association between factors and OST varied. The time spent on-scene and its influencing factors were dependent on the patient's condition. Our results provide a basis for efforts to improve decision making and reduce OST for selected patient groups. Conclusions: The most important factors associated with increased on-scene time were the severity of the patient's condition, the need for intubation or intravenous analgesic, helicopter transport, and trauma missions.	[Osteras, Oyvind; Heltne, Jon-Kenneth; Vikenes, Bjorn-Christian; Brattebo, Guttorm] Haukeland Hosp, Dept Anaesthesia & Intens Care, POB 1400, N-5021 Bergen, Norway; [Osteras, Oyvind; Heltne, Jon-Kenneth; Brattebo, Guttorm] Univ Bergen, Fac Med, Dept Clin Med, POB 7804, N-5020 Bergen, Norway; [Assmus, Jorg] Haukeland Hosp, Ctr Clin Res, POB 1400, N-5021 Bergen, Norway; [Brattebo, Guttorm] Oslo Univ Hosp, Div Emergencies & Crit Care, Norwegian Natl Advisory Unit Trauma, POB 4950 Nydalen, N-0424 Oslo, Norway		Osteras, O (corresponding author), Haukeland Hosp, Dept Anaesthesia & Intens Care, POB 1400, N-5021 Bergen, Norway.; Osteras, O (corresponding author), Univ Bergen, Fac Med, Dept Clin Med, POB 7804, N-5020 Bergen, Norway.	oyvind.osteras@uib.no		Brattebo, Guttorm/0000-0002-7124-5641			Andruszkow H, 2013, CRIT CARE, V17, DOI 10.1186/cc12796; Aydin S, 2010, J TRAUMA, V69, P589, DOI 10.1097/TA.0b013e3181e74858; BONATTI J, 1995, RESUSCITATION, V30, P133, DOI 10.1016/0300-9572(95)00883-U; Botker MT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-12; Carr BG, 2008, PREHOSP EMERG CARE, V12, P327, DOI 10.1080/10903120802096928; Carr BG, 2006, PREHOSP EMERG CARE, V10, P198, DOI 10.1080/10903120500541324; Dickinson E T, 1997, Prehosp Emerg Care, V1, P132, DOI 10.1080/10903129708958805; Dissmann PD, 2007, EMERG MED J, V24, P59, DOI 10.1136/emj.2006.038844; Flin R, 2004, QUAL SAF HEALTH CARE, V13, pI80, DOI 10.1136/qshc.2004.009993; Flin R, 2010, BRIT J ANAESTH, V105, P38, DOI 10.1093/bja/aeq134; Funder KS, 2011, EMERG MED J, V28, P797, DOI 10.1136/emj.2010.097535; Garner A, 1999, AUST NZ J SURG, V69, P697, DOI 10.1046/j.1440-1622.1999.01688.x; Gonzalez RP, 2006, J TRAUMA, V61, P404, DOI 10.1097/01.ta.0000229816.16305.94; Goodacre SW, 1997, J ACCID EMERG MED, V14, P283; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Herlitz J, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-48; Hoejenbos MJJ, 2008, PREHOSPITAL DISASTER, V23, pS74, DOI 10.1017/S1049023X00021294; Hoyer CCS, 2006, EUR J EMERG MED, V13, P156; Krafft T, 2003, EUR J PUBLIC HEALTH, V13, P85, DOI 10.1093/eurpub/13.suppl_1.85; Kruger AJ, 2013, ACTA ANAESTH SCAND, V57, P1175, DOI 10.1111/aas.12181; Kruger AJ, 2010, RESUSCITATION, V81, P427, DOI 10.1016/j.resuscitation.2009.12.019; McCoy CE, 2013, ANN EMERG MED, V61, P167, DOI 10.1016/j.annemergmed.2012.08.026; Meizoso JP, 2015, J TRAUMA ACUTE CARE, V79, P227, DOI 10.1097/TA.0000000000000748; Newgard CD, 2015, ANN EMERG MED, V66, P30, DOI 10.1016/j.annemergmed.2014.12.004; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; Nielsen EW, 2002, ACTA ANAESTH SCAND, V46, P785, DOI 10.1034/j.1399-6576.2002.460705.x; Osteras O, 2016, ACTA ANAESTH SCAND, V60, P659, DOI 10.1111/aas.12673; Pakkanen T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0256-x; Pinheiro J BD, D R CORE TEAM NLME L; R Core Team, 2016, R LANG ENV STAT COMP; Reid BO, 2016, EUR J EMERG MED; Roberts K, 2009, EMERG MED J, V26, P128, DOI 10.1136/emj.2008.059899; Schuster M, 2010, EMERG MED J, V27, P398, DOI 10.1136/emj.2009.074211; Simonsen SA, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0065-z; SPAITE DW, 1991, ANN EMERG MED, V20, P1299, DOI 10.1016/S0196-0644(05)81070-4; Talving P, 2009, WORLD J SURG, V33, P2469, DOI 10.1007/s00268-009-0185-1; Taylor CB, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-402; Tryba M, 1980, NOTFALLSMEDIZIN, V6, P725; van der Velden MWA, 2008, EMERG MED J, V25, P444, DOI 10.1136/emj.2007.052662; Wyen H, 2013, EMERG MED J, V30, P1048, DOI 10.1136/emermed-2012-201962	40	7	8	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	SEP 21	2017	25								97	10.1186/s13049-017-0442-5			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FH7OD	WOS:000411378300001	28934985	gold, Green Published			2022-02-06	
J	Ekeke, ON; Okonta, KE				Ekeke, Onyeanunam Ngozi; Okonta, Kelechi Emmanuel			Trauma: a major cause of death among surgical inpatients of a Nigerian tertiary hospital	PAN AFRICAN MEDICAL JOURNAL			English	Article						Trauma; mortality; surgical wards; Port Harcourt; Nigeria	GLOBAL BURDEN; MORTALITY; MORBIDITY; INJURIES	Introduction: Trauma presents a significant global health burden. Death resulting from trauma remains high in low income countries despite a steady decrease in developed countries. Analysis of the pattern of death will enable intervention to reduce these deaths from trauma in developing countries. This study aims to present the pattern of trauma-related deaths in the surgical wards of University of Port Harcourt Teaching Hospital (UPTH). Methods: This was a retrospective study of all patients who died from trauma during admission into the surgical wards of UPTH from 2007 to 2012. Data on demography and traumatic events leading to death were collected from surgical wards, the emergency unit, and theatre records and analyzed using SPSS version 16.0. Results: Trauma accounted for 219 (42.4%) of the 527 mortalities recorded. Most of the deaths (62.6 %) occurred between 20 and 59 years. There were 148 males (67.6 %). The yearly mortality rates were as follows: 2007(12.3 %); 2008 (16.9%); 2009 (9.1%), 2010 (12.8 %), 2011 (23.3%) and 2012 (25.6%). Most of the patients (91.3%) died within 1 month of admission. The major events leading to deaths were burns 105(47.9%), traumatic brain injuries were 63(28.8%), and spinal cord injuries 21(9.6%). The secondary causes of death were mainly septic shock 112(51.1%); Respiratory failure 60(27.4%); and Multiple organ dysfunction 44(20.1%). Conclusion: Trauma is a leading cause of mortality in the surgical wards of our hospital. Trauma -related deaths continues to increase over the years. Safe keeping of petroleum products and adherence to traffic rules will reduce these avoidable deaths.	[Ekeke, Onyeanunam Ngozi; Okonta, Kelechi Emmanuel] Univ Port Harcourt Teaching Hosp, Dept Surg, Port Harcourt, Nigeria		Ekeke, ON (corresponding author), Univ Port Harcourt Teaching Hosp, Dept Surg, Port Harcourt, Nigeria.			Okonta, Kelechi/0000-0002-1160-880X			Ae-Ngibise KA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001721; Ayoade BA, 2013, WORLD J SURG, V37, P504, DOI 10.1007/s00268-012-1877-5; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; DATUBOBROWN DD, 1989, BURNS, V15, P152, DOI 10.1016/0305-4179(89)90170-8; Elachi Itodo C, 2015, Int J Crit Illn Inj Sci, V5, P99, DOI 10.4103/2229-5151.158404; Ernstberger A, 2015, INJURY, V46, pS135, DOI 10.1016/S0020-1383(15)30033-4; Etebu E N, 2004, Niger J Med, V13, P140; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hazen A, 2006, J NATL MED ASSOC, V98, P73; Kleber C, 2013, WORLD J SURG, V37, P1154, DOI 10.1007/s00268-013-1964-2; Liu BC, 2008, COCHRANE DB SYST REV, V23, P1; Masiira-Mukasa N, 2002, East Afr Med J, V79, P373; Mathers CD, UPDATED PROJECTIONS; Murad MK, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-13; Nzegwu MA, 2008, ANN AFR MED, V7, P102, DOI 10.4103/1596-3519.55669; Okonta KE, 2015, AFR J PAEDIAT SURG, V12, P15; Olabanji J K, 2007, Ann Burns Fire Disasters, V20, P115; Oladele A O, 2010, Ann Burns Fire Disasters, V23, P120; Olugbenga S A, 2005, Ann Burns Fire Disasters, V18, P40; Osifo OD, 2012, PREHOSP DISASTER MED, V27, P136, DOI 10.1017/S1049023X12000465; Osime OC, 2007, PREHOSP DISASTER MED, V22, P75, DOI 10.1017/S1049023X00004374; Outwater AH, 2013, INT J BURNS TRAUMA, V3, P18; Sanddal TL, 2011, J TRAUMA, V70, P970, DOI 10.1097/TA.0b013e3181fec9ba; Seleye-Fubara D, 2012, Niger Postgrad Med J, V19, P107; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Siddiqui Arshad A, 2004, J Coll Physicians Surg Pak, V14, P173; Thanni L O A, 2006, Afr Health Sci, V6, P104; Ugare GU, 2012, AFR HEALTH SCI, V12, P530, DOI 10.4314/ahs.v12i4.21; Wang H, 2015, INJURY, V46, P2113, DOI 10.1016/j.injury.2015.08.039; Watters David A. K., 1996, Papua New Guinea Medical Journal, V39, P121	30	7	7	0	0	AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET	KAMPALA	PO BOX 12874, KAMPALA, 00000, UGANDA	1937-8688			PAN AFR MED J	Pan Afr. Med. J.	SEP 5	2017	28								6	10.11604/pamj.2017.28.6.10690			7	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	FJ2OU	WOS:000412569800001	29138652	gold, Green Submitted, Green Published			2022-02-06	
J	Agoston, D; Arun, P; Bellgowan, P; Broglio, S; Cantu, R; Cook, D; da Silva, UO; Dickstein, D; Elder, G; Fudge, E; Gandy, S; Gill, J; Glenn, JF; Gupta, RK; Hinds, S; Hoffman, S; Lattimore, T; Lin, A; Lu, KP; Maroon, J; Okonkwo, D; Perl, D; Robinson, M; Rosen, C; Smith, D				Agoston, Denes; Arun, Peethambaran; Bellgowan, Patrick; Broglio, Steven; Cantu, Robert; Cook, David; da Silva, Uade Olaghere; Dickstein, Dara; Elder, Gregory; Fudge, Elizabeth; Gandy, Sam; Gill, Jessica; Glenn, John F.; Gupta, Raj K.; Hinds, Sidney; Hoffman, Stuart; Lattimore, Theresa; Lin, Alexander; Lu, Kun Ping; Maroon, Joseph; Okonkwo, David; Perl, Daniel; Robinson, Meghan; Rosen, Charles; Smith, Douglas			Military Blast Injury and Chronic Neurodegeneration: Research Presentations from the 2015 International State-of-the-Science Meeting	JOURNAL OF NEUROTRAUMA			English	Article						blast injury; chronic traumatic encephalopathy; neurodegeneration; repetitive head trauma; traumatic brain injury	TRAUMATIC BRAIN-INJURY; UNFOLDED PROTEIN RESPONSE; ALZHEIMERS-DISEASE; TAU PATHOLOGY; CONCUSSION; ENCEPHALOPATHY; EXPOSURE; ASSOCIATION; HIPPOCAMPUS; IMPAIRMENT	Blast-related traumatic brain injury (TBI) is a signature injury of recent military conflicts, leading to increased Department of Defense (DoD) interest in its potential long-term effects, such as chronic traumatic encephalopathy (CTE). The DoD Blast Injury Research Program Coordinating Office convened the 2015 International State-of-the-Science Meeting to discuss the existing evidence regarding a causal relationship between TBI and CTE. Over the course of the meeting, experts across government, academia, and the sports community presented cutting edge research on the unique pathological characteristics of blast-related TBI, blast-related neurodegenerative mechanisms, risk factors for CTE, potential biomarkers for CTE, and treatment strategies for chronic neurodegeneration. The current paper summarizes these presentations. Although many advances have been made to address these topics, more research is needed to establish the existence of links between the long-term effects of single or multiple blast-related TBI and CTE.	[Agoston, Denes; Perl, Daniel] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Arun, Peethambaran] Walter Reed Army Inst Res, Walter Reed Army Inst, Silver Spring, MD USA; [Bellgowan, Patrick] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Broglio, Steven] Univ Michigan, Ann Arbor, MI 48109 USA; [Cantu, Robert] Boston Univ, Sch Med, Boston, MA 02118 USA; [Cook, David] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [da Silva, Uade Olaghere] Naval Med Res Ctr, San Diego, CA USA; [Dickstein, Dara; Gandy, Sam] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Elder, Gregory; Gandy, Sam] James J Peters VA Med Ctr, Bronx, NY USA; [Fudge, Elizabeth; Lattimore, Theresa] Off Assistant Secretary Def, Hlth Affairs, Falls Church, VA USA; [Gill, Jessica] NIH, Bldg 10, Bethesda, MD 20892 USA; [Glenn, John F.; Gupta, Raj K.] US Army, Med Res & Mat Command, Ft Detrik, MD USA; [Hinds, Sidney] Def & Vet Brain Injury Ctr, Rockville, MD USA; [Hoffman, Stuart] US Dept Vet Affairs, Washington, DC USA; [Lin, Alexander] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Lu, Kun Ping] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Maroon, Joseph; Okonkwo, David] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Robinson, Meghan] VA Boston Healthcare Syst, Boston, MA USA; [Rosen, Charles] West Virginia Univ, Dept Neurosurg, Morgantown, WV USA; [Smith, Douglas] Univ Penn, Philadelphia, PA 19104 USA		Gupta, RK (corresponding author), US Army, Med Res & Mat Command, US Dept Def, Blast Injury Res Program Coordinating Off, 504 Scott St, Ft Detrick, MD 21702 USA.	raj.k.gupta.civ@mail.mil	Gill, Gill M/Q-2020-2017; Dickstein, Dara/AAH-6603-2020		NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG046319] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS096835] Funding Source: Medline; RRD VA [I01 RX000996] Funding Source: Medline; BLRD VA [I01 BX002311] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS096835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG046319] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002311, I01RX000996] Funding Source: NIH RePORTER; VAUS Department of Veterans Affairs [5I01BX002311-04] Funding Source: Federal RePORTER		Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bellgowan P., 2015, 2015 INT STAT SCI M; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Bloomfield PS, 2016, AM J PSYCHIAT, V173, P44, DOI 10.1176/appi.ajp.2015.14101358; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio S. P., 2015, 2015 INT STAT SCI M; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Da Silva U. U., 2015, 2015 INT STAT SCI M; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glenn J., 2015, 2015 INT STAT SCI M; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Hinds S., 2015, 2015 INT STAT SCI M; Ho YS, 2012, J ALZHEIMERS DIS, V28, P839, DOI 10.3233/JAD-2011-111037; Hoffman S., 2015, 2015 INT STAT SCI M; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lattimore T., 2015, 2015 INT STAT SCI M; Lin A., 2014, 10 WORLD C BRAIN INJ; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; LOWENHIELM P, 1975, J BIOMECH, V8, P351, DOI 10.1016/0021-9290(75)90069-X; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Maroon J., 2015, 2015 INT STAT SCI M; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McKee A. C., 2015, NEUROLOGY, V84, P2; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Nijholt DAT, 2012, J PATHOL, V226, P693, DOI 10.1002/path.3969; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009	59	7	7	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34			1			S6	S17		10.1089/neu.2017.5220			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FI2DA	WOS:000411746000003	28937955	Green Published, Bronze			2022-02-06	
J	Alsalaheen, B; Stockdale, K; Pechumer, D; Broglio, SP; Marchetti, GF				Alsalaheen, Bara; Stockdale, Kayla; Pechumer, Dana; Broglio, Steven P.; Marchetti, Gregory F.			A Comparative Meta-Analysis of the Effects of Concussion on a Computerized Neurocognitive Test and Self-Reported Symptoms	JOURNAL OF ATHLETIC TRAINING			English	Article						ImPACT; effect size; mild traumatic brain injuries	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; POSTTRAUMATIC MIGRAINE; FOOTBALL PLAYERS; ASSESSMENT TOOLS; SOCCER PLAYERS; RECOVERY; PERFORMANCE; MANAGEMENT; STATEMENT	Context: Meta-analyses examining construct-specific cognitive impairment concurrently with self-reported symptoms postconcussion are sparse. Objective: To review the literature on the effects of concussion on construct-specific neurocognitive declines and to compare them with self-reported symptoms before 1 week and between 1 and 3 weeks postconcussion. Data Sources: Relevant studies in PubMed, CINAHL, and PsycINFO published from January 1, 1999 through November 30, 2015. Study Selection: Studies were included if participants completed the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) before and after concussion and if test performance and Postconcussion Symptom Scale (PCSS) scores were reported at both times. Data Extraction: After reviewing the full texts, we extracted data from 17 studies consisting of 29 independent samples; therefore, this meta-analysis consisted of 1777 unique participants. Data Synthesis: The Hedges g effect size (ES) was estimated. A random-effects or fixed-effects model was used based on heterogeneity findings. When heterogeneity was present, we used meta-regression to assess unexplained between-studies variance. Within the first week of injury, the ESs were small to moderate for cognitive declines, ranging from -0.43 (95% confidence interval [CI] = -0.52, -0.35) to -0.67 (95% CI = -0.77, -0.58), and large for the PCSS score (Hedges g = -0.81; 95% CI = -0.91, -0.71). After 1 week, the ESs for cognitive declines (Hedges g range = -0.25 [95% CI = -0.35, -0.15] to -0.37 [95% CI = -0.55, -0.19]) and PCSS score (Hedges g = -0.38; 95% CI = -0.53, -0.22) were also small. Within 2 weeks of injury, PCSS score and time since injury weakly moderated the cognitive ES. Conclusions: When a neurocognitive test was administered within 1 week of injury, the ES was larger for self-reported symptoms than for ImPACT scores generated at the same session. After 1 week of injury, the ESs for ImPACT and PCSS scores were comparable. If the athlete reports symptoms within 1 week of injury, administering a cognitive test does not appear to offer additional information to the clinician. However, if the athlete does not report symptoms postconcussion, cognitive testing may inform the clinical management of the injury.	[Alsalaheen, Bara; Stockdale, Kayla; Pechumer, Dana] Univ Michigan, Dept Phys Therapy, 2157 William S White Bldg,303 East Kearsley St, Flint, MI 48502 USA; [Alsalaheen, Bara] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Alsalaheen, Bara] Univ Michigan Hlth Syst, Michigan NeuroSport, Ann Arbor, MI USA; [Broglio, Steven P.] Univ Michigan, Neurotrauma Res Lab, Ann Arbor, MI 48109 USA; [Marchetti, Gregory F.] Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA 15219 USA		Alsalaheen, B (corresponding author), Univ Michigan, Dept Phys Therapy, 2157 William S White Bldg,303 East Kearsley St, Flint, MI 48502 USA.	alsalahe@umich.edu					Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cohen J., 1988, STAT POWER ANAL BEHA, P25; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Covassin T, 2013, BRAIN INJURY, V27, P1589, DOI 10.3109/02699052.2013.823656; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Echlin PS, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12286; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gleser L., 2009, HDB RES SYNTHESIS ME, P357; Hedges L., 1985, STAT METHODS METAANA, P76; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR, 2003, IMPACT VERSION 2 0 C, P18; Lovell MR, 2013, J PEDIAT, V163; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Randolph C, 2005, J ATHL TRAINING, V40, P139; Resch JE, 2013, CLIN NEUROPSYCHOL, V27, P1265, DOI 10.1080/13854046.2013.845247; Rothstein HR, 2009, INTRO METAANALYSIS, P187, DOI DOI 10.1002/9780470743386.CH20; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Van den Noortgate W, 2015, BEHAV RES METHODS, V47, P1274, DOI 10.3758/s13428-014-0527-2; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Yuen KM, 2016, APPL NEUROPSYCH-ADUL, V23, P322, DOI 10.1080/23279095.2015.1057638; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	60	7	7	0	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP	2017	52	9					834	846		10.4085/1062-6050-52.7.05			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FN2LO	WOS:000415824000005	28809606	Green Published, Bronze			2022-02-06	
J	Fingelkurts, AA; Fingelkurts, AA				Fingelkurts, Andrew A.; Fingelkurts, Alexander A.			Longitudinal Dynamics of 3-Dimensional Components of Selfhood After Severe Traumatic Brain Injury: A qEEG Case Study	CLINICAL EEG AND NEUROSCIENCE			English	Article						self-referential network; default-mode network (DMN); subjective sense of self; first-person perspective; electroencephalogram; EEG; alpha rhythm; operational synchrony; functional connectivity; coma; vegetative state; unresponsive wakefulness syndrome; minimally conscious state	DEFAULT MODE NETWORK; EEG ALPHA OSCILLATIONS; UNRESPONSIVE WAKEFULNESS; RESTING STATE; CONSCIOUSNESS; MEDITATION; FMRI; NEUROPSYCHOLOGY; CRANIOPLASTY; ORGANIZATION	In this report, we describe the case of a patient who sustained extremely severe traumatic brain damage with diffuse axonal injury in a traffic accident and whose recovery was monitored during 6 years. Specifically, we were interested in the recovery dynamics of 3-dimensional components of selfhood (a 3-dimensional construct model for the complex experiential selfhood has been recently proposed based on the empirical findings on the functional-topographical specialization of 3 operational modules of brain functional network responsible for the self-consciousness processing) derived from the electroencephalographic (EEG) signal. The analysis revealed progressive (though not monotonous) restoration of EEG functional connectivity of 3 modules of brain functional network responsible for the self-consciousness processing, which was also paralleled by the clinically significant functional recovery. We propose that restoration of normal integrity of the operational modules of the self-referential brain network may underlie the positive dynamics of 3 aspects of selfhood and provide a neurobiological mechanism for their recovery. The results are discussed in the context of recent experimental studies that support this inference. Studies of ongoing recovery after severe brain injury utilizing knowledge about each separate aspect of complex selfhood will likely help to develop more efficient and targeted rehabilitation programs for patients with brain trauma.	[Fingelkurts, Andrew A.; Fingelkurts, Alexander A.] BM Sci Brain & Mind Technol Res Ctr, POB 77, FI-02601 Espoo, Finland		Fingelkurts, AA (corresponding author), BM Sci Brain & Mind Technol Res Ctr, POB 77, FI-02601 Espoo, Finland.	andrew.fingelkurts@bm-science.com					Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Andrews-Hanna JR, 2012, NEUROSCIENTIST, V18, P251, DOI 10.1177/1073858411403316; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Basar E, 2009, INT J PSYCHOPHYSIOL, V71, P2, DOI 10.1016/j.ijpsycho.2008.07.018; Berlucchi G, 1997, TRENDS NEUROSCI, V20, P560, DOI 10.1016/S0166-2236(97)01136-3; Blackmore S., 2015, SCI CONSC 2015 C JUN; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Boccagni C, 2011, J CLIN NEUROPHYSIOL, V28, P489, DOI 10.1097/WNP.0b013e318231c8c8; Brownsett SLE, 2010, CEREB CORTEX, V20, P517, DOI 10.1093/cercor/bhp120; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Congedo M., 2003, Journal of Neurotherapy, V7, P1, DOI 10.1300/J184v07n03_01; Cottrell JE, 2012, MT SINAI J MED, V79, P75, DOI 10.1002/msj.21283; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Cruse D, 2016, CLIN NEUROPHYSIOL, V127, P1001, DOI 10.1016/j.clinph.2015.08.018; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Damasio A., 1999, FEELING WHAT HAPPENS; de Vignemont F, 2004, CONSCIOUS COGN, V13, P1, DOI 10.1016/S1053-8100(03)00022-9; Demertzi A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00538; Doucet G, 2011, J NEUROPHYSIOL, V105, P2753, DOI 10.1152/jn.00895.2010; Fingelkurts AA, 2015, NEUROMETHODS, V91, P1, DOI DOI 10.1007/7657_2013_60; Fingelkurts Al A, 2010, Open Neuroimag J, V4, P130, DOI 10.2174/1874440001004010130; Fingelkurts Alexander A, 2016, Open Neuroimag J, V10, P41, DOI 10.2174/1874440001610010041; Fingelkurts AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087507; Fingelkurts AA, 2012, CONSCIOUS COGN, V21, P149, DOI 10.1016/j.concog.2011.10.004; Fingelkurts AA, 2016, SELF IDENTITY, V15, P381, DOI 10.1080/15298868.2015.1136351; Fingelkurts AA, 2016, COGN PROCESS, V17, P27, DOI 10.1007/s10339-015-0743-4; Fingelkurts Andrew A, 2012, Open Neuroimag J, V6, P55, DOI 10.2174/1874440001206010055; Fingelkurts AA, 2011, BRAIN COGNITION, V75, P79, DOI 10.1016/j.bandc.2010.11.015; Fingelkurts AA, 2010, PHYS LIFE REV, V7, P195, DOI 10.1016/j.plrev.2010.04.001; Fingelkurts AA, 2010, INT J PSYCHOPHYSIOL, V76, P93, DOI 10.1016/j.ijpsycho.2010.02.009; Fingelkurts Andrew A, 2008, Open Neuroimag J, V2, P73, DOI 10.2174/1874440000802010073; Flanagan O.J., 1995, CONSCIOUSNESS RECONS, V3rd; Friston KJ., 2011, IMPLICATIONS EMBODIM, P89; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Granger CV, ARCH PHYS MED REHABI, V72, P84; Gusnard DA, 2005, CONSCIOUS COGN, V14, P679, DOI 10.1016/j.concog.2005.04.004; Hohwy J., 2007, PSYCHE, V13, P1; Huang ZR, 2014, HUM BRAIN MAPP, V35, P1997, DOI 10.1002/hbm.22308; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Jirmunskaya E. A., 1980, HUM PHYSL, V6, P1039; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; Jung JY, 2012, KOREAN J PHYSIOL PHA, V16, P231, DOI 10.4196/kjpp.2012.16.4.231; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Kaiser DA, 2000, J NEUROTHERAPY, V1530-017X, P57, DOI DOI 10.1300/J184V04N02_07; Kerr CE, 2011, CLIN PSYCHOL PSYCHOT, V18, P80, DOI 10.1002/cpp.700; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Knyazev GG, 2011, BRAIN RES, V1402, P67, DOI 10.1016/j.brainres.2011.05.052; Koessler L, 2009, NEUROIMAGE, V46, P64, DOI 10.1016/j.neuroimage.2009.02.006; Kwon SM, 2012, J KOREAN NEUROSURG S, V51, P117, DOI 10.3340/jkns.2012.51.2.117; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Limanowski J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00547; Longe O, 2010, NEUROIMAGE, V49, P1849, DOI 10.1016/j.neuroimage.2009.09.019; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; Metzinger T., 2003, Phenomenology and the Cognitive Sciences, V2, P353, DOI 10.1023/B:PHEN.0000007366.42918.eb; Metzinger T., 2004, BEING NO ONE SELF MO; Moran JM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00391; Moriguchi Y, 2006, NEUROIMAGE, V32, P1472, DOI 10.1016/j.neuroimage.2006.04.186; Moseley P, 2013, NEUROSCI BIOBEHAV R, V37, P2794, DOI 10.1016/j.neubiorev.2013.10.001; Munera Claudia P, 2014, Epilepsy Res Treat, V2014, P157452, DOI 10.1155/2014/157452; Musholt K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00536; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Newberg AB, 2003, MED HYPOTHESES, V61, P282, DOI 10.1016/S0306-9877(03)00175-0; Newen A, 2003, CONSCIOUS COGN, V12, P529, DOI 10.1016/S1053-8100(03)00080-1; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Qin PM, 2011, NEUROIMAGE, V57, P1221, DOI 10.1016/j.neuroimage.2011.05.028; Revonsuo A., 2006, INNER PRESENCE CONSC; Ribbers G. M., 2010, INT ENCY REHABILITAT; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Shaw JC, 2007, BRAINS ALPHA RHYTHMS; Sprinthall R.C., 2011, BASIC STAT ANAL, V9th edition.; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Trehub A, 2007, CONSCIOUS COGN, V16, P310, DOI 10.1016/j.concog.2006.06.004; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vigario RN, 1997, ELECTROEN CLIN NEURO, V103, P395, DOI 10.1016/S0013-4694(97)00042-8; VOLAVKA J, 1981, PSYCHOPHARMACOLOGY, V72, P185, DOI 10.1007/BF00431654; Windt J. M., 2007, NEW SCI DREAMING, P193; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zahavi D., 2002, Phenomenology and the Cognitive Sciences, V1, P7, DOI 10.1023/A:1015568518276; Zahavi D., 1999, SELF AWARENESS ALTER	95	7	7	1	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1550-0594	2169-5202		CLIN EEG NEUROSCI	Clin. EEG Neurosci.	SEP	2017	48	5					327	337		10.1177/1550059417696180			11	Clinical Neurology; Neurosciences; Neuroimaging; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	FC9AJ	WOS:000407132800004	28771043				2022-02-06	
J	Geremia, NM; Hryciw, T; Bao, F; Streijger, F; Okon, E; Lee, JHT; Weaver, LC; Dekaban, GA; Kwon, BK; Brown, A				Geremia, N. M.; Hryciw, T.; Bao, F.; Streijger, F.; Okon, E.; Lee, J. H. T.; Weaver, L. C.; Dekaban, G. A.; Kwon, B. K.; Brown, A.			The effectiveness of the anti-CD11 d treatment is reduced in rat models of spinal cord injury that produce significant levels of intraspinal hemorrhage	EXPERIMENTAL NEUROLOGY			English	Article						Spinal cord injury; Neuroprotection; CD11/CD18 integrin; Anti-CD11d; Anti-inflammatory	INFLAMMATORY RESPONSE SYNDROME; MONOCLONAL-ANTIBODY TREATMENT; TRAUMATIC BRAIN-INJURY; INTEGRIN BLOCKADE; ANTIINFLAMMATORY TREATMENT; CELL-DEATH; ALPHA-D; RECOVERY; DAMAGE; MACROPHAGES	We have previously reported that administration of a CD11 d monoclonal antibody (mAb) improves recovery in a clip-compression model of SCI. In this model the CD11d mAb reduces the infiltration of activated leukocytes into the injured spinal cord (as indicated by reduced intraspinal MPO). However not all anti-inflammatory strategies have reported beneficial results, suggesting that success of the CD11d mAb treatment may depend on the type or severity of the injury. We therefore tested the CD11d mAb treatment in a rat hemi-contusion model of cervical SCI. In contrast to its effects in the clip-compression model, the CD11d mAb treatment did not improve forelimb function nor did it significantly reduce MPO levels in the hemi-contused cord. To determine if the disparate results using the CD11d mAb were due to the biomechanical nature of the cord injury (compression SCI versus contusion SO) or to the spinal level of the injury (12th thoracic level versus cervical) we further evaluated the CD11d mAb treatment after a T12 contusion SO. In contrast to the T12 clip compression SCI, the CD11d mAb treatment did not improve locomotor recovery or significantly reduce MPO levels after T12 contusion SCI. Lesion analyses revealed increased levels of hemorrhage after contusion SCI compared to clip-compression SCI. SCI that is accompanied by increased intraspinal hemorrhage would be predicted to be refractory to the CD11d mAb therapy as this approach targets leukocyte diapedesis through the intact vasculature. These results suggest that the disparate results of the anti-CD11d treatment in contusion and clip-compression models of SCI are due to the different pathophysiological mechanisms that dominate these two types of spinal cord injuries. Crown Copyright (C) 2017 Published by Elsevier Inc.	[Geremia, N. M.; Hryciw, T.; Bao, F.; Weaver, L. C.; Dekaban, G. A.; Brown, A.] Univ Western Ontario, Robarts Res Inst, Mol Med Res Grp, 1151 Richmond St North, London, ON N6A 5B7, Canada; [Streijger, F.; Okon, E.; Lee, J. H. T.; Kwon, B. K.] Univ British Columbia, ICORD, Blusson Spinal Cord Ctr, 818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada		Brown, A (corresponding author), Univ Western Ontario, Robarts Res Inst, Schulich Sch Med, 100 Perth Dr, London, ON N6A 5K8, Canada.	abrown@robarts.ca	Brown, Arthur/K-8328-2013; Dekaban, Gregory/L-1987-2013; Weaver, Lynne C/K-8491-2013; Geremia, Nicole/AAC-3285-2021	Brown, Arthur/0000-0002-8725-3195; Dekaban, Gregory/0000-0002-3087-4660; Okon, Elena/0000-0001-8568-5771	U.S. Department of DefenseUnited States Department of Defense [W81XWH-10-1-1014, W81XWH-10-1-1018]; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [PJT 148651]	This work was supported by grants from the U.S. Department of Defense (grant agreement numbers W81XWH-10-1-1014 and W81XWH-10-1-1018) and the Canadian Institutes of Health Research (CIHR reference number PJT 148651).	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Anwar MA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00098; Bao F, 2005, J NEUROCHEM, V94, P1361, DOI 10.1111/j.1471-4159.2005.03280.x; Bao F, 2004, J NEUROCHEM, V90, P1194, DOI 10.1111/j.1471-4159.2004.02580.x; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Bao F, 2011, EXP NEUROL, V231, P272, DOI 10.1016/j.expneurol.2011.07.001; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; BARTHOLDI D, 1995, BRAIN RES, V672, P177, DOI 10.1016/0006-8993(94)01410-J; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; Choo AMT, 2009, J NEUROSCI METH, V181, P6, DOI 10.1016/j.jneumeth.2009.04.007; Ditor DS, 2006, J NEUROSURG-SPINE, V5, P343, DOI 10.3171/spi.2006.5.4.343; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; FEHLINGS MG, 1989, ELECTROEN CLIN NEURO, V74, P241, DOI 10.1016/0168-5597(89)90055-5; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fleming JC, 2008, EXP NEUROL, V214, P147, DOI 10.1016/j.expneurol.2008.04.024; Geremia NM, 2012, J NEUROTRAUM, V29, P539, DOI 10.1089/neu.2011.1976; Gorio A, 2007, J PHARMACOL EXP THER, V322, P973, DOI 10.1124/jpet.107.123679; Grayson MH, 1999, INT ARCH ALLERGY IMM, V118, P263, DOI 10.1159/000024094; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Hamada Y, 1996, J NEUROCHEM, V66, P1525; Hurtado A, 2012, EXP NEUROL, V233, P606, DOI 10.1016/j.expneurol.2010.11.015; Kesani AK, 2014, J NEUROSURG-SPINE, V21, P296, DOI 10.3171/2014.3.SPINE13784; Lee J. H., 2012, JOVE-J VIS EXP, V65, P3313; Lee YL, 2000, NEUROCHEM INT, V36, P417, DOI 10.1016/S0197-0186(99)00133-3; Mabon PJ, 2000, EXP NEUROL, V166, P52, DOI 10.1006/exnr.2000.7488; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Oatway MA, 2005, J NEUROSCI, V25, P637, DOI 10.1523/JNEUROSCI.3960-04.2005; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; QUENCER RM, 1992, NEURORADIOLOGY, V34, P85, DOI 10.1007/BF00588148; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Saville LR, 2004, J NEUROIMMUNOL, V156, P42, DOI 10.1016/j.jneuroim.2004.07.002; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Takigawa T, 2010, J NEUROTRAUM, V27, P739, DOI 10.1089/neu.2009.1111; Taoka Y, 1998, PROG NEUROBIOL, V56, P341, DOI 10.1016/S0301-0082(98)00049-5; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Tonai T, 2001, J NEUROCHEM, V78, P1064, DOI 10.1046/j.1471-4159.2001.00488.x; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; VanderVieren M, 1995, IMMUNITY, V3, P683, DOI 10.1016/1074-7613(95)90058-6; Weaver LC, 2015, EXP NEUROL, V271, P409, DOI 10.1016/j.expneurol.2015.07.003; Weaver LC, 2012, EXP NEUROL, V233, P612, DOI 10.1016/j.expneurol.2011.06.009; Witiw CD, 2015, J SPINAL DISORD TECH, V28, P202, DOI 10.1097/BSD.0000000000000287	50	7	7	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2017	295						125	134		10.1016/j.expneurol.2017.06.002			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC4OS	WOS:000406820900012	28587875	hybrid			2022-02-06	
J	Kuhn, AW; Zuckerman, SL; Yengo-Kahn, AM; Kerr, ZY; Totten, DJ; Rubel, KE; Sills, AK; Solomon, GS				Kuhn, Andrew W.; Zuckerman, Scott L.; Yengo-Kahn, Aaron M.; Kerr, Zachary Y.; Totten, Douglas J.; Rubel, Kolin E.; Sills, Allen K.; Solomon, Gary S.			Factors Associated With Playing Through a Sport-Related Concussion	NEUROSURGERY			English	Article; Proceedings Paper	64th Annual Meeting of the Congress-of-Neurological-Surgeons (CNS)	SEP 24-28, 2016	San Diego, CA	Cong Neurol Surg			SCHOOL FOOTBALL PLAYERS; UNITED-STATES; KNOWLEDGE; EDUCATION; SYMPTOMS; EPIDEMIOLOGY; BEHAVIORS; ATTITUDES; INJURY; YOUTH		[Kuhn, Andrew W.; Zuckerman, Scott L.; Yengo-Kahn, Aaron M.; Totten, Douglas J.; Sills, Allen K.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Zuckerman, Scott L.; Yengo-Kahn, Aaron M.; Sills, Allen K.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Med Ctr North T-4224, Nashville, TN 37212 USA; [Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Rubel, Kolin E.] Indiana Sch Med, Bloomington, IN USA; [Sills, Allen K.] Natl Football League, New York, NY USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Surg, Med Ctr North T-4224, Nashville, TN 37212 USA.	scott.zuckerman@vanderbilt.edu	Solomon, Gary/K-9011-2019; Yengo-Kahn, Aaron/AAV-7647-2020; Kuhn, Andrew W/AAM-4820-2020	Yengo-Kahn, Aaron/0000-0002-5989-3064; Kuhn, Andrew W/0000-0003-1836-7575; Totten, Douglas/0000-0002-0665-9653	Tennessee Titans; Nashville Predators	Dr Sills serves as the Chief Medical Officer for the National Football League (NFL). Dr Solomon receives consulting fees from the Tennessee Titans (NFL), the Nashville Predators (NHL), and the athletic departments of several universities, fees paid to institution. In addition, he is a member of the ImPACT Advisory Board and receives reimbursement for expenses to board meetings. The other authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Centers for Disease Control and Prevention, HEADS ACT PLAN RESP; Centers for Disease Control and Prevention National Center for Health Statistics, 2014, 2013 NCHS URB RUR CL; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Fraas MR, 2016, EUR J SPORT SCI, V16, P1212, DOI 10.1080/17461391.2016.1170207; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Taylor ME, 2017, J SCH NURS, V33, P73, DOI 10.1177/1059840515619683; Zuckerman Scott L, 2016, Neurosurgery, V63 Suppl 1, P102, DOI 10.1227/NEU.0000000000001280; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	26	7	7	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2017	64			1			211	216		10.1093/neuros/nyx294			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Surgery	GO9ZV	WOS:000440467800033	28899055				2022-02-06	
J	Lang, S; Gaxiola-Valdez, I; Opoku-Darko, M; Partlo, LA; Goodyear, BG; Kelly, JJP; Federico, P				Lang, Stefan; Gaxiola-Valdez, Ismael; Opoku-Darko, Michael; Partlo, Lisa A.; Goodyear, Bradley G.; Kelly, John J. P.; Federico, Paolo			Functional Connectivity in Frontoparietal Network: Indicator of Preoperative Cognitive Function and Cognitive Outcome Following Surgery in Patients with Glioma	WORLD NEUROSURGERY			English	Article						Cognition; Frontoparietal network; Neurooncology; Neurosurgery; Resting-state functional connectivity	TRAUMATIC BRAIN-INJURY; DEFAULT MODE NETWORK; LOW-GRADE GLIOMA; FRONTAL-INTEGRATION-THEORY; RESTING-STATE FMRI; NIH TOOLBOX; INDIVIDUAL-DIFFERENCES; NEUROCOGNITIVE FUNCTION; BEHAVIORAL FUNCTION; WORKING-MEMORY	BACKGROUND: Patients with diffuse glioma are known to have impaired cognitive functions preoperatively. However, the mechanism of these cognitive deficits remains unclear. Resting-state functional connectivity in the frontoparietal network (FPN) is associated with cognitive performance in healthy subjects. For this reason, it was hypothesized that functional connectivity of the FPN would be related to cognitive functioning in patients with glioma. To assess this relationship, preoperative cognitive status was correlated to patient-specific connectivity within the FPN. Further, we assessed whether connectivity could predict neuropsychologic outcome following surgery. METHODS: Sixteen patients with diffuse glioma underwent neuropsychologic assessment and preoperative functional magnetic resonance imaging using task (n-back) and resting-state scans. Thirteen patients had postoperative cognitive assessment. An index of patientspecific functional connectivity in the FPN was derived by averaging connectivity values between 2 prefrontal and 2 parietal cortex regions defined by activation during the n-back task. The relationship of these indices with cognitive performance was assessed. RESULTS: Higher average connectivity within the FPN is associated with lower composite cognitive scores. Higher connectivity of the parietal region of the tumor-affected hemisphere is associated specifically with lower fluid cognition. Lower connectivity of the parietal region of the nontumor hemisphere is associated with worse neuropsychologic outcome 1 month after surgery. CONCLUSION: Resting-state functional connectivity between key regions of the FPN is associated with cognitive performance in patients with glioma and is related to cognitive outcome following surgery.	[Lang, Stefan; Gaxiola-Valdez, Ismael; Opoku-Darko, Michael; Goodyear, Bradley G.; Kelly, John J. P.; Federico, Paolo] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Lang, Stefan; Partlo, Lisa A.; Goodyear, Bradley G.; Federico, Paolo] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Goodyear, Bradley G.] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Kelly, John J. P.] Univ Calgary, Charbonneau Canc Inst, Calgary, AB, Canada; [Gaxiola-Valdez, Ismael; Goodyear, Bradley G.; Federico, Paolo] Foothills Med Ctr, Seaman Family MR Res Ctr, Calgary, AB, Canada		Lang, S (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.; Lang, S (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.	stefan.t.lang@gmail.com			Hotchkiss Brain Institute/Hopewell Professorship in Clinical Neuroscience Pilot Research Fund Program	This work was supported by the Hotchkiss Brain Institute/Hopewell Professorship in Clinical Neuroscience Pilot Research Fund Program.	Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bosma I, 2008, NEURO-ONCOLOGY, V10, P734, DOI 10.1215/15228517-2008-034; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Charras P, 2015, CORTEX, V63, P27, DOI 10.1016/j.cortex.2014.08.010; Choe AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140134; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Crossley NA, 2013, P NATL ACAD SCI USA, V110, P11583, DOI 10.1073/pnas.1220826110; Duffau H, 2015, NAT REV NEUROL, V11, P255, DOI 10.1038/nrneurol.2015.51; Duffau H, 2014, CORTEX, V58, P325, DOI 10.1016/j.cortex.2013.08.005; Esposito R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040231; Gardini S, 2015, J ALZHEIMERS DIS, V45, P457, DOI 10.3233/JAD-142547; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Giovagnoli AR, 2012, J NEURO-ONCOL, V108, P277, DOI 10.1007/s11060-012-0815-6; Harris RJ, 2014, J NEURO-ONCOL, V116, P373, DOI 10.1007/s11060-013-1304-2; Hearne LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32328; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Klein M, 2012, J NEURO-ONCOL, V108, P309, DOI 10.1007/s11060-012-0811-x; Krainik A, 2004, NEUROLOGY, V62, P1323, DOI 10.1212/01.WNL.0000120547.83482.B1; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Lang S, 2017, WORLD NEUROSURG, V99, P448, DOI 10.1016/j.wneu.2016.12.061; Lang S, 2014, NEUROSURGERY, V74, P453, DOI 10.1227/NEU.0000000000000307; Maesawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118072; Noll KR, 2015, NEURO-ONCOLOGY, V17, P580, DOI 10.1093/neuonc/nou233; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Ralph MAL, 2017, NAT REV NEUROSCI, V18, P42, DOI 10.1038/nrn.2016.150; Reijneveld JC, 2001, NEUROLOGY, V56, P618, DOI 10.1212/WNL.56.5.618; Reineberg AE, 2016, HUM BRAIN MAPP, V37, P2959, DOI 10.1002/hbm.23219; Scolari M, 2015, CURR OPIN BEHAV SCI, V1, P32, DOI 10.1016/j.cobeha.2014.08.003; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shomstein S, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00038; Taphoorn MJB, 2004, LANCET NEUROL, V3, P159, DOI 10.1016/S1474-4422(04)00680-5; Teixidor P, 2007, J NEURO-ONCOL, V81, P305, DOI 10.1007/s11060-006-9233-y; Tucha O, 2000, NEUROSURGERY, V47, P324, DOI 10.1097/00006123-200008000-00011; Vakhtin AA, 2014, NEUROIMAGE, V103, P349, DOI 10.1016/j.neuroimage.2014.09.055; Wefel JS, 2016, NEURO-ONCOLOGY, V18, P1656, DOI 10.1093/neuonc/now165; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Yoshii Y, 2008, SURG NEUROL, V69, P51, DOI 10.1016/j.surneu.2007.07.064; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012	46	7	7	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2017	105						913	+		10.1016/j.wneu.2017.05.149			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FH3EJ	WOS:000411027600118	28583454				2022-02-06	
J	Onose, G; Teoibas-Serban, D; Popescu, C; Andone, I; Bruma, E; Mihaescu, A; Haras, M; Bumbea, AM; Anghelescu, A; Spircu, T; Badiu, C; Daia, C				Onose, Gelu; Teoibas-Serban, Doroteea; Popescu, Cristina; Andone, Ioana; Bruma, Elena; Mihaescu, Anca; Haras, Monica; Bumbea, Ana Maria; Anghelescu, Aurelian; Spircu, Tiberiu; Badiu, Cristinel; Daia, Cristina			NEW APPROACHES REGARDING THE USE OF ACTOVEGIN (R) IN SUBACUTE/POSTACUTE/SUBCHRONIC TRAUMATIC BRAIN INJURY PATIENTS	FARMACIA			English	Article						Actovegin (R); Activities of Daily Living scale (ADL); Disability Rating Scale (DRS); Functional Independence Measure (FIM); Glasgow Outcome Score Scale (GOS); modified Rankin Scale/Rankin Disability Score (mRDS); rehabilitation outcome; traumatic brain injury (TBI)	RATS	Traumatic brain injuries (TBIs) are a major cause, including for significant disabilities, currently with no cure. The neurobiotrophic Actovegin (R) is considered, yet scarcely studied in TBI. The aim of the study was to comparatively assess the outcomes of Actovegin (R) therapy on post-TBI patients treated with this medicine versus patients who received standard therapy. The study was conducted on patients who were admitted for the first time to the Rehabilitation Medicine Clinic Division of The "Bagdasar-Arseni" Teaching Emergency Hospital, Bucharest, Romania, between December 2004 - May 2016, with the diagnosis of (post-acute) TBI at their first hospitalization (about 1 month duration), within 4 months since trauma. We reviewed medical records of 74 post TBI inpatients, admitted in our unit. The control group included 41 patients with only standard supportive and neuro-rehabilitative, therapies; the study group (33 patients) received additionally 200 mg Actovegin (R), 2 tablets/day. Outcomes were objectified through the following scales: Functional Independence Measure (FIM - total (t), motor (m), cognitive (c)) modified Rankin (Disability) Score (mR(D)S), Glasgow Outcome Score (GOS), Disability Rating Scale (DRS), Activities of Daily Living (ADL), comparatively: at discharge versus admission. The evolution scores showed a mean increase in FIMt, FIMm, FIMc and respectively, DRS values, highly significant, for the Actovegin (R) group than for the control group (p < 0.001) and, in percentages, significantly higher on GOS (p = 0.001), mR(D) S (p = 0.011) and ADL (p = 0.021). Actovegin (R) administration appears to improve functional outcomes post TBI, measured on all the standardized scales we used. However, larger patients groups, prophensive including for adequate meta-analyses, are needed.	[Onose, Gelu; Teoibas-Serban, Doroteea; Popescu, Cristina; Andone, Ioana; Bruma, Elena; Mihaescu, Anca; Haras, Monica; Anghelescu, Aurelian; Badiu, Cristinel; Daia, Cristina] Bagdasar Arseni Teaching Emergency Hosp, Bucharest, Romania; [Onose, Gelu; Popescu, Cristina; Haras, Monica; Anghelescu, Aurelian; Spircu, Tiberiu; Badiu, Cristinel; Daia, Cristina] Carol Davila Univ Med & Pharm, Bucharest, Romania; [Bumbea, Ana Maria] Teaching Neuropsychiat Hosp, Craiova, Romania; [Bumbea, Ana Maria] Univ Med & Pharm, Craiova, Romania		Onose, G (corresponding author), Bagdasar Arseni Teaching Emergency Hosp, Bucharest, Romania.; Onose, G (corresponding author), Carol Davila Univ Med & Pharm, Bucharest, Romania.	geluonose@gmail.com	Popescu, Cristina/AAE-1571-2021; Ioana, Andone/AAD-5933-2021; Daia, Cristina/ABB-8725-2021; Daia, Cristina/R-6294-2018; Onose, Gelu/AAC-6786-2021; Badiu, Corin/C-5783-2012; Badiu, Dumitru-Cristinel/G-4545-2016	Daia, Cristina/0000-0002-9872-6496; Daia, Cristina/0000-0002-9872-6496; Onose, Gelu/0000-0002-6346-8941; Badiu, Corin/0000-0002-8087-8125; Ioana, Andone/0000-0001-9720-7742			[Anonymous], 2001, INP REH FAC PAT ASS; Armitage P., 1987, STAT METHODS MED RES; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Branson SM, 2017, J MIND MED SCI, V4, P38, DOI 10.22543/7674.41.P3848; Buchmayer F, 2011, WIEN MED WOCHENSCHR, V161, P80, DOI 10.1007/s10354-011-0865-y; Derev'yannykh E A, 2008, Neurosci Behav Physiol, V38, P873, DOI 10.1007/s11055-008-9051-0; Dieckmann A, 2012, EXP CLIN ENDOCR DIAB, V120, P132, DOI 10.1055/s-0031-1291248; Echaudemaison Claude, 1993, DICT EC SCI SOCIALES; Elmlinger MW, 2011, NEUROMOL MED, V13, P266, DOI 10.1007/s12017-011-8157-7; Isaac L., 2016, DISABILITY RATING SC; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KANOWSKI S, 1995, PHARMACOPSYCHIATRY, V28, P125, DOI 10.1055/s-2007-979604; Lehmann E., 2005, TESTING STAT HYPOTHE; Machicao F, 2012, J NEUROL SCI, V322, P222, DOI 10.1016/j.jns.2012.07.069; Meilin S, 2014, J CELL MOL MED, V18, P1623, DOI 10.1111/jcmm.12297; Muresanu DF, 2010, ACTA NEUROCHIR SUPPL, V106, P291, DOI 10.1007/978-3-211-98811-4_54; Nicolae AC, 2016, FARMACIA, V64, P844; RANKIN J, 1957, Scott Med J, V2, P200; Shamalov NA, 2010, ZH NEVROL PSIKHIATR, V110, P13; Sirbu CA, 2016, FARMACIA, V64, P651; Skoog I, 2012, J NEUROL SCI, V322, P232, DOI 10.1016/j.jns.2012.02.013; Talypov A E, 2008, Zh Nevrol Psikhiatr Im S S Korsakova, V108, P20; Wallace M, 2008, AM J NURS, V108, P67; Ziegler D, 2009, DIABETES CARE, V32, P1479, DOI 10.2337/dc09-0545	25	7	7	1	8	SOC STIINTE FARMACEUTICE ROMANIA	BUCURESTI	BUCURESTI, STR TRAIAN VUIA 6, SECT 1, BUCURESTI, 020956, ROMANIA	0014-8237	2065-0019		FARMACIA	Farmacia	SEP-OCT	2017	65	5					772	777					6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FK8BB	WOS:000413731300019					2022-02-06	
J	Ordonez-Rubiano, EG; Johnson, J; Enciso-Olivera, CO; Marin-Munoz, JH; Cortes-Lozano, W; Baquero-Herrera, PE; Ordonez-Mora, EG; Cifuentes-Lobelo, HA				Ordonez-Rubiano, Edgar Gerardo; Johnson, Jason; Enciso-Olivera, Cesar O.; Marin-Munoz, Jorge H.; Cortes-Lozano, William; Baquero-Herrera, Pablo E.; Ordonez-Mora, Edgar G.; Cifuentes-Lobelo, Hernando A.			Reconstruction of the Ascending Reticular Activating System with Diffusion Tensor Tractography in Patients with a Disorder of Consciousness after Traumatic Brain Injury	CUREUS			English	Article						diffusion tensor imaging; arousal; consciousness; ascending reticular activating system; tractography; traumatic brain injury; neurosurgery	AROUSAL SYSTEM	This work describes the reconstruction of the ascending reticular activating system (ARAS) with diffusion tensor tractography in three patients with altered consciousness after traumatic brain injury. A diffusion tensor tractography was performed in three patients with impaired consciousness after a severe traumatic brain injury. A 1.5 T scanner was used to obtain the tensor sequences; axial tensors were acquired. Post-processing was performed, and the mean fractional anisotropy (FA) values were recorded. The FA maps were used to do a manual tracing of the following regions of interest (ROIs): the ventromedial midbrain, the anterior thalamus, and the hypothalamus. Case 1 presented destruction of the right dorsal and ventral tegmental tracts as well as destruction of the right middle forebrain bundle, case 2 had destruction of the right dorsal tegmental tract, and case 3 had destruction of the bilateral ventral and dorsal tegmental tracts, as well as destruction of the right middle forebrain bundle. The affected fibers of the ascending reticular activating system with diffuse axonal injury and the FA values abnormalities in the ascending reticular activating system in three patients with a disorder of consciousness (DOC) after traumatic brain injury are described.	[Ordonez-Rubiano, Edgar Gerardo] Hosp Infantil Univ San Jose, Hosp San Jose, Fdn Univ Ciencias Salud, Neurosurg Dept, Bogota, Colombia; [Johnson, Jason] MD Anderson, Neuroradiol, Houston, TX USA; [Enciso-Olivera, Cesar O.] Hosp Infantil Univ San Jose, Crit Care & Intens Care Unit, Fdn Univ Ciencias Salud, Bogota, Colombia; [Marin-Munoz, Jorge H.] Hosp Infantil Univ San Jose, Neuroradiol, Fdn Univ Ciencias Salud, Bogota, Colombia; [Cortes-Lozano, William] Hosp Infantil Univ San Jose, Hosp San Jose, Fdn Univ Ciencias Salud, Neurosurg, Bogota, Colombia; [Baquero-Herrera, Pablo E.; Ordonez-Mora, Edgar G.; Cifuentes-Lobelo, Hernando A.] Hosp Infantil Univ San Jose, Neurosurg Dept, Fdn Univ Ciencias Salud, Bogota, Colombia		Ordonez-Rubiano, EG (corresponding author), Hosp Infantil Univ San Jose, Hosp San Jose, Fdn Univ Ciencias Salud, Neurosurg Dept, Bogota, Colombia.	edgar_o88@hotmail.com	Ordonez-Rubiano, Edgar G/Z-4435-2019; Ordonez-Rubiano, Edgar Gerardo/ABF-7821-2020	Ordonez-Rubiano, Edgar Gerardo/0000-0003-1179-5825			Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002628; Jang SH, 2015, NEUROSCI LETT, V590, P58, DOI 10.1016/j.neulet.2015.01.071; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Pape TLB, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.03.0032; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Turner-Stokes L, 2014, CLIN MED, V14, P4, DOI 10.7861/clinmedicine.14-1-4; van der Eerden AW, 2014, RADIOLOGY, V270, P506, DOI 10.1148/radiol.13122720	10	7	7	1	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	SEP	2017	9	9							e1723	10.7759/cureus.1723			14	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HE7NR	WOS:000453625000089	29188167	gold, Green Published			2022-02-06	
J	Paci, M; Infante-Rivard, C; Marcoux, J				Paci, Michael; Infante-Rivard, Claire; Marcoux, Judith			Traumatic Brain Injury in the Workplace	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						brain injury - traumatic; head trauma; neurotrauma	SEVERE HEAD-INJURY; CONSTRUCTION-INDUSTRY; CONCOMITANT INJURIES; WASHINGTON-STATE; WORK; OUTCOMES; IMPACT; EPIDEMIOLOGY; SCALE; AGE	Objectives: Work-related traumatic brain injuries (TBIs) are not well documented in the literature. Published studies mostly rely on worker databases that fail to provide clinically relevant information. Our objective is to describe the characteristics of hospitalized patients and their work-related TBI. Methods: We used the Quebec provincial trauma and TBI program databases to identify all patients with a diagnosis of work-related TBI admitted to the Montreal General Hospital, a level 1 trauma center, between 2000 and 2014. Data from their medical records were extracted using a predetermined information sheet. Simple descriptive statistics (means and percentages) were used to summarize the data. Results: A total of 285 cases were analyzed. Workplace TBI patients were middle-aged (mean, 43.62 years), overwhelmingly male (male: female 18: 1), mostly healthy, and had completed a high school level education. Most workers were from the construction industry; falling was the most common mechanism of injury. The majority of patients (76.8%) presented with a mild TBI; only a minority (14%) required neurosurgery. The most common finding on computed tomography was skull fracture. The median length of hospitalization was 7 days, after which most patients were discharged directly home. A total of 8.1% died of their injuries. Conclusions: Our study found that most hospitalized victims of work-related TBI had mild injury; however, some required neurosurgical intervention and a non-negligible proportion died of their injury. Improving fall prevention, accurately document helmet use and increasing the safety practice in the construction industry may help decrease work-related TBI burden.	[Paci, Michael; Marcoux, Judith] McGill Univ, Dept Neurosurg, Montreal, PQ, Canada; [Infante-Rivard, Claire] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Infante-Rivard, Claire] McGill Univ, Dept Biostat & Occupat Hlth, Montreal, PQ, Canada; [Marcoux, Judith] McGill Univ, Hlth Ctr, Dept Neurosurg, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada		Marcoux, J (corresponding author), McGill Univ, Hlth Ctr, Dept Neurosurg, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	judith.marcoux@mcgill.ca					AGNEW J, 1993, HUM FACTORS, V35, P731, DOI 10.1177/001872089303500411; American College of Surgeons Committe on Trauma, 2008, ADV TRAUM LIF SUPP D; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bush DM, 2015, SAMHSA          0406; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; COLEMAN VP, 1986, J OCCUP ACCID, V8, P161, DOI 10.1016/0376-6349(86)90002-7; Gyekye SA, 2009, INT J AGING HUM DEV, V68, P171, DOI 10.2190/AG.68.2.d; Hagan PE, 2014, ACCIDENT PREVENTION; HEYER NJ, 1994, AM J PUBLIC HEALTH, V84, P1106, DOI 10.2105/AJPH.84.7.1106; Janicak CA, 1998, J OCCUP ENVIRON MED, V40, P347, DOI 10.1097/00043764-199804000-00009; Kica J, 2014, J SAFETY RES, V51, P49, DOI 10.1016/j.jsr.2014.09.003; Kim H, 2006, NEUROREHABILITATION, V21, P269; Kirkeleit J, 2013, AM J EPIDEMIOL, V177, P1218, DOI 10.1093/aje/kws373; Konda S, 2015, INJURY PREV, V57, P245; Konda S, 2016, AM J IND MED, V59, P212, DOI 10.1002/ajim.22557; KRAUS JF, 1985, J OCCUP ENVIRON MED, V27, P757; Kristman VL, 2010, OPEN OCCUP HLTH SAF, V2, P1, DOI [10.2174/1876216601002010001, DOI 10.2174/1876216601002010001]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Moore Lynne, 2013, J Emerg Trauma Shock, V6, P95, DOI 10.4103/0974-2700.110754; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; Salem AMO, 2013, OCCUP MED-OXFORD, V63, P358, DOI 10.1093/occmed/kqt037; Sampalis JS, 1999, J TRAUMA, V46, P565, DOI 10.1097/00005373-199904000-00004; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Sise MJ, 2009, J TRAUMA, V66, P32, DOI 10.1097/TA.0b013e318191bb0c; Siu OL, 2003, J SAFETY RES, V34, P199, DOI 10.1016/S0022-4375(02)00072-5; Statistics Canada, 2006, CENS TOP BAS TAB; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wrona RM, 2010, DISABIL REHABIL, V32, P650, DOI 10.3109/09638280903186327	40	7	7	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	SEP	2017	44	5					518	524		10.1017/cjn.2017.43			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FP5IX	WOS:000417654300008	28528589	Bronze			2022-02-06	
J	Pruitt, DT; Danaphongse, TT; Schmid, AN; Morrison, RA; Kilgard, MP; Rennaker, RL; Hays, SA				Pruitt, David T.; Danaphongse, Tanya T.; Schmid, Ariel N.; Morrison, Robert A.; Kilgard, Michael P.; Rennaker, Robert L., II; Hays, Seth A.			Traumatic Brain Injury Occludes Training-Dependent Cortical Reorganization in the Contralesional Hemisphere	JOURNAL OF NEUROTRAUMA			English	Article						contralesional hemisphere; map plasticity; motor recovery; traumatic brain injury	VAGUS NERVE-STIMULATION; LONG-TERM POTENTIATION; TRANSCRANIAL MAGNETIC STIMULATION; SENSORIMOTOR CORTEX ACTIVATION; MOTOR CORTEX; FORELIMB STRENGTH; INTACT HEMISPHERE; PREMOTOR CORTEX; UNITED-STATES; STROKE	Rehabilitative training drives plasticity in the ipsilesional (injured) motor cortex that is believed to support recovery of motor function after either stroke or traumatic brain injury (TBI). In addition, adaptive plasticity in the contralesional (uninjured) motor cortex has been well-characterized in the context of stroke. While similar rehabilitation-dependent plasticity in the intact hemisphere may occur after TBI, this has yet to be thoroughly explored. In this study, we investigated the effects of TBI and forelimb training on reorganization of movement representations in the intact motor cortex. Rats were trained to proficiency on the isometric pull task and then received a controlled cortical impact (CCI) in the left motor cortex to impair function of the trained right forelimb. After TBI, animals underwent forelimb training on the pull task for 2 months. At the end of training, intracortical microstimulation was used to document the organization of the intact motor cortex (the contralesional hemisphere). TBI significantly decreased the cortical area eliciting movements of the impaired forelimb in untrained animals. In the absence of TBI, training significantly increased forelimb map area, compared with in untrained controls. However, training of the impaired forelimb after TBI was insufficient to increase forelimb map area. These findings are consistent with other studies showing impaired rehabilitation-dependent plasticity after TBI and provide a novel characterization of TBI on rehabilitation-dependent plasticity in contralesional motor circuits.	[Pruitt, David T.; Danaphongse, Tanya T.; Schmid, Ariel N.; Morrison, Robert A.; Kilgard, Michael P.; Rennaker, Robert L., II] Univ Texas Dallas, Sch Behav Brain Sci, Richardson, TX 75083 USA; [Pruitt, David T.; Danaphongse, Tanya T.; Rennaker, Robert L., II; Hays, Seth A.] Univ Texas Dallas, Erik Jonsson Sch Engn & Comp Sci, Richardson, TX 75083 USA; [Pruitt, David T.; Danaphongse, Tanya T.; Schmid, Ariel N.; Morrison, Robert A.; Kilgard, Michael P.; Rennaker, Robert L., II; Hays, Seth A.] Univ Texas Dallas, Texas Biomed Device Ctr, 800 West Campbell Rd,BSB11, Richardson, TX 75080 USA		Pruitt, DT (corresponding author), Univ Texas Dallas, Texas Biomed Device Ctr, 800 West Campbell Rd,BSB11, Richardson, TX 75080 USA.	dtp110020@utdallas.edu	, David/ABG-7327-2020; Hays, Seth/U-4701-2019; Rennaker II, Robert/K-9049-2013	, David/0000-0001-8356-0887; Hays, Seth/0000-0003-4225-241X; Kilgard, Michael/0000-0002-6699-1818; Rennaker II, Robert/0000-0003-1260-1973; Morrison, Robert/0000-0001-7524-4729	Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) ElectRx program through the Space and Naval Warfare Systems Center [HR0011-15-2-0017]; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS094384-01, R01 NS085167-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS085167, R01NS094384] Funding Source: NIH RePORTER	This work was sponsored by the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) ElectRx program under the auspices of Dr. Doug Weber through the Space and Naval Warfare Systems Center, Pacific Cooperative Agreement No. HR0011-15-2-0017 (RLR, MPK, and SAH) and by NIH NINDS R01 NS094384-01 (SAH) and R01 NS085167-01 (RLR and MPK).	Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Bach-y-Rita P, 2003, BRAIN INJURY, V17, P643, DOI 10.1080/0269905031000107133; Barbay S, 2013, NEUROREHAB NEURAL RE, V27, P381, DOI 10.1177/1545968312465193; Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Brus-Ramer M, 2009, J NEUROSCI, V29, P6196, DOI 10.1523/JNEUROSCI.5852-08.2009; Calautti C, 2003, NEUROIMAGE, V19, P1650, DOI 10.1016/S1053-8119(03)00205-2; Combs HL, 2016, J NEUROTRAUM, V33, P741, DOI 10.1089/neu.2015.4136; Delvaux V, 2003, CLIN NEUROPHYSIOL, V114, P1217, DOI 10.1016/S1388-2457(03)00070-1; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Faul M, 2010, TRAUMATIC BRAIN INJU; Fridman EA, 2004, BRAIN, V127, P747, DOI 10.1093/brain/awh082; Hagemann G, 1998, ANN NEUROL, V44, P255, DOI 10.1002/ana.410440217; Harris NG, 2013, J NEUROTRAUM, V30, P1137, DOI 10.1089/neu.2012.2785; Hays SA, 2016, NEUROTHERAPEUTICS, V13, P382, DOI 10.1007/s13311-015-0417-z; Hays SA, 2013, J NEUROSCI METH, V212, P329, DOI 10.1016/j.jneumeth.2012.11.007; Honda M, 1997, J NEUROL SCI, V146, P117, DOI 10.1016/S0022-510X(96)00291-2; Hulsey DR, 2016, BRAIN STIMUL, V9, P174, DOI 10.1016/j.brs.2015.12.007; Jefferson SC, 2016, NEUROREHAB NEURAL RE, V30, P155, DOI 10.1177/1545968315600274; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Khodaparast N, 2013, NEUROBIOL DIS, V60, P80, DOI 10.1016/j.nbd.2013.08.002; Khodaparast N, 2014, NEUROREHAB NEURAL RE, V28, P698, DOI 10.1177/1545968314521006; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kopp B, 1999, NEUROREPORT, V10, P807, DOI 10.1097/00001756-199903170-00026; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Muellbacher W, 1999, J NEUROL, V246, P250, DOI 10.1007/s004150050343; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Pineiro R, 2001, STROKE, V32, P1134, DOI 10.1161/01.STR.32.5.1134; Porter BA, 2012, CEREB CORTEX, V22, P2365, DOI 10.1093/cercor/bhr316; Pruitt D, 2014, BRAIN RES, V1582, P91, DOI 10.1016/j.brainres.2014.07.039; Pruitt DT, 2016, BEHAV BRAIN RES, V313, P10, DOI 10.1016/j.bbr.2016.07.005; Pruitt DT, 2016, J NEUROTRAUM, V33, P871, DOI 10.1089/neu.2015.3972; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Rodriguez LC, 2015, J BIOACT COMPAT POL, V30, P34, DOI 10.1177/0883911514566130; Rossini PM, 1998, NEUROREPORT, V9, P2141, DOI 10.1097/00001756-199806220-00043; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sloan AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141254; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Turton A, 1996, ELECTROMYOGR MOTOR C, V101, P316, DOI 10.1016/0924-980X(96)95560-5; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502	47	7	7	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2495	2503		10.1089/neu.2016.4796			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200002	28462608	Green Published			2022-02-06	
J	Sang, XG; Wang, ZY; Qin, T; Li, YG				Sang, Xiguang; Wang, Zhiyong; Qin, Tao; Li, Yonggang			Elevated concentrations of hypoxia-inducible factor-1 in patients with fracture and concomitant traumatic brain injury	ANNALS OF CLINICAL BIOCHEMISTRY			English	Article						Fracture healing; traumatic brain injury; HIF-1; serum; fracture haematoma	ENDOTHELIAL GROWTH-FACTOR; OSTEOGENESIS; HIF-1-ALPHA; FACTOR-1-ALPHA; ANGIOGENESIS; ACTIVATION; VEGF; EXPRESSION; RECOVERY; RELEASE	Background Compelling evidence indicate that traumatic brain injury is highly related to accelerated bone fracture repair, but the underlying mechanism still remains elusive. Fracture repair process relies greatly on the formation of new blood vessels in fracture site, and angiogenic factors have been confirmed to be essential for the initiation and maintenance of the fracture healing. Hypoxia-inducible factor-1 was demonstrated to be a critical regulator of angiogenic-osteogenic coupling during bone development and regeneration. The aim of the present study was to investigate the local and circulating concentrations of hypoxia-inducible factor-1 in patients with long-bone fractures and concomitant traumatic brain injury and to determine the potential role of hypoxia-inducible factor-1 in fracture healing. Methods Twenty-five patients with a long-bone fracture and concomitant traumatic brain injury (FT group) and 33 without a brain injury (Fr group) were enrolled in this study. Healthy subjects donated serum samples as control. Serum samples were collected over a period of six months, following a standardized time schedule. Hypoxia-inducible factor-1 concentrations were measured in fracture haematoma and serum of patients in both groups using enzyme-linked immunosorbent assay. Results Patients in FT group had a short time to union. Serum hypoxia-inducible factor-1 concentrations elevated in the early healing period and reached the maximum level during intramembranous bone formation phase in both groups. Thereafter, it decreased continuously and approached to the minimum levels until the end of the observation period. Serum hypoxia-inducible factor-1 concentrations in both groups were significantly higher compared with controls and hypoxia-inducible factor-1 concentrations in both serum and fracture haematoma were higher in FT group than that in Fr group. Fracture haematoma contained significantly higher hypoxia-inducible factor-1 concentrations compared with hypoxia-inducible factor-1 concentrations in serum. Serum hypoxia-inducible factor-1 concentrations had a positive correlation with hypoxia-inducible factor-1 concentrations in fracture haematoma in patients with fractures. Conclusions These findings suggest the local and systemic involvement of hypoxia-inducible factor-1 in fracture healing and the accelerated fracture repair in patients with traumatic brain injury might be associated with elevated hypoxia-inducible factor-1 concentrations in fracture haematoma and serum.	[Sang, Xiguang; Wang, Zhiyong; Qin, Tao; Li, Yonggang] Shandong Univ, Dept Emergency Surg, Qilu Hosp, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China		Sang, XG (corresponding author), Shandong Univ, Dept Emergency Surg, Qilu Hosp, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.	xiguangsang@sina.com			Department of Science and Technology of Shandong Province [2008GG3002002]	This work was supported by the Department of Science and Technology of Shandong Province (No. 2008GG3002002).	Agarwal S, 2016, P NATL ACAD SCI USA, V113, pE338, DOI 10.1073/pnas.1515397113; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; BRIGHTON CT, 1972, J BONE JOINT SURG AM, VA 54, P323, DOI 10.2106/00004623-197254020-00010; Cerrada I, 2013, STEM CELLS DEV, V22, P501, DOI 10.1089/scd.2012.0340; CITTAPIETROLUNGO TJ, 1992, ARCH PHYS MED REHAB, V73, P258; Einhorn TA, 2005, J ORTHOP TRAUMA, V19, pS4, DOI 10.1097/00005131-200511101-00002; Gao YZ, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0219-3; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; GAZIT D, 1990, ENDOCRINOLOGY, V126, P2607, DOI 10.1210/endo-126-5-2607; Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701; Gelse K, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2508; Giannoudis PV, 2008, BONE, V42, P751, DOI 10.1016/j.bone.2007.12.219; Grad S, 1998, CLIN CHEM LAB MED, V36, P379, DOI 10.1515/CCLM.1998.064; Gross TS, 2001, J APPL PHYSIOL, V90, P2514, DOI 10.1152/jappl.2001.90.6.2514; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Hofer T, 2001, FASEB J, V15, P2715, DOI 10.1096/fj.01-0546fje; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Huang RQ, 2010, NEUROSCI LETT, V473, P22, DOI 10.1016/j.neulet.2010.02.011; KELLY PJ, 1990, CLIN ORTHOP RELAT R, P275; Kim HH, 2002, CYTOKINE, V17, P14, DOI 10.1006/cyto.2001.0985; Komatsu DE, 2004, BONE, V34, P680, DOI 10.1016/j.bone.2003.12.024; Lee JS, 2015, BONE, V78, P34, DOI 10.1016/j.bone.2015.04.044; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Riddle RC, 2009, J MOL MED, V87, P583, DOI 10.1007/s00109-009-0477-9; Sarahrudi K, 2011, INJURY, V42, P833, DOI 10.1016/j.injury.2011.03.055; Sarahrudi K, 2009, J ORTHOP RES, V27, P1293, DOI 10.1002/jor.20906; Schipani E, 2001, GENE DEV, V15, P2865; Semenza GL, 2001, J CLIN INVEST, V108, P39, DOI 10.1172/JCI200113374; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Wang Y, 2007, ANN NY ACAD SCI, V1117, P1, DOI 10.1196/annals.1402.049; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Weiss S, 2002, J BONE MINER RES, V17, P1280, DOI 10.1359/jbmr.2002.17.7.1280; Yang JF, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/128627	42	7	7	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0004-5632	1758-1001		ANN CLIN BIOCHEM	Ann. Clin. Biochem.	SEP	2017	54	5					584	592		10.1177/0004563216673087			9	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	FD4PJ	WOS:000407512700010	27687082				2022-02-06	
J	Zhao, YY; Lou, L; Yang, KC; Wang, HB; Xu, Y; Lu, G; He, HY				Zhao, Yuan-Yuan; Lou, Lin; Yang, Kai-Chuang; Wang, Hai-Bo; Xu, Yan; Lu, Gang; He, Hai-Yan			Correlation of tenascin-C concentrations in serum with outcome of traumatic brain injury in humans	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Tenascin-C; Mortality; Prognosis; Outcome; Biomarker	GLASGOW COMA SCALE; SUBARACHNOID HEMORRHAGE; EXPRESSION; PROGNOSIS; PATHOPHYSIOLOGY; BIOMARKERS; MANAGEMENT; MODERATE; RATS	Background: Tenascin-C, a matricellular protein, is involved in brain injury. However, change of tenascin-C concentrations in peripheral blood remains unknown after traumatic brain injury (TBI). Methods: Serum tenascin-C concentrations were measured in 100 healthy controls, 108 severe TBI patients, 79 moderate TBI patients and 32 mild TBI patients. Results: Serum tenascin-C concentrations of patients were significantly higher than those of controls. Tenascin-C concentrations negatively correlated with Glasgow Coma Scale (GCS) scores in all patients (r = - 0.658, P < 0.001). In severe TBI patients, tenascin-C in serum significantly discriminated patients at risk of 6-month mortality (area under curve, 0.821; 95% confidence interval, 0.735-0.888) and poor outcome (Glasgow Outcome Scale score of 1-3) (area under curve, 0.833; 95% confidence interval, 0.749-0.898) and emerged as an independent predictor for 6-month mortality (odds ratio, 1.114; 95% confidence interval, 1.008-1.233; P = 0.005), overall survival (hazard ratio, 1.085; 95% confidence interval, 1.010-1.166; P = 0.003) and unfavorable outcome (odds ratio, 1.049; 95% confidence interval, 1.014-1.076; P = 0.001). By receiver-operating characteristic analysis, serum tenascin-C concentrations had similar prognostic value compared with GCS scores. Conclusions: Enhanced serum tenascin-C concentrations are closely related to trauma severity and clinical outcomes, substantializing tenascin-C as a potential prognostic biomarker after TBI.	[Zhao, Yuan-Yuan; Lou, Lin; Yang, Kai-Chuang; Wang, Hai-Bo; Xu, Yan; Lu, Gang] Zhejiang Prov Peoples Hosp, Peoples Hosp, Hangzhou Med Coll, Dept Neurosurg,Zhaohui Hosp Dist, 158 Shangtang Rd, Hangzhou 310014, Zhejiang, Peoples R China; [He, Hai-Yan] Zhejiang Prov Peoples Hosp, Peoples Hosp, Hangzhou Med Coll, Zone 6,Wangjiang Mt Hosp Dist, 642 Zhuantang Shuangliu, Hangzhou 310024, Zhejiang, Peoples R China		He, HY (corresponding author), Zhejiang Prov Peoples Hosp, Peoples Hosp, Hangzhou Med Coll, Zone 6,Wangjiang Mt Hosp Dist, 642 Zhuantang Shuangliu, Hangzhou 310024, Zhejiang, Peoples R China.	yumingpanan@163.com					Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Clancy P, 2014, BIOFACTORS, V40, P448, DOI 10.1002/biof.1170; de Sousa Ismalia, 2016, Emerg Nurse, V24, P33; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Ferhat L, 1996, J NEUROCYTOL, V25, P535, DOI 10.1007/BF02284821; Frattalone AR, 2013, NEUROSURG CLIN N AM, V24, P309, DOI 10.1016/j.nec.2013.03.006; Fujimoto M, 2017, MOL NEUROBIOL; Fujimoto M, 2016, J NEUROSURG, V124, P1693, DOI 10.3171/2015.4.JNS15484; Hatefi M, 2016, J CLIN DIAGN RES, V10, pOC20, DOI 10.7860/JCDR/2016/21918.8993; Irintchev A, 2005, CEREB CORTEX, V15, P950, DOI 10.1093/cercor/bhh195; Maserati M, 2016, J NEUROSCI NURS, V48, P311, DOI 10.1097/JNN.0000000000000242; Maseruka H, 1997, BRIT J OPHTHALMOL, V81, P677, DOI 10.1136/bjo.81.8.677; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Reith FCM, 2017, NEUROSURGERY, V80, P829, DOI 10.1093/neuros/nyw178; Schnyder B, 1997, INT J CANCER, V72, P217; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Shiba Masato, 2015, Acta Neurochir Suppl, V120, P69, DOI 10.1007/978-3-319-04981-6_12; Shiba M, 2014, TRANSL STROKE RES, V5, P238, DOI 10.1007/s12975-014-0333-2; Strekalova T, 2002, MOL CELL NEUROSCI, V21, P173, DOI 10.1006/mcne.2002.1172; Suzuki Hidenori, 2015, Acta Neurochir Suppl, V120, P117, DOI 10.1007/978-3-319-04981-6_20; Suzuki H, 2010, NEUROL RES, V32, P179, DOI 10.1179/174313208X355495; Vollmer G, 1997, CRIT REV ONCOL HEMAT, V25, P187, DOI 10.1016/S1040-8428(97)00004-8; Yang DB, 2017, CLIN CHIM ACTA, V469, P99, DOI 10.1016/j.cca.2017.03.030; Yuasa S, 2001, ARCH HISTOL CYTOL, V64, P149, DOI 10.1679/aohc.64.149; Zammit Christopher, 2013, Emerg Med Pract, V15, P1; Zhang Y, 1997, J NEUROSCI RES, V49, P433; Zhang ZY, 2014, PEPTIDES, V60, P13, DOI 10.1016/j.peptides.2014.07.016	27	7	9	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	SEP	2017	472						46	50		10.1016/j.cca.2017.07.018			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	FH9RU	WOS:000411550200009	28732652				2022-02-06	
J	Krieg, SM; Voigt, F; Knuefermann, P; Kirschning, CJ; Plesnila, N; Ringel, F				Krieg, Sandro M.; Voigt, Florian; Knuefermann, Pascal; Kirschning, Carsten Juergen; Plesnila, Nikolaus; Ringel, Florian			Decreased Secondary Lesion Growth and Attenuated Immune Response after Traumatic Brain Injury in Tlr2/4(-/-) Mice	FRONTIERS IN NEUROLOGY			English	Article						toll-like receptors; brain edema; intracranial pressure; secondary brain damage; traumatic brain injury	TOLL-LIKE RECEPTORS; CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; INFLAMMATORY RESPONSES; CORTICAL CONTUSION; SIGNALING PATHWAY; NECROTIC CELLS; NEURONAL DEATH; HEAD-INJURY; IN-VIVO	Danger-associated molecular patterns are released by damaged cells and trigger neuroinflammation through activation of non-specific pattern recognition receptors, e. g., toll-like receptors (TLRs). Since the role of TLR2 and 4 after traumatic brain injury (TBI) is still unclear, we examined the outcome and the expression of pro-inflammatory mediators after experimental TBI in Tlr2/4(-/-) and wild-type (WT) mice. Tlr2/4(-/-) and WT mice were subjected to controlled cortical injury and contusion volume and brain edema formation were assessed 24 h thereafter. Expression of inflammatory markers in brain tissue was measured by quantitative PCR 15 min, 3 h, 6 h, 12 h, and 24 h after controlled cortical impact (CCI). Contusion volume was significantly attenuated in Tlr2/4(-/-) mice (29.7 +/- 0.7 mm3 as compared to 33.5 +/- 0.8 mm(3) in WT; p < 0.05) after CCI while brain edema was not affected. Only interleukin (IL)-1 beta gene expression was increased after CCI in the Tlr2/4(-/-) relative to WT mice. Inducible nitric oxide synthetase, TNF, IL-6, and COX-2 were similar in injured WT and Tlr2/4(-/-) mice, while the increase in high-mobility group box 1 was attenuated at 6 h. TLR2 and 4 are consequently shown to potentially promote secondary brain injury after experimental CCI via neuroinflammation and may therefore represent a novel therapeutic target for the treatment of TBI.	[Krieg, Sandro M.; Voigt, Florian; Ringel, Florian] Tech Univ Munich, Dept Neurosurg, Munich, Germany; [Voigt, Florian; Plesnila, Nikolaus] Ludwig Maximilians Univ Munchen, Univ Munich, Inst Surg Res, Med Ctr, Munich, Germany; [Knuefermann, Pascal] Univ Hosp Bonn, Dept Anesthesiol & Intens Care Med, Bonn, Germany; [Kirschning, Carsten Juergen] Univ Duisburg Essen, Inst Med Microbiol, Essen, Germany; [Plesnila, Nikolaus] Ludwig Maximilians Univ Munchen, Univ Munich, Inst Stroke & Dementia Res, Med Ctr, Munich, Germany; [Ringel, Florian] Johannes Gutenberg Univ Mainz, Dept Neurosurg, Mainz, Germany		Krieg, SM (corresponding author), Tech Univ Munich, Dept Neurosurg, Munich, Germany.	sandro.krieg@tum.de	Krieg, Sandro M./L-8902-2016; Plesnila, Nikolaus/T-7522-2019; Ringel, Florian/E-4933-2014	Krieg, Sandro M./0000-0003-4050-1531; 			Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; Beschorner R, 2000, NEUROPATH APPL NEURO, V26, P522, DOI 10.1046/j.0305-1846.2000.287.x; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Buchanan MM, 2010, J NEUROCHEM, V114, P13, DOI 10.1111/j.1471-4159.2010.06736.x; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; da Costa CUP, 2004, EUR J IMMUNOL, V34, P2874, DOI 10.1002/eji.200425101; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Impellizzeri D, 2015, IMMUNOBIOLOGY, V220, P1039, DOI 10.1016/j.imbio.2015.05.013; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Kilic U, 2008, NEUROBIOL DIS, V31, P33, DOI 10.1016/j.nbd.2008.03.002; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Koedel U, 2007, AM J PATHOL, V171, P200, DOI 10.2353/ajpath.2007.060821; Krieg SM, 2017, J NEUROTRAUM, V34, P1329, DOI 10.1089/neu.2016.4514; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Wang CQ, 2017, NEUROSCIENCE, V343, P30, DOI 10.1016/j.neuroscience.2016.11.029; Yu ZQ, 2012, ANN CLIN LAB SCI, V42, P26; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	44	7	7	0	9	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 30	2017	8								455	10.3389/fneur.2017.00455			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FF6AI	WOS:000409084000001	28912751	Green Published, gold			2022-02-06	
J	Thompson, L; Hill, M; Davies, C; Shaw, G; Kiernan, MD				Thompson, Lee; Hill, Michael; Davies, Caroline; Shaw, Gary; Kiernan, Matthew D.			Identifying pre-hospital factors associated with outcome for major trauma patients in a regional trauma network: an exploratory study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Pre-hospital; Trauma; Outcome; Age; Timings; Response	MORTALITY; TIME; HYPOTENSION; INJURY; CARE	Background: Major trauma is often life threatening and the leading cause of death in the United Kingdom (UK) for adults aged less than 45 years old. This study aimed to identify pre-hospital factors associated with patient outcomes for major trauma within one Regional Trauma Network. Method: Secondary analysis of pre-hospital audit data and patient outcome data from the Trauma Audit Research Network (TARN) was undertaken. The primary outcome used in analysis was 'Status at Discharge' (alive/deceased). Independent variables considered included 'Casualty Characteristics' such as mechanism of injury (MOI), age, and physiological measurements, as well as 'Response Characteristics' such as response timings and skill mix. Binary Logistic Regression analysis using the ` forward stepwise' method was undertaken for physiological measures taken at the scene. Results: The study analysed 1033 major trauma records (mean age of 38.5 years, SD 21.5, 95% CI 37-40). Adults comprised 82.6% of the sample (n = 853), whilst 12.9% of the sample were children (n = 133). Men comprised 68. 5% of the sample (n = 708) in comparison to 28.8% women (n = 298). Glasgow Coma Score (GCS) (p < 0.000), Respiration Rate (p < 0.001) and Age (p < 0.000), were all significant when associated with the outcome 'Status at Discharge' (alive/deceased). Isolated bivariate associations provided tentative support for response characteristics such as existing dispatching practices and the value of rapid crew arrival. However, these measurements appear to be of limited utility in predictive modelling of outcomes. Discussion: The complexity of physiological indices potentially complicate their predictive utility e.g. whilst a Systolic Blood Pressure (SBP) of < 90 mmHg serves as a trigger for bypass to a Major Trauma Centre, the utility of this observation is nullified in cases of Traumatic Brain Injury. Analysis suggested that as people age, outcomes from major trauma significantly worsened. This finding is consistent with existing research highlighting the relationship between trauma in elderly patients and poorer outcomes. Conclusion: Findings lend further validity to GCS, Respiration Rate and Age as predictive triggers for transport to a Major Trauma Centre. Analysis of interactions between response times, skill mix and triage demand further exploration but tentatively support the ` Golden Hour' concept and suggest a potential ` load and go and play on the way' approach.	[Thompson, Lee; Davies, Caroline; Shaw, Gary] North East Ambulance Serv NHS Fdn Trust, Bernicia House,Goldcrest Way, Newcastle Upon Tyne NE15 8NY, Tyne & Wear, England; [Hill, Michael; Kiernan, Matthew D.] Northumbria Univ, Coach Lane Campus, Newcastle Upon Tyne NE7 7XA, Tyne & Wear, England		Thompson, L (corresponding author), North East Ambulance Serv NHS Fdn Trust, Bernicia House,Goldcrest Way, Newcastle Upon Tyne NE15 8NY, Tyne & Wear, England.	lee.thompson5@nhs.net	Thompson, Lester D. R./J-8404-2016; Thompson, Lee/N-8723-2017	Thompson, Lester D. R./0000-0003-3714-1432; Thompson, Lee/0000-0002-0820-1662			Bowling, 2004, MEASURING HLTH REV Q; BULMER M, 1980, SOCIOLOGY, V14, P505, DOI 10.1177/003803858001400401; Carr BG, 2008, PREHOSP EMERG CARE, V12, P327, DOI 10.1080/10903120802096928; Carr BG, 2006, PREHOSP EMERG CARE, V10, P198, DOI 10.1080/10903120500541324; CICCHETTI DV, 1976, BRIT J PSYCHIAT, V129, P452, DOI 10.1192/bjp.129.5.452; Cox S, 2014, INJURY, V45, P1312, DOI 10.1016/j.injury.2014.02.028; Di Bartolomeo S, 2007, INJURY, V38, P305, DOI 10.1016/j.injury.2006.10.005; Dissmann PD, 2007, EMERG MED J, V24, P59, DOI 10.1136/emj.2006.038844; Eckstein M, 2000, AM J EMERG MED, V19, P439; GARNER AA, 2015, SCAND J TRAUMA RESUS, V23; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Kehoe A, 2015, EMERG MED J, V32, P911, DOI 10.1136/emermed-2015-205265; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Lin G, 2011, J PARAMEDIC PRACT, V3, P558; MacLeod JBA, 2004, AM SURGEON, V70, P805; National Audit Office, 2010, MAJ TRAUM CAR ENGL; National Confidential Enquiry into Patient Outcome and Death, 2007, TRAUM WHO CAR REP NA; Ocak G, 2009, LANGENBECK ARCH SURG, V394, P285, DOI 10.1007/s00423-008-0340-4; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; STARR P, 1976, HASTINGS CENT REP, V6, P24, DOI 10.2307/3561255; Sukumaran S, 2005, EMERG MED J, V22, P60, DOI 10.1136/emj.2004.016873; Turner J, 2006, COSTS BENEFITS CHANG; Victorino GP, 2003, J AM COLL SURGEONS, V196, P679, DOI 10.1016/S1072-7515(03)00128-5; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]	25	7	7	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	AUG 23	2017	25								83	10.1186/s13049-017-0419-4			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FF1ZE	WOS:000408696900001	28835283	Green Accepted, Green Published, gold			2022-02-06	
J	Wang, YS; Sawyer, TW; Tse, YC; Fan, CY; Hennes, G; Barnes, J; Josey, T; Weiss, T; Nelson, P; Wong, TP				Wang, Yushan; Sawyer, Thomas W.; Tse, Yiu Chung; Fan, Changyang; Hennes, Grant; Barnes, Julia; Josey, Tyson; Weiss, Tracy; Nelson, Peggy; Wong, Tak Pan			Primary Blast-Induced Changes in Akt and GsK(3 beta) Phosphorylation in Rat Hippocampus	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; Akt; primary blast; N-methyl-D-aspartate receptor; neurotrauma	TRAUMATIC BRAIN-INJURY; GLYCOGEN-SYNTHASE KINASE-3; NEURONAL SURVIVAL; CELL-DEATH; NEUROPROTECTION; CONSEQUENCES; INHIBITION; MODULATION; MECHANISMS; INDUCTION	Traumatic brain injury (TBI) due to blast from improvised explosive devices has been a leading cause of morbidity and mortality in recent conflicts in Iraq and Afghanistan. However, the mechanisms of primary blast-induced TBI are not well understood. The Akt signal transduction pathway has been implicated in various brain pathologies including TBI. In the present study, the effects of simulated primary blast waves on the phosphorylation status of Akt and its downstream effector kinase, glycogen synthase kinase 3 beta (GSK(3 beta)), in rat hippocampus, were investigated. Male Sprague-Dawley (SD) rats (350-400 g) were exposed to a single pulse shock wave (25 psi; similar to 7 ms duration) and sacrificed 1 day, 1 week, or 6 weeks after exposure. Total and phosphorylated Akt, as well as phosphorylation of its downstream effector kinase GSK(3 beta) (at serine 9), were detected with western blot analysis and immunohistochemistry. Results showed that Akt phosphorylation at both serine 473 and threonine 308 was increased 1 day after blast on the ipsilateral side of the hippocampus, and this elevation persisted until at least 6 weeks postexposure. Similarly, phosphorylation of GSK(3 beta) at serine 9, which inhibits GSK(3 beta) activity, was also increased starting at 1 day and persisted until at least 6 weeks after primary blast on the ipsilateral side. In contrast, p-Akt was increased at 1 and 6 weeks on the contralateral side, while p-GSK(3 beta) was increased 1 day and 1 week after primary blast exposure. No significant changes in total protein levels of Akt and GSK were observed on either side of the hippocampus at any time points. Immunohistochemical results showed that increased p-Akt was mainly of neuronal origin in the CA1 region of the hippocampus and once phosphorylated, the majority was translocated to the dendritic and plasma membranes. Finally, electrophysiological data showed that evoked synaptic N-methyl-d-aspartate (NMDA) receptor activity was significantly increased 6 weeks after primary blast, suggesting that increased Akt phosphorylation may enhance synaptic NMDA receptor activation, or that enhanced synaptic NMDA receptor activation may increase Akt phosphorylation.	[Wang, Yushan; Sawyer, Thomas W.; Fan, Changyang; Hennes, Grant; Barnes, Julia; Josey, Tyson; Weiss, Tracy; Nelson, Peggy] Def Res & Dev Canada, Suffield Res Ctr, Medicine Hat, AB, Canada; [Tse, Yiu Chung; Wong, Tak Pan] McGill Univ, Douglas Mental Hlth Univ Inst, Dept Psychiat, Montreal, PQ, Canada		Wang, YS (corresponding author), Def Res & Dev Canada, Suffield Res Ctr, Medicine Hat, AB, Canada.	yushan.wang@drdc-rddc.gc.ca		Wong, Tak Pan/0000-0001-8611-4911			Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Appelboom G, 2012, ACTA NEUROCHIR, V154, P131, DOI 10.1007/s00701-011-1210-3; Bailey ZS, 2016, METHODS MOL BIOL, V1462, P119, DOI 10.1007/978-1-4939-3816-2_8; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bowen I., 1968, ESTIMATE TOLERANCE D; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen CL, 2015, J ANESTH, V29, P600, DOI 10.1007/s00540-014-1964-x; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; Department of the Army, 1986, FUND PROT DES CONV W; Eagle AL, 2013, NEUROSCI RES, V75, P130, DOI 10.1016/j.neures.2012.11.001; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Faden AI, 2001, ARCH NEUROL-CHICAGO, V58, P1553, DOI 10.1001/archneur.58.10.1553; Fields RD, 2014, NEUROSCIENTIST, V20, P426, DOI 10.1177/1073858413504465; Finkel MF, 2006, J NEUROL SCI, V249, P63, DOI 10.1016/j.jns.2006.06.005; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hermida Miguel A., 2017, Advances in Biological Regulation, V65, P5, DOI 10.1016/j.jbior.2017.06.003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kitagishi Y, 2013, ALZHEIMERS RES THER, V5, DOI [10.1186/alzrt208, 10.1186/1758-9193-5-42]; Kumaran D, 2016, TRENDS COGN SCI, V20, P512, DOI 10.1016/j.tics.2016.05.004; Lei Peng, 2011, Int J Alzheimers Dis, V2011, P189246, DOI 10.4061/2011/189246; Liberzon I, 2016, NEURON, V92, P14, DOI 10.1016/j.neuron.2016.09.039; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0371-z; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Nagamoto-Combs K, 2010, J NEUROTRAUM, V27, P565, DOI 10.1089/neu.2009.0966; Norrmen C, 2013, BIOCHEM SOC T, V41, P944, DOI 10.1042/BST20130046; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Park K, 2013, FUTUR NEUROL, V8, P555, DOI 10.2217/FNL.13.35; Pezet S, 2008, J NEUROSCI, V28, P4261, DOI 10.1523/JNEUROSCI.5392-07.2008; Ramage JG, 2016, HEALTH SECUR, V14, P351, DOI 10.1089/hs.2016.0041; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Sanchez-Perez AM, 2006, NEUROCHEM INT, V49, P351, DOI 10.1016/j.neuint.2006.02.005; Sawyer TW, 2018, J NEUROTRAUM, V35, P174, DOI 10.1089/neu.2016.4961; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Shim SS, 2016, J NEUROTRAUM, V33, P2065, DOI 10.1089/neu.2015.4177; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Thomas JM, 2016, PHYS CHEM CHEM PHYS, V18, P22962, DOI 10.1039/c6cp03432b; Vogel EW, 2017, J NEUROTRAUM, V34, P1063, DOI 10.1089/neu.2016.4578; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Wang J, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/6138251; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Yano S, 2001, J CEREBR BLOOD F MET, V21, P351, DOI 10.1097/00004647-200104000-00004; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238	61	7	7	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 18	2017	8								413	10.3389/fneur.2017.00413			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FE6KM	WOS:000408318400001	28868045	Green Published, gold			2022-02-06	
J	Charry, JD; Falla, JD; Ochoa, JD; Pinzon, MA; Tejada, JH; Henriquez, MJ; Solano, JP; Calvache, C				Charry, Jose D.; Falla, Jesus D.; Ochoa, Juan D.; Pinzon, Miguel A.; Tejada, Jorman H.; Henriquez, Maria J.; Pablo Solano, Juan; Calvache, Camilo			External validation of the rotterdam computed tomography score in the prediction of mortality in severe traumatic brain injury	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Neurological outcome; prognosis models; traumatic brain injury	DECOMPRESSIVE CRANIECTOMY; CLASSIFICATION; MODERATE	Introduction: Traumatic brain injury (TBI) is a public health problem. It is a pathology that causes significant mortality and disability in Colombia. Different calculators and prognostic models have been developed to predict the neurological outcomes of these patients. The Rotterdam computed tomography (CT) score was developed for prognostic purposes in TBI. We aimed to examine the accuracy of the prognostic discrimination and prediction of mortality of the Rotterdam CT score in a cohort of trauma patients with severe TBI in a university hospital in Colombia. Materials and Methods: We analyzed 127 patients with severe TBI treated in a regional trauma center in Colombia over a 2-year period. Bivariate and multivariate analyses were used. The discriminatory power of the score, its accuracy, and precision were assessed by logistic regression and as the area under the receiver operating characteristic curve. ShapirouWilk, Chi-square, and Wilcoxon tests were used to compare the real outcomes in the cohort against the predicted outcomes. Results: The median age of the patient cohort was 33 years, and 84.25% were male. The median injury severity score was 25, the median Glasgow Coma Scale motor score was 3, the basal cisterns were closed in 46.46% of the patients, and a midline shift of 5 mm was seen in 50.39%. The 6-month mortality was 29.13%, and the Rotterdam CT score predicted a mortality of 26% (P < 0.0001) (area under the curve: 0.825; 95% confidence interval: 0.745u0.903). Conclusions: The Rotterdam CT score predicted mortality at 6 months in patients with severe head trauma in a university hospital in Colombia. The Rotterdam CT score is useful for predicting early death and the prognosis of patients with TBI.	[Charry, Jose D.; Henriquez, Maria J.] Fdn Univ UNINAVARRA, Dept Res, Sch Med, Neiva, Colombia; [Charry, Jose D.; Falla, Jesus D.; Ochoa, Juan D.; Pinzon, Miguel A.; Tejada, Jorman H.] Univ Surcolombiana, Sch Med, Neiva, Colombia; [Henriquez, Maria J.; Pablo Solano, Juan; Calvache, Camilo] Hosp Univ Neiva, Dept Neurosurg, Neiva, Colombia; [Charry, Jose D.] Univ Jaen, Dept Res, Jaen, Spain		Charry, JD (corresponding author), Fdn Univ Navarra, Calle 10 6-41, Neiva, Colombia.	danielcharry06@gmail.com		Pinzon Pinzon, Miguel Angel/0000-0001-5828-9212; Charry, Jose D./0000-0002-8789-7281			Byass P, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001477; De La Hoz GA, 2013, COMPORTAMIENTO HOMIC, P79; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Honeybul S, 2014, J NEUROSURG, V120, P1131, DOI 10.3171/2014.1.JNS131559; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; JENNETT B, 1975, LANCET, V1, P480; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Munakomi S, 2016, CHIN J TRAUMATOL, V19, P25, DOI 10.1016/j.cjtee.2015.12.005; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Talari HR, 2016, WORLD NEUROSURG, V87, P195, DOI 10.1016/j.wneu.2015.11.055; Waqas M, 2016, BRIT J NEUROSURG, V30, P258, DOI 10.3109/02688697.2016.1139047	17	7	7	0	2	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	AUG	2017	8			1			23	26		10.4103/jnrp.jnrp_434_16			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FE9OJ	WOS:000408532700007	28936067	gold, Green Published			2022-02-06	
J	Chen, S; Liu, JZ; Cai, JY; Zheng, W; Li, ZW; Chen, W; Fan, CY				Chen, Shuai; Liu, Jiazhi; Cai, Jiangyu; Zheng, Wei; Li, Zhiwei; Chen, Wei; Fan, Cunyi			Results and outcome predictors after open release of complete ankylosis of the elbow caused by heterotopic ossification	INTERNATIONAL ORTHOPAEDICS			English	Article						Risk factor; Prognostic factor; Elbow ankylosis; Ankylosed elbow; Open release; Heterotopic ossification	TRAUMATIC BRAIN-INJURY; RADIAL HEAD RESECTION; SURGICAL RELEASE; PROSTHETIC REPLACEMENT; EARLY EXCISION; RISK-FACTORS; BONE; ARTHROPLASTY; CHILDREN; THERAPY	Background Heterotopic ossification (HO) may lead to complete elbow ankylosis, resulting in severe disability. The prognostic factors that may be valuable in guiding treatment of this condition have not yet been evaluated. The goals of this study were to describe the outcomes of open release for ankylosed elbow caused by HO and to analyse factors associated with clinical outcomes. Method This retrospective study assessed 41 patients with ankylosed elbows treated by open release surgery. We report final clinical outcomes and analyses of the association between outcomes and clinical variables. Results Mean patient age was 36.4 years; follow-up was 36.1 months. Mean arc of motion increased from 0 to 112A degrees post-operatively, mean pronation from 34 to 52A degrees, supination from a mean of 51 to 76A degrees, and Mean Mayo Elbow Performance Score (MEPS) from 42.8 to 84.2. Eight patients experienced recurrence, two of whom underwent a second operation: one for elbow instability and one for revision surgery. Linear regression analysis demonstrated that initial injury type (p = 0.020), articular surface damage (p = 0.001), coma iduringthe initial injury (p = 0.001) and concomitant radial head replacement (p = 0.029) were independent factors affecting the final MEPS. Conclusions Satisfactory outcomes were achieved, indicating that open release is effective for ankylosed elbows. Our findings demonstrated that initial injury type, articular surface damage, coma and radial head replacement are outcome predictors affecting final outcomes.	[Chen, Shuai; Liu, Jiazhi; Zheng, Wei; Li, Zhiwei; Chen, Wei; Fan, Cunyi] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Liu, Jiazhi] Taishan Med Univ, 619 Changcheng Rd, Tai An 271016, Shandong, Peoples R China; [Cai, Jiangyu] Fudan Univ, Sports Med Ctr, 12 Middle Urumqi Rd, Shanghai 200040, Peoples R China; [Cai, Jiangyu] Fudan Univ, Huashan Hosp, Dept Sports Med & Arthroscopy Surg, 12 Middle Urumqi Rd, Shanghai 200040, Peoples R China		Fan, CY (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed, 600 Yishan Rd, Shanghai 200233, Peoples R China.	fancunyi888@163.com	fan, cunyi/ABI-7199-2020	fan, cunyi/0000-0002-7854-5233; Chen, Wei/0000-0001-8366-8978			Baldwin K, 2011, J HAND SURG-AM, V36A, P798, DOI 10.1016/j.jhsa.2011.01.015; Beingessner DM, 2004, J BONE JOINT SURG AM, V86A, P1730, DOI 10.2106/00004623-200408000-00018; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Gaur A, 2003, J BONE JOINT SURG AM, V85A, P1538, DOI 10.2106/00004623-200308000-00016; Hall JA, 2005, J BONE JOINT SURG AM, V87A, P1571, DOI 10.2106/JBJS.D.02829; HASTINGS H, 1994, HAND CLIN, V10, P417; HURVITZ EA, 1992, ARCH PHYS MED REHAB, V73, P459; Jensen SL, 2005, J SHOULDER ELB SURG, V14, P78, DOI 10.1016/j.jse.2004.05.009; Jupiter Jesse B, 2003, Instr Course Lect, V52, P93; Koh KH, 2013, J SHOULDER ELB SURG, V22, P1128, DOI 10.1016/j.jse.2013.04.019; Lee EK, 2013, J SHOULDER ELB SURG, V22, P716, DOI 10.1016/j.jse.2012.11.020; Maender C, 2010, J SHOULDER ELB SURG, V19, P1269, DOI 10.1016/j.jse.2010.05.029; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; MORREY BF, 1991, CLIN ORTHOP RELAT R, P187; MORREY BF, 1990, J BONE JOINT SURG AM, V72A, P601, DOI 10.2106/00004623-199072040-00019; Park MJ, 2010, J BONE JOINT SURG AM, V92A, P2692, DOI 10.2106/JBJS.I.01367; Ring D, 2003, J BONE JOINT SURG AM, V85A, P849, DOI 10.2106/00004623-200305000-00012; Ring David, 2004, J Bone Joint Surg Am, V86-A Suppl 1, P2; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; Ruan HJ, 2013, ARCH ORTHOP TRAUM SU, V133, P179, DOI 10.1007/s00402-012-1659-4; Salazar D, 2014, CLIN ORTHOP RELAT R, V472, P2269, DOI 10.1007/s11999-014-3591-0; Streubel PN, 2015, J AM ACAD ORTHOP SUR, V23, P328, DOI 10.5435/JAAOS-D-14-00051; Thompson H C 3rd, 1967, Clin Orthop Relat Res, V50, P129; van Kampen PJ, 2011, J HEAD TRAUMA REHAB, V26, P384, DOI 10.1097/HTR.0b013e3181f78a59; Viola RW, 2000, CLIN ORTHOP RELAT R, P65; Yu SY, 2015, INT ORTHOP, V39, P73, DOI 10.1007/s00264-014-2594-5	26	7	7	2	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	AUG	2017	41	8					1627	1632		10.1007/s00264-016-3395-9			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	FB7QC	WOS:000406334100018	28083670				2022-02-06	
J	Essien, EO; Fioretti, K; Scalea, TM; Stein, DM				Essien, Eno-Obong; Fioretti, Kristina; Scalea, Thomas M.; Stein, Deborah M.			Physiologic Features of Brain Death	AMERICAN SURGEON			English	Article							ORGAN DONOR; HEAD-INJURY; DYSFUNCTION; PROCUREMENT; MANAGEMENT; QUALITY	Brain death is known to be associated with physiologic derangements but their incidence is poorly described. Knowledge of the changes that occur during brain death is important for management of the potential organ donor. Thus, we sought to characterize the pathophysiology that occurs during brain death in patients with traumatic injuries. All brain-dead patients over a 10-year period were identified from the trauma registry at a level 1 urban trauma center. Patient demographics, injury characteristics, and clinical data for defining organ dysfunction were reviewed for the 24 hours surrounding brain-death declaration. Three hundred and seventy-three patients were identified. Mean age was 37 years (+/- 17.2). Seventy-five per cent were male. Major mechanism of injury was blunt trauma in 66 per cent. Median injury severity score was 34 (IQR 25-43) with a median head abbreviated injury scale score of 5. The most common physiological disturbance was hypotension with 91 per cent of subjects requiring vasopressors. Thrombocytopenia and acidosis both had an incidence of 79 per cent. The next most common disturbances were hypothermia and moderate-to-severe respiratory dysfunction in 62 per cent. Myocardial injury was seen in 91 per cent but only 5.7 per cent of patients manifested severe cardiac dysfunction with an ejection fraction of < 35. Diabetes insipidus was diagnosed in 50 per cent of patients. Interestingly, coagulopathy was noted in only 61.3 per cent, and hyperglycemia was seen in 36 per cent despite widespread belief that these occur universally during brain death. This is the first and largest study to characterize the incidence of pathophysiological disturbances following brain death in humans. Appropriate management of these dysfunctions is important for support of potential brain-dead organ donors.	Univ Maryland, Sch Med, Shock Trauma Anesthesia Res Organized Res Ctr, Baltimore, MD 21201 USA; R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA		Essien, EO (corresponding author), Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Shock Trauma Anesthesia Res Organized Res Ctr, 22 South Greene St,T1R52, Baltimore, MD 21201 USA.	eno-obong.essien@som.umaryland.edu		Stein, Deborah/0000-0003-3683-3963			Al-Khafaji A, 2015, INTENS CARE MED, V41, P418, DOI 10.1007/s00134-014-3621-0; Apostolakis E, 2010, J CARDIAC SURG, V25, P98, DOI 10.1111/j.1540-8191.2008.00790.x; Barklin A, 2009, ACTA ANAESTH SCAND, V53, P425, DOI 10.1111/j.1399-6576.2008.01879.x; Blasi-Ibanez A, 2009, ANESTHESIOLOGY, V110, P333, DOI 10.1097/ALN.0b013e318194ca8a; Chen EP, 1996, CRIT CARE MED, V24, P1352, DOI 10.1097/00003246-199608000-00014; DICKINSON CJ, 1990, CLIN SCI, V79, P543, DOI 10.1042/cs0790543; Dujardin KS, 2001, J HEART LUNG TRANSPL, V20, P350, DOI 10.1016/S1053-2498(00)00193-5; Faul M, 2010, TRAUMATIC BRAIN INJU; Floerchinger B, 2012, TRANSPLANT REV-ORLAN, V26, P54, DOI 10.1016/j.trre.2011.10.001; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Liu KJM, 2001, AM SURGEON, V67, P215; Maciel CB, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0682-1; MACOVIAK JA, 1987, TRANSPLANTATION, V43, P824, DOI 10.1097/00007890-198743060-00010; Mi ZB, 2015, CLIN EPIDEMIOL, V7, P17, DOI 10.2147/CLEP.S71403; Novitzky D, 1984, J HEART TRANSPLANT, V4, P63; Powner D J, 2000, Prog Transplant, V10, P146; Rech TH, 2014, TRANSPLANTATION, V97, P212, DOI 10.1097/TP.0b013e3182a949fa; Salim A, 2006, AM SURGEON, V72, P377; Smith M, 2004, J HEART LUNG TRANSPL, V23, pS217, DOI 10.1016/j.healun.2004.06.017; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tuttle-Newhall JE, 2009, AM J TRANSPLANT, V9, P879, DOI 10.1111/j.1600-6143.2009.02565.x; VECHT CJ, 1975, J NEUROL NEUROSUR PS, V38, P567, DOI 10.1136/jnnp.38.6.567; Wijdicks EFM, 2010, NEUROLOGY, V74, P1911, DOI 10.1212/WNL.0b013e3181e242a8	23	7	8	0	3	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	AUG	2017	83	8					850	854					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FE5PH	WOS:000408262900035	28822390				2022-02-06	
J	Gao, M; Yao, H; Dong, Q; Zhang, Y; Yang, Y; Zhang, YH; Yang, ZJ; Xu, MH; Xu, RX				Gao, Mou; Yao, Hui; Dong, Qin; Zhang, Yan; Yang, Yang; Zhang, Yihua; Yang, Zhijun; Xu, Minhui; Xu, Ruxiang			Neurotrophy and immunomodulation of induced neural stem cell grafts in a mouse model of closed head injury	STEM CELL RESEARCH			English	Article						Induced neural stem cell; Closed head injury; Neurotrophy; Immunomodulation; Neuroinflammation	NF-KAPPA-B; BRAIN-INJURY; ALZHEIMERS-DISEASE; INFLAMMATION; THERAPY; NEUROPROTECTION; ACTIVATION; NEURONS; CNS	Closed head injury (CHI) usually results in severe and permanent neurological impairments, which are caused by several intertwined phenomena, such as cerebral edema, blood-brain barrier (BBB) disruption, neuronal loss, astroglial scarring and inflammation. We previously reported that induced neural stem cells (iNSCs), similar to neural stem cells (NSCs), can accelerate neurological recovery in vivo and produce neurotrophic factors in vitro. However, the effects of iNSC neurotrophy following CHI were not determined. Moreover, whether iNSCs have immunomodulatory properties is unknown. Mouse models of CHI were established using a standardized weight-drop device and assessed by neurological severity score (NSS). Although these models fail to mimic the complete spectrum of human CHI, they reproduce impairment in neurological function observed in clinical patients. Syngeneic iNSCs or NSCs were separately transplanted into the brains of CHI mice at 12 h after CHI. Neurological impairment post-CHI was evaluated by several tests. Animals were sacrificed for morphological and molecular biological analyses. We discovered that iNSC administration promoted neurological functional recovery in CHI mice and reduced cerebral edema, BBB disruption, cell death and astroglial scarring following trauma. Implanted iNSCs could up-regulate brain-derived neurotrophic factor (BDNF) and glial-derived neurotrophic factor (GDNF) levels to support the survival of existing neurons after CHI. In addition, engrafted iNSCs decreased immune cell recruitment and pro-inflammatory cytokine expression in the brain post-injury. Moreover, we found significant nuclear factor-kappaB (NF-kappa B) inhibition in the presence of iNSC grafts. In short, iNSCs exert neurotrophic and immunomodulatory effects that mitigate CHI-induced neurological impairment. (C) 2017 The Authors. Published by Elsevier B.V.	[Gao, Mou; Zhang, Yihua; Xu, Minhui] Third Mil Med Univ, Affiliated Hosp 3, Dept Neurosurg, Chongqing 400042, Peoples R China; [Gao, Mou; Yao, Hui; Zhang, Yan; Yang, Yang; Yang, Zhijun; Xu, Ruxiang] PLA Army Gen Hosp, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China; [Dong, Qin] Capital Med Univ, Fu Xing Hosp, Dept Neurol, Beijing 100038, Peoples R China		Xu, MH (corresponding author), Third Mil Med Univ, Affiliated Hosp 3, Dept Neurosurg, Chongqing 400042, Peoples R China.; Xu, RX (corresponding author), PLA Army Gen Hosp, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China.	huyao@med.umich.edu; 201510111225@stu.shmtu.edu.cn	Yang, Yang/AAL-1670-2020	Yang, Yang/0000-0001-6645-2454	Military Twelfth Five-Year Key SciTech Research Projects [BWS12J010]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2013M532138]; National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81671189]	This work was supported by the Military Twelfth Five-Year Key SciTech Research Projects (Grant Nos. BWS12J010), the China Postdoctoral Science Foundation (2013M532138), and the National Natural Science Foundation of China (NSFC) (No. 81671189).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Ager RR, 2015, HIPPOCAMPUS, V25, P813, DOI 10.1002/hipo.22405; Aguiar AS, 2014, NEUROSCIENCE, V271, P56, DOI 10.1016/j.neuroscience.2014.04.027; Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Anderson ST, 2015, BRAIN BEHAV IMMUN, V43, P98, DOI 10.1016/j.bbi.2014.07.007; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Benarroch EE, 2015, NEUROLOGY, V84, P2076, DOI 10.1212/WNL.0000000000001601; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Cordero-Llana O, 2014, EXP NEUROL, V256, P93, DOI 10.1016/j.expneurol.2014.04.001; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Dooley D, 2014, PHARMACOL THERAPEUT, V141, P21, DOI 10.1016/j.pharmthera.2013.08.001; Filippo TRM, 2013, STEM CELL RES, V11, P913, DOI 10.1016/j.scr.2013.06.003; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Gao MW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33230; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar RG, 2016, BRAIN BEHAV IMMUN, V53, P183, DOI 10.1016/j.bbi.2015.12.008; Lemmens R, 2013, CURR OPIN NEUROL, V26, P617, DOI 10.1097/WCO.0000000000000023; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Rossignol J, 2014, STEM CELLS, V32, P500, DOI 10.1002/stem.1508; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Skripuletz T, 2013, BRAIN, V136, P147, DOI 10.1093/brain/aws262; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tang XH, 2016, STEM CELL RES, V16, P236, DOI 10.1016/j.scr.2016.01.016; Van K. C., 2013, PLOS ONE, V8; Verma R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25176; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yao H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137211; Zhang ML, 2016, CELL STEM CELL, V18, P653, DOI 10.1016/j.stem.2016.03.020; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	41	7	7	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	AUG	2017	23						132	142		10.1016/j.scr.2017.07.015			11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology	FH2GW	WOS:000410958100019	28743043	gold			2022-02-06	
J	Giorgi-Coll, S; Blunt-Foley, H; Hutchinson, PJ; Carpenter, KLH				Giorgi-Coll, Susan; Blunt-Foley, Holly; Hutchinson, Peter J.; Carpenter, Keri L. H.			Heparin-gold nanoparticles for enhanced microdialysis sampling	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Microdialysis; Cytokines; Heparin; Gold nanoparticles; Brain injury	TRAUMATIC BRAIN-INJURY; INFLAMMATION; INHIBITOR; CYTOKINES; STABILITY; LIGANDS	Cerebral microdialysis is a sampling technique which offers much potential for understanding inflammatory pathophysiology following traumatic brain injury (TBI). At present, the recovery of cytokines via microdialysis in clinical studies is not straightforward primarily due to their size, steric properties and low concentrations. Heparin and heparin-coated microspheres have previously shown promise as cytokine-binding agents for enhanced microdialysis sampling in animal models (Duo and Stenken in Anal Bioanal Chem 399(2):773-82, 2011; Anal Bioanal Chem 399(2):783-93, 2011). However, there are several factors limiting application for microdialysis in patients. The aim of this study was to produce heparin-coated gold nanoparticles as cytokine capture agents for enhanced microdialysis sampling, potentially applicable to a clinical setting. Gold nanoparticles (AuNP) were chemically conjugated to heparin via a bifunctional polyethylene glycol (PEG) linker. The heparin-AuNP (AuNP-Hep) were characterised, demonstrating the successful addition of heparin to the gold surface. The performance of the AuNP-Hep during in vitro testing was compared both to current methodology (Helmy et al. in J Neurotrauma 26(4):549-61, 2009) and to the heparin-coated microspheres developed by Duo and Stenken (Anal Bioanal Chem 399(2):773-82, 2011; Anal Bioanal Chem 399(2):783-93, 2011). The AuNP-Hep yielded a higher recovery of cytokines compared to current methodology and heparin-coated microspheres, during in vitro testing designed to mimic the human environment and the intensive care unit. In this study, AuNP-Hep were developed for enhanced microdialysis sampling of cytokines, potentially applicable in a clinical setting. Based on the success of the AuNP-Hep in vitro, the proposed method offers an alternative to the use of current protocols that rely on a blood product (albumin) for microdialysis sampling of cytokines in patients.	[Giorgi-Coll, Susan; Blunt-Foley, Holly; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Box 65,Cambridge Biomed Campus, Cambridge CB2 0QQ, England		Giorgi-Coll, S (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	sv377@cam.ac.uk		Carpenter, Keri/0000-0001-8236-7727	National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); University of MelbourneUniversity of Melbourne; National Institute for Health Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; National Institute for Health Research Biomedical Research Centre, CambridgeNational Institute for Health Research (NIHR); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1002277] Funding Source: UKRI	The work was supported by funding for SGC and KLHC from the National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). HBF was supported by a University of Melbourne Global Scholar's Award and a University of Melbourne Mobility Financial Assistance Grant for travel to Cambridge. PJH is funded by a National Institute for Health Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the National Institute for Health Research Biomedical Research Centre, Cambridge. The authors gratefully acknowledge Dr Giorgio Divitini (Department of Materials Science and Metallurgy, University of Cambridge) for electron microscope access and assistance. We also thank Dr Mark Kotter's research group (Anne McLaren Laboratory, Department of Clinical Neurosciences, University of Cambridge) for access to the light microscope and, in particular, Dr Ana Amaral for the technical support during bead counting and imaging.	Bai SH, 2007, J PHARM SCI-US, V96, P2090, DOI 10.1002/jps.20849; BELL FK, 1950, J AM PHARM ASSOC SCI, V39, P94, DOI 10.1002/jps.3030390211; Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; CADENE M, 1995, J BIOL CHEM, V270, P13204, DOI 10.1074/jbc.270.22.13204; Duo J, 2006, BIOSENS BIOELECTRON, V22, P449, DOI 10.1016/j.bios.2006.05.004; Duo J, 2011, ANAL BIOANAL CHEM, V399, P783, DOI 10.1007/s00216-010-4333-0; Duo J, 2011, ANAL BIOANAL CHEM, V399, P773, DOI 10.1007/s00216-010-4170-1; Hamley IW, 2014, BIOMACROMOLECULES, V15, P1543, DOI 10.1021/bm500246w; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Huang CC, 2005, ANAL CHEM, V77, P5735, DOI 10.1021/ac050957q; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Liu XO, 2007, COLLOID SURFACE B, V58, P3, DOI 10.1016/j.colsurfb.2006.08.005; Manson J, 2011, GOLD BULL, V44, P99, DOI 10.1007/s13404-011-0015-8; Schulz F, 2013, LANGMUIR, V29, P9897, DOI 10.1021/la401956c; Storhoff JJ, 2000, J AM CHEM SOC, V122, P4640, DOI 10.1021/ja993825l; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055; TURKEVICH J, 1953, J PHYS CHEM-US, V57, P670, DOI 10.1021/j150508a015; van der Heide S, 2016, J COLLOID INTERF SCI, V471, P127, DOI 10.1016/j.jcis.2016.03.001; Wang YX, 2009, ANAL CHIM ACTA, V651, P105, DOI 10.1016/j.aca.2009.08.009	23	7	8	1	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	AUG	2017	409	21					5031	5042		10.1007/s00216-017-0447-y			12	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	FC1LF	WOS:000406598000010	28664332	hybrid, Green Published			2022-02-06	
J	Lucas, S; Blume, HK				Lucas, Sylvia; Blume, Heidi K.			Sport-Related Headache	NEUROLOGIC CLINICS			English	Article						Concussion; Postconcussive syndrome; Posttraumatic headache; Sports concussion; Migraine; Tension-type headache	TRAUMATIC BRAIN-INJURY; QUALITY STANDARDS SUBCOMMITTEE; CHRONIC POSTTRAUMATIC HEADACHES; EPISODIC MIGRAINE PREVENTION; AMERICAN-ACADEMY; UNITED-STATES; PHARMACOLOGICAL-TREATMENT; POSTCONCUSSION SYMPTOMS; ADULTS REPORT; CONCUSSION	Headache occurring in a sports setting may be primary or secondary headache. Headache is the primary symptom reported after concussion. Cumulative incidence and prevalence of posttraumatic headache (PTH) are higher following mild traumatic brain injury (TBI) compared with moderate to severe TBI. Frequency is higher in those with more severe PTH. Migraine or probable migraine is the most common headache type after any severity TBI using primary headache disorder criteria. Management is empiric. Expert opinion recommends treating PTH according to clinical characteristics of primary headache. The most important factor in this approach is the recognition of the severity of headache.	[Lucas, Sylvia] Univ Washington, Dept Neurol Surg, Med Ctr, Seattle Sports Concuss Program,Harborview Med Ctr, Box 359924,325 Ninth Ave, Seattle, WA 98104 USA; [Blume, Heidi K.] Univ Washington, Seattle Childrens Hosp, Div Child Neurol, 4800 Sand Point Way,MS M-S MB 7-420, Seattle, WA 98105 USA; [Blume, Heidi K.] Univ Washington, Res Inst, Div Child Neurol, 4800 Sand Point Way,MS M-S MB 7-420, Seattle, WA 98105 USA		Lucas, S (corresponding author), Univ Washington, Dept Neurol Surg, Med Ctr, Seattle Sports Concuss Program,Harborview Med Ctr, Box 359924,325 Ninth Ave, Seattle, WA 98104 USA.	lucass@uw.edu					Alperin N, 2015, NEUROSURGERY, V77, P96, DOI 10.1227/NEU.0000000000000740; Arnautovic A, 2015, J NEUROSURG-PEDIATR, V15, P161, DOI 10.3171/2014.10.PEDS14295; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Castillo J, 1999, HEADACHE, V39, P190, DOI 10.1046/j.1526-4610.1999.3903190.x; Centers for Disease Control and Prevention, TRAUM BRAIN INJ STAT; Choe MC, 2016, J CHILD NEUROL, V31, P76, DOI 10.1177/0883073814568152; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Corbin-Berrigan LA, 2017, CLIN J SPORT MED, V27, P325, DOI 10.1097/JSM.0000000000000355; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Martins HAD, 2009, ARQ NEURO-PSIQUIAT, V67, P43; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Dubrovsky AS, 2014, HEADACHE, V54, P878, DOI 10.1111/head.12334; Echlin PS, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12286; Eckner JT, 2017, CLIN J SPORT MED, V27, P266, DOI 10.1097/JSM.0000000000000346; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Evans RW, 2008, HEADACHE, V48, P1216, DOI 10.1111/j.1526-4610.2008.01216.x; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Friedman Mark H, 2002, Heart Dis, V4, P212, DOI 10.1097/00132580-200207000-00003; GAWEL MJ, 1993, HEADACHE, V33, P96, DOI 10.1111/j.1526-4610.1993.hed3302096.x; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Holland S, 2012, NEUROLOGY, V78, P1346, DOI 10.1212/WNL.0b013e3182535d0c; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Imperato J, 2003, ANN EMERG MED, V41, P98, DOI 10.1067/mem.2003.21; JENSEN OK, 1990, CEPHALALGIA, V10, P241, DOI 10.1046/j.1468-2982.1990.1005241.x; Kirk C, 2008, DEV MED CHILD NEUROL, V50, P422, DOI 10.1111/j.1469-8749.2008.02063.x; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lansink Jette G H, 2014, Ned Tijdschr Geneeskd, V158, pA8434; Lay CL, 1999, HEADACHE, V39, P275, DOI 10.1046/j.1526-4610.1999.3904275.x; Lerman B, 2011, J NEUROTRAUM, V28, pA16; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lewis D, 2004, NEUROLOGY, V63, P2215, DOI 10.1212/01.WNL.0000147332.41993.90; Lewis DW, 2007, PEDIATR REV, V28, P43, DOI 10.1542/pir.28-2-43; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Linder Steven L, 2007, Curr Pain Headache Rep, V11, P396, DOI 10.1007/s11916-007-0223-3; Lucas S, 2013, NEUROLOGY, P80; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; Matharu MS, 2001, NEUROLOGY, V56, P273, DOI 10.1212/WNL.56.2.273; MCBEATH JG, 1994, HEADACHE, V34, P148, DOI 10.1111/j.1526-4610.1994.hed3403148.x; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, P552, DOI 10.1136/bjsm.2004.014878; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Oliver JM, 2016, MED SCI SPORT EXER, V48, P974, DOI 10.1249/MSS.0000000000000875; Packard RC, 2000, HEADACHE, V40, P736, DOI 10.1046/j.1526-4610.2000.00128.x; Piovesan EJ, 1996, ARQ NEURO-PSIQUIAT, V54, P494, DOI 10.1590/S0004-282X1996000300022; Ramsden CE, 2013, PAIN, V154, P2441, DOI 10.1016/j.pain.2013.07.028; SARAN A, 1988, INT J PSYCHIAT MED, V18, P75, DOI 10.2190/15AH-JB7Q-U94T-JEAF; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Speer Marcy C, 2003, J Genet Couns, V12, P297, DOI 10.1023/A:1023948921381; Stam AH, 2009, J NEUROL NEUROSUR PS, V80, P1125, DOI 10.1136/jnnp.2009.177279; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; STOVNER LJ, 1993, HEADACHE, V33, P175, DOI 10.1111/j.1526-4610.1993.hed33040175.x; Tfelt-Hansen PC, 2013, NEUROLOGY, V80, P869, DOI 10.1212/01.wnl.0000427909.23467.39; Toldo I, 2014, HEADACHE, V54, P899, DOI 10.1111/head.12341; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Victor TW, 2010, CEPHALALGIA, V30, P1065, DOI 10.1177/0333102409355601; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu AG, 2014, NEUROREHAB NEURAL RE, V28, P75, DOI 10.1177/1545968313498650; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	84	7	7	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	AUG	2017	35	3					501	+		10.1016/j.ncl.2017.03.012			22	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC4OI	WOS:000406819500009	28673412				2022-02-06	
J	Riccomi, G; Fornaciari, G; Vitiello, A; Bini, A; Caramella, D; Giuffra, V				Riccomi, Giulia; Fornaciari, Gino; Vitiello, Angelica; Bini, Anna; Caramella, Davide; Giuffra, Valentina			Trepanation to Treat a Head Wound: A Case of Neurosurgery from 13th-Century Tuscany	WORLD NEUROSURGERY			English	Article						Bone "rondella"; Head wound; Italy; Middle ages; Neurosurgery; Trepanation	EARLY-MEDIEVAL PERIOD; SOUTHWESTERN GERMANY; THERAPY; AGES	During the archaeological excavations conducted in the 13th century cemetery of the Church of Sant'Agostino in Poggibonsi (Tuscany, Italy), a skull with evidence of neurosurgical intervention was brought to light. The skull, belonging to an adult male, shows two traumatic lesions produced by bladed instruments. The first lesion, located on the anterior part of the parietal bones, involved only the outer cranial table; bone remodeling indicates that the individual survived the injury for a long time. The second lesion, located on the frontal bone, involved all the thickness of the bone; the absence of reparative processes allows a diagnosis of peri mortem lesion. To treat this wound, the patient underwent surgical intervention. In fact, in correspondence to the lesion, an oval bone loss, with clean and well-defined cutting edges, can be interpreted as the result of a trepanation, probably performed to clean the wound and to remove any bone splinters. Half of the bone "rondella" was found in situ; it can be hypothesized that the surgeon decided to replace the bony piece to protect the brain. However, the surgical intervention failed, and the patient died soon afterwards. Trepanation for the treatment of cranial traumas is described by several medical classical and medieval authors, whose texts were available in the 13th century. This case represents rare Middle Ages evidence of neurosurgery used to treat a bone injury.	[Riccomi, Giulia; Fornaciari, Gino; Vitiello, Angelica; Giuffra, Valentina] Univ Pisa, Div Paleopathol, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Fornaciari, Gino; Bini, Anna; Giuffra, Valentina] Univ Sassari, Dept Biomed Sci, Ctr Anthropol Paleopathol & Hist Studies Sardinia, Sassari, Italy; [Caramella, Davide] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Diagnost & Intervent Radiol, Pisa, Italy		Riccomi, G (corresponding author), Univ Pisa, Div Paleopathol, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.	giulia.riccomi@med.unipi.it	Giuffra, Valentina/C-5933-2018; Caramella, Davide/K-7187-2018	Caramella, Davide/0000-0002-9951-2916; Fornaciari, Gino/0000-0002-1334-1707	ARPA Foundation	This work was supported by a grant from the ARPA Foundation (www.fondazionearpa.it). The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Adams F, 1846, 7 BOOKS P AEGINETA, V2, P429; Albucasis, 1973, URGERY INSTRUMENTS D, P699; Arnott R, 2003, TREPANATION HIST DIS; Aufderheide A. C., 1998, CAMBRIDGE ENCY HUMAN; Capasso L, 1996, INT J OSTEOARCHAEOL, V6, P316, DOI 10.1002/(SICI)1099-1212(199606)6:3<316::AID-OA271>3.0.CO;2-G; Clower WT, 2001, NEUROSURGERY, V49, P1417, DOI 10.1097/00006123-200112000-00021; Di Salvo R, 2002, DETTAGLI ANTROPOLOGI, V132, P323; Erdal YS, 2011, INT J OSTEOARCHAEOL, V21, P505, DOI 10.1002/oa.1154; Galen, 2011, METHOD OF MED, V6, P215; Garosi A, 1957, SIENA NELLA STORIA M; Gauliaco G, CHIRURGIA MAGNA, V1585, P59; Germana F., 1992, TRAPANAZIONI CRANIOT; Hippocrates Ganz J., 2015, HIST MED, V2, P78; Holck P, 2008, INT J OSTEOARCHAEOL, V18, P188, DOI 10.1002/oa.933; JORDANOV J, 1988, ACTA NEUROCHIR, V92, P15, DOI 10.1007/BF01401967; Kimmerle EH, 2008, SKELETAL TRAUMA: IDENTIFICATION OF INJURIES RESULTING FROM HUMAN RIGHTS ABUSE AND ARMED CONFLICT, P1, DOI 10.1201/9781420009118; L'Africano Costantino, 1960, COST AFR CHIR, P138; Lewis JE, 2008, J ARCHAEOL SCI, V35, P2001, DOI 10.1016/j.jas.2008.01.016; Lopez B, 2011, ANTHROPOL SCI, V119, P247, DOI 10.1537/ase.100913; Papadakis M, 2015, ANZ J SURG; Sauer N.J., 1998, FORENSIC OSTEOLOGY A, V2nd ed., P321; Sperati G, 2007, Acta Otorhinolaryngol Ital, V27, P151; Tabanelli M, 1965, CHIRURGIA ITALIANA N, VI, p[27, 126, 281]; Tabanelli M, 1970, BRUNO LONGOBURGO CHI, P50; UBELAKER D., 1994, ARKANSAS ARCHAEOLOGI, V44; Weber J, 2001, AM J PHYS ANTHROPOL, V114, P352, DOI 10.1002/ajpa.1047.abs; Weber J, 2001, ZBL NEUROCHIR, V62, P10, DOI 10.1055/s-2001-16333; Withington ET, 1928, WOUNDS HEAD SURG FRA, VIII, P1; Zanello M, 2015, ACTA NEUROCHIR, V157, P303, DOI 10.1007/s00701-014-2239-x	29	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2017	104						9	13		10.1016/j.wneu.2017.04.160			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	FD7NP	WOS:000407713100003	28479520	Green Accepted			2022-02-06	
J	Schussler, E; Stark, D; Bolte, JH; Kang, YS; Onate, JA				Schussler, Eric; Stark, David; Bolte, John H.; Kang, Yun Seok; Onate, James A.			COMPARISON OF A HEAD MOUNTED IMPACT MEASUREMENT DEVICE TO THE HYBRID III ANTHROPOMORPHIC TESTING DEVICE IN A CONTROLLED LABORATORY SETTING	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Concussion; head acceleration; head velocity	HIGH-SCHOOL FOOTBALL; LIFE COGNITIVE IMPAIRMENT; INSTRUMENTED MOUTHGUARD; PLAYERS; CONCUSSION; EXPOSURE; ACCELERATION; BIOMECHANICS; COLLEGIATE; SYSTEM	Background: Reports estimate that 1.6 to 3.8 million cases of concussion occur in sports and recreation each year in the United States. Despite continued efforts to reduce the occurrence of concussion, the rate of diagnosis continues to increase. The mechanisms of concussion are thought to involve linear and rotational head accelerations and velocities. One method of quantifying the kinematics experienced during sport participation is to place measurement devices into the athlete's helmet or directly on the athlete's head. Purpose: The purpose of this research to determine the accuracy of a head mounted device for measuring the head accelerations experienced by the wearer. This will be accomplished by identifying the error in Peak Linear Acceleration (PLA), Peak Rotational Acceleration (PRA) and Peak Rotational Velocity (PRV) of the device. Study Design: Laboratory study. Methods: A helmeted Hybrid III 50th percentile male headform was impacted via a pneumatic ram from the front, side, rear, front oblique and rear oblique at speeds from 1.5 to 5 m/s. The X2 Biosystems xPatch (R) (Seattle, WA) sensor was placed on the headform's right side at the approximate location of the mastoid process. Measures of PLA, PRA, PRV from the xPatch (R) and Hybrid III were analyzed for Root Mean Square Error (RMSE), and Absolute and Relative Error (AE, RE). Result: Seventy-six impacts were analyzed. All measures of correlation, fixed through the origin, were found to be strong: PLA R-2 = 0.967 p < 0.01, PRA R-2 = 0.933 p < 0.01, PRV R-2 = 0.999 p < 0.00. PLA RMSE was 34%, RE 31.0% +/- 14.0, and AE 31.1% +/- 13.7. PRA RMSE was 23.4%, RE -6.7 +/- 22.4 and AE 18.9% +/- 13.8. PRV RMSE was 2.2%, RE 0.1 +/- 2.2, and AE 1.8 +/- 1.3. Conclusion: Without including corrections for effect of skin artifact, the xPatch (R) produces measurements highly correlated with the gold standard yet above the average error of testing devices in both PLA and PRA, but a low error in PRV. PLA measures from the xPatch (R) system demonstrated a high level of correlation with the PLA data from the Hybrid III mounted data collection system.	[Schussler, Eric] Old Dominion Univ, 3107 Hlth Sci Bldg, Norfolk, VA 23529 USA; [Stark, David; Bolte, John H.; Kang, Yun Seok; Onate, James A.] Ohio State Univ, Columbus, OH 43210 USA		Schussler, E (corresponding author), Old Dominion Univ, 3107 Hlth Sci Bldg, Norfolk, VA 23529 USA.	ESchussl@odu.edu	Schussler, Eric/AAF-3444-2020; Bolte, John/AAK-9695-2021	Schussler, Eric/0000-0002-0101-0986			Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Daniel Ray W, 2014, Biomed Sci Instrum, V50, P291; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Greenhill DA, 2016, SPORTS HEALTH, V8, P238, DOI 10.1177/1941738116639027; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hernandez F., 2014, ANN BIOMED ENG; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Mertz H J, 2001, Stapp Car Crash J, V45, P319; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Society of Automotive Engineers, 1995, J211 1 INSTR IMP TES; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; X2Biosystems, 2011, DET HEAD ACC INSTR M; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	31	7	7	0	2	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	AUG	2017	12	4					592	600					9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	FG9AF	WOS:000410729800010	28900565				2022-02-06	
J	Vanderby, BL; Gelinas, C				Vanderby, Brandy L.; Gelinas, Celine			Family Perspectives of Traumatically Brain-Injured Patient Pain Behaviors in the Intensive Care Unit	PAIN MANAGEMENT NURSING			English	Article							COMMON PROCEDURES; OBSERVATION TOOL; CONSCIOUSNESS; ADULTS	Behavioral scales allow for the pain assessment of vulnerable critically ill patients who are unable to self-report. However, validity of the use of such scales is limited in traumatic brain injury patients with an altered level of consciousness as a result of the different way that these patients express pain. Family participation is considered as an important component of pain assessment for those unable to self report, but research in this area is minimal so far. This study aimed to describe what behaviors family caregivers deemed relevant to pain for patients with a traumatic brain injury with an altered level of consciousness in the intensive care unit. Using a mixed-method descriptive design, semistructured interviews were conducted and behaviors' relevance was quantitatively rated by seven family caregivers of nonverbal patients with traumatic brain injury in the intensive care unit of a tertiary trauma center in Montreal, Canada. Family caregivers were able to provide rich descriptions of a number of behaviors they observed in their loved ones that were perceived to be relevant indicators of pain, such as muscle tension and key facial expressions and body movements. Several factors influenced how behaviors were interpreted by family, including personal medical beliefs and intimate knowledge of the patient's history. The pain behaviors determined by family caregivers can be useful in the pain assessment process of traumatic brain injury patients with an altered level of consciousness. Their input could also be helpful in further development of pain assessment tools. (C) 2017 by the American Society for Pain Management Nursing	[Vanderby, Brandy L.; Gelinas, Celine] Jewish Gen Hosp, Montreal, PQ, Canada; [Gelinas, Celine] McGill Univ, Ingram Sch Nursing, Montreal, PQ, Canada		Gelinas, C (corresponding author), Ingram Sch Nursing, Wilson Hall,3506 Univ St, Montreal, PQ H3A 2A7, Canada.	gelinas@mcgill.ca			Fonds de recherche du Quebec-Sante (FRQS) [25094]; Ministere de l'Education, du Loisir et du Sport (MELS)	The authors would like to thank Dr. Margaret Purden from McGill University Ingram School of Nursing for helpful comments on the study development and manuscript. We would also like to acknowledge the nurse manager and the assistant nurse managers of the ICU for supporting participant recruitment and data collection. Finally, this study was supported by an operating grant from the Fonds de recherche du Quebec-Sante (FRQS grant #25094) and a Master's Degree Award from the Ministere de l'Education, du Loisir et du Sport (MELS).	Arbour C, 2014, CLIN J PAIN, V30, P960, DOI 10.1097/AJP.0000000000000061; Arbour C, 2014, PAIN MANAG NURS, V15, P506, DOI 10.1016/j.pmn.2012.03.004; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Chanques G, 2006, CRIT CARE MED, V34, P1691, DOI 10.1097/01.CCM.0000218416.62457.56; Chanques G, 2007, ANESTHESIOLOGY, V107, P858, DOI 10.1097/01.anes.0000287211.98642.51; DAVIS RA, 1982, NEUROSURGERY, V10, P635, DOI 10.1227/00006123-198205000-00017; de Jong A, 2013, CRIT CARE, V17, DOI 10.1186/cc12683; Faul M, 2010, TRAUMATIC BRAIN INJU; Gelinas C, 2006, AM J CRIT CARE, V15, P420; Gelinas C, 2013, SEMIN RESP CRIT CARE, V34, P153, DOI 10.1055/s-0033-1342970; Gelinas C, 2011, INT J NURS STUD, V48, P1495, DOI 10.1016/j.ijnurstu.2011.03.012; Gelinas C, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.01.013; Gelinas Celine, 2007, Intensive Crit Care Nurs, V23, P298, DOI 10.1016/j.iccn.2007.03.002; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Herr K, 2011, PAIN MANAG NURS, V12, P230, DOI 10.1016/j.pmn.2011.10.002; Le Q, 2013, PAIN MANAG NURS, V14, pE251, DOI 10.1016/j.pmn.2012.02.005; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Myhren H, 2009, INTENS CARE MED, V35, P2078, DOI 10.1007/s00134-009-1614-1; Payen JF, 2009, ANESTHESIOLOGY, V111, P1308, DOI 10.1097/ALN.0b013e3181c0d4f0; Powell R. A., 2010, PAIN HIST PAIN ASSES; Puntillo K A, 2001, Am J Crit Care, V10, P238; Puntillo KA, 2004, CRIT CARE MED, V32, P421, DOI 10.1097/01.CCM.0000108875.35298.D2; Puntillo KA, 2014, AM J RESP CRIT CARE, V189, P39, DOI 10.1164/rccm.201306-1174OC; Puntillo KA, 2012, CRIT CARE MED, V40, P2760, DOI 10.1097/CCM.0b013e31825b94d8; Rose L, 2013, AM J CRIT CARE, V22, P246, DOI 10.4037/ajcc2013200; Roulin MJ, 2014, INTENS CARE MED, V40, P1115, DOI 10.1007/s00134-014-3380-y; Sandelowski M, 2000, RES NURS HEALTH, V23, P246, DOI 10.1002/1098-240X(200006)23:3<246::AID-NUR9>3.0.CO;2-H; TEASDALE G, 1974, LANCET, V2, P81	28	7	7	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1524-9042	1532-8635		PAIN MANAG NURS	Pain Manag. Nurs.	AUG	2017	18	4					202	213		10.1016/j.pmn.2017.04.005			12	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	FC6ZI	WOS:000406989800003	28601477				2022-02-06	
J	Wetzler, G; Roland, M; Fryer-Dietz, S; Dettmann-Ahern, D				Wetzler, Gail; Roland, Melinda; Fryer-Dietz, Sally; Dettmann-Ahern, Dee			CranioSacral Therapy and Visceral Manipulation: A New Treatment Intervention for Concussion Recovery	MEDICAL ACUPUNCTURE			English	Article						concussion; traumatic brain injury; CranioSacral Therapy; Visceral Manipulation; Neural Manipulation; treatment intervention	RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; PAIN; FOOTBALL; SUICIDE	Background: Military service members and veterans face health issues related to traumatic brain injury (TBI), especially during combat, use of heavy equipment, and exposures to environmental hazards and explosives. There were 400,000 TBIs reported in deployed U.S. troops in 2012. Athletes are also subject to TBI. Studies have indicated that some manual therapies could be helpful for treating patients who have post-concussive syndrome. Objective: This case series report describes the effects of CranioSacral Therapy (CST), Visceral Manipulation (VM), and Neural Manipulation (NM) modalities for treating patients who have post-concussion syndrome. The goal of this study was to evaluate these effects on immobility, pain intensity, quality of life, sleep disorders, and cognition in these patients. Materials and Methods: This single-blinded case series was conducted at the Upledger Institute, in West Palm Beach, FL. The patients were 11 male retired professional football players from the National Football League and the Canadian Football League who had been medically diagnosed with post-concussion syndrome. Each participant received a morning and afternoon 2-hour session of these three specific manual therapies, which were capable of accessing and addressing the structural, vascular, and neurologic tissues of the cranium and brainas well addressing far-reaching ramifications throughout the body following trauma. The main outcome measures were scores on the: Impact Neurocognitive Test; Dynavision(tm) Test; Short Form-36 Quality of Life Survey, Headache Impact Test, Dizziness Handicap Inventory; a numeric pain rating scale; orthopedic range of motion tests (ROM); and vestibular testing. Hours of sleep were also checked. These outcome measures were registered at baseline, after treatment, and after a 3-month follow up. Results: Statistically significant differences were seen with a decrease in overall pain rating scale scores (P=0.0448), and cervicogenic pain levels decreased (P=0.0486). There were statistically significant increases in Dynavision Average Reaction Time (P=0.0332), Memory Test (P=0.0156) scores, and cervical ROM scores (P=0.0377). Hours of sleep averaged 2 hours on the first day of treatment and increased to 4.0 hours at the end of treatment and were continuing to increase, as noted at a 3-month evaluation. Conclusions: Ten sessions of specific CST/VM/NM therapy resulted in statistically greater improvements in pain intensity, ROM, memory, cognition, and sleep in concussed patients.	[Wetzler, Gail; Dettmann-Ahern, Dee] Barral Inst, Clin Res, W Palm Beach, FL USA; [Wetzler, Gail] Wetzler Integrat Phys Therapy, Denver, CO USA; [Roland, Melinda; Fryer-Dietz, Sally] Upledger Inst, Clin Res, W Palm Beach, FL USA; [Roland, Melinda] Integral Therapies, San Diego, CA USA; [Fryer-Dietz, Sally] Integrat Concuss Therapy, Dallas, TX USA; [Dettmann-Ahern, Dee] Dee Ahern Phys Therapy, Stuart, FL USA		Wetzler, G (corresponding author), 7853 East Arapahoe Court,Suite 1400, Centennial, CO 80116 USA.	wetzlerdpt@gmail.com			John E. Upledger Foundation; Ricky Williams Foundation	This research was supported by the John E. Upledger Foundation and the Ricky Williams Foundation.	Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Arnadottir TS, 2013, COMPLEMENT THER CLIN, V19, P11, DOI 10.1016/j.ctcp.2012.09.003; Barral JP, 1988, VISCERAL MANIPULATIO, P1; Barral JP, 2008, MANUAL THERAPY CRANI, P1; BLOOD SD, 1986, J AM OSTEOPATH ASSOC, V86, P512; Gerdner LA, 2008, J GERONTOL NURS, V34, P36, DOI 10.3928/00989134-20080301-04; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grady MF, 2012, PEDIATR ANN, V41, P377, DOI 10.3928/00904481-20120827-12; Haller H, 2016, CLIN J PAIN, V32, P441, DOI 10.1097/AJP.0000000000000290; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Kallakuri S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169239; Castro-Sanchez AM, 2016, J ALTERN COMPLEM MED, V22, P650, DOI 10.1089/acm.2016.0068; Castro-Sanchez AM, 2011, CLIN REHABIL, V25, P25, DOI 10.1177/0269215510375909; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; MedlinePlus, TRAUMATIC BRAIN INJU; Nedergaard M, 2010, CELL CALCIUM, V47, P140, DOI 10.1016/j.ceca.2009.11.010; Nourbakhsh MR, 2008, J HAND THER, V21, P4, DOI 10.1197/j.jht.2007.09.005; Raviv Gil, 2009, Complement Ther Clin Pract, V15, P72, DOI 10.1016/j.ctcp.2008.12.006; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Ries E, 2017, REST PHYS THERAPISTS, P22; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Upledger JE, 1983, CRANIOSACRAL THERAPY, P5; Vander Kolk B., 2014, BODY KEEPS SCORE BRA, P62; Wanveer T, 2015, BRAIN STARS, P1; Webner D, 2016, BRAIN INJURY, V30, P1718, DOI 10.1080/02699052.2016.1202451	26	7	7	1	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1933-6586	1933-6594		MED ACUPUNCT	Med. Acupunct.	AUG	2017	29	4			SI		239	248		10.1089/acu.2017.1222			10	Integrative & Complementary Medicine	Emerging Sources Citation Index (ESCI)	Integrative & Complementary Medicine	FE5BR	WOS:000408227500014	28874926	Green Published, Bronze			2022-02-06	
J	Yoon, YK; Lee, KC; Cho, HE; Chae, M; Chang, JW; Chang, WS; Cho, SR				Yoon, Young Kwon; Lee, Kil Chan; Cho, Han Eol; Chae, Minji; Chang, Jin Woo; Chang, Won Seok; Cho, Sung-Rae			Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury	MEDICINE			English	Article						acquired brain injury; cerebral palsy; intrathecal baclofen; spasticity	SEVERE SPASTICITY; PUMP IMPLANTATION; SURGICAL-MANAGEMENT; INFUSION; CHILDREN; COMPLICATIONS; ADOLESCENTS; SAFETY	Intrathecal baclofen (ITB) has been known to reduce spasticity which did not respond to oral medications and botulinum toxin treatment. However, few results have been reported comparing the effects of ITB therapy in patients with cerebral palsy (CP) and acquired brain injury. This study aimed to investigate beneficial and adverse effects of ITB bolus injection and pump therapy in patients with CP and to compare outcomes to patients with acquired brain injury such as traumatic brain injury and hypoxic brain injury. ITB test trials were performed in 37 patients (19 CP and 18 acquired brain injury). Based on ambulatory function, CP patients were divided into 2 groups: 11 patients with nonambulatory CP and 8 patients with ambulatory CP. Change of spasticity was evaluated using the Modified Ashworth Scale. Additional positive or negative effects were also evaluated after ITB bolus injection. In patients who received ITB pump implantation, outcomes of spasticity, subjective satisfaction and adverse events were evaluated until 12 months post-treatment. After ITB bolus injection, 32 patients (86.5%) (CP 84.2% versus acquired brain injury 88.9%) showed a positive response of reducing spasticity. However, 8 patients with CP had negative adverse effects. Particularly, 3 ambulatory CP patients showed standing impairment and 1 ambulatory CP patient showed impaired gait pattern such as foot drop because of excessive reduction of lower extremity muscle tone. Ambulatory CP patients received ITB pump implantation less than patients with acquired brain injury after ITB test trials (P=.003 by a chi-squared test). After the pump implantation, spasticity was significantly reduced within 1 month and the effect maintained for 12 months. Seventeen patients or their caregivers (73.9%) were very satisfied, whereas 5 patients (21.7%) suffered from adverse events showed no subjective satisfaction. In conclusion, ITB therapy was effective in reducing spasticity in patients with CP and acquired brain injury. Before ITB pump implantation, it seems necessary to perform the ITB bolus injection to verify beneficial effects and adverse effects especially in ambulatory CP.	[Yoon, Young Kwon; Lee, Kil Chan; Cho, Han Eol; Chae, Minji; Cho, Sung-Rae] Yonsei Univ, Coll Med, Dept & Res Inst Rehabil Med, Seoul, South Korea; [Yoon, Young Kwon; Lee, Kil Chan; Cho, Han Eol] Yonsei Univ, Grad Sch, Dept Med, Seoul, South Korea; [Cho, Han Eol; Cho, Sung-Rae] Yonsei Univ, Coll Med, Rehabil Inst Neuromuscular Dis, Seoul, South Korea; [Chang, Jin Woo; Chang, Won Seok] Yonsei Univ, Coll Med, Dept Neurosurg, 50-1 Yonsei Ro, Seoul, South Korea; [Chang, Jin Woo; Chang, Won Seok] Yonsei Univ, Coll Med, Brain Res Inst, Seoul, South Korea; [Cho, Sung-Rae] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Cho, Sung-Rae] Avison Biomed Res Ctr, Yonsei Stem Cell Res Ctr, Seoul, South Korea		Chang, WS (corresponding author), Yonsei Univ, Coll Med, Dept Neurosurg, 50-1 Yonsei Ro, Seoul, South Korea.; Cho, SR (corresponding author), Yonsei Univ, Coll Med, Dept Rehabil Med, 50-1 Yonsei Ro, Seoul, South Korea.	CHANGWS0716@yuhs.ac; srcho918@yuhs.ac	CHO, HAN EOL/ABC-8472-2020	CHO, HAN EOL/0000-0001-5625-3013; Chang, Won Seok/0000-0003-3145-4016; Chang, Jin Woo/0000-0002-2717-0101; Cho, Sung-Rae/0000-0003-1429-2684	National Research Foundation [NRF-2014R1A2A1A11052042, 2015M3A9B4067068]; Ministry of Science and Technology, Republic of KoreaMinistry of Science and Technology (MOST) Korea; Korean Health Technology RD Project [HI16C1012]; Ministry of Health & Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of Korea	This study was supported by grants from the National Research Foundation (NRF-2014R1A2A1A11052042; 2015M3A9B4067068), the Ministry of Science and Technology, Republic of Korea, the Korean Health Technology R&D Project (HI16C1012), Ministry of Health & Welfare, Republic of Korea.	Awaad Y, 2012, ISRN NEUROL, V2012, DOI DOI 10.5402/2012/575168; Bernuz B, 2012, J REHABIL MED, V44, P184, DOI 10.2340/16501977-0918; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Borowski A, 2010, J PEDIATR ORTHOPED, V30, P76, DOI 10.1097/BPO.0b013e3181c6b257; Bose P, 2015, BRAIN NEUROTRAUMA MO; Brennan PM, 2008, BRIT J NEUROSURG, V22, P508, DOI 10.1080/02688690802233364; Dickerman Rob D, 2002, J Pediatr Surg, V37, pE17, DOI 10.1053/jpsu.2002.32928; Grzegorzewski Przemyslaw, 2007, Przegl Lek, V64 Suppl 2, P8; Huraibi HA, 2000, ANESTH ANALG, V91, P429, DOI 10.1097/00000539-200008000-00037; Kan P, 2008, CHILD NERV SYST, V24, P239, DOI 10.1007/s00381-007-0457-8; Khurana SR, 2014, PHYS MED REH CLIN N, V25, P655, DOI 10.1016/j.pmr.2014.04.008; Kim AR, 2014, ANN REHABIL MED-ARM, V38, P209, DOI 10.5535/arm.2014.38.2.209; Lynn AK, 2009, PM&R, V1, P834, DOI 10.1016/j.pmrj.2009.07.016; Maneyapanda MB, 2017, PHYS MED REHAB, V17, P30020; Marquardt G, 2008, REV NEUROLOGIA, V47, P557, DOI 10.33588/rn.4710.2008422; Motta F, 2007, J NEUROSURG, V107, P32, DOI 10.3171/PED-07/07/032; Ordia JI, 2002, NEUROMODULATION, V5, P103, DOI 10.1046/j.1525-1403.2002.02015.x; PENN RD, 1985, LANCET, V2, P125; Phillips MM, 2015, PM&R, V7, P1052, DOI 10.1016/j.pmrj.2015.03.020; Pin TW, 2011, DEV MED CHILD NEUROL, V53, P885, DOI 10.1111/j.1469-8749.2011.03992.x; Rekand T, 2010, ACTA NEUROL SCAND, V122, P62, DOI 10.1111/j.1600-0404.2010.01378.x; Roberts A, 2013, J CHILD ORTHOP, V7, P389, DOI 10.1007/s11832-013-0512-9; Sampson FC, 2002, J NEUROSURG, V96, P1052, DOI 10.3171/jns.2002.96.6.1052; Sansone JM, 2006, J PEDIATR ORTHOPED, V26, P125, DOI 10.1097/01.bpo.0000191555.11326.bd; Saulino M, 2016, NEUROMODULATION, V19, P607, DOI 10.1111/ner.12447; Sgouros S, 2010, PEDIATR NEUROSURG, V46, P62, DOI 10.1159/000315319; Skalsky AJ, 2015, PHYS MED REH CLIN N, V26, P89, DOI 10.1016/j.pmr.2014.09.011; Sohn MK, 2011, ANN REHABIL MED-ARM, V35, P599, DOI 10.5535/arm.2011.35.5.599; Theroux Mary C, 2014, Anesthesiol Clin, V32, P63, DOI 10.1016/j.anclin.2013.10.014; Ueta Takayoshi, 2008, Brain and Nerve (Tokyo), V60, P1415; Van Schaeybroeck P, 2000, NEUROSURGERY, V46, P603, DOI 10.1097/00006123-200003000-00017; Vidal J, 2000, NEUROMODULATION, V3, P175, DOI 10.1046/j.1525-1403.2000.00175.x	32	7	9	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	AUG	2017	96	34							e7472	10.1097/MD.0000000000007472			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE9DQ	WOS:000408504800005	28834868	Green Published, gold			2022-02-06	
J	Suehiro, E; Fujiyama, Y; Koizumi, H; Suzuki, M				Suehiro, Eiichi; Fujiyama, Yuichi; Koizumi, Hiroyasu; Suzuki, Michiyasu		Japan Neurotrauma Data Bank Comm	Directions for Use of Intracranial Pressure Monitoring in the Treatment of Severe Traumatic Brain Injury Using Data from The Japan Neurotrauma Data Bank	JOURNAL OF NEUROTRAUMA			English	Article						epidemiology; ICP; neurointensive care; neuromonitoring; TBI	CEREBRAL PERFUSION-PRESSURE; HEAD-INJURY; HYPERTENSION; GUIDELINES; AGE	Neuromonitoring can be used to observe intracranial pathological conditions in neurointensive care; however, use of intracranial pressure (ICP) monitoring is low in Japan. In this study, we retrospectively investigated the effects of ICP monitoring in the treatment of severe traumatic brain injury (TBI), using data from the Japan Neurotrauma Data Bank (JNTDB). The study was conducted in 1091 subjects enrolled in the JNTDB (Project 2009) from July 2009 to June 2011. The subjects were divided into those treated with and treated without ICP monitoring in intensive care for severe TBI. Age at admission, sex, level of consciousness (Glasgow Coma Scale [GCS] score), pupillary findings, findings on head CT, treatment, and outcome were compared between these groups. The subjects were also classified into two groups based on the outcome. Relationships among patient background factors, including ICP and clinical outcome were evaluated. The rate of ICP monitoring in treatment of severe TBI was 28%. Therapies were performed aggressively in the ICP monitoring group, and this group had a significant reduction in mortality, but no increase in the favorable outcome rate. In multivariate analysis, age, GCS, pupillary abnormalities, perimesencephalic cistern disappearance or compression, and ICP were associated with a favorable outcome, but the therapeutic method did not affect outcome. We conclude that ICP monitoring and management of ICP are both important for management and care of severe TBI. However, current therapies do not control ICP sufficiently, and more effective therapies are needed.	[Suehiro, Eiichi; Fujiyama, Yuichi; Koizumi, Hiroyasu; Suzuki, Michiyasu] Yamaguchi Univ, Dept Neurosurg, Sch Med, Ube, Yamaguchi 7558505, Japan; [Suehiro, Eiichi; Koizumi, Hiroyasu; Suzuki, Michiyasu; Japan Neurotrauma Data Bank Comm] Japan Soc Neurotraumatol, Japan Neurotrauma Data Bank Comm, Tokyo, Japan		Suehiro, E (corresponding author), Yamaguchi Univ, Dept Neurosurg, Sch Med, Ube, Yamaguchi 7558505, Japan.	suehiro-nsu@umin.ac.jp	Suehiro, Eiichi/I-5852-2019				Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kawamata T., 2008, NEUROTRAUMATOLOGY, V31, P158; Lang E W, 1995, New Horiz, V3, P400; Lannoo E, 1998, INTENS CARE MED, V24, P236, DOI 10.1007/s001340050556; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Stevens RD, 2012, NEUROCRIT CARE, V17, P60, DOI 10.1007/s12028-012-9754-5; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Suehiro E, 2011, WORLD NEUROSURG, V75, P563, DOI 10.1016/j.wneu.2010.09.013; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Yuan Q., 2016, NEUROSURGERY S1, V63, pS213	21	7	7	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2017	34	14					2230	2234		10.1089/neu.2016.4948			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EZ8RQ	WOS:000404995000005	28335668				2022-02-06	
J	Szarka, N; Amrein, K; Horvath, P; Ivic, I; Czeiter, E; Buki, A; Koller, A; Toth, P				Szarka, Nikolett; Amrein, Krisztina; Horvath, Peter; Ivic, Ivan; Czeiter, Endre; Buki, Andras; Koller, Akos; Toth, Peter			Hypertension-Induced Enhanced Myogenic Constriction of Cerebral Arteries Is Preserved after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						20-HETE; autoregulation; cerebral blood flow; high pressure	BLOOD-FLOW; OXIDATIVE STRESS; AUTOREGULATION; 20-HETE; RAT; EPIDEMIOLOGY; INHIBITOR; CA2+; DYSFUNCTION; REACTIVITY	Traumatic brain injury (TBI) was shown to impair pressure-induced myogenic response of cerebral arteries, which is associated with vascular and neural dysfunction and increased mortality of TBI patients. Hypertension was shown to enhance myogenic tone of cerebral arteries via increased vascular production of 20-hydroxyeicosatrienoic acid (HETE). This adaptive mechanism protects brain tissue from pressure/volume overload; however, it can also lead to increased susceptibility to cerebral ischemia. Although both effects may potentiate the detrimental vascular consequences of TBI, it is not known how hypertension modulates the effect of TBI on myogenic responses of cerebral vessels. We hypothesized that in hypertensive rats, the enhanced myogenic cerebrovascular response is preserved after TBI. Therefore, we investigated the myogenic responses of isolated middle cerebral arteries (MCA) of normotensive and spontaneously hypertensive rats (SHR) after severe impact acceleration diffuse brain injury. TBI diminished myogenic constriction of MCAs isolated from normotensive rats, whereas the 20-HETE-mediated enhanced myogenic response of MCAs isolated from SHRs was not affected by TBI. These results suggest that the optimal cerebral perfusion pressure values and vascular signaling pathways can be different and, therefore, should be targeted differently in normotensive and hypertensive patients following TBI.	[Szarka, Nikolett; Amrein, Krisztina; Horvath, Peter; Czeiter, Endre; Buki, Andras; Koller, Akos; Toth, Peter] Univ Pecs, Dept Neurosurg, 2 Ret St, H-7624 Pecs, Hungary; [Szarka, Nikolett; Amrein, Krisztina; Horvath, Peter; Czeiter, Endre; Buki, Andras; Koller, Akos; Toth, Peter] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary; [Szarka, Nikolett; Ivic, Ivan; Toth, Peter] Univ Pecs, Dept Translat Med, Pecs, Hungary; [Amrein, Krisztina; Czeiter, Endre; Buki, Andras; Toth, Peter] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Koller, Akos] Univ Phys Educ, Inst Nat Sci, Budapest, Hungary; [Koller, Akos] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Toth, Peter] Univ Oklahoma, Hlth Sci Ctr, Donald W Reynolds Dept Geriatr Med, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK USA		Toth, P (corresponding author), Univ Pecs, Dept Neurosurg, 2 Ret St, H-7624 Pecs, Hungary.; Toth, P (corresponding author), Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary.	peter-toth@ouhsc.edu	Czeiter, Endre/B-1404-2009; Akos, Koller/Q-4672-2019	Czeiter, Endre/0000-0002-9578-6944	Marie Curie Actions SMARTER 7th Framework Program of the European Union [606998]; Hungarian Academy of Sciences (the Bolyai Research Scholarship) [BO/00634/15]; PTE AOK-KA [3/2016 04.01/F]; Hungarian Brain Research Program [KTIA_13_NAP-A-II/8]; Hungarian Scientific Research FundOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [K108444]	This work was supported by grants from the Marie Curie Actions SMARTER 7th Framework Program of the European Union 606998 (to N.S. and A.K.), the Hungarian Academy of Sciences (the Bolyai Research Scholarship BO/00634/15 to P.T.), the PTE AOK-KA 3/2016 04.01/F (to P.T.), the Hungarian Brain Research Program (Grant No. KTIA_13_NAP-A-II/8 to P.T., E.C. and A.B.) and the Hungarian Scientific Research Fund (K108444 to A.K.).	Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Bailey-Downs LC, 2012, J GERONTOL A-BIOL, V67, P313, DOI 10.1093/gerona/glr164; BOHLEN HG, 1984, CIRC RES, V55, P554, DOI 10.1161/01.RES.55.4.554; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dunn KM, 2008, AM J PHYSIOL-HEART C, V295, pH2455, DOI 10.1152/ajpheart.00512.2008; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; ENEVOLDSEN EM, 1977, ACTA NEUROL SCAND, V56, P514; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Golding EM, 1998, J NEUROTRAUM, V15, P973, DOI 10.1089/neu.1998.15.973; Kamal VK, 2016, BRAIN INJURY, V30, P393, DOI 10.3109/02699052.2015.1113568; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P211, DOI 10.1111/j.1469-7793.1998.211br.x; KONTOS HA, 1981, ANNU REV PHYSIOL, V43, P397, DOI 10.1146/annurev.ph.43.030181.002145; Krishnamoorthy V., 2016, J NEUROSURG ANESTHES; Krishnamoorthy V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0113-4; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; LASSEN NA, 1964, CIRC RES, V15, P201; Mathew BP, 1999, J NEUROTRAUM, V16, P1177, DOI 10.1089/neu.1999.16.1177; Miyata N, 2001, BRIT J PHARMACOL, V133, P325, DOI 10.1038/sj.bjp.0704101; OSOL G, 1985, AM J PHYSIOL, V249, pH914, DOI 10.1152/ajpheart.1985.249.5.H914; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sellmann T, 2012, DTSCH ARZTEBL INT, V109, P849, DOI 10.3238/arztebl.2012.0849; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Toth P, 2013, AM J PHYSIOL-HEART C, V305, pH1698, DOI 10.1152/ajpheart.00377.2013; Toth P, 2013, J CEREBR BLOOD F MET, V33, P1732, DOI 10.1038/jcbfm.2013.143; Toth P, 2013, BRIT J PHARMACOL, V168, P1878, DOI 10.1111/bph.12079; Toth P, 2011, J CEREBR BLOOD F MET, V31, P2096, DOI 10.1038/jcbfm.2011.74; Ungvari Z, 1999, STROKE, V30, P1949, DOI 10.1161/01.STR.30.9.1949; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; Zou AP, 1996, AM J PHYSIOL-REG I, V270, pR228, DOI 10.1152/ajpregu.1996.270.1.R228	38	7	7	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2017	34	14					2315	2319		10.1089/neu.2016.4962			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EZ8RQ	WOS:000404995000014	28249552				2022-02-06	
J	Ronje, EI; Barry, KP; Sinclair, C; Grace, MA; Barros, N; Allen, J; Balmer, B; Panike, A; Toms, C; Mullin, KD; Wells, RS				Ronje, Errol I.; Barry, Kevin P.; Sinclair, Carrie; Grace, Mark A.; Barros, Nelio; Allen, Jason; Balmer, Brian; Panike, Anna; Toms, Christina; Mullin, Keith D.; Wells, Randall S.			A common bottlenose dolphin (Tursiops truncatus) prey handling technique for marine catfish (Ariidae) in the northern Gulf of Mexico	PLOS ONE			English	Article							FORAGING BEHAVIOR; BAY; PATTERNS; SHARKS; SPECIALIZATION; PERFORMANCE; KINEMATICS; MORTALITY; HABITATS; ECOLOGY	Few accounts describe predator-prey interactions between common bottlenose dolphins (Tursiops truncatus Montagu 1821) and marine catfish (Ariopsis felis Linnaeus 1766, Bagre marinus Mitchill 1815). Over the course of 50,167 sightings of bottlenose dolphin groups in Mississippi Sound and along the Florida coast of the Gulf of Mexico, severed catfish heads were found floating and exhibiting movements at the surface in close proximity to 13 dolphin groups that demonstrated feeding behavior. These observations prompted a multi-disciplinary approach to study the predator-prey relationship between bottlenose dolphins and marine catfish. A review was conducted of bottlenose dolphin visual survey data and dorsal fin photographs from sightings where severed catfish heads were observed. Recovered severed catfish heads were preserved and studied, whole marine catfish were collected and examined, and stranding network pathology reports were reviewed for references to injuries related to fish spines. Photographic identification analysis confirms eight dolphins associated with severed catfish heads were present in three such sightings across an approximately 350 km expanse of coast between the Mississippi Sound and Saint Joseph Bay, FL. An examination of the severed catfish heads indicated interaction with dolphins, and fresh-caught whole hardhead catfish (A. felis) were examined to estimate the presumed total length of the catfish before decapitation. Thirty-eight instances of significant trauma or death in dolphins attributed to ingesting whole marine catfish were documented in stranding records collected from the southeastern United States of America. Bottlenose dolphins typically adhere to a ram-feeding strategy for prey capture followed by whole prey ingestion; however, marine catfish skull morphology may pose a consumption hazard due to rigid spines that can puncture and migrate through soft tissue, prompting a prey handling technique for certain dolphins, facilitating consumption of the posterior portion of the fish without the head.	[Ronje, Errol I.; Barry, Kevin P.; Sinclair, Carrie; Grace, Mark A.; Mullin, Keith D.] NOAA, Mississippi Labs, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Pascagoula, MS 39567 USA; [Barros, Nelio; Allen, Jason; Balmer, Brian; Wells, Randall S.] Mote Marine Lab, Chicago Zool Soc Sarasota Dolphin Res Program, Sarasota, FL USA; [Balmer, Brian] NOAA, Natl Ctr Coastal Ocean Sci, Charleston, SC USA; [Panike, Anna] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Marine Mammal Pathobiol Lab, St Petersburg, FL USA; [Toms, Christina] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA		Ronje, EI (corresponding author), NOAA, Mississippi Labs, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Pascagoula, MS 39567 USA.	errol.ronje@noaa.gov		Ronje, Errol/0000-0003-3312-5662			Ajmal N, 2003, WILD ENVIRON MED, V14, P101, DOI 10.1580/1080-6032(2003)014[0101:CSEACO]2.0.CO;2; Allen SJ, 2011, MAR MAMMAL SCI, V27, P449, DOI 10.1111/j.1748-7692.2010.00409.x; Anderson DK, 2002, PROCEEDINGS OF THE FIFTY-THIRD ANNUAL GULF AND CARIBBEAN FISHERIES INSTITUTE, P378; Armbruster JW, 2011, AM FISH S S, V77, P15; Arukwe Augustine, 2003, Comp Hepatol, V2, P4; AVISE JC, 1987, EVOLUTION, V41, P991, DOI 10.1111/j.1558-5646.1987.tb05872.x; BAIRD RW, 1995, CAN J ZOOL, V73, P1300, DOI 10.1139/z95-154; Balmer B. C., 2008, Journal of Cetacean Research and Management, V10, P157; Balmer Brian, 2016, Gulf of Mexico Science, V33, P93; BANNER A, 1972, B MAR SCI, V22, P251; Barros N.B., 1990, P309; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; Barros NB, 1993, THESIS; Barros Nelio B., 2004, Aquatic Mammals, V30, P179, DOI 10.1578/AM.30.1.2004.179; Barros Nelio B., 2000, Aquatic Mammals, V26, P2; Barry KP, 2008, J FISH BIOL, V73, P650, DOI 10.1111/j.1095-8649.2008.01963.x; Best Robin C., 1993, Mammalian Species, V426, P1; Bethea DM, 2006, B MAR SCI, V78, P287; Bethea DM, 2004, MAR ECOL PROG SER, V268, P245, DOI 10.3354/meps268245; Bloodworth B, 2005, J EXP BIOL, V208, P3721, DOI 10.1242/jeb.01807; Brooks S, 1997, REV FISH BIOL FISHER, V7, P387, DOI 10.1023/A:1018400130692; Brower K, 1979, WAKE WHALE; Carrasquillo-Casado B, 2002, J AQUAT ANIM HEALTH, V14, P65, DOI 10.1577/1548-8667(2002)014&lt;0065:FPAPCB&gt;2.0.CO;2; Chardon M, 2003, CATFISHES, VOLS 1-2, P71; Chesney EJ, 2000, ECOL APPL, V10, P350; Christmas J. Y., 1983, MENHADEN FISHERY GUL; Christmas JY, 1966, GULF RES REP, V2; CLARK EUGENIE, 1965, BULL MAR SCI, V15, P13; Clark LS, 2006, J COMP PATHOL, V135, P208, DOI 10.1016/j.jcpa.2006.07.005; Connor RC, 2000, MAR MAMMAL SCI, V16, P646, DOI 10.1111/j.1748-7692.2000.tb00959.x; Costa Daniel P., 1999, P176; DARNELL REZNEAT M., 1958, PUBL INST MARINE SCI PUBL [PORT ARANSAS TEXAS], V5, P353; dos Santos M.E., 1987, Aquatic Mammals, V13, P65; dos Santos ME, 2009, REV BRAS ZOOCIENCIAS, V9; Duffy-Echevarria EE, 2008, MAR MAMMAL SCI, V24, P202, DOI 10.1111/j.1748-7692.2007.00151.x; Dunshea G, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1036; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Fertl D., 1994, THESIS; Finn J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004217; Fish M.P., 1970, SOUNDS W N ATLANTIC; Franks J. S., 1970, Gulf Res. Reps, V3, P3; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gannon DP, 2005, ANIM BEHAV, V69, P709, DOI 10.1016/j.anbehav.2004.06.020; Gregory WK., 1933, FISH SKULLS STUDY EV, V1959th; GUNTER G, 1947, COPEIA, P217; Gunter G., 1938, ECOL MONOGR, V8, P314; Gunter Gordon, 1942, JOUR MAMMAL, V23, P267, DOI 10.2307/1374993; HALSTEAD BRUCE W., 1953, TRANS AMER MICROSC SOC, V72, P297, DOI 10.2307/3223475; Herman, 1980, CETACEAN BEHAV MECH, P319; HOESE HD, 1971, J MAMMAL, V52, P222, DOI 10.2307/1378455; Houser DS, 2006, J ACOUST SOC AM, V120, P1713, DOI 10.1121/1.2229286; Hubard Carrie W., 2004, Aquatic Mammals, V30, P299, DOI 10.1578/AM.30.2.2004.299; Kane EA, 2009, J EXP BIOL, V212, P3939, DOI 10.1242/jeb.034686; Kemp RJ., 1949, REPORT STOMACH ANAL; Leatherwood S., 1975, MARINE FISHERIES REV, V37; LeBlanc BD, 1992, GULF RES REP, V8; Lewis Jennifer S., 2003, Gulf of Mexico Science, V21, P92; Litz JA, 2014, DIS AQUAT ORGAN, V112, P161, DOI 10.3354/dao02807; LJUNGBLAD DK, 1982, J ACOUST SOC AM, V72, P1726, DOI 10.1121/1.388666; Lodi L, 1999, BIOCIENCIAS, V7, P29; Maresh JL, 2004, MAR MAMMAL SCI, V20, P498, DOI 10.1111/j.1748-7692.2004.tb01175.x; Marley SA, 2013, AQUAT MAMM, V39, P107, DOI 10.1578/AM.39.2.2013.107; Marshall CD, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P406; MCBEE JT, 1982, GULF RES REP, V7, P115; McCabe EJB, 2010, MAR BIOL, V157, P931, DOI 10.1007/s00227-009-1371-2; Mcfee WE, 2009, J WILDLIFE DIS, V45, P575; Melancon R, 2011, NMFSSEFSC627 NOAA, P46; Merriman D., 1940, ZOOLOGICA, V25, P11; MODDE T, 1980, GULF RES REP, V6, P377; Muller Harshany, 1996, STOCK ASSESSMENT HAR; Mullin K, 1990, NE GULF SCI, P113; Mullin KD, 1988, THESIS; Nowacek DP, 1999, THESIS; O'Connell MT, 2007, ESTUAR COAST, V30, P567, DOI 10.1007/BF02841954; Overstreet RM, 1982, FOOD CONTENT 6 COMME; Patterson EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022243; Perry HM, 1975, GULF RES REP, V5; Pitman Robert L., 2002, Pacific Science, V56, P447, DOI 10.1353/psc.2002.0043; Reynosa J, 1986, VET MEXICO, P213; Rigley L, 1981, P PA ACAD SCI; Rommel S., 1990, P29; Rommel SA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1033; Rossbach KA, 1997, MAR MAMMAL SCI, V13, P498, DOI 10.1111/j.1748-7692.1997.tb00658.x; Sargeant BL, 2005, CAN J ZOOL, V83, P1400, DOI 10.1139/Z05-136; Sargeant BL, 2007, BEHAV ECOL SOCIOBIOL, V61, P679, DOI 10.1007/s00265-006-0296-8; Sargeant BL, 2009, ANIM BEHAV, V78, P715, DOI 10.1016/j.anbehav.2009.05.037; Scott EM, 2005, BEHAVIOUR, V142, P21, DOI 10.1163/1568539053627712; Scott M.D., 1990, P235; Shane S.H., 1990, P245; Shane S.H., 1977, THESIS; Sinclair C, 2016, THESIS; Smith HC, 2016, AUST J ZOOL; Smolker R, 1997, ETHOLOGY, V103, P454, DOI 10.1111/j.1439-0310.1997.tb00160.x; Snyder RA, 2009, ACCUMULATION POLLUTA; Spitz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050096; Stephens D. W., 2007, FORAGING BEHAV ECOLO; Stolen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066828; Tavolga W. N., 1962, B AM MUS NAT HIST, V124, P1; TAVOLGA WN, 1977, J EXP BIOL, V67, P97; Urian KW, NMFSSEFSC393 NOAA; VALENTINE JF, 1991, B MAR SCI, V48, P597; Ward, 1957, COPEIA, V1957, P295; Waring GT, 238 NOAA NMFS NE NAT; Watson Alastair, 2005, Aquatic Mammals, V31, P447, DOI 10.1578/AM.31.4.2005.447; Weiss Jessica, 2006, Aquatic Mammals, V32, P10, DOI 10.1578/AM.32.1.2006.10; Wells R.S., 1987, Current Mammalogy, V1, P247; Wells R. S., 2014, PRIMATES CETACEANS, P149; Wells Randall S, 2013, Front Endocrinol (Lausanne), V4, P139, DOI 10.3389/fendo.2013.00139; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; Werth A, 2000, FEEDING FORM FUNCTIO, P487; Wiegand MD, 1996, REV FISH BIOL FISHER, V6, P259, DOI 10.1007/BF00122583; Wingo W.M., 1983, SPECIES PROFILES LIF; Wright JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-282; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755	114	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181179	10.1371/journal.pone.0181179			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	WOS:000405649600064	28704486	Green Submitted, Green Published, gold			2022-02-06	
J	Yang, SS; Flores, B; Magal, R; Harris, K; Gross, J; Ewbank, A; Davenport, S; Ormachea, P; Nasser, W; Le, WD; Peacock, WF; Katz, Y; Eagleman, DM				Yang, Suosuo; Flores, Benjamin; Magal, Rotem; Harris, Kyrsti; Gross, Jonathan; Ewbank, Amy; Davenport, Sasha; Ormachea, Pablo; Nasser, Waleed; Le, Weidong; Peacock, W. Frank; Katz, Yael; Eagleman, David M.			Diagnostic accuracy of tablet-based software for the detection of concussion	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; EMERGENCY-DEPARTMENT; RAPID SCREEN; SENSITIVITY; PERFORMANCE; CHILDREN; TESTS; IDENTIFICATION; SPECIFICITY	Despite the high prevalence of traumatic brain injuries (TBI), there are few rapid and straightforward tests to improve its assessment. To this end, we developed a tablet-based software battery ("BrainCheck") for concussion detection that is well suited to sports, emergency department, and clinical settings. This article is a study of the diagnostic accuracy of BrainCheck. We administered BrainCheck to 30 TBI patients and 30 pain-matched controls at a hospital Emergency Department (ED), and 538 healthy individuals at 10 control test sites. We compared the results of the tablet-based assessment against physician diagnoses derived from brain scans, clinical examination, and the SCAT3 test, a traditional measure of TBI. We found consistent distributions of normative data and high test-retest reliability. Based on these assessments, we defined a composite score that distinguishes TBI from non-TBI individuals with high sensitivity (83%) and specificity (87%). We conclude that our testing application provides a rapid, portable testing method for TBI.	[Yang, Suosuo; Le, Weidong] Dalian Med Univ, Dalian, Liaoning Provin, Peoples R China; [Yang, Suosuo; Peacock, W. Frank] Baylor Coll Med, Dept Emergency Med, Houston, TX 77030 USA; [Flores, Benjamin; Magal, Rotem; Harris, Kyrsti; Gross, Jonathan; Ewbank, Amy; Davenport, Sasha; Ormachea, Pablo; Nasser, Waleed; Katz, Yael; Eagleman, David M.] BrainCheck Inc, Houston, TX 77021 USA; [Davenport, Sasha] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Eagleman, David M.] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA USA		Le, WD (corresponding author), Dalian Med Univ, Dalian, Liaoning Provin, Peoples R China.; Katz, Y (corresponding author), BrainCheck Inc, Houston, TX 77021 USA.	wdle@sibs.ac.cn; yael@braincheck.com			Brain Check, Inc	Brain Check, Inc, provided support in the form of salaries for authors DE, YK, BF, RM, KH, AE, SD, WN but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of some of the authors' salaries and research materials (the software battery of tests) Nothing about this funding alters our adherence to PLOSONE policies on sharing data and materials. The specific roles of these authors are articulated in the 'author contributions' section.	Archibald SJ, 1999, CHILD NEUROPSYCHOL, V5, P115, DOI 10.1076/chin.5.2.115.3167; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Berg DB, 2011, J SURG EDUC, V68, P10, DOI 10.1016/j.jsurg.2010.08.005; BOONE KB, 1990, DEV NEUROPSYCHOL, V6, P215, DOI 10.1080/87565649009540462; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; Control CfD, 2011, MMWR-MORBID MORTAL W, V60, P1337; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; De Monte VE, 2010, J CLIN EXP NEUROPSYC, V32, P28, DOI 10.1080/13803390902806519; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Homack S, 2004, ARCH CLIN NEUROPSYCH, V19, P725, DOI 10.1016/j.acn.2003.09.003; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Lew HL, 2007, J REHABIL RES DEV, V44, P963, DOI 10.1682/JRRD.2006.12.0169; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Melara RD, 2003, PSYCHOL REV, V110, P422, DOI 10.1037/0033-295X.110.3.422; Miller P, 2015, EMERG MED AUSTRALAS, V27, P225, DOI 10.1111/1742-6723.12369; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Ortega E, 2003, EXERC IMMUNOL REV, V9, P70; Ricard C, 2013, SANTE PUBLIQUE, V25, P711, DOI 10.3917/spub.136.0711; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363	33	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e.0179352	10.1371/journal.pone.0179352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	WOS:000405464100014	28686616	gold, Green Published, Green Submitted			2022-02-06	
J	Abcejo, AS; Savica, R; Lanier, WL; Pasternak, JJ				Abcejo, Arnoley S.; Savica, Rodolfo; Lanier, William L.; Pasternak, Jeffrey J.			Exposure to Surgery and Anesthesia After Concussion Due to Mild Traumatic Brain Injury	MAYO CLINIC PROCEEDINGS			English	Article							CEREBRAL-BLOOD-FLOW; EXTRACELLULAR POTASSIUM; PATHOPHYSIOLOGY; VULNERABILITY; CHILDREN; RELEASE	Objective: To describe the epidemiology of surgical and anesthetic procedures in patients recently diagnosed as having a concussion due to mild traumatic brain injury. Patients and Methods: Study patients presented to a tertiary care center after a concussion due to mild traumatic brain injury from July 1, 2005, through June 30, 2015, and underwent a surgical procedure and anesthesia support under the direct or indirect care of a physician anesthesiologist. Results: During the study period, 1038 patients met all the study inclusion criteria and subsequently received 1820 anesthetics. In this population of anesthetized patients, rates of diagnosed concussions due to sports injuries, falls, and assaults, but not motor vehicle accidents, increased during 2010-2011. Concussions were diagnosed in 965 patients (93%) within 1 week after injury. In the 552 patients who had surgery within 1 week after concussive injury, 29 (5%) had anesthesia and surgical procedures unrelated to their concussion-producing traumatic injury. The highest use of surgery occurred early after injury and most frequently required general anesthesia. Orthopedic and general surgical procedures accounted for 57% of procedures. Nine patients received 29 anesthetics before a concussion diagnosis, and all of these patients had been involved in motor vehicle accidents and received at least 1 anesthetic within 1 week of injury. Conclusion: Surgical and anesthesia use are common in patients after concussion. Clinicians should have increased awareness for concussion in patients who sustain a trauma and may need to take measures to avoid potentially injury-augmenting cerebral physiology in these patients. (C) 2017 Mayo Foundation for Medical Education and Research	[Abcejo, Arnoley S.; Lanier, William L.; Pasternak, Jeffrey J.] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA; [Savica, Rodolfo] Mayo Clin, Dept Neurol, Rochester, MN USA		Pasternak, JJ (corresponding author), Mayo Clin, Coll Med, Dept Anesthesiol & Perioperat Med, 200 First St SW, Rochester, MN 55905 USA.	pasternak.jeffrey@mayo.edu			Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine	This study was supported by the Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine.	Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Becelewski Janusz, 2003, Neurol Neurochir Pol, V37, P339; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gross JB, 2002, ANESTHESIOLOGY, V96, P1004; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KATAYAMA Y, 1991, BRAIN RES, V558, P136, DOI 10.1016/0006-8993(91)90730-J; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mandera M, 2002, CHILD NERV SYST, V18, P124, DOI 10.1007/s00381-002-0572-5; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Schrader Harald, 2009, BMC Med Imaging, V9, P11, DOI 10.1186/1471-2342-9-11; Schwarz A, 2009, NY TIMES, pA1; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	30	7	7	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0025-6196	1942-5546		MAYO CLIN PROC	Mayo Clin. Proc.	JUL	2017	92	7					1042	1052		10.1016/j.mayocp.2017.03.012			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ7JE	WOS:000404898500008	28601422				2022-02-06	
J	Akbari, M; Khaksari, M; Rezaeezadeh-Roukerd, M; Mirzaee, M; Nazari-Robati, M				Akbari, Mahboobe; Khaksari, Mohammad; Rezaeezadeh-Roukerd, Maryam; Mirzaee, Moghaddameh; Nazari-Robati, Mandieh			Effect of chondroitinase ABC on inflammatory and oxidative response following spinal cord injury	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Chondroitinase ABC; Functional recovery; Inflammation; Oxidative stress; Spinal cord injury	CENTRAL-NERVOUS-SYSTEM; LIPID-PEROXIDATION; IMPACT INJURY; NITRIC-OXIDE; CNS INJURY; RAT-BRAIN; PROMOTES; PEROXYNITRITE; MACROPHAGES; MECHANISMS	Objective(s): Chondroitinase ABC (cABC) treatment improves functional recovery following spinal cord injury (SCI) through degrading inhibitory molecules to axon growth. However, cABC involvement in other pathological processes contributing to SCI remains to be investigated. Here, we studied the effect of cABC I on oxidative stress and inflammation developed in a rat model of SCI. Materials and Methods: Male rats (220-250 g) were divided into three groups (n=28) including rats that underwent SCI (SCI group), rats subjected to SCI and received an intrathecal injection of phosphate buffer saline (SCI+PBS group), and rats that underwent SCI and received cABC intrathecally (SCI+E group). Then, the level of TNF-alpha, Il-1 beta, malondialdehyde, nitric oxide, and myeloperoxidase in injured tissues, as well as hindlimb motor function, were measured at 4 hr, 1, 3 and 7 days post-SCI. Results: Our data showed that cABC treatment reduced the development of inflammation and oxidative stress associated with SCI at all-time points. In addition, functional recovery was improved in rats that received cABC at 7 days post-SCI. Conclusion: The present findings indicate that cABC treatment can exert its neuroprotective effect through modulation of post-traumatic inflammatory and oxidative response.	[Akbari, Mahboobe; Nazari-Robati, Mandieh] Kerman Univ Med Sci, Sch Med, Dept Clin Biochem, Kerman, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran; [Rezaeezadeh-Roukerd, Maryam] Shahid Bahonar Univ, Fac Vet Med, Kerman, Iran; [Mirzaee, Moghaddameh] Kerman Univ Med Sci, Sch Publ Hlth, Dept Biostat & Epidemiol, Kerman, Iran; [Nazari-Robati, Mandieh] Kerman Univ Med Sci, Neuropharmacol Inst, Neurosci Res Ctr, Kerman, Iran		Nazari-Robati, M (corresponding author), Kerman Univ Med Sci, Neuropharmacol Inst, Neurosci Res Ctr, Dept Clin Biochem, Kerman, Iran.	mnazari@kmu.ac.ir	Haddad, Mohammad Khaksari/AAB-9025-2019; Nazari-robati, Mahdieh/ABD-6666-2020; Mirzaee, Moghadameh/AAD-3175-2019	Haddad, Mohammad Khaksari/0000-0003-0770-4281; 	Kerman Neuroscience Research Center [93-58]; Kerman University of Medical Sciences, Kerman, Iran [94146]	This work was supported by Kerman Neuroscience Research Center (grant no. 93-58) and Kerman University of Medical Sciences (grant no. 94146), Kerman, Iran.	Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Bao F, 2002, NEUROSCIENCE, V115, P839, DOI 10.1016/S0306-4522(02)00506-7; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chan Carmen C M, 2008, Recent Pat CNS Drug Discov, V3, P189, DOI 10.2174/157488908786242434; Didangelos A, 2014, J NEUROSCI, V34, P16424, DOI 10.1523/JNEUROSCI.2927-14.2014; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; James ND, 2015, EXP NEUROL, V271, P131, DOI 10.1016/j.expneurol.2015.05.022; Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131; Leski ML, 2001, FREE RADICAL BIO MED, V30, P613, DOI 10.1016/S0891-5849(00)00500-1; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Matsuyama Y, 1998, J SPINAL DISORD, V11, P248; McPhail LT, 2004, EUR J NEUROSCI, V20, P1984, DOI 10.1111/j.1460-9568.2004.03662.x; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PANASENKO OM, 1995, FREE RADICAL BIO MED, V19, P133, DOI 10.1016/0891-5849(94)00211-2; Pannu R, 2005, J NEUROSCI RES, V79, P340, DOI 10.1002/jnr.20345; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Popovich PG, 2003, TRENDS PHARMACOL SCI, V24, P13, DOI 10.1016/S0165-6147(02)00006-8; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Qian H, 1997, NEUROCHEM RES, V22, P1231, DOI 10.1023/A:1021980929422; Ramer LM, 2014, LANCET NEUROL, V13, P1241, DOI 10.1016/S1474-4422(14)70144-9; Rolls A, 2006, FASEB J, V20, P547, DOI 10.1096/fj.05-4540fje; Rolls A, 2004, EUR J NEUROSCI, V20, P1973, DOI 10.1111/j.1460-9568.2004.03676.x; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Taskiran D, 1997, NEUROREPORT, V8, P881, DOI 10.1097/00001756-199703030-00013; Vaishnav RA, 2010, J NEUROTRAUM, V27, P1311, DOI 10.1089/neu.2009.1172; Zuo J, 1998, EXP NEUROL, V154, P654, DOI 10.1006/exnr.1998.6951	37	7	8	0	2	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	JUL	2017	20	7					806	812		10.22038/IJBMS.2017.9016			7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	EZ8VU	WOS:000405007300011	28852446				2022-02-06	
J	Gause, LR; Finn, JA; Lamberty, GJ; Tang, X; Stevens, LF; Eapen, BC; Nakase-Richardson, R				Gause, Leah R.; Finn, Jacob A.; Lamberty, Greg J.; Tang, Xinyu; Stevens, Lillian Flores; Eapen, Blessen C.; Nakase-Richardson, Risa			Predictors of Satisfaction With Life in Veterans After Traumatic Brain Injury: A VA TBI Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						quality of life; traumatic brain injury; United States Department of Veterans Affairs; Veterans	QUALITY-OF-LIFE; FUNCTIONAL INDEPENDENCE MEASURE; DISABILITY; HEALTH; REHABILITATION; EPIDEMIOLOGY; INDIVIDUALS; POPULATION; VALIDITY; MODERATE	Objective: To identify predictors of satisfaction with life in Veterans 1 year after traumatic brain injury (TBI). Setting: The VA TBI Model Systems (TBIMS) project includes 5 Veterans Affairs (VA) Polytrauma Rehabilitation Centers. Participants: Veterans enrolled in the VA TBIMS study who completed the Satisfaction With Life Scale at year 1 follow-up. The sample is largely male (96%) and Caucasian (72%), with a median age of 27 years upon enrollment. Design: Prospective observational cohort study measuring including demographics (eg, education), preinjury variables (eg, mental health history and employment), and military variables (eg, injury during deployment and injury during active duty status). Main Outcome Measure: Satisfaction With Life Scale. Results: Multivariate regression analyses revealed that age, marital status, preinjury employment status, preinjury mental health history, and active duty status at the time of injury were significant predictors of life satisfaction at year 1 follow-up. Conclusions: Results of this study suggest that satisfaction with life in Veterans with TBI is mediated by several factors thatmight inform rehabilitation interventions and discharge recommendations. Preinjury variables and active duty status (a unique aspect of the Veteran population) influence life satisfaction at 1 year postinjury. Limitations and future clinical implications will be discussed.	[Gause, Leah R.; Finn, Jacob A.] Minneapolis VA Hlth Care Syst, Extended Care & Rehabil Serv, Minneapolis, MN USA; [Lamberty, Greg J.] Minneapolis VA Hlth Care Syst, Mental Hlth Serv, Minneapolis, MN USA; [Finn, Jacob A.; Lamberty, Greg J.] Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA; [Finn, Jacob A.; Lamberty, Greg J.; Stevens, Lillian Flores; Nakase-Richardson, Risa] Def & Vet Brain Injury Ctr, Minneapolis, MN USA; [Tang, Xinyu] Univ Arkansas Med Sci, Dept Pediat, Biostat Program, Little Rock, AR 72205 USA; [Stevens, Lillian Flores] Hunter Holmes McGuire Vet Affairs Med Ctr, Mental Hlth Serv, Richmond, VA USA; [Stevens, Lillian Flores] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Stevens, Lillian Flores] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Eapen, Blessen C.] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, MHBS, Tampa, FL USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Med, Tampa, FL USA; [Nakase-Richardson, Risa] HSR&D Ctr Innovat Disabil & Rehabil Res, Tampa, FL USA		Lamberty, GJ (corresponding author), Minneapolis VA Hlth Care Syst, One Vet Dr, Minneapolis, MN 55417 USA.	Gregory.Lamberty@va.gov			VHA Central Office VA TBI Model Systems Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency, US Department of Veterans Affairs grants [W91YTZ-13-C-0015, 1 I50 HX001233-01, W81XWH-13-2-0095]; US Department of Defense Congressionally Directed Medical Research Programs; US Department of Veterans Affairs Health Services Research and Development COIN grant (CINDRR) [1 I50 HX001233-01]	This research was sponsored by VHA Central Office VA TBI Model Systems Program of Research, Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center within the Defense Health Agency, US Department of Veterans Affairs grants (1 I50 HX001233-01, W81XWH-13-2-0095) and US Department of Defense Congressionally Directed Medical Research Programs.; The authors would like to acknowledge the support of US Department of Veterans Affairs Health Services Research and Development COIN grant (1 I50 HX001233-01; CINDRR) for assistance in article preparation.	Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; Brickell TA, 2014, MIL MED, V179, P839, DOI 10.7205/MILMED-D-14-00016; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Carufel P, 2011, AC SPIN CORD INJ PRO; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, J HEAD TRAUMA REHAB, V28, P489, DOI 10.1097/HTR.0000000000000004; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Goverover Y, 2014, BRAIN INJURY, V28, P174, DOI 10.3109/02699052.2013.860474; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Ketchum JM, 2012, NEUROREHABILITATION, V30, P23, DOI 10.3233/NRE-2012-0724; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; McCord CE, 2016, J HAPPINESS STUD, V17, P553, DOI 10.1007/s10902-014-9610-8; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Saban KL, 2011, J WOMENS HEALTH, V20, P179, DOI 10.1089/jwh.2010.2334; Schulz-Heik RJ, 2016, BRAIN INJURY, V30, P271, DOI 10.3109/02699052.2015.1113567; Seidl JNT, 2015, REHABIL PSYCHOL, V60, P335, DOI 10.1037/rep0000064; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Williamson MLC, 2016, J HEAD TRAUMA REHAB, V31, P167, DOI 10.1097/HTR.0000000000000111; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512	39	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2017	32	4					255	263		10.1097/HTR.0000000000000309			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FA2KB	WOS:000405269200013	28520659				2022-02-06	
J	Gomez, MF; Aljure, O; Ciancio, G; Lynn, M				Gomez, M. F.; Aljure, O.; Ciancio, G.; Lynn, M.			Hemoglobin-Based Oxygen Carrier Rescues Double-Transplant Patient From Life-Threatening Anemia	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article							DECLINE BLOOD-TRANSFUSION; JEHOVAH-WITNESS PATIENT; TRAUMATIC BRAIN-INJURY; HEMORRHAGIC-SHOCK; BOVINE HEMOGLOBIN; SWINE MODEL; HBOC-201; MANAGEMENT; RESUSCITATION; COAGULATION	This case describes a 46-year-old male recipient of a kidney-pancreas transplant who is Jehovah's Witness. Early in the postoperative period, he was found to have splenic vein thrombosis requiring heparin infusion. Two days later, he developed severe symptomatic anemia (hemoglobin <6 g/dL). Standard medical therapy for bloodless surgical patients with severe anemia was instituted. Nevertheless, the patient's hemoglobin concentration continued to decline to critical levels (2 g/dL). Because he was Jehovah's Witness, transfusion of allogeneic blood products was not an option, prompting use of a hemoglobin-based oxygen carrier (HBOC). After approval by the U.S. Food and Drug Administration and the local institutional review board, 12 Uof HBOC-201 were transfused over a period of 8 days. Two weeks later, the patient's hemoglobin levels had increased to 6.8 g/dL. The patient's overall clinical condition improved, and he was discharged home. This case describes the first use of HBOC transfusion in a double solid organ transplant patient. HBOC may represent a viable option in patients with severe symptomatic anemia when allogeneic blood transfusion is not an option.	[Gomez, M. F.] Univ Miami, Jackson Mem Hosp, DeWitt Daughtry Family Dept Surg, Ryder Trauma Ctr,Div Trauma & Surg Crit Care,Mill, Miami, FL 33136 USA; [Aljure, O.] Univ Miami, Jackson Mem Hosp, DeWitt Daughtry Family Dept Surg, Miller Sch Med, Miami, FL 33136 USA; [Ciancio, G.] Univ Miami, Miller Sch Med, Miami Transplant Inst, Kidney Transplant Clin Surg & Urol,Jackson Hlth S, Miami, FL 33136 USA; [Lynn, M.] Univ Miami, Miller Sch Med, Dept Surg, Div Trauma & Surg Crit Care,Bloodless Surg Ctr, Miami, FL 33136 USA		Lynn, M (corresponding author), Univ Miami, Miller Sch Med, Dept Surg, Div Trauma & Surg Crit Care,Bloodless Surg Ctr, Miami, FL 33136 USA.	mlynn@med.miami.edu					Arnaud F, 2005, SHOCK, V24, P145, DOI 10.1097/01.shk.0000170354.18437.2f; Arnaud F, 2007, TRANSFUSION, V47, P2098, DOI 10.1111/j.1537-2995.2007.01435.x; Beliaev AM, 2012, VOX SANG, V103, P18, DOI 10.1111/j.1423-0410.2011.01573.x; Carson JL, 2002, TRANSFUSION, V42, P812, DOI 10.1046/j.1537-2995.2002.00123.x; Donahue LL, 2010, TRANSFUSION, V50, P1561, DOI 10.1111/j.1537-2995.2010.02603.x; Freitag M, 2005, CAN J ANAESTH, V52, P904, DOI 10.1007/BF03022050; HOMER LD, 1981, MICROVASC RES, V22, P308, DOI 10.1016/0026-2862(81)90099-6; Jahr JS, 2008, J TRAUMA, V64, P1484, DOI 10.1097/TA.0b013e318173a93f; James MF, 2004, ANESTH ANALG, V99, P1593, DOI 10.1213/01.ANE.0000136477.46472.EB; Jordan Shane D, 2013, J Pharm Pract, V26, P257, DOI 10.1177/0897190012451928; Katz LM, 2002, RESUSCITATION, V54, P77, DOI 10.1016/S0300-9572(02)00053-9; Mackenzie CF, 2010, ANESTH ANALG, V110, P685, DOI 10.1213/ANE.0b013e3181cd473b; Mackenzie CF, 2008, J CLIN ANESTH, V20, P538, DOI 10.1016/j.jclinane.2008.05.012; McNeil JD, 2001, J TRAUMA, V50, P1063, DOI 10.1097/00005373-200106000-00015; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Patel MB, 2006, J TRAUMA, V61, P46, DOI 10.1097/01.ta.0000219730.71206.3a; Shander A, 2014, TRANSFUSION, V54, P2688, DOI 10.1111/trf.12565; Sprung J, 2001, ANESTH ANALG, V92, P1413, DOI 10.1097/00000539-200106000-00010; Stern S, 2009, SHOCK, V31, P64, DOI 10.1097/SHK.0b013e3181778dc3; Van Hemelrijck J, 2014, ANESTH ANALG, V119, P766, DOI 10.1213/ANE.0000000000000305	20	7	7	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	JUL	2017	17	7					1941	1944		10.1111/ajt.14226			4	Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Transplantation	EZ0EI	WOS:000404372900031	28188676	Bronze			2022-02-06	
J	Hoch, SE; Kirov, II; Tal, A				Hoch, Sarah E.; Kirov, Ivan I.; Tal, Assaf			When are metabolic ratios superior to absolute quantification? A statistical analysis	NMR IN BIOMEDICINE			English	Article						magnetic resonance spectroscopy; metabolite ratios; MRS; quantification; receiver operator characteristic; ROC; sample size	PROTON MR SPECTROSCOPY; MAGNETIC-RESONANCE-SPECTROSCOPY; QUADRATIC-FORMS; WHITE-MATTER; BASIC PRINCIPLES; BRAIN-TUMORS; VARIABLES; DENSITY; NAA/CHO; CHO/CR	Metabolite levels measured using magnetic resonance spectroscopy (MRS) are often expressed as ratios rather than absolute concentrations. However, the inter-subject variability of the denominator metabolite can introduce uncertainty into a metabolite ratio. In a clinical setting, there are no guidelines on whether ratios or absolute quantification should be used for a more accurate classification of normal versus abnormal results based on their statistical properties. In a research setting, the choice of one over the other can have significant implications on sample size, which must be factored in at the study design stage. Herein, we derive the probability distribution function for the ratio of two normally distributed random variables, and present analytical expressions for the comparison of ratios with absolute quantification in terms of both sample size and area under the receiver operator characteristic curve. The two approaches are compared for typical metabolite values found in the literature, and their respective merits are illustrated using previously acquired clinical MRS data in two pathologies: mild traumatic brain injury and multiple sclerosis. Our analysis shows that the decision between ratios and absolute quantification is non-trivial: in some cases, ratios might offer a reduction in sample size, whereas, in others, absolute quantification might prove more desirable for individual (i.e. clinical) use. The decision is straightforward and exact guidelines are provided in the text, given that population means and standard deviations of numerator and denominator can be reliably estimated.	[Hoch, Sarah E.] Sheba Med Ctr, Dept Diagnost Imaging, Ramat Gan, Israel; [Kirov, Ivan I.] NYU, Sch Med, Bernard & Irene Schwartz Ctr Biomed Imaging, New York, NY USA; [Kirov, Ivan I.] NYU, Sch Med, CAI2R, Dept Radiol, New York, NY USA; [Tal, Assaf] Weizmann Inst Sci, Dept Chem Phys, 234 Herzel St, IL-7610001 Rehovot, Israel		Tal, A (corresponding author), Weizmann Inst Sci, Dept Chem Phys, 234 Herzel St, IL-7610001 Rehovot, Israel.	assaf.tal@weizmann.ac.il	Kirov, Ivan/I-2792-2019	Kirov, Ivan/0000-0001-5641-8578; Tal, Assaf/0000-0001-6718-6522	Monroy-Marks Career Development Fund; Carolito Stiftung Fund; Leona M. and Harry B. Helmsley Charitable Trust; historic generosity of the Harold Perlman Family; Sylvia Schaefer Alzheimer's Research Fund; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS097494, P41 EB017183]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB017183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS097494] Funding Source: NIH RePORTER	A.T. acknowledges the support of the Monroy-Marks Career Development Fund, the Carolito Stiftung Fund, the Leona M. and Harry B. Helmsley Charitable Trust and the historic generosity of the Harold Perlman Family. This research was supported by a research grant from the Sylvia Schaefer Alzheimer's Research Fund. I.I.K. acknowledges National Institutes of Health (NIH) funding grants R01 NS097494 and P41 EB017183.	Akoka S, 1999, ANAL CHEM, V71, P2554, DOI 10.1021/ac981422i; Ao YC, 2013, J ELECTRON TEST, V29, P555, DOI 10.1007/s10836-013-5382-z; Ariza M, 2004, ARCH NEUROL-CHICAGO, V61, P541, DOI 10.1001/archneur.61.4.541; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Broda S, 2009, COMPUT STAT DATA AN, V53, P1264, DOI 10.1016/j.csda.2008.10.035; Celano G, 2016, QUAL RELIAB ENG INT, V32, P291, DOI 10.1002/qre.1748; Desal H, 2010, J NEURORADIOLOGY, V37, P292, DOI 10.1016/j.neurad.2009.11.002; DUNLAP WP, 1986, BEHAV RES METH INSTR, V18, P469, DOI 10.3758/BF03201412; Forchini G, 2002, ECONOMET THEOR, V18, P823, DOI 10.1017/S0266466602184015; GEARY RC, 1947, BIOMETRIKA, V34, P209, DOI 10.1093/biomet/34.3-4.209; GUIARD V, 1989, BIOMETRICAL J, V31, P681, DOI 10.1002/bimj.4710310605; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Heinzer-Schweizer S, 2010, NMR BIOMED, V23, P406, DOI 10.1002/nbm.1476; Henderson AR, 2006, CLIN CHIM ACTA, V366, P112, DOI 10.1016/j.cca.2005.11.007; HINKLEY DV, 1969, BIOMETRIKA, V56, P635, DOI 10.1093/biomet/56.3.635; Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314; JONES MC, 1987, STAT PROBABIL LETT, V6, P129, DOI 10.1016/0167-7152(87)90086-1; Kantarci K, 2003, NEUROIMAG CLIN N AM, V13, P197, DOI 10.1016/S1052-5149(03)00025-X; Kendall GS, 2014, RADIOLOGY, V271, P230, DOI 10.1148/radiol.13122679; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kirov II, 2013, NEUROLOGY, V80, P39, DOI 10.1212/WNL.0b013e31827b1a8c; Li BSY, 2003, MAGN RESON IMAGING, V21, P923, DOI 10.1016/S0730-725X(03)00181-4; LONGO R, 1995, JMRI-J MAGN RESON IM, V5, P281, DOI 10.1002/jmri.1880050311; Majos C, 2003, EUR RADIOL, V13, P582, DOI 10.1007/s00330-002-1547-3; Marsaglia G, 2006, J STAT SOFTW, V16, P1; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mostert JP, 2008, EUR RADIOL, V18, P1736, DOI 10.1007/s00330-008-0925-x; Mueller SG, 2011, J NEUROL, V258, P603, DOI 10.1007/s00415-010-5799-6; Nadarajah S, 2005, KYBERNETIKA, V41, P787; Pham-Gia T, 2006, COMMUN STAT-THEOR M, V35, P1569, DOI 10.1080/03610920600683689; Samarakoon S., 2013, 77 VEH TECHN C VTC S, P1; Serles W, 1999, EPILEPSIA, V40, P1821, DOI 10.1111/j.1528-1157.1999.tb01605.x; Soher BJ, 1996, MAGNET RESON MED, V35, P356, DOI 10.1002/mrm.1910350313; Soher BJ, 1998, MAGNET RESON MED, V40, P822, DOI 10.1002/mrm.1910400607; Tal A, 2012, NMR BIOMED, V25, P1392, DOI 10.1002/nbm.2812; Tong ZY, 2004, MAGN RESON IMAGING, V22, P1017, DOI 10.1016/j.mri.2004.02.007; van Erkel AR, 1998, EUR J RADIOL, V27, P88, DOI 10.1016/S0720-048X(97)00157-5; Veenith TV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115304; Wang X, 2014, J MAGN RESON, V243, P81, DOI 10.1016/j.jmr.2014.03.010; Wiguna T, 2012, CLIN NEUROPHARMACOL, V35, P81, DOI 10.1097/WNF.0b013e3182452572; WIMMER M, 1985, HISTOCHEMISTRY, V83, P571, DOI 10.1007/BF00492462	41	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	JUL	2017	30	7							e3710	10.1002/nbm.3710			9	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	FA3EP	WOS:000405325100003	28272763	Green Accepted			2022-02-06	
J	Hu, J; Xu, XH; Zuo, YY; Gao, XT; Wang, Y; Xiong, CQ; Zhou, HC; Zhu, SH				Hu, Jun; Xu, Xuehua; Zuo, Yuanyi; Gao, Xiangting; Wang, Yun; Xiong, Cunquan; Zhou, Hongcheng; Zhu, Shaohua			NPY Impairs Cell Viability and Mitochondrial Membrane Potential Through Ca2+ and p38 Signaling Pathways in Neonatal Rat Cardiomyocytes	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY			English	Article						neuropeptide Y (NPY); cardiomyocytes; cell viability; peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha); mitochondrial membrane potential	CHRONIC MYOCARDIAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; NEUROPEPTIDE-Y; STRESS CARDIOMYOPATHY; PGC-1 COACTIVATORS; ENERGY-METABOLISM; HEART-FAILURE; SWINE MODEL; HYPERTROPHY; ACTIVATION	NPY is involved in stress cardiomyopathy. However, the associated mechanism for NPY-induced stress cardiomyopathy remains unclear. In this study, we aimed to explore potential cell signaling pathways that are related to NPY-mediated cell viability in neonatal rat cardiomyocytes. We found that NPY induced cell viability suppression in cultured cardiomyocytes in a dose-dependent manner. After NPY treatment, expression of CaN and p-CAMKII increased significantly, and phosphorylation of p38 but not ERK and JNK was changed. Moreover, NPY treatment significantly increased PGC-1 alpha (the key factor of mitochondrial biogenesis and energy metabolism) expression but decreased mitochondrial membrane potential in cultured cardiomyocytes. More importantly, the blockage of CaN, CAMKII, and p38 signaling pathways by their inhibitors could rescue the reduced cell viability and mitochondrial membrane potential in NPY-treated cardiomyocytes. Collectively, our data demonstrated that NPY mediated cell viability and mitochondrial membrane potential in cardiomyocytes through CaN, CAMKII, and p38 signaling pathways.	[Hu, Jun; Xu, Xuehua; Zuo, Yuanyi; Gao, Xiangting; Wang, Yun; Zhu, Shaohua] Soochow Univ, Med Coll, Dept Forens Med, East Gan Jiang Rd 178, Suzhou 215123, Peoples R China; [Xiong, Cunquan; Zhou, Hongcheng] Yancheng Vocat Inst Hlth Sci, Lab Biomed Technol, Yancheng, Peoples R China		Zhu, SH (corresponding author), Soochow Univ, Med Coll, Dept Forens Med, East Gan Jiang Rd 178, Suzhou 215123, Peoples R China.	zhushaohua@suda.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571848]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Supported by the grants from the National Natural Science Foundation of China (No. 81571848) and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Allen AR, 2006, J PHARMACOL EXP THER, V319, P1286, DOI 10.1124/jpet.106.110445; Armstead WM, 2012, NEUROL RES, V34, P530, DOI 10.1179/1743132812Y.0000000039; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bohman LE, 2016, J NEUROTRAUM, V33, P168, DOI 10.1089/neu.2015.3885; Boland TA, 2015, CRIT CARE MED, V43, P686, DOI 10.1097/CCM.0000000000000851; Chen MS, 2005, REGUL PEPTIDES, V125, P9, DOI 10.1016/j.regpep.2004.07.034; Crnkovic S, 2014, BRIT J PHARMACOL, V171, P3895, DOI 10.1111/bph.12751; Dvorakova MC, 2014, PEPTIDES, V61, P1, DOI 10.1016/j.peptides.2014.08.004; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Goodloe AH, 2014, EUR J HEART FAIL, V16, P942, DOI 10.1002/ejhf.145; Gumbs MCR, 2016, PHYSIOL BEHAV, V162, P161, DOI 10.1016/j.physbeh.2016.04.049; Heredia MD, 2005, J MOL CELL CARDIOL, V38, P205, DOI 10.1016/j.yjmcc.2004.11.001; Koene S, 2011, J INHERIT METAB DIS, V34, P315, DOI 10.1007/s10545-010-9162-y; Kourtesis I, 2015, ASN NEURO, V7, DOI 10.1177/1759091415610115; Lecat S, 2015, CELL SIGNAL, V27, P1297, DOI 10.1016/j.cellsig.2015.03.016; Luo GC, 2015, PEPTIDES, V71, P162, DOI 10.1016/j.peptides.2015.07.001; Matyal R, 2013, EUR J PHARMACOL, V718, P261, DOI 10.1016/j.ejphar.2013.08.023; Matyal R, 2012, J MOL CELL CARDIOL, V53, P891, DOI 10.1016/j.yjmcc.2012.08.027; Mori J, 2013, J MOL CELL CARDIOL, V63, P98, DOI 10.1016/j.yjmcc.2013.07.010; Nef HM, 2008, J MOL CELL CARDIOL, V44, P395, DOI 10.1016/j.yjmcc.2007.10.015; Nozdrachev A D, 2011, Zh Evol Biokhim Fiziol, V47, P105; Patten IS, 2012, TRENDS ENDOCRIN MET, V23, P90, DOI 10.1016/j.tem.2011.09.007; Pellieux C, 2000, P NATL ACAD SCI USA, V97, P1595, DOI 10.1073/pnas.030533197; Pons J, 2008, CAN J PHYSIOL PHARM, V86, P438, DOI 10.1139/y08-054; Prasad AM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001949; Reichmann F, 2016, NEUROPEPTIDES, V55, P99, DOI 10.1016/j.npep.2015.09.008; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035; Shanks J, 2013, AM J PHYSIOL-HEART C, V305, pH980, DOI 10.1152/ajpheart.00255.2013; Sihag S, 2009, J MOL CELL CARDIOL, V46, P201, DOI 10.1016/j.yjmcc.2008.10.025; Szardien S, 2011, INT J CARDIOL, V147, P155, DOI 10.1016/j.ijcard.2010.05.010; Tang HN, 2015, ENDOCR J, V62, P835, DOI 10.1507/endocrj.EJ15-0133; TATEMOTO K, 1982, NATURE, V296, P659, DOI 10.1038/296659a0; te Kamp V, 2015, BIOSENS BIOELECTRON, V67, P386, DOI 10.1016/j.bios.2014.08.066; Turer AT, 2013, J MOL CELL CARDIOL, V55, P12, DOI 10.1016/j.yjmcc.2012.08.025; Wan Y, 2015, PEPTIDES, V63, P126, DOI 10.1016/j.peptides.2014.10.018; Wilkins BJ, 2002, J PHYSIOL-LONDON, V541, P1, DOI 10.1113/jphysiol.2002.017129; Zhang P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131124; Zhang R, 2015, CELL PHYSIOL BIOCHEM, V37, P94, DOI 10.1159/000430336	40	7	7	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0160-2446	1533-4023		J CARDIOVASC PHARM	J. Cardiovasc. Pharmacol.	JUL	2017	70	1					52	59		10.1097/FJC.0000000000000493			8	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	FA1RD	WOS:000405216300008	28437279				2022-02-06	
J	Reid, MW; Hannemann, NP; York, GE; Ritter, JL; Kini, JA; Lewis, JD; Sherman, PM; Velez, CS; Drennon, AM; Bolzenius, JD; Tate, DF				Reid, Matthew W.; Hannemann, Nathan P.; York, Gerald E.; Ritter, John L.; Kini, Jonathan A.; Lewis, Jeffrey D.; Sherman, Paul M.; Velez, Carmen S.; Drennon, Ann Marie; Bolzenius, Jacob D.; Tate, David F.			Comparing Two Processing Pipelines to Measure Subcortical and Cortical Volumes in Patients with and without Mild Traumatic Brain Injury	JOURNAL OF NEUROIMAGING			English	Article						FreeSurfer; NeuroQuant (R); quantitative MRI; service members; mild TBI	SEGMENTATION; NEUROQUANT(R); FREESURFER; VALIDATION; IMAGES	PURPOSETo compare volumetric results from NeuroQuant (R) and FreeSurfer in a service member setting. Since the advent of medical imaging, quantification of brain anatomy has been a major research and clinical effort. Rapid advancement of methods to automate quantification and to deploy this information into clinical practice has surfaced in recent years. NeuroQuant (R) is one such tool that has recently been used in clinical settings. Accurate volumetric data are useful in many clinical indications; therefore, it is important to assess the intermethod reliability and concurrent validity of similar volume quantifying tools. METHODSVolumetric data from 148 U.S. service members across three different experimental groups participating in a study of mild traumatic brain injury (mTBI) were examined. Groups included mTBI (n = 71), posttraumatic stress disorder (n = 22), or a noncranial orthopedic injury (n = 55). Correlation coefficients and nonparametric group mean comparisons were used to assess reliability and concurrent validity, respectively. RESULTSComparison of these methods across our entire sample demonstrates generally fair to excellent reliability as evidenced by large intraclass correlation coefficients (ICC = .4 to .99), but little concurrent validity as evidenced by significantly different Mann-Whitney U comparisons for 26 of 30 brain structures measured. CONCLUSIONWhile reliability between the two segmenting tools is fair to excellent, volumetric outcomes are statistically different between the two methods. As suggested by both developers, structure segmentation should be visually verified prior to clinical use and rigor should be used when interpreting results generated by either method.	[Reid, Matthew W.; Ritter, John L.; Drennon, Ann Marie] San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, San Antonio, TX USA; [Hannemann, Nathan P.] Brooke Army Med Ctr, Dept Radiol, San Antonio, TX USA; [York, Gerald E.] Alaska Radiol Associates, TBI Imaging & Res, Anchorage, AK USA; [Kini, Jonathan A.] Austin Radiol Assoc, Austin, TX USA; [Lewis, Jeffrey D.] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Neurol, Bethesda, MD 20814 USA; [Sherman, Paul M.] US Air Force Sch Aerosp Med, Dept Aeromed Res, Human Performance Wing 711, Dayton, OH USA; [Sherman, Paul M.] Wilford Hall ASC, Dept Radiol, Med Wing 59, San Antonio, TX USA; [Velez, Carmen S.; Bolzenius, Jacob D.; Tate, David F.] Univ Missouri St Louis, Missouri Inst Mental Hlth, 4633 World Pkwy Circle, Berkeley, MO 63134 USA; [Tate, David F.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Tate, DF (corresponding author), Univ Missouri St Louis, Missouri Inst Mental Hlth, 4633 World Pkwy Circle, Berkeley, MO 63134 USA.	david.tate@mimh.edu	Ritter, John/AAG-8899-2020; Tate, David F/I-3963-2013	Tate, David F/0000-0003-0213-1920	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; U.S. Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0025]; Chronic Effects of Neurotrauma Consortium (CENC) [PT108802-SC104835]	This work is supported by the Defense and Veterans Brain Injury Center, the U.S. Army Medical Research and Materiel Command (USAMRMC; W81XWH-13-2-0025) and the Chronic Effects of Neurotrauma Consortium (CENC; PT108802-SC104835).	Barth M, 2016, MAGN RESON MED, V75, P63, DOI 10.1002/mrm.25897; Brewer JB, 2009, AM J NEURORADIOL, V30, P578, DOI 10.3174/ajnr.A1402; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cohen J, 1977, STAT POWER ANAL BEHA; Dang M, 2013, COMPUT METH PROG BIO, V111, P480, DOI 10.1016/j.cmpb.2013.04.011; Durand-Dubief F, 2012, AM J NEURORADIOL, V33, P1918, DOI 10.3174/ajnr.A3107; Fama R, 2015, NEUROSCI BIOBEHAV R, V54, P29, DOI 10.1016/j.neubiorev.2015.03.008; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Golkov V, 2016, IEEE T MED IMAGING, V35, P1344, DOI 10.1109/TMI.2016.2551324; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kazemifar S, 2014, J NEUROSCI METH, V227, P35, DOI 10.1016/j.jneumeth.2014.01.033; Maclaren J, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.37; Nimsky C, 2016, ADV TECH STAND NEURO, V43, P37, DOI 10.1007/978-3-319-21359-0_2; O'Doherty DCM, 2015, PSYCHIAT RES-NEUROIM, V232, P1, DOI 10.1016/j.pscychresns.2015.01.002; Ochs AL, 2015, J NEUROIMAGING, V25, P721, DOI 10.1111/jon.12229; Proix T, 2016, NEUROIMAGE, V142, P135, DOI 10.1016/j.neuroimage.2016.06.016; Ross DE, 2014, NEUROIMAGE, V102, P565, DOI 10.1016/j.neuroimage.2014.07.043; Ross DE, 2013, J NEUROPSYCH CLIN N, V25, P32, DOI 10.1176/appi.neuropsych.11120377; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Roy PK, 2015, COMPUT MED IMAG GRAP, V45, P102, DOI 10.1016/j.compmedimag.2015.08.005; Tabatabaei-Jafari Hossein, 2015, Alzheimers Dement (Amst), V1, P487, DOI 10.1016/j.dadm.2015.11.002; Tae WS, 2008, NEURORADIOLOGY, V50, P569, DOI 10.1007/s00234-008-0383-9; Tokuda J, 2015, ACAD RADIOL, V22, P722, DOI 10.1016/j.acra.2015.01.007; Visser E, 2016, NEUROIMAGE, V125, P479, DOI 10.1016/j.neuroimage.2015.10.013; Wilde EA, 2016, BRAIN INJURY, V30, P1442, DOI 10.1080/02699052.2016.1219063; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Woodson J., 2015, HLTH AFFAIRS MEMORAN	29	7	7	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	JUL-AUG	2017	27	4					365	371		10.1111/jon.12431			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FB1HH	WOS:000405893900002	28194831	Bronze			2022-02-06	
J	Taylor, JB; Stern, TA				Taylor, John B.; Stern, Theodore A.			Meeting Its Mission: Does Psychosomatics Align With the Mission of Its Parent Organization, the Academy of Psychosomatic Medicine?	PSYCHOSOMATICS			English	Article						Journal; Mission statement; Psychosomatic medicine; Consultation psychiatry	QUALITY-OF-LIFE; CONSULTATION-LIAISON PSYCHIATRY; POSITIVE PSYCHOLOGY INTERVENTIONS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; WERNICKE-KORSAKOFF-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; SOMATIC SYMPTOM DISORDER; DECISION-MAKING CAPACITY; TRAUMATIC BRAIN-INJURY; CASE SERIES	Background: The vision and mission statements of the Academy of Psychosomatic Medicine (APM) indicate that the APM should promote excellence in clinical care for patients with comorbid psychiatric and general medical conditions by seeking to influence research, public policy, and interdisciplinary education. Objective: As the APM owns the journal, Psychosomatics, we sought to assess whether the APM's journal was fulfilling the vision and mission of its parent organization by reviewing the content of articles published in the journal to determine whether it sufficiently addresses the various clinical care knowledge areas it seeks to influence. Methods: We categorized content in all review articles, case reports, and original research articles published in Psychosomatics in 2015 and 2016. Each article was assigned to as many categories that it covered. Results: In the 163 articles reviewed, the most frequently covered fund of knowledge area was psychiatric morbidity in medical populations (44.2%); among psychiatric disorders, mood disorders (22.1%), psychiatric disorders due to a general medical condition or toxic substance (21.5%), anxiety disorders (14.7%), and delirium (13.5) were the most frequently covered. Of the medical and surgical topics, neurology (19.6%), coping with chronic illnesslpsychological response to illness (17.8%), toxicology (11.7%), outpatient medicine (10.4%), and cardiology (9.8%) appeared most often. Conclusions: Psychosomatics appears to be successfully providing content relevant to the APM's vision and mission statements and to practitioners of psychosomatic medicine.	[Taylor, John B.] Massachusetts Gen Hosp, Dept Psychiat, Warren 605,55 Fruit St, Boston, MA 02114 USA		Taylor, JB (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Warren 605,55 Fruit St, Boston, MA 02114 USA.	JBTAYLOR@PARTNERS.ORG					Ackerman S, 2015, PSYCHOSOMATICS, V56, P89, DOI 10.1016/j.psym.2013.12.006; Alhurani AS, 2015, PSYCHOSOMATICS, V56, P371, DOI 10.1016/j.psym.2014.05.022; Ali A, 2015, PSYCHOSOMATICS, V56, P414, DOI 10.1016/j.psym.2014.05.018; Allen ND, 2016, PSYCHOSOMATICS, V57, P409, DOI 10.1016/j.psym.2016.02.012; Annamalai A, 2015, PSYCHOSOMATICS, V56, P59, DOI 10.1016/j.psym.2014.02.009; [Anonymous], AC PSYCH MED VIS STA; Apodaca K, 2015, PSYCHOSOMATICS, V56, P561, DOI 10.1016/j.psym.2015.02.002; Armontrout J, 2016, PSYCHOSOMATICS, V57, P472, DOI 10.1016/j.psym.2016.04.002; Armontrout J, 2015, PSYCHOSOMATICS, V56, P691, DOI 10.1016/j.psym.2015.07.001; Arnold LM, 2015, PSYCHOSOMATICS, V56, P242, DOI 10.1016/j.psym.2014.12.003; Babine RL, 2016, PSYCHOSOMATICS, V57, P273, DOI 10.1016/j.psym.2016.01.003; Bar-Shai M, 2015, PSYCHOSOMATICS, V56, P286, DOI 10.1016/j.psym.2013.12.017; Baslet G, 2016, PSYCHOSOMATICS, V57, P1, DOI 10.1016/j.psym.2015.10.004; Batka C, 2016, PSYCHOSOMATICS, V57, P586, DOI 10.1016/j.psym.2016.05.008; Bautovich A, 2016, PSYCHOSOMATICS, V57, P305, DOI 10.1016/j.psym.2015.11.006; Beresnevaite M, 2016, PSYCHOSOMATICS, V57, P605, DOI 10.1016/j.psym.2016.04.004; Bhuvaneswar C, 2015, PSYCHOSOMATICS, V56, P1, DOI 10.1016/j.psym.2014.06.001; Bingham KS, 2016, PSYCHOSOMATICS, V57, P638, DOI 10.1016/j.psym.2016.07.001; Biradavolu M, 2016, PSYCHOSOMATICS, V57, P64, DOI 10.1016/j.psym.2015.07.014; Boland RJ, 2015, PSYCHOSOMATICS, V56, P153, DOI 10.1016/j.psym.2014.11.003; Brezing C, 2015, PSYCHOSOMATICS, V56, P107, DOI 10.1016/j.psym.2014.10.006; Briet JP, 2016, PSYCHOSOMATICS, V57, P401, DOI 10.1016/j.psym.2016.02.004; Bronheim HE, 1998, PSYCHOSOMATICS, V39, pS8, DOI 10.1016/S0033-3182(98)71317-9; Brown TM, 2015, PSYCHOSOMATICS, V56, P12, DOI 10.1016/j.psym.2014.05.010; Butwicka A, 2016, PSYCHOSOMATICS, V57, P185, DOI 10.1016/j.psym.2015.11.001; Caro MA, 2016, PSYCHOSOMATICS, V57, P229, DOI 10.1016/j.psym.2016.01.002; Chang TS, 2015, PSYCHOSOMATICS, V56, P302, DOI 10.1016/j.psym.2015.02.005; Chaudhry SK, 2016, PSYCHOSOMATICS, V57, P319, DOI 10.1016/j.psym.2015.09.004; Chavooshi B, 2016, PSYCHOSOMATICS, V57, P292, DOI 10.1016/j.psym.2016.01.001; Chen JJ, 2015, PSYCHOSOMATICS, V56, P206, DOI 10.1016/j.psym.2014.07.006; Chen XH, 2016, PSYCHOSOMATICS, V57, P465, DOI 10.1016/j.psym.2016.04.003; Chiba Y, 2015, PSYCHOSOMATICS, V56, P85, DOI 10.1016/j.psym.2013.07.001; Claessen FMAP, 2016, PSYCHOSOMATICS, V57, P47, DOI 10.1016/j.psym.2015.09.005; Clinebell K, 2016, PSYCHOSOMATICS, V57, P25, DOI 10.1016/j.psym.2015.10.010; Cook SC, 2015, PSYCHOSOMATICS, V56, P685, DOI 10.1016/j.psym.2015.07.002; Courtwright AM, 2016, PSYCHOSOMATICS, V57, P238, DOI 10.1016/j.psym.2015.12.008; Cruz C, 2015, PSYCHOSOMATICS, V56, P576, DOI 10.1016/j.psym.2015.05.005; Degenhardt EK, 2016, PSYCHOSOMATICS, V57, P208, DOI 10.1016/j.psym.2015.12.002; Devantier TA, 2016, PSYCHOSOMATICS, V57, P369, DOI 10.1016/j.psym.2016.02.005; Dickstein LP, 2015, PSYCHOSOMATICS, V56, P44, DOI 10.1016/j.psym.2014.05.008; Dixon LJ, 2016, PSYCHOSOMATICS, V57, P498, DOI 10.1016/j.psym.2016.03.001; Do A, 2016, PSYCHOSOMATICS, V57, P57, DOI 10.1016/j.psym.2015.09.003; Doernberg SN, 2016, PSYCHOSOMATICS, V57, P556, DOI 10.1016/j.psym.2016.06.005; Doherty-Torstrick ER, 2016, PSYCHOSOMATICS, V57, P390, DOI 10.1016/j.psym.2016.02.002; Drzyzga K, 2016, PSYCHOSOMATICS, V57, P414, DOI 10.1016/j.psym.2016.02.013; Durnitrascu CI, 2015, PSYCHOSOMATICS, V56, P609, DOI 10.1016/j.psym.2015.07.006; Elmore H, 2016, PSYCHOSOMATICS, V57, P651, DOI 10.1016/j.psym.2016.08.007; Epstein SA, 2016, PSYCHOSOMATICS, V57, P566, DOI 10.1016/j.psym.2016.04.005; Eshel N, 2016, PSYCHOSOMATICS, V57, P97, DOI 10.1016/j.psym.2015.09.007; Eworuke E, 2015, PSYCHOSOMATICS, V56, P495, DOI 10.1016/j.psym.2014.09.001; Feigal J, 2016, PSYCHOSOMATICS, V57, P310, DOI 10.1016/j.psym.2015.11.005; Feldman WB, 2015, PSYCHOSOMATICS, V56, P306, DOI 10.1016/j.psym.2014.08.002; Foldes-Busque G, 2015, PSYCHOSOMATICS, V56, P513, DOI 10.1016/j.psym.2014.07.005; Freudenreich O, 2015, PSYCHOSOMATICS, V56, P445, DOI 10.1016/j.psym.2015.04.001; Gan JJ, 2016, PSYCHOSOMATICS, V57, P598, DOI 10.1016/j.psym.2016.08.002; Gold JA, 2016, PSYCHOSOMATICS, V57, P445, DOI 10.1016/j.psym.2016.05.005; Goldzweig G, 2015, PSYCHOSOMATICS, V56, P521, DOI 10.1016/j.psym.2014.10.001; Golkari S, 2015, PSYCHOSOMATICS, V56, P652, DOI 10.1016/j.psym.2015.03.008; Herold S, 2016, PSYCHOSOMATICS, V57, P634, DOI 10.1016/j.psym.2016.05.007; Herskovitz M, 2015, PSYCHOSOMATICS, V56, P78, DOI 10.1016/j.psym.2014.05.024; Hitschfeld MJ, 2016, PSYCHOSOMATICS, V57, P489, DOI 10.1016/j.psym.2016.05.003; Ho CE, 2016, PSYCHOSOMATICS, V57, P142, DOI 10.1016/j.psym.2015.10.007; Huang H, 2015, PSYCHOSOMATICS, V56, P658, DOI 10.1016/j.psym.2015.03.006; Iacoviello BM, 2015, PSYCHOSOMATICS, V56, P254, DOI 10.1016/j.psym.2015.02.001; Iglewicz A, 2015, PSYCHOSOMATICS, V56, P329, DOI 10.1016/j.psym.2014.05.005; Inamura K, 2016, PSYCHOSOMATICS, V57, P378, DOI 10.1016/j.psym.2016.02.006; Inamura K, 2015, PSYCHOSOMATICS, V56, P486, DOI 10.1016/j.psym.2014.10.004; Isenberg-Grzeda E, 2016, PSYCHOSOMATICS, V57, P71, DOI 10.1016/j.psym.2015.10.001; Jain FA, 2015, PSYCHOSOMATICS, V56, P140, DOI 10.1016/j.psym.2014.10.007; Janssen SJ, 2015, PSYCHOSOMATICS, V56, P338, DOI 10.1016/j.psym.2014.05.009; Jimenez XF, 2015, PSYCHOSOMATICS, V56, P592, DOI 10.1016/j.psym.2015.06.002; Johnston MC, 2015, PSYCHOSOMATICS, V56, P168, DOI 10.1016/j.psym.2014.10.005; Julnes PS, 2016, PSYCHOSOMATICS, V57, P423, DOI 10.1016/j.psym.2016.02.015; Kenner WD, 2015, PSYCHOSOMATICS, V56, P119, DOI 10.1016/j.psym.2014.09.004; Ketterer MW, 2016, PSYCHOSOMATICS, V57, P194, DOI 10.1016/j.psym.2015.10.008; Knight JC, 2015, PSYCHOSOMATICS, V56, P598, DOI 10.1016/j.psym.2015.06.003; Kontos N, 2015, PSYCHOSOMATICS, V56, P217, DOI 10.1016/j.psym.2014.11.004; Kruse JL, 2015, PSYCHOSOMATICS, V56, P227, DOI 10.1016/j.psym.2015.01.003; Kumari S, 2016, PSYCHOSOMATICS, V57, P431, DOI 10.1016/j.psym.2016.02.003; La Rosa AJ, 2015, PSYCHOSOMATICS, V56, P202, DOI 10.1016/j.psym.2014.10.003; Lama M, 2016, PSYCHOSOMATICS, V57, P325, DOI 10.1016/j.psym.2015.12.011; Laughon SL, 2016, PSYCHOSOMATICS, V57, P534, DOI 10.1016/j.psym.2016.05.002; Lauterbach MD, 2015, PSYCHOSOMATICS, V56, P567, DOI 10.1016/j.psym.2014.11.001; Lavakumar M, 2015, PSYCHOSOMATICS, V56, P262, DOI 10.1016/j.psym.2015.02.004; Lemmens GMD, 2015, PSYCHOSOMATICS, V56, P362, DOI 10.1016/j.psym.2014.05.002; Leung JG, 2015, PSYCHOSOMATICS, V56, P542, DOI 10.1016/j.psym.2015.02.003; Lokko HN, 2016, PSYCHOSOMATICS, V57, P31, DOI 10.1016/j.psym.2015.09.006; Lokko HN, 2015, PSYCHOSOMATICS, V56, P556, DOI 10.1016/j.psym.2015.04.003; Lucette A, 2016, PSYCHOSOMATICS, V57, P505, DOI 10.1016/j.psym.2016.03.005; Lundberg AB, 2015, PSYCHOSOMATICS, V56, P94, DOI 10.1016/j.psym.2014.09.005; Magnani M, 2016, PSYCHOSOMATICS, V57, P616, DOI 10.1016/j.psym.2016.05.004; Martin K, 2016, PSYCHOSOMATICS, V57, P341, DOI 10.1016/j.psym.2016.02.011; McCoy TH, 2016, PSYCHOSOMATICS, V57, P480, DOI 10.1016/j.psym.2016.06.001; McEvoy K, 2015, PSYCHOSOMATICS, V56, P98, DOI 10.1016/j.psym.2014.08.001; McFarland DC, 2016, PSYCHOSOMATICS, V57, P174, DOI 10.1016/j.psym.2015.11.008; McKean AJS, 2015, PSYCHOSOMATICS, V56, P583, DOI 10.1016/j.psym.2015.05.003; McKenna K, 2015, PSYCHOSOMATICS, V56, P381, DOI 10.1016/j.psym.2014.06.003; McLafferty LP, 2016, PSYCHOSOMATICS, V57, P115, DOI 10.1016/j.psym.2015.12.001; McLafferty LP, 2015, PSYCHOSOMATICS, V56, P298, DOI 10.1016/j.psym.2014.04.001; Merideth FL, 2016, PSYCHOSOMATICS, V57, P102, DOI 10.1016/j.psym.2015.07.011; Millard H, 2015, PSYCHOSOMATICS, V56, P700, DOI 10.1016/j.psym.2015.07.008; Miller-Matero LR, 2016, PSYCHOSOMATICS, V57, P522, DOI 10.1016/j.psym.2016.04.001; Morgan RJ, 2015, PSYCHOSOMATICS, V56, P572, DOI 10.1016/j.psym.2014.09.008; Moroze RM, 2015, PSYCHOSOMATICS, V56, P397, DOI 10.1016/j.psym.2014.03.003; Mulders P, 2016, PSYCHOSOMATICS, V57, P529, DOI 10.1016/j.psym.2016.05.001; Murphy M, 2016, PSYCHOSOMATICS, V57, P547, DOI 10.1016/j.psym.2016.04.006; Muskin PR, 2016, PSYCHOSOMATICS, V57, P258, DOI 10.1016/j.psym.2016.02.001; Nefs G, 2015, PSYCHOSOMATICS, V56, P662, DOI 10.1016/j.psym.2015.06.006; Nelson S, 2016, PSYCHOSOMATICS, V57, P131, DOI 10.1016/j.psym.2015.11.003; Nichols SD, 2016, PSYCHOSOMATICS, V57, P543, DOI 10.1016/j.psym.2016.06.003; Nikrahan GR, 2016, PSYCHOSOMATICS, V57, P348, DOI 10.1016/j.psym.2016.03.003; Nikrahan GR, 2016, PSYCHOSOMATICS, V57, P359, DOI 10.1016/j.psym.2016.02.007; Nisavic M, 2015, PSYCHOSOMATICS, V56, P319, DOI 10.1016/j.psym.2014.12.006; Nota SPFT, 2015, PSYCHOSOMATICS, V56, P479, DOI 10.1016/j.psym.2014.09.003; O'Cleirigh C, 2015, PSYCHOSOMATICS, V56, P470, DOI 10.1016/j.psym.2014.08.004; Ojeda-Lopez C, 2015, PSYCHOSOMATICS, V56, P696, DOI 10.1016/j.psym.2015.07.004; Olagunju AT, 2015, PSYCHOSOMATICS, V56, P67, DOI 10.1016/j.psym.2014.03.006; Oldham MA, 2016, PSYCHOSOMATICS, V57, P246, DOI 10.1016/j.psym.2015.12.007; Park EM, 2015, PSYCHOSOMATICS, V56, P52, DOI 10.1016/j.psym.2014.05.003; Paulson D, 2016, PSYCHOSOMATICS, V57, P514, DOI 10.1016/j.psym.2016.03.006; Pellegrino LD, 2016, PSYCHOSOMATICS, V57, P301, DOI 10.1016/j.psym.2015.12.009; Phillips CT, 2016, PSYCHOSOMATICS, V57, P89, DOI 10.1016/j.psym.2015.10.002; Puri NV, 2015, PSYCHOSOMATICS, V56, P268, DOI 10.1016/j.psym.2013.08.010; Quon BS, 2015, PSYCHOSOMATICS, V56, P345, DOI 10.1016/j.psym.2014.05.017; Repchak AT, 2016, PSYCHOSOMATICS, V57, P217, DOI 10.1016/j.psym.2015.11.007; Robinson RL, 2015, PSYCHOSOMATICS, V56, P274, DOI 10.1016/j.psym.2014.08.003; Rodgers B, 2015, PSYCHOSOMATICS, V56, P588, DOI 10.1016/j.psym.2015.04.004; Roy K, 2016, PSYCHOSOMATICS, V57, P645, DOI 10.1016/j.psym.2016.08.001; Rustad JK, 2015, PSYCHOSOMATICS, V56, P196, DOI 10.1016/j.psym.2014.09.007; Rustad JK, 2015, PSYCHOSOMATICS, V56, P21, DOI 10.1016/j.psym.2014.09.006; Saito S, 2015, PSYCHOSOMATICS, V56, P419, DOI 10.1016/j.psym.2014.05.023; Scarella TM, 2016, PSYCHOSOMATICS, V57, P200, DOI 10.1016/j.psym.2015.10.006; Schry AR, 2015, PSYCHOSOMATICS, V56, P674, DOI 10.1016/j.psym.2015.07.010; Sepulveda E, 2015, PSYCHOSOMATICS, V56, P530, DOI 10.1016/j.psym.2015.03.005; Shaw RJ, 2016, PSYCHOSOMATICS, V57, P576, DOI 10.1016/j.psym.2016.05.006; Sher Y, 2015, PSYCHOSOMATICS, V56, P615, DOI 10.1016/j.psym.2015.09.008; Shim J, 2015, PSYCHOSOMATICS, V56, P644, DOI 10.1016/j.psym.2015.05.002; Shu JE, 2015, PSYCHOSOMATICS, V56, P547, DOI 10.1016/j.psym.2014.12.002; Sockalingam S, 2016, PSYCHOSOMATICS, V57, P264, DOI 10.1016/j.psym.2016.01.005; Soe K, 2016, PSYCHOSOMATICS, V57, P315, DOI 10.1016/j.psym.2015.10.003; Sowa NA, 2016, PSYCHOSOMATICS, V57, P152, DOI 10.1016/j.psym.2015.12.006; Stanciu CN, 2015, PSYCHOSOMATICS, V56, P210, DOI 10.1016/j.psym.2014.03.004; Stevens JR, 2015, PSYCHOSOMATICS, V56, P423, DOI 10.1016/j.psym.2015.03.007; Stoudemire A, 1998, PSYCHOSOMATICS, V39, pS3, DOI 10.1016/S0033-3182(98)71316-7; Suarez L, 2015, PSYCHOSOMATICS, V56, P181, DOI 10.1016/j.psym.2014.12.005; Suzuki J, 2015, PSYCHOSOMATICS, V56, P129, DOI 10.1016/j.psym.2014.11.002; Sveen J, 2015, PSYCHOSOMATICS, V56, P390, DOI 10.1016/j.psym.2014.05.019; Takeshima M, 2016, PSYCHOSOMATICS, V57, P540, DOI 10.1016/j.psym.2016.02.009; Tampi RR, 2015, PSYCHOSOMATICS, V56, P36, DOI 10.1016/j.psym.2014.09.002; Tang KT, 2015, PSYCHOSOMATICS, V56, P190, DOI 10.1016/j.psym.2014.05.020; Tang PL, 2015, PSYCHOSOMATICS, V56, P634, DOI 10.1016/j.psym.2015.06.005; Tateishi H, 2016, PSYCHOSOMATICS, V57, P107, DOI 10.1016/j.psym.2015.07.007; Thiara G, 2016, PSYCHOSOMATICS, V57, P165, DOI 10.1016/j.psym.2015.12.003; Tseng YT, 2015, PSYCHOSOMATICS, V56, P410, DOI 10.1016/j.psym.2014.02.007; Tu CY, 2016, PSYCHOSOMATICS, V57, P283, DOI 10.1016/j.psym.2015.12.010; Upshaw WN, 2015, PSYCHOSOMATICS, V56, P580, DOI 10.1016/j.psym.2015.05.004; van Noorden MS, 2015, PSYCHOSOMATICS, V56, P404, DOI 10.1016/j.psym.2014.03.002; Viguera AC, 2015, PSYCHOSOMATICS, V56, P460, DOI 10.1016/j.psym.2015.04.005; Wade TW, 2015, PSYCHOSOMATICS, V56, P354, DOI 10.1016/j.psym.2014.05.012; Wellisch DK, 2015, PSYCHOSOMATICS, V56, P504, DOI 10.1016/j.psym.2014.07.001; Whiting WL, 2016, PSYCHOSOMATICS, V57, P330, DOI 10.1016/j.psym.2016.01.004; Wijnia JW, 2016, PSYCHOSOMATICS, V57, P624, DOI 10.1016/j.psym.2016.06.004; Wilson JE, 2016, PSYCHOSOMATICS, V57, P18, DOI 10.1016/j.psym.2015.10.009; Worley LLM, 2009, PSYCHOSOMATICS, V50, P557, DOI 10.1176/appi.psy.50.6.557; Yost GL, 2016, PSYCHOSOMATICS, V57, P41, DOI 10.1016/j.psym.2015.07.013; Younossi I, 2016, PSYCHOSOMATICS, V57, P82, DOI 10.1016/j.psym.2015.10.005; Zalpuri I, 2015, PSYCHOSOMATICS, V56, P292, DOI 10.1016/j.psym.2014.09.009	167	7	7	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	JUL-AUG	2017	58	4					375	385		10.1016/j.psym.2017.03.008			11	Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	FA3QT	WOS:000405360200005	28449827				2022-02-06	
J	Tran, J; Hammond, F; Dams-O'Connor, K; Tang, X; Eapen, B; McCarthy, M; Nakase-Richardson, R				Tran, Johanna; Hammond, Flora; Dams-O'Connor, Kristen; Tang, Xinyu; Eapen, Blessen; McCarthy, Marissa; Nakase-Richardson, Risa			Rehospitalization in the First Year Following Veteran and Service Member TBI: A VA TBI Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Military; readmission; rehabilitation; rehospitalization; TBI; Veterans Health Administration	TRAUMATIC BRAIN-INJURY; MULTICENTER ANALYSIS; REHABILITATION	Objective: To determine the incidence and causes of rehospitalization following military or Veteran traumatic brain injury (TBI). Setting: Department of Veterans Affairs (VA) Veterans Health Administration Polytrauma Rehabilitation Centers (VHA PRCs). Participants: Consecutive sample of VHA TBI Model System participants (N = 401). Design: Prospective observational cohort study. Main Measures: Number and type of rehospitalizations in first year post-TBI. Results: Forty-one percent of 401 participants were rehospitalized. Rehospitalization status was associated with greater injury severity and receipt of TBI while active duty. Of those rehospitalized, 30% had 2 or more readmissions. Participants experiencing multiple rehospitalizations (2+) were more likely to have sustained their TBI during deployment than those with none or single rehospitalization. This group also sustained more severe injuries and spent more time in VA PRC inpatient rehabilitation. Common reasons for rehospitalization included inpatient rehabilitation (33%), unspecified (26%), orthopedic (10%), seizures (8%), infection (8%), and psychiatric (7%). Conclusion: This is the first study examining military and Veteran rehospitalization following TBI requiring inpatient rehabilitation at a VA PRC. Findings indicate frequent rehospitalizations in the first year postinjury, suggesting the need for preventive models of health maintenance following inpatient rehabilitation discharge. Greater surveillance of those with deployment-related TBI or active duty at the time of injury and greater TBI severity may be warranted.	[Tran, Johanna] James A Haley Vet Hosp, PMRS, Tampa, FL USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, MHBS, Tampa, FL USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, VA HSR&D Ctr Innovat Disabil Rehabil & Res CINDRR, Tampa, FL USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, DVBIC, Tampa, FL USA; [Tran, Johanna] Univ S Florida, Dept Neurol, Tampa, FL USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Tampa, FL USA; [Hammond, Flora] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hammond, Flora] Rehabil Hosp Indiana, Indianapolis, IN USA; [Hammond, Flora] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Tran, Johanna] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Tran, Johanna] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Eapen, Blessen] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, Polytrauma Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Risa.Richardson@va.gov		Tran, Johanna/0000-0001-6231-5620	Department of Veterans AffairsUS Department of Veterans Affairs; Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research; VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center, Defense Health Agency [W91YTZ-13-C-0015]; US Department of Veterans Affairs grant (VA HSRD)US Department of Veterans Affairs [1 I50 HX001233-01]; US Department Of Health and Services, National Institute on Disability, Independent Living and Rehabilitation Research [H133A120084, 90DP0036]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 K01 HD07465101A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U48DP000036] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01HX001089, I50HX001233] Funding Source: NIH RePORTER	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research. This research is sponsored by VHA Central Office VA TBI Model System Program of Research and subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015 [Nakase-Richardson]) from the Defense and Veterans Brain Injury Center, Defense Health Agency. This work was partly supported by US Department of Veterans Affairs grant (VA HSRD; 1 I50 HX001233-01 [Nakase-Richardson]), US Department Of Health and Services, National Institute on Disability, Independent Living and Rehabilitation Research grants (H133A120084 [Dams-O'Conner], 90DP0036 [Hammond]), and National Institute of Health grant (1 K01 HD07465101A1 [Dams-O'Conner]). The authors acknowledge the contributions of Susan Schultz, MD.	Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dams-O'Connor K, 2017, J HEAD TRAUMA REHAB, V32, P147, DOI 10.1097/HTR.0000000000000263; Duchnick JJ, 2015, PSYCHOL SERV, V12, P313, DOI 10.1037/ser0000034; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS330, DOI 10.1016/j.apmr.2014.09.041; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016	9	7	7	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2017	32	4					264	270		10.1097/HTR.0000000000000296			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FA2KB	WOS:000405269200014	28195958	Green Accepted			2022-02-06	
J	Clement, A; Mitchelmore, C; Andersson, DR; Asuni, AA				Clement, Amalie; Mitchelmore, Cathy; Andersson, Daniel R.; Asuni, Ayodeji A.			CEREBROSPINAL FLUID NEUROFILAMENT LIGHT CHAIN AS A BIOMARKER OF NEURODEGENERATION IN THE TG4510 AND MITOPARK MOUSE MODELS	NEUROSCIENCE			English	Article						Alzheimer's disease; neurodegeneration; neurofilament light; MitoPark; Tg4510	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; PARKINSONS-DISEASE; PROTEIN-LEVELS; MICE; TAU; PROGRESSION; CSF; SEVERITY	A challenge in working with preclinical models of neurodegeneration has been how to non-invasively monitor disease progression. Neurofilament proteins are established axonal damage markers and have been found to be elevated in cerebrospinal fluid (CSF) and blood from patients with neurodegenerative disorders like Alzheimer's disease (AD), Parkinson's disease (PD) and tauopathies. We hypothesized that CSF neurofilament light (NF-L) can be used to track progression of neurodegeneration and potentially monitor the efficacy of novel therapeutic agents in preclinical development. To substantiate this, we examined whether changes in NF-L levels in brain, plasma, and CSF reflect the changing disease status of preclinical models of neurodegeneration. Using Western Blot and ELISA we characterized NF-L and disease-related proteins in brain, CSF and plasma samples from Tg4510 mice (tauopathy/AD), MitoPark mice (PD), and their age-matched control littermates.We found that CSF NF-L clearly discriminates Tg4510 from control littermates, which was not observed for the MitoPark model. However, both Tg4510 and MitoPark showed altered expression and solubilization of NFs compared to control littermates. We found a significant correlation between CSF NF-L and plasma NF-L in Tg4510, suggesting a similar biomarker potential of plasma NF-L. Also, CSF NF-L correlated significantly with tau in Tg4510 brains, suggesting a surrogate biomarker potential of CSF NF-L. Overall, our findings provide further evidence that NF-L correlates with disease severity and our results suggests, that CSF NF-L has utility as a surrogate or adjunct biomarker for neurodegeneration in the Tg4510 model, but independent validation is warranted. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.	[Clement, Amalie; Mitchelmore, Cathy] Roskilde Univ, Dept Nat Sci & Environm, Roskilde, Denmark; [Clement, Amalie; Andersson, Daniel R.; Asuni, Ayodeji A.] H Lundbeck & Co AS, Dept Neurodegenerat In Vivo, Copenhagen, Denmark		Clement, A (corresponding author), Roskilde Univ, Dept Nat Sci & Environm, Roskilde, Denmark.; Asuni, AA (corresponding author), H Lundbeck & Co AS, Dept Neurodegenerat, Ottiliavej 9, DK-2500 Copenhagen, Denmark.	amcl@RUC.dk; aara@lundbeck.com	Asuni, Ayodeji/F-4285-2011	Asuni, Ayodeji/0000-0003-3488-6893; Mitchelmore, Cathy/0000-0001-7292-8252			Bacioglu M, 2016, NEURON, V91, P56, DOI 10.1016/j.neuron.2016.05.018; Bailey RM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-8; Brinkmalm A, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-53; Crabtree Gregg W, 2014, Front Synaptic Neurosci, V6, P28, DOI 10.3389/fnsyn.2014.00028; CROWE A, 1991, AM J PATHOL, V139, P1463; DAHL D, 1982, J HISTOCHEM CYTOCHEM, V30, P207, DOI 10.1177/30.3.7037941; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Ekstrand MI, 2009, PARKINSONISM RELAT D, V15, pS185, DOI 10.1016/S1353-8020(09)70811-9; Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x; Gellhaar S, 2015, GENES BRAIN BEHAV, V14, P260, DOI 10.1111/gbb.12210; Girard SD, 2016, BEHAV BRAIN RES, V296, P254, DOI 10.1016/j.bbr.2015.09.004; Gong CX, 2003, NEUROSCI LETT, V340, P107, DOI 10.1016/S0304-3940(03)00096-X; Hall S, 2012, ARCH NEUROL-CHICAGO, V69, P1445, DOI 10.1001/archneurol.2012.1654; HOESS RH, 1984, P NATL ACAD SCI-BIOL, V81, P1026, DOI 10.1073/pnas.81.4.1026; Hu YY, 2002, NEUROSCI LETT, V320, P156, DOI 10.1016/S0304-3940(02)00047-2; Hunsberger HC, 2014, BEHAV BRAIN RES, V272, P181, DOI 10.1016/j.bbr.2014.06.057; Jul P, 2016, J ALZHEIMERS DIS, V49, P783, DOI 10.3233/JAD-150292; Kanazawa T, 2008, BRAIN PATHOL, V18, P415, DOI 10.1111/j.1750-3639.2008.00140.x; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Kvartsberg H, 2015, ALZHEIMERS DEMENT, V11, P1180, DOI 10.1016/j.jalz.2014.10.009; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P7384, DOI 10.1073/pnas.85.19.7384; Leko MB, 2016, J ALZHEIMERS DIS, V50, P765, DOI 10.3233/JAD-150705; Liu M, 2012, AM J PHYSIOL-REG I, V303, pR903, DOI 10.1152/ajpregu.00219.2012; Liu Q, 2004, CELL MOL LIFE SCI, V61, P3057, DOI 10.1007/s00018-004-4268-8; Magdalinou NK, 2015, J NEUROL NEUROSUR PS, V86, P1240, DOI 10.1136/jnnp-2014-309562; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; McKinney BC, 2008, GENES BRAIN BEHAV, V7, P203, DOI 10.1111/j.1601-183X.2007.00339.x; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/s1474-4422(16)00070-3, 10.1016/S1474-4422(16)00070-3]; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Petzold A, 2007, NEURODEGENER DIS, V4, P185, DOI 10.1159/000101843; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Pugh PL, 2004, BEHAV BRAIN RES, V155, P283, DOI 10.1016/j.bbr.2004.04.021; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; RODER HM, 1991, J NEUROSCI, V11, P3325; Rudrabhatla P, 2011, FASEB J, V25, P3896, DOI 10.1096/fj.11-181297; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Scherling CS, 2014, ANN NEUROL, V75, P116, DOI 10.1002/ana.24052; SCHMIDT ML, 1990, AM J PATHOL, V136, P1069; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shan LF, 2015, BRAIN RES, V1618, P261, DOI 10.1016/j.brainres.2015.06.005; Sharma S, 2013, NEUROCHEM INT, V63, P201, DOI 10.1016/j.neuint.2013.06.005; SHEA TB, 1993, J NEUROSCI RES, V35, P507, DOI 10.1002/jnr.490350507; Skillback T, 2014, NEUROLOGY, V83, P1945, DOI 10.1212/WNL.0000000000001015; Skillback T, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt212; Sprengel R, 2007, Handb Exp Pharmacol, P49; Tortelli R, 2012, EUR J NEUROL, V19, P1561, DOI 10.1111/j.1468-1331.2012.03777.x; TORUDELBAUFFE D, 1983, FEBS LETT, V162, P230, DOI 10.1016/0014-5793(83)80761-3; URRUTIA R, 1991, P NATL ACAD SCI USA, V88, P6701, DOI 10.1073/pnas.88.15.6701; Waldo ML, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-54; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729; Zanier ER, 2011, J NEUROL NEUROSUR PS, V82, P157, DOI 10.1136/jnnp.2009.177667; Zetterberg H, 2016, JAMA NEUROL, V73, P60, DOI 10.1001/jamaneurol.2015.3037	56	7	7	2	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUN 23	2017	354						101	109		10.1016/j.neuroscience.2017.04.030			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EW4MO	WOS:000402475800008	28461218				2022-02-06	
J	Ng, LJ; Volman, V; Gibbons, MM; Phohomsiri, P; Cui, JX; Swenson, DJ; Stuhmiller, JH				Ng, Laurel J.; Volman, Vladislav; Gibbons, Melissa M.; Phohomsiri, Pi; Cui, Jianxia; Swenson, Darrell J.; Stuhmiller, James H.			A Mechanistic End-to-End Concussion Model That Translates Head Kinematics to Neurologic Injury	FRONTIERS IN NEUROLOGY			English	Article						concussion mechanism; mTBI; internal dose; node of Ranvier; axon injury; axonal dysfunction; kinematic correlates; dose-response	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT SIMULATIONS; WHITE-MATTER; REACTION-TIME; IN-VITRO; INTERHEMISPHERIC COMMUNICATION; BIOMECHANICAL DETERMINANTS; PROFESSIONAL FOOTBALL; ATTENTION DEFICITS; AXONAL ELONGATION	Past concussion studies have focused on understanding the injury processes occurring on discrete length scales (e.g., tissue-level stresses and strains, cell-level stresses and strains, or injury-induced cellular pathology). A comprehensive approach that connects all length scales and relates measurable macroscopic parameters to neurological outcomes is the first step toward rationally unraveling the complexity of this multi-scale system, for better guidance of future research. This paper describes the development of the first quantitative end-to-end (E2E) multi-scale model that links gross head motion to neurological injury by integrating fundamental elements of tissue and cellular mechanical response with axonal dysfunction. The model quantifies axonal stretch (i.e., tension) injury in the corpus callosum, with axonal functionality parameterized in terms of axonal signaling. An internal injury correlate is obtained by calculating a neurological injury measure (the average reduction in the axonal signal amplitude) over the corpus callosum. By using a neurologically based quantity rather than externally measured head kinematics, the E2E model is able to unify concussion data across a range of exposure conditions and species with greater sensitivity and specificity than correlates based on external measures. In addition, this model quantitatively links injury of the corpus callosum to observed specific neurobehavioral outcomes that reflect clinical measures of mild traumatic brain injury. This comprehensive modeling framework provides a basis for the systematic improvement and expansion of this mechanistic-based understanding, including widening the range of neurological injury estimation, improving concussion risk correlates, guiding the design of protective equipment, and setting safety standards.	[Ng, Laurel J.; Volman, Vladislav; Gibbons, Melissa M.; Phohomsiri, Pi; Cui, Jianxia; Stuhmiller, James H.] L 3 Appl Technol Inc, Simulat Engn & Testing, San Diego, CA 92121 USA; [Swenson, Darrell J.] Medtronic, Cardiac Rhythm & Heart Failure Numer Modeling, Mounds View, MN USA		Ng, LJ (corresponding author), L 3 Appl Technol Inc, Simulat Engn & Testing, San Diego, CA 92121 USA.	Laurel.Ng@L3T.com			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-D-0011, W81XWH-16-C-0042]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS076827]; National Institute of Biomedical Imaging and Bioengineering (NIBIB)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R21EB006525]	This work is supported by the US Army Medical Research and Materiel Command under Contract Numbers W81XWH-11-D-0011 and W81XWH-16-C-0042. The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation. Cleared for Public Release by U.S. Army Medical and Materiel Command Public Affairs Office, dated August 1, 2016. The IIT Human Brain Atlas project was supported by Grant Number R21NS076827 from the National Institute of Neurological Disorders and Stroke (NINDS) and Award Number R21EB006525 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB). The content is solely the responsibility of the authors and does not represent the official views of NINDS, NIBIB, or the National Institute of Health.	ABEL JM, 1978, 22 STAPP CAR CRASH C, P35; Aboitiz F, 2003, BRAZ J MED BIOL RES, V36, P409, DOI 10.1590/S0100-879X2003000400002; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Al-Bsharat A. S., 1999, STAPP CAR CRASH J, V43, P321; Antona-Makoshi J, 2012, P 2012 INT IRCOBI C, V2012, P441; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Armiger RS, 2014, MECH BIOL SYSTEMS MA, V4, P127, DOI DOI 10.1007/978-3-319-00777-9_18; Babbs CF, 2006, J MECH MED BIOL, V6, P349, DOI 10.1142/S021951940600200X; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; BLACK JA, 1990, TRENDS NEUROSCI, V13, P48, DOI 10.1016/0166-2236(90)90068-L; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Carlsen RW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00028; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chen Xi-Ping, 2006, Neurosci Bull, V22, P165; Chiu SY, 2011, NEUROSCIENTIST, V17, P343, DOI 10.1177/1073858410393740; Cui J, 2016, SOC NEUR M SAN DIEG; Cui JX, 2016, J NEUROPHYSIOL, V116, P2892, DOI 10.1152/jn.00603.2016; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; Darling T, 2016, COMPUT METHOD BIOMEC, V19, P1432, DOI 10.1080/10255842.2016.1149574; DENNERLL TJ, 1989, J CELL BIOL, V109, P3073, DOI 10.1083/jcb.109.6.3073; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; DoD Blast Injury Research Program Coordinating Office, 2014, 2014 INT STAT OF THE; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Ferrario CR, 2013, J NEUROPHYSIOL, V110, P131, DOI 10.1152/jn.01011.2012; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hosmer D, 1989, APPL LOGISTIC REGRES; Houzel JC, 2002, BRAZ J MED BIOL RES, V35, P1441, DOI 10.1590/S0100-879X2002001200005; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; HYND GW, 1991, J LEARN DISABIL, V24, P141, DOI 10.1177/002221949102400302; Jerusalem A, 2014, BIOMECH MODEL MECHAN, V13, P883, DOI 10.1007/s10237-013-0543-7; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; KANDA R, 1981, Neurologia Medico-Chirurgica, V21, P645; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Lee M-C, 1987, 31 STAPP CAR CRASH C; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Magou GC, 2015, BRAIN RES, V1624, P525, DOI 10.1016/j.brainres.2015.07.056; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McElhaney J, 1971, 17 STAPP CAR CRASH C; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Merkle AC, 2012, PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE, PTS A AND B, P663; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Newman J A, 2000, Stapp Car Crash J, V44, P215; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Prescott SA, 2008, J NEUROPHYSIOL, V100, P3030, DOI 10.1152/jn.90634.2008; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Rickett T, 2011, J MED SYST, V35, P787, DOI 10.1007/s10916-010-9468-1; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sachse F. B., 1996, P 1 US C NAT LIB MED; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Singh A, 2009, J NEUROTRAUM, V26, P627, DOI 10.1089/neu.2008.0621; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Stalnaker RL, 1973, 17 STAPP CAR CRASH C; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STYS PK, 1992, J NEUROSCI, V12, P430; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Ursino M, 2006, J THEOR BIOL, V242, P171, DOI 10.1016/j.jtbi.2006.02.012; van der Knaap LJ, 2011, BEHAV BRAIN RES, V223, P211, DOI 10.1016/j.bbr.2011.04.018; Varentsova A, 2014, NEUROIMAGE, V91, P177, DOI 10.1016/j.neuroimage.2014.01.009; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Volman V, 2016, J NEUROPHYSIOL, V115, P1003, DOI 10.1152/jn.00912.2015; Volman V, 2014, J COMPUT NEUROSCI, V37, P439, DOI 10.1007/s10827-014-0515-7; Volman V, 2013, NEURAL COMPUT, V25, P2646, DOI 10.1162/NECO_a_00491; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; Wang XJ, 1996, J NEUROSCI, V16, P6402; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; WAXMAN SG, 1972, NATURE-NEW BIOL, V238, P217, DOI 10.1038/newbio238217a0; Weber B, 2005, J COGNITIVE NEUROSCI, V17, P113, DOI 10.1162/0898929052880002; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239	124	7	7	1	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 15	2017	8								269	10.3389/fneur.2017.00269			18	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EX6ZH	WOS:000403390500001	28663736	Green Published, gold			2022-02-06	
J	Baker, LM; Laidlaw, DH; Cabeen, R; Akbudak, E; Conturo, TE; Correia, S; Tate, DF; Heaps-Woodruff, JM; Brier, MR; Bolzenius, J; Salminen, LE; Lane, EM; McMichael, AR; Paul, RH				Baker, Laurie M.; Laidlaw, David H.; Cabeen, Ryan; Akbudak, Erbil; Conturo, Thomas E.; Correia, Stephen; Tate, David F.; Heaps-Woodruff, Jodi M.; Brier, Matthew R.; Bolzenius, Jacob; Salminen, Lauren E.; Lane, Elizabeth M.; McMichael, Amanda R.; Paul, Robert H.			Cognitive reserve moderates the relationship between neuropsychological performance and white matter fiber bundle length in healthy older adults	BRAIN IMAGING AND BEHAVIOR			English	Article						Cognition; Aging; Neuropsychological assessment; Diffusion tensor imaging; RBANS	TRAUMATIC BRAIN-INJURY; WATER DIFFUSION; NERVE-FIBERS; EDUCATION; AGE; TRACTOGRAPHY; INTEGRITY; MRI; TRACKING; DISEASE	Recent work using novel neuroimaging methods has revealed shorter white matter fiber bundle length (FBL) in older compared to younger adults. Shorter FBL also corresponds to poorer performance on cognitive measures sensitive to advanced age. However, it is unclear if individual factors such as cognitive reserve (CR) effectively moderate the relationship between FBL and cognitive performance. This study examined CR as a potential moderator of cognitive performance and brain integrity as defined by FBL. Sixty-three healthy adults underwent neuropsychological evaluation and 3T brain magnetic resonance imaging. Cognitive performance was measured using the Repeatable Battery of Assessment of Neuropsychological Status (RBANS). FBL was quantified from tractography tracings of white matter fiber bundles, derived from the diffusion tensor imaging. CR was determined by estimated premorbid IQ. Analyses revealed that lower scores on the RBANS were associated with shorter whole brain FBL (p = 0.04) and lower CR (p = 0.01) CR moderated the relationship between whole brain FBL and RBANS score (p < 0.01). Tract-specific analyses revealed that CR also moderated the association between FBL in the hippocampal segment of the cingulum and RBANS performance (p = 0.03). These results demonstrate that lower cognitive performance on the RBANS is more common with low CR and short FBL. On the contrary, when individuals have high CR, the relationship between FBL and cognitive performance is attenuated. Overall, CR protects older adults against lower cognitive performance despite age-associated reductions in FBL.	[Baker, Laurie M.; Salminen, Lauren E.; Paul, Robert H.] Univ Missouri, Dept Psychol Sci, One Univ Blvd,Stadler Hall 327, St Louis, MO 63121 USA; [Laidlaw, David H.; Cabeen, Ryan] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Akbudak, Erbil; Conturo, Thomas E.; McMichael, Amanda R.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Correia, Stephen] Brown Med Sch, Div Biol & Med, Providence, RI 02912 USA; [Tate, David F.; Heaps-Woodruff, Jodi M.; Bolzenius, Jacob; Paul, Robert H.] Missouri Inst Mental Hlth, St Louis, MO 63134 USA; [Brier, Matthew R.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Lane, Elizabeth M.] Vanderbilt Univ, Dept Neurol, Med Ctr, Nashville, TN 37232 USA		Baker, LM (corresponding author), Univ Missouri, Dept Psychol Sci, One Univ Blvd,Stadler Hall 327, St Louis, MO 63121 USA.	lauriebaker@umsl.edu	Tate, David F/I-3963-2013; Salminen, Lauren/T-1400-2019; Laidlaw, David/M-4686-2019; Woodruff, Jodi M./AAE-6728-2020	Tate, David F/0000-0003-0213-1920; Salminen, Lauren/0000-0002-0684-9991; Woodruff, Jodi M./0000-0002-9949-1334	National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS052470, R01 NS039538]; National Institutes of Health/National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH090494, R21MH105822]; National Institutes of Health/National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 TR000448]	Supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke grant number R01 NS052470 and R01 NS039538, National Institutes of Health/National Institute of Mental Health grant R21MH090494 and R21MH105822. Recruitment database searches were supported in part by National Institutes of Health/National Center for Research Resources grant UL1 TR000448.	Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; Arenaza-Urquijo EM, 2011, AM J GERIAT PSYCHIAT, V19, P33, DOI 10.1097/JGP.0b013e3181e448e1; Baek SO, 2013, NEUROREHABILITATION, V33, P465, DOI 10.3233/NRE-130979; Baker LM, 2014, NEUROLOGY, V83, P247, DOI 10.1212/WNL.0000000000000597; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrman-Lay A. M., 2014, BRAIN IMAGING BEHAV, P1; Bleecker ML, 2007, NEUROLOGY, V69, P470, DOI 10.1212/01.wnl.0000266628.43760.8c; Bolzenius JD, 2013, BRAIN IMAGING BEHAV, V7, P300, DOI 10.1007/s11682-013-9230-7; Booth T, 2013, NEUROPSYCHOLOGY, V27, P595, DOI 10.1037/a0033354; Brickman AM, 2011, NEUROBIOL AGING, V32, P1588, DOI 10.1016/j.neurobiolaging.2009.10.013; Chambers J. M., 1992, S ANAL VARIANCE DESI; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Conturo TE, 1996, MAGNET RESON MED, V35, P399, DOI 10.1002/mrm.1910350319; Correia S, 2008, NEUROIMAGE, V42, P568, DOI 10.1016/j.neuroimage.2008.05.022; Cremers LGM, 2016, NEUROBIOL AGING, V39, P108, DOI 10.1016/j.neurobiolaging.2015.11.021; Dufouil C, 2003, NEUROLOGY, V60, P831, DOI 10.1212/01.WNL.0000049456.33231.96; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; Foley JM, 2012, APPL NEUROPSYCH-ADUL, V19, P16, DOI 10.1080/09084282.2011.595601; Glutting J., 2005, WIDE RANGE ARCHIEVEM; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; HAJNAL JV, 1992, J COMPUT ASSIST TOMO, V16, P841, DOI 10.1097/00004728-199211000-00001; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jeong H, 2011, AM J NEURORADIOL, V32, P1893, DOI 10.3174/ajnr.A2683; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Lane EM, 2011, J INT NEUROPSYCH SOC, V17, P531, DOI 10.1017/S1355617711000324; Lori NF, 2002, NMR BIOMED, V15, P493, DOI 10.1002/nbm.779; Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2; Marner L, 2003, J COMP NEUROL, V462, P144, DOI 10.1002/cne.10714; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mortimer JA, 2003, J CLIN EXP NEUROPSYC, V25, P671, DOI 10.1076/jcen.25.5.671.14584; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Murray AD, 2011, BRAIN, V134, P3684, DOI 10.1093/brain/awr259; Nebes RD, 2006, AGING NEUROPSYCHOL C, V13, P326, DOI 10.1080/138255890969294; Peters A, 2002, J NEUROCYTOL, V31, P581, DOI 10.1023/A:1025731309829; Randolph C., 1998, REPEATABLE BATTERY A; Salat DH, 2005, ANN NY ACAD SCI, V1064, P37, DOI 10.1196/annals.1340.009; Salminen LE, 2013, BRAIN IMAGING BEHAV, V7, P274, DOI 10.1007/s11682-013-9225-4; Sanchez JL, 2002, NEUROPSY NEUROPSY BE, V15, P113, DOI 10.1097/01.WNN.0000016331.45409.7A; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Sawrie SM, 2000, EPILEPSY BEHAV, V1, P106, DOI 10.1006/ebeh.2000.0042; Schmidt R, 2011, ACTA NEUROPATHOL, V122, P171, DOI 10.1007/s00401-011-0851-x; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Stern RA, 1996, ARCH NEUROL-CHICAGO, V53, P148, DOI 10.1001/archneur.1996.00550020052015; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sun SW, 2005, MAGN RESON MED, V53, P1447, DOI 10.1002/mrm.20488; Tang Y, 1997, NEUROBIOL AGING, V18, P609, DOI 10.1016/S0197-4580(97)00155-3; VOINESKOS AN, 2012, NEUROBIOL AGING, V33, P21, DOI DOI 10.1016/j.neurobiolaging.2010.02.009; West S. G., 1991, MULTIPLE REGRESSION; Zhang S, 2003, IEEE T VIS COMPUT GR, V9, P454, DOI 10.1109/TVCG.2003.1260740	51	7	7	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2017	11	3					632	639		10.1007/s11682-016-9540-7			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EY0VE	WOS:000403676400003	26961092	Green Accepted			2022-02-06	
J	Beeckmans, K; Crunelle, C; Van Ingelgom, S; Michiels, K; Dierckx, E; Vancoillie, P; Hauman, H; Sabbe, B				Beeckmans, Kurt; Crunelle, Cleo; Van Ingelgom, Silke; Michiels, Karla; Dierckx, Eva; Vancoillie, Patrick; Hauman, Henri; Sabbe, Bernard			Persistent cognitive deficits after whiplash injury: a comparative study with mild traumatic brain injury patients and healthy volunteers	ACTA NEUROLOGICA BELGICA			English	Article						Whiplash injury; Mild traumatic brain injury; Attention; Memory	NEUROPSYCHOLOGICAL DEFICITS; SYMPTOMS; MRI; PERFORMANCE; DYSFUNCTION; IMPAIRMENT; CONCUSSION; COMPLAINTS; DISORDERS; LESIONS	In this study, we evaluated persistent cognitive deficits in whiplash injury (WI) patients and compared these to cognitive functioning in mild traumatic brain injury (MTBI) patients and healthy controls (HC). Sixty-one patients suffering from a WI were compared with 57 patients suffering from a MTBI and with 30 HC. They were examined with an extensive neuropsychological test battery assessing attention, memory, and visuospatial and executive functions. In both patient groups, participants showed persistent cognitive symptoms (more than 6 months post-injury). The two patient groups did not differ significantly with regard to measurements of attention, memory, and visuospatial and executive functions. The WI group, as compared to the HC group, was found to be significantly more deficient in speed of performance during sustained and divided attention, focused attention, alternating attention, the storage of new auditory-verbal unrelated information into memory, the long-term delayed recall of stored auditory-verbal related information from memory, abstract reasoning and accuracy of performance during planning and problem solving. No differences could be found between both groups concerning speed of information processing, visuospatial abilities and verbal fluency.	[Beeckmans, Kurt; Vancoillie, Patrick; Hauman, Henri] Ctr Epilepsy & Acquired Brain Injury CEPOS, Rooienberg 21, B-2570 Duffel, Belgium; [Beeckmans, Kurt] Free Univ Brussels, Dept Biol Psychol, Fac Psychol & Educ Sci, Pleinlaan 2, B-1050 Brussels, Belgium; [Crunelle, Cleo] Antwerp Univ, Toxicol Ctr, Univ Pl 1, B-2610 Antwerp, Belgium; [Crunelle, Cleo] Univ Hosp Brussels, Dept Psychiat, Laarbeeklaan 101, B-1090 Brussels, Belgium; [Van Ingelgom, Silke] Free Univ Brussels, Fac Psychol & Educ Sci, Pleinlaan 2, B-1050 Brussels, Belgium; [Michiels, Karla] Univ Hosp Louvain, Dept Phys Med & Rehabil, Weligerveld 1, B-3212 Pellenberg, Belgium; [Dierckx, Eva] Free Univ Brussels, Dept Clin & Lifespan Psychol, Fac Psychol & Educ Sci, Pleinlaan 2, B-1050 Brussels, Belgium; [Sabbe, Bernard] Antwerp Univ, Collaborat Antwerp Psychiat Res Inst, Univ Pl 1, B-2610 Antwerp, Belgium		Beeckmans, K (corresponding author), Ctr Epilepsy & Acquired Brain Injury CEPOS, Rooienberg 21, B-2570 Duffel, Belgium.; Beeckmans, K (corresponding author), Free Univ Brussels, Dept Biol Psychol, Fac Psychol & Educ Sci, Pleinlaan 2, B-1050 Brussels, Belgium.	kurt.beeckmans@emmaus.be	Crunelle, Cleo L/L-6649-2017	Crunelle, Cleo L/0000-0002-8798-0448; Dierckx, Eva/0000-0002-2839-4027			Alexander MP, 1998, NEUROLOGY, V51, P336, DOI 10.1212/WNL.51.2.336; Antepohl W, 2003, NEUROREHABILITATION, V18, P307; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blokhorst M, 2002, J CLIN EXP NEUROPSYC, V24, P471, DOI 10.1076/jcen.24.4.471.1042; Bosma FK, 2002, NEUROPSY NEUROPSY BE, V15, P56; Brickenkamp R, 2011, D 2 AANDACHTS CONCEN; CHAPUIS F, 1992, LABYRINTHTEST; Datta SGS, 2009, NEUROL INDIA, V57, P594, DOI 10.4103/0028-3886.57810; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gimse R, 1997, J CLIN EXP NEUROPSYC, V19, P838, DOI 10.1080/01688639708403764; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Hammes J., 1978, STROOP KLEUR WOORD T; Hanten G, 2013, J NEUROTRAUM, V30, P618, DOI 10.1089/neu.2012.2392; Holli KK, 2010, ACAD RADIOL, V17, P1096, DOI 10.1016/j.acra.2010.04.009; Hooper HE., 1983, HOOPER VISUAL ORG TE; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Jennett B, 1981, CONT NEUROLOGY SERIE; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Luteijn F, 2004, GRONINGER INTELLIGEN; Meeus M, 2015, CLIN RHEUMATOL, V34, P545, DOI 10.1007/s10067-013-2446-5; Meyers JE., 1995, REY COMPLEX FIGURE T; Miatton M, 2004, PSYCHOL BELG, V44, P189; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; NAS J, 1961, Ned Tijdschr Psychol, V16, P360; RADANOV BP, 1991, LANCET, V338, P712, DOI 10.1016/0140-6736(91)91441-V; Radanov BP, 1999, J NEUROL NEUROSUR PS, V66, P485, DOI 10.1136/jnnp.66.4.485; Radanov BP, 1996, SPINE, V21, P392, DOI 10.1097/00007632-199602010-00029; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1964, EXAMEN CLIN PSYCHOL; Robinson JP, 2007, ARCH PHYS MED REHAB, V88, P774, DOI 10.1016/j.apmr.2007.03.004; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; Smed A, 1997, ACTA NEUROL SCAND, V95, P73, DOI 10.1111/j.1600-0404.1997.tb00072.x; Sturzenegger M, 2008, ACTA NEUROL SCAND, V117, P49, DOI 10.1111/j.1600-0404.2007.00939.x; Taylor AE, 1996, ARCH PHYS MED REHAB, V77, P529, DOI 10.1016/S0003-9993(96)90290-7; [No title captured]	44	7	7	0	12	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	JUN	2017	117	2					493	500		10.1007/s13760-017-0745-3			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EV7EU	WOS:000401938600009	28102492				2022-02-06	
J	Bendella, H; Maegele, M; Hartmann, A; Spreer, J; Rommel, N; Lefering, R; Nakamura, M; Igressa, A				Bendella, Habib; Maegele, Marc; Hartmann, Alexander; Spreer, Joachim; Rommel, Nadine; Lefering, Rolf; Nakamura, Makoto; Igressa, Alhadi			Cerebral Ventricular Dimensions After Decompressive Craniectomy: A Comparison Between Bedside Sonographic Duplex Technique and Cranial Computed Tomography	NEUROCRITICAL CARE			English	Article						Brain trauma; Decompressive craniectomy; Cranial computed tomography; Sonographic duplex technique; Ventricle dimensions; Bedside examination	TRAUMATIC BRAIN-INJURY; REAL-TIME SONOGRAPHY; TEMPORAL BONE WINDOW; HEAD-INJURY; MALIGNANT INFARCTION; RADIATION-EXPOSURE; CT; STROKE; DESTINY; SURGERY	Background The objective of this study was to assess and compare ventricle diameters in patients after decompressive craniectomy by using cranial computed tomography (CCT) versus sonographic duplex technique (SDT). Methods A total of 102 consecutive patients after decompressive craniectomy following brain infarct, bleeding and trauma were examined by CCT and SDT. SDT was performed within 24 h after repeated postinterventional control CCT and the correlation between both methods was assessed via measurement of dimensions of all four ventricles. In addition, midline shifts and overall cerebral anatomy was evaluated. Results A high correlation was found between CCT and SDT in measuring the diameters of all four ventricles (right lateral r = 0.978, p < 0.001; left lateral r = 0.975, p < 0.001; third r = 0.987, p < 0.001 and fourth ventricle r = 0.954, p < 0.001). Deviations of midline structure was observed in SDT as well as in CCT (r = 0.992, p < 0.001). Conclusion SDT in patients after decompressive craniectomy may represent an additional bedside tool to assess the dimensions of the ventricular system, anatomical structures, e.g., subdural hygromas, hematomas, midline shifts, gyri and sulci. The measurement of the dimensions of all four ventricles by using SDT delivers accurate values and may be considered as an alternative to CCT or a trigger for CCT prior to further treatment.	[Bendella, Habib; Hartmann, Alexander; Nakamura, Makoto; Igressa, Alhadi] Univ Witten Herdecke, CMMC, Dept Neurosurg, Ostmerheimerstr 200, D-51109 Cologne, Germany; [Maegele, Marc] Univ Witten Herdecke, CMMC, Dept Traumatol Orthoped Surg & Sportsmed, Cologne, Germany; [Spreer, Joachim] Univ Witten Herdecke, CMMC, Div Neuroradiol, Dept Radiol, Cologne, Germany; [Hartmann, Alexander; Rommel, Nadine] RehaNova Rehabil Hosp, Cologne, Germany; [Maegele, Marc; Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany		Bendella, H (corresponding author), Univ Witten Herdecke, CMMC, Dept Neurosurg, Ostmerheimerstr 200, D-51109 Cologne, Germany.	Habib@Bendella.de					BECKER G, 1993, J ULTRAS MED, V12, P395; Becker G, 1993, J Neuroimaging, V3, P41; Caricato A, 2014, WORLD J RADIOL, V6, P636, DOI 10.4329/wjr.v6.i9.636; Caricato A, 2012, CRIT CARE MED, V40, P1745, DOI 10.1097/CCM.0b013e318246b6ea; Cohnen M, 2006, AM J NEURORADIOL, V27, P1741; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; GENTRY LR, 1994, RADIOLOGY, V191, P1; Hopper KD, 2001, AM J NEURORADIOL, V22, P1194; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Juttler E, 2011, INT J STROKE, V6, P79, DOI 10.1111/j.1747-4949.2010.00544.x; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kern R, 2005, ULTRASOUND MED BIOL, V31, P311, DOI 10.1016/j.ultrasmedbio.2004.12.006; Kobayashi S, 1989, Neurol Med Chir (Tokyo), V29, P740; KOO AH, 1977, RADIOLOGY, V123, P345, DOI 10.1148/123.2.345; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; OSTRUP R, 1983, NEUROSURGERY, V12, P225, DOI 10.1227/00006123-198302000-00018; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Postert T, 1997, ULTRASOUND MED BIOL, V23, P857, DOI 10.1016/S0301-5629(97)00047-1; QUATTROCCHI KB, 1991, SURG NEUROL, V35, P183, DOI 10.1016/0090-3019(91)90069-L; Scholz M, 2005, J ULTRAS MED, V24, P985, DOI 10.7863/jum.2005.24.7.985; Seidel G, 1995, J Neuroimaging, V5, P105; The British Medical Ultrasound Society, 2009, ULTRASOUND; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; van Velthoven V, 2003, ACT NEUR S, V85, P95; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wang J, 2012, RADIOLOGY, V262, P191, DOI 10.1148/radiol.11110470; Wijnhoud AD, 2008, ULTRASOUND MED BIOL, V34, P923, DOI 10.1016/j.ultrasmedbio.2007.11.022	31	7	7	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2017	26	3					321	329		10.1007/s12028-016-0359-2			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EV9JA	WOS:000402101100002	28054287				2022-02-06	
J	Callaway, L; Enticott, J; Farnworth, L; McDonald, R; Migliorini, C; Willer, B				Callaway, Libby; Enticott, Joanne; Farnworth, Louise; McDonald, Rachael; Migliorini, Christine; Willer, Barry			Community integration outcomes of people with spinal cord injury and multiple matched controls: A pilot study	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						community integration; outcome measurement; spinal cord injury	QUALITY-OF-LIFE; SOCIAL-PARTICIPATION; BRAIN-INJURY; QUESTIONNAIRE; INDIVIDUALS; AUSTRALIA; PREVALENCE; BARRIERS; HEALTH; CIQ	Background/aim: Australia's National Disability Insurance Scheme(NDIS) is designed to influence home, social and economic participation for Schemeparticipants. Given the major disability reform underway, this pilot study aimed to: (i) examine community integration outcomes of people with spinal cord injury (SCI); (ii) compare findings with multiple matched controls and (iii) consider findings within the context of Australia's NDIS. Methods: Setting: Victoria, Australia. Design: Matched analysis (people with and without SCI). Instrumentation: Community Integration Questionnaire (CIQ). Participants: n=40 adults with SCI (M age=52.8years; 61% male; 77% traumatic SCI). Analyses: Matched analyses from each SCI subject aged <70years (n=31) with four CIQ normative data subjects (from n=1927) was undertaken, with key demographic variables matched (age range, gender, living location and living situation). Risk of low CIQ score as a function of SCI was also examined using conditional Poisson regression. Results: With key demographic variables held constant, small to medium effect sizes were found in favour of the normative sample, with statistically significant differences in home (=0.003) and productivity integration (=0.02). Relative risk of low home integration was significant in the SCI cohort (conditional RR (95% CI)=3.1 (1.5-6.3), =0.001). Relative risk of low CIQ total, social integration and productivity scores did not reach significance. Conclusion: This cohort of SCI participants was less integrated into home and productive occupations than matched norms, holding implications for planning and allocation of supports to influence outcomes within an NDIS. Further research is necessary to understand community integration outcomes in larger matched samples.	[Callaway, Libby; Farnworth, Louise; Migliorini, Christine] Monash Univ, Occupat Therapy Dept, Frankston, Vic 3199, Australia; [Enticott, Joanne] Monash Univ, Southern Clin Sch, Dept Psychiat, Clayton, Vic, Australia; [Enticott, Joanne] Southern Synergy, Clayton, Vic, Australia; [McDonald, Rachael] Swinburne Univ Technol, Dept Hlth & Med Sci, Hawthorn, Vic, Australia; [Willer, Barry] State Univ Buffalo, Dept Psychiat, Buffalo, NY USA		Callaway, L (corresponding author), Monash Univ, Occupat Therapy Dept, Frankston, Vic 3199, Australia.	libby.callaway@monash.edu	enticott, joanne C/I-1587-2014	enticott, joanne C/0000-0002-4480-5690; McDonald, Rachael/0000-0002-9991-1255			Access Economics , 2009, EC COST SPIN CORD IN; Barclay L, 2016, AUST OCCUP THER J, V63, P19, DOI 10.1111/1440-1630.12241; Barclay L, 2015, INT J REHABIL RES, V38, P1, DOI 10.1097/MRR.0000000000000085; Boschen KA, 2003, INT J REHABIL RES, V26, P157, DOI 10.1097/00004356-200309000-00001; Brown M, 2002, TOPICS SPINAL CORD I, V7, P83, DOI DOI 10.1310/7U35-GDQ4-FDV3-GVYV; Callaway L., 2015, COMMUNITY INTEGRATIO; Callaway L., 2015, TRANSITION SUPPORTED; Callaway L, 2016, AUST OCCUP THER J, V63, P143, DOI 10.1111/1440-1630.12284; Callaway L, 2015, AUST OCCUP THER J, V62, P246, DOI 10.1111/1440-1630.12206; Carpenter C, 2007, ARCH PHYS MED REHAB, V88, P427, DOI 10.1016/j.apmr.2006.12.043; Cripps R. A., 2008, SPINAL CORD INJURY A, V48; Cummings P, 2004, STATA J, V4, P274, DOI 10.1177/1536867X0400400305; Department of Social Services, 2010, NAT DIS STRAT 2010 2; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Gontkovsky ST, 2009, NEUROREHABILITATION, V24, P185, DOI 10.3233/NRE-2009-0467; Jensen MP, 2005, SPINAL CORD, V43, P704, DOI 10.1038/sj.sc.3101777; Kratz AL, 2015, J SPINAL CORD MED, V38, P446, DOI 10.1179/2045772313Y.0000000182; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lund ML, 2005, J REHABIL MED, V37, P3, DOI 10.1080/16501970410031246; Lysack Cathy, 2007, Can J Occup Ther, V74 Spec No., P243; McVeigh SA, 2009, J SPINAL CORD MED, V32, P115, DOI 10.1080/10790268.2009.11760762; Migliorini C, 2016, BRAIN INJURY, V30, P1201, DOI 10.1080/02699052.2016.1175666; Migliorini C, 2013, J SPINAL CORD MED, V36, P660, DOI 10.1179/2045772313Y.0000000100; National Disability Insurance Agency, 2015, MAINSTR INT HLTH SUP; National Disability Insurance Scheme, 2016, REAS NEC SUPP; New PW, 2008, SPINAL CORD, V46, P406, DOI 10.1038/sj.sc.3102152; New PW, 2015, ARCH PHYS MED REHAB, V96, P76, DOI 10.1016/j.apmr.2014.08.013; Noreau L, 2000, DISABIL REHABIL, V22, P170; O'Connor PJ, 2005, SPINAL CORD, V43, P42, DOI 10.1038/sj.sc.3101666; Pang D, 1999, OCCUP ENVIRON MED, V56, P67, DOI 10.1136/oem.56.1.67; Pershouse KJ, 2012, ARCH PHYS MED REHAB, V93, P413, DOI 10.1016/j.apmr.2011.10.014; Price P, 2011, OTJR-OCCUP PART HEAL, V31, P81, DOI 10.3928/15394492-20100521-01; Productivity Commission, 2011, 54 PROD COMM COMM AU; Rigby AS, 2000, DISABIL REHABIL, V22, P259, DOI 10.1080/096382800296719; Russi MV, 2014, AUST OCCUP THER J, V61, P364, DOI 10.1111/1440-1630.12138; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Schopp LH, 2007, REHABIL PSYCHOL, V52, P82, DOI 10.1037/0090-5550.52.1.82; Stewart KE, 2016, CAN J OCCUP THER, V83, P249, DOI 10.1177/0008417415625425; Wheeler S., 2005, HUMAN DEV PERFORMANC, P264; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; World Health Organization, 2007, INT CLASS FUNCT DIS	42	7	7	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	JUN	2017	64	3					226	234		10.1111/1440-1630.12350			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	EY3PZ	WOS:000403886300004	28026011	Green Published			2022-02-06	
J	Castellani, RJ; Mojica-Sanchez, G; Schwartzbauer, G; Hersh, DS				Castellani, Rudy J.; Mojica-Sanchez, Gruschenka; Schwartzbauer, Gary; Hersh, David S.			Symptomatic Acute-on-Chronic Subdural Hematoma A Clinicopathological Study	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						acute-on-chronic subdural hematoma; neomembrane; Glasgow Coma Scale; burr hole; craniotomy; subdural drain	ABUSIVE HEAD TRAUMA; CLINICAL ARTICLE; HEMORRHAGE; RECURRENCE; PACHYMENINGITIS; NEOMEMBRANES; DETERIORATE; INJURIES; CHILDREN; INFANTS	The pathophysiology of acute-on-chronic subdural hematoma (ACSDH) is complex and incompletely understood. Evidence to date indicates that the overall process is initiated by rotational force with movement of the brain inside the skull, which exerts tensile strain and rupture of bridging veins, leading in turn to acute hemorrhage in the subdural potential space. This is followed by the proliferation of mesenchymal elements with angiogenesis and inflammation, which in turn becomes a substrate for repeated hemorrhage and expansion of the lesion. Given the prevalence of traumatic subdural processes in the forensic setting and the importance of proper assessment of timing, etiology, risk factors, and clinicopathological correlation, we studied 47 patients presenting to the University of Maryland Shock Trauma Center, all of whom underwent craniotomy with resection of the outer membrane due to symptomatic ACSDH. The surgically resected tissue was examined for histopathologic features in all cases. Our findings highlight that ACSDH is a condition precipitated by trauma that affects middle-aged and older adults, is relatively indolent, is unilateral or asymmetric, and has a low in-hospital mortality rate. Pathological analysis demonstrates a substantial outer membrane in all cases with varying degrees of inflammation and organization that cannot be precisely dated as a function of clinical presentation. The extrapolation of adult ACSDH to mixed acute and chronic subdural hemorrhage in the pediatric setting is problematic due to substantial differences in clinical presentation, severity of underlying brain injury, gross and microscopic findings, and outcome.	[Castellani, Rudy J.; Mojica-Sanchez, Gruschenka] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Castellani, Rudy J.] Western Michigan Univ, Homer Stryker MD Sch Med, Ctr Neuropathol, 300 Portage St, Kalamazoo, MI 49007 USA; [Schwartzbauer, Gary; Hersh, David S.] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA		Castellani, RJ (corresponding author), Western Michigan Univ, Homer Stryker MD Sch Med, Ctr Neuropathol, 300 Portage St, Kalamazoo, MI 49007 USA.	Rudolph.castellani@med.wmich.edu		Hersh, David/0000-0003-1177-2201			Bradford R, 2013, J NEUROSURG-PEDIATR, V12, P110, DOI 10.3171/2013.4.PEDS12596; Burhans CW, 1923, J AMER MED ASSOC, V80, P0604, DOI 10.1001/jama.1923.02640360012005; Caldarelli M, 2002, ACTA NEUROCHIR, V144, P581, DOI 10.1007/s00701-002-0947-0; Chen CY, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-97; Di Rocco F, 2006, ACTA NEUROCHIR, V148, P1097, DOI 10.1007/s00701-006-0861-y; Feldman KW, 2015, J NEUROSURG-PEDIATR, V16, P177, DOI 10.3171/2014.12.PEDS14607; Frati A, 2004, J NEUROSURG, V100, P24, DOI 10.3171/jns.2004.100.1.0024; FRIEDE RL, 1978, AM J PATHOL, V92, P69; FRIEDE RL, 1971, J NEUROL NEUROSUR PS, V34, P439, DOI 10.1136/jnnp.34.4.439; Funai M, 2011, J NEUROTRAUM, V28, P1127, DOI 10.1089/neu.2010.1498; Gandhoke GS, 2013, J CLIN NEUROSCI, V20, P1398, DOI 10.1016/j.jocn.2013.01.010; Hymel Kent P, 2002, Child Maltreat, V7, P329, DOI 10.1177/107755902237263; Kalamatianos T, 2013, J NEUROSURG, V118, P353, DOI 10.3171/2012.10.JNS12327; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; Pang CH, 2015, J NEUROSURG, V123, P65, DOI 10.3171/2014.12.JNS141189; POZZATI E, 1986, NEUROCHIRURGIA, V29, P61; Putnam TJ, 1925, ARCH SURG-CHICAGO, V11, P329, DOI 10.1001/archsurg.1925.01120150002001; Schuss P, 2013, J NEUROSURG, V118, P984, DOI 10.3171/2012.11.JNS121435; Suzuki M, 1998, ACTA NEUROCHIR, V140, P51, DOI 10.1007/s007010050057; Takahashi S, 2012, J STROKE CEREBROVASC, V21, P338, DOI 10.1016/j.jstrokecerebrovasdis.2009.12.011; Trotter W, 1914, BRIT J SURG, V2, P271, DOI 10.1002/bjs.1800020608; Weigel R, 2001, ACTA NEUROCHIR, V143, P811, DOI 10.1007/s007010170035; Weigel R, 2007, NEUROSURGERY, V61, P788, DOI 10.1227/01.NEU.0000298907.56012.E8; Wiglesworth J., 1892, BRAIN, V15, P431; Willman KY, 1997, CHILD ABUSE NEGLECT, V21, P929, DOI 10.1016/S0145-2134(97)00054-9	27	7	7	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	JUN	2017	38	2					126	130		10.1097/PAF.0000000000000300			5	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	EU7CR	WOS:000401192900009	28319470				2022-02-06	
